PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Matei, E; Zheng, A; Furey, W; Rose, J; Aiken, C; Gronenborn, AM				Matei, Elena; Zheng, Andrew; Furey, William; Rose, Jeremy; Aiken, Christopher; Gronenborn, Angela M.			Anti-HIV Activity of Defective Cyanovirin-N Mutants Is Restored by Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENVELOPE GLYCOPROTEIN GP120; DOMAIN-SWAPPED DIMER; INACTIVATING PROTEIN; ANTIVIRAL ACTIVITY; BINDING-SITE; CONTAINS 2; X-RAY; NMR; 2G12	Cyanovirin-N (CV-N) is a two-domain, cyanobacterial protein that inhibits human immunodeficiency virus (HIV) at nano-molar concentrations by binding to high mannose sugars on the HIV envelope glycoprotein gp120. The wild type protein can exist as a monomer or a domain-swapped dimer with the monomer and dimer containing two or four sugar binding sites, respectively, one on each domain. Here we demonstrate that monomeric, single binding site mutants are completely inactive and that a single site, whether located on domain A or B, is insufficient to impart the antiviral activity. Linking inactive, monomeric proteins in a head-to-head fashion by an intermolecular disulfide bond or by creating an exclusively domain-swapped dimer via a hinge residue deletion restored antiviral activity to levels similar to that of wild type CV-N. These findings demonstrate unequivocally that multisite binding by CV-N type lectins is necessary for viral inhibition.	[Gronenborn, Angela M.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA; [Zheng, Andrew] Duke Univ, Dept Chem, Durham, NC 27708 USA; [Rose, Jeremy; Aiken, Christopher] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Vanderbilt University	Gronenborn, AM (corresponding author), Univ Pittsburgh, Sch Med, Dept Biol Struct, 3501 5th Ave,BST3-Rm 1050, Pittsburgh, PA 15260 USA.	amg100@pitt.edu	Matei, Elena/AAP-8706-2020; Aiken, Christopher/Y-9252-2019; matei, elena/HHC-6815-2022	Gronenborn, Angela M/0000-0001-9072-3525; Matei, Elena/0000-0002-1625-2814	National Institutes of Health [RO1GM080642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080642] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM080642 (to A. M. G.).	Barrientos LG, 2006, PROTEIN ENG DES SEL, V19, P525, DOI 10.1093/protein/gzl040; Barrientos LG, 2004, J INFECT DIS, V189, P1440, DOI 10.1086/382658; Barrientos LG, 2002, STRUCTURE, V10, P673, DOI 10.1016/S0969-2126(02)00758-X; Barrientos LG, 2005, MINI-REV MED CHEM, V5, P21, DOI 10.2174/1389557053402783; Barrientos LG, 2002, BIOCHEM BIOPH RES CO, V298, P598, DOI 10.1016/S0006-291X(02)02489-0; Bewley CA, 1998, NAT STRUCT BIOL, V5, P571, DOI 10.1038/828; Bewley CA, 2001, J AM CHEM SOC, V123, P3892, DOI 10.1021/ja004040e; Bolmstedt AJ, 2001, MOL PHARMACOL, V59, P949, DOI 10.1124/mol.59.5.949; Botos I, 2002, BIOCHEM BIOPH RES CO, V294, P184, DOI 10.1016/S0006-291X(02)00455-2; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chang LC, 2002, J MOL BIOL, V318, P1, DOI 10.1016/S0022-2836(02)00045-1; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esser MT, 1999, J VIROL, V73, P4360, DOI 10.1128/JVI.73.5.4360-4371.1999; FESIK SW, 1990, Q REV BIOPHYS, V23, P97, DOI 10.1017/S0033583500005515; Fromme R, 2007, BIOCHEMISTRY-US, V46, P9199, DOI 10.1021/bi700666m; Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389; GRZESIEK S, 1993, J BIOMOL NMR, V3, P487; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kiessling L.L., 2008, GLYCOSCIENCE, P2483, DOI 10.1007/978-3-540-30429-6_64; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Matei E, 2008, STRUCTURE, V16, P1183, DOI 10.1016/j.str.2008.05.011; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; O'Keefe BR, 2003, ANTIMICROB AGENTS CH, V47, P2518, DOI 10.1128/AAC.47.8.2518-2525.2003; PATTERSON GML, 1993, J PHYCOL, V29, P125, DOI 10.1111/j.1529-8817.1993.tb00290.x; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Shenoy SR, 2002, CHEM BIOL, V9, P1109, DOI 10.1016/S1074-5521(02)00237-5; Shenoy SR, 2001, J PHARMACOL EXP THER, V297, P704; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Yang F, 1999, J MOL BIOL, V288, P403, DOI 10.1006/jmbi.1999.2693; Yang RF, 2007, J VIROL, V81, P3749, DOI 10.1128/JVI.02634-06	41	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13057	13065		10.1074/jbc.M109.094938	http://dx.doi.org/10.1074/jbc.M109.094938			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20147291	Green Published, hybrid			2022-12-27	WOS:000276787800063
J	Ba, XQ; Gupta, S; Davidson, M; Garg, NJ				Ba, Xueqing; Gupta, Shivali; Davidson, Mercy; Garg, Nisha Jain			Trypanosoma cruzi Induces the Reactive Oxygen Species-PARP-1-RelA Pathway for Up-regulation of Cytokine Expression in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; POLY(ADP-RIBOSE) POLYMERASE-1; CHAGASIC CARDIOMYOPATHY; OXIDATIVE STRESS; DNA-BINDING; IFN-GAMMA; INFECTION; PARP-1; ALPHA	In this study, we demonstrate that human cardiomyocytes (AC16) produce reactive oxygen species (ROS) and inflammatory cytokines in response to Trypanosoma cruzi. ROS were primarily produced by mitochondria, some of which diffused to cytosol of infected cardiomyocytes. These ROS resulted in an increase in 8-hydroxyguanine lesions and DNA fragmentation that signaled PARP-1 activation evidenced by poly(ADP-ribose) ( PAR) modification of PARP-1 and other proteins in infected cardiomyocytes. Phenyl-alpha-tert-butylnitrone blocked the mitochondrial ROS (mtROS) formation, DNA damage, and PARP-1 activation in infected cardiomyocytes. Further inhibition studies demonstrated that ROS and PARP-1 signaled TNF-alpha and IL-1 beta expression in infected cardiomyocytes. ROS directly signaled the nuclear translocation of RelA (p65), NF-kappa B activation, and cytokine gene expression. PARP-1 exhibited no direct interaction with p65 and did not signal its translocation to nuclei in infected cardiomyocytes. Instead, PARP-1 contributed to PAR modification of p65-interacting nuclear proteins and assembly of the NF-kappa B transcription complex. PJ34 (PARP-1 inhibitor) also prevented mitochondrial poly(ADP-ribosyl)ation (PARylation) and ROS formation. We conclude that T. cruzimediated mtROS provide primary stimulus for PARP-1-NF-kappa B activation and cytokine gene expression in infected cardiomyocytes. PAR modification of mitochondrial membranes then results in a feedback cycle of mtROS formation and DNA damage/PARP-1 activation. ROS, either through direct modulation of cytosolic NF-kappa B, or via PARP-1-dependent PAR modification of p65-interacting nuclear proteins, contributes to cytokine gene expression. Our results demonstrate a link between ROS and inflammatory responses in cardiomyocytes infected by T. cruzi and provide a clue to the pathomechanism of sustained inflammation in Chagas disease.	[Ba, Xueqing; Gupta, Shivali; Garg, Nisha Jain] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA; [Garg, Nisha Jain] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA; [Davidson, Mercy] Columbia Univ, Dept Neurol, New York, NY 10032 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Columbia University	Garg, NJ (corresponding author), Univ Texas Med Branch, Dept Microbiol & Immunol, 3-142C Med Res Bldg,301 Univ Blvd, Galveston, TX 77555 USA.	nigarg@utmb.edu		Ba, Xueqing/0000-0002-1075-5496	National Institutes of Health [RO1-HL094802]; NHLBI; NIAID [RO1-AI054578]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054578] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL094802 from NHLBI and RO1-AI054578 from NIAID (to N. J. G.).	Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; de Oliveira TB, 2007, INT J CARDIOL, V116, P357, DOI 10.1016/j.ijcard.2006.04.046; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Boulares AH, 2003, AM J RESP CELL MOL, V28, P322, DOI 10.1165/rcmb.2001-0015OC; Cardoni RL, 1999, MEDICINA-BUENOS AIRE, V59, P84; CARDONI RL, 1990, CELL IMMUNOL, V128, P11, DOI 10.1016/0008-8749(90)90002-9; Cardoni RL, 1997, AM J TROP MED HYG, V56, P329, DOI 10.4269/ajtmh.1997.56.329; Chandrasekar B, 1998, AM J PATHOL, V152, P925; Chang WJ, 2001, J BIOL CHEM, V276, P47664, DOI 10.1074/jbc.M104666200; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; Druzhyna N, 2000, DIABETES, V49, P1849, DOI 10.2337/diabetes.49.11.1849; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; DYER RB, 1995, BIOTECHNIQUES, V19, P192; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Genova ML, 2004, ANN NY ACAD SCI, V1011, P86, DOI 10.1196/annals.1293.010; Gupta S., 2009, INTERDISCIP PERSPECT, V2009, P1, DOI [DOI 10.1155/2009/190354, 10.1155/2009/190354]; Gupta S, 2009, FREE RADICAL BIO MED, V47, P1414, DOI 10.1016/j.freeradbiomed.2009.08.008; Hassa PO, 1999, BIOL CHEM, V380, P953, DOI 10.1515/BC.1999.118; Hassa PO, 2001, J BIOL CHEM, V276, P45588, DOI 10.1074/jbc.M106528200; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Liaudet L, 2002, AM J RESP CRIT CARE, V165, P372, DOI 10.1164/ajrccm.165.3.2106050; Lima ECS, 1997, INFECT IMMUN, V65, P457, DOI 10.1128/IAI.65.2.457-465.1997; Mabley JG, 2001, INFLAMM RES, V50, P561, DOI 10.1007/PL00000234; Machado FS, 2008, MICROBES INFECT, V10, P1558, DOI 10.1016/j.micinf.2008.09.009; Machado FS, 2000, CIRCULATION, V102, P3003, DOI 10.1161/01.CIR.102.24.3003; MUNOZFERNANDEZ MA, 1992, IMMUNOL LETT, V33, P35, DOI 10.1016/0165-2478(92)90090-B; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Pankotai E, 2009, MITOCHONDRION, V9, P159, DOI 10.1016/j.mito.2009.01.013; Perez-Fuentes R, 2003, INT J PARASITOL, V33, P293, DOI 10.1016/S0020-7519(02)00283-7; ROSSI MA, 2003, FRONT BIOSCI, V8, P94; Saklatvala J, 2003, BIOCHEM SOC SYMP, V70, P95, DOI 10.1042/bss0700095; Sheeran FL, 2006, BBA-BIOENERGETICS, V1757, P543, DOI 10.1016/j.bbabio.2006.03.008; Talvani A, 2000, MICROBES INFECT, V2, P851, DOI 10.1016/S1286-4579(00)00388-9; Talvani A, 2004, CLIN INFECT DIS, V38, P943, DOI 10.1086/381892; Tanowitz HB, 2009, PROG CARDIOVASC DIS, V51, P524, DOI 10.1016/j.pcad.2009.02.001; Wen JJ, 2006, AM J PATHOL, V169, P1953, DOI 10.2353/ajpath.2006.060475; Wen JJ, 2006, FREE RADICAL BIO MED, V41, P270, DOI 10.1016/j.freeradbiomed.2006.04.009; Wen JJ, 2010, ANTIOXID REDOX SIGN, V12, P27, DOI [10.1089/ars.2008.2418, 10.1089/ARS.2008.2418]; Wen JJ, 2008, J BIOENERG BIOMEMBR, V40, P587, DOI 10.1007/s10863-008-9184-4; Wen JJ, 2004, FREE RADICAL BIO MED, V37, P1821, DOI 10.1016/j.freeradbiomed.2004.08.018; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; World Health Organization (WHO), 2006, REP SCI WORK GROUP C; Zacks MA, 2005, AN ACAD BRAS CIENC, V77, P695, DOI 10.1590/S0001-37652005000400009	44	97	100	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11596	11606		10.1074/jbc.M109.076984	http://dx.doi.org/10.1074/jbc.M109.076984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145242	hybrid, Green Published			2022-12-27	WOS:000276286200065
J	Hilton, T; Gross, MK; Kioussi, C				Hilton, Traci; Gross, Michael K.; Kioussi, Chrissa			Pitx2-dependent Occupancy by Histone Deacetylases Is Associated with T-box Gene Regulation in Mammalian Abdominal Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VENTRAL BODY-WALL; TRANSCRIPTION FACTOR; HEART DEVELOPMENT; BETA-CATENIN; TOOTH MORPHOGENESIS; PATTERN-FORMATION; RIEGER-SYNDROME; EXPRESSION; PITX2; TBX5	The homeodomain transcription factor Pitx2 and the T-box transcription factors are essential for organogenesis. Pitx2 and T-box genes are induced by growth factors and function as transcriptional activators or repressors. Gene expression analyses on abdominal tissue were used to identify seven of the T-box genes of the genome as Pitx2 target genes in the abdomen at embryonic day. 10.5. Pitx2 activated Tbx4, Tbx15, and Mga and repressed Tbx1, Tbx2, Tbx5, and Tbx6 expression. As expected, activated genes showed reduced expression patterns, and repressed T-box genes showed increased expression patterns in the abdomen of Pitx2 mutants. Pitx2 occupied chromatin sites near all of these T-box genes. Co-occupancy by coactivators, corepressors, and histone acetylation at these sites was frequently Pitx2-dependent. Genes repressed by Pitx2 generally showed increased histone acetylation and decreased histone deacetylase (HDAC)/corepressor occupancy in Pitx2 mutants. The lower N-CoR, HDAC1, and HDAC3 occupancy observed at multiple sites along Tbx1 chromatin in mutants is consistent with the model that increased histone acetylation and gene expression of Tbx1 may result from a loss of recruitment of corepressors by Pitx2. Genes activated by Pitx2 showed less consistent patterns in chromatin analyses. Reduced H4 acetylation and increased HDAC1/nuclear receptor corepressor (N-CoR) occupancy at some Tbx4 sites were accompanied by increased H3 acetylation and reduced HDAC3 occupancy at the same or other more distal chromatin sites in mutants. Pitx2-dependent occupancy by corepressors resulted in alteration of the acetylation levels of several T-box genes, whereas Pitx2-dependent occupancy by coactivators was more site-localized. These studies will provide the basic scientific underpinning to understand abdominal wall syndromes.	[Hilton, Traci; Gross, Michael K.; Kioussi, Chrissa] Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	Oregon State University	Gross, MK (corresponding author), Oregon State Univ, Coll Pharm, Dept Pharmaceut Sci, Corvallis, OR 97331 USA.	grossm@onid.orst.edu; chrissa.kioussi@oregonstate.edu		Kioussi, Chrissa/0000-0001-8226-9908	National Institutes of Health [AR054406]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054406] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR054406 (to C. K.).	Agarwal P, 2003, DEVELOPMENT, V130, P623, DOI 10.1242/dev.00191; Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1999, MOL CELL BIOL, V19, P7001; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Arce L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-159; Arnold JS, 2006, DEVELOPMENT, V133, P977, DOI 10.1242/dev.02264; Behesti H, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-62; Brewer S, 2004, BIOESSAYS, V26, P1307, DOI 10.1002/bies.20137; Brewer S, 2004, DEV BIOL, V267, P399, DOI 10.1016/j.ydbio.2003.11.021; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Candille SI, 2004, PLOS BIOL, V2, P30, DOI 10.1371/journal.pbio.0020003; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Choi M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000395; DeLaurier A, 2006, DEV BIOL, V299, P22, DOI 10.1016/j.ydbio.2006.06.055; Edelstein LC, 2003, MOL CELL BIOL, V23, P2749, DOI 10.1128/MCB.23.8.2749-2761.2003; Gage PJ, 1999, DEVELOPMENT, V126, P4643; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ge XJ, 2009, MOL BIOL CELL, V20, P419, DOI 10.1091/mbc.E08-08-0792; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Hurlin PJ, 1999, EMBO J, V18, P7019, DOI 10.1093/emboj/18.24.7019; Jepsen K, 2002, J CELL SCI, V115, P689; Jerome LA, 2001, NAT GENET, V27, P286, DOI 10.1038/85845; Jones PL, 2003, CURR TOP MICROBIOL, V274, P237; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kimelman D, 2000, CURR OPIN GENET DEV, V10, P350, DOI 10.1016/S0959-437X(00)00095-2; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kioussi C, 2006, P NATL ACAD SCI USA, V103, P18621, DOI 10.1073/pnas.0609055103; Kioussi C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002179; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus F, 2001, MECH DEVELOP, V100, P87, DOI 10.1016/S0925-4773(00)00499-8; Krause A, 2004, DEV BIOL, V273, P106, DOI 10.1016/j.ydbio.2004.05.024; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Liu JX, 2001, P NATL ACAD SCI USA, V98, P8674, DOI 10.1073/pnas.141234898; Lu MF, 1999, NATURE, V401, P276, DOI 10.1038/45797; Maira M, 2003, J BIOL CHEM, V278, P46523, DOI 10.1074/jbc.M305626200; MENGUS G, 1995, EMBO J, V14, P1520, DOI 10.1002/j.1460-2075.1995.tb07138.x; Mitsiadis TA, 2008, DEV BIOL, V320, P39, DOI 10.1016/j.ydbio.2008.04.006; Naiche LA, 2007, DEVELOPMENT, V134, P93, DOI 10.1242/dev.02712; Naiche LA, 2005, ANNU REV GENET, V39, P219, DOI 10.1146/annurev.genet.39.073003.105925; Naiche LA, 2003, DEVELOPMENT, V130, P2681, DOI 10.1242/dev.00504; OREILLY MAJ, 1995, DEVELOPMENT, V121, P1351; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Shih HP, 2007, P NATL ACAD SCI USA, V104, P5907, DOI 10.1073/pnas.0701122104; Shih HP, 2007, GENE EXPR PATTERNS, V7, P441, DOI 10.1016/j.modgep.2006.11.004; Shima Y, 2008, MOL ENDOCRINOL, V22, P1633, DOI 10.1210/me.2007-0444; Singh MK, 2005, MECH DEVELOP, V122, P131, DOI 10.1016/j.mod.2004.10.011; Singh R, 2009, CIRC RES, V105, P442, DOI 10.1161/CIRCRESAHA.109.196063; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Tada M, 2001, DEV GROWTH DIFFER, V43, P1; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Wang GS, 2004, NEURON, V42, P113, DOI 10.1016/S0896-6273(04)00139-4; Wardle FC, 2006, SEMIN CELL DEV BIOL, V17, P99, DOI 10.1016/j.semcdb.2005.11.008; Wardle FC, 2008, CURR OPIN GENET DEV, V18, P418, DOI 10.1016/j.gde.2008.07.017; White JA, 2008, J EXP ZOOL PART B, V310B, P73, DOI 10.1002/jez.b.21153; Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886; Wiper-Bergeron N, 2003, EMBO J, V22, P2135, DOI 10.1093/emboj/cdg218; Yang Y, 2007, J MOL BIOL, V369, P917, DOI 10.1016/j.jmb.2007.04.004	64	19	20	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11129	11142		10.1074/jbc.M109.087429	http://dx.doi.org/10.1074/jbc.M109.087429			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20129917	hybrid, Green Published			2022-12-27	WOS:000276286200018
J	Manna, SK; Babajan, B; Raghavendra, PB; Raviprakash, N; Sureshkumar, C				Manna, Sunil K.; Babajan, Banaganapalli; Raghavendra, Pongali B.; Raviprakash, Nune; Sureshkumar, Chitta			Inhibiting TRAF2-mediated Activation of NF-kappa B Facilitates Induction of AP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; POTENTIATES APOPTOSIS; RELA PHOSPHORYLATION; PROTEIN; MECHANISM; CELLS; TRADD-TRAF2; PROGRESSION; EXPRESSION; ANTITUMOR	The compound 5-(4-methoxyarylimino)-2-N-(3,4-dichlorophenyl)3-oxo-1,2,4-thiadiazolidine (P-3-25) is known to possess anti-bacterial, anti-fungal, and anti-tubercular activities. In this report, we provide evidence that P-3-25 inhibits NF-kappa B, known to induce inflammatory and tumorigenic responses. It activates AP-1, another transcription factor. It inhibits TRAF2-mediated NF-kappa B activation but not TRAF6-mediated NF-kappa B DNA binding by preventing its association with TANK ( TRAF for NF-kappa B). It facilitates binding of MEKK1 with TRAF2 and thereby activates JNK and AP-1. We provide evidence, for the first time, that suggests that the interaction of P3-25 with TRAF2 leads to inhibition of the NF-kappa B pathway and activation of AP-1 pathway. These results suggest novel approaches to design of P3-25 as an anti-cancer/inflammatory drug for therapy through regulation of the TRAF2 pathway.	[Manna, Sunil K.; Raghavendra, Pongali B.; Raviprakash, Nune] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India; [Babajan, Banaganapalli; Raghavendra, Pongali B.; Sureshkumar, Chitta] Sri Krishnadevaraya Univ, Dept Biochem, Anantapur 515003, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Sri Krishnadevaraya University	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India.	manna@cdfd.org.in	Banaganapalli, Babajan/A-6282-2013	Banaganapalli, Babajan/0000-0001-8089-2210	Department of Biotechnology, Government of India; University Grants Commission, India; Council for Scientific and Industrial Research, New Delhi	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); University Grants Commission, India(University Grants Commission, India); Council for Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Government of India. This work was also supported by a University Grants Commission, India, Major Research Project (to B. B.) and a Council for Scientific and Industrial Research, New Delhi, Senior Research Fellowship (to P. B. R.).	Baeuerle PA, 1997, ADV IMMUNOL, V65, P111, DOI 10.1016/S0065-2776(08)60742-7; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BERNSTEIN FC, 1977, J MOL BIOL, V112, P542; Binkowski TA, 2003, NUCLEIC ACIDS RES, V31, P3352, DOI 10.1093/nar/gkg512; Chadee DN, 2002, MOL CELL BIOL, V22, P737, DOI 10.1128/MCB.22.3.737-749.2002; Chin AID, 1999, MOL CELL BIOL, V19, P6665; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Duffey DC, 1999, CANCER RES, V59, P3468; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kim JW, 2001, J BIOL CHEM, V276, P27064, DOI 10.1074/jbc.M009364200; Kriehuber E, 2005, BLOOD, V106, P175, DOI 10.1182/blood-2004-08-3072; Manna P, 2005, INT J CANCER, V113, P549, DOI 10.1002/ijc.20590; Manna P, 2004, INDIAN J HETEROCY CH, V13, P249; Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Manna SK, 2005, J BIOL CHEM, V280, P7010, DOI 10.1074/jbc.M410994200; Manna SK, 1999, J IMMUNOL, V162, P1510; Manna SK, 2009, MOL IMMUNOL, V46, P1340, DOI 10.1016/j.molimm.2008.11.014; McWhirter SM, 1999, P NATL ACAD SCI USA, V96, P8408, DOI 10.1073/pnas.96.15.8408; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Pedretti A, 2002, J MOL GRAPH MODEL, V21, P47, DOI 10.1016/S1093-3263(02)00123-7; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Sarkar A, 2004, J BIOL CHEM, V279, P33768, DOI 10.1074/jbc.M403424200; Shaulian E, 2001, ONCOGENE, V20, P2390, DOI 10.1038/sj.onc.1204383; Sreenivasan Y, 2003, ONCOGENE, V22, P4356, DOI 10.1038/sj.onc.1206486; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Wisdom R, 1999, EMBO J, V18, P188, DOI 10.1093/emboj/18.1.188	33	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11617	11627		10.1074/jbc.M109.094961	http://dx.doi.org/10.1074/jbc.M109.094961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20133937	Green Published, hybrid			2022-12-27	WOS:000276286200067
J	Sun, XL; Jones, WT; Harvey, D; Edwards, PJB; Pascal, SM; Kirk, C; Considine, T; Sheerin, DJ; Rakonjac, J; Oldfield, CJ; Xue, B; Dunker, AK; Uversky, VN				Sun, Xiaolin; Jones, William T.; Harvey, Dawn; Edwards, Patrick J. B.; Pascal, Steven M.; Kirk, Christopher; Considine, Therese; Sheerin, David J.; Rakonjac, Jasna; Oldfield, Christopher J.; Xue, Bin; Dunker, A. Keith; Uversky, Vladimir N.			N-terminal Domains of DELLA Proteins Are Intrinsically Unstructured in the Absence of Interaction with GID1/Gibberellic Acid Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR RECOGNITION FEATURES; NATIVELY UNFOLDED PROTEINS; LONG DISORDERED REGIONS; FUNCTIONAL ANTHOLOGY; FLORAL DEVELOPMENT; GIBBERELLIN RESPONSES; SECONDARY STRUCTURE; SEED-GERMINATION; ARABIDOPSIS; BINDING	The plant growth-repressing DELLA proteins (DELLAs) are known to represent a convergence point in integration of multiple developmental and environmental signals in planta, one of which is hormone gibberellic acid (GA). Binding of the liganded GA receptor (GID1/GA) to the N-terminal domain of DELLAs is required for GA-induced degradation of DELLAs via the ubiquitin-proteasome pathway, thus derepressing plant growth. However, the conformational changes of DELLAs upon binding to GID1/GA, which are the key to understanding the precise mechanism of GID1/GA-mediated degradation of DELLAs, remain unclear. Using biophysical, biochemical, and bioinformatics approaches, we demonstrated for the first time that the unbound N-terminal domains of DELLAs are intrinsically unstructured proteins under physiological conditions. Within the intrinsically disordered N-terminal domain of DELLAs, we have identified several molecular recognition features, sequences known to undergo disorder-to-order transitions upon binding to interacting proteins in intrinsically unstructured proteins. In accordance with the molecular recognition feature analyses, we have observed the binding-induced folding of N-terminal domains of DELLAs upon interaction with AtGID1/GA. Our results also indicate that DELLA proteins can be divided into two subgroups in terms of their molecular compactness and their interactions with monoclonal antibodies.	[Sun, Xiaolin; Jones, William T.; Harvey, Dawn; Kirk, Christopher] New Zealand Inst Plant & Food Res, Palmerston North, New Zealand; [Edwards, Patrick J. B.; Pascal, Steven M.] Massey Univ, Struct Biol Ctr, Inst Fundamental Sci, Palmerston North, New Zealand; [Kirk, Christopher; Sheerin, David J.; Rakonjac, Jasna] Massey Univ, Inst Mol Biosci, Palmerston North, New Zealand; [Considine, Therese] Fonterra Res Ctr, Palmerston North, New Zealand; [Oldfield, Christopher J.; Xue, Bin; Dunker, A. Keith; Uversky, Vladimir N.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Pushchino 142290, Moscow Region, Russia	New Zealand Institute for Plant & Food Research Ltd; Massey University; Massey University; Fonterra; Indiana University System; Indiana University-Purdue University Indianapolis; Russian Academy of Sciences	Sun, XL (corresponding author), New Zealand Inst Plant & Food Res, Private Bag 11 030, Palmerston North, New Zealand.	Xiaolin.Sun@plantandfood.co.nz; William.Jones@plantandfood.co.nz	Harvey, Dawn/R-2697-2016; Edwards, P/E-2804-2018; xue, bin/E-5617-2011; Uversky, Vladimir N./F-4515-2011; Rakonjac, Jasna V/E-6836-2011; Sun, Xiaolin/P-4882-2016; Pascal, Steven/AAP-5684-2021	Harvey, Dawn/0000-0001-7457-9703; Edwards, P/0000-0003-3776-7582; xue, bin/0000-0002-6344-0623; Uversky, Vladimir N./0000-0002-4037-5857; Rakonjac, Jasna V/0000-0002-6756-4682; Sun, Xiaolin/0000-0001-7538-1301; 	National Institutes of Health [R01 LM007688-01A1, GM071714-01A2]; New Zealand Foundation for Research, Science, and Technology [C06X0207]; Russian Academy of Sciences for "Molecular and Cellular Biology"; Indiana University Purdue University Indianapolis Signature Centers Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071714] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Zealand Foundation for Research, Science, and Technology(New Zealand Foundation for Research, Science and Technology); Russian Academy of Sciences for "Molecular and Cellular Biology"; Indiana University Purdue University Indianapolis Signature Centers Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 LM007688-01A1 and GM071714-01A2. This work was also supported by New Zealand Foundation for Research, Science, and Technology Grant C06X0207 and the Program of the Russian Academy of Sciences for "Molecular and Cellular Biology." This work was also supported by the Indiana University Purdue University Indianapolis Signature Centers Initiative.	Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Allen NPC, 2002, MOL CELL PROTEOMICS, V1, P930, DOI 10.1074/mcp.T200012-MCP200; BARROW CJ, 1992, J MOL BIOL, V225, P1075, DOI 10.1016/0022-2836(92)90106-T; Cao DN, 2006, PLANT PHYSIOL, V142, P509, DOI 10.1104/pp.106.082289; Chen AA, 2007, J PHYS CHEM B, V111, P11884, DOI 10.1021/jp0765392; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Crick SL, 2006, P NATL ACAD SCI USA, V103, P16764, DOI 10.1073/pnas.0608175103; de Lucas M, 2008, NATURE, V451, P480, DOI 10.1038/nature06520; Deane CM, 2002, MOL CELL PROTEOMICS, V1, P349, DOI 10.1074/mcp.M100037-MCP200; Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Feng SH, 2008, NATURE, V451, P475, DOI 10.1038/nature06448; Fu XD, 2002, PLANT CELL, V14, P3191, DOI 10.1105/tpc.006197; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Griffiths J, 2006, PLANT CELL, V18, P3399, DOI 10.1105/tpc.106.047415; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; Hou XL, 2008, PLANT PHYSIOL, V147, P1126, DOI 10.1104/pp.108.121301; Hua QX, 1998, BIOCHEMISTRY-US, V37, P5858, DOI 10.1021/bi9800808; Hussain A, 2005, PLANT J, V44, P88, DOI 10.1111/j.1365-313X.2005.02512.x; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; KOORNNEEF M, 1980, THEOR APPL GENET, V58, P257, DOI 10.1007/BF00265176; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; McGinnis KM, 2003, PLANT CELL, V15, P1120, DOI 10.1105/tpc.010827; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nakajima M, 2006, PLANT J, V46, P880, DOI 10.1111/j.1365-313X.2006.02748.x; Navarro L, 2008, CURR BIOL, V18, P650, DOI 10.1016/j.cub.2008.03.060; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schlessinger A, 2007, PLOS COMPUT BIOL, V3, P1335, DOI 10.1371/journal.pcbi.0030140; Schwechheimer C, 2008, CURR OPIN PLANT BIOL, V11, P9, DOI 10.1016/j.pbi.2007.10.011; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Silverstone AL, 2007, PLANT PHYSIOL, V143, P987, DOI 10.1104/pp.106.091025; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Sun XL, 2008, PROTEIN EXPRES PURIF, V58, P168, DOI 10.1016/j.pep.2007.09.003; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Ueguchi-Tanaka M, 2007, PLANT CELL, V19, P2140, DOI 10.1105/tpc.106.043729; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wen CK, 2002, PLANT CELL, V14, P87, DOI 10.1105/tpc.010325; Willige BC, 2007, PLANT CELL, V19, P1209, DOI 10.1105/tpc.107.051441; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u	63	52	60	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11557	11571		10.1074/jbc.M109.027011	http://dx.doi.org/10.1074/jbc.M109.027011			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20103592	Green Published, hybrid			2022-12-27	WOS:000276286200062
J	Lee, HJ; Suk, JE; Patrick, C; Bae, EJ; Cho, JH; Rho, S; Hwang, D; Masliah, E; Lee, SJ				Lee, He-Jin; Suk, Ji-Eun; Patrick, Christina; Bae, Eun-Jin; Cho, Ji-Hoon; Rho, Sangchul; Hwang, Daehee; Masliah, Eliezer; Lee, Seung-Jae			Direct Transfer of alpha-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; LEWY BODIES; GLIAL-CELLS; CORTICOBASAL DEGENERATION; FILAMENTOUS INCLUSIONS; ACTIVATES MICROGLIA; MESSENGER-RNA; PICKS-DISEASE; HUMAN BRAIN; ASTROCYTES	Abnormal neuronal aggregation of alpha-synuclein is implicated in the development of many neurological disorders, including Parkinson disease and dementia with Lewy bodies. Glial cells also show extensive alpha-synuclein pathology and may contribute to disease progression. However, the mechanism that produces the glial alpha-synuclein pathology and the interaction between neurons and glia in the disease-inflicted microenvironment remain unknown. Here, we show that alpha-synuclein proteins released from neuronal cells are taken up by astrocytes through endocytosis and form inclusion bodies. The glial accumulation of alpha-synuclein through the transmission of the neuronal protein was also demonstrated in a transgenic mouse model expressing human alpha-synuclein. Furthermore, astrocytes that were exposed to neuronal alpha-synuclein underwent changes in the gene expression profile reflecting an inflammatory response. Induction of pro-inflammatory cytokines and chemokines correlated with the extent of glial accumulation of alpha-synuclein. Together, these results suggest that astroglial alpha-synuclein pathology is produced by direct transmission of neuronal alpha-synuclein aggregates, causing inflammatory responses. This transmission step is thus an important mediator of pathogenic glial responses and could qualify as a new therapeutic target.	[Suk, Ji-Eun; Bae, Eun-Jin; Lee, Seung-Jae] Konkuk Univ, Dept Biomed Sci & Technol, IBST, Seoul 143701, South Korea; [Lee, He-Jin] Konkuk Univ, Sch Med, Dept Anat, Seoul 143701, South Korea; [Patrick, Christina; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci & Pathol, La Jolla, CA 92093 USA; [Cho, Ji-Hoon; Rho, Sangchul; Hwang, Daehee] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang 790784, Kyoungbuk, South Korea; [Cho, Ji-Hoon; Rho, Sangchul; Hwang, Daehee] Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, Kyoungbuk, South Korea	Konkuk University; Konkuk University; Konkuk University Medical Center; University of California System; University of California San Diego; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Lee, SJ (corresponding author), Konkuk Univ, Dept Biomed Sci & Technol, IBST, 1 Hwayang Dong, Seoul 143701, South Korea.	sjlee@konkuk.ac.kr	Bae, Eun-Jin/N-3007-2019	Bae, Eun-Jin/0000-0002-4369-7405; Lee, Seung-Jae/0000-0002-5155-5335	National Institutes of Health [AG5131, AG18440]; Ministry of Education, Science and Technology, Republic of Korea [20090084180]; Korea government [20090083737]; NATIONAL INSTITUTE ON AGING [P50AG005131, R01AG018440, R37AG018440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government(Korean Government); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG5131 and AG18440. This work was also supported by the Disease Network Research Program (Grant 20090084180) from the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, Republic of Korea and by the Korea Science and Engineering Foundation funded by the Korea government (Grant 20090083737).	Arai T, 2001, ACTA NEUROPATHOL, V101, P167; Arima K, 1997, ACTA NEUROPATHOL, V93, P558, DOI 10.1007/s004010050652; Bien S, 2004, MOL PHARMACOL, V65, P1092, DOI 10.1124/mol.65.5.1092; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Croisier E, 2006, ACTA NEUROPATHOL, V112, P517, DOI 10.1007/s00401-006-0119-z; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Ferrer I, 2001, J NEURAL TRANSM, V108, P1397, DOI 10.1007/s007020100016; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; Hansen LA, 1998, J NEUROL NEUROSUR PS, V64, P653, DOI 10.1136/jnnp.64.5.653; Herrmann F, 2003, IMMUNOGENETICS, V55, P379, DOI 10.1007/s00251-003-0597-2; Hwang D, 2005, P NATL ACAD SCI USA, V102, P17296, DOI 10.1073/pnas.0508647102; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Klegeris A, 2006, FASEB J, V20, P2000, DOI 10.1096/fj.06-6183com; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Komori T, 1999, BRAIN PATHOL, V9, P663; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lee HJ, 2002, J BIOL CHEM, V277, P5411, DOI 10.1074/jbc.M105326200; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Miller DW, 2005, J NEURAL TRANSM, V112, P1613, DOI 10.1007/s00702-005-0378-1; Mori F, 2002, EXP NEUROL, V176, P98, DOI 10.1006/exnr.2002.7929; Ossendorp F, 2005, J IMMUNOL, V174, P7815, DOI 10.4049/jimmunol.174.12.7815; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Reynolds AD, 2008, J NEUROCHEM, V104, P1504, DOI 10.1111/j.1471-4159.2007.05087.x; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2002, J NEURAL TRANSM-SUPP, P327; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; Schofield E, 2003, BRAIN, V126, P827, DOI 10.1093/brain/awg085; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin CY, 2001, BRAIN RES, V902, P198; Solano SM, 2000, ANN NEUROL, V47, P201, DOI 10.1002/1531-8249(200002)47:2<201::AID-ANA10>3.0.CO;2-F; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Terada S, 2003, ACTA NEUROPATHOL, V105, P163, DOI 10.1007/s00401-002-0622-9; Thomas MP, 2007, J NEUROCHEM, V100, P503, DOI 10.1111/j.1471-4159.2006.04315.x; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; WRIGHT KL, 1995, J EXP MED, V181, P1459, DOI 10.1084/jem.181.4.1459; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yonetani M, 2009, J BIOL CHEM, V284, P7940, DOI 10.1074/jbc.M807482200; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	64	564	575	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9262	9272		10.1074/jbc.M109.081125	http://dx.doi.org/10.1074/jbc.M109.081125			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071342	Green Published, hybrid			2022-12-27	WOS:000275553700074
J	Mallik, S; Yang, WB; Norstrom, EM; Mastrianni, JA				Mallik, Suparna; Yang, Wenbin; Norstrom, Eric M.; Mastrianni, James A.			Live Cell Fluorescence Resonance Energy Transfer Predicts an Altered Molecular Association of Heterologous PrPSc with PrPC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; HUMAN PRION PROTEIN; TRANSGENIC MICE; CONFORMATION; TRANSMISSION; SUSCEPTIBILITY; INSOMNIA	Prion diseases result from the accumulation of a misfolded isoform (PrPSc) of the normal host prion protein (PrPC). PrPSc propagates by templating its conformation onto resident PrPC to generate new PrPSc. Although the nature of the PrPSc-PrPC complex is unresolved, certain segments or specific residues are thought to feature critically in its formation. The polymorphic residue 129 is one such site under considerable study. We combined transmission studies with a novel live cell yeast-based fluorescence resonance energy transfer (FRET) system that models the molecular association of PrP in a PrPSc-like state, as a way to explore the role of residue 129 in this process. We show that a reduction in efficiency of prion transmission between donor PrPSc and recipient PrPC that are mismatched at residue 129 correlates with a reduction in FRET between PrP-129M and PrP-129V in our yeast model. We further show that this effect depends on the different secondary structure propensities of Met and Val, rather than the specific amino acids. Finally, introduction of the disease-associated P101L mutation (mouse-equivalent) abolished FRET with wild-type mouse PrP, whereas mutant PrP-P101L displayed high FRET with homologous PrP-P101L, as long as residue 129 matched. These studies provide the first evidence for a physical alteration in the molecular association of PrP molecules differing in one or more residues, and they further predict that the different secondary structure propensities of Met and Val define the impaired association observed between PrPSc and PrPC mismatched at residue 129.	[Mallik, Suparna; Yang, Wenbin; Norstrom, Eric M.; Mastrianni, James A.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of Chicago	Mastrianni, JA (corresponding author), Univ Chicago, Dept Neurol, MC2030,5841 S Maryland Ave, Chicago, IL 60637 USA.	jmastria@uchicago.edu	Yang, Wenbin/B-5303-2011		National Institutes of Health [R01NS046037, R01NS051480]; Brain Research Foundation; Pioneer Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051480, R01NS046037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Foundation; Pioneer Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS046037 and R01NS051480, The Brain Research Foundation, The Pioneer Fund, and a gift from Barbara and Marc Posner.	Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; COLLINGE J, 1993, BRIT MED J, V306, P301, DOI 10.1136/bmj.306.6873.301; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; KASCSAK RJ, 1993, DEV BIOL STAND, V80, P141; Kobayashi A, 2007, J BIOL CHEM, V282, P30022, DOI 10.1074/jbc.M704597200; Korth C, 2003, P NATL ACAD SCI USA, V100, P4784, DOI 10.1073/pnas.2627989100; Li XH, 2005, ANN NEUROL, V58, P858, DOI 10.1002/ana.20646; Ma JY, 1999, NAT CELL BIOL, V1, P358, DOI 10.1038/14053; Mastrianni JA, 1999, NEW ENGL J MED, V340, P1630, DOI 10.1056/NEJM199905273402104; Mastrianni JA, 2000, SEMIN NEUROL, V20, P337, DOI 10.1055/s-2000-9396; Mead S, 2006, EUR J HUM GENET, V14, P273, DOI 10.1038/sj.ejhg.5201544; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; Moore RA, 2005, ARCH VIROL, P187; Norstrom EM, 2005, J BIOL CHEM, V280, P27236, DOI 10.1074/jbc.M413441200; OWEN F, 1990, AM J HUM GENET, V46, P1215; Parchi P, 1999, ANN NEUROL, V46, P224, DOI 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W; Parchi P, 1999, NEUROLOGY, V52, P1757, DOI 10.1212/WNL.52.9.1757; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; Telling GC, 1996, GENE DEV, V10, P1736, DOI 10.1101/gad.10.14.1736; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TELLING GC, 1994, P NATL ACAD SCI USA, V91, P9936, DOI 10.1073/pnas.91.21.9936; Wadsworth JDF, 2004, SCIENCE, V306, P1793, DOI 10.1126/science.1103932	24	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8967	8975		10.1074/jbc.M109.058107	http://dx.doi.org/10.1074/jbc.M109.058107			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086009	Green Published, hybrid			2022-12-27	WOS:000275553700048
J	Zhang, C; Browne, A; Child, D; DiVito, JR; Stevenson, JA; Tanzi, RE				Zhang, Can; Browne, Andrew; Child, Daniel; DiVito, Jason R.; Stevenson, Jesse A.; Tanzi, Rudolph E.			Loss of Function of ATXN1 Increases Amyloid beta-Protein Levels by Potentiating beta-Secretase Processing of beta-Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING ATAXIN-1; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASE; SPINOCEREBELLAR ATAXIA; APP; CELLS; SCA1; PRESENILIN-1; TRAFFICKING; ASSOCIATION	Alzheimer disease (AD) is a devastating neurodegenerative disease with complex and strong genetic inheritance. Four genes have been established to either cause familial early onset AD (APP, PSEN1, and PSEN2) or to increase susceptibility for late onset AD (APOE). To date similar to 80% of the late onset AD genetic variance remains elusive. Recently our genome-wide association screen identified four novel late onset AD candidate genes. Ataxin 1 (ATXN1) is one of these four AD candidate genes and has been indicated to be the disease gene for spinocerebellar ataxia type 1, which is also a neurodegenerative disease. Mounting evidence suggests that the excessive accumulation of A beta, the proteolytic product of beta-amyloid precursor protein (APP), is the primary AD pathological event. In this study, we ask whether ATXN1 may lead to AD pathogenesis by affecting A beta and APP processing utilizing RNA interference in a human neuronal cell model and mouse primary cortical neurons. We show that knock-down of ATXN1 significantly increases the levels of both A beta 40 and A beta 42. This effect could be rescued with concurrent overexpression of ATXN1. Moreover, overexpression of ATXN1 decreased A beta levels. Regarding the underlying molecular mechanism, we show that the effect of ATXN1 expression on A beta levels is modulated via beta-secretase cleavage of APP. Taken together, ATXN1 functions as a genetic risk modifier that contributes to AD pathogenesis through a loss-of-function mechanism by regulating beta-secretase cleavage of APP and A beta levels.	[Zhang, Can; Browne, Andrew; Child, Daniel; DiVito, Jason R.; Stevenson, Jesse A.; Tanzi, Rudolph E.] Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis,Dept Neurol, Genet & Aging Res Unit,Massachusetts Gen Hosp, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Tanzi, RE (corresponding author), Harvard Univ, Sch Med, MassGen Inst Neurodegenerat Dis,Dept Neurol, Genet & Aging Res Unit,Massachusetts Gen Hosp, 114 16th St, Charlestown, MA 02129 USA.	tanzi@helix.mgh.harvard.edu	Tanzi, Rudolph/AAE-9622-2019	Tanzi, Rudolph/0000-0002-7032-1454; Child, Daniel/0000-0002-4309-0144	NIMH; Cure Alzheimers Fund; Massachusetts General Hospital Fund for Medical Discovery (FMD); NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Cure Alzheimers Fund; Massachusetts General Hospital Fund for Medical Discovery (FMD); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the NIMH, the Cure Alzheimers Fund, and the Massachusetts General Hospital Fund for Medical Discovery (FMD).	BANFI S, 1994, NAT GENET, V7, P513, DOI 10.1038/ng0894-513; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Bertram L, 2005, NEW ENGL J MED, V352, P884, DOI 10.1056/NEJMoa042765; Bertram L, 2008, AM J HUM GENET, V83, P623, DOI 10.1016/j.ajhg.2008.10.008; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Bolger TA, 2007, J BIOL CHEM, V282, P29186, DOI 10.1074/jbc.M704182200; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gandy S, 2007, J NEUROCHEM, V102, P619, DOI 10.1111/j.1471-4159.2007.04587.x; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Goold R, 2007, HUM MOL GENET, V16, P2122, DOI 10.1093/hmg/ddm162; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Majercak J, 2006, P NATL ACAD SCI USA, V103, P17967, DOI 10.1073/pnas.0605461103; Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Patel N, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-10; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Skinner PJ, 2001, AM J PATHOL, V159, P905, DOI 10.1016/S0002-9440(10)61766-X; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Xia WM, 1997, J BIOL CHEM, V272, P7977, DOI 10.1074/jbc.272.12.7977; Xie ZC, 2005, J BIOL CHEM, V280, P15413, DOI 10.1074/jbc.M414353200; Xie ZC, 2007, J BIOL CHEM, V282, P4318, DOI 10.1074/jbc.M609293200; Zhang C, 2010, CURR ALZHEIMER RES, V7, P21, DOI 10.2174/156720510790274428; Zhang C, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-15; Zhang Can, 2009, Discov Med, V8, P18; Zhang Can, 2007, Discov Med, V7, P113; Zhang JM, 1998, J BIOL CHEM, V273, P12436, DOI 10.1074/jbc.273.20.12436; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	35	46	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8515	8526		10.1074/jbc.M109.079079	http://dx.doi.org/10.1074/jbc.M109.079079			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097758	hybrid, Green Published			2022-12-27	WOS:000275553700003
J	Jung, DJ; Jin, DH; Hong, SW; Kim, JE; Shin, JS; Kim, D; Cho, BJ; Hwang, YI; Kang, JS; Lee, WJ				Jung, Da-Jung; Jin, Dong-Hoon; Hong, Seung-Woo; Kim, Jee-Eun; Shin, Jae-Sik; Kim, DaeJin; Cho, Byung-Joo; Hwang, Young-Il; Kang, Jae-Seung; Lee, Wang-Jae			Foxp3 Expression in p53-dependent DNA Damage Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; BREAST-CANCER; P53; TRANSCRIPTION; SUPPRESSION; ACTIVATION; MECHANISMS; APOPTOSIS; PHOSPHORYLATION; INHIBITOR	The forkhead transcription factor, Foxp3, is thought to act as a master regulator that controls (suppresses) expression of the breast cancer oncogenes, SKP2 and HER-2/ErbB2. However, the mechanisms that regulate Foxp3 expression and thereby modulate tumor development remain largely unexplored. Here, we demonstrate that Foxp3 up-regulation requires p53 function, showing that Foxp3 expression is directly regulated by p53 upon DNA damage responses in human breast and colon carcinoma cells. Treatment with the genotoxic agents, doxorubicin or etoposide, induced Foxp3 expression in p53-positive carcinoma cells, but not in cells lacking p53 function. Furthermore, knock down of endogenous wild-type p53 using RNA interference abrogated Foxp3 induction by genotoxic agents, and exogenous expression of p53 in cells lacking p53 restored the responsiveness of Foxp3 to DNA-damaging stresses. In addition, Foxp3 knock down blunted the p53-mediated growth inhibitory response to DNA-damaging agents. These results suggest that induction of Foxp3 in the context of tumor suppression is regulated in a p53-dependent manner and implicate Foxp3 as a key determinant of cell fate in p53-dependent DNA damage responses.	[Hwang, Young-Il; Kang, Jae-Seung; Lee, Wang-Jae] Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110744, South Korea; [Hwang, Young-Il; Kang, Jae-Seung; Lee, Wang-Jae] Seoul Natl Univ, Coll Med, Tumor Immun Med Res Ctr, Seoul 110744, South Korea; [Jung, Da-Jung; Jin, Dong-Hoon; Hong, Seung-Woo; Kim, Jee-Eun; Shin, Jae-Sik; Lee, Wang-Jae] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea; [Cho, Byung-Joo] Konkuk Univ, Konkuk Univ Hosp, Sch Med, Dept Ophthalmol, Seoul 143729, South Korea; [Kim, DaeJin] Chung Ang Univ, Coll Med, Dept Anat, Seoul 156756, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Konkuk University; Konkuk University Medical Center; Chung Ang University; Chung Ang University Hospital	Lee, WJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Anat, Seoul 110744, South Korea.	kinglee@snu.ac.kr	Kang, Jae Seung/J-5363-2012; Lee, Wang Jae/J-5586-2012		Korean Science and Engineering Foundation through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine [R13-2002-025-02001-0]; Science Research Center Program through the Research Center for Women's Diseases [R11-2005-017-03001]	Korean Science and Engineering Foundation through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine; Science Research Center Program through the Research Center for Women's Diseases	This work was supported by the Korean Science and Engineering Foundation through the Tumor Immunity Medical Research Center at Seoul National University College of Medicine Grant R13-2002-025-02001-0 and Science Research Center Program through the Research Center for Women's Diseases Grant R11-2005-017-03001.	Choi BM, 2005, BIOCHEM BIOPH RES CO, V327, P1066, DOI 10.1016/j.bbrc.2004.12.106; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Jung MS, 2004, J BIOL CHEM, V279, P17765, DOI 10.1074/jbc.M305015200; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Kinyamu HK, 2007, MOL CELL BIOL, V27, P4891, DOI 10.1128/MCB.02162-06; Kojima K, 2006, BLOOD, V108, P993, DOI 10.1182/blood-2005-12-5148; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Liu Y, 2007, PHARMACOGENOMICS, V8, P1485, DOI 10.2217/14622416.8.11.1485; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Manzotti CN, 2002, EUR J IMMUNOL, V32, P2888, DOI 10.1002/1521-4141(2002010)32:10<2888::AID-IMMU2888>3.0.CO;2-F; MCILWRATH AJ, 1994, CANCER RES, V54, P3718; Nagaoka H, 2005, P NATL ACAD SCI USA, V102, P2022, DOI 10.1073/pnas.0409491102; Ou-Yang HF, 2009, MOL CELL BIOCHEM, V320, P109, DOI 10.1007/s11010-008-9912-4; Park WS, 2000, GASTROENTEROLOGY, V119, P691, DOI 10.1053/gast.2000.16483; Provinciali M, 2007, CANCER RES, V67, P2022, DOI 10.1158/0008-5472.CAN-06-2601; Taams LS, 2005, CURR TOP MICROBIOL, V293, P115, DOI 10.1007/3-540-27702-1_6; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Traub F, 2006, BREAST CANCER RES TR, V99, P185, DOI 10.1007/s10549-006-9202-3; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zuo T, 2007, J CLIN INVEST, V117, P3765, DOI 10.1172/JCI32538; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	33	48	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7995	8002		10.1074/jbc.M109.047985	http://dx.doi.org/10.1074/jbc.M109.047985			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075077	Green Published, hybrid			2022-12-27	WOS:000275413800017
J	Lee, JS; Lee, YM; Kim, JY; Park, HW; Grinstein, S; Orlowski, J; Kim, E; Kim, KH; Lee, MG				Lee, Jung-Soo; Lee, Young Mee; Kim, Joo Young; Park, Hyun Woo; Grinstein, Sergio; Orlowski, John; Kim, Eunjoon; Kim, Kyung Hwan; Lee, Min Goo			beta Pix Up-regulates Na+/H+ Exchanger 3 through a Shank2-mediated Protein-Protein Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SHANK FAMILY; PROXIMAL TUBULE; APICAL MEMBRANE; RHO-GTPASES; KINASE-A; NHE3; LOCALIZATION; EXPRESSION; ISOFORM	Na+/H+ exchanger 3 (NHE3) plays an important role in neutral Na+ transport in mammalian epithelial cells. The Rho family of small GTPases and the PDZ (PSD-95/discs large/ZO-1) domain-based adaptor Shank2 are known to regulate the membrane expression and activity of NHE3. In this study we examined the role of beta Pix, a guanine nucleotide exchange factor for the Rho GTPase and a strong binding partner to Shank2, in NHE3 regulation using integrated molecular and physiological approaches. Immunoprecipitation and pulldown assays revealed that NHE3, Shank2, and beta Pix form a macromolecular complex when expressed heterologously in mammalian cells as well as endogenously in rat colon, kidney, and pancreas. In addition, these proteins co-segregated at the apical surface of rat colonic epithelial cells, as detected by immunofluorescence staining. When expressed in PS120/NHE3 cells, beta Pix increased membrane expression and basal activity of NHE3. Interestingly, the effects of beta Pix on NHE3 were abolished by cotransfection with dominant-negative Shank2 mutants and by treatment with Clostridium difficile toxin B, a Rho GTPase inhibitor, indicating that Shank2 and Rho GTPases are involved in beta Pix-mediated NHE3 regulation. Knockdown of endogenous beta Pix by RNA interference decreased Shank2-induced increase of NHE3 membrane expression in HEK 293T cells. These results indicate that beta Pix up-regulates NHE3 membrane expression and activity by Shank2-mediated protein-protein interaction and by activating Rho GTPases in the apical regions of epithelial cells.	[Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Coll Med, Dept Pharmacol, Seoul 120752, South Korea; [Kim, Kyung Hwan; Lee, Min Goo] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Inst Gastroenterol, Seoul 120752, South Korea; [Grinstein, Sergio] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Orlowski, John] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; Korea Advanced Institute of Science & Technology (KAIST)	Lee, MG (corresponding author), Yonsei Univ, Coll Med, Dept Pharmacol, 134 Sinchon Dong, Seoul 120752, South Korea.	mlee@yuhs.ac	Lee, Min Goo/AAS-4636-2020; Kim, Joo Young/X-7562-2019; Lee, Min Goo/D-5635-2012; Kim, Eunjoon/C-1566-2011	Lee, Min Goo/0000-0001-7436-012X; Kim, Joo Young/0000-0003-2623-1491; Lee, Min Goo/0000-0001-7436-012X; Orlowski, John/0000-0001-7371-175X; Park, Hyun Woo/0000-0001-7736-2286	Korea Science and Engineering Foundation [R11-2007-040-01001-0, R01-2007-000-20710-0]; Ministry of Education, Science and Technology, Korea; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A070001]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea	This work was supported in part by Grants R11-2007-040-01001-0 and R01-2007-000-20710-0 from the Korea Science and Engineering Foundation, Ministry of Education, Science and Technology, Korea, and by Grant A070001 from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea.	Ahn W, 2001, J BIOL CHEM, V276, P17236, DOI 10.1074/jbc.M011763200; Alexander RT, 2005, P NATL ACAD SCI USA, V102, P12253, DOI 10.1073/pnas.0409197102; AMEMIYA M, 1995, KIDNEY INT, V48, P1206, DOI 10.1038/ki.1995.404; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bookstein C, 1997, AM J PHYSIOL-CELL PH, V273, pC1496, DOI 10.1152/ajpcell.1997.273.5.C1496; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Chen J, 2005, J BIOL CHEM, V280, P29912, DOI 10.1074/jbc.M504516200; Donowitz M, 2000, ANN NY ACAD SCI, V915, P30; Donowitz M, 2007, PHYSIOL REV, V87, P825, DOI 10.1152/physrev.00030.2006; Fuster DG, 2008, J AM SOC NEPHROL, V19, P1547, DOI 10.1681/ASN.2007111245; Gawenis LR, 2002, AM J PHYSIOL-GASTR L, V282, pG776, DOI 10.1152/ajpgi.00297.2001; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han W, 2006, J BIOL CHEM, V281, P1461, DOI 10.1074/jbc.M509786200; Hayashi H, 2004, J GEN PHYSIOL, V123, P491, DOI 10.1085/jgp.200308979; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Koh CG, 2001, J CELL SCI, V114, P4239; Kurashima K, 1998, J BIOL CHEM, V273, P20828, DOI 10.1074/jbc.273.33.20828; Lee J, 2005, EXP CELL RES, V307, P315, DOI 10.1016/j.yexcr.2005.03.028; Lee JH, 2007, J BIOL CHEM, V282, P10414, DOI 10.1074/jbc.M610857200; Lee MG, 1999, J BIOL CHEM, V274, P3414, DOI 10.1074/jbc.274.6.3414; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; McWilliams RR, 2005, AM J PHYSIOL-CELL PH, V289, pC1042, DOI 10.1152/ajpcell.00568.2004; McWilliams RR, 2004, BIOCHEM J, V380, P181, DOI 10.1042/BJ20031577; MOE OW, 1995, J CLIN INVEST, V96, P2187, DOI 10.1172/JCI118273; Oh WK, 1997, BIOCHEM BIOPH RES CO, V235, P794, DOI 10.1006/bbrc.1997.6875; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Schiller MR, 2006, J BIOL CHEM, V281, P18774, DOI 10.1074/jbc.M512482200; Sheng M, 2000, J CELL SCI, V113, P1851; Staruschenko A, 2004, J BIOL CHEM, V279, P49989, DOI 10.1074/jbc.M409812200; Storey NM, 2002, CURR BIOL, V12, P27, DOI 10.1016/S0960-9822(01)00625-X; Szaszi K, 2000, CELL PHYSIOL BIOCHEM, V10, P265, DOI 10.1159/000016358; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Weinman EJ, 2005, PFLUG ARCH EUR J PHY, V450, P137, DOI 10.1007/s00424-005-1384-8; Xiang MH, 2007, P NATL ACAD SCI USA, V104, P18677, DOI 10.1073/pnas.0707120104; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004; ZHAO H, 1994, J GEN PHYSIOL, V104, P57, DOI 10.1085/jgp.104.1.57; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	42	16	16	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8104	8113		10.1074/jbc.M109.055079	http://dx.doi.org/10.1074/jbc.M109.055079			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080968	Green Published, hybrid			2022-12-27	WOS:000275413800028
J	Loseva, O; Jemth, AS; Bryant, HE; Schuler, H; Lehtio, L; Karlberg, T; Helleday, T				Loseva, Olga; Jemth, Ann-Sofie; Bryant, Helen E.; Schuler, Herwig; Lehtio, Lari; Karlberg, Tobias; Helleday, Thomas			PARP-3 Is a Mono-ADP-ribosylase That Activates PARP-1 in the Absence of DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE) POLYMERASE; CATALYTIC FRAGMENT; REPAIR; IDENTIFICATION; CELLS; INTERFERES; INHIBITOR; SUBSTRATE; RESIDUES; DOMAIN	The PARP-3 protein is closely related to the PARP-1 and PARP-2 proteins, which are involved in DNA repair and genome maintenance. Here, we characterized the biochemical properties of human PARP-3. PARP-3 is able to ADP-ribosylate itself as well as histone H1, a previously unknown substrate for PARP-3. PARP-3 is not activated upon binding to DNA and is a mono-ADP-ribosylase, in contrast to PARP-1 and PARP-2. PARP-3 interacts with PARP-1 and activates PARP-1 in the absence of DNA, resulting in synthesis of polymers of ADPribose. The N-terminal WGR domain of PARP-3 is involved in this activation. The functional interaction between PARP-3 and PARP-1 suggests that it may have a role in DNA repair. However, here we report that PARP-3 small interfering RNA-depleted cells are not sensitive to the topoisomerase I poison camptothecin, inducing DNA single-strand breaks, and repair these lesions as efficiently as wild-type cells. Altogether, these results suggest that the interaction between PARP-1 and PARP-3 is unrelated to DNA single-strand break repair.	[Helleday, Thomas] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden; [Bryant, Helen E.] Univ Sheffield, Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; [Schuler, Herwig; Lehtio, Lari; Karlberg, Tobias] Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, S-17177 Stockholm, Sweden; [Helleday, Thomas] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, England	Stockholm University; University of Sheffield; Karolinska Institutet; University of Oxford	Helleday, T (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	helleday@gmt.su.se	Helleday, Thomas/D-5224-2013; Schuler, Herwig/E-5751-2011; bryant, helen/AHB-1139-2022	Schuler, Herwig/0000-0003-4059-3501; bryant, helen/0000-0003-2720-7020; Helleday, Thomas/0000-0002-7384-092X; Jemth, Ann-Sofie/0000-0002-7550-1833; Lehtio, Lari/0000-0001-7250-832X	Swedish Cancer Society; Swedish Children's Cancer Foundation; Swedish Research Council; Swedish Pain Relief Foundation; Medical Research Council; Lars Hierta Memorial Foundation; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Medical Research Council [G0700730] Funding Source: researchfish; MRC [G0700730] Funding Source: UKRI	Swedish Cancer Society(Swedish Cancer Society); Swedish Children's Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Pain Relief Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lars Hierta Memorial Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Swedish Cancer Society, the Swedish Children's Cancer Foundation, the Swedish Research Council, the Swedish Pain Relief Foundation, and the Medical Research Council (to T. H.) and by the Lars Hierta Memorial Foundation (to A.-S.J.). The Structural Genomics Consortium is a registered charity (1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, the Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Allinson SL, 2003, ACTA BIOCHIM POL, V50, P169; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Augustin A, 2003, J CELL SCI, V116, P1551, DOI 10.1242/jcs.00341; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Bryant HE, 2009, EMBO J, V28, P2601, DOI 10.1038/emboj.2009.206; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Hakme A, 2008, EMBO REP, V9, P1094, DOI 10.1038/embor.2008.191; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Jones P, 2009, J MED CHEM, V52, P7170, DOI 10.1021/jm901188v; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Lehtio L, 2009, J MED CHEM, V52, P3108, DOI 10.1021/jm900052j; LOESBERG C, 1990, BIOCHIM BIOPHYS ACTA, V1037, P92, DOI 10.1016/0167-4838(90)90106-P; Mendoza-Alvarez H, 2004, J MOL BIOL, V336, P105, DOI 10.1016/j.jmb.2003.11.055; OGATA N, 1980, J BIOL CHEM, V255, P7610; OGATA N, 1980, J BIOL CHEM, V255, P7616; Oliver AW, 2004, NUCLEIC ACIDS RES, V32, P456, DOI 10.1093/nar/gkh215; PANZETER PL, 1990, NUCLEIC ACIDS RES, V18, P2194, DOI 10.1093/nar/18.8.2194; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Rouleau M, 2009, J HISTOCHEM CYTOCHEM, V57, P675, DOI 10.1369/jhc.2009.953380; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Sallmann FR, 2000, J BIOL CHEM, V275, P15504, DOI 10.1074/jbc.275.20.15504; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Smith LM, 2005, CLIN CANCER RES, V11, P8449, DOI 10.1158/1078-0432.CCR-05-1224; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d	31	121	120	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8054	8060		10.1074/jbc.M109.077834	http://dx.doi.org/10.1074/jbc.M109.077834			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064938	Green Published, hybrid			2022-12-27	WOS:000275413800023
J	Malnou, CE; Brockly, F; Favard, C; Moquet-Torcy, G; Piechaczyk, M; Jariel-Encontre, I				Malnou, Cecile E.; Brockly, Frederique; Favard, Cyril; Moquet-Torcy, Gabriel; Piechaczyk, Marc; Jariel-Encontre, Isabelle			Heterodimerization with Different Jun Proteins Controls c-Fos Intranuclear Dynamics and Distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY GENE-PRODUCTS; LIVING CELLS; ANDROGEN RECEPTOR; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; PROTEASOMAL DEGRADATION; NUCLEAR TRANSLOCATION; G0-TO-G1 TRANSITION; MOUSE FIBROBLASTS; LAMIN A/C	The c-Fos proto-oncogenic transcription factor defines a multigene family controlling many processes both at the cell and the whole organism level. To bind to its target AP-1/12-O-tetradecanoylphorbol-13-acetate-responsive element or cAMP-responsive element DNA sequences in gene promoters and exert its transcriptional part, c-Fos must heterodimerize with other bZip proteins, its best studied partners being the Jun proteins (c-Jun, JunB, and JunD). c-Fos expression is regulated at many transcriptional and post-transcriptional levels, yet little is known on how its localization is dynamically regulated in the cell. Here we have investigated its intranuclear mobility using fluorescence recovery after photobleaching, genetic, and biochemical approaches. Whereas monomeric c-Fos is highly mobile and distributed evenly with nucleolar exclusion in the nucleus, heterodimerization with c-Jun entails intranuclear redistribution and dramatic reduction in mobility of c-Fos caused by predominant association with the nuclear matrix independently of any binding to AP-1/12-O-tetradecanoylphorbol-13-acetate-responsive element or cAMP-responsive element sequences. In contrast to c-Jun, dimerization with JunB does not detectably affect c-Fos mobility. However, dimerization with JunB affects intranuclear distribution with significant differences in the localization of c-Fos.c-Jun and c-Fos.JunB dimers. Moreover, c-Jun and JunB exert comparable effects on another Fos family member, Fra-1. Thus, we report a novel regulation, i.e. differentially regulated intranuclear mobility and distribution of Fos proteins by their Jun partners, and suggest the existence of intranuclear storage sites for latent c-Fos.c-Jun AP-1 complexes. This may affect the numerous physiopathological functions these transcription factors control.	[Malnou, Cecile E.; Brockly, Frederique; Moquet-Torcy, Gabriel; Piechaczyk, Marc; Jariel-Encontre, Isabelle] CNRS, IGMM, UMR5535, F-34293 Montpellier 5, France; [Malnou, Cecile E.; Brockly, Frederique; Moquet-Torcy, Gabriel; Piechaczyk, Marc; Jariel-Encontre, Isabelle] Univ Montpellier 2, F-34095 Montpellier 5, France; [Malnou, Cecile E.; Brockly, Frederique; Moquet-Torcy, Gabriel; Piechaczyk, Marc; Jariel-Encontre, Isabelle] Univ Montpellier 1, F-34967 Montpellier 2, France; [Favard, Cyril] Aix Marseille Univ, Ecole Cent Marseille, CNRS, UMR6133,Inst Fresnel, F-13013 Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Jariel-Encontre, I (corresponding author), CNRS, IGMM, UMR5535, 1919 Route Mende, F-34293 Montpellier 5, France.	marc.piechaczyk@igmm.cnrs.fr; isabelle.jariel@igmm.cnrs.fr	PIECHACZYK, Marc/E-7896-2013; Favard, Cyril/P-6392-2016; MALNOU, Cécile/O-9970-2019; MALNOU, Cécile E/K-1569-2014	PIECHACZYK, Marc/0000-0003-1367-2597; Favard, Cyril/0000-0002-8304-2980; MALNOU, Cécile/0000-0002-1223-0247; MALNOU, Cécile E/0000-0002-1223-0247	ARC, Association pour la Recherche sur le Cancer; Agence Nationale de Recherches [ANR-08-BLAN-007-01]; French Ligue Nationale Contre le Cancer; CNRS	ARC, Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de Recherches(French National Research Agency (ANR)); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by grants from the ARC, Association pour la Recherche sur le Cancer, the Agence Nationale de Recherches (ANR-08-BLAN-007-01), the French Ligue Nationale Contre le Cancer, and by the CNRS.	Albrethsen J, 2009, J PROTEOMICS, V72, P71, DOI 10.1016/j.jprot.2008.09.005; Arnold M, 2006, J BIOL CHEM, V281, P5492, DOI 10.1074/jbc.M513281200; Basbous J, 2008, BIOCHIMIE, V90, P296, DOI 10.1016/j.biochi.2007.07.016; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2003, MOL CELL BIOL, V23, P7425, DOI 10.1128/MCB.23.20.7425-7436.2003; Burch PM, 2004, MOL CELL BIOL, V24, P4696, DOI 10.1128/MCB.24.11.4696-4709.2004; Bussolino DF, 2001, FASEB J, V15, P556; Chalmers CJ, 2007, CELL SIGNAL, V19, P695, DOI 10.1016/j.cellsig.2006.09.001; CHEN RH, 1993, P NATL ACAD SCI USA, V90, P10952, DOI 10.1073/pnas.90.23.10952; Chinenov Y, 2001, ONCOGENE, V20, P2438, DOI 10.1038/sj.onc.1204385; Christensen MO, 2004, J BIOL CHEM, V279, P21873, DOI 10.1074/jbc.M400498200; Damdimopoulos AE, 2008, ENDOCRINOLOGY, V149, P339, DOI 10.1210/en.2007-0198; DENG TL, 1994, NATURE, V371, P171, DOI 10.1038/371171a0; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Farla P, 2004, J STRUCT BIOL, V147, P50, DOI 10.1016/j.jsb.2004.01.002; Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200; Ferrara P, 2003, ONCOGENE, V22, P1461, DOI 10.1038/sj.onc.1206266; Gil GA, 2004, MOL BIOL CELL, V15, P1881, DOI 10.1091/mbc.e03-09-0705; Gilley R, 2009, CELL SIGNAL, V21, P969, DOI 10.1016/j.cellsig.2009.02.006; Gomard T, 2008, BIOCHEM SOC T, V36, P858, DOI 10.1042/BST0360858; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Higashi N, 2004, GENES CELLS, V9, P233, DOI 10.1111/j.1356-9597.2004.00715.x; Houtsmuller AB, 2001, HISTOCHEM CELL BIOL, V115, P13, DOI 10.1007/s004180000234; Ivorra' C, 2006, GENE DEV, V20, P307, DOI 10.1101/gad.349506; JARIELENCONTRE I, 2008, TARGETED PROTEIN DAT, DOI DOI 10.2970/TPDB.2009.0218; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Karpova TS, 2004, EMBO REP, V5, P1064, DOI 10.1038/sj.embor.7400281; Koga K, 2009, IMMUNITY, V30, P372, DOI 10.1016/j.immuni.2008.12.021; KOVARY K, 1992, MOL CELL BIOL, V12, P5015, DOI 10.1128/MCB.12.11.5015; KOVARY K, 1991, MOL CELL BIOL, V11, P2451, DOI 10.1128/MCB.11.5.2451; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Laricchia-Robbio L, 2005, P NATL ACAD SCI USA, V102, P14368, DOI 10.1073/pnas.0504014102; Lever E, 2010, J PATHOL, V220, P114, DOI 10.1002/path.2651; MacKeigan JP, 2005, MOL CELL BIOL, V25, P4676, DOI 10.1128/MCB.25.11.4676-4682.2005; Malnou CE, 2007, J BIOL CHEM, V282, P31046, DOI 10.1074/jbc.M702833200; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049; Maruvada P, 2003, J BIOL CHEM, V278, P12425, DOI 10.1074/jbc.M202752200; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Mayr BM, 2005, J BIOL CHEM, V280, P15103, DOI 10.1074/jbc.M414144200; Monje P, 2003, MOL CELL BIOL, V23, P7030, DOI 10.1128/MCB.23.19.7030-7043.2003; Monje P, 2005, J BIOL CHEM, V280, P35081, DOI 10.1074/jbc.C500353200; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Murphy LO, 2004, MOL CELL BIOL, V24, P144, DOI 10.1128/MCB.24.1.144-153.2004; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; OKAZAKI K, 1995, EMBO J, V14, P5048, DOI 10.1002/j.1460-2075.1995.tb00187.x; PIECHACZYK M, 1994, CRIT REV ONCOL HEMAT, V17, P93, DOI 10.1016/1040-8428(94)90021-3; Prufer K, 2008, EXP CELL RES, V314, P2652, DOI 10.1016/j.yexcr.2008.05.005; RANSONE LJ, 1990, P NATL ACAD SCI USA, V87, P3806, DOI 10.1073/pnas.87.10.3806; Rayasam GV, 2005, MOL CELL BIOL, V25, P2406, DOI 10.1128/MCB.25.6.2406-2418.2005; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; ROUX P, 1990, CELL, V63, P341, DOI 10.1016/0092-8674(90)90167-D; ROUX P, 1994, C FOS C JUN FAMILIES, P87; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schaaf MJM, 2006, J BIOL CHEM, V281, P22409, DOI 10.1074/jbc.M511086200; Schaaf MJM, 2003, MOL CELL BIOL, V23, P1922, DOI 10.1128/MCB.23.6.1922-1934.2003; SCHUERMANN M, 1989, CELL, V56, P507, DOI 10.1016/0092-8674(89)90253-5; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SPECTOR DL, 1998, CELLS LAB MANUAL, V1; Sprague BL, 2005, TRENDS CELL BIOL, V15, P84, DOI 10.1016/j.tcb.2004.12.001; Tanos T, 2005, J BIOL CHEM, V280, P18842, DOI 10.1074/jbc.M500620200; Tempe D, 2008, BIOCHEM SOC T, V36, P874, DOI 10.1042/BST0360874; TRATNER I, 1991, ONCOGENE, V6, P2049; van Drogen Frank, 2004, Methods Mol Biol, V284, P287; Vinson C, 2002, MOL CELL BIOL, V22, P6321, DOI 10.1128/MCB.22.18.6321-6335.2002; Vinson C, 2006, BBA-GENE STRUCT EXPR, V1759, P4, DOI 10.1016/j.bbaexp.2005.12.005; VRIZ S, 1992, MOL CELL BIOL, V12, P3548, DOI 10.1128/MCB.12.8.3548; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wysocka J, 2001, MOL CELL BIOL, V21, P3820, DOI 10.1128/MCB.21.11.3820-3829.2001; Zenz R, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2338	72	26	27	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6552	6562		10.1074/jbc.M109.032680	http://dx.doi.org/10.1074/jbc.M109.032680			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20053986	Green Published, hybrid			2022-12-27	WOS:000275367500060
J	Miriyala, S; Subramanian, T; Panchatcharam, M; Ren, HM; McDermott, MI; Sunkara, M; Drennan, T; Smyth, SS; Spielmann, HP; Morris, AJ				Miriyala, Sumitra; Subramanian, Thangaiah; Panchatcharam, Manikandan; Ren, Hongmei; McDermott, Mark I.; Sunkara, Manjula; Drennan, Tracy; Smyth, Susan S.; Spielmann, H. Peter; Morris, Andrew J.			Functional Characterization of the Atypical Integral Membrane Lipid Phosphatase PDP1/PPAPDC2 Identifies a Pathway for Interconversion of Isoprenols and Isoprenoid Phosphates in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRESQUALENE DIPHOSPHATE PHOSPHATASE; LYSOPHOSPHATIDIC ACID; RHO GTPASES; PROTEIN; FARNESYL; BIOSYNTHESIS; CHOLESTEROL; ACTIVATION; MECHANISMS; INHIBITOR	The polyisoprenoid diphosphates farnesyl diphosphate (FPP) and geranylgeranyl diphosphate (GGPP) are intermediates in the synthesis of cholesterol and related sterols by the mevalonate pathway and precursors for the addition of isoprenyl anchors to many membrane proteins. We developed tandem mass spectrometry assays to evaluate polyisoprenoid diphosphate phosphatase activity of an unusual integral membrane lipid enzyme: type 1 polyisoprenoid diphosphate phosphatase encoded by the PPAPDC2 gene (PDP1/PPAPDC2). In vitro, recombinant PDP1/PPAPDC2 preferentially hydrolyzed polyisoprenoid diphosphates, including FPP and GGPP over a variety of glycerol-and sphingo-phospholipid substrates. Overexpression of mammalian PDP1/PPAPDC2 in budding yeast depletes cellular pools of FPP leading to growth defects and sterol auxotrophy. In mammalian cells, PDP1/PPAPDC2 localizes to the endoplasmic reticulum and nuclear envelope and, unlike the structurally related lipid phosphate phosphatases, is predicted to be oriented with key residues of its catalytic domain facing the cytoplasmic face of the membrane. Studies using synthetic isoprenols with chemical properties that facilitate detection by mass spectrometry identify a pathway for interconversion of isoprenols and isoprenoid diphosphates in intact mammalian cells and demonstrate a role for PDP1/PPAPDC2 in this process. Overexpression of PDP1/PPAPDC2 in mammalian cells substantially decreases protein isoprenylation and results in defects in cell growth and cytoskeletal organization that are associated with dysregulation of Rho family GTPases. Taken together, these results focus attention on integral membrane lipid phosphatases as regulators of isoprenoid phosphate metabolism and suggest that PDP1/PPAPDC2 is a functional isoprenoid diphosphate phosphatase.	[Miriyala, Sumitra; Panchatcharam, Manikandan; Ren, Hongmei; Sunkara, Manjula; Drennan, Tracy; Smyth, Susan S.; Spielmann, H. Peter; Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, Lexington, KY 40536 USA; [Subramanian, Thangaiah; Morris, Andrew J.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Spielmann, H. Peter] Univ Kentucky, Dept Chem, Lexington, KY 40536 USA; [Spielmann, H. Peter] Univ Kentucky, Struct Biol Ctr, Lexington, KY 40536 USA; [Smyth, Susan S.] Dept Vet Affairs Med Ctr, Lexington, KY 40511 USA; [McDermott, Mark I.] NHLBI, NIH, Bethesda, MD 20892 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Morris, AJ (corresponding author), Univ Kentucky, Div Cardiovasc Med, Gill Heart Inst, 900 S Limestone St,326 CTW Bldg, Lexington, KY 40536 USA.	a.j.morris@uky.edu	Thangaiah, Subramanian/H-3824-2011; Morris, Andrew/B-7869-2010; sunkara, Manjula/H-7944-2016	sunkara, Manjula/0000-0001-6151-1929; Miriyala, Sumitra/0000-0001-7158-9295; Panchatcharam, Manikandan/0000-0002-7691-8948	National Institutes of Health [5R01GM050388, P20RR001954, 5R01GM066152]; Lexington VA Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, P20RR021954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066152, R01GM050388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lexington VA Medical Center(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM050388, P20RR001954, and 5R01GM066152 (to A.J.M., H. P. S., and S. S. S.). This study is the result of work supported with resources and the use of facilities at the Lexington VA Medical Center.	BANSAL VS, 1994, ARCH BIOCHEM BIOPHYS, V315, P393, DOI 10.1006/abbi.1994.1516; Brindley DN, 2004, J CELL BIOCHEM, V92, P900, DOI 10.1002/jcb.20126; Carlo T, 2009, BIOCHEMISTRY-US, V48, P2997, DOI 10.1021/bi8020636; CHRISTOPHE J, 1961, J LIPID RES, V2, P244; Coffinier C, 2008, J BIOL CHEM, V283, P9797, DOI 10.1074/jbc.M709629200; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Crick D C, 1996, SAAS Bull Biochem Biotechnol, V9, P37; Edwards PA, 1999, ANNU REV BIOCHEM, V68, P157, DOI 10.1146/annurev.biochem.68.1.157; Faulkner A, 1999, J BIOL CHEM, V274, P14831, DOI 10.1074/jbc.274.21.14831; Fukunaga K, 2006, J BIOL CHEM, V281, P9490, DOI 10.1074/jbc.M512970200; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grkovich A, 2009, BBA-MOL CELL BIOL L, V1791, P975, DOI 10.1016/j.bbalip.2009.02.002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JENNINGS SM, 1991, P NATL ACAD SCI USA, V88, P6038, DOI 10.1073/pnas.88.14.6038; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; Levy BD, 2005, BRIT J PHARMACOL, V146, P344, DOI 10.1038/sj.bjp.0706338; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Liu GH, 2009, MOL CELL BIOL, V29, P5800, DOI 10.1128/MCB.00684-09; Long JS, 2006, BIOCHEM J, V394, P495, DOI 10.1042/BJ20051674; McDermot MI, 2006, METHODS, V39, P169, DOI 10.1016/j.ymeth.2006.05.010; McDermott MI, 2004, NAT NEUROSCI, V7, P789, DOI 10.1038/nn0804-789a; Meredith D, 2009, ARTERIOSCL THROM VAS, V29, P465, DOI 10.1161/ATVBAHA.109.184234; Morris KE, 2006, J BIOL CHEM, V281, P9297, DOI 10.1074/jbc.M511710200; Munck A, 2005, FEBS J, V272, P1718, DOI 10.1111/j.1742-4658.2005.04601.x; Pamuklar Z, 2008, ARTERIOSCL THROM VAS, V28, P555, DOI 10.1161/ATVBAHA.107.151837; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; Roberts RZ, 2000, BBA-MOL CELL BIOL L, V1487, P33, DOI 10.1016/S1388-1981(00)00081-0; Rolfe BE, 2005, ATHEROSCLEROSIS, V183, P1, DOI 10.1016/j.atherosclerosis.2005.04.023; Schirmer EC, 2005, TRENDS BIOCHEM SCI, V30, P551, DOI 10.1016/j.tibs.2005.08.003; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; Sigal YJ, 2007, J CELL SCI, V120, P340, DOI 10.1242/jcs.03335; Sturley SL, 1998, CURR OPIN LIPIDOL, V9, P85, DOI 10.1097/00041433-199804000-00002; Su W, 2009, MOL PHARMACOL, V75, P437, DOI 10.1124/mol.108.053298; Subramanian T, 2005, ORG LETT, V7, P2109, DOI 10.1021/ol050386o; Tanyi JL, 2003, CANCER RES, V63, P1073; Thai L, 1999, P NATL ACAD SCI USA, V96, P13080, DOI 10.1073/pnas.96.23.13080; Theofilopoulos S, 2008, BBA-MOL CELL BIOL L, V1781, P731, DOI 10.1016/j.bbalip.2008.09.001; Tong H, 2008, ANAL BIOCHEM, V378, P138, DOI 10.1016/j.ab.2008.04.021; Troutman JM, 2005, BIOCONJUGATE CHEM, V16, P1209, DOI 10.1021/bc050068+; Vaidya S, 1998, ARCH BIOCHEM BIOPHYS, V355, P84, DOI 10.1006/abbi.1998.0704; Yang SH, 2008, J CLIN INVEST, V118, P3291, DOI 10.1172/JCI35876; Zhang FL, 1996, ANNU REV BIOCHEM, V65, P241, DOI 10.1146/annurev.bi.65.070196.001325	45	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13918	13929		10.1074/jbc.M109.083931	http://dx.doi.org/10.1074/jbc.M109.083931			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20110354	Green Published, hybrid			2022-12-27	WOS:000276987700066
J	Tseng, YT; Wang, SM; Huang, KJ; Lee, AIR; Chiang, CC; Wang, CT				Tseng, Ying-Tzu; Wang, Shiu-Mei; Huang, Kuo-Jung; Lee, Amber I-Ru; Chiang, Chien-Cheng; Wang, Chin-Tien			Self-assembly of Severe Acute Respiratory Syndrome Coronavirus Membrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL ENVELOPE PROTEIN; MOUSE HEPATITIS-VIRUS; MOLECULAR-BIOLOGY; GOLGI-COMPLEX; MURINE CORONAVIRUS; E1 GLYCOPROTEIN; LIPID RAFTS; PARTICLES; EXPRESSION; RETENTION	Coronavirus membrane (M) protein can form virus-like particles (VLPs) when coexpressed with nucleocapsid (N) or envelope (E) proteins, suggesting a pivotal role for M in virion assembly. Here we demonstrate the self-assembly and release of severe acute respiratory syndrome coronavirus (SARS-CoV) M protein in medium in the form of membrane-enveloped vesicles with densities lower than those of VLPs formed by M plus N. Although efficient N-N interactions require the presence of RNA, we found that M-M interactions were RNA-independent. SARS-CoV M was observed in both the Golgi area and plasma membranes of a variety of cells. Blocking M glycosylation does not appear to significantly affect M plasma membrane labeling intensity, M-containing vesicle release, or VLP formation. Results from a genetic analysis indicate involvement of the third transmembrane domain of M in plasma membrane-targeting signal. Fusion proteins containing M amino-terminal 50 residues encompassing the first transmembrane domain were found to be sufficient for membrane binding, multimerization, and Golgi retention. Surprisingly, we found that fusion proteins lacking all three transmembrane domains were still capable of membrane binding, Golgi retention, and interacting with M. The data suggest that multiple SARS-CoV M regions are involved in M self-assembly and subcellular localization.	[Wang, Chin-Tien] Natl Yang Ming Univ, Dept Med Res & Educ, Taipei Vet Gen Hosp, Sch Med, Taipei 11217, Taiwan; [Wang, Shiu-Mei; Lee, Amber I-Ru; Chiang, Chien-Cheng; Wang, Chin-Tien] Natl Yang Ming Univ, Inst Clin Med, Sch Med, Taipei 11217, Taiwan	National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Wang, CT (corresponding author), Natl Yang Ming Univ, Dept Med Res & Educ, Taipei Vet Gen Hosp, Sch Med, 201 Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.	chintien@ym.edu.tw			Taipei Veterans General Hospital [V96C1-035]; National Science Council, Taiwan, Republic of China [NSC95-2320-B-010-041-MY2]; Ministry of Education	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education	This work was supported by Grant V96C1-035 from Taipei Veterans General Hospital, by Grant NSC95-2320-B-010-041-MY2 from the National Science Council, Taiwan, Republic of China, and by a grant from the Ministry of Education, Aim for the Top University Plan.	Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; ARMSTRONG J, 1990, J CELL SCI, V95, P191; Bai BK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002685; Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998; Baudoux P, 1998, ADV EXP MED BIOL, V440, P377; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165; Chan CM, 2007, ARCH BIOCHEM BIOPHYS, V459, P197, DOI 10.1016/j.abb.2007.01.012; Cheung CY, 2005, J VIROL, V79, P7819, DOI 10.1128/JVI.79.12.7819-7826.2005; Choi KS, 2005, J VIROL, V79, P9862, DOI 10.1128/JVI.79.15.9862-9871.2005; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; de Haan CAM, 2000, J VIROL, V74, P4967, DOI 10.1128/JVI.74.11.4967-4978.2000; de Haan CAM, 1998, J VIROL, V72, P6838, DOI 10.1128/JVI.72.8.6838-6850.1998; de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7; Escors D, 2001, J VIROL, V75, P1312, DOI 10.1128/JVI.75.3.1312-1324.2001; Hatakeyama S, 2008, VIROLOGY, V380, P99, DOI 10.1016/j.virol.2008.07.012; Hsieh PK, 2005, J VIROL, V79, P13848, DOI 10.1128/JVI.79.22.13848-13855.2005; Huang Y, 2004, J VIROL, V78, P12557, DOI 10.1128/JVI.78.22.12557-12565.2004; Hurst KR, 2005, J VIROL, V79, P13285, DOI 10.1128/JVI.79.21.13285-13297.2005; JACOBSEGEELS HEL, 1983, J GEN VIROL, V64, P1859, DOI 10.1099/0022-1317-64-9-1859; KLUMPERMAN J, 1994, J VIROL, V68, P6523, DOI 10.1128/JVI.68.10.6523-6534.1994; KRIJNSELOCKER J, 1994, J CELL BIOL, V124, P55, DOI 10.1083/jcb.124.1.55; Kuo L, 2002, J VIROL, V76, P4987, DOI 10.1128/JVI.76.10.4987-4999.2002; Lai CW, 2006, FEBS LETT, V580, P3829, DOI 10.1016/j.febslet.2006.06.003; Lai M M, 1987, Adv Exp Med Biol, V218, P7; LAVIADA MD, 1990, VIRUS RES, V16, P247, DOI 10.1016/0168-1702(90)90051-C; Li GM, 2007, MICROBES INFECT, V9, P96, DOI 10.1016/j.micinf.2006.10.015; LOCKER JK, 1994, J BIOL CHEM, V269, P28263; Luo HB, 2006, INT J BIOCHEM CELL B, V38, P589, DOI 10.1016/j.biocel.2005.10.022; Ma HC, 2008, J BIOMED SCI, V15, P301, DOI 10.1007/s11373-008-9235-1; MACHAMER CE, 1987, J CELL BIOL, V105, P1205, DOI 10.1083/jcb.105.3.1205; MACHAMER CE, 1993, MOL BIOL CELL, V4, P695, DOI 10.1091/mbc.4.7.695; MACHAMER CE, 1990, P NATL ACAD SCI USA, V87, P6944, DOI 10.1073/pnas.87.18.6944; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Narayanan K, 2000, J VIROL, V74, P8127, DOI 10.1128/JVI.74.17.8127-8134.2000; Narayanan K, 2003, J VIROL, V77, P2922, DOI 10.1128/JVI.77.5.2922-2927.2003; Narayanan K, 2001, J VIROL, V75, P9059, DOI 10.1128/JVI.75.19.9059-9067.2001; Ono A, 2001, P NATL ACAD SCI USA, V98, P13925, DOI 10.1073/pnas.241320298; PAGE KA, 1990, J VIROL, V64, P5270, DOI 10.1128/JVI.64.11.5270-5276.1990; PULFORD DJ, 1991, VIRUS RES, V18, P203, DOI 10.1016/0168-1702(91)90019-R; Risco C, 1996, J VIROL, V70, P4773, DOI 10.1128/JVI.70.7.4773-4777.1996; Sambrook J., 2001, MOL CLONING LAB MANU; Satija N, 2007, ANN NY ACAD SCI, V1102, P26, DOI 10.1196/annals.1408.002; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; SPAAN W, 1988, J GEN VIROL, V69, P2939, DOI 10.1099/0022-1317-69-12-2939; Spiegel M, 2005, J VIROL, V79, P2079, DOI 10.1128/JVI.79.4.2079-2086.2005; STURMAN LS, 1980, J VIROL, V33, P449, DOI 10.1128/JVI.33.1.449-462.1980; Sun XJ, 2003, J VIROL, V77, P12543, DOI 10.1128/JVI.77.23.12543-12551.2003; SWIFT AM, 1991, J CELL BIOL, V115, P19, DOI 10.1083/jcb.115.1.19; TO LT, 1991, VET MICROBIOL, V29, P361, DOI 10.1016/0378-1135(91)90143-4; TOOZE J, 1984, EUR J CELL BIOL, V33, P281; TOOZE J, 1985, EUR J CELL BIOL, V37, P203; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; VO D, 2006, FEBS LETT, V580, P968; Wang CT, 1999, J MED VIROL, V59, P180; Wang SM, 2008, J BIOMED SCI, V15, P719, DOI 10.1007/s11373-008-9265-8; Wang SM, 2009, VIROLOGY, V388, P112, DOI 10.1016/j.virol.2009.03.010; Ziebuhr J, 2004, CURR OPIN MICROBIOL, V7, P412, DOI 10.1016/j.mib.2004.06.007	62	46	50	4	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12862	12872		10.1074/jbc.M109.030270	http://dx.doi.org/10.1074/jbc.M109.030270			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20154085	Green Published, hybrid			2022-12-27	WOS:000276787800044
J	Chan, KT; Bennin, DA; Huttenlocher, A				Chan, Keefe T.; Bennin, David A.; Huttenlocher, Anna			Regulation of Adhesion Dynamics by Calpain-mediated Proteolysis of Focal Adhesion Kinase (FAK)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEASE CALPAIN; CELL-MIGRATION; MYOBLAST MIGRATION; CLEAVAGE; SRC; APOPTOSIS; MOTILITY; TRANSFORMATION; PP125(FAK); PAXILLIN	The coordinated and dynamic regulation of adhesions is required for cell migration. We demonstrated previously that limited proteolysis of talin1 by the calcium-dependent protease calpain 2 plays a critical role in adhesion disassembly in fibroblasts (Franco, S.J., Rodgers, M. A., Perrin, B.J., Han, J., Bennin, D. A., Critchley, D. R., and Huttenlocher, A. (2004) Nat. Cell Biol. 6, 977-983). However, little is known about the contribution of other calpain substrates to the regulation of adhesion dynamics. We now provide evidence that calpain 2-mediated proteolysis of focal adhesion kinase (FAK) regulates adhesion dynamics in motile cells. We mapped the preferred calpain cleavage site between the two C-terminal proline-rich regions after Ser-745, resulting in a C-terminal fragment similar in size to the FAK-related non-kinase (FRNK). We generated mutant FAK with a point mutation (V744G) that renders FAK resistant to calpain proteolysis but retains other biochemical properties of FAK. Using time-lapse microscopy, we show that the dynamics of green fluorescent protein-talin1 are impaired in FAK-deficient cells. Expression of wild-type but not calpain-resistant FAK rescues talin dynamics in FAK-deficient cells. Taken together, our findings suggest a novel role for calpain proteolysis of FAK in regulating adhesion dynamics in motile cells.	[Chan, Keefe T.; Bennin, David A.; Huttenlocher, Anna] Univ Wisconsin, Dept Med Microbiol & Immunol, Madison, WI 53706 USA; [Chan, Keefe T.] Univ Wisconsin, Dept Mol & Cellular Pharmacol, Madison, WI 53706 USA; [Chan, Keefe T.; Bennin, David A.; Huttenlocher, Anna] Univ Wisconsin, Dept Pediat, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Huttenlocher, A (corresponding author), Univ Wisconsin, Dept Med Microbiol & Immunol, 4225 Microbial Sci Bldg,1550 Linden Dr, Madison, WI 53706 USA.	huttenlocher@wisc.edu	Chan, Keefe/AAG-4153-2020	Chan, Keefe/0000-0001-6114-3724	National Institutes of Health [R01 CA085862-08]; NATIONAL CANCER INSTITUTE [R01CA085862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA085862-08 (to A.H.).	Barbero S, 2009, CANCER RES, V69, P3755, DOI 10.1158/0008-5472.CAN-08-3937; Bhatt A, 2002, J CELL SCI, V115, P3415; Bougie JK, 2009, J NEUROCHEM, V109, P1129, DOI 10.1111/j.1471-4159.2009.06045.x; Carragher NO, 1999, J CELL BIOL, V147, P619, DOI 10.1083/jcb.147.3.619; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Carragher NO, 2003, CURR BIOL, V13, P1442, DOI 10.1016/S0960-9822(03)00544-X; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; Carragher NO, 2001, J BIOL CHEM, V276, P4270, DOI 10.1074/jbc.M008972200; Chan KT, 2009, J CELL BIOL, V185, P357, DOI 10.1083/jcb.200809110; Cooley MA, 2000, MOL BIOL CELL, V11, P3247, DOI 10.1091/mbc.11.9.3247; Cooray P, 1996, BIOCHEM J, V318, P41, DOI 10.1042/bj3180041; Dedieu S, 2003, BIOL CELL, V95, P615, DOI 10.1016/j.biolcel.2003.09.005; Dedieu S, 2004, EXP CELL RES, V292, P187, DOI 10.1016/j.yexcr.2003.08.014; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Gervais FG, 1998, J BIOL CHEM, V273, P17102, DOI 10.1074/jbc.273.27.17102; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Hamadi A, 2005, J CELL SCI, V118, P4415, DOI 10.1242/jcs.02565; Heidkamp MC, 2002, CIRC RES, V90, P1282, DOI 10.1161/01.RES.0000023201.41774.EA; Hernandez AI, 2003, J BIOL CHEM, V278, P40305, DOI 10.1074/jbc.M307065200; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Libertini SJ, 2005, CANCER RES, V65, P10700, DOI 10.1158/0008-5472.CAN-05-1666; Lim Y, 2008, J CELL BIOL, V180, P187, DOI 10.1083/jcb.200708194; Lokuta MA, 2007, MOL BIOL CELL, V18, P5069, DOI 10.1091/mbc.E07-05-0428; Mian MF, 2008, CHEM-BIOL INTERACT, V171, P57, DOI 10.1016/j.cbi.2007.08.009; Nolan K, 1999, MOL CELL BIOL, V19, P6120; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Palecek SP, 1998, J CELL SCI, V111, P929; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; RUOSLAHTI E, 1982, METHOD ENZYMOL, V82, P803; SCHALLER MD, 1993, MOL CELL BIOL, V13, P785, DOI 10.1128/MCB.13.2.785; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Sieg DJ, 1999, J CELL SCI, V112, P2677; Stabach PR, 1997, BIOCHEMISTRY-US, V36, P57, DOI 10.1021/bi962034i; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Tomar A, 2009, J CELL SCI, V122, P1852, DOI 10.1242/jcs.046870; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wen LP, 1997, J BIOL CHEM, V272, P26056, DOI 10.1074/jbc.272.41.26056; Westhoff MA, 2004, MOL CELL BIOL, V24, P8113, DOI 10.1128/MCB.24.18.8113-8133.2004; Zamir E, 1999, J CELL SCI, V112, P1655	47	153	158	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11418	11426		10.1074/jbc.M109.090746	http://dx.doi.org/10.1074/jbc.M109.090746			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150423	Green Published, hybrid			2022-12-27	WOS:000276286200048
J	Grigg, JC; Cooper, JD; Cheung, J; Heinrichs, DE; Murphy, MEP				Grigg, Jason C.; Cooper, John D.; Cheung, Johnson; Heinrichs, David E.; Murphy, Michael E. P.			The Staphylococcus aureus Siderophore Receptor HtsA Undergoes Localized Conformational Changes to Enclose Staphyloferrin A in an Arginine-rich Binding Pocket	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; MEDIATED IRON ACQUISITION; TREPONEMA-PALLIDUM TROA; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; BACILLUS-SUBTILIS; PROTEIN FHUD; ANTIBIOTIC ALBOMYCIN; MONOCLINIC CRYSTALS	Staphylococcus aureus uses several efficient iron acquisition strategies to overcome iron limitation. Recently, the genetic locus encoding biosynthetic enzymes for the iron chelating molecule, staphyloferrin A (SA), was determined. S. aureus synthesizes and secretes SA into its environment to scavenge iron. The membrane-anchored ATP binding cassette-binding protein, HtsA, receives the ferric-chelate for import into the cell. Recently, we determined the apoHtsA crystal structure, the first siderophore receptor from Gram-positive bacteria to be structurally characterized. Herein we present the x-ray crystal structure of the HtsA-ferric-SA complex. HtsA adopts a class III binding protein fold composed of separate N- and C-terminal domains bridged by a single alpha-helix. Recombinant HtsA can efficiently sequester ferric-SA from S. aureus culture supernatants where it is bound within the pocket formed between distinct N- and C-terminal domains. A basic patch composed mainly of six Arg residues contact the negatively charged siderophore, securing it within the pocket. The x-ray crystal structures from two different ligand-bound crystal forms were determined. The structures represent the first structural characterization of an endogenous alpha-hydroxycarboxylate-type siderophore-receptor complex. One structure is in an open form similar to apoHtsA, whereas the other is in a more closed conformation. The conformational change is highlighted by isolated movement of three loops within the C-terminal domain, a domain movement unique to known class III binding protein structures.	[Grigg, Jason C.; Murphy, Michael E. P.] Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Cooper, John D.; Cheung, Johnson; Heinrichs, David E.] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	University of British Columbia; Western University (University of Western Ontario)	Murphy, MEP (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada.	Michael.Murphy@ubc.ca	Heinrichs, David/ABD-5702-2021; Murphy, Michael/R-6805-2017	Murphy, Michael/0000-0003-2589-0014; Heinrichs, David/0000-0002-7217-2456	Canadian Institutes of Health [MOP-49597, MOP-38002]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grants MOP-49597 and MOP-38002 (to M. E. P. M. and D. E. H., respectively).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Annamalai R, 2004, J BACTERIOL, V186, P3578, DOI 10.1128/JB.186.11.3578-3589.2004; Baichoo N, 2002, MOL MICROBIOL, V45, P1613, DOI 10.1046/j.1365-2958.2002.03113.x; Beasley FC, 2010, J INORG BIOCHEM, V104, P282, DOI 10.1016/j.jinorgbio.2009.09.011; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Borths EL, 2002, P NATL ACAD SCI USA, V99, P16642, DOI 10.1073/pnas.262659699; Braun V, 2007, J BACTERIOL, V189, P6913, DOI 10.1128/JB.00884-07; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cabrera G, 2001, APPL ENVIRON MICROB, V67, P1001, DOI 10.1128/AEM.67.2.1001-1003.2001; *CCPR, 1994, ACTA CRYSTALLOGR D, V50, P760; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Clarke SR, 2004, MOL MICROBIOL, V51, P1509, DOI 10.1111/j.1365-2958.2003.03938.x; Clarke TE, 2000, NAT STRUCT BIOL, V7, P287; Clarke TE, 2002, J BIOL CHEM, V277, P13966, DOI 10.1074/jbc.M109385200; Claverys JP, 2001, RES MICROBIOL, V152, P231, DOI 10.1016/S0923-2508(01)01195-0; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; Cobessi D, 2005, J MOL BIOL, V347, P121, DOI 10.1016/j.jmb.2005.01.021; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; DeLano W.L, PYMOL MOL GRAPHICS S; DRECHSEL H, 1993, BIOMETALS, V6, P185; Drechsel H, 2005, BIOMETALS, V18, P75, DOI 10.1007/s10534-004-5774-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; Ferguson AD, 2000, PROTEIN SCI, V9, P956, DOI 10.1110/ps.9.5.956; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Goetz DH, 2002, MOL CELL, V10, P1033, DOI 10.1016/S1097-2765(02)00708-6; Grigg JC, 2007, J BIOL CHEM, V282, P28815, DOI 10.1074/jbc.M704602200; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; HAAG H, 1994, FEMS MICROBIOL LETT, V115, P125; Hamdane D, 2009, ACTA CRYSTALLOGR D, V65, P388, DOI 10.1107/S0907444909003382; Heitmann D, 2008, ACTA CRYSTALLOGR D, V64, P993, DOI 10.1107/S0907444908019197; Ho WW, 2007, J BIOL CHEM, V282, P35796, DOI 10.1074/jbc.M706761200; Hoegy FO, 2005, J BIOL CHEM, V280, P20222, DOI 10.1074/jbc.M500776200; Hoette TM, 2008, J AM CHEM SOC, V130, P17584, DOI 10.1021/ja8074665; Holmes MA, 2005, STRUCTURE, V13, P29, DOI 10.1016/j.str.2004.10.009; Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; KONETSCHNYRAPP S, 1990, EUR J BIOCHEM, V191, P65, DOI 10.1111/j.1432-1033.1990.tb19094.x; Krewulak KD, 2005, BIOMETALS, V18, P375, DOI 10.1007/s10534-005-3712-z; Lee WC, 2008, J BIOL CHEM, V283, P30957, DOI 10.1074/jbc.M709486200; Lee YH, 2002, J BACTERIOL, V184, P2300, DOI 10.1128/JB.184.8.2300-2304.2002; Lee YH, 1999, NAT STRUCT BIOL, V6, P628; Leslie AGW, 1992, JOINT CCP4 ESF EACMB; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; MEIWES J, 1990, FEMS MICROBIOL LETT, V67, P201, DOI 10.1111/j.1574-6968.1990.tb13863.x; Muller A, 2006, ANGEW CHEM INT EDIT, V45, P5132, DOI 10.1002/anie.200601198; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Peuckert F, 2009, ANGEW CHEM INT EDIT, V48, P7924, DOI 10.1002/anie.200902495; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Radtke AL, 2006, CELL MICROBIOL, V8, P1720, DOI 10.1111/j.1462-5822.2006.00795.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; ROHRBACH MR, 1995, J BACTERIOL, V177, P7186, DOI 10.1128/jb.177.24.7186-7193.1995; Sebulsky MT, 2000, J BACTERIOL, V182, P4394, DOI 10.1128/JB.182.16.4394-4400.2000; Sebulsky MT, 2004, J BIOL CHEM, V279, P53152, DOI 10.1074/jbc.M409793200; Sebulsky MT, 2003, J BIOL CHEM, V278, P49890, DOI 10.1074/jbc.M305073200; Sebulsky MT, 2001, J BACTERIOL, V183, P4994, DOI 10.1128/JB.183.17.4994-5000.2001; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Shi R, 2009, PROTEINS, V75, P598, DOI 10.1002/prot.22272; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Speziali CD, 2006, J BACTERIOL, V188, P2048, DOI 10.1128/JB.188.6.2048-2055.2006; Stojiljkovic I, 2002, DNA CELL BIOL, V21, P281, DOI 10.1089/104454902753759708; Sultana A, 2007, ACTA CRYSTALLOGR D, V63, P149, DOI 10.1107/S0907444906044271; TAM R, 1993, MICROBIOL REV, V57, P320, DOI 10.1128/MMBR.57.2.320-346.1993; Taylor JM, 2002, MOL MICROBIOL, V43, P1603, DOI 10.1046/j.1365-2958.2002.02850.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Weems JJ, 2001, POSTGRAD MED, V110, P24, DOI 10.3810/pgm.2001.10.1042; Wittmann JG, 2007, ACTA CRYSTALLOGR D, V63, P744, DOI 10.1107/S0907444907016605; Zawadzka AM, 2009, P NATL ACAD SCI USA, V106, P21854, DOI 10.1073/pnas.0904793106; Zawadzka AM, 2009, BIOCHEMISTRY-US, V48, P3645, DOI 10.1021/bi8018674	83	57	59	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11162	11171		10.1074/jbc.M109.097865	http://dx.doi.org/10.1074/jbc.M109.097865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147287	Green Published, hybrid			2022-12-27	WOS:000276286200021
J	Dron, M; Moudjou, M; Chapuis, J; Salamat, MKF; Bernard, J; Cronier, S; Langevin, C; Laude, H				Dron, Michel; Moudjou, Mohammed; Chapuis, Jerome; Salamat, Muhammad Khalid Farooq; Bernard, Julie; Cronier, Sabrina; Langevin, Christelle; Laude, Hubert			Endogenous Proteolytic Cleavage of Disease-associated Prion Protein to Produce C2 Fragments Is Strongly Cell- and Tissue-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY; SHEEP SCRAPIE; NEURONAL CELLS; CULTURED-CELLS; BIOCHEMICAL FINGERPRINTS; COPPER-BINDING; NORMAL BRAIN; MOUSE-BRAIN; PRPSC TYPES	The abnormally folded form of the prion protein (PrPSc) accumulating in nervous and lymphoid tissues of prion-infected individuals can be naturally cleaved to generate a N-terminaltruncated fragment called C2. Information about the identity of the cellular proteases involved in this process and its possible role in prion biology has remained limited and controversial. We investigated PrPSc N-terminal trimming in different cell lines and primary cultured nerve cells, and in the brain and spleen tissue from transgenic mice infected by ovine and mouse prions. We found the following: (i) the full-length to C2 ratio varies considerably depending on the infected cell or tissue. Thus, in primary neurons and brain tissue, PrPSc accumulated predominantly as untrimmed species, whereas efficient trimming occurred in Rov and MovS cells, and in spleen tissue. (ii) Although C2 is generally considered to be the counterpart of the PrPSc proteinase K-resistant core, the N termini of the fragments cleaved in vivo and in vitro can actually differ, as evidenced by a different reactivity toward the Pc248 anti-octarepeat antibody. (iii) In lysosome-impaired cells, the ratio of full-length versus C2 species dramatically increased, yet efficient prion propagation could occur. Moreover, cathepsin but not calpain inhibitors markedly inhibited C2 formation, and in vitro cleavage by cathepsins B and L produced PrPSc fragments lacking the Pc248 epitope, strongly arguing for the primary involvement of acidic hydrolases of the endolysosomal compartment. These findings have implications on the molecular analysis of PrPSc and cell pathogenesis of prion infection.	[Dron, Michel; Moudjou, Mohammed; Chapuis, Jerome; Salamat, Muhammad Khalid Farooq; Bernard, Julie; Cronier, Sabrina; Langevin, Christelle; Laude, Hubert] INRA, Virol Immunol Mol U892, F-78350 Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Laude, H (corresponding author), Batiment 440, F-78350 Jouy En Josas, France.	hubert.laude@jouy.inra.fr	DRON, Michel/M-7093-2017	Langevin, Christelle/0000-0002-6013-4460	Institut National de la Recherche Agronomique	Institut National de la Recherche Agronomique	This work was supported by the Institut National de la Recherche Agronomique.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Archer F, 2004, J VIROL, V78, P482, DOI 10.1128/JVI.78.1.482-490.2004; Arima K, 2005, J VIROL, V79, P7104, DOI 10.1128/JVI.79.11.7104-7112.2005; Arjona A, 2004, P NATL ACAD SCI USA, V101, P8768, DOI 10.1073/pnas.0400158101; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; BORCHELT DR, 1993, GLYCOBIOLOGY, V3, P319, DOI 10.1093/glycob/3.4.319; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2007, J VIROL, V81, P13794, DOI 10.1128/JVI.01502-07; Deslys JP, 2001, NATURE, V409, P476, DOI 10.1038/35054134; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Dron M, 2009, J GEN VIROL, V90, P2050, DOI 10.1099/vir.0.010082-0; Ecroyd H, 2004, BIOL REPROD, V71, P993, DOI 10.1095/biolreprod.104.029801; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Flechsig E, 2000, NEURON, V27, P399, DOI 10.1016/S0896-6273(00)00046-5; Gambetti P, 2003, BRIT MED BULL, V66, P213, DOI 10.1093/bmb/66.1.213; Gielbert A, 2009, J MASS SPECTROM, V44, P384, DOI 10.1002/jms.1516; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; Howells LC, 2008, BIOMARKERS, V13, P393, DOI [10.1080/13547500801903719, 10.1080/13547500801903719 ]; Iwamaru Y, 2007, J VIROL, V81, P1524, DOI 10.1128/JVI.01379-06; Jeffrey M, 2007, NEUROPATH APPL NEURO, V33, P373, DOI 10.1111/j.1365-2990.2007.00868.x; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; Jeffrey M, 2009, BRAIN PATHOL, V19, P1, DOI 10.1111/j.1750-3639.2008.00150.x; Jimenez-Huete A, 1998, AM J PATHOL, V153, P1561, DOI 10.1016/S0002-9440(10)65744-6; JORDANS S, 2009, BMC BIOCH, V22, P10; Langeveld Jan P M, 2006, BMC Vet Res, V2, P19, DOI 10.1186/1746-6148-2-19; Luhr KM, 2004, NEUROREPORT, V15, P1663, DOI 10.1097/01.wnr.0000134931.81690.34; MCKINLEY MP, 1991, LAB INVEST, V65, P622; Moudjou M, 2004, J VIROL, V78, P9270, DOI 10.1128/JVI.78.17.9270-9276.2004; Moudjou M, 2001, J GEN VIROL, V82, P2017, DOI 10.1099/0022-1317-82-8-2017; Moudjou M, 2007, NEUROCHEM INT, V50, P689, DOI 10.1016/j.neuint.2007.01.001; Muller H, 2005, BIOCHEM J, V388, P371, DOI 10.1042/BJ20041291; Notari S, 2007, LAB INVEST, V87, P1103, DOI 10.1038/labinvest.3700676; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Owen JP, 2007, MOL BIOTECHNOL, V35, P161, DOI 10.1007/BF02686111; Pan T, 2005, J VIROL, V79, P934, DOI 10.1128/JVI.79.2.934-943.2005; Pan T, 2005, J NEUROCHEM, V92, P132, DOI 10.1111/j.1471-4159.2004.02859.x; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Pimpinelli F, 2005, EUR J NEUROSCI, V21, P2063, DOI 10.1111/j.1460-9568.2005.04049.x; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Qi YP, 1997, J NEUROSCI, V17, P1217; Sakudo A, 2005, BIOCHEM BIOPH RES CO, V333, P448, DOI 10.1016/j.bbrc.2005.05.128; Shaked Y, 2001, J VIROL, V75, P7872, DOI 10.1128/JVI.75.17.7872-7874.2001; STAHL N, 1993, BIOCHEMISTRY-US, V32, P1991, DOI 10.1021/bi00059a016; Taguchi Y, 2009, MOL BIOL CELL, V20, P233, DOI 10.1091/mbc.E08-06-0635; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Vincent B, 2001, J BIOL CHEM, V276, P37743; Wadsworth JDF, 2007, BBA-MOL BASIS DIS, V1772, P598, DOI 10.1016/j.bbadis.2007.02.010; Westergard L, 2007, BBA-MOL BASIS DIS, V1772, P629, DOI 10.1016/j.bbadis.2007.02.011; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Zanusso G, 2002, ELECTROPHORESIS, V23, P347, DOI 10.1002/1522-2683(200202)23:2<347::AID-ELPS347>3.0.CO;2-1; Zeng FN, 2003, J NEUROCHEM, V84, P480, DOI 10.1046/j.1471-4159.2003.01529.x	61	49	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10252	10264		10.1074/jbc.M109.083857	http://dx.doi.org/10.1074/jbc.M109.083857			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20154089	Green Published, hybrid			2022-12-27	WOS:000276264600009
J	Hansen, KK; Stafflinger, E; Schneider, M; Hauser, F; Cazzamali, G; Williamson, M; Kollmann, M; Schachtner, J; Grimmelikhuijzen, CJP				Hansen, Karina K.; Stafflinger, Elisabeth; Schneider, Martina; Hauser, Frank; Cazzamali, Giuseppe; Williamson, Michael; Kollmann, Martin; Schachtner, Joachim; Grimmelikhuijzen, Cornelis J. P.			Discovery of a Novel Insect Neuropeptide Signaling System Closely Related to the Insect Adipokinetic Hormone and Corazonin Hormonal Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; MALARIA MOSQUITO; MOLECULAR-IDENTIFICATION; NEUROHORMONE GPCRS; DROSOPHILA; GENOME; GENES; EXPRESSION; PEPTIDE; CLONING	Neuropeptides and their G protein-coupled receptors (GPCRs) play a central role in the physiology of insects. One large family of insect neuropeptides are the adipokinetic hormones (AKHs), which mobilize lipids and carbohydrates from the insect fat body. Other peptides are the corazonins that are structurally related to the AKHs but represent a different neuropeptide signaling system. We have previously cloned an orphan GPCR from the malaria mosquito Anopheles gambiae that was structurally intermediate between the A. gambiae AKH and corazonin GPCRs. Using functional expression of the receptor in cells in cell culture, we have now identified the ligand for this orphan receptor as being pQVTFSRD-WNAamide, a neuropeptide that is structurally intermediate between AKH and corazonin and that we therefore named ACP (AKH/corazonin-related peptide). ACP does not activate the A. gambiae AKH and corazonin receptors and, vice versa, AKH and corazonin do not activate the ACP receptor, showing that the ACP/receptor couple is an independent and so far unknown peptidergic signaling system. Because ACP is structurally intermediate between AKH and corazonin and the ACP receptor between the AKH and corazonin receptors, this is a prominent example of receptor/ligand co-evolution, probably originating from receptor and ligand gene duplications followed by mutations and evolutionary selection, thereby yielding three independent hormonal systems. The ACP signaling system occurs in the mosquitoes A. gambiae, Aedes aegypti, and Culex pipiens (Diptera), the silkworm Bombyx mori (Lepidoptera), the red flour beetle Tribolium castaneum (Coleoptera), the parasitic wasp Nasonia vitripennis (Hymenoptera), and the bug Rhodnius prolixus (Hemiptera). However, the ACP system is not present in 12 Drosophila species (Diptera), the honeybee Apis mellifera (Hymenoptera), the pea aphid Acyrthosiphon pisum (Hemiptera), the body louse Pediculus humanus (Phthiraptera), and the crustacean Daphnia pulex, indicating that it has been lost several times during arthropod evolution. In particular, this frequent loss of hormonal systems is unique for arthropods compared with vertebrates.	[Hansen, Karina K.; Stafflinger, Elisabeth; Schneider, Martina; Hauser, Frank; Cazzamali, Giuseppe; Williamson, Michael; Grimmelikhuijzen, Cornelis J. P.] Univ Copenhagen, Ctr Funct & Comparat Insect Genom, Dept Biol, DK-2100 Copenhagen, Denmark; [Kollmann, Martin; Schachtner, Joachim] Univ Marburg, Dept Anim Physiol, D-35032 Marburg, Germany	University of Copenhagen; Philipps University Marburg	Grimmelikhuijzen, CJP (corresponding author), Univ Copenhagen, Ctr Funct & Comparat Insect Genom, Dept Biol, DK-2100 Copenhagen, Denmark.	cgrimmelikhuijzen@bio.ku.dk	Hauser, Frank/M-2952-2014; Schachtner, Joachim/D-5522-2009; Schachtner, Joachim/AAG-1101-2020	Hauser, Frank/0000-0001-5563-2345; Schachtner, Joachim/0000-0001-7268-0699; Grimmelikhuijzen, Cornelis Johannes Pieter/0000-0001-6486-2046	Danish Research Agency; Novo Nordisk Foundation; Deutsche Forschungsgemeinschaft	Danish Research Agency; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Danish Research Agency, Novo Nordisk Foundation, and Deutsche Forschungsgemeinschaft.	Belmont M, 2006, BIOCHEM BIOPH RES CO, V344, P160, DOI 10.1016/j.bbrc.2006.03.117; BIRNBAUMER M, 1992, NATURE, V357, P333, DOI 10.1038/357333a0; Cazzamali G, 2003, BIOCHEM BIOPH RES CO, V303, P146, DOI 10.1016/S0006-291X(03)00302-4; Cazzamali G, 2002, BIOCHEM BIOPH RES CO, V298, P31, DOI 10.1016/S0006-291X(02)02398-7; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; Dreborg S, 2008, P NATL ACAD SCI USA, V105, P15487, DOI 10.1073/pnas.0805590105; Gade G, 1997, PHYSIOL REV, V77, P963, DOI 10.1152/physrev.1997.77.4.963; Glenner H, 2006, SCIENCE, V314, P1883, DOI 10.1126/science.1129844; Hauser F, 2008, FRONT NEUROENDOCRIN, V29, P142, DOI 10.1016/j.yfrne.2007.10.003; Hauser F, 2006, PROG NEUROBIOL, V80, P1, DOI 10.1016/j.pneurobio.2006.07.005; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Kaufmann C, 2006, INSECT BIOCHEM MOLEC, V36, P466, DOI 10.1016/j.ibmb.2006.03.009; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; KIMURA T, 1992, NATURE, V356, P526, DOI 10.1038/356526a0; Li B, 2008, GENOME RES, V18, P113, DOI 10.1101/gr.6714008; Lindemans M, 2009, P NATL ACAD SCI USA, V106, P1642, DOI 10.1073/pnas.0809881106; Nassel DR, 2002, PROG NEUROBIOL, V68, P1, DOI 10.1016/S0301-0082(02)00057-6; Park JI, 2005, ENDOCRINE, V26, P267, DOI 10.1385/ENDO:26:3:267; Park Y, 2002, P NATL ACAD SCI USA, V99, P11423, DOI 10.1073/pnas.162276199; Riehle MA, 2002, SCIENCE, V298, P172, DOI 10.1126/science.1076827; Salaneck E, 2008, GENE, V409, P61, DOI 10.1016/j.gene.2007.11.011; Siegert KJ, 1999, FEBS LETT, V447, P237, DOI 10.1016/S0014-5793(99)00299-9; Stables J, 1997, ANAL BIOCHEM, V252, P115, DOI 10.1006/abio.1997.2308; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; Staubli F, 2002, P NATL ACAD SCI USA, V99, P3446, DOI 10.1073/pnas.052556499; Tawfik AI, 1999, P NATL ACAD SCI USA, V96, P7083, DOI 10.1073/pnas.96.12.7083; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VEENSTRA JA, 1989, FEBS LETT, V250, P231, DOI 10.1016/0014-5793(89)80727-6; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Zitnan D, 2007, GEN COMP ENDOCR, V153, P88, DOI 10.1016/j.ygcen.2007.04.002	33	113	116	3	42	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10736	10747		10.1074/jbc.M109.045369	http://dx.doi.org/10.1074/jbc.M109.045369			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20068045	Green Published, hybrid			2022-12-27	WOS:000276264600060
J	Kim, SH; Richardson, M; Chinnakannu, K; Bai, VU; Menon, M; Barrack, ER; Reddy, GPV				Kim, Sahn-Ho; Richardson, Michelle; Chinnakannu, Kannagi; Bai, V. Uma; Menon, Mani; Barrack, Evelyn R.; Reddy, G. Prem-Veer			Androgen Receptor Interacts with Telomeric Proteins in Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRF2; TIN2; EXPRESSION; DNA; LOCALIZATION; MAINTENANCE; DYSFUNCTION; REGULATOR; PHENOTYPE; COMPLEX	The telomeric complex, shelterin, plays a critical role in protecting chromosome ends from erosion, and disruption of these complexes can lead to chromosomal instability culminating in cell death or malignant transformation. We reported previously that dominant-negative mutants of one of the telomeric proteins called TIN2 cause death of androgen receptor (AR)-negative but not AR-positive prostate cancer cells, raising the question of a possible role of AR in the structural stability of telomeric complexes. Consistent with this possibility, in the present study, we observed that the AR antagonist Casodex (bicalutamide) disrupted telomeric complexes in AR-positive LNCaP cells but not in AR-negative PC-3 cells. Immunofluorescent studies revealed colocalization of TIN2 and AR. Reciprocal immunoprecipitation studies showed association of AR with telomeric proteins. Furthermore, telomeric proteins were overexpressed in prostate cancer cells compared with normal prostate epithelial cells, and sucrose density gradient analysis showed co-sedimentation of AR with telomeric proteins in a shelterin-like mega complex. Together, these observations suggest an allosteric role of AR in telomere complex stability in prostate cancer cells and suggest that AR-antagonist Casodex-mediated cell death may be due to telomere complex disruption.	[Kim, Sahn-Ho; Richardson, Michelle; Chinnakannu, Kannagi; Bai, V. Uma; Menon, Mani; Barrack, Evelyn R.; Reddy, G. Prem-Veer] Henry Ford Hosp, Vattikuti Urol Inst, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital	Kim, SH (corresponding author), Henry Ford Hlth Syst, 1 Ford Pl, Detroit, MI 48202 USA.	skim3@hfhs.org			Henry Ford Health System	Henry Ford Health System	This work was funded by Institutional Research Support from the Henry Ford Health System (to S. K.).	Bai VU, 2007, P NATL ACAD SCI USA, V104, P2343, DOI 10.1073/pnas.0610504104; Cifuentes E, 2004, P NATL ACAD SCI USA, V101, P464, DOI 10.1073/pnas.0307161101; Cifuentes E, 2003, J CELL PHYSIOL, V195, P337, DOI 10.1002/jcp.10317; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Else T, 2009, CANCER CELL, V15, P465, DOI 10.1016/j.ccr.2009.04.011; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 2008, J CELL BIOL, V181, P447, DOI 10.1083/jcb.200710028; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Legrier ME, 2009, INT J CANCER, V124, P1103, DOI 10.1002/ijc.24073; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Mayeur GL, 2005, J BIOL CHEM, V280, P10827, DOI 10.1074/jbc.M413336200; Murthy S, 2006, J CELL PHYSIOL, V209, P711, DOI 10.1002/jcp.20842; Nakanishi K, 2003, CLIN CANCER RES, V9, P1105; NOGUCHI H, 1983, CELL, V32, P443, DOI 10.1016/0092-8674(83)90464-6; Oh BK, 2005, AM J PATHOL, V166, P73, DOI 10.1016/S0002-9440(10)62233-X; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Poncet D, 2008, BLOOD, V111, P2388, DOI 10.1182/blood-2007-09-111245; REDDY GPV, 1983, NATURE, V304, P86; Rodier F, 2005, INT J BIOCHEM CELL B, V37, P977, DOI 10.1016/j.biocel.2004.10.012; ROSEN S, 2004, IVD TECH, V10, P39; Schoeftner S, 2009, P NATL ACAD SCI USA, V106, P19387, DOI 10.1073/pnas.0909265106; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Song K, 2000, FEBS LETT, V481, P81, DOI 10.1016/S0014-5793(00)01958-X; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; VELDSCHOLTE J, 1992, BIOCHEMISTRY-US, V31, P2393, DOI 10.1021/bi00123a026; Waller AS, 2000, J MOL ENDOCRINOL, V24, P339, DOI 10.1677/jme.0.0240339; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhan P, 2002, J STEROID BIOCHEM, V83, P101, DOI 10.1016/S0960-0760(02)00275-3; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	32	22	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10472	10476		10.1074/jbc.M109.098798	http://dx.doi.org/10.1074/jbc.M109.098798			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110352	Green Published, hybrid			2022-12-27	WOS:000276264600033
J	Kthiri, F; Le, HT; Gautier, V; Caldas, T; Malki, A; Landoulsi, A; Bohn, C; Bouloc, P; Richarme, G				Kthiri, Fatoum; Le, Hai-Tuong; Gautier, Valerie; Caldas, Teresa; Malki, Abderrahim; Landoulsi, Ahmed; Bohn, Chantal; Bouloc, Philippe; Richarme, Gilbert			Protein Aggregation in a Mutant Deficient in YajL, the Bacterial Homolog of the Parkinsonism-associated Protein DJ-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; RIBOSOME BIOGENESIS; CHAPERONE ACTIVITY; HYDROGEN-PEROXIDE; GENE-EXPRESSION; ALPHA-SYNUCLEIN; ATP; HSP31; DNAK	YajL is the closest prokaryotic homolog of the parkinsonism-associated protein DJ-1 (40% sequence identity and similar three-dimensional structure), a protein of unknown function involved in the cellular response to oxidative stress. We report here that a yajL mutant of Escherichia coli displays an increased sensitivity to oxidative stress. It also exhibits a protein aggregation phenotype in aerobiosis, but not in anaerobiosis or in aerobic cells overexpressing superoxide dismutase, suggesting that protein aggregation depends on the presence of reactive oxygen species produced by respiratory chains. The protein aggregation phenotype of the yajL mutant, which can be rescued by the wildtype yajL gene, but not by the corresponding cysteine 106 mutant allele, is similar to that of multiple mutants deficient in superoxide dismutases and catalases, although intracellular hydrogen peroxide levels were not increased in the yajL mutant, suggesting that protein aggregation in this strain does not result from a hydrogen peroxide detoxification defect. Aggregation-prone proteins included 17 ribosomal proteins, the ATP synthase beta subunit, flagellin, and the outer membrane proteins OmpA and PAL; all of them are part of multiprotein complexes, suggesting that YajL might be involved in optimal expression of these complexes, especially during oxidative stress. YajL stimulated the renaturation of urea-unfolded citrate synthase and the solubilization of the urea-unfolded ribosomal proteins S1 and L3 and was more efficient as a chaperone in its oxidized form than in its reduced form. The mRNA levels of several aggregated proteins of the yajL mutant were severely affected, suggesting that YajL also acts at the level of gene expression. These two functions of YajL might explain the protein aggregation phenotype of the yajL mutant.	[Kthiri, Fatoum; Le, Hai-Tuong; Gautier, Valerie; Caldas, Teresa; Malki, Abderrahim; Richarme, Gilbert] Univ Paris 07, Inst Jacques Monod, F-75013 Paris, France; [Kthiri, Fatoum; Landoulsi, Ahmed] Fac Sci Bizerte, Lab Biochim & Biol Mol, Zarzouna 7021, Bizerte, Tunisia; [Bohn, Chantal; Bouloc, Philippe] Univ Paris 11, Lab Signalisat & Reseaux Regulat Bacteriens, CNRS, Inst Genet & Microbiol,UMR8621, F-91405 Orsay, France	UDICE-French Research Universities; Universite Paris Cite; Universite de Carthage; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Richarme, G (corresponding author), Univ Paris 07, Inst Jacques Monod, 15 Rue Helene Brion, F-75013 Paris, France.	richarme@paris7.jussieu.fr	Bouloc, Philippe/ABA-5732-2021	Bouloc, Philippe/0000-0003-4601-3387; Landoulsi, Ahmed/0000-0002-5101-7641; Bohn, Chantal/0000-0003-1569-9072				Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Al Refaii A, 2009, MOL MICROBIOL, V71, P748, DOI 10.1111/j.1365-2958.2008.06561.x; Aldridge P, 2006, J BACTERIOL, V188, P4487, DOI 10.1128/JB.00094-06; Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bisaglia M, 2003, J BIOL CHEM, V278, P15261, DOI 10.1074/jbc.M212731200; Blackinton J, 2009, NEUROSCI LETT, V452, P8, DOI 10.1016/j.neulet.2008.12.053; Caldas T, 2000, J BIOL CHEM, V275, P16414, DOI 10.1074/jbc.M001854200; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; Campbell BCV, 2000, NEUROBIOL DIS, V7, P192, DOI 10.1006/nbdi.2000.0286; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Clavel T, 1998, MOL MICROBIOL, V29, P359, DOI 10.1046/j.1365-2958.1998.00945.x; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Collier J, 2004, J BIOL CHEM, V279, P54193, DOI 10.1074/jbc.M314012200; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Culver GM, 1999, RNA, V5, P832, DOI 10.1017/S1355838299990714; ElYaagoubi A, 1996, MICROBIOL-SGM, V142, P2595; Ferrer I, 2007, NEUROSCI LETT, V415, P205, DOI 10.1016/j.neulet.2007.01.026; Fredriksson A, 2006, MOL MICROBIOL, V59, P350, DOI 10.1111/j.1365-2958.2005.04947.x; Fredriksson A, 2005, J BACTERIOL, V187, P4207, DOI 10.1128/JB.187.12.4207-4213.2005; GEORGELLIS D, 1995, MOL MICROBIOL, V16, P1259, DOI 10.1111/j.1365-2958.1995.tb02347.x; GonzalezFlecha B, 1997, J BACTERIOL, V179, P382, DOI 10.1128/jb.179.2.382-388.1997; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Jin JH, 2007, MOL CELL PROTEOMICS, V6, P845, DOI 10.1074/mcp.M600182-MCP200; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kaczanowska M, 2007, MICROBIOL MOL BIOL R, V71, P477, DOI 10.1128/MMBR.00013-07; Kushnirov VV, 2006, METHODS, V39, P50, DOI 10.1016/j.ymeth.2006.04.007; LAGONI OR, 1993, J BACTERIOL, V175, P5791, DOI 10.1128/JB.175.18.5791-5797.1993; Maisonneuve E, 2008, J BACTERIOL, V190, P887, DOI 10.1128/JB.01603-07; Malki A, 2005, J BIOL CHEM, V280, P14420, DOI 10.1074/jbc.M408296200; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; OSIPIUK J, 1993, J BIOL CHEM, V268, P4821; Papapetropoulos S, 2006, GENE EXPRESSION, V13, P205, DOI 10.3727/000000006783991827; Quigley PM, 2003, P NATL ACAD SCI USA, V100, P3137, DOI 10.1073/pnas.0530312100; Sambrook J., 2001, MOL CLONING LAB MANU; Sastry MSR, 2002, J BIOL CHEM, V277, P46026, DOI 10.1074/jbc.M205800200; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Semrad K, 2004, RNA, V10, P1855, DOI 10.1261/rna.7121704; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; Udekwu KI, 2005, GENE DEV, V19, P2355, DOI 10.1101/gad.354405; van der Brug MP, 2008, P NATL ACAD SCI USA, V105, P10244, DOI 10.1073/pnas.0708518105; Wang X, 2008, PRION, V2, P57, DOI 10.4161/pri.2.2.6746; Watanabe S, 2007, BIOSCI BIOTECH BIOCH, V71, P279, DOI 10.1271/bbb.60647; Wei Y, 2007, PLOS COMPUT BIOL, V3, P120, DOI 10.1371/journal.pcbi.0030010; Wilson MA, 2005, J MOL BIOL, V353, P678, DOI 10.1016/j.jmb.2005.08.033; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Yoon H, 2008, J MICROBIOL BIOTECHN, V18, P228; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	52	30	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10328	10336		10.1074/jbc.M109.077529	http://dx.doi.org/10.1074/jbc.M109.077529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20124404	Green Published, hybrid			2022-12-27	WOS:000276264600017
J	Rouillon, C; White, MF				Rouillon, Christophe; White, Malcolm F.			The XBP-Bax1 Helicase-Nuclease Complex Unwinds and Cleaves DNA IMPLICATIONS FOR EUKARYAL AND ARCHAEAL NUCLEOTIDE EXCISION REPAIR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL INTERACTIONS; FACTOR TFIIH; XPD; PROTEIN; DAMAGE; TRANSCRIPTION; RECOGNITION; PHENOTYPES; MUTATIONS; MECHANISM	XPB helicase is an integral part of transcription factor TFIIH, required for both transcription initiation and nucleotide excision repair (NER). Along with the XPD helicase, XPB plays a crucial but only partly understood role in defining and extending the DNA repair bubble around lesions in NER. Archaea encode clear homologues of XPB and XPD, and structural studies of these proteins have yielded key insights relevant to the eukaryal system. Here we show that archaeal XPB functions with a structure-specific nuclease, Bax1, as a helicase-nuclease machine that unwinds and cleaves model NER substrates. DNA bubbles are extended by XPB and cleaved by Bax1 at a position equivalent to that cut by the XPG nuclease in eukaryal NER. The helicase activity of archaeal XPB is dependent on the conserved Thumb domain, which may act as the helix breaker. The N-terminal damage recognition domain of XPB is shown to be crucial for XPB-Bax1 activity and may be unique to the archaea. These findings have implications for the role of XPB in both archaeal and eukaryal NER and for the evolution of the NER pathway. XPB is shown to be a very limited helicase that can act on small DNAbubbles and open a defined region of the DNA duplex. The specialized functions of the accessory domains of XPB are now more clearly delineated. This is also the first direct demonstration of a repair function for archaeal XPB and suggests strongly that the role of XPB in transcription occurred later in evolution than that in repair.	[Rouillon, Christophe; White, Malcolm F.] Univ St Andrews, Ctr Biomol Sci, Haugh KY16 9ST, Fife, Scotland	University of St Andrews	White, MF (corresponding author), Univ St Andrews, Ctr Biomol Sci, Haugh KY16 9ST, Fife, Scotland.	mfw2@st-and.ac.uk	White, Malcolm F/A-6055-2010	White, Malcolm F/0000-0003-1543-9342; Rouillon, Christophe/0000-0003-4038-315X	Cancer Research UK [C22223]	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK Grant C22223.	Andressoo JO, 2009, MOL CELL BIOL, V29, P1276, DOI 10.1128/MCB.01229-08; Araujo SJ, 2001, MOL CELL BIOL, V21, P2281, DOI 10.1128/MCB.21.7.2281-2291.2001; Coin F, 1998, NAT GENET, V20, P184, DOI 10.1038/2491; Coin F, 2007, MOL CELL, V26, P245, DOI 10.1016/j.molcel.2007.03.009; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cubeddu L, 2005, J MOL BIOL, V353, P507, DOI 10.1016/j.jmb.2005.08.050; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; Fan L, 2006, MOL CELL, V22, P27, DOI 10.1016/j.molcel.2006.02.017; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Garrett R. A., 2007, ARCHAEA EVOLUTION, P171; Grogan DW, 2000, TRENDS MICROBIOL, V8, P180, DOI 10.1016/S0966-842X(00)01729-7; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; Jawhari A, 2002, J BIOL CHEM, V277, P31761, DOI 10.1074/jbc.M203792200; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Kvaratskhelia M, 2000, J MOL BIOL, V295, P193, DOI 10.1006/jmbi.1999.3363; Lehmann AR, 2003, BIOCHIMIE, V85, P1101, DOI 10.1016/j.biochi.2003.09.010; Liu H, 2008, CELL, V133, P801, DOI 10.1016/j.cell.2008.04.029; Liu HT, 2009, PROTEIN EXPRES PURIF, V63, P102, DOI 10.1016/j.pep.2008.09.008; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; NAEGELI H, 1993, J BIOL CHEM, V268, P10386; Nishino T, 2005, STRUCTURE, V13, P143, DOI 10.1016/j.str.2004.11.008; Oksenych V, 2009, EMBO J, V28, P2971, DOI 10.1038/emboj.2009.230; Richards JD, 2008, J MOL BIOL, V376, P634, DOI 10.1016/j.jmb.2007.12.019; Roberts JA, 2005, NUCLEIC ACIDS RES, V33, P6662, DOI 10.1093/nar/gki974; Roberts JA, 2005, J BIOL CHEM, V280, P5924, DOI 10.1074/jbc.M412766200; Roth HM, 2009, J BIOL CHEM, V284, P32272, DOI 10.1074/jbc.M109.055913; Rudolf J, 2006, MOL CELL, V23, P801, DOI 10.1016/j.molcel.2006.07.019; Rudolf J, 2010, NUCLEIC ACIDS RES, V38, P931, DOI 10.1093/nar/gkp1058; Scharer OD, 2007, MOL CELL, V28, P184, DOI 10.1016/j.molcel.2007.10.006; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Tapias A, 2004, J BIOL CHEM, V279, P19074, DOI 10.1074/jbc.M312611200; Tirode F, 1999, MOL CELL, V3, P87, DOI 10.1016/S1097-2765(00)80177-X; Winkler GS, 2001, BIOCHEMISTRY-US, V40, P160, DOI 10.1021/bi002021b; Wolski SC, 2008, PLOS BIOL, V6, P1332, DOI 10.1371/journal.pbio.0060149; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109	35	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					11013	11022		10.1074/jbc.M109.094763	http://dx.doi.org/10.1074/jbc.M109.094763			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139443	Green Published, hybrid			2022-12-27	WOS:000276264600085
J	Zhou, XE; Suino-Powell, KM; Li, J; He, YZ; MacKeigan, JP; Melcher, K; Yong, EL; Xu, HE				Zhou, X. Edward; Suino-Powell, Kelly M.; Li, Jun; He, Yuanzheng; MacKeigan, Jeffrey P.; Melcher, Karsten; Yong, Eu-Leong; Xu, H. Eric			Identification of SRC3/AIB1 as a Preferred Coactivator for Hormone-activated Androgen Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-PROLIFERATION; LIGAND-BINDING DOMAIN; PROSTATE-CANCER; BIOCHEMICAL BASIS; STRUCTURAL BASIS; GENE; BREAST; RECRUITMENT; MUTATIONS; COREGULATORS	Transcription activation by androgen receptor (AR), which depends on recruitment of coactivators, is required for the initiation and progression of prostate cancer, yet the mechanisms of how hormone-activated AR interacts with coactivators remain unclear. This is because AR, unlike any other nuclear receptor, prefers its own N-terminal FXXLF motif to the canonical LXXLL motifs of coactivators. Through biochemical and crystallographic studies, we identify that steroid receptor coactivator-3 (SRC3) (also named as amplified in breast cancer-1 or AIB1) interacts strongly with AR via synergistic binding of its first and third LXXLL motifs. Mutagenesis and functional studies confirm that SRC3 is a preferred coactivator for hormone-activated AR. Importantly, AR mutations found in prostate cancer patients correlate with their binding potency to SRC3, corroborating with the emerging role of SRC3 as a prostate cancer oncogene. These results provide a molecular mechanism for the selective utilization of SRC3 by hormone-activated AR, and they link the functional relationship between AR and SRC3 to the development and growth of prostate cancer.	[Zhou, X. Edward; Suino-Powell, Kelly M.; Li, Jun; He, Yuanzheng; Melcher, Karsten; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [MacKeigan, Jeffrey P.] Van Andel Res Inst, Lab Syst Biol, Grand Rapids, MI 49503 USA; [Li, Jun; Yong, Eu-Leong] Natl Univ Singapore, Natl Univ Hosp, Yong Loo Lin Sch Med, Dept Obstet & Gynecol, Singapore 119077, Singapore	Van Andel Institute; Van Andel Institute; National University of Singapore	Xu, HE (corresponding author), Van Andel Res Inst, Lab Struct Sci, 333 Bostwick Ave,NE, Grand Rapids, MI 49503 USA.	eric.xu@vai.org	Melcher, Karsten/AAZ-3861-2020; Xu, H. Eric/ABD-7487-2021	Melcher, Karsten/0000-0002-9125-4027; He, Yuanzheng/0000-0001-9131-140X; MacKeigan, Jeffrey/0000-0002-0198-5679; Yong, Eu-Leong/0000-0001-6511-770X; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [DK071662, DK066202, HL089301]; Jay and Betty Van Andel Foundation; Department of Defense Prostate Cancer [W81XWH0510043]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066202, R01DK071662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jay and Betty Van Andel Foundation; Department of Defense Prostate Cancer(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK071662, DK066202, and HL089301 (to H. E. X.). This work was also supported in part by a grant from the Jay and Betty Van Andel Foundation and a Department of Defense Prostate Cancer Grant W81XWH0510043 (to H. E. X.).	Alen P, 1999, MOL CELL BIOL, V19, P6085; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; Bevan CL, 1999, MOL CELL BIOL, V19, P8383; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002; Chen GC, 2005, PROSTATE, V63, P395, DOI 10.1002/pros.20191; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chung ACK, 2007, CANCER RES, V67, P5965, DOI 10.1158/0008-5472.CAN-06-3168; Culig Z, 2004, CURR CANCER DRUG TAR, V4, P455, DOI 10.2174/1568009043332925; CULIG Z, 1993, MOL ENDOCRINOL, V7, P1541, DOI 10.1210/me.7.12.1541; Dehm SM, 2005, EXPERT REV ANTICANC, V5, P63, DOI 10.1586/14737140.5.1.63; Dubbink HJ, 2006, MOL ENDOCRINOL, V20, P1742, DOI 10.1210/me.2005-0348; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Fereshteh MP, 2008, CANCER RES, V68, P3697, DOI 10.1158/0008-5472.CAN-07-6702; Glass CK, 2000, GENE DEV, V14, P121; Gottlieb B, 1998, NUCLEIC ACIDS RES, V26, P234, DOI 10.1093/nar/26.1.234; Grossmann ME, 2001, JNCI-J NATL CANCER I, V93, P1687, DOI 10.1093/jnci/93.22.1687; He B, 2002, J BIOL CHEM, V277, P25631, DOI 10.1074/jbc.M202809200; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; He B, 2003, MOL CELL BIOL, V23, P2135, DOI 10.1128/MCB.23.6.2135-2150.2003; He B, 2001, J BIOL CHEM, V276, P42293, DOI 10.1074/jbc.M107492200; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hur E, 2004, PLOS BIOL, V2, P1303, DOI 10.1371/journal.pbio.0020274; Kirkegaard T, 2007, CLIN CANCER RES, V13, P1405, DOI 10.1158/1078-0432.CCR-06-1933; Kuang SQ, 2004, CANCER RES, V64, P1875, DOI 10.1158/0008-5472.CAN-03-3745; Li JW, 2006, MOL ENDOCRINOL, V20, P776, DOI 10.1210/me.2005-0298; Li B, 2008, CANCER LETT, V261, P64, DOI 10.1016/j.canlet.2007.11.013; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Li Y, 2005, P NATL ACAD SCI USA, V102, P9505, DOI 10.1073/pnas.0501204102; Li Y, 2005, MOL CELL, V17, P491, DOI 10.1016/j.molcel.2005.02.002; Li Y, 2008, J BIOL CHEM, V283, P19132, DOI 10.1074/jbc.M802040200; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Ma H, 1999, MOL CELL BIOL, V19, P6164; Marcelli M, 2000, CANCER RES, V60, P944; Matias PM, 2000, J BIOL CHEM, V275, P26164, DOI 10.1074/jbc.M004571200; Miyamoto H, 2004, PROSTATE, V61, P332, DOI 10.1002/pros.20115; Mononen N, 2000, CANCER RES, V60, P6479; Mussi P, 2006, MOL ENDOCRINOL, V20, P3105, DOI 10.1210/me.2005-0522; NAVAZA J, 1992, MOL REPLACEMENT; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QUARMBY VE, 1990, MOL ENDOCRINOL, V4, P1399, DOI 10.1210/mend-4-9-1399; Rahman M, 2004, CLIN CANCER RES, V10, P2208, DOI 10.1158/1078-0432.CCR-0746-3; Sanchez D, 2006, BJU INT, V98, P1320, DOI 10.1111/j.1464-410X.2006.06438.x; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Su QB, 2008, ONCOLOGY-BASEL, V75, P159, DOI 10.1159/000159267; Suino K, 2004, MOL CELL, V16, P893, DOI 10.1016/j.molcel.2004.11.036; Suino-Powell K, 2008, MOL CELL BIOL, V28, P1915, DOI 10.1128/MCB.01541-07; Taplin ME, 1999, CANCER RES, V59, P2511; TAPLIN ME, 1995, NEW ENGL J MED, V332, P1393, DOI 10.1056/NEJM199505253322101; Tindall D J, 2000, Mayo Clin Proc, V75 Suppl, pS26; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Yan J, 2006, ACTA PHARMACOL SIN, V27, P387, DOI 10.1111/j.1745-7254.2006.00315.x; Yan J, 2008, CANCER RES, V68, P5460, DOI 10.1158/0008-5472.CAN-08-0955; Zhang H, 2004, GENE DEV, V18, P1753, DOI 10.1101/gad.1194704; Zheng FHF, 2005, MOL CELL BIOL, V25, P8273, DOI 10.1128/MCB.25.18.8273-8284.2005; Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076; Zhou XE, 2010, PROTEIN EXPRES PURIF, V71, P21, DOI 10.1016/j.pep.2009.12.002; Zou JX, 2006, PROSTATE, V66, P1474, DOI 10.1002/pros.20477	65	63	66	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9161	9171		10.1074/jbc.M109.085779	http://dx.doi.org/10.1074/jbc.M109.085779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086010	hybrid, Green Published			2022-12-27	WOS:000275553700065
J	Kirino, Y; Vourekas, A; Kim, N; Alves, FD; Rappsilber, J; Klein, PS; Jongens, TA; Mourelatos, Z				Kirino, Yohei; Vourekas, Anastassios; Kim, Namwoo; Alves, Flavia de Lima; Rappsilber, Juri; Klein, Peter S.; Jongens, Thomas A.; Mourelatos, Zissimos			Arginine Methylation of Vasa Protein Is Conserved across Phyla	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERM-CELL FORMATION; SPLICEOSOMAL SM PROTEINS; DROSOPHILA POLE PLASM; METHYLTRANSFERASE CAPSULEEN; PROTEOMIC ANALYSIS; TUDOR DOMAINS; SOMATIC-CELLS; RNA HELICASE; LOCALIZATION; COMPONENT	Recent studies have uncovered an unexpected relationship between factors that are essential for germline development in Drosophila melanogaster: the arginine protein methyltransferase 5 (dPRMT5/Csul/Dart5) and its cofactor Valois, methylate the Piwi family protein Aub, enabling it to bind Tudor. The RNA helicase Vasa is another essential protein in germline development. Here, we report that mouse (mouse Vasa homolog), Xenopus laevis, and D. melanogaster Vasa proteins contain both symmetrical and asymmetrical dimethylarginines. We find that dPRMT5 is required for the production of sDMAs of Vasa in vivo. Furthermore, we find that the mouse Vasa homolog associates with Tudor domain-containing proteins, Tdrd1 and Tdrd6, as well as the Piwi proteins, Mili and Miwi. Arginine methylation is thus emerging as a conserved and pivotal post-translational modification of proteins that is essential for germline development.	[Mourelatos, Zissimos] Univ Penn, Sch Med, Dept Pathol & Lab Med, Div Neuropathol, Philadelphia, PA 19104 USA; [Jongens, Thomas A.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Klein, Peter S.] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Alves, Flavia de Lima; Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH8 9YL, Midlothian, Scotland	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Edinburgh	Mourelatos, Z (corresponding author), 613B Stellar Chance Bldg,422 Curie Blvd, Philadelphia, PA 19104 USA.	mourelaz@uphs.upenn.edu	Vourekas, Anastassios/J-6108-2017; Rappsilber, Juri/B-7265-2015; Vourekas, Anastasios/AAI-8278-2020; Rappsilber, Juri/ABF-3328-2020	Vourekas, Anastassios/0000-0002-1850-5635; Rappsilber, Juri/0000-0001-5999-1310; Mourelatos, Zissimos/0000-0002-9852-1845; Kirino, Yohei/0000-0001-5232-4742; Kim, Namwoo/0000-0002-1684-5417	National Institutes of Health [GM76621, MH086705, GM0720777, NS056070]; Human Frontier Science Program; The Institute for the Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056070] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); The Institute for the Translational Medicine and Therapeutics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM76621 (to P. S. K.), MH086705 (to T. A. J.), GM0720777, and NS056070 (to Z. M.). This work was also supported by a Human Frontier Science Program Long Term fellowship (to Y. K.) and in part by The Institute for the Translational Medicine and Therapeutics grants (to Z. M.).	Anne J, 2005, DEVELOPMENT, V132, P2167, DOI 10.1242/dev.01809; Anne J, 2007, DEVELOPMENT, V134, P137, DOI 10.1242/dev.02687; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Arkov AL, 2006, DEVELOPMENT, V133, P4053, DOI 10.1242/dev.02572; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boisvert FM, 2003, MOL CELL PROTEOMICS, V2, P1319, DOI 10.1074/mcp.M300088-MCP200; Bossi Elena, 2007, V375, P107; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Boulanger MC, 2004, BIOCHEM J, V379, P283, DOI 10.1042/BJ20031176; Brahms H, 2000, J BIOL CHEM, V275, P17122, DOI 10.1074/jbc.M000300200; Breitwieser W, 1996, GENE DEV, V10, P2179, DOI 10.1101/gad.10.17.2179; Cavey M, 2005, DEVELOPMENT, V132, P459, DOI 10.1242/dev.01590; Chen C, 2009, P NATL ACAD SCI USA, V106, P20336, DOI 10.1073/pnas.0911640106; Cote J, 2005, J BIOL CHEM, V280, P28476, DOI 10.1074/jbc.M414328200; Dansereau David A., 2008, V450, P3, DOI 10.1007/978-1-60327-214-8_1; EPHRUSSI A, 1992, NATURE, V358, P387, DOI 10.1038/358387a0; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Girard A, 2008, TRENDS CELL BIOL, V18, P136, DOI 10.1016/j.tcb.2008.01.004; Gonsalvez GB, 2006, CURR BIOL, V16, P1077, DOI 10.1016/j.cub.2006.04.037; Harris AN, 2001, DEVELOPMENT, V128, P2823; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; Hosokawa M, 2007, DEV BIOL, V301, P38, DOI 10.1016/j.ydbio.2006.10.046; Ikenishi K, 2000, DEV GROWTH DIFFER, V42, P95; Ikenishi K, 1997, DEV GROWTH DIFFER, V39, P625; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Johnstone O, 2004, DEVELOPMENT, V131, P4167, DOI 10.1242/dev.01286; Kirino Y, 2010, RNA, V16, P70, DOI 10.1261/rna.1869710; Kirino Y, 2009, NAT CELL BIOL, V11, P652, DOI 10.1038/ncb1872; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; KOMIYA T, 1994, DEV BIOL, V162, P354, DOI 10.1006/dbio.1994.1093; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Kuramochi-Miyagawa S, 2004, DEVELOPMENT, V131, P839, DOI 10.1242/dev.00973; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; Lau NC, 2009, EMBO J, V28, P2945, DOI 10.1038/emboj.2009.237; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; LEROY P, 1989, CELL, V57, P549, DOI 10.1016/0092-8674(89)90125-6; LIANG L, 1994, DEVELOPMENT, V120, P1201; Liu NK, 2003, CURR BIOL, V13, P1905, DOI 10.1016/j.cub.2003.10.026; Nishida KM, 2009, EMBO J, V28, P3820, DOI 10.1038/emboj.2009.365; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Raz E, 2000, GENOME BIOL, V1, P1, DOI [10.1186/gb-2000-1-3-reviews1017, DOI 10.1186/GB-2000-1-3-REVIEWS1017]; Reuter M, 2009, NAT STRUCT MOL BIOL, V16, P639, DOI 10.1038/nsmb.1615; Rongo C, 1996, TRENDS GENET, V12, P102, DOI 10.1016/0168-9525(96)81421-1; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shoji M, 2009, DEV CELL, V17, P775, DOI 10.1016/j.devcel.2009.10.012; Siomi MC, 2008, FEBS LETT, V582, P2473, DOI 10.1016/j.febslet.2008.06.018; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Styhler S, 2002, DEV CELL, V3, P865, DOI 10.1016/S1534-5807(02)00361-1; Tanaka SS, 2000, GENE DEV, V14, P841; Thomson T, 2005, CELL RES, V15, P281, DOI 10.1038/sj.cr.7290297; Thomson T, 2008, MECH DEVELOP, V125, P865, DOI 10.1016/j.mod.2008.06.005; Tinker R, 1998, DEV BIOL, V199, P1, DOI 10.1006/dbio.1998.8941; Tomancak P, 1998, DEVELOPMENT, V125, P1723; Vagin VV, 2009, GENE DEV, V23, P1749, DOI 10.1101/gad.1814809; Vasileva A, 2009, CURR BIOL, V19, P630, DOI 10.1016/j.cub.2009.02.047; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Williamson A, 1996, ANNU REV CELL DEV BI, V12, P365, DOI 10.1146/annurev.cellbio.12.1.365	58	62	62	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8148	8154		10.1074/jbc.M109.089821	http://dx.doi.org/10.1074/jbc.M109.089821			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080973	hybrid, Green Published			2022-12-27	WOS:000275413800033
J	Sarilla, S; Habib, SY; Kravtsov, DV; Matafonov, A; Gailani, D; Verhamme, IM				Sarilla, Suryakala; Habib, Sally Y.; Kravtsov, Dmitri V.; Matafonov, Anton; Gailani, David; Verhamme, Ingrid M.			Sucrose Octasulfate Selectively Accelerates Thrombin Inactivation by Heparin Cofactor II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST-GROWTH-FACTOR; CATALYZED PROTEASE INACTIVATION; BLOOD-COAGULATION PROTEINASES; DISSEMINATED INTRAVASCULAR COAGULATION; PEPTIDE CHLOROMETHYL KETONES; LACTOBIONIC ACID-AMIDES; REGULATORY EXOSITE I; HUMAN-FACTOR V; ANTITHROMBIN-III; FACTOR-XA	Inactivation of thrombin (T) by the serpins heparin cofactor II (HCII) and antithrombin (AT) is accelerated by a heparin template between the serpin and thrombin exosite II. Unlike AT, HCII also uses an allosteric interaction of its NH2-terminal segment with exosite I. Sucrose octasulfate (SOS) accelerated thrombin inactivation by HCII but not AT by 2000-fold. SOS bound to two sites on thrombin, with dissociation constants (K-D) of 10 +/- 4 mu M and 400 +/- 300 mu M that were not kinetically resolvable, as evidenced by single hyperbolic SOS concentration dependences of the inactivation rate (k(obs)). SOS bound HCII with K-D 1.45 +/- 0.30 mM, and this binding was tightened in the T.SOS.HCII complex, characterized by K-complex of similar to 0.20 mu M. Inactivation data were incompatible with a model solely depending on HCII.SOS but fit an equilibrium linkage model employing T.SOS binding in the pathway to higher order complex formation. Hirudin-(54-65)(SO3-) caused a hyperbolic decrease of the inactivation rates, suggesting partial competitive binding of hirudin-(54-65)(SO3-) and HCII to exosite I. Meizothrombin(des-fragment 1), binding SOS with K-D = 1600 +/- 300 mu M, and thrombin were inactivated at comparable rates, and an exosite II aptamer had no effect on the inactivation, suggesting limited exosite II involvement. SOS accelerated inactivation of meizothrombin 1000-fold, reflecting the contribution of direct exosite I interaction with HCII. Thrombin generation in plasma was suppressed by SOS, both in HCII-dependent and -independent processes. The ex vivo HCII-dependent process may utilize the proposed model and suggests a potential for oversulfated disaccharides in controlling HCII-regulated thrombin generation.	[Sarilla, Suryakala; Habib, Sally Y.; Kravtsov, Dmitri V.; Matafonov, Anton; Gailani, David; Verhamme, Ingrid M.] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University	Verhamme, IM (corresponding author), C3321A Med Ctr N, Nashville, TN 37232 USA.	ingrid.verhamme@vanderbilt.edu			National Institutes of Health, NHLBI [RO1 HL 080018, RO1 HL058837]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080018, R01HL058837] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health, NHLBI, Grants RO1 HL 080018 (to I. M. V.) and RO1 HL058837 (to D. G.).	Baglin T, 2005, BRIT J HAEMATOL, V130, P653, DOI 10.1111/j.1365-2141.2005.05612.x; Baglin TP, 2002, P NATL ACAD SCI USA, V99, P11079, DOI 10.1073/pnas.162232399; Bauman SJ, 1999, J BIOL CHEM, V274, P34556, DOI 10.1074/jbc.274.49.34556; BEGUIN SS, 1991, SEMIN THROMB HEMOST, V17, P126; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; Bock PE, 1997, J BIOL CHEM, V272, P19837, DOI 10.1074/jbc.272.32.19837; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1992, J BIOL CHEM, V267, P14974; BODE W, 1992, PROTEIN SCI, V1, P426; Bohme C, 2002, EUR J BIOCHEM, V269, P977, DOI 10.1046/j.0014-2956.2001.02732.x; Buddai SK, 2002, J BIOL CHEM, V277, P26689, DOI 10.1074/jbc.M202507200; CHURCH FC, 1989, J BIOL CHEM, V264, P3618; CHURCH FC, 1987, ARCH BIOCHEM BIOPHYS, V259, P331, DOI 10.1016/0003-9861(87)90499-1; Colwell NS, 1999, BBA-PROTEIN STRUCT M, V1431, P148, DOI 10.1016/S0167-4838(99)00051-5; CRAIG PA, 1989, J BIOL CHEM, V264, P5452; DANIELSSON A, 1986, J BIOL CHEM, V261, P5467; DESAI UR, 1995, CARBOHYD RES, V275, P391, DOI 10.1016/0008-6215(95)00159-Q; Desai UR, 1998, J BIOL CHEM, V273, P7478, DOI 10.1074/jbc.273.13.7478; Dharmawardana KR, 1999, J BIOL CHEM, V274, P18635, DOI 10.1074/jbc.274.26.18635; Dharmawardana KR, 1998, BIOCHEMISTRY-US, V37, P13143, DOI 10.1021/bi9812165; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; DOYLE MF, 1990, J BIOL CHEM, V265, P10693; DUGGLEBY RG, 1977, BIOCHIM BIOPHYS ACTA, V481, P297, DOI 10.1016/0005-2744(77)90264-9; Fannon M, 2008, J CELL PHYSIOL, V215, P434, DOI 10.1002/jcp.21327; FENTON JW, 1977, J BIOL CHEM, V252, P3587; Gettins PGW, 2009, J BIOL CHEM, V284, P20441, DOI 10.1074/jbc.R800064200; Hayakawa Y, 2000, BBA-PROTEIN STRUCT M, V1543, P86, DOI 10.1016/S0167-4838(00)00193-X; He L, 2002, J CLIN INVEST, V109, P213, DOI 10.1172/JCI200213432; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Hiebert LM, 2002, PHARM RES-DORDR, V19, P838, DOI 10.1023/A:1016161001013; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; HORTIN GL, 1989, J BIOL CHEM, V264, P13979; Hung KW, 2005, BIOCHEMISTRY-US, V44, P15787, DOI 10.1021/bi051030n; Innis CA, 2003, J BIOL CHEM, V278, P39969, DOI 10.1074/jbc.M211284200; Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; KARIO K, 1992, THROMB RES, V66, P435, DOI 10.1016/0049-3848(92)90292-I; KLAUSER RJ, 1991, J PHARMACOL EXP THER, V259, P8; KLAUSER RJ, 1991, SEMIN THROMB HEMOST, V17, P118; KLAUSER RJ, 1991, THROMB RES, V62, P557, DOI 10.1016/0049-3848(91)90028-U; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Kulahin N, 2008, ACTA CRYSTALLOGR F, V64, P448, DOI 10.1107/S174430910801066X; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; MAIMONE MM, 1990, J BIOL CHEM, V265, P18263; Mammen EF, 2008, SEMIN THROMB HEMOST, V34, pA22, DOI 10.1055/s-2007-995819; MANN KG, 1981, METHOD ENZYMOL, V80, P286; Martin DJ, 1999, J PHARMACOL EXP THER, V288, P516; Meagher JL, 2000, J BIOL CHEM, V275, P2698, DOI 10.1074/jbc.275.4.2698; Mitchell JW, 2002, J BIOL CHEM, V277, P19823, DOI 10.1074/jbc.M200630200; Myles T, 1998, J BIOL CHEM, V273, P31203, DOI 10.1074/jbc.273.47.31203; NAGASHIMA R, 1981, J CLIN GASTROENTEROL, V3, P117; Noda A, 2002, CLIN APPL THROMB-HEM, V8, P265, DOI 10.1177/107602960200800311; O'Keeffe D, 2004, J BIOL CHEM, V279, P50267, DOI 10.1074/jbc.M408774200; OFOSU FA, 1992, EUR J BIOCHEM, V203, P121, DOI 10.1111/j.1432-1033.1992.tb19836.x; OLSON ST, 1986, J BIOL CHEM, V261, P3151; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1988, J BIOL CHEM, V263, P1698; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; RAAKE W, 1991, SEMIN THROMB HEMOST, V17, P129; RAGG H, 1990, J BIOL CHEM, V265, P22386; Rand MD, 1996, BLOOD, V88, P3432, DOI 10.1182/blood.V88.9.3432.bloodjournal8893432; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; ROGERS SJ, 1992, J BIOL CHEM, V267, P3613; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Tasset DM, 1997, J MOL BIOL, V272, P688, DOI 10.1006/jmbi.1997.1275; Tchaikovski SN, 2007, J THROMB HAEMOST, V5, P2079, DOI 10.1111/j.1538-7836.2007.02719.x; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; TOLLEFSEN DM, 1995, THROMB HAEMOSTASIS, V74, P1209; TOLLEFSEN DM, 1983, J BIOL CHEM, V258, P6713; Turk B, 1997, BIOCHEMISTRY-US, V36, P6682, DOI 10.1021/bi9702492; VANDEERLIN VMD, 1991, J BIOL CHEM, V266, P20223; Verhamme IM, 2004, J BIOL CHEM, V279, P9785, DOI 10.1074/jbc.M313962200; Verhamme IM, 2002, J BIOL CHEM, V277, P6788, DOI 10.1074/jbc.M110257200; VOLKIN DB, 1993, BIOCHIM BIOPHYS ACTA, V1203, P18, DOI 10.1016/0167-4838(93)90031-L; Wall D, 2001, THROMB RES, V103, P325, DOI 10.1016/S0049-3848(01)00314-0; Yeh BK, 2002, MOL CELL BIOL, V22, P7184, DOI 10.1128/MCB.22.20.7184-7192.2002; ZHU XT, 1993, STRUCTURE, V1, P27, DOI 10.1016/0969-2126(93)90006-3	80	8	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8278	8289		10.1074/jbc.M109.005967	http://dx.doi.org/10.1074/jbc.M109.005967			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20053992	hybrid, Green Published			2022-12-27	WOS:000275413800046
J	Bellei, B; Maresca, V; Flori, E; Pitisci, A; Larue, L; Picardo, M				Bellei, Barbara; Maresca, Vittoria; Flori, Enrica; Pitisci, Angela; Larue, Lionel; Picardo, Mauro			p38 Regulates Pigmentation via Proteasomal Degradation of Tyrosinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; MELANOMA-CELL DIFFERENTIATION; NORMAL HUMAN MELANOCYTES; ULTRAVIOLET-B RADIATION; TRANSCRIPTION FACTOR; MAP KINASE; MOUSE MELANOMA; ERK ACTIVATION; NITRIC-OXIDE; INDUCED MELANOGENESIS	The synthesis of melanin pigments, or melanogenesis, is regulated by the balance of a variety of signal transduction pathways. Among these pathways, p38 MAPK signaling was found to be involved in stress-induced melanogenesis and to be activated by alpha-melanocyte-stimulating hormone (alpha-MSH) and ultraviolet irradiation. Previous studies have shown that alpha-MSH-stimulated melanogenesis can be inhibited by blocking p38 MAPK activity with SB203580, a pyridinyl imidazole compound. Consistent with this, we observed that pyridinyl imidazoles (SB203580 and SB202190) inhibited both basal and alpha-MSH-induced melanogenesis in B16 melanoma cells. However, SB202474, which has no ability to inhibit p38 MAPK activity and is usually used as a negative control compound in p38 MAPK studies, also suppressed melanin synthesis induction. Furthermore, the independence of the p38 kinase pathway from the repression of melanogenesis by pyridinyl imidazole compounds was also confirmed by small interfering RNA experiments. Interfering with p38 MAPK expression surprisingly stimulated melanogenesis and tyrosinase family protein expression. Although the molecular mechanism(s) by which p38 promotes the degradation of melanogenic enzymes remain to be determined, the involvement of the ubiquitin-proteasome pathway was demonstrated by co-treatment with the proteasome-specific inhibitor MG132 and the relative decrease in the ubiquitination of tyrosinase in cells transfected with p38-specific small interfering RNA.	[Bellei, Barbara] IRCCS, Lab Cutaneous Physiopathol, Ist Dermatol San Gallicano, I-00144 Rome, Italy; [Larue, Lionel] CNRS, Inst Curie, UMR 146, F-91405 Orsay, France	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Bellei, B (corresponding author), IRCCS, Lab Cutaneous Physiopathol, Ist Dermatol San Gallicano, Via Elio Chianesi 53, I-00144 Rome, Italy.	citolab@ifo.it	Pitisci, Angela/AAH-9415-2019; maresca, vittoria/J-3272-2016; Larue, Lionel/I-6532-2016; Picardo, Mauro/A-6978-2011; Larue, Lionel/F-7355-2013; Flori, Enrica/H-4417-2014; Bellei, Barbara/K-5288-2016	maresca, vittoria/0000-0001-9239-6978; Picardo, Mauro/0000-0003-4899-6639; Flori, Enrica/0000-0002-9275-1041; Bellei, Barbara/0000-0002-3883-5500	Ministero della Salute (Italy) [onc-ord/32/07]	Ministero della Salute (Italy)(Ministry of Health, Italy)	This work was supported in part by Grant onc-ord/32/07 from the Ministero della Salute (Italy).	ABDELMALEK Z, 1994, PIGM CELL RES, V7, P326, DOI 10.1111/j.1600-0749.1994.tb00635.x; ABDELMALEK Z, 1995, P NATL ACAD SCI USA, V92, P1789, DOI 10.1073/pnas.92.5.1789; Ahn JH, 2008, ARCH DERMATOL RES, V300, P325, DOI 10.1007/s00403-008-0863-0; Aksan I, 1998, MOL CELL BIOL, V18, P6930, DOI 10.1128/MCB.18.12.6930; Al-Shanti N, 2008, J ENDOCRINOL, V198, P243, DOI 10.1677/JOE-08-0151; Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; Benedito E, 1997, BBA-GEN SUBJECTS, V1336, P59, DOI 10.1016/S0304-4165(97)00011-1; Bertolotto C, 1998, ONCOGENE, V16, P1665, DOI 10.1038/sj.onc.1201685; Bertolotto C, 1998, MOL CELL BIOL, V18, P694, DOI 10.1128/MCB.18.2.694; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Borovansky J, 2008, PIGM CELL MELANOMA R, V21, P298; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Casanovas O, 2004, ONCOGENE, V23, P7537, DOI 10.1038/sj.onc.1208040; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chung SY, 2009, BIOSCI BIOTECH BIOCH, V73, P1704, DOI 10.1271/bbb.80766; Corre S, 2004, J BIOL CHEM, V279, P51226, DOI 10.1074/jbc.M409768200; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Fang D, 2001, PIGM CELL RES, V14, P132, DOI 10.1034/j.1600-0749.2001.140209.x; FULLER BB, 1987, J BIOL CHEM, V262, P4024; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Godbole D, 2006, CELL BIOL INT, V30, P895, DOI 10.1016/j.cellbi.2006.06.009; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; HALABAN R, 1983, J CELL BIOL, V97, P480, DOI 10.1083/jcb.97.2.480; Halaban R, 1997, P NATL ACAD SCI USA, V94, P6210, DOI 10.1073/pnas.94.12.6210; HALABAN R, 1977, EXP CELL RES, V108, P111, DOI 10.1016/S0014-4827(77)80016-5; Hasegawa T, 2008, J NEUROCHEM, V105, P1700, DOI 10.1111/j.1471-4159.2008.05277.x; Hata K, 2003, J BIOCHEM, V134, P441, DOI 10.1093/jb/mvg162; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hornyak TJ, 2000, J INVEST DERMATOL, V115, P106, DOI 10.1046/j.1523-1747.2000.00030.x; Huang M, 2002, J BIOL CHEM, V277, P28364, DOI 10.1074/jbc.C200321200; Im SB, 1998, CANCER RES, V58, P47; Jimenez-Cervantes C, 2001, J CELL SCI, V114, P2335; Khaled M, 2003, J INVEST DERMATOL, V121, P831, DOI 10.1046/j.1523-1747.2003.12420.x; Kida A, 2007, ONCOGENE, V26, P6630, DOI 10.1038/sj.onc.1210490; Kim DS, 2007, ARCH PHARM RES, V30, P581, DOI 10.1007/BF02977652; Kim DS, 2006, PIGM CELL RES, V19, P146, DOI 10.1111/j.1600-0749.2005.00287.x; Kim DS, 2004, ARCH PHARM RES, V27, P334, DOI 10.1007/BF02980069; Kim DS, 2003, J CELL SCI, V116, P1699, DOI 10.1242/jcs.00366; Kim DS, 2002, CELL SIGNAL, V14, P779, DOI 10.1016/S0898-6568(02)00024-4; KOBAYASHI T, 1994, EMBO J, V13, P5818, DOI 10.1002/j.1460-2075.1994.tb06925.x; Kono M, 2006, MOL CANCER RES, V4, P779, DOI 10.1158/1541-7786.MCR-06-0077; LASKIN JD, 1982, J CELL PHYSIOL, V113, P481, DOI 10.1002/jcp.1041130318; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Lee J, 2007, BIOCHEM PHARMACOL, V74, P960, DOI 10.1016/j.bcp.2007.06.007; Newton RA, 2007, J INVEST DERMATOL, V127, P2216, DOI 10.1038/sj.jid.5700840; PARK HY, 1993, J BIOL CHEM, V268, P11742; Park HY, 1996, EXP CELL RES, V227, P70, DOI 10.1006/excr.1996.0251; Park HY, 1999, J BIOL CHEM, V274, P16470, DOI 10.1074/jbc.274.23.16470; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; RomeroGraillet C, 1997, J CLIN INVEST, V99, P635, DOI 10.1172/JCI119206; RomeroGraillet C, 1996, J BIOL CHEM, V271, P28052, DOI 10.1074/jbc.271.45.28052; Rouzaud F, 2003, FASEB J, V17, P2154, DOI 10.1096/fj.03-0206fje; Sasaki M, 2000, PIGM CELL RES, V13, P248, DOI 10.1034/j.1600-0749.2000.130406.x; Shibazaki M, 2004, J BIOL CHEM, V279, P3869, DOI 10.1074/jbc.M305880200; Shimo T, 2007, J CELL COMMUN SIGNAL, V1, P103, DOI 10.1007/s12079-007-0010-2; SIEGRIST W, 1986, ANAL BIOCHEM, V159, P191, DOI 10.1016/0003-2697(86)90327-1; Singh SK, 2005, PIGM CELL RES, V18, P113, DOI 10.1111/j.1600-0749.2005.00219.x; Smalley K, 2000, FEBS LETT, V476, P198, DOI 10.1016/S0014-5793(00)01726-9; Smalley KSM, 2002, MELANOMA RES, V12, P187, DOI 10.1097/00008390-200206000-00001; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; WINDER A, 1994, CELL MOL BIOL RES, V40, P613; WONG G, 1975, NATURE, V255, P644, DOI 10.1038/255644a0; Wu M, 2000, GENE DEV, V14, P301; YOKOYAMA K, 1994, BBA-GENE STRUCT EXPR, V1217, P317, DOI 10.1016/0167-4781(94)90292-5; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	68	89	90	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7288	7299		10.1074/jbc.M109.070573	http://dx.doi.org/10.1074/jbc.M109.070573			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053998	Green Published, hybrid			2022-12-27	WOS:000275415600041
J	Hirayama, H; Seino, J; Kitajima, T; Jigami, Y; Suzuki, T				Hirayama, Hiroto; Seino, Junichi; Kitajima, Toshihiko; Jigami, Yoshifumi; Suzuki, Tadashi			Free Oligosaccharides to Monitor Glycoprotein Endoplasmic Reticulum-associated Degradation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; BETA-N-ACETYLGLUCOSAMINIDASE; ASPARAGINE-LINKED OLIGOSACCHARIDES; PERFORMANCE LIQUID-CHROMATOGRAPHY; POLYMANNOSE-TYPE OLIGOSACCHARIDES; VACUOLE TARGETING PATHWAY; UNFOLDED PROTEIN RESPONSE; OUTER CHAIN ELONGATION; QUALITY-CONTROL; ALPHA-MANNOSIDASE	In eukaryotic cells, N-glycosylation has been recognized as one of the mostcommonand functionally important co-or post-translational modifications of proteins. "Free" forms of N-glycans accumulate in the cytosol of mammalian cells, but the precise mechanism for their formation and degradation remains unknown. Here, we report a method for the isolation of yeast free oligosaccharides (fOSs) using endo-beta-1,6-glucanase digestion. fOSs were undetectable in cells lacking PNG1, coding the cytoplasmic peptide: N-glycanase gene, suggesting that almost all fOSs were formed from misfolded glycoproteins by Png1p. Structural studies revealed that the most abundant fOS was M8B, which is not recognized well by the endoplasmic reticulum-associated degradation (ERAD)-related lectin, Yos9p. In addition, we provide evidence that some of the ERAD substrates reached the Golgi apparatus prior to retrotranslocation to the cytosol. N-Glycan structures on misfolded glycoproteins in cells lacking the cytosol/vacuole alpha-mannosidase, Ams1p, was still quite diverse, indicating that processing of N-glycans on misfolded glycoproteins was more complex than currently envisaged. Under ER stress, an increase in fOSs was observed, whereas levels of M7C, a key glycan structure recognized by Yos9p, were unchanged. Our method can thus provide valuable information on the molecular mechanism of glycoprotein ERAD in Saccharomyces cerevisiae.	[Hirayama, Hiroto; Seino, Junichi; Suzuki, Tadashi] RIKEN Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, Wako, Saitama 3510198, Japan; [Kitajima, Toshihiko; Jigami, Yoshifumi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Tsukuba, Ibaraki 3058566, Japan; [Suzuki, Tadashi] Japan Sci & Technol Agcy, Core Res Evolutionary Sci & Technol, Kawaguchi, Saitama 3320012, Japan	RIKEN; National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST)	Suzuki, T (corresponding author), RIKEN Adv Sci Inst, Syst Glycobiol Res Grp, Glycometabolome Team, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	tsuzuki_gm@riken.jp	hirayama, hiroto/HCH-9202-2022; Suzuki, Tadashi/AAX-5707-2021; Kitajima, Toshihiko/K-2894-2013; Suzuki, Tadashi/I-4536-2014; Kitajima, Toshihiko/D-2463-2016	Suzuki, Tadashi/0000-0003-1030-7631; Kitajima, Toshihiko/0000-0002-0202-5282; Kitajima, Toshihiko/0000-0001-9677-5086; Hirayama, Hiroto/0000-0003-1909-9488	Global Center of Excellence; RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Global Center of Excellence Program, the RIKEN President's Discretionary Fund (Strategic Programs for R&D), and a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.S.).	ANUMULA KR, 1983, J BIOL CHEM, V258, P5274; BALLOU L, 1990, P NATL ACAD SCI USA, V87, P3368, DOI 10.1073/pnas.87.9.3368; BELARD M, 1988, BIOCHEM J, V255, P235; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; CHANG YH, 1989, J BIOL CHEM, V264, P6979; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chapman RE, 1997, CURR BIOL, V7, P850, DOI 10.1016/S0960-9822(06)00373-3; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; CUEVA R, 1989, FEBS LETT, V259, P125, DOI 10.1016/0014-5793(89)81510-8; Fujita M, 2006, MOL BIOL CELL, V17, P834, DOI 10.1091/mbc.E05-05-0443; Haga Y, 2009, GLYCOBIOLOGY, V19, P987, DOI 10.1093/glycob/cwp075; HASE S, 1994, METHOD ENZYMOL, V230, P225; HASE S, 1992, BIOSCI BIOTECH BIOCH, V56, P1676, DOI 10.1271/bbb.56.1676; Hebert DN, 1996, EMBO J, V15, P2961, DOI 10.1002/j.1460-2075.1996.tb00659.x; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hirayama H, 2008, J BIOCHEM, V143, P555, DOI 10.1093/jb/mvm249; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; HIURA N, 1987, AGR BIOL CHEM TOKYO, V51, P3315; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2009, J BIOL CHEM, V284, P17061, DOI 10.1074/jbc.M809725200; Hutchins MU, 2001, J BIOL CHEM, V276, P20491, DOI 10.1074/jbc.M101150200; Iwai K, 1999, J BIOCHEM, V125, P70, DOI 10.1093/oxfordjournals.jbchem.a022270; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; Kario E, 2008, J BIOL CHEM, V283, P244, DOI 10.1074/jbc.M706237200; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Kato T, 1997, J BIOCHEM, V122, P1167, DOI 10.1093/oxfordjournals.jbchem.a021877; Kato T, 2007, J BIOL CHEM, V282, P22080, DOI 10.1074/jbc.M700805200; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kawahara T, 1997, MOL BIOL CELL, V8, P1845, DOI 10.1091/mbc.8.10.1845; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kitajima T, 2006, FEBS J, V273, P5074, DOI 10.1111/j.1742-4658.2006.05505.x; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MOORE SEH, 1995, EMBO J, V14, P6034, DOI 10.1002/j.1460-2075.1995.tb00292.x; MOORE SEH, 1994, J BIOL CHEM, V269, P12715; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Mosse CA, 1998, J EXP MED, V187, P37, DOI 10.1084/jem.187.1.37; Munro S, 2001, FEBS LETT, V498, P223, DOI 10.1016/S0014-5793(01)02488-7; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Nakayama K, 1997, FEBS LETT, V412, P547, DOI 10.1016/S0014-5793(97)00634-0; Natsuka S, 2002, J BIOCHEM, V131, P807, DOI 10.1093/oxfordjournals.jbchem.a003169; Nikawa J, 1996, NUCLEIC ACIDS RES, V24, P4222, DOI 10.1093/nar/24.21.4222; Ohashi S, 1999, J BIOCHEM-TOKYO, V126, P852, DOI 10.1093/oxfordjournals.jbchem.a022526; Okamoto M, 2008, EUKARYOT CELL, V7, P310, DOI 10.1128/EC.00333-07; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; Ostankovitch M, 2009, J IMMUNOL, V182, P4830, DOI 10.4049/jimmunol.0802902; OU WJ, 1993, NATURE, V364, P771, DOI 10.1038/364771a0; Oyama S, 2002, BIOSCI BIOTECH BIOCH, V66, P1378, DOI 10.1271/bbb.66.1378; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; Saint-Pol A, 1999, J BIOL CHEM, V274, P13547, DOI 10.1074/jbc.274.19.13547; SaintPol A, 1997, J CELL BIOL, V136, P45, DOI 10.1083/jcb.136.1.45; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Skipper JCA, 1996, J EXP MED, V183, P527, DOI 10.1084/jem.183.2.527; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V302, P1, DOI 10.1016/S0006-291X(03)00052-4; Suzuki T, 2002, P NATL ACAD SCI USA, V99, P9691, DOI 10.1073/pnas.152333599; Suzuki T, 1997, P NATL ACAD SCI USA, V94, P6244, DOI 10.1073/pnas.94.12.6244; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2006, BIOCHEM J, V400, P33, DOI 10.1042/BJ20060945; Suzuki T, 2006, GLYCOCONJUGATE J, V23, P291, DOI 10.1007/s10719-006-6975-x; Suzuki T, 2009, TRENDS GLYCOSCI GLYC, V21, P219, DOI 10.4052/tigg.21.219; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; TAKATSUKI A, 1971, J ANTIBIOT, V24, P215, DOI 10.7164/antibiotics.24.215; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; TRIMBLE RB, 1986, J BIOL CHEM, V261, P9815; TRUMBLY RJ, 1983, J BACTERIOL, V156, P36, DOI 10.1128/JB.156.1.36-48.1983; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Xu XH, 2004, FEBS LETT, V570, P155, DOI 10.1016/j.febslet.2004.06.039; YOSHIHISA T, 1989, BIOCHEM BIOPH RES CO, V163, P908, DOI 10.1016/0006-291X(89)92308-5; YOSHIHISA T, 1990, J BIOL CHEM, V265, P22418	89	72	74	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12390	12404		10.1074/jbc.M109.082081	http://dx.doi.org/10.1074/jbc.M109.082081			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20150426	hybrid, Green Published			2022-12-27	WOS:000276787100067
J	Teoh, SSY; Whisstock, JC; Bird, PI				Teoh, Sonia S. Y.; Whisstock, James C.; Bird, Phillip I.			Maspin (SERPINB5) Is an Obligate Intracellular Serpin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY EPITHELIAL-CELLS; TUMOR-SUPPRESSOR; PLASMINOGEN-ACTIVATOR; BREAST-CANCER; EXTRACELLULAR-MATRIX; OVALBUMIN FAMILY; SIGNAL SEQUENCES; MAMMALIAN-CELLS; EXPRESSION; PROTEIN	Maspin (SERPINB5) is a tumor suppressor lost in breast and prostate cancer whose molecular function is unknown. It is a non-inhibitory member of the clade B serpins suggested to play a role in a plethora of intracellular and extracellular settings, yet its normal cellular distribution has never been clarified. Here we investigate the distribution of maspin in non-transformed human epithelial cells. By indirect immunofluorescence, maspin has a nucleocytoplasmic distribution in breast (MCF10A) and prostate (RWPE-1) cells and, by immunoblotting and pulse-chase analyses, is neither glycosylated nor secreted. Cell surface biotinylation studies also show that maspin is not present at the cell surface. Differentiation of MCF10A cells into three-dimensional acini results in the redistribution of maspin from the nucleus to the cytoplasm but does not result in secretion. Addition of an efficient conventional signal peptide to maspin directs it into the secretory pathway and results in glycosylation but not secretion. We further show that maspin in the cytoplasm of MCF10A cells is a soluble monomeric protein that is not detectably associated with the cytoskeleton or other extractable components. Taken together, these results suggest that maspin is restricted to an intracellular, possibly nuclear, role in which it influences cell-matrix interactions indirectly. It is probably released only as a consequence of cell damage or necrosis.	[Teoh, Sonia S. Y.; Whisstock, James C.; Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia; [Whisstock, James C.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Sch Biomed Sci, Clayton, Vic 3800, Australia	Monash University; Monash University	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Sch Biomed Sci, Clayton, Vic 3800, Australia.	phil.bird@med.monash.edu.au		Whisstock, James/0000-0003-4200-5611; Bird, Phillip/0000-0002-6695-606X	National Health and Medical Research Council of Australia [490900]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council of Australia Program Grant 490900.	Abraham S, 2003, J UROLOGY, V169, P1157, DOI 10.1097/01.ju.0000040245.70349.37; Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Belin D, 2004, J MOL BIOL, V335, P437, DOI 10.1016/j.jmb.2003.10.076; Bello D, 1997, CARCINOGENESIS, V18, P1215, DOI 10.1093/carcin/18.6.1215; Bettstetter M, 2005, J PATHOL, V205, P606, DOI 10.1002/path.1732; Biliran H, 2001, CANCER RES, V61, P8676; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; BIRD P, 1987, J CELL BIOL, V105, P2905, DOI 10.1083/jcb.105.6.2905; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; BROCK TG, 1994, J BIOL CHEM, V269, P22059; Cella N, 2006, FASEB J, V20, P1510, DOI 10.1096/fj.05-5500fje; CHAO CCK, 1987, MOL CELL BIOL, V7, P3842, DOI 10.1128/MCB.7.10.3842; Chu M, 1998, THROMB HAEMOSTASIS, V80, P119, DOI 10.1055/s-0037-1615150; Chua I, 2009, J AM ACAD DERMATOL, V60, P758, DOI 10.1016/j.jaad.2009.01.018; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kulasingam V, 2007, MOL CELL PROTEOMICS, V6, P1997, DOI 10.1074/mcp.M600465-MCP200; Latha K, 2005, MOL CELL BIOL, V25, P1737, DOI 10.1128/MCB.25.5.1737-1748.2005; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Liu JY, 2004, CANCER RES, V64, P1703, DOI 10.1158/0008-5472.CAN-03-2568; Lomas DA, 2002, NAT REV GENET, V3, P759, DOI 10.1038/nrg907; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Lonardo F, 2006, LUNG CANCER, V51, P31, DOI 10.1016/j.lungcan.2005.07.011; Maass N, 2001, CLIN CANCER RES, V7, P812; Machtens S, 2001, INT J CANCER, V95, P337, DOI 10.1002/1097-0215(20010920)95:5<337::AID-IJC1059>3.0.CO;2-1; MADISON EL, 1992, GENE, V121, P179, DOI 10.1016/0378-1119(92)90179-S; Martin DB, 2004, CANCER RES, V64, P347, DOI 10.1158/0008-5472.CAN-03-2062; McGowen R, 2000, CANCER RES, V60, P4771; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mikus P, 1996, J BIOL CHEM, V271, P10048, DOI 10.1074/jbc.271.17.10048; Mohsin SK, 2003, J PATHOL, V199, P432, DOI 10.1002/path.1319; Murai S, 2006, CANCER SCI, V97, P883, DOI 10.1111/j.1349-7006.2006.00266.x; Ngamkitidechakul C, 2001, INVEST OPHTH VIS SCI, V42, P3135; Ngamkitidechakul C, 2003, J BIOL CHEM, V278, P31796, DOI 10.1074/jbc.M302408200; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Odero-Marah VA, 2003, CANCER BIOL THER, V2, P398, DOI 10.4161/cbt.2.4.471; Petrich BG, 2009, THROMB HAEMOSTASIS, V101, P1020, DOI 10.1160/TH08-08-0553; Plopper GE, 1998, BREAST CANCER RES TR, V51, P57, DOI 10.1023/A:1006086218174; REMOLDODONNELL E, 1993, FEBS LETT, V315, P105, DOI 10.1016/0014-5793(93)81143-N; Romani AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-255; Scott FL, 1996, J BIOL CHEM, V271, P1605, DOI 10.1074/jbc.271.3.1605; Sheng S, 1996, P NATL ACAD SCI USA, V93, P11669, DOI 10.1073/pnas.93.21.11669; Shi HY, 2007, CELL MOTIL CYTOSKEL, V64, P338, DOI 10.1002/cm.20187; Silverman GA, 2004, CELL MOL LIFE SCI, V61, P301, DOI 10.1007/s00018-003-3240-3; Sternlicht MD, 1997, CLIN CANCER RES, V3, P1949; Uemura Y, 2000, INT J CANCER, V89, P368, DOI 10.1002/1097-0215(20000720)89:4<368::AID-IJC9>3.0.CO;2-6; Ulmasov B, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-8; WIRTH DF, 1979, J CELL BIOL, V81, P154, DOI 10.1083/jcb.81.1.154; Yin SP, 2006, CANCER RES, V66, P4173, DOI 10.1158/0008-5472.CAN-05-3514; Yu M, 2007, HUM PATHOL, V38, P1248, DOI 10.1016/j.humpath.2006.11.025; Yu X, 2006, CANCER RES, V66, P4795, DOI 10.1158/0008-5472.CAN-05-4579; Zhang WG, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-50; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	55	35	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10862	10869		10.1074/jbc.M109.073171	http://dx.doi.org/10.1074/jbc.M109.073171			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123984	hybrid, Green Published			2022-12-27	WOS:000276264600071
J	Elbein, AD; Pastuszak, I; Tackett, AJ; Wilson, T; Pan, YT				Elbein, Alan D.; Pastuszak, Irena; Tackett, Alan J.; Wilson, Tyler; Pan, Yuan T.			Last Step in the Conversion of Trehalose to Glycogen A MYCOBACTERIAL ENZYME THAT TRANSFERS MALTOSE FROM MALTOSE 1-PHOSPHATE TO GLYCOGEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYCOBACTERIUM-SMEGMATIS; 3 PATHWAYS; BIOSYNTHESIS; CLONING; TREHALOSE-6-PHOSPHATE; PURIFICATION; SYNTHASE; METABOLISM; INHIBITORS; EXPRESSION	We show that Mycobacterium smegmatis has an enzyme catalyzing transfer of maltose from [C-14] maltose 1-phosphate to glycogen. This enzyme was purified 90-fold from crude extracts and characterized. Maltose transfer required addition of an acceptor. Liver, oyster, or mycobacterial glycogens were the best acceptors, whereas amylopectin had good activity, but amylose was a poor acceptor. Maltosaccharides inhibited the transfer of maltose from [C-14]maltose-1-P to glycogen because they were also acceptors of maltose, and they caused production of larger sized radioactive maltosaccharides. When maltotetraose was the acceptor, over 90% of the C-14-labeled product was maltohexaose, and no radioactivity was in maltopentaose, demonstrating that maltose was transferred intact. Stoichiometry showed that 0.89 mu mol of inorganic phosphate was produced for each micromole of maltose transferred to glycogen, and 56% of the added maltose-1-P was transferred to glycogen. This enzyme has been named alpha 1,4-glucan:maltose-1-P maltosyltransferase (GMPMT). Transfer of maltose to glycogen was inhibited by micromolar amounts of inorganic phosphate or arsenate but was only slightly inhibited by millimolar concentrations of glucose-1-P, glucose-6-P, or inorganic pyrophosphate. GMPMT was compared with glycogen phosphorylase (GP). GMPMT catalyzed transfer of [C-14] maltose-1-P, but not [C-14] glucose-1-P, to glycogen, whereas GP transferred radioactivity from glucose-1-P but not maltose-1-P. GMPMT and GP were both inhibited by 1,4-dideoxy-1,4-imino-D-arabinitol, but only GP was inhibited by isofagomine. Because mycobacteria that contain trehalose synthase accumulate large amounts of glycogen when grown in high concentrations of trehalose, we propose that trehalose synthase, maltokinase, and GMPMT represent a new pathway of glycogen synthesis using trehalose as the source of glucose.	[Elbein, Alan D.; Pastuszak, Irena; Tackett, Alan J.; Wilson, Tyler; Pan, Yuan T.] Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Tackett, AJ (corresponding author), Univ Arkansas Med Sci, Dept Biochem & Mol Biol, Little Rock, AR 72205 USA.	ajtackett@uams.edu						BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Carroll JD, 2007, FEBS J, V274, P1701, DOI 10.1111/j.1742-4658.2007.05715.x; CHRISTENSEN HN, 1974, ENZYME KINETICS, P75; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199; Elbein A D, 1974, Adv Carbohydr Chem Biochem, V30, P227, DOI 10.1016/S0065-2318(08)60266-8; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; HOTTIGER T, 1987, FEBS LETT, V220, P113, DOI 10.1016/0014-5793(87)80886-4; Jakobsen P, 2001, BIOORGAN MED CHEM, V9, P733, DOI 10.1016/S0968-0896(00)00291-1; Jarling M, 2004, J BASIC MICROB, V44, P360, DOI 10.1002/jobm.200410403; Klutts S, 2003, J BIOL CHEM, V278, P2093, DOI 10.1074/jbc.M209937200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latsis T, 2002, BIOCHEM J, V368, P309, DOI 10.1042/BJ20021070; LOEWUS FA, 1952, ANAL CHEM, V24, P219, DOI 10.1021/ac60061a050; MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309; Maruta K, 1996, BIOSCI BIOTECH BIOCH, V60, P717, DOI 10.1271/bbb.60.717; Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200; Niehues B, 2003, ARCH MICROBIOL, V180, P233, DOI 10.1007/s00203-003-0575-y; Nwaka S, 1998, PROG NUCLEIC ACID RE, V58, P197; Pan YT, 2004, EUR J BIOCHEM, V271, P4259, DOI 10.1111/j.1432-1033.2004.04365.x; Pan YT, 2008, FEBS J, V275, P3408, DOI 10.1111/j.1742-4658.2008.06491.x; RATH VL, 1987, PROTEINS, V2, P225, DOI 10.1002/prot.340020307; TAKAYAMA K, 1976, BIOCHEMISTRY-US, V15, P441, DOI 10.1021/bi00647a032; TREVELYAN WE, 1950, NATURE, V166, P444, DOI 10.1038/166444b0; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; VEECH RL, 1979, J BIOL CHEM, V254, P6538; Vogel G, 1998, PLANT J, V13, P673, DOI 10.1046/j.1365-313X.1998.00064.x; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x	30	48	51	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9803	9812		10.1074/jbc.M109.033944	http://dx.doi.org/10.1074/jbc.M109.033944			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118231	Green Published, hybrid			2022-12-27	WOS:000276165900052
J	He, YJ; Hakvoort, TBM; Kohler, SE; Vermeulen, JLM; de Waart, DR; de Theije, C; ten Have, GAM; van Eijk, HMH; Kunne, C; Labruyere, WT; Houten, SM; Sokolovic, M; Ruijter, JM; Deutz, NEP; Lamers, WH				He, Youji; Hakvoort, Theodorus B. M.; Kohler, S. Eleonore; Vermeulen, Jacqueline L. M.; de Waart, D. Rudi; de Theije, Chiel; ten Have, Gabrie A. M.; van Eijk, Hans M. H.; Kunne, Cindy; Labruyere, Wilhelmina T.; Houten, Sander M.; Sokolovic, Milka; Ruijter, Jan M.; Deutz, Nicolaas E. P.; Lamers, Wouter H.			Glutamine Synthetase in Muscle Is Required for Glutamine Production during Fasting and Extrahepatic Ammonia Detoxification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METHIONINE-DL-SULFOXIMINE; ACUTE LIVER-FAILURE; SKELETAL-MUSCLE; AMINO-ACIDS; PROTEIN BREAKDOWN; WHOLE-BODY; IN-VIVO; METABOLISM; EXPRESSION; RATS	The main endogenous source of glutamine is de novo synthesis in striated muscle via the enzyme glutamine synthetase (GS). The mice in which GS is selectively but completely eliminated from striated muscle with the Cre-loxP strategy (GS-KO/M mice) are, nevertheless, healthy and fertile. Compared with controls, the circulating concentration and net production of glutamine across the hindquarter were not different in fed GS-KO/M mice. Only a similar to 3-fold higher escape of ammonia revealed the absence of GS in muscle. However, after 20 h of fasting, GSKO/M mice were not able to mount the similar to 4-fold increase in glutamine production across the hindquarter that was observed in control mice. Instead, muscle ammonia production was similar to 5-fold higher than in control mice. The fasting-induced metabolic changes were transient and had returned to fed levels at 36 h of fasting. Glucose consumption and lactate and ketone-body production were similar in GS-KO/M and control mice. Challenging GS-KO/M and control mice with intravenous ammonia in stepwise increments revealed that normal muscle can detoxify similar to 2.5 mu mol ammonia/g muscle.h in a muscle GS-dependent manner, with simultaneous accumulation of urea, whereas GSKO/M mice responded with accumulation of glutamine and other amino acids but not urea. These findings demonstrate that GS in muscle is dispensable in fed mice but plays a key role in mounting the adaptive response to fasting by transiently facilitating the production of glutamine. Furthermore, muscle GS contributes to ammonia detoxification and urea synthesis. These functions are apparently not vital as long as other organs function normally.	[He, Youji; Hakvoort, Theodorus B. M.; Vermeulen, Jacqueline L. M.; de Waart, D. Rudi; Kunne, Cindy; Labruyere, Wilhelmina T.; Sokolovic, Milka; Ruijter, Jan M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Ctr Liver, NL-1105 BK Amsterdam, Netherlands; [He, Youji; Hakvoort, Theodorus B. M.; Vermeulen, Jacqueline L. M.; de Waart, D. Rudi; Kunne, Cindy; Labruyere, Wilhelmina T.; Sokolovic, Milka; Ruijter, Jan M.; Lamers, Wouter H.] Univ Amsterdam, Acad Med Ctr, Dept Anat & Embryol, NL-1105 BK Amsterdam, Netherlands; [Kohler, S. Eleonore; de Theije, Chiel; Lamers, Wouter H.] Univ Maastricht, Dept Anat & Embryol, NL-6200 MD Maastricht, Netherlands; [ten Have, Gabrie A. M.; van Eijk, Hans M. H.; Deutz, Nicolaas E. P.] Univ Maastricht, Dept Surg, NL-6200 MD Maastricht, Netherlands; [Houten, Sander M.] Univ Amsterdam, Acad Med Ctr, Lab Genet Metab Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam	Lamers, WH (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Liver, Meibergdreef 69-71, NL-1105 BK Amsterdam, Netherlands.	w.h.lamers@amc.uva.nl	Sokolovic, Milka/C-2115-2009; Houten, Sander/Y-3599-2019; Sokolovic, Milka/AAY-1618-2020; Lamers, Wouter H./D-2965-2012; Deutz, Nicolaas E/J-5200-2012; Köhler, Eleonore/D-2915-2012	Houten, Sander/0000-0002-6167-9147; Sokolovic, Milka/0000-0002-3957-4656; Köhler, Eleonore/0000-0003-1977-9977; Deutz, Nicolaas/0000-0001-5845-6447	Netherlands Organization for Scientific Research (NWO) [SGC210009]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	l This work was supported by Netherlands Organization for Scientific Research (NWO) Grant SGC210009 (to W. H. L.).	APOSTOLAKIS M, 1989, BRAIN RES BULL, V23, P257, DOI 10.1016/0361-9230(89)90155-X; AROLA L, 1981, ARCH INT PHYSIOL BIO, V89, P189, DOI 10.3109/13813458109069465; BHANDARI B, 1986, MOL CELL ENDOCRINOL, V47, P49, DOI 10.1016/0303-7207(86)90015-8; Biolo G, 2000, CLIN SCI, V99, P189, DOI 10.1042/CS19990254; Biolo G, 2005, INT J BIOCHEM CELL B, V37, P2169, DOI 10.1016/j.biocel.2005.05.001; BIOLO G, 1995, AM J PHYSIOL-ENDOC M, V268, pE75, DOI 10.1152/ajpendo.1995.268.1.E75; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; CHANG TW, 1978, J BIOL CHEM, V253, P3677; CHANG TW, 1978, J BIOL CHEM, V253, P3685; Chatauret N, 2006, J HEPATOL, V44, P1083, DOI 10.1016/j.jhep.2005.11.048; Clemmesen JO, 2000, GASTROENTEROLOGY, V118, P1131, DOI 10.1016/S0016-5085(00)70366-0; CURTHOYS NP, 1995, ANNU REV NUTR, V15, P133, DOI 10.1146/annurev.nu.15.070195.001025; Damink SWMO, 2002, NEUROCHEM INT, V41, P177, DOI 10.1016/S0197-0186(02)00040-2; Damink SWMO, 1999, CLIN SCI, V96, P639, DOI 10.1042/CS19980389; Danielyan L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004416; DARMAUN D, 1988, AM J PHYSIOL, V255, pE366, DOI 10.1152/ajpendo.1988.255.3.E366; deBlaauw I, 1996, CLIN SCI, V90, P457, DOI 10.1042/cs0900457; DEJONG CHC, 1993, J CLIN INVEST, V92, P2834, DOI 10.1172/JCI116903; Deprez RHL, 2002, ANAL BIOCHEM, V307, P63, DOI 10.1016/S0003-2697(02)00021-0; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Finn PF, 2006, NUTRITION, V22, P830, DOI 10.1016/j.nut.2006.04.008; Hallemeesch MM, 2001, LAB ANIM-UK, V35, P101, DOI 10.1258/0023677011911426; HE Y, 2010, GLIA IN PRESS, V58; He Y, 2007, DEV DYNAM, V236, P1865, DOI 10.1002/dvdy.21185; HEENEMAN S, 1993, CLIN NUTR, V12, P182, DOI 10.1016/0261-5614(93)90078-I; HICKSON RC, 1995, AM J PHYSIOL-ENDOC M, V268, pE730, DOI 10.1152/ajpendo.1995.268.4.E730; Jagoe RT, 2002, FASEB J, V16, P1697, DOI 10.1096/fj.02-0312com; JEPSON MM, 1988, AM J PHYSIOL, V255, pE166, DOI 10.1152/ajpendo.1988.255.2.E166; Kuhn KS, 1999, AM J CLIN NUTR, V70, P484; Labow BI, 1999, AM J PHYSIOL-ENDOC M, V276, pE1136, DOI 10.1152/ajpendo.1999.276.6.E1136; LI B, 1979, AM J PHYSIOL-ENDOC M, V5, pE222; Lie-Venema H, 1998, PROG NUCLEIC ACID RE, V61, P243, DOI 10.1016/S0079-6603(08)60829-6; Listrom CD, 1997, BIOCHEM J, V328, P159; MACLENNAN PA, 1988, FEBS LETT, V237, P133, DOI 10.1016/0014-5793(88)80186-8; McGivan JD, 2007, FRONT BIOSCI, V12, P874, DOI 10.2741/2109; Melis GC, 2004, CURR OPIN CLIN NUTR, V7, P59, DOI 10.1097/00075197-200401000-00011; NURJHAN N, 1995, J CLIN INVEST, V95, P272, DOI 10.1172/JCI117651; RAO VLR, 1991, NEUROSCI LETT, V126, P13, DOI 10.1016/0304-3940(91)90359-2; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rutten EPA, 2005, CURR OPIN CLIN NUTR, V8, P41, DOI 10.1097/00075197-200501000-00007; SELLINGER OZ, 1982, J NEUROCHEM, V38, P1676, DOI 10.1111/j.1471-4159.1982.tb06649.x; SHANRONG S, 2000, ANTIGEN RETRIEVAL TE; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tang H, 2000, MOL CELL NEUROSCI, V16, P127, DOI 10.1006/mcne.2000.0864; THOMPSON JR, 1991, COMP BIOCHEM PHYS B, V100, P209, DOI 10.1016/0305-0491(91)90363-I; Tjader I, 2007, CRIT CARE MED, V35, pS553, DOI 10.1097/01.CCM.0000278602.41352.0E; van Acker BAC, 1998, CLIN SCI, V95, P339, DOI 10.1042/CS19980053; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x	50	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9516	9524		10.1074/jbc.M109.092429	http://dx.doi.org/10.1074/jbc.M109.092429			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20064933	Green Published, hybrid			2022-12-27	WOS:000276165900025
J	Kobayashi, M; AB, E; Bonvin, AMJJ; Siegal, G				Kobayashi, Masakazu; AB, Eiso; Bonvin, Alexander M. J. J.; Siegal, Gregg			Structure of the DNA-bound BRCA1 C-terminal Region from Human Replication Factor C p140 and Model of the Protein-DNA Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; LARGE SUBUNIT; PHOSPHOPEPTIDE RECOGNITION; BACH1 PHOSPHOPEPTIDE; BACKBONE DYNAMICS; ESCHERICHIA-COLI; CLAMP LOADER; LIGASE-III; CANCER; NMR	BRCA1 C-terminal domain (BRCT)-containing proteins are found widely throughout the animal and bacteria kingdoms where they are exclusively involved in cell cycle regulation and DNA metabolism. Whereas most BRCT domains are involved in protein-protein interactions, a small subset has bona fide DNA binding activity. Here, we present the solution structure of the BRCT region of the large subunit of replication factor C bound to DNA and a model of the structure-specific complex with 5'-phosphorylated double-stranded DNA. The replication factor C BRCT domain possesses a large basic patch on one face, which includes residues that are structurally conserved and ligate the phosphate in phosphopeptide binding BRCT domains. An extra alpha-helix at the N terminus, which is required for DNA binding, inserts into the major groove and makes extensive contacts to the DNA backbone. The model of the protein-DNA complex suggests 5'-phosphate recognition by the BRCT domains of bacterial NAD(+)-dependent ligases and a non-clamp loading role for the replication factor C complex in DNA transactions.	[Siegal, Gregg] Leiden Univ, Gorlaeus Lab, Leiden Inst Chem, NL-2300 RA Leiden, Netherlands; [AB, Eiso; Bonvin, Alexander M. J. J.] Univ Utrecht, Dept NMR Spect, Bijvoet Ctr Biomol Res, NL-3584 Utrecht, Netherlands	Leiden University; Leiden University - Excl LUMC; Utrecht University	Siegal, G (corresponding author), Leiden Univ, Gorlaeus Lab, Leiden Inst Chem, Postbus 9502, NL-2300 RA Leiden, Netherlands.	g.siegal@chem.leidenuniv.nl	AB, Eiso/H-8177-2012; Bonvin, Alexandre M.J.J./A-5420-2009	Bonvin, Alexandre M.J.J./0000-0001-7369-1322; Siegal, Gregg/0000-0003-3806-4811; AB, Eiso/0000-0002-5758-0435				Allen BL, 1998, NUCLEIC ACIDS RES, V26, P3877, DOI 10.1093/nar/26.17.3877; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Botuyan MVE, 2004, STRUCTURE, V12, P1137, DOI 10.1016/j.str.2004.06.002; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Caldecott KW, 2003, SCIENCE, V302, P579, DOI 10.1126/science.1091463; Clapperton JA, 2004, NAT STRUCT MOL BIOL, V11, P512, DOI 10.1038/nsmb775; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dulic A, 2001, BIOCHEMISTRY-US, V40, P5906, DOI 10.1021/bi002701e; Ekblad CMS, 2002, J MOL BIOL, V320, P431, DOI 10.1016/S0022-2836(02)00478-3; Feng H, 2004, BIOCHEMISTRY-US, V43, P12648, DOI 10.1021/bi049451c; Gaiser OJ, 2004, BIOCHEMISTRY-US, V43, P15983, DOI 10.1021/bi049550q; Gomes XV, 2000, J BIOL CHEM, V275, P14541, DOI 10.1074/jbc.275.19.14541; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HUBBARD SJ, 2008, NACCESS; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; Jeon HJ, 2004, FEMS MICROBIOL LETT, V237, P111, DOI 10.1016/j.femsle.2004.06.018; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Keller R., 2004, COMPUTER AIDED RESON, P15; Kobayashi M, 2006, J BIOL CHEM, V281, P4308, DOI 10.1074/jbc.M511090200; Kobayashi M, 2005, J BIOMOL NMR, V31, P183, DOI 10.1007/s10858-004-7913-5; Koonin EV, 1996, NAT GENET, V13, P266, DOI 10.1038/ng0796-266; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Krishnan VV, 2001, BIOCHEMISTRY-US, V40, P13158, DOI 10.1021/bi010979g; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Levin DS, 2004, J BIOL CHEM, V279, P55196, DOI 10.1074/jbc.M409250200; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Nederveen AJ, 2005, PROTEINS, V59, P662, DOI 10.1002/prot.20408; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Pervushin K, 1996, J MOL BIOL, V264, P1002, DOI 10.1006/jmbi.1996.0692; Shiozaki EN, 2004, MOL CELL, V14, P405, DOI 10.1016/S1097-2765(04)00238-2; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; Viadiu H, 2000, MOL CELL, V5, P889, DOI 10.1016/S1097-2765(00)80329-9; WAGA S, 1994, NATURE, V369, P207, DOI 10.1038/369207a0; Wilkinson A, 2005, BBA-PROTEINS PROTEOM, V1749, P113, DOI 10.1016/j.bbapap.2005.03.003; Williams RS, 2004, NAT STRUCT MOL BIOL, V11, P519, DOI 10.1038/nsmb776; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zhang XD, 1998, EMBO J, V17, P6404, DOI 10.1093/emboj/17.21.6404	45	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10087	10097		10.1074/jbc.M109.054106	http://dx.doi.org/10.1074/jbc.M109.054106			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20081198	Green Published, hybrid			2022-12-27	WOS:000276165900076
J	Kim, KS; Yoon, YR; Lee, HJ; Yoon, S; Kim, SY; Shin, SW; An, JJ; Kim, MS; Choi, SY; Sun, W; Baik, JH				Kim, Kyu Seok; Yoon, Ye Ran; Lee, Hyo Jin; Yoon, Sehyoun; Kim, Sa-Yong; Shin, Seung Woo; An, Juan Ji; Kim, Min-Seon; Choi, Se-Young; Sun, Woong; Baik, Ja-Hyun			Enhanced Hypothalamic Leptin Signaling in Mice Lacking Dopamine D-2 Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANIN-CONCENTRATING HORMONE; FOOD-INTAKE; GENE-EXPRESSION; NEUROPEPTIDE-Y; ENERGY HOMEOSTASIS; FEEDING-BEHAVIOR; TARGET NEURONS; MESSENGER-RNA; D2 RECEPTORS; LONG FORM	The dopamine D-2 receptor (D2R) plays a critical role in diverse neurophysiological functions. D2R knock-out mice (D2R(-/-)) show reduced food intake and body weight while displaying an increased basal energy expenditure level, compared with their wild type littermates. Thus, these mice show a lean phenotype. D2R(-/-) mice displayed increased leptin sensitivity, and leptin injection induced increased phosphorylation of the hypothalamic signal transducer and activator of transcription 3 (STAT3) in D2R(-/-) mice relative to wild type littermates. Using double immunofluorescence histochemistry, we have demonstrated that D2Rs are present in leptin-sensitive STAT3-positive cells in the arcuate nucleus of the hypothalamus and that leptin injection induces STAT3 phosphorylation in hypothalamic neurons expressing D2Rs. Stimulation of D2R by the D2R agonist quinpirole suppressed the leptin-induced STAT3 phosphorylation and nuclear trans-localization of phospho-STAT3 in the hypothalamus of wild type mice. However, this regulation was not detected in the D2R(-/-) mice. Treatment of D2R agonist and antagonist could modulate the leptin-induced food intake and body weight changes in wild type mice but not in D2R(-/-) mice. Together, our findings suggest that the interaction between the dopaminergic system and leptin signaling in hypothalamus is important in control of energy homeostasis.	[Baik, Ja-Hyun] Korea Univ, Mol Neurobiol Lab, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [An, Juan Ji] Yonsei Univ, Med Res Ctr, Coll Med, Brain Korea Project Med Sci 21, Seoul 120752, South Korea; [Kim, Min-Seon] Univ Ulsan, Dept Internal Med, Coll Med, Seoul 138736, South Korea; [Choi, Se-Young] Seoul Natl Univ, Dept Physiol, Seoul 110749, South Korea; [Choi, Se-Young] Seoul Natl Univ, Mol & Cellular Neurosci Program, Coll Dent, Seoul 110749, South Korea; [Choi, Se-Young] Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea; [Sun, Woong] Korea Univ, Dept Anat, Coll Med, Seoul 136705, South Korea	Korea University; Yonsei University; Yonsei University Health System; University of Ulsan; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Baik, JH (corresponding author), Korea Univ, Mol Neurobiol Lab, Sch Life Sci & Biotechnol, Seoul 136701, South Korea.	jahyunb@korea.ac.kr		sun, woong/0000-0003-1792-4894; Choi, Se-Young/0000-0001-7534-5167; Yoon, Sehyoun/0000-0001-6545-3615	Korean Government (MOEHRD) [KRF-2006-311-C00478]; Brain Research Center of the 21st Century Frontier Research [M103KV010015-07K2201-01510, M103KV010014-08K2201-01410]; Korea Science and Engineering Foundation [M1-0311-00-0069]; Korean Ministry of Science and Technology; AstraZeneca	Korean Government (MOEHRD)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Brain Research Center of the 21st Century Frontier Research; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); AstraZeneca(AstraZeneca)	This work was supported by Korea Research Foundation Research Grant KRF-2006-311-C00478, funded by the Korean Government (MOEHRD), Grants M103KV010015-07K2201-01510 and M103KV010014-08K2201-01410 from the Brain Research Center of the 21st Century Frontier Research Program, Grant M1-0311-00-0069 from the Korea Science and Engineering Foundation, funded by the Korean Ministry of Science and Technology, and a grant award from the AstraZeneca VRI Program.	Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; An JJ, 2004, MOL CELL NEUROSCI, V25, P732, DOI 10.1016/j.mcn.2003.12.010; BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Bates SH, 2004, DIABETES, V53, P3067, DOI 10.2337/diabetes.53.12.3067; Beaulieu JM, 2004, P NATL ACAD SCI USA, V101, P5099, DOI 10.1073/pnas.0307921101; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522; Bolan EA, 2007, MOL PHARMACOL, V71, P1222, DOI 10.1124/mol.106.027763; Brami-Cherrier K, 2002, J NEUROSCI, V22, P8911; Comings DE, 1996, MOL PSYCHIATR, V1, P325; Diaz-Torga G, 2002, ENDOCRINOLOGY, V143, P1270, DOI 10.1210/en.143.4.1270; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Epstein LH, 2007, BEHAV NEUROSCI, V121, P877, DOI 10.1037/0735-7044.121.5.877; Fang YJ, 2005, INT J CARDIOL, V102, P111, DOI 10.1016/j.ijcard.2004.05.010; Fetissov SO, 2000, NEUROSCIENCE, V101, P657, DOI 10.1016/S0306-4522(00)00374-2; Fetissov SO, 2002, AM J PHYSIOL-REG I, V283, pR905, DOI 10.1152/ajpregu.00092.2002; Flier JS, 1998, CELL, V92, P437, DOI 10.1016/S0092-8674(00)80937-X; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Hakansson ML, 1999, J NEUROENDOCRINOL, V11, P653; Hakansson ML, 1998, NEUROENDOCRINOLOGY, V68, P420, DOI 10.1159/000054392; Hakansson ML, 1998, J NEUROSCI, V18, P559; Hill JW, 2008, J CLIN INVEST, V118, P1796, DOI 10.1172/JCI32964; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; HORNYKIEWICZ O, 1966, PHARMACOL REV, V18, P925; Jenkinson CP, 2000, INT J OBESITY, V24, P1233, DOI 10.1038/sj.ijo.0801381; Kelly MA, 1997, NEURON, V19, P103, DOI 10.1016/S0896-6273(00)80351-7; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kim RY, 2005, BIOCHEM BIOPH RES CO, V329, P1178, DOI 10.1016/j.bbrc.2005.02.105; Kim SY, 2006, J NEUROSCI, V26, P4567, DOI 10.1523/JNEUROSCI.5236-05.2006; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kok P, 2006, J CLIN ENDOCR METAB, V91, P3236, DOI 10.1210/jc.2005-2529; Kokkotou EG, 2001, ENDOCRINOLOGY, V142, P680, DOI 10.1210/en.142.2.680; Leinninger GM, 2009, CELL METAB, V10, P89, DOI 10.1016/j.cmet.2009.06.011; Leshan RL, 2006, OBESITY, V14, P208, DOI 10.1038/oby.2006.310; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maldonado R, 1997, NATURE, V388, P586, DOI 10.1038/41567; MANSOUR A, 1990, J NEUROSCI, V10, P2587; Meguid MM, 2000, NUTRITION, V16, P843, DOI 10.1016/S0899-9007(00)00449-4; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Munzberg H, 2003, ENDOCRINOLOGY, V144, P2121, DOI 10.1210/en.2002-221037; Munzberg H, 2007, J NEUROSCI, V27, P69, DOI 10.1523/JNEUROSCI.3168-06.2007; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Palmiter RD, 2007, TRENDS NEUROSCI, V30, P375, DOI 10.1016/j.tins.2007.06.004; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Ramos EJB, 2005, NUTRITION, V21, P269, DOI 10.1016/j.nut.2004.06.021; Sahu A, 2003, FRONT NEUROENDOCRIN, V24, P225, DOI 10.1016/j.yfrne.2003.10.001; Saiardi A, 1997, NEURON, V19, P115, DOI 10.1016/S0896-6273(00)80352-9; Sato T, 2001, AM J PHYSIOL-REG I, V281, pR1907, DOI 10.1152/ajpregu.2001.281.6.R1907; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Sindelar DK, 2004, ENDOCRINOLOGY, V145, P3363, DOI 10.1210/en.2003-1727; Smith DG, 2005, J NEUROSCI, V25, P914, DOI 10.1523/JNEUROSCI.4079-04.2005; Stice E, 2008, SCIENCE, V322, P449, DOI 10.1126/science.1161550; STRICKER EM, 1984, INT J OBESITY, V8, P39; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Tataranni PA, 2001, DIABETES, V50, P901, DOI 10.2337/diabetes.50.4.901; Thomas GN, 2000, HYPERTENSION, V36, P177, DOI 10.1161/01.HYP.36.2.177; Trivedi P, 1998, FEBS LETT, V438, P71, DOI 10.1016/S0014-5793(98)01266-6; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Xu AW, 2005, J CLIN INVEST, V115, P951, DOI 10.1172/JCI200524301; YANG ZJ, 1995, NEUROREPORT, V6, P1191, DOI 10.1097/00001756-199505300-00029; Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; ZIGMOND MJ, 1980, PROG NEURO-PSYCHOPHA, V4, P351, DOI 10.1016/0364-7722(80)90005-3; ZIGMOND MJ, 1972, SCIENCE, V177, P1211	73	63	65	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8905	8917		10.1074/jbc.M109.079590	http://dx.doi.org/10.1074/jbc.M109.079590			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080963	Green Published, hybrid			2022-12-27	WOS:000275553700042
J	Ratchford, AM; Baker, OJ; Camden, JM; Rikka, S; Petris, MJ; Seye, CI; Erb, L; Weisman, GA				Ratchford, Ann M.; Baker, Olga J.; Camden, Jean M.; Rikka, Shivaji; Petris, Michael J.; Seye, Cheikh I.; Erb, Laurie; Weisman, Gary A.			P2Y(2) Nucleotide Receptors Mediate Metalloprotease-dependent Phosphorylation of Epidermal Growth Factor Receptor and ErbB3 in Human Salivary Gland Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; ADHESION MOLECULE-1 EXPRESSION; FOCAL TYROSINE KINASE; SMOOTH-MUSCLE-CELLS; SUBMANDIBULAR-GLAND; EGF RECEPTOR; BRANCHING MORPHOGENESIS; UP-REGULATION; SIGNAL-TRANSDUCTION; P-2 PURINOCEPTORS	The G protein-coupled receptor P2Y(2) nucleotide receptor (P2Y(2)R) has been shown to be up-regulated in a variety of tissues in response to stress or injury. Recent studies have suggested that P2Y(2)Rs may play a role in immune responses, wound healing, and tissue regeneration via their ability to activate multiple signaling pathways, including activation of growth factor receptors. Here, we demonstrate that in human salivary gland (HSG) cells, activation of the P2Y(2)R by its agonist induces phosphorylation of ERK1/2 via two distinct mechanisms, a rapid, protein kinase C-dependent pathway and a slower and prolonged, epidermal growth factor receptor (EGFR)-dependent pathway. The EGFR-dependent stimulation of UTP-induced ERK1/2 phosphorylation in HSG cells is inhibited by the adamalysin inhibitor tumor necrosis factor-alpha protease inhibitor or by small interfering RNA that selectively silences ADAM10 and ADAM17 expression, suggesting that ADAM metalloproteases are required for P2Y(2)R-mediated activation of the EGFR. G-protein-coupled receptors have been shown to promote proteolytic release of EGFR ligands; however, neutralizing antibodies to known ligands of the EGFR did not inhibit UTP-induced EGFR phosphorylation. Immunoprecipitation experiments indicated that UTP causes association of the EGFR with another member of the EGF receptor family, ErbB3. Furthermore, stimulation of HSG cells with UTP induced phosphorylation of ErbB3, and silencing of ErbB3 expression inhibited UTP-induced phosphorylation of both ErbB3 and EGFR. UTP-induced phosphorylation of ErbB3 and EGFR was also inhibited by silencing the expression of the ErbB3 ligand neuregulin 1 (NRG1). These results suggest that P2Y(2)R activation in salivary gland cells promotes the formation of EGFR/ErbB3 heterodimers and metalloprotease-dependent neuregulin 1 release, resulting in the activation of both EGFR and ErbB3.	[Ratchford, Ann M.; Baker, Olga J.; Camden, Jean M.; Rikka, Shivaji; Petris, Michael J.; Seye, Cheikh I.; Erb, Laurie; Weisman, Gary A.] Univ Missouri, Dept Biochem, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Weisman, GA (corresponding author), Univ Missouri, Dept Biochem, Life Sci Ctr 540E, 1201 Rollins Rd, Columbia, MO 65211 USA.	weismang@missouri.edu		Erb, Laurie/0000-0001-6372-3378; Baker, Olga/0000-0002-0628-8645				Ahn JS, 2000, AM J PHYSIOL-CELL PH, V279, pC286, DOI 10.1152/ajpcell.2000.279.2.C286; Arthur DB, 2006, BIOCHEM BIOPH RES CO, V347, P678, DOI 10.1016/j.bbrc.2006.06.141; Arthur DB, 2006, J NEUROSCI, V26, P3798, DOI 10.1523/JNEUROSCI.5338-05.2006; Baker OJ, 2008, MOL IMMUNOL, V45, P65, DOI 10.1016/j.molimm.2007.05.009; Beldi G, 2008, GASTROENTEROLOGY, V135, P1751, DOI 10.1053/j.gastro.2008.07.025; Berasain C, 2009, ANN NY ACAD SCI, V1155, P206, DOI 10.1111/j.1749-6632.2009.03704.x; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; BOARDER MR, 1995, TRENDS PHARMACOL SCI, V16, P133, DOI 10.1016/S0165-6147(00)89001-X; Camden JM, 2005, J BIOL CHEM, V280, P18696, DOI 10.1074/jbc.M500219200; Chang SJ, 2008, CELL SIGNAL, V20, P1248, DOI 10.1016/j.cellsig.2008.02.011; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Crooke A, 2009, MOL VIS, V15, P1169; Daub H, 1997, EMBO J, V16, P7032, DOI 10.1093/emboj/16.23.7032; Degagne E, 2009, J IMMUNOL, V183, P4521, DOI 10.4049/jimmunol.0803977; Dhanasekaran N., 1995, Endocrine Reviews, V16, P259; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dixon CJ, 1999, BRIT J PHARMACOL, V127, P1680, DOI 10.1038/sj.bjp.0702653; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Erb L, 2001, J CELL BIOL, V153, P491, DOI 10.1083/jcb.153.3.491; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Frank GD, 2003, ANTIOXID REDOX SIGN, V5, P771, DOI 10.1089/152308603770380070; Frank GD, 2003, MOL CELL BIOL, V23, P1581, DOI 10.1128/MCB.23.5.1581-1589.2003; Frolov A, 2007, CANCER BIOL THER, V6, P548, DOI 10.4161/cbt.6.4.3849; Fukuhara S, 2001, ONCOGENE, V20, P1661, DOI 10.1038/sj.onc.1204182; Hoffman MP, 1998, J BIOL CHEM, V273, P28633, DOI 10.1074/jbc.273.44.28633; Hoffman MP, 1996, J CELL SCI, V109, P2013; Hoffman MP, 2002, DEVELOPMENT, V129, P5767, DOI 10.1242/dev.00172; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hsieh M, 2005, TRENDS ENDOCRIN MET, V16, P320, DOI 10.1016/j.tem.2005.07.005; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kalmes A, 2000, CIRC RES, V87, P92, DOI 10.1161/01.RES.87.2.92; Keely SJ, 1998, J BIOL CHEM, V273, P27111, DOI 10.1074/jbc.273.42.27111; Keely SJ, 2000, J BIOL CHEM, V275, P12619, DOI 10.1074/jbc.275.17.12619; Kim HH, 1998, BIOCHEM J, V334, P189, DOI 10.1042/bj3340189; KNOWLES MR, 1992, CHEST, V101, pS60, DOI 10.1378/chest.101.3_Supplement.60S; Larsen M, 2003, DEV BIOL, V255, P178, DOI 10.1016/S0012-1606(02)00047-7; Li ZM, 2007, CELL SIGNAL, V19, P466, DOI 10.1016/j.cellsig.2006.07.020; Liu J, 2004, J BIOL CHEM, V279, P8212, DOI 10.1074/jbc.M312230200; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; McCole DF, 2002, J BIOL CHEM, V277, P42603, DOI 10.1074/jbc.M206487200; Mediero A, 2006, INVEST OPHTH VIS SCI, V47, P4500, DOI 10.1167/iovs.06-0209; Miyazaki Y, 2004, DEV DYNAM, V230, P591, DOI 10.1002/dvdy.20078; Moon Y, 2007, TOXICOL APPL PHARM, V223, P155, DOI 10.1016/j.taap.2007.04.018; New David C, 2007, J Mol Signal, V2, P2, DOI 10.1186/1750-2187-2-2; Noone PG, 1999, AM J RESP CRIT CARE, V160, P144, DOI 10.1164/ajrccm.160.1.9806146; Ohtsu H, 2005, ANTIOXID REDOX SIGN, V7, P1315, DOI 10.1089/ars.2005.7.1315; Ohtsu H, 2006, AM J PHYSIOL-CELL PH, V291, pC1, DOI 10.1152/ajpcell.00620.2005; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; PARR CE, 1994, P NATL ACAD SCI USA, V91, P3275, DOI 10.1073/pnas.91.8.3275; Patel VN, 2006, DIFFERENTIATION, V74, P349, DOI 10.1111/j.1432-0436.2006.00088.x; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schrader AM, 2005, ARCH ORAL BIOL, V50, P533, DOI 10.1016/j.archoralbio.2004.11.005; Seye CI, 2004, J BIOL CHEM, V279, P35679, DOI 10.1074/jbc.M401799200; Seye CI, 2003, J BIOL CHEM, V278, P24960, DOI 10.1074/jbc.M301439200; Shin SY, 2006, EXP MOL MED, V38, P677, DOI 10.1038/emm.2006.80; Soltoff SP, 1998, J BIOL CHEM, V273, P2653, DOI 10.1074/jbc.273.5.2653; Soltoff SP, 1998, J BIOL CHEM, V273, P23110, DOI 10.1074/jbc.273.36.23110; Tsai W, 1997, EMBO J, V16, P4597, DOI 10.1093/emboj/16.15.4597; Turner JT, 1998, AM J PHYSIOL-CELL PH, V275, pC367, DOI 10.1152/ajpcell.1998.275.2.C367; Turner JT, 1997, AM J PHYSIOL-CELL PH, V273, pC1100, DOI 10.1152/ajpcell.1997.273.3.C1100; Ueno Y, 2008, INT J CANCER, V123, P340, DOI 10.1002/ijc.23465; vanBiesen T, 1996, ENDOCR REV, V17, P698, DOI 10.1210/er.17.6.698; Wang M, 2005, J NEUROCHEM, V95, P630, DOI 10.1111/j.1471-4159.2005.03408.x; Warren CM, 2006, CELL SIGNAL, V18, P923, DOI 10.1016/j.cellsig.2005.12.007; Weisman GA, 1996, J PHARMACOL EXP THER, V277, P1; Witters L, 2008, CANCER RES, V68, P7083, DOI 10.1158/0008-5472.CAN-08-0739; Yang CF, 2006, MOL CELL BIOL, V26, P831, DOI 10.1128/MCB.26.3.831-842.2006; Zheng CY, 1998, J CELL PHYSIOL, V177, P628, DOI 10.1002/(SICI)1097-4652(199812)177:4<628::AID-JCP13>3.0.CO;2-L; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zwick E, 1997, J BIOL CHEM, V272, P24767, DOI 10.1074/jbc.272.40.24767	79	43	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7545	7555		10.1074/jbc.M109.078170	http://dx.doi.org/10.1074/jbc.M109.078170			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20064929	hybrid, Green Published			2022-12-27	WOS:000275415600066
J	Hasegawa, K; Wakino, S; Yoshioka, K; Tatematsu, S; Hara, Y; Minakuchi, H; Sueyasu, K; Washida, N; Tokuyama, H; Tzukerman, M; Skorecki, K; Hayashi, K; Itoh, H				Hasegawa, Kazuhiro; Wakino, Shu; Yoshioka, Kyoko; Tatematsu, Satoru; Hara, Yoshikazu; Minakuchi, Hitoshi; Sueyasu, Keiko; Washida, Naoki; Tokuyama, Hirobumi; Tzukerman, Maty; Skorecki, Karl; Hayashi, Koichi; Itoh, Hiroshi			Kidney-specific Overexpression of Sirt1 Protects against Acute Kidney Injury by Retaining Peroxisome Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED NEPHROTOXICITY; ISCHEMIA-REPERFUSION INJURY; OXIDATIVE STRESS; CALORIE RESTRICTION; TRANSGENIC MICE; RAT-KIDNEY; MITOCHONDRIAL BIOGENESIS; CELLS; METABOLISM; APOPTOSIS	Sirt1, a NAD-dependent protein deacetylase, is reported to regulate intracellular metabolism and attenuate reactive oxidative species (ROS)-induced apoptosis leading to longevity and acute stress resistance. We created transgenic (TG) mice with kidney-specific overexpression of Sirt1 using the promoter sodium-phosphate cotransporter IIa (Npt2) driven specifically in proximal tubules and investigated the kidney-specific role of Sirt1 in the protection against acute kidney injury (AKI). We also elucidated the role of number or function of peroxisome and mitochondria in mediating the mechanisms for renal protective effects of Sirt1 in AKI. Cisplatin-induced AKI decreased the number and function of peroxisomes as well as mitochondria and led to increased local levels of ROS production and renal tubular apoptotic cells. TG mice treated with cisplatin mitigated AKI, local ROS, and renal tubular apoptotic tubular cells. Consistent with these results, TG mice treated with cisplatin also exhibited recovery of peroxisome number and function, as well as rescued mitochondrial function; however, mitochondrial number was not recovered. Immunoelectron microscopic findings consistently demonstrated that the decrease in peroxisome number by cisplatin in wild type mice was restored in transgenic mice. In HK-2 cells, a cultured proximal tubule cell line, overexpression of Sirt1 rescued the cisplatin-induced cell apoptosis through the restoration of peroxisome number, although the mitochondria number was not restored. These results indicate that Sirt1 overexpression in proximal tubules rescues cisplatin-induced AKI by maintaining peroxisomes number and function, concomitant up-regulation of catalase, and elimination of renal ROS levels. Renal Sirt1 can be a potential therapeutic target for the treatment of AKI.	[Tzukerman, Maty; Skorecki, Karl] Technion Israel Inst Technol, Rappaport Fac Med, IL-31096 Haifa, Israel; [Wakino, Shu] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Tzukerman, Maty; Skorecki, Karl] Technion Israel Inst Technol, Res Inst, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Keio University; Technion Israel Institute of Technology	Wakino, S (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	swakino@sc.itc.keio.ac.jp						Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Brezniceanu ML, 2008, DIABETES, V57, P451, DOI 10.2337/db07-0013; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Do Amaral CL, 2008, ARCH TOXICOL, V82, P363, DOI 10.1007/s00204-007-0262-x; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Giovannini L, 2001, J CARDIOVASC PHARM, V37, P262, DOI 10.1097/00005344-200103000-00004; Guarente L, 2000, GENE DEV, V14, P1021; GULATI S, 1992, ARCH BIOCHEM BIOPHYS, V295, P90, DOI 10.1016/0003-9861(92)90492-F; Hasegawa K, 2002, FEBS LETT, V520, P47, DOI 10.1016/S0014-5793(02)02761-8; Hasegawa K, 2008, BIOCHEM BIOPH RES CO, V372, P51, DOI 10.1016/j.bbrc.2008.04.176; Hashiguchi N, 2002, MOL BIOL CELL, V13, P711, DOI 10.1091/mbc.01-10-0479; Kim J, 2006, J BIOL CHEM, V281, P20349, DOI 10.1074/jbc.M512740200; LAWRENCE JW, 1995, BIOCHEM PHARMACOL, V49, P915, DOI 10.1016/0006-2952(95)00002-H; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Negishi K, 2007, KIDNEY INT, V72, P348, DOI 10.1038/sj.ki.5002304; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Plotnikov EY, 2007, KIDNEY INT, V72, P1493, DOI 10.1038/sj.ki.5002568; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Rasbach KA, 2007, J BIOL CHEM, V282, P2355, DOI 10.1074/jbc.M608009200; Rosenberg T, 2007, AM J PHYSIOL-RENAL, V292, pF1617, DOI 10.1152/ajprenal.00412.2006; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Tenorio-Velazquez Veronica M, 2005, BMC Nephrol, V6, P12, DOI 10.1186/1471-2369-6-12; Van Hoek AN, 2000, AM J PHYSIOL-RENAL, V278, pF310, DOI 10.1152/ajprenal.2000.278.2.F310; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; Wakino S, 2001, J BIOL CHEM, V276, P47650, DOI 10.1074/jbc.M108719200; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zhang QJ, 2008, CARDIOVASC RES, V80, P191, DOI 10.1093/cvr/cvn224; Zhou ZX, 2000, J HISTOCHEM CYTOCHEM, V48, P585, DOI 10.1177/002215540004800502	35	169	183	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13045	13056		10.1074/jbc.M109.067728	http://dx.doi.org/10.1074/jbc.M109.067728			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20139070	Green Published, hybrid			2022-12-27	WOS:000276787800062
J	Buttar, NS; DeMars, CJ; Lomberk, G; Rizvi, S; Bonilla-Velez, J; Achra, S; Rashtak, S; Wang, KK; Fernandez-Zapico, ME; Urrutia, R				Buttar, Navtej S.; DeMars, Cathrine J.; Lomberk, Gwen; Rizvi, Sumera; Bonilla-Velez, Juliana; Achra, Shalini; Rashtak, Shahrooz; Wang, Kenneth K.; Fernandez-Zapico, Martin E.; Urrutia, Raul			Distinct Role of Kruppel-like Factor 11 in the Regulation of Prostaglandin E-2 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); NONSTEROIDAL ANTIINFLAMMATORY DRUGS; APC(DELTA-716) KNOCKOUT MICE; COLON-CANCER CELLS; BARRETTS-ESOPHAGUS; TRANSCRIPTIONAL REPRESSION; INTESTINAL POLYPOSIS; CARDIOVASCULAR RISK; COX-2 INHIBITORS; CYCLOOXYGENASE-2	Kruppel-like factor (KLF) proteins are emerging as key regulators of lipid metabolism, diabetes, and the biosynthesis of immunological cytokines. However, their role in the synthesis of prostaglandins, widely known biochemical mediators that act in a myriad of cell biological processes remain poorly understood. Consequently, in this study a comprehensive investigation at the cellular, biochemical, and molecular levels reveal that KLF11 inhibits prostaglandin E-2 synthesis via transcriptional silencing of the promoter of its biosynthetic enzyme, cytosolic phospholipase A2 alpha. Mechanistically, KLF11 accomplishes this function by binding to the promoter via specific GC-rich sites and recruiting the Sin3-histone deacetylase chromatin remodeling complex. Further functional characterization reveals that this function of KLF11 can be reversed by epidermal growth factor receptor-AKT-mediated post-translational modification of threonine 56, a residue within its Sin3-binding domain. This is the first evidence supporting a relevant role for any KLF protein in doing both: transcriptionally inhibiting prostaglandin biosynthesis and its reversibility by an epidermal growth factor receptor-AKT signaling-mediated posttranslational mechanisms.	[Buttar, Navtej S.; DeMars, Cathrine J.; Lomberk, Gwen; Rizvi, Sumera; Bonilla-Velez, Juliana; Achra, Shalini; Rashtak, Shahrooz; Wang, Kenneth K.; Fernandez-Zapico, Martin E.; Urrutia, Raul] Mayo Clin, Div Gastroenterol, Rochester, MN 55902 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Rochester, MN 55902 USA	Mayo Clinic; Mayo Clinic	Buttar, NS (corresponding author), Guggenheim 10,200 1st St SW, Rochester, MN 55902 USA.	buttar.navtej@mayo.edu	Lomberk, Gwen/AAL-8490-2020	Lomberk, Gwen/0000-0001-5463-789X	National Institutes of Health [CA110022-01, DK076845-01, CA125127, CA136526, DK52913]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R03CA125127, R01CA136526, R03CA110022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052913, K08DK076845, R01DK052913] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA110022-01 and DK076845-01 (to N.S.B.), CA125127 and CA136526 (to M.E.F.-Z.), and DK52913 (to R. U.) and by the Mayo Foundation.	Anderson LA, 2006, CANCER RES, V66, P4975, DOI 10.1158/0008-5472.CAN-05-4253; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Brien TP, 2000, HUM PATHOL, V31, P35, DOI 10.1016/S0046-8177(00)80195-1; Buttar NS, 2004, NAT CLIN PRACT GASTR, V1, P106, DOI 10.1038/ncpgasthep0057; Buttar NS, 2002, JNCI-J NATL CANCER I, V94, P422; Buttar NS, 2002, GASTROENTEROLOGY, V122, P1101, DOI 10.1053/gast.2002.32371; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao S, 2005, J BIOL CHEM, V280, P1901, DOI 10.1074/jbc.M407941200; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Coffey RJ, 1997, P NATL ACAD SCI USA, V94, P657, DOI 10.1073/pnas.94.2.657; Cook T, 1999, J BIOL CHEM, V274, P29500, DOI 10.1074/jbc.274.41.29500; Cook T, 1998, J BIOL CHEM, V273, P25929, DOI 10.1074/jbc.273.40.25929; Das A, 2006, J BIOL CHEM, V281, P39105, DOI 10.1074/jbc.M607720200; Diaz BL, 2003, PROSTAG LEUKOTR ESS, V69, P87, DOI 10.1016/S0952-3278(03)00069-3; Ellenrieder V, 2002, EMBO J, V21, P2451, DOI 10.1093/emboj/21.10.2451; Emlet DR, 2006, BRIT J CANCER, V94, P1144, DOI 10.1038/sj.bjc.6603078; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gammon MD, 2004, CANCER EPIDEM BIOMAR, V13, P34, DOI 10.1158/1055-9965.EPI-03-0198; Ghosh M, 2004, AM J RESP CELL MOL, V30, P91, DOI 10.1165/rcmb.2003-0005OC; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hong KH, 2001, P NATL ACAD SCI USA, V98, P3935, DOI 10.1073/pnas.051635898; Hormi-Carver K, 2009, CANCER RES, V69, P672, DOI 10.1158/0008-5472.CAN-08-3703; Kaur BS, 2002, GASTROENTEROLOGY, V123, P60, DOI 10.1053/gast.2002.34244; Kuwata H, 1998, J BIOL CHEM, V273, P1733, DOI 10.1074/jbc.273.3.1733; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lomberk G, 2005, BIOCHEM J, V392, P1, DOI 10.1042/BJ20051234; Markowitz SD, 2007, NEW ENGL J MED, V356, P2195, DOI 10.1056/NEJMe078044; Minuz P, 2008, J AM COLL CARDIOL, V52, P1637, DOI 10.1016/j.jacc.2008.08.042; Morgan S, 2009, EXP CELL RES, V315, P572, DOI 10.1016/j.yexcr.2008.08.009; Moshkin YM, 2009, MOL CELL, V35, P782, DOI 10.1016/j.molcel.2009.07.020; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2004, PROG LIPID RES, V43, P3, DOI 10.1016/S0163-7827(03)00037-7; Murakami M, 1998, J BIOL CHEM, V273, P14411, DOI 10.1074/jbc.273.23.14411; Naraba H, 1998, J IMMUNOL, V160, P2974; Neve B, 2005, P NATL ACAD SCI USA, V102, P4807, DOI 10.1073/pnas.0409177102; Nibu Y, 1998, EMBO J, V17, P7009, DOI 10.1093/emboj/17.23.7009; Oshima M, 1996, CELL, V87, P803, DOI 10.1016/S0092-8674(00)81988-1; Pawliczak R, 2004, J BIOL CHEM, V279, P48550, DOI 10.1074/jbc.M408926200; Poortinga G, 1998, EMBO J, V17, P2067, DOI 10.1093/emboj/17.7.2067; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Rustgi AK, 2006, SEMIN ONCOL, V33, pS57, DOI 10.1053/j.seminoncol.2006.10.013; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Sonoshita M, 2001, NAT MED, V7, P1048, DOI 10.1038/nm0901-1048; Souza RF, 2000, CANCER RES, V60, P5767; Spindler KLG, 2006, INT J ONCOL, V29, P1159; Takaku K, 2000, J BIOL CHEM, V275, P34013, DOI 10.1074/jbc.C000586200; Trebino CE, 2005, J BIOL CHEM, V280, P16579, DOI 10.1074/jbc.M412075200; Trebino CE, 2003, P NATL ACAD SCI USA, V100, P9044, DOI 10.1073/pnas.1332766100; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Vadlamudi R, 1999, ONCOGENE, V18, P305, DOI 10.1038/sj.onc.1202307; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wick MJ, 2005, BIOCHEM J, V387, P239, DOI 10.1042/BJ20041458; Wild CP, 2003, NAT REV CANCER, V3, P676, DOI 10.1038/nrc1166; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Wilson KT, 1998, CANCER RES, V58, P2929; Zhang JS, 2001, MOL CELL BIOL, V21, P5041, DOI 10.1128/MCB.21.15.5041-5049.2001	64	33	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11433	11444		10.1074/jbc.M109.077065	http://dx.doi.org/10.1074/jbc.M109.077065			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154088	hybrid, Green Published			2022-12-27	WOS:000276286200050
J	Fu, JJ; Lv, XY; Lin, HY; Wu, L; Wang, R; Zhou, Z; Zhang, BH; Wang, YL; Tsang, BK; Zhu, C; Wang, HM				Fu, Jiejun; Lv, Xiaoyin; Lin, Haiyan; Wu, Liang; Wang, Rui; Zhou, Zhi; Zhang, Baohua; Wang, Yan-Ling; Tsang, Benjamin K.; Zhu, Cheng; Wang, Hongmei			Ubiquitin Ligase Cullin 7 Induces Epithelial-Mesenchymal Transition in Human Choriocarcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR-TRANSFORMATION; TROPHOBLAST INVASION; GROWTH-RETARDATION; CYCLIN-E; CUL7; EXPRESSION; COMPLEX; TUMOR; PREECLAMPSIA; METASTASIS	Germ line mutations of the ubiquitin ligase cullin 7 (CUL7) are linked to 3-M syndrome and Yakuts short stature syndrome, both of which are characterized by pre- and post-natal growth retardation. CUL7 knock-out mice show placental and embryonic defects similar to intrauterine growth retardation, suggesting a role of CUL7 in placentation. CUL7 was found in this study to be highly expressed in first trimester invasive human placental villi as well as in HTR8/SVneo and B6Tert cells, two cell lines derived from human first trimester trophoblast cells. However, CUL7 levels in term trophoblast cells or JEG-3 cells, which are derived from human choriocarcinoma but exhibit weak invasion capacity, were low or undetectable. Forced expression of CUL7 in JEG-3 cells induced cell morphological changes characteristic of epithelial-mesenchymal transition, which was accompanied by a complete loss of the epithelial markers E-cadherin and P-cadherin and a significant elevation of mesenchymal markers Vimentin and N-cadherin. JEG-3 cells expressing CUL7 exhibited enhanced cell migration and invasion. Conversely, CUL7-specific RNA interference in HTR8/SVneo cells resulted in increased E-cadherin expression and reduced cell migration and invasion. Furthermore, CUL7 expression downregulated E-cadherin mRNA expression by up-regulating ZEB1 and Slug, two transcriptional repressors of E-cadherin. Finally, CUL7-induced loss of E-cadherin expression was partially reversed by treatment of CUL7-expressing cells with the proteasome inhibitor MG-132. These results suggest that the CUL7 E3 ligase is a key regulator in trophoblast cell epithelial-mesenchymal transition and placental development.	[Zhu, Cheng; Wang, Hongmei] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Fu, Jiejun; Lv, Xiaoyin; Wu, Liang; Wang, Rui; Zhou, Zhi; Zhang, Baohua] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Tsang, Benjamin K.] Univ Ottawa, Chron Dis Program, Ottawa Hosp Res Inst, Dept Obstet & Gynecol, Ottawa, ON K1Y 4E9, Canada; [Tsang, Benjamin K.] Univ Ottawa, Chron Dis Program, Ottawa Hosp Res Inst, Dept Cellular & Mol Med, Ottawa, ON K1Y 4E9, Canada	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; Ottawa Hospital Research Institute	Wang, HM (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	wanghm@ioz.ac.cn	Lu, Xiaoyin/AAO-5561-2021	Lu, Xiaoyin/0000-0002-9244-325X; Tsang, Benjamin K./0000-0003-1213-3946	Ministry of Science and Technology of the People's Republic of China [2006CB504006, 2006CB944008]; Chinese Academy of Sciences [KSCX2-YW-R-080]; National Natural Science Foundation of China [30971088, 30770323]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by 973 Program Grants 2006CB504006 and 2006CB944008 from the Ministry of Science and Technology of the People's Republic of China (to H. W.), Chinese Academy of Sciences Knowledge Innovation Program Grant KSCX2-YW-R-080 (to H. W.), and National Natural Science Foundation of China Grants 30971088 and 30770323 (to H. W. and H. Lin).	Ali SH, 2004, J VIROL, V78, P2749, DOI 10.1128/JVI.78.6.2749-2757.2004; Arai T, 2003, P NATL ACAD SCI USA, V100, P9855, DOI 10.1073/pnas.1733908100; Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Blechschmidt K, 2007, VIRCHOWS ARCH, V450, P195, DOI 10.1007/s00428-006-0343-x; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Dias DC, 2002, P NATL ACAD SCI USA, V99, P16601, DOI 10.1073/pnas.252646399; Fu JJ, 2009, PLACENTA, V30, P305, DOI 10.1016/j.placenta.2009.01.005; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Huber C, 2005, NAT GENET, V37, P1119, DOI 10.1038/ng1628; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Karmakar S, 2004, J BIOL CHEM, V279, P55297, DOI 10.1074/jbc.M407013200; Kasper JS, 2005, J VIROL, V79, P11685, DOI 10.1128/JVI.79.18.11685-11692.2005; Kaufmann P, 2003, BIOL REPROD, V69, P1, DOI 10.1095/biolreprod.102.014977; Kim SS, 2007, CANCER RES, V67, P9616, DOI 10.1158/0008-5472.CAN-07-0644; Knoeller S, 2003, AM J REPROD IMMUNOL, V50, P41, DOI 10.1034/j.1600-0897.2003.00046.x; Li BH, 2002, MOL CELL BIOL, V22, P4997, DOI 10.1128/MCB.22.14.4997-5005.2002; Maksimova N, 2007, J MED GENET, V44, P772, DOI 10.1136/jmg.2007.051979; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Palmieri C, 2005, LANCET, V366, P688, DOI 10.1016/S0140-6736(05)67143-7; Sarikas A, 2008, CELL CYCLE, V7, P3154, DOI 10.4161/cc.7.20.6922; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skaar JR, 2005, MOL CELL BIOL, V25, P5579, DOI 10.1128/mcb.25.13.5579-5589.2005; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tsunematsu R, 2006, MOL CELL BIOL, V26, P6157, DOI 10.1128/MCB.00595-06; Tsutsumi T, 2008, MOL CELL BIOL, V28, P743, DOI 10.1128/MCB.01665-07; Vicovac L, 1996, ACTA ANAT, V156, P202; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	30	60	66	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10870	10879		10.1074/jbc.M109.004200	http://dx.doi.org/10.1074/jbc.M109.004200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139075	Green Published, hybrid			2022-12-27	WOS:000276264600072
J	Wen, J; Chiang, YJ; Gao, C; Xue, H; Xu, JY; Ning, YH; Hodes, RJ; Gao, X; Chen, YG				Wen, Jun; Chiang, Y. Jeffrey; Gao, Chan; Xue, Hua; Xu, Jingyue; Ning, Yuanheng; Hodes, Richard J.; Gao, Xiang; Chen, Ye-Guang			Loss of Dact1 Disrupts Planar Cell Polarity Signaling by Altering Dishevelled Activity and Leads to Posterior Malformation in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERGENT EXTENSION; MESODERM INDUCTION; WNT; CATENIN; PATHWAY; REGULATOR; INHIBITOR; DAPPER1; PROTEIN; INVOLVEMENT	Wnt signaling plays a key role in embryogenesis and cancer development. Dvl (Dishevelled) is a central mediator for both the canonical and noncanonical Wnt pathways. Dact1 (Dapper1, Dpr1), a Dvl interactor, has been shown to negatively modulate Wnt signaling by promoting lysosomal degradation of Dvl. Here we report that Dact1-deficient mice have multiple physiological defects that resemble the human neonate disease congenital caudal regression syndrome, including caudal vertebrae agenesis, anorectal malformation, renal agenesis/dysplasia, fused kidneys, and loss of bladder. These urogenital defects can be traced to impaired hindgut formation starting at embryonic day 8.25. Examination of morphological changes and Wnt target gene expression revealed that the planar cell polarity (PCP) signaling is deregulated, whereas the canonical Wnt/beta-catenin pathway is largely unaffected in mutant embryos. Consistently, the activity of the PCP signal mediators Rho GTPase and c-Jun N-terminal kinase is altered in Dact1(-/-) mouse embryonic fibroblasts. We further observed alterations in the protein level and the cellular distribution of Dvl in the primitive streak of mutant embryos. An increased amount of Dvl2 tends to be accumulated in the cortical regions of the cells, especially at the primitive streak ectoderm close to the posterior endoderm that lately forms the hindgut diverticulum. Together, these data suggest that Dact1 may regulate vertebrate PCP by controlling the level and the cellular localization of Dvl protein.	[Wen, Jun; Gao, Chan; Xue, Hua; Ning, Yuanheng; Chen, Ye-Guang] Tsinghua Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Chiang, Y. Jeffrey; Hodes, Richard J.] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Hodes, Richard J.] NIA, NIH, Bethesda, MD 20892 USA; [Xu, Jingyue; Gao, Xiang] Nanjing Univ, MOE, Key Lab Model Anim Dis Study, Nanjing 210061, Peoples R China; [Xu, Jingyue; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China	Tsinghua University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Nanjing University; Nanjing University	Chen, YG (corresponding author), Tsinghua Univ, Coll Life Sci, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China.	ygchen@tsinghua.edu.cn	Chen, Ye-Guang/L-6998-2019; Gao, Chan/D-7964-2013		National Natural Science Foundation of China [30930050, 30921004]; 973 Program [2006CB943401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China)	This work was supported, in whole or in part, by a National Institutes of Health Intramural Research Program grant ( to Y.J.C.). This work was also supported by National Natural Science Foundation of China Grants 30930050 and 30921004 and 973 Program Grant 2006CB943401 ( to Y.-G.C.).	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Behringer R, 2003, MANIPULATING MOUSE E, P371; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Brott BK, 2005, DEV CELL, V8, P703, DOI 10.1016/j.devcel.2005.02.012; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fisher DA, 2006, DEV DYNAM, V235, P2620, DOI 10.1002/dvdy.20917; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Gao X, 2008, J BIOL CHEM, V283, P35679, DOI 10.1074/jbc.M804088200; Gloy J, 2002, NAT CELL BIOL, V4, P351, DOI 10.1038/ncb784; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Haraguchi R, 2007, DEVELOPMENT, V134, P525, DOI 10.1242/dev.02736; Hikasa H, 2004, DEVELOPMENT, V131, P4725, DOI 10.1242/dev.01369; Huang H, 2008, CURR OPIN CELL BIOL, V20, P119, DOI 10.1016/j.ceb.2008.01.009; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Katoh M, 2003, INT J ONCOL, V22, P907; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; KUCZUK MH, 1984, TERATOLOGY, V29, P427, DOI 10.1002/tera.1420290314; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Merei JM, 2004, PEDIATR SURG INT, V20, P439, DOI 10.1007/s00383-004-1172-0; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Michos O, 2009, CURR OPIN GENET DEV, V19, P484, DOI 10.1016/j.gde.2009.09.003; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Philips MF, 1997, PEDIATR NEUROSURG, V26, P130, DOI 10.1159/000121178; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Saburi S, 2005, CURR OPIN CELL BIOL, V17, P482, DOI 10.1016/j.ceb.2005.08.011; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sikandar Rozina, 2009, JPMA Journal of the Pakistan Medical Association, V59, P721; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Singh SK, 2005, PEDIATR SURG INT, V21, P578, DOI 10.1007/s00383-005-1451-4; Su Y, 2007, FASEB J, V21, P682, DOI 10.1096/fj.06-6246com; Suriben R, 2009, NAT GENET, V41, P977, DOI 10.1038/ng.435; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tessarollo L, 2000, METH MOL B, V158, P47; van Amerongen R, 2006, TRENDS GENET, V22, P678, DOI 10.1016/j.tig.2006.10.001; Wallingford JB, 2002, DEVELOPMENT, V129, P5815, DOI 10.1242/dev.00123; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Wang YS, 2007, DEVELOPMENT, V134, P647, DOI 10.1242/dev.02772; Waxman JS, 2004, DEVELOPMENT, V131, P5909, DOI 10.1242/dev.01520; WU D, 2010, TRENDS BIOC IN PRESS; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yau TO, 2005, ONCOGENE, V24, P1607, DOI 10.1038/sj.onc.1208340; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Yi HF, 2009, BLOOD, V113, P5819, DOI 10.1182/blood-2008-11-190033; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200; Zhang LX, 2004, SCIENCE, V306, P114, DOI 10.1126/science.1100569; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250	64	46	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					11023	11030		10.1074/jbc.M109.085381	http://dx.doi.org/10.1074/jbc.M109.085381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145239	hybrid, Green Published			2022-12-27	WOS:000276264600086
J	Huang, J; Dorsey, J; Chuikov, S; Zhang, XY; Jenuwein, T; Reinberg, D; Berger, SL				Huang, Jing; Dorsey, Jean; Chuikov, Sergei; Zhang, Xinyue; Jenuwein, Thomas; Reinberg, Danny; Berger, Shelley L.			G9a and Glp Methylate Lysine 373 in the Tumor Suppressor p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PATHWAY; H3-K9	The tumor suppressor p53 is regulated by numerous post-translational modifications. Lysine methylation has recently emerged as a key post-translational modification that alters the activity of p53. Here, we describe a novel lysine methylation site in p53 that is carried out by two homologous histone methyltransferases, G9a and Glp. G9a and Glp specifically methylate p53 at Lys(373), resulting mainly in dimethylation. During DNA damage, the overall level of p53 modified at Lys(373)me2 does not increase, despite the dramatic increase in total p53, indicating that Lys(373)me2 correlates with inactive p53. Further, reduction of G9a and/or Glp levels leads to a larger population of apoptotic cells. Examination of the Oncomine data base shows that G9a and Glp are overexpressed in various cancers compared with corresponding normal tissues, suggesting that they are putative oncogenes. These data reveal a new methylation site within p53 mediated by the methylases G9a and Glp and indicate that G9a is a potential inhibitory target for cancer treatment.	[Huang, Jing; Zhang, Xinyue] NCI, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Huang, Jing; Dorsey, Jean; Berger, Shelley L.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Jenuwein, Thomas] Res Inst Mol Pathol, A-1030 Vienna, Austria; [Jenuwein, Thomas] Max Planck Inst Immunobiol, D-076151080 Freiburg, Germany; [Chuikov, Sergei; Reinberg, Danny] NYU, Sch Med, Smilow Res Ctr, New York, NY 10016 USA; [Reinberg, Danny] Univ Med & Dent New Jersey, Piscataway, NJ 08854 USA; [Berger, Shelley L.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); The Wistar Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; New York University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Huang, J (corresponding author), NCI, Lab Canc Biol & Genet, NIH, 37 Convent Dr,MSC 4258,Bldg 37,Rm 3140, Bethesda, MD 20892 USA.	huangj3@mail.nih.gov	Huang, Jing/A-2566-2009	Huang, Jing/0000-0002-7163-5156; Berger, Shelley/0000-0001-5398-4400; Reinberg, Danny/0000-0003-4288-2016	NCI, National Institutes of Health Intramural Research Program and Center for Cancer Research [CA 078831]; NATIONAL CANCER INSTITUTE [ZIABC011158, R01CA078831, ZIABC011260, R55CA078831] Funding Source: NIH RePORTER	NCI, National Institutes of Health Intramural Research Program and Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the NCI, National Institutes of Health Intramural Research Program and Center for Cancer Research (J. H.). This work was also supported by NCI, National Institutes of Health Grant CA 078831 (to S. L. B.).	Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Feng LJ, 2005, MOL CELL BIOL, V25, P5389, DOI 10.1128/MCB.25.13.5389-5395.2005; Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; LYSACHIRSKAIA I, 2008, J BIOL CHEM, V283, P34660; LYSAHL P, 2006, CANCER RES, V66, P11341; LYSRUMMEL L, 2005, P NATL ACAD SCI USA, V102, P10188; Prives C, 2001, CELL, V107, P815, DOI 10.1016/S0092-8674(01)00619-5; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schulte JH, 2009, CANCER RES, V69, P2065, DOI 10.1158/0008-5472.CAN-08-1735; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012	18	282	297	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9636	9641		10.1074/jbc.M109.062588	http://dx.doi.org/10.1074/jbc.M109.062588			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118233	Green Published, hybrid			2022-12-27	WOS:000276165900036
J	Jensen, AA; Bergmann, ML; Sander, T; Balle, T				Jensen, Anders A.; Bergmann, Marianne L.; Sander, Tommy; Balle, Thomas			Ginkgolide X Is a Potent Antagonist of Anionic Cys-loop Receptors with a Unique Selectivity Profile at Glycine Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; BETA-SUBUNIT; FUNCTIONAL-CHARACTERIZATION; TERPENE TRILACTONES; EXTRACELLULAR HALF; 5-HT3 RECEPTOR; LIGAND-BINDING; M2 REGION; CHANNEL; FLUORESCENCE	The novel ginkgolide analog ginkgolide X was characterized functionally at human glycine and gamma-aminobutyric acid type A receptors (GlyRs and GABA(A)Rs, respectively) in the fluorescence-based FLIPR (TM) Membrane Potential assay. The compound inhibited the signaling of all GABA(A)R subtypes included in the study with high nanomolar/low micromolar IC50 values, except the rho 1 receptor at which it was a significantly weaker antagonist. Ginkgolide X also displayed high nanomolar/low micromolar IC50 values at the homomeric alpha 1 and alpha 2 GlyRs, whereas it was inactive at the heteromeric alpha 1 beta and alpha 2 beta subtypes at concentrations up to 300 mu M. Thus, the functional properties of the compound were significantly different from those of the naturally occurring ginkgolides A, B, C, J, and M but similar to those of picrotoxin. In a mutagenesis study the 6' M2 residues in the GlyR ion channel were identified as the primary molecular determinant of the selectivity profile of ginkgolide X, and a 6' M2 ring consisting of five Thr residues was found to be of key importance for its activity at the GABAAR. Conformational analysis and docking of low-energy conformations of the native ginkgolide A and ginkgolide X into a alpha 1 GlyR homology model revealed two distinct putative binding sites formed by the 6' M2 residues together with the 2' residues and the 10' and 13' residues, respectively. Thus, we propose that the distinct functionalities of ginkgolide X compared with the other ginkgolides could arise from different flexibility and thus different binding modes to the ion channel of the anionic Cys-loop receptor.	[Jensen, Anders A.; Bergmann, Marianne L.; Sander, Tommy; Balle, Thomas] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark	University of Copenhagen	Jensen, AA (corresponding author), Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, Univ Parken 2, DK-2100 Copenhagen, Denmark.	aaj@farma.ku.dk	Jensen, Anders/AAJ-3335-2020	Jensen, Anders/0000-0002-7927-5052; Balle, Thomas/0000-0002-0233-8350	The Lundbeck Foundation; The Carlsberg Foundation; Direktor Ib Henriksen Foundation; Danish Medical Research Council; Lundbeck Foundation [R9-2007-928] Funding Source: researchfish	The Lundbeck Foundation(Lundbeckfonden); The Carlsberg Foundation(Carlsberg Foundation); Direktor Ib Henriksen Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	This work was supported by The Lundbeck Foundation, The Carlsberg Foundation, Direktor Ib Henriksen Foundation, and the Danish Medical Research Council. Part of this work was presented at the Society of Neuroscience conference, November 15-19, 2008, in Washington D. C.	[Anonymous], 2008, GLID VERS 5 0; [Anonymous], 2008, MAESTR VERS 8 5; [Anonymous], 2008, MACROMODEL VERS 9 6; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; Bostrom J, 1998, J COMPUT AID MOL DES, V12, P383, DOI 10.1023/A:1008007507641; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Breitinger HG, 2002, CHEMBIOCHEM, V3, P1043, DOI 10.1002/1439-7633(20021104)3:11<1042::AID-CBIC1042>3.0.CO;2-7; Chatterjee SS, 2002, N-S ARCH PHARMACOL, V365, pR79; Chen LG, 2006, J BIOL CHEM, V281, P38871, DOI 10.1074/jbc.M608301200; Da Settimo F, 2007, CURR MED CHEM, V14, P2680, DOI 10.2174/092986707782023190; Dalziel JE, 1999, EUR J PHARMACOL, V370, P345, DOI 10.1016/S0014-2999(99)00138-7; Dang H, 2000, MOL PHARMACOL, V57, P1114; DeLano W.L, PYMOL MOL GRAPHICS S; DEVILLERSTHIERY A, 1992, NEUROREPORT, V3, P1001, DOI 10.1097/00001756-199211000-00014; Fitch RW, 2003, P NATL ACAD SCI USA, V100, P4909, DOI 10.1073/pnas.0630641100; Francis MM, 2000, MOL PHARMACOL, V58, P109, DOI 10.1124/mol.58.1.109; Goren EN, 2004, J BIOL CHEM, V279, P11198, DOI 10.1074/jbc.M314050200; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; GURLEY D, 1995, RECEPTOR CHANNEL, V3, P13; Hawthorne R, 2006, J NEUROCHEM, V98, P395, DOI 10.1111/j.1471-4159.2006.03875.x; Heads JA, 2008, J NEUROCHEM, V105, P1418, DOI 10.1111/j.1471-4159.2008.05244.x; Huang SH, 2004, EUR J PHARMACOL, V494, P131, DOI 10.1016/j.ejphar.2004.04.051; Ivic L, 2003, J BIOL CHEM, V278, P49279, DOI 10.1074/jbc.M304034200; Jaracz S, 2004, CHEM-EUR J, V10, P1507, DOI 10.1002/chem.200305473; Jensen AA, 2005, EUR J PHARMACOL, V521, P39, DOI 10.1016/j.ejphar.2005.08.002; Jensen AA, 2004, BIOCHEM PHARMACOL, V67, P1789, DOI 10.1016/j.bcp.2003.12.037; Jensen AA, 2005, J MED CHEM, V48, P4705, DOI 10.1021/jm040219e; Jensen AA, 2007, J MED CHEM, V50, P4616, DOI 10.1021/jm070574f; Jensen AA, 2007, J MED CHEM, V50, P1610, DOI 10.1021/jm070003n; Joesch C, 2008, J BIOMOL SCREEN, V13, P218, DOI 10.1177/1087057108315036; Karadsheh MS, 2004, J NEUROCHEM, V91, P1138, DOI 10.1111/j.1471-4159.2004.02801.x; Kirsch J, 2006, CELL TISSUE RES, V326, P535, DOI 10.1007/s00441-006-0261-x; Kondratskaya EL, 2005, NEUROPHARMACOLOGY, V49, P945, DOI 10.1016/j.neuropharm.2005.07.001; Kondratskaya EL, 2004, BRAIN RES BULL, V63, P309, DOI 10.1016/j.brainresbull.2004.03.007; Korpi ER, 2006, PHARMACOL THERAPEUT, V109, P12, DOI 10.1016/j.pharmthera.2005.05.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Nakanishi K, 2005, BIOORGAN MED CHEM, V13, P4987, DOI 10.1016/j.bmc.2005.06.014; Nemeroff Charles B, 2003, Psychopharmacol Bull, V37, P133; Orser Beverley A, 2002, Curr Opin Anaesthesiol, V15, P427, DOI 10.1097/00001503-200208000-00004; PRIBILLA I, 1992, EMBO J, V11, P4305, DOI 10.1002/j.1460-2075.1992.tb05529.x; Price KL, 2005, J NEUROSCI METH, V149, P172, DOI 10.1016/j.jneumeth.2005.05.014; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; *SCHROD LLC, 2008, SCHROD SUIT 2008 IND; *SCHROD LLC, 2005, PRIM VERS 1 7; *SCHROD LLC, 2008, IMP VERS 5 0; Shan Q, 2003, J NEUROCHEM, V86, P498, DOI 10.1046/j.1471-4159.2003.01872.x; Shan Q, 2001, J NEUROCHEM, V76, P1109, DOI 10.1046/j.1471-4159.2001.00124.x; Sieghart W., 2002, Current Topics in Medicinal Chemistry, V2, P795, DOI 10.2174/1568026023393507; Sinkkonen ST, 2000, J NEUROSCI, V20, P3588, DOI 10.1523/JNEUROSCI.20-10-03588.2000; Stromgaard K, 2004, ANGEW CHEM INT EDIT, V43, P1640, DOI 10.1002/anie.200300601; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Tierney ML, 1997, RECEPTOR CHANNEL, V5, P113; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Wenningmann I, 2001, MOL PHARMACOL, V60, P584; Whiting PJ, 2003, CURR OPIN DRUG DISC, V6, P648; Whiting PJ, 2003, DRUG DISCOV TODAY, V8, P445, DOI 10.1016/S1359-6446(03)02703-X; Xiao YX, 1998, MOL PHARMACOL, V54, P322, DOI 10.1124/mol.54.2.322; Yang Z, 2007, J NEUROCHEM, V103, P580, DOI 10.1111/j.1471-4159.2007.04850.x	63	33	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10141	10153		10.1074/jbc.M109.079319	http://dx.doi.org/10.1074/jbc.M109.079319			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106969	Green Published, hybrid			2022-12-27	WOS:000276165900081
J	Lu, L; Wang, L; Li, T; Wang, J				Lu, Luo; Wang, Ling; Li, Tie; Wang, Jie			NF-kappa B Subtypes Regulate CCCTC Binding Factor Affecting Corneal Epithelial Cell Fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR CTCF; K+ CHANNEL; SIGNALING PATHWAY; EGFR ACTIVATION; DOWN-REGULATION; IN-VIVO; APOPTOSIS; PAX6; EXPRESSION; STRESS	CCCTC binding factor (CTCF) controls DNA imprinting, insulates important gene expression, and mediates growth factor and stress-induced cell fate. However, regulatory mechanisms involved in intracellular CTCF activity are largely unknown. In this study, we show that epidermal growth factor (EGF)-induced increase and UV stress-induced decrease in CTCF activities mediate human corneal epithelial cell proliferation and apoptosis, respectively. CTCF is regulated by activation of different NF-kappa B subtypes via stimulation by EGF and UV stress. EGF-induced formation of a p65/p50 heterodimer activated CTCF transcription to promote cellular proliferation. This was accomplished by the heterodimer binding to a kappa B site in the promoter region of CTCF gene. In contrast, UV stress induced formation of a p50/p50 homodimer, which suppressed CTCF expression leading to apoptosis. Thus, CTCF by itself plays a central role in mediating the dichotomous effects of growth factor- and stress-stimulated NF-kappa B activation on cell survival and death. These results suggest that CTCF is a downstream component of the NF-kappa B pathway involved in the core transcriptional network of cell fate.	[Lu, Luo; Wang, Ling; Li, Tie; Wang, Jie] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Torrance, CA 90502 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Lu, L (corresponding author), Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, 1124 W Carson St,H-H Bldg, Torrance, CA 90502 USA.	lluou@ucla.edu			National Institutes of Health [R01-EY015282]; NATIONAL EYE INSTITUTE [R01EY015281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-EY015282 (to L.L.).	Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BANIAHMAD A, 1990, CELL, V61, P505, DOI 10.1016/0092-8674(90)90532-J; Belandia B, 1998, J BIOL CHEM, V273, P30366, DOI 10.1074/jbc.273.46.30366; Bell KD, 2000, CORNEA, V19, P40, DOI 10.1097/00003226-200001000-00009; BUSCHER M, 1988, ONCOGENE, V3, P301; Chen FE, 1999, ONCOGENE, V18, P6845, DOI 10.1038/sj.onc.1203224; Chi ZL, 2007, EXP EYE RES, V84, P254, DOI 10.1016/j.exer.2006.09.016; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; DeBiasi RL, 2003, J VIROL, V77, P8934, DOI 10.1128/JVI.77.16.8934-8947.2003; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; Docquier F, 2005, CANCER RES, V65, P5112, DOI 10.1158/0008-5472.CAN-03-3498; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; HERRLICH P, 1992, REV PHYSIOL BIOCH P, V119, P187; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Holbrook N J, 1996, EXS, V77, P273; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Kumala W, 2006, HELICOBACTER, V11, P21; Kumar A, 2007, BIOCHEM BIOPH RES CO, V354, P955, DOI 10.1016/j.bbrc.2007.01.072; Lee DH, 2005, OPHTHAL RES, V37, P83, DOI 10.1159/000084249; Li H, 2006, IMMUNOLOGY, V117, P167, DOI 10.1111/j.1365-2567.2005.02275.x; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Li T, 2002, J BIOL CHEM, V277, P32668, DOI 10.1074/jbc.M203519200; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Li T, 2006, INVEST OPHTH VIS SCI, V47, P5218, DOI 10.1167/iovs.06-0254; Li W, 2008, J PATHOL, V214, P114, DOI 10.1002/path.2256; Liu JJ, 1999, EXP EYE RES, V68, P295, DOI 10.1006/exer.1998.0593; Lu L, 2003, INVEST OPHTH VIS SCI, V44, P5102, DOI 10.1167/iovs.03-0591; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Lu L, 2006, PROG RETIN EYE RES, V25, P515, DOI 10.1016/j.preteyeres.2006.07.004; Mattson MP, 2001, J CLIN INVEST, V107, P247, DOI 10.1172/JCI11916; Mattson MP, 2006, CELL DEATH DIFFER, V13, P852, DOI 10.1038/sj.cdd.4401837; Miyamoto T, 2006, J CATARACT REFR SURG, V32, P1736, DOI 10.1016/j.jcrs.2006.05.005; Nishi M, 2005, DIABETIC MED, V22, P641, DOI 10.1111/j.1464-5491.2005.01469.x; Ouyang J, 2006, INVEST OPHTH VIS SCI, V47, P2397, DOI 10.1167/iovs.05-1083; Qi CF, 2003, P NATL ACAD SCI USA, V100, P633, DOI 10.1073/pnas.0237127100; Rajala MS, 2005, J VIROL, V79, P12332, DOI 10.1128/JVI.79.19.12332-12341.2005; Rasko JEJ, 2001, CANCER RES, V61, P6002; Scheidereit C, 2006, ONCOGENE, V25, P6685, DOI 10.1038/sj.onc.1209934; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shiraishi A, 1998, INVEST OPHTH VIS SCI, V39, P2554; Wang L, 2005, EXP CELL RES, V311, P39, DOI 10.1016/j.yexcr.2005.08.020; Wang L, 2005, ONCOGENE, V24, P3020, DOI 10.1038/sj.onc.1208547; Wu D, 2006, INVEST OPHTH VIS SCI, V47, P2422, DOI 10.1167/iovs.05-0536; Xu KP, 2004, INVEST OPHTH VIS SCI, V45, P813, DOI 10.1167/iovs.03-0851; Yin J, 2009, INVEST OPHTH VIS SCI, V50, P132, DOI 10.1167/iovs.08-2246; Zaragoza C, 2006, P NATL ACAD SCI USA, V103, P19051, DOI 10.1073/pnas.0606019103; Zhang L, 2005, MOL CELL BIOL, V25, P60, DOI 10.1128/MCB.25.1.60-65.2005; Zhang MC, 2006, OCUL IMMUNOL INFLAMM, V14, P359, DOI 10.1080/09273940601001322; Zhou H, 2007, CELL PROLIFERAT, V40, P431, DOI 10.1111/j.1365-2184.2007.00444.x	54	16	17	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9373	9382		10.1074/jbc.M109.094425	http://dx.doi.org/10.1074/jbc.M109.094425			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110362	Green Published, hybrid			2022-12-27	WOS:000276165900009
J	Jolly, PS; Berkowitz, P; Bektas, M; Lee, HE; Chua, M; Diaz, LA; Rubenstein, DS				Jolly, Puneet S.; Berkowitz, Paula; Bektas, Meryem; Lee, Hua-En; Chua, Michael; Diaz, Luis A.; Rubenstein, David S.			p38MAPK Signaling and Desmoglein-3 Internalization Are Linked Events in Pemphigus Acantholysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARCINOMA-CELL LINE; VULGARIS-IGG; CULTURED KERATINOCYTES; E-CADHERIN; PHOSPHORYLATION; ENDOCYTOSIS; SKIN; INHIBITION; ACTIVATION; COMPLEX	Pemphigus vulgaris (PV) is an autoimmune blistering disease in which antibodies against the desmosomal cadherin, DSG3 (desmoglein-3), cause acantholysis. It has become increasingly clear that loss of cell-cell adhesion in PV is a complex and active process involving multiple signaling events such as activation of p38MAPK. It has also been demonstrated that incubating keratinocytes with PV IgG causes a redistribution of DSG3 from the cell surface to endosomes, which target these proteins for degradation. This study was undertaken to determine the relationship between p38MAPK and DSG3 endocytosis in pemphigus. In this work, we confirm that PV IgG causes internalization of cell-surface DSG3 into endosomes (as early as 4 h), which are then depleted from both detergent-soluble and detergent-insoluble pools. Cell-surface DSG3 internalization and depletion from both the detergent-soluble and detergent-insoluble fractions were blocked by the p38MAPK inhibitor SB202190. These data suggest that p38MAPK is capable of regulating PV IgG-mediated DSG3 internalization and that previously isolated mechanistic observations may be linked to a common pathway by which pemphigus autoantibodies lead to acantholysis.	[Rubenstein, David S.] Univ N Carolina, Sch Med, Dept Dermatol, Chapel Hill, NC 27599 USA; [Chua, Michael] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rubenstein, DS (corresponding author), Univ N Carolina, Sch Med, Dept Dermatol, Suite 3100,Thurston Bowles CB 7287, Chapel Hill, NC 27599 USA.	druben@med.unc.edu	Lee, Hua/AAC-9489-2021	Diaz, Luis/0000-0002-7079-8914; Bektas, Meryem/0000-0001-8080-7557	National Institutes of Health [RO1 AI49427, AR30281, AR32599]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI49427 (to D. S. R.) and Grants AR30281 and AR32599 (to L. A. D.). P. B., L. A. D., and D. S. R. are co-inventors on a patent application identifying p38MAPK and HSP27 as targets for the treatment of pemphigus. Neither licensing agreements nor financial benefits have accrued to the inventors.	Aoyama Y, 1999, J INVEST DERMATOL, V112, P67, DOI 10.1046/j.1523-1747.1999.00463.x; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Berkowitz P, 2008, AM J PATHOL, V173, P1628, DOI 10.2353/ajpath.2008.080391; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Cirillo N, 2008, INT J IMMUNOPATH PH, V21, P189, DOI 10.1177/039463200802100121; Cirillo N, 2007, J CELL PHYSIOL, V210, P411, DOI 10.1002/jcp.20856; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; FUTAMURA S, 1989, J INVEST DERMATOL, V93, P480, DOI 10.1111/1523-1747.ep12284041; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Lee HE, 2009, J BIOL CHEM, V284, P12524, DOI 10.1074/jbc.M808204200; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Mao XM, 2009, J INVEST DERMATOL, V129, P908, DOI 10.1038/jid.2008.339; Ogata S, 2007, GENE DEV, V21, P1817, DOI 10.1101/gad.1541807; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Puviani M, 2003, J INVEST DERMATOL, V120, P164, DOI 10.1046/j.1523-1747.2003.12014.x; Sato M, 2000, LAB INVEST, V80, P1583, DOI 10.1038/labinvest.3780168; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; Sousa S, 2007, CELL MICROBIOL, V9, P2629, DOI 10.1111/j.1462-5822.2007.00984.x; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224	25	68	68	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8936	8941		10.1074/jbc.M109.087999	http://dx.doi.org/10.1074/jbc.M109.087999			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093368	Green Published, hybrid			2022-12-27	WOS:000275553700045
J	Lee, MC; Toh, LL; Yaw, LP; Luo, Y				Lee, Mei-Chin; Toh, Ling-Ling; Yaw, Lai-Ping; Luo, Yan			Drosophila Octamer Elements and Pdm-1 Dictate the Coordinated Transcription of Core Histone Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE REGULATION; COACTIVATOR OCA-B; DNA-BINDING; CAJAL BODIES; POU DOMAIN; EXPRESSION; REPLICATION; OCT-1; PHOSPHORYLATION; IDENTIFICATION	We reveal a set of divergent octamer elements in Drosophila melanogaster (dm) core histone gene promoters. These elements recruit transcription factor POU-domain protein in D. melanogaster 1 (Pdm-1), which along with co-activator dmOct-1 coactivator in S-phase (dmOCA-S), activates transcription from at least the Drosophila histone 2B (dmH2B) and 4 (dmH4) promoters in a fashion similar to the transcription of mammalian histone 2B (H2B) gene activated by octamer binding transcription factor 1 (Oct-1) and Oct-1 coactivator in S-phase (OCA-S). The expression of core histone genes in both kingdoms is coordinated; however, although the expression of mammalian histone genes involves subtype-specific transcription factors and/or co-activator(s), the expression of Drosophila core histone genes is regulated by a common module (Pdm-1/dmOCA-S) in a directly coordinated manner. Finally, dmOCA-S is recruited to the Drosophila histone locus bodies in the S-phase, marking S-phase-specific transcription activation of core histone genes.	[Luo, Yan] Natl Univ Singapore, Dept Biochem, Singapore 117597, Singapore; Inst Mol & Cell Biol, Singapore 138673, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Luo, Y (corresponding author), Natl Univ Singapore, Dept Biochem, 8 Med Dr, Singapore 117597, Singapore.	yluo@imcb.a-star.edu.sg		Lee, Mei Chin/0000-0001-7689-6446	Agency for Science, Technology, and Research, Singapore	Agency for Science, Technology, and Research, Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research, Singapore.	Babb R, 1997, MOL CELL BIOL, V17, P7295, DOI 10.1128/MCB.17.12.7295; BHAT KM, 1995, MOL CELL BIOL, V15, P4052; Cepek KL, 1996, GENE DEV, V10, P2079, DOI 10.1101/gad.10.16.2079; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Dai RP, 2008, J BIOL CHEM, V283, P26894, DOI 10.1074/jbc.M804307200; DAVIS FM, 1983, P NATL ACAD SCI-BIOL, V80, P2926, DOI 10.1073/pnas.80.10.2926; Ewen ME, 2000, GENE DEV, V14, P2265, DOI 10.1101/gad.842100; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; HAN M, 1987, CELL, V48, P589, DOI 10.1016/0092-8674(87)90237-6; Hedges SB, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-31; HEINTZ N, 1991, BIOCHIM BIOPHYS ACTA, V1088, P327, DOI 10.1016/0167-4781(91)90122-3; HENTSCHEL CC, 1981, CELL, V25, P301, DOI 10.1016/0092-8674(81)90048-9; HERR W, 1995, GENE DEV, V9, P1679, DOI 10.1101/gad.9.14.1679; Isogai Y, 2007, GENE DEV, V21, P2936, DOI 10.1101/gad.1608807; KITAMOTO T, 1995, J NEUROBIOL, V28, P70, DOI 10.1002/neu.480280107; KREMER H, 1990, NUCLEIC ACIDS RES, V18, P1573, DOI 10.1093/nar/18.6.1573; LIFTON RP, 1977, COLD SPRING HARB SYM, V42, P1047, DOI 10.1101/SQB.1978.042.01.105; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; LLOYD A, 1991, MECH DEVELOP, V36, P87, DOI 10.1016/0925-4773(91)90075-H; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; Ma TL, 2000, GENE DEV, V14, P2298, DOI 10.1101/gad.829500; MacAlpine DM, 2004, GENE DEV, V18, P3094, DOI 10.1101/gad.1246404; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Marzluff WF, 2002, CURR OPIN CELL BIOL, V14, P692, DOI 10.1016/S0955-0674(02)00387-3; Matera AG, 2006, J CELL BIOL, V172, P791, DOI 10.1083/jcb.200602002; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MEEKSWAGNER D, 1986, CELL, V44, P43, DOI 10.1016/0092-8674(86)90483-6; Neumann CJ, 1998, SCIENCE, V281, P409, DOI 10.1126/science.281.5375.409; OSLEY MA, 1991, ANNU REV BIOCHEM, V60, P827, DOI 10.1146/annurev.biochem.60.1.827; PERRY M, 1985, J MOL BIOL, V185, P479, DOI 10.1016/0022-2836(85)90065-8; Roberts TG, 1998, MOL CELL BIOL, V18, P4409, DOI 10.1128/MCB.18.8.4409; Roeder RG, 2003, NAT MED, V9, P1239, DOI 10.1038/nm938; Sauter P, 1998, MOL CELL BIOL, V18, P7397, DOI 10.1128/MCB.18.12.7397; SEGIL N, 1991, SCIENCE, V254, P1814, DOI 10.1126/science.1684878; Siegel R, 2006, CELL, V125, P761, DOI 10.1016/j.cell.2006.03.036; SMITH AV, 1993, GENETICS, V135, P817; Wang ZF, 1996, GENOME RES, V6, P688, DOI 10.1101/gr.6.8.688; White AE, 2007, MOL BIOL CELL, V18, P2491, DOI 10.1091/mbc.E06-11-1033; YEE SL, 1995, GENE DEV, V9, P1223; Yu FX, 2009, CELL CYCLE, V8, P773, DOI 10.4161/cc.8.5.7880; Zhao JY, 2000, GENE DEV, V14, P2283, DOI 10.1101/gad.827700; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	43	12	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9041	9053		10.1074/jbc.M109.075358	http://dx.doi.org/10.1074/jbc.M109.075358			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097756	hybrid, Green Published			2022-12-27	WOS:000275553700055
J	Wang, ZV; Rothermel, BA; Hill, JA				Wang, Zhao V.; Rothermel, Beverly A.; Hill, Joseph A.			Autophagy in Hypertensive Heart Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ENDOPLASMIC-RETICULUM STRESS; CARDIAC-HYPERTROPHY; CELL-DEATH; ISCHEMIA/REPERFUSION INJURY; AORTIC CONSTRICTION; REGIONAL BURDEN; PROTEIN-KINASE; RISK-FACTORS; INHIBITION; PRESSURE	In response to hypertension, the heart manifests robust hypertrophic growth, which offsets load-induced elevations in wall stress. If sustained, this hypertrophic response is a major risk factor for systolic dysfunction and heart failure. Extensive research efforts have focused on the progression from hypertrophy to failure; however, precise understanding of underlying mechanisms remains elusive. Recently, autophagy, a process of cellular cannibalization, has been implicated. Autophagy is activated during ventricular hypertrophy, serving to maintain cellular homeostasis. Excessive autophagy eliminates, however, essential cellular elements and possibly provokes cell death, which together contribute to hypertension-related heart disease.	[Wang, Zhao V.; Rothermel, Beverly A.; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Med Cardiol, Dallas, TX 75390 USA; [Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hill, JA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med Cardiol, Dallas, TX 75390 USA.	joseph.hill@utsouthwestern.edu		Wang, Zhao/0000-0002-9904-9538	National Institutes of Health [HL-075173, HL-080144, HL-090842, HL-072016, HL-097768]; American Heart Association [0640084N]; American Heart Association-Jon Holden DeHaan Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072016, R01HL080144, R01HL090842, R01HL075173, R01HL097768] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Heart Association-Jon Holden DeHaan Foundation(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-075173, HL-080144, HL-090842, HL-072016, and HL-097768. This work was also supported by American Heart Association Grant 0640084N and the American Heart Association-Jon Holden DeHaan Foundation. This is the first of five articles in the "Biochemistry in Medicine: Hypertension Minireview Series."	Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BURCH GE, 1952, CIRCULATION, V5, P504, DOI 10.1161/01.CIR.5.4.504; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; DAMMRICH J, 1983, VIRCHOWS ARCH B, V43, P287, DOI 10.1007/BF02932962; DECKER RS, 1980, J MOL CELL CARDIOL, V12, P1175, DOI 10.1016/0022-2828(80)90064-4; DECKER RS, 1980, AM J PATHOL, V98, P425; Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827; Diwan A, 2007, J CLIN INVEST, V117, P2825, DOI 10.1172/JCI32490; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gurusamy N, 2009, J CELL MOL MED, V13, P373, DOI 10.1111/j.1582-4934.2008.00495.x; Gustafsson AB, 2009, CIRC RES, V104, P150, DOI 10.1161/CIRCRESAHA.108.187427; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Izumiya Y, 2006, HYPERTENSION, V47, P887, DOI 10.1161/01.HYP.0000215207.54689.31; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kamada Y, 2003, CURR TOP MICROBIOL, V279, P73; Kanamori H, 2009, AM J PATHOL, V174, P1705, DOI 10.2353/ajpath.2009.080875; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Knaapen MWM, 2001, CARDIOVASC RES, V51, P304, DOI 10.1016/S0008-6363(01)00290-5; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; LEVY D, 1990, NEW ENGL J MED, V0322; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maron BJ, 2009, JAMA-J AM MED ASSOC, V301, P1253, DOI 10.1001/jama.2009.371; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Miyata S, 2006, AM J PATHOL, V168, P386, DOI 10.2353/ajpath.2006.050137; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; Nishida K, 2009, CELL DEATH DIFFER, V16, P31, DOI 10.1038/cdd.2008.163; Nishida K, 2008, CIRC RES, V103, P343, DOI 10.1161/CIRCRESAHA.108.175448; Nishino I, 2000, NATURE, V406, P906, DOI 10.1038/35022604; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; PFEIFER U, 1987, J MOL CELL CARDIOL, V19, P1179, DOI 10.1016/S0022-2828(87)80528-X; Porrello ER, 2009, HYPERTENSION, V53, P1032, DOI 10.1161/HYPERTENSIONAHA.108.128488; Rothermel BA, 2008, CIRC RES, V103, P1363, DOI 10.1161/CIRCRESAHA.108.186551; Shiojima I, 2005, J CLIN INVEST, V115, P2108, DOI 10.1172/JCI24682; Sybers H D, 1976, Recent Adv Stud Cardiac Struct Metab, V12, P453; Tanaka Y, 2000, NATURE, V406, P902, DOI 10.1038/35022595; Tannous P, 2008, CIRCULATION, V117, P3070, DOI 10.1161/CIRCULATIONAHA.107.763870; Valentim L, 2006, J MOL CELL CARDIOL, V40, P846, DOI 10.1016/j.yjmcc.2006.03.428; Vasan RS, 2001, NEW ENGL J MED, V345, P1291, DOI 10.1056/NEJMoa003417; Wang YF, 2004, ARCH INTERN MED, V164, P2126, DOI 10.1001/archinte.164.19.2126; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Yitzhaki S, 2009, BASIC RES CARDIOL, V104, P157, DOI 10.1007/s00395-009-0006-6; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	61	91	97	2	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8509	8514		10.1074/jbc.R109.025023	http://dx.doi.org/10.1074/jbc.R109.025023			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20118246	hybrid, Green Published			2022-12-27	WOS:000275553700002
J	Cale, JM; Li, SH; Warnock, M; Su, EJ; North, PR; Sanders, KL; Puscau, MM; Emal, CD; Lawrence, DA				Cale, Jacqueline M.; Li, Shih-Hon; Warnock, Mark; Su, Enming J.; North, Paul R.; Sanders, Karen L.; Puscau, Maria M.; Emal, Cory D.; Lawrence, Daniel A.			Characterization of a Novel Class of Polyphenolic Inhibitors of Plasminogen Activator Inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAI-1 INHIBITOR; ENDOTHELIAL-CELLS; GENE-EXPRESSION; BINDING-SITE; TANNIC-ACID; IN-VITRO; TYPE-1; MECHANISM; MICE; THROMBOSIS	Plasminogen activator inhibitor type 1, (PAI-1) the primary inhibitor of the tissue-type (tPA) and urokinase-type (uPA) plasminogen activators, has been implicated in a wide range of pathological processes, making it an attractive target for pharmacologic inhibition. Currently available small-molecule inhibitors of PAI-1 bind with relatively low affinity and do not inactivate PAI-1 in the presence of its cofactor, vitronectin. To search for novel PAI-1 inhibitors with improved potencies and new mechanisms of action, we screened a library selected to provide a range of biological activities and structural diversity. Five potential PAI-1 inhibitors were identified, and all were polyphenolic compounds including two related, naturally occurring plant polyphenols that were structurally similar to compounds previously shown to provide cardiovascular benefit in vivo. Unique second generation compounds were synthesized and characterized, and several showed IC50 values for PAI-1 between 10 and 200 nM. This represents an enhanced potency of 10-1000-fold over previously reported PAI-1 inactivators. Inhibition of PAI-1 by these compounds was reversible, and their primary mechanism of action was to block the initial association of PAI-1 with a protease. Consistent with this mechanism and in contrast to previously described PAI-1 inactivators, these compounds inactivate PAI-1 in the presence of vitronectin. Two of the compounds showed efficacy in ex vivo plasma and one blocked PAI-1 activity in vivo in mice. These data describe a novel family of high affinity PAI-1-inactivating compounds with improved characteristics and in vivo efficacy, and suggest that the known cardiovascular benefits of dietary polyphenols may derive in part from their inactivation of PAI-1.	[Lawrence, Daniel A.] Univ Michigan, Sch Med, Div Cardiovasc Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [North, Paul R.; Sanders, Karen L.; Puscau, Maria M.; Emal, Cory D.] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA	University of Michigan System; University of Michigan; Eastern Michigan University	Lawrence, DA (corresponding author), 7301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	dlawrenc@umich.edu		Lawrence, Daniel/0000-0003-3126-1935	National Institutes of Health [HL55374, HL54710, HL089407]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL089407, P01HL054710, R01HL055374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL55374, HL54710, and HL089407 (to D. A. L.).	Abou-Agag LH, 2001, ALCOHOL CLIN EXP RES, V25, P155, DOI 10.1111/j.1530-0277.2001.tb02193.x; Andreasen PA, 2007, CURR DRUG TARGETS, V8, P1030, DOI 10.2174/138945007781662346; Baxi S, 2008, THROMB HAEMOSTASIS, V99, P749, DOI 10.1160/TH07-11-0669; Bjorquist P, 1998, BIOCHEMISTRY-US, V37, P1227, DOI 10.1021/bi971554q; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Charlton PA, 1996, THROMB HAEMOSTASIS, V75, P808; Chen X, 2003, CLIN CANCER RES, V9, P3115; Clement Y, 2009, PREV MED, V49, P83, DOI 10.1016/j.ypmed.2009.05.005; Crandall DL, 2006, ARTERIOSCL THROM VAS, V26, P2209, DOI 10.1161/01.ATV.0000235605.51400.9d; Crandall DL, 2004, J THROMB HAEMOST, V2, P1422, DOI 10.1111/j.1538-7836.2004.00829.x; De Taeye BM, 2006, J BIOL CHEM, V281, P32796, DOI 10.1074/jbc.M606214200; Di Santo A, 2003, J THROMB HAEMOST, V1, P1089, DOI 10.1046/j.1538-7836.2003.00217.x; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Einholm AP, 2003, BIOCHEM J, V373, P723, DOI 10.1042/BJ20021880; Eitzman DT, 1996, J CLIN INVEST, V97, P232, DOI 10.1172/JCI118396; Elokdah H, 2004, J MED CHEM, V47, P3491, DOI 10.1021/jm049766q; FITZPATRICK DF, 1993, AM J PHYSIOL, V265, pH774; Folkes A, 2002, BIOORG MED CHEM LETT, V12, P1063, DOI 10.1016/S0960-894X(02)00078-1; Gardell SJ, 2007, MOL PHARMACOL, V72, P897, DOI 10.1124/mol.107.037010; Gils A, 2002, THROMB HAEMOSTASIS, V88, P137; Gohil R, 2009, THROMB HAEMOSTASIS, V102, P360, DOI 10.1160/TH09-01-0013; Gopalsamy A, 2004, BIOORG MED CHEM LETT, V14, P3477, DOI 10.1016/j.bmcl.2004.04.058; Gorlatova NV, 2007, J BIOL CHEM, V282, P9288, DOI 10.1074/jbc.M611642200; Hennan JK, 2005, J PHARMACOL EXP THER, V314, P710, DOI 10.1124/jpet.105.084129; Huang YF, 2003, J CLIN INVEST, V112, P379, DOI 10.1172/JCI200318038; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; Izuhara Y, 2008, ARTERIOSCL THROM VAS, V28, P672, DOI 10.1161/ATVBAHA.107.157479; Lawrence DA, 1997, J BIOL CHEM, V272, P7676, DOI 10.1074/jbc.272.12.7676; Leik CE, 2006, J THROMB HAEMOST, V4, P2710, DOI 10.1111/j.1538-7836.2006.02244.x; Liang A, 2005, THROMB RES, V115, P341, DOI 10.1016/j.thromres.2004.09.021; Lijnen HR, 2009, THROMB RES, V123, pS46, DOI 10.1016/S0049-3848(09)70143-4; Liu XQ, 2005, J NUTR, V135, P165, DOI 10.1093/jn/135.2.165; Ma LJ, 2004, DIABETES, V53, P336, DOI 10.2337/diabetes.53.2.336; Maquerlot F, 2006, AM J PATHOL, V169, P1624, DOI 10.2353/ajpath.2006.051053; McMahon GA, 2001, J BIOL CHEM, V276, P33964, DOI 10.1074/jbc.M105980200; Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+; Neve J, 1999, J NAT PROD, V62, P324, DOI 10.1021/np980286+; Pasten C, 2007, THROMB RES, V121, P59, DOI 10.1016/j.thromres.2007.02.001; Pinsky DJ, 1998, J CLIN INVEST, V102, P919, DOI 10.1172/JCI307; Rupin A, 2008, THROMB RES, V122, P265, DOI 10.1016/j.thromres.2007.11.006; Saremi A, 2008, AM J THER, V15, P265, DOI 10.1097/MJT.0b013e3180a5e61a; Schafer K, 2001, FASEB J, V15, P1840, DOI 10.1096/fj.00-0750fje; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Sobel BE, 2003, ARTERIOSCL THROM VAS, V23, P1979, DOI 10.1161/01.ATV.0000091250.53231.4D; Stefansson S, 1996, NATURE, V383, P441, DOI 10.1038/383441a0; Stefansson S, 1998, J BIOL CHEM, V273, P6358, DOI 10.1074/jbc.273.11.6358; Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028; Van Gorkom BAP, 1999, ALIMENT PHARM THERAP, V13, P443; Vaughan DE, 2007, CURR DRUG TARGETS, V8, P962, DOI 10.2174/138945007781662364; Webb DJ, 2001, J CELL BIOL, V152, P741, DOI 10.1083/jcb.152.4.741; Wiman B, 2000, ARTERIOSCL THROM VAS, V20, P2019, DOI 10.1161/01.ATV.20.8.2019; Wu Qingyu, 2002, Current Drug Targets - Cardiovascular and Haematological Disorders, V2, P27, DOI 10.2174/1568006023337727; YEPES M, 2006, HEMOSTASIS THROMBOSI, P335	53	33	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7892	7902		10.1074/jbc.M109.067967	http://dx.doi.org/10.1074/jbc.M109.067967			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061381	Green Published, hybrid			2022-12-27	WOS:000275413800006
J	Cao, Y; Oswald, F; Wacker, SA; Bundschu, K; Knochel, W				Cao, Ying; Oswald, Franz; Wacker, Stephan A.; Bundschu, Karin; Knoechel, Walter			Reversal of Xenopus Oct25 Function by Disruption of the POU Domain Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; TRANSCRIPTION FACTOR; BETA-CATENIN; DNA-BINDING; MESODERM INDUCTION; EXPRESSION; GENE; PROTEINS; TRANSACTIVATION; REQUIREMENTS	Xenopus Oct25 is a POU family subclass V(POU-V) transcription factor with a distinct domain structure. To investigate the contribution of different domains to the function of Oct25, we have performed gain of function analyses. Deletions of the N- or C-terminal regions and of the Hox domain ( except its nuclear localization signal) result in mutants being indistinguishable from the wild type protein in the suppression of genes promoting germ layer formation. Deletion of the complete POU domain generates a mutant that has no effect on embryogenesis. However, disruption of the alpha-helical structures in the POU domain, even by a single amino acid mutation, causes reversal of protein function. Overexpression of such mutants leads to dorsalization of embryos and formation of secondary axial structures. The underlying mechanism is an enhanced transcription of genes coding for antagonists of the ligands for ventralizing bone morphogenetic protein and Wnt pathways. Corresponding deletion mutants of Xenopus Oct60, Oct91, or mouse Oct4 also exhibit such a dominant-negative effect. Therefore, our results reveal that the integrity of the POU domain is crucial for the function of POU-V transcription factors in the regulation of genes that promote germ layer formation.	[Cao, Ying; Wacker, Stephan A.; Knoechel, Walter] Univ Ulm, Inst Biochem, D-89081 Ulm, Germany; [Oswald, Franz] Univ Ulm, Dept Internal Med 1, D-89081 Ulm, Germany; [Bundschu, Karin] Univ Ulm, Inst Biochem & Mol Biol, D-89081 Ulm, Germany; [Cao, Ying] Nanjing Univ, Model Anim Res Ctr, Nanjing 210061, Peoples R China	Ulm University; Ulm University; Ulm University; Nanjing University	Knochel, W (corresponding author), Univ Ulm, Inst Biochem, Albert Einstein Allee 11, D-89081 Ulm, Germany.	walter.knoechel@uni-ulm.de	Oswald, Franz/AAO-9584-2020		Deutsche Forschungsgemeinschaft [SFB497/A1, SFB497/B9]; European Social Fund; Ministry of Science, Research; Arts Baden-Wurttemberg Margarete von Wrangell scholarship	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Social Fund(European Social Fund (ESF)); Ministry of Science, Research; Arts Baden-Wurttemberg Margarete von Wrangell scholarship	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB497/A1 (to W. K.) and SFB497/B9 (to F. O.), the European Social Fund, and by the Ministry of Science, Research and the Arts Baden-Wurttemberg Margarete von Wrangell scholarship (to K. B.).	Agius E, 2000, DEVELOPMENT, V127, P1173; Ambrosetti DC, 2000, J BIOL CHEM, V275, P23387, DOI 10.1074/jbc.M000932200; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Cao Y, 2004, J BIOL CHEM, V279, P43735, DOI 10.1074/jbc.M407544200; Cao Y, 2007, EMBO J, V26, P2942, DOI 10.1038/sj.emboj.7601736; Cao Y, 2006, MECH DEVELOP, V123, P614, DOI 10.1016/j.mod.2006.06.004; Cao Y, 2008, J BIOL CHEM, V283, P34168, DOI 10.1074/jbc.M803532200; Clements D, 1999, DEVELOPMENT, V126, P4903; De Robertis EM, 2000, NAT REV GENET, V1, P171, DOI 10.1038/35042039; Frisch A, 1998, DEVELOPMENT, V125, P431; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; HINKLEY CS, 1992, MOL CELL BIOL, V12, P638, DOI 10.1128/MCB.12.2.638; Hussain SK, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-15; Hyde CE, 2000, DEVELOPMENT, V127, P1221; IMAGAWA M, 1991, NUCLEIC ACIDS RES, V19, P4503, DOI 10.1093/nar/19.16.4503; Jacobson EM, 1997, GENE DEV, V11, P198, DOI 10.1101/gad.11.2.198; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; McKendry R, 1997, DEV BIOL, V192, P420, DOI 10.1006/dbio.1997.8797; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 2003, BIOCHEM BIOPH RES CO, V302, P581, DOI 10.1016/S0006-291X(03)00218-3; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pan GJ, 2004, J BIOL CHEM, V279, P37013, DOI 10.1074/jbc.M405117200; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Ring C, 2002, GENE DEV, V16, P820, DOI 10.1101/gad.963802; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takahashi S, 2000, DEVELOPMENT, V127, P5319; Vigano MA, 1996, NUCLEIC ACIDS RES, V24, P2112, DOI 10.1093/nar/24.11.2112; Wacker SA, 2004, DEV BIOL, V266, P123, DOI 10.1016/j.ydbio.2003.10.011; Wegner M, 1993, CURR OPIN CELL BIOL, V5, P488, DOI 10.1016/0955-0674(93)90015-I; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; White RJ, 2002, DEVELOPMENT, V129, P4867; WHITFIELD T, 1993, DEV BIOL, V155, P361, DOI 10.1006/dbio.1993.1035; WHITFIELD TT, 1995, DEV BIOL, V169, P759, DOI 10.1006/dbio.1995.1185; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	45	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8408	8421		10.1074/jbc.M109.064386	http://dx.doi.org/10.1074/jbc.M109.064386			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064932	hybrid, Green Published			2022-12-27	WOS:000275413800056
J	Chang, W; Wei, K; Jacobs, SS; Upadhyay, D; Weill, D; Rosen, GD				Chang, Wenteh; Wei, Ke; Jacobs, Susan S.; Upadhyay, Daya; Weill, David; Rosen, Glenn D.			SPARC Suppresses Apoptosis of Idiopathic Pulmonary Fibrosis Fibroblasts through Constitutive Activation of beta-Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; LUNG FIBROBLASTS; PATHWAY; INHIBITOR-1; CELLS; MICE; MYOFIBROBLASTS; PROLIFERATION; TRANSITION; EXPRESSION	Idiopathic pulmonary fibrosis (IPF) is a poorly understood progressive disease characterized by the accumulation of scar tissue in the lung interstitium. A hallmark of the disease is areas of injury to type II alveolar epithelial cells with attendant accumulation of fibroblasts in areas called fibroblastic foci. In an effort to better characterize the lung fibroblast phenotype in IPF patients, we isolated fibroblasts from patients with IPF and looked for activation of signaling proteins, which could help explain the exaggerated fibrogenic response in IPF. We found that IPF fibroblasts constitutively expressed increased basal levels of SPARC, plasminogen activator inhibitor-1 (PAI-1), and active beta-catenin compared with control cells. Control of basal PAI-1 expression in IPF fibroblasts was regulated by SPARC-mediated activation of Akt, leading to inhibition of glycogen synthase kinase-3 beta and activation of beta-catenin. Additionally, IPF fibroblasts (but not control fibroblasts) were resistant to plasminogen-induced apoptosis and were sensitized to plasminogen-mediated apoptosis by inhibition of SPARC or beta-catenin. These findings uncover a newly discovered regulatory pathway in IPF fibroblasts that is characterized by elevated SPARC, giving rise to activated beta-catenin, which regulates expression of downstream genes, such as PAI-1, and confers an apoptosis-resistant phenotype. Disruption of this pathway may represent a novel therapeutic target in IPF.	[Chang, Wenteh; Wei, Ke; Jacobs, Susan S.; Upadhyay, Daya; Weill, David; Rosen, Glenn D.] Stanford Univ, Med Ctr, Dept Med, Div Pulm & Crit Care Med, Stanford, CA 94305 USA	Stanford University	Rosen, GD (corresponding author), Stanford Univ, Med Ctr, Dept Med, Div Pulm & Crit Care Med, MC 5236,300 Pasteur Dr, Stanford, CA 94305 USA.	grosen@stanford.edu			SAMFUND, Division of Pulmonary and Critical Care, Department of Medicine, Stanford University	SAMFUND, Division of Pulmonary and Critical Care, Department of Medicine, Stanford University(Stanford University)	This work was supported by SAMFUND, Division of Pulmonary and Critical Care, Department of Medicine, Stanford University.	ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Cadigan KM, 2008, DEV CELL, V14, P322, DOI 10.1016/j.devcel.2008.02.006; Caraci F, 2008, PHARMACOL RES, V57, P274, DOI 10.1016/j.phrs.2008.02.001; Chang WT, 2001, J BIOL CHEM, V276, P2221, DOI 10.1074/jbc.M009713200; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Clark CJ, 2008, J CELL BIOCHEM, V104, P721, DOI 10.1002/jcb.21688; Cronkhite JT, 2008, AM J RESP CRIT CARE, V178, P729, DOI 10.1164/rccm.200804-550OC; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; HASSELAAR P, 1991, J BIOL CHEM, V266, P13178; Horowitz JC, 2004, J BIOL CHEM, V279, P1359, DOI 10.1074/jbc.M306248200; Horowitz JC, 2008, AM J RESP CELL MOL, V38, P78, DOI 10.1165/rcmb.2007-0174OC; Huang SK, 2008, AM J RESP CRIT CARE, V177, P66, DOI 10.1164/rccm.200706-963OC; Huang SK, 2009, FASEB J, V23, P4317, DOI 10.1096/fj.08-128801; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jurukovski V, 2005, METH MOLEC MED, V117, P161; KAPANCI Y, 1995, AM J RESP CRIT CARE, V152, P2163, DOI 10.1164/ajrccm.152.6.8520791; Kerkela R, 2008, J CLIN INVEST, V118, P3609, DOI 10.1172/JCI36245; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Kortlever RM, 2008, J BIOL CHEM, V283, P24308, DOI 10.1074/jbc.M803341200; Kortlever RM, 2006, CELL CYCLE, V5, P2697, DOI 10.4161/cc.5.23.3510; KUHN C, 1995, AM J PATHOL, V147, P1759; Kulasekaran P, 2009, AM J RESP CELL MOL, V41, P484, DOI 10.1165/rcmb.2008-0447OC; Larsson O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003220; Lazar MH, 2004, AM J RESP CELL MOL, V31, P672, DOI 10.1165/rcmb.2004-0025OC; Liu RM, 2008, ANTIOXID REDOX SIGN, V10, P303, DOI 10.1089/ars.2007.1903; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Medina M, 2008, CURR OPIN DRUG DISC, V11, P533; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Nie J, 2009, J BIOL CHEM, V284, P1279, DOI 10.1074/jbc.M808285200; Phan SH, 2002, CHEST, V122, p286S, DOI 10.1378/chest.122.6_suppl.286S; Ramasamy SK, 2007, DEV BIOL, V307, P237, DOI 10.1016/j.ydbio.2007.04.033; Shi-Wen Xu, 2006, Mol Cell Biol, V26, P5518, DOI 10.1128/MCB.00625-06; Strandjord TP, 1999, AM J PHYSIOL-LUNG C, V277, pL628, DOI 10.1152/ajplung.1999.277.3.L628; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhou XD, 2005, ARTHRITIS RHEUM-US, V52, P257, DOI 10.1002/art.20785; Zisman DA, 2005, METH MOLEC MED, V117, P3	45	82	83	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8196	8206		10.1074/jbc.M109.025684	http://dx.doi.org/10.1074/jbc.M109.025684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061390	Green Published, hybrid			2022-12-27	WOS:000275413800038
J	Kapeta, S; Chondrogianni, N; Gonos, ES				Kapeta, Suzanne; Chondrogianni, Niki; Gonos, Efstathios S.			Nuclear Erythroid Factor 2-mediated Proteasome Activation Delays Senescence in Human Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSIVE ELEMENTS; TRANSCRIPTION FACTOR NRF2; OXIDATIVE STRESS; SIGNALING PATHWAY; LIFE-SPAN; NF-E2-RELATED FACTOR-2; MOLECULAR-MECHANISMS; INDUCTION; KEAP1; EXPRESSION	Replicative senescence in human fibroblasts is accompanied with alterations of various biological processes, including the impaired function of the proteasome. The proteasome is responsible for the removal of both normal and damaged proteins. Due to its latter function, proteasome is also considered a representative secondary antioxidant cellular mechanism. Nrf2 is a basic transcription factor responsible for the regulation of the cellular antioxidant response that has also been shown to regulate several proteasome subunits in mice. We have established in this study the proteasome-related function of Nrf2 in human fibroblasts undergoing replicative senescence. We demonstrate that Nrf2 has a declined function in senescence, whereas its silencing leads to premature senescence. However, upon its activation by a novel Nrf2 inducer, elevated levels of proteasome activity and content are recorded only in cell lines possessing a functional Nrf2. Moreover, treatment by the Nrf2 inducer results in the enhanced survival of cells following oxidative stress, whereas continuous treatment leads to lifespan extension of human fibroblasts. Importantly the Nrf2-proteasome axis is functional in terminally senescent cultures as these cells retain their responsiveness to the Nrf2 stimuli. In conclusion, these findings open up new directions for future manipulation of the senescence phenotype.	[Kapeta, Suzanne; Chondrogianni, Niki; Gonos, Efstathios S.] Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, Athens 11635, Greece	National Hellenic Research Foundation	Chondrogianni, N (corresponding author), Natl Hellen Res Fdn, Inst Biol Res & Biotechnol, 48 Vassileos Constantinou Ave, Athens 11635, Greece.	nikichon@eie.gr; sgonos@eie.gr			General Secretariat of Research and Technology [PENED 03EDelta9]; Ministry of Development; European Union [LSHM-CT-518230]	General Secretariat of Research and Technology(Greek Ministry of Development-GSRT); Ministry of Development(Turkiye Cumhuriyeti Kalkinma Bakanligi); European Union(European Commission)	This work was supported by General Secretariat of Research and Technology Grant PENED 03E Delta 9 (75% from the European Union & 25% from the Ministry of Development, Measure 8.3/Operational Program "Competitiveness"/ 3rd Community Support Framework) and European Union "Proteomage" Grant LSHM-CT-518230 (to E. S. G.). Data presented in this article are patent protected (patent submission number 2009-0100242).	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Chen QH, 2006, FREE RADICAL BIO MED, V40, P120, DOI 10.1016/j.freeradbiomed.2005.08.048; Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004; Chondrogianni N, 2005, J BIOL CHEM, V280, P11840, DOI 10.1074/jbc.M413007200; Chondrogianni N, 2004, BIOGERONTOLOGY, V5, P55, DOI 10.1023/B:BGEN.0000017687.55667.42; Chondrogianni N, 2003, J BIOL CHEM, V278, P28026, DOI 10.1074/jbc.M301048200; Chondrogianni N, 2000, EXP GERONTOL, V35, P721, DOI 10.1016/S0531-5565(00)00137-6; Chondrogianni N, 2008, AGING CELL, V7, P717, DOI 10.1111/j.1474-9726.2008.00425.x; Ciechanover A, 2005, ANGEW CHEM INT EDIT, V44, P5944, DOI 10.1002/anie.200501428; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; DeMartino GN, 2007, CELL, V129, P659, DOI 10.1016/j.cell.2007.05.007; Dhawan V, 2004, MOL CELL BIOCHEM, V266, P109, DOI 10.1023/B:MCBI.0000049146.89059.53; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, P NATL ACAD SCI USA, V102, P4584, DOI 10.1073/pnas.0500815102; Droge W, 2007, AGING CELL, V6, P361, DOI 10.1111/j.1474-9726.2007.00294.x; DUGAN LL, 2005, SCI AGING KNOWLEDGE; Eggler AL, 2008, MOL NUTR FOOD RES, V52, pS84, DOI 10.1002/mnfr.200700249; Fahey JW, 2002, P NATL ACAD SCI USA, V99, P7610, DOI 10.1073/pnas.112203099; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Harlow E., 1999, USING ANTIBODIES LAB; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hong F, 2005, CHEM RES TOXICOL, V18, P1917, DOI 10.1021/tx0502138; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Katsiki M, 2007, REJUV RES, V10, P157, DOI 10.1089/rej.2006.0513; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Kraft AD, 2004, J NEUROSCI, V24, P1101, DOI 10.1523/JNEUROSCI.3817-03.2004; Kwak MK, 2007, FREE RADICAL BIO MED, V43, P809, DOI 10.1016/j.freeradbiomed.2007.05.029; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; MOI P, 1994, P NATL ACAD SCI USA, V91, P9926, DOI 10.1073/pnas.91.21.9926; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Pearson KJ, 2008, P NATL ACAD SCI USA, V105, P2325, DOI 10.1073/pnas.0712162105; Petropoulou C, 2000, ANN NY ACAD SCI, V908, P133; PLISKO A, 1983, J GERONTOL, V38, P513, DOI 10.1093/geronj/38.5.513; Przybysz AJ, 2009, MECH AGEING DEV, V130, P357, DOI 10.1016/j.mad.2009.02.004; Sakurai T, 2006, CHEM RES TOXICOL, V19, P1196, DOI 10.1021/tx0601105; Shih PH, 2007, BIOGERONTOLOGY, V8, P71, DOI 10.1007/s10522-006-9033-y; Suh JH, 2004, P NATL ACAD SCI USA, V101, P3381, DOI 10.1073/pnas.0400282101; Surh YJ, 2008, PLANTA MED, V74, P1526, DOI 10.1055/s-0028-1088302; Suzuki M, 2008, AM J RESP CELL MOL, V39, P673, DOI 10.1165/rcmb.2007-0424OC; Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195; Tanigawa S, 2007, FREE RADICAL BIO MED, V42, P1690, DOI 10.1016/j.freeradbiomed.2007.02.017; Thimmulappa RK, 2007, ANTIOXID REDOX SIGN, V9, P1963, DOI 10.1089/ars.2007.1745; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Wei P, 1998, J STEROID BIOCHEM, V64, P1, DOI 10.1016/S0022-1759(97)89907-3; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974	58	152	158	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8171	8184		10.1074/jbc.M109.031575	http://dx.doi.org/10.1074/jbc.M109.031575			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068043	Green Published, hybrid			2022-12-27	WOS:000275413800036
J	Murai-Takeda, A; Shibata, H; Kurihara, I; Kobayashi, S; Yokota, K; Suda, N; Mitsuishi, Y; Jo, R; Kitagawa, H; Kato, S; Saruta, T; Itoh, H				Murai-Takeda, Ayano; Shibata, Hirotaka; Kurihara, Isao; Kobayashi, Sakiko; Yokota, Kenichi; Suda, Noriko; Mitsuishi, Yuko; Jo, Rie; Kitagawa, Hirochika; Kato, Shigeaki; Saruta, Takao; Itoh, Hiroshi			NF-YC Functions as a Corepressor of Agonist-bound Mineralocorticoid Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR-I; SELECTIVE COREGULATOR; DEPENDENT INTERACTION; NUCLEAR RECEPTORS; COACTIVATOR; BINDING; ACTIVATION; TRANSACTIVATION; SPECIFICITY; EXPRESSION	The role of aldosterone has been implicated in the metabolic syndrome and cardiovascular diseases. The biological actions of aldosterone are mediated through mineralocorticoid receptor (MR). Nuclear receptor-mediated gene expression is regulated by dynamic and coordinated recruitment of coactivators and corepressors. To identify new coregulators of the MR, full-length MR was used as bait in yeast two-hybrid screening. We isolated NF-YC, one of the subunits of heterotrimeric transcription factor NF-Y. Specific interaction between MR and NF-YC was confirmed by yeast two-hybrid, mammalian two-hybrid, coimmunoprecipitation assays, and fluorescence subcellular imaging. Transient transfection experiments in COS-7 cells demonstrated that NF-YC repressed MR transactivation in a hormone-sensitive manner. Moreover, reduction of NF-YC protein levels by small interfering RNA potentiated hormonal activation of endogenous target genes in stably MR-expressing cells, indicating that NF-YC functions as an agonist-dependent MR corepressor. The corepressor function of NF-YC is selective for MR, because overexpression of NF-YC did not affect transcriptional activity mediated by androgen, progesterone, or glucocorticoid receptors. Chromatin immunoprecipitation experiments showed that endogenous MR and steroid receptor coactivator-1 were recruited to an endogenous ENaC gene promoter in a largely aldosterone-dependent manner, and endogenous NF-YC was sequentially recruited to the same element. Immunohistochemistry showed that endogenous MR and NF-YC were colocalized within the mouse kidney. Although aldosterone induces interaction of the N and C termini of MR, NF-YC inhibited the N/C interaction. These findings indicate that NF-YC functions as a new corepressor of agonist-bound MR via alteration of aldosterone-induced MR conformation.	[Shibata, Hirotaka] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Kitagawa, Hirochika; Kato, Shigeaki] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1130032, Japan	Keio University; University of Tokyo	Shibata, H (corresponding author), Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	hiro-405@cb3.so-net.ne.jp			Pfizer Pharmaceuticals Inc.; Ministry of Health, Labor, and Welfare, Japan; Advancement of Education and Research; Keio Gijuku Academic Development Funds; Smoking Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045999] Funding Source: NIH RePORTER	Pfizer Pharmaceuticals Inc.(Pfizer); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Advancement of Education and Research; Keio Gijuku Academic Development Funds; Smoking Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an investigator-initiated research grant from Pfizer Pharmaceuticals Inc. (to H. S.), a Health Labor Science Research Grant for Disorders of Adrenocortical Hormone Production from the Ministry of Health, Labor, and Welfare, Japan (to H. S.), Keio Gijuku Fukuzawa Memorial Fund for the Advancement of Education and Research (to H. S.), Keio Gijuku Academic Development Funds (to H. S.), and a grant from Smoking Research Foundation (to H. I. and H. S.).	Bellorini M, 1997, GENE, V193, P119, DOI 10.1016/S0378-1119(97)00109-1; Bellorini M, 1997, NUCLEIC ACIDS RES, V25, P2174, DOI 10.1093/nar/25.11.2174; di Silvio A, 1999, NUCLEIC ACIDS RES, V27, P2578; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fernandes I, 2003, MOL CELL, V11, P139, DOI 10.1016/S1097-2765(03)00014-5; Frontini M, 2004, CELL CYCLE, V3, P217; Fuse H, 2000, MOL ENDOCRINOL, V14, P889, DOI 10.1210/me.14.6.889; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6; Hultman ML, 2005, MOL ENDOCRINOL, V19, P1460, DOI 10.1210/me.2004-0537; Kahle J, 2005, MOL CELL BIOL, V25, P5339, DOI 10.1128/MCB.25.13.5339-5354.2005; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kitagawa H, 2002, MOL CELL BIOL, V22, P3698, DOI 10.1128/MCB.22.11.3698-3706.2002; Kobayashi S, 2004, J MOL ENDOCRINOL, V32, P69, DOI 10.1677/jme.0.0320069; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Li Y, 2005, MOL CELL, V19, P367, DOI 10.1016/j.molcel.2005.06.026; Mantovani R, 1999, GENE, V239, P15, DOI 10.1016/S0378-1119(99)00368-6; Matuoka K, 1999, EXP CELL RES, V253, P365, DOI 10.1006/excr.1999.4605; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Metivier R, 2001, MOL ENDOCRINOL, V15, P1953, DOI 10.1210/me.15.11.1953; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; ONATE SA, 1995, SCIENCE, V270, P1354; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P1158, DOI 10.1210/me.2004-0331; Pippal JB, 2009, MOL ENDOCRINOL, V23, P1360, DOI 10.1210/me.2009-0032; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rogerson FM, 2004, MOL CELL ENDOCRINOL, V217, P203, DOI 10.1016/j.mce.2003.10.021; Rogerson FM, 2003, J STEROID BIOCHEM, V85, P389, DOI 10.1016/S0960-0760(03)00200-0; Rogerson FM, 2003, MOL CELL ENDOCRINOL, V200, P45, DOI 10.1016/S0303-7207(02)00413-6; Romier C, 2003, J BIOL CHEM, V278, P1336, DOI 10.1074/jbc.M209635200; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Sanchez-Martinez R, 2008, MOL CELL BIOL, V28, P3817, DOI 10.1128/MCB.01909-07; Shibata H, 1997, MOL ENDOCRINOL, V11, P714, DOI 10.1210/me.11.6.714; Smith CL, 2004, ENDOCR REV, V25, P45, DOI 10.1210/er.2003-0023; Tetel MJ, 1999, MOL ENDOCRINOL, V13, P910, DOI 10.1210/me.13.6.910; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Yang J, 2009, J MOL ENDOCRINOL, V43, P53, DOI 10.1677/JME-09-0031; Yokota K, 2007, J BIOL CHEM, V282, P1998, DOI 10.1074/jbc.M607741200; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	40	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8084	8093		10.1074/jbc.M109.053371	http://dx.doi.org/10.1074/jbc.M109.053371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20054001	hybrid, Green Published			2022-12-27	WOS:000275413800026
J	Marom, M; Hagalili, Y; Sebag, A; Tzvier, L; Atlas, D				Marom, Merav; Hagalili, Yamit; Sebag, Ariel; Tzvier, Lior; Atlas, Daphne			Conformational Changes Induced in Voltage-gated Calcium Channel Cav1.2 by BayK 8644 or FPL64176 Modify the Kinetics of Secretion Independently of Ca2+ Influx	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY DIHYDROPYRIDINE-BINDING; DEPOLARIZATION-INDUCED EXOCYTOSIS; ADRENAL CHROMAFFIN CELLS; FUSION-PORE KINETICS; SYNTAXIN 1A; HIPPOCAMPAL-NEURONS; LC-TYPE; NEUROTRANSMITTER RELEASE; ALLOSTERIC INTERACTIONS; MEMBRANE CAPACITANCE	The role of the L-type calcium channel (Cav1.2) as a molecular switch that triggers secretion prior to Ca2+ transport has previously been demonstrated in bovine chromaffin cells and rat pancreatic beta cells. Here, we examined the effect of specific Cav1.2 allosteric modulators, BayK 8644 (BayK) and FPL64176 (FPL), on the kinetics of catecholamine release, as monitored by amperometry in single bovine chromaffin cells. We show that 2 mu M BayK or 0.5 mu M FPL accelerates the rate of catecholamine secretion to a similar extent in the presence either of the permeable Ca2+ and Ba2+ or the impermeable charge carrier La3+. These results suggest that structural rearrangements generated through the binding of BayK or FPL, by altering the channel activity, could affect depolarization-evoked secretion prior to cation transport. FPL also accelerated the rate of secretion mediated by a Ca2+-impermeable channel made by replacing the wild type alpha(1)1.2 subunit was replaced with the mutant alpha(1)1.2/L775P. Furthermore, BayK and FPL modified the kinetic parameters of the fusion pore formation, which represent the initial contact between the vesicle lumen and the extracellular medium. A direct link between the channel activity and evoked secretion lends additional support to the view that the voltage-gated Ca2+ channels act as a signaling molecular switch, triggering secretion upstream to ion transport into the cell.	[Marom, Merav; Hagalili, Yamit; Sebag, Ariel; Tzvier, Lior; Atlas, Daphne] Hebrew Univ Jerusalem, Dept Biol Chem, Inst Life Sci, IL-919104 Jerusalem, Israel	Hebrew University of Jerusalem	Atlas, D (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Inst Life Sci, IL-919104 Jerusalem, Israel.	datlas@vms.huji.ac.il			Betty Feffer Fund; H. L. Lauterbach; The Zentner Fund	Betty Feffer Fund; H. L. Lauterbach; The Zentner Fund	This work was supported by an operating grant (to D. A.) from The Betty Feffer Fund, H. L. Lauterbach, and The Zentner Fund.	Arien H, 2003, J BIOL CHEM, V278, P29231, DOI 10.1074/jbc.M301401200; ARTALEJO CR, 1994, NATURE, V367, P72, DOI 10.1038/367072a0; Atlas D, 2001, CELL MOL NEUROBIOL, V21, P717, DOI 10.1023/A:1015104105262; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; BAXTER AJG, 1993, J MED CHEM, V36, P2739, DOI 10.1021/jm00071a004; Borges R, 2002, ANN NY ACAD SCI, V971, P184, DOI 10.1111/j.1749-6632.2002.tb04462.x; BOSSU JL, 1991, J PHYSIOL-LONDON, V437, P603, DOI 10.1113/jphysiol.1991.sp018614; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Cano-Abad MF, 2001, J BIOL CHEM, V276, P39695, DOI 10.1074/jbc.M102334200; Catterall WA, 1999, ANN NY ACAD SCI, V868, P144, DOI 10.1111/j.1749-6632.1999.tb11284.x; CENA V, 1983, NEUROSCIENCE, V10, P1455, DOI 10.1016/0306-4522(83)90126-4; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cloues RK, 1997, J NEUROSCI, V17, P6493; Cohen R, 2005, BIOPHYS J, V89, P4364, DOI 10.1529/biophysj.105.064642; Cohen R, 2003, J BIOL CHEM, V278, P9258, DOI 10.1074/jbc.M210270200; Cohen Roy, 2008, V440, P269, DOI 10.1007/978-1-59745-178-9_21; Cohen R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001273; Colliver TL, 2000, J NEUROCHEM, V74, P1086; Fan JS, 2001, AM J PHYSIOL-CELL PH, V280, pC565, DOI 10.1152/ajpcell.2001.280.3.C565; FISHER RE, 1990, J NEUROPHYSIOL, V64, P91, DOI 10.1152/jn.1990.64.1.91; GARCIA AG, 1984, NATURE, V309, P69, DOI 10.1038/309069a0; Garcia-Palomero E, 2001, NEUROENDOCRINOLOGY, V74, P251, DOI 10.1159/000054692; Hagalili Y, 2008, BIOCHEMISTRY-US, V47, P13822, DOI 10.1021/bi801619f; He M, 1997, J BIOL CHEM, V272, P2629, DOI 10.1074/jbc.272.5.2629; Herzig S, 1996, EUR J PHARMACOL, V295, P113, DOI 10.1016/0014-2999(95)00673-7; HESS P, 1984, NATURE, V311, P538, DOI 10.1038/311538a0; Hohaus A, 2005, J BIOL CHEM, V280, P38471, DOI 10.1074/jbc.M507013200; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Hui K, 2005, BIOCHEM BIOPH RES CO, V338, P783, DOI 10.1016/j.bbrc.2005.10.014; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Kavalali ET, 1996, J NEUROSCI, V16, P1072; KOKUBUN S, 1984, P NATL ACAD SCI-BIOL, V81, P4824, DOI 10.1073/pnas.81.15.4824; KUNZE DL, 1992, MOL PHARMACOL, V42, P666; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; Lauven M, 1999, N-S ARCH PHARMACOL, V360, P122, DOI 10.1007/s002109900059; Lerner I, 2006, J NEUROCHEM, V97, P116, DOI 10.1111/j.1471-4159.2006.03709.x; LESZCZYSZYN DJ, 1991, J NEUROCHEM, V56, P1855, DOI 10.1111/j.1471-4159.1991.tb03441.x; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Liu LW, 2003, NEUROPHARMACOLOGY, V45, P281, DOI 10.1016/S0028-3908(03)00153-9; Marom M, 2007, CHANNELS, V1, P377, DOI 10.4161/chan.5398; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; McDonough SI, 2005, BIOPHYS J, V88, P211, DOI 10.1529/biophysj.104.051714; MONTIEL C, 1994, EUR J PHARM-MOLEC PH, V268, P293, DOI 10.1016/0922-4106(94)90053-1; Peterson BZ, 2006, MOL PHARMACOL, V70, P667, DOI 10.1124/mol.105.020644; PETERSON BZ, 1995, J BIOL CHEM, V270, P18201, DOI 10.1074/jbc.270.31.18201; Peterson BZ, 1996, J BIOL CHEM, V271, P5293, DOI 10.1074/jbc.271.10.5293; RAMPE D, 1991, J PHARMACOL EXP THER, V259, P982; Rodriguez-Contreras A, 2003, BIOPHYS J, V84, P3457, DOI 10.1016/S0006-3495(03)70066-6; Rosa JM, 2009, PFLUG ARCH EUR J PHY, V458, P795, DOI 10.1007/s00424-009-0662-2; Striessnig J, 1998, TRENDS PHARMACOL SCI, V19, P108, DOI 10.1016/S0165-6147(98)01171-7; Tavalin SJ, 2004, J NEUROPHYSIOL, V92, P824, DOI 10.1152/jn.00700.2003; Tobi D, 1998, RECEPTOR CHANNEL, V6, P89; Trus M, 2001, NEUROSCIENCE, V104, P599, DOI 10.1016/S0306-4522(01)00083-5; Trus M, 2007, BIOCHEMISTRY-US, V46, P14461, DOI 10.1021/bi7016816; USOWICZ MM, 1995, J PHARMACOL EXP THER, V275, P638; VONRUDEN L, 1993, SCIENCE, V262, P1061, DOI 10.1126/science.8235626; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wiser O, 1997, FEBS LETT, V404, P203, DOI 10.1016/S0014-5793(97)00130-0; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wiser O, 2002, P NATL ACAD SCI USA, V99, P3968, DOI 10.1073/pnas.052017299; Wiser O, 1999, P NATL ACAD SCI USA, V96, P248, DOI 10.1073/pnas.96.1.248; Yamaguchi S, 2000, J BIOL CHEM, V275, P41504, DOI 10.1074/jbc.M007165200; ZHENG W, 1991, MOL PHARMACOL, V40, P734	64	23	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6996	7005		10.1074/jbc.M109.059865	http://dx.doi.org/10.1074/jbc.M109.059865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20054004	Green Published, hybrid			2022-12-27	WOS:000275415600013
J	Tronconi, MA; Maurino, VG; Andreo, CS; Drincovich, MF				Tronconi, Marcos A.; Maurino, Veronica G.; Andreo, Carlos S.; Drincovich, Maria F.			Three Different and Tissue-specific NAD-Malic Enzymes Generated by Alternative Subunit Association in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; PHYSIOLOGICAL-FUNCTION; REGULATORY MECHANISM; EXPRESSION ANALYSIS; KINETIC-BEHAVIOR; PLANT DEFENSE; METABOLISM; MALATE; PURIFICATION; MAIZE	The Arabidopsis thaliana genome contains two genes encoding the mitochondrial NAD-malic enzyme (NAD-ME), NAD-ME1 (At2g13560) and NAD-ME2 (At4g00570). The characterization of recombinant NAD-ME1 and -2 indicated that both enzymes assemble as active homodimers; however, a heterodimeric enzyme (NAD-MEH) can also be detected by electrophoretic studies. To analyze the metabolic contribution of each enzymatic entity, NAD-MEH was obtained by a co-expression-based recombinant approach, and its kinetic and regulatory properties were analyzed. The three NAD-MEs show similar kinetic properties, although they differ in the regulation by several metabolic effectors. In this regard, whereas fumarate activates NAD-ME1 and CoA activates NAD-ME2, both compounds act synergistically on NAD-MEH activity. The characterization of two chimeric enzymes between NAD-ME1 and -2 allowed specific domains of the primary structure, which are involved in the differential allosteric regulation, to be identified. NAD-ME1 and -2 subunits showed a distinct pattern of accumulation in the separate components of the floral organ. In sepals, the NAD-ME1 subunit is present at a slightly higher proportion than the NAD-ME2 subunit, and thus, NAD-MEH and NAD-ME1 act in concert in this tissue. On the other hand, NAD-ME2 is the only isoform present in anthers. In view of the different properties of NAD-ME1, -2, and -H, we suggest that mitochondrial NAD-ME activity may be regulated by varying native association in vivo, rendering enzymatic entities with distinct allosteric regulation to fulfill specific roles. The presence of three different NAD-ME entities, which originate by alternative associations of two subunits, is suggested to be a novel phenomenon unique to plant mitochondria.	[Tronconi, Marcos A.; Andreo, Carlos S.; Drincovich, Maria F.] Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, RA-2000 Rosario, Santa Fe, Argentina; [Maurino, Veronica G.] Univ Cologne, Inst Bot, D-50674 Cologne, Germany	National University of Rosario; University of Cologne	Andreo, CS (corresponding author), Univ Nacl Rosario, Ctr Estudios Fotosintet & Bioquim, Suipacha 531, RA-2000 Rosario, Santa Fe, Argentina.	candreo@fbioyf.unr.edu.ar	Drincovich, Maria F/F-3902-2017; Drincovich, Maria F/Q-4195-2019	Drincovich, Maria F/0000-0003-4897-3285; Drincovich, Maria F/0000-0003-4897-3285; Tronconi, Marcos/0000-0001-9568-7818	Agencia de Promocion Cientifica y Tecnologica [32233]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina); Deutsche Forschungsgemeinschaft (Germany)	Agencia de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Deutsche Forschungsgemeinschaft (Germany)(German Research Foundation (DFG))	This work was supported by the Agencia de Promocion Cientifica y Tecnologica (PICT Grant 32233) and the Consejo Nacional de Investigaciones Cientificas y Tecnicas (Argentina) and the Deutsche Forschungsgemeinschaft (Germany).	Andre C, 2007, PLANT CELL, V19, P2006, DOI 10.1105/tpc.106.048629; Brown NJ, 2010, PLANT J, V61, P122, DOI 10.1111/j.1365-313X.2009.04040.x; CANELLAS PF, 1984, ARCH BIOCHEM BIOPHYS, V229, P414, DOI 10.1016/0003-9861(84)90171-1; Casati P, 1999, PHOTOSYNTH RES, V61, P99, DOI 10.1023/A:1006209003096; Casati P, 1997, PLANT CELL PHYSIOL, V38, P928, DOI 10.1093/oxfordjournals.pcp.a029253; DAVISSON VJ, 1985, BIOCHEM J, V225, P335, DOI 10.1042/bj2250335; de Bari L, 2007, BBA-BIOENERGETICS, V1767, P281, DOI 10.1016/j.bbabio.2007.02.010; Detarsio E, 2004, BIOCHEM J, V382, P1025, DOI 10.1042/BJ20040594; Drincovich MF, 2001, FEBS LETT, V490, P1, DOI 10.1016/S0014-5793(00)02331-0; Eastmond PJ, 1997, PLANT PHYSIOL, V114, P851, DOI 10.1104/pp.114.3.851; Fahnenstich H, 2007, PLANT PHYSIOL, V145, P640, DOI 10.1104/pp.107.104455; Farre EM, 2001, PLANT PHYSIOL, V127, P685, DOI 10.1104/pp.127.2.685; GROVER SD, 1982, PLANT PHYSIOL, V70, P1169, DOI 10.1104/pp.70.4.1169; Hung HC, 2005, BIOCHEM J, V392, P39, DOI 10.1042/BJ20050641; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kapri R., 2000, ACTA HORTIC, V535, P113; Karsten WE, 2003, BIOCHEMISTRY-US, V42, P9712, DOI 10.1021/bi034101w; Kurimoto K, 2004, PLANT CELL PHYSIOL, V45, P1015, DOI 10.1093/pcp/pch116; LAEMMLI UK, 1970, NATURE, V227, P685; Lemaitre T, 2006, PLANT CELL PHYSIOL, V47, P634, DOI 10.1093/pcp/pcj030; Liu SK, 2007, PLANT MOL BIOL, V64, P49, DOI 10.1007/s11103-007-9133-3; LONG JJ, 1994, J BIOL CHEM, V269, P2827; MARTINOIA E, 1994, ANNU REV PLANT PHYS, V45, P447, DOI 10.1146/annurev.pp.45.060194.002311; Maurino VG, 2001, PLANT MOL BIOL, V45, P409, DOI 10.1023/A:1010665910095; MOREADITH RW, 1984, J BIOL CHEM, V259, P6222; Muller GL, 2008, PLANT CELL PHYSIOL, V49, P469, DOI 10.1093/pcp/pcn022; MURATA T, 1989, PLANT PHYSIOL, V89, P316, DOI 10.1104/pp.89.1.316; NAGEL WO, 1982, J BIOL CHEM, V257, P2405; O'Leary B, 2009, J BIOL CHEM, V284, P24797, DOI 10.1074/jbc.M109.022863; Plaxton WC, 2006, CRIT REV PLANT SCI, V25, P159, DOI 10.1080/07352680600563876; Rontein D, 2002, J BIOL CHEM, V277, P43948, DOI 10.1074/jbc.M206366200; Saigo M, 2004, PLANT MOL BIOL, V55, P97, DOI 10.1007/s11103-004-0472-z; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SMITH RG, 1992, PLANT PHYSIOL, V98, P1233, DOI 10.1104/pp.98.4.1233; Suzuki J., 2003, Genetics and Molecular Research, V2, P376; Tronconi MA, 2008, PLANT PHYSIOL, V146, P1540, DOI 10.1104/pp.107.114975; WEDDING RT, 1989, PLANT PHYSIOL, V90, P367, DOI 10.1104/pp.90.2.367; Wheeler MCG, 2005, PLANT PHYSIOL, V139, P39, DOI 10.1104/pp.105.065953; WILLEFORD KO, 1987, J BIOL CHEM, V262, P8423; WINNING BM, 1994, J BIOL CHEM, V269, P4780; Yang ZR, 2002, STRUCTURE, V10, P951, DOI 10.1016/S0969-2126(02)00788-8; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	42	32	35	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11870	11879		10.1074/jbc.M109.097477	http://dx.doi.org/10.1074/jbc.M109.097477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20133948	hybrid, Green Published			2022-12-27	WOS:000276787100015
J	Chatterjee, C; Muir, TW				Chatterjee, Champak; Muir, Tom W.			Chemical Approaches for Studying Histone Modifications	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							METHYL-LYSINE; SUBSTRATE-SPECIFICITY; CHROMATIN-STRUCTURE; PROTEIN LIGATION; ACETYLATION; H3; NUCLEOSOME; CYSTEINE; TRIMETHYLATION; DIMETHYLATION	Histones form the protein core around which genomic DNA is wrapped in eukaryotic chromatin. Numerous genetic studies have established that the structure and transcriptional state of chromatin are closely related to histone post-translational modifications. Further elucidation of the precise mechanistic roles for individual histone modifications requires the ability to isolate and study homogeneously modified histones. However, the highly heterogeneous nature of histone modifications in vivo poses a significant challenge for such studies. Chemical tools that have enabled biochemical and biophysical studies of site-specifically modified histones are the focus of this minireview.	[Chatterjee, Champak; Muir, Tom W.] Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA	Rockefeller University	Muir, TW (corresponding author), Rockefeller Univ, Lab Synthet Prot Chem, New York, NY 10065 USA.	muirt@rockefeller.edu	Muir, Tom/AHD-0860-2022; Chatterjee, Champak/R-7214-2017	Muir, Tom/0000-0001-9635-0344; 				ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Allis CD, 2007, EPIGENETICS; Bernardes GJL, 2008, J AM CHEM SOC, V130, P5052, DOI 10.1021/ja800800p; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Blanco-Canosa JB, 2008, ANGEW CHEM INT EDIT, V47, P6851, DOI 10.1002/anie.200705471; BUTLER JAV, 1965, NATURE, V207, P1041, DOI 10.1038/2071041a0; Chatterjee C, 2007, ANGEW CHEM INT EDIT, V46, P2814, DOI 10.1002/anie.200605155; Chiang KP, 2009, CHEMBIOCHEM, V10, P2182, DOI 10.1002/cbic.200900238; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Garske AL, 2008, BIOCHEMISTRY-US, V47, P8094, DOI 10.1021/bi800766k; George EA, 2008, J AM CHEM SOC, V130, P4914, DOI 10.1021/ja711126e; GOODMAN M, 1967, TETRAHEDRON, V23, P2031, DOI 10.1016/0040-4020(67)80037-1; Guo JT, 2008, ANGEW CHEM INT EDIT, V47, P6399, DOI 10.1002/anie.200802336; Gurard-Levin ZA, 2008, BIOCHEMISTRY-US, V47, P6242, DOI 10.1021/bi800053v; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hung T, 2009, MOL CELL, V33, P248, DOI 10.1016/j.molcel.2008.12.016; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kossel A., 1928, PROTAMINES HISTONES; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KRIEGER DE, 1974, J BIOL CHEM, V249, P332; KRIEGER DE, 1979, BIOORG CHEM, V8, P409, DOI 10.1016/0045-2068(79)90044-0; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Lu X, 2008, NAT STRUCT MOL BIOL, V15, P1122, DOI 10.1038/nsmb.1489; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; McGinty RK, 2008, NATURE, V453, P812, DOI 10.1038/nature06906; McGinty RK, 2009, ACS CHEM BIOL, V4, P958, DOI 10.1021/cb9002255; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muir TW, 1998, P NATL ACAD SCI USA, V95, P6705, DOI 10.1073/pnas.95.12.6705; Muralidharan V, 2006, NAT METHODS, V3, P429, DOI 10.1038/NMETH886; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nguyen DP, 2009, J AM CHEM SOC, V131, P14194, DOI 10.1021/ja906603s; PHILLIPS DM, 1963, BIOCHEM J, V87, P258, DOI 10.1042/bj0870258; Rathert P, 2008, CHEM BIOL, V15, P5, DOI 10.1016/j.chembiol.2007.11.013; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; SCHMIDT U, 1976, ANGEW CHEM INT EDIT, V15, P42, DOI 10.1002/anie.197600421; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Shogren-Knaak MA, 2003, J BIOL CHEM, V278, P15744, DOI 10.1074/jbc.M301445200; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; STEDMAN E, 1950, NATURE, V166, P780, DOI 10.1038/166780a0; Wan Q, 2007, ANGEW CHEM INT EDIT, V46, P9248, DOI 10.1002/anie.200704195; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Zhu Y, 2001, ORG LETT, V3, P1189, DOI 10.1021/ol015648a	49	75	78	1	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11045	11050		10.1074/jbc.R109.080291	http://dx.doi.org/10.1074/jbc.R109.080291			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147749	Green Published, hybrid			2022-12-27	WOS:000276286200005
J	Fernandez, IS; Cuevas, P; Angulo, J; Lopez-Navajas, P; Canales-Mayordomo, A; Gonzalez-Corrochano, R; Lozano, RM; Valverde, S; Jimenez-Barbero, J; Romero, A; Gimenez-Gallego, G				Fernandez, Israel S.; Cuevas, Pedro; Angulo, Javier; Lopez-Navajas, Pilar; Canales-Mayordomo, Angeles; Gonzalez-Corrochano, Rocio; Lozano, Rosa M.; Valverde, Serafin; Jimenez-Barbero, Jesus; Romero, Antonio; Gimenez-Gallego, Guillermo			Gentisic Acid, a Compound Associated with Plant Defense and a Metabolite of Aspirin, Heads a New Class of in Vivo Fibroblast Growth Factor Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FACTOR RECEPTOR; HEPARIN-BINDING; TUMOR-GROWTH; FACTOR FGF; C6 GLIOMA; ANGIOGENESIS; AFFINITY; CELLS; RESISTANCE	Fibroblast growth factors are key proteins in many intercellular signaling networks. They normally remain attached to the extracellular matrix, which confers on them a considerable stability. The unrestrained accumulation of fibroblast growth factors in the extracellular milieu, either due to uncontrolled synthesis or enzymatic release, contributes to the pathology of many diseases. Consequently, the neutralization of improperly mobilized fibroblast growth factors is of clear therapeutic interest. In pursuing described rules to identify potential inhibitors of these proteins, gentisic acid, a plant pest-controlling compound, an aspirin and vegetarian diet common catabolite, and a component of many traditional liquors and herbal remedies, was singled out as a powerful inhibitor of fibroblast growth factors. Gentisic acid was used as a lead to identify additional compounds with better inhibitory characteristics generating a new chemical class of fibroblast growth factor inhibitors that includes the agent responsible for alkaptonuria. Through low and high resolution approaches, using representative members of the fibroblast growth factor family and their cell receptors, it was shown that this class of inhibitors may employ two different mechanisms to interfere with the assembly of the signaling complexes that trigger fibroblast growth factor-driven mitogenesis. In addition, we obtained evidence from in vivo disease models that this group of inhibitors may be of interest to treat cancer and angiogenesis-dependent diseases.	[Fernandez, Israel S.; Lopez-Navajas, Pilar; Canales-Mayordomo, Angeles; Gonzalez-Corrochano, Rocio; Lozano, Rosa M.; Jimenez-Barbero, Jesus; Romero, Antonio; Gimenez-Gallego, Guillermo] CSIC, Ctr Invest Biol, Dept Biol Fis Quim, Madrid 28040, Spain; [Cuevas, Pedro; Angulo, Javier; Gonzalez-Corrochano, Rocio] Hosp Univ Ramon y Cajal, Dept Invest, Serv Histol, Madrid 28034, Spain; [Valverde, Serafin] CSIC, Inst Quim Organ Gen, Dept Nat Prod, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario Ramon y Cajal; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Organica General (IQOG)	Gimenez-Gallego, G (corresponding author), Ramiro de Maeztu 9, Madrid 28040, Spain.	gimenez_gallego@cib.csic.es	Canales, Angeles/K-7499-2015; Romero, Antonio/K-5754-2014; JIMENEZ-BARBERO, JESUS/D-4431-2014	Canales, Angeles/0000-0003-0542-3080; Romero, Antonio/0000-0002-6990-6973; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Lozano, Rosa Maria/0000-0003-2762-6938	Ministerio de Educacion y Ciencia (Spain) [BFU2008-02595]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Ministerio de Educacion y Ciencia (Spain)(Spanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by BFU2008-02595 from the Ministerio de Educacion y Ciencia (Spain).	Abuharbeid S, 2006, INT J BIOCHEM CELL B, V38, P1463, DOI 10.1016/j.biocel.2005.10.017; ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Aoki T, 2002, INT J ONCOL, V21, P629; Asada M, 2009, BBA-GEN SUBJECTS, V1790, P40, DOI 10.1016/j.bbagen.2008.09.001; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAIRD A, 1990, HDB EXPT PHARM, V95, P369; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blaber M, 1996, BIOCHEMISTRY-US, V35, P2086, DOI 10.1021/bi9521755; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGESS WH, 1990, J CELL BIOL, V111, P2129, DOI 10.1083/jcb.111.5.2129; CAMPBEL WF, 1964, J RANGE MANAGE, V37, P365; Canales A, 2006, FEBS J, V273, P4716, DOI 10.1111/j.1742-4658.2006.05474.x; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Cuevas P, 2005, NEUROL RES, V27, P797, DOI 10.1179/016164105X63665; Cuevas P, 2004, NEUROL RES, V26, P273, DOI 10.1179/016164104225013941; Cuevas P, 1997, GROWTH FACTORS, V15, P29, DOI 10.3109/08977199709002110; CUEVAS P, 1994, NEUROL RES, V16, P310; Cuevas P, 1996, NEUROSCI LETT, V221, P25, DOI 10.1016/S0304-3940(96)13277-8; Cuevas P, 1996, P NATL ACAD SCI USA, V93, P11996, DOI 10.1073/pnas.93.21.11996; CUEVAS P, 1994, CELL SIGNAL TRANSDUCTION, SECOND MESSENGERS, AND PROTEIN PHOSPHORYLATION IN HEALTH AND DISEASE, P161; Cuevas P, 1999, NEUROL RES, V21, P191, DOI 10.1080/01616412.1999.11740917; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; Dirix LY, 1997, BRIT J CANCER, V76, P238, DOI 10.1038/bjc.1997.368; Dvorak P, 2006, FEBS LETT, V580, P2869, DOI 10.1016/j.febslet.2006.01.095; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERIKSSON AE, 1993, PROTEIN SCI, V2, P1274, DOI 10.1002/pro.5560020810; ESCH F, 1985, P NATL ACAD SCI USA, V82, P6507, DOI 10.1073/pnas.82.19.6507; Fernandez-Tornero C, 2005, J BIOL CHEM, V280, P19948, DOI 10.1074/jbc.M501236200; Fernandez-Tornero C, 2003, J BIOL CHEM, V278, P21774, DOI 10.1074/jbc.M212833200; Fernandez-Tornero C, 2001, NAT STRUCT BIOL, V8, P1020, DOI 10.1038/nsb724; Finetti F, 2008, J BIOL CHEM, V283, P2139, DOI 10.1074/jbc.M703090200; FISCHER DC, 1990, J ENTOMOL SCI, V25, P230, DOI 10.18474/0749-8004-25.2.230; Gerstner ER, 2007, EXPERT OPIN INV DRUG, V16, P1895, DOI 10.1517/13543784.16.12.1895; GIMENEZGALLEGO G, 1986, BIOCHEM BIOPH RES CO, V135, P541, DOI 10.1016/0006-291X(86)90028-8; Greber B, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-46; GRIFFITHS LA, 1958, NATURE, V182, P733, DOI 10.1038/182733a0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harada M, 2009, NAT GENET, V41, P289, DOI 10.1038/ng.316; HARPER JW, 1988, BIOCHEMISTRY-US, V27, P671, DOI 10.1021/bi00402a027; HOUSSAINT E, 1990, P NATL ACAD SCI USA, V87, P8180, DOI 10.1073/pnas.87.20.8180; Indraccolo S, 2006, P NATL ACAD SCI USA, V103, P4216, DOI 10.1073/pnas.0506200103; Itoh N, 2004, TRENDS GENET, V20, P563, DOI 10.1016/j.tig.2004.08.007; Jeffers Michael, 2002, Expert Opin Ther Targets, V6, P469, DOI 10.1517/14728222.6.4.469; KAN MK, 1993, SCIENCE, V259, P1918, DOI 10.1126/science.8456318; KLAGSBRUN M, 1985, P NATL ACAD SCI USA, V82, P805, DOI 10.1073/pnas.82.3.805; Lee JT, 2007, J CELL PHYSIOL, V213, P603, DOI 10.1002/jcp.21252; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; Loges S, 2009, CANCER CELL, V15, P167, DOI 10.1016/j.ccr.2009.02.007; Lozano RM, 1998, J MOL BIOL, V281, P899, DOI 10.1006/jmbi.1998.1977; Lozano RM, 2001, J BIOL CHEM, V276, P35723, DOI 10.1074/jbc.M101565200; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; McKeehan WL, 1997, IN VITRO CELL DEV-AN, V33, P727, DOI 10.1007/s11626-997-0146-7; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEEDS CJ, 1985, CLIN PHARMACOKINET, V10, P164, DOI 10.2165/00003088-198510020-00004; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; OKUMURA N, 1989, J BIOCHEM-TOKYO, V106, P904, DOI 10.1093/oxfordjournals.jbchem.a122950; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; ORNITZ DM, 1992, J BIOL CHEM, V267, P16305; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; ORTEGA S, 1992, BIO-TECHNOL, V10, P795, DOI 10.1038/nbt0792-795; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Peranen J, 1996, ANAL BIOCHEM, V236, P371, DOI 10.1006/abio.1996.0187; PESENTI E, 1992, BRIT J CANCER, V66, P367, DOI 10.1038/bjc.1992.272; PinedaLucena A, 1996, J MOL BIOL, V264, P162, DOI 10.1006/jmbi.1996.0631; PINEDALUCENA A, 1994, J MOL BIOL, V242, P81, DOI 10.1006/jmbi.1994.1558; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; RODTS GE, 1994, NEUROL RES, V16, P184; Romero A, 1996, EUR J BIOCHEM, V241, P453, DOI 10.1111/j.1432-1033.1996.00453.x; Santiago R, 2005, J ECON ENTOMOL, V98, P1349, DOI 10.1603/0022-0493-98.4.1349; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Scrutton NS, 1996, BIOCHEM J, V319, P1; Song SH, 2000, P NATL ACAD SCI USA, V97, P8658, DOI 10.1073/pnas.140210697; Stauber DJ, 2000, P NATL ACAD SCI USA, V97, P49, DOI 10.1073/pnas.97.1.49; STEFANIK DF, 1991, CANCER RES, V51, P5760; Szebenyi G, 1999, INT REV CYTOL, V185, P45; THOMAS KA, 1985, P NATL ACAD SCI USA, V82, P6409, DOI 10.1073/pnas.82.19.6409; THOMAS KA, 1986, TRENDS BIOCHEM SCI, V11, P81, DOI 10.1016/0968-0004(86)90271-9; TODD GW, 1971, ANN ENTOMOL SOC AM, V64, P718, DOI 10.1093/aesa/64.3.718; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; VLODAVSKY I, 1991, J CELL BIOCHEM, V45, P167, DOI 10.1002/jcb.240450208; Wang HM, 1997, BIOCHEM BIOPH RES CO, V235, P369, DOI 10.1006/bbrc.1997.6789; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W	90	53	55	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11714	11729		10.1074/jbc.M109.064618	http://dx.doi.org/10.1074/jbc.M109.064618			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145243	hybrid, Green Published			2022-12-27	WOS:000276286200075
J	Iyer, RR; Pluciennik, A; Genschel, J; Tsai, MS; Beese, LS; Modrich, P				Iyer, Ravi R.; Pluciennik, Anna; Genschel, Jochen; Tsai, Miaw-Sheue; Beese, Lorena S.; Modrich, Paul			MutL alpha and Proliferating Cell Nuclear Antigen Share Binding Sites on MutS beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH REPAIR; INTERSTRAND CROSS-LINKS; RECOGNITION COMPLEX; HMUTS-ALPHA; EXCISION; MSH2-MSH6; PROTEINS; INTERACT; SYSTEM; RECONSTITUTION	MutS beta (MSH2-MSH3) mediates repair of insertion-deletion heterologies but also triggers triplet repeat expansions that cause neurological diseases. Like other DNA metabolic activities, MutS beta interacts with proliferating cell nuclear antigen (PCNA) via a conserved motif (QXX(L/I)XXFF). We demonstrate that MutS beta-PCNA complex formation occurs with an affinity of similar to 0.1 mu M and a preferred stoichiometry of 1:1. However, up to 20% of complexes are multivalent under conditions where MutS beta is in molar excess over PCNA. Conformational studies indicate that the two proteins associate in an end-to-end fashion in solution. Surprisingly, mutation of the PCNA-binding motif of MutS beta not only abolishes PCNA binding, but unlike MutS beta, also dramatically attenuates MutS beta-MutL alpha interaction, MutL alpha endonuclease activation, and bidirectional mismatch repair. As predicted by these findings, PCNA competes with MutL alpha for binding to MutS beta, an effect that is blocked by the cell cycle regulator p21(CIP1). We propose that MutS beta-MutL alpha interaction is mediated in part by residues ((L/I)SRFF) embedded within the MSH3 PCNA-binding motif. To our knowledge this is the first case where residues important for PCNA binding also mediate interaction with a second protein. These findings also indicate that MutS beta- and MutS alpha-initiated repair events differ in fundamental ways.	[Iyer, Ravi R.; Pluciennik, Anna; Genschel, Jochen; Beese, Lorena S.; Modrich, Paul] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Modrich, Paul] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Tsai, Miaw-Sheue] Univ Calif Berkeley, Lawrence Berkeley Lab, Dept Canc & DNA Damage Responses, Berkeley, CA 94720 USA	Duke University; Duke University; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Modrich, P (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.	modrich@biochem.duke.edu	Classen, Scott/AAY-8176-2020; beese, lorena/G-4993-2010	Modrich, Paul/0000-0001-8708-9885	National Institutes of Health [R01 GM45190, P01 CA92584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM45190 and P01 CA92584.	Blackwell LJ, 1998, J BIOL CHEM, V273, P32049, DOI 10.1074/jbc.273.48.32049; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Charbonneau N, 2009, CANCER BIOL THER, V8, P1411, DOI 10.4161/cbt.8.14.8886; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Constantin N, 2005, J BIOL CHEM, V280, P39752, DOI 10.1074/jbc.M509701200; Dherin C, 2009, MOL CELL BIOL, V29, P907, DOI 10.1128/MCB.00945-08; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Drummond JT, 1997, P NATL ACAD SCI USA, V94, P10144, DOI 10.1073/pnas.94.19.10144; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; Flores-Rozas H, 2000, NAT GENET, V26, P375, DOI 10.1038/81708; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Galio L, 1999, NUCLEIC ACIDS RES, V27, P2325, DOI 10.1093/nar/27.11.2325; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Genschel J, 2006, METHOD ENZYMOL, V408, P273, DOI 10.1016/S0076-6879(06)08017-7; Genschel J, 2009, J BIOL CHEM, V284, P21536, DOI 10.1074/jbc.M109.021287; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Gu LY, 1998, NUCLEIC ACIDS RES, V26, P1173, DOI 10.1093/nar/26.5.1173; Guinier A., 1955, SMALL ANGLE SCATTERI; Habraken Y, 1997, CURR BIOL, V7, P790, DOI 10.1016/S0960-9822(06)00337-X; Habraken Y, 1998, J BIOL CHEM, V273, P9837, DOI 10.1074/jbc.273.16.9837; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Iyer RR, 2008, J BIOL CHEM, V283, P13310, DOI 10.1074/jbc.M800606200; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Johnson RE, 1996, J BIOL CHEM, V271, P27987, DOI 10.1074/jbc.271.45.27987; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; KRATKY O, 1963, PROG BIOPHYS MOL BIO, V13, P105, DOI 10.1016/S0079-6107(63)80015-2; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Plotz G, 2006, NUCLEIC ACIDS RES, V34, P6574, DOI 10.1093/nar/gkl944; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002; Zhang YB, 2005, CELL, V122, P693, DOI 10.1016/j.cell.2005.06.027; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399	49	37	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11730	11739		10.1074/jbc.M110.104125	http://dx.doi.org/10.1074/jbc.M110.104125			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154325	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000276286200076
J	Takeuchi, Y; Yahagi, N; Izumida, Y; Nishi, M; Kubota, M; Teraoka, Y; Yamamoto, T; Matsuzaka, T; Nakagawa, Y; Sekiya, M; Iizuka, Y; Ohashi, K; Osuga, J; Gotoda, T; Ishibashi, S; Itaka, K; Kataoka, K; Nagai, R; Yamada, N; Kadowaki, T; Shimano, H				Takeuchi, Yoshinori; Yahagi, Naoya; Izumida, Yoshihiko; Nishi, Makiko; Kubota, Midori; Teraoka, Yuji; Yamamoto, Takashi; Matsuzaka, Takashi; Nakagawa, Yoshimi; Sekiya, Motohiro; Iizuka, Yoko; Ohashi, Ken; Osuga, Jun-ichi; Gotoda, Takanari; Ishibashi, Shun; Itaka, Keiji; Kataoka, Kazunori; Nagai, Ryozo; Yamada, Nobuhiro; Kadowaki, Takashi; Shimano, Hitoshi			Polyunsaturated Fatty Acids Selectively Suppress Sterol Regulatory Element-binding Protein-1 through Proteolytic Processing and Autoloop Regulatory Circuit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR; GENE-TRANSCRIPTION; PROMOTER ANALYSIS; TRANSGENIC MICE; CULTURED-CELLS; MESSENGER-RNAS; MOUSE-LIVER; X-RECEPTOR; EXPRESSION; SREBP-1	Sterol regulatory element-binding protein (SREBP)-1 is a key transcription factor for the regulation of lipogenic enzyme genes in the liver. Polyunsaturated fatty acids (PUFA) selectively suppress hepatic SREBP-1, but molecular mechanisms remain largely unknown. To gain insight into this regulation, we established in vivo reporter assays to assess the activities of Srebf1c transcription and proteolytic processing. Using these in vivo reporter assays, we showed that the primary mechanism for PUFA suppression of SREBP-1 is at the proteolytic processing level and that this suppression in turn decreases the mRNA transcription through lowering SREBP-1 binding to the SREBP-binding element on the promoter ("autoloop regulatory circuit"), although liver X receptor, an activator for Srebf1c transcription, is not involved in this regulation by PUFA. The mechanisms for PUFA suppression of SREBP-1 confirm that the autoloop regulation for transcription is crucial for the nutritional regulation of triglyceride synthesis.	[Takeuchi, Yoshinori; Yahagi, Naoya; Izumida, Yoshihiko; Nishi, Makiko; Kubota, Midori; Teraoka, Yuji; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Lab Mol Physiol Energy Metab, Tokyo 1138655, Japan; [Takeuchi, Yoshinori; Yahagi, Naoya; Izumida, Yoshihiko; Nishi, Makiko; Kubota, Midori; Teraoka, Yuji; Yamamoto, Takashi; Sekiya, Motohiro; Iizuka, Yoko; Ohashi, Ken; Osuga, Jun-ichi; Gotoda, Takanari; Ishibashi, Shun; Nagai, Ryozo; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Internal Med, Tokyo 1138655, Japan; [Itaka, Keiji; Kataoka, Kazunori] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Tokyo 1138655, Japan; [Takeuchi, Yoshinori; Matsuzaka, Takashi; Nakagawa, Yoshimi; Yamada, Nobuhiro; Shimano, Hitoshi] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan	University of Tokyo; University of Tokyo; University of Tokyo; University of Tsukuba	Yahagi, N (corresponding author), 7-3-1 Hongo,Bunkyoku, Tokyo 1138655, Japan.	nyahagi-tky@umin.ac.jp; shimano-tky@umin.ac.jp	Yahagi, Naoya/D-2360-2014; Shimano, Hitoshi/V-1761-2019; Shimano, Hitoshi/AAI-5648-2020	Yahagi, Naoya/0000-0002-1823-1865; Shimano, Hitoshi/0000-0002-5562-5572; Kataoka, Kazunori/0000-0002-8591-413X	Ministry of Science, Education, Culture and Technology of Japan; The Uehara Memorial Foundation; ONO Medical Research Foundation; Takeda Science Foundation; Suzuken Memorial Foundation; Japan Heart Foundation; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Japan Foundation for Applied Enzymology; Okinaka Memorial Institute for Medical Research; Grants-in-Aid for Scientific Research [21591123] Funding Source: KAKEN	Ministry of Science, Education, Culture and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Uehara Memorial Foundation(Uehara Memorial Foundation); ONO Medical Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Japan Heart Foundation; Kanae Foundation for the Promotion of Medical Science; Senri Life Science Foundation; Japan Foundation for Applied Enzymology; Okinaka Memorial Institute for Medical Research; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants-in-aid from the Ministry of Science, Education, Culture and Technology of Japan (to N.Y. and H. S.) and research grants from The Uehara Memorial Foundation, ONO Medical Research Foundation, Takeda Science Foundation, Suzuken Memorial Foundation, Japan Heart Foundation, Kanae Foundation for the Promotion of Medical Science, Senri Life Science Foundation, Japan Foundation for Applied Enzymology, and Okinaka Memorial Institute for Medical Research (to N.Y.).	ALLMANN DW, 1965, J LIPID RES, V6, P51; Amemiya-Kudo M, 2000, J BIOL CHEM, V275, P31078, DOI 10.1074/jbc.M005353200; Botolin D, 2006, J LIPID RES, V47, P181, DOI 10.1194/jlr.M500365-JLR200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; CLARKE SD, 1994, ANNU REV NUTR, V14, P83, DOI 10.1146/annurev.nu.14.070194.000503; Contag PR, 1998, NAT MED, V4, P245, DOI 10.1038/nm0298-245; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; FOLCH J, 1957, J BIOL CHEM, V226, P497; GOODRIDGE AG, 1991, BIOCH LIPIDS LIPOPRO, P111; Hannah VC, 2001, J BIOL CHEM, V276, P4365, DOI 10.1074/jbc.M007273200; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Inoue N, 2005, MOL CELL BIOL, V25, P8938, DOI 10.1128/MCB.25.20.8938-8947.2005; Irisawa M, 2009, J BIOL CHEM, V284, P28995, DOI 10.1074/jbc.M109.041376; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; Kumadaki S, 2008, BIOCHEM BIOPH RES CO, V368, P261, DOI 10.1016/j.bbrc.2008.01.075; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; Nakatani T, 2003, J LIPID RES, V44, P369, DOI 10.1194/jlr.M200289-JLR200; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; SATTLER W, 1991, ANAL BIOCHEM, V198, P184, DOI 10.1016/0003-2697(91)90526-Y; Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Takeuchi Y, 2007, BIOCHEM BIOPH RES CO, V363, P329, DOI 10.1016/j.bbrc.2007.08.165; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; Xu J, 2001, J BIOL CHEM, V276, P9800, DOI 10.1074/jbc.M008973200; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Yoshikawa T, 2002, J BIOL CHEM, V277, P1705, DOI 10.1074/jbc.M105711200; Yoshikawa T, 2001, MOL CELL BIOL, V21, P2991, DOI 10.1128/MCB.21.9.2991-3000.2001	37	101	104	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11681	11691		10.1074/jbc.M109.096107	http://dx.doi.org/10.1074/jbc.M109.096107			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145241	Green Published, hybrid			2022-12-27	WOS:000276286200072
J	Cailotto, F; Sebillaud, S; Netter, P; Jouzeau, JY; Bianchi, A				Cailotto, Frederic; Sebillaud, Sylvie; Netter, Patrick; Jouzeau, Jean-Yves; Bianchi, Arnaud			The Inorganic Pyrophosphate Transporter ANK Preserves the Differentiated Phenotype of Articular Chondrocyte	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; RHEUMATOID-ARTHRITIS; SIGNALING PATHWAY; GENE-EXPRESSION; MESSENGER-RNA; WNT PATHWAY; CARTILAGE; MECHANISMS; JOINT; CELLS	The differentiated phenotype of chondrocyte is lost in pathological situations and after interleukin (IL)-1 beta challenge. Wnt proteins and the inorganic pyrophosphate (PPi) transporter Ank regulate the differentiation process in many cell types. We investigated the possible contribution of Ank and/or PPi to the maintenance of the differentiated chondrocyte phenotype with special care to Wnt signaling. Primary articular chondrocytes lost their phenotype upon IL-1 beta challenge, with cessation of type II collagen and Sox-9 expression. Ank expression and PPi transport were strongly reduced by IL-1 beta, whereas Wnt-5a was the only Wnt protein increased. Transient overexpression of Ank counteracted most of IL-1 beta effects on Type II collagen, Sox-9, and Wnt-5a expression. When resting chondrocytes were transfected with a siRNA against Ank, this reproduced the phenotype induced by IL-1 beta. In both cases, no markers for hypertrophic chondrocytes were detected. The conditioned supernatant from chondrocytes knocked-down for Ank contained Wnt-5a, which activated Tcf/Lef reporter plasmids and promoted translocation of beta-catenin into the nucleus without activating the c-Jun N-terminal kinase (JNK) pathway. Supplementation with PPi compensated for most effects of Ank deficiency on Type II collagen, Sox-9, and Wnt-5 expression, both in IL-1 beta and Ank knock-down conditions. Phenotype changes induced by IL-1 beta were also supported by activation of the JNK pathway, but this latter was not sensitive to PPi supplementation. Altogether our data demonstrate that the transport of PPi by ANK contributed to the maintenance of the differentiated phenotype of chondrocyte by controlling the canonical Wnt pathway in a Wnt-5a-dependent manner.	[Cailotto, Frederic; Sebillaud, Sylvie; Netter, Patrick; Jouzeau, Jean-Yves; Bianchi, Arnaud] Nancy Univ, LPPIA, UMR 7561, Fac Med,CNRS, F-54505 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine	Cailotto, F (corresponding author), Nancy Univ, LPPIA, UMR 7561, Fac Med,CNRS, Ave Foret de Haye,BP184, F-54505 Vandoeuvre Les Nancy, France.	frederic.cailotto@hotmail.fr; arnaud.bianchi@medecine.uhp-nancy	bianchi, arnaud/AAY-7059-2021	bianchi, arnaud/0000-0003-4925-5269; Cailotto, Frederic/0000-0002-4941-9238	Fondation pour la Recherche Medicale (FRM); University Hospital of Nancy (CPRC/PHRC); Region Lorraine; Conseil General 54; Communaute Urbaine du Grand Nancy	Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); University Hospital of Nancy (CPRC/PHRC); Region Lorraine(Region Grand-Est); Conseil General 54; Communaute Urbaine du Grand Nancy(Region Grand-Est)	This work was supported by grants from the Fondation pour la Recherche Medicale ( FRM) and from the University Hospital of Nancy ( CPRC/PHRC), the Region Lorraine, the Conseil General 54, and the Communaute Urbaine du Grand Nancy.	Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Aigner T, 2002, CELL MOL LIFE SCI, V59, P5, DOI 10.1007/s00018-002-8400-3; Aigner T, 2007, NAT CLIN PRACT RHEUM, V3, P391, DOI 10.1038/ncprheum0534; Badger AM, 2000, OSTEOARTHR CARTILAGE, V8, P434, DOI 10.1053/joca.1999.0319; Bergwitz C, 2001, BBA-MOL CELL RES, V1538, P129, DOI 10.1016/S0167-4889(00)00123-3; Bianchi A, 2005, ARTHRITIS RES THER, V7, pR1325, DOI 10.1186/ar1830; Cailotto F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2330; Cheung HS, 2005, FRONT BIOSCI-LANDMRK, V10, P1336, DOI 10.2741/1623; Choy EHS, 2001, NEW ENGL J MED, V344, P907, DOI 10.1056/NEJM200103223441207; Church VL, 2002, INT J DEV BIOL, V46, P927; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; Dell'Accio F, 2008, ARTHRITIS RHEUM-US, V58, P1410, DOI 10.1002/art.23444; Denison TA, 2009, J CELL BIOCHEM, V107, P155, DOI 10.1002/jcb.22111; Foster BL, 2006, CALCIFIED TISSUE INT, V78, P103, DOI 10.1007/s00223-005-0184-7; Ge XP, 2009, ARTHRITIS RHEUM-US, V60, P2714, DOI 10.1002/art.24779; Goldring MB, 2006, BEST PRACT RES CL RH, V20, P1003, DOI 10.1016/j.berh.2006.06.003; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; GOLDRING MB, 1988, J CLIN INVEST, V82, P2026, DOI 10.1172/JCI113823; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hartmann C, 2000, DEVELOPMENT, V127, P3141; Huelsken J, 2001, CURR OPIN GENET DEV, V11, P547, DOI 10.1016/S0959-437X(00)00231-8; Hwang SG, 2005, FEBS LETT, V579, P4837, DOI 10.1016/j.febslet.2005.07.067; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Johnson K, 2004, OSTEOARTHR CARTILAGE, V12, P321, DOI 10.1016/j.joca.2003.12.004; Julien M, 2007, ENDOCRINOLOGY, V148, P530, DOI 10.1210/en.2006-0763; Katoh M, 2005, INT J MOL MED, V15, P749; Katoh M, 2007, INT J MOL MED, V19, P273; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; KUETTNER KE, 1982, J CELL BIOL, V93, P743, DOI 10.1083/jcb.93.3.743; LOTZ M, 1995, P NATL ACAD SCI USA, V92, P10364, DOI 10.1073/pnas.92.22.10364; Martel-Pelletier Johanne, 1999, Frontiers in Bioscience, V4, pd694, DOI 10.2741/Martel; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Nakamura Y, 2005, AM J PATHOL, V167, P97, DOI 10.1016/S0002-9440(10)62957-4; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; Pacifici M, 2006, ANN NY ACAD SCI, V1068, P74, DOI 10.1196/annals.1346.010; Robbins JR, 2000, ARTHRITIS RHEUM, V43, P2189, DOI 10.1002/1529-0131(200010)43:10<2189::AID-ANR6>3.0.CO;2-S; Ryu JH, 2006, J BIOL CHEM, V281, P22039, DOI 10.1074/jbc.M601804200; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Seidensticker MJ, 2000, BBA-MOL CELL RES, V1495, P168, DOI 10.1016/S0167-4889(99)00158-5; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; Sohn P, 2002, OSTEOARTHR CARTILAGE, V10, P482, DOI 10.1053/joca.2002.0810; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; Tew SR, 2006, J BIOL CHEM, V281, P39471, DOI 10.1074/jbc.M604322200; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; VANDERSTRAETEN EF, 1995, DIS COLON RECTUM, V38, P172, DOI 10.1007/BF02052446; Wang W, 2005, MOL CELL BIOL, V25, P312, DOI 10.1128/MCB.25.1.312-323.2005; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Yang Yingzi, 2003, Birth Defects Research, V69, P305, DOI 10.1002/bdrc.10026; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Zaka R, 2009, J BONE MINER RES, V24, P1869, DOI [10.1359/JBMR.090512, 10.1359/jbmr.090512]; Zhao Q, 1997, DEV DYNAM, V209, P377, DOI 10.1002/(SICI)1097-0177(199708)209:4<377::AID-AJA5>3.0.CO;2-F; Zwerina J, 2007, P NATL ACAD SCI USA, V104, P11742, DOI 10.1073/pnas.0610812104	56	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10572	10582		10.1074/jbc.M109.050534	http://dx.doi.org/10.1074/jbc.M109.050534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133941	Green Published, hybrid			2022-12-27	WOS:000276264600044
J	Cheng, GJ; Sun, J; Fridlender, ZG; Wang, LCS; Ching, LM; Albelda, SM				Cheng, Guanjun; Sun, Jing; Fridlender, Zvi G.; Wang, Liang-Chuan S.; Ching, Lai-Ming; Albelda, Steven M.			Activation of the Nucleotide Oligomerization Domain Signaling Pathway by the Non-bacterially Derived Xanthone Drug 5 ' 6-Dimethylxanthenone-4-acetic Acid (Vadimezan)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR-DISRUPTING AGENT; FLAVONE ACETIC-ACID; P38 MAP KINASE; KAPPA-B; 5,6-DIMETHYLXANTHENONE-4-ACETIC ACID; MURAMYL DIPEPTIDE; HOST RECOGNITION; PHASE-II; NOD1; INHIBITION	The cytosolic nucleotide-binding oligomerization domain 1 (NOD1)/CARD4 and NOD2/CARD15 proteins are members of NOD-like receptors recognizing specific motifs within peptidoglycans of both Gram-negative and Gram-positive bacteria. NOD1 and NOD2 signal via the downstream adaptor serine/threonine kinase RIP2/CARDIAK/RICK to initiate NF-kappa B activation and the release of inflammatory cytokines/chemokines. In this report, we show that 5,6-dimethylxanthenone-4-aceticacid(DMXAA), a cell-permeable, small molecule that has anti-tumor activity, can also activate NOD1 and NOD2. This was demonstrated: 1) by using human embryonic kidney epithelial (HEK) 293 cells transfected with a NF-kappa B reporter plasmid in combination with NOD1 or NOD2 expression plasmids; 2) by inhibiting DMXAA-induced chemokine (CXCL10) mRNA and protein production in the AB12 mesothelioma cell line using a pharmacological inhibitor of RICK kinase, SB20358; and 3) by using small interfering RNA to knock down NOD2 and lentiviral short hairpin RNA to knock down RICK. These findings expand the potential ligands for the NOD-like receptors, suggesting that other xanthone compounds may act similarly and could be developed as anti-tumor agents. This information also expands our knowledge on the mechanisms of action of the anti-tumor agent DMXAA (currently in clinical trials) and may be important for its biological activity.	[Cheng, Guanjun] Univ Penn, Thorac Oncol Res Lab, ARC 1016B, Philadelphia, PA 19104 USA; [Ching, Lai-Ming] Univ Auckland, Fac Med & Hlth Sci, Auckland Canc Soc, Res Ctr, Auckland 1023, New Zealand	University of Pennsylvania; University of Auckland	Cheng, GJ (corresponding author), Univ Penn, Thorac Oncol Res Lab, ARC 1016B, 3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	guanjun@mail.med.upenn.edu			NCI [PO1 CA 66726]; NATIONAL CANCER INSTITUTE [P01CA066726] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 CA 66726 from NCI.	ATASSI G, 1985, EUR J MED CHEM, V20, P393; Barbera M, 2009, INT J ONCOL, V34, P273, DOI 10.3892/ijo_00000149; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; CORBETT TH, 1986, INVEST NEW DRUG, V4, P207; Fidler I J, 1994, Adv Pharmacol, V30, P271, DOI 10.1016/S1054-3589(08)60177-5; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; HAVLIN KA, 1991, J NATL CANCER I, V83, P124; Hollenbach E, 2004, FASEB J, V18, P1550, DOI 10.1096/fj.04-1642fje; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Inohara N, 2003, J BIOL CHEM, V278, P5509, DOI 10.1074/jbc.C200673200; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Jassar AS, 2005, CANCER RES, V65, P11752, DOI 10.1158/0008-5472.CAN-05-1658; KERR DJ, 1989, BRIT J CANCER, V60, P104, DOI 10.1038/bjc.1989.230; KERR DJ, 1987, CANCER RES, V47, P6776; Kim S, 2008, CANCER RES, V68, P10247, DOI 10.1158/0008-5472.CAN-08-1494; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Li J, 2008, CLIN CANCER RES, V14, P2102, DOI 10.1158/1078-0432.CCR-07-1475; McKeage MJ, 2008, BRIT J CANCER, V99, P2006, DOI 10.1038/sj.bjc.6604808; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Meyers PA, 2008, J CLIN ONCOL, V26, P633, DOI 10.1200/JCO.2008.14.0095; Netea MG, 2005, J BIOL CHEM, V280, P35859, DOI 10.1074/jbc.M504924200; Odaka M, 2001, CANCER RES, V61, P6201; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Pinto MMM, 2005, CURR MED CHEM, V12, P2517, DOI 10.2174/092986705774370691; REWCASTLE GW, 1989, J MED CHEM, V32, P793, DOI 10.1021/jm00124a012; Roberts ZJ, 2007, J EXP MED, V204, P1559, DOI 10.1084/jem.20061845; Wallace A, 2007, CANCER RES, V67, P7011, DOI 10.1158/0008-5472.CAN-06-3757; Wang LCS, 2006, ONCOL RES, V16, P1; Wang LCS, 2009, NEOPLASIA, V11, P793, DOI 10.1593/neo.09506; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Wolfert MA, 2002, J BIOL CHEM, V277, P39179, DOI 10.1074/jbc.M204885200; Woon ST, 2001, ONCOL RES, V13, P95; Zhao L, 2007, J BIOL CHEM, V282, P11618, DOI 10.1074/jbc.M608644200	39	18	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10553	10562		10.1074/jbc.M109.065631	http://dx.doi.org/10.1074/jbc.M109.065631			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118240	Green Published, hybrid			2022-12-27	WOS:000276264600042
J	Wakamatsu, T; Kitamura, Y; Kotera, Y; Nakagawa, N; Kuramitsu, S; Masui, R				Wakamatsu, Taisuke; Kitamura, Yoshiaki; Kotera, Yutaro; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji			Structure of RecJ Exonuclease Defines Its Specificity for Single-stranded DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTED MISMATCH REPAIR; ESCHERICHIA-COLI; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; RNASE-II; OB-FOLD; IN-VIVO; PROTEIN; BINDING; IDENTIFICATION	RecJ is a single-stranded DNA (ssDNA)-specific 5'-3' exonuclease that plays an important role in DNA repair and recombination. To elucidate how RecJ achieves its high specificity for ssDNA, we determined the entire structures of RecJ both in a ligand-free form and in a complex with Mn2+ or Mg2+ by x-ray crystallography. The entire RecJ consists of four domains that form a molecule with an O-like structure. One of two newly identified domains had structural similarities to an oligonucleotide/oligosaccharide-binding (OB) fold. The OB fold domain alone could bind to DNA, indicating that this domain is a novel member of the OB fold superfamily. The truncated RecJ containing only the core domain exhibited much lower affinity for the ssDNA substrate compared with intact RecJ. These results support the hypothesis that these structural features allow specific binding of RecJ to ssDNA. In addition, the structure of the RecJ-Mn2+ complex suggests that the hydrolysis reaction catalyzed by RecJ proceeds through a two-metal ion mechanism.	[Kotera, Yutaro; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; [Wakamatsu, Taisuke; Kuramitsu, Seiki] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Kitamura, Yoshiaki; Nakagawa, Noriko; Kuramitsu, Seiki; Masui, Ryoji] RIKEN, SPring Ctr 8, Harima Inst, Sayo, Hyogo 6795148, Japan	Osaka University; Osaka University; RIKEN	Masui, R (corresponding author), Osaka Univ, Grad Sch Sci, Dept Biol, 1-1 Machikaneyama Cho, Osaka 5600043, Japan.	rmasui@bio.sci.osaka-u.ac.jp	Wakamatsu, Taisuke/AAD-8007-2022		Ministry of Education, Science, Sports and Culture of Japan [20570131, 19770083]	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research 20570131 (to R. M.) and 19770083 (to N. N.) from the Ministry of Education, Science, Sports and Culture of Japan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P17, DOI 10.1016/S0968-0004(97)01162-6; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; Bochkarev A, 2004, CURR OPIN STRUC BIOL, V14, P36, DOI 10.1016/j.sbi.2004.01.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burdett V, 2001, P NATL ACAD SCI USA, V98, P6765, DOI 10.1073/pnas.121183298; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DIANOV G, 1994, NUCLEIC ACIDS RES, V22, P993, DOI 10.1093/nar/22.6.993; Han ES, 2006, NUCLEIC ACIDS RES, V34, P1084, DOI 10.1093/nar/gkj503; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kovall RA, 1999, CURR OPIN CHEM BIOL, V3, P578, DOI 10.1016/S1367-5931(99)00012-5; KURAMITSU S, 1990, BIOCHEMISTRY-US, V29, P5469, DOI 10.1021/bi00475a010; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; LOVETT ST, 1989, P NATL ACAD SCI USA, V86, P2627, DOI 10.1073/pnas.86.8.2627; LOVETT ST, 1984, J BACTERIOL, V157, P190, DOI 10.1128/JB.157.1.190-196.1984; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Meier B, 2009, EMBO J, V28, P3549, DOI 10.1038/emboj.2009.278; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rajman LA, 2000, J BACTERIOL, V182, P607, DOI 10.1128/JB.182.3.607-612.2000; Schubert M, 2004, J MOL BIOL, V341, P37, DOI 10.1016/j.jmb.2004.05.061; Sharma R, 2009, J MOL BIOL, V385, P1375, DOI 10.1016/j.jmb.2008.11.041; Sutera VA, 1999, J BACTERIOL, V181, P6098, DOI 10.1128/JB.181.19.6098-6102.1999; Theobald DL, 2003, ANNU REV BIOPH BIOM, V32, P115, DOI 10.1146/annurev.biophys.32.110601.142506; Ugochukwu E, 2007, J MOL BIOL, V371, P1007, DOI 10.1016/j.jmb.2007.05.066; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Viswanathan M, 2001, J BIOL CHEM, V276, P31053, DOI 10.1074/jbc.M105481200; Yamagata A, 2002, P NATL ACAD SCI USA, V99, P5908, DOI 10.1073/pnas.092547099; Yamagata A, 2001, NUCLEIC ACIDS RES, V29, P4617, DOI 10.1093/nar/29.22.4617; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	34	48	51	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9762	9769		10.1074/jbc.M109.096487	http://dx.doi.org/10.1074/jbc.M109.096487			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20129927	Green Published, hybrid			2022-12-27	WOS:000276165900048
J	Reed, JR; Eyer, M; Backes, WL				Reed, James R.; Eyer, Marilyn; Backes, Wayne L.			Functional Interactions between Cytochromes P450 1A2 and 2B4 Require Both Enzymes to Reside in the Same Phospholipid Vesicle EVIDENCE FOR PHYSICAL COMPLEX FORMATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; CATALYTIC-ACTIVITY; P-450 REDUCTASE; LIVER-MICROSOMES; NADPH-CYTOCHROME-P-450 REDUCTASE; RABBIT LIVER; MOLECULAR-INTERACTIONS; CROSS-LINKING; LIVING CELLS; NADPH	Previous studies have shown that the combined presence of two cytochrome P450 enzymes (P450s) can affect the function of both enzymes, results that are consistent with the formation of heteromeric P450.P450 complexes. The goal of this study was to provide direct evidence for a physical interaction between P450 1A2 (CYP1A2) and P450 2B4 (CYP2B4), by determining if the interactions required both enzymes to reside in the same lipid vesicles. When NADPH-cytochrome P450 reductase (CPR) and a single P450 were incorporated into separate vesicles, extremely slow reduction rates were observed, demonstrating that the enzymes were anchored in the vesicles. Next, several reconstituted systems were prepared: 1) CPR.CYP1A2, 2) CPR.CYP2B4, 3) a mixture of CPR.CYP1A2 vesicles with CPR.CYP2B4 vesicles, and 4) CPR.CYP1A2.CYP2B4 in the same vesicles (ternary system). When in the ternary system, CYP2B4-mediated metabolism was significantly inhibited, and CYP1A2 activities were stimulated by the presence of the alternate P450. In contrast, P450s in separate vesicles were unable to interact. These data demonstrate that P450s must be in the same vesicles to alter metabolism. Additional evidence for a physical interaction among CPR, CYP1A2, and CYP2B4 was provided by cross-linking with bis(sulfosuccinimidyl) suberate. The results showed that after cross-linking, antibody to CYP1A2 was able to co-immunoprecipitate CYP2B4 but only when both proteins were in the same phospholipid vesicles. These results clearly demonstrate that the alterations in P450 function require both P450s to be present in the same vesicles and support a mechanism whereby P450s form a physical complex in the membrane.	[Backes, Wayne L.] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, New Orleans, LA 70112 USA; Louisiana State Univ, Hlth Sci Ctr, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Backes, WL (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol, 533 Bolivar St, New Orleans, LA 70112 USA.				National Institutes of Health, NIEHS, United States Public Health Service [R01-ES004344]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004344] Funding Source: NIH RePORTER	National Institutes of Health, NIEHS, United States Public Health Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)United States Public Health Service); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health, NIEHS, United States Public Health Service Grant R01-ES004344.	ALSTON K, 1991, J BIOL CHEM, V266, P735; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Backes WL, 1998, BIOCHEMISTRY-US, V37, P12852, DOI 10.1021/bi980674a; Backes WL, 2003, PHARMACOL THERAPEUT, V98, P221, DOI 10.1016/S0163-7258(03)00031-7; BASKIN LS, 1982, BIOCHIM BIOPHYS ACTA, V684, P263, DOI 10.1016/0005-2736(82)90015-3; BASKIN LS, 1980, BIOCHEMISTRY-US, V19, P2260, DOI 10.1021/bi00551a041; CAUSEY KM, 1990, MOL PHARMACOL, V38, P134; CAWLEY GF, 1995, BIOCHEMISTRY-US, V34, P1244, DOI 10.1021/bi00004a018; Coon M J, 1978, Methods Enzymol, V52, P109; Davydov DR, 2000, BIOCHEM BIOPH RES CO, V276, P1005, DOI 10.1006/bbrc.2000.3596; Davydov DR, 2005, BIOCHEMISTRY-US, V44, P13902, DOI 10.1021/bi0509346; Davydov DR, 1996, BIOCHIMIE, V78, P734, DOI 10.1016/S0300-9084(97)82531-X; DAVYDOV DR, 1995, ARCH BIOCHEM BIOPHYS, V320, P330, DOI 10.1016/0003-9861(95)90017-9; de Andrade JB, 1996, AM LAB, V28, P56; DEAN WL, 1982, J BIOL CHEM, V257, P4679; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; GUT J, 1982, J BIOL CHEM, V257, P7030; Hanna IH, 2000, ARCH BIOCHEM BIOPHYS, V376, P206, DOI 10.1006/abbi.2000.1708; Hazai E, 2005, J COMPUT AID MOL DES, V19, P271, DOI 10.1007/s10822-005-4995-4; Hazai E, 2005, DRUG METAB DISPOS, V33, P157, DOI 10.1124/dmd.104.001578; HOLLOWAY PW, 1973, ANAL BIOCHEM, V53, P304, DOI 10.1016/0003-2697(73)90436-3; HUANG CH, 1969, BIOCHEMISTRY-US, V8, P344, DOI 10.1021/bi00829a048; INGELMANSUNDBERG M, 1980, BIOCHIM BIOPHYS ACTA, V599, P417, DOI 10.1016/0005-2736(80)90188-1; INGELMANSUNDBERG M, 1983, EUR J BIOCHEM, V134, P157, DOI 10.1111/j.1432-1033.1983.tb07546.x; INGELMANSUNDBERG M, 1980, BIOCHEMISTRY-US, V19, P4004, DOI 10.1021/bi00558a018; Jamakhandi AP, 2007, BIOCHEMISTRY-US, V46, P10192, DOI 10.1021/bi7003476; KAMINSKY LS, 1985, EUR J BIOCHEM, V149, P479, DOI 10.1111/j.1432-1033.1985.tb08950.x; KANAEVA IP, 1992, ARCH BIOCHEM BIOPHYS, V298, P395, DOI 10.1016/0003-9861(92)90427-X; KAWATO S, 1982, J BIOL CHEM, V257, P7023; Kelley RW, 2006, BIOCHEMISTRY-US, V45, P15807, DOI 10.1021/bi061803n; Kelley RW, 2005, BIOCHEMISTRY-US, V44, P2632, DOI 10.1021/bi0477900; Li DN, 1999, J PHARMACOL EXP THER, V289, P661; LUBET RA, 1985, ARCH BIOCHEM BIOPHYS, V238, P43, DOI 10.1016/0003-9861(85)90138-9; Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ozalp C, 2005, DRUG METAB DISPOS, V33, P1382, DOI 10.1124/dmd.105.005538; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Reed JR, 2008, DRUG METAB DISPOS, V36, P582, DOI 10.1124/dmd.107.018473; Reed JR, 2006, DRUG METAB DISPOS, V34, P660, DOI 10.1124/dmd.105.006825; STROBEL HW, 1970, J BIOL CHEM, V245, P4851; Szczesna-Skorupa E, 2003, J BIOL CHEM, V278, P31269, DOI 10.1074/jbc.M301489200; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; Tan YZ, 1997, ARCH BIOCHEM BIOPHYS, V342, P82, DOI 10.1006/abbi.1997.9995; WAGNER SL, 1984, J BIOL CHEM, V259, P2390; Wang M, 1997, P NATL ACAD SCI USA, V94, P8411, DOI 10.1073/pnas.94.16.8411; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125	48	35	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8942	8952		10.1074/jbc.M109.076885	http://dx.doi.org/10.1074/jbc.M109.076885			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071338	Green Published, hybrid			2022-12-27	WOS:000275553700046
J	Dennison, JB; Ayres, ML; Kaluarachchi, K; Plunkett, W; Gandhi, V				Dennison, Jennifer B.; Ayres, Mary L.; Kaluarachchi, Kumar; Plunkett, William; Gandhi, Varsha			Intracellular Succinylation of 8-Chloroadenosine and Its Effect on Fumarate Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIQUID-CHROMATOGRAPHY METHOD; MULTIPLE-MYELOMA CELLS; RENAL-CANCER; INHIBITION; HYDRATASE; 8-CHLORO-ADENOSINE; ADENYLOSUCCINASE; DEFICIENCY; ATP; 8-AMINO-ADENOSINE	8-Chloroadenosine (8-Cl-Ado) is a ribosyl nucleoside analog currently in phase I testing for the treatment of chronic lymphocytic leukemia (CLL). 8-Cl-Ado activity is dependent on adenosine kinase and requires intracellular accumulation of 8-Cl-Ado as mono-, di-, and tri-phosphates. In the current study with four mantle cell lymphoma cell lines, we report a new major metabolic pathway for 8-Cl-Ado intracellular metabolism, the formation of succinyl-8-chloro-adenosine (S-8-Cl-Ado) and its monophosphate (S-8-Cl-AMP). 8-Cl-AMP levels were highly associated with S-8-Cl- AMP levels and reached a steady-state prior to the secondary metabolites, 8-Cl-ATP and S-8-Cl-Ado. Consistent with fumarate as a required substrate for formation of succinyl-8-Cl-adenylate metabolites, the S-8-Cl- adenylate concentrations in multiple cell lines were associated with fumarate loss. The distribution of metabolites was also altered using the energy metabolism modifiers, metformin and oligomycin. The rates of succinyl-8-Cl-adenylate metabolism were enhanced by increasing the intracellular fumarate concentrations after metformin co-treatment. In addition, the S-8-Cl-AMP concentrations were increased after acute inhibition of ATP synthase by oligomycin. We conclude that 8-Cl-Ado metabolism not only affects intracellular purine metabolism; 8-Cl-Ado conversion to succinyl analogs ties its metabolism to the citric acid cycle by reduction of the fumarate pool.	Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Plunkett, William; Gandhi, Varsha] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Gandhi, V (corresponding author), 1515 Holcombe Blvd,Unit 71, Houston, TX 77030 USA.	vgandhi@mdanderson.org			National Institutes of Health, NCI [CA 85915]; Lymphoma SPORE [CA136411]; NATIONAL CANCER INSTITUTE [R01CA085915, P50CA136411, P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lymphoma SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 85915 from the NCI and Lymphoma SPORE CA136411.	[Anonymous], SPECTROMETRIC IDENTI; Balakrishnan K, 2005, BLOOD, V105, P4455, DOI 10.1182/blood-2004-05-1699; BENNETT LL, 1985, NUCLEOS NUCLEOT, V4, P107, DOI 10.1080/07328318508077834; Bosi E, 2009, DIABETES OBES METAB, V11, P3, DOI 10.1111/j.1463-1326.2008.01031.x; CARTER CE, 1956, J BIOL CHEM, V222, P17; Carvajal-Carmona LG, 2006, J CLIN ENDOCR METAB, V91, P3071, DOI 10.1210/jc.2006-0183; Chen LS, 2009, BIOCHEM PHARMACOL, V78, P583, DOI 10.1016/j.bcp.2009.05.019; Chen LS, 2004, J BIOL CHEM, V279, P40405, DOI 10.1074/jbc.M401752200; DEKORTE D, 1985, CLIN CHIM ACTA, V148, P185, DOI 10.1016/0009-8981(85)90145-7; Dennison JB, 2009, BRIT J HAEMATOL, V147, P297, DOI 10.1111/j.1365-2141.2009.07850.x; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Gandhi V, 2002, CANCER CHEMOTH PHARM, V50, P85, DOI 10.1007/S00280-002-0456-0; Gandhi V, 2001, CANCER RES, V61, P5474; Ghias K, 2005, MOL CANCER THER, V4, P569, DOI 10.1158/1535-7163.MCT-04-0303; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Krett NL, 2004, MOL CANCER THER, V3, P1411; Liu R, 2009, MOL CELL PROTEOMICS, V8, P70, DOI 10.1074/mcp.M800195-MCP200; Rodriguez CO, 2000, J CHROMATOGR B, V745, P421, DOI 10.1016/S0378-4347(00)00303-0; STELLRECHT C, 2009, BREAST CANC RES TREA; Stellrecht CM, 2007, CANCER RES, V67, P9913, DOI 10.1158/0008-5472.CAN-07-0770; Stellrecht CM, 2003, CANCER RES, V63, P7968; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; TORTORA G, 1995, CLIN CANCER RES, V1, P377; VANDENBERGH F, 1991, ANAL BIOCHEM, V193, P287, DOI 10.1016/0003-2697(91)90023-M; VandenBerghe G, 1997, J INHERIT METAB DIS, V20, P193, DOI 10.1023/A:1005304722259; Xie H, 2009, MOL CANCER THER, V8, P626, DOI 10.1158/1535-7163.MCT-08-1049; Zeman J, 2000, J INHERIT METAB DIS, V23, P371, DOI 10.1023/A:1005639516342	32	10	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8022	8030		10.1074/jbc.M109.085803	http://dx.doi.org/10.1074/jbc.M109.085803			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064937	Green Published, hybrid			2022-12-27	WOS:000275413800020
J	Li, N; Henry, E; Guiot, E; Rigolet, P; Brochon, JC; Xi, XG; Deprez, E				Li, Na; Henry, Etienne; Guiot, Elvire; Rigolet, Pascal; Brochon, Jean-Claude; Xi, Xu-Guang; Deprez, Eric			Multiple Escherichia coli RecQ Helicase Monomers Cooperate to Unwind Long DNA Substrates A FLUORESCENCE CROSS-CORRELATION SPECTROSCOPY STUDY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOMS-SYNDROME HELICASE; SINGLE-STRANDED-DNA; C VIRUS HELICASE; HIV-1 INTEGRASE; IN-VITRO; UNZIPPING MECHANISM; HEXAMERIC HELICASE; SYNDROME PROTEIN; RING HELICASE; BINDING	The RecQ family helicases catalyze the DNA unwinding reaction in an ATP hydrolysis-dependent manner. We investigated the mechanism of DNA unwinding by the Escherichia coli RecQ helicase using a new sensitive helicase assay based on fluorescence cross-correlation spectroscopy (FCCS) with two-photon excitation. The FCCS-based assay can be used to measure the unwinding activity under both single and multiple turnover conditions with no limitation related to the size of the DNA strands constituting the DNA substrate. We found that the monomeric helicase was sufficient to perform the unwinding of short DNA substrates. However, a significant increase in the activity was observed using longer DNA substrates, under single turnover conditions, originating from the simultaneous binding of multiple helicase monomers to the same DNA molecule. This functional cooperativity was strongly dependent on several factors, including DNA substrate length, the number and size of single-stranded 3'-tails, and the temperature. Regarding the latter parameter, a strong cooperativity was observed at 37 degrees C, whereas only modest or no cooperativity was observed at 25 degrees C regardless of the nature of the DNA substrate. Consistently, the functional cooperativity was found to be tightly associated with a cooperative DNA binding mode. We also showed that the cooperative binding of helicase to the DNA substrate indirectly accounts for the sigmoidal dependence of unwinding activity on ATP concentration, which also occurs only at 37 degrees C but not at 25 degrees C. Finally, we further examined the influences of spontaneous DNA rehybridization (after helicase translocation) and the single-stranded DNA binding property of helicase on the unwinding activity as detected in the FCCS assay.	[Li, Na; Henry, Etienne; Guiot, Elvire; Brochon, Jean-Claude; Deprez, Eric] Ecole Normale Super, Lab Biol & Pharmacol Appl, CNRS, Inst Alembert,UMR8113, F-94235 Cachan, France; [Rigolet, Pascal; Xi, Xu-Guang] Ctr Univ Orsay, Lab Genotoxicol & Cycle Cellulaire, CNRS, Inst Curie Sect Rech,UMR2027, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay	Deprez, E (corresponding author), Ecole Normale Super, Lab Biol & Pharmacol Appl, CNRS, Inst Alembert,UMR8113, 61 Ave President Wilson, F-94235 Cachan, France.	deprez@lbpa.ens-cachan.fr	Rigolet, Pascal/S-8602-2018; Xi, Xu Guang/AAK-4511-2020; HENRY, Etienne/J-8118-2014	Rigolet, Pascal/0000-0001-6868-4953; HENRY, Etienne/0000-0002-2547-3467	CNRS; Ecole Normale Superieure de Cachan; East China Normal University (ECNU)-Shanghai; Institut d'Alembert	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure de Cachan; East China Normal University (ECNU)-Shanghai; Institut d'Alembert	This work was supported by grants from the CNRS, Ecole Normale Superieure de Cachan, East China Normal University (ECNU)-Shanghai, and the Institut d'Alembert.	Bernstein DA, 2003, EMBO J, V22, P4910, DOI 10.1093/emboj/cdg500; Boule JB, 2007, NUCLEIC ACIDS RES, V35, P5809, DOI 10.1093/nar/gkm613; Brosh RM, 2007, NUCLEIC ACIDS RES, V35, P7527, DOI 10.1093/nar/gkm1008; Byrd AK, 2004, NAT STRUCT MOL BIOL, V11, P531, DOI 10.1038/nsmb774; Cheng W, 2001, J MOL BIOL, V310, P327, DOI 10.1006/jmbi.2001.4758; Cheok CF, 2005, NUCLEIC ACIDS RES, V33, P3932, DOI 10.1093/nar/gki712; Choudhary S, 2004, J BIOL CHEM, V279, P34603, DOI 10.1074/jbc.M401901200; Clamme JP, 2003, BIOPHYS J, V84, P1960, DOI 10.1016/S0006-3495(03)75004-8; Collini M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni166; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Delelis O, 2008, J BIOL CHEM, V283, P27838, DOI 10.1074/jbc.M803257200; Deprez E, 2004, MOL PHARMACOL, V65, P85, DOI 10.1124/mol.65.1.85; Dou SX, 2004, J BIOL CHEM, V279, P6354, DOI 10.1074/jbc.M311272200; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hanada K, 1997, P NATL ACAD SCI USA, V94, P3860, DOI 10.1073/pnas.94.8.3860; Harmon FG, 2001, J BIOL CHEM, V276, P232, DOI 10.1074/jbc.M006555200; Haustein E, 2007, ANNU REV BIOPH BIOM, V36, P151, DOI 10.1146/annurev.biophys.36.040306.132612; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Jahnz M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni060; Janscak P, 2003, J MOL BIOL, V330, P29, DOI 10.1016/S0022-2836(03)00534-5; Jeong YJ, 2004, P NATL ACAD SCI USA, V101, P7264, DOI 10.1073/pnas.0400372101; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Karow JK, 1999, CURR BIOL, V9, P597, DOI 10.1016/S0960-9822(99)80264-4; Kettling U, 1998, P NATL ACAD SCI USA, V95, P1416, DOI 10.1073/pnas.95.4.1416; Killoran MP, 2006, NUCLEIC ACIDS RES, V34, P4098, DOI 10.1093/nar/gkl538; Kohl T, 2005, BIOPHYS J, V89, P2770, DOI 10.1529/biophysj.105.061127; Levin MK, 2005, NAT STRUCT MOL BIOL, V12, P429, DOI 10.1038/nsmb920; Levin MK, 2004, J BIOL CHEM, V279, P26005, DOI 10.1074/jbc.M403257200; Maluf NK, 2003, J MOL BIOL, V325, P913, DOI 10.1016/S0022-2836(02)01277-9; Martin SL, 2001, MOL CELL BIOL, V21, P467, DOI 10.1128/MCB.21.2.467-475.2001; Mechanic LE, 1999, J BIOL CHEM, V274, P12488, DOI 10.1074/jbc.274.18.12488; Mortier-Barriere I, 2007, CELL, V130, P824, DOI 10.1016/j.cell.2007.07.038; NAKAYAMA H, 1984, MOL GEN GENET, V195, P474, DOI 10.1007/BF00341449; Norcum MT, 2005, P NATL ACAD SCI USA, V102, P3623, DOI 10.1073/pnas.0500713102; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Pinskaya M, 2004, BIOCHEMISTRY-US, V43, P8735, DOI 10.1021/bi049706m; Rarbach M, 2001, METHODS, V24, P104, DOI 10.1006/meth.2001.1172; ROMAN LJ, 1991, P NATL ACAD SCI USA, V88, P3367, DOI 10.1073/pnas.88.8.3367; Sharma S, 2008, CELL CYCLE, V7, P989, DOI 10.4161/cc.7.8.5707; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; Soultanas P, 2000, EMBO J, V19, P3799, DOI 10.1093/emboj/19.14.3799; Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3; Xu HQ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng070; Xu HQ, 2003, J BIOL CHEM, V278, P34925, DOI 10.1074/jbc.M303581200; Yang Y, 2008, NUCLEIC ACIDS RES, V36, P1976, DOI 10.1093/nar/gkm1174; Yu X, 2000, J MOL BIOL, V299, P1279, DOI 10.1006/jmbi.2000.3810; Yu X, 1996, J MOL BIOL, V259, P7, DOI 10.1006/jmbi.1996.0297; Zhang XD, 2006, J BIOL CHEM, V281, P12655, DOI 10.1074/jbc.M513089200; Zhang XD, 2005, ACTA BIOCH BIOPH SIN, V37, P593, DOI 10.1111/j.1745-7270.2005.00084.x; Zhang X, 2008, J GENE MED, V10, P527, DOI 10.1002/jgm.1167	56	17	19	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6922	6936		10.1074/jbc.M109.069286	http://dx.doi.org/10.1074/jbc.M109.069286			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20048388	Green Published, hybrid			2022-12-27	WOS:000275415600006
J	Nomura, T; Kutchan, TM				Nomura, Taiji; Kutchan, Toni M.			Three New O-Methyltransferases Are Sufficient for All O-Methylation Reactions of Ipecac Alkaloid Biosynthesis in Root Culture of Psychotria ipecacuanha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALANGIUM-LAMARCKII THW; STRICTOSIDINE SYNTHASE; MOLECULAR-CLONING; COPTIS-JAPONICA; CATHARANTHUS-ROSEUS; OPIUM POPPY; PAPAVER-SOMNIFERUM; RAUVOLFIA-SERPENTINA; N-METHYLTRANSFERASE; PURIFICATION	The medicinal plant Psychotria ipecacuanha produces ipecac alkaloids, a series of monoterpenoid-isoquinoline alkaloids such as emetine and cephaeline, whose biosynthesis derives from condensation of dopamine and secologanin. Here, we identified three cDNAs, IpeOMT1-IpeOMT3, encoding ipecac alkaloid O-methyltransferases (OMTs) from P. ipecacuanha. They were coordinately transcribed with the recently identified ipecac alkaloid beta-glucosidase Ipeglu1. Their amino acid sequences were closely related to each other and rather to the flavonoid OMTs than to the OMTs involved in benzylisoquinoline alkaloid biosynthesis. Characterization of the recombinant IpeOMT enzymes with integration of the enzymatic properties of the IpeGlu1 revealed that emetine biosynthesis branches off from N-deacetylisoipecoside through its 6-O-methylation by IpeOMT1, with a minor contribution by IpeOMT2, followed by deglucosylation by IpeGlu1. The 7-hydroxy group of the isoquinoline skeleton of the aglycon is methylated by IpeOMT3 prior to the formation of protoemetine that is condensed with a second dopamine molecule, followed by sequential O-methylations by IpeOMT2 and IpeOMT1 to form cephaeline and emetine, respectively. In addition to this central pathway of ipecac alkaloid biosynthesis, formation of all methyl derivatives of ipecac alkaloids in P. ipecacuanha could be explained by the enzymatic activities of IpeOMT1-IpeOMT3, indicating that they are sufficient for all O-methylation reactions of ipecac alkaloid biosynthesis.	[Nomura, Taiji; Kutchan, Toni M.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Kutchan, TM (corresponding author), Toyama Prefectural Univ, Dept Biotechnol, Fac Engn, 5180 Kurokawa, Toyama 9390398, Japan.	tnomura@pu-toyama.ac.jp	Kutchan, Toni/L-4625-2013	Nomura, Taiji/0000-0003-4876-9866	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Supported by a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad. Present address: Dept. of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama 939-0398, Japan.	BRACHER D, 1992, ARCH BIOCHEM BIOPHYS, V294, P717, DOI 10.1016/0003-9861(92)90746-J; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cacace S, 2003, PHYTOCHEMISTRY, V62, P127, DOI 10.1016/S0031-9422(02)00483-1; Choi KB, 2002, J BIOL CHEM, V277, P830, DOI 10.1074/jbc.M106405200; De-Eknamkul W, 2000, PHYTOCHEMISTRY, V55, P177, DOI 10.1016/S0031-9422(00)00260-0; DeEknamkul W, 1997, PHYTOCHEMISTRY, V45, P477, DOI 10.1016/S0031-9422(96)00828-X; DEWAAL A, 1989, BIOCHEM J, V306, P571; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; Frick S, 1999, PLANT J, V17, P329, DOI 10.1046/j.1365-313X.1999.00379.x; Fujii T, 1998, ALKALOIDS CHEM BIOL, V51, P271; Goodman CD, 2004, PLANT CELL, V16, P1812, DOI 10.1105/tpc.022574; HAMPP N, 1988, PHYTOCHEMISTRY, V27, P3811, DOI 10.1016/0031-9422(88)83023-1; Inui T, 2007, PLANT CELL PHYSIOL, V48, P252, DOI 10.1093/pcp/pcl062; ITOH A, 1995, J NAT PRODUCTS, V58, P1228, DOI 10.1021/np50122a011; Itoh A, 1999, PHYTOCHEMISTRY, V52, P1169, DOI 10.1016/S0031-9422(99)00361-1; JANOT MM, 1953, ALKALOIDS-CHEM BIOL, V3, P363; Jonczyk R, 2008, PLANT PHYSIOL, V146, P1053, DOI 10.1104/pp.107.111237; KUTCHAN TM, 1998, ALKALOIDS, V50, P257; Levac D, 2008, PLANT J, V53, P225, DOI 10.1111/j.1365-313X.2007.03337.x; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Martinoia E, 2007, J EXP BOT, V58, P83, DOI 10.1093/jxb/erl183; MCKNIGHT TD, 1991, PLANTA, V185, P148, DOI 10.1007/BF00194055; Morishige T, 2000, J BIOL CHEM, V275, P23398, DOI 10.1074/jbc.M002439200; Morishige T, 2002, EUR J BIOCHEM, V269, P5659, DOI 10.1046/j.1432-1033.2002.03275.x; NAGAKURA N, 1978, PLANTA MED, V34, P381, DOI 10.1055/s-0028-1097467; NAGAKURA N, 1978, J CHEM SOC CHEM COMM, P896, DOI 10.1039/c39780000896; Nomura T, 2008, J BIOL CHEM, V283, P34650, DOI 10.1074/jbc.M806953200; Ounaroon A, 2003, PLANT J, V36, P808, DOI 10.1046/j.1365-313X.2003.01928.x; PFITZNER U, 1989, PLANTA MED, P525, DOI 10.1055/s-2006-962086; Pienkny S, 2009, PLANT J, V60, P56, DOI 10.1111/j.1365-313X.2009.03937.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schmidlin L, 2008, PLANT PHYSIOL, V148, P1630, DOI 10.1104/pp.108.126003; SHOEB A, 1975, J CHEM SOC PERK T 1, P1245, DOI 10.1039/p19750001245; STEVENS LH, 1993, PLANT CELL REP, V12, P573, DOI 10.1007/BF00233063; STEVENS LH, 1993, PHYTOCHEMISTRY, V33, P99, DOI 10.1016/0031-9422(93)85403-E; TAKESHITA N, 1995, PLANT CELL PHYSIOL, V36, P29; TREIMER JF, 1979, EUR J BIOCHEM, V101, P225, DOI 10.1111/j.1432-1033.1979.tb04235.x; Weid M, 2004, P NATL ACAD SCI USA, V101, P13957, DOI 10.1073/pnas.0405704101; Yamazaki Y, 2003, PLANT CELL PHYSIOL, V44, P395, DOI 10.1093/pcp/pcg051; Yazaki K, 2005, CURR OPIN PLANT BIOL, V8, P301, DOI 10.1016/j.pbi.2005.03.011	41	28	32	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7722	7738		10.1074/jbc.M109.086157	http://dx.doi.org/10.1074/jbc.M109.086157			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20061395	Green Published, hybrid			2022-12-27	WOS:000275415600081
J	Xue, L; Sun, Y; Chiang, L; He, B; Kang, C; Nolla, H; Winoto, A				Xue, Ling; Sun, Yuefang; Chiang, Leslie; He, Bo; Kang, Chulho; Nolla, Hector; Winoto, Astar			Coupling of the Cell Cycle and Apoptotic Machineries in Developing T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED THYMOCYTE APOPTOSIS; THYMIC NEGATIVE SELECTION; TRANSCRIPTION FACTOR; POSITIVE SELECTION; DEPENDENT KINASES; TUMOR SUPPRESSION; GENE-EXPRESSION; DISTINCT ROLES; TCR-ALPHA; DEATH	Proliferation and apoptosis are diametrically opposite processes. Expression of certain genes like c-Myc, however, can induce both, pointing to a possible linkage between them. Developing CD4(+)CD8(+) thymocytes are intrinsically sensitive to apoptosis, but the molecular basis is not known. We have found that these noncycling cells surprisingly express many cell cycle proteins. We generated transgenic mice expressing a CDK2 kinase-dead (CDK2-DN) protein in the T cell compartment. Analysis of these mice showed that the CDK2-DN protein acts as a dominant negative mutant in mature T cells as expected, but surprisingly, it acts as a dominant active protein in CD4(+)CD8(+) thymocytes. The levels of CDK2 kinase activity, cyclin E, cyclin A, and other cell cycle proteins in transgenic CD4(+)CD8(+) thymocytes are increased. Concurrently, caspase levels are elevated, and apoptosis is significantly enhanced in vitro and in vivo. E2F-1, the unique E2F member capable of inducing apoptosis when overexpressed, is specifically up-regulated in transgenic CD4(+)CD8(+) thymocytes but not in other T cell populations. These results demonstrate that the cell cycle and apoptotic machineries are normally linked, and expression of cell cycle proteins in developing T cells contributes to their inherent 1 sensitivity to apoptosis.	[Winoto, Astar] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol & Pathogenesis, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Winoto, A (corresponding author), Univ Calif Berkeley, Canc Res Lab, 465 LSA, Berkeley, CA 94720 USA.	winoto@berkeley.edu			National Institutes of Health [CA66236]; NATIONAL CANCER INSTITUTE [R01CA066236] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA66236 ( to A. W.).	Abrams JM, 2004, CURR OPIN CELL BIOL, V16, P634, DOI 10.1016/j.ceb.2004.09.010; Abrams JM, 2002, CELL, V110, P403, DOI 10.1016/S0092-8674(02)00904-2; Adlam M, 2003, IMMUNITY, V18, P173, DOI 10.1016/S1074-7613(03)00021-9; Berthet C, 2007, MOL CELL BIOL, V27, P5079, DOI 10.1128/MCB.00029-07; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Costa RH, 2005, CURR OPIN GENET DEV, V15, P42, DOI 10.1016/j.gde.2004.12.007; Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Ferguson KL, 2000, J BIOL CHEM, V275, P33593, DOI 10.1074/jbc.M004879200; Field SJ, 1996, CELL, V85, P549, DOI 10.1016/S0092-8674(00)81255-6; GOLSTEIN P, 1991, IMMUNOL REV, V121, P29, DOI 10.1111/j.1600-065X.1991.tb00822.x; Granes F, 2004, EUR J IMMUNOL, V34, P2781, DOI 10.1002/eji.200425154; Green DR, 2000, CELL, V102, P1, DOI 10.1016/S0092-8674(00)00003-9; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; Hofmann F, 1996, GENE DEV, V10, P851, DOI 10.1101/gad.10.7.851; Hu B, 2001, MOL CELL BIOL, V21, P2755, DOI 10.1128/MCB.21.8.2755-2766.2001; Huang YH, 2004, P NATL ACAD SCI USA, V101, P4936, DOI 10.1073/pnas.0401133101; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kowalik TF, 1998, CELL GROWTH DIFFER, V9, P113; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; Krutzik PO, 2005, J IMMUNOL, V175, P2357, DOI 10.4049/jimmunol.175.4.2357; La Thangue NB, 2003, NAT CELL BIOL, V5, P587, DOI 10.1038/ncb0703-587; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Murphy DJ, 2008, CANCER CELL, V14, P447, DOI 10.1016/j.ccr.2008.10.018; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Nahle Z, 2002, NAT CELL BIOL, V4, P859, DOI 10.1038/ncb868; Osborn SL, 2007, J BIOL CHEM, V282, P22786, DOI 10.1074/jbc.M703163200; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Pellicciari C, 1996, EXP CELL RES, V229, P370, DOI 10.1006/excr.1996.0382; PENIT C, 1986, J IMMUNOL, V137, P2115; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rudolph B, 2000, ONCOGENE, V19, P1891, DOI 10.1038/sj.onc.1203508; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; SHAN B, 1994, MOL CELL BIOL, V14, P299, DOI 10.1128/MCB.14.1.299; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Sherr CJ, 2000, CURR OPIN GENET DEV, V10, P94, DOI 10.1016/S0959-437X(99)00038-6; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; THOMPSON SD, 1990, J IMMUNOL, V145, P2347; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; von Boehmer H, 2003, IMMUNOL REV, V191, P62, DOI 10.1034/j.1600-065X.2003.00010.x; Wierstra I, 2007, BIOL CHEM, V388, P1257, DOI 10.1515/BC.2007.159; Williams O, 2000, EUR J IMMUNOL, V30, P709; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Xue L, 2008, P NATL ACAD SCI USA, V105, P2022, DOI 10.1073/pnas.0712059105; Xue L, 2008, EUR J IMMUNOL, V38, P3200, DOI 10.1002/eji.200838614; Zhu JW, 1999, CELL GROWTH DIFFER, V10, P829	67	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7556	7565		10.1074/jbc.M109.035535	http://dx.doi.org/10.1074/jbc.M109.035535			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20068041	hybrid, Green Published			2022-12-27	WOS:000275415600067
J	Breuer, P; Haacke, A; Evert, BO; Wullner, U				Breuer, Peter; Haacke, Annette; Evert, Bernd O.; Wuellner, Ullrich			Nuclear Aggregation of Polyglutamine-expanded Ataxin-3 FRAGMENTS ESCAPE THE CYTOPLASMIC QUALITY CONTROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCA1 TRANSGENIC MICE; IN-VIVO; MAMMALIAN-CELLS; INTRANUCLEAR INCLUSIONS; MOLECULAR CHAPERONES; HUNTINGTONS-DISEASE; PROTEIN; LOCALIZATION; PROTEASOME; STRESS	Expansion of a polymorphic polyglutamine segment is the common denominator of neurodegenerative polyglutamine diseases. The expanded proteins typically accumulate in large intranuclear inclusions and induce neurodegeneration. However, the mechanisms that determine the subcellular site and rate of inclusion formation are largely unknown. We found that the conserved putative nuclear localization sequence Arg-Lys-Arg-Arg, which is retained in a highly aggregation-prone fragment of ataxin-3, did not affect the site and degree of inclusion formation in a cell culture model of spinocerebellar ataxia type 3. Addition of synthetic nuclear export or import signals led to the expected localization of ataxin-3 and determined the subcellular site of aggregate formation. Triggering a cellular stress response by heat shock transcription factor Delta HSF1 coexpression abrogated aggregation in the cytoplasm but not in the nucleus. These findings indicate that native aggregation-prone fragments derived from expanded ataxin-3 may eventually escape the cytoplasmic quality control, resulting in aggregation in the nuclear compartment.	[Breuer, Peter; Evert, Bernd O.; Wuellner, Ullrich] Univ Bonn, Dept Neurol, D-53105 Bonn, Germany; [Haacke, Annette] Max Planck Inst Biochem, D-82152 Martinsried, Germany	University of Bonn; Max Planck Society	Breuer, P (corresponding author), Univ Bonn, Dept Neurol, Sigmund Freud Str 25, D-53105 Bonn, Germany.	peter.breuer@ukb.uni-bonn.de	Wüllner, Ullrich/R-6790-2019		Deutsche Forschungsgemeinschaft [HA 1466/2, WU 184/6-1]; European Union (EUROSCA); National Ataxia Foundation; University of Bonn Center	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union (EUROSCA)(European Commission); National Ataxia Foundation; University of Bonn Center	This work was supported by Deutsche Forschungsgemeinschaft Grants HA 1466/2 and WU 184/6-1, the European Union (EUROSCA), the National Ataxia Foundation, and a University of Bonn Center (BONFOR) grant.	Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Bader N, 2007, EXP GERONTOL, V42, P864, DOI 10.1016/j.exger.2007.03.010; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bichelmeier U, 2007, J NEUROSCI, V27, P7418, DOI 10.1523/JNEUROSCI.4540-06.2007; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; Chen M, 2008, J CELL BIOL, V180, P697, DOI 10.1083/jcb.200708131; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Fujigasaki H, 2000, EXP NEUROL, V165, P248, DOI 10.1006/exnr.2000.7479; Gidalevitz T, 2006, SCIENCE, V311, P1471, DOI 10.1126/science.1124514; Guigas G, 2007, FEBS LETT, V581, P5094, DOI 10.1016/j.febslet.2007.09.054; Haacke A, 2006, HUM MOL GENET, V15, P555, DOI 10.1093/hmg/ddi472; Haacke A, 2007, J BIOL CHEM, V282, P18851, DOI 10.1074/jbc.M611914200; Hageman J, 2007, J BIOL CHEM, V282, P34334, DOI 10.1074/jbc.M703876200; Hands S, 2008, BBA-GENE REGUL MECH, V1779, P507, DOI 10.1016/j.bbagrm.2008.05.008; Ikeda H, 1996, NAT GENET, V13, P196, DOI 10.1038/ng0696-196; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lepock JR, 2001, CELL STRESS CHAPERON, V6, P136, DOI 10.1379/1466-1268(2001)006<0136:TNMIAT>2.0.CO;2; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; MICHELS AA, 1995, EUR J BIOCHEM, V234, P382, DOI 10.1111/j.1432-1033.1995.382_b.x; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Sakahira H, 2002, P NATL ACAD SCI USA, V99, P16412, DOI 10.1073/pnas.182426899; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Sieradzan KA, 2001, NEUROPATH APPL NEURO, V27, P1, DOI 10.1046/j.0305-1846.2001.00299.x; Skinner PJ, 2002, NEUROMOL MED, V1, P33, DOI 10.1385/NMM:1:1:33; TATZELT J, 1995, P NATL ACAD SCI USA, V92, P2944, DOI 10.1073/pnas.92.7.2944; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Winklhofer KF, 2001, J BIOL CHEM, V276, P45160, DOI 10.1074/jbc.M104873200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Zourlidou A, 2007, HUM MOL GENET, V16, P1078, DOI 10.1093/hmg/ddm057; ZUO JR, 1995, MOL CELL BIOL, V15, P4319	35	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6532	6537		10.1074/jbc.M109.036335	http://dx.doi.org/10.1074/jbc.M109.036335			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20064935	Green Published, hybrid			2022-12-27	WOS:000275367500058
J	Wolthers, KR; Levy, C; Scrutton, NS; Leys, D				Wolthers, Kirsten R.; Levy, Colin; Scrutton, Nigel S.; Leys, David			Large-scale Domain Dynamics and Adenosylcobalamin Reorientation Orchestrate Radical Catalysis in Ornithine 4,5-Aminomutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; ELECTRON-PARAMAGNETIC-RESONANCE; METHYLMALONYL-COA MUTASE; GLUTAMATE MUTASE; COENZYME B-12; PROTEIN; SUBSTRATE; INTERMEDIATE; MECHANISM	D-Ornithine 4,5-aminomutase (OAM) from Clostridium sticklandii converts D-ornithine to 2,4-diaminopentanoic acid by way of radical propagation from an adenosylcobalamin (AdoCbl) to a pyridoxal 5'-phosphate (PLP) cofactor. We have solved OAM crystal structures in different catalytic states that together demonstrate unusual stability of the AdoCbl Co-C bond and that radical catalysis is coupled to large-scale domain motion. The 2.0-angstrom substrate-free enzyme crystal structure reveals the Rossmann domain, harboring the intact AdoCbl cofactor, is tilted toward the edge of the PLP binding triosephosphate isomerase barrel domain. The PLP forms an internal aldimine link to the Rossmann domain through Lys(629), effectively locking the enzyme in this "open" pre-catalytic conformation. The distance between PLP and 5'-deoxyadenosyl group is 23 angstrom, and large-scale domain movement is thus required prior to radical catalysis. The OAM crystals contain two Rossmann domains within the asymmetric unit that are unconstrained by the crystal lattice. Surprisingly, the binding of various ligands to OAM crystals (in an oxygen-free environment) leads to transimination in the absence of significant reorientation of the Rossmann domains. In contrast, when performed under aerobic conditions, this leads to extreme disorder in the latter domains correlated with the loss of the 5'-deoxyadenosyl group. Our data indicate turnover and hence formation of the "closed" conformation is occurring within OAM crystals, but that the equilibrium is poised toward the open conformation. We propose that substrate binding induces large-scale domain motion concomitant with a reconfiguration of the 5'-deoxyadenosyl group, triggering radical catalysis in OAM.	[Wolthers, Kirsten R.; Levy, Colin; Scrutton, Nigel S.; Leys, David] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Manchester	Wolthers, KR (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	kirsten.wolthers@manchester.ac.uk; nigel.scrutton@manchester.ac.uk; david.leys@manchester.ac.uk	Wolthers, Kirsten/M-6833-2019	Levy, Colin/0000-0002-9724-310X	Biotechnology and Biological Sciences Research Council [BB/D01963X/1, BB/G001383/1, BB/H000577/1] Funding Source: Medline; BBSRC [BB/H000577/1, BB/D01963X/1, BB/G001383/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Agarwal PK, 2002, P NATL ACAD SCI USA, V99, P2794, DOI 10.1073/pnas.052005999; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323; Berkovitch F, 2004, P NATL ACAD SCI USA, V101, P15870, DOI 10.1073/pnas.0407074101; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bothe H, 1998, BIOCHEMISTRY-US, V37, P4105, DOI 10.1021/bi971393q; Brown KL, 1998, POLYHEDRON, V17, P2213, DOI 10.1016/S0277-5387(98)00053-9; Chang CH, 1996, BIOCHEMISTRY-US, V35, P11081, DOI 10.1021/bi960850k; Chen HP, 2001, J BIOL CHEM, V276, P44744, DOI 10.1074/jbc.M108365200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DRENNAN CL, 1994, SCIENCE, V266, P1669, DOI 10.1126/science.7992050; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gruber K, 2001, ANGEW CHEM INT EDIT, V40, P3377, DOI 10.1002/1521-3773(20010917)40:18<3377::AID-ANIE3377>3.0.CO;2-8; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LENHERT PG, 1961, NATURE, V192, P937, DOI 10.1038/192937a0; Mancia F, 1998, STRUCTURE, V6, P711, DOI 10.1016/S0969-2126(98)00073-2; Mancia F, 1996, STRUCTURE, V4, P339, DOI 10.1016/S0969-2126(96)00037-8; Mansoorabadi SO, 2005, BIOCHEMISTRY-US, V44, P3153, DOI 10.1021/bi0482102; Masuda J, 2000, STRUCTURE, V8, P775, DOI 10.1016/S0969-2126(00)00164-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ouyang LZ, 2004, INORG CHEM, V43, P1235, DOI 10.1021/ic0348446; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Reitzer R, 1999, STRUCTURE, V7, P891, DOI 10.1016/S0969-2126(99)80116-6; SCHEPLER KL, 1975, BIOCHIM BIOPHYS ACTA, V397, P510, DOI 10.1016/0005-2744(75)90141-2; SUMMERS MF, 1986, J AM CHEM SOC, V108, P4285, DOI 10.1021/ja00275a008; Toraya T, 2003, CHEM REV, V103, P2095, DOI 10.1021/cr020428b; Wetmore SD, 2001, J AM CHEM SOC, V123, P8678, DOI 10.1021/ja010211j; Wolthers KR, 2008, J BIOL CHEM, V283, P34615, DOI 10.1074/jbc.M807911200; Yoon M, 2006, BIOCHEMISTRY-US, V45, P11650, DOI 10.1021/bi061067n; ZHAO Y, 1994, EUR J BIOCHEM, V225, P891, DOI 10.1111/j.1432-1033.1994.0891b.x	33	37	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13942	13950		10.1074/jbc.M109.068908	http://dx.doi.org/10.1074/jbc.M109.068908			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20106986	hybrid, Green Published			2022-12-27	WOS:000276987700068
J	Fernandez-Alvarez, A; Alvarez, MS; Cucarella, C; Casado, M				Fernandez-Alvarez, Ana; Soledad Alvarez, Maria; Cucarella, Carme; Casado, Marta			Characterization of the Human Insulin-induced Gene 2 (INSIG2) Promoter THE ROLE OF Ets-BINDING MOTIFS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERNARY COMPLEX FACTORS; FATTY-ACID SYNTHESIS; TRANSCRIPTION FACTORS; SIGNAL-TRANSDUCTION; RESPONSE FACTOR; FACTORS ELK-1; ELEMENT; LIVER; OBESITY; CHOLESTEROL	Insulin-induced gene 2 (INSIG2) and its homolog INSIG1 encode closely related endoplasmic reticulum proteins that regulate the proteolytic activation of sterol regulatory element-binding proteins, transcription factors that activate the synthesis of cholesterol and fatty acids in animal cells. Several studies have been carried out to identify INSIG2 genetic variants associated with metabolic diseases. However, few data have been published regarding the regulation of INSIG2 gene expression. Two Insig2 transcripts have been described in rodents through the use of different promoters that produce different noncoding first exons that splice into a common second exon. Herein we report the cloning and characterization of the human INSIG2 promoter and the detection of an INSIG2-specific transcript homologous to the Insig2b mouse variant in human liver. Deletion analyses on 3 kb of 5'-flanking DNA of the human INSIG2 gene revealed the functional importance of a 350-bp region upstream of the transcription start site. Mutated analyses, chromatin immunoprecipitation assays, and RNA interference analyses unveiled the significance of an Ets-consensus motif in the proximal region and the interaction of the Ets family member SAP1a (serum response factor (SRF) accessory protein-1a) with this region of the human INSIG2 promoter. Moreover, our findings suggest that insulin activated the human INSIG2 promoter in a process mediated by phosphorylated SAP1a. Overall, these results map the functional elements in the human INSIG2 promoter sequence and suggest an unexpected regulation of INSIG2 gene expression in human liver.	[Fernandez-Alvarez, Ana; Soledad Alvarez, Maria; Cucarella, Carme; Casado, Marta] IBV CSIC, Valencia 46010, Spain; [Casado, Marta] CIBERehd, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD	Casado, M (corresponding author), IBV CSIC, Jaime Roig 11, Valencia 46010, Spain.	mcasado@ibv.csic.es	Casado, Marta/L-2078-2014	Casado, Marta/0000-0001-6457-4650; Fernandez-Alvarez, Ana/0000-0002-5296-5678	Ministry of Science and Innovation [SAF2006-06760]; Carlos III Health Institute (Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA) [RD06/0014/0025]; Spanish Ministry of Education and Science [BES-2004-6151]; Consejo Superior de Investigaciones Cientificas	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute (Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA)(Instituto de Salud Carlos III); Spanish Ministry of Education and Science(Spanish Government); Consejo Superior de Investigaciones Cientificas	This work was supported by Ministry of Science and Innovation Grant SAF2006-06760 and the Carlos III Health Institute (Red Tematica de Investigacion Cooperativa en Enfermedades Cardiovasculares (RECAVA) RD06/0014/0025).; Supported by Spanish Ministry of Education and Science Fellowship BES-2004-6151.; Supported by Consejo Superior de Investigaciones Cientificas Fellowship JAE-predoc.	Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415; Boros J, 2009, NUCLEIC ACIDS RES, V37, P7368, DOI 10.1093/nar/gkp804; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje; Cervino AC, 2005, GENOMICS, V86, P505, DOI 10.1016/j.ygeno.2005.07.010; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Cheverud JM, 2004, DIABETES, V53, P3328, DOI 10.2337/diabetes.53.12.3328; Clarkson RWE, 1999, MOL ENDOCRINOL, V13, P619, DOI 10.1210/me.13.4.619; Deng X, 2002, BIOCHEM BIOPH RES CO, V290, P256, DOI 10.1006/bbrc.2001.6148; DIAMOND RH, 1993, J BIOL CHEM, V268, P15185; Fernandez-Alvarez A, 2008, FEBS LETT, V582, P177, DOI 10.1016/j.febslet.2007.11.083; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; GIOVANE A, 1994, GENE DEV, V8, P1502, DOI 10.1101/gad.8.13.1502; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; JACOB KK, 1995, J BIOL CHEM, V270, P27773, DOI 10.1074/jbc.270.46.27773; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; JOLLIFF K, 1991, NUCLEIC ACIDS RES, V19, P2267, DOI 10.1093/nar/19.9.2267; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6; MYERS MG, 1994, TRENDS BIOCHEM SCI, V19, P289, DOI 10.1016/0968-0004(94)90007-8; Nilsson M, 2007, NUCLEIC ACIDS RES, V35, P4858, DOI 10.1093/nar/gkm492; Oliva JL, 2004, J BIOL CHEM, V279, P33480, DOI 10.1074/jbc.M404058200; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; Sewter C, 2002, DIABETES, V51, P1035, DOI 10.2337/diabetes.51.4.1035; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Strahl T, 1996, P NATL ACAD SCI USA, V93, P11563, DOI 10.1073/pnas.93.21.11563; Tobe K, 2001, J BIOL CHEM, V276, P38337, DOI 10.1074/jbc.C100160200; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Watson DK, 1997, ONCOGENE, V14, P213, DOI 10.1038/sj.onc.1200839; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Yamazaki Y, 2003, J BIOL CHEM, V278, P30642, DOI 10.1074/jbc.M212242200; Yellaturu CR, 2009, J BIOL CHEM, V284, P31726, DOI 10.1074/jbc.M109.050914; Yordy JS, 2000, ONCOGENE, V19, P6503, DOI 10.1038/sj.onc.1204036	41	19	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11765	11774		10.1074/jbc.M109.067447	http://dx.doi.org/10.1074/jbc.M109.067447			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20145255	Green Published, hybrid			2022-12-27	WOS:000276787100003
J	Li, SJ; Zhao, Q; Zhou, QJ; Unno, H; Zhai, YJ; Sun, F				Li, Shu Jie; Zhao, Qing; Zhou, Qiangjun; Unno, Hideaki; Zhai, Yujia; Sun, Fei			The Role and Structure of the Carboxyl-terminal Domain of the Human Voltage-gated Proton Channel Hv1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-ION CURRENTS; ALVEOLAR EPITHELIAL-CELLS; NADPH OXIDASE; HUMAN-NEUTROPHILS; PH; PROTEIN; CONDUCTANCE; SNAIL	The voltage-gated proton channel Hv1 has a voltage sensor domain but lacks a pore domain. Although the C-terminal domain of Hv1 is known to be responsible for dimeric architecture of the channel, its role and structure are not known. We report that the full-length Hv1 is mainly localized in intracellular compartment membranes rather than the plasma membrane. Truncation of either the N or C terminus alone or both together revealed that the N-terminal deletion did not alter localization, but deletion of the C terminus either alone or together with the N terminus resulted in expression throughout the cell. These results indicate that the C terminus is essential for Hv1 localization but not the N terminus. In the 2.0 angstrom structure of the C-terminal domain, the two monomers form a dimer via a parallel C-helical coiled-coil, in which one chloride ion binds with the N eta atom of Arg(264). A pH-dependent structural change of the protein has been observed, but it remains a dimer irrespective of pH value.	[Li, Shu Jie; Zhao, Qing] Nankai Univ, Key Lab Bioact Mat, Minist Educ, Coll Phys Sci, Tianjin 300071, Peoples R China; [Zhou, Qiangjun; Zhai, Yujia; Sun, Fei] Chinese Acad Sci, Lab Biol Electron Microscopy & Struct Biol, Inst Biophys, Beijing 100101, Peoples R China; [Zhou, Qiangjun; Zhai, Yujia; Sun, Fei] Chinese Acad Sci, Natl Lab Biomacromol, Inst Biophys, Beijing 100101, Peoples R China; [Unno, Hideaki] Nagasaki Univ, Dept Appl Chem, Fac Engn, Nagasaki 8528521, Japan	Nankai University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Nagasaki University	Li, SJ (corresponding author), Nankai Univ, Key Lab Bioact Mat, Minist Educ, Coll Phys Sci, 94 Weijin Rd, Tianjin 300071, Peoples R China.	shujieli@nankai.edu.cn; feisun@ibp.ac.cn	Sun, Fei/C-4190-2015; Hideaki, UNNO/ABG-9471-2020	Sun, Fei/0000-0002-0351-5144; Hideaki, UNNO/0000-0001-5917-269X; Zhou, Qiangjun/0000-0002-7768-0249; Zhou, Qiangjun/0000-0003-1789-9588	National Natural Science Foundation of China [30840028, 30970579, 30623005]; Chinese Ministry of Science and Technology [2006AA02Z173]; Basic Science and Advance Technology Research Program of Tianjin [08JCY-BJC25800]; Ministry of Education of China [200800551035]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Basic Science and Advance Technology Research Program of Tianjin; Ministry of Education of China(Ministry of Education, China)	This work was supported by National Natural Science Foundation of China Grants 30840028, 30970579, and 30623005; "863" program from the Chinese Ministry of Science and Technology Grant 2006AA02Z173; Basic Science and Advance Technology Research Program of Tianjin Grant 08JCY-BJC25800; and Ph.D. Program Foundation of the Ministry of Education of China Grant 200800551035.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BYERLY L, 1984, J PHYSIOL-LONDON, V351, P199, DOI 10.1113/jphysiol.1984.sp015241; Cherny VV, 1999, J GEN PHYSIOL, V114, P819, DOI 10.1085/jgp.114.6.819; CHERNY VV, 1995, J GEN PHYSIOL, V105, P861, DOI 10.1085/jgp.105.6.861; CLARK RA, 1987, J BIOL CHEM, V262, P4065; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DECOURSEY TE, 1991, BIOPHYS J, V60, P1243, DOI 10.1016/S0006-3495(91)82158-0; DECOURSEY TE, 1994, J MEMBRANE BIOL, V141, P203; Eder C, 2001, PROG NEUROBIOL, V64, P277, DOI 10.1016/S0301-0082(00)00062-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; KAPUS A, 1993, J GEN PHYSIOL, V102, P729, DOI 10.1085/jgp.102.4.729; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Li SJ, 2009, ACTA CRYSTALLOGR F, V65, P279, DOI 10.1107/S1744309109003777; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SAXENA VP, 1971, P NATL ACAD SCI USA, V68, P969, DOI 10.1073/pnas.68.5.969; THOMAS RC, 1982, NATURE, V299, P826, DOI 10.1038/299826a0; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; UVERSKY VN, 1993, BIOCHEMISTRY-US, V32, P13288, DOI 10.1021/bi00211a042; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200	30	53	57	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12047	12054		10.1074/jbc.M109.040360	http://dx.doi.org/10.1074/jbc.M109.040360			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147290	Green Published, hybrid			2022-12-27	WOS:000276787100033
J	Odyniec, AN; Barral, DC; Garg, S; Tatituri, RV; Besra, GS; Brenner, MB				Odyniec, Artur N.; Barral, Duarte C.; Garg, Salil; Tatituri, Raju V.; Besra, Gurdyal S.; Brenner, Michael B.			Regulation of CD1 Antigen-presenting Complex Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MOLECULES; T-CELLS; CYTOPLASMIC TAIL; LIPID ANTIGENS; MONOCLONAL-ANTIBODIES; B-CELLS; RECOGNITION; TRAFFICKING; EXPRESSION; BINDING	For major histocompatibility complex class I and II molecules, the binding of specific peptide antigens is essential for assembly and trafficking and is at the center of their quality control mechanism. However, the role of lipid antigen binding in stabilization and quality control of CD1 heavy chain (HC).beta(2)-microglobulin (beta(2)m) complexes is unclear. Furthermore, the distinct trafficking and loading routes of CD1 proteins take them from mildly acidic pH in early endososmal compartments (pH 6.0) to markedly acidic pH in lysosomes (pH 5.0) and back to neutral pH of the cell surface (pH 7.4). Here, we present evidence that the stability of each CD1 HC.beta(2)m complex is determined by the distinct pH optima identical to that of the intracellular compartments in which each CD1 isoform resides. Although stable at acidic endosomal pH, complexes are only stable at cell surface pH 7.4 when bound to specific lipid antigens. The proposed model outlines a quality control program that allows lipid exchange at low endosomal pH without dissociation of the CD1 HC.beta(2)m complex and then stabilizes the antigen-loaded complex at neutral pH at the cell surface.	[Odyniec, Artur N.; Barral, Duarte C.; Garg, Salil; Tatituri, Raju V.; Brenner, Michael B.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Birmingham	Brenner, MB (corresponding author), Smith Bldg,Rm 552,1 Jimmy Fund Way, Boston, MA 02115 USA.	mbrenner@rics.bwh.harvard.edu	Garg, Salil/GXH-2201-2022; Barral, Duarte/E-7548-2013	Garg, Salil/0000-0002-7198-1833; Barral, Duarte/0000-0001-8867-2407; Besra, Gurdyal/0000-0002-5605-0395; Odyniec, Artur/0000-0001-7593-0809; Wojcik-Odyniec, Joanna/0000-0002-8495-4316	National Institutes of Health [R01 AI 028973, R01 AI 063428]; Royal Society; Medical Council; Wellcome Trust [084923/B/08/7]; Medical Research Council [G0400421] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063428, R01AI028973, R56AI063428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; MRC [G0400421] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Royal Society(Royal Society of London); Medical Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI 028973 and AI 063428 (to M. B. B.). This work was also supported by a personal research chair from Mr. James Badrick, Royal Society Wolfson Research Merit Award, as a former Lister Institute-Jenner Research Fellow, the Medical Council, and the Wellcome Trust (084923/B/08/7) (to G. S. B.).	BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Barral DC, 2008, TRAFFIC, V9, P1446, DOI 10.1111/j.1600-0854.2008.00781.x; Beckman EM, 1996, J IMMUNOL, V157, P2795; BEHAR SM, 1995, J EXP MED, V182, P2007, DOI 10.1084/jem.182.6.2007; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Cernadas M, 2003, J IMMUNOL, V171, P4149, DOI 10.4049/jimmunol.171.8.4149; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; De Silva AD, 2002, J IMMUNOL, V168, P723, DOI 10.4049/jimmunol.168.2.723; Dougan SK, 2005, J EXP MED, V202, P529, DOI 10.1084/jem.20050183; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Gumperz JE, 2000, IMMUNITY, V12, P211, DOI 10.1016/S1074-7613(00)80174-0; Jackman RM, 1998, IMMUNITY, V8, P341, DOI 10.1016/S1074-7613(00)80539-7; Jayawardena-Wolf J, 2001, IMMUNITY, V15, P897, DOI 10.1016/S1074-7613(01)00240-0; Kang SJ, 2004, NAT IMMUNOL, V5, P175, DOI 10.1038/ni1034; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; Kaser A, 2008, EUR J IMMUNOL, V38, P2351, DOI 10.1002/eji.200738102; Koch M, 2005, NAT IMMUNOL, V6, P819, DOI 10.1038/ni1225; Lawton AP, 2005, J IMMUNOL, V174, P3179, DOI 10.4049/jimmunol.174.6.3179; Leadbetter EA, 2008, P NATL ACAD SCI USA, V105, P8339, DOI 10.1073/pnas.0801375105; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Manolova V, 2006, EUR J IMMUNOL, V36, P1083, DOI 10.1002/eji.200535544; MCMICHAEL AJ, 1979, EUR J IMMUNOL, V9, P205, DOI 10.1002/eji.1830090307; Melian A, 2000, J IMMUNOL, V165, P4494, DOI 10.4049/jimmunol.165.8.4494; MINNIKIN DE, 1985, J GEN MICROBIOL, V131, P2007; Moody DB, 2002, NAT IMMUNOL, V3, P435, DOI 10.1038/ni780; OLIVE D, 1984, IMMUNOGENETICS, V20, P253, DOI 10.1007/BF00364207; Paulsson KM, 2004, FASEB J, V18, P31, DOI 10.1096/fj.03-0846rev; Relloso M, 2008, IMMUNITY, V28, P774, DOI 10.1016/j.immuni.2008.04.017; Roark JH, 1998, J IMMUNOL, V160, P3121; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SMITH LM, 1982, P NATL ACAD SCI-BIOL, V79, P608, DOI 10.1073/pnas.79.2.608; Spada FM, 1998, J EXP MED, V188, P1529, DOI 10.1084/jem.188.8.1529; Spada FM, 2000, EUR J IMMUNOL, V30, P3468, DOI 10.1002/1521-4141(2000012)30:12<3468::AID-IMMU3468>3.0.CO;2-C; Sugita M, 2000, P NATL ACAD SCI USA, V97, P8445, DOI 10.1073/pnas.150236797; Sugita M, 1999, IMMUNITY, V11, P743, DOI 10.1016/S1074-7613(00)80148-X; Sugita M, 1996, SCIENCE, V273, P349, DOI 10.1126/science.273.5273.349; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035; Wubbolts R, 1999, IMMUNOL REV, V172, P189, DOI 10.1111/j.1600-065X.1999.tb01366.x; Yuan WM, 2007, P NATL ACAD SCI USA, V104, P5551, DOI 10.1073/pnas.0700617104	43	17	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11937	11947		10.1074/jbc.M109.077933	http://dx.doi.org/10.1074/jbc.M109.077933			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20133943	Green Published, hybrid			2022-12-27	WOS:000276787100022
J	You, JJ; Lin-Chao, S				You, Jhong-Jhe; Lin-Chao, Sue			Gas7 Functions with N-WASP to Regulate the Neurite Outgrowth of Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; DEMYELINATING PERIPHERAL NEUROPATHY; ACTIN-DEPOLYMERIZING PROTEIN; ARREST-SPECIFIC PROTEIN; ARP2/3 COMPLEX; GROWTH-ARREST; PC12 CELLS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; MEMBRANE INVAGINATION; MICROSPIKE FORMATION	Neuritogenesis, or neurite outgrowth, is a critical process for neuronal differentiation and maturation in which growth cones are formed from highly dynamic actin structures. Gas7 ( growth arrest-specific gene 7), a new member of the PCH( Pombe Cdc15 homology) protein family, is predominantly expressed in neurons and is required for the maturation of primary cultured Purkinje neurons as well as the neuron-like differentiation of PC12 cells upon nerve growth factor stimulation. We report that Gas7 co-localizes and physically interacts with N-WASP, a key regulator of Arp2/3 complex-mediated actin polymerization, in the cortical region of Gas7-transfected Neuro-2a cells and growth cones of hippocampal neurons. The interaction between Gas7 and N-WASP is mediated by WW-Prodomains, which is unique in the PCH protein family, where most interactions are of the SH3-Pro kind. The interaction contributes to the formation of membrane protrusions and processes by recruiting the Arp2/3 complex in a Cdc42-independent manner. Importantly, specific interaction between Gas7 and N-WASP is required for regular neurite outgrowth of hippocampal neurons. The data demonstrate an essential role of Gas7 through its interaction with N-WASP during neuronal maturation/differentiation.	[Lin-Chao, Sue] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10002, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Lin-Chao, S (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	mbsue@gate.sinica.edu.tw	Lin-Chao, Sue/AAZ-8246-2021; Lin-Chao, Sue/AGI-2030-2022	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304	Academia Sinica [AS-95-TP-B04]; National Science Council of Taiwan	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by an intramural fund and Program Project Grant AS-95-TP-B04 from Academia Sinica and by grants from the National Science Council of Taiwan. This work fulfilled in part the requirements for the Ph.D. thesis of J.-J. You, Graduate Institute of Molecular Medicine, College of Medicine, National Taiwan University, Taiwan.	Abe T, 2003, J CELL SCI, V116, P155, DOI 10.1242/jcs.00208; ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Aspenstrom P, 1997, CURR BIOL, V7, P479, DOI 10.1016/S0960-9822(06)00219-3; Banzai Y, 2000, J BIOL CHEM, V275, P11987, DOI 10.1074/jbc.275.16.11987; Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; BRENNER DG, 1989, P NATL ACAD SCI USA, V86, P5517, DOI 10.1073/pnas.86.14.5517; Carlier MF, 2000, J BIOL CHEM, V275, P21946, DOI 10.1074/jbc.M000687200; Chao CCK, 2005, J NEUROSCI RES, V81, P153, DOI 10.1002/jnr.20552; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; Chitu V, 2007, TRENDS CELL BIOL, V17, P145, DOI 10.1016/j.tcb.2007.01.003; Dent EW, 2003, NEUROSCIENTIST, V9, P343, DOI 10.1177/1073858403252683; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; FABBRETTI E, 1995, GENE DEV, V9, P1846, DOI 10.1101/gad.9.15.1846; Fukuoka M, 2001, J CELL BIOL, V152, P471, DOI 10.1083/jcb.152.3.471; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Innocenti M, 2005, NAT CELL BIOL, V7, P969, DOI 10.1038/ncb1304; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; Kim AS, 2000, NATURE, V404, P151, DOI 10.1038/35004513; Lazakovitch EM, 1999, GENOMICS, V61, P298, DOI 10.1006/geno.1999.5964; Lee KKH, 1999, DEV BIOL, V207, P14; Lih CJ, 1996, P NATL ACAD SCI USA, V93, P4617, DOI 10.1073/pnas.93.10.4617; Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T; Lortie K, 2005, BRAIN RES, V1036, P27, DOI 10.1016/j.brainres.2004.12.024; Macias MJ, 2002, FEBS LETT, V513, P30, DOI 10.1016/S0014-5793(01)03290-2; MIKI H, 1994, J BIOL CHEM, V269, P5489; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; Miki H, 1996, EMBO J, V15, P5326, DOI 10.1002/j.1460-2075.1996.tb00917.x; Miura K, 1996, BIOCHEM J, V316, P639, DOI 10.1042/bj3160639; Mizutani K, 2004, BIOCHEM BIOPH RES CO, V313, P468, DOI 10.1016/j.bbrc.2003.11.139; Moorthy PP, 2005, STEM CELLS DEV, V14, P664, DOI 10.1089/scd.2005.14.664; Purpura D P, 1982, Brain Res, V281, P287; Rohatgi R, 2000, J CELL BIOL, V150, P1299, DOI 10.1083/jcb.150.6.1299; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohatgi R, 2001, J BIOL CHEM, V276, P26448, DOI 10.1074/jbc.M103856200; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Sekino Y, 2007, NEUROCHEM INT, V51, P92, DOI 10.1016/j.neuint.2007.04.029; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; So CW, 2003, CANCER CELL, V4, P99, DOI 10.1016/S1535-6108(03)00188-0; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Su WB, 2009, POMBE CDC15 HOMOLOGY; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Takenawa T, 2005, NOVART FDN SYMP, V269, P10; Takenawa Tadaomi, 2005, Novartis Found Symp, V269, P3; Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069; Tomasevic N, 2007, BIOCHEMISTRY-US, V46, P3494, DOI 10.1021/bi062152y; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Wegner AM, 2008, J BIOL CHEM, V283, P15912, DOI 10.1074/jbc.M801555200; WISNIEWSKI KE, 1991, AM J MED GENET, V38, P476, DOI 10.1002/ajmg.1320380267; Yamaguchi H, 2000, P NATL ACAD SCI USA, V97, P12631, DOI 10.1073/pnas.190351397; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0	57	37	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11652	11666		10.1074/jbc.M109.051094	http://dx.doi.org/10.1074/jbc.M109.051094			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150425	Green Published, hybrid			2022-12-27	WOS:000276286200070
J	Bruscoli, S; Donato, V; Velardi, E; Di Sante, M; Migliorati, G; Donato, R; Riccardi, C				Bruscoli, Stefano; Donato, Valerio; Velardi, Enrico; Di Sante, Moises; Migliorati, Graziella; Donato, Rosario; Riccardi, Carlo			Glucocorticoid-induced Leucine Zipper (GILZ) and Long GILZ Inhibit Myogenic Differentiation and Mediate Anti-myogenic Effects of Glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; MUSCLE; MYOD; PROTEIN; APOPTOSIS; PATHWAY; ACETYLATION; MACROPHAGES; RECRUITMENT; ACTIVATION	Myogenesis is a process whereby myoblasts differentiate and fuse into multinucleated myotubes, the precursors of myofibers. Various signals and factors modulate this process, and glucocorticoids (GCs) are important regulators of skeletal muscle metabolism. We show that glucocorticoid-induced leucine zipper (GILZ), a GC-induced gene, and the newly identified isoform long GILZ (L-GILZ) are expressed in skeletal muscle tissue and in C2C12 myoblasts where GILZ/L-GILZ maximum expression occurs during the first few days in differentiation medium. Moreover, we observed that GC treatment of myoblasts, which increased GILZ/L-GILZ expression, resulted in reduced myotube formation, whereas GILZ and L-GILZ silencing dampened GC effects. Inhibition of differentiation caused by GILZ/L-GILZ overexpression correlated with inhibition of MyoD function and reduced expression of myogenin. Notably, results indicate that GILZ and L-GILZ bind and regulate MyoD/HDAC1 transcriptional activity, thus mediating the anti-myogenic effect of GCs.	[Bruscoli, Stefano; Donato, Valerio; Velardi, Enrico; Di Sante, Moises; Migliorati, Graziella; Riccardi, Carlo] Univ Perugia, Dipartimento Med Clin & Sperimentale, Sez Farmacol Tossicol & Chemioterapia, I-06122 Perugia, Italy; [Donato, Rosario] Univ Perugia, Dipartimento Med Sperimentale & Sci Biochim, Sez Anat, I-06122 Perugia, Italy	University of Perugia; University of Perugia	Riccardi, C (corresponding author), Via Giochetto, I-06122 Perugia, Italy.	riccardi@unipg.it	Donato, Rosario/I-3943-2019; Velardi, Enrico/AAB-7443-2019; Riccardi, Carlo/N-4610-2014; di sante, moises/AAZ-4936-2020; velardi, Enrico/AAC-5440-2022	Velardi, Enrico/0000-0001-8383-0453; Riccardi, Carlo/0000-0001-9257-3997; bruscoli, stefano/0000-0003-0313-1615; MIGLIORATI, Graziella/0000-0002-9475-6399; Di Sante, Moises/0000-0002-4174-1257	Associazione Italiana per la Ricerca sul Cancro Milan; Ministero Istruzione Universita della Ricerca; Fondo per gli Investimenti della Ricerca di Base [RBPR05NWWC CHEM-PROFARMA-NET]	Associazione Italiana per la Ricerca sul Cancro Milan(Fondazione AIRC per la ricerca sul cancro); Ministero Istruzione Universita della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondo per gli Investimenti della Ricerca di Base(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was been supported by grants from Associazione Italiana per la Ricerca sul Cancro Milan (to C. R.) and by Ministero Istruzione Universita della Ricerca, Fondo per gli Investimenti della Ricerca di Base Grant RBPR05NWWC CHEM-PROFARMA-NET.	Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Berrebi D, 2003, BLOOD, V101, P729, DOI 10.1182/blood-2002-02-0538; Betters JL, 2008, MUSCLE NERVE, V37, P203, DOI 10.1002/mus.20915; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; Brunelli S, 2007, P NATL ACAD SCI USA, V104, P264, DOI 10.1073/pnas.0608277104; Bruscoli S, 2006, EUR J PHARMACOL, V529, P63, DOI 10.1016/j.ejphar.2005.10.053; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cannarile L, 2001, CELL DEATH DIFFER, V8, P201, DOI 10.1038/sj.cdd.4400798; Cannarile L, 2009, GASTROENTEROLOGY, V136, P530, DOI 10.1053/j.gastro.2008.09.024; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Dekelbab BH, 2007, STEROIDS, V72, P705, DOI 10.1016/j.steroids.2007.05.007; Delfino DV, 2004, BLOOD, V104, P4134, DOI 10.1182/blood-2004-03-0920; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Gross KL, 2008, TRENDS ENDOCRIN MET, V19, P331, DOI 10.1016/j.tem.2008.07.009; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hopkins RL, 2005, ENDOCRIN METAB CLIN, V34, P371, DOI 10.1016/j.ecl.2005.01.013; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; KHAN MA, 1993, J NEUROL SCI, V120, P8, DOI 10.1016/0022-510X(93)90017-S; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lovett FA, 2006, J CELL SCI, V119, P4828, DOI 10.1242/jcs.03278; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lundberg I, 2000, ARTHRITIS RHEUM, V43, P336, DOI 10.1002/1529-0131(200002)43:2<336::AID-ANR13>3.0.CO;2-V; Mal A, 2003, P NATL ACAD SCI USA, V100, P1735, DOI 10.1073/pnas.0437843100; Mal A, 2001, EMBO J, V20, P1739, DOI 10.1093/emboj/20.7.1739; Mastaglia FL, 2003, MUSCLE NERVE, V27, P407, DOI 10.1002/mus.10313; Menconi M, 2007, CRIT CARE MED, V35, pS602, DOI 10.1097/01.CCM.0000279194.11328.77; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Muller OG, 2003, J AM SOC NEPHROL, V14, P1107, DOI 10.1097/01.ASN.0000061777.67332.77; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Pujols L, 2002, AM J PHYSIOL-CELL PH, V283, pC1324, DOI 10.1152/ajpcell.00363.2001; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Song YH, 2005, J CLIN INVEST, V115, P451, DOI 10.1172/JCI200522324; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Soundararajan R, 2005, J BIOL CHEM, V280, P39970, DOI 10.1074/jbc.M508658200; Soundararajan R, 2007, J BIOL CHEM, V282, P36303, DOI 10.1074/jbc.M707287200; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Zhang WX, 2008, J BIOL CHEM, V283, P4723, DOI 10.1074/jbc.M704147200	57	49	55	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10385	10396		10.1074/jbc.M109.070136	http://dx.doi.org/10.1074/jbc.M109.070136			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20124407	Green Published, hybrid			2022-12-27	WOS:000276264600024
J	Cook, A; Hippensteel, R; Shimizu, S; Nicolai, J; Fatatis, A; Meucci, O				Cook, Anna; Hippensteel, Randi; Shimizu, Saori; Nicolai, Jaclyn; Fatatis, Alessandro; Meucci, Olimpia			Interactions between Chemokines REGULATION OF FRACTALKINE/CX(3)CL1 HOMEOSTASIS BY SDF/CXCL12 IN CORTICAL NEURONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; RAT HIPPOCAMPAL-NEURONS; CENTRAL-NERVOUS-SYSTEM; METHYL-D-ASPARTATE; TRANSMEMBRANE CHEMOKINES; MEDIATED EXCITOTOXICITY; ALPHA-SECRETASE; CXCR4; NEUROTOXICITY; SURVIVAL	The soluble form of the chemokine fractalkine/CX(3)CL1 regulates microglia activation in the central nervous system (CNS), ultimately affecting neuronal survival. This study aims to determine whether CXCL12, another chemokine constitutively expressed in the CNS (known as stromal cell-derived factor 1; SDF-1), regulates cleavage of fractalkine from neurons. To this end, ELISA was used to measure protein levels of soluble fractalkine in the medium of rat neuronal cultures exposed to SDF-1. Gene arrays, quantitative RT-PCR, and Western blot were used to measure overall fractalkine expression in neurons. The data show that the rate of fractalkine shedding in healthy cultures positively correlates with in vitro differentiation and survival. In analogy to non-neuronal cells, metalloproteinases (ADAM10/17) are involved in cleavage of neuronal fractalkine as indicated by studies with pharmacologic inhibitors. Moreover, treatment of the neuronal cultures with SDF-1 stimulates expression of the inducible metalloproteinase ADAM17 and increases soluble fractalkine content in culture medium. The effect of SDF-1 is blocked by an inhibitor of both ADAM10 and -17, but only partially affected by a more specific inhibitor of ADAM10. In addition, SDF-1 also up-regulates expression of the fractalkine gene. Conversely, exposure of neurons to an excitotoxic stimulus (i.e. NMDA) inhibits alpha-secretase activity and markedly diminishes soluble fractalkine levels, leading to cell death. These results, along with previous findings on the neuroprotective role of both SDF-1 and fractalkine, suggest that this novel interaction between the two chemokines may contribute to in vivo regulation of neuronal survival by modulating microglial neurotoxic properties.	[Cook, Anna; Hippensteel, Randi; Shimizu, Saori; Nicolai, Jaclyn; Fatatis, Alessandro; Meucci, Olimpia] Drexel Univ, Coll Med, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA; [Meucci, Olimpia] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19102 USA	Drexel University; Drexel University	Meucci, O (corresponding author), Drexel Univ, Coll Med, Dept Physiol & Pharmacol, 245 N 15th St,NCB Rm 8804, Philadelphia, PA 19102 USA.	omeucci@drexelmed.edu			National Institutes of Health [DA15014, DA19808, GM067892]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015014, R01DA019808, R01DA015014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA15014 and DA19808 (to O.M.) and GM067892 (to A. F.).	BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bardi G, 2006, J NEUROVIROL, V12, P211, DOI 10.1080/13550280600848373; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Biber K, 2007, TRENDS NEUROSCI, V30, P596, DOI 10.1016/j.tins.2007.08.007; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Bruno V, 2000, EUR J PHARMACOL, V399, P117, DOI 10.1016/S0014-2999(00)00367-8; Bruno V, 2000, J NEUROSCI, V20, P6413, DOI 10.1523/JNEUROSCI.20-17-06413.2000; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chalasani SH, 2003, J NEUROSCI, V23, P4601; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Clark AK, 2007, P NATL ACAD SCI USA, V104, P10655, DOI 10.1073/pnas.0610811104; Corti C, 2007, J NEUROSCI, V27, P8297, DOI 10.1523/JNEUROSCI.1889-07.2007; Deiva K, 2004, EUR J NEUROSCI, V20, P3222, DOI 10.1111/j.1460-9568.2004.03800.x; Garton KJ, 2001, J BIOL CHEM, V276, P37993; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hughes PM, 2002, GLIA, V37, P314, DOI 10.1002/glia.10037; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Hundhausen C, 2007, J IMMUNOL, V178, P8064, DOI 10.4049/jimmunol.178.12.8064; Jamieson WL, 2008, CANCER RES, V68, P1715, DOI 10.1158/0008-5472.CAN-07-1315; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Khan MZ, 2008, CELL DEATH DIFFER, V15, P1663, DOI 10.1038/cdd.2008.95; Khan MZ, 2005, MOL CELL NEUROSCI, V30, P58, DOI 10.1016/j.mcn.2005.05.007; Khan MZ, 2004, AIDS RES HUM RETROV, V20, P1063, DOI 10.1089/aid.2004.20.1063; Klein RS, 2004, TRENDS IMMUNOL, V25, P306, DOI 10.1016/j.it.2004.04.002; Lafon-Cazal M, 1999, EUR J NEUROSCI, V11, P663, DOI 10.1046/j.1460-9568.1999.00475.x; Lauro C, 2006, J IMMUNOL, V177, P7599, DOI 10.4049/jimmunol.177.11.7599; Lesne S, 2005, J NEUROSCI, V25, P9367, DOI 10.1523/JNEUROSCI.0849-05.2005; Limatola C, 2005, J NEUROIMMUNOL, V166, P19, DOI 10.1016/j.jneuroim.2005.03.023; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Ludwig A, 2008, J NEUROIMMUNOL, V198, P92, DOI 10.1016/j.jneuroim.2008.04.024; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Meucci O, 1996, J NEUROSCI, V16, P4080; Meucci O, 2000, P NATL ACAD SCI USA, V97, P8075, DOI 10.1073/pnas.090017497; Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; Neumann J, 2008, J NEUROSCI, V28, P5965, DOI 10.1523/JNEUROSCI.0060-08.2008; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Patel JP, 2006, J NEUROVIROL, V12, P492, DOI 10.1080/13550280601064798; Ragozzino D, 2006, J NEUROSCI, V26, P10488, DOI 10.1523/JNEUROSCI.3192-06.2006; Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1; Rostene W, 2007, NAT REV NEUROSCI, V8, P895, DOI 10.1038/nrn2255; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Sengupta R, 2009, J NEUROSCI, V29, P2534, DOI 10.1523/JNEUROSCI.5865-08.2009; Shiraishi K, 2000, CANCER RES, V60, P3722; Tong N, 2000, J IMMUNOL, V164, P1333, DOI 10.4049/jimmunol.164.3.1333; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Yang P, 2006, PROG NEUROBIOL, V79, P73, DOI 10.1016/j.pneurobio.2006.05.001; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	51	45	45	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10563	10571		10.1074/jbc.M109.035477	http://dx.doi.org/10.1074/jbc.M109.035477			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20124406	hybrid, Green Published			2022-12-27	WOS:000276264600043
J	Kwak, YD; Wang, B; Pan, W; Xu, HX; Jiang, XJ; Liao, FF				Kwak, Young-Don; Wang, Bin; Pan, Wei; Xu, Huaxi; Jiang, Xuejun; Liao, Francesca-Fang			Functional Interaction of Phosphatase and Tensin Homologue (PTEN) with the E3 Ligase NEDD4-1 during Neuronal Response to Zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; PYRROLIDINE DITHIOCARBAMATE; PROTEIN STABILITY; UBIQUITIN LIGASE; NUCLEAR PTEN; CELL-DEATH; KAPPA-B; PHOSPHORYLATION; ACTIVATION; EXPRESSION	The contribution of zinc-mediated neuronal death in the process of both acute and chronic neurodegeneration has been increasingly appreciated. Phosphatase and tensin homologue, deleted on chromosome 10 (PTEN), the major tumor suppressor and key regulator of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, plays a critical role in neuronal death in response to various insults. NEDD4-1-mediated PTEN ubiquitination and subsequent degradation via the ubiquitin proteosomal system have recently been demonstrated to be the important regulatory mechanism for PTEN in several cancer types. We now demonstrate that PTEN is also the key mediator of the PI3K/Akt pathway in the neuronal response to zinc insult. We used primary cortical neurons and neuroblastoma N2a cells to show that zinc treatment results in a reduction of the PTEN protein level in parallel with increased NEDD4-1 gene/protein expression. The reduced PTEN level is associated with an activated PI3K pathway as determined by elevated phosphorylation of both Akt and GSK-3 as well as by the attenuating effect of a specific PI3K inhibitor (wortmannin). The reduction of PTEN can be attributed to increased protein degradation via the ubiquitin proteosomal system, as we show NEDD4-1 to be the major E3 ligase responsible for PTEN ubiquitination in neurons. Moreover, PTEN and NEDD4-1 appear to be able to counter-regulate each other to mediate the neuronal response to zinc. This reciprocal regulation requires the PI3K signaling pathway, suggesting a feedback loop mechanism. This study demonstrates that NEDD4-1-mediated PTEN ubiquitination is crucial in the regulation of PI3K/Akt signaling by PTEN during the neuronal response to zinc, which may represent a common mechanism in neurodegeneration.	[Wang, Bin; Liao, Francesca-Fang] Univ Tennessee, Dept Pharmacol, Hlth Sci Ctr, Coll Med, Memphis, TN 38163 USA; [Kwak, Young-Don; Xu, Huaxi] Burnham Inst Med Res, Neurodegenerat Dis Program, La Jolla, CA 92037 USA; [Pan, Wei; Jiang, Xuejun] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	University of Tennessee System; University of Tennessee Health Science Center; Sanford Burnham Prebys Medical Discovery Institute; Memorial Sloan Kettering Cancer Center	Liao, FF (corresponding author), Univ Tennessee, Dept Pharmacol, Hlth Sci Ctr, Coll Med, 874 Union Ave, Memphis, TN 38163 USA.	ykwak@uthsc.edu; fliao@uthsc.edu	Xu, Huaxi/AAV-7177-2021; Wang, Bin/K-3986-2015	Wang, Bin/0000-0001-9032-5009	National Institutes of Health [R01 NS054880, AG031893]; American Cancer Society; Geoffrey Beene Cancer Research Fund; Alzheimer Association Investigator Initiated Research [IIRG-06-26070]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046673, R01NS054880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030197, R01AG021173, R01AG031893] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Geoffrey Beene Cancer Research Fund; Alzheimer Association Investigator Initiated Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS054880 and AG031893 (to F.-F.L.). This work was also supported by American Cancer Society grant (to X.J.), Geoffrey Beene Cancer Research Fund (to X.J.), and the Alzheimer Association Investigator Initiated Research Award IIRG-06-26070 (to F.-F.L.).	Alirezaei M, 1999, J BIOL CHEM, V274, P32433, DOI 10.1074/jbc.274.45.32433; Anan T, 1998, GENES CELLS, V3, P751, DOI 10.1046/j.1365-2443.1998.00227.x; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Chung KC, 2000, J NEUROSCI RES, V59, P117, DOI 10.1002/(SICI)1097-4547(20000101)59:1<117::AID-JNR14>3.0.CO;2-Q; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; FREDERICKSON CJ, 1983, BRAIN RES, V273, P335, DOI 10.1016/0006-8993(83)90858-2; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Gimm O, 2000, AM J PATHOL, V156, P1693, DOI 10.1016/S0002-9440(10)65040-7; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Hwang SR, 2008, FEBS LETT, V582, P2527, DOI 10.1016/j.febslet.2008.06.017; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Kim JH, 2000, ARCH BIOCHEM BIOPHYS, V382, P72, DOI 10.1006/abbi.2000.1996; Kim S, 2000, J BIOL CHEM, V275, P25979, DOI 10.1074/jbc.M001975200; Kim SS, 2008, APMIS, V116, P779, DOI 10.1111/j.1600-0463.2008.00999.x; Koh JY, 2001, MOL NEUROBIOL, V24, P99, DOI 10.1385/MN:24:1-3:099; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Lachyankar MB, 2000, J NEUROSCI, V20, P1404; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Ma T, 2009, J NEUROSCI, V29, P11226, DOI 10.1523/JNEUROSCI.6150-08.2009; Min YK, 2003, J NEUROSCI RES, V71, P689, DOI 10.1002/jnr.10520; Min YK, 2007, EXP CELL RES, V313, P312, DOI 10.1016/j.yexcr.2006.10.013; Nagoshi T, 2005, J CLIN INVEST, V115, P2128, DOI 10.1172/JCI23073; Ning K, 2004, J NEUROSCI, V24, P4052, DOI 10.1523/JNEUROSCI.5449-03.2004; Okahara F, 2004, J BIOL CHEM, V279, P45300, DOI 10.1074/jbc.C400377200; Okumura K, 2006, J BIOL CHEM, V281, P26562, DOI 10.1074/jbc.M605391200; Qian AQ, 2006, J NEUROSCI, V26, P10899, DOI 10.1523/JNEUROSCI.3453-06.2006; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Samet JM, 1998, AM J PHYSIOL-LUNG C, V275, pL551, DOI 10.1152/ajplung.1998.275.3.L551; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Tachibana M, 2002, CANCER-AM CANCER SOC, V94, P1955, DOI 10.1002/cncr.0678; Teng DHF, 1997, CANCER RES, V57, P5221; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Van Diepen MT, 2008, DEV NEUROSCI-BASEL, V30, P59, DOI 10.1159/000109852; Van Themsche C, 2009, J BIOL CHEM, V284, P20462, DOI 10.1074/jbc.C109.009522; Vazquez F, 2000, MOL CELL BIOL, V20, P5010, DOI 10.1128/MCB.20.14.5010-5018.2000; Wang XJ, 2008, BIOCHEM J, V414, P221, DOI 10.1042/BJ20080674; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; Whiteman DC, 2002, INT J CANCER, V99, P63, DOI 10.1002/ijc.10294; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430; Wu WD, 2003, J BIOL CHEM, V278, P28258, DOI 10.1074/jbc.M303318200; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yim EK, 2009, CANCER CELL, V15, P304, DOI 10.1016/j.ccr.2009.02.012; Yue Q, 2005, DEVELOPMENT, V132, P3281, DOI 10.1242/dev.01891; Zhou MX, 2003, CANCER RES, V63, P6357	57	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9847	9857		10.1074/jbc.M109.091637	http://dx.doi.org/10.1074/jbc.M109.091637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100827	Green Published, hybrid			2022-12-27	WOS:000276165900056
J	Mimura, S; Yamaguchi, T; Ishii, S; Noro, E; Katsura, T; Obuse, C; Kamura, T				Mimura, Satoru; Yamaguchi, Tsuyoshi; Ishii, Satoru; Noro, Emiko; Katsura, Tomoya; Obuse, Chikashi; Kamura, Takumi			Cul8/Rtt101 Forms a Variety of Protein Complexes That Regulate DNA Damage Response and Transcriptional Silencing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; UBIQUITIN LIGASE; REPLICATION FORKS; BUDDING YEAST; PROMOTES REPLICATION; HISTONE H3; S-PHASE; RECOMBINATION; DEGRADATION	The budding yeast, Saccharomyces cerevisiae, has three cullin proteins, which act as platforms for Cullin-based E3 ubiquitin ligases. Genetic evidence indicates that Cul8, together with Mms1, Mms22, and Esc4, is involved in the repair of DNA damage that can occur during DNA replication. Cul8 is thought to form a complex with these proteins, but the composition and the function of Cul8-based E3 ubiquitin ligases remain largely uncharacterized. Herein, we report a comprehensive biochemical analysis of Cul8 complexes. Cul8 was found to form a Cul8-Mms1-Mms22-Esc4 complex under physiological conditions, with Mms1 bridging Cul8 and Mms22 and Mms22 bridging Mms1 and Esc4. Domain analysis demonstrated that the N-terminal region of Mms1 and the C-terminal region of Mms22 are required for the Mms1-Mms22 interaction, whereas the N-terminal region of Mms22 is required for the Mms22-Esc4 interaction. We also found other Cul8-Mms1-binding proteins Ctf4, Esc2, and Orc5 using yeast two-hybrid screening. Esc4 and Ctf4 bound to Mms22 directly and bound to Cul8-Mms1 in the presence of Mms22, whereas Esc2 and Orc5 interacted with both Cul8 and Mms1, independently. We found that Cul8, Mms1, and Mms22 participated in the regulation of transcriptional silencing of yeast telomeres. These results suggest that Cul8-Mms1, as part of various protein complexes, is involved in the regulation of chromatin metabolism.	[Mimura, Satoru; Yamaguchi, Tsuyoshi; Ishii, Satoru; Katsura, Tomoya; Kamura, Takumi] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Noro, Emiko; Obuse, Chikashi] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0010021, Japan	Nagoya University; Hokkaido University	Kamura, T (corresponding author), Nagoya Univ, Div Biol Sci, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	z47617a@nucc.cc.nagoya-u.ac.jp	Obuse, Chikashi/F-5273-2011	Yamaguchi, Tsuyoshi/0000-0001-5341-4184	Ministry of Education, Science, Sports, and Culture of Japan; Sumitomo Foundation; Uehara Foundation; Saibou Kagaku Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Uehara Foundation(Uehara Memorial Foundation); Saibou Kagaku Foundation	This work was supported in part by grants from the Ministry of Education, Science, Sports, and Culture of Japan, the Sumitomo Foundation, the Uehara Foundation, and the Saibou Kagaku Foundation.	Andrulis ED, 2004, GENETICS, V166, P631, DOI 10.1534/genetics.166.1.631; Baldwin EL, 2005, NUCLEIC ACIDS RES, V33, P1021, DOI 10.1093/nar/gki246; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cuperus G, 2002, GENETICS, V162, P633; Dovey CL, 2007, GENETICS, V177, P47, DOI 10.1534/genetics.107.077255; Dula ML, 2000, GENETICS, V156, P933; Duro E, 2008, DNA REPAIR, V7, P811, DOI 10.1016/j.dnarep.2008.01.007; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Glover JNM, 2004, TRENDS BIOCHEM SCI, V29, P579, DOI 10.1016/j.tibs.2004.09.010; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kishi T, 2008, P NATL ACAD SCI USA, V105, P14497, DOI 10.1073/pnas.0806253105; Kishi T, 2007, P NATL ACAD SCI USA, V104, P17418, DOI 10.1073/pnas.0704951104; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Luke B, 2006, CURR BIOL, V16, P786, DOI 10.1016/j.cub.2006.02.071; Mankouri HW, 2009, MOL BIOL CELL, V20, P1683, DOI 10.1091/mbc.E08-08-0877; Michel JJ, 2003, J BIOL CHEM, V278, P22828, DOI 10.1074/jbc.M210358200; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Mimura S, 2009, EMBO J, V28, P3693, DOI 10.1038/emboj.2009.320; Morohashi H, 2009, CURR BIOL, V19, P1943, DOI 10.1016/j.cub.2009.09.062; Novatchkova M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-22; Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187; Ogiwara H, 2007, BIOCHEM BIOPH RES CO, V354, P222, DOI 10.1016/j.bbrc.2006.12.185; Ohya T, 2008, GENETICS, V180, P41, DOI 10.1534/genetics.107.086249; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Roberts TM, 2008, MOL BIOL CELL, V19, P171, DOI 10.1091/mbc.E07-09-0961; Scholes DT, 2001, GENETICS, V159, P1449; Sollier J, 2009, MOL BIOL CELL, V20, P1671, DOI 10.1091/mbc.E08-08-0875; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Xu F, 2007, MOL CELL, V27, P890, DOI 10.1016/j.molcel.2007.07.021; Yang B, 2008, MOL BIOL CELL, V19, P4993, DOI 10.1091/mbc.E08-05-0524; Zaidi IW, 2008, EMBO REP, V9, P1034, DOI 10.1038/embor.2008.155	40	31	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9858	9867		10.1074/jbc.M109.082107	http://dx.doi.org/10.1074/jbc.M109.082107			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20139071	Green Published, hybrid			2022-12-27	WOS:000276165900057
J	Song, WF; Wei, SP; Zhou, YJ; Lazrak, A; Liu, G; Londino, JD; Squadrito, GL; Matalon, S				Song, Weifeng; Wei, Shipeng; Zhou, Yongjian; Lazrak, Ahmed; Liu, Gang; Londino, James D.; Squadrito, Giuseppe L.; Matalon, Sadis			Inhibition of Lung Fluid Clearance and Epithelial Na+ Channels by Chlorine, Hypochlorous Acid, and Chloramines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CHANNELS; LONGITUDINAL DISTRIBUTION; HISTIDINE-RESIDUES; HUMAN-NEUTROPHILS; HUMAN AIRWAYS; IN-VITRO; TRANSPORT; MYELOPEROXIDASE; OXIDATION; ACTIVATION	We investigated the mechanisms by which chlorine (Cl-2) and its reactive byproducts inhibit Na+-dependent alveolar fluid clearance (AFC) in vivo and the activity of amiloride-sensitive epithelial Na+ channels (ENaC) by measuring AFC in mice exposed to Cl-2 (0-500 ppm for 30 min) and Na+ and amiloride-sensitive currents (I-Na and I-amil, respectively) across Xenopus oocytes expressing human alpha-, beta-, and gamma-ENaC incubated with HOCl (1-2000 mu M). Both Cl-2 and HOCl-derived products decreased AFC in mice and whole cell and single channel I-Na in a dose-dependent manner; these effects were counteracted by serine proteases. Mass spectrometry analysis of the oocyte recording medium identified organic chloramines formed by the interaction of HOCl with HEPES (used as an extracellular buffer). In addition, chloramines formed by the interaction of HOCl with taurine or glycine decreased I-Na in a similar fashion. Preincubation of oocytes with serine proteases prevented the decrease of I-Na by HOCl, whereas perfusion of oocytes with a synthetic 51-mer peptide corresponding to the putative furin and plasmin cleaving segment in the gamma-ENaC subunit restored the ability of HOCl to inhibit I-Na. Finally, I-Na of oocytes expressing wild type alpha- and gamma-ENaC and a mutant form of beta ENaC (S520K), known to result in ENaC channels locked in the open position, were not altered by HOCl. We concluded that HOCl and its reactive intermediates (such as organic chloramines) inhibit ENaC by affecting channel gating, which could be relieved by proteases cleavage.	[Song, Weifeng; Wei, Shipeng; Zhou, Yongjian; Lazrak, Ahmed; Londino, James D.; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Dept Anesthesiol, Birmingham, AL 35205 USA; [Liu, Gang; Matalon, Sadis] Univ Alabama Birmingham, Sch Med, Dept Med, Birmingham, AL 35205 USA; [Squadrito, Giuseppe L.] Univ Alabama Birmingham, Sch Med, Dept Environm Hlth Sci, Birmingham, AL 35205 USA; [Squadrito, Giuseppe L.] Univ Alabama Birmingham, Sch Publ Hlth, Birmingham, AL 35205 USA; [Song, Weifeng; Wei, Shipeng; Lazrak, Ahmed; Liu, Gang; Londino, James D.; Squadrito, Giuseppe L.; Matalon, Sadis] Univ Alabama Birmingham, Ctr Pulm Injury & Repair, Birmingham, AL 35205 USA; [Squadrito, Giuseppe L.; Matalon, Sadis] Univ Alabama Birmingham, Ctr Free Rad Biol, Birmingham, AL 35205 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Matalon, S (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Anesthesiol, 224 BMR II,901 19th St S, Birmingham, AL 35205 USA.	sadis@uab.edu	Londino, James/GXH-4404-2022	Londino, James/0000-0001-7647-6927; , Gang/0000-0002-6999-7633; Lazrak, Ahmed/0000-0002-4127-1937; Liu, Gang/0000-0003-2615-131X	United States Public Health Service [HL-31197, HL-51173, U01ES015676, 1U54ES017218]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051173, R01HL031197, R37HL031197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES017218, U01ES015676] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by United States Public Health Service Grants HL-31197, HL-51173, U01ES015676, and 1U54ES017218.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Batchinsky AL, 2006, J TRAUMA, V60, P944, DOI 10.1097/01.ta.0000205862.57701.48; Bell D.P., 2008, AM J RESP CRIT CARE, V176, pA314; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Chen L, 2004, AM J PHYSIOL-RENAL, V286, pF1202, DOI 10.1152/ajprenal.00352.2003; Chen L, 2008, AM J RESP CELL MOL, V39, P150, DOI 10.1165/rcmb.2008-0005OC; Cho HY, 2007, FREE RADICAL BIO MED, V42, P433, DOI 10.1016/j.freeradbiomed.2006.11.021; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Crow JP, 1999, METHOD ENZYMOL, V301, P151; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Davis IC, 2007, AM J RESP CELL MOL, V37, P379, DOI 10.1165/rcmb.2007-0142OC; Davis IC, 2006, AM J RESP CRIT CARE, V173, P673, DOI 10.1164/rccm.200508-1200OC; Davis IC, 2002, FREE RADICAL BIO MED, V33, P1703, DOI 10.1016/S0891-5849(02)01170-X; Deborde M, 2008, WATER RES, V42, P13, DOI 10.1016/j.watres.2007.07.025; den Hartog GJM, 2002, BIOL CHEM, V383, P709; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; DuVall MD, 1998, AM J PHYSIOL-CELL PH, V274, pC1417, DOI 10.1152/ajpcell.1998.274.5.C1417; Eiserich JP, 1996, J BIOL CHEM, V271, P19199, DOI 10.1074/jbc.271.32.19199; Fang XH, 2006, AM J PHYSIOL-LUNG C, V290, pL242, DOI 10.1152/ajplung.00178.2005; Ghosh S, 2006, J IMMUNOL, V176, P5587, DOI 10.4049/jimmunol.176.9.5587; Guo Y, 1998, AM J PHYSIOL-LUNG C, V274, pL369, DOI 10.1152/ajplung.1998.274.3.L369; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; HEINECKE JW, 1994, BIOCHEMISTRY-US, V33, P10127, DOI 10.1021/bi00199a041; Hickman-Davis JM, 2006, AM J RESP CRIT CARE, V173, P334, DOI 10.1164/rccm.200501-155OC; Hughey RP, 2007, CURR OPIN NEPHROL HY, V16, P444, DOI 10.1097/MNH.0b013e32821f6072; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; IWASE H, 1995, BIOCHEM BIOPH RES CO, V215, P945, DOI 10.1006/bbrc.1995.2555; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Kleyman TR, 2006, KIDNEY INT, V70, P1391, DOI 10.1038/sj.ki.5001860; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Knight KK, 2008, J BIOL CHEM, V283, P27477, DOI 10.1074/jbc.M804176200; LANG JDJ, 2006, OXIDATIVE NITROSATIV, P359; Lazrak A, 2009, FASEB J, V23, P3829, DOI 10.1096/fj.09-135590; Lazrak A, 2009, AM J RESP CELL MOL, V41, P261, DOI 10.1165/rcmb.2008-0384OC; Leduc-Nadeau A, 2007, AM J PHYSIOL-CELL PH, V292, pC1132, DOI 10.1152/ajpcell.00136.2006; Lentner C., 1984, GEIGY SCI TABLES, V3, P92; Leustik M, 2008, AM J PHYSIOL-LUNG C, V295, pL733, DOI 10.1152/ajplung.90240.2008; Maarouf AB, 2009, J BIOL CHEM, V284, P7756, DOI 10.1074/jbc.M807060200; Martin JG, 2003, AM J RESP CRIT CARE, V168, P568, DOI 10.1164/rccm.200201-021OC; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Matthay MA, 2002, PHYSIOL REV, V82, P569, DOI 10.1152/physrev.00003.2002; Midwinter RG, 2006, BIOCHEM J, V396, P71, DOI 10.1042/BJ20052026; Nielsen VG, 1998, AM J PHYSIOL-LUNG C, V275, pL1127, DOI 10.1152/ajplung.1998.275.6.L1127; NIELSON DW, 1986, J APPL PHYSIOL, V60, P972, DOI 10.1152/jappl.1986.60.3.972; Nodelman V, 1999, J APPL PHYSIOL, V86, P1984, DOI 10.1152/jappl.1999.86.6.1984; Nodelman V, 1999, J APPL PHYSIOL, V87, P2073, DOI 10.1152/jappl.1999.87.6.2073; Pattison DI, 2007, BIOCHEMISTRY-US, V46, P9853, DOI 10.1021/bi7008294; Peskin AV, 2004, FREE RADICAL BIO MED, V37, P1622, DOI 10.1016/j.freeradbiomed.2004.08.010; Pittet JF, 2001, J IMMUNOL, V166, P6301, DOI 10.4049/jimmunol.166.10.6301; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; Prutz WA, 1996, ARCH BIOCHEM BIOPHYS, V332, P110, DOI 10.1006/abbi.1996.0322; Prutz WA, 1998, ARCH BIOCHEM BIOPHYS, V349, P183, DOI 10.1006/abbi.1997.0440; Prutz WA, 1998, ARCH BIOCHEM BIOPHYS, V357, P265, DOI 10.1006/abbi.1998.0822; Pullar JM, 1999, AM J PHYSIOL-HEART C, V277, pH1505, DOI 10.1152/ajpheart.1999.277.4.H1505; Rahman I, 1996, THORAX, V51, P348, DOI 10.1136/thx.51.4.348; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Sartori C, 2001, ADV EXP MED BIOL, V502, P315; Sartori C, 2002, NEW ENGL J MED, V346, P1631, DOI 10.1056/NEJMoa013183; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Song WF, 2007, AM J PHYSIOL-LUNG C, V293, pL855, DOI 10.1152/ajplung.00305.2007; Spalteholz H, 2006, ARCH BIOCHEM BIOPHYS, V445, P225, DOI 10.1016/j.abb.2005.06.025; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; WEISS SJ, 1982, J CLIN INVEST, V70, P598, DOI 10.1172/JCI110652; Winterton N, 1997, MUTAT RES-FUND MOL M, V373, P293, DOI 10.1016/S0027-5107(96)00239-4; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200	75	40	40	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9716	9728		10.1074/jbc.M109.073981	http://dx.doi.org/10.1074/jbc.M109.073981			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106988	Green Published, hybrid			2022-12-27	WOS:000276165900044
J	Birukou, I; Schweers, RL; Olson, JS				Birukou, Ivan; Schweers, Rachel L.; Olson, John S.			Distal Histidine Stabilizes Bound O-2 and Acts as a Gate for Ligand Entry in Both Subunits of Adult Human Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURES; SITE-DIRECTED MUTAGENESIS; RATE CONSTANTS; CO BINDING; CARBON-MONOXIDE; HEME-PROTEINS; BETA-SUBUNITS; R-STATE; MYOGLOBIN; OXYGEN	The role of the distal histidine in regulating ligand binding to adult human hemoglobin (HbA) was re-examined systematically by preparing His(E7) to Gly, Ala, Leu, Gln, Phe, and Trp mutants of both Hb subunits. Rate constants for O-2, CO, and NO binding were measured using rapid mixing and laser photolysis experiments designed to minimize autoxidation of the unstable apolar E7 mutants. Replacing His(E7) with Gly, Ala, Leu, or Phe causes 20-500-fold increases in the rates of O-2 dissociation from either Hb subunit, demonstrating unambiguously that the native His(E7) imidazole side chain forms a strong hydrogen bond with bound O-2 in both the alpha and beta chains (Delta G(His(E7)H-bond) approximate to -8 kJ/mol). As the size of the E7 amino acid is increased from Gly to Phe, decreases in k(O2)', k(NO)', and calculated bimolecular rates of CO entry (k(entry)') are observed. Replacing His(E7) with Trp causes further decreases in k(O2)', k(NO)', and k(entry)' to 1-2 mu M-1 s(-1) in beta subunits, whereas ligand rebinding to alpha Trp(E7) subunits after photolysis is markedly biphasic, with fast k(O2)', k(CO)', and k(NO)' values approximate to 150 mu M-1 s(-1) and slow rate constants approximate to 0.1 to 1 mu M-1 s(-1). Rapid bimolecular rebinding to an open alpha subunit conformation occurs immediately after photolysis of the alpha Trp(E7) mutant at high ligand concentrations. However, at equilibrium the closed alpha Trp(E7) side chain inhibits the rate of ligand binding > 200-fold. These data suggest strongly that the E7 side chain functions as a gate for ligand entry in both HbA subunits.	[Olson, John S.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, WM Keck Ctr Computat Biol, Houston, TX 77005 USA	Rice University; Rice University	Olson, JS (corresponding author), Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA.	olson@rice.edu		Olson, John/0000-0002-0760-5403	National Institutes of Health [GM035649, HL047020]; Robert A. Welch Foundation [C0612]; Welch Foundation; Houston Area Molecular Biophysics [GM 80820]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080820, R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Welch Foundation(The Welch Foundation); Houston Area Molecular Biophysics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM035649 and HL047020. This work was also supported by Grant C0612 from The Robert A. Welch Foundation (to J. S. O.), a Welch Foundation predoctoral fellowship (to I. B.), and Predoctoral Training Fellowship Grant GM 80820 from the Houston Area Molecular Biophysics (to R. L. S.).	CARLSON ML, 1994, BIOCHEMISTRY-US, V33, P10597, DOI 10.1021/bi00201a005; CARVER TE, 1990, J BIOL CHEM, V265, P20007; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; Elber R, 2008, J PHYS CHEM B, V112, P6147, DOI 10.1021/jp0769779; Franzen S, 2002, J AM CHEM SOC, V124, P13271, DOI 10.1021/ja017708d; FRIEDMAN JM, 1985, SCIENCE, V229, P187, DOI 10.1126/science.4012316; GIBSON QH, 1986, J BIOL CHEM, V261, P228; Hargrove MS, 1997, J MOL BIOL, V266, P1032, DOI 10.1006/jmbi.1996.0833; Hvitved AN, 2001, J BIOL CHEM, V276, P34714, DOI 10.1074/jbc.M105175200; IKEDASAITO M, 1993, J BIOL CHEM, V268, P6855; JAMESON GB, 1980, J AM CHEM SOC, V102, P3224, DOI 10.1021/ja00529a055; JONGEWARD KA, 1988, J AM CHEM SOC, V110, P380, DOI 10.1021/ja00210a011; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; LIN SH, 1990, BIOCHEMISTRY-US, V29, P5562, DOI 10.1021/bi00475a021; LOOKER D, 1994, METHOD ENZYMOL, V231, P364; Lukin JA, 2000, P NATL ACAD SCI USA, V97, P10354, DOI 10.1073/pnas.190254697; Maillett DH, 2008, BIOCHEMISTRY-US, V47, P10551, DOI 10.1021/bi800816v; MATHEWS AJ, 1991, J BIOL CHEM, V266, P21631; MATHEWS AJ, 1989, J BIOL CHEM, V264, P16573; MATHEWS AJ, 1994, METHOD ENZYMOL, V232, P363; MCKINNIE RE, 1981, J BIOL CHEM, V256, P8928; MOMENTEAU M, 1994, CHEM REV, V94, P659, DOI 10.1021/cr00027a006; MORIKIS D, 1989, BIOCHEMISTRY-US, V28, P4791, DOI 10.1021/bi00437a041; Nienhaus K, 2005, J AM CHEM SOC, V127, P40, DOI 10.1021/ja0466917; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; OLSON JS, 1987, J BIOL CHEM, V262, P12930; Olson JS, 2003, METH MOLEC MED, V82, P65; OLSON JS, 1983, J AM CHEM SOC, V105, P1522, DOI 10.1021/ja00344a019; OLSON JS, 1988, NATURE, V336, P265, DOI 10.1038/336265a0; Park ES, 1999, J PHYS CHEM B, V103, P9813, DOI 10.1021/jp992329g; Park ES, 2002, J PHYS CHEM B, V106, P5800, DOI 10.1021/jp0203043; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; PARKHURST KM, 1992, INT J BIOCHEM, V24, P993, DOI 10.1016/0020-711X(92)90109-E; PAULING L, 1964, NATURE, V203, P182, DOI 10.1038/203182b0; PERUTZ MF, 1970, NATURE, V228, P726, DOI 10.1038/228726a0; PERUTZ MF, 1966, J MOL BIOL, V21, P199, DOI 10.1016/0022-2836(66)90088-X; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; RAY GB, 1994, J AM CHEM SOC, V116, P162, DOI 10.1021/ja00080a019; ROHLFS RJ, 1990, J BIOL CHEM, V265, P3168; Salter MD, 2008, J BIOL CHEM, V283, P35689, DOI 10.1074/jbc.M805727200; Scherlis DA, 2001, J AM CHEM SOC, V123, P8436, DOI 10.1021/ja015665v; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SHAANAN B, 1983, J MOL BIOL, V171, P31, DOI 10.1016/S0022-2836(83)80313-1; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Slebodnick C, 1997, J BIOL INORG CHEM, V2, P521, DOI 10.1007/s007750050165; Smagghe BJ, 2009, BIOPOLYMERS, V91, P1083, DOI 10.1002/bip.21256; Spiro TG, 2001, ACCOUNTS CHEM RES, V34, P137, DOI 10.1021/ar000108j; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; SPRINGER BA, 1989, J BIOL CHEM, V264, P3057; Thorsteinsson MV, 1999, BIOCHEMISTRY-US, V38, P2117, DOI 10.1021/bi9819172; TIAN WD, 1993, J MOL BIOL, V233, P155, DOI 10.1006/jmbi.1993.1491; Tian WD, 1996, BIOCHEMISTRY-US, V35, P3487, DOI 10.1021/bi952474u; TRAYLOR TG, 1983, J BIOL CHEM, V258, P2147; Trent JT, 2001, J BIOL CHEM, V276, P30106, DOI 10.1074/jbc.C100300200; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Unno M, 1998, J AM CHEM SOC, V120, P2670, DOI 10.1021/ja973293d; Unzai S, 1998, J BIOL CHEM, V273, P23150, DOI 10.1074/jbc.273.36.23150; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123	64	83	83	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8840	8854		10.1074/jbc.M109.053934	http://dx.doi.org/10.1074/jbc.M109.053934			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080971	Green Published, hybrid			2022-12-27	WOS:000275553700036
J	Piccinini, AM; Knebl, K; Rek, A; Wildner, G; Diedrichs-Mohring, M; Kungl, AJ				Piccinini, Anna Maria; Knebl, Kerstin; Rek, Angelika; Wildner, Gerhild; Diedrichs-Moehring, Maria; Kungl, Andreas J.			Rationally Evolving MCP-1/CCL2 into a Decoy Protein with Potent Anti-inflammatory Activity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CC-CHEMOKINE; GLYCOSAMINOGLYCAN BINDING; CHEMOTACTIC PROTEIN-1; HEPARAN-SULFATE; EXPRESSION; RECEPTOR; MICE; ANTAGONIST; ARTHRITIS	Leukocyte recruitment from the blood into injured tissues during inflammatory diseases is the result of sequential events involving chemokines binding to their GPC receptors as well as to their glycosaminoglycan (GAG) co-receptors. The induction and the crucial role of MCP-1/CCL2 in the course of diseases that feature monocyte-rich infiltrates have been validated in many animal models, and several MCP-1/CCL2 as well as CCR2 antagonists have since been generated. However, despite some of them being shown to be efficacious in a number of animal models, many failed in clinical trials, and therapeutically interfering with the activity of this chemokine is not yet possible. We have therefore generated novel MCP-1/CCL2 mutants with increased GAG binding affinity and knocked out CCR2 activity, which were designed to interrupt the MCP-1/CCL2-related signaling cascade. We provide evidence that our lead mutant MCP-1(Y13A/S21K/Q23R) exhibits a 4-fold higher affinity toward the natural MCP-1 GAG ligand heparan sulfate and that it shows a complete deficiency in activating CCR2 on THP-1 cells. Furthermore, a significantly longer residual time on GAG ligands was observed by surface plasmon resonance. Finally, we were able to show that MCP-1(Y13A/S21K/Q23R) had a mild ameliorating effect on experimental autoimmune uveitis and that a marginal effect on oral tolerance in the group co-fed with Met-MCP-1(Y13A/S21K/Q23R) plus immunogenic peptide PDSAg was observed. These results suggest that disrupting wild type chemokine-GAG interactions by a chemokine-based antagonist can result in anti-inflammatory activity that could have potential therapeutic implications.	[Piccinini, Anna Maria; Knebl, Kerstin; Rek, Angelika; Kungl, Andreas J.] ProtAffin Biotechnol AG, A-8020 Graz, Austria; [Wildner, Gerhild; Diedrichs-Moehring, Maria] Clin Ludwig Maximilians Univ, Dept Ophthalmol, Immunobiol Sect, D-80336 Munich, Germany; [Kungl, Andreas J.] Graz Univ, Inst Pharmaceut Sci, A-8010 Graz, Austria	University of Munich; University of Graz	Kungl, AJ (corresponding author), ProtAffin Biotechnol AG, Reininghausstr 13A, A-8020 Graz, Austria.	akungl@protaffin.com		Kungl, Andreas/0000-0003-3362-797X; Piccinini, Anna Maria/0000-0002-7588-0415	Austrian Science Fund, FWF [P17872-B09]	Austrian Science Fund, FWF(Austrian Science Fund (FWF))	2This work was supported by the Austrian Science Fund, FWF Project P17872-B09.	Alcami A, 1998, J IMMUNOL, V160, P624; Aukrust P, 1998, CIRCULATION, V97, P1136, DOI 10.1161/01.CIR.97.12.1136; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Boring L, 1996, J BIOL CHEM, V271, P7551, DOI 10.1074/jbc.271.13.7551; Brodmerkel CM, 2005, J IMMUNOL, V175, P5370, DOI 10.4049/jimmunol.175.8.5370; Bruhl H, 2004, J IMMUNOL, V172, P890, DOI 10.4049/jimmunol.172.2.890; Dawson TC, 1999, ATHEROSCLEROSIS, V143, P205; DESMET MD, 1993, J AUTOIMMUN, V6, P587, DOI 10.1006/jaut.1993.1048; Diedrichs-Mohring M, 2005, J NEUROIMMUNOL, V164, P22, DOI 10.1016/j.jneuroim.2005.02.023; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Gong JH, 2004, RHEUMATOLOGY, V43, P39, DOI 10.1093/rheumatology/keg459; GONG JH, 1995, J EXP MED, V181, P631, DOI 10.1084/jem.181.2.631; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Grewal IS, 1997, J IMMUNOL, V159, P401; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; Handel TM, 2008, J LEUKOCYTE BIOL, V84, P1101, DOI 10.1189/jlb.0108061; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Hemmerich S, 1999, BIOCHEMISTRY-US, V38, P13013, DOI 10.1021/bi991029m; Hohensinner PJ, 2006, FEBS LETT, V580, P3532, DOI 10.1016/j.febslet.2006.05.043; Horvath C, 2002, CIRC RES, V90, P488, DOI 10.1161/hh0402.105956; HOSAKA S, 1994, CLIN EXP IMMUNOL, V97, P451; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jarnagin K, 1999, BIOCHEMISTRY-US, V38, P16167, DOI 10.1021/bi9912239; Johnson Z, 2004, J IMMUNOL, V173, P5776, DOI 10.4049/jimmunol.173.9.5776; KANE JF, 1995, CURR OPIN BIOTECH, V6, P494, DOI 10.1016/0958-1669(95)80082-4; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lau EK, 2004, J BIOL CHEM, V279, P22294, DOI 10.1074/jbc.M311224200; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Lloyd GM, 1997, J EXP MED, V185, P1371, DOI 10.1084/jem.185.7.1371; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MacDermott RP, 1999, J CLIN IMMUNOL, V19, P266, DOI 10.1023/A:1020583306627; Mo JS, 1999, EXP EYE RES, V68, P333, DOI 10.1006/exer.1998.0618; Nakano K, 2007, ATHEROSCLEROSIS, V194, P309, DOI 10.1016/j.atherosclerosis.2006.10.029; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Paavola CD, 1998, J BIOL CHEM, V273, P33157, DOI 10.1074/jbc.273.50.33157; Parish CR, 2005, NAT IMMUNOL, V6, P861, DOI 10.1038/ni0905-861; Potzinger H, 2006, BIOCHEM SOC T, V34, P435, DOI 10.1042/BST0340435; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Ricard-Blum S, 2004, J BIOL CHEM, V279, P2927, DOI 10.1074/jbc.M309868200; ROBINSON E, 1995, CLIN EXP IMMUNOL, V101, P398; Sanderson RD, 2001, SEMIN CELL DEV BIOL, V12, P89, DOI 10.1006/scdb.2000.0241; Schepers A, 2006, ARTERIOSCL THROM VAS, V26, P2063, DOI 10.1161/01.ATV.0000235694.69719.e2; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Thurau SR, 2004, INT IMMUNOL, V16, P1573, DOI 10.1093/intimm/dxh158; Tuaillon N, 2002, INVEST OPHTH VIS SCI, V43, P1493; YLA HS, 1991, P NATL ACAD SCI USA, V88, P5252; Yoshida Y, 2007, BRIT J OPHTHALMOL, V91, P737, DOI 10.1136/bjo.2006.109843; Yu YH, 2005, J BIOL CHEM, V280, P32200, DOI 10.1074/jbc.M505738200	53	36	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8782	8792		10.1074/jbc.M109.043299	http://dx.doi.org/10.1074/jbc.M109.043299			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097750	Green Published, hybrid			2022-12-27	WOS:000275553700030
J	Zhao, CY; Datta, S; Mandal, P; Xu, SQ; Hamilton, T				Zhao, Chenyang; Datta, Shyamasree; Mandal, Palash; Xu, Shuqing; Hamilton, Thomas			Stress-sensitive Regulation of IFRD1 mRNA Decay Is Mediated by an Upstream Open Reading Frame	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; TRANSLATIONAL CONTROL; GENE-EXPRESSION; MAMMALIAN-CELLS; TIS7; INITIATION; PATHWAY; PC4; TRANSCRIPTION	In this report, we demonstrate that cellular stress regulates expression of IFRD1 by a post-transcriptional control mechanism. IFRD1 mRNA and protein are elevated in tunicamycin-treated human kidney epithelial cells via stabilization of the mRNA. IFRD1 mRNA instability in resting cells requires translation of an upstream open reading frame (ORF) that represses translation of the major ORF. During stress response, the mRNA is stabilized via inhibition of translational initiation mediated by phosphorylated eIF2 alpha. Translation of the major ORF of IFRD1 involves both leaky scanning at the upstream AUG codon and re-initiation at the major AUG codon and is not altered during stress. Finally, the instability mechanism depends upon UPF1, suggesting that it is related to nonsense-mediated decay. Importantly, the sequence and length of the upstream ORF are critical but do not need to code for a specific peptide. Moreover the sequence environment of the upstream ORF termination site is not an essential feature of instability. These features of decay collectively define a distinct upstream ORF-mediated instability mechanism whereby cellular stress can modulate specific gene expression through alteration of mRNA half-life.	[Hamilton, Thomas] Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Hamilton, T (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Immunol, NE40,9500 Euclid Ave, Cleveland, OH 44195 USA.	hamiltt@ccf.org	MANDAL, PALASH/I-5238-2019	MANDAL, PALASH/0000-0001-6612-3773; Hamilton, Thomas/0000-0002-9817-242X; Zhao, Chenyang/0000-0002-4716-2002	National Institutes of Health [CA62220]; NATIONAL CANCER INSTITUTE [P01CA062220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA62220 from USPHS.	ARENANDER AT, 1989, J NEUROSCI RES, V23, P247, DOI 10.1002/jnr.490230302; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; Gardner LB, 2008, MOL CELL BIOL, V28, P3729, DOI 10.1128/MCB.02284-07; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811; GUARDAVACCARO D, 1995, CELL GROWTH DIFFER, V6, P159; Gurova KV, 2004, CANCER RES, V64, P1951, DOI 10.1158/0008-5472.CAN-03-1541; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; HINNEBUSCH AG, 1993, MOL MICROBIOL, V10, P215, DOI 10.1111/j.1365-2958.1993.tb01947.x; Iacopetti P, 1996, BRAIN RES, V707, P293; Kaygun H, 2005, NAT STRUCT MOL BIOL, V12, P794, DOI 10.1038/nsmb972; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kitamura M, 2008, AM J PHYSIOL-RENAL, V295, pF323, DOI 10.1152/ajprenal.00050.2008; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lee YY, 2009, J BIOL CHEM, V284, P6661, DOI 10.1074/jbc.M806735200; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Matsui M, 2007, FEBS LETT, V581, P4184, DOI 10.1016/j.febslet.2007.07.057; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Micheli L, 2005, MOL CELL BIOL, V25, P2242, DOI 10.1128/MCB.25.6.2242-2259.2005; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Morris DR, 2000, MOL CELL BIOL, V20, P8635, DOI 10.1128/MCB.20.23.8635-8642.2000; Nelson DP, 2002, ANN THORAC SURG, V73, P156, DOI 10.1016/S0003-4975(01)03303-3; Novotny M, 2005, J BIOL CHEM, V280, P30166, DOI 10.1074/jbc.M502280200; Perkins DJ, 2004, MOL CELL BIOL, V24, P2025, DOI 10.1128/MCB.24.5.2025-2040.2004; Pickering BM, 2005, SEMIN CELL DEV BIOL, V16, P39, DOI 10.1016/j.semcdb.2004.11.006; Rebbapragada I, 2009, CURR OPIN CELL BIOL, V21, P394, DOI 10.1016/j.ceb.2009.02.007; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roth A, 2003, MOL CELL NEUROSCI, V22, P353, DOI 10.1016/S1044-7431(02)00039-8; Rubin DC, 1998, AM J PHYSIOL-GASTR L, V275, pG506, DOI 10.1152/ajpgi.1998.275.3.G506; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; Ruiz-Echevarria MJ, 1998, EMBO J, V17, P575, DOI 10.1093/emboj/17.2.575; Sachs MS, 2006, GENE DEV, V20, P915, DOI 10.1101/gad.1427006; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stockklausner C, 2006, NUCLEIC ACIDS RES, V34, P2355, DOI 10.1093/nar/gkl277; Sun XL, 1998, P NATL ACAD SCI USA, V95, P10009, DOI 10.1073/pnas.95.17.10009; Thoma C, 2004, MOL CELL, V15, P925, DOI 10.1016/j.molcel.2004.08.021; Vadivelu SK, 2004, MOL CELL BIOL, V24, P3514, DOI 10.1128/MCB.24.8.3514-3525.2004; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Vietor I, 2005, J BIOL CHEM, V280, P39795, DOI 10.1074/jbc.M509836200; Vietor I, 2002, EMBO J, V21, P4621, DOI 10.1093/emboj/cdf461; Vilela C, 2003, MOL MICROBIOL, V49, P859, DOI 10.1046/j.1365-2958.2003.03622.x; Vilela C, 1998, NUCLEIC ACIDS RES, V26, P1150, DOI 10.1093/nar/26.5.1150; Vilela C, 1999, EMBO J, V18, P3139, DOI 10.1093/emboj/18.11.3139; Wang Y, 2005, J BIOL CHEM, V280, P34764, DOI 10.1074/jbc.M507058200; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Wick N, 2004, J MOL BIOL, V336, P589, DOI 10.1016/j.jmb.2003.11.060; Yaman I, 2003, CELL, V113, P519, DOI 10.1016/S0092-8674(03)00345-3; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhao CY, 2007, J BIOL CHEM, V282, P20230, DOI 10.1074/jbc.M700180200; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200	63	26	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8552	8562		10.1074/jbc.M109.070920	http://dx.doi.org/10.1074/jbc.M109.070920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080976	Green Published, hybrid			2022-12-27	WOS:000275553700007
J	Feranchak, AP; Lewis, MA; Kresge, C; Sathe, M; Bugde, A; Luby-Phelps, K; Antich, PP; Fitz, JG				Feranchak, Andrew P.; Lewis, Matthew A.; Kresge, Charles; Sathe, Meghana; Bugde, Abhijit; Luby-Phelps, Kate; Antich, Peter P.; Fitz, J. Gregory			Initiation of Purinergic Signaling by Exocytosis of ATP-containing Vesicles in Liver Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENOSINE-TRIPHOSPHATE; RELEASE; CELL; SECRETION; MECHANISM; CHOLANGIOCYTES; NUCLEOTIDES; CONDUCTANCE; CONTRIBUTES; TRANSPORT	Extracellular ATP represents an important autocrine/ paracrine signaling molecule within the liver. The mechanisms responsible for ATP release are unknown, and alternative pathways have been proposed, including either conductive ATP movement through channels or exocytosis of ATP-enriched vesicles, although direct evidence from liver cells has been lacking. Utilizing dynamic imaging modalities (confocal and total internal reflection fluorescence microscopy and luminescence detection utilizing a high sensitivity CCD camera) at different scales, including confluent cell populations, single cells, and the intracellular submembrane space, we have demonstrated in a model liver cell line that (i) ATP release is not uniform but reflects point source release by a defined subset of cells; (ii) ATP within cells is localized to discrete zones of high intensity that are similar to 1 mu m in diameter, suggesting a vesicular localization; (iii) these vesicles originate from a bafilomycin A(1)-sensitive pool, are depleted by hypotonic exposure, and are not rapidly replenished from recycling of endocytic vesicles; and (iv) exocytosis of vesicles in response to cell volume changes depends upon a complex series of signaling events that requires intact microtubules as well as phosphoinositide 3-kinase and protein kinase C. Collectively, these findings are most consistent with an essential role for exocytosis in regulated release of ATP and initiation of purinergic signaling in liver cells.	Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Lewis, Matthew A.; Antich, Peter P.] Univ Texas SW Med Ctr Dallas, Dept Radiol, Dallas, TX 75390 USA; [Bugde, Abhijit; Luby-Phelps, Kate] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Fitz, J. Gregory] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Feranchak, AP (corresponding author), Univ Texas SW Med Sch, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	drew.feranchak@UTSouthwestern.edu		Luby-Phelps, Katherine/0000-0002-8378-1409	National Institutes of Health, NIDDK [DK078587, DK43278, DK46082]; Cystic Fibrosis Foundation [FERANC08G0]; Children's Medical Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK046082, R01DK043278, R01DK046082, R01DK078587] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Children's Medical Center Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health, NIDDK, Grants DK078587 (to A. P. F.), DK43278, and DK46082 (to J.G.F.). This study was also supported by the Cystic Fibrosis Foundation (FERANC08G0) and the Children's Medical Center Foundation.	ALUND M, 1979, BRAIN RES, V166, P121, DOI 10.1016/0006-8993(79)90654-1; Arcuino G, 2002, P NATL ACAD SCI USA, V99, P9840, DOI 10.1073/pnas.152588599; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Bankston LA, 1996, J BIOL CHEM, V271, P17132, DOI 10.1074/jbc.271.29.17132; Bodily K, 1997, HEPATOLOGY, V25, P403; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; Braunstein GM, 2001, J BIOL CHEM, V276, P6621, DOI 10.1074/jbc.M005893200; Camacho M, 2006, J NEUROCHEM, V96, P324, DOI 10.1111/j.1471-4159.2005.03526.x; Carabelli V, 1998, NEURON, V20, P1255, DOI 10.1016/S0896-6273(00)80505-X; Coco S, 2003, J BIOL CHEM, V278, P1354, DOI 10.1074/jbc.M209454200; COSTA JL, 1984, RES COMMUN CHEM PATH, V45, P389; Doctor RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1042, DOI 10.1152/ajpcell.00367.2001; Feranchak AP, 2007, GASTROENTEROLOGY, V133, P1726, DOI 10.1053/j.gastro.2007.09.050; Feranchak AP, 1999, J BIOL CHEM, V274, P30979, DOI 10.1074/jbc.274.43.30979; Feranchak AP, 2000, J HEPATOL, V33, P174, DOI 10.1016/S0168-8278(00)80357-8; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Gatof D, 2004, AM J PHYSIOL-GASTR L, V286, pG538, DOI 10.1152/ajpgi.00355.2003; Knight GE, 2002, AM J PHYSIOL-RENAL, V282, pF281, DOI 10.1152/ajprenal.00293.2000; Koyama T, 2001, J PHYSIOL-LONDON, V532, P759, DOI 10.1111/j.1469-7793.2001.0759e.x; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Maroto R, 2001, J BIOL CHEM, V276, P23867, DOI 10.1074/jbc.M101500200; MILLER B, 2007, J NUCL MED S2, V48; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; PAINTER GR, 1989, P NATL ACAD SCI USA, V86, P2239, DOI 10.1073/pnas.86.7.2239; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pryazhnikov E, 2008, GLIA, V56, P38, DOI 10.1002/glia.20590; Roman RM, 1999, AM J PHYSIOL-GASTR L, V276, pG1391, DOI 10.1152/ajpgi.1999.276.6.G1391; Roman RM, 2001, J MEMBRANE BIOL, V183, P165, DOI 10.1007/s00232-001-0064-7; Roman RM, 2001, AM J PHYSIOL-GASTR L, V280, pG344, DOI 10.1152/ajpgi.2001.280.3.G344; Sawada K, 2008, P NATL ACAD SCI USA, V105, P5683, DOI 10.1073/pnas.0800141105; Schlosser SF, 1996, P NATL ACAD SCI USA, V93, P9948, DOI 10.1073/pnas.93.18.9948; Schock SC, 2008, BIOCHEM BIOPH RES CO, V368, P138, DOI 10.1016/j.bbrc.2008.01.054; Soesbe TC, 2007, IEEE T NUCL SCI, V54, P1516, DOI 10.1109/TNS.2007.906408; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Steyer JA, 2001, NAT REV MOL CELL BIO, V2, P268, DOI 10.1038/35067069; Suadicani SO, 2006, J NEUROSCI, V26, P1378, DOI 10.1523/JNEUROSCI.3902-05.2006; Taylor AL, 1998, AM J PHYSIOL-CELL PH, V275, pC1391, DOI 10.1152/ajpcell.1998.275.5.C1391; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; UEDA I, 1994, BIOPHYS J, V66, P2107, DOI 10.1016/S0006-3495(94)81005-7; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; WHITE PN, 1995, HEARING RES, V90, P97, DOI 10.1016/0378-5955(95)00151-1; Woo K, 2008, J PHYSIOL-LONDON, V586, P2779, DOI 10.1113/jphysiol.2008.153015	44	57	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8138	8147		10.1074/jbc.M109.065482	http://dx.doi.org/10.1074/jbc.M109.065482			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071341	hybrid, Green Published			2022-12-27	WOS:000275413800032
J	Baek, K; Knodler, A; Lee, SH; Zhang, XY; Orlando, K; Zhang, J; Foskett, TJ; Guo, W; Dominguez, R				Baek, Kyuwon; Knoedler, Andreas; Lee, Sung Haeng; Zhang, Xiaoyu; Orlando, Kelly; Zhang, Jian; Foskett, Trevor J.; Guo, Wei; Dominguez, Roberto			Structure-Function Study of the N-terminal Domain of Exocyst Subunit Sec3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN-HOMOLOGY DOMAINS; BRUTONS TYROSINE KINASE; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; PH DOMAIN; POLARIZED SECRETION; PLASMA-MEMBRANE; COMPLEX; EXOCYTOSIS; PROTEIN	The exocyst is an evolutionarily conserved octameric complex involved in polarized exocytosis from yeast to humans. The Sec3 subunit of the exocyst acts as a spatial landmark for exocytosis through its ability to bind phospholipids and small GTPases. The structure of the N-terminal domain of Sec3 (Sec3N) was determined ab initio and defines a new subclass of pleckstrin homology (PH) domains along with a new family of proteins carrying this domain. Respectively, N- and C-terminal to the PH domain Sec3N presents an additional alpha-helix and two beta-strands that mediate dimerization through domain swapping. The structure identifies residues responsible for phospholipid binding, which when mutated in cells impair the localization of exocyst components at the plasma membrane and lead to defects in exocytosis. Through its ability to bind the small GTPase Cdc42 and phospholipids, the PH domain of Sec3 functions as a coincidence detector at the plasma membrane.	[Knoedler, Andreas; Zhang, Xiaoyu; Orlando, Kelly; Zhang, Jian; Guo, Wei] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Baek, Kyuwon; Lee, Sung Haeng; Foskett, Trevor J.; Dominguez, Roberto] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Guo, W (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	guowei@sas.upenn.edu; droberto@mail.med.upenn.edu	Zhang, xiaoyu/GXA-3206-2022		Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064690, R01GM073791] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by a fellowship from the Deutsche Forschungsgemeinschaft.	Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Constable JRL, 2005, J BIOL CHEM, V280, P31615, DOI 10.1074/jbc.M505858200; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cronin TC, 2004, EMBO J, V23, P3711, DOI 10.1038/sj.emboj.7600388; Croteau NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004443; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; DINITTO JP, 2003, SCI STKE 2003; Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4; Fukai S, 2003, EMBO J, V22, P3267, DOI 10.1093/emboj/cdg329; Godi A, 2004, NAT CELL BIOL, V6, P393, DOI 10.1038/ncb1119; Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hsu SC, 2004, INT REV CYTOL, V233, P243, DOI 10.1016/S0074-7696(04)33006-8; Hsu SC, 1996, NEURON, V17, P1209, DOI 10.1016/S0896-6273(00)80251-2; Hutagalung AH, 2009, MOL BIOL CELL, V20, P153, DOI 10.1091/mbc.E08-02-0157; Jackson SG, 2006, ACTA CRYSTALLOGR D, V62, P324, DOI 10.1107/S0907444905043179; Janin J, 1995, PROTEINS, V23, P580, DOI 10.1002/prot.340230413; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Jin RS, 2005, EMBO J, V24, P2064, DOI 10.1038/sj.emboj.7600699; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Lemmon MA, 2007, BIOCHEM SOC SYMP, V74, P81, DOI 10.1042/BSS2007c08; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu JL, 2007, MOL BIOL CELL, V18, P4483, DOI 10.1091/mbc.E07-05-0461; LO CL, 1999, J MOL BIOL, V285, P2177; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lutz S, 2007, SCIENCE, V318, P1923, DOI 10.1126/science.1147554; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Munson M, 2006, NAT STRUCT MOL BIOL, V13, P577, DOI 10.1038/nsmb1097; Murayama K, 2008, BIOCHEM BIOPH RES CO, V377, P23, DOI 10.1016/j.bbrc.2008.09.055; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Robinson NCG, 1999, MOL CELL BIOL, V19, P3580; Scales SJ, 2002, J BIOL CHEM, V277, P28271, DOI 10.1074/jbc.M204929200; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; TERBUSH DR, 1995, J CELL BIOL, V130, P299, DOI 10.1083/jcb.130.2.299; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Vetter IR, 1999, NATURE, V398, P39, DOI 10.1038/17969; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zhang XY, 2008, J CELL BIOL, V180, P145, DOI 10.1083/jcb.200704128; Zhang XY, 2005, J BIOL CHEM, V280, P20356, DOI 10.1074/jbc.M500511200; Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	57	41	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10424	10433		10.1074/jbc.M109.096966	http://dx.doi.org/10.1074/jbc.M109.096966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139078	Green Published, hybrid			2022-12-27	WOS:000276264600028
J	Emara, MM; Ivanov, P; Hickman, T; Dawra, N; Tisdale, S; Kedersha, N; Hu, GF; Anderson, P				Emara, Mohamed M.; Ivanov, Pavel; Hickman, Tyler; Dawra, Nemisha; Tisdale, Sarah; Kedersha, Nancy; Hu, Guo-Fu; Anderson, Paul			Angiogenin-induced tRNA-derived Stress-induced RNAs Promote Stress-induced Stress Granule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC TRANSLATION INITIATION; INHIBITS TRANSLATION; SURVIVAL; PHOSPHORYLATION; EXPRESSION; TRANSCRIPTION; RECRUITMENT; APOPTOSIS; PROTEINS; PATHWAY	Angiogenin (ANG) is a secreted ribonuclease that cleaves tRNA to initiate a stress-response program in mammalian cells. Here we show that ANG inhibits protein synthesis and promotes arsenite-and pateamine A-induced assembly of stress granules (SGs). These effects are abrogated in cells transfected with the ANG inhibitor RNH1. Transfection of natural or synthetic 5'-but not 3'-tRNA fragments (tRNA-derived stress-induced RNAs; tiRNAs) induces the phospho-eukaryotic translation initiation factor 2 alpha-independent assembly of SGs. Natural 5'-tiRNAs but not 3'-tiRNAs are capped with a 5'-monophosphate that is required for optimal SG assembly. These findings reveal that SG assembly is a component of the ANG- and tiRNA-induced stress response program.	[Anderson, Paul] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Hu, Guo-Fu] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Emara, Mohamed M.] Cairo Univ, Sch Vet Med, Dept Virol, Giza 12211, Egypt	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Egyptian Knowledge Bank (EKB); Cairo University	Anderson, P (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Smith Bldg 652,1 Jimmy Fund Way, Boston, MA 02115 USA.	panderson@rics.bwh.harvard.edu	Ivanov, Pavel/AAZ-9197-2021; Ivanov, Pavel/F-3339-2016	Ivanov, Pavel/0000-0002-7986-7760; Ivanov, Pavel/0000-0002-7986-7760; Hickman, Tyler/0000-0003-2623-3251	National Institutes of Health [AI065858, AI033600, AR0514732]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065858, R01AI033600, R56AI033600] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065237] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI065858, AI033600, and AR0514732.	Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Blazquez M, 1996, J BIOL CHEM, V271, P18638, DOI 10.1074/jbc.271.31.18638; Bordeleau ME, 2005, P NATL ACAD SCI USA, V102, P10460, DOI 10.1073/pnas.0504249102; Dang YJ, 2006, J BIOL CHEM, V281, P32870, DOI 10.1074/jbc.M606149200; Farny NG, 2009, RNA, V15, P1814, DOI 10.1261/rna.1684009; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Hatzi E, 1999, EUR J BIOCHEM, V260, P825, DOI 10.1046/j.1432-1327.1999.00222.x; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hu GF, 1997, P NATL ACAD SCI USA, V94, P2204, DOI 10.1073/pnas.94.6.2204; Ibaragi S, 2009, MOL CANCER RES, V7, P415, DOI 10.1158/1541-7786.MCR-08-0137; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2008, METHOD ENZYMOL, V448, P521, DOI 10.1016/S0076-6879(08)02626-8; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kim WJ, 2007, EMBO J, V26, P5020, DOI 10.1038/sj.emboj.7601920; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Low WK, 2005, MOL CELL, V20, P709, DOI 10.1016/j.molcel.2005.10.008; Low WK, 2007, CHEM BIOL, V14, P715, DOI 10.1016/j.chembiol.2007.05.012; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Monti DM, 2007, FEBS LETT, V581, P930, DOI 10.1016/j.febslet.2007.01.072; MOROIANU J, 1994, P NATL ACAD SCI USA, V91, P1677, DOI 10.1073/pnas.91.5.1677; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Scadden ADJ, 2007, MOL CELL, V28, P491, DOI 10.1016/j.molcel.2007.09.005; Schwarz DS, 2002, MOL CELL, V10, P537, DOI 10.1016/S1097-2765(02)00651-2; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; Shi J, 2006, ONCOGENE, V25, P4923, DOI 10.1038/sj.onc.1209495; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yuan Y, 2009, LUNG CANCER, V66, P28, DOI 10.1016/j.lungcan.2008.12.027	43	318	336	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10959	10968		10.1074/jbc.M109.077560	http://dx.doi.org/10.1074/jbc.M109.077560			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20129916	Green Published, hybrid			2022-12-27	WOS:000276264600080
J	Kim, JH; Konieczkowski, M; Mukherjee, A; Schechtman, S; Khan, S; Schelling, JR; Ross, MD; Bruggeman, LA; Sedor, JR				Kim, Jane H.; Konieczkowski, Martha; Mukherjee, Amitava; Schechtman, Sam; Khan, Shenaz; Schelling, Jeffrey R.; Ross, Michael D.; Bruggeman, Leslie A.; Sedor, John R.			Podocyte Injury Induces Nuclear Translocation of WTIP via Microtubule-dependent Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-JUN; AXONAL-TRANSPORT; RETROGRADE TRANSPORT; ACTIN CYTOSKELETON; GENE-EXPRESSION; LIM DOMAIN; PROTEIN; KINASE; AJUBA; NEPHRIN	Podocyte structural and transcriptional phenotype plasticity characterizes glomerular injury. Transcriptional activity of WT1 (Wilm's tumor 1) is required for normal podocyte structure and is repressed by the podocyte adherens junction protein, WTIP (WT1 interacting protein). Here we show that WTIP translocated into podocyte nuclei in lipopolysaccharide (LPS)-treated mice, a model of transient nephrotic syndrome. Cultured podocytes, which stably expressed an epitope-tagged WTIP, were treated with LPS. Imaging and cellular fractionation studies demonstrated that WTIP translocated from podocyte cell contacts into nuclei within 6 h and relocalized to cell contacts within 24 h after LPS treatment. LPS-stimulated WTIP nuclear translocation required JNK activity, which assembled a multiprotein complex of the scaffolding protein JNK-interacting protein 3 and the molecular motor dynein. Intact microtubule networks and dynein activity were necessary for LPS-stimulated WTIP translocation. Podocytes expressing sh-Wtip change morphology and demonstrate altered actin assembly in cell spreading assays. Stress signaling pathways initiate WTIP nuclear translocation, and the concomitant loss of WTIP from cell contacts changes podocyte morphology and dynamic actin assembly, suggesting a mechanism that transmits changes in podocyte morphology to the nucleus.	[Schelling, Jeffrey R.; Bruggeman, Leslie A.; Sedor, John R.] Case Western Reserve Univ, Dept Med, Sch Med, Cleveland, OH 44109 USA; [Konieczkowski, Martha; Mukherjee, Amitava; Schechtman, Sam; Khan, Shenaz; Schelling, Jeffrey R.; Bruggeman, Leslie A.; Sedor, John R.] Case Western Reserve Univ, Ctr Study Kidney Dis & Biol, Sch Med, Cleveland, OH 44109 USA; [Kim, Jane H.; Sedor, John R.] Case Western Reserve Univ, Dept Physiol & Biophys, Sch Med, Cleveland, OH 44109 USA; [Ross, Michael D.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital	Sedor, JR (corresponding author), 2500 MetroHealth Dr,R415, Cleveland, OH 44109 USA.	john.sedor@case.edu	Mukherjee, Amitava/AAK-4002-2020	Mukherjee, Amitava/0000-0001-5603-5147	National Institutes of Health [DK-07470, P50 DK-054178, DK-064719, F30 DK083897]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK054178, T32DK007470, F30DK083897, R01DK067528, R01DK059997, R01DK064719, R01DK072348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-07470, P50 DK-054178, DK-064719, and F30 DK083897.	Arndt PG, 2004, J BIOL CHEM, V279, P10883, DOI 10.1074/jbc.M309901200; Asanuma K, 2007, P NATL ACAD SCI USA, V104, P10134, DOI 10.1073/pnas.0700917104; Ayyanathan K, 2007, CANCER RES, V67, P9097, DOI 10.1158/0008-5472.CAN-07-2987; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Cortes P, 2000, KIDNEY INT, V58, P2452, DOI 10.1046/j.1523-1755.2000.00428.x; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GUNSTREAM JD, 1995, J NEUROSCI, V15, P439; Hauser PV, 2009, NEPHRON EXP NEPHROL, V112, pE43, DOI 10.1159/000213505; Jeon YJ, 2008, MOL BIOL CELL, V19, P5116, DOI 10.1091/mbc.E08-06-0576; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kanungo J, 2000, MOL BIOL CELL, V11, P3299, DOI 10.1091/mbc.11.10.3299; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Kerjaschki D, 2001, J CLIN INVEST, V108, P1583, DOI 10.1172/JCI200114629; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Langer EM, 2008, DEV CELL, V14, P424, DOI 10.1016/j.devcel.2008.01.005; Lindwall C, 2005, MOL CELL NEUROSCI, V29, P269, DOI 10.1016/j.mcn.2005.03.002; Liu G, 2006, J BIOL CHEM, V281, P39681, DOI 10.1074/jbc.M606664200; Matsuguchi T, 2003, EMBO J, V22, P4455, DOI 10.1093/emboj/cdg438; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Montoya-Durango DE, 2008, J BIOL CHEM, V283, P32056, DOI 10.1074/jbc.M802320200; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Mundel P, 2002, J AM SOC NEPHROL, V13, P3005, DOI 10.1097/01.ASN.0000039661.06947.FD; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Rastaldi MP, 2006, FASEB J, V20, P976, DOI 10.1096/fj.05-4962fje; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Ronco P, 2007, J CLIN INVEST, V117, P2079, DOI 10.1172/JCI32966; Saleem MA, 2002, AM J PATHOL, V161, P1459, DOI 10.1016/S0002-9440(10)64421-5; Sever S, 2007, J CLIN INVEST, V117, P2095, DOI 10.1172/JCI32022; Smoyer WE, 1998, J MOL MED, V76, P172, DOI 10.1007/s001090050206; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Srichai MB, 2004, J BIOL CHEM, V279, P14398, DOI 10.1074/jbc.M314155200; Takino T, 2005, J BIOL CHEM, V280, P37772, DOI 10.1074/jbc.M505241200; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Verhey KJ, 2007, CURR BIOL, V17, pR804, DOI 10.1016/j.cub.2007.07.005	44	23	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9995	10004		10.1074/jbc.M109.061671	http://dx.doi.org/10.1074/jbc.M109.061671			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20086015	Green Published, hybrid			2022-12-27	WOS:000276165900068
J	Li, DQ; Pakala, SB; Reddy, SDN; Ohshiro, K; Peng, SH; Lian, Y; Fu, SW; Kumar, R				Li, Da-Qiang; Pakala, Suresh B.; Reddy, Sirigiri Divijendra Natha; Ohshiro, Kazufumi; Peng, Shao-Hua; Lian, Yi; Fu, Sidney W.; Kumar, Rakesh			Revelation of p53-independent Function of MTA1 in DNA Damage Response via Modulation of the p21(WAF1)-Proliferating Cell Nuclear Antigen Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; TRANSCRIPTIONAL REPRESSION; INDIVIDUAL CELLS; EXCISION-REPAIR; HISTONE H2AX; PCNA; P21; P53; EXPRESSION; REPLICATION	Although metastasis-associated protein 1 (MTA1), a component of the nucleosome remodeling and deacetylase (NuRD) complex, is a DNA-damage response protein and regulates p53-dependent DNA repair, it remains unknown whether MTA1 also participates in p53-independent DNA damage response. Here, we provide evidence that MTA1 is a p53-independent transcriptional corepressor of p21(WAF1), and the underlying mechanism involves recruitment of MTA1-histone deacetylase 2 (HDAC2) complexes onto two selective regions of the p21(WAF1) promoter. Accordingly, MTA1 depletion, despite its effect on p53 down-regulation, superinduces p21(WAF1), increases p21(WAF1) binding to proliferating cell nuclear antigen (PCNA), and decreases the nuclear accumulation of PCNA in response to ionizing radiation. In support of a p53-independent role of MTA1 in DNA damage response, we further demonstrate that induced expression of MTA1 in p53-null cells inhibits p21(WAF1) promoter activity and p21(WAF1) binding to PCNA. Consequently, MTA1 expression in p53-null cells results in increased induction of gamma H2AX foci and DNA double strand break repair, and decreased DNA damage sensitivity following ionizing radiation treatment. These findings uncover a new target of MTA1 and the existence of an additional p53-independent role of MTA1 in DNA damage response, at least in part, by modulating the p21(WAF1)-PCNA pathway, and thus, linking two previously unconnected NuRD complex and DNA-damage response pathways.	[Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; George Washington Univ, Med Ctr, Inst Coregulator Biol, Washington, DC 20037 USA	George Washington University; George Washington University	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendra reddy/E-1031-2017; sirigiri, divijendranathareddy/A-9857-2010	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Pakala, Suresh Babu/0000-0002-5679-4837	National Institutes of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA98823 and CA98823-S1 (to R.K.).	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Balasenthil S, 2007, CANCER RES, V67, P7132, DOI 10.1158/0008-5472.CAN-07-0750; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; de Rozieres S, 2000, ONCOGENE, V19, P1691, DOI 10.1038/sj.onc.1203468; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; HARPER JW, 1993, CELL, V75, P805; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DQ, 2009, J BIOL CHEM, V284, P34545, DOI 10.1074/jbc.M109.056499; Li DQ, 2009, P NATL ACAD SCI USA, V106, P17493, DOI 10.1073/pnas.0908027106; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; MICHIELI P, 1994, CANCER RES, V54, P3391; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Molli PR, 2008, ONCOGENE, V27, P1971, DOI 10.1038/sj.onc.1210839; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; PARKER SB, 1995, SCIENCE, V267, P1024, DOI 10.1126/science.7863329; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Savio M, 1998, CARCINOGENESIS, V19, P591, DOI 10.1093/carcin/19.4.591; SHIVJI MKK, 1994, CURR BIOL, V4, P1062, DOI 10.1016/S0960-9822(00)00244-X; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Tom S, 2001, J BIOL CHEM, V276, P48781, DOI 10.1074/jbc.M109626200; TOSCHI L, 1988, J CELL BIOL, V107, P1623, DOI 10.1083/jcb.107.5.1623; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Walsh CP, 2006, CURR TOP MICROBIOL, V301, P283; Zeng YX, 1996, ONCOGENE, V12, P1557	39	48	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10044	10052		10.1074/jbc.M109.079095	http://dx.doi.org/10.1074/jbc.M109.079095			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20071335	Green Published, hybrid			2022-12-27	WOS:000276165900072
J	Maltsev, AS; Oswald, RE				Maltsev, Alexander S.; Oswald, Robert E.			Hydrophobic Side Chain Dynamics of a Glutamate Receptor Ligand Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIME-SCALE DYNAMICS; GLUR2 AMPA RECEPTOR; CRYSTAL-STRUCTURES; NMR-SPECTROSCOPY; CONFORMATIONAL-CHANGES; PARTIAL AGONISTS; PEPTIDE COMPLEX; CAVITY MUTANT; ION CHANNELS; T4 LYSOZYME	Ionotropic glutamate receptors are ligand-gated ion channels that mediate much of the fast excitatory neurotransmission in the central nervous system. The extracellular ligand binding core (S1S2) of the GluR2 subtype of ionotropic glutamate receptors can be produced as a soluble protein with properties essentially identical to the corresponding domain in the intact, membrane-bound protein. Using a variety of biophysical techniques, much has been learned about the structure and dynamics of S1S2 and the relationship between its ligand-induced conformational changes and the function of the receptor. It is clear that dynamic processes are essential to the function of ionotropic glutamate receptors. We have isotopically labeled side chain methyls of GluR2 S1S2 and used NMR spectroscopy to study their dynamics on the ps-ns and mu s-ms time scales. Increased disorder is seen in regions that are part of the key dimer interface in the intact protein. When glutamate is bound, the degree of ps-ns motion is less than that observed with other ligands, suggesting that the physiological agonist binds to a preformed binding site. At the slower time scales, the degree of S1S2 flexibility induced by ligand binding is greatest for willardiine partial agonists, least for antagonists, and intermediate for full agonists. Notable differences among bound ligands are in the region of the protein that forms a hinge between two lobes that close upon agonist binding, and along the beta-sheet in Lobe 2. These motions provide clues as to the functional properties of partial agonists and to the conformational changes associated with lobe closure and channel activation.	[Maltsev, Alexander S.; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	reo1@cornell.edu	Maltsev, Alexander/A-8175-2012		National Institutes of Health [R01-GM068935]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant R01-GM068935 from the National Institutes of Health.	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Ahmed AH, 2009, BIOCHEMISTRY-US, V48, P3894, DOI 10.1021/bi900107m; Ahmed AH, 2007, J BIOL CHEM, V282, P12773, DOI 10.1074/jbc.M610077200; Akke M, 1996, J AM CHEM SOC, V118, P911, DOI 10.1021/ja953503r; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Asztely F, 1996, MOL NEUROBIOL, V12, P1, DOI 10.1007/BF02740744; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; Cheng Q, 2002, BIOCHEMISTRY-US, V41, P1602, DOI 10.1021/bi015729e; DAVIS DG, 1994, J MAGN RESON SER B, V104, P266, DOI 10.1006/jmrb.1994.1084; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dingledine R, 1999, PHARMACOL REV, V51, P7; Du M, 2005, J BIOL CHEM, V280, P8633, DOI 10.1074/jbc.C400590200; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; Gill A, 2008, BIOCHEMISTRY-US, V47, P13831, DOI 10.1021/bi8013196; Gizachew D, 2001, BIOCHEMISTRY-US, V40, P14368, DOI 10.1021/bi010989h; Goddard T. D., SPARKY3; Goto NK, 1999, J BIOMOL NMR, V13, P369, DOI 10.1023/A:1008393201236; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Ishima R, 1999, J AM CHEM SOC, V121, P11589, DOI 10.1021/ja992836b; Jayaraman V, 2000, BIOCHEMISTRY-US, V39, P8693, DOI 10.1021/bi000892f; Jayaraman V, 2000, FEBS LETT, V475, P278, DOI 10.1016/S0014-5793(00)01690-2; Kasper C, 2006, J MOL BIOL, V357, P1184, DOI 10.1016/j.jmb.2006.01.024; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Madden DR, 2000, EUR J BIOCHEM, V267, P4281; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2001, J MOL BIOL, V311, P815, DOI 10.1006/jmbi.2001.4884; McFeeters RL, 2002, J BIOMOL NMR, V22, P297, DOI 10.1023/A:1014954931635; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; Mulder FAA, 2001, J AM CHEM SOC, V123, P967, DOI 10.1021/ja003447g; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Skrynnikov NR, 2001, J AM CHEM SOC, V123, P4556, DOI 10.1021/ja004179p; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Tugarinov V, 2005, BIOCHEMISTRY-US, V44, P15970, DOI 10.1021/bi0519809; Tugarinov V, 2003, J AM CHEM SOC, V125, P13868, DOI 10.1021/ja030345s; Valentine ER, 2005, BIOCHEMISTRY-US, V44, P3410, DOI 10.1021/bi047984f; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581	51	14	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10154	10162		10.1074/jbc.M109.088641	http://dx.doi.org/10.1074/jbc.M109.088641			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110365	Green Published, hybrid			2022-12-27	WOS:000276165900082
J	Rosato, RR; Kolla, SS; Hock, SK; Almenara, JA; Patel, A; Amin, S; Atadja, P; Fisher, PB; Dent, P; Grant, S				Rosato, Roberto R.; Kolla, Sarah S.; Hock, Stefanie K.; Almenara, Jorge A.; Patel, Ankita; Amin, Sanjay; Atadja, Peter; Fisher, Paul B.; Dent, Paul; Grant, Steven			Histone Deacetylase Inhibitors Activate NF-kappa B in Human Leukemia Cells through an ATM/NEMO-related Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; RISK MYELODYSPLASTIC SYNDROME; SUPEROXIDE-DISMUTASE GENE; ALPHA-INDUCED APOPTOSIS; DOUBLE-STRAND BREAKS; DNA-DAMAGE; REACTIVE OXYGEN; TNF-ALPHA; CANCER-CELLS; GENOTOXIC STRESS	Mechanisms underlying histone deacetylase inhibitor (HDACI)-mediated NF-kappa B activation were investigated in human leukemia cells. Exposure of U937 and other leukemia cells to LBH-589 induced reactive oxygen species (ROS) followed by single strand (XRCC1) and double strand (gamma-H2AX) DNA breaks. Notably, LBH-589 lethality was markedly attenuated by small interfering RNA (siRNA) knockdown of the DNA damage-linked histone, H1.2.LBH-589 triggered p65/RelA activation, NF-kappa B-dependent induction of Mn-SOD2, and ROS elimination. Interference with LBH-589-mediated NF-kappa B activation (e.g. in I kappa B alpha super-repressor transfected cells) diminished HDACI-mediated Mn-SOD2 induction and increased ROS accumulation, DNA damage, and apoptosis. The Mn-SOD2 mimetic TBAP (manganese(III)-tetrakis 4-benzoic acid porphyrin) prevented HDACI-induced ROS and NF-kappa B activation while dramatically attenuating DNA damage and cell death. In contrast, TRAF2 siRNA knockdown, targeting receptor-mediated NF-kappa B activation, blocked TNF alpha- but not HDACI-mediated NF-kappa B activation and lethality. Consistent with ROS-mediated DNA damage, LBH-589 exposure activated ATM (on serine 1981) and increased its association with NEMO. Significantly, siRNA NEMO or ATM knockdown blocked HDACI-mediated NF-kappa B activation, resulting in diminished Mn-SOD2 induction and enhanced oxidative DNA damage and cell death. In accord with the recently described DNA damage/ATM/NEMO pathway, SUMOylation site mutant NEMO (K277A or K309A) cells exposed to LBH-589 displayed diminished ATM/NEMO association, NEMO and p65/RelA nuclear localization/activation, and MnSOD2 up-regulation. These events were accompanied by increased ROS production, gamma-H2AX formation, and cell death. Together, these findings indicate that in human leukemia cells, HDACIs activate the cytoprotective NF-kappa B pathway through an ATM/NEMO/SUMOylation-dependent process involving the induction of ROS and DNA damage and suggest that blocking NF-kappa B activation via the atypical ATM/NEMO nuclear pathway can enhance HDACI antileukemic activity.	[Rosato, Roberto R.; Kolla, Sarah S.; Hock, Stefanie K.; Almenara, Jorge A.; Patel, Ankita; Amin, Sanjay; Grant, Steven] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA; [Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23298 USA; [Dent, Paul; Grant, Steven] Virginia Commonwealth Univ, Dept Biochem, Massey Canc Ctr, Richmond, VA 23298 USA; [Fisher, Paul B.; Dent, Paul; Grant, Steven] Virginia Commonwealth Univ, Inst Mol Med, Richmond, VA 23298 USA; [Atadja, Peter] Novartis Inst Biomed Res, Dept Oncol, Cambridge, MA 02139 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Novartis	Grant, S (corresponding author), MCV Stn Box 230, Richmond, VA 23298 USA.	stgrant@vcu.edu			National Cancer Institute [CA63753, CA93738, CA100866]; Leukemia and Lymphoma Society of America; Lymphoma SPORE [1P50 CA130805]; The V Foundation for Cancer Research; National Institutes of Health [P30CA16059]; NATIONAL CANCER INSTITUTE [R01CA093738, R01CA141703, R01CA063753, P50CA130805, R01CA100866, P30CA016059, R01CA150214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052825] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society of America(Leukemia and Lymphoma Society); Lymphoma SPORE; The V Foundation for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA63753, CA93738, and CA100866 from the National Cancer Institute, the Leukemia and Lymphoma Society of America, and Lymphoma SPORE Award 1P50 CA130805. This work was also supported by an award from The V Foundation for Cancer Research.; We thank Frances White for help with confocal imaging at the Confocal Imaging and Flow Cytometry Core Facility at Massey Cancer Center, supported in part by National Institutes of Health Grant P30CA16059.	Adam E, 2003, MOL CELL BIOL, V23, P6200, DOI 10.1128/MCB.23.17.6200-6209.2003; Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Aggarwal BB, 1996, EUR CYTOKINE NETW, V7, P93; [Anonymous], 2003, NAT CELL BIOL, V5, P489, DOI 10.1038/ncb0603-490; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bartek J, 2006, SCIENCE, V311, P1110, DOI 10.1126/science.1124540; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Bhalla KN, 2005, J CLIN ONCOL, V23, P3971, DOI 10.1200/JCO.2005.16.600; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Boehrer S, 2009, ONCOGENE, V28, P2205, DOI 10.1038/onc.2009.69; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Carvalho G, 2007, ONCOGENE, V26, P2299, DOI 10.1038/sj.onc.1210043; Chen CS, 2007, CANCER RES, V67, P5318, DOI 10.1158/0008-5472.CAN-06-3996; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2002, EMBO J, V21, P6539, DOI 10.1093/emboj/cdf660; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Chen ZJ, 2006, CELL DEATH DIFFER, V13, P687, DOI 10.1038/sj.cdd.4401869; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Dai Y, 2005, MOL CELL BIOL, V25, P5429, DOI 10.1128/MCB.25.13.5429-5444.2005; Dai Y, 2003, CELL CYCLE, V2, P467, DOI 10.4161/cc.2.5.465; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Delhalle S, 2002, ONCOGENE, V21, P3917, DOI 10.1038/sj.onc.1205489; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Djavaheri-Mergny M, 2004, FEBS LETT, V578, P111, DOI 10.1016/j.febslet.2004.10.082; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Gaymes TJ, 2006, MOL CANCER RES, V4, P563, DOI 10.1158/1541-7786.MCR-06-0111; Geng L, 2006, CANCER RES, V66, P11298, DOI 10.1158/0008-5472.CAN-06-0049; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Gloire G, 2006, BIOCHEM PHARMACOL, V72, P1493, DOI 10.1016/j.bcp.2006.04.011; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Grant S, 2007, NAT REV DRUG DISCOV, V6, P21, DOI 10.1038/nrd2227; Greene Warner C, 2004, Novartis Found Symp, V259, P208; Grosjean-Raillard J, 2009, ONCOGENE, V28, P1099, DOI 10.1038/onc.2008.457; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hayakawa M, 2003, EMBO J, V22, P3356, DOI 10.1093/emboj/cdg332; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Hur GM, 2003, GENE DEV, V17, P873, DOI 10.1101/gad.1062403; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kato T, 2003, MOL CELL, V12, P829, DOI 10.1016/S1097-2765(03)00358-7; Kim YK, 2006, CELL DEATH DIFFER, V13, P2033, DOI 10.1038/sj.cdd.4401915; Kiningham KK, 2004, BIOCHEM J, V384, P543, DOI 10.1042/BJ20040714; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Krappmann D, 2005, EMBO REP, V6, P321, DOI 10.1038/sj.embor.7400380; Liu J, 2008, MOL IMMUNOL, V45, P3984, DOI 10.1016/j.molimm.2008.06.012; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; Mayo MW, 2003, J BIOL CHEM, V278, P18980, DOI 10.1074/jbc.M211695200; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Neumann M, 2007, FASEB J, V21, P2642, DOI 10.1096/fj.06-7615rev; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Rahmani M, 2007, MOL CELL BIOL, V27, P5499, DOI 10.1128/MCB.01080-06; Rosato RR, 2008, MOL CANCER THER, V7, P3285, DOI 10.1158/1535-7163.MCT-08-0385; Rosato RR, 2003, CANCER RES, V63, P3637; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiotani B, 2006, MOL CANCER RES, V4, P125, DOI 10.1158/1541-7786.MCR-05-0104; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; Tapia MA, 2007, CELL CYCLE, V6, P2284, DOI 10.4161/cc.6.18.4721; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513; Wuerzberger-Davis SM, 2007, ONCOGENE, V26, P641, DOI 10.1038/sj.onc.1209815; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Xu WS, 2006, P NATL ACAD SCI USA, V103, P15540, DOI 10.1073/pnas.0607518103; Xu Y, 1999, ONCOGENE, V18, P93, DOI 10.1038/sj.onc.1202265; Zhang LQ, 2009, J MOL BIOL, V389, P495, DOI 10.1016/j.jmb.2009.04.054	79	51	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10064	10077		10.1074/jbc.M109.095208	http://dx.doi.org/10.1074/jbc.M109.095208			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20065354	Green Published, hybrid			2022-12-27	WOS:000276165900074
J	Limapichat, W; Lester, HA; Dougherty, DA				Limapichat, Walrati; Lester, Henry A.; Dougherty, Dennis A.			Chemical Scale Studies of the Phe-Pro Conserved Motif in the Cys Loop of Cys Loop Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; UNNATURAL AMINO-ACIDS; GATED ION-CHANNEL; SUPPRESSOR TRANSFER-RNAS; CIS-TRANS ISOMERIZATION; IN-VIVO INCORPORATION; X-RAY-STRUCTURE; PROLINE RESIDUES; AGONIST BINDING; PEPTIDE-BONDS	The functions of two conserved residues, Phe(135) and Pro(136), located at the apex of the Cys loop of the nicotinic acetylcholine receptor are investigated. Both residues were substituted with natural and unnatural amino acids, focusing on the role of aromaticity at Phe(135), backbone conformation at Pro(136), side chain polarity and volume, and the specific interaction between the aromatic side chain and the proline. NMR spectroscopy studies of model peptides containing proline and unnatural proline analogues following a Phe show a consistent increase in the population of the cis conformer relative to peptides lacking the Phe. In the receptor, a strong interaction between the Phe and Pro residues is evident, as is a strong preference for aromaticity and hydrophobicity at the Phe site. A similar influence of hydrophobicity is observed at the proline site. In addition, across a simple homologous series of proline analogues, the results reveal a correlation between receptor function and cis bias at the proline backbone. This could suggest a significant role for the cis proline conformer at this site in receptor function.	[Limapichat, Walrati; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Lester, Henry A.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Dougherty, DA (corresponding author), CALTECH, Div Chem, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu			National Institutes of Health [NS-34407, NS-11756]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756, R01NS034407, R37NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS-34407 and NS-11756.	Bhattacharyya R, 2003, J MOL BIOL, V331, P925, DOI 10.1016/S0022-2836(03)00759-9; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cashin AL, 2005, J AM CHEM SOC, V127, P350, DOI 10.1021/ja0461771; Chakrapani S, 2004, J GEN PHYSIOL, V123, P341, DOI 10.1085/jgp.200309004; Cheng XL, 2007, BIOPHYS J, V93, P2622, DOI 10.1529/biophysj.107.109843; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Deane CM, 2001, J BIOL CHEM, V276, P37962; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dugave C, 2003, CHEM REV, V103, P2475, DOI 10.1021/cr0104375; Fu DX, 1996, J BIOL CHEM, V271, P31479, DOI 10.1074/jbc.271.49.31479; Gleitsman KR, 2008, J BIOL CHEM, V283, P35638, DOI 10.1074/jbc.M807226200; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; McMenimen KA, 2006, ACS CHEM BIOL, V1, P227, DOI 10.1021/cb6000944; Millar NS, 2003, BIOCHEM SOC T, V31, P869, DOI 10.1042/BST0310869; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Paulsen IM, 2009, J NEUROCHEM, V110, P870, DOI 10.1111/j.1471-4159.2009.06180.x; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; RICKERT KW, 1995, CHEM BIOL, V2, P751, DOI 10.1016/1074-5521(95)90103-5; Rodriguez EA, 2007, RNA, V13, P1715, DOI 10.1261/rna.667607; Rodriguez EA, 2007, RNA, V13, P1703, DOI 10.1261/rna.666807; Saks ME, 1996, J BIOL CHEM, V271, P23169, DOI 10.1074/jbc.271.38.23169; Sansom MSP, 2000, TRENDS PHARMACOL SCI, V21, P445; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Thomas KM, 2006, J AM CHEM SOC, V128, P2216, DOI 10.1021/ja057901y; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Wu WJ, 1998, J ORG CHEM, V63, P6689, DOI 10.1021/jo981340u	39	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8976	8984		10.1074/jbc.M109.060939	http://dx.doi.org/10.1074/jbc.M109.060939			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20068044	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000275553700049
J	Volkmann, G; Murphy, PW; Rowland, EE; Cronan, JE; Liu, XQ; Blouin, C; Byers, DM				Volkmann, Gerrit; Murphy, Peter W.; Rowland, Elden E.; Cronan, John E., Jr.; Liu, Xiang-Qin; Blouin, Christian; Byers, David M.			Intein-mediated Cyclization of Bacterial Acyl Carrier Protein Stabilizes Its Folded Conformation but Does Not Abolish Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHASE; MOLECULAR-DYNAMICS; IN-VIVO; RESIDUES; BINDING; REVEAL; SITE; IDENTIFICATION; MUTAGENESIS; FORMS	Bacterial acyl carrier protein (ACP) is essential for the synthesis of fatty acids and serves as the major acyl donor for the formation of phospholipids and other lipid products. Acyl-ACP encloses attached fatty acyl groups in a hydrophobic pocket within a four-helix bundle, but must at least partially unfold to present the acyl chain to the active sites of its multiple enzyme partners. To further examine the constraints of ACP structure and function, we have constructed a cyclic version of Vibrio harveyi ACP, using split-intein technology to covalently join its closely apposed N and C termini. Cyclization stabilized ACP in a folded helical conformation as indicated by gel electrophoresis, circular dichroism, fluorescence, and mass spectrometry. Molecular dynamics simulations also indicated overall decreased polypeptide chain mobility in cyclic ACP, although no major conformational rearrangements over a 10-ns period were noted. In vivo complementation assays revealed that cyclic ACP can functionally replace the linear wild-type protein and support growth of an Escherichia coli ACP-null mutant strain. Cyclization of a folding-deficient ACP mutant (F50A) both restored its ability to adopt a folded conformation and enhanced complementation of growth. Our results thus suggest that ACP must be able to adopt a folded conformation for biological activity, and that its function does not require complete unfolding of the protein.	[Volkmann, Gerrit; Murphy, Peter W.; Liu, Xiang-Qin; Blouin, Christian; Byers, David M.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada; [Murphy, Peter W.; Rowland, Elden E.; Byers, David M.] Dalhousie Univ, Dept Pediat, Atlantic Res Ctr, Halifax, NS B3H 4H7, Canada; [Cronan, John E., Jr.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E., Jr.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Blouin, Christian] Dalhousie Univ, Fac Comp Sci, Halifax, NS B3H 1W5, Canada	Dalhousie University; Dalhousie University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Dalhousie University	Byers, DM (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, 5850 Coll St, Halifax, NS B3H 1X5, Canada.	david.byers@dal.ca	Cronan, John/V-6626-2019	Blouin, Christian/0000-0002-4434-4142	National Institutes of Health [AI15650]; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; IWK Health Centre Studentship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); IWK Health Centre Studentship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650 (to J.E.C.). This work was also supported by the Natural Sciences and Engineering Research Council of Canada (to D. M. B.), Canadian Institutes of Health Research (to X. Q. L.), and by an IWK Health Centre Studentship (to P. W. M.).	ANDREC M, 1995, PROTEIN SCI, V4, P983; Battesti A, 2009, J BACTERIOL, V191, P616, DOI 10.1128/JB.01195-08; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Chan DI, 2008, J BIOL CHEM, V283, P33620, DOI 10.1074/jbc.M805323200; Colizzi F, 2008, J CHEM INF MODEL, V48, P2289, DOI 10.1021/ci800297v; De Lay NR, 2007, J BIOL CHEM, V282, P20319, DOI 10.1074/jbc.M703789200; De Lay NR, 2006, J BACTERIOL, V188, P287, DOI 10.1128/JB.188.1.287-296.2006; DeLano W.L, PYMOL MOL GRAPHICS S; Dennis JJ, 1998, BIOTECHNIQUES, V25, P772, DOI 10.2144/98255bm04; Flaman AS, 2001, J BIOL CHEM, V276, P35934, DOI 10.1074/jbc.M101849200; Gong H, 2003, BIOCHEM BIOPH RES CO, V302, P35, DOI 10.1016/S0006-291X(03)00108-6; Gong HS, 2008, BBA-PROTEINS PROTEOM, V1784, P1835, DOI 10.1016/j.bbapap.2008.07.017; Gong HS, 2007, J BIOL CHEM, V282, P4494, DOI 10.1074/jbc.M608234200; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KATTA V, 1991, RAPID COMMUN MASS SP, V5, P214, DOI 10.1002/rcm.1290050415; Keating MM, 2002, BBA-PROTEINS PROTEOM, V1601, P208, DOI 10.1016/S1570-9639(02)00470-3; Kim Y, 2006, BIOCHEM BIOPH RES CO, V341, P776, DOI 10.1016/j.bbrc.2006.01.025; KIM YM, 1990, PROTEINS, V8, P377, DOI 10.1002/prot.340080411; Konermann L, 1997, BIOCHEMISTRY-US, V36, P12296, DOI 10.1021/bi971266u; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Leibundgut M, 2008, CURR OPIN STRUC BIOL, V18, P714, DOI 10.1016/j.sbi.2008.09.008; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Murphy PW, 2007, J AM SOC MASS SPECTR, V18, P1525, DOI 10.1016/j.jasms.2007.05.012; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ploskon E, 2008, J BIOL CHEM, V283, P518, DOI 10.1074/jbc.M703454200; Rafi S, 2006, J BIOL CHEM, V281, P39285, DOI 10.1074/jbc.M608758200; ROCK CO, 1981, J BIOL CHEM, V256, P2669; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Roujeinikova A, 2007, J MOL BIOL, V365, P135, DOI 10.1016/j.jmb.2006.09.049; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Watt SJ, 2007, J AM SOC MASS SPECTR, V18, P1605, DOI 10.1016/j.jasms.2007.06.004; Worsham LAS, 2003, BIOCHEMISTRY-US, V42, P167, DOI 10.1021/bi0261950; Wu BN, 2009, PROTEIN SCI, V18, P240, DOI 10.1002/pro.11; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zhang YM, 2003, J LIPID RES, V44, P1, DOI 10.1194/jlr.R200016-JLR200; Zhang YM, 2001, J BIOL CHEM, V276, P8231, DOI 10.1074/jbc.M008042200; Zornetzer GA, 2006, BIOCHEMISTRY-US, V45, P5217, DOI 10.1021/bi052062d	41	18	23	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8605	8614		10.1074/jbc.M109.060863	http://dx.doi.org/10.1074/jbc.M109.060863			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20083605	Green Published, hybrid			2022-12-27	WOS:000275553700012
J	Jiao, XM; Katiyar, S; Willmarth, NE; Liu, MR; Ma, XJ; Flomenberg, N; Lisanti, MP; Pestell, RG				Jiao, Xuanmao; Katiyar, Sanjay; Willmarth, Nicole E.; Liu, Manran; Ma, Xiaojing; Flomenberg, Neal; Lisanti, Michael P.; Pestell, Richard G.			c-Jun Induces Mammary Epithelial Cellular Invasion and Breast Cancer Stem Cell Expansion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDEHYDE DEHYDROGENASE-ACTIVITY; CHEMOKINE RANTES; TYROSINE KINASE; TRANSGENIC MICE; EXPRESSION; METASTASIS; CARCINOMA; MIGRATION; PROGRESSION; MOTILITY	The molecular mechanisms governing breast tumor cellular self-renewal contribute to breast cancer progression and therapeutic resistance. The ErbB2 oncogene is overexpressed in similar to 30% of human breast cancers. c-Jun, the first cellular protooncogene, is overexpressed in human breast cancer. However, the role of endogenous c-Jun in mammary tumor progression is unknown. Herein, transgenic mice expressing the mammary gland-targeted ErbB2 oncogene were crossed with c-jun(f/f) transgenic mice to determine the role of endogenous c-Jun in mammary tumor invasion and stem cell function. The excision of c-jun by Cre recombinase reduced cellular migration, invasion, and mammosphere formation of ErbB2-induced mammary tumors. Proteomic analysis identified a subset of secreted proteins (stem cell factor (SCF) and CCL5) induced by ErbB2 expression that were dependent upon endogenous c-Jun expression. SCF and CCL5 were identified as transcriptionally induced by c-Jun. CCL5 rescued the c-Jun-deficient breast tumor cellular invasion phenotype. SCF rescued the c-Jun-deficient mammosphere production. Endogenous c-Jun thus contributes to ErbB2-induced mammary tumor cell invasion and self-renewal.	[Lisanti, Michael P.; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Flomenberg, Neal; Lisanti, Michael P.; Pestell, Richard G.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Oncol, Philadelphia, PA 19107 USA; [Ma, Xiaojing] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10065 USA	Jefferson University; Jefferson University; Cornell University	Pestell, RG (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	richard.pestell@jefferson.edu	Lisanti, Michael/B-6131-2018; Lisanti, Michael P/C-6866-2013	Lisanti, Michael/0000-0003-2034-1382; Katiyar, Sanjay/0000-0003-1622-5661	National Institutes of Health [R01CA70896, R01CA75503, R01CA107382, R01CA120876]; Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R01CA120876, R01CA070896, R01CA107382, R01CA075503, R01CA100223, P30CA056036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Ralph and Marian C. Falk Medical Research Trust; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA70896, R01CA75503, and R01CA107382 (to R. G. P.) and R01CA120876 (to M. P. L.). This project was also funded in part by grants from the Dr. Ralph and Marian C. Falk Medical Research Trust and the Pennsylvania Department of Health (to R. G. P.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Ali S, 2000, AM J PATHOL, V157, P313, DOI 10.1016/S0002-9440(10)64542-7; Armstrong L, 2004, STEM CELLS, V22, P1142, DOI 10.1634/stemcells.2004-0170; Azenshtein E, 2002, CANCER RES, V62, P1093; Bottcher MF, 2000, PEDIATR RES, V47, P592, DOI 10.1203/00006450-200005000-00006; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; D'Amico M, 2003, CANCER RES, V63, P3395; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Eferl R, 1999, J CELL BIOL, V145, P1049, DOI 10.1083/jcb.145.5.1049; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grange C, 2008, NEOPLASIA, V10, P1433, DOI 10.1593/neo.08902; Gu JG, 1999, J CELL BIOL, V146, P389, DOI 10.1083/jcb.146.2.389; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Hulit J, 2006, CANCER RES, V66, P8529, DOI 10.1158/0008-5472.CAN-06-0149; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jiao XM, 2008, MOL BIOL CELL, V19, P1378, DOI 10.1091/mbc.E07-08-0753; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Katiyar S, 2007, MOL CELL BIOL, V27, P1356, DOI 10.1128/MCB.01061-06; Leek RD, 1996, CANCER RES, V56, P4625; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Li ZP, 2006, CANCER RES, V66, P9986, DOI 10.1158/0008-5472.CAN-06-1596; Li ZP, 2006, MOL CELL BIOL, V26, P4240, DOI 10.1128/MCB.02124-05; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lindsay J, 2008, CTS-CLIN TRANSL SCI, V1, P107, DOI 10.1111/j.1752-8062.2008.00041.x; Liu YM, 2004, ONCOGENE, V23, P8238, DOI 10.1038/sj.onc.1207889; Luboshits G, 1999, CANCER RES, V59, P4681; Maeda S, 2003, CANCER CELL, V3, P102, DOI 10.1016/S1535-6108(03)00025-4; Matsui J, 2004, J BIOL CHEM, V279, P18600, DOI 10.1074/jbc.M311643200; Michie CA, 1998, EUR CYTOKINE NETW, V9, P123; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Negus RPM, 1997, AM J PATHOL, V150, P1723; Neumeister P, 2003, MOL BIOL CELL, V14, P2005, DOI 10.1091/mbc.02-07-0102; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; SONNENBERG JL, 1989, SCIENCE, V246, P1622, DOI 10.1126/science.2512642; Sugimoto Y, 1999, J CELL PHYSIOL, V181, P285, DOI 10.1002/(SICI)1097-4652(199911)181:2<285::AID-JCP10>3.0.CO;2-O; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; VANNETTEN JP, 1993, LANCET, V342, P872, DOI 10.1016/0140-6736(93)92734-B; Velasco-Velazquez MA, 2009, EXPERT REV ANTICANC, V9, P275, DOI 10.1586/14737140.9.3.275; Vial E, 2003, CANCER CELL, V4, P67, DOI 10.1016/S1535-6108(03)00162-4; Vleugel MM, 2006, HUM PATHOL, V37, P668, DOI 10.1016/j.humpath.2006.01.022; vonLuettichau I, 1996, CYTOKINE, V8, P89, DOI 10.1006/cyto.1996.0012; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; West RB, 2005, PLOS BIOL, V3, P1101, DOI 10.1371/journal.pbio.0030187; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Xia Y, 2004, TRENDS CELL BIOL, V14, P94, DOI 10.1016/j.tcb.2003.12.005; YARDEN Y, 1987, EMBO J, V6, P3341, DOI 10.1002/j.1460-2075.1987.tb02655.x; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	56	100	107	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8218	8226		10.1074/jbc.M110.100792	http://dx.doi.org/10.1074/jbc.M110.100792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20053993	Green Published, hybrid			2022-12-27	WOS:000275413800040
J	Glazer, L; Shechter, A; Tom, M; Yudkovski, Y; Weil, S; Aflalo, ED; Pamuru, RR; Khalaila, I; Bentov, S; Berman, A; Sagi, A				Glazer, Lilah; Shechter, Assaf; Tom, Moshe; Yudkovski, Yana; Weil, Simy; Aflalo, Eliahu David; Pamuru, Ramachandra Reddy; Khalaila, Isam; Bentov, Shmuel; Berman, Amir; Sagi, Amir			A Protein Involved in the Assembly of an Extracellular Calcium Storage Matrix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRAYFISH CHERAX-QUADRICARINATUS; PROCAMBARUS-CLARKII; MOLT CYCLE; CUTICULAR PROTEINS; ORGANIC MATRIX; GEL-ELECTROPHORESIS; SKELETAL STRUCTURES; VIRILIS HAGEN; EXOSKELETON; EXPRESSION	Gastroliths, the calcium storage organs of crustaceans, consist of chitin-protein-mineral complexes in which the mineral component is stabilized amorphous calcium carbonate. To date, only three proteins, GAP 65, gastrolith matrix protein (GAMP), and orchestin, have been identified in gastroliths. Here, we report a novel protein, GAP 10, isolated from the gastrolith of the crayfish Cherax quadricarinatus and specifically expressed in its gastrolith disc. The encoding gene was cloned by partial sequencing of the protein extracted from the gastrolith matrix. Based on an assembled microarray cDNA chip, GAP 10 transcripts were found to be highly (12-fold) up-regulated in premolt gastrolith disc and significantly down-regulated in the hypodermis at the same molt stage. The deduced protein sequence of GAP 10 lacks chitin-binding domains and does not show homology to known proteins in the GenBank (TM) data base. It does, however, have an amino acid composition that has similarity to proteins extracted from invertebrate and ascidian-calcified extracellular matrices. The GAP 10 sequence contains a predicted signal peptide and predicted phosphorylation sites. In addition, the protein is phosphorylated and exhibits calcium-binding ability. Repeated daily injections of GAP 10 double strand RNA to premolt C. quadricarinatus resulted in a prolonged premolt stage and in the development of gastroliths with irregularly rough surfaces. These findings suggest that GAP 10 may be involved in the assembly of the gastrolith chitin-protein-mineral complex, particularly in the deposition of amorphous calcium carbonate.	[Bentov, Shmuel; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Glazer, Lilah; Shechter, Assaf; Aflalo, Eliahu David; Berman, Amir; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel; [Khalaila, Isam; Berman, Amir] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Tom, Moshe; Yudkovski, Yana] Israel Oceanog & Limnol Res, IL-31096 Haifa, Israel; [Pamuru, Ramachandra Reddy] Yogi Vemana Univ, Dept Biochem, Kadapa 516003, Andhra Pradesh, India	Ben Gurion University; Ben Gurion University; Ben Gurion University; Israel Oceanographic & Limnological Research Institute; Yogi Vemana University	Sagi, A (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, POB 653, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	Pamuru, Ramachandra Reddy/K-3509-2019; Pamuru, Ramachandra Reddy/B-3782-2015; Aflalo, Eliahu/F-1484-2012; khalaila, Isam/F-1498-2012; Berman, Amir/F-1870-2012	Pamuru, Ramachandra Reddy/0000-0002-9017-974X; khalaila, Isam/0000-0003-3250-5778; Sagi, Amir/0000-0002-4229-1059; berman, amir/0000-0001-7359-9016; Aflalo, Eli/0000-0003-1385-2387	Israel Science Foundation [1080/05]; German Israel Foundation [950-9.5/2007]; Amorphical Ltd.	Israel Science Foundation(Israel Science Foundation); German Israel Foundation(German-Israeli Foundation for Scientific Research and Development); Amorphical Ltd.	This work was supported in part by Israel Science Foundation Grant 1080/05, by German Israel Foundation Grant 950-9.5/2007, and by a grant from Amorphical Ltd.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Aizenberg J, 2002, J AM CHEM SOC, V124, P32, DOI 10.1021/ja016990l; ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J; Arnott D, 1998, ANAL BIOCHEM, V258, P1, DOI 10.1006/abio.1998.2566; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENSON SC, 1986, J CELL BIOL, V102, P1878, DOI 10.1083/jcb.102.5.1878; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Futahashi R, 2008, INSECT BIOCHEM MOLEC, V38, P1138, DOI 10.1016/j.ibmb.2008.05.007; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Gayathri S, 2007, CHEM-EUR J, V13, P3262, DOI 10.1002/chem.200600825; Gotliv BA, 2003, CHEMBIOCHEM, V4, P522, DOI 10.1002/cbic.200200548; GREENAWAY P, 1985, BIOL REV, V60, P425, DOI 10.1111/j.1469-185X.1985.tb00424.x; HALLORAN BA, 1995, COMP BIOCHEM PHYS B, V111, P221, DOI 10.1016/0305-0491(94)00245-P; Hecker A, 2003, FEBS LETT, V535, P49, DOI 10.1016/S0014-5793(02)03856-5; Inoue H, 2003, COMP BIOCHEM PHYS B, V136, P755, DOI 10.1016/S1096-4959(03)00210-0; Inoue H, 2004, BIOCHEM BIOPH RES CO, V318, P649, DOI 10.1016/j.bbrc.2004.04.075; Inoue H, 2001, BIOSCI BIOTECH BIOCH, V65, P1840, DOI 10.1271/bbb.65.1840; Ishii K, 1998, BIOSCI BIOTECH BIOCH, V62, P291, DOI 10.1271/bbb.62.291; Ishii K, 1996, BIOSCI BIOTECH BIOCH, V60, P1479, DOI 10.1271/bbb.60.1479; Karouzou MV, 2007, INSECT BIOCHEM MOLEC, V37, P754, DOI 10.1016/j.ibmb.2007.03.007; Kuballa AV, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-45; LAEMMLI UK, 1970, NATURE, V227, P685; Luquet G, 2004, CR PALEVOL, V3, P515, DOI 10.1016/j.crpv.2004.07.015; Magkrioti CK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-138; Marie B, 2007, FEBS J, V274, P2933, DOI 10.1111/j.1742-4658.2007.05825.x; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; Pereira-Mouries L, 2002, EUR J BIOCHEM, V269, P4994, DOI 10.1046/j.1432-1033.2002.03203.x; Pratoomchat B, 2002, J EXP ZOOL, V293, P414, DOI 10.1002/jez.90002; Raz S, 2003, ADV FUNCT MATER, V13, P480, DOI 10.1002/adfm.200304285; ROER R, 1984, AM ZOOL, V24, P893; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Shechter A, 2005, BIOL REPROD, V73, P72, DOI 10.1095/biolreprod.104.038554; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Shechter A, 2008, BIOL BULL-US, V214, P122, DOI 10.2307/25066669; Shechter A, 2007, J EXP BIOL, V210, P3525, DOI 10.1242/jeb.006791; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Sugawara A, 2006, ANGEW CHEM INT EDIT, V45, P2876, DOI 10.1002/anie.200503800; Takagi Y, 2000, ZOOL SCI, V17, P179, DOI 10.2108/zsj.17.179; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Testeniere O, 2002, BIOCHEM J, V361, P327, DOI 10.1042/0264-6021:3610327; TRAVIS DF, 1960, BIOL BULL, V118, P137, DOI 10.2307/1539064; TRAVIS DF, 1963, J ULTRA MOL STRUCT R, V9, P285, DOI 10.1016/S0022-5320(63)80008-8; Tsutsui N, 1999, ZOOL SCI, V16, P619, DOI 10.2108/zsj.16.619; UENO M, 1980, J EXP ZOOL, V213, P161, DOI 10.1002/jez.1402130202; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; Watanabe T, 2000, COMP BIOCHEM PHYS B, V125, P127, DOI 10.1016/S0305-0491(99)00153-4; Wynn A, 2005, COMP BIOCHEM PHYS B, V141, P294, DOI 10.1016/j.cbpc.2005.04.002; YANO I, 1975, B JPN SOC SCI FISH, V41, P1079; Yudkovski Y, 2007, INSECT MOL BIOL, V16, P661, DOI 10.1111/j.1365-2583.2007.00762.x; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P565, DOI 10.1016/S1096-4959(03)00138-6	51	40	40	1	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12831	12839		10.1074/jbc.M109.071068	http://dx.doi.org/10.1074/jbc.M109.071068			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20150428	Green Published, hybrid			2022-12-27	WOS:000276787800041
J	de la Vega, M; Burrows, JF; McFarlane, C; Govender, U; Scott, CJ; Johnston, JA				de la Vega, Michelle; Burrows, James F.; McFarlane, Cheryl; Govender, Ureshnie; Scott, Christopher J.; Johnston, James A.			The Deubiquitinating Enzyme USP17 Blocks N-Ras Membrane Trafficking and Activation but Leaves K-Ras Unaffected	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; GOLGI-COMPLEX; H-RAS; B-RAF; CANCER; CELL; TRANSFORMATION; PROLIFERATION; PATHWAY; FAMILY	The proto-oncogenic Ras isoforms (H, N, and K) have a C-terminal CAAX motif and undergo the same post-translational processing steps, although they traffic to the plasma membrane through different routes. Previously, we have shown that overexpression of the deubiquitinating enzyme USP17 inhibits H-Ras localization to the plasma membrane. Now we report that whereas H-Ras and N-Ras were unable to localize to the plasma membrane in the presence of USP17, K-Ras4b localization was unaffected. EGF stimulation was unable to induce N-Ras membrane localization in USP17-expressing cells. In addition, N-Ras activity and downstream signaling through the MAPK MEK/ERK and PI3K/JNK pathways were blunted. However, we still detected abundant N-Ras localization at the ER and Golgi in USP17-expressing cells. Collectively, our data showed that the deubiquitinating enzyme USP17 blocks EGF-induced N-Ras membrane trafficking and activation, but left K-Ras unaffected.	[de la Vega, Michelle; Burrows, James F.; McFarlane, Cheryl; Govender, Ureshnie; Johnston, James A.] Queens Univ Belfast, Ctr Infect & Immun, Sch Med Dent & Biomed Sci, Belfast BT9 7BL, Antrim, North Ireland; [Burrows, James F.; Scott, Christopher J.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland	Queens University Belfast; Queens University Belfast	Johnston, JA (corresponding author), Rm 330,Whitla Med Bldg,97 Lisburn Rd, Belfast BT9 7BL, Antrim, North Ireland.	jim.johnston@qub.ac.uk						Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Ballard-Croft C, 2006, AM J PHYSIOL-HEART C, V291, pH658, DOI 10.1152/ajpheart.01354.2005; Bannykh SI, 2005, TRAFFIC, V6, P803, DOI 10.1111/j.1600-0854.2005.00319.x; Bergo MO, 2004, J CLIN INVEST, V113, P539, DOI 10.1172/JCI200418829; Bergo MO, 2002, MOL CELL BIOL, V22, P171, DOI 10.1128/MCB.22.1.171-181.2002; Bivona TG, 2003, NATURE, V424, P694, DOI 10.1038/nature01806; Blum R, 2008, RECENT PAT ANTI-CANC, V3, P31; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Casar B, 2009, MOL CELL BIOL, V29, P1338, DOI 10.1128/MCB.01359-08; Chiu VK, 2002, NAT CELL BIOL, V4, P343, DOI 10.1038/ncb783; Choy E, 1999, CELL, V98, P69, DOI 10.1016/S0092-8674(00)80607-8; Ibiza S, 2008, P NATL ACAD SCI USA, V105, P10507, DOI 10.1073/pnas.0711062105; Inder K, 2008, MOL BIOL CELL, V19, P4776, DOI 10.1091/mbc.E08-04-0407; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Liu L, 2009, BBA-PROTEINS PROTEOM, V1794, P1485, DOI 10.1016/j.bbapap.2009.06.016; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Matallanas D, 2006, MOL CELL BIOL, V26, P100, DOI 10.1128/MCB.26.1.100-116.2006; Michaelson D, 2005, MOL BIOL CELL, V16, P1606, DOI 10.1091/mbc.e04-11-0960; Nakamura K, 2008, ONCOGENE, V27, P2961, DOI 10.1038/sj.onc.1210956; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Omerovic J, 2008, ONCOGENE, V27, P2754, DOI 10.1038/sj.onc.1210925; Perez de Castro I, 2004, MOL CELL BIOL, V24, P3485, DOI 10.1128/MCB.24.8.3485-3496.2004; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rotblat B, 2006, CANCER RES, V66, P1974, DOI 10.1158/0008-5472.CAN-05-3791; Saxena N, 2008, CANCER INVEST, V26, P948, DOI 10.1080/07357900802087275; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Sousa SF, 2008, CURR MED CHEM, V15, P1478, DOI 10.2174/092986708784638825; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Wong KK, 2009, RECENT PAT ANTI-CANC, V4, P28, DOI 10.2174/157489209787002461; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200; Zheng H, 2007, J BIOL CHEM, V282, P25760, DOI 10.1074/jbc.M700437200	38	25	26	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12028	12036		10.1074/jbc.M109.081448	http://dx.doi.org/10.1074/jbc.M109.081448			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147298	Green Published, hybrid			2022-12-27	WOS:000276787100031
J	El Mortaji, L; Terrasse, R; Dessen, A; Vernet, T; Di Guilmi, AM				El Mortaji, Lamya; Terrasse, Remi; Dessen, Andrea; Vernet, Thierry; Di Guilmi, Anne Marie			Stability and Assembly of Pilus Subunits of Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROCOCCUS-FAECALIS; ISOPEPTIDE BONDS; HUG MODEL; SORTASE; COLLAGEN; SURFACE; BINDING; AGALACTIAE; ADHESIN; PROTEIN	Pili are surface-exposed virulence factors involved in bacterial adhesion to host cells. The Streptococcus pneumoniae pilus is composed of three structural proteins, RrgA, RrgB, and RrgC and three transpeptidase enzymes, sortases SrtC-1, SrtC-2, and SrtC-3. To gain insights into the mechanism of pilus formation we have exploited biochemical approaches using recombinant proteins expressed in Escherichia coli. Using site-directed mutagenesis, mass spectrometry, limited proteolysis, and thermal stability measurements, we have identified isopeptide bonds in RrgB and RrgC and demonstrate their role in protein stabilization. Co-expression in E. coli of RrgB together with RrgC and SrtC-1 leads to the formation of a covalent RrgB-RrgC complex. Inactivation of SrtC-1 by mutation of the active site cysteine impairs RrgB-RrgC complex formation, indicating that the association between RrgB and RrgC is specifically catalyzed by SrtC-1. Mass spectrometry analyses performed on purified samples of the RrgB-RrgC complex show that the complex has 1: 1 stoichiometry. The deletion of the IPQTG RrgB sorting signal, but not the corresponding sequence in RrgC, abolishes complex formation, indicating that SrtC-1 recognizes exclusively the sorting motif of RrgB. Finally, we show that the intramolecular bonds that stabilize RrgB may play a role in its efficient recognition by SrtC-1. The development of a methodology to generate covalent pilin complexes in vitro, facilitating the study of sortase specificity and the importance of isopeptide bond formation for pilus biogenesis, provide key information toward the understanding of this complex macromolecular process.	UJF, CNRS, CEA,UMR 5075, Inst Biol Struct Jean Pierre Ebel,Lab Ingn Macrom, F-38027 Grenoble, France; [Dessen, Andrea] UJF, CNRS, CEA,UMR 5075, Inst Biol Struct Jean Pierre Ebel,Bacterial Patho, F-38027 Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA		diguilmi@ibs.fr	Vernet, Thierry/G-1118-2012	Dessen, Andrea/0000-0001-6487-4020; Di Guilmi, Anne Marie/0000-0001-7335-3470	EC [LSHM-CT-2004-512138]; ANR [05-JC-JC-0049]	EC(European CommissionEuropean Commission Joint Research Centre); ANR(French National Research Agency (ANR))	This work was supported in part by EC Grant LSHM-CT-2004-512138 and ANR Grant 05-JC-JC-0049.	Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2009, J BIOL CHEM, V284, P12989, DOI 10.1074/jbc.M900927200; Deivanayagam CCS, 2000, STRUCTURE, V8, P67, DOI 10.1016/S0969-2126(00)00081-2; Dramsi S, 2008, FEMS MICROBIOL REV, V32, P307, DOI 10.1111/j.1574-6976.2008.00102.x; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Izore T, 2010, STRUCTURE, V18, P106, DOI 10.1016/j.str.2009.10.019; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08; Liu Q, 2007, J BIOL CHEM, V282, P19629, DOI 10.1074/jbc.M611137200; Manzano C, 2009, BIOCHEMISTRY-US, V48, P10549, DOI 10.1021/bi901261y; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Maresso AW, 2008, PHARMACOL REV, V60, P128, DOI 10.1124/pr.107.07110; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rosini R, 2006, MOL MICROBIOL, V61, P126, DOI 10.1111/j.1365-2958.2006.05225.x; Symersky J, 1997, NAT STRUCT BIOL, V4, P833, DOI 10.1038/nsb1097-833; Zong YN, 2005, EMBO J, V24, P4224, DOI 10.1038/sj.emboj.7600888	30	31	37	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12405	12415		10.1074/jbc.M109.082776	http://dx.doi.org/10.1074/jbc.M109.082776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147289	Green Published, hybrid			2022-12-27	WOS:000276787100068
J	Heller, B; Adu-Gyamfi, E; Smith-Kinnaman, W; Babbey, C; Vora, M; Xue, Y; Bittman, R; Stahelin, RV; Wells, CD				Heller, Brigitte; Adu-Gyamfi, Emmanuel; Smith-Kinnaman, Whitney; Babbey, Cliff; Vora, Mohsin; Xue, Yi; Bittman, Robert; Stahelin, Robert V.; Wells, Clark D.			Amot Recognizes a Juxtanuclear Endocytic Recycling Compartment via a Novel Lipid Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; DIFFERENTIAL SUBCELLULAR-LOCALIZATION; PHOSPHATIDYLINOSITOL TRANSFER PROTEIN; ENDOTHELIAL-CELL MIGRATION; GPI-ANCHORED PROTEINS; TRANS-GOLGI NETWORK; EPITHELIAL-CELLS; MEMBRANE CURVATURE; PLASMA-MEMBRANE; LIVING CELLS	Polarity proteins promote the asymmetric organization of cells by orienting intracellular sorting mechanisms, such as protein trafficking and cytoskeletal assembly. The localization of individual polarity proteins in turn is often determined by association with factors that mediate contact with other cells or the substratum. This arrangement for the Par and Crb apical polarity complexes at the tight junction is disrupted by the adaptor protein Amot. Amot directly binds the scaffolding proteins Patj and Mupp1 and redistributes them and their binding partners from the plasma membrane to endosomes. However, the mechanism by which Amot is targeted to endosomes is unknown. Here, a novel lipid binding domain within Amot is shown to selectively bind with high affinity to membranes containing monophosphorylated phosphatidylinositols and cholesterol. With similar lipid specificity, Amot inserts into and tubulates membranes in vitro and enlarges perinuclear endosomal compartments in cells. Based on the similar distribution of Amot with cholesterol, Rab11, and Arf6, such membrane interactions are identified at juxtanuclear endocytic recycling compartments. Taken together, these findings indicate that Amot is targeted along with associated apical polarity proteins to the endocytic recycling compartment via this novel membrane binding domain.	[Wells, Clark D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Babbey, Cliff; Wells, Clark D.] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Vora, Mohsin; Xue, Yi; Stahelin, Robert V.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, South Bend, IN 46617 USA; [Bittman, Robert] CUNY, Dept Chem, Queens Coll, Flushing, NY 11367 USA; [Adu-Gyamfi, Emmanuel; Stahelin, Robert V.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Stahelin, Robert V.] Univ Notre Dame, Walther Ctr Canc Res, Notre Dame, IN 46556 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University South Bend; City University of New York (CUNY) System; Queens College NY (CUNY); University of Notre Dame; University of Notre Dame; Walther Cancer Institute	Stahelin, RV (corresponding author), 143 Raclin Carmichael Hall,1234 Notre Dame Ave, South Bend, IN 46617 USA.	rstaheli@iupui.edu; wells4@iupui.edu	Stahelin, Robert/L-3567-2019	Stahelin, Robert/0000-0001-5443-7863	American Cancer Society [IRG-84-002-22]; Notre Dame Integrated Imaging Facility; Show-alter Foundation, American Cancer Society [IRG-81-003-20]; United States Department of Defense [W81XWH]	American Cancer Society(American Cancer Society); Notre Dame Integrated Imaging Facility; Show-alter Foundation, American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense)	This work was supported by an Indiana University School of Medicine Biomedical research grant, American Cancer Society Grant IRG-84-002-22, and the Notre Dame Integrated Imaging Facility (to R.V.S.) and by the Show-alter Foundation, American Cancer Society Grant IRG-81-003-20, and United States Department of Defense Grant W81XWH (to C.D.W.).	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Babbey CM, 2006, MOL BIOL CELL, V17, P3156, DOI 10.1091/mbc.E05-08-0799; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Balla A, 2005, MOL BIOL CELL, V16, P1282, DOI 10.1091/mbc.E04-07-0578; Bittova L, 2001, J BIOL CHEM, V276, P4218, DOI 10.1074/jbc.M008491200; Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200; Brockman H, 1999, CURR OPIN STRUC BIOL, V9, P438, DOI 10.1016/S0959-440X(99)80061-X; Brown FD, 2001, J CELL BIOL, V154, P1007, DOI 10.1083/jcb.200103107; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chen XY, 2005, NAT CELL BIOL, V7, P262, DOI 10.1038/ncb1226; Colwill K, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-13; De Matteis MA, 2002, CURR OPIN CELL BIOL, V14, P434, DOI 10.1016/S0955-0674(02)00357-5; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fivaz M, 2002, EMBO J, V21, P3989, DOI 10.1093/emboj/cdf398; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Halet G, 2005, BIOL CELL, V97, P501; Hao MM, 2002, J BIOL CHEM, V277, P609, DOI 10.1074/jbc.M108861200; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Hirose T, 2002, J CELL SCI, V115, P2485; Holtta-Vuori M, 2002, MOL BIOL CELL, V13, P3107, DOI 10.1091/mbc.E02-01-0025; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Jones SM, 1998, J BIOL CHEM, V273, P10349, DOI 10.1074/jbc.273.17.10349; KIRBY C, 1990, DEV BIOL, V142, P203, DOI 10.1016/0012-1606(90)90164-E; Kisurina-Evgenieva O, 2004, J CELL SCI, V117, P6391, DOI 10.1242/jcs.01568; Lee SA, 2005, P NATL ACAD SCI USA, V102, P13052, DOI 10.1073/pnas.0503900102; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; LIU PS, 1995, J BIOL CHEM, V270, P27179, DOI 10.1074/jbc.270.45.27179; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Marsh D, 1996, BBA-REV BIOMEMBRANES, V1286, P183, DOI 10.1016/S0304-4157(96)00009-3; Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Mobius W, 2003, TRAFFIC, V4, P222; Mukherjee S, 1998, BIOPHYS J, V75, P1915, DOI 10.1016/S0006-3495(98)77632-5; Muralidharan-Chari V, 2009, CANCER RES, V69, P2201, DOI 10.1158/0008-5472.CAN-08-1301; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Naslavsky N, 2003, MOL BIOL CELL, V14, P417, DOI 10.1091/mbc.02-04-0053; Naslavsky N, 2007, BIOCHEM BIOPH RES CO, V357, P792, DOI 10.1016/j.bbrc.2007.04.022; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Nelson WJ, 2003, NATURE, V422, P766, DOI 10.1038/nature01602; ORCI L, 1983, LAB INVEST, V48, P80; Palacios F, 2001, EMBO J, V20, P4973, DOI 10.1093/emboj/20.17.4973; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; PETERS PJ, 1995, J CELL BIOL, V128, P1003, DOI 10.1083/jcb.128.6.1003; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; Ross JW, 2009, PHYSIOL GENOMICS, V36, P140, DOI 10.1152/physiolgenomics.00022.2008; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Schweitzer JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005193; Shimono A, 2003, CURR BIOL, V13, P613, DOI 10.1016/S0960-9822(03)00204-5; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Simon JP, 1998, P NATL ACAD SCI USA, V95, P11181, DOI 10.1073/pnas.95.19.11181; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Stahelin RV, 2004, J BIOL CHEM, V279, P29501, DOI 10.1074/jbc.M403191200; Stahelin RV, 2003, J BIOL CHEM, V278, P12452, DOI 10.1074/jbc.M212864200; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Stahelin RV, 2002, J BIOL CHEM, V277, P26379, DOI 10.1074/jbc.M201106200; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; TEPASS U, 1993, DEV BIOL, V159, P311, DOI 10.1006/dbio.1993.1243; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Wang Q, 2007, MOL BIOL CELL, V18, P874, DOI 10.1091/mbc.E06-07-0651; Wang WC, 2007, BIOPHYS J, V92, P2819, DOI 10.1529/biophysj.106.097923; Weigert R, 2004, MOL BIOL CELL, V15, P3758, DOI 10.1091/mbc.E04-04-0342; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; WOLFE DH, 1988, P NATL ACAD SCI USA, V85, P4285, DOI 10.1073/pnas.85.12.4285; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015; Yu CJ, 2005, J LIPID RES, V46, P1678, DOI 10.1194/jlr.M500060-JLR200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156; Zimmermann P, 2005, DEV CELL, V9, P377, DOI 10.1016/j.devcel.2005.07.011	91	37	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12308	12320		10.1074/jbc.M109.096230	http://dx.doi.org/10.1074/jbc.M109.096230			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20080965	Green Published, hybrid			2022-12-27	WOS:000276787100060
J	Matsushita, K; Morello, F; Wu, YJ; Zhang, LN; Iwanaga, S; Pratt, RE; Dzau, VJ				Matsushita, Kenichi; Morello, Fulvio; Wu, Yaojiong; Zhang, Lunan; Iwanaga, Shiro; Pratt, Richard E.; Dzau, Victor J.			Mesenchymal Stem Cells Differentiate into Renin-producing Juxtaglomerular (JG)-like Cells under the Control of Liver X Receptor-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; LXR-ALPHA; REGULATORY ELEMENTS; ADHERENT CELLS; MOUSE; CAMP; PROMOTER; KIDNEY; MICE; IDENTIFICATION	Renin is a key enzyme for cardiovascular and renal homeostasis and is produced by highly specialized endocrine cells in the kidney, known as juxtaglomerular (JG) cells. The nature and origin of these cells remain as mysteries. Previously, we have shown that the nuclear hormone receptor liver X receptor-alpha (LXR alpha) is a major transcriptional regulator of the expression of renin, c-myc, and other genes involved with growth/differentiation. In this study we test the hypothesis that LXR alpha plays an important role not only in renin expression but also in renin-containing cell differentiation, specifically from the mesenchymal stem cell (MSC), which may be the origin of the JG cell. Indeed, our data demonstrated that LXR alpha activation by its ligands or cAMP stimulated renin gene expression in both murine and human MSCs. Furthermore, sustained cAMP stimulation of murine MSCs overexpressing LXR alpha led to their differentiation into JG-like cells expressing renin and alpha-smooth muscle actin. These MSC-derived JG-like cells contained renin in secretory granules and released active renin in response to cAMP. In conclusion, the activation of LXR alpha stimulates renin expression and induces MSCs differentiation into renin-secreting, JG-like cells. Our results suggest that the MSC may be the origin of the juxtaglomerular cell and provide insight into novel understanding of pathophysiology of the renin-angiotensin system.	[Dzau, Victor J.] Duke Univ, Off Chancellor, Med Ctr, Mandel Ctr Hypertens & Atherosclerosis Res, Durham, NC 27710 USA; [Matsushita, Kenichi; Morello, Fulvio; Wu, Yaojiong; Zhang, Lunan; Pratt, Richard E.; Dzau, Victor J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Matsushita, Kenichi; Iwanaga, Shiro] Keio Univ, Div Cardiol, Dept Med, Sch Med, Tokyo 1608582, Japan	Duke University; Duke University; Keio University	Dzau, VJ (corresponding author), Duke Univ, Off Chancellor, Med Ctr, Mandel Ctr Hypertens & Atherosclerosis Res, DUMC Box 3178, Durham, NC 27710 USA.	victor.dzau@duke.edu	Morello, Fulvio/G-8519-2011; Matsushita, Kenichi/R-1902-2018	Morello, Fulvio/0000-0002-7833-9632; Matsushita, Kenichi/0000-0001-7668-3117	National Institutes of Health, NHLBI [RO1 HL35610, HL58516, HL72010, HL73219]; Edna Mandel Foundation; Leducq Foundation; Ministry of Education, Culture, Sports, Science, and Technology of Japan [KAKENHI 21790745]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073219, R01HL035610, R01HL072010, R01HL058516] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Edna Mandel Foundation; Leducq Foundation(Leducq Foundation); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL35610, HL58516, HL72010, and HL73219 from NHLBI (to V.J.D.). This work was also supported by the Edna Mandel Foundation and the Leducq Foundation (to V.J.D.) and in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (KAKENHI 21790745, to K. M.).	Ahn D, 2004, J CLIN INVEST, V114, P504, DOI 10.1172/JCI200421064; Al-Awqati Q, 2002, KIDNEY INT, V61, P387, DOI 10.1046/j.1523-1755.2002.00164.x; Anderson LM, 2003, J BIOL CHEM, V278, P15252, DOI 10.1074/jbc.M208644200; Anglani F, 2004, J CELL MOL MED, V8, P474, DOI 10.1111/j.1582-4934.2004.tb00472.x; Bader M, 2000, J MOL MED, V78, P130, DOI 10.1007/s001090000089; Bjorkhem I, 2002, ARTERIOSCL THROM VAS, V22, P734, DOI 10.1161/01.ATV.0000013312.32196.49; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; BURT DW, 1989, J BIOL CHEM, V264, P7357; CATANZARO DF, 1994, KIDNEY INT, V46, P1513, DOI 10.1038/ki.1994.433; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Fujino T, 2004, J CLIN INVEST, V114, P805, DOI 10.1172/JCI200421382; Germain S, 1996, BIOCHEM J, V316, P107, DOI 10.1042/bj3160107; HORIUCHI M, 1993, J CLIN INVEST, V92, P1805, DOI 10.1172/JCI116770; HORIUCHI M, 1991, J BIOL CHEM, V266, P16247; ICE KS, 1988, CLIN EXP HYPERTENS A, V10, P1169, DOI 10.1080/07300077.1988.11878809; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Janke J, 2002, DIABETES, V51, P1699, DOI 10.2337/diabetes.51.6.1699; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; KON Y, 1992, ACTA ANAT, V144, P354; LANG JA, 1995, HYPERTENSION, V25, P704, DOI 10.1161/01.HYP.25.4.704; Lantelme P, 2002, HYPERTENSION, V39, P1007, DOI 10.1161/01.HYP.0000016177.20565.A0; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez MLSS, 2004, DEV CELL, V6, P719; Lopez MLSS, 2001, AM J PHYSIOL-RENAL, V281, pF345, DOI 10.1152/ajprenal.2001.281.2.F345; Mackins CJ, 2006, J CLIN INVEST, V116, P1063, DOI 10.1172/JCI25713; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Matsushita K, 2006, HYPERTENSION, V48, P1095, DOI 10.1161/01.HYP.0000248211.82232.a7; Matsushita K, 2007, J AM SOC HYPERTENS, V1, P164, DOI 10.1016/j.jash.2007.02.004; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Morello F, 2005, J CLIN INVEST, V115, P1913, DOI 10.1172/JCI24594; Morigi M, 2004, J AM SOC NEPHROL, V15, P1794, DOI 10.1097/01.ASN.0000128974.07460.34; NAKAMURA N, 1989, P NATL ACAD SCI USA, V86, P56, DOI 10.1073/pnas.86.1.56; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; OWEN RA, 1995, TOXICOL PATHOL, V23, P606, DOI 10.1177/019262339502300319; Pan L, 2005, HYPERTENSION, V45, P3, DOI 10.1161/01.HYP.0000149717.55920.45; Pan L, 2001, J BIOL CHEM, V276, P45530, DOI 10.1074/jbc.M103010200; PEREIRA RF, 1995, P NATL ACAD SCI USA, V92, P4857, DOI 10.1073/pnas.92.11.4857; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459; Schmitz G, 2005, BBA-MOL CELL BIOL L, V1735, P1, DOI 10.1016/j.bbalip.2005.04.004; Schoof E, 2001, J CLIN ENDOCR METAB, V86, P1313, DOI 10.1210/jc.86.3.1313; SIGMUND CD, 1990, J BIOL CHEM, V265, P19916; TAMURA K, 1994, J CLIN INVEST, V94, P1959, DOI 10.1172/JCI117547; Tamura K, 2000, P NATL ACAD SCI USA, V97, P8513, DOI 10.1073/pnas.100519097; Tamura K, 2004, MOL CELL ENDOCRINOL, V224, P11, DOI 10.1016/j.mce.2004.07.005; Watorek E, 2006, ARCH IMMUNOL THER EX, V54, P45, DOI 10.1007/s00005-006-0004-4; Whitney KD, 2001, J BIOL CHEM, V276, P43509, DOI 10.1074/jbc.M106155200; Yokoo T, 2005, P NATL ACAD SCI USA, V102, P3296, DOI 10.1073/pnas.0406878102; Zhang ZP, 2007, HYPERTENSION, V50, pE100	51	26	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11974	11982		10.1074/jbc.M109.099671	http://dx.doi.org/10.1074/jbc.M109.099671			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20118482	Green Published, hybrid			2022-12-27	WOS:000276787100026
J	Moss, SC; Lightell, DJ; Marx, SO; Marks, AR; Woods, TC				Moss, Stephanie C.; Lightell, Daniel J., Jr.; Marx, Steven O.; Marks, Andrew R.; Woods, T. Cooper			Rapamycin Regulates Endothelial Cell Migration through Regulation of the Cyclin-dependent Kinase Inhibitor p27(Kip1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; SIROLIMUS-ELUTING STENTS; BARE-METAL STENTS; MAMMALIAN TARGET; BINDING PARTNER; IN-VITRO; PHOSPHORYLATION; MTOR; P27; TEMSIROLIMUS	Rapamycin is a macrolide antibiotic that inhibits vascular smooth muscle cell proliferation and migration and that is used clinically on drug-eluting stents to inhibit in-stent restenosis. Although inhibition of cell migration is an asset in preventing restenosis, it also leads to impaired stent endothelialization, a significant limitation of current drug-eluting stent technology that necessitates prolonged antiplatelet therapy. We measured the ability of rapamycin to inhibit the migration of human umbilical vein endothelial cells (HUVECs) and human coronary artery endothelial cells (HCAEC) toward the chemoattractant vascular endothelial cell growth factor. Although acute administration of rapamycin had no effect, exposure for 24 h inhibited HUVEC and HCAEC migration. Disruption of the mTORC2 via small interfering RNA was also effective in inhibiting HCAEC migration. Treatment of HCAECs for this period with rapamycin produced an increase in the cyclin-dependent kinase inhibitor p27(Kip), through a decrease in the targeting of the protein for degradation by phosphorylation at Thr(187). ECs isolated from a knock-in mouse expressing p27(Kip1) with a mutation of this residue to an alanine, blocking this phosphorylation, exhibited reduced migration compared with wild-type controls. Silencing of p27(Kip1) with small interfering RNA blocked the effects of rapamycin on migration and tube formation as well as RhoA activation and cytoskeletal reorganization. We conclude that prolonged exposure of ECs to rapamycin increases p27(Kip1) and in turn inhibits RhoA activation, blocking cell migration and differentiation. These data elucidate the molecular mechanism underlying regulation of p27(Kip1) protein and cell migration by rapamycin.	[Moss, Stephanie C.; Lightell, Daniel J., Jr.; Woods, T. Cooper] Ochsner Clin Fdn, Mol Cardiol Lab, New Orleans, LA 70121 USA; [Marx, Steven O.; Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Div Cardiol, Dept Med, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA; [Marks, Andrew R.] Columbia Univ Coll Phys & Surg, Dept Physiol & Cellular Biophys, Clyde & Helen Wu Ctr Mol Cardiol, New York, NY 10032 USA; [Woods, T. Cooper] LSU Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	Ochsner Health System; Columbia University; Columbia University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Woods, TC (corresponding author), Ochsner Clin Fdn, Mol Cardiol Lab, Biomed Res Bldg,1N412,1514 Jefferson Highway, New Orleans, LA 70121 USA.	twoods@ochsner.org			National Institutes of Health, National Center for Research Resources [P20RR018766]; American Heart Association [0665320B, 0855316E]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Award P20RR018766 from the National Center for Research Resources. This work was also supported by Grants 0665320B and 0855316E from the Greater SE Affiliate of the American Heart Association.	Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bloom J, 2003, SEMIN CANCER BIOL, V13, P41, DOI 10.1016/S1044-579X(02)00098-6; Braun-Dullaeus RC, 2001, ARTERIOSCL THROM VAS, V21, P1152, DOI 10.1161/hq0701.092104; Castro C, 2003, J BIOL CHEM, V278, P4482, DOI 10.1074/jbc.M204716200; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; Del Bufalo D, 2006, CANCER RES, V66, P5549, DOI 10.1158/0008-5472.CAN-05-2825; Diez-Juan A, 2003, CIRC RES, V92, P402, DOI 10.1161/01.RES.0000059306.71961.ED; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Goukassian D, 2001, FASEB J, V15, P1877, DOI 10.1096/fj.01-0065com; Grimmler M, 2007, CELL, V128, P269, DOI 10.1016/j.cell.2006.11.047; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Holmes DR, 2004, CIRCULATION, V109, P634, DOI 10.1161/01.CIR.0000112572.57794.22; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kastrati A, 2007, NEW ENGL J MED, V356, P1030, DOI 10.1056/NEJMoa067484; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Koff A, 1995, Prog Cell Cycle Res, V1, P141; Luo Y, 1996, MOL CELL BIOL, V16, P6744; Malek NP, 2001, NATURE, V413, P323, DOI 10.1038/35095083; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; McAndrew CW, 2007, CELL CYCLE, V6, P1937, DOI 10.4161/cc.6.15.4520; Nakayama M, 2005, GENES CELLS, V10, P107, DOI 10.1111/j.1365-2443.2005.00823.x; NOURSE J, 1994, NATURE, V372, P570, DOI 10.1038/372570a0; RASBAND WS, 1997, IMAGE J NAT I HLTH B; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roque M, 2001, LAB INVEST, V81, P895, DOI 10.1038/labinvest.3780298; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Spaulding C, 2007, NEW ENGL J MED, V356, P989, DOI 10.1056/NEJMoa066633; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Sun J, 2001, CIRCULATION, V103, P2967, DOI 10.1161/01.CIR.103.24.2967; Tossidou I, 2008, CELL CYCLE, V7, P3858, DOI 10.4161/cc.7.24.7260; Witzig TE, 2005, J CLIN ONCOL, V23, P5347, DOI 10.1200/JCO.2005.13.466	39	48	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11991	11997		10.1074/jbc.M109.066621	http://dx.doi.org/10.1074/jbc.M109.066621			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20097763	Green Published, hybrid			2022-12-27	WOS:000276787100028
J	Rangarajan, ES; Park, H; Fortin, E; Sygusch, J; Izard, T				Rangarajan, Erumbi S.; Park, HaJeung; Fortin, Emanuelle; Sygusch, Jurgen; Izard, Tina			Mechanism of Aldolase Control of Sorting Nexin 9 Function in Endocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; ALDRICH-SYNDROME PROTEIN; MAXIMUM-LIKELIHOOD; ANONYMOUS PROTEIN; BINDING-SITE; F-ACTIN; MEMBRANE; DYNAMIN; TRAFFICKING; REFINEMENT	Sorting nexin 9 (SNX9) functions in a complex with the GTPase dynamin-2 at clathrin-coated pits, where it provokes fission of vesicles to complete endocytosis. Here the SNX9.dynamin-2 complex binds to clathrin and adapter protein complex 2 (AP-2) that line these pits, and this occurs through interactions of the low complexity domain (LC4) of SNX9 with AP-2. Intriguingly, localization of the SNX9.dynamin-2 complex to clathrin-coated pits is blocked by interactions with the abundant glycolytic enzyme aldolase, which also binds to the LC4 domain of SNX9. The crystal structure of the LC4 motif of human SNX9 in complex with aldolase explains the biochemistry and biology of this interaction, where SNX9 binds near the active site of aldolase via residues 165-171 that are also required for the interactions of SNX9 with AP-2. Accordingly, SNX9 binding to aldolase is structurally precluded by the binding of substrate to the active site. Interactions of SNX9 with aldolase are far more extensive and differ from those of the actin-nucleating factor WASP with aldolase, indicating considerable plasticity in mechanisms that direct the functions of the aldolase as a scaffold protein.	[Sygusch, Jurgen] Univ Montreal, Stn Ctr Ville, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Rangarajan, Erumbi S.; Park, HaJeung; Izard, Tina] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA	Universite de Montreal; Scripps Research Institute	Sygusch, J (corresponding author), Univ Montreal, Stn Ctr Ville, Dept Biochem, CP 6128, Montreal, PQ H3C 3J7, Canada.	Jurgen.Sygusch@UMontreal.CA		Sygusch, Jurgen/0000-0002-6629-2128	National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by a National Institutes of Health grant (to T.I.). This is Publication Number 20157 from The Scripps Research Institute.	Alto NM, 2007, J CELL BIOL, V178, P1265, DOI 10.1083/jcb.200705021; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Bricogne G, 1997, METHOD ENZYMOL, V276, P361, DOI 10.1016/S0076-6879(97)76069-5; Buscaglia CA, 2006, J BIOL CHEM, V281, P1324, DOI 10.1074/jbc.M506346200; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Chu HY, 2006, BIOCHEM J, V400, P143, DOI 10.1042/BJ20060792; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Haberg K, 2008, J CELL SCI, V121, P1495, DOI 10.1242/jcs.028530; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Kusakabe T, 1997, ARCH BIOCHEM BIOPHYS, V344, P184, DOI 10.1006/abbi.1997.0204; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leatherbarrow R J, 2007, GRAFIT VERSION 6; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; MATHEWS CK, 2000, BIOCHEMISTRY-US, P383; Mayer BJ, 2001, J CELL SCI, V114, P1253; MIDELFORT CF, 1976, BIOCHEMISTRY-US, V15, P2178, DOI 10.1021/bi00655a023; MORRIS AJ, 1993, J BIOL CHEM, V268, P1095; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PENHOET E, 1967, BIOCHEMISTRY-US, V6, P2940, DOI 10.1021/bi00861a039; RACKER E, 1947, J BIOL CHEM, V167, P843; Raikar LS, 2006, J CELL BIOCHEM, V98, P861, DOI 10.1002/jcb.20732; Schindler R, 2001, BIOCHEM CELL BIOL, V79, P719, DOI 10.1139/bcb-79-6-719; Schmid SL, 1998, CURR OPIN CELL BIOL, V10, P504, DOI 10.1016/S0955-0674(98)80066-5; SMART OS, 2008, ANN M AM CRYST ASS K; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; St-Jean M, 2007, J BIOL CHEM, V282, P14309, DOI 10.1074/jbc.M611505200; STECK TL, 1978, J SUPRAMOL STR CELL, V8, P311, DOI 10.1002/jss.400080309; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volker KW, 1997, ARCH BIOCHEM BIOPHYS, V338, P237, DOI 10.1006/abbi.1996.9819; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Worby CA, 2001, J BIOL CHEM, V276, P41782, DOI 10.1074/jbc.M107080200	41	26	28	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11983	11990		10.1074/jbc.M109.092049	http://dx.doi.org/10.1074/jbc.M109.092049			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20129922	Green Published, hybrid			2022-12-27	WOS:000276787100027
J	Wang, GR; Guo, XX; DiAngelo, S; Thomas, NJ; Floros, J				Wang, Guirong; Guo, Xiaoxuan; DiAngelo, Susan; Thomas, Neal J.; Floros, Joanna			Humanized SFTPA1 and SFTPA2 Transgenic Mice Reveal Functional Divergence of SP-A1 and SP-A2 FORMATION OF TUBULAR MYELIN IN VIVO REQUIRES BOTH GENE PRODUCTS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACTANT-PROTEIN-A; HUMAN FETAL LUNG; DEFICIENT MICE; OZONE EXPOSURE; SP-C; PSEUDOMONAS-AERUGINOSA; BIOCHEMICAL-PROPERTIES; INSITU HYBRIDIZATION; BIOLOGICAL FUNCTION; CYTOKINE PRODUCTION	Surfactant protein A (SP-A) plays a role in lung innate immunity and surfactant-related functions. Two functional genes, SP-A1 (SFTPA1) and SP-A2 (SFTPA2), are present in humans and primates (rodents have one gene). Single gene SP-A1 or SP-A2 proteins expressed in vitro are functional. To study their role in vivo, we generated humanized transgenic (hTG) C57BL/6 mice, SP-A1(6A(4)) and SP-A2(1A(3)). The SP-A cDNA in experimental constructs was driven by the 3.7-kb SP-C promoter. Positive hTG mice were bred with SP-A knock-out mice to generate F8 offspring for study. Epithelial alveolar type II cells were SPA-positive, and Clara cells were negative by immunohistochemistry in hTG mice. The levels of SP-A in lungs of two hTG lines used were comparable with those in human lungs. Southern blot analysis indicated that two cDNA copies of either SP-A1(6A4) or SP-A2(1A(3)) were integrated as a concatemer into the genome of each of the two hTG lines. Electron microscopy analysis revealed that hTG mice with a single SP-A1(6A(4)) or SP-A2(1A(3)) gene product lacked tubular myelin (TM), but hTG mice carrying both had TM. Furthermore, TM was observed in human bronchoalveolar lavage fluid only if both SP-A1 and SP-A2 gene products were present and not in those containing primarily (>99.7%) either SP-A1 or SP-A2 gene products. In vivo rescue study confirmed that TM can only be restored after administering exogenous SP-A containing both SP-A1 and SP-A2 into the lungs of SP-A knock-out mice. These observations indicate that SP-A1 and SP-A2 diverged functionally at least in terms of TM formation.	[Wang, Guirong; DiAngelo, Susan; Thomas, Neal J.; Floros, Joanna] Penn State Univ, Penn State Hershey Coll Med, Penn State Ctr Host Def Inflammat & Lung Dis Res, Dept Pediat, Hershey, PA 17033 USA; [Guo, Xiaoxuan] Penn State Univ, Penn State Hershey Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Thomas, Neal J.] Penn State Univ, Penn State Hershey Coll Med, Dept Publ Hlth Sci, Hershey, PA 17033 USA; [Floros, Joanna] Penn State Univ, Penn State Hershey Coll Med, Dept Obstet & Gynecol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Floros, J (corresponding author), Penn State Univ, Coll Med, Penn State CHILD Res, Dept Pediat, H085,500 Univ Dr, Hershey, PA 17033 USA.	jfloros@psu.edu		Thomas, Neal/0000-0002-7991-7510	National Institutes of Health [ES09882]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES009882] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES09882.	Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; Albertelli MA, 2006, MOL ENDOCRINOL, V20, P1248, DOI 10.1210/me.2006-0021; AUTEN RL, 1990, AM J RESP CELL MOL, V3, P491, DOI 10.1165/ajrcmb/3.5.491; Bates SR, 2008, AM J PHYSIOL-LUNG C, V294, pL325, DOI 10.1152/ajplung.00341.2007; Berg T, 2000, BBA-PROTEIN STRUCT M, V1543, P159, DOI 10.1016/S0167-4838(00)00184-9; Condon JC, 2004, P NATL ACAD SCI USA, V101, P4978, DOI 10.1073/pnas.0401124101; Elhalwagi BM, 1999, AM J RESP CELL MOL, V21, P380, DOI 10.1165/ajrcmb.21.3.3676; Fehrenbach H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-60; FLOROS J, 1986, J BIOL CHEM, V261, P9029; FLOROS J, 2002, SURFACTANT UPDATE IN, V6, P87; Floros J, 2009, CRIT REV EUKAR GENE, V19, P125, DOI 10.1615/CritRevEukarGeneExpr.v19.i2.30; FROH D, 1990, BIOCHIM BIOPHYS ACTA, V1052, P78, DOI 10.1016/0167-4889(90)90060-Q; FungLeung WP, 1996, J EXP MED, V183, P49, DOI 10.1084/jem.183.1.49; Garcia-Verdugo I, 2002, BIOCHEMISTRY-US, V41, P14041, DOI 10.1021/bi026540l; Giannoni E, 2006, AM J RESP CELL MOL, V34, P704, DOI 10.1165/rcmb.2005-0461OC; Glasser SW, 2005, AM J PHYSIOL-LUNG C, V288, pL625, DOI 10.1152/ajplung.00250.2004; Glasser SW, 2000, AM J PHYSIOL-LUNG C, V278, pL933, DOI 10.1152/ajplung.2000.278.5.L933; GLASSER SW, 1991, AM J PHYSIOL, V261, pL349, DOI 10.1152/ajplung.1991.261.4.L349; Gonzalez FJ, 2006, ANNU REV PHARMACOL, V46, P41, DOI 10.1146/annurev.pharmtox.45.120403.100007; Goss KL, 1998, AM J RESP CELL MOL, V19, P613, DOI 10.1165/ajrcmb.19.4.3155; Haque R, 2007, TOXICOL APPL PHARM, V220, P72, DOI 10.1016/j.taap.2006.12.017; Hattori A, 1996, BIOCHEM J, V317, P939, DOI 10.1042/bj3170939; Hattori A, 1996, AM J RESP CELL MOL, V14, P608, DOI 10.1165/ajrcmb.14.6.8652189; Hoover RR, 1999, AM J PHYSIOL-LUNG C, V276, pL917, DOI 10.1152/ajplung.1999.276.6.L917; Huang WX, 2004, AM J PHYSIOL-LUNG C, V286, pL546, DOI 10.1152/ajplung.00267.2003; Ikegami M, 1998, AM J PHYSIOL-LUNG C, V275, pL247, DOI 10.1152/ajplung.1998.275.2.L247; Ikegami M, 2001, J BIOL CHEM, V276, P38542, DOI 10.1074/jbc.M102054200; Jain D, 2003, AM J PHYSIOL-LUNG C, V284, pL759, DOI 10.1152/ajplung.00200.2002; Karinch AM, 1997, BIOCHEM J, V321, P39, DOI 10.1042/bj3210039; Kingma PS, 2006, J BIOL CHEM, V281, P24496, DOI 10.1074/jbc.M600651200; Korfhagen TR, 1996, P NATL ACAD SCI USA, V93, P9594, DOI 10.1073/pnas.93.18.9594; LeVine AM, 1997, J IMMUNOL, V158, P4336; LeVine AM, 1998, AM J RESP CELL MOL, V19, P700, DOI 10.1165/ajrcmb.19.4.3254; Li G, 2002, AM J RESP CELL MOL, V26, P277, DOI 10.1165/ajrcmb.26.3.4584; Lin ZW, 2001, PEDIATR PATHOL MOL M, V20, P367, DOI 10.1080/15513810109168621; MacNeill C, 2004, IMMUNOLOGY, V111, P91, DOI 10.1111/j.1365-2567.2004.01782.x; Mikerov AN, 2005, AM J PHYSIOL-LUNG C, V288, pL150, DOI 10.1152/ajplung.00135.2004; Mikerov AN, 2008, AM J PHYSIOL-LUNG C, V294, pL121, DOI 10.1152/ajplung.00288.2007; Mikerov AN, 2007, INFECT IMMUN, V75, P1403, DOI 10.1128/IAI.01341-06; Mikerov AN, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-77; Oberley RE, 2003, AM J PHYSIOL-LUNG C, V284, pL871, DOI 10.1152/ajplung.00241.2002; Ochs M, 2002, AM J RESP CELL MOL, V26, P91, DOI 10.1165/ajrcmb.26.1.4570; Palaniyar N, 2002, J BIOL CHEM, V277, P26971, DOI 10.1074/jbc.M110080200; PHELPS DS, 1988, AM REV RESPIR DIS, V137, P939, DOI 10.1164/ajrccm/137.4.939; PHELPS DS, 1991, EXP LUNG RES, V17, P985, DOI 10.3109/01902149109064330; POULAIN FR, 1992, AM J PHYSIOL, V262, pL730, DOI 10.1152/ajplung.1992.262.6.L730; Poulain FR, 1999, AM J RESP CELL MOL, V20, P1049, DOI 10.1165/ajrcmb.20.5.3497; Raquel R, 2009, PNEUMON, V22, P143; Reaume AG, 1996, J BIOL CHEM, V271, P23380, DOI 10.1074/jbc.271.38.23380; Saitoh H, 1998, AM J RESP CELL MOL, V19, P202, DOI 10.1165/ajrcmb.19.2.3239; Scheer N, 2008, J CLIN INVEST, V118, P3228, DOI 10.1172/JCI35483; Schmiedl A, 2007, PEDIATR PULM, V42, P548, DOI 10.1002/ppul.20623; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Tagaram HRS, 2007, AM J PHYSIOL-LUNG C, V292, pL1052, DOI 10.1152/ajplung.00249.2006; Taneja V, 1998, J CLIN INVEST, V101, P921, DOI 10.1172/JCI2860; VOORHOUT WF, 1991, J HISTOCHEM CYTOCHEM, V39, P1331, DOI 10.1177/39.10.1940306; VOSS T, 1991, AM J RESP CELL MOL, V4, P88, DOI 10.1165/ajrcmb/4.1.88; Wang GR, 2005, AM J PHYSIOL-LUNG C, V289, pL497, DOI 10.1152/ajplung.00100.2005; Wang GR, 2004, BIOCHEMISTRY-US, V43, P4227, DOI 10.1021/bi036023i; Wang GR, 2002, ENVIRON HEALTH PERSP, V110, P79, DOI 10.1289/ehp.0211079; Wang GR, 2000, AM J PHYSIOL-LUNG C, V278, pL946, DOI 10.1152/ajplung.2000.278.5.L946; Wang GR, 2007, BBA-BIOMEMBRANES, V1768, P2060, DOI 10.1016/j.bbamem.2007.06.025; Wang GR, 2007, BIOCHEMISTRY-US, V46, P8425, DOI 10.1021/bi7004569; WILLIAMS MC, 1991, AM J RESP CELL MOL, V5, P41, DOI 10.1165/ajrcmb/5.1.41; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528	65	57	59	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11998	12010		10.1074/jbc.M109.046243	http://dx.doi.org/10.1074/jbc.M109.046243			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20048345	Green Published, hybrid			2022-12-27	WOS:000276787100029
J	Gould, AD; Shilton, BH				Gould, Alister D.; Shilton, Brian H.			Studies of the Maltose Transport System Reveal a Mechanism for Coupling ATP Hydrolysis to Substrate Translocation without Direct Recognition of Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DEPENDENT TRANSPORT; BINDING-PROTEIN; ESCHERICHIA-COLI; ABC-TRANSPORTER; MEMBRANE-COMPONENTS; ACTIVE-TRANSPORT; LIGAND-BINDING; EVOLUTION; MALFGK(2); INTERACTS	The ATPase activity of the maltose transporter (MalFGK2) is dependent on interactions with the maltose-binding protein (MBP). To determine whether direct interactions between the translocated sugar and MalFGK2 are important for the regulation of ATP hydrolysis, we used an MBP mutant (sMBP) that is able to bind either maltose or sucrose. We observed that maltose-and sucrose-bound sMBP stimulate equal levels of MalFGK2 ATPase activity. Therefore, the ATPase activity of MalFGK2 is coupled to translocation of maltose solely by interactions between MalFGK2 and MBP. For both maltose and sucrose, the ability of sMBP to stimulate the MalFGK2 ATPase was greatly reduced compared with wild-type MBP, indicating that the mutations in sMBP have interfered with important interactions between MBP and MalFGK2. High resolution crystal structure analysis of sMBP shows that in the closed conformation with bound sucrose, three of four mutations are buried, and the fourth causes only a minor change in the accessible surface. In contrast, in the open form of sMBP, all of the mutations are accessible, and the main chain of Tyr(62)-Gly(69) is destabilized and occupies an alternative conformation due to the W62Y mutation. On this basis, the compromised ability of sMBP to stimulate ATP hydrolysis by MalFGK2 is most likely due to a disruption of interactions between MalFGK2 and the open, rather than the closed, conformation of sMBP. Modeling the open sMBP structure bound to MalFGK2 in the transition state for ATP hydrolysis points to an important site of interaction and suggests a mechanism for coupling ATP hydrolysis to substrate translocation that is independent of the exact structure of the substrate.	[Gould, Alister D.; Shilton, Brian H.] Univ Western Ontario, Dept Biochem, London, ON N6B 2G3, Canada	Western University (University of Western Ontario)	Shilton, BH (corresponding author), Univ Western Ontario, Dept Biochem, 1151 Richmond St, London, ON N6B 2G3, Canada.	bshilton@uwo.ca	Shilton, Brian H/A-6667-2011		Natural Sciences and Engineering Research Council of Canada [217494-2008]; Natural Sciences and Engineering Research Council of Canada; National Research Council; Canadian Institutes of Health Research; University of Saskatchewan; United States Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-ENG-38]; National Institutes of Health Research [RR-08630]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan; United States Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Discovery Grant 217494-2008 from the Natural Sciences and Engineering Research Council of Canada.; We thank Lee-Ann Briere and Dr. Stanley Nithianantham for help with crystallization and data collection, and Dr. Marc Ostermeier for providing the expression construct for sMBP. Crystallographic data were collected at the Canadian Light Source, which is supported by Natural Sciences and Engineering Research Council of Canada, National Research Council, Canadian Institutes of Health Research, and the University of Saskatchewan. Use of the Advanced Photon Source is supported by the United States Department of Energy, Basic Energy Sciences, Office of Science, under Contract W-31-109-ENG-38, and BioCAT is supported by National Institutes of Health Research Grant RR-08630.	Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200; BOHL E, 1995, J THEOR BIOL, V172, P83, DOI 10.1006/jtbi.1995.0006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Daus ML, 2009, J BACTERIOL, V191, P754, DOI 10.1128/JB.01439-08; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gould AD, 2009, BIOCHEMISTRY-US, V48, P8051, DOI 10.1021/bi9007066; Grote M, 2009, J BIOL CHEM, V284, P17521, DOI 10.1074/jbc.M109.006270; Guntas G, 2005, P NATL ACAD SCI USA, V102, P11224, DOI 10.1073/pnas.0502673102; Hall JA, 1997, J BIOL CHEM, V272, P17610, DOI 10.1074/jbc.272.28.17610; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; HOR LI, 1993, J MOL BIOL, V233, P659, DOI 10.1006/jmbi.1993.1543; Jones PM, 2009, TRENDS BIOCHEM SCI, V34, P520, DOI 10.1016/j.tibs.2009.06.004; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Merino G, 1997, J BACTERIOL, V179, P7687, DOI 10.1128/jb.179.24.7687-7694.1997; Nelson BD, 1998, J BACTERIOL, V180, P2507, DOI 10.1128/JB.180.9.2507-2514.1998; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Quiocho FA, 1997, STRUCTURE, V5, P997, DOI 10.1016/S0969-2126(97)00253-0; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shilton BH, 2008, BBA-BIOMEMBRANES, V1778, P1772, DOI 10.1016/j.bbamem.2007.09.005; SHUMAN HA, 1982, J BIOL CHEM, V257, P5455; TREPTOW NA, 1988, J MOL BIOL, V202, P809, DOI 10.1016/0022-2836(88)90560-8	25	21	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11290	11296		10.1074/jbc.M109.089078	http://dx.doi.org/10.1074/jbc.M109.089078			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147285	hybrid, Green Published			2022-12-27	WOS:000276286200035
J	Mauris, J; Evans, TC				Mauris, Jerome; Evans, Thomas C., Jr.			A Human PMS2 Homologue from Aquifex aeolicus Stimulates an ATP-dependent DNA Helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MISMATCH REPAIR; ESCHERICHIA-COLI; MUTL-ALPHA; UVRD HELICASE; ENDONUCLEASE ACTIVITY; PROTEIN; MECHANISMS; REPLICATION; HYDROLYSIS; BINDING	Mismatch repair in Escherichia coli involves a number of proteins including MutL and UvrD. Eukaryotes also possess MutL homologues; however, no UvrD helicase homologues have been identified. The hyperthermophilic bacterium Aquifex aeolicus has a MutL protein (Aae MutL) that possesses a latent endonuclease activity similar to eukaryotic, but different from E. coli, MutL proteins. By sequence homology Aq793 is a member of the PcrA/UvrD/Rep helicase subfamily. We expressed Aae MutL and the putative A. aeolicus DNA helicase (Aq793) proteins in E. coli. Using synthetic oligonucleotide substrates, we observed that lower concentrations of Aq793 were required to unwind double-stranded DNA that had a 3'-poly(dT) overhang as compared with double-stranded DNA with a 5'-poly(dT) or lacking a poly(dT) tail. This unwinding activity was stimulated by adding Aae MutL with maximal stimulation observed at an similar to 1.5:1 (MutL: Aq793) stoichiometric ratio. The enhancement of Aq793 helicase activity did not require the Aae MutL protein to retain endonuclease activity. Furthermore, the C-terminal 123 amino acid residues of Aae MutL were sufficient to stimulate Aq793 helicase activity, albeit at a significantly reduced efficacy. To the best of our knowledge this is the first time a human PMS2 homologue has been demonstrated to stimulate a PcrA/UvrD/Rep subfamily helicase, and this finding may further our understanding of the evolution of the mismatch repair pathway.	[Mauris, Jerome; Evans, Thomas C., Jr.] New England Biolabs Inc, Ipswich, MA 01938 USA	New England Biolabs	Evans, TC (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	evans@neb.com						An LX, 2005, J BIOL CHEM, V280, P28952, DOI 10.1074/jbc.M503096200; Atkinson J, 2009, J BIOL CHEM, V284, P9612, DOI 10.1074/jbc.M808030200; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; Bruand C, 2000, MOL MICROBIOL, V35, P204, DOI 10.1046/j.1365-2958.2000.01700.x; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Evans TC, 1999, BIOPOLYMERS, V51, P333, DOI 10.1002/(SICI)1097-0282(1999)51:5<333::AID-BIP3>3.3.CO;2-R; Fukui K, 2008, J BIOL CHEM, V283, P12136, DOI 10.1074/jbc.M800110200; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Harfe BD, 2000, ANNU REV GENET, V34, P359, DOI 10.1146/annurev.genet.34.1.359; Horiike T, 2009, GENE, V429, P59, DOI 10.1016/j.gene.2008.10.006; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, CELL, V126, P239, DOI 10.1016/j.cell.2006.07.003; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kolodner R, 1996, GENE DEV, V10, P1433, DOI 10.1101/gad.10.12.1433; Kosinski J, 2008, J MOL BIOL, V382, P610, DOI 10.1016/j.jmb.2008.06.056; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; LAHUE RS, 1989, SCIENCE, V245, P160, DOI 10.1126/science.2665076; LAHUE RS, 1988, MUTAT RES, V198, P37, DOI 10.1016/0027-5107(88)90037-1; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; Matson SW, 2006, NUCLEIC ACIDS RES, V34, P4089, DOI 10.1093/nar/gkl450; MATSON SW, 1986, J BIOL CHEM, V261, P169; Mauris J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007175; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Robertson AB, 2006, J BIOL CHEM, V281, P19949, DOI 10.1074/jbc.M601604200; SANCAR A, 1994, SCIENCE, V266, P1954, DOI 10.1126/science.7801120; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Tomko EJ, 2007, MOL CELL, V26, P335, DOI 10.1016/j.molcel.2007.03.024; Yamaguchi M, 1998, J BIOL CHEM, V273, P9197, DOI 10.1074/jbc.273.15.9197; YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658	31	7	7	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11087	11092		10.1074/jbc.M109.050955	http://dx.doi.org/10.1074/jbc.M109.050955			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20129926	Green Published, hybrid			2022-12-27	WOS:000276286200012
J	Bolz, DD; Tenor, JL; Aballay, A				Bolz, Devin D.; Tenor, Jennifer L.; Aballay, Alejandro			A Conserved PMK-1/p38 MAPK Is Required in Caenorhabditis elegans Tissue-specific Immune Response to Yersinia pestis Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATA TRANSCRIPTION FACTOR; C-ELEGANS; INNATE IMMUNITY; VIRULENCE FACTORS; OUTER PROTEINS; EXPRESSION; BACTERIAL; DEFENSE; ANTIGEN; SYSTEM	Yersinia pestis has acquired a variety of complex strategies that enable the bacterium to overcome defenses in different hosts and ensure its survival and successful transmission. A full-genome microarray analysis on Caenorhabditis elegans infected with Y. pestis shows enrichment in genes that are markers of innate immune responses and regulated by a conserved PMK-1/p38 MAPK. Consistent with a role in regulating expression of immune effectors, inhibition of PMK-1/p38 by mutation or RNA interference enhances susceptibility to Y. pestis. Further studies of mosaic animals where PMK-1/p38 is exclusively inhibited or overexpressed in a tissue-specific manner indicate that PMK-1/p38 controls expression of a CUB-like family of immune genes at the cell-autonomous level. Given the conserved nature of PMK-1/p38 MAPK-mediated signaling and innate immune responses, PMK-1/p38 MAPK may play a role in the immune response against Y. pestis in natural hosts.	[Bolz, Devin D.; Tenor, Jennifer L.; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA	Duke University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 268 Jones,Box 3054 DUMC, Durham, NC 27710 USA.	a.aballay@duke.edu			National Institutes of Health [GM070977, AI075844]; National Institutes of Health National Center for Research Resources; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI075844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM070977 (to A. A.) and AI075844 (to D. D. B.).; We thank the Duke Microarray Facility, Dr. Timothy Hammond (Durham Veterans Affairs Medical Center), for use of the COPAS Biosort instrument, and members of the Aballay laboratory for helpful discussions. Some strains used in this work were provided by the Caenorhabditis Genetics Center (University of Minnesota), which is funded by the National Institutes of Health National Center for Research Resources. Strain VP303 was kindly provided by Kevin Strange (Vanderbilt University).	Achtman M, 1999, P NATL ACAD SCI USA, V96, P14043, DOI 10.1073/pnas.96.24.14043; Ajees AA, 2006, NATURE, V444, P221, DOI 10.1038/nature05258; Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; An JH, 2005, P NATL ACAD SCI USA, V102, P16275, DOI 10.1073/pnas.0508105102; Anisimov AP, 2005, INFECT IMMUN, V73, P7324, DOI 10.1128/IAI.73.11.7324-7331.2005; Bartra SS, 2008, INFECT IMMUN, V76, P612, DOI 10.1128/IAI.01125-07; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; BORK P, 1993, J MOL BIOL, V231, P539, DOI 10.1006/jmbi.1993.1305; BRENNER S, 1974, GENETICS, V77, P71; Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Huang XZ, 2004, INFECT IMMUN, V72, P7212, DOI 10.1128/IAI.72.12.7212-7219.2004; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kolodziejek AM, 2007, MICROBIOL-SGM, V153, P2941, DOI 10.1099/mic.0.2006/005694-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Mollenhauer J, 2000, CANCER RES, V60, P1704; Montminy SW, 2006, NAT IMMUNOL, V7, P1066, DOI 10.1038/ni1386; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Oka T, 2001, J BIOL CHEM, V276, P33079, DOI 10.1074/jbc.M101652200; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Pujol U, 2005, CLIN IMMUNOL, V114, P216, DOI 10.1016/j.clim.2004.07.013; Pulak Rock, 2006, V351, P275; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Styer KL, 2005, EMBO REP, V6, P992, DOI 10.1038/sj.embor.7400516; Titball RW, 2003, BIOCHEM SOC T, V31, P104, DOI 10.1042/BST0310104; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; UNE T, 1984, INFECT IMMUN, V43, P895, DOI 10.1128/IAI.43.3.895-900.1984; Vallet-Gely I, 2008, NAT REV MICROBIOL, V6, P302, DOI 10.1038/nrmicro1870; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; Wang JJ, 2002, DEVELOPMENT, V129, P4989; Welkos S, 1998, MICROB PATHOGENESIS, V24, P185, DOI 10.1006/mpat.1997.0188; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730; Zugasti O, 2009, NAT IMMUNOL, V10, P249, DOI 10.1038/ni.1700	45	82	88	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10832	10840		10.1074/jbc.M109.091629	http://dx.doi.org/10.1074/jbc.M109.091629			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133945	Green Published, hybrid			2022-12-27	WOS:000276264600068
J	Buser, R; Lazar, Z; Kaser, S; Kunzler, M; Aebi, M				Buser, Reto; Lazar, Zbigniew; Kaeser, Sonja; Kuenzler, Markus; Aebi, Markus			Identification, Characterization, and Biosynthesis of a Novel N-Glycan Modification in the Fruiting Body of the Basidiomycete Coprinopsis cinerea	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCOPROTEIN-SYNTHESIS; COPRINUS-CINEREUS; GOLGI-APPARATUS; GLYCOSYLATION; ACETYLGLUCOSAMINYLTRANSFERASE; TRANSFORMATION; EXPRESSION; ENZYME; GENE	Coprinopsis cinerea is a model organism for fruiting body development in homobasidiomycetes. Here, we focused on N-linked oligosaccharides (NLO) of cell wall proteins in the hyphae of two developmental stages, vegetative mycelium and fruiting body. High mannose-type glycans were the most commonly found structures. In addition, we observed a novel glycan, predominantly present in fruiting body. This oligosaccharide structure was of the high mannose type with at least five mannoses and a bisecting alpha 1-4 N-acetylglucosamine (GlcNAc) at the beta-mannose of the N-glycan core. The transferase responsible for this modification, CcGnt1 (C. cinerea GlcNAc transferase 1), was identified and expressed in insect cells. In vitro activity of CcGnt1 was demonstrated. This novel glycosyltransferase belongs to the glycosyltransferase family 8 (GT8) and is predicted to be a type II membrane protein. Expression of the CcGnt1 locus was up-regulated in fruiting body, but down-regulation of expression by means of RNAi decreased the level of bisected NLO; however had no apparent effect on fruiting body formation.	[Buser, Reto; Lazar, Zbigniew; Kaeser, Sonja; Kuenzler, Markus; Aebi, Markus] Swiss Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland; [Lazar, Zbigniew] WUELS, Dept Biotechnol & Food Microbiol, PL-50375 Wroclaw, Poland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Wroclaw University of Environmental & Life Sciences	Aebi, M (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	aebi@micro.biol.ethz.ch	Lazar, Zbigniew/A-2744-2017; Lazar, Zbigniew/AAA-1972-2020	Lazar, Zbigniew/0000-0001-7315-1983; Lazar, Zbigniew/0000-0001-7315-1983; Kunzler, Markus/0000-0003-1275-0629	ETH Zurich; ESKAS Swiss Federal Scholarship	ETH Zurich(ETH Zurich); ESKAS Swiss Federal Scholarship	This work was supported in part by ETH Zurich and by an ESKAS Swiss Federal Scholarship (to Z. L.).	Berends E, 2009, APPL ENVIRON MICROB, V75, P4648, DOI 10.1128/AEM.00352-09; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Dean N, 1999, BBA-GEN SUBJECTS, V1426, P309, DOI 10.1016/S0304-4165(98)00132-9; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gibson RP, 2002, CHEM BIOL, V9, P1337, DOI 10.1016/S1074-5521(02)00292-2; Granado JD, 1997, MOL GEN GENET, V256, P28, DOI 10.1007/s004380050542; Grewal PK, 2005, GLYCOBIOLOGY, V15, P912, DOI 10.1093/glycob/cwi094; GRUBENMANN CE, 2004, THESIS U ZURICH ZURI; Gu J, 2009, J PROTEOME RES, V8, P431, DOI 10.1021/pr800674g; Guillen E, 1999, J BIOL CHEM, V274, P6641, DOI 10.1074/jbc.274.10.6641; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herscovics A, 1999, BBA-GEN SUBJECTS, V1473, P96, DOI 10.1016/S0304-4165(99)00171-3; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kaiser C., 1994, METHODS YEAST GENETI; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MAY G, 1991, GENETICS, V128, P529; Morelle W, 2005, EUKARYOT CELL, V4, P1308, DOI 10.1128/EC.4.7.1308-1316.2005; NARASIMHAN S, 1982, J BIOL CHEM, V257, P235; Patnaik SK, 2005, J BIOL CHEM, V280, P20851, DOI 10.1074/jbc.M500069200; Peyrard M, 1999, P NATL ACAD SCI USA, V96, P598, DOI 10.1073/pnas.96.2.598; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; SMITH WL, 1975, J BIOL CHEM, V250, P3426; Stanley P., 2009, ESSENTIALS GLYCOBIOL; SWAMY S, 1984, J GEN MICROBIOL, V130, P3219; TAI T, 1977, J BIOL CHEM, V252, P6687; Taniguchi N., 2002, HDB GLYCOSYLTRANSFER; Wallis GLF, 2001, EUR J BIOCHEM, V268, P4134, DOI 10.1046/j.1432-1327.2001.02322.x; Walti MA, 2006, EUKARYOT CELL, V5, P732, DOI 10.1128/EC.5.4.732-744.2006; Yoko-o T, 2003, GLYCOBIOLOGY, V13, P581, DOI 10.1093/glycob/cwg063	36	18	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10715	10723		10.1074/jbc.M109.076075	http://dx.doi.org/10.1074/jbc.M109.076075			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20061575	hybrid, Green Published			2022-12-27	WOS:000276264600058
J	Chang, YW; Chuang, YC; Ho, YC; Cheng, MY; Sun, YJ; Hsiao, CD; Wang, C				Chang, Yi-Wei; Chuang, Yi-Chien; Ho, Yu-Chi; Cheng, Ming-Yuan; Sun, Yuh-Ju; Hsiao, Chwan-Deng; Wang, Chung			Crystal Structure of Get4-Get5 Complex and Its Interactions with Sgt2, Get3, and Ydj1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAIL-ANCHORED PROTEINS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; DATA QUALITY; YEAST; IDENTIFICATION; ACTIVATOR; DENSITY; GENES; HSP70	Get3, Get4, and Get5 in Saccharomyces cerevisiae participate in the insertion of tail-anchored proteins into the endoplasmic reticulum membrane. We elucidated the interaction between Get4 and Get5 and investigated their interaction with Get3 and a tetratricopeptide repeat-containing protein, Sgt2. Based on co-immunoprecipitation and crystallographic studies, Get4 and Get5 formed a tight complex, suggesting that they constitute subunits of a larger complex. In contrast, although Get3 interacted physically with the Get4-Get5 complex, low amounts of Get3 co-precipitated with Get5, implying a transient interaction between Get3 and Get4-Get5. Sgt2 also interacted with Get5, although the amount of Sgt2 that co-precipitated with Get5 varied. Moreover, GET3, GET4, and GET5 interacted genetically with molecular chaperone YDJ1, suggesting that chaperones might also be involved in the insertion of tail-anchored proteins.	[Chang, Yi-Wei; Chuang, Yi-Chien; Ho, Yu-Chi; Hsiao, Chwan-Deng; Wang, Chung] Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan; [Chang, Yi-Wei; Sun, Yuh-Ju] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu 300, Taiwan; [Cheng, Ming-Yuan] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Yang Ming Chiao Tung University	Hsiao, CD (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 115, Taiwan.	hsiao@gate.sinica.edu.tw; mbcw@gate.sinica.edu.tw	Chang, Yi-Wei/ABH-1418-2020; Hsiao, Chwan-Deng/D-7327-2013; Hsiao, Chwan-Deng/AAZ-8869-2021	Chang, Yi-Wei/0000-0003-2391-473X; Hsiao, Chwan-Deng/0000-0002-7012-1532	National Science Council [NSC96-2311-B-001-035-MY3, NSC-95-2311-B-001-064]; Academia Sinica Taiwan, ROC	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica Taiwan, ROC(Academia Sinica - Taiwan)	This work was supported by National Science Council Grants NSC96-2311-B-001-035-MY3 (to C. W.) and NSC-95-2311-B-001-064 (to C.-D.H.) and grants from the Academia Sinica Taiwan, ROC.	Amberg DC., 2005, METHODS YEAST GENETI; Becker J, 1996, MOL CELL BIOL, V16, P4378; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan G, 2007, CANCER RES, V67, P10087, DOI 10.1158/0008-5472.CAN-07-1646; D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007; Dutta S, 2008, BIOCHEMISTRY-US, V47, P10123, DOI 10.1021/bi800758a; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fernandes JMO, 2008, GENOMICS, V91, P315, DOI 10.1016/j.ygeno.2007.10.017; Fleischer TC, 2006, GENE DEV, V20, P1294, DOI 10.1101/gad.1422006; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hainzl O, 2004, J BIOL CHEM, V279, P23267, DOI 10.1074/jbc.M402189200; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hu Z, 2006, J CELL SCI, V119, P326, DOI 10.1242/jcs.02754; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kordes E, 1998, GENOMICS, V52, P90, DOI 10.1006/geno.1998.5385; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Liou ST, 2007, CELL STRESS CHAPERON, V12, P59, DOI 10.1379/CSC-220R.1; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rabu C, 2008, J BIOL CHEM, V283, P27504, DOI 10.1074/jbc.M804591200; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shen S, 2009, MOL BIOL CELL, V20, P2438, DOI 10.1091/mbc.E08-10-0987; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Wegele H, 2003, J BIOL CHEM, V278, P25970, DOI 10.1074/jbc.M301548200; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Winnefeld M, 2006, EXP CELL RES, V312, P2500, DOI 10.1016/j.yexcr.2006.04.020; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	34	65	67	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9962	9970		10.1074/jbc.M109.087098	http://dx.doi.org/10.1074/jbc.M109.087098			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106980	Green Published, hybrid			2022-12-27	WOS:000276165900065
J	Dong, MQ; Lam, PCH; Pinon, DI; Orry, A; Sexton, PM; Abagyan, R; Miller, LJ				Dong, Maoqing; Lam, Polo C-H.; Pinon, Delia I.; Orry, Andrew; Sexton, Patrick M.; Abagyan, Ruben; Miller, Laurence J.			Secretin Occupies a Single Protomer of the Homodimeric Secretin Receptor Complex INSIGHTS FROM PHOTOAFFINITY LABELING STUDIES USING DUAL SITES OF COVALENT ATTACHMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE; CORTICOTROPIN-RELEASING-FACTOR; GLUCAGON-LIKE PEPTIDE-1; AMINO-TERMINUS; SPATIAL APPROXIMATION; EXTRACELLULAR DOMAIN; CALCITONIN RECEPTOR; MOLECULAR RECOGNITION; PARATHYROID-HORMONE	The secretin receptor, a prototypic family B G protein-coupled receptor, forms a constitutive homodimeric complex that is stable even in the presence of hormone. Recently, a model of this agonist-bound receptor was built based on high resolution structures reported for amino-terminal domains of other family members. Although this model provided the best solution for all extant data, including 10 photoaffinity labeling constraints, a new such constraint now obtained with a position 16 photo-labile probe was inconsistent with this model. As the secretin receptor forms constitutive homodimers, we explored whether secretin might dock across both protomers of the complex, an observation that could also contribute to the negative cooperativity observed. To directly explore this, we prepared six secretin analogue probes that simultaneously incorporated two photo-labile benzoylphenylalanines as sites of covalent attachment, in positions known to label distinct receptor subdomains. Each bifunctional probe was a full agonist that labeled the receptor specifically and saturably, with electrophoretic migration consistent with labeling a single protomer of the homodimeric secretin receptor. No band representing radiolabeled receptor dimer was observed with any bifunctional probe. The labeled monomeric receptor bands were cleaved with cyanogen bromide to demonstrate that both of the photolabile benzoylphenylalanines within a single probe had established covalent adducts with a single receptor in the complex. These data are consistent with a model of secretin occupying a single secretin receptor protomer within the homodimeric receptor complex. A new molecular model accommodating all constraints is now proposed.	[Dong, Maoqing; Pinon, Delia I.; Miller, Laurence J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Scottsdale, AZ 85259 USA; [Lam, Polo C-H.; Orry, Andrew; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA; [Lam, Polo C-H.; Orry, Andrew; Abagyan, Ruben] Molsoft LLC, La Jolla, CA 92037 USA; [Sexton, Patrick M.] Monash Univ, Drug Discovery Biol Lab, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Sexton, Patrick M.] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia	Mayo Clinic; Mayo Clinic Phoenix; University of California System; University of California San Diego; Monash University; Monash University	Miller, LJ (corresponding author), Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, 13400 E Shea Blvd, Scottsdale, AZ 85259 USA.	miller@mayo.edu	Sexton, Patrick M/B-1319-2008	Sexton, Patrick M/0000-0001-8902-2473	National Institutes of Health [DK46577]; Fiterman Foundation; Mayo Clinic; National Health and Medical Research Council of Australia [436781, 519461]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK046577, R01DK046577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fiterman Foundation; Mayo Clinic; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK46577. This work was also supported by the Fiterman Foundation and Mayo Clinic and by National Health and Medical Research Council of Australia Grants 436781 and 519461.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; CAO YJ, 1995, BIOCHEM BIOPH RES CO, V212, P673, DOI 10.1006/bbrc.1995.2021; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; De Meyts P, 2009, ANN NY ACAD SCI, V1160, P45, DOI 10.1111/j.1749-6632.2009.03837.x; Dong MQ, 2008, MOL PHARMACOL, V74, P413, DOI 10.1124/mol.108.047209; Dong MQ, 2007, MOL PHARMACOL, V72, P280, DOI 10.1124/mol.107.035402; Dong MQ, 2006, MOL PHARMACOL, V70, P206, DOI 10.1124/mol.105.021840; Dong MQ, 2009, J BIOL CHEM, V284, P21839, DOI 10.1074/jbc.M109.011924; Dong MQ, 2000, J BIOL CHEM, V275, P26032, DOI 10.1074/jbc.M000612200; Dong MQ, 2004, J BIOL CHEM, V279, P2894, DOI 10.1074/jbc.M310407200; Dong MQ, 1999, J BIOL CHEM, V274, P903, DOI 10.1074/jbc.274.2.903; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; GARDNER JD, 1977, GASTROENTEROLOGY, V73, P52; Gourlet P, 1996, PEPTIDES, V17, P825, DOI 10.1016/0196-9781(96)00107-6; Grace CRR, 2007, P NATL ACAD SCI USA, V104, P4858, DOI 10.1073/pnas.0700682104; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Hadac EM, 1999, J MED CHEM, V42, P2105, DOI 10.1021/jm980732q; Hadac EM, 1996, PANCREAS, V13, P130, DOI 10.1097/00006676-199608000-00003; Harikumar KG, 2007, J BIOL CHEM, V282, P32834, DOI 10.1074/jbc.M704563200; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Harikumar KG, 2008, J MOL NEUROSCI, V36, P279, DOI 10.1007/s12031-008-9060-z; Harikumar KG, 2006, MOL PHARMACOL, V69, P363, DOI 10.1124/mol.105.015776; Harikurnar KG, 2008, BBA-BIOMEMBRANES, V1778, P2555, DOI 10.1016/j.bbamem.2008.07.008; HOLTMANN MH, 1995, J BIOL CHEM, V270, P14394, DOI 10.1074/jbc.270.24.14394; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; ISHIHARA T, 1991, EMBO J, V10, P1635, DOI 10.1002/j.1460-2075.1991.tb07686.x; Ji ZS, 1997, J BIOL CHEM, V272, P24393, DOI 10.1074/jbc.272.39.24393; JUPPNER H, 1994, ENDOCRINOLOGY, V134, P879, DOI 10.1210/en.134.2.879; KOFOD H, 1991, INT J PEPT PROT RES, V37, P185; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN HY, 1991, SCIENCE, V254, P1022, DOI 10.1126/science.1658940; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Parthier C, 2007, P NATL ACAD SCI USA, V104, P13942, DOI 10.1073/pnas.0706404104; Pioszak AA, 2008, J BIOL CHEM, V283, P32900, DOI 10.1074/jbc.M805749200; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWERS SP, 1988, INT J PEPT PROT RES, V31, P429; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Seck T, 2003, J BIOL CHEM, V278, P23085, DOI 10.1074/jbc.M211280200; STROOP SD, 1995, BIOCHEMISTRY-US, V34, P1050, DOI 10.1021/bi00003a040; Sun CH, 2007, P NATL ACAD SCI USA, V104, P7875, DOI 10.1073/pnas.0611397104; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; ULRICH CD, 1993, GASTROENTEROLOGY, V105, P1534, DOI 10.1016/0016-5085(93)90162-6; Zang MW, 2003, MOL PHARMACOL, V63, P993, DOI 10.1124/mol.63.5.993	46	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9919	9931		10.1074/jbc.M109.089730	http://dx.doi.org/10.1074/jbc.M109.089730			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100828	hybrid, Green Published			2022-12-27	WOS:000276165900062
J	Featherstone, K; Wood, AL; Bowen, AJ; Corcoran, AE				Featherstone, Karen; Wood, Andrew L.; Bowen, Adam J.; Corcoran, Anne E.			The Mouse Immunoglobulin Heavy Chain V-D Intergenic Sequence Contains Insulators That May Regulate Ordered V(D)J Recombination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELL DEVELOPMENT; ALLELIC EXCLUSION; INTRONIC ENHANCER; LYMPHOCYTE DEVELOPMENT; CHROMATIN-STRUCTURE; GENE REARRANGEMENT; BONE-MARROW; CTCF SITES; IGH LOCUS; 3' END	During immunoglobulin heavy chain (Igh) V(D)J recombination, D to J precedes V to DJ recombination in an ordered manner, controlled by differential chromatin accessibility of the V and DJ regions and essential for correct antibody assembly. However, with the exception of the intronic enhancer E mu, which regulates D to J recombination, cis-acting regulatory elements have not been identified. We have assembled the sequence of a strategically located 96-kb V-D intergenic region in the mouse Igh and analyzed its activity during lymphocyte development. We show that E mu-dependent D antisense transcription, proposed to open chromatin before D to J recombination, extends into the V-D region for more than 30 kb in B cells before, during, and after V(D) J recombination and in T cells but terminates 40 kb from the first V gene. Thus, subsequent V antisense transcription before V to DJ recombination is actively prevented and must be independently activated. To find cis-acting elements that regulate this differential chromatin opening, we identified six DNase I-hypersensitive sites (HSs) in the V-D region. One conserved HS upstream of the first D gene locally regulates D genes. Two further conserved HSs near the D region mark a sharp decrease in antisense transcription, and both HSs bind CTCF in vivo. Further, they both possess enhancer-blocking activity in vivo. Thus, we propose that they are enhancer-blocking insulators preventing E mu-dependent chromatin opening extending into the V region. Thus, they are the first elements identified that may control ordered V(D) J recombination and correct assembly of antibody genes.	[Featherstone, Karen; Wood, Andrew L.; Bowen, Adam J.; Corcoran, Anne E.] Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Corcoran, AE (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Babraham Res Campus, Cambridge CB22 3AT, England.	anne.corcoran@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council (BBSRC); Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C163] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by Biotechnology and Biological Sciences Research Council (BBSRC) Ph.D. studentships.	Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; ALESSANDRINI A, 1991, MOL CELL BIOL, V11, P2096, DOI 10.1128/MCB.11.4.2096; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Bates JG, 2007, J EXP MED, V204, P3247, DOI 10.1084/jem.20071787; Bolland DJ, 2007, MOL CELL BIOL, V27, P5523, DOI 10.1128/MCB.02407-06; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; BORN W, 1988, J IMMUNOL, V140, P3228; BUTCHER EC, 1980, EUR J IMMUNOL, V10, P556, DOI 10.1002/eji.1830100713; Chakraborty T, 2007, MOL CELL, V27, P842, DOI 10.1016/j.molcel.2007.07.010; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Choi IC, 2004, GENOMICS, V83, P636, DOI 10.1016/j.ygeno.2003.10.001; Chou WC, 2006, BLOOD, V108, P3005, DOI 10.1182/blood-2006-05-024430; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Corcoran AE, 2005, SEMIN IMMUNOL, V17, P141, DOI 10.1016/j.smim.2005.01.002; Corcoran AE, 1998, NATURE, V391, P904, DOI 10.1038/36122; Daly J, 2007, EMBO J, V26, P4273, DOI 10.1038/sj.emboj.7601846; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; Hawwari A, 2005, J EXP MED, V202, P467, DOI 10.1084/jem.20050680; Heng HHQ, 2004, J CELL SCI, V117, P999, DOI 10.1242/jcs.00976; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Johnson K, 2003, MOL CELL BIOL, V23, P2438, DOI 10.1128/MCB.23.7.2438-2450.2003; Johnston CM, 2006, J IMMUNOL, V176, P4221, DOI 10.4049/jimmunol.176.7.4221; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kirch SA, 1998, EMBO J, V17, P4881, DOI 10.1093/emboj/17.16.4881; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Maes J, 2006, J IMMUNOL, V176, P5409, DOI 10.4049/jimmunol.176.9.5409; Matsuda F, 1998, J EXP MED, V188, P2151, DOI 10.1084/jem.188.11.2151; Mitchell JA, 2008, GENE DEV, V22, P20, DOI 10.1101/gad.454008; Morshead KB, 2003, P NATL ACAD SCI USA, V100, P11577, DOI 10.1073/pnas.1932643100; NAKAGOMI K, 1994, MOL CELL BIOL, V14, P1852, DOI 10.1128/MCB.14.3.1852; Nitschke L, 2001, J IMMUNOL, V166, P2540, DOI 10.4049/jimmunol.166.4.2540; Pawlitzky I, 2006, J IMMUNOL, V176, P6839, DOI 10.4049/jimmunol.176.11.6839; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; RALPH P, 1973, J IMMUNOL, V110, P1470; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Senoo M, 2003, J IMMUNOL, V171, P829, DOI 10.4049/jimmunol.171.2.829; Sieh P, 2001, J IMMUNOL, V167, P2121, DOI 10.4049/jimmunol.167.4.2121; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; THOMPSON A, 1995, EUR J IMMUNOL, V25, P257, DOI 10.1002/eji.1830250142; Tripathi R, 2002, J IMMUNOL, V168, P2316, DOI 10.4049/jimmunol.168.5.2316; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Wei W, 2001, MOL CELL BIOL, V21, P1429, DOI 10.1128/MCB.21.4.1429-1439.2001; Williams A, 2008, J EXP MED, V205, P747, DOI 10.1084/jem.20080066; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Yang QX, 2005, MOL CELL BIOL, V25, P6021, DOI 10.1128/MCB.25.14.6021-6030.2005; Ye J, 2004, IMMUNOGENETICS, V56, P399, DOI 10.1007/s00251-004-0712-z; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	65	56	91	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9327	9338		10.1074/jbc.M109.098251	http://dx.doi.org/10.1074/jbc.M109.098251			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100833	hybrid, Green Published			2022-12-27	WOS:000276165900004
J	He, JZ; Ho, JJD; Gingerich, S; Courtman, DW; Marsden, PA; Ward, ME				He, Jeff Z.; Ho, J. J. David; Gingerich, Sheena; Courtman, David W.; Marsden, Philip A.; Ward, Michael E.			Enhanced Translation of Heme Oxygenase-2 Preserves Human Endothelial Cell Viability during Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; PROLONGED HYPOXIA; OXIDATIVE STRESS; GENE-EXPRESSION; CARBON-MONOXIDE; RAT-BRAIN; APOPTOSIS; HO-2; MECHANISMS; MUSCLE	Heme oxygenases (HOs) -1 and -2 catalyze the breakdown of heme to release carbon monoxide, biliverdin, and ferrous iron, which may preserve cell function during oxidative stress. HO-1 levels decrease in endothelial cells exposed to hypoxia, whereas the effect of hypoxia on HO-2 expression is unknown. The current study was carried out to determine if hypoxia alters HO-2 protein levels in human endothelial cells and whether this enzyme plays a role in preserving their viability during hypoxic stress. Human umbilical vein endothelial cells (HUVECs), human aortic endothelial cells (HAECs), and human blood outgrowth endothelial cells were exposed to 21% or 1% O-2 for 48 or 16 h in the presence or absence of tumor necrosis factor-alpha (10 ng/ml) or H2O2 (100 mu M). In all three endothelial cell types HO-1 mRNA and protein levels were decreased following hypoxic incubation, whereas HO-2 protein levels were unaltered. In HUVECs HO-2 levels were maintained during hypoxia despite a 57% reduction in steady-state HO-2 mRNA level and a 43% reduction in total protein synthesis. Polysome profiling revealed increased HO-2 transcript association with polysomes during hypoxia consistent with enhanced translation of these transcripts. Importantly, inhibition of HO-2 expression by small interference RNA increased oxidative stress, exacerbated mitochondrial membrane depolarization, and enhanced caspase activation and apoptotic cell death in cells incubated under hypoxic but not normoxic conditions. These data indicate that HO-2 is important in maintaining endothelial viability and may preserve local regulation of vascular tone, thrombosis, and inflammatory responses during reductions in systemic oxygen delivery.	[Marsden, Philip A.] Univ Toronto, Dept Med, Div Nephrol, Toronto, ON M5S 1A8, Canada; [He, Jeff Z.; Courtman, David W.; Ward, Michael E.] St Michaels Hosp, Terrence Donnelly Labs, Toronto, ON M5B 1W8, Canada; [He, Jeff Z.; Courtman, David W.; Marsden, Philip A.; Ward, Michael E.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [He, Jeff Z.; Ward, Michael E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Ho, J. J. David] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Ward, Michael E.] Univ Toronto, Dept Med, Div Respirol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Toronto; University of Toronto	Marsden, PA (corresponding author), Univ Toronto, Dept Med, Div Nephrol, Rm 7358,Med Sci Bldg,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	p.marsden@utoronto.ca	Marsden, Philip A/B-1441-2012		Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation [T-5834]; Peterborough K. M. Hunter Graduate Studentship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Peterborough K. M. Hunter Graduate Studentship	This work was supported in part by the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation (Grant T-5834).; Recipient of a Peterborough K. M. Hunter Graduate Studentship.; Recipient of a CIHR Molecular Collaborative Graduate Training Studentship.	Adachi T, 2004, BIOCHEM BIOPH RES CO, V320, P514, DOI 10.1016/j.bbrc.2004.05.195; Auer G, 1998, J APPL PHYSIOL, V85, P411, DOI 10.1152/jappl.1998.85.2.411; Basuroy S, 2006, AM J PHYSIOL-CELL PH, V291, pC897, DOI 10.1152/ajpcell.00032.2006; Bitzan MM, 1998, J CLIN INVEST, V101, P372, DOI 10.1172/JCI522; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Chen J, 2004, BIOCHEM BIOPH RES CO, V318, P88, DOI 10.1016/j.bbrc.2004.03.187; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Dennery PA, 2003, FREE RADICAL BIO MED, V34, P124, DOI 10.1016/S0891-5849(02)01295-9; Dennery PA, 1998, J CLIN INVEST, V101, P1001, DOI 10.1172/JCI448; Di Filippo C, 2006, CARDIOVASC DRUG REV, V24, P77; EWING JF, 1995, ENDOCRINOLOGY, V136, P2294, DOI 10.1210/en.136.5.2294; Fish JE, 2007, J BIOL CHEM, V282, P15652, DOI 10.1074/jbc.M608318200; Foltz WD, 2008, BIOMATERIALS, V29, P1844, DOI 10.1016/j.biomaterials.2007.12.012; Goodman AI, 2006, J AM SOC NEPHROL, V17, P1073, DOI 10.1681/ASN.2004121082; Govindaraju V, 2005, AM J PHYSIOL-HEART C, V288, pH962, DOI 10.1152/ajpheart.01218.2003; Hartsfield C, 1999, AM J PHYSIOL-LUNG C, V277, pL1133, DOI 10.1152/ajplung.1999.277.6.L1133; Kim JY, 2003, FEBS LETT, V549, P94, DOI 10.1016/S0014-5793(03)00795-6; Kim YM, 2008, BMB REP, V41, P164, DOI 10.5483/BMBRep.2008.41.2.164; Kim YS, 2005, FREE RADICAL BIO MED, V38, P85, DOI 10.1016/j.freeradbiomed.2004.09.031; Kim YS, 2005, FREE RADICAL BIO MED, V39, P558, DOI 10.1016/j.freeradbiomed.2005.04.009; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; Koritzinsky M, 2006, EMBO J, V25, P1114, DOI 10.1038/sj.emboj.7600998; Lee PJ, 1997, J BIOL CHEM, V272, P5375, DOI 10.1074/jbc.272.9.5375; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; MCCOUBREY WK, 1992, ARCH BIOCHEM BIOPHYS, V295, P13, DOI 10.1016/0003-9861(92)90481-B; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; MCCOUBREY WK, 1995, BIOL REPROD, V53, P1330, DOI 10.1095/biolreprod53.6.1330; MORITA T, 1995, P NATL ACAD SCI USA, V92, P1475, DOI 10.1073/pnas.92.5.1475; Motterlini R, 2000, J BIOL CHEM, V275, P13613, DOI 10.1074/jbc.275.18.13613; Nakayama M, 2000, BIOCHEM BIOPH RES CO, V271, P665, DOI 10.1006/bbrc.2000.2683; Newby D, 2005, PLACENTA, V26, P201, DOI 10.1016/j.placenta.2004.05.002; Panchenko MV, 2000, AM J PHYSIOL-CELL PH, V278, pC92, DOI 10.1152/ajpcell.2000.278.1.C92; Parfenova H, 2006, AM J PHYSIOL-CELL PH, V290, pC1399, DOI 10.1152/ajpcell.00386.2005; Park EH, 2005, J BIOL CHEM, V280, P20945, DOI 10.1074/jbc.M412744200; Raju VS, 1997, BBA-GENE STRUCT EXPR, V1351, P89, DOI 10.1016/S0167-4781(96)00183-2; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Stempien-Otero A, 1999, J BIOL CHEM, V274, P8039, DOI 10.1074/jbc.274.12.8039; SUN Y, 1990, J BIOL CHEM, V265, P8212; Ward ME, 2005, J CLIN INVEST, V115, P3128, DOI 10.1172/JCI20806; Ward ME, 1999, J APPL PHYSIOL, V86, P1644, DOI 10.1152/jappl.1999.86.5.1644; Yang ZZ, 2001, AM J PHYSIOL-RENAL, V281, pF900, DOI 10.1152/ajprenal.2001.281.5.F900; Zacour ME, 1998, PULM PHARMACOL THER, V11, P197, DOI 10.1006/pupt.1998.0137; Zapelini PH, 2008, MITOCHONDRION, V8, P211, DOI 10.1016/j.mito.2008.03.002; Zhang YZ, 2006, FEBS J, V273, P3136, DOI 10.1111/j.1742-4658.2006.05319.x	45	34	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9452	9461		10.1074/jbc.M109.077230	http://dx.doi.org/10.1074/jbc.M109.077230			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118244	Green Published, hybrid			2022-12-27	WOS:000276165900018
J	Liu, Z; Lin, L; Yuan, C; Nicolaes, GAF; Chen, LQ; Meehan, EJ; Furie, B; Furie, B; Huang, MD				Liu, Zhuo; Lin, Lin; Yuan, Cai; Nicolaes, Gerry A. F.; Chen, Liqing; Meehan, Edward J.; Furie, Bruce; Furie, Barbara; Huang, Mingdong			Trp(2313)-His(2315) of Factor VIII C2 Domain Is Involved in Membrane Binding STRUCTURE OF A COMPLEX BETWEEN THE C2 DOMAIN AND AN INHIBITOR OF MEMBRANE BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION-FACTOR-VIII; VON-WILLEBRAND-FACTOR; HUMAN-FACTOR-V; CRYSTAL-STRUCTURE; PROTEIN; IDENTIFICATION; HEMOPHILIA; ACTIVATION; MUTATION; SURFACE	Factor VIII (FVIII) plays a critical role in blood coagulation by forming the tenase complex with factor IXa and calcium ions on a membrane surface containing negatively charged phospholipids. The tenase complex activates factor X during blood coagulation. The carboxyl-terminal C2 domain of FVIII is the main membrane-binding and von Willebrand factor-binding region of the protein. Mutations of FVIII cause hemophilia A, whereas elevation of FVIII activity is a risk factor for thromboembolic diseases. The C2 domain-membrane interaction has been proposed as a target of intervention for regulation of blood coagulation. A number of molecules that interrupt FVIII or factor V (FV) binding to cell membranes have been identified through high throughput screening or structure-based design. We report crystal structures of the FVIII C2 domain under three new crystallization conditions, and a high resolution (1.15 angstrom) crystal structure of the FVIII C2 domain bound to a small molecular inhibitor. The latter structure shows that the inhibitor binds to the surface of an exposed beta-strand of the C2 domain, Trp(2313)-His(2315). This result indicates that the Trp(2313)-His(2315) segment is an important constituent of the membrane binding motif and provides a model to understand the molecular mechanism of the C2 domain membrane interaction.	[Liu, Zhuo; Yuan, Cai; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China; [Lin, Lin; Furie, Bruce; Furie, Barbara; Huang, Mingdong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hemostasis & Thrombosis, Boston, MA 02215 USA; [Nicolaes, Gerry A. F.] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6229 ER Maastricht, Netherlands; [Chen, Liqing; Meehan, Edward J.] Univ Alabama, Dept Chem, Struct Biol Lab, Huntsville, AL 35899 USA; [Liu, Zhuo] Chinese Acad Sci, Grad Univ, Beijing 10039, Peoples R China	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Maastricht University; University of Alabama System; University of Alabama Huntsville; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China.	mhuang@fjirsm.ac.cn	Nicolaes, Gerry A.F./A-8421-2016; Huang, Mingdong/J-4278-2017	Nicolaes, Gerry A.F./0000-0002-2482-0412; Huang, Mingdong/0000-0003-0085-9141	National Institutes of Health [HL086584]; Natural Science Foundation of China [30811130467, 30625011]; Ministry of Science and Technology [2006AA02A313, 2007CB914304]; Chinese Academy of Sciences [KSCX2-YW-R-082]; National Science Foundation (NSF-EPSCoR); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation (NSF-EPSCoR)(National Science Foundation (NSF)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL086584. This work was also supported by grants from the Natural Science Foundation of China (30811130467 and 30625011), the Ministry of Science and Technology (2006AA02A313 and 2007CB914304), the Chinese Academy of Sciences (KSCX2-YW-R-082), and the National Science Foundation (NSF-EPSCoR).; Use of the Advanced Photon Source is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract W-31-109-Eng-38. We thank the staff of the Argonne Advanced Photon Source Southeast Regional Collaborative Access Team beamline 22ID for help during data collection.	Adams TE, 2004, P NATL ACAD SCI USA, V101, P8918, DOI 10.1073/pnas.0403072101; FAY PJ, 1991, J BIOL CHEM, V266, P2172; FOSTER PA, 1990, BLOOD, V75, P1999; FURIE B, 1990, SEMIN HEMATOL, V27, P270; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; KANE WH, 1986, P NATL ACAD SCI USA, V83, P6800, DOI 10.1073/pnas.83.18.6800; Kemball-Cook G, 1998, NUCLEIC ACIDS RES, V26, P216, DOI 10.1093/nar/26.1.216; Lin L, 2007, J MOL BIOL, V371, P717, DOI 10.1016/j.jmb.2007.05.054; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Mollica L, 2006, PROTEINS, V64, P363, DOI 10.1002/prot.20986; Ngo JCK, 2008, STRUCTURE, V16, P597, DOI 10.1016/j.str.2008.03.001; PITTMAN DD, 1988, P NATL ACAD SCI USA, V85, P2429, DOI 10.1073/pnas.85.8.2429; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; SAENKO EL, 1995, J BIOL CHEM, V270, P13826, DOI 10.1074/jbc.270.23.13826; Schatz SM, 2004, BRIT J HAEMATOL, V125, P629, DOI 10.1111/j.1365-2141.2004.04959.x; Segers K, 2007, P NATL ACAD SCI USA, V104, P12697, DOI 10.1073/pnas.0701051104; Shen BW, 2008, BLOOD, V111, P1240, DOI 10.1182/blood-2007-08-109918; Spiegel PC, 2004, CHEM BIOL, V11, P1413, DOI 10.1016/j.chembiol.2004.08.006; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; Stoilova-McPhie S, 2002, BLOOD, V99, P1215, DOI 10.1182/blood.V99.4.1215; Tagariello G, 2000, HAEMATOLOGICA, V85, P525; TOOLE JJ, 1984, NATURE, V312, P342, DOI 10.1038/312342a0; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANDIEIJEN G, 1981, J BIOL CHEM, V256, P3433; WOOD WI, 1984, NATURE, V312, P330, DOI 10.1038/312330a0	25	35	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8824	8829		10.1074/jbc.M109.080168	http://dx.doi.org/10.1074/jbc.M109.080168			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089867	Green Published, hybrid			2022-12-27	WOS:000275553700034
J	Xu, JL; Maurer, LM; Hoffmann, BR; Annis, DS; Mosher, DF				Xu, Jielin; Maurer, Lisa M.; Hoffmann, Brian R.; Annis, Douglas S.; Mosher, Deane F.			iso-DGR Sequences Do Not Mediate Binding of Fibronectin N-terminal Modules to Adherent Fibronectin-null Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM BETA-ZIPPER; STREPTOCOCCUS-PYOGENES; BORRELIA-BURGDORFERI; INTEGRIN BINDING; MATRIX; SITES; POLYMERIZATION; FIBRILLOGENESIS; CONFORMATION; DOMAIN	Fibronectin (FN) without an RGD sequence (FN-RGE), and thus lacking the principal binding site for alpha 5 beta 1 integrin, is deposited into the extracellular matrix of mouse embryos. Spontaneous conversion of (263)NGR and/or (501)NGR to iso-DGR possibly explains this enigma, i.e. ligation of iso-DGR by alpha v beta 3 integrin may allow cells to assemble FN. Partial modification of (263)NGR to DGR or iso-DGR was detected in purified plasma FN by mass spectrometry. To test functions of the conversion, one or both NGR sequences were mutated to QGR in recombinant N-terminal 70-kDa construct of FN (70K), full-length FN, or FN-RGE. The mutations did not affect the binding of soluble 70K to already adherent fibroblasts or the ability of soluble 70K to compete with non-mutant FN or FN-RGE for binding to FN assembly sites. Non-mutant FN and FN-N263Q/N501Q with both NGRs mutated to QGRs were assembled equally well by adherent fibroblasts. FN-RGE and FN-RGE-N263Q/N501Q were also assembled equally well. Although substrate-bound 70K mediated cell adhesion in the presence of 1 mM Mn2+ by a mechanism that was inhibited by cyclic RGD peptide, the peptide did not inhibit 70K binding to cell surface. Mutations of the NGR sequences had no effect on Mn2+-enhanced cell adhesion to adsorbed 70K but caused a decrease in cell adhesion to reduced and alkylated 70K. These results demonstrate that iso-DGR sequences spontaneously converted from NGR are cryptic and do not mediate the interaction of the 70K region of FN with the cell surface during FN assembly.	Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Med, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Mosher, DF (corresponding author), 4285 Med Sci Ctr, 1300 Univ Ave, Madison, WI 53706 USA.	dfmosher@wisc.edu		Maurer, Lisa/0000-0003-0492-9805	National Institutes of Health [HL021644, T32-HL007899]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL021644, T32HL007899] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL021644 (to D. F. M.) and National Institutes of Health Training Grant T32-HL007899 (to L. M. M. and B. R. H.).	AGUIRRE KM, 1994, J BIOL CHEM, V269, P27863; Bae E, 2004, J BIOL CHEM, V279, P35749, DOI 10.1074/jbc.M406283200; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BITTORF SV, 1993, J BIOL CHEM, V268, P24838; Bultmann H, 1998, J BIOL CHEM, V273, P2601, DOI 10.1074/jbc.273.5.2601; Cho J, 2006, J THROMB HAEMOST, V4, P1461, DOI 10.1111/j.1538-7836.2006.01943.x; Cho J, 2006, J THROMB HAEMOST, V4, P943, DOI 10.1111/j.1538-7836.2006.01862.x; Cho JH, 2006, BLOOD, V107, P3555, DOI 10.1182/blood-2005-10-4168; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Curnis F, 2008, CANCER RES, V68, P7073, DOI 10.1158/0008-5472.CAN-08-1272; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Di Matteo P, 2006, MOL IMMUNOL, V43, P1509, DOI 10.1016/j.molimm.2005.10.009; Ensenberger MG, 2004, BIOPHYS CHEM, V112, P201, DOI 10.1016/j.bpc.2004.07.020; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gimond C, 1999, J CELL BIOL, V147, P1325, DOI 10.1083/jcb.147.6.1325; GODYNA S, 1995, MATRIX BIOL, V14, P467, DOI 10.1016/0945-053X(95)90004-7; Hocking DC, 1998, J CELL BIOL, V141, P241, DOI 10.1083/jcb.141.1.241; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047; Kim JH, 2004, J BIOL CHEM, V279, P41706, DOI 10.1074/jbc.M401691200; Kinsey R, 2008, J CELL SCI, V121, P2696, DOI 10.1242/jcs.029819; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; Mosher DF, 2002, METHOD CELL BIOL, V69, P69, DOI 10.1016/S0091-679X(02)69008-9; MOSHER DF, 1983, J BIOL CHEM, V258, P6595; Ohashi T, 2002, J CELL SCI, V115, P1221; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pankov R, 2000, J CELL BIOL, V148, P1075, DOI 10.1083/jcb.148.5.1075; PFAFF M, 1994, J BIOL CHEM, V269, P20233; Raibaud S, 2005, J BIOL CHEM, V280, P18803, DOI 10.1074/jbc.M501731200; Retta SF, 2001, MOL BIOL CELL, V12, P3126, DOI 10.1091/mbc.12.10.3126; Sabatier L, 2009, MOL BIOL CELL, V20, P846, DOI 10.1091/mbc.E08-08-0830; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; Schwarzbauer JE, 1999, CURR OPIN CELL BIOL, V11, P622, DOI 10.1016/S0955-0674(99)00017-4; SCHWARZBAUER JE, 1991, J CELL BIOL, V113, P1463, DOI 10.1083/jcb.113.6.1463; Sechler JL, 2000, J CELL SCI, V113, P1491; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; SOTTILE J, 1991, J BIOL CHEM, V266, P12840; Sottile J, 2000, J CELL SCI, V113, P4287; Spitaleri A, 2008, J BIOL CHEM, V283, P19757, DOI 10.1074/jbc.M710273200; SUN X, 1991, J CLIN INVEST, V87, P171, DOI 10.1172/JCI114967; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2009, J BIOL CHEM, V284, P15668, DOI 10.1074/jbc.M109.003673; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Wennerberg K, 1996, J CELL BIOL, V132, P227, DOI 10.1083/jcb.132.1.227; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607	56	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8563	8571		10.1074/jbc.M109.062646	http://dx.doi.org/10.1074/jbc.M109.062646			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097751	hybrid, Green Published			2022-12-27	WOS:000275553700008
J	Matsunaga-Udagawa, R; Fujita, Y; Yoshiki, S; Terai, K; Kamioka, Y; Kiyokawa, E; Yugi, K; Aoki, K; Matsuda, M				Matsunaga-Udagawa, Rie; Fujita, Yoshihisa; Yoshiki, Sayaka; Terai, Kenta; Kamioka, Yuji; Kiyokawa, Etsuko; Yugi, Katsuyuki; Aoki, Kazuhiro; Matsuda, Michiyuki			The Scaffold Protein Shoc2/SUR-8 Accelerates the Interaction of Ras and Raf	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; KINASE; ACTIVATION; PHOSPHORYLATION; MECHANISM; CASCADES; DYNAMICS; COMPLEX; DOMAIN; SUR-8	Shoc2/SUR-8 positively regulates Ras/ERK MAP kinase signaling by serving as a scaffold for Ras and Raf. Here, we examined the role of Shoc2 in the spatio-temporal regulation of Ras by using a fluorescence resonance energy transfer (FRET)-based biosensor, together with computational modeling. In epidermal growth factor-stimulated HeLa cells, RNA-mediated Shoc2 knockdown reduced the phosphorylation of MEK and ERK with half-maximal inhibition, but not the activation of Ras. For the live monitoring of Ras binding to Raf, we utilized a FRET biosensor wherein Ras and the Ras-binding domain of Raf were connected tandemly and sandwiched with acceptor and donor fluorescent proteins for the FRET measurement. With this biosensor, we found that Shoc2 was required for the rapid interaction of Ras with Raf upon epidermal growth factor stimulation. To decipher the molecular mechanisms underlying the kinetics, we developed two computational models that might account for the action of Shoc2 in the Ras-ERK signaling. One of these models, the Shoc2 accelerator model, provided a reasonable explanation of the experimental observations. In this Shoc2 accelerator model, Shoc2 accelerated both the association and dissociation of Ras-Raf interaction. We propose that Shoc2 regulates the spatio-temporal patterns of the Ras-ERK signaling pathway primarily by accelerating the Ras-Raf interaction.	[Aoki, Kazuhiro; Matsuda, Michiyuki] Kyoto Univ, Lab Bioimaging & Cell Signaling, Grad Sch Biostudies, Kyoto 6068501, Japan; [Kamioka, Yuji; Kiyokawa, Etsuko; Matsuda, Michiyuki] Kyoto Univ, Dept Pathol & Biol Dis, Grad Sch Med, Kyoto 6068501, Japan; [Yugi, Katsuyuki] Keio Univ, Dept Biosci & Informat, Kanagawa 2238522, Japan; [Aoki, Kazuhiro] Japan Sci & Technol Agcy JST, PREST, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; Keio University; Japan Science & Technology Agency (JST)	Aoki, K (corresponding author), Kyoto Univ, Lab Bioimaging & Cell Signaling, Grad Sch Biostudies, Kyoto 6068501, Japan.	k-aoki@lif.kyoto-u.ac.jp	寺井, 健太/AFQ-7663-2022; Aoki, Kazuhiro/I-5483-2019; Aoki, Kazuhiro/B-5777-2013	寺井, 健太/0000-0001-7638-3720; Aoki, Kazuhiro/0000-0001-7263-1555; Aoki, Kazuhiro/0000-0001-7263-1555; Matsuda, Michiyuki/0000-0002-5876-9969; Fujita, Yoshihisa/0000-0002-5086-8188	Ministry of Education, Culture, Sports, and Science of Japan; Sagawa Cancer Research; Japan Science and Technology PRESTO; Kyoto University Global COE	Ministry of Education, Culture, Sports, and Science of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sagawa Cancer Research; Japan Science and Technology PRESTO; Kyoto University Global COE(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, and Science of Japan, a Sagawa Cancer Research Grant, the Japan Science and Technology PRESTO program, and funds from the Kyoto University Global COE program, "Center for Frontier Medicine."	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100; Anselmo AN, 2002, J BIOL CHEM, V277, P5940, DOI 10.1074/jbc.M110498200; Aoki K, 2008, PHILOS T R SOC B, V363, P2143, DOI 10.1098/rstb.2008.2267; Aoki K, 2007, J CELL BIOL, V177, P817, DOI 10.1083/jcb.200609017; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; BOS JL, 1989, CANCER RES, V49, P4682; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen D, 1996, J BIOL CHEM, V271, P6328, DOI 10.1074/jbc.271.11.6328; Dai PG, 2006, J BIOL CHEM, V281, P927, DOI 10.1074/jbc.M507360200; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939094; deRooij J, 1997, ONCOGENE, V14, P623, DOI 10.1038/sj.onc.1201005; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; Hara S, 2008, MOL BIOL CELL, V19, P3823, DOI 10.1091/mbc.E08-03-0314; Ishikawa M, 2004, EMBO J, V23, P2745, DOI 10.1038/sj.emboj.7600298; Kitano H, 2005, NAT BIOTECHNOL, V23, P961, DOI 10.1038/nbt1111; Kiyokawa E, 2006, CANCER SCI, V97, P8, DOI 10.1111/j.1349-7006.2006.00141.x; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Lewis TS, 1998, ADV CANCER RES, V74, P49, DOI 10.1016/S0065-230X(08)60765-4; Li WQ, 2000, GENE DEV, V14, P895; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; McCormick F, 1996, CURR OPIN BIOTECH, V7, P449, DOI 10.1016/S0958-1669(96)80123-6; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Mochizuki N, 2001, NATURE, V411, P1065, DOI 10.1038/35082594; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; Ohba Y, 2003, EMBO J, V22, P859, DOI 10.1093/emboj/cdg087; Ovadi J, 2004, MOL CELL BIOCHEM, V256, P5, DOI 10.1023/B:MCBI.0000009855.14648.2c; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pollok BA, 1999, TRENDS CELL BIOL, V9, P57, DOI 10.1016/S0962-8924(98)01434-2; Rodriguez-Viciana P, 2006, MOL CELL, V22, P217, DOI 10.1016/j.molcel.2006.03.027; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Shaw AS, 2009, NAT REV IMMUNOL, V9, P47, DOI 10.1038/nri2473; Sieburth DS, 1998, CELL, V94, P119, DOI 10.1016/S0092-8674(00)81227-1; STURGILL TW, 1991, BIOCHIM BIOPHYS ACTA, V1092, P350, DOI 10.1016/S0167-4889(97)90012-4; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Wu N, 2001, J AM CHEM SOC, V123, P6465, DOI 10.1021/ja010219t	41	42	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7818	7826		10.1074/jbc.M109.053975	http://dx.doi.org/10.1074/jbc.M109.053975			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051520	hybrid, Green Published			2022-12-27	WOS:000275415600089
J	Bernot, D; Barruet, E; Poggi, M; Bonardo, B; Alessi, MC; Peiretti, F				Bernot, Denis; Barruet, Emilie; Poggi, Marjorie; Bonardo, Bernadette; Alessi, Marie-Christine; Peiretti, Franck			Down-regulation of Tissue Inhibitor of Metalloproteinase-3 (TIMP-3) Expression Is Necessary for Adipocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUTRITIONALLY INDUCED OBESITY; SP1 TRANSCRIPTION FACTOR; WHITE ADIPOSE-TISSUE; MATRIX METALLOPROTEINASES; GENE-TRANSCRIPTION; FUNCTIONAL-ROLE; MICE; ADIPOGENESIS; APOPTOSIS; PROMOTER	Matrix metalloproteinase activity is essential for proper extracellular matrix remodeling that takes place during adipose tissue formation. Four tissue inhibitors of matrix metalloproteinases (TIMPs) regulate their activity. However, the role of TIMPs in adipocyte differentiation is poorly understood. We found that the expression of all TIMPs was modified during adipocyte differentiation, but that of TIMP-3 was distinguished by its extreme down-regulation. TIMP-3 expression was closely linked to the differentiation process. Indeed, it remained low during the adipocyte differentiation but increased when cell differentiation was prevented. We identified the transcription factor Sp1 as being responsible for the regulation of TIMP-3 expression during adipocyte differentiation. Overexpression of TIMP-3 reduced adipocyte differentiation, underlining its active role in this process. TIMP-3 overexpression decreased the expression of the early and obligate key inductors of adipogenesis Kruppel-like factor 4 (Klf4), early growth response 2 (Egr2/Krox20), and CAAT/enhancer-binding protein beta (C/EBP beta). Our results indicate that during preadipocyte differentiation, the Sp1-dependent decrease in TIMP-3 expression is required for the successful implementation of the adipocyte differentiation program.	[Bernot, Denis; Barruet, Emilie; Poggi, Marjorie; Bonardo, Bernadette; Alessi, Marie-Christine; Peiretti, Franck] Univ Aix Marseille 2, Fac Med, INSERM, U626, F-13385 Marseille 5, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Peiretti, F (corresponding author), Univ Aix Marseille 2, Fac Med, INSERM, U626, 27 Blvd Jean Moulin, F-13385 Marseille 5, France.	Franck.Peiretti@univmed.fr	poggi, marjorie/ABG-6438-2021; peiretti, franck/L-2718-2017; ALESSI, Marie-christine/AAK-3582-2020; Peiretti, Franck/GLV-3378-2022	poggi, marjorie/0000-0001-6331-9682; peiretti, franck/0000-0001-7198-0534; ALESSI, Marie-christine/0000-0003-3927-5792; Peiretti, Franck/0000-0001-7198-0534	INSERM (Paris, France)	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was supported by INSERM (Paris, France).	Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Boyle KB, 2009, CELL DEATH DIFFER, V16, P782, DOI 10.1038/cdd.2009.11; Butler GS, 1999, J BIOL CHEM, V274, P10846, DOI 10.1074/jbc.274.16.10846; Chavey C, 2003, J BIOL CHEM, V278, P11888, DOI 10.1074/jbc.M209196200; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; Christiaens V, 2008, THROMB HAEMOSTASIS, V99, P290, DOI 10.1160/TH07-10-0589; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Croissandeau G, 2002, BIOCHEM J, V364, P739, DOI 10.1042/BJ20011158; Deng XY, 2006, EUR J CANCER, V42, P3267, DOI 10.1016/j.ejca.2006.07.003; Drynda A, 2005, J IMMUNOL, V174, P6524, DOI 10.4049/jimmunol.174.10.6524; Fata JE, 2001, J CLIN INVEST, V108, P831, DOI 10.1172/JCI13171; Finan KM, 2006, LUNG CANCER-J IASLC, V53, P273, DOI 10.1016/j.lungcan.2006.06.006; Lijnen HR, 2003, THROMB HAEMOSTASIS, V89, P249; Lijnen HR, 2002, ARTERIOSCL THROM VAS, V22, P374, DOI 10.1161/hq0302.104522; Lijnen HR, 2001, THROMB HAEMOSTASIS, V85, P1111; Lijnen HR, 2002, THROMB HAEMOSTASIS, V87, P530; Malemud CJ, 2006, FRONT BIOSCI-LANDMRK, V11, P1696, DOI 10.2741/1915; Mansilla S, 2004, BIOCHEMISTRY-US, V43, P7584, DOI 10.1021/bi036185e; Mansilla S, 2008, BIOCHIMIE, V90, P976, DOI 10.1016/j.biochi.2007.12.008; Maquoi E, 2003, THROMB HAEMOSTASIS, V89, P696, DOI 10.1055/s-0037-1613586; Maquoi E, 2002, DIABETES, V51, P1093, DOI 10.2337/diabetes.51.4.1093; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Poggi M, 2009, DIABETOLOGIA, V52, P1152, DOI 10.1007/s00125-009-1267-1; Qureshi HY, 2005, J CELL PHYSIOL, V203, P345, DOI 10.1002/jcp.20228; Rosen ED, 2000, GENE DEV, V14, P1293; Scroyen I, 2007, J THROMB HAEMOST, V5, P139, DOI 10.1111/j.1538-7836.2006.02284.x; Stohr H, 1995, GENOME RES, V5, P483, DOI 10.1101/gr.5.5.483; SUN Y, 1995, J BIOL CHEM, V270, P19312, DOI 10.1074/jbc.270.33.19312; Tang QQ, 1999, MOL CELL BIOL, V19, P4855; Van Hul M, 2008, J THROMB HAEMOST, V6, P1198, DOI 10.1111/j.1538-7836.2008.02988.x; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Wang YH, 2006, MOL CELL BIOL, V26, P5421, DOI 10.1128/MCB.02437-05; WICK M, 1995, BIOCHEM J, V311, P549, DOI 10.1042/bj3110549; Zhang Y, 2008, GYNECOL ONCOL, V108, P234, DOI 10.1016/j.ygyno.2007.09.033	38	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6508	6514		10.1074/jbc.M109.078444	http://dx.doi.org/10.1074/jbc.M109.078444			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20056610	hybrid, Green Published			2022-12-27	WOS:000275367500055
J	Kwon, SK; Woo, J; Kim, SY; Kim, H; Kim, E				Kwon, Seok-Kyu; Woo, Jooyeon; Kim, Soo-Young; Kim, Hyun; Kim, Eunjoon			Trans-synaptic Adhesions between Netrin-G Ligand-3 (NGL-3) and Receptor Tyrosine Phosphatases LAR, Protein-tyrosine Phosphatase delta (PTP delta), and PTP sigma via Specific Domains Regulate Excitatory Synapse Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; HIPPOCAMPAL CHOLINERGIC INNERVATION; CENTRAL-NERVOUS-SYSTEM; LIPRIN-ALPHA; MICE LACKING; SYNAPTOGENIC PROTEINS; SULFATE PROTEOGLYCAN; DEFICIENT MICE; ACTIVE ZONE; RPTP-DELTA	Synaptic cell adhesion molecules regulate various steps of synapse formation. The trans-synaptic adhesion between postsynaptic NGL-3 (for netrin-G ligand-3) and presynaptic LAR (for leukocyte antigen-related) regulates excitatory synapse formation in a bidirectional manner. However, little is known about the molecular details of the NGL-3-LAR adhesion and whether two additional LAR family proteins, protein-tyrosine phosphatase delta (PTP delta), and PTP sigma, also interact with NGL-3 and are involved in synapse formation. We report here that the leucine-rich repeat (LRR) domain of NGL-3, containing nine LRRs, interacts with the first two fibronectin III (FNIII) domains of LAR to induce bidirectional synapse formation. Moreover, Gln-96 in the first LRR motif of NGL-3 is critical for LAR binding and induction of presynaptic differentiation. PTP delta and PTP sigma also interact with NGL-3 via their first two FNIII domains. These two interactions promote synapse formation in a different manner; the PTP sigma-NGL-3 interaction promotes synapse formation in a bidirectional manner, whereas the PTP delta-NGL-3 interaction instructs only presynaptic differentiation in a unidirectional manner. mRNAs encoding LAR family proteins display overlapping and differential expression patterns in various brain regions. These results suggest that trans-synaptic adhesion between NGL-3 and the three LAR family proteins regulates excitatory synapse formation in shared and distinct neural circuits.	[Kwon, Seok-Kyu; Woo, Jooyeon; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Dept Biol Sci, Taejon 305701, South Korea; [Kwon, Seok-Kyu; Woo, Jooyeon; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Nanosci & Technol, Taejon 305701, South Korea; [Kim, Soo-Young; Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Kim, Soo-Young; Kim, Hyun] Korea Univ, Coll Med, Div Brain Korea Biomed Sci 21, Seoul 136705, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Kim, E (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 205701, South Korea.	kime@kaist.ac.kr	Kim, Eunjoon/C-1566-2011; Kim, SooYoung/AAS-7899-2021; kim, soo-young/G-2365-2014	Kim, SooYoung/0000-0003-3632-8246; kim, soo-young/0000-0003-3632-8246; Kim, Hyun/0000-0002-7210-5798; Kwon, Seok-Kyu/0000-0002-7280-9867	Korean Ministry of Education, Science and Technology; Brain Research Center	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Brain Research Center	This work was supported by the National Creative Research Initiative Program of the Korean Ministry of Education, Science and Technology (to E. K.).; We thank the In Situ Hybridization facility at Korea University supported by the Brain Research Center under the 21st Century Frontier Research Program.	Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Akins MR, 2006, CURR OPIN NEUROBIOL, V16, P83, DOI 10.1016/j.conb.2006.01.009; Alete DE, 2006, FEBS J, V273, P4668, DOI 10.1111/j.1742-4658.2006.05471.x; Aoto J, 2007, BRAIN RES, V1184, P72, DOI 10.1016/j.brainres.2006.11.033; Apperson ML, 1996, J NEUROSCI, V16, P6839; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Biederer T, 2008, CURR OPIN NEUROBIOL, V18, P261, DOI 10.1016/j.conb.2008.07.014; Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92; Brose N, 2009, NEURON, V61, P650, DOI 10.1016/j.neuron.2009.02.014; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011; Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075; Dolan J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-320; Elchebly M, 1999, NAT GENET, V21, P330, DOI 10.1038/6859; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Fukata Y, 2006, SCIENCE, V313, P1792, DOI 10.1126/science.1129947; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Gonzalez-Brito MR, 2006, INT J DEV NEUROSCI, V24, P425, DOI 10.1016/j.ijdevneu.2006.08.006; Han K, 2008, PROG NEUROBIOL, V84, P263, DOI 10.1016/j.pneurobio.2007.10.011; Huang YZ, 2001, J BIOL CHEM, V276, P19318, DOI 10.1074/jbc.M100494200; Huang ZJ, 2008, CURR OPIN NEUROBIOL, V18, P77, DOI 10.1016/j.conb.2008.05.008; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2006, NEURON, V49, P517, DOI 10.1016/j.neuron.2006.01.026; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko J, 2007, J NEUROSCI RES, V85, P2824, DOI 10.1002/jnr.21306; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krasnoperov V, 2002, J BIOL CHEM, V277, P35887, DOI 10.1074/jbc.M205478200; Kurusu M, 2008, NEURON, V59, P972, DOI 10.1016/j.neuron.2008.07.037; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McLean J, 2002, J NEUROSCI, V22, P5481; Meathrel K, 2002, J NEUROSCI RES, V70, P24, DOI 10.1002/jnr.10382; MIZUNO K, 1993, MOL CELL BIOL, V13, P5513, DOI 10.1128/MCB.13.9.5513; Nakashiba T, 2002, MECH DEVELOP, V111, P47, DOI 10.1016/S0925-4773(01)00600-1; Nakashiba T, 2000, J NEUROSCI, V20, P6540, DOI 10.1523/JNEUROSCI.20-17-06540.2000; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; PULIDO R, 1995, P NATL ACAD SCI USA, V92, P11686, DOI 10.1073/pnas.92.25.11686; Rashid-Doubell F, 2002, J NEUROSCI, V22, P5024, DOI 10.1523/JNEUROSCI.22-12-05024.2002; Sajnani G, 2005, J NEUROBIOL, V65, P59, DOI 10.1002/neu.20175; Sapieha PS, 2005, MOL CELL NEUROSCI, V28, P625, DOI 10.1016/j.mcn.2004.10.011; Schaapveld RQJ, 1998, MECH DEVELOP, V77, P59, DOI 10.1016/S0925-4773(98)00119-1; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Shen YJ, 2009, SCIENCE, V326, P592, DOI 10.1126/science.1178310; Sommer L, 1997, DEV DYNAM, V208, P48, DOI 10.1002/(SICI)1097-0177(199701)208:1<48::AID-AJA5>3.0.CO;2-1; Stepanek L, 2005, J NEUROSCI, V25, P3813, DOI 10.1523/JNEUROSCI.4531-04.2005; Stryker E, 2007, J CELL SCI, V120, P3723, DOI 10.1242/jcs.03491; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sun QL, 2000, MOL CELL NEUROSCI, V16, P686, DOI 10.1006/mcne.2000.0893; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; Thompson KM, 2003, MOL CELL NEUROSCI, V23, P681, DOI 10.1016/S1044-7431(03)00120-9; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Van Lieshout EMM, 2001, NEUROSCIENCE, V102, P833, DOI 10.1016/S0306-4522(00)00526-1; Wallace MJ, 1999, NAT GENET, V21, P334, DOI 10.1038/6866; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Wang J, 1999, MOL CELL NEUROSCI, V14, P370, DOI 10.1006/mcne.1999.0789; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Woo J, 2009, MOL CELL NEUROSCI, V42, P1, DOI 10.1016/j.mcn.2009.05.008; Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; YAN H, 1993, J BIOL CHEM, V268, P24880; Yeo TT, 1997, J NEUROSCI RES, V47, P348, DOI 10.1002/(SICI)1097-4547(19970201)47:3<348::AID-JNR13>3.0.CO;2-Y; Yin Y, 2002, MOL CELL NEUROSCI, V19, P344, DOI 10.1006/mcne.2001.1089; Zhang JS, 1998, MOL CELL NEUROSCI, V10, P271, DOI 10.1006/mcne.1998.0663; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	75	108	110	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13966	13978		10.1074/jbc.M109.061127	http://dx.doi.org/10.1074/jbc.M109.061127			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20139422	Green Published, hybrid			2022-12-27	WOS:000276987700071
J	Fenwick, MK; Oswald, RE				Fenwick, Michael K.; Oswald, Robert E.			On the Mechanisms of alpha-Amino-3-hydroxy-5-methylisoxazole-4-propionic Acid (AMPA) Receptor Binding to Glutamate and Kainate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP HYDROGEN-EXCHANGE; CONFORMATIONAL-CHANGES; IONOTROPIC GLUTAMATE-RECEPTOR-2; SYNAPTIC-TRANSMISSION; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; NMR-SPECTROSCOPY; PARTIAL AGONISTS; STRUCTURAL BASIS; ION CHANNELS	The alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) subtype of ionotropic glutamate receptors mediates much of the fast excitatory neurotransmission in the central nervous system. The ability of these receptors to shape such responses appears to be due in part to dynamic processes induced by agonists in the ligand-binding domain. Previous studies employing fluorescence spectroscopy and whole cell recording suggest that agonist binding is followed by sequential transitions to one or more distinct conformational states. Here, we used hydrogen-deuterium exchange to determine the mechanisms of binding of glutamate and kainate (full and partial agonists, respectively) to a soluble ligand-binding domain of GluR2. Our results provide a structural basis for sequential state models of agonist binding and the free energy changes of the associated state-to-state transitions. For glutamate, a multi-equilibrium binding reaction was discerned involving distinct ligand docking, domain isomerization, and lobe-locking steps. In contrast, kainate binding involves a simpler dock-isomerization process in which the isomerization equilibrium is shifted dramatically toward open domain conformations. In light of increasing evidence that the stability, in addition to the extent, of domain closure is a critical component of the channel activation mechanism, the differences in domain opening and closing equilibria detected for glutamate and kainate should be useful structural measures for interpreting the markedly different current responses evoked by these agonists.	[Fenwick, Michael K.; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University	Oswald, RE (corresponding author), Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA.	reo1@cornell.edu			National Institutes of Health [T32CA09682, GM068935]; NATIONAL CANCER INSTITUTE [T32CA009682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32CA09682 (M. K. F.) and GM068935 (to R. E. O.).	Abele R, 2000, J BIOL CHEM, V275, P21355, DOI 10.1074/jbc.M909883199; Ahmed AH, 2009, PROTEINS, V75, P628, DOI 10.1002/prot.22274; Anderson JS, 2008, BIOCHEMISTRY-US, V47, P6178, DOI 10.1021/bi800284y; Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Arvola M, 1996, J BIOL CHEM, V271, P15527, DOI 10.1074/jbc.271.26.15527; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; BERGER ARIEH, 1957, ARCH BIOCHEM AND BIOPHYS, V69, P106, DOI 10.1016/0003-9861(57)90478-2; Chen GQ, 1997, P NATL ACAD SCI USA, V94, P13431, DOI 10.1073/pnas.94.25.13431; Cheng Q, 2005, NAT CHEM BIOL, V1, P329, DOI 10.1038/nchembio738; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dempsey CE, 2001, PROG NUCL MAG RES SP, V39, P135, DOI 10.1016/S0079-6565(01)00032-2; DINGLEDINE R, 1999, PHARMACOL REV, V7, P61; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Fenwick MK, 2007, BIOMOL NMR ASSIGN, V1, P241, DOI 10.1007/s12104-007-9067-3; Fenwick MK, 2008, J MOL BIOL, V378, P673, DOI 10.1016/j.jmb.2008.03.012; GLASOE PK, 1960, J PHYS CHEM-US, V64, P188, DOI 10.1021/j100830a521; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; Hogner A, 2002, J MOL BIOL, V322, P93, DOI 10.1016/S0022-2836(02)00650-2; HOLLMANN M, 1994, ANNU REV NEUROSCI, V108, P17; Holm MM, 2005, J BIOL CHEM, V280, P35469, DOI 10.1074/jbc.M507800200; Holm MM, 2005, P NATL ACAD SCI USA, V102, P12053, DOI 10.1073/pnas.0505522102; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2002, BIOCHEMISTRY-US, V41, P15635, DOI 10.1021/bi020583k; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Kessler M, 2008, NEUROCHEM INT, V52, P1383, DOI 10.1016/j.neuint.2008.02.009; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Madden DR, 2005, J BIOL CHEM, V280, P23637, DOI 10.1074/jbc.M414523200; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Maity H, 2003, PROTEIN SCI, V12, P153, DOI 10.1110/ps.0225803; Maltsev AS, 2008, BIOCHEMISTRY-US, V47, P10600, DOI 10.1021/bi800843c; Mamonova T, 2008, BIOCHEMISTRY-US, V47, P11077, DOI 10.1021/bi801367d; Mankiewicz KA, 2007, BIOCHEMISTRY-US, V46, P1343, DOI 10.1021/bi062270l; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; McFeeters RL, 2002, J BIOMOL NMR, V22, P297, DOI 10.1023/A:1014954931635; McFeeters RL, 2002, BIOCHEMISTRY-US, V41, P10472, DOI 10.1021/bi026010p; Milne JS, 1998, PROTEIN SCI, V7, P739, DOI 10.1002/pro.5560070323; MOLDAY RS, 1972, BIOCHEMISTRY-US, V11, P150, DOI 10.1021/bi00752a003; Oswald RE, 2004, ADV PROTEIN CHEM, V68, P313; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; ROBERTSON AD, 1991, BIOCHEMISTRY-US, V30, P9907, DOI 10.1021/bi00105a014; RODER H, 1985, BIOCHEMISTRY-US, V24, P7407, DOI 10.1021/bi00346a056; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; Valentine ER, 2005, BIOCHEMISTRY-US, V44, P3410, DOI 10.1021/bi047984f; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Zhang W, 2006, BIOPHYS J, V91, P1336, DOI 10.1529/biophysj.106.084426	56	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12334	12343		10.1074/jbc.M109.086371	http://dx.doi.org/10.1074/jbc.M109.086371			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20110361	hybrid, Green Published			2022-12-27	WOS:000276787100062
J	Mayers, CM; Wadell, J; McLean, K; Venere, M; Malik, M; Shibata, T; Driggers, PH; Kino, T; Guo, XC; Koide, H; Gorivodsky, M; Grinberg, A; Mukhopadhyay, M; Abu-Asab, M; Westphal, H; Segars, JH				Mayers, Chantal M.; Wadell, Jennifer; McLean, Kate; Venere, Monica; Malik, Minnie; Shibata, Takahisa; Driggers, Paul H.; Kino, Tomoshige; Guo, X. Catherine; Koide, Hisashi; Gorivodsky, Marat; Grinberg, Alex; Mukhopadhyay, Mahua; Abu-Asab, Mones; Westphal, Heiner; Segars, James H.			Rho Guanine Nucleotide Exchange Factor AKAP13 (BRX) Is Essential for Cardiac Development in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; PROTEIN-KINASE-A; MOUSE EMBRYOGENESIS; GENE-EXPRESSION; ACTIVATION; HEART; LBC; CARDIOMYOCYTES; MORPHOGENESIS; RAS	A fundamental biologic principle is that diverse biologic signals are channeled through shared signaling cascades to regulate development. Large scaffold proteins that bind multiple proteins are capable of coordinating shared signaling pathways to provide specificity to activation of key developmental genes. Although much is known about transcription factors and target genes that regulate cardiomyocyte differentiation, less is known about scaffold proteins that couple signals at the cell surface to differentiation factors in developing heart cells. Here we show that AKAP13( also known as Brx-1, AKAP-Lbc, andproto-Lbc), a unique protein kinase A-anchoring protein (AKAP) guanine nucleotide exchange region belonging to the Dbl family of oncogenes, is essential for cardiac development. Cardiomyocytes of Akap13-null mice had deficient sarcomere formation, and developing hearts were thin-walled and mice died at embryonic day 10.5-11.0. Disruption of Akap13 was accompanied by reduced expression of Mef2C. Consistent with a role of AKAP13 upstream of MEF2C, Akap13 siRNA led to a reduction in Mef2C mRNA, and overexpression of AKAP13 augmented MEF2C-dependent reporter activity. The results suggest that AKAP13 coordinates G alpha(12) and Rho signaling to an essential transcription program in developing cardiomyocytes.	[Driggers, Paul H.; Kino, Tomoshige; Guo, X. Catherine; Koide, Hisashi] NICHD, Program Reprod & Adult Endocrinol, Bethesda, MD 20892 USA; [Gorivodsky, Marat; Grinberg, Alex; Mukhopadhyay, Mahua; Westphal, Heiner] NICHD, Lab Mammalian Genes & Dev, Bethesda, MD 20892 USA; [Abu-Asab, Mones] NIH, Pathol Lab, Bethesda, MD 20892 USA; [Malik, Minnie] Uniformed Serv Univ Hlth Sci, Dept Obstet & Gynecol, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; Uniformed Services University of the Health Sciences - USA	Segars, JH (corresponding author), Clin Res Ctr, Bldg 10,Rm 1E-3140,10 Ctr Dr,MSC1109, Bethesda, MD 20892 USA.	segarsj@mail.nih.gov		Koide, Hisashi/0000-0002-8545-7530; Abu-Asab, Mones/0000-0002-4047-1232; Malik, Minnie/0000-0003-1129-6575	NICHD, National Institutes of Health [ZO1-HD-008737-07-URE]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000071, ZIAHD008732] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008737, Z01HD008737] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the Intramural Research Program of NICHD, National Institutes of Health, Grant ZO1-HD-008737-07-URE.	Adams JW, 2001, ONCOGENE, V20, P1626, DOI 10.1038/sj.onc.1204275; Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Arsenian S, 1998, EMBO J, V17, P6289, DOI 10.1093/emboj/17.21.6289; Baisamy L, 2005, J BIOL CHEM, V280, P15405, DOI 10.1074/jbc.M414440200; Balza RO, 2006, J BIOL CHEM, V281, P6498, DOI 10.1074/jbc.M509487200; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Driggers PH, 2001, J BIOL CHEM, V276, P46792, DOI 10.1074/jbc.M106927200; Dutt P, 2002, FEBS LETT, V531, P565, DOI 10.1016/S0014-5793(02)03625-6; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hoshijima M, 1998, J BIOL CHEM, V273, P7725, DOI 10.1074/jbc.273.13.7725; Ichida M, 2001, J BIOL CHEM, V276, P3524, DOI 10.1074/jbc.M004275200; Kino T, 2006, J BIOL CHEM, V281, P9118, DOI 10.1074/jbc.M509339200; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Majumdar M, 1999, J BIOL CHEM, V274, P26815, DOI 10.1074/jbc.274.38.26815; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miller BT, 2000, AM J OBSTET GYNECOL, V182, P286, DOI 10.1016/S0002-9378(00)70213-4; Park B, 2002, J BIOL CHEM, V277, P45361, DOI 10.1074/jbc.M202447200; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Rubino D, 1998, ONCOGENE, V16, P2513, DOI 10.1038/sj.onc.1201783; Ruehr ML, 2004, J MOL CELL CARDIOL, V37, P653, DOI 10.1016/j.yjmcc.2004.04.017; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; Sah VP, 1996, J BIOL CHEM, V271, P31185, DOI 10.1074/jbc.271.49.31185; Sahai E, 1998, EMBO J, V17, P1350, DOI 10.1093/emboj/17.5.1350; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Schratt G, 2002, J CELL BIOL, V156, P737, DOI 10.1083/jcb.200106008; Sterpetti P, 1999, MOL CELL BIOL, V19, P1334; Teramoto H, 2003, ONCOGENE, V22, P2689, DOI 10.1038/sj.onc.1206364; TOKSOZ D, 1994, ONCOGENE, V9, P621; Uhlen P, 2006, P NATL ACAD SCI USA, V103, P2160, DOI 10.1073/pnas.0510876103; Wei L, 2001, FASEB J, V15, P785, DOI 10.1096/fj.00-026com; Wei L, 1998, J BIOL CHEM, V273, P30287, DOI 10.1074/jbc.273.46.30287; Wettschureck N, 2002, J MOL MED, V80, P629, DOI 10.1007/s00109-002-0370-2; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; Zakhary DR, 2000, CIRCULATION, V101, P1459, DOI 10.1161/01.CIR.101.12.1459; Zakhary DR, 2000, J BIOL CHEM, V275, P41389, DOI 10.1074/jbc.M004212200	45	43	52	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12344	12354		10.1074/jbc.M110.106856	http://dx.doi.org/10.1074/jbc.M110.106856			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20139090	Green Published, hybrid			2022-12-27	WOS:000276787100063
J	Cravatt, BF; Gottesfeld, JM				Cravatt, Benjamin F.; Gottesfeld, Joel M.			Chemical Biology Meets Biological Chemistry Minireview Series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									[Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jgottesfeld@asbmb.orb		Gottesfeld, Joel/0000-0002-4643-5777					0	3	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11031	11032		10.1074/jbc.R110.113126	http://dx.doi.org/10.1074/jbc.R110.113126			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147295	Green Published, hybrid			2022-12-27	WOS:000276286200002
J	Cremers, CM; Reichmann, D; Hausmann, J; Ilbert, M; Jakob, U				Cremers, Claudia M.; Reichmann, Dana; Hausmann, Jens; Ilbert, Marianne; Jakob, Ursula			Unfolding of Metastable Linker Region Is at the Core of Hsp33 Activation as a Redox-regulated Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; CRYSTAL-STRUCTURE; MOLECULAR CHAPERONES; STRUCTURAL DISORDER; SUBSTRATE-BINDING; ESCHERICHIA-COLI; IN-VIVO; STRESS; MECHANISM; DOMAIN	Hsp33, a molecular chaperone specifically activated by oxidative stress conditions that lead to protein unfolding, protects cells against oxidative protein aggregation. Stress sensing in Hsp33 occurs via its C-terminal redox switch domain, which consists of a zinc center that responds to the presence of oxidants and an adjacent metastable linker region, which responds to unfolding conditions. Here we show that single mutations in the N terminus of Hsp33 are sufficient to either partially (Hsp33-M172S) or completely (Hsp33-Y12E) abolish this post-translational regulation of Hsp33 chaperone function. Both mutations appear to work predominantly via the destabilization of the Hsp33 linker region without affecting zinc coordination, redox sensitivity, or substrate binding of Hsp33. We found that the M172S substitution causes moderate destabilization of the Hsp33 linker region, which seems sufficient to convert the redox-regulated Hsp33 into a temperature-controlled chaperone. The Y12E mutation leads to the constitutive unfolding of the Hsp33 linker region thereby turning Hsp33 into a constitutively active chaperone. These results demonstrate that the redox-controlled unfolding of the Hsp33 linker region plays the central role in the activation process of Hsp33. The zinc center of Hsp33 appears to act as the redox-sensitive toggle that adjusts the thermostability of the linker region to the cell redox status. In vivo studies confirmed that even mild overexpression of the Hsp33-Y12E mutant protein inhibits bacterial growth, providing important evidence that the tight functional regulation of Hsp33 chaperone activity plays a vital role in bacterial survival.	[Cremers, Claudia M.; Reichmann, Dana; Hausmann, Jens; Ilbert, Marianne; Jakob, Ursula] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Jakob, U (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	ujakob@umich.edu	Reichmann, Dana/J-4999-2019; Ilbert, marianne/ABG-5015-2021	Reichmann, Dana/0000-0003-0315-5334; ilbert, marianne/0000-0002-9070-2334; Hausmann, Jens/0000-0001-8960-6225	National Institutes of Health [GM065318]; Human Frontiers; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health Grant GM065318 (to U.J.) and a Human Frontiers postdoctoral fellowship (to D. R.).	Akhtar MW, 2004, J BIOL CHEM, V279, P55760, DOI 10.1074/jbc.M406333200; BARRETTE WC, 1989, BIOCHEMISTRY-US, V28, P9172, DOI 10.1021/bi00449a032; Beissinger M, 1998, BIOL CHEM, V379, P245; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Franzmann TM, 2008, MOL CELL, V29, P207, DOI 10.1016/j.molcel.2007.11.025; Giese KC, 2002, J BIOL CHEM, V277, P46310, DOI 10.1074/jbc.M208926200; Graf PCF, 2004, J BIOL CHEM, V279, P20529, DOI 10.1074/jbc.M401764200; Graf PCF, 2002, CELL MOL LIFE SCI, V59, P1624, DOI 10.1007/PL00012489; Graumann J, 2001, STRUCTURE, V9, P377, DOI 10.1016/S0969-2126(01)00599-8; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hong WZ, 2005, J BIOL CHEM, V280, P27029, DOI 10.1074/jbc.M503934200; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Janda I, 2004, STRUCTURE, V12, P1901, DOI 10.1016/j.str.2004.08.003; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kang HJ, 2007, BIOCHEM BIOPH RES CO, V358, P743, DOI 10.1016/j.bbrc.2007.04.184; Kim SJ, 2001, NAT STRUCT BIOL, V8, P459, DOI 10.1038/87639; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Raman B, 2001, FEBS LETT, V489, P19, DOI 10.1016/S0014-5793(01)02074-9; Reichmann D, 2007, J MOL BIOL, V365, P663, DOI 10.1016/j.jmb.2006.09.076; Reichmann D, 2008, BIOCHEMISTRY-US, V47, P1051, DOI 10.1021/bi7019639; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2009, FEBS J, V276, P5406, DOI 10.1111/j.1742-4658.2009.07250.x; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Vijayalakshmi J, 2001, STRUCTURE, V9, P367, DOI 10.1016/S0969-2126(01)00597-4; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2005, MOL CELL, V17, P381, DOI 10.1016/j.molcel.2004.12.027; Winter J, 2004, CRIT REV BIOCHEM MOL, V39, P297, DOI 10.1080/10409230490900658; Wu YE, 2008, BIOCHEM J, V412, P389, DOI 10.1042/BJ20071682; Yang HM, 1999, PROTEIN SCI, V8, P174; Zhou ZHS, 1999, BIOCHEMISTRY-US, V38, P15915, DOI 10.1021/bi992062b	36	40	42	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11243	11251		10.1074/jbc.M109.084350	http://dx.doi.org/10.1074/jbc.M109.084350			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139072	hybrid, Green Published			2022-12-27	WOS:000276286200030
J	Li, K; Bethea, HN; Liu, J				Li, Kai; Bethea, Heather N.; Liu, Jian			Using Engineered 2-O-Sulfotransferase to Determine the Activity of Heparan Sulfate C-5-epimerase and Its Mutants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-IDURONIC ACID; GLUCURONYL C5-EPIMERASE; HEPARIN/HEPARAN SULFATE; STRUCTURAL SPECIFICITY; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; ENTRY RECEPTOR; HEPARINASE-II; BIOSYNTHESIS; ANTITHROMBIN	Heparan sulfate (HS) is involved in essential physiological and pathophysiological functions. HS is a highly sulfated polysaccharide consisting of glucuronic acid (or iduronic acid) linked to glucosamine carrying various sulfo groups. Biosynthesis of HS involves sulfotransferases and an epimerase. The HS C-5-epimerase converts glucuronic acid to iduronic acid. The method for determining the activity has been cumbersome due to the use of a site-specifically H-3-labeled polysaccharide substrate. Here, we report a two-enzyme coupling assay to determine the activity of C-5-epimerase. HS 2-O-sulfotransferase (2OST) transfers the sulfo group to the 2-OH-position of glucuronic or iduronic acid. Unlike the wild type protein, 2-O-sulfotransferase mutant (2OST Y94I) transfers sulfate to the iduronic acid but not to the glucuronic acid. Thus, 2OST Y94I cannot sulfate N-sulfated heparosan, a polysaccharide containing glucuronic acid. Incubating N-sulfated heparosan with C-5-epimerase converts some of the glucuronic acid to iduronic acid, thus becoming a substrate for 2OST Y94I. The susceptibility of the C-5-epimerase-treated N-sulfated heparosan to 2OST Y94I modification directly correlates to the amount of the activity of C-5-epimerase, proving that this two-enzyme coupling system can be used to assay for C-5-epimerase. The method was further used to determine the activities of various C-5-epimerase mutants. Our approach will significantly reduce the complexity for assaying the activity of C-5-epimerase and facilitate the structural and functional analysis of C-5-epimerase.	[Li, Kai; Bethea, Heather N.; Liu, Jian] Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Liu, J (corresponding author), Univ N Carolina, Div Med Chem & Nat Prod, Eshelman Sch Pharm, Rm 303A,Beard Hall, Chapel Hill, NC 27599 USA.	jian_liu@unc.edu			National Institutes of Health [AI50050, HL094463]; American Heart Association; MidAtlantic Affiliate [0855424E]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); MidAtlantic Affiliate; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI50050 and HL094463. This work is also supported by American Heart Association, MidAtlantic Affiliate, Grant-in-aid 0855424E.	Bethea HN, 2008, P NATL ACAD SCI USA, V105, P18724, DOI 10.1073/pnas.0806975105; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; CAMPBELL P, 1994, J BIOL CHEM, V269, P26953; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chen JH, 2005, BBA-GEN SUBJECTS, V1725, P190, DOI 10.1016/j.bbagen.2005.06.012; Chen JH, 2003, GLYCOBIOLOGY, V13, P785, DOI 10.1093/glycob/cwg101; Chen J, 2007, CHEM BIOL, V14, P986, DOI 10.1016/j.chembiol.2007.07.015; Das SK, 2001, CHEM-EUR J, V7, P4821; Duncan MB, 2006, BIOCHEM BIOPH RES CO, V339, P1232, DOI 10.1016/j.bbrc.2005.11.142; Edavettal SC, 2004, J BIOL CHEM, V279, P25789, DOI 10.1074/jbc.M401089200; Gama CI, 2006, NAT CHEM BIOL, V2, P467, DOI 10.1038/nchembio810; Habuchi H, 2004, GLYCOCONJUGATE J, V21, P47, DOI 10.1023/B:GLYC.0000043747.87325.5e; Jia J, 2009, J BIOL CHEM, V284, P15942, DOI 10.1074/jbc.M809577200; Kakuta Y, 2003, BIOCHEM SOC T, V31, P331, DOI 10.1042/BST0310331; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li JP, 1997, J BIOL CHEM, V272, P28158, DOI 10.1074/jbc.272.44.28158; Lindahl U, 2005, J MED CHEM, V48, P349, DOI 10.1021/jm049812m; Liu J, 2002, MED RES REV, V22, P1, DOI 10.1002/med.1026; Liu J, 2007, APPL MICROBIOL BIOT, V74, P263, DOI 10.1007/s00253-006-0722-x; Moon AF, 2004, J BIOL CHEM, V279, P45185, DOI 10.1074/jbc.M405013200; Munoz E, 2006, BIOCHEM BIOPH RES CO, V339, P597, DOI 10.1016/j.bbrc.2005.11.051; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Pacheco B, 2009, J BIOL CHEM, V284, P1741, DOI 10.1074/jbc.M805479200; Peterson S, 2009, NAT PROD REP, V26, P610, DOI 10.1039/b803795g; Pinhal MAS, 2001, P NATL ACAD SCI USA, V98, P12984, DOI 10.1073/pnas.241175798; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Shaya D, 2006, J BIOL CHEM, V281, P15525, DOI 10.1074/jbc.M512055200; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Shriver Z, 1998, J BIOL CHEM, V273, P22904, DOI 10.1074/jbc.273.36.22904; VANN WF, 1981, EUR J BIOCHEM, V116, P359, DOI 10.1111/j.1432-1033.1981.tb05343.x; Xia GQ, 2002, J BIOL CHEM, V277, P37912, DOI 10.1074/jbc.M204209200; Xu D, 2008, NAT CHEM BIOL, V4, P200, DOI 10.1038/nchembio.66	35	19	23	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11106	11113		10.1074/jbc.M109.081059	http://dx.doi.org/10.1074/jbc.M109.081059			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20118238	Green Published, hybrid			2022-12-27	WOS:000276286200015
J	Renna, M; Jimenez-Sanchez, M; Sarkar, S; Rubinsztein, DC				Renna, Maurizio; Jimenez-Sanchez, Maria; Sarkar, Sovan; Rubinsztein, David C.			Chemical Inducers of Autophagy That Enhance the Clearance of Mutant Proteins in Neurodegenerative Diseases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AGGREGATE-PRONE PROTEINS; HUNTINGTONS-DISEASE; ALPHA-SYNUCLEIN; INOSITOL TRISPHOSPHATE; REDUCE TOXICITY; CELL-GROWTH; MOUSE MODEL; BECLIN 1; RAPAMYCIN; POLYGLUTAMINE	Many of the neurodegenerative diseases that afflict people are caused by intracytoplasmic aggregate-prone proteins. These include Parkinson disease, tauopathies, and polyglutamine expansion diseases such as Huntington disease. In Mendelian forms of these diseases, the mutations generally confer toxic novel functions on the relevant proteins. Thus, one potential strategy for dealing with these mutant proteins is to enhance their degradation. This can be achieved by up-regulating macroautophagy, which we will henceforth call autophagy. In this minireview, we will consider the reasons why autophagy up-regulation may be a powerful strategy for these diseases. In addition, we will consider some of the drugs and associated signaling pathways that can be used to induce autophagy with these therapeutic aims in mind.	[Renna, Maurizio; Jimenez-Sanchez, Maria; Sarkar, Sovan; Rubinsztein, David C.] Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Addenbrookes Hosp, Cambridge CB2 0XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Rubinsztein, DC (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Inst Med Res, Addenbrookes Hosp, Hills Rd, Cambridge CB2 0XY, England.	dcr1000@hermes.cam.ac.uk	Sarkar, Sovan/F-8486-2017; Rubinsztein, David C/C-3472-2011; Jimenez-Sanchez, Maria/ABH-7666-2020	Sarkar, Sovan/0000-0002-9456-4362; Jimenez-Sanchez, Maria/0000-0002-2287-1582	Medical Research Council; European Union Framework VI (EUROSCA); National Institute for Health Research Biomedical Research Centre at Addenbrooke's Hospital; MRC [G0600194] Funding Source: UKRI; Medical Research Council [G0600194] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union Framework VI (EUROSCA)(European Commission); National Institute for Health Research Biomedical Research Centre at Addenbrooke's Hospital(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Medical Research Council, European Union Framework VI (EUROSCA), and the National Institute for Health Research Biomedical Research Centre at Addenbrooke's Hospital. This is the sixth of six articles in the "Chemical Biology Meets Biological Chemistry Minireview Series." This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Carmichael J, 2002, J BIOL CHEM, V277, P33791, DOI 10.1074/jbc.m204861200; Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Floto RA, 2007, AUTOPHAGY, V3, P620, DOI 10.4161/auto.4898; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; GORDON PB, 1993, J BIOL CHEM, V268, P26107; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Heiseke A, 2009, J NEUROCHEM, V109, P25, DOI 10.1111/j.1471-4159.2009.05906.x; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Imarisio S, 2008, BIOCHEM J, V412, P191, DOI 10.1042/BJ20071619; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Iwata A, 2005, P NATL ACAD SCI USA, V102, P13135, DOI 10.1073/pnas.0505801102; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Ravikumar B, 2005, NAT GENET, V37, P771, DOI 10.1038/ng1591; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Ravikumar B, 2002, HUM MOL GENET, V11, P1107, DOI 10.1093/hmg/11.9.1107; Ravikumar B, 2003, HUM MOL GENET, V12, P985, DOI 10.1093/hmg/ddg109; Ravikumar B, 2009, J CELL SCI, V122, P1707, DOI 10.1242/jcs.031773; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Rowe Michael K., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008385; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rubinsztein DC, 2002, TRENDS GENET, V18, P202, DOI 10.1016/S0168-9525(01)02625-7; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2009, CELL DEATH DIFFER, V16, P46, DOI 10.1038/cdd.2008.110; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2009, AUTOPHAGY, V5, P307, DOI 10.4161/auto.5.3.7664; Sarkar S, 2009, METHOD ENZYMOL, V453, P83, DOI 10.1016/S0076-6879(08)04005-6; Sato-Kusubata K, 2000, BIOCHEM J, V347, P733, DOI 10.1042/0264-6021:3470733; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Vicencio JM, 2009, CELL DEATH DIFFER, V16, P1006, DOI 10.1038/cdd.2009.34; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	64	159	164	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11061	11067		10.1074/jbc.R109.072181	http://dx.doi.org/10.1074/jbc.R109.072181			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147746	Green Published, hybrid			2022-12-27	WOS:000276286200008
J	Schaefer, JS; Sabherwal, Y; Shi, HY; Sriraman, V; Richards, J; Minella, A; Turner, DP; Watson, DK; Zhang, M				Schaefer, Jeremy S.; Sabherwal, Yamini; Shi, Heidi Y.; Sriraman, Venkataraman; Richards, JoAnne; Minella, Alex; Turner, David P.; Watson, Dennis K.; Zhang, Ming			Transcriptional Regulation of p21/CIP1 Cell Cycle Inhibitor by PDEF Controls Cell Proliferation and Mammary Tumor Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR MESSENGER-RNA; HUMAN BREAST-CANCER; ETS FACTOR; FUNCTIONAL-ANALYSIS; ANDROGEN RECEPTOR; EPITHELIAL-CELLS; GENE-EXPRESSION; TARGET GENES; DNA-DAMAGE; IN-VIVO	The Ets family of transcription factors control a myriad of cellular processes and contribute to the underlying genetic loss of cellular homeostasis resulting in cancer. PDEF (prostate-derived Ets factor) has been under investigation for its role in tumor development and progression. However, the role of PDEF in cancer development has been controversial. Some reports link PDEF to tumor promoter, and others show tumor-suppressing functions in various systems under different conditions. So far, there has been no conclusive evidence from in vivo experiments to prove the role of PDEF. We have used both in vitro and in vivo systems to provide a conclusive role of PDEF in the progression process. PDEF-expressing cells block the cell growth rate, and this retardation was reversible when PDEF expression was silenced with PDEF-specific small interfering RNA. When these PDEF-expressing cells were orthotopically implanted into the mouse mammary gland, tumor incidence and growth rate were significantly retarded. Cell cycle analysis revealed that PDEF expression partially blocked cell cycle progression at G(1)/S without an effect on apoptosis. PDEF overexpression resulted in an increase in p21/CIP1 at both the mRNA and protein levels, resulting in decreased Cdk2 activity. Promoter deletion analysis, electrophoresis mobility shift assays, and chromatin immunoprecipitation studies identified the functional Ets DNA binding site at -2118 bp of the p21/CIP1 gene promoter. This site is capable of binding and responding to PDEF. Furthermore, we silenced p21/CIP1 expression in PDEF-overexpressing cells by small interfering RNA. p21-silenced PDEF cells exhibited significantly increased cell growth in vitro and in vivo, demonstrating the p21 regulation by PDEF as a key player. These experiments identified PDEF as a new transcription factor that directly regulates p21/CIP1 expression under non-stressed conditions. This study conclusively proves that PDEF is a breast tumor suppressor for the first time using both in vitro and in vivo systems. PDEF can be further developed as a target for designing therapeutic intervention of breast cancer.	[Sabherwal, Yamini; Shi, Heidi Y.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Sabherwal, Yamini; Shi, Heidi Y.; Zhang, Ming] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA; [Minella, Alex] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Hematol & Oncol, Chicago, IL 60611 USA; [Schaefer, Jeremy S.; Sriraman, Venkataraman; Richards, JoAnne] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Turner, David P.; Watson, Dennis K.] Med Univ S Carolina, Coll Med, Dept Pathol & Lab Med, Charleston, SC 29425 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Baylor College of Medicine; Medical University of South Carolina	Zhang, M (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.	m-zhang@northwestern.edu		Minella, Alex/0000-0001-6693-3362	National Institutes of Health, NCI [CA79736]; Susan Komen Breast Cancer Foundation; IPDH; Northwestern University Zell; NATIONAL CANCER INSTITUTE [R01CA079736, K22CA130984] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); IPDH; Northwestern University Zell; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Grant CA79736. This work was also supported by a Susan Komen Breast Cancer Foundation fellowship (to J.S.S.) and by the IPDH fund and the Northwestern University Zell fund (to M.Z.).	Altieri Dario C, 2003, Prog Cell Cycle Res, V5, P447; Altieri Dario C, 2003, Methods Mol Biol, V223, P533; Altieri DC, 2003, NAT REV CANCER, V3, P46, DOI 10.1038/nrc968; Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Altieri DC, 2003, ADV CANCER RES, V88, P31, DOI 10.1016/S0065-230X(03)88303-3; Anderson GR, 2001, CANCER RES, V61, P8274; Chen H, 2005, J CELL BIOCHEM, V94, P168, DOI 10.1002/jcb.20297; Chen H, 2002, CANCER RES, V62, P338; Clark DW, 2008, CURR CANCER DRUG TAR, V8, P421, DOI 10.2174/156800908785133196; DATTO MB, 1995, J BIOL CHEM, V270, P28623, DOI 10.1074/jbc.270.48.28623; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dowell SP, 1996, CYTOPATHOLOGY, V7, P340, DOI 10.1111/j.1365-2303.1996.tb00313.x; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Falender AE, 2003, ENDOCRINOLOGY, V144, P3598, DOI 10.1210/en.2002-0137; Feldman RJ, 2003, CANCER RES, V63, P4626; Feldman RJ, 2003, ANTICANCER RES, V23, P2125; Findlay VJ, 2008, CANCER RES, V68, P8499, DOI 10.1158/0008-5472.CAN-08-0907; Fowler M, 2006, J CELL BIOCHEM, V97, P1, DOI 10.1002/jcb.20664; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Ghadersohi A, 2001, CLIN CANCER RES, V7, P2731; Ghadersohi A, 2007, BREAST CANCER RES TR, V102, P19, DOI 10.1007/s10549-006-9314-9; Hengst L, 1998, GENE DEV, V12, P3882, DOI 10.1101/gad.12.24.3882; Hill R, 2008, CELL CYCLE, V7, P2535; HOFFMAN BD, 1991, CYTOMETRY, V12, P26, DOI 10.1002/cyto.990120105; Hsouna A, 2004, GENE EXPR PATTERNS, V5, P285, DOI 10.1016/j.modgep.2004.07.002; Hsu T, 2004, J CELL BIOCHEM, V91, P896, DOI 10.1002/jcb.20012; Kong G, 2002, ONCOGENE, V21, P7214, DOI 10.1038/sj.onc.1205895; Krude T, 1999, EXP CELL RES, V247, P148, DOI 10.1006/excr.1998.4342; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Nozawa M, 2000, CANCER RES, V60, P1348; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Oikawa T, 2004, CANCER SCI, V95, P626, DOI 10.1111/j.1349-7006.2004.tb03320.x; PAPAS TS, 1990, PROG CLIN BIOL RES, V360, P137; PAPAS TS, 1989, CURR TOP MICROBIOL, V149, P143; Russell DL, 1996, BIOL REPROD, V55, P1029, DOI 10.1095/biolreprod55.5.1029; SAID TK, 1995, CARCINOGENESIS, V16, P823, DOI 10.1093/carcin/16.4.823; Said TK, 2004, J MAMMARY GLAND BIOL, V9, P81, DOI 10.1023/B:JOMG.0000023590.63974.f8; Said TK, 2001, CELL GROWTH DIFFER, V12, P285; Salz W, 2005, CANCER RES, V65, P3531, DOI 10.1158/0008-5472.CAN-04-4284; Sementchenko VI, 2000, ONCOGENE, V19, P6533, DOI 10.1038/sj.onc.1204034; Seth A, 2005, EUR J CANCER, V41, P2462, DOI 10.1016/j.ejca.2005.08.013; Sood AK, 2007, HUM PATHOL, V38, P1628, DOI 10.1016/j.humpath.2007.03.010; Thompson HGR, 2003, ONCOGENE, V22, P2322, DOI 10.1038/sj.onc.1206325; Tsujimoto Y, 2002, INT J UROL, V9, P167, DOI 10.1046/j.1442-2042.2002.00444.x; Turner DP, 2007, CANCER RES, V67, P1618, DOI 10.1158/0008-5472.CAN-06-2913; WATSON D K, 1990, Critical Reviews in Oncogenesis, V1, P409; WATSON PA, 1991, CYTOMETRY, V12, P242, DOI 10.1002/cyto.990120306; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Yamada N, 2000, GENE, V241, P267, DOI 10.1016/S0378-1119(99)00484-9; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179	54	30	33	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11258	11269		10.1074/jbc.M109.073932	http://dx.doi.org/10.1074/jbc.M109.073932			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139077	Green Published, hybrid			2022-12-27	WOS:000276286200032
J	Bulfer, SL; Scott, EM; Pillus, L; Trievel, RC				Bulfer, Stacie L.; Scott, Erin M.; Pillus, Lorraine; Trievel, Raymond C.			Structural Basis for L-Lysine Feedback Inhibition of Homocitrate Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-AMINOADIPATE PATHWAY; SACCHAROMYCES-CEREVISIAE; MYCOBACTERIUM-TUBERCULOSIS; ISOPROPYLMALATE SYNTHASE; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; BIOSYNTHESIS; MECHANISM; ENZYME; FUNGI	The alpha-aminoadipate pathway of lysine biosynthesis is modulated at the transcriptional and biochemical levels by feedback inhibition. The first enzyme in the alpha-aminoadipate pathway, homocitrate synthase (HCS), is the target of the feedback regulation and is strongly inhibited by L-lysine. Here we report the structure of Schizosaccharomyces pombe HCS (SpHCS) in complex with L-lysine. The structure illustrates that the amino acid directly competes with the substrate 2-oxoglutarate for binding within the active site of HCS. Differential recognition of the substrate and inhibitor is achieved via a switch position within the (alpha/beta) 8 TIM barrel of the enzyme that can distinguish between the C5-carboxylate group of 2-oxoglutarate and the epsilon-ammonium group of L-lysine. In vitro and in vivo assays demonstrate that mutations of the switch residues, which interact with the L-lysine epsilon-ammonium group, abrogate feedback inhibition, as do substitutions of residues within the C-terminal domain that were identified in a previous study of L-lysine-insensitive HCS mutants in Saccharomyces cerevisiae. Together, these results yield new insights into the mechanism of feedback regulation of an enzyme central to lysine biosynthesis.	[Trievel, Raymond C.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Scott, Erin M.; Pillus, Lorraine] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Scott, Erin M.; Pillus, Lorraine] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA	University of Michigan System; University of Michigan; University of California System; University of California San Diego; University of California System; University of California San Diego	Trievel, RC (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	rtrievel@umich.edu			National Institutes of Health [GM090177, GM073839]; University of Michigan Biomedical Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008353, R01GM090177, R01GM073839] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan Biomedical Research Council(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM090177 (to L. P.) and GM073839 (to R. C. T.). Research for this project was funded in part through a University of Michigan Biomedical Research Council Pilot Grant (to R. C. T.).	Andi B, 2005, J BIOL CHEM, V280, P31624, DOI 10.1074/jbc.M502846200; Andi B, 2004, BIOCHEMISTRY-US, V43, P11790, DOI 10.1021/bi048766p; Becker B, 1998, MOL MICROBIOL, V29, P151, DOI 10.1046/j.1365-2958.1998.00916.x; BHATTACHARJEE JK, 1985, CRC CR REV MICROBIOL, V12, P131, DOI 10.3109/10408418509104427; Bulfer SL, 2009, J BIOL CHEM, V284, P35769, DOI 10.1074/jbc.M109.046821; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Carvalho LPS, 2005, J AM CHEM SOC, V127, P10004, DOI 10.1021/ja052513h; de Carvalho LPS, 2006, BIOCHEMISTRY-US, V45, P8988, DOI 10.1021/bi0606602; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feller A, 1999, EUR J BIOCHEM, V261, P163, DOI 10.1046/j.1432-1327.1999.00262.x; GAILLARDIN CM, 1976, BIOCHIM BIOPHYS ACTA, V422, P390, DOI 10.1016/0005-2744(76)90150-9; GARRAD RC, 1992, J BACTERIOL, V174, P7379, DOI 10.1128/jb.174.22.7379-7384.1992; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hans MA, 2001, APPL MICROBIOL BIOT, V56, P776, DOI 10.1007/s002530100708; JAKLITSCH WM, 1990, BIOCHEM J, V269, P247, DOI 10.1042/bj2690247; Koon N, 2004, P NATL ACAD SCI USA, V101, P8295, DOI 10.1073/pnas.0400820101; Kosuge T, 1998, FEMS MICROBIOL LETT, V169, P361, DOI 10.1016/S0378-1097(98)00502-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Okada T, 2010, J BIOL CHEM, V285, P4195, DOI 10.1074/jbc.M109.086330; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAMOS F, 1988, EUR J BIOCHEM, V171, P171, DOI 10.1111/j.1432-1033.1988.tb13773.x; Rimon G, 2010, P NATL ACAD SCI USA, V107, P28, DOI 10.1073/pnas.0909765106; URRESTARAZU LA, 1985, CURR GENET, V9, P341, DOI 10.1007/BF00421603; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; WOLFNER M, 1975, J MOL BIOL, V96, P273, DOI 10.1016/0022-2836(75)90348-4; Wulandari AP, 2002, FEBS LETT, V522, P35, DOI 10.1016/S0014-5793(02)02877-6; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; Yuan C, 2006, P NATL ACAD SCI USA, V103, P6142, DOI 10.1073/pnas.0601805103; Yuan C, 2009, J BIOL CHEM, V284, P10046, DOI 10.1074/jbc.M808634200; Zabriskie TM, 2000, NAT PROD REP, V17, P85, DOI 10.1039/a801345d	31	21	21	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10446	10453		10.1074/jbc.M109.094383	http://dx.doi.org/10.1074/jbc.M109.094383			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20089861	Green Published, hybrid			2022-12-27	WOS:000276264600030
J	Caromile, LA; Oganesian, A; Coats, SA; Seifert, RA; Bowen-Pope, DF				Caromile, Leslie A.; Oganesian, Anush; Coats, Scott A.; Seifert, Ronald A.; Bowen-Pope, Daniel F.			The Neurosecretory Vesicle Protein Phogrin Functions as a Phosphatidylinositol Phosphatase to Regulate Insulin Secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PTEN TUMOR-SUPPRESSOR; SECRETAGOGUE-DEPENDENT PHOSPHORYLATION; PLECKSTRIN HOMOLOGY DOMAIN; PANCREATIC BETA-CELLS; TYROSINE-PHOSPHATASE; MEMBRANE-PROTEIN; TRANSMEMBRANE PROTEIN; PHOSPHOINOSITIDE PHOSPHATASES; LIPID 2ND-MESSENGER; DIABETES-MELLITUS	Phogrin is a transmembrane protein expressed in cells with stimulus-coupled peptide hormone secretion, including pancreatic beta cells, in which it is localized to the membrane of insulin-containing dense-core vesicles. By sequence, phogrin is a member of the family of receptor-like protein-tyrosine phosphatases, but it contains substitutions in conserved catalytic sequences, and no significant enzymatic activity for phogrin has ever been reported. We report here that phogrin is able to dephosphorylate specific inositol phospholipids, including phosphatidylinositol (PI) 3-phosphate and PI 4,5-diphosphate but not PI 3,4,5-trisphosphate. The phosphatidylinositol phosphatase (PIPase) activity of phogrin was measurable but low when evaluated by the ability of a catalytic domain fusion protein to hydrolyze soluble short-chain phosphatidylinositol phospholipids. Unlike most PIPases, which are cytoplasmic proteins that associate with membranes, mature phogrin is a transmembrane protein. When the transmembrane form of phogrin was overexpressed in mammalian cells, it reduced plasma membrane phosphatidylinositol 4,5-disphosphate levels in a dose-dependent manner. When purified and assayed in vitro, the transmembrane form had a specific activity of 142 mol/min/mol, 75-fold more active than the catalytic domain fusion protein and comparable with the specific activities of the other PIPases. The PIPase activity of phogrin depended on the catalytic site cysteine and correlated with effects on glucose-stimulated insulin secretion. We propose that phogrin functions as a phosphatidylinositol phosphatase that contributes to maintaining subcellular differences in levels of PIP that are important for regulating stimulus-coupled exocytosis of insulin.	[Caromile, Leslie A.; Coats, Scott A.; Seifert, Ronald A.; Bowen-Pope, Daniel F.] Univ Washington, Dept Pathol, Seattle, WA 98109 USA; [Oganesian, Anush] Univ Washington, Dept Anesthesiol, Seattle, WA 98109 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bowen-Pope, DF (corresponding author), 815 Mercer St, Seattle, WA 98109 USA.	bp@uw.edu	Caromile, Leslie A/Q-2980-2016	Caromile, Leslie A/0000-0003-2193-5190; Seifer, Ronald/0000-0003-4879-2839	National Institutes of Health [HL69066, HL007312]; Juvenile Diabetes Research Foundation; Samuel and Althea Stroum Endowed Diabetes Fellowship; Ruth L. Kirschstein National Research Service Award [DK081307]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312, R01HL069066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F31DK081307] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Samuel and Althea Stroum Endowed Diabetes Fellowship; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL69066 (to D. F. B.-P.) and Training Grant HL007312 (to L. A. C.). This work was also supported by a grant from the Juvenile Diabetes Research Foundation (to D. F. B.-P.) and by a Samuel and Althea Stroum Endowed Diabetes Fellowship and Ruth L. Kirschstein National Research Service Award DK081307 (to L. A. C.).	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Begley MJ, 2005, CURR OPIN STRUC BIOL, V15, P614, DOI 10.1016/j.sbi.2005.10.016; Bonifacio E, 1998, J IMMUNOL, V161, P2648; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Chi YL, 2004, J BIOL CHEM, V279, P44987, DOI 10.1074/jbc.M406416200; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Cremona O, 2001, J CELL SCI, V114, P1041; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Dirkx R Jr, 1998, Adv Pharmacol, V42, P243; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Drake PG, 2003, BIOCHEM J, V373, P393, DOI 10.1042/BJ20021851; Fitzgerald LR, 1997, J NEUROCHEM, V68, P1820; Georgescu MM, 1999, P NATL ACAD SCI USA, V96, P10182, DOI 10.1073/pnas.96.18.10182; Georgescu MM, 2000, CANCER RES, V60, P7033; Gong LW, 2005, P NATL ACAD SCI USA, V102, P5204, DOI 10.1073/pnas.0501412102; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Gromada J, 2005, P NATL ACAD SCI USA, V102, P10303, DOI 10.1073/pnas.0504487102; Guipponi M, 2001, HUM GENET, V109, P569, DOI 10.1007/s004390100607; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; Henquin JC, 2008, J ENDOCRINOL, V196, P573, DOI 10.1677/JOE-07-0496; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Hu Yafang, 2009, Diabetes, V58, pe8, DOI 10.2337/db09-0168; Hu YF, 2005, DIABETOLOGIA, V48, P2576, DOI 10.1007/s00125-005-0037-y; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Jiang SX, 1998, GENE, V215, P345, DOI 10.1016/S0378-1119(98)00282-0; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kubosaki A, 2005, DIABETES, V54, pS46, DOI 10.2337/diabetes.54.suppl_2.S46; Kubosaki A, 2004, DIABETES, V53, P1684, DOI 10.2337/diabetes.53.7.1684; Kumanovics A, 2002, FASEB J, V16, P1623, DOI 10.1096/fj.02-0238hyp; LAN MS, 1994, DNA CELL BIOL, V13, P505, DOI 10.1089/dna.1994.13.505; Lan MS, 1996, P NATL ACAD SCI USA, V93, P6367, DOI 10.1073/pnas.93.13.6367; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Liao H, 2007, BIOCHEMISTRY-US, V46, P10909, DOI 10.1021/bi701121j; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; LU J, 1994, BIOCHEM BIOPH RES CO, V204, P930, DOI 10.1006/bbrc.1994.2549; Lu J, 1996, P NATL ACAD SCI USA, V93, P2307, DOI 10.1073/pnas.93.6.2307; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Magistrelli G, 1996, BIOCHEM BIOPH RES CO, V227, P581, DOI 10.1006/bbrc.1996.1549; Malecz N, 2000, CURR BIOL, V10, P1383, DOI 10.1016/S0960-9822(00)00778-8; Martin MM, 2001, MOL CELL ENDOCRINOL, V183, P81, DOI 10.1016/S0303-7207(01)00595-0; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Mziaut H, 2008, P NATL ACAD SCI USA, V105, P674, DOI 10.1073/pnas.0710931105; Oganesian A, 2003, P NATL ACAD SCI USA, V100, P7563, DOI 10.1073/pnas.1336511100; Olsen HL, 2003, P NATL ACAD SCI USA, V100, P5187, DOI 10.1073/pnas.0931282100; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Solimena M, 1996, EMBO J, V15, P2102, DOI 10.1002/j.1460-2075.1996.tb00564.x; Taraska JW, 2004, P NATL ACAD SCI USA, V101, P8780, DOI 10.1073/pnas.0401316101; Taylor GS, 2001, ANAL BIOCHEM, V295, P122, DOI 10.1006/abio.2001.5179; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; Torii S, 2005, TRAFFIC, V6, P1213, DOI 10.1111/j.1600-0854.2005.00353.x; Torii S, 2009, DIABETES, V58, P682, DOI 10.2337/db08-0970; Walker SM, 2001, BIOCHEM J, V360, P277, DOI 10.1042/0264-6021:3600277; Waselle L, 2005, MOL ENDOCRINOL, V19, P3097, DOI 10.1210/me.2004-0530; Wasmeier C, 1999, BIOCHEM J, V341, P563, DOI 10.1042/0264-6021:3410563; Wasmeier C, 2005, TRAFFIC, V6, P474, DOI 10.1111/j.1600-0854.2005.00292.x; Wasmeier C, 1996, J BIOL CHEM, V271, P18161, DOI 10.1074/jbc.271.30.18161; Wasmeier C, 2002, TRAFFIC, V3, P654, DOI 10.1034/j.1600-0854.2002.30907.x; Wasmeier C, 2001, J BIOL CHEM, V276, P31919, DOI 10.1074/jbc.M102580200; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; Whisstock JC, 2002, IUBMB LIFE, V53, P15, DOI 10.1080/15216540210814; Wu Y, 2001, J BIOL CHEM, V276, P21745, DOI 10.1074/jbc.M101480200; Xie H, 1996, CANCER RES, V56, P2742	69	33	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10487	10496		10.1074/jbc.M109.066563	http://dx.doi.org/10.1074/jbc.M109.066563			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20097759	Green Published, hybrid			2022-12-27	WOS:000276264600035
J	Girija, UV; Furze, C; Toth, J; Schwaeble, WJ; Mitchell, DA; Keeble, AH; Wallis, R				Girija, Umakhanth Venkatraman; Furze, Christopher; Toth, Julia; Schwaeble, Wilhelm J.; Mitchell, Daniel A.; Keeble, Anthony H.; Wallis, Russell			Engineering Novel Complement Activity into a Pulmonary Surfactant Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE-BINDING PROTEIN; COLLAGEN-LIKE DOMAIN; 1ST COMPONENT; ELECTRON-MICROSCOPY; SERINE PROTEASES; STRUCTURAL BASIS; LECTIN; LOCALIZATION; RECOGNITION; ACTIVATION	Complement neutralizes invading pathogens, stimulates inflammatory and adaptive immune responses, and targets no-nor altered-self structures for clearance. In the classical and lectin activation pathways, it is initiated when complexes composed of separate recognition and activation subcomponents bind to a pathogen surface. Despite its apparent complexity, recognition-mediated activation has evolved independently in three separate protein families, C1q, mannose-binding lectins (MBLs), and serum ficolins. Although unrelated, all have bouquet-like architectures and associate with complement-specific serine proteases: MBLs and ficolins with MBL-associated serine protease-2 (MASP-2) and C1q with C1r and C1s. To examine the structural requirements for complement activation, we have created a number of novel recombinant rat MBLs in which the position and orientation of the MASP-binding sites have been changed. We have also engineered MASP binding into a pulmonary surfactant protein (SP-A), which has the same domain structure and architecture as MBL but lacks any intrinsic complement activity. The data reveal that complement activity is remarkably tolerant to changes in the size and orientation of the collagenous stalks of MBL, implying considerable rotational and conformational flexibility in unbound MBL. Furthermore, novel complement activity is introduced concurrently with MASP binding in SP-A but is uncontrolled and occurs even in the absence of a carbohydrate target. Thus, the active rather than the zymogen state is default in lectin.MASP complexes and must be inhibited through additional regions in circulating MBLs until triggered by pathogen recognition.	[Girija, Umakhanth Venkatraman; Furze, Christopher; Toth, Julia; Schwaeble, Wilhelm J.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester LE1 9HN, Leics, England	University of Leicester		rw73@le.ac.uk	Mitchell, Daniel A/A-6580-2009	Mitchell, Daniel A/0000-0003-0936-6212; VENKATRAMAN GIRIJA, UMAKHANTH/0000-0002-0761-5994; Schwaeble, Wilhelm/0000-0001-8927-0864; Furze, Christopher/0000-0002-2785-4618; Keeble, Anthony/0000-0002-4873-6960; Wallis, Russell/0000-0002-8705-5295	Medical Research Council [G0501425]; Wellcome Trust [077400]; MRC [G0501425] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Grant G0501425 from the Medical Research Council and Grant 077400 from The Wellcome Trust.	BRODSKYDOYLE B, 1976, BIOCHEM J, V159, P279, DOI 10.1042/bj1590279; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Chen CB, 2001, J BIOL CHEM, V276, P25894, DOI 10.1074/jbc.M103539200; Doliana R, 1999, J BIOL CHEM, V274, P16773, DOI 10.1074/jbc.274.24.16773; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043; Feinberg H, 2003, EMBO J, V22, P2348, DOI 10.1093/emboj/cdg236; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; HAURUM JS, 1993, BIOCHEM J, V293, P873, DOI 10.1042/bj2930873; Heise CT, 2000, J IMMUNOL, V165, P1403, DOI 10.4049/jimmunol.165.3.1403; Hohenester E, 2008, P NATL ACAD SCI USA, V105, P18273, DOI 10.1073/pnas.0808452105; HOPPE HJ, 1994, PROTEIN SCI, V3, P1143, DOI 10.1002/pro.5560030801; Jensenius H, 2009, J MOL BIOL, V391, P246, DOI 10.1016/j.jmb.2009.05.083; KAUFMAN RJ, 1991, NUCLEIC ACIDS RES, V19, P4485, DOI 10.1093/nar/19.16.4485; KURATA H, 1993, BIOCHEM BIOPH RES CO, V191, P1204, DOI 10.1006/bbrc.1993.1345; Phillips AE, 2009, J IMMUNOL, V182, P7708, DOI 10.4049/jimmunol.0900666; PORTER RR, 1978, NATURE, V275, P699, DOI 10.1038/275699a0; REID KBM, 1977, BIOCHEM J, V161, P239, DOI 10.1042/bj1610239; REID KBM, 1976, BIOCHEM J, V155, P19, DOI 10.1042/bj1550019; Reid KBM, 1998, IMMUNOL TODAY, V19, P56, DOI 10.1016/S0167-5699(97)01207-3; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Sim RB, 2004, BIOCHEM SOC T, V32, P21, DOI 10.1042/BST0320021; STRANG CJ, 1982, P NATL ACAD SCI-BIOL, V79, P586, DOI 10.1073/pnas.79.2.586; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Uemura T, 2006, BIOCHEMISTRY-US, V45, P14543, DOI 10.1021/bi061338u; Wallis R, 1999, J BIOL CHEM, V274, P3580, DOI 10.1074/jbc.274.6.3580; Wallis R, 1999, J IMMUNOL, V163, P4953; Wallis R, 2004, J BIOL CHEM, V279, P14065, DOI 10.1074/jbc.M400171200; Wallis R, 1997, BIOCHEM J, V325, P391, DOI 10.1042/bj3250391; Wallis R, 2007, IMMUNOBIOLOGY, V212, P289, DOI 10.1016/j.imbio.2006.11.004; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006	32	6	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10546	10552		10.1074/jbc.M109.097493	http://dx.doi.org/10.1074/jbc.M109.097493			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118239	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000276264600041
J	Labriola, JM; daCosta, CJB; Wang, SZ; Figeys, D; Smith, JC; Sturgeon, RM; Baenziger, JE				Labriola, Jonathan M.; daCosta, Corrie J. B.; Wang, Shuzhi; Figeys, Daniel; Smith, Jeffrey C.; Sturgeon, R. Michel; Baenziger, John E.			Phospholipase C Activity Affinity Purifies with the Torpedo Nicotinic Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PROTEIN INTERACTIONS; PHOSPHATE PHOSPHOHYDROLASES; NONCOMPETITIVE INHIBITORS; RAPID METHOD; MEMBRANES; ACID; CONFORMATION; INFLAMMATION; CALIFORNICA; ACTIVATION	Nicotinic acetylcholine receptors mediate fast synaptic transmission by fluxing ions across the membrane in response to neurotransmitter binding. We show here that during affinity purification of the nicotinic acetylcholine receptor from Torpedo, phosphatidic acid, but not other anionic or zwitterionic phospholipids, is hydrolyzed to diacylglycerol. The phospholipase C activity elutes with the acetylcholine receptor and is inhibited by a lipid phosphate phosphohydrolase inhibitor, sodium vanadate, but not a phosphatidate phosphohydrolase inhibitor, N-ethylmaleimide. Further, the hydrolysis product of phosphatidic acid, diacylglycerol, enhances the functional capabilities of the acetylcholine receptor in the presence of anionic lipids. We conclude that a phospholipase C activity, which appears to be specific for phosphatidic acid, is associated with the nicotinic acetylcholine receptor. The acetylcholine receptor may directly or indirectly influence lipid metabolism in a manner that enhances its own function.	[Labriola, Jonathan M.; daCosta, Corrie J. B.; Wang, Shuzhi; Sturgeon, R. Michel; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Figeys, Daniel; Smith, Jeffrey C.] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Labriola, JM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	John.Baenziger@uottawa.ca		Baenziger, John/0000-0002-2888-5328; Sturgeon, Raymond/0000-0002-0043-0241; Figeys, Daniel/0000-0002-5373-7546	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to J. E. B.).	Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Blanchet MR, 2006, AM J PHYSIOL-LUNG C, V291, pL757, DOI 10.1152/ajplung.00409.2005; BLEASDALE JE, 1976, BIOCHEM J, V158, P557, DOI 10.1042/bj1580557; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta CJB, 2004, J BIOL CHEM, V279, P14967, DOI 10.1074/jbc.M310037200; daCosta CJB, 2003, ACTA CRYSTALLOGR D, V59, P77, DOI 10.1107/S0907444902019236; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; daCosta CJB, 2009, J BIOL CHEM, V284, P17819, DOI 10.1074/jbc.M900030200; de Jonge WJ, 2007, BRIT J PHARMACOL, V151, P915, DOI 10.1038/sj.bjp.0707264; Dougherty DA, 2008, CHEM REV, V108, P1642, DOI 10.1021/cr078207z; ELLENA JF, 1983, BIOCHEMISTRY-US, V22, P5523, DOI 10.1021/bi00293a012; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Goetz T, 2007, PROG BRAIN RES, V160, P21, DOI 10.1016/S0079-6123(06)60003-4; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HERZ JM, 1991, J BIOL CHEM, V266, P16691; HERZ JM, 1987, J BIOL CHEM, V262, P7238; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; MCCARTHY MP, 1992, J BIOL CHEM, V267, P7655; Reue K, 2008, J LIPID RES, V49, P2493, DOI 10.1194/jlr.R800019-JLR200; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Simon MF, 2002, J BIOL CHEM, V277, P23131, DOI 10.1074/jbc.M201530200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sturgeon RM, 2010, BIOPHYS J, V98, P989, DOI 10.1016/j.bpj.2009.11.030; Suzuki T, 2006, J NEUROSCI RES, V83, P1461, DOI 10.1002/jnr.20850; Thompson AJ, 2006, CURR PHARM DESIGN, V12, P3615, DOI 10.2174/138161206778522029	30	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10337	10343		10.1074/jbc.M109.071993	http://dx.doi.org/10.1074/jbc.M109.071993			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133947	Green Published, hybrid			2022-12-27	WOS:000276264600018
J	Reed, D; Shen, Y; Shelat, AA; Arnold, LA; Ferreira, AM; Zhu, FY; Mills, N; Smithson, DC; Regni, CA; Bashford, D; Cicero, SA; Schulman, BA; Jochemsen, AG; Guy, RK; Dyer, MA				Reed, Damon; Shen, Ying; Shelat, Anang A.; Arnold, Leggy A.; Ferreira, Antonio M.; Zhu, Fangyi; Mills, Nicholas; Smithson, David C.; Regni, Catherine A.; Bashford, Donald; Cicero, Samantha A.; Schulman, Brenda A.; Jochemsen, Aart G.; Guy, R. Kiplin; Dyer, Michael A.			Identification and Characterization of the First Small Molecule Inhibitor of MDMX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN STABILITY; P53 ACTIVATION; RING DOMAIN; ANTAGONISTS; APOPTOSIS; BINDING; OVEREXPRESSION; AMPLIFICATION; INACTIVATION; P53-MDM2	The p53 pathway is disrupted in virtually every human tumor. In similar to 50% of human cancers, the p53 gene is mutated, and in the remaining cancers, the pathway is dysregulated by genetic lesions in other genes that modulate the p53 pathway. One common mechanism for inactivation of the p53 pathway in tumors that express wild-type p53 is increased expression of MDM2 or MDMX. MDM2 and MDMX bind p53 and inhibit its function by distinct nonredundant mechanisms. Small molecule inhibitors and small peptides have been developed that bind MDM2 in the p53-binding pocket and displace the p53 protein, leading to p53-mediated cell cycle exit and apoptosis. To date, peptide inhibitors of MDMX have been developed, but no small molecule inhibitors have been reported. We have developed biochemical and cell-based assays for high throughput screening of chemical libraries to identify MDMX inhibitors and identified the first MDMX inhibitor SJ-172550. This compound binds reversibly to MDMX and effectively kills retinoblastoma cells in which the expression of MDMX is amplified. The effect of SJ-172550 is additive when combined with an MDM2 inhibitor. Results from a series of biochemical and structural modeling studies suggest that SJ-172550 binds the p53-binding pocket of MDMX, thereby displacing p53. This lead compound is a useful chemical scaffold for further optimization of MDMX inhibitors that may eventually be used to treat pediatric cancers and various adult tumors that overexpress MDMX or have similar genetic lesions. When combined with selective MDM2 inhibitors, SJ-172550 may also be useful for treating tumors that express wild-type p53.	[Dyer, Michael A.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Shelat, Anang A.; Arnold, Leggy A.; Zhu, Fangyi; Mills, Nicholas; Smithson, David C.; Guy, R. Kiplin] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA; [Ferreira, Antonio M.; Regni, Catherine A.; Bashford, Donald; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Schulman, Brenda A.; Dyer, Michael A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Jochemsen, Aart G.] Leiden Univ, Med Ctr, Dept Mol & Cellular Biol, NL-2333 ZA Leiden, Netherlands	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; Howard Hughes Medical Institute; St Jude Children's Research Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Dyer, MA (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, MS323,262 Danny Thomas Pl, Memphis, TN 38105 USA.	michael.dyer@stjude.org	Ferreira, Antonio/I-4423-2013; Shelat, Anang/J-4995-2013; Guy, Rodney/J-7107-2013; Dyer, Michael/N-8134-2018; Bashford, Donald/F-5905-2011; Reed, Damon/R-8179-2019	Shelat, Anang/0000-0002-6266-2910; Guy, Rodney/0000-0002-9638-2060; Bashford, Donald/0000-0001-5776-3744; Reed, Damon/0000-0002-8238-2465; Ferreira, Antonio/0000-0002-6581-6233; Arnold, Leggy/0000-0003-1411-1572	NCI, Cancer Center Support; Howard Hughes Medical Institute; American Cancer Society; Research to Prevent Blindness; Pearle Vision Foundation; International Retinal Research Foundation; Pew Charitable Trust; American Lebanese Syrian Associated Charities; NATIONAL EYE INSTITUTE [R01EY014867] Funding Source: NIH RePORTER	NCI, Cancer Center Support(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Cancer Society(American Cancer Society); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Pearle Vision Foundation; International Retinal Research Foundation; Pew Charitable Trust; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health grants from NCI, Cancer Center Support. This work was also supported by Howard Hughes Medical Institute, American Cancer Society, Research to Prevent Blindness, Pearle Vision Foundation, International Retinal Research Foundation, Pew Charitable Trust, and American Lebanese Syrian Associated Charities (to M. A. D.).	Anderson JJ, 2007, INT J ONCOL, V31, P545; Bartel F, 2005, INT J CANCER, V117, P469, DOI 10.1002/ijc.21206; Bottger V, 1999, ONCOGENE, V18, P189, DOI 10.1038/sj.onc.1202281; Coll-Mulet L, 2006, BLOOD, V107, P4109, DOI 10.1182/blood-2005-08-3273; Dang JJ, 2002, CANCER RES, V62, P1222; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; Gu JJ, 2002, J BIOL CHEM, V277, P19251, DOI 10.1074/jbc.C200150200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hu B, 2007, CANCER RES, V67, P8810, DOI 10.1158/0008-5472.CAN-07-1140; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; Jackson MW, 2000, MOL CELL BIOL, V20, P1001, DOI 10.1128/MCB.20.3.1001-1007.2000; Kallen J, 2009, J BIOL CHEM, V284, P8803, DOI 10.1074/jbc.M809096200; Kojima K, 2005, BLOOD, V106, P3150, DOI 10.1182/blood-2005-02-0553; Laurie NA, 2007, CURR CANCER DRUG TAR, V7, P689, DOI 10.2174/156800907782418266; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Levine EM, 1997, J COMP NEUROL, V387, P439; Linke K, 2008, CELL DEATH DIFFER, V15, P841, DOI 10.1038/sj.cdd.4402309; Lor LA, 2007, J BIOMOL SCREEN, V12, P881, DOI 10.1177/1087057107304113; Lu F, 2006, J COMB CHEM, V8, P315, DOI 10.1021/cc050142v; Marine JC, 2004, CELL CYCLE, V3, P900; Marine JE, 2006, HEART RHYTHM, V3, P342, DOI 10.1016/j.hrthm.2006.01.010; Marine JCW, 2007, J CELL SCI, V120, P371, DOI 10.1242/jcs.03362; Migliorini D, 2002, MOL CELL BIOL, V22, P5527, DOI 10.1128/MCB.22.15.5527-5538.2002; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Popowicz GM, 2007, CELL CYCLE, V6, P2386, DOI 10.4161/cc.6.19.4740; Senisterra GA, 2008, J BIOMOL SCREEN, V13, P337, DOI 10.1177/1087057108317825; Senisterra GA, 2009, MOL BIOSYST, V5, P217, DOI 10.1039/b814377c; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shvarts A, 1997, GENOMICS, V43, P34, DOI 10.1006/geno.1997.4775; Stad R, 2001, EMBO REP, V2, P1029, DOI 10.1093/embo-reports/kve227; Stricher F, 2005, BIOCHEM J, V390, P29, DOI 10.1042/BJ20041953; Toledo F, 2006, CANCER CELL, V9, P273, DOI 10.1016/j.ccr.2006.03.014; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Udayakumar TS, 2008, MOL CANCER RES, V6, P1742, DOI 10.1158/1541-7786.MCR-08-0102; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864	39	154	163	0	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10786	10796		10.1074/jbc.M109.056747	http://dx.doi.org/10.1074/jbc.M109.056747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20080970	Green Published, hybrid			2022-12-27	WOS:000276264600064
J	Volkov, A; Liavonchanka, A; Kamneva, O; Fiedler, T; Goebel, C; Kreikemeyer, B; Feussner, I				Volkov, Anton; Liavonchanka, Alena; Kamneva, Olga; Fiedler, Tomas; Goebel, Cornelia; Kreikemeyer, Bernd; Feussner, Ivo			Myosin Cross-reactive Antigen of Streptococcus pyogenes M49 Encodes a Fatty Acid Double Bond Hydratase That Plays a Role in Oleic Acid Detoxification and Bacterial Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENOYL-COA HYDRATASE; ESCHERICHIA-COLI; LINOLEIC-ACID; SEQUENCE; MECHANISM; BIOHYDROGENATION; INHIBITION; BINDING; GROWTH; GENE	The myosin cross-reactive antigen (MCRA) protein family is highly conserved among different bacterial species ranging from Gram-positive to Gram-negative bacteria. Besides their ubiquitous occurrence, knowledge about the biochemical and physiological function of MCRA proteins is scarce. Here, we show that MCRA protein from Streptococcus pyogenes M49 is a FAD enzyme, which acts as hydratase on (9Z)- and (12Z)-double bonds of C-16, C-18 non-esterified fatty acids. Products are 10-hydroxy and 10,13-dihydroxy fatty acids. Kinetic analysis suggests that FAD rather stabilizes the active conformation of the enzyme and is not directly involved in catalysis. Analysis of S. pyogenes M49 grown in the presence of either oleic or linoleic acid showed that 10-hydroxy and 10,13-dihydroxy derivatives were the only products. No further metabolism of these hydroxy fatty acids was detected. Deletion of the hydratase gene caused a 2-fold decrease in minimum inhibitory concentration against oleic acid but increased survival of the mutant strain in whole blood. Adherence and internalization properties to human keratinocytes were reduced in comparison with the wild type. Based on these results, we conclude that the previously identified MCRA protein can be classified as a FAD-containing double bond hydratase, within the carbon-oxygen lyase family, that plays a role in virulence of at least S. pyogenes M49.	[Volkov, Anton; Liavonchanka, Alena; Goebel, Cornelia; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany; [Fiedler, Tomas; Kreikemeyer, Bernd] Univ Hosp Rostock, Inst Med Microbiol Virol & Hyg, D-18057 Rostock, Germany; [Kamneva, Olga] Univ Wyoming, Coll Agr, Dept Mol Biol, Laramie, WY 82072 USA	University of Gottingen; University of Rostock; University of Wyoming	Feussner, I (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-377077 Gottingen, Germany.	ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003; Kreikemeyer, Bernd/0000-0001-9527-5098; Fiedler, Tomas/0000-0001-6717-1865	Molecular Sciences and Biotechnology of Crop Plants	Molecular Sciences and Biotechnology of Crop Plants	Supported by the Ph.D. program "Molecular Sciences and Biotechnology of Crop Plants."	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Bahnson BJ, 2002, BIOCHEMISTRY-US, V41, P2621, DOI 10.1021/bi015844p; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Bevers LE, 2009, J BACTERIOL, V191, P5010, DOI 10.1128/JB.00306-09; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CROMARTIE TH, 1976, J BIOL CHEM, V251, P329; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Duggleby RG, 2000, J BIOCHEM MOL BIOL, V33, P1; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engel CK, 1998, J MOL BIOL, V275, P847, DOI 10.1006/jmbi.1997.1491; FEUSSNER I, 2008, Patent No. 119735; GREENWAY DLA, 1979, J GEN MICROBIOL, V115, P233, DOI 10.1099/00221287-115-1-233; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KAUPPINEN S, 1988, CARLSBERG RES COMMUN, V53, P357, DOI 10.1007/BF02983311; KEPLER CR, 1970, J BIOL CHEM, V245, P3612; KEPLER CR, 1967, J BIOL CHEM, V242, P5686; KEPLER CR, 1966, J BIOL CHEM, V241, P1350; KIL KS, 1994, INFECT IMMUN, V62, P2440, DOI 10.1128/IAI.62.6.2440-2449.1994; Kleiger G, 2002, J MOL BIOL, V323, P69, DOI 10.1016/S0022-2836(02)00885-9; Kleinfeld AM, 1996, AM J CARDIOL, V78, P1350, DOI 10.1016/S0002-9149(96)00651-0; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Liavonchanka A, 2006, P NATL ACAD SCI USA, V103, P2576, DOI 10.1073/pnas.0510144103; Liavonchanka A, 2008, CHEMBIOCHEM, V9, P1867, DOI 10.1002/cbic.200800141; Liavonchanka A, 2009, J BIOL CHEM, V284, P8005, DOI 10.1074/jbc.M809060200; Maia MRG, 2007, ANTON LEEUW INT J G, V91, P303, DOI 10.1007/s10482-006-9118-2; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Price AC, 2001, J BIOL CHEM, V276, P6551, DOI 10.1074/jbc.M007101200; RAYCHOWDHURY MK, 1985, J APPL BACTERIOL, V59, P183, DOI 10.1111/j.1365-2672.1985.tb03319.x; RICHIERI GV, 1995, J LIPID RES, V36, P229; ROSSON RA, 2004, Patent No. 6743609; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenz L, 2008, FEMS MICROBIOL LETT, V287, P149, DOI 10.1111/j.1574-6968.2008.01316.x; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ValentinWeigand P, 1996, INFECT IMMUN, V64, P2467, DOI 10.1128/IAI.64.7.2467-2473.1996; VARGO D, 1981, J BIOL CHEM, V256, P6027; VERBRUGH HA, 1985, IMMUNOLOGY, V54, P643; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zheng CJ, 2005, FEBS LETT, V579, P5157, DOI 10.1016/j.febslet.2005.08.028	47	91	98	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10353	10361		10.1074/jbc.M109.081851	http://dx.doi.org/10.1074/jbc.M109.081851			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145247	hybrid, Green Published			2022-12-27	WOS:000276264600020
J	Lampe, JN; Brandman, R; Sivaramakrishnan, S; de Montellano, PRO				Lampe, Jed N.; Brandman, Relly; Sivaramakrishnan, Santhosh; de Montellano, Paul R. Ortiz			Two-dimensional NMR and All-atom Molecular Dynamics of Cytochrome P450 CYP119 Reveal Hidden Conformational Substates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTENTIAL FUNCTIONS; INTRINSIC DYNAMICS; CRYSTAL-STRUCTURES; LIGAND-BINDING; INDUCED FIT; PROTEIN; P450CAM; MODEL; SITE; 3A4	Cytochrome P450 enzymes are versatile catalysts involved in a wide variety of biological processes from hormonal regulation and antibiotic synthesis to drug metabolism. A hallmark of their versatility is their promiscuous nature, allowing them to recognize a wide variety of chemically diverse substrates. However, the molecular details of this promiscuity have remained elusive. Here, we have utilized two-dimensional heteronuclear single quantum coherence NMR spectroscopy to examine a series of mutants site-specific labeled with the unnatural amino acid, [C-13] p-methoxyphenylalanine, in conjunction with all-atom molecular dynamics simulations to examine substrate and inhibitor binding to CYP119, a P450 from Sulfolobus acidocaldarius. The results suggest that tight binding hydrophobic ligands tend to lock the enzyme into a single conformational substate, whereas weak binding low affinity ligands bind loosely in the active site, resulting in a distribution of localized conformers. Furthermore, the molecular dynamics simulations suggest that the ligand-free enzyme samples ligand-bound conformations of the enzyme and, therefore, that ligand binding may proceed largely through a process of conformational selection rather than induced fit.	[Lampe, Jed N.; Sivaramakrishnan, Santhosh; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Brandman, Relly] Simprota Corp, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Lampe, Jed N./J-8930-2019	Lampe, Jed N./0000-0003-0794-2263	National Institutes of Health [GM25515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM025515, R01GM025515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by National Institutes of Health Grant GM25515.	Altarsha M, 2009, J PHYS CHEM B, V113, P9577, DOI 10.1021/jp809838k; Arnold GE, 1997, BIOPHYS J, V73, P1147, DOI 10.1016/S0006-3495(97)78147-5; Asciutto EK, 2009, J MOL BIOL, V388, P801, DOI 10.1016/j.jmb.2009.03.046; Atkins WM, 2001, CHEM RES TOXICOL, V14, P338, DOI 10.1021/tx0002132; Bakan A, 2009, P NATL ACAD SCI USA, V106, P14349, DOI 10.1073/pnas.0904214106; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Bosshard HR, 2001, NEWS PHYSIOL SCI, V16, P171; Cellitti SE, 2008, J AM CHEM SOC, V130, P9268, DOI 10.1021/ja801602q; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; Cupp-Vickery J, 2000, P NATL ACAD SCI USA, V97, P3050, DOI 10.1073/pnas.050406897; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Eyal E, 2006, BIOINFORMATICS, V22, P2619, DOI 10.1093/bioinformatics/btl448; Ferscht A., 1999, STRUCTURE MECH PROTE, P54; Fishelovitch D, 2007, J AM CHEM SOC, V129, P1602, DOI 10.1021/ja066007j; Gogonea V, 2006, J PHYS CHEM B, V110, P22861, DOI 10.1021/jp061653q; Groves J. T., 2005, CYTOCHROME P450, P1, DOI DOI 10.1007/0-387-27447-2_1; Hansen DF, 2008, J BIOMOL NMR, V41, P113, DOI 10.1007/s10858-008-9251-5; Hays AMA, 2004, J MOL BIOL, V344, P455, DOI 10.1016/j.jmb.2004.09.046; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Isin EM, 2008, ANAL BIOANAL CHEM, V392, P1019, DOI 10.1007/s00216-008-2244-0; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; Jones DH, 2010, J BIOMOL NMR, V46, P89, DOI 10.1007/s10858-009-9365-4; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Karkola S, 2009, MOL CELL ENDOCRINOL, V301, P235, DOI 10.1016/j.mce.2008.10.003; KOLEY AP, 1995, J BIOL CHEM, V270, P5014, DOI 10.1074/jbc.270.10.5014; Koo LS, 2000, J BIOL CHEM, V275, P14112, DOI 10.1074/jbc.275.19.14112; Lamb DC, 2007, CURR OPIN BIOTECH, V18, P504, DOI 10.1016/j.copbio.2007.09.010; Lampe JN, 2008, J AM CHEM SOC, V130, P16168, DOI 10.1021/ja8071463; Liu CC, 2006, NAT BIOTECHNOL, V24, P1436, DOI 10.1038/nbt1254; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Mestres J, 2005, PROTEINS, V58, P596, DOI 10.1002/prot.20354; Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964; Muralidhara BK, 2006, J BIOL CHEM, V281, P8051, DOI 10.1074/jbc.M509696200; Nishida CR, 2005, BIOCHEM BIOPH RES CO, V338, P437, DOI 10.1016/j.bbrc.2005.08.093; Park SY, 2002, J INORG BIOCHEM, V91, P491, DOI 10.1016/S0162-0134(02)00446-4; Pochapsky SS, 2009, BIOCHEMISTRY-US, V48, P4254, DOI 10.1021/bi900002k; Pochapsky TC, 2001, BIOCHEMISTRY-US, V40, P5602, DOI 10.1021/bi0028845; Ravindranathan KP, 2006, J AM CHEM SOC, V128, P5786, DOI 10.1021/ja058465i; Ringe D, 2008, SCIENCE, V320, P1428, DOI 10.1126/science.1159747; Savino C, 2009, J BIOL CHEM, V284, P29170, DOI 10.1074/jbc.M109.003590; Schleinkofer K, 2005, EMBO REP, V6, P584, DOI 10.1038/sj.embor.7400420; Strickler M, 2003, BIOCHEMISTRY-US, V42, P11943, DOI 10.1021/bi034833o; Sun H, 2009, DRUG METAB DISPOS, V37, P672, DOI 10.1124/dmd.108.022707; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wade RC, 2005, BBA-PROTEINS PROTEOM, V1754, P239, DOI 10.1016/j.bbapap.2005.07.044; Wester MR, 2003, BIOCHEMISTRY-US, V42, P9335, DOI 10.1021/bi034556l; Williams PA, 2003, NATURE, V424, P464, DOI 10.1038/nature01862; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yano JK, 2003, J BIOL CHEM, V278, P608, DOI 10.1074/jbc.M206568200; Yao H, 2007, PROTEINS, V69, P125, DOI 10.1002/prot.21508; Zhang HM, 2009, J BIOL CHEM, V284, P25678, DOI 10.1074/jbc.M109.032748	64	40	40	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9594	9603		10.1074/jbc.M109.087593	http://dx.doi.org/10.1074/jbc.M109.087593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097757	Green Published, hybrid			2022-12-27	WOS:000276165900032
J	Asahi, T; Kondo, H; Masuda, M; Nishino, H; Aratani, Y; Naito, Y; Yoshikawa, T; Hisaka, S; Kato, Y; Osawa, T				Asahi, Takashi; Kondo, Hajime; Masuda, Mitsuharu; Nishino, Hoyoku; Aratani, Yasuaki; Naito, Yuji; Yoshikawa, Toshikazu; Hisaka, Shinsuke; Kato, Yoji; Osawa, Toshihiko			Chemical and Immunochemical Detection of 8-Halogenated Deoxyguanosines at Early Stage Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; LOW-DENSITY-LIPOPROTEIN; EOSINOPHIL PEROXIDASE; HUMAN NEUTROPHILS; NITRIC-OXIDE; LIPID HYDROPEROXIDE; MONOCLONAL-ANTIBODY; ENDOGENOUS MUTAGEN; OXIDATIVE STRESS; MYELOPEROXIDASE	Myeloperoxidase (MPO) generates reactive halogenating species that can modify DNA. The aim of this study was to investigate the formation of 8-halogenated 2'-deoxyguanosines (8-halo-dGs) during inflammatory events. 8-Bromo-2'-dG (8-BrdG) and 8-chloro-2'-dG (8-CldG) were generated by treatment of MPO with hydrogen peroxide at physiological concentrations of Cl- and Br-. The formation of 8-halo-dGs with other oxidative stress biomarkers in lipopolysaccharide-treated rats was assessed by liquid chromatography tandem mass spectrometry and immunohistochemistry using a novel monoclonal antibody (mAb8B3) to 8-BrdG-conjugated keyhole limpet hemocyanin. The antibody recognized both 8-BrdG and 8-CldG. In the liver of lipopolysaccharide-treated rats, immunostaining for 8-halo-dGs, halogenated tyrosines, and MPO were increased at 8 h, whereas those of 8-oxo-2'-dG (8-OxodG) and 3-nitrotyrosine were increased at 24 h. Urinary excretion of both 8-CldG and 8-BrdG was also observed earlier than those of 8-OxodG and modified tyrosines (3-nitrotyrosine, 3-chlorotyrosine, and 3-bromotyrosine). Moreover, the levels of the 8-halo-dGs in urine from human diabetic patients were 8-fold higher than in healthy subjects (n = 10, healthy and diabetic, p < 0.0001), whereas there was a moderate difference in 8-OxodG between the two groups (p < 0.001). Interestingly, positive mAb8B3 antibody staining was observed in liver tissue from hepatocellular carcinoma patients but not in liver tissue from human cirrhosis patients. These data suggest that 8-halo-dGs may be potential biomarkers of early inflammation.	[Kato, Yoji] Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan; [Asahi, Takashi; Kondo, Hajime; Hisaka, Shinsuke; Osawa, Toshihiko] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan; [Masuda, Mitsuharu] Kyoto Prefectural Univ Med, Dept Hlth Sci & Prevent Med, Kyoto 6028566, Japan; [Nishino, Hoyoku] Kyoto Prefectural Univ Med, Ctr Canc, Kyoto 6028566, Japan; [Aratani, Yasuaki] Yokohama City Univ, Grad Sch Nanobiosci, Dept Genome Syst Sci, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Naito, Yuji; Yoshikawa, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Kyoto 6028566, Japan	University of Hyogo; Nagoya University; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Yokohama City University; Kyoto Prefectural University of Medicine	Kato, Y (corresponding author), Univ Hyogo, Sch Human Sci & Environm, Himeji, Hyogo 6700092, Japan.	yojikato@shse.u-hyogo.ac.jp	Kato, Yoji/W-4779-2019	Kato, Yoji/0000-0002-8295-7337	Ministry of Education, Culture, Sports, Science, and Technology; COE Program; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a research grant from the Ministry of Education, Culture, Sports, Science, and Technology, by the COE Program in the 21st Century in Japan, and by research fellowships of the Japan Society for the Promotion of Science.	Akaike T, 2003, P NATL ACAD SCI USA, V100, P685, DOI 10.1073/pnas.0235623100; Albert CJ, 2003, J BIOL CHEM, V278, P8942, DOI 10.1074/jbc.M211634200; Aratani Y, 1999, INFECT IMMUN, V67, P1828; Badouard C, 2005, J CHROMATOGR B, V827, P26, DOI 10.1016/j.jchromb.2005.03.025; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; BECKMANN JS, 1994, BIOL CHEM H-S, V375, P81, DOI 10.1515/bchm3.1994.375.2.81; BHATNAGAR SK, 1991, J BIOL CHEM, V266, P9050; Brown KE, 2001, AM J PATHOL, V159, P2081, DOI 10.1016/S0002-9440(10)63059-3; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Byun J, 2003, ANAL BIOCHEM, V317, P201, DOI 10.1016/S0003-2697(03)00093-9; DOMIGAN NM, 1995, J BIOL CHEM, V270, P16542, DOI 10.1074/jbc.270.28.16542; Eiserich JP, 1998, NATURE, V391, P393, DOI 10.1038/34923; Fabrega C, 2001, NUCLEOS NUCLEOT NUCL, V20, P251, DOI 10.1081/NCN-100002085; Furtmuller PG, 1998, BIOCHEMISTRY-US, V37, P17923, DOI 10.1021/bi9818772; Gaut JP, 2001, P NATL ACAD SCI USA, V98, P11961, DOI 10.1073/pnas.211190298; Haghdoost S, 2006, FREE RADICAL BIO MED, V41, P620, DOI 10.1016/j.freeradbiomed.2006.05.003; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; Hazen SL, 1996, J CLIN INVEST, V98, P1283, DOI 10.1172/JCI118914; HEINECKE JW, 1993, J BIOL CHEM, V268, P4069; Heineman D, 2002, J HIST SEXUALITY, V11, P22; Henderson JP, 1999, J BIOL CHEM, V274, P33440, DOI 10.1074/jbc.274.47.33440; Henderson JP, 2003, J BIOL CHEM, V278, P23522, DOI 10.1074/jbc.M303928200; Henderson JP, 2001, P NATL ACAD SCI USA, V98, P1631, DOI 10.1073/pnas.041146998; Henderson JP, 2001, BIOCHEMISTRY-US, V40, P2052, DOI 10.1021/bi002015f; Huang X, 2001, FREE RADICAL BIO MED, V31, P1341, DOI 10.1016/S0891-5849(01)00681-5; Iida T, 2001, NEURO-ONCOLOGY, V3, P73, DOI 10.1093/neuonc/3.2.73; ITOH K, 1993, GASTROENTEROL JPN, V28, P541; Kato Y, 2005, FREE RADICAL BIO MED, V38, P24, DOI 10.1016/j.freeradbiomed.2004.09.013; Kato Y, 1999, J BIOL CHEM, V274, P20406, DOI 10.1074/jbc.274.29.20406; Kato Y, 1997, J LIPID RES, V38, P1334; Kato Y, 2009, J CLIN BIOCHEM NUTR, V44, P67, DOI 10.3164/jcbn.08-185; Kawai Y, 2004, J BIOL CHEM, V279, P51241, DOI 10.1074/jbc.M408210200; Kimura S, 2006, BASIC CLIN PHARMACOL, V98, P496, DOI 10.1111/j.1742-7843.2006.pto_217.x; Kobayashi Y, 1998, CARCINOGENESIS, V19, P1809, DOI 10.1093/carcin/19.10.1809; Masuda M, 2001, J BIOL CHEM, V276, P40486, DOI 10.1074/jbc.M102700200; OHSHIMA H, 1994, MUTAT RES, V305, P253, DOI 10.1016/0027-5107(94)90245-3; Shen ZZ, 2001, BIOCHEMISTRY-US, V40, P2041, DOI 10.1021/bi001961t; Suzuki T, 2002, FEBS LETT, V516, P67, DOI 10.1016/S0014-5793(02)02503-6; Takeshita J, 2006, J BIOL CHEM, V281, P3096, DOI 10.1074/jbc.M509236200; Thukkani AK, 2003, J BIOL CHEM, V278, P36365, DOI 10.1074/jbc.M305449200; Toyokuni S, 1997, LAB INVEST, V76, P365; WEITZMAN SA, 1990, BLOOD, V76, P655; Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017; Yoshitake J, 2004, J VIROL, V78, P8709, DOI 10.1128/JVI.78.16.8709-8719.2004; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200	45	50	50	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9282	9291		10.1074/jbc.M109.054213	http://dx.doi.org/10.1074/jbc.M109.054213			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20081197	Green Published, hybrid			2022-12-27	WOS:000275553700076
J	Nedumaran, B; Kim, GS; Hong, S; Yoon, YS; Kim, YH; Lee, CH; Lee, YC; Koo, SH; Choi, HS				Nedumaran, Balachandar; Kim, Gwang Sik; Hong, Sungpyo; Yoon, Young-Sil; Kim, Yong-Hoon; Lee, Chul-Ho; Lee, Young Chul; Koo, Seung-Hoi; Choi, Hueng-Sik			Orphan Nuclear Receptor DAX-1 Acts as a Novel Corepressor of Liver X Receptor alpha and Inhibits Hepatic Lipogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITA CRITICAL REGION; ELEMENT-BINDING PROTEIN; TRANSCRIPTIONAL ACTIVITY; GENE-EXPRESSION; SHP; LXR; TRANSACTIVATION; ACTIVATION; CHROMOSOME; REPRESSES	DAX-1 (dosage-sensitive sex reversal adrenal hypoplasia congenital critical regionon X chromosome, gene1) is a member of the nuclear receptor superfamily that can repress diverse nuclear receptors and has a key role in adreno-gonadal development. Our previous report has demonstrated that DAX-1 can inhibit hepatocyte nuclear factor 4 alpha transactivity and negatively regulate gluconeogenic gene expression (Nedumaran, B., Hong, S., Xie, Y. B., Kim, Y. H., Seo, W. Y., Lee, M. W., Lee, C. H., Koo, S. H., and Choi, H. S. (2009) J. Biol. Chem. 284, 27511-27523). Here, we further expand the role of DAX-1 in hepatic energy metabolism. Transfection assays have demonstrated that DAX-1 can inhibit the transcriptional activity of nuclear receptor liver X receptor alpha (LXR alpha). Physical interaction between DAX-1 and LXR alpha was confirmed Immunofluorescent staining in mouse liver shows that LXR alpha and DAX-1 are colocalized in the nucleus. Domain mapping analysis shows that the entire region of DAX-1 is involved in the interaction with the ligand binding domain region of LXR alpha. Competition analyses demonstrate that DAX1 competes with the coactivator SRC-1 for repressing LXR alpha transactivity. Chromatin immunoprecipitation assay showed that endogenous DAX-1 recruitment on the SREBP-1c gene promoter was decreased in the presence of LXR alpha agonist. Overexpression of DAX-1 inhibits T7-induced LXR alpha target gene expression, whereas knockdown of endogenous DAX-1 significantly increases T7-induced LXR alpha target gene expression in HepG2 cells. Finally, overexpression of DAX-1 in mouse liver decreases T7-induced LXR alpha target gene expression, liver triglyceride level, and lipid accumulation. Overall, this study suggests that DAX-1, a novel corepressor of LXR alpha, functions as a negative regulator of lipogenic enzyme gene expression in liver.	[Nedumaran, Balachandar; Kim, Gwang Sik; Lee, Young Chul; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biomed Sci, Kwangju 501746, South Korea; [Hong, Sungpyo; Yoon, Young-Sil; Koo, Seung-Hoi; Choi, Hueng-Sik] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Kim, Yong-Hoon; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea	Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Choi, HS (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, 300 Chunchun Dong, Suwon 440746, South Korea.	shkoo@med.skku.ac.kr	Nedumaran, Balachandar/V-9958-2019; Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	Ministry of Science and Technology [M10500000047-06J0000-04710]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported in part by the Korea Science and Engineering Foundation through the National Research Laboratory Program funded by the Ministry of Science and Technology Grant M10500000047-06J0000-04710.	Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Crawford PA, 1998, MOL CELL BIOL, V18, P2949, DOI 10.1128/MCB.18.5.2949; Delvecchio CJ, 2008, J ENDOCRINOL, V197, P121, DOI 10.1677/JOE-07-0525; Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gobinet J, 2005, BIOCHEMISTRY-US, V44, P6312, DOI 10.1021/bi047308d; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Holter E, 2002, MOL ENDOCRINOL, V16, P515, DOI 10.1210/me.16.3.515; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Hu X, 2003, MOL ENDOCRINOL, V17, P1019, DOI 10.1210/me.2002-0399; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101; Iyer AK, 2004, MOL GENET METAB, V83, P60, DOI 10.1016/j.ymgme.2004.07.018; Iyer AK, 2006, MOL ENDOCRINOL, V20, P2326, DOI 10.1210/me.2005-0383; Jakobsson T, 2007, BIOCHEM J, V405, P31, DOI 10.1042/BJ20070004; Kawajiri K, 2003, MOL ENDOCRINOL, V17, P994, DOI 10.1210/me.2002-0360; Kim GS, 2008, BIOCHEM BIOPH RES CO, V370, P264, DOI 10.1016/j.bbrc.2008.03.098; Kim KH, 2009, MOL ENDOCRINOL, V23, P466, DOI 10.1210/me.2008-0295; Kim SW, 2003, MOL CELL BIOL, V23, P3583, DOI 10.1128/MCB.23.10.3583-3592.2003; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2002, MOL ENDOCRINOL, V16, P506, DOI 10.1210/me.16.3.506; Moore JMR, 2004, J BIOL CHEM, V279, P27584, DOI 10.1074/jbc.M403453200; Nedumaran B, 2009, J BIOL CHEM, V284, P27511, DOI 10.1074/jbc.M109.034660; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Smith CA, 2000, J MOL ENDOCRINOL, V24, P23, DOI 10.1677/jme.0.0240023; Song KH, 2004, MOL ENDOCRINOL, V18, P1929, DOI 10.1210/me.2004-0043; Sugita J, 2001, GENE, V280, P67, DOI 10.1016/S0378-1119(01)00739-9; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Wang DS, 2002, BIOCHEM BIOPH RES CO, V297, P632, DOI 10.1016/S0006-291X(02)02252-0; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Yamamoto T, 2007, J BIOL CHEM, V282, P11687, DOI 10.1074/jbc.M611911200; Yoon YS, 2009, J BIOL CHEM, V284, P10446, DOI 10.1074/jbc.M900096200; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang H, 2000, J BIOL CHEM, V275, P39855, DOI 10.1074/jbc.C000567200; Zhou J, 2008, MOL ENDOCRINOL, V22, P1521, DOI 10.1210/me.2007-0273	44	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9221	9232		10.1074/jbc.M109.073650	http://dx.doi.org/10.1074/jbc.M109.073650			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080977	Green Published, hybrid			2022-12-27	WOS:000275553700071
J	Sun, W; Jin, JF; Xu, RJ; Hu, W; Szulc, ZM; Bielawski, J; Obeid, LM; Mao, CG				Sun, Wei; Jin, Junfei; Xu, Ruijuan; Hu, Wei; Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui			Substrate Specificity, Membrane Topology, and Activity Regulation of Human Alkaline Ceramidase 2 (ACER2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; ACID CERAMIDASE; GOLGI-APPARATUS; SPHINGOSINE; ENZYME; PUMP	Human alkaline ceramidase 2 (ACER2) plays an important role in cellular responses by regulating the hydrolysis of ceramides in cells. Here we report its biochemical characterization, membrane topology, and activity regulation. Recombinant ACER2 was expressed in yeast mutant cells (Delta ypc1 Delta ydc1) that lack endogenous ceramidase activity, and microsomes from ACER2-expressiong yeast cells were used to biochemically characterize ACER2. ACER2 catalyzed the hydrolysis of various ceramides and followed Michaelis-Menten kinetics. ACER2 required Ca2+ for both its in vitro and cellular activities. ACER2 has 7 putative transmembrane domains, and its amino (N) and carboxyl (C) termini were found to be oriented in the lumen of the Golgi complex and cytosol, respectively. ACER2 mutant (ACER2 Delta N36) lacking the N-terminal tail (the first 36 amino acid residues) exhibited undetectable activity and was mislocalized to the endoplasmic reticulum, suggesting that the N-terminal tail is necessary for both ACER2 activity and Golgi localization. ACER2 mutant (ACER2 Delta N13) lacking the first 13 residues was also mislocalized to the endoplasmic reticulum although it retained ceramidase activity. Overexpression of ACER2, ACER2 Delta N13, but not ACER2 Delta N36 increased the release of sphingosine 1-phosphate from cells, suggesting that its mislocalization does not affect the ability of ACER2 to regulate sphingosine 1-phosphate secretion. However, overexpression of ACER2 but not ACER2 Delta N13 or ACER2 Delta N36 inhibited the glycosylation of integrin beta 1 subunit and Lamp1, suggesting that its mistargeting abolishes the ability of ACER2 to regulation protein glycosylation. These data suggest that ACER2 has broad substrate specificity and requires Ca2+ for its activity and that ACER2 has the cytosolic C terminus and luminal N terminus, which are essential for its activity, correct cellular localization, and regulation for protein glycosylation.	[Sun, Wei; Jin, Junfei; Xu, Ruijuan; Hu, Wei; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Med, Div Gen Internal Med, Charleston, SC 29425 USA; [Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Ralph H Johnson Vet Affairs Hosp, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mao, CG (corresponding author), Med Univ S Carolina, Dept Med, Div Gen Internal Med, 114 Doughty St,Rm 646,STB,POB 250779, Charleston, SC 29425 USA.	maoc@musc.edu	xu, rui/GRX-5734-2022	obeid, lina/0000-0002-0734-0847; Jin, Junfei/0000-0002-9237-9024	National Institutes of Health [R01CA104834]; Veterans Affairs Merit award; NATIONAL CANCER INSTITUTE [R01CA104834] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA104834 (to C. M.) and a Veterans Affairs Merit award (to L.M.O.).	Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 2002, J LIPID RES, V43, P141; el Bawab Samer, 2002, Subcell Biochem, V36, P187; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; Lin P, 1999, J CELL BIOL, V145, P279, DOI 10.1083/jcb.145.2.279; Luo X, 2008, BIOCHEM J, V414, P399, DOI 10.1042/BJ20080948; Maceyka M, 2005, PROSTAG OTH LIPID M, V77, P15, DOI 10.1016/j.prostaglandins.2004.09.010; Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876; Mao CG, 2001, J BIOL CHEM, V276, P26577, DOI 10.1074/jbc.M102818200; Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Spiegel S, 1999, J LEUKOCYTE BIOL, V65, P341, DOI 10.1002/jlb.65.3.341; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Sun W, 2009, FASEB J, V23, P656, DOI 10.1096/fj.08-115634; Usta J, 2001, BIOCHEMISTRY-US, V40, P9657, DOI 10.1021/bi010535k; Van Baelen K, 2003, BIOCHEM BIOPH RES CO, V306, P430, DOI 10.1016/S0006-291X(03)00977-X; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P1779, DOI 10.1093/bioinformatics/btn309; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com	26	38	41	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8995	9007		10.1074/jbc.M109.069203	http://dx.doi.org/10.1074/jbc.M109.069203			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089856	hybrid, Green Published			2022-12-27	WOS:000275553700051
J	Huang, YJ; Chen, IC; Yu, CM; Lee, YC; Hsu, HJ; Ching, ATC; Chang, HJ; Yang, AS				Huang, Yi-Jen; Chen, Ing-Chien; Yu, Chung-Ming; Lee, Yu-Ching; Hsu, Hung-Ju; Ching, Anna Tung Ching; Chang, Hung-Ju; Yang, An-Suei			Engineering Anti-vascular Endothelial Growth Factor Single Chain Disulfide-stabilized Antibody Variable Fragments (sc-dsFv) with Phage-displayed sc-dsFv Libraries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TRANSLOCATION CHANNEL; SIGNAL SEQUENCES; FV FRAGMENTS; FILAMENTOUS PHAGE; ESCHERICHIA-COLI; AFFINITY; DOMAINS; FAB; MACHINERY; EVOLUTION	Phage display of antibody fragments from natural or synthetic antibody libraries with the single chain constructs combining the variable fragments (scFv) has been one of the most prominent technologies in antibody engineering. However, the nature of the artificial single chain constructs results in unstable proteins expressed on the phage surface or as soluble proteins secreted in the bacterial culture medium. The stability of the variable domain structures can be enhanced with interdomain disulfide bond, but the single chain disulfide-stabilized constructs (sc-dsFv) have yet to be established as a feasible format for bacterial phage display due to diminishing expression levels on the phage surface in known phage display systems. In this work, biological combinatorial searches were used to establish that the c-region of the signal sequence is critically responsible for effective expression and functional folding of the sc-dsFv on the phage surface. The optimum signal sequences increase the expression of functional sc-dsFv by 2 orders of magnitude compared with wild-type signal sequences, enabling the construction of phage-displayed synthetic antivascular endothelial growth factor sc-dsFv libraries. Comparison of the scFv and sc-dsFv variants selected from the phage-displayed libraries for vascular endothelial growth factor binding revealed the sequence preference differences resulting from the interdomain disulfide bond. These results underlie a new phage display format for antibody fragments with all the benefits from the scFv format but without the downside due to the instability of the dimeric interface in scFv.	[Huang, Yi-Jen; Chen, Ing-Chien; Yu, Chung-Ming; Lee, Yu-Ching; Hsu, Hung-Ju; Ching, Anna Tung Ching; Chang, Hung-Ju; Yang, An-Suei] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Huang, Yi-Jen] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan; [Hsu, Hung-Ju] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Chang, Hung-Ju] Acad Sinica, Taiwan Int Grad Program, Taipei 115, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Defense Medical Center; Academia Sinica - Taiwan	Yang, AS (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sect 2, Taipei 115, Taiwan.	yangas@gate.sinica.edu.tw	Ching, Ana T. C./J-4718-2015	Yang, An-Suei/0000-0002-4699-873X; Chang, Hung-Ju/0000-0003-2062-9212	National Health Research Institutes [NHRI-EX98-9802EI]; National Science Council [96-2311-B-001-030-MY3]; Genomics Research Center at Academia Sinica, Taipei, Taiwan	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council(Ministry of Science and Technology, Taiwan); Genomics Research Center at Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	This work was supported by National Health Research Institutes Grant NHRI-EX98-9802EI, National Science Council Grant 96-2311-B-001-030-MY3, and the Genomics Research Center at Academia Sinica, Taipei, Taiwan.	BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Bradbury ARM, 2004, J IMMUNOL METHODS, V290, P29, DOI 10.1016/j.jim.2004.04.007; BREITLING F, 1991, GENE, V104, P147, DOI 10.1016/0378-1119(91)90244-6; BRINKMANN U, 1995, J IMMUNOL METHODS, V182, P41, DOI 10.1016/0022-1759(95)00016-4; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chang HJ, 2009, STRUCTURE, V17, P620, DOI 10.1016/j.str.2009.01.011; Chen CT, 2008, BIOINFORMATICS, V24, P2691, DOI 10.1093/bioinformatics/btn538; Clerico EM, 2008, BIOPOLYMERS, V90, P307, DOI 10.1002/bip.20856; DELANO WL, 2004, PHAGE DISPLAY, P85; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; Hsu HJ, 2008, J BIOL CHEM, V283, P12343, DOI 10.1074/jbc.M708843200; Hsu HJ, 2006, STRUCTURE, V14, P1499, DOI 10.1016/j.str.2006.08.006; Hust M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-14; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Jestin JL, 2001, RES MICROBIOL, V152, P187, DOI 10.1016/S0923-2508(01)01191-3; Kim SJ, 2002, DEV CELL, V2, P207, DOI 10.1016/S1534-5807(01)00120-4; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Luirink J, 2004, BBA-MOL CELL RES, V1694, P17, DOI 10.1016/j.bbamcr.2004.03.013; MARKS JD, 1992, BIO-TECHNOL, V10, P779, DOI 10.1038/nbt0792-779; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0; Michnick SW, 2008, NAT CHEM BIOL, V4, P326, DOI 10.1038/nchembio0608-326; RAAG R, 1995, FASEB J, V9, P73, DOI 10.1096/fasebj.9.1.7821762; Rajagopal V, 1997, PROTEIN ENG, V10, P1453, DOI 10.1093/protein/10.12.1453; RAPOZA MP, 1993, J BACTERIOL, V175, P1856, DOI 10.1128/JB.175.6.1856-1859.1993; Reiter Y, 1995, PROTEIN ENG, V8, P1323, DOI 10.1093/protein/8.12.1323; Reiter Y, 1996, NAT BIOTECHNOL, V14, P1239, DOI 10.1038/nbt1096-1239; Rothlisberger D, 2005, J MOL BIOL, V347, P773, DOI 10.1016/j.jmb.2005.01.053; Sidhu SS, 2004, PHAGE DISPLAY, V1st, P27; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Steiner D, 2006, NAT BIOTECHNOL, V24, P823, DOI 10.1038/nbt1218; Thie H, 2008, NEW BIOTECHNOL, V25, P49, DOI 10.1016/j.nbt.2008.01.001; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; Wark KL, 2006, ADV DRUG DELIVER REV, V58, P657, DOI 10.1016/j.addr.2006.01.025; Winter G, 1998, FEBS LETT, V430, P92, DOI 10.1016/S0014-5793(98)00628-0; Worn A, 1999, BIOCHEMISTRY-US, V38, P8739, DOI 10.1021/bi9902079; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; YOKOTA T, 1992, CANCER RES, V52, P3402; Young NM, 1995, FEBS LETT, V377, P135, DOI 10.1016/0014-5793(95)01325-3; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	47	16	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7880	7891		10.1074/jbc.M109.061457	http://dx.doi.org/10.1074/jbc.M109.061457			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068035	hybrid, Green Published			2022-12-27	WOS:000275413800005
J	Tsukamoto, H; Terakita, A; Shichida, Y				Tsukamoto, Hisao; Terakita, Akihisa; Shichida, Yoshinori			A Pivot between Helices V and VI near the Retinal-binding Site Is Necessary for Activation in Rhodopsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; MOVEMENT; IDENTIFICATION; ABILITY; PIGMENT; FAMILY; OPSIN	Rhodopsins are photoreceptor proteins that have diverged from ligand-binding G protein-coupled receptors (GPCRs). Unlike other GPCRs, rhodopsins contain an intrinsic antagonist, 11-cis-retinal, which is converted to the agonist all-transretinal upon absorption of a photon. Through evolution, vertebrate rhodopsins have lost the ability of direct binding to the agonist, but some invertebrate and vertebrate non-visual rhodopsins have retained this ability. Here, we investigated the difference in the agonist-binding state between these rhodopsins to further our understanding of the structural and functional diversity of rhodopsins. Mutational analyses of agonist-binding rhodopsin showed that replacement of Ala-269, one of the residues constituting the antagonist-binding site, with bulky amino acids resulted in a large spectral shift in its active state and a great reduction in G protein activity, whereas these were rescued by subsequent replacement of Phe-208 with smaller amino acids. Although similar replacements in vertebrate rhodopsin did not cause a spectral shift in the active state, a similar reduction in and recovery of G protein activity was observed. Therefore, the agonist is located close to Ala-269 in the agonist-binding rhodopsin, but not in vertebrate rhodopsins, and Ala-269 with Phe-208 acts as a pivot for the formation of the G protein-activating state in both rhodopsins. The positions corresponding to Ala-269 and Phe-208 in other GPCRs have been reported to form part of an agonist-binding site. Therefore, an agonist-binding rhodopsin has the molecular architecture of the agonist-binding site similar to that of a general GPCR, whereas vertebrate rhodopsins changed the architecture, resulting in loss of agonist binding during molecular evolution.	[Tsukamoto, Hisao; Terakita, Akihisa; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan	Kyoto University	Shichida, Y (corresponding author), Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto 6068502, Japan.	shichida@rh.biophys.kyoto-u.ac.jp		Terakita, Akihisa/0000-0002-8379-8913	Japanese Ministry of Education, Science, Sports, and Culture; Yamada Science Foundation; Japan Society for the Promotion of Science for Young Scientists	Japanese Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Yamada Science Foundation; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid for scientific research from the Japanese Ministry of Education, Science, Sports, and Culture (to Y. S. and A. T.) and by the Yamada Science Foundation (to A. T.).; Supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists.	Ahuja S, 2009, J BIOL CHEM, V284, P10190, DOI 10.1074/jbc.M805725200; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Blackshaw S, 1997, J NEUROSCI, V17, P8083; Borhan B, 2000, SCIENCE, V288, P2209, DOI 10.1126/science.288.5474.2209; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; DIXON RAF, 1988, COLD SPRING HARB SYM, V53, P487, DOI 10.1101/SQB.1988.053.01.056; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Johnson MP, 1997, MOL BRAIN RES, V49, P1, DOI 10.1016/S0169-328X(97)00115-0; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Koyanagi M, 2004, P NATL ACAD SCI USA, V101, P6687, DOI 10.1073/pnas.0400819101; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Patel AB, 2004, P NATL ACAD SCI USA, V101, P10048, DOI 10.1073/pnas.0402848101; Roth BL, 1997, MOL PHARMACOL, V52, P259, DOI 10.1124/mol.52.2.259; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256; STRADER CD, 1989, J BIOL CHEM, V264, P13572; Struthers M, 1999, BIOCHEMISTRY-US, V38, P6597, DOI 10.1021/bi9902384; Terakita A, 2004, NAT STRUCT MOL BIOL, V11, P284, DOI 10.1038/nsmb731; Tsukamoto H, 2005, P NATL ACAD SCI USA, V102, P6303, DOI 10.1073/pnas.0500378102; Tsukamoto H, 2009, J BIOL CHEM, V284, P20676, DOI 10.1074/jbc.M109.016212	26	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7351	7357		10.1074/jbc.M109.078709	http://dx.doi.org/10.1074/jbc.M109.078709			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053991	Green Published, hybrid			2022-12-27	WOS:000275415600047
J	Vina-Vilaseca, A; Sorkin, A				Vina-Vilaseca, Arnau; Sorkin, Alexander			Lysine 63-linked Polyubiquitination of the Dopamine Transporter Requires WW3 and WW4 Domains of Nedd4-2 and UBE2D Ubiquitin-conjugating Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; EGF RECEPTOR; NA+ CHANNEL; LIGASE; DEGRADATION; ENDOCYTOSIS; INTERNALIZATION; UBIQUITYLATION; TRAFFICKING; ISOFORMS	RNA interference screen previously revealed that a HECT-domain E3 ubiquitin ligase, neuronal precursor cell expressed, developmentally down-regulated 4-2 (Nedd4-2), is necessary for ubiquitination and endocytosis of the dopamine transporter (DAT) induced by the activation of protein kinase C (PKC). To further confirm the role of Nedd4-2 in DAT ubiquitination and endocytosis, we demonstrated that the depletion of Nedd4-2 by two different small interfering RNA ( siRNA) duplexes suppressed PKC-dependent ubiquitination and endocytosis of DAT in human and porcine cells, whereas knock-down of a highly homologous E3 ligase, Nedd4-1, had no effect on DAT. The abolished DAT ubiquitination in Nedd4-2-depleted cells was rescued by expression of recombinant Nedd4-2. Moreover, overexpression of Nedd4-2 resulted in increased PKC-dependent ubiquitination of DAT. Mutational inactivation of the HECT domain of Nedd4-2 inhibited DAT ubiquitination and endocytosis. Structure-function analysis of Nedd4-2-mediated DAT ubiquitination revealed that the intact WW4 domain and to a lesser extent WW3 domain are necessary for PKC-dependent DAT ubiquitination. Moreover, a fragment of the Nedd4-2 molecule containing WW3, WW4, and HECT domains was sufficient for fully potentiating PKC-dependent ubiquitination of DAT. Analysis of DAT ubiquitination using polyubiquitin chain-specific antibodies showed that DAT is mainly conjugated with Lys(63)-linked ubiquitin chains. siRNA analysis demonstrated that this polyubiquitination is mediated by Nedd4-2 cooperation with UBE2D and UBE2L3 E2 ubiquitin-conjugating enzymes. The model is proposed whereby each ubiquitinated DAT molecule is modified by a single four-ubiquitin Lys(63)-linked chain that can be conjugated to various lysine residues of DAT.	[Vina-Vilaseca, Arnau; Sorkin, Alexander] Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80010 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Sorkin, A (corresponding author), Univ Colorado, Denver Sch Med, Dept Pharmacol, Aurora, CO 80010 USA.	alexander.sorkin@ucdenver.edu	Vina-Vilaseca, Arnau/O-1779-2015	Vina-Vilaseca, Arnau/0000-0003-0447-5268; Sorkin, Alexander/0000-0002-4446-1920	NIDA, National Institutes of Health [DA014204]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014204] Funding Source: NIH RePORTER	NIDA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA014204 from the NIDA.	Almaca J, 2009, PFLUG ARCH EUR J PHY, V458, P713, DOI 10.1007/s00424-009-0660-4; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; Asher C, 2003, BBA-BIOMEMBRANES, V1612, P59, DOI 10.1016/S0005-2736(03)00083-X; Belgareh-Touze N, 2008, BIOCHEM SOC T, V36, P791, DOI 10.1042/BST0360791; Bhandari D, 2009, MOL BIOL CELL, V20, P1324, DOI 10.1091/mbc.E08-03-0308; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Conkright JJ, 2010, AM J RESP CELL MOL, V42, P181, DOI 10.1165/rcmb.2009-0058OC; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Debonneville C, 2004, MOL CELL BIOL, V24, P2397, DOI 10.1128/MCB.24.6.2397-2409.2004; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Edinger RS, 2009, J BIOL CHEM, V284, P150, DOI 10.1074/jbc.M807358200; Ekberg J, 2007, J BIOL CHEM, V282, P12135, DOI 10.1074/jbc.M609385200; Erpapazoglou Z, 2008, TRAFFIC, V9, P1372, DOI 10.1111/j.1600-0854.2008.00766.x; Flores SY, 2003, PFLUG ARCH EUR J PHY, V446, P334, DOI 10.1007/s00424-003-1027-x; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Itani OA, 2005, AM J PHYSIOL-RENAL, V289, pF334, DOI 10.1152/ajprenal.00394.2004; Itani OA, 2003, AM J PHYSIOL-RENAL, V285, pF916, DOI 10.1152/ajprenal.00203.2003; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kaliszewski P, 2008, ACTA BIOCHIM POL, V55, P649; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Lee JRE, 2009, J BIOL CHEM, V284, P32126, DOI 10.1074/jbc.M109.048629; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Mosesson Y, 2006, ISR MED ASSOC J, V8, P233; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nikko E, 2008, EMBO REP, V9, P1216, DOI 10.1038/embor.2008.199; Paiva S, 2009, J BIOL CHEM, V284, P19228, DOI 10.1074/jbc.M109.008318; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V294, pF1157, DOI 10.1152/ajprenal.00339.2007; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Umebayashi K, 2008, MOL BIOL CELL, V19, P3454, DOI 10.1091/mbc.E07-10-0988; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Vecchione A, 2003, MOL CELL BIOL, V23, P3363, DOI 10.1128/MCB.23.9.3363-3372.2003; Woelk T, 2006, NAT CELL BIOL, V8, P1246, DOI 10.1038/ncb1484; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	58	53	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7645	7656		10.1074/jbc.M109.058990	http://dx.doi.org/10.1074/jbc.M109.058990			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051513	Green Published, hybrid			2022-12-27	WOS:000275415600075
J	Hanson, KA; Kim, SH; Wassarman, DA; Tibbetts, RS				Hanson, Keith A.; Kim, Sang Hwa; Wassarman, David A.; Tibbetts, Randal S.			Ubiquilin Modifies TDP-43 Toxicity in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; FUNCTIONAL IMPLICATIONS; MUTATIONS; NEURODEGENERATION; PROTEASOME; PROTEINS; PHOSPHORYLATION; IDENTIFICATION; PRESENILIN; MOUSE	TDP-43 (43-kDa TAR DNA-binding protein) is a major constituent of ubiquitin-positive cytosolic aggregates present in neurons of patients with amyotrophic lateral sclerosis (ALS) and ubiquitin-positive fronto-temporal lobar degeneration (FTLD-U). Inherited mutations in TDP-43 have been linked to familial forms of ALS, indicating a key role for TDP-43 in disease pathogenesis. Here, we describe a Drosophila melanogaster model of TDP-43 proteinopathy. Expression of wild-type human TDP-43 protein in Drosophila motor neurons led to motor dysfunction and dramatic reduction of life span. Interestingly, coexpression of ubiquilin 1, a previously identified TDP-43-interacting protein with suspected functions in autophagy and proteasome targeting, reduced steady-state TDP-43 expression but enhanced the severity of TDP-43 phenotypes. Finally, ectopically expressed TDP-43 was largely localized to motor neuron nuclei, suggesting that expression of wild-type TDP-43 alone is detrimental even in the absence of cytosolic aggregation. Our findings demonstrate that TDP-43 exerts cell-autonomous neurotoxicity in Drosophila and further imply that dose-dependent alterations of TDP-43 nuclear function may underlie motor neuron death in ALS.	[Hanson, Keith A.; Kim, Sang Hwa; Wassarman, David A.; Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [CA124722, NS059001]; American Cancer Society; Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA124722 (to R. S. T.) and NS059001 (to D. A. W.). This work was also supported by grants from the American Cancer Society and a Shaw Scientist Award from the Greater Milwaukee Foundation (to R. S. T.).	Andersen PM, 2003, AMYOTROPH LATERAL SC, V4, P62, DOI 10.1080/14660820310011700; Ayala YM, 2008, P NATL ACAD SCI USA, V105, P3785, DOI 10.1073/pnas.0800546105; Banks GT, 2008, MAMM GENOME, V19, P299, DOI 10.1007/s00335-008-9117-x; Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Fiesel FC, 2010, EMBO J, V29, P209, DOI 10.1038/emboj.2009.324; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Hasegawa M, 2008, ANN NEUROL, V64, P60, DOI 10.1002/ana.21425; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132; Kim SH, 2009, J BIOL CHEM, V284, P8083, DOI 10.1074/jbc.M808064200; Ko HS, 2004, FEBS LETT, V566, P110, DOI 10.1016/j.febslet.2004.04.031; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Mitsumoto H., 1998, AMYOTROPHIC LATERAL; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; R Core Team, 2020, R LANG ENV STAT COMP; Rasband W, 2009, IMAGEJ; Rimkus SA, 2008, GENE DEV, V22, P1205, DOI 10.1101/gad.1639608; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; THERNEAU T, 2009, SURVIVAL R PACKAGE V; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wegorzewska I, 2009, P NATL ACAD SCI USA, V106, P18809, DOI 10.1073/pnas.0908767106; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930	31	107	108	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11068	11072		10.1074/jbc.C109.078527	http://dx.doi.org/10.1074/jbc.C109.078527			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154090	hybrid, Green Published			2022-12-27	WOS:000276286200009
J	Kee, Y; Yang, KL; Cohn, MA; Haas, W; Gygi, SP; D'Andrea, AD				Kee, Younghoon; Yang, Kailin; Cohn, Martin A.; Haas, Wilhelm; Gygi, Steven P.; D'Andrea, Alan D.			WDR20 Regulates Activity of the USP12 center dot UAF1 Deubiquitinating Enzyme Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FANCONI-ANEMIA PATHWAY; PROTEASOME; UCH37; SUBUNIT	The UAF1 (Usp1-associated factor 1) protein binds and stimulates three deubiquitinating enzymes: USP1, USP12, and USP46. Although the USP1 center dot UAF1 complex is required for regulation of the Fanconi anemia (FA) DNA repair pathway, less is known about the USP12 center dot UAF1 and the USP46 center dot UAF1 complexes. To understand further the nature of the USP12 and USP46 complexes, we attempted to identify proteins that interact with the USP12 and USP46 deubiquitinating enzyme complexes. We identified WDR20, a WD40-repeat containing protein, as a common binding partner of UAF1, USP12, and USP46. Further analysis showed that WDR20 associates exclusively with USP12 and USP46, not with USP1. Furthermore, we demonstrate the purification of a ternary USP12 center dot UAF1 center dot WDR20 complex. Interestingly, and consistent with the binding assays, WDR20 stimulated the enzymatic activity of USP12 center dot UAF1, but not of USP1 center dot UAF1. Consistent with our previous report that USP12 and USP46 do not regulate the FA pathway, small interference RNA-mediated depletion of WDR20 protein did not affect the FA pathway or DNA damage responses. We provide a model in which WDR20 serves as a stimulatory subunit for preserving and regulating the activity of the subset of the UAF1 center dot USP complexes.	[Kee, Younghoon; Yang, Kailin; Cohn, Martin A.; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA; [Yang, Kailin] Harvard Univ, Sch Med, Leder Human Biol Program, Biol & Biomed Sci Program, Boston, MA 02115 USA; [Haas, Wilhelm; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	D'Andrea, AD (corresponding author), 44 Binney St, Boston, MA 02115 USA.	alan_dandrea@dfci.harvard.edu	Kee, Younghoon/J-4107-2019; Yang, Kailin/D-7966-2013; Classen, Scott/AAY-8176-2020; Yang, Kailin/L-2205-2013	Yang, Kailin/0000-0001-5968-6738; Cohn, Martin/0000-0002-2988-3009	National Institutes of Health [R01DK43889, R01HL52725, P01CA092584, U19A1067751]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725, R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK43889, R01HL52725, P01CA092584, and U19A1067751.	Borodovsky A, 2001, EMBO J, V20, P5187, DOI 10.1093/emboj/20.18.5187; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; KON N, 2009, ONCOGENE        1130, DOI DOI 10.1038/ONC.2009.427; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Lockington RA, 2002, MOL MICROBIOL, V43, P1173, DOI 10.1046/j.1365-2958.2002.02811.x; Massoumi R, 2006, CELL, V125, P665, DOI 10.1016/j.cell.2006.03.041; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Oestergaard VH, 2007, MOL CELL, V28, P798, DOI 10.1016/j.molcel.2007.09.020; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460	21	71	80	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11252	11257		10.1074/jbc.M109.095141	http://dx.doi.org/10.1074/jbc.M109.095141			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147737	Green Published, hybrid			2022-12-27	WOS:000276286200031
J	Nagai, Y; Nishimura, A; Tago, K; Mizuno, N; Itoh, H				Nagai, Yusuke; Nishimura, Akiyuki; Tago, Kenji; Mizuno, Norikazu; Itoh, Hiroshi			Ric-8B Stabilizes the alpha Subunit of Stimulatory G Protein by Inhibiting Its Ubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC DIVISION; SIGNAL-TRANSDUCTION; DROSOPHILA RIC-8; PLASMA-MEMBRANE; SYNEMBRYN; DEGRADATION; EXPRESSION; INTERACTS; RECEPTOR; GTP	The alpha subunit of stimulatory G protein (G alpha(s)) activates adenylyl cyclase, which catalyzes cAMP production, and regulates many physiological aspects, such as cardiac regulation and endocrine systems. Ric-8B (resistance to inhibitors of cholinesterase 8B) has been identified as the G alpha(s)-binding protein; however, its role in G(s) signaling remains obscure. In this study, we present evidence that Ric-8B specifically and positively regulates G(s) signaling by stabilizing the G alpha(s) protein. An in vitro biochemical study suggested that Ric-8B does not possess guanine nucleotide exchange factor activity. However, knockdown of Ric-8B attenuated beta-adrenergic agonist-induced cAMP accumulation, indicating that Ric-8B positively regulates G(s) signaling. Interestingly, overexpression and knockdown of Ric-8B resulted in an increase and a decrease in the G alpha(s) protein, respectively, without affecting the G alpha(s) mRNA level. We found that the G alpha(s) protein is ubiquitinated and that this ubiquitination is inhibited by Ric-8B. This Ric-8B-mediated inhibition of G alpha(s) ubiquitination requires interaction between Ric-8B and G alpha(s) because Ric-8B splicing variants, which are defective for G alpha(s) binding, failed to inhibit the ubiquitination. Taken together, these results suggest that Ric-8B plays a critical and specific role in the control of G alpha(s) protein levels by modulating G alpha(s) ubiquitination and positively regulates G(s) signaling.	[Nagai, Yusuke; Nishimura, Akiyuki; Tago, Kenji; Mizuno, Norikazu; Itoh, Hiroshi] Nara Inst Sci & Technol, Dept Cell Biol, Grad Sch Biol Sci, Nara 6300192, Japan	Nara Institute of Science & Technology	Itoh, H (corresponding author), Nara Inst Sci & Technol, Dept Cell Biol, Grad Sch Biol Sci, 8916-5 Takayama, Nara 6300192, Japan.	hitoh@bs.naist.jp			Ministry of Education, Culture, Sports, Science, and Technology [17079006]	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Scientific Research on Priority Areas 17079006 from the Ministry of Education, Culture, Sports, Science, and Technology.	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; CHANG FH, 1989, J BIOL CHEM, V264, P5352; Couwenbergs C, 2004, CURR BIOL, V14, P1871, DOI 10.1016/j.cub.2004.09.059; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Fischer T, 2003, P NATL ACAD SCI USA, V100, P8270, DOI 10.1073/pnas.1432965100; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; He L, 2003, SCIENCE, V299, P710, DOI 10.1126/science.1079694; ITOH H, 1991, J BIOL CHEM, V266, P16226; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Kim BY, 2007, MOL BIOL CELL, V18, P1129, DOI 10.1091/mbc.E06-09-0787; Klattenhoff C, 2003, J CELL PHYSIOL, V195, P151, DOI 10.1002/jcp.10300; Kozasa Tohru, 2003, V237, P21; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; LEVIS MJ, 1992, J CELL BIOL, V119, P1297, DOI 10.1083/jcb.119.5.1297; Marotti LA, 2002, BIOCHEMISTRY-US, V41, P5067, DOI 10.1021/bi015940q; Miller KG, 2000, NEURON, V27, P289, DOI 10.1016/S0896-6273(00)00037-4; Miller KG, 2000, GENETICS, V156, P1649; Nagayoshi S, 2008, DEVELOPMENT, V135, P159, DOI 10.1242/dev.009050; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Perez-Oliva AB, 2009, J BIOL CHEM, V284, P31714, DOI 10.1074/jbc.M109.028100; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Von Dannecker LEC, 2005, J NEUROSCI, V25, P3793, DOI 10.1523/JNEUROSCI.4595-04.2005; Von Dannecker LEC, 2006, P NATL ACAD SCI USA, V103, P9310, DOI 10.1073/pnas.0600697103; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	35	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11114	11120		10.1074/jbc.M109.063313	http://dx.doi.org/10.1074/jbc.M109.063313			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20133939	Green Published, hybrid			2022-12-27	WOS:000276286200016
J	Sung, B; Park, B; Yadav, VR; Aggarwal, BB				Sung, Bokyung; Park, Byoungduck; Yadav, Vivek R.; Aggarwal, Bharat B.			RETRACTED: Celastrol, a Triterpene, Enhances TRAIL-induced Apoptosis through the Down-regulation of Cell Survival Proteins and Up-regulation of Death Receptors (Retracted article. See vol. 291, pg. 16920, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							CCAAT/ENHANCER-BINDING PROTEIN; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ENDOPLASMIC-RETICULUM STRESS; PROSTATE-CANCER CELLS; NF-KAPPA-B; PROTEASOME INHIBITOR; HOMOLOGOUS PROTEIN; DR5 EXPRESSION; GENE-PRODUCTS; HEAT-SHOCK	Whether celastrol, a triterpene from traditional Chinese medicine, can modulate the anticancer effects of TRAIL, the cytokine that is currently in clinical trial, was investigated. As indicated by assays that measure plasma membrane integrity, phosphatidylserine exposure, mitochondrial activity, and activation of caspase-8, caspase-9, and caspase-3, celastrol potentiated the TRAIL-induced apoptosis in human breast cancer cells, and converted TRAIL-resistant cells to TRAIL-sensitive cells. When examined for its mechanism, we found that the triterpene down-regulated the expression of cell survival proteins including cFLIP, IAP-1, Bcl-2, Bcl-xL, survivin, and XIAP and up-regulated Bax expression. In addition, we found that celastrol induced the cell surface expression of both the TRAIL receptors DR4 and DR5. This increase in receptors was noted in a wide variety of cancer cells including breast, lung, colorectal, prostate, esophageal, and pancreatic cancer cells, and myeloid and leukemia cells. Gene silencing of the death receptor abolished the effect of celastrol on TRAIL-induced apoptosis. Induction of the death receptor by the triterpenoid was found to be p53-independent but required the induction of CAAT/enhancer-binding protein homologous protein ( CHOP), inasmuch as gene silencing of CHOP abolished the induction of DR5 expression by celastrol and associated enhancement of TRAIL-induced apoptosis. We found that celastrol also induced reactive oxygen species (ROS) generation, and ROS sequestration inhibited celastrol-induced expression of CHOP and DR5, and consequent sensitization to TRAIL. Overall, our results demonstrate that celastrol can potentiate the apoptotic effects of TRAIL through down-regulation of cell survival proteins and up-regulation of death receptors via the ROS-mediated up-regulation of CHOP pathway.	[Sung, Bokyung; Park, Byoungduck; Yadav, Vivek R.; Aggarwal, Bharat B.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Cytokine Res Lab, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Aggarwal, BB (corresponding author), 1515 Holcombe Blvd,Box 143, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Aggarwal, Bharat B/G-3388-2013		National Institutes of Health [CA-16 672, CA-124787-01A2]; Clayton Foundation for Research; Center for Targeted Therapy of M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA124787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; Center for Targeted Therapy of M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Core Grant CA-16 672 and Program Project Grant CA-124787-01A2. This work was also supported by a grant from the Clayton Foundation for Research (to B. B. A.) and the Center for Targeted Therapy of M. D. Anderson Cancer Center.	Abbas S, 2007, CLIN CANCER RES, V13, P6769, DOI 10.1158/1078-0432.CCR-07-1536; Baritaki S, 2008, J IMMUNOL, V180, P6199, DOI 10.4049/jimmunol.180.9.6199; Bhardwaj A, 2003, J CLIN IMMUNOL, V23, P317, DOI 10.1023/A:1025319031417; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Cleren C, 2005, J NEUROCHEM, V94, P995, DOI 10.1111/j.1471-4159.2005.03253.x; Dyer MJS, 2007, J CLIN ONCOL, V25, P4505, DOI 10.1200/JCO.2007.13.1011; Fulda S, 2002, NAT MED, V8, P808, DOI 10.1038/nm735; He MF, 2009, J ETHNOPHARMACOL, V121, P61, DOI 10.1016/j.jep.2008.09.033; He Q, 2004, ONCOGENE, V23, P2554, DOI 10.1038/sj.onc.1207351; Hieronymus H, 2006, CANCER CELL, V10, P321, DOI 10.1016/j.ccr.2006.09.005; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Holen I, 2002, CANCER RES, V62, P1619; Huang YL, 2008, CANCER LETT, V264, P101, DOI 10.1016/j.canlet.2008.01.043; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167; Jung HW, 2007, EXP MOL MED, V39, P715, DOI 10.1038/emm.2007.78; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kim YH, 2008, FREE RADICAL BIO MED, V44, P1055, DOI 10.1016/j.freeradbiomed.2007.12.001; Kim Y, 2009, EUR J PHARMACOL, V612, P131, DOI 10.1016/j.ejphar.2009.03.071; Li H, 2005, EUR J PHARMACOL, V512, P231, DOI 10.1016/j.ejphar.2005.02.030; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Liu XG, 2007, CANCER RES, V67, P4981, DOI 10.1158/0008-5472.CAN-06-4274; Lu M, 2008, CANCER RES, V68, P1180, DOI 10.1158/0008-5472.CAN-07-2978; Ma YL, 2006, MOL CANCER THER, V5, P170, DOI 10.1158/1535-7163.MCT-05-0129; Mahalingam D, 2009, CANCER TREAT REV, V35, P280, DOI 10.1016/j.ctrv.2008.11.006; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pinna GF, 2004, BIOCHEM BIOPH RES CO, V322, P778, DOI 10.1016/j.bbrc.2004.07.186; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Ravi R, 2002, CANCER RES, V62, P1583; Ricci MS, 2007, CANCER CELL, V12, P66, DOI 10.1016/j.ccr.2007.05.006; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Sethi G, 2007, BLOOD, V109, P2727, DOI 10.1182/blood-2006-10-050807; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Sun SY, 2007, J BIOL CHEM, V282, P18800, DOI 10.1074/jbc.M611438200; Sung B, 2007, MOL PHARMACOL, V71, P1703, DOI 10.1124/mol.107.034512; Taniai M, 2004, CANCER RES, V64, P3517, DOI 10.1158/0008-5472.CAN-03-2770; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1999, ONCOGENE, V18, P6411, DOI 10.1038/sj.onc.1203025; Xu X, 2003, ANN RHEUM DIS, V62, P377, DOI 10.1136/ard.62.4.377; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yoshida T, 2009, MOL CANCER RES, V7, P1835, DOI 10.1158/1541-7786.MCR-09-0244; Zhang T, 2008, MOL CANCER THER, V7, P162, DOI 10.1158/1535-7163.MCT-07-0484; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	50	106	118	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11498	11507		10.1074/jbc.M109.090209	http://dx.doi.org/10.1074/jbc.M109.090209			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154087	Green Published, hybrid			2022-12-27	WOS:000276286200056
J	Welman, A; Serrels, A; Brunton, VG; Ditzel, M; Frame, MC				Welman, Arkadiusz; Serrels, Alan; Brunton, Valerie G.; Ditzel, Mark; Frame, Margaret C.			Two-color Photoactivatable Probe for Selective Tracking of Proteins and Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED FLUORESCENT PROTEIN; MONOMERIC RED; DROSOPHILA; EXPRESSION; CONVERSION; MIGRATION; DYNAMICS; SYSTEM; GENES	We report the development and application of photoactivatable Green Cherry (G(PA)C), the first genetically encoded "continuously red-photoactivatable green" two-color probe for live cell imaging. G(PA)C is unique in that it enables real-time tracking of selected subpopulations of proteins and organelles in the cell or of cells within tissues and whole organisms, with constant reference to the entire population of the probe. Using G(PA)C-zyxin as proof of utility, we obtained new insights into the dynamic movement of the cytoskeletal protein zyxin. We show that zyxin is continuously and rapidly recruited from the cytosol into established focal adhesions. It can also move rapidly within a given focal adhesion and "hop" between adjacent focal adhesions, emphasizing the dynamic nature of proteins within these structures. The in vivo utility of G(PA)C is exemplified by tracking hemocyte movements using a versatile transgenic Drosophila model engineered to express G(PA)C in tissues and cells of interest under the control of the GAL4-inducible promoter.	[Welman, Arkadiusz; Serrels, Alan; Brunton, Valerie G.; Ditzel, Mark; Frame, Margaret C.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Edinburgh EH4 2XR, Midlothian, Scotland	University of Edinburgh	Welman, A (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	a.welman@ed.ac.uk		Frame, Margaret/0000-0001-5882-1942	Cancer Research UK [C157/A9148]	Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK Grant C157/A9148.	Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Block MR, 2008, EUR J CELL BIOL, V87, P491, DOI 10.1016/j.ejcb.2008.02.012; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2005, TRENDS BIOTECHNOL, V23, P605, DOI 10.1016/j.tibtech.2005.10.005; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; Elliott David A., 2008, V420, P79, DOI 10.1007/978-1-59745-583-1_5; Giebel B, 1997, MECH DEVELOP, V63, P75, DOI 10.1016/S0925-4773(97)00029-4; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Jans DA, 1996, PHYSIOL REV, V76, P651, DOI 10.1152/physrev.1996.76.3.651; Lindberg U, 2008, SEMIN CANCER BIOL, V18, P2, DOI 10.1016/j.semcancer.2007.10.002; Lippincott-Schwartz J, 2009, TRENDS CELL BIOL, V19, P555, DOI 10.1016/j.tcb.2009.09.003; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; Matsuda T, 2008, NAT METHODS, V5, P339, DOI [10.1038/nmeth.1193, 10.1038/NMETH.1193]; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Silvius JR, 2002, J MEMBRANE BIOL, V190, P83, DOI 10.1007/s00232-002-1026-4; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Subramani S, 1998, PHYSIOL REV, V78, P171, DOI 10.1152/physrev.1998.78.1.171; Thomas SM, 1999, J CELL SCI, V112, P181; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Verkhusha VV, 2005, CHEM BIOL, V12, P279, DOI 10.1016/j.chembiol.2005.01.005; Welman A, 2000, ONCOGENE, V19, P4582, DOI 10.1038/sj.onc.1203818; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Worth DC, 2008, INT J BIOCHEM CELL B, V40, P2397, DOI 10.1016/j.biocel.2008.04.008; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	36	32	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11607	11616		10.1074/jbc.M110.102392	http://dx.doi.org/10.1074/jbc.M110.102392			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139076	Green Published, hybrid			2022-12-27	WOS:000276286200066
J	Arlehamn, CSL; Petrilli, V; Gross, O; Tschopp, J; Evans, TJ				Arlehamn, Cecilia S. Lindestam; Petrilli, Virginie; Gross, Olaf; Tschopp, Juerg; Evans, Tom J.			The Role of Potassium in Inflammasome Activation by Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; PSEUDOMONAS-AERUGINOSA; NALP3 INFLAMMASOME; CASPASE-1 ACTIVATION; GENE FAMILY; CELL-DEATH; IPAF; IDENTIFICATION; SECRETION; RECEPTOR	Many Gram-negative bacteria possess a type III secretion system (TTSS center dot) that can activate the NLRC4 inflammasome, process caspase-1 and lead to secretion of mature IL-1 beta. This is dependent on the presence of intracellular flagellin. Previous reports have suggested that this activation is independent of extracellular K+ and not accompanied by leakage of K+ from the cell, in contrast to activation of the NLRP3 inflammasome. However, non-flagellated strains of Pseudomonas aeruginosa are able to activate NLRC4, suggesting that formation of a pore in the cell membrane by the TTSS apparatus may be sufficient for inflammasome activation. Thus, we set out to determine if extracellular K+ influenced P. aeruginosa inflammasome activation. We found that raising extracellular K+ prevented TTSS NLRC4 activation by the non-flagellated P. aeruginosa strain PA103 Delta U Delta T at concentrations above 90mM, higher than those reported to inhibit NLRP3 activation. Infection was accompanied by efflux of K+ from a minority of cells as determined using the K+-sensitive fluorophore PBFI, but no formation of a leaky pore. We obtained exactly the same results following infection with Salmonella typhimurium, previously described as independent of extracellular K+. The inhibitory effect of raised extracellular K+ on NLRC4 activation thus reflects a requirement for a decrease in intracellular K+ for this inflammasome component as well as that described for NLRP3.	[Arlehamn, Cecilia S. Lindestam; Evans, Tom J.] Univ Glasgow, Div Immunol Infect & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Petrilli, Virginie; Gross, Olaf; Tschopp, Juerg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	University of Glasgow; University of Lausanne	Evans, TJ (corresponding author), Glasgow Biomed Res Ctr, Level 4,120 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	t.evans@clinmed.gla.ac.uk	Gross, Olaf/E-4570-2010; Petrilli, Virginie/ABI-8199-2020	Gross, Olaf/0000-0001-8660-3619; Petrilli, Virginie/0000-0001-8502-6979; Lindestam Arlehamn, Cecilia/0000-0001-7302-8002	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust.	Arora SK, 2000, INFECT IMMUN, V68, P1474, DOI 10.1128/IAI.68.3.1474-1479.2000; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Brodsky IE, 2009, SEMIN IMMUNOL, V21, P199, DOI 10.1016/j.smim.2009.05.007; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; CELADA A, 1984, J EXP MED, V160, P55, DOI 10.1084/jem.160.1.55; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Evans TJ, 2009, FUTURE MICROBIOL, V4, P65, DOI 10.2217/17460913.4.1.65; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; FROM WWW, THOMSON; Gurcel L, 2006, CELL, V126, P1135, DOI 10.1016/j.cell.2006.07.033; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Jacob T, 2002, INFECT IMMUN, V70, P6399, DOI 10.1128/IAI.70.11.6399-6408.2002; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2004, CURR BIOL, V14, P1929, DOI 10.1016/j.cub.2004.10.027; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mayor A, 2007, NAT IMMUNOL, V8, P497, DOI 10.1038/ni1459; McGuffie EM, 1998, INFECT IMMUN, V66, P2607, DOI 10.1128/IAI.66.6.2607-2613.1998; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; MINTA A, 1989, J BIOL CHEM, V264, P8171; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stirling FR, 2006, CELL MICROBIOL, V8, P1294, DOI 10.1111/j.1462-5822.2006.00710.x; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; WALEV I, 1995, EMBO J, V14, P1607, DOI 10.1002/j.1460-2075.1995.tb07149.x; Ye ZM, 2008, CURR OPIN IMMUNOL, V20, P3, DOI 10.1016/j.coi.2008.01.003; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	43	78	86	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10508	10518		10.1074/jbc.M109.067298	http://dx.doi.org/10.1074/jbc.M109.067298			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20097760	hybrid, Green Published			2022-12-27	WOS:000276264600037
J	Chen, RL; Chou, YC; Lan, YJ; Huang, TS; Shen, CKJ				Chen, Ruei-Lin; Chou, Yu-Chi; Lan, Yii-Jenq; Huang, Ting-Shuo; Shen, C. -K. James			Developmental Silencing of Human zeta-Globin Gene Expression Is Mediated by the Transcriptional Repressor RREB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEIN; LEUKEMIC CELL-LINE; ERYTHROID-DIFFERENTIATION; ERYTHROLEUKEMIA-CELLS; REGULATORY ELEMENT; PROMOTER; BINDING; LOCUS; ALPHA; MOUSE	The mammalian embryonic zeta-globin genes, including that of humans, are expressed at the early embryonic stage and then switched off during erythroid development. This autonomous silencing of the zeta-globin gene transcription is probably regulated by the cooperative work of various protein-DNA and protein-protein complexes formed at the zeta-globin promoter and its upstream enhancer (HS-40). We present data here indicating that a protein-binding motif, ZF2, contributes to the repression of the HS-40-regulated human zeta-promoter activity in erythroid cell lines and in transgenic mice. Combined site-directed mutagenesis and EMSA suggest that repression of the human zeta-globin promoter is mediated through binding of the zinc finger factor RREB1 to ZF2. This model is further supported by the observation that human zeta-globin gene transcription is elevated in the human erythroid K562 cell line or the primary erythroid culture upon RNA interference (RNAi)(2) knockdown of RREB1 expression. These data together suggest that RREB1 is a putative repressor for the silencing of the mammalian zeta-globin genes during erythroid development. Because zeta-globin is a powerful inhibitor of HbS polymerization, our experiments have provided a foundation for therapeutic up-regulation of zeta-globin gene expression in patients with severe hemoglobinopathies.	[Chen, Ruei-Lin; Chou, Yu-Chi; Shen, C. -K. James] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan; [Chen, Ruei-Lin; Shen, C. -K. James] Natl Yang Ming Univ, Dept Life Sci, Taipei 11221, Taiwan; [Chen, Ruei-Lin; Shen, C. -K. James] Natl Yang Ming Univ, Inst Genome Sci, Taipei 11221, Taiwan; [Lan, Yii-Jenq; Huang, Ting-Shuo] Chang Gung Univ, Sch Med, Tao Yuan 333, Taiwan; [Lan, Yii-Jenq] Chang Gung Mem Hosp, Dept Internal Med, Div Hematooncol, Keelung Branch, Chilung 204, Taiwan; [Huang, Ting-Shuo] Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Keelung Branch, Chilung 204, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Shen, CKJ (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	ckshen@imb.sinica.edu.tw	Huang, Ting-Shuo/ABD-3205-2021; shen, Che-Kun James/L-1343-2015	Huang, Ting-Shuo/0000-0002-2932-6878; 	National Health Research Institute [NHRI-EX99- 9514SI]; Academia Sinica (AS)	National Health Research Institute(National Health Research Institutes - Taiwan); Academia Sinica (AS)(Academia Sinica - Taiwan)	This work was supported in part by National Health Research Institute Grant NHRI-EX99- 9514SI and by Academia Sinica (AS).	BENZ EJ, 1980, P NATL ACAD SCI-BIOL, V77, P3509, DOI 10.1073/pnas.77.6.3509; Bieker JJ, 2005, MT SINAI J MED, V72, P333; BROWN BA, 1982, P NATL ACAD SCI-BIOL, V79, P2753, DOI 10.1073/pnas.79.9.2753; Bulger M, 2002, CURR OPIN GENET DEV, V12, P170, DOI 10.1016/S0959-437X(02)00283-6; Chen ZY, 2009, BLOOD CELL MOL DIS, V42, P144, DOI 10.1016/j.bcmd.2008.12.003; FRASER PJ, 1987, GENE DEV, V1, P855, DOI 10.1101/gad.1.8.855; GONG QH, 1991, MOL CELL BIOL, V11, P2558, DOI 10.1128/MCB.11.5.2558; Higgs DR, 2008, ADV GENET, V61, P143, DOI 10.1016/S0065-2660(07)00005-3; HIGGS DR, 1990, GENE DEV, V4, P1588, DOI 10.1101/gad.4.9.1588; Huang BL, 1998, P NATL ACAD SCI USA, V95, P14669, DOI 10.1073/pnas.95.25.14669; Kingsley PD, 2006, BLOOD, V107, P1665, DOI 10.1182/blood-2005-08-3097; Kobayashi M, 2007, J BIOCHEM, V142, P1, DOI 10.1093/jb/mvm122; LEDER A, 1992, DEVELOPMENT, V116, P1041; Li QL, 1997, P NATL ACAD SCI USA, V94, P2444, DOI 10.1073/pnas.94.6.2444; MACLEOD K, 1991, MOL CELL BIOL, V11, P4324, DOI 10.1128/MCB.11.9.4324; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mukhopadhyay NK, 2007, MOL ENDOCRINOL, V21, P2056, DOI 10.1210/me.2006-0503; ORKIN SH, 1992, BLOOD, V80, P575; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; RAICH N, 1995, EMBO J, V14, P801, DOI 10.1002/j.1460-2075.1995.tb07058.x; RUTHERFORD T, 1981, P NATL ACAD SCI-BIOL, V78, P348, DOI 10.1073/pnas.78.1.348; Sankaran VG, 2008, SCIENCE, V322, P1839, DOI 10.1126/science.1165409; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Shyu YC, 2005, MOL CELL BIOL, V25, P10365, DOI 10.1128/MCB.25.23.10365-10378.2005; Shyu YC, 2007, MOL CELL BIOL, V27, P2309, DOI 10.1128/MCB.01875-06; Stamatoyannopoulos G, 2001, MOL BASIS BLOOD DIS; STEIN B, 1989, MOL CELL BIOL, V9, P5169, DOI 10.1128/MCB.9.11.5169; STRAUSS EC, 1992, MOL CELL BIOL, V12, P2135, DOI 10.1128/MCB.12.5.2135; Tanabe O, 2002, EMBO J, V21, P3434, DOI 10.1093/emboj/cdf340; Tanabe O, 2007, EMBO J, V26, P2295, DOI 10.1038/sj.emboj.7601676; Tanimoto K, 2000, TRENDS CARDIOVAS MED, V10, P15, DOI 10.1016/S1050-1738(00)00035-9; Thiagalingam A, 1996, MOL CELL BIOL, V16, P5335; Trimborn T, 1999, GENE DEV, V13, P112, DOI 10.1101/gad.13.1.112; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; Wen SC, 2000, MOL CELL BIOL, V20, P1993, DOI 10.1128/MCB.20.6.1993-2003.2000; YU CY, 1990, MOL CELL BIOL, V10, P282, DOI 10.1128/MCB.10.1.282; ZHANG Q, 1995, MOL BIOL HEMOGLOBIN; ZHANG QY, 1993, MOL CELL BIOL, V13, P2298, DOI 10.1128/MCB.13.4.2298; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257; Zhao Q, 2006, BLOOD, V107, P2138, DOI 10.1182/blood-2005-06-2497; Zhou WL, 2000, MOL CELL BIOL, V20, P7662, DOI 10.1128/MCB.20.20.7662-7672.2000	42	12	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10189	10197		10.1074/jbc.M109.049130	http://dx.doi.org/10.1074/jbc.M109.049130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133935	Green Published, hybrid			2022-12-27	WOS:000276264600003
J	Czymai, T; Viemann, D; Sticht, C; Molema, G; Goebeler, M; Schmidt, M				Czymai, Tobias; Viemann, Dorothee; Sticht, Carsten; Molema, Grietje; Goebeler, Matthias; Schmidt, Marc			FOXO3 Modulates Endothelial Gene Expression and Function by Classical and Alternative Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTORS; NF-KAPPA-B; CELL-SURVIVAL; ANGIOGENESIS; CANCER; INHIBITION; APOPTOSIS; COMPLEX; PROTEIN; ACTIVATION	FOXO transcription factors represent targets of the phosphatidylinositol 3-kinase/protein kinase B survival pathway controlling important biological processes, such as cell cycle progression, apoptosis, vascular remodeling, stress responses, and metabolism. Recent studies suggested the existence of alternative mechanisms of FOXO-dependent gene expression beyond classical binding to a FOXO-responsive DNA-binding element (FRE). Here we analyzed the relative contribution of those mechanisms to vascular function by comparing the transcriptional and cellular responses to conditional activation of FOXO3 and a corresponding FRE-binding mutant in human primary endothelial cells. We demonstrate that FOXO3 controls expression of vascular remodeling genes in an FRE-dependent manner. In contrast, FOXO3-induced cell cycle arrest and apoptosis occurs independently of FRE binding, albeit FRE-dependent gene expression augments the proapoptotic response. These findings are supported by bioinformatical analysis, which revealed a statistical overrepresentation of cell cycle regulators and apoptosis-related genes in the group of co-regulated genes. Molecular analysis of FOXO3-induced endothelial apoptosis excluded modulators of the extrinsic death receptor pathway and demonstrated important roles for the BCL-2 family members BIM and NOXA in this process. Although NOXA essentially contributed to FRE-dependent apoptosis, BIM was effectively induced in the absence of FRE-binding, and small interfering RNA-mediated BIM depletion could rescue apoptosis induced by both FOXO3 mutants. These data suggest BIM as a critical cell type-specific mediator of FOXO3-induced endothelial apoptosis, whereas NOXA functions as an amplifying factor. Our study provides the first comprehensive analysis of alternatively regulated FOXO3 targets in relevant primary cells and underscores the importance of such genes for endothelial function and integrity.	[Sticht, Carsten] Heidelberg Univ, Univ Med Ctr Mannheim, Med Res Ctr, D-68167 Mannheim, Germany; [Czymai, Tobias; Goebeler, Matthias; Schmidt, Marc] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Dermatol, D-68167 Mannheim, Germany; [Viemann, Dorothee] Univ Munster, Dept Immunol, D-48149 Munster, Germany; [Viemann, Dorothee] Univ Munster, Dept Pediat, D-48149 Munster, Germany; [Molema, Grietje] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, NL-9713 GZ Groningen, Netherlands; [Goebeler, Matthias; Schmidt, Marc] Univ Giessen, Univ Hosp Giessen, Dept Dermatol, D-35392 Giessen, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Munster; University of Munster; University of Groningen; Justus Liebig University Giessen; University Hospital of Giessen & Marburg	Schmidt, M (corresponding author), Univ Hosp Giessen, Dept Dermatol, Gaffkystr 14, D-35392 Giessen, Germany.	schmidt.marc@gmx.de	Schmidt, Marc/E-8821-2010; Goebeler, Matthias/P-3612-2019; Goebeler, Matthias/F-7118-2013	Schmidt, Marc/0000-0002-8643-1615; Viemann, Dorothee/0000-0002-9009-3559; Molema, Grietje/0000-0002-4147-6676	Deutsche Forschungsgemeinschaft [880/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft "International Research Training Group Vascular Medicine" (Graduiertenkolleg 880/2) (to M. S. and M. G.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bernard DJ, 2001, RECENT PROG HORM RES, V56, P417, DOI 10.1210/rp.56.1.417; Bettini M, 2002, J IMMUNOL, V169, P1713, DOI 10.4049/jimmunol.169.4.1713; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buitenhuis M, 2005, BLOOD, V105, P4272, DOI 10.1182/blood-2004-12-4883; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Daly C, 2004, GENE DEV, V18, P1060, DOI 10.1101/gad.1189704; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Delpuech O, 2007, MOL CELL BIOL, V27, P4917, DOI 10.1128/MCB.01789-06; Dijkers PF, 2000, MOL CELL BIOL, V20, P9138, DOI 10.1128/MCB.20.24.9138-9148.2000; Dijkers PF, 2002, J CELL BIOL, V156, P531, DOI 10.1083/jcb.200108084; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hsieh WP, 2003, GENETICS, V165, P747; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Ji M, 2008, BLOOD, V112, P1068, DOI 10.1182/blood-2008-01-133504; Joslin JM, 2007, BLOOD, V110, P719, DOI 10.1182/blood-2007-01-068809; Khachigian LM, 1996, SCIENCE, V271, P1427, DOI 10.1126/science.271.5254.1427; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin L, 2004, IMMUNITY, V21, P203, DOI 10.1016/j.immuni.2004.06.016; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lucerna M, 2006, CANCER RES, V66, P6708, DOI 10.1158/0008-5472.CAN-05-2732; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Meng Y, 2008, MOL CANCER THER, V7, P2192, DOI 10.1158/1535-7163.MCT-08-0333; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Schmidt M, 2010, J CELL MOL MED, V14, P1760, DOI 10.1111/j.1582-4934.2009.00823.x; Shav-Tal Y, 2002, STEM CELLS, V20, P493, DOI 10.1634/stemcells.20-6-493; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Stassi G, 2000, NAT IMMUNOL, V1, P483, DOI 10.1038/82725; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Viemann D, 2007, J IMMUNOL, V178, P3198, DOI 10.4049/jimmunol.178.5.3198; Yamamura Y, 2006, J BIOL CHEM, V281, P5267, DOI 10.1074/jbc.M512151200; Zhao HH, 2001, J BIOL CHEM, V276, P27907, DOI 10.1074/jbc.M104278200	57	32	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10163	10178		10.1074/jbc.M109.056663	http://dx.doi.org/10.1074/jbc.M109.056663			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123982	hybrid, Green Published			2022-12-27	WOS:000276264600001
J	Girard, V; Cote, JP; Charbonneau, ME; Campos, M; Berthiaume, F; Hancock, MA; Siddiqui, N; Mourez, M				Girard, Victoria; Cote, Jean-Philippe; Charbonneau, Marie-Eve; Campos, Manuel; Berthiaume, Frederic; Hancock, Mark A.; Siddiqui, Nadeem; Mourez, Michael			Conformation Change in a Self-recognizing Autotransporter Modulates Bacterial Cell-Cell Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTEROAGGREGATIVE ESCHERICHIA-COLI; OUTER-MEMBRANE PROTEIN; BIOFILM FORMATION; DIFFUSE ADHERENCE; AIDA-I; POSTWEANING DIARRHEA; EDEMA DISEASE; ADHESIN; PIGS; AUTOAGGREGATION	Bacteria mostly live as multicellular communities, although they are unicellular organisms, yet the mechanisms that tie individual bacteria together are often poorly understood. The adhesin involved in diffuse adherence (AIDA-I) is an adhesin of diarrheagenic Escherichia coli strains. AIDA-I also mediates bacterial auto-aggregation and biofilm formation and thus could be important for the organization of communities of pathogens. Using purified protein and whole bacteria, we provide direct evidence that AIDA-I promotes auto-aggregation by interacting with itself. Using various biophysical and biochemical techniques, we observed a conformational change in the protein during AIDA-AIDA interactions, strengthening the notion that this is a highly specific interaction. The self-association of AIDA-I is of high affinity but can be modulated by sodium chloride. We observe that a bile salt, sodium deoxycholate, also prevents AIDA-I oligomerization and bacterial auto-aggregation. Thus, we propose that AIDA-I, and most likely other similar autotransporters such as antigen 43 (Ag43) and TibA, organize bacterial communities of pathogens through a self-recognition mechanism that is sensitive to the environment. This could permit bacteria to switch between multicellular and unicellular lifestyles to complete their infection.	[Girard, Victoria; Cote, Jean-Philippe; Charbonneau, Marie-Eve; Campos, Manuel; Berthiaume, Frederic; Mourez, Michael] Univ Montreal, Fac Med Vet, Canada Res Chair Bacterial Anim Dis, St Hyacinthe, PQ J2S 7C6, Canada; [Siddiqui, Nadeem] Univ Montreal, Inst Rech Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Hancock, Mark A.] McGill Univ, Sheldon Biotechnol Ctr, Montreal, PQ H3A 2B4, Canada	Universite de Montreal; Universite de Montreal; McGill University	Mourez, M (corresponding author), Univ Montreal, Fac Med Vet, Canada Res Chair Bacterial Anim Dis, 3200 Sicotte, St Hyacinthe, PQ J2S 7C6, Canada.	m.mourez@umontreal.ca			Canadian Institutes for Health Research [84578]; Groupe de Recherche et d'Etudes sur les Maladies Infectieuses du Porc; Canada Research Chair; Canada Foundation for Innovation [201414]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Groupe de Recherche et d'Etudes sur les Maladies Infectieuses du Porc; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This work was supported by Canadian Institutes for Health Research Grant 84578, funds from the Groupe de Recherche et d'Etudes sur les Maladies Infectieuses du Porc, Canada Research Chair and Canada Foundation for Innovation Grant 201414, and a research resource grant from Canadian Institutes for Health Research.	Alamuri P, 2008, MOL MICROBIOL, V68, P997, DOI 10.1111/j.1365-2958.2008.06199.x; Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; BENZ I, 1989, INFECT IMMUN, V57, P1506, DOI 10.1128/IAI.57.5.1506-1511.1989; Berge A, 1997, J BIOL CHEM, V272, P20774, DOI 10.1074/jbc.272.33.20774; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Charbonneau ME, 2007, J BACTERIOL, V189, P9020, DOI 10.1128/JB.01238-07; Charbonneau ME, 2006, J BACTERIOL, V188, P8504, DOI 10.1128/JB.00864-06; Charbonneau ME, 2009, J BIOL CHEM, V284, P17340, DOI 10.1074/jbc.M109.010108; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; ELSINGHORST EA, 1994, INFECT IMMUN, V62, P3463, DOI 10.1128/IAI.62.8.3463-3471.1994; Felek S, 2008, MICROBIOL-SGM, V154, P1802, DOI 10.1099/mic.0.2007/010918-0; Frick IM, 2000, MOL MICROBIOL, V37, P1232, DOI 10.1046/j.1365-2958.2000.02084.x; Girard V, 2006, RES MICROBIOL, V157, P407, DOI 10.1016/j.resmic.2006.02.001; Ha SK, 2003, J VET DIAGN INVEST, V15, P378, DOI 10.1177/104063870301500414; Hammar M, 1996, P NATL ACAD SCI USA, V93, P6562, DOI 10.1073/pnas.93.13.6562; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Henderson IR, 1997, FEMS MICROBIOL LETT, V149, P115, DOI 10.1016/S0378-1097(97)00065-7; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kajava AV, 2006, J STRUCT BIOL, V155, P306, DOI 10.1016/j.jsb.2006.01.015; Klemm P, 2004, MOL MICROBIOL, V51, P283, DOI 10.1046/j.1365-2958.2003.03833.x; Klemm P, 2006, INT J MED MICROBIOL, V296, P187, DOI 10.1016/j.ijmm.2005.10.002; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Leckband D, 2006, ANNU REV BIOMED ENG, V8, P259, DOI 10.1146/annurev.bioeng.8.061505.095753; Mainil JG, 2002, VET MICROBIOL, V86, P303, DOI 10.1016/S0378-1135(02)00019-6; Malik-Kale P, 2008, J BACTERIOL, V190, P2286, DOI 10.1128/JB.01736-07; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; MENOZZI FD, 1994, INFECT IMMUN, V62, P4261, DOI 10.1128/IAI.62.10.4261-4269.1994; NATARO JP, 1992, INFECT IMMUN, V60, P2297, DOI 10.1128/IAI.60.6.2297-2304.1992; Ngeleka M, 2003, J VET DIAGN INVEST, V15, P242, DOI 10.1177/104063870301500305; Niewerth U, 2001, CLIN DIAGN LAB IMMUN, V8, P143, DOI 10.1128/CDLI.8.1.143-149.2001; OCHIAI K, 1993, J MED MICROBIOL, V39, P183, DOI 10.1099/00222615-39-3-183; Ravi M, 2007, VET MICROBIOL, V120, P308, DOI 10.1016/j.vetmic.2006.10.035; Schembri MA, 2001, MOL MICROBIOL, V41, P1419, DOI 10.1046/j.1365-2958.2001.02613.x; Sheikh J, 2002, J CLIN INVEST, V110, P1329, DOI 10.1172/JCI200216172; Sherlock O, 2005, INFECT IMMUN, V73, P1954, DOI 10.1128/IAI.73.4.1954-1963.2005; Sherlock O, 2004, J BACTERIOL, V186, P8058, DOI 10.1128/JB.186.23.8058-8065.2004; Sherlock O, 2006, J BACTERIOL, V188, P1798, DOI 10.1128/JB.188.5.1798-1807.2006; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Suhr M, 1996, MOL MICROBIOL, V22, P31, DOI 10.1111/j.1365-2958.1996.tb02653.x; Verstraeten N, 2008, TRENDS MICROBIOL, V16, P496, DOI 10.1016/j.tim.2008.07.004; Zhang WP, 2007, VET MICROBIOL, V123, P145, DOI 10.1016/j.vetmic.2007.02.018	41	20	22	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10616	10626		10.1074/jbc.M109.069070	http://dx.doi.org/10.1074/jbc.M109.069070			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123991	Green Published, hybrid			2022-12-27	WOS:000276264600049
J	Wu, YT; Tan, HL; Shui, GH; Bauvy, C; Huang, Q; Wenk, MR; Ong, CN; Codogno, P; Shen, HM				Wu, You-Tong; Tan, Hui-Ling; Shui, Guanghou; Bauvy, Chantal; Huang, Qing; Wenk, Markus R.; Ong, Choon-Nam; Codogno, Patrice; Shen, Han-Ming			Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONITORING AUTOPHAGY; DEPENDENT REGULATION; MAMMALIAN TARGET; PROTEIN; COMPLEX; MTOR; LC3; MACROAUTOPHAGY; DEGRADATION; RAPAMYCIN	A group of phosphoinositide 3-kinase (PI3K) inhibitors, such as 3-methyladenine (3-MA) and wortmannin, have been widely used as autophagy inhibitors based on their inhibitory effect on class III PI3K activity, which is known to be essential for induction of autophagy. In this study, we systematically examined and compared the effects of these two inhibitors on autophagy under both nutrient-rich and deprivation conditions. To our surprise, 3-MA is found to promote autophagy flux when treated under nutrient-rich conditions with a prolonged period of treatment, whereas it is still capable of suppressing starvation-induced autophagy. We first observed that there are marked increases of the autophagic markers in cells treated with 3-MA in full medium for a prolonged period of time (up to 9 h). Second, we provide convincing evidence that the increase of autophagic markers is the result of enhanced autophagic flux, not due to suppression of maturation of autophagosomes or lysosomal function. More importantly, we found that the autophagy promotion activity of 3-MA is due to its differential temporal effects on class I and class III PI3K; 3-MA blocks class I PI3K persistently, whereas its suppressive effect on class III PI3K is transient. Because 3-MA has been widely used as an autophagy inhibitor in the literature, understanding the dual role of 3-MA in autophagy thus suggests that caution should be exercised in the application of 3-MA in autophagy study.	[Wu, You-Tong; Tan, Hui-Ling; Huang, Qing; Ong, Choon-Nam; Shen, Han-Ming] Natl Univ Singapore, Dept Epidemiol & Publ Hlth, Singapore 117597, Singapore; [Shui, Guanghou; Wenk, Markus R.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117597, Singapore; [Wenk, Markus R.; Shen, Han-Ming] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; [Bauvy, Chantal; Codogno, Patrice] Univ Paris 11, INSERM, U756, F-92290 Chatenay Malabry, France	National University of Singapore; National University of Singapore; National University of Singapore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Shen, HM (corresponding author), Level 4,16 Med Dr, Singapore 117597, Singapore.	ephshm@nus.edu.sg	Wenk, Markus Rene/D-1441-2014; SHEN, Han-Ming/B-5942-2011; Codogno, Patrice/G-1384-2013; Ong, Choon Nam/E-8638-2010	SHEN, Han-Ming/0000-0001-7369-5227; Codogno, Patrice/0000-0002-5492-3180; Shui, Guanghou/0000-0002-1621-9643; Ong, Choon Nam/0000-0002-4002-1725	National University of Singapore (NUS) University Research Council; Singapore Biomedical Research Council; Life Science Institute, NUS	National University of Singapore (NUS) University Research Council(National University of Singapore); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Life Science Institute, NUS(National University of Singapore)	The work was supported in part by research grants from the National University of Singapore (NUS) University Research Council and Singapore Biomedical Research Council and the Toxicology Program of the Life Science Institute, NUS.	Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Bains M, 2009, METHOD ENZYMOL, V453, P145, DOI 10.1016/S0076-6879(08)04007-X; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Chang YY, 2009, BIOCHEM SOC T, V37, P232, DOI 10.1042/BST0370232; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Galluzzi L, 2008, CURR MOL MED, V8, P78; Gao M, 2008, CANCER RES, V68, P9348, DOI 10.1158/0008-5472.CAN-08-1642; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Ito H, 2005, INT J ONCOL, V26, P1401; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2009, ANN SURG ONCOL, V16, P761, DOI 10.1245/s10434-008-0260-0; Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740; Longo L, 2008, MOL CANCER THER, V7, P2476, DOI 10.1158/1535-7163.MCT-08-0361; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Meijer AJ, 2009, CRIT REV CL LAB SCI, V46, P210, DOI 10.1080/10408360903044068; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2009, METHOD ENZYMOL, V452, P13, DOI 10.1016/S0076-6879(08)03602-1; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nasuhoglu C, 2002, ANAL BIOCHEM, V301, P243, DOI 10.1006/abio.2001.5489; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2008, BIOCHIMIE, V90, P313, DOI 10.1016/j.biochi.2007.08.014; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; POWIS G, 1994, CANCER RES, V54, P2419; PUNNONEN EL, 1994, EUR J CELL BIOL, V65, P14; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Scarlatti F, 2009, CELL DEATH DIFFER, V16, P12, DOI 10.1038/cdd.2008.101; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Vergne I, 2009, EMBO J, V28, P2244, DOI 10.1038/emboj.2009.159; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Wu YT, 2009, AUTOPHAGY, V5, P824, DOI 10.4161/auto.9099; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Xiong HY, 2010, CANCER LETT, V288, P68, DOI 10.1016/j.canlet.2009.06.039; Xue LZ, 2002, BIOCHEM PHARMACOL, V64, P441, DOI 10.1016/S0006-2952(02)01181-4; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	70	812	845	7	107	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10850	10861		10.1074/jbc.M109.080796	http://dx.doi.org/10.1074/jbc.M109.080796			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123989	Green Published, hybrid			2022-12-27	WOS:000276264600070
J	Goh, YM; Cinghu, S; Hong, ETH; Lee, YS; Kim, JH; Jang, JW; Li, YH; Chi, XZ; Lee, KS; Wee, H; Ito, Y; Oh, BC; Bae, SC				Goh, Yun-Mi; Cinghu, Senthilkumar; Hong, Eileen Tan Hwee; Lee, You-Soub; Kim, Jang-Hyun; Jang, Ju-Won; Li, Ying-Hui; Chi, Xin-Zi; Lee, Kyeong-Sook; Wee, Heejun; Ito, Yoshiaki; Oh, Byung-Chul; Bae, Suk-Chul			Src Kinase Phosphorylates RUNX3 at Tyrosine Residues and Localizes the Protein in the Cytoplasm	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPG ISLAND HYPERMETHYLATION; TUMOR-RELATED GENES; RING-FINGER DOMAIN; CANCER CELL-LINES; PROMOTER HYPERMETHYLATION; NUCLEAR EXPORT; CLEIDOCRANIAL DYSPLASIA; GASTRIC-CARCINOMA; FREQUENT LOSS; C-SRC	RUNX3 is a transcription factor that functions as a tumor suppressor. In some cancers, RUNX3 expression is down-regulated, usually due to promoter hypermethylation. Recently, it was found that RUNX3 can also be inactivated by the mislocalization of the protein in the cytoplasm. The molecular mechanisms controlling this mislocalization are poorly understood. In this study, we found that the overexpression of Src results in the tyrosine phosphorylation and cytoplasmic localization of RUNX3. We also found that the tyrosine residues of endogenous RUNX3 are phosphorylated and that the protein is localized in the cytoplasm in Src-activated cancer cell lines. We further showed that the knockdown of Src by small interfering RNA, or the inhibition of Src kinase activity by a chemical inhibitor, causes the re-localization of RUNX3 to the nucleus. Collectively, our results demonstrate that the tyrosine phosphorylation of RUNX3 by activated Src is associated with the cytoplasmic localization of RUNX3 in gastric and breast cancers.	[Oh, Byung-Chul] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Goh, Yun-Mi; Cinghu, Senthilkumar; Lee, You-Soub; Kim, Jang-Hyun; Jang, Ju-Won; Chi, Xin-Zi; Lee, Kyeong-Sook; Wee, Heejun; Bae, Suk-Chul] Chungbuk Natl Univ, Inst Tumor Res, Dept Biochem, Sch Med, Cheongju 361763, South Korea; [Hong, Eileen Tan Hwee; Ito, Yoshiaki] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 138673, Singapore; [Hong, Eileen Tan Hwee; Ito, Yoshiaki] Inst Mol & Cell Biol, Singapore 138673, Singapore	Gachon University; Chungbuk National University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Oh, BC (corresponding author), Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, 7-45 Songdo Dong, Inchon 406840, South Korea.	bcoh@gachon.ac.kr; scbae@chungbuk.ac.kr		Oh, Byung-Chul/0000-0002-4277-7083	Korean Science and Engineering Foundation [R16-2003-002-01001-02006]	Korean Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Research Grant R16-2003-002-01001-02006 (to S.-C.B.) from the Korean Science and Engineering Foundation.	Balmain A, 2002, NATURE, V417, P235, DOI 10.1038/417235a; Biscardi JS, 1998, MOL CARCINOGEN, V21, P261, DOI 10.1002/(SICI)1098-2744(199804)21:4<261::AID-MC5>3.0.CO;2-N; Blain SW, 2002, NAT MED, V8, P1076, DOI 10.1038/nm1002-1076; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Goel A, 2004, INT J CANCER, V112, P754, DOI 10.1002/ijc.20472; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Ito K, 2005, CANCER RES, V65, P7743, DOI 10.1158/0008-5472.CAN-05-0743; Ito K, 2008, CANCER CELL, V14, P226, DOI 10.1016/j.ccr.2008.08.004; Kang GH, 2004, J PATHOL, V202, P233, DOI 10.1002/path.1503; Kang S, 2005, GYNECOL ONCOL, V96, P173, DOI 10.1016/j.ygyno.2004.09.031; KAPLAN KB, 1994, EMBO J, V13, P4745, DOI 10.1002/j.1460-2075.1994.tb06800.x; Kastan MB, 2003, CELL, V112, P1, DOI 10.1016/S0092-8674(02)01281-3; Kato N, 2003, AM J PATHOL, V163, P387, DOI 10.1016/S0002-9440(10)63668-1; Kim HP, 2004, BIOCHEM J, V379, P141, DOI 10.1042/BJ20031408; Kim HR, 2008, J CELL BIOCHEM, V105, P1048, DOI 10.1002/jcb.21906; Kim TY, 2004, LAB INVEST, V84, P479, DOI 10.1038/labinvest.3700060; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kopetz S, 2007, CLIN CANCER RES, V13, P7232, DOI 10.1158/1078-0432.CCR-07-1902; Ku JL, 2004, ONCOGENE, V23, P6736, DOI 10.1038/sj.onc.1207731; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lau QC, 2006, CANCER RES, V66, P6512, DOI 10.1158/0008-5472.CAN-06-0369; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Li QL, 2002, CELL, V109, P113, DOI 10.1016/S0092-8674(02)00690-6; Li QL, 2004, BIOCHEM BIOPH RES CO, V314, P223, DOI 10.1016/j.bbrc.2003.12.079; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; Mori T, 2005, LIVER INT, V25, P380, DOI 10.1111/j.1478-3231.2005.1059.x; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakase Y, 2005, BRIT J CANCER, V92, P562, DOI 10.1038/sj.bjc.6602372; Osaki M, 2004, EUR J CLIN INVEST, V34, P605, DOI 10.1111/j.1365-2362.2004.01401.x; Oshimo Y, 2004, PATHOBIOLOGY, V71, P137, DOI 10.1159/000076468; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pande S, 2009, J CELL PHYSIOL, V218, P473, DOI 10.1002/jcp.21630; Pockwinse SM, 2006, J CELL PHYSIOL, V206, P354, DOI 10.1002/jcp.20469; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Sakakura C, 2005, INT J CANCER, V113, P221, DOI 10.1002/ijc.20551; Schulmann K, 2005, ONCOGENE, V24, P4138, DOI 10.1038/sj.onc.1208598; Shah N, 2008, EUR J CANCER, V44, P2144, DOI 10.1016/j.ejca.2008.06.044; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tamura G, 2004, HISTOL HISTOPATHOL, V19, P221, DOI 10.14670/HH-19.221; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Wada M, 2004, ONCOGENE, V23, P2401, DOI 10.1038/sj.onc.1207395; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Xiao WH, 2004, WORLD J GASTROENTERO, V10, P376; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Yanagawa N, 2003, CANCER SCI, V94, P589, DOI 10.1111/j.1349-7006.2003.tb01487.x; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	51	39	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10122	10129		10.1074/jbc.M109.071381	http://dx.doi.org/10.1074/jbc.M109.071381			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100835	Green Published, hybrid			2022-12-27	WOS:000276165900079
J	Jeong, HS; Kim, SM; Lim, MS; Kim, KS; Choi, SH				Jeong, Hye Sook; Kim, Seung Min; Lim, Moon Sub; Kim, Kun Soo; Choi, Sang Ho			Direct Interaction between Quorum-sensing Regulator SmcR and RNA Polymerase Is Mediated by Integration Host Factor to Activate vvpE Encoding Elastase in Vibrio vulnificus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRULENCE GENE-EXPRESSION; HARVEYI-LUXR; ESCHERICHIA-COLI; BACTERIAL PROMOTERS; FUNCTIONAL-ANALYSIS; CONSENSUS SEQUENCE; RECEPTOR PROTEIN; IDENTIFICATION; CHOLERAE; HOMOLOG	It has been suggested that quorum sensing is an important signal transduction system regulating the expression of numerous virulence genes in bacterial pathogens. We previously revealed that SmcR, a LuxR homologue of Vibrio vulnificus, activates promoter S, an RpoS-dependent promoter of vvpE encoding a potential virulence factor elastase and binds in vitro to a binding site centered at -196.5. In this study, chromatin immunoprecipitation assays and promoter deletion analyses demonstrated that SmcR binds to the vvpE regulatory region in vivo and directly interacts with RNAP for activation of the vvpE expression. A search for regulatory genes involved in the regulation of elastase production singled out ihfA, which encodes for a subunit of integration host factor (IHF). Levels of both elastase activity and vvpE transcript decreased significantly as a result of inactivation of ihfA, and primer extension analyses demonstrated that IHF regulates the vvpE transcription by activating PS. Direct binding of IHF to the two distinct binding sites centered at -174 and -131, respectively, was determined using an electrophoretic mobility shift assay and a DNase I protection assay. Chromatin immunoprecipitation assays revealed that the interaction of SmcR with RNAP in vivo was mediated by IHF. Collectively, the results proposed a model whereby IHF positions SmcR to contact RNAP by looping the vvpE regulatory DNA, thus allowing precise control of the expression level of VvpE during the pathogenesis of V. vulnificus.	[Jeong, Hye Sook; Kim, Seung Min; Lim, Moon Sub; Choi, Sang Ho] Seoul Natl Univ, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Ctr Agr Biomat, Seoul 151921, South Korea; [Jeong, Hye Sook; Kim, Seung Min; Lim, Moon Sub; Choi, Sang Ho] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Kim, Kun Soo] Sogang Univ, Dept Life Sci, Seoul 121742, South Korea; [Kim, Kun Soo] Sogang Univ, Interdisciplinary Program Integrated Biotechnol, Seoul 121742, South Korea	Seoul National University (SNU); Seoul National University (SNU); Sogang University; Sogang University	Choi, SH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Natl Res Lab Mol Microbiol & Toxicol, Ctr Agr Biomat, Seoul 151921, South Korea.	choish@snu.ac.kr		KIM, KUN-SOO/0000-0002-5433-4175; Choi, Sang Ho/0000-0003-3865-1039	World Class University [R32-2008-000-10183-0]; 21C Frontier Microbial Genomics and Applications Center Program; National Research Laboratory [R0A-2007-00020039-0]; Ministry of Education, Science and Technology of the Republic of Korea	World Class University; 21C Frontier Microbial Genomics and Applications Center Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Laboratory(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology of the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by World Class University Program Grant R32-2008-000-10183-0, a 21C Frontier Microbial Genomics and Applications Center Program grant, National Research Laboratory Grant R0A-2007-00020039-0, and funds from the Ministry of Education, Science and Technology of the Republic of Korea (to S. H. C.).	Arfin SM, 2000, J BIOL CHEM, V275, P29672, DOI 10.1074/jbc.M002247200; Barnard A, 2004, CURR OPIN MICROBIOL, V7, P102, DOI 10.1016/j.mib.2004.02.011; Beyhan S, 2007, J BACTERIOL, V189, P388, DOI 10.1128/JB.00981-06; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Choi HK, 2002, J BIOL CHEM, V277, P47292, DOI 10.1074/jbc.M206893200; CRAIG NL, 1984, CELL, V39, P707, DOI 10.1016/0092-8674(84)90478-1; Croxatto A, 2002, J BACTERIOL, V184, P1617, DOI 10.1128/JB.184.6.1617-1629.2002; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Estrem ST, 1998, P NATL ACAD SCI USA, V95, P9761, DOI 10.1073/pnas.95.17.9761; Fuqua C, 2002, NAT REV MOL CELL BIO, V3, P685, DOI 10.1038/nrm907; Jeong HS, 2003, J BIOL CHEM, V278, P45072, DOI 10.1074/jbc.M308184200; Jeong HS, 2001, J BIOL CHEM, V276, P13875, DOI 10.1074/jbc.M010567200; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; Jobling MG, 1997, MOL MICROBIOL, V26, P1023, DOI 10.1046/j.1365-2958.1997.6402011.x; KEEN NT, 1988, GENE, V70, P191, DOI 10.1016/0378-1119(88)90117-5; Kim HJ, 2002, J MICROBIOL BIOTECHN, V12, P318; Kovacikova G, 2002, MOL MICROBIOL, V46, P1135, DOI 10.1046/j.1365-2958.2002.03229.x; LANGE R, 1991, MOL MICROBIOL, V5, P49, DOI 10.1111/j.1365-2958.1991.tb01825.x; Lee BC, 2008, INFECT IMMUN, V76, P1509, DOI 10.1128/IAI.01503-07; Lee DH, 2008, J BIOL CHEM, V283, P23610, DOI 10.1074/jbc.M801480200; Lee JH, 2007, J MICROBIOL, V45, P146; Lee JH, 2007, J MICROBIOL BIOTECHN, V17, P325; Lee JH, 2006, MOL MICROBIOL, V60, P513, DOI 10.1111/j.1365-2958.2006.05115.x; Lin W, 2007, MOL MICROBIOL, V64, P953, DOI 10.1111/j.1365-2958.2007.05693.x; McCarter LL, 1998, J BACTERIOL, V180, P3166, DOI 10.1128/JB.180.12.3166-3173.1998; McDougald D, 2001, J BACTERIOL, V183, P758, DOI 10.1128/JB.183.2.758-762.2001; McDougald D, 2000, GENE, V248, P213, DOI 10.1016/S0378-1119(00)00117-7; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; MIYAMOTO CM, 1994, MOL MICROBIOL, V14, P255, DOI 10.1111/j.1365-2958.1994.tb01286.x; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Rhee JE, 2005, J BACTERIOL, V187, P7870, DOI 10.1128/JB.187.22.7870-7875.2005; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; Roh JB, 2006, J BIOL CHEM, V281, P34775, DOI 10.1074/jbc.M607844200; Sambrook J., 2001, MOL CLONING LAB MANU; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; TANAKA K, 1993, P NATL ACAD SCI USA, V90, P3511, DOI 10.1073/pnas.90.8.3511; Waters CM, 2006, GENE DEV, V20, P2754, DOI 10.1101/gad.1466506; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	43	31	31	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9357	9366		10.1074/jbc.M109.089987	http://dx.doi.org/10.1074/jbc.M109.089987			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110369	hybrid, Green Published			2022-12-27	WOS:000276165900007
J	Zhang, RZ; Zou, YQ; Pan, TC; Markova, D; Fertala, A; Hu, Y; Squarzoni, S; Reed, UC; Marie, SKN; Bonnemann, CG; Chu, ML				Zhang, Rui-Zhu; Zou, Yaqun; Pan, Te-Cheng; Markova, Dessislava; Fertala, Andrzej; Hu, Ying; Squarzoni, Stefano; Reed, Umbertina Conti; Marie, Suely K. N.; Boennemann, Carsten G.; Chu, Mon-Li			Recessive COL6A2 C-globular Missense Mutations in Ullrich Congenital Muscular Dystrophy ROLE OF THE C2a SPLICE VARIANT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; COLLAGEN ALPHA-3 CHAIN; BETHLEM MYOPATHY; CRYSTAL-STRUCTURE; VONWILLEBRAND-FACTOR; SEQUENCE-ANALYSIS; VI MUTATIONS; GENE CAUSES; A-DOMAINS; I-DOMAIN	Ullrich congenital muscular dystrophy (UCMD) is a disabling and life-threatening disorder resulting from either recessive or dominant mutations in genes encoding collagen VI. Although the majority of the recessive UCMD cases have frameshift or nonsense mutations in COL6A1, COL6A2, or COL6A3, recessive structural mutations in the COL6A2 C-globular region are emerging also. However, the underlying molecular mechanisms have remained elusive. Here we identified a homozygous COL6A2 E624K mutation (C1 subdomain) and a homozygous COL6A2 R876S mutation (C2 subdomain) in two UCMD patients. The consequences of the mutations were investigated using fibroblasts from patients and cells stably transfected with the mutant constructs. In contrast to expectations based on the clinical severity of these two patients, secretion and assembly of collagen VI were moderately affected by the E624K mutation but severely impaired by the R876S substitution. The E624K substitution altered the electrostatic potential of the region surrounding the metal ion-dependent adhesion site, resulting in a collagen VI network containing thick fibrils and spots with densely packed microfibrils. The R876S mutation prevented the chain from assembling into triple-helical collagen VI molecules. The minute amount of collagen VI secreted by the R876S fibroblasts was solely composed of a faster migrating chain corresponding to the C2a splice variant with an alternative C2 subdomain. In transfected cells, the C2a splice variant was able to assemble into short microfibrils. Together, the results suggest that the C2a splice variant may functionally compensate for the loss of the normal COL6A2 chain when mutations occur in the C2 subdomain.	[Zhang, Rui-Zhu; Pan, Te-Cheng; Markova, Dessislava; Fertala, Andrzej; Chu, Mon-Li] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA; [Chu, Mon-Li] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Zou, Yaqun; Hu, Ying; Boennemann, Carsten G.] Univ Penn, Div Neurol, Childrens Hosp Philadelphia, Sch Med, Philadelphia, PA 19104 USA; [Squarzoni, Stefano] CNR, Inst Mol Genet, Unit Bologna, I-40136 Bologna, Italy; [Reed, Umbertina Conti; Marie, Suely K. N.] Univ Sao Paulo, Dept Neurol, Fac Med, BR-05403000 Sao Paulo, Brazil	Jefferson University; Jefferson University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Universidade de Sao Paulo	Chu, ML (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	mon-li.chu@jefferson.edu	Squarzoni, Stefano/AAM-9729-2020; Marie, Suely Kazue Nagahashi/D-1870-2012	Squarzoni, Stefano/0000-0001-6538-5923; Marie, Suely Kazue Nagahashi/0000-0003-4419-7928	National Institutes of Health [AR053251, AR049537, AR051999]; Muscular Dystrophy Association USA [3896]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051999, R01AR053251, R01AR049537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association USA(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053251 (to M. L. C.), AR049537 (to A. F.), and AR051999 (to C. G. B.). This work was also supported by Muscular Dystrophy Association USA (Grant 3896 to C. G. B.).	Baker NL, 2007, ANN NEUROL, V62, P390, DOI 10.1002/ana.21213; Baker NL, 2005, HUM MOL GENET, V14, P279, DOI 10.1093/hmg/ddi025; Ball S, 2003, J BIOL CHEM, V278, P15326, DOI 10.1074/jbc.M209977200; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; CHU ML, 1990, EMBO J, V9, P385, DOI 10.1002/j.1460-2075.1990.tb08122.x; CHU ML, 1989, EMBO J, V8, P1939, DOI 10.1002/j.1460-2075.1989.tb03598.x; Demir E, 2002, AM J HUM GENET, V70, P1446, DOI 10.1086/340608; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Fitzgerald J, 2008, J BIOL CHEM, V283, P20170, DOI 10.1074/jbc.M710139200; Gara SK, 2008, J BIOL CHEM, V283, P10658, DOI 10.1074/jbc.M709540200; Giusti B, 2005, ANN NEUROL, V58, P400, DOI 10.1002/ana.20586; Gonzalez-Manchon C, 2004, THROMB HAEMOSTASIS, V92, P1377, DOI 10.1160/TH04-06-0380; Higuchi I, 2001, ANN NEUROL, V50, P261, DOI 10.1002/ana.1120; Huizinga EG, 1997, STRUCTURE, V5, P1147, DOI 10.1016/S0969-2126(97)00266-9; Jenkins PV, 1998, BLOOD, V91, P2032, DOI 10.1182/blood.V91.6.2032.2032_2032_2044; Lamande SR, 1998, J BIOL CHEM, V273, P7423, DOI 10.1074/jbc.273.13.7423; Lampe AK, 2008, HUM MUTAT, V29, P809, DOI 10.1002/humu.20704; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; Lampe AK, 2005, J MED GENET, V42, P108, DOI 10.1136/jmg.2004.023754; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Merlini L, 2008, NEUROLOGY, V71, P1245, DOI 10.1212/01.wnl.0000327611.01687.5e; Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009; Pace RA, 2008, ANN NEUROL, V64, P294, DOI 10.1002/ana.21439; Pan TC, 2003, AM J HUM GENET, V73, P355, DOI 10.1086/377107; Pan TC, 1998, HUM MOL GENET, V7, P807, DOI 10.1093/hmg/7.5.807; Peat RA, 2008, NEUROLOGY, V71, P312, DOI 10.1212/01.wnl.0000284605.27654.5a; Petrini S, 2005, MOL CELL NEUROSCI, V30, P408, DOI 10.1016/j.mcn.2005.08.005; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; SAITTA B, 1990, J BIOL CHEM, V265, P6473; Sasaki T, 2000, FASEB J, V14, P761, DOI 10.1096/fasebj.14.5.761; Scacheri PC, 2002, NEUROLOGY, V58, P593, DOI 10.1212/WNL.58.4.593; SPECKS U, 1992, EMBO J, V11, P4281, DOI 10.1002/j.1460-2075.1992.tb05527.x; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; Timpl R, 1994, EXTRACELLULAR MATRIX, P207, DOI 10.1016/B978-0-12-775170-2.50012-3; Vanegas OC, 2001, P NATL ACAD SCI USA, V98, P7516; Vorup-Jensen T, 2003, P NATL ACAD SCI USA, V100, P1873, DOI 10.1073/pnas.0237387100; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Zhang RZ, 2002, J BIOL CHEM, V277, P43557, DOI 10.1074/jbc.M207696200	40	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10005	10015		10.1074/jbc.M109.093666	http://dx.doi.org/10.1074/jbc.M109.093666			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106987	Green Published, hybrid			2022-12-27	WOS:000276165900069
J	Fujimori, K; Ueno, T; Nagata, N; Kashiwagi, K; Aritake, K; Amano, F; Urade, Y				Fujimori, Ko; Ueno, Toshiyuki; Nagata, Nanae; Kashiwagi, Kaori; Aritake, Kosuke; Amano, Fumio; Urade, Yoshihiro			Suppression of Adipocyte Differentiation by Aldo-keto Reductase 1B3 Acting as Prostaglandin F-2 alpha Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; BOVINE LUNG; F SYNTHASE; PREADIPOCYTE DIFFERENTIATION; PROSTANOID RECEPTORS; SIGNALING PATHWAY; E-2 BIOSYNTHESIS; GENE-EXPRESSION; 3T3-L1 CELLS; SUPERFAMILY	Prostaglandin (PG) F-2 alpha suppresses adipocyte differentiation by inhibiting the function of peroxisome proliferator-activated receptor gamma. However, PGF(2 alpha) synthase (PGFS) in adipocytes remains to be identified. Here, we studied the expression of members of the aldo-keto reductase (AKR) 1B family acting as PGFS during adipogenesis of mouse 3T3-L1 cells. AKR1B3 mRNA was expressed in preadipocytes, and its level increased about 4-fold at day 1 after initiation of adipocyte differentiation, and then quickly decreased the following day to a level lower than that in the preadipocytes. In contrast, the mRNA levels of Akr1b8 and 1b10 were clearly lower than that level of Akr1b3 in preadipocytes and remained unchanged during adipogenesis. The transient increase in Akr1b3 during adipogenesis was also observed by Western blot analysis. The mRNA for the FP receptor, which is selective for PGF(2 alpha), was also expressed in preadipocytes. Its level increased about 2-fold within 1 h after the initiation of adipocyte differentiation and was maintained at almost the same level throughout adipocyte differentiation. The small interfering RNA for Akr1b3, but not for Akr1b8 or 1b10, suppressed PGF(2 alpha) production and enhanced the expression of adipogenic genes such as peroxisome proliferator-activated receptor gamma, fatty acid-binding protein 4 (aP2), and stearoyl-CoA desaturase. Moreover, an FP receptor agonist, Fluprostenol, suppressed the expression of those adipogenic genes in 3T3-L1 cells; whereas an FP receptor antagonist, AL-8810, efficiently inhibited the suppression of adipogenesis caused by the endogenous PGF(2 alpha). These results indicate that AKR1B3 acts as the PGFS in adipocytes and that AKR1B3-produced PGF(2 alpha) suppressed adipocyte differentiation by acting through FP receptors.	[Fujimori, Ko; Ueno, Toshiyuki; Amano, Fumio] Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, Osaka 5691094, Japan; [Nagata, Nanae; Kashiwagi, Kaori; Aritake, Kosuke; Urade, Yoshihiro] Osaka Biosci Inst, Dept Mol Behav Biol, Osaka 5650874, Japan	Osaka University of Pharmaceutical Sciences	Fujimori, K (corresponding author), Osaka Univ Pharmaceut Sci, Lab Biodef & Regulat, 4-20-1 Nasahara, Osaka 5691094, Japan.	fujimori@gly.oups.ac.jp	Fujimori, Ko/AAD-5428-2021	Fujimori, Ko/0000-0002-2506-0769	Ministry of Education, Culture, Sports, Science and Technology of Japan; Research for Promoting Technological Seeds from Japan Science and Technology Agency; Suzuken Memorial Foundation; Sumitomo Foundation; Gushinkai Foundation; Takeda Science Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research for Promoting Technological Seeds from Japan Science and Technology Agency; Suzuken Memorial Foundation; Sumitomo Foundation; Gushinkai Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K. F. and K. A.) and by grants from the Research for Promoting Technological Seeds from Japan Science and Technology Agency, the Suzuken Memorial Foundation, the Sumitomo Foundation, the Gushinkai Foundation (to K. F.), and the Takeda Science Foundation (to K. F. and Y. U.).	Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Casimir DA, 1996, DIFFERENTIATION, V60, P203, DOI 10.1046/j.1432-0436.1996.6040203.x; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fujimori K, 2005, J BIOL CHEM, V280, P18452, DOI 10.1074/jbc.M411755200; Fujimori K, 2007, J BIOL CHEM, V282, P18458, DOI 10.1074/jbc.M701141200; Fujino H, 2001, J BIOL CHEM, V276, P12489, DOI 10.1074/jbc.C100039200; Griffin BW, 1999, J PHARMACOL EXP THER, V290, P1278; Hayaishi O, 1988, Prog Clin Biol Res, V274, P577; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 1997, BIOCHEM PHARMACOL, V54, P639, DOI 10.1016/S0006-2952(97)84253-0; Kabututu Z, 2009, J BIOCHEM, V145, P161, DOI 10.1093/jb/mvn152; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kubata BK, 2000, J EXP MED, V192, P1327, DOI 10.1084/jem.192.9.1327; Kubata BK, 2002, J EXP MED, V196, P1241, DOI 10.1084/jem.20020885; Lambert-Langlais S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007309; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Liu L, 2007, J CELL BIOCHEM, V100, P161, DOI 10.1002/jcb.21044; Madore E, 2003, J BIOL CHEM, V278, P11205, DOI 10.1074/jbc.M208318200; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; Moriuchi H, 2008, J BIOL CHEM, V283, P792, DOI 10.1074/jbc.M705638200; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Nakashima K, 2003, BBA-MOL CELL BIOL L, V1633, P96, DOI 10.1016/S1388-1981(03)00092-1; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Penning TM, 2007, ARCH BIOCHEM BIOPHYS, V464, P241, DOI 10.1016/j.abb.2007.04.024; Pierce KL, 1999, J BIOL CHEM, V274, P35944, DOI 10.1074/jbc.274.50.35944; Serrero G, 1997, BIOCHEM BIOPH RES CO, V233, P200, DOI 10.1006/bbrc.1997.6433; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Svensson PA, 2008, CELL MOL BIOL LETT, V13, P599, DOI 10.2478/s11658-008-0025-6; Tanioka T, 2000, J BIOL CHEM, V275, P32775, DOI 10.1074/jbc.M003504200; Tirard J, 2007, ENDOCRINOLOGY, V148, P1996, DOI 10.1210/en.2006-1707; Tsuboi H, 2004, BIOCHEM BIOPH RES CO, V322, P1066, DOI 10.1016/j.bbrc.2004.08.018; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; WATANABE K, 1986, P NATL ACAD SCI USA, V83, P1583, DOI 10.1073/pnas.83.6.1583; WATANABE K, 1985, J BIOL CHEM, V260, P7035; WATANABE K, 1988, P NATL ACAD SCI USA, V85, P11, DOI 10.1073/pnas.85.1.11; WATANABE T, 1994, J BIOL CHEM, V269, P17619	38	49	50	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8880	8886		10.1074/jbc.M109.077164	http://dx.doi.org/10.1074/jbc.M109.077164			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093363	Green Published, hybrid			2022-12-27	WOS:000275553700039
J	Chowdhury, G; Calcutt, MW; Guengerich, FP				Chowdhury, Goutam; Calcutt, M. Wade; Guengerich, F. Peter			Oxidation of N-Nitrosoalkylamines by Human Cytochrome P450 2A6 SEQUENTIAL OXIDATION TO ALDEHYDES AND CARBOXYLIC ACIDS AND ANALYSIS OF REACTION STEPS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL CYTOCHROME-P-450; NUCLEAR-MAGNETIC-RESONANCE; HIV-1 REVERSE-TRANSCRIPTASE; ELECTRON-TRANSFER; IN-VIVO; METABOLIC-ACTIVATION; SUCCESSIVE REACTIONS; ALIPHATIC-ALDEHYDES; KINETIC-ANALYSIS; RAT-LIVER	Cytochrome P450 (P450) 2A6 activates nitrosamines, including N,N-dimethylnitrosamine (DMN) and N,N-diethylnitrosamine (DEN), to alkyl diazohydroxides (which are DNA-alkylating agents) and also aldehydes (HCHO from DMN and CH3CHO from DEN). The N-dealkylation of DMN had a high intrinsic kinetic deuterium isotope effect ((D)k(app) similar to 10), which was highly expressed in a variety of competitive and non-competitive experiments. The (D)k(app) for DEN was similar to 3 and not expressed in non-competitive experiments. DMN and DEN were also oxidized to HCO2H and CH3CO2H, respectively. In neither case was a lag observed, which was unexpected considering the k(cat) and K-m parameters measured for oxidation of DMN and DEN to the aldehydes and for oxidation of the aldehydes to the carboxylic acids. Spectral analysis did not indicate strong affinity of the aldehydes for P450 2A6, but pulse-chase experiments showed only limited exchange with added (unlabeled) aldehydes in the oxidations of DMN and DEN to carboxylic acids. Substoichiometric kinetic bursts were observed in the pre-steady-state oxidations of DMN and DEN to aldehydes. A minimal kinetic model was developed that was consistent with all of the observed phenomena and involves a conformational change of P450 2A6 following substrate binding, equilibrium of the P450-substrate complex with a non-productive form, and oxidation of the aldehydes to carboxylic acids in a process that avoids relaxation of the conformation following the first oxidation (i.e. of DMN or DEN to an aldehyde).	[Guengerich, F. Peter] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Toxicol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 638 Robinson Res Bldg,2200 Pierce Ave, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu			National Institutes of Health [R37 CA090426, T32 ES007028, F32 ES012123, P30 ES000267]; Merck fellowship; NATIONAL CANCER INSTITUTE [R37CA090426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007028, P30ES000267, F32ES012123] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 CA090426 and T32 ES007028 (to M. W. C.), F32 ES012123 (to M. W. C.), and P30 ES000267 (to G. C.). This work was also supported by a Merck fellowship (to G.C.)	BARTSCH H, 1990, MUTAT RES, V238, P255, DOI 10.1016/0165-1110(90)90017-6; Bell LC, 1997, J BIOL CHEM, V272, P29643, DOI 10.1074/jbc.272.47.29643; Bell R., 1966, ADV PHYS ORG CHEM, V4, P1, DOI DOI 10.1016/S0065-3160(08)60351-2; Bell-Parikh LC, 1999, J BIOL CHEM, V274, P23833, DOI 10.1074/jbc.274.34.23833; Carey F. A., 1990, ADV ORGANIC CHEM A, P683; COOK PF, 1993, BIOCHEMISTRY-US, V32, P1795, DOI 10.1021/bi00058a013; CRESPI CL, 1990, CARCINOGENESIS, V11, P1293, DOI 10.1093/carcin/11.8.1293; Fersht A., 1999, STRUCTURE MECH PROTE, P98; FISHMAN J, 1982, CANCER RES, V42, P3277; Furge LL, 1999, BIOCHEMISTRY-US, V38, P4818, DOI 10.1021/bi982163u; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; GREENZAID P, 1967, J AM CHEM SOC, V89, P756, DOI 10.1021/ja00980a005; GREENZAID P, 1967, J AM CHEM SOC, V89, P749, DOI 10.1021/ja00980a004; GROGAN J, 1993, BIOCHEMISTRY-US, V32, P12007, DOI 10.1021/bi00096a010; GROVES JT, 1978, BIOCHEM BIOPH RES CO, V81, P154, DOI 10.1016/0006-291X(78)91643-1; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Guengerich F. P., 2007, PRINCIPLES METHODS T, P1981; Guengerich FP, 1996, J BIOL CHEM, V271, P27321, DOI 10.1074/jbc.271.44.27321; GUENGERICH FP, 1984, J AM CHEM SOC, V106, P6446, DOI 10.1021/ja00333a071; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Guengerich FP, 2004, BIOCHEMISTRY-US, V43, P10775, DOI 10.1021/bi0491393; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HANZLIK RP, 1985, J AM CHEM SOC, V107, P7164, DOI 10.1021/ja00310a066; HANZLIK RP, 1993, J AM CHEM SOC, V115, P9363, DOI 10.1021/ja00074a001; Harrelson JP, 2008, BIOCHEMISTRY-US, V47, P2978, DOI 10.1021/bi702020y; Harrelson JP, 2007, BIOCHEM BIOPH RES CO, V352, P843, DOI 10.1016/j.bbrc.2006.11.071; Hecht SS, 1998, CHEM RES TOXICOL, V11, P559, DOI 10.1021/tx980005y; HJELMELAND LM, 1977, BIOCHEM BIOPH RES CO, V76, P541, DOI 10.1016/0006-291X(77)90758-6; Imai T, 1998, BIOCHEMISTRY-US, V37, P8097, DOI 10.1021/bi9802768; Jalas JR, 2003, CHEM RES TOXICOL, V16, P794, DOI 10.1021/tx034022l; Johnson EF, 2005, BIOCHEM BIOPH RES CO, V338, P331, DOI 10.1016/j.bbrc.2005.08.190; Johnson Kenneth A., 2003, P1; KEEFER LK, 1973, J NATL CANCER I, V51, P299, DOI 10.1093/jnci/51.1.299; KOOP DR, 1982, J BIOL CHEM, V257, P8472; Kunitoh S, 1997, J PHARMACOL EXP THER, V280, P527; LEVIN W, 1986, ARCH BIOCHEM BIOPHYS, V248, P158, DOI 10.1016/0003-9861(86)90412-1; LIJINSKY W, 1972, J NATL CANCER I, V49, P1239; LIJINSKY W, 1972, NATURE-NEW BIOL, V236, P177, DOI 10.1038/newbio236177a0; LOEPPKY RN, 1982, IARC SCI PUBL, V41, P41; Mariano P, 1993, ADV ELECT T, V3, P191; Matsson O, 1998, ADV PHYS ORG CHEM, V31, P143; Mesic M, 1996, J AM CHEM SOC, V118, P7412, DOI 10.1021/ja961178h; MICO BA, 1985, CANCER RES, V45, P6280; MIWA GT, 1987, BIOESSAYS, V7, P215, DOI 10.1002/bies.950070506; NORTHROP DB, 1975, BIOCHEMISTRY-US, V14, P2644, DOI 10.1021/bi00683a013; NORTHROP DB, 1982, METHOD ENZYMOL, V87, P607; OMURA T, 1964, J BIOL CHEM, V239, P2370; Ortiz de Montellano P. R., 2005, CYTOCHROME P450 STRU; Ortiz de Montellano P.R., 2005, CYTOCHROME P450 STRU, P183, DOI [10.1007/b139087, DOI 10.1007/B139087]; PALMER G, 1992, J BIOL CHEM, V267, P665; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Poulos T. L., 2005, CYTOCHROME P450 STRU, P87; PREUSSMANN R, 1984, CHEM CARCINOGENS, V2, P643; RYAN DE, 1986, ARCH BIOCHEM BIOPHYS, V246, P633, DOI 10.1016/0003-9861(86)90319-X; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Shaik S, 2004, J BIOL INORG CHEM, V9, P661, DOI 10.1007/s00775-004-0576-6; SHIMADA T, 1986, J BIOL CHEM, V261, P909; Soucek P, 1999, ARCH BIOCHEM BIOPHYS, V370, P190, DOI 10.1006/abbi.1999.1388; Soucy P, 2000, EUR J BIOCHEM, V267, P3243, DOI 10.1046/j.1432-1327.2000.01349.x; Spence RA, 1996, BIOCHEMISTRY-US, V35, P1054, DOI 10.1021/bi952058+; SUGIYAMA K, 1994, DRUG METAB DISPOS, V22, P584; Suo ZC, 1997, BIOCHEMISTRY-US, V36, P12459, DOI 10.1021/bi971217h; SUZUKI E, 1980, CHEM PHARM BULL, V28, P979; SWANN PF, 1983, CARCINOGENESIS, V4, P821, DOI 10.1093/carcin/4.7.821; TERELIUS Y, 1991, BIOCHEM BIOPH RES CO, V179, P689, DOI 10.1016/0006-291X(91)91427-E; TU YY, 1985, ARCH BIOCHEM BIOPHYS, V242, P32, DOI 10.1016/0003-9861(85)90476-X; VAZ ADN, 1994, BIOCHEMISTRY-US, V33, P13651, DOI 10.1021/bi00250a015; Vaz ADN, 1996, P NATL ACAD SCI USA, V93, P4644, DOI 10.1073/pnas.93.10.4644; WADE D, 1987, CANCER RES, V47, P3373; WALSH C, 1979, ENZYMATIC REACTION M, P122; Wang Q, 2009, J AM CHEM SOC, V131, P10629, DOI 10.1021/ja9031105; Wayner DDM, 1997, J AM CHEM SOC, V119, P8925, DOI 10.1021/ja971365v; WHITE RE, 1980, ANNU REV BIOCHEM, V49, P315, DOI 10.1146/annurev.bi.49.070180.001531; WRIGHTON SA, 1986, BIOCHEMISTRY-US, V25, P6731, DOI 10.1021/bi00370a001; WRIGHTON SA, 1987, ARCH BIOCHEM BIOPHYS, V258, P292, DOI 10.1016/0003-9861(87)90347-X; YAMAZAKI H, 1992, CARCINOGENESIS, V13, P1789, DOI 10.1093/carcin/13.10.1789; Yamazaki T, 1998, BIOCHEMISTRY-US, V37, P2800, DOI 10.1021/bi9715066; YANG CS, 1991, CHEM RES TOXICOL, V4, P408, DOI 10.1021/tx00022a002; Yano JK, 2006, J MED CHEM, V49, P6987, DOI 10.1021/jm060519r; Yano JK, 2005, NAT STRUCT MOL BIOL, V12, P822, DOI 10.1038/nsmb971; YOO JSH, 1988, CANCER RES, V48, P1499; Yun CH, 2005, J BIOL CHEM, V280, P12279, DOI 10.1074/jbc.M411019200; Yun CH, 2001, BIOCHEMISTRY-US, V40, P4521, DOI 10.1021/bi002906n	84	41	41	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8031	8044		10.1074/jbc.M109.088039	http://dx.doi.org/10.1074/jbc.M109.088039			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061389	Green Published, hybrid			2022-12-27	WOS:000275413800021
J	Gomes, AM; Kozlowski, EO; Pomin, VH; de Barros, CM; Zaganeli, JL; Pavao, MSG				Gomes, Angelica M.; Kozlowski, Eliene O.; Pomin, Vitor H.; de Barros, Cintia Monteiro; Zaganeli, Jose L.; Pavao, Mauro S. G.			Unique Extracellular Matrix Heparan Sulfate from the Bivalve Nodipecten nodosus (Linnaeus, 1758) Safely Inhibits Arterial Thrombosis after Photochemically Induced Endothelial Lesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHRIMP PENAEUS-BRASILIENSIS; HIGH ANTICOAGULANT ACTIVITY; MOLECULAR-WEIGHT HEPARIN; ANOMALOCARDIA-BRASILIANA; BINDING SEQUENCE; GLYCOSAMINOGLYCANS; PURIFICATION; TUNICATA; MOLLUSKS; C-13	Heparin-like glycans with diverse disaccharide composition and high anticoagulant activity have been described in several families of marine mollusks. The present work focused on the structural characterization of a new heparan sulfate (HS)-like polymer isolated from the mollusk Nodipecten nodosus (Linnaeus, 1758) and on its anticoagulant and antithrombotic properties. Total glycans were extracted from the mollusk and fractionated by ethanol precipitation. The main component (> 90%) was identified as HS-like glycosaminoglycan, representing similar to 4.6 mg g(-1) of dry tissue. The mollusk HS resists degradation with heparinase I but is cleaved by nitrous acid. Analysis of the mollusk glycan by one-dimensional H-1, two-dimensional correlated spectroscopy, and heteronuclear single quantum coherence nuclear magnetic resonance revealed characteristic signals of glucuronic acid and glucosamine residues. Signals corresponding to anomeric protons of nonsulfated, 3- or 2-sulfated glucuronic acid as well as N-sulfated and/or 6-sulfated glucosamine were also observed. The mollusk HS has an anticoagulant activity of 36 IU mg(-1), 5-fold lower than porcine heparin (180 IU mg(-1)), as measured by the activated partial thromboplastin time assay. It also inhibits factor Xa (IC50 = 0.835 mu g ml(-1)) and thrombin (IC50 = 9.3 mu g ml(-1)) in the presence of antithrombin. In vivo assays demonstrated that at the dose of 1 mg kg(-1), the mollusk HS inhibited thrombus growth in photochemically injured arteries. No bleeding effect, factor XIIa-mediated kallikrein activity, or toxic effect on fibroblast cells was induced by the invertebrate HS at the antithrombotic dose.	[Gomes, Angelica M.; Kozlowski, Eliene O.; de Barros, Cintia Monteiro; Pavao, Mauro S. G.] Univ Fed Rio de Janeiro, Lab Tecido Conjunt, Inst Bioquim Med, Programa Glicobiol, BR-21941590 Rio De Janeiro, Brazil; [Gomes, Angelica M.; Kozlowski, Eliene O.; de Barros, Cintia Monteiro; Pavao, Mauro S. G.] Univ Fed Rio de Janeiro, Hosp Univ Clementino Fraga Filho, BR-21941590 Rio De Janeiro, Brazil; [Pomin, Vitor H.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zaganeli, Jose L.] Inst Ecodesenvolvimento Baia Ilha Grande, BR-23905000 Angra Dos Reis, RJ, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; University System of Georgia; University of Georgia	Pavao, MSG (corresponding author), Hosp Univ Clementino Fraga Filho, Lab Tecido Conjunt, Rua Rodolpho Paulo Rocco 255,4 Andar,Sala 4A-8,Ci, BR-21941913 Rio De Janeiro, Brazil.	mpavao@hucff.ufrj.br	Wang, Lingchong/G-8417-2011; de Barros, Cintia Monteiro/AAP-8834-2021; Pavao, Mauro Sergio Goncalves/B-1979-2010	Pavao, Mauro Sergio Goncalves/0000-0002-1336-4271	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [PDE 201019/2008-6]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro; Mizutani Foundation for Glycoscience	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Mizutani Foundation for Glycoscience	The work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, and the Mizutani Foundation for Glycoscience (to M. S. G.; Supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Postdoctoral Fellowship PDE 201019/2008-6.	Arumugam M., 2004, Indian Journal of Experimental Biology, V42, P529; BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7; Bourne NF, 2000, AQUACULT INT, V8, P113, DOI 10.1023/A:1009212226803; BURSON SL, 1956, J AM CHEM SOC, V78, P5874, DOI 10.1021/ja01603a045; CARDOSO LEM, 1994, ARTERIOSCLER THROMB, V14, P115, DOI 10.1161/01.ATV.14.1.115; CASU B, 1981, BIOCHEM J, V197, P599, DOI 10.1042/bj1970599; Cavalcante MCM, 2000, J BIOL CHEM, V275, P36189, DOI 10.1074/jbc.M005830200; Cesaretti M, 2004, GLYCOBIOLOGY, V14, P1275, DOI 10.1093/glycob/cwh128; CHANTAL C, 2004, ADV SEA CUCUMBER AQU, P439; Chavante SF, 2000, INT J BIOL MACROMOL, V27, P49, DOI 10.1016/S0141-8130(99)00114-2; Choay J, 1981, Ann N Y Acad Sci, V370, P644, DOI 10.1111/j.1749-6632.1981.tb29770.x; Demir M, 2001, CLIN APPL THROMB-HEM, V7, P44, DOI 10.1177/107602960100700110; DIETRICH CP, 1985, BIOCHIM BIOPHYS ACTA, V843, P1, DOI 10.1016/0304-4165(85)90041-8; DIETRICH CP, 1989, INT J BIOL MACROMOL, V11, P361, DOI 10.1016/0141-8130(89)90008-1; Dietrich CP, 1999, BBA-GEN SUBJECTS, V1428, P273, DOI 10.1016/S0304-4165(99)00087-2; Guerrini M, 2005, ANAL BIOCHEM, V337, P35, DOI 10.1016/j.ab.2004.10.012; HELM MM, 2004, HATCHERY CULTURE BIV, P201; Herbert JM, 1996, CIRC RES, V79, P590, DOI 10.1161/01.RES.79.3.590; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; HOVINGH P, 1982, J BIOL CHEM, V257, P9840; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; JORDAN RE, 1986, ARCH BIOCHEM BIOPHYS, V248, P690, DOI 10.1016/0003-9861(86)90524-2; JORDAN RE, 1980, J BIOL CHEM, V255, P73; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; LINDAHL U, 1980, P NATL ACAD SCI-BIOL, V77, P6551, DOI 10.1073/pnas.77.11.6551; LINHARDT RJ, 1992, BIOCHEMISTRY-US, V31, P12441, DOI 10.1021/bi00164a020; Liu HY, 2009, NAT PROD REP, V26, P313, DOI 10.1039/b819896a; Luppi E, 2005, BIOMACROMOLECULES, V6, P1672, DOI 10.1021/bm049196b; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; MAEDAMARTINEZ AN, 2001, MOLUSCOS PECTINIDOS, P469; Melo EI, 2008, REV BRAS CIR CARDIOV, V23, P169, DOI 10.1590/S0102-76382008000200004; Mulloy B, 2000, THROMB HAEMOSTASIS, V84, P1052; NADER HB, 1984, J BIOL CHEM, V259, P1431; Pavao MSG, 1998, J BIOL CHEM, V273, P27848, DOI 10.1074/jbc.273.43.27848; PEJLER G, 1987, J BIOL CHEM, V262, P11413; Pomin VH, 2005, GLYCOBIOLOGY, V15, P1376, DOI 10.1093/glycob/cwj030; Santos JC, 2007, THROMB RES, V121, P213, DOI 10.1016/j.thromres.2007.03.025; Saravanan R, 2010, APPL BIOCHEM BIOTECH, V160, P791, DOI 10.1007/s12010-008-8498-3; Vicente CP, 2004, BLOOD, V104, P3965, DOI 10.1182/blood-2004-02-0598; Vijayabaskar P, 2008, METHOD FIND EXP CLIN, V30, P175, DOI 10.1358/mf.2008.30.3.1159654	40	52	52	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7312	7323		10.1074/jbc.M109.091546	http://dx.doi.org/10.1074/jbc.M109.091546			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053999	Green Published, hybrid			2022-12-27	WOS:000275415600043
J	Choi, LJ; Jenikova, G; Hanson, E; Spehlmann, ME; Boehling, NS; Kirstein, SL; Bundey, RA; Smith, JR; Insel, PA; Eckmann, L				Choi, Lillian J.; Jenikova, Gabriela; Hanson, Elaine; Spehlmann, Martina E.; Boehling, Nicholas S.; Kirstein, Shelli L.; Bundey, Richard A.; Smith, Jennifer R.; Insel, Paul A.; Eckmann, Lars			Coordinate Down-regulation of Adenylyl Cyclase Isoforms and the Stimulatory G Protein (G(s)) in Intestinal Epithelial Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; CHLORIDE SECRETION; PROSTAGLANDIN E-2; RETINOIC ACID; MESSENGER-RNA; COLON; RAT; CRYPT; CAMP; QUANTIFICATION	The intestinal epithelium is dynamic, with proliferation of undifferentiated crypt cells balanced by terminal differentiation and cell death at the colon surface or small intestinal villus tips. Cyclic AMP, induced by agonists such as prostaglandin E-2 and vasoactive intestinal polypeptide, promotes proliferation and ion secretion and suppresses apoptosis in intestinal epithelial cells. Here, we show that cell differentiation in a model intestinal epithelium leads to attenuation of cAMP production in response to G protein-coupled receptor and receptor-independent agonists. Concomitantly, key components of the cAMP cascade, the alpha subunit of the stimulatory G protein, G(s), and adenylyl cyclase (AC) isoforms 3, 4, 6, and 7 are down-regulated. By contrast, AC1, AC2, AC8, and AC9, and the receptors for prostaglandin E2 and vasoactive intestinal polypeptide, are not expressed or not affected by differentiation. We confirmed key findings in normal murine colon epithelium, in which the major AC isoforms and G(s)alpha are markedly down-regulated in differentiated surface cells. Suppression of AC isoforms and G(s)alpha is functionally important, because their constitutive expression completely reverses differentiation-induced cAMP attenuation. Thus, down-regulation of AC isoforms and G(s)alpha is an integral part of the intestinal epithelial differentiation program, perhaps serving to release cells from cAMP-promoted anti-apoptosis as a prerequisite for cell death upon terminal differentiation.	[Choi, Lillian J.; Jenikova, Gabriela; Hanson, Elaine; Spehlmann, Martina E.; Smith, Jennifer R.; Insel, Paul A.; Eckmann, Lars] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Boehling, Nicholas S.; Kirstein, Shelli L.; Bundey, Richard A.; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Eckmann, L (corresponding author), Univ Calif San Diego, Dept Med 0063, 9500 Gilman Dr, La Jolla, CA 92093 USA.	leckmann@ucsd.edu	Jenikova, Gabriela/G-6196-2014	Jenikova, Gabriela/0000-0002-1847-5456	National Institutes of Health [DK035108, HL066941, GM066232, T32 DK007202]; Digestive Diseases Research Development Center [DK80506]; Ellison Medical Foundation; Mucosaimmunologie gemeinnutzige Forschungsgesellschaft Educative Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL066941, T32HL007444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK080506, T32DK007202, P01DK035108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066232] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Development Center; Ellison Medical Foundation(Lawrence Ellison Foundation); Mucosaimmunologie gemeinnutzige Forschungsgesellschaft Educative Science; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK035108 (to L.E.), HL066941 (to P.A.I.), GM066232 (to P.A.I.), and Digestive Diseases Research Development Center Grant DK80506. This work was also supported by grants from the Ellison Medical Foundation (to P.A I.). 1 Supported by National Institutes of Health Training Grant T32 DK007202. 2 Supported by a fellowship from the Mucosaimmunologie gemeinnutzige Forschungsgesellschaft Educative Science.	Alrefai WA, 2007, AM J PHYSIOL-GASTR L, V293, pG923, DOI 10.1152/ajpgi.00029.2007; Amelsberg M, 1996, SCAND J GASTROENTERO, V31, P233, DOI 10.3109/00365529609004872; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; Belley A, 1999, GASTROENTEROLOGY, V117, P1352, DOI 10.1016/S0016-5085(99)70285-4; BRAY P, 1986, P NATL ACAD SCI USA, V83, P8893, DOI 10.1073/pnas.83.23.8893; Bundey RA, 2003, ANAL BIOCHEM, V319, P318, DOI 10.1016/S0003-2697(03)00325-7; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Dudeja PK, 1996, AM J PHYSIOL-GASTR L, V271, pG483, DOI 10.1152/ajpgi.1996.271.3.G483; Freeman SL, 2004, GUT, V53, P214, DOI 10.1136/gut.2003.023895; Gao MH, 1998, P NATL ACAD SCI USA, V95, P1038, DOI 10.1073/pnas.95.3.1038; Guo J, 2009, J BIOL CHEM, V284, P134, DOI 10.1074/jbc.M806133200; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Hanoune J, 1997, MOL CELL ENDOCRINOL, V128, P179, DOI 10.1016/S0303-7207(97)04013-6; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Hoogerwerf WA, 1996, AM J PHYSIOL-GASTR L, V270, pG29, DOI 10.1152/ajpgi.1996.270.1.G29; Izu LT, 2002, J MEMBRANE BIOL, V186, P145, DOI 10.1007/s00232-001-0145-7; Jourdan KB, 2001, AM J PHYSIOL-LUNG C, V280, pL1359, DOI 10.1152/ajplung.2001.280.6.L1359; Kolachala V, 2005, J BIOL CHEM, V280, P4048, DOI 10.1074/jbc.M409577200; Kosinski C, 2007, P NATL ACAD SCI USA, V104, P15418, DOI 10.1073/pnas.0707210104; Krupinski John, 1998, Advances in Second Messenger and Phosphoprotein Research, V32, P53; Lipskaia L, 1997, FEBS LETT, V415, P275, DOI 10.1016/S0014-5793(97)01001-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Marnett LJ, 2002, ANNU REV PHARMACOL, V42, P55, DOI 10.1146/annurev.pharmtox.42.082301.164620; Matthews JB, 1998, J CLIN INVEST, V101, P2072, DOI 10.1172/JCI1042; Milligan G, 1996, CELL SIGNAL, V8, P87, DOI 10.1016/0898-6568(95)02034-9; Morimoto K, 1997, AM J PHYSIOL-GASTR L, V272, pG681, DOI 10.1152/ajpgi.1997.272.3.G681; Mutoh M, 2002, CANCER RES, V62, P28; Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100; Nlend MC, 2007, FEBS LETT, V581, P3241, DOI 10.1016/j.febslet.2007.06.015; Olsen L, 2005, AM J PHYSIOL-GASTR L, V289, pG220, DOI 10.1152/ajpgi.00449.2004; Ostrom RS, 2000, J PHARMACOL EXP THER, V294, P407; POST SR, 1995, BIOCHEM J, V311, P75, DOI 10.1042/bj3110075; QUILL H, 1975, GASTROENTEROLOGY, V69, P470; Resta-Lenert S, 2001, AM J PHYSIOL-CELL PH, V281, pC1837, DOI 10.1152/ajpcell.2001.281.6.C1837; Sadana R, 2009, NEUROSIGNALS, V17, P5, DOI 10.1159/000166277; Shao JY, 2005, J BIOL CHEM, V280, P26565, DOI 10.1074/jbc.M413056200; Sheng HM, 1998, CANCER RES, V58, P362; Strazzabosco M, 2009, HEPATOLOGY, V50, P244, DOI 10.1002/hep.22926; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Tabuchi Y, 2002, BIOCHEM BIOPH RES CO, V293, P1287, DOI 10.1016/S0006-291X(02)00365-0; Takahashi H, 1998, ARCH DERMATOL RES, V290, P407, DOI 10.1007/s004030050327; TRABER PG, 1992, AM J PHYSIOL, V262, pG123, DOI 10.1152/ajpgi.1992.262.1.G123; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; Zachos NC, 2005, ANNU REV PHYSIOL, V67, P411, DOI 10.1146/annurev.physiol.67.031103.153004	47	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12504	12511		10.1074/jbc.M109.059741	http://dx.doi.org/10.1074/jbc.M109.059741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157112	hybrid, Green Published			2022-12-27	WOS:000276787800007
J	Popp, D; Iwasa, M; Erickson, HP; Narita, A; Maeda, Y; Robinson, RC				Popp, David; Iwasa, Mitsusada; Erickson, Harold P.; Narita, Akihiro; Maeda, Yuichiro; Robinson, Robert C.			Suprastructures and Dynamic Properties of Mycobacterium tuberculosis FtsZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL-DIVISION; COUNTERION CONDENSATION; ACTIN BUNDLE; Z-RING; HYDROLYSIS; NUCLEATION; MECHANISM; GROWTH; MODEL; SIZE	Tuberculosis causes the most death in humans by any bacterium. Drug targeting of bacterial cytoskeletal proteins requires detailed knowledge of the various filamentous suprastructures and dynamic properties. Here, we have investigated by high resolution electron microscopy the assembly of cell division protein and microtubule homolog FtsZ from Mycobacterium tuberculosis (MtbFtsZ) in vitro in the presence of various monovalent salts, crowding agents and polycations. Supramolecular structures, including two-dimensional rings, three-dimensional toroids, and multistranded helices formed in the presence of molecular crowding, were similar to those observed by fluorescence microscopy in bacteria in vivo. Dynamic properties of MtbFtsZ filaments were visualized by light scattering and real time total internal reflection fluorescence microscopy. Interestingly, MtbFtsZ revealed a form of dynamic instability at steady state. Cation-induced condensation phenomena of bacterial cytomotive polymers have not been investigated in any detail, although it is known that many bacteria can contain high amounts of polycations, which may modulate the prokaryotic cytoskeleton. We find that above a threshold concentration of polycations which varied with the valence of the cation, ionic strength, and pH, MtbFtsZ mainly formed sheets. The general features of these cation-induced condensation phenomena could be explained in the framework of the Manning condensation theory. Chirality and packing defects limited the dimensions of sheets and toroids at steady state as predicted by theoretical models. In first approximation simple physical principles seem to govern the formation of MtbFtsZ suprastructures.	[Popp, David; Robinson, Robert C.] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Popp, David; Iwasa, Mitsusada; Narita, Akihiro; Maeda, Yuichiro] RIKEN, Harima Inst Spring 8, Japan Sci & Technol Corp, ERATO Actin Filament Dynam Project, Sayo, Hyogo 6795148, Japan; [Erickson, Harold P.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Narita, Akihiro; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Japan Science & Technology Agency (JST); RIKEN; Duke University; Nagoya University; Nagoya University	Popp, D (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Proteos 138673, Singapore.	dpopp@imcb.a-star.edu.sg	Robinson, Robert/G-9702-2011	Robinson, Robert/0000-0001-6367-6903	Agency for Science, Technology, and Research (A*STAR), Singapore	Agency for Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology, and Research (A*STAR), Singapore (R.C.R.).	Adams DW, 2009, NAT REV MICROBIOL, V7, P642, DOI 10.1038/nrmicro2198; Borukhov L, 2005, P NATL ACAD SCI USA, V102, P3673, DOI 10.1073/pnas.0404140102; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chen Y, 2007, J BIOL CHEM, V282, P27736, DOI 10.1074/jbc.M703788200; Chen YD, 2009, BIOCHEMISTRY-US, V48, P6664, DOI 10.1021/bi8022653; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; Flyvbjerg H, 1996, PHYS REV E, V54, P5538, DOI 10.1103/PhysRevE.54.5538; Gov NS, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.011916; Grason GM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098101; Ha BY, 1999, EUROPHYS LETT, V46, P624, DOI 10.1209/epl/i1999-00311-6; Henle ML, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.060801; Hud NV, 2005, ANNU REV BIOPH BIOM, V34, P295, DOI 10.1146/annurev.biophys.34.040204.144500; KRULWICH TA, 1985, J BACTERIOL, V162, P768, DOI 10.1128/JB.162.2.768-772.1985; Kwon HJ, 2006, BIOCHEMISTRY-US, V45, P10313, DOI 10.1021/bi060721w; Lai GH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.187802; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Manning GS, 1998, J BIOMOL STRUCT DYN, V16, P461, DOI 10.1080/07391102.1998.10508261; MANNING GS, 1978, BIOPHYS CHEM, V9, P65, DOI 10.1016/0301-4622(78)87016-1; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Oosawa F., 1975, THERMODYNAMICS POLYM; Park SY, 1998, BIOPHYS J, V75, P714, DOI 10.1016/S0006-3495(98)77561-7; Peters PC, 2007, MOL MICROBIOL, V64, P487, DOI 10.1111/j.1365-2958.2007.05673.x; Popp D, 2008, BIOPOLYMERS, V89, P711, DOI 10.1002/bip.20999; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2009, BIOPOLYMERS, V91, P340, DOI 10.1002/bip.21136; Romberg L, 2004, BIOCHEMISTRY-US, V43, P282, DOI 10.1021/bi035465r; SHINDLER DB, 1977, J BACTERIOL, V130, P698, DOI 10.1128/JB.130.2.698-703.1977; TABOR CW, 1985, MICROBIOL REV, V49, P81, DOI 10.1128/MMBR.49.1.81-99.1985; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; VIOTTI A, 1971, BIOCHIM BIOPHYS ACTA, V244, P329, DOI 10.1016/0304-4165(71)90234-0; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025	34	34	36	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11281	11289		10.1074/jbc.M109.084079	http://dx.doi.org/10.1074/jbc.M109.084079			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139085	Green Published, hybrid			2022-12-27	WOS:000276286200034
J	Boysen, A; Moller-Jensen, J; Kallipolitis, B; Valentin-Hansen, P; Overgaard, M				Boysen, Anders; Moller-Jensen, Jakob; Kallipolitis, Birgitte; Valentin-Hansen, Poul; Overgaard, Martin			Translational Regulation of Gene Expression by an Anaerobically Induced Small Non-coding RNA in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERODIMERIC ABC TRANSPORTER; SM-LIKE PROTEIN; OUTER-MEMBRANE; FNR PROTEIN; SUPEROXIDE-DISMUTASE; TARGET RECOGNITION; OXIDATIVE STRESS; HFQ; TRANSCRIPTION; MANGANESE	Small non-coding RNAs (sRNA) have emerged as important elements of gene regulatory circuits. In enterobacteria such as Escherichia coli and Salmonella many of these sRNAs interact with the Hfq protein, an RNA chaperone similar to mammalian Sm-like proteins and act in the post-transcriptional regulation of many genes. A number of these highly conserved ribo-regulators are stringently regulated at the level of transcription and are part of major regulons that deal with the immediate response to various stress conditions, indicating that every major transcription factor may control the expression of at least one sRNA regulator. Here, we extend this view by the identification and characterization of a highly conserved, anaerobically induced small sRNA in E. coli, whose expression is strictly dependent on the anaerobic transcriptional fumarate and nitrate reductase regulator (FNR). The sRNA, named FnrS, possesses signatures of base-pairing RNAs, and we show by employing global proteomic and transcriptomic profiling that the expression of multiple genes is negatively regulated by the sRNA. Intriguingly, many of these genes encode enzymes with "aerobic" functions or enzymes linked to oxidative stress. Furthermore, in previous work most of the potential target genes have been shown to be repressed by FNR through an undetermined mechanism. Collectively, our results provide insight into the mechanism by which FNR negatively regulates genes such as sodA, sodB, cydDC, and metE, thereby demonstrating that adaptation to anaerobic growth involves the action of a small regulatory RNA.	[Boysen, Anders; Moller-Jensen, Jakob; Kallipolitis, Birgitte; Valentin-Hansen, Poul; Overgaard, Martin] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Southern Denmark	Valentin-Hansen, P (corresponding author), Campusvej 55, DK-5230 Odense M, Denmark.	valentin@bmb.sdu.dk	Møller-Jensen, Jakob/AAO-8480-2020	Møller-Jensen, Jakob/0000-0002-6008-3771; Kallipolitis, Birgitte H./0000-0003-1233-9776; Overgaard, Martin/0000-0003-2277-590X; Boysen, Anders/0000-0001-9171-6669	Danish National Research Foundation; Lundbeck Foundation; Danish Natural Science Research Council	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Danish Natural Science Research Council(Danish Natural Science Research Council)	This work was supported by the Danish National Research Foundation (Grundforskningsfonden), The Lundbeck Foundation, and the Danish Natural Science Research Council.	Aiba H, 2007, CURR OPIN MICROBIOL, V10, P134, DOI 10.1016/j.mib.2007.03.010; Altuvia S, 1997, CELL, V90, P43, DOI 10.1016/S0092-8674(00)80312-8; Arluison V, 2007, NUCLEIC ACIDS RES, V35, P999, DOI 10.1093/nar/gkl1124; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; BEAUMONT MD, 1993, J GEN MICROBIOL, V139, P2677, DOI 10.1099/00221287-139-11-2677; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; COMPAN I, 1993, J BACTERIOL, V175, P1687, DOI 10.1128/JB.175.6.1687-1696.1993; COMPAN I, 1994, MOL MICROBIOL, V11, P955, DOI 10.1111/j.1365-2958.1994.tb00374.x; Constantinidou C, 2006, J BIOL CHEM, V281, P4802, DOI 10.1074/jbc.M512312200; Cook GM, 1997, J BACTERIOL, V179, P6525, DOI 10.1128/jb.179.20.6525-6530.1997; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; De Lay N, 2009, J BACTERIOL, V191, P461, DOI 10.1128/JB.01157-08; Delihas N, 2001, J MOL BIOL, V313, P1, DOI 10.1006/jmbi.2001.5029; DURAND S, 2010, MOL MICROBI IN PRESS; Franch T, 1997, J MOL BIOL, V273, P38, DOI 10.1006/jmbi.1997.1294; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Grainger DC, 2007, NUCLEIC ACIDS RES, V35, P269, DOI 10.1093/nar/gkl1023; GUEST RJ, 1996, REGULATION GENE EXPR, P317; Guillier M, 2006, MOL MICROBIOL, V59, P231, DOI 10.1111/j.1365-2958.2005.04929.x; Hammer BK, 2007, P NATL ACAD SCI USA, V104, P11145, DOI 10.1073/pnas.0703860104; HASSAN HM, 1992, P NATL ACAD SCI USA, V89, P3217, DOI 10.1073/pnas.89.8.3217; Hondorp ER, 2004, PLOS BIOL, V2, P1738, DOI 10.1371/journal.pbio.0020336; HOPKIN KA, 1992, J BIOL CHEM, V267, P24253; Johansen J, 2008, J MOL BIOL, V383, P1, DOI 10.1016/j.jmb.2008.06.058; Kang YS, 2005, J BACTERIOL, V187, P1135, DOI 10.1128/JB.187.3.1135-1160.2005; Khoroshilova N, 1997, P NATL ACAD SCI USA, V94, P6087, DOI 10.1073/pnas.94.12.6087; Lazazzera BA, 1996, J BIOL CHEM, V271, P2762, DOI 10.1074/jbc.271.5.2762; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Li B, 1998, NUCLEIC ACIDS RES, V26, P2075, DOI 10.1093/nar/26.9.2075; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Masse E, 2007, CURR OPIN MICROBIOL, V10, P140, DOI 10.1016/j.mib.2007.03.013; Melville SB, 1996, P NATL ACAD SCI USA, V93, P1226, DOI 10.1073/pnas.93.3.1226; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Moon K, 2009, MOL MICROBIOL, V74, P1314, DOI 10.1111/j.1365-2958.2009.06944.x; Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Overgaard M, 2009, MOL MICROBIOL, V73, P790, DOI 10.1111/j.1365-2958.2009.06807.x; Papenfort K, 2008, MOL MICROBIOL, V68, P890, DOI 10.1111/j.1365-2958.2008.06189.x; Partridge JD, 2006, J BIOL CHEM, V281, P27806, DOI 10.1074/jbc.M603450200; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; POOLE RK, 1994, FEMS MICROBIOL LETT, V117, P217, DOI 10.1111/j.1574-6968.1994.tb06768.x; Prokhorova TA, 2006, VACCINE, V24, P6446, DOI 10.1016/j.vaccine.2006.05.085; Rasmussen AA, 2009, MOL MICROBIOL, V72, P566, DOI 10.1111/j.1365-2958.2009.06688.x; Rogowska-Wrzesinska A, 2001, COMP FUNCT GENOM, V2, P207, DOI 10.1002/cfg.94; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Salmon K, 2003, J BIOL CHEM, V278, P29837, DOI 10.1074/jbc.M213060200; Sambrook J., 1989, MOL CLONING LAB MANU, P3; SAWERS RG, 1988, ARCH MICROBIOL, V149, P240, DOI 10.1007/BF00422011; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; SMITH MW, 1983, J BACTERIOL, V154, P336, DOI 10.1128/JB.154.1.336-343.1983; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Urban JH, 2007, NUCLEIC ACIDS RES, V35, P1018, DOI 10.1093/nar/gkl1040; Urban Johannes H., 2009, V540, P301, DOI 10.1007/978-1-59745-558-9_22; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; Vanderpool CK, 2007, CURR OPIN MICROBIOL, V10, P146, DOI 10.1016/j.mib.2007.03.011; Vogel J, 2009, MOL MICROBIOL, V71, P1, DOI 10.1111/j.1365-2958.2008.06505.x; Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	67	83	90	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10690	10702		10.1074/jbc.M109.089755	http://dx.doi.org/10.1074/jbc.M109.089755			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20075074	Green Published, hybrid			2022-12-27	WOS:000276264600056
J	Ritchie, MF; Yue, CY; Zhou, YD; Houghton, PJ; Soboloff, J				Ritchie, Michael F.; Yue, Chanyu; Zhou, Yandong; Houghton, Peter J.; Soboloff, Jonathan			Wilms Tumor Suppressor 1 (WT1) and Early Growth Response 1 (EGR1) Are Regulators of STIM1 Expression*	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE WT1; CALCIUM INFLUX; RHABDOID TUMOR; IN-VITRO; CELL; ORAI1; CRAC; DIFFERENTIATION; ACTIVATION; INHIBITION	Store-operated calcium entry (SOCE) is a key evolutionarily conserved process whereby decreases in endoplasmic reticulum Ca2+ content lead to the influx of Ca2+ across the plasma membrane. How this process is regulated in specific tumor cell types is poorly understood. In an effort to address this concern, we obtained and tested primary Wilms tumor cells, finding no detectable SOCE in this cell type. Analysis of the expression levels of STIM1 and ORAI1 (the molecular mediators of SOC) revealed poor STIM1 expression. Analysis of the STIM1 promoter using the TESS search system (University of Pennsylvania) revealed four putative response elements to the zinc-finger proteins WT1 (Wilms tumor suppressor 1) and EGR1 (early growth response 1). Either overexpression of WT1 or knockdown of EGR1 resulted in loss of STIM1 expression and a resultant decrease in SOCE. Furthermore, examination of Egr1 knock-out animals revealed loss of STIM1 expression in multiple tissues. Finally, using chromatin immunoprecipitation, we reveal direct binding of both WT1 and EGR1 to putative response elements located within 500 bp of the transcriptional start site of STIM1. Considering that WT1 and EGR1 are well described oncogenes and tumor suppressors, these observations may reveal new mechanisms responsible for distinct Ca2+ signals in cancer cells.	[Ritchie, Michael F.; Yue, Chanyu; Zhou, Yandong; Soboloff, Jonathan] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Houghton, Peter J.] Nationwide Childrens Hosp, Childrens Canc Ctr, Columbus, OH 43205 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Soboloff, J (corresponding author), Temple Univ, Sch Med, Dept Biochem, 3400 N Broad St, Philadelphia, PA 19140 USA.	soboloff@temple.edu	Yue, Chanyu/H-1792-2015; Soboloff, Jonathan/I-6995-2012	Soboloff, Jonathan/0000-0001-5192-1297	Pennsylvania Department of Health; American Heart Association [0730184N]	Pennsylvania Department of Health; American Heart Association(American Heart Association)	This work was supported by a grant from the Pennsylvania Department of Health (to J.S.) and by Grant 0730184N from the American Heart Association (to J.S.).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Ahn BH, 2007, FEBS LETT, V581, P5940, DOI 10.1016/j.febslet.2007.11.077; Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; COLE K, 1994, CANCER METAST REV, V13, P31, DOI 10.1007/BF00690417; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Deng XX, 2009, J BIOL CHEM, V284, P22501, DOI 10.1074/jbc.R109.018655; DEY BR, 1994, MOL ENDOCRINOL, V8, P595, DOI 10.1210/me.8.5.595; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; GARVIN AJ, 1993, AM J PATHOL, V142, P375; Ghanem MA, 2000, CLIN CANCER RES, V6, P4265; Graham C, 2006, CLIN CANCER RES, V12, P223, DOI 10.1158/1078-0432.CCR-05-1225; GRUBB GR, 1994, LAB INVEST, V71, P472; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hamilton TB, 1998, BIOCHEMISTRY-US, V37, P2051, DOI 10.1021/bi9717993; HARRINGTON MA, 1993, J BIOL CHEM, V268, P21271; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Krones-Herzig A, 2005, CANCER RES, V65, P5133, DOI 10.1158/0008-5472.CAN-04-3742; LEE SL, 1995, J BIOL CHEM, V270, P9971, DOI 10.1074/jbc.270.17.9971; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Little M, 1997, HUM MUTAT, V9, P209, DOI 10.1002/(SICI)1098-1004(1997)9:3<209::AID-HUMU2>3.0.CO;2-2; Loeb DM, 2001, CANCER RES, V61, P921; Luik RM, 2007, TRENDS MOL MED, V13, P103, DOI 10.1016/j.molmed.2007.01.004; Ma HT, 2000, SCIENCE, V287, P1647, DOI 10.1126/science.287.5458.1647; MIWA H, 1992, LEUKEMIA, V6, P405; Morton CL, 2007, INVEST NEW DRUG, V25, P285, DOI 10.1007/s10637-007-9042-y; Oji Y, 2004, CANCER SCI, V95, P822, DOI 10.1111/j.1349-7006.2004.tb02188.x; Potier M, 2009, FASEB J, V23, P2425, DOI 10.1096/fj.09-131128; POWIS G, 1994, CANCER CHEMOTH PHARM, V34, P344, DOI 10.1007/BF00686043; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sabbioni S, 1999, CYTOGENET CELL GENET, V86, P214, DOI 10.1159/000015341; Sabbioni S, 1997, CANCER RES, V57, P4493; Sarfstein R, 2006, J NEUROCHEM, V99, P818, DOI 10.1111/j.1471-4159.2006.04119.x; Soboloff J, 2005, J BIOL CHEM, V280, P39786, DOI 10.1074/jbc.M506064200; Soboloff J, 2002, EXP HEMATOL, V30, P1219, DOI 10.1016/S0301-472X(02)00893-7; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; SUKHATME VP, 1988, CELL, V53, P37, DOI 10.1016/0092-8674(88)90485-0; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; WANG ZY, 1992, J BIOL CHEM, V267, P21999; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900	45	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10591	10596		10.1074/jbc.M109.083493	http://dx.doi.org/10.1074/jbc.M109.083493			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123987	hybrid, Green Published			2022-12-27	WOS:000276264600046
J	Wang, Y; Fu, Y; Gao, L; Zhu, GX; Liang, J; Gao, C; Huang, BL; Fenger, U; Niehrs, C; Chen, YG; Wu, W				Wang, Ying; Fu, Yu; Gao, Lei; Zhu, Guixin; Liang, Juan; Gao, Chan; Huang, Binlu; Fenger, Ursula; Niehrs, Christof; Chen, Ye-Guang; Wu, Wei			Xenopus Skip Modulates Wnt/beta-Catenin Signaling and Functions in Neural Crest Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED TRANSCRIPTION; BETA-CATENIN; INTERACTING PROTEIN; WNT PATHWAY; SNW DOMAIN; ACTIVATION; GENE; TRANSDUCTION; EXPRESSION; CANCER	The beta-catenin-lymphoid enhancer factor (LEF) protein complex is the key mediator of canonical Wnt signaling and initiates target gene transcription upon ligand stimulation. In addition to beta-catenin and LEF themselves, many other proteins have been identified as necessary cofactors. Here we report that the evolutionally conserved splicing factor and transcriptional co-regulator, SKIP/SNW/NcoA62, forms a ternary complex with LEF1 and HDAC1 and mediates the repression of target genes. Loss-of-function studies showed that SKIP is obligatory for Wnt signaling-induced target gene transactivation, suggesting an important role of SKIP in the canonical Wnt signaling. Consistent with its involvement in beta-catenin signaling, the C-terminally truncated forms of SKIP are able to stabilize beta-catenin and enhance Wnt signaling. In Xenopus embryos, both overexpression and knockdown of Skip lead to reduced neural crest induction, consistent with down-regulated Wnt signaling in both cases. Our results indicate that SKIP is a novel component of the beta-catenin transcriptional complex.	[Chen, Ye-Guang; Wu, Wei] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Ying; Fu, Yu; Gao, Lei; Zhu, Guixin; Liang, Juan; Huang, Binlu; Wu, Wei] Tsinghua Univ, Prot Sci Lab, Minist Educ, Beijing 100084, Peoples R China; [Gao, Chan; Chen, Ye-Guang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Fenger, Ursula; Niehrs, Christof] German Canc Res Ctr, Div Mol Embryol, D-69120 Heidelberg, Germany	Tsinghua University; Tsinghua University; Tsinghua University; Helmholtz Association; German Cancer Research Center (DKFZ)	Wu, W (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	wwu@mail.tsinghua.edu.cn	Gao, Chan/D-7964-2013; Chen, Ye-Guang/L-6998-2019		Major Science Programs of China [2006CB943401, 2006CB943402]	Major Science Programs of China	This work was supported by Grants 2006CB943401 (to Y. G. C.) and 2006CB943402 (to W. W.) from The Major Science Programs of China.	Abu-Elmagd M, 2006, DEV BIOL, V298, P285, DOI 10.1016/j.ydbio.2006.06.037; Agius E, 2000, DEVELOPMENT, V127, P1173; Albers M, 2003, RNA, V9, P138, DOI 10.1261/rna.2119903; Ambrozkova M, 2001, BIOCHEM BIOPH RES CO, V284, P1148, DOI 10.1006/bbrc.2001.5108; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Baudino TA, 1998, J BIOL CHEM, V273, P16434, DOI 10.1074/jbc.273.26.16434; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; BLITZ IL, 1995, DEVELOPMENT, V121, P993; Brembeck FH, 2006, CURR OPIN GENET DEV, V16, P51, DOI 10.1016/j.gde.2005.12.007; Bres V, 2005, GENE DEV, V19, P1211, DOI 10.1101/gad.1291705; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dahl R, 1998, ONCOGENE, V16, P1579, DOI 10.1038/sj.onc.1201687; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Folk P, 2004, CELL MOL LIFE SCI, V61, P629, DOI 10.1007/s00018-003-3215-4; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Heeg-Truesdell E, 2006, DEV BIOL, V298, P71, DOI 10.1016/j.ydbio.2006.06.015; Hong CS, 2008, DEVELOPMENT, V135, P3903, DOI 10.1242/dev.026229; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jurica MS, 2002, RNA, V8, P426, DOI 10.1017/S1355838202021088; Kim YJ, 2001, HUM MOL GENET, V10, P1129, DOI 10.1093/hmg/10.11.1129; Knochel S, 2001, MECH DEVELOP, V109, P79, DOI 10.1016/S0925-4773(01)00506-8; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kostrouchova M, 2002, P NATL ACAD SCI USA, V99, P9254, DOI 10.1073/pnas.112213799; LaBonne C, 1998, DEVELOPMENT, V125, P2403; Leong GM, 2001, J BIOL CHEM, V276, P18243, DOI 10.1074/jbc.M010815200; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Martinkova K, 2002, J BIOCHEM, V132, P557, DOI 10.1093/oxfordjournals.jbchem.a003257; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Negeri D, 2002, MECH DEVELOP, V117, P151, DOI 10.1016/S0925-4773(02)00193-4; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Prathapam T, 2002, NUCLEIC ACIDS RES, V30, P5261, DOI 10.1093/nar/gkf658; Prathapam T, 2001, ONCOGENE, V20, P7677, DOI 10.1038/sj.onc.1204960; Prathapam T, 2001, NUCLEIC ACIDS RES, V29, P3469, DOI 10.1093/nar/29.17.3469; Raible DW, 2006, CURR OPIN CELL BIOL, V18, P698, DOI 10.1016/j.ceb.2006.09.003; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Ryo A, 2001, NAT CELL BIOL, V3, P793, DOI 10.1038/ncb0901-793; Sakai D, 2005, DEV GROWTH DIFFER, V47, P471, DOI 10.1111/j.1440-169X.2005.00821.x; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Vallin J, 2001, J BIOL CHEM, V276, P30350, DOI 10.1074/jbc.M103167200; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018; Willert K, 1998, CURR OPIN GENET DEV, V8, P95, DOI 10.1016/S0959-437X(98)80068-3; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Wu JL, 2005, DEV BIOL, V279, P220, DOI 10.1016/j.ydbio.2004.12.016; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000; Zhou SF, 2000, J VIROL, V74, P1939, DOI 10.1128/JVI.74.4.1939-1947.2000	66	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10890	10901		10.1074/jbc.M109.058347	http://dx.doi.org/10.1074/jbc.M109.058347			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20103590	hybrid, Green Published			2022-12-27	WOS:000276264600074
J	Jang, PG; Namkoong, C; Kang, GM; Hur, MW; Kim, SW; Kim, GH; Kang, Y; Jeon, MJ; Kim, EH; Lee, MS; Karin, M; Baik, JH; Park, JY; Lee, KU; Kim, YB; Kim, MS				Jang, Pil-Geum; Namkoong, Cherl; Kang, Gil Myoung; Hur, Man-Wook; Kim, Seung-Whan; Kim, Geun Hyang; Kang, Yeoungsup; Jeon, Min-Jae; Kim, Eun Hee; Lee, Myung-Shik; Karin, Michael; Baik, Ja-Hyun; Park, Joong-Yeol; Lee, Ki-Up; Kim, Young-Bum; Kim, Min-Seon			NF-kappa B Activation in Hypothalamic Pro-opiomelanocortin Neurons Is Essential in Illness- and Leptin-induced Anorexia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOOD-INTAKE; RECEPTOR; ALPHA; CACHEXIA; PROTEIN; LIPOPOLYSACCHARIDE; PHOSPHORYLATION; SUPPRESSION; EXPRESSION; CYTOKINES	Anorexia and weight loss are prevalent in infectious diseases. To investigate the molecular mechanisms underlying these phenomena, we established animal models of infection-associated anorexia by administrating bacterial and viral products, lipopolysaccharide (LPS) and human immunodeficiency virus-1 transactivator protein (Tat). In these models, we found that the nuclear factor-kappa B (NF-kappa B), a pivotal transcription factor for inflammation-related proteins, was activated in the hypothalamus. In parallel, administration of LPS and Tat increased hypothalamic pro-inflammatory cytokine production, which was abrogated by inhibition of hypothalamic NF-kappa B. In vitro, NF-kappa B activation directly stimulated the transcriptional activity of proopiomelanocortin (POMC), a precursor of anorexigenic melanocortin, and mediated the stimulatory effects of LPS, Tat, and pro-inflammatory cytokines on POMC transcription, implying the involvement of NF-kappa B in controlling feeding behavior. Consistently, hypothalamic injection of LPS and Tat caused a significant reduction in food intake and body weight, which was prevented by blockade of NF-kappa B and melanocortin. Furthermore, disruption of I kappa B kinase-beta, an upstream kinase of NF-kappa B, in POMC neurons attenuated LPS- and Tat-induced anorexia. These findings suggest that infection-associated anorexia and weight loss are mediated via NF-kappa B activation in hypothalamic POMC neurons. In addition, hypothalamic NF-kappa B was activated by leptin, an important anorexigenic hormone, and mediates leptin-stimulated POMC transcription, indicating that hypothalamic NF-kappa B also serves as a downstream signaling pathway of leptin.	[Kim, Min-Seon] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Seoul 138736, South Korea; [Jang, Pil-Geum; Namkoong, Cherl; Kang, Gil Myoung; Kang, Yeoungsup; Jeon, Min-Jae] Univ Ulsan, Coll Med, Asan Inst Life Sci, Seoul 138736, South Korea; [Kim, Seung-Whan; Kim, Geun Hyang] Univ Ulsan, Coll Med, Dept Pharmacol, Seoul 138736, South Korea; [Hur, Man-Wook] Yonsei Univ, Coll Med, Dept Biochem & Mol Biol, Seoul 120752, South Korea; [Lee, Myung-Shik] Sungkyunkwan Univ, Sch Med, Dept Med, Seoul 135710, South Korea; [Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, La Jolla, CA 92093 USA; [Baik, Ja-Hyun] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA 02215 USA	University of Ulsan; Asan Medical Center; University of Ulsan; University of Ulsan; Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); University of California System; University of California San Diego; Korea University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Kim, MS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Internal Med,Div Endocrinol & Metab, 388-1 Pungnap Dong, Seoul 138736, South Korea.	mskim@amc.seoul.kr	Choi, Hyung Jin/AAU-9629-2020; Lee, Myung Shik/C-9606-2011	Lee, Myung-Shik/0000-0003-3292-1720; Kim, Seung-Whan/0000-0001-6983-0481; Hur, Man-Wook/0000-0002-3416-1334; NamKoong, Cherl/0000-0002-1869-4405	Korean Ministry of Health Welfare [A06-2363]; Korea government [2006-0050225, 2007-0056866, 2009-0079566, KRF-2008-313-E00083, 2009-0084114]; Asan Institute for Life Science [06-326]	Korean Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Korea government(Korean Government); Asan Institute for Life Science	This work was supported by the Korean Ministry of Health & Welfare (Grant A06-2363), the National Research Foundation of Korea funded by the Korea government (Grants 2006-0050225, 2007-0056866, 2009-0079566, KRF-2008-313-E00083, and 2009-0084114), and the Asan Institute for Life Science (Grant 06-326).	AUBERT A, 1995, PHYSIOL BEHAV, V57, P869, DOI 10.1016/0031-9384(94)00391-H; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bjorbaek C, 1998, MOL CELL, V1, P619, DOI 10.1016/S1097-2765(00)80062-3; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Catania A, 2000, TRENDS ENDOCRIN MET, V11, P304, DOI 10.1016/S1043-2760(00)00296-4; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; DeBoer MD, 2007, CURR OPIN CLIN NUTR, V10, P457, DOI 10.1097/MCO.0b013e328108f441; Ellacott KLJ, 2006, PHILOS T R SOC B, V361, P1265, DOI 10.1098/rstb.2006.1861; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Grinspoon S, 2003, CLIN INFECT DIS, V36, pS69, DOI 10.1086/367561; GRUNFELD C, 1992, NEW ENGL J MED, V327, P329, DOI 10.1056/NEJM199207303270506; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864; Joppa MA, 2007, PEPTIDES, V28, P636, DOI 10.1016/j.peptides.2006.11.021; Joppa MA, 2005, PEPTIDES, V26, P2294, DOI 10.1016/j.peptides.2005.03.002; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kawamura I, 1999, GENE THER, V6, P91, DOI 10.1038/sj.gt.3300819; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kim MS, 2004, NAT MED, V10, P727, DOI 10.1038/nm1061; LANGHANS W, 1990, PHYSIOL BEHAV, V47, P805, DOI 10.1016/0031-9384(90)90001-K; Lawrence CB, 2001, J NEUROENDOCRINOL, V13, P490, DOI 10.1046/j.1365-2826.2001.00660.x; Marks DL, 2003, ENDOCRINOLOGY, V144, P1513, DOI 10.1210/en.2002-221099; MCCARTHY DO, 1984, AM J CLIN NUTR, V40, P310, DOI 10.1093/ajcn/40.2.310; Meffert MK, 2005, TRENDS NEUROSCI, V28, P37, DOI 10.1016/j.tins.2004.11.002; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; MURRAY MJ, 1979, AM J CLIN NUTR, V32, P593, DOI 10.1093/ajcn/32.3.593; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; Plata-Salaman C, 2001, INT J OBESITY, V25, pS48, DOI 10.1038/sj.ijo.0801911; Plata-Salaman CR, 1998, AM J PHYSIOL-REG I, V275, pR566, DOI 10.1152/ajpregu.1998.275.2.R566; Raso GM, 2006, NEUROSCI LETT, V396, P121, DOI 10.1016/j.neulet.2005.11.022; RICE AP, 1988, NATURE, V332, P551, DOI 10.1038/332551a0; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Seeley RJ, 1997, NATURE, V390, P349, DOI 10.1038/37016; Tang CH, 2007, J IMMUNOL, V179, P1292, DOI 10.4049/jimmunol.179.2.1292; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Valerio A, 2009, STROKE, V40, P610, DOI 10.1161/STROKEAHA.108.528588; Wisse BE, 2003, ANN NY ACAD SCI, V994, P275, DOI 10.1111/j.1749-6632.2003.tb03190.x; Wisse BE, 2007, ENDOCRINOLOGY, V148, P5230, DOI 10.1210/en.2007-0394; Yamamoto Y, 2004, TRENDS BIOCHEM SCI, V29, P72, DOI 10.1016/j.tibs.2003.12.003; Yang Li, 2007, Neurosci Bull, V23, P307, DOI 10.1007/s12264-007-0046-6; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	42	67	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9706	9715		10.1074/jbc.M109.070706	http://dx.doi.org/10.1074/jbc.M109.070706			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097762	Green Published, hybrid			2022-12-27	WOS:000276165900043
J	Mao, AP; Li, S; Zhong, B; Li, Y; Yan, J; Li, Q; Teng, CW; Shu, HB				Mao, Ai-Ping; Li, Shu; Zhong, Bo; Li, Ying; Yan, Jie; Li, Qi; Teng, Chengwen; Shu, Hong-Bing			Virus-triggered Ubiquitination of TRAF3/6 by cIAP1/2 Is Essential for Induction of Interferon-beta (IFN-beta) and Cellular Antiviral Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NEGATIVE REGULATION; SIGNALING COMPLEX; ADAPTER PROTEIN; ACTIVATION PATHWAYS; I INTERFERON; LIGASE; INNATE; KINASE; TRANSDUCTION	Viral infection causes activation of transcription factors NF-kappa B and IRF3, which collaborate to induce type I interferons (IFNs) and cellular antiviral response. Here we show that knockdown of the E3 ubiquitin ligases cIAP1 and cIAP2 markedly inhibited virus-triggered activation of IRF3 and NF-kappa B as well as IFN-beta induction. Knockdown of cIAP1 and cIAP2 also inhibited cytoplasmic dsRNA-triggered cellular antiviral response. Endogenous coimmunoprecipitation experiments indicated that viral infection caused recruitment of cIAP1 and cIAP2 to TRAF3, TRAF6, and VISA. Furthermore, we demonstrated that cIAP1- and cIAP2-mediated virus-triggered ubiquitination of TRAF3 and TRAF6. These findings suggest that virus-triggered ubiquitination of TRAF3 and TRAF6 by cIAP1 and cIAP2 is essential for type I IFN induction and cellular antiviral response.	[Mao, Ai-Ping; Li, Shu; Zhong, Bo; Li, Ying; Yan, Jie; Li, Qi; Teng, Chengwen; Shu, Hong-Bing] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University	Shu, HB (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China.	shuh@whu.edu.cn	Teng, Chengwen/G-8393-2019	Teng, Chengwen/0000-0001-9239-2125	Chinese 973 Program [2006CB504301, 2010CB911802]; National Natural Science Foundation of China [30630019, 30921001]; Chinese Science and Technology Key Project [2008ZX10002-014]; Chinese 111 project [B06018]	Chinese 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Science and Technology Key Project; Chinese 111 project(Ministry of Education, China - 111 Project)	This work was supported by grants from the Chinese 973 Program (2006CB504301, 2010CB911802), the National Natural Science Foundation of China (30630019 and 30921001), the Chinese Science and Technology Key Project (2008ZX10002-014), and the Chinese 111 project (B06018).	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhang Y, 2008, T NONFERR METAL SOC, V18, P1094, DOI 10.1016/S1003-6326(08)60187-9; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	36	105	113	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9470	9476		10.1074/jbc.M109.071043	http://dx.doi.org/10.1074/jbc.M109.071043			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097753	hybrid, Green Published			2022-12-27	WOS:000276165900020
J	Oakley, AJ; Coggan, M; Board, PG				Oakley, Aaron J.; Coggan, Marjorie; Board, Philip G.			Identification and Characterization of gamma-Glutamylamine Cyclotransferase, an Enzyme Responsible for gamma-Glutamyl-epsilon-lysine Catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; GLUTAMYLCYCLOTRANSFERASE; ERYTHROCYTES; PURIFICATION; SPECIFICITY; ALIGNMENT; CYCLASE; SYSTEM	gamma-Glutamylamine cyclotransferase (GGACT) is an enzyme that converts gamma-glutamylamines to free amines and 5-oxoproline. GGACT shows high activity toward gamma-glutamyl-epsilon-lysine, derived from the breakdown of fibrin and other proteins crosslinked by transglutaminases. The enzyme adopts the newly identified cyclotransferase fold, observed in gamma-glutamylcyclotransferase (GGCT), an enzyme with activity toward gamma-glutamyl-alpha-amino acids (Oakley, A. J., Yamada, T., Liu, D., Coggan, M., Clark, A. G., and Board, P. G. (2008) J. Biol. Chem. 283, 22031-22042). Despite the absence of significant sequence identity, several residues are conserved in the active sites of GGCT and GGACT, including a putative catalytic acid/base residue (GGACT Glu(82)). The structure of GGACT in complex with the reaction product 5-oxoproline provides evidence for a common catalytic mechanism in both enzymes. The proposed mechanism, combined with the three-dimensional structures, also explains the different substrate specificities of these enzymes. Despite significant sequence divergence, there are at least three subfamilies in prokaryotes and eukaryotes that have conserved the GGCT fold and GGCT enzymatic activity.	[Coggan, Marjorie; Board, Philip G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Oakley, Aaron J.] CSIRO, Div Mol & Hlth Technol, Parkville, Vic 3052, Australia	Australian National University; John Curtin School of Medical Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Board, PG (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, POB 334, Canberra, ACT 2601, Australia.	Philip.Board@anu.edu.au	Oakley, Aaron/A-9464-2013	Oakley, Aaron/0000-0002-4764-014X	Australian Research Council [DP0880027]; National Health and Medical Research Council [525458]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by Australian Research Council Discovery Grant DP0880027 and National Health and Medical Research Council Project Grant 525458.	BOARD PG, 1978, J LAB CLIN MED, V91, P127; BOARD PG, 1978, BIOCHEM J, V173, P427, DOI 10.1042/bj1730427; Catanzariti AM, 2004, PROTEIN SCI, V13, P1331, DOI 10.1110/ps.04618904; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FINK ML, 1980, P NATL ACAD SCI-BIOL, V77, P4564, DOI 10.1073/pnas.77.8.4564; FINK ML, 1981, MOL CELL BIOCHEM, V38, P59, DOI 10.1007/BF00235688; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Klock HE, 2005, PROTEINS, V61, P1132, DOI 10.1002/prot.20610; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Llewellyn NM, 2007, CHEM BIOL, V14, P379, DOI 10.1016/j.chembiol.2007.02.005; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oakley AJ, 2008, J BIOL CHEM, V283, P22031, DOI 10.1074/jbc.M803623200; ORLOWSKI M, 1969, BIOCHEMISTRY-US, V8, P1048, DOI 10.1021/bi00831a036; ORLOWSKI M, 1973, J BIOL CHEM, V248, P2836; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; PISANO JJ, 1968, SCIENCE, V160, P892, DOI 10.1126/science.160.3830.892; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; STEINKAMP R, 1987, PHYSIOL PLANTARUM, V69, P499, DOI 10.1111/j.1399-3054.1987.tb09231.x; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029	23	30	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9642	9648		10.1074/jbc.M109.082099	http://dx.doi.org/10.1074/jbc.M109.082099			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110353	Green Published, hybrid			2022-12-27	WOS:000276165900037
J	Sunagawa, Y; Morimoto, T; Takaya, T; Kaichi, S; Wada, H; Kawamura, T; Fujita, M; Shimatsu, A; Kita, T; Hasegawa, K				Sunagawa, Yoichi; Morimoto, Tatsuya; Takaya, Tomohide; Kaichi, Shinji; Wada, Hiromichi; Kawamura, Teruhisa; Fujita, Masatoshi; Shimatsu, Akira; Kita, Toru; Hasegawa, Koji			Cyclin-dependent Kinase-9 Is a Component of the p300/GATA4 Complex Required for Phenylephrine-induced Hypertrophy in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE ACETYLTRANSFERASE ACTIVITY; TRANSCRIPTION FACTOR GATA-4; P-TEFB; CARDIAC MYOCYTES; HEART-FAILURE; IN-VIVO; COACTIVATOR P300; GENE-EXPRESSION; CDK9/CYCLIN T2	A zinc finger protein GATA4 is one of the hypertrophy-responsive transcription factors and forms a complex with an intrinsic histone acetyltransferase, p300. Disruption of this complex results in the inhibition of cardiomyocyte hypertrophy and heart failure in vivo. By tandem affinity purification and mass spectrometric analyses, we identified cyclin-dependent kinase-9 (Cdk9) as a novel GATA4-binding partner. Cdk9 also formed a complex with p300 as well as GATA4 and cyclin T1. We showed that p300 was required for the interaction of GATA4 with Cdk9 and for the kinase activity of Cdk9. Conversely, Cdk9 kinase activity was required for the p300-induced transcriptional activities, DNA binding, and acetylation of GATA4. Furthermore, the kinase activity of Cdk9 was required for the phosphorylation of p300 as well as for cardiomyocyte hypertrophy. These findings demonstrate that Cdk9 forms a functional complex with the p300/GATA4 and is required for p300/GATA4-transcriptional pathway during cardiomyocyte hypertrophy.	[Sunagawa, Yoichi; Morimoto, Tatsuya; Takaya, Tomohide; Kaichi, Shinji; Wada, Hiromichi; Kawamura, Teruhisa; Hasegawa, Koji] Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Fushimi Ku, Kyoto 6128555, Japan; [Shimatsu, Akira] Natl Hosp Org, Kyoto Med Ctr, Clin Res Inst, Fushimi Ku, Kyoto 6128555, Japan; [Takaya, Tomohide; Kita, Toru] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Sakyo Ku, Kyoto 6068507, Japan; [Kaichi, Shinji] Kyoto Univ, Grad Sch Med, Dept Pediat, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Kyoto University	Morimoto, T (corresponding author), Natl Hosp Org, Kyoto Med Ctr, Div Translat Res, Fushimi Ku, 1-1 Mukaihata Cho, Kyoto 6128555, Japan.	mori@kuhp.kyoto-u.ac.jp	Shimatsu, Akira/I-3856-2019; Takaya, Tomohide/D-6372-2012; Sunagawa, Yoichi/AAU-6354-2021	Takaya, Tomohide/0000-0002-3610-0906; Wada, Hiromichi/0000-0002-8980-224X	Ministry of Education, Culture, Sports, Science and Technology of Japan; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation; Ichiro Kanehara Foundation for the Promotion of Medical Science and Medical Care	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Ichiro Kanehara Foundation for the Promotion of Medical Science and Medical Care	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to K.H. and T.M.) and by grants (to T.M.) from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, Takeda Science Foundation, Mitsubishi Pharma Research Foundation, The Uehara Memorial Foundation, and The Ichiro Kanehara Foundation for the Promotion of Medical Science and Medical Care.	Ait-Si-Ali S, 1999, BIOCHEM BIOPH RES CO, V262, P157, DOI 10.1006/bbrc.1999.1132; Ait-Si-Ali S, 1998, NATURE, V396, P184, DOI 10.1038/24190; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Belaguli NS, 2000, MOL CELL BIOL, V20, P7550, DOI 10.1128/MCB.20.20.7550-7558.2000; Chan HM, 2001, J CELL SCI, V114, P2363; Charron F, 1999, MOL CELL BIOL, V19, P4355; Dai YS, 2001, J BIOL CHEM, V276, P37178, DOI 10.1074/jbc.M103731200; Dominguez L J, 1999, Cardiologia, V44, P801; Eberhardy SR, 2002, J BIOL CHEM, V277, P40156, DOI 10.1074/jbc.M207441200; Fu JHJ, 2007, MOL CELL BIOL, V27, P4641, DOI 10.1128/MCB.00857-06; Giacinti C, 2006, J CELL PHYSIOL, V206, P807, DOI 10.1002/jcp.20523; Hirai M, 2004, J BIOL CHEM, V279, P37640, DOI 10.1074/jbc.M401737200; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Kakita T, 1999, J BIOL CHEM, V274, P34096, DOI 10.1074/jbc.274.48.34096; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kanazawa S, 2000, IMMUNITY, V12, P61, DOI 10.1016/S1074-7613(00)80159-4; Kawamura T, 2005, J BIOL CHEM, V280, P19682, DOI 10.1074/jbc.M412428200; Kawamura T, 2004, BIOCHEM BIOPH RES CO, V315, P733, DOI 10.1016/j.bbrc.2004.01.105; Li HL, 2008, J CLIN INVEST, V118, P879, DOI 10.1172/JCI32865; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liou LY, 2002, J VIROL, V76, P10579, DOI 10.1128/JVI.76.21.10579-10587.2002; Miyamoto S, 2006, CIRCULATION, V113, P679, DOI 10.1161/CIRCULATIONAHA.105.585182; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Morimoto T, 2000, J BIOL CHEM, V275, P13721, DOI 10.1074/jbc.275.18.13721; Morimoto T, 2008, J CLIN INVEST, V118, P868, DOI 10.1172/JCI33160; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Peterkin T, 2005, SEMIN CELL DEV BIOL, V16, P83, DOI 10.1016/j.semcdb.2004.10.003; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000; Sano M, 2004, EMBO J, V23, P3559, DOI 10.1038/sj.emboj.7600351; Sano M, 2002, NAT MED, V8, P1310, DOI 10.1038/nm778; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Takaya T, 2008, J BIOL CHEM, V283, P9828, DOI 10.1074/jbc.M707391200; Tanaka T, 2006, J BIOL CHEM, V281, P15320, DOI 10.1074/jbc.M510954200; Temsah R, 2005, REGUL PEPTIDES, V128, P177, DOI 10.1016/j.regpep.2004.12.026; Tian YN, 2003, J BIOL CHEM, V278, P44041, DOI 10.1074/jbc.M306443200; Verdecchia P, 2001, J AM COLL CARDIOL, V38, P1829, DOI 10.1016/S0735-1097(01)01663-1; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Wang J, 2005, MOL CELL BIOL, V25, P9829, DOI 10.1128/MCB.25.22.9829-9844.2005; Yanazume T, 2003, MOL CELL BIOL, V23, P3593, DOI 10.1128/MCB.23.10.3593-3606.2003; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575; Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5; Yuan LW, 2002, BBA-MOL CELL RES, V1592, P205, DOI 10.1016/S0167-4889(02)00327-0; Yuan WC, 1996, J BIOL CHEM, V271, P9009, DOI 10.1074/jbc.271.15.9009	50	58	64	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9556	9568		10.1074/jbc.M109.070458	http://dx.doi.org/10.1074/jbc.M109.070458			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20081228	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000276165900029
J	Wen, H; Li, JZ; Song, TJ; Lu, M; Kan, PY; Lee, MG; Sha, BD; Shi, XB				Wen, Hong; Li, Jingzhi; Song, Tanjing; Lu, Ming; Kan, Pu-Yeh; Lee, Min Gyu; Sha, Bingdong; Shi, Xiaobing			Recognition of Histone H3K4 Trimethylation by the Plant Homeodomain of PHF2 Modulates Histone Demethylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; LYSINE-4 TRIMETHYLATION; CHROMATIN MODIFICATIONS; GENE-EXPRESSION; METHYLATION; TRANSCRIPTION; DOMAIN; COMPLEX; NURF; CODE	Distinct lysine methylation marks on histones create dynamic signatures deciphered by the "effector" modules, although the underlying mechanisms remain unclear. We identified the plant homeodomain-and Jumonji C domain-containing protein PHF2 as a novel histone H3K9 demethylase. We show in biochemical and crystallographic analyses that PHF2 recognizes histone H3K4 trimethylation through its plant homeodomain finger and that this interaction is essential for PHF2 occupancy and H3K9 demethylation at rDNA promoters. Our study provides molecular insights into the mechanism by which distinct effector domains within a protein cooperatively modulate the "cross-talk" of histone modifications.	[Wen, Hong; Song, Tanjing; Lu, Ming; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kan, Pu-Yeh; Lee, Min Gyu] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wen, Hong; Song, Tanjing; Kan, Pu-Yeh; Lee, Min Gyu; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Houston, TX 77030 USA; [Wen, Hong; Song, Tanjing; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Genes & Dev Grad Program, Houston, TX 77030 USA; [Li, Jingzhi; Sha, Bingdong] Univ Alabama, Dept Cell Biol, Birmingham, AL 35205 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Alabama System; University of Alabama Birmingham	Shi, XB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	xbshi@mdanderson.org	song, tanjing/N-7539-2013	Shi, Xiaobing/0000-0001-5242-8189; Wen, Hong/0000-0001-8739-4572	Welch Foundation [G1719]; American Cancer Society; University of Texas M. D. Anderson Cancer Center	Welch Foundation(The Welch Foundation); American Cancer Society(American Cancer Society); University of Texas M. D. Anderson Cancer Center	This work was supported by Welch Foundation Grant G1719 and institutional research grants from the American Cancer Society and The University of Texas M. D. Anderson Cancer Center.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wen H, 2008, GENE DEV, V22, P601, DOI 10.1101/gad.1626308; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	26	110	113	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9322	9326		10.1074/jbc.C109.097667	http://dx.doi.org/10.1074/jbc.C109.097667			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20129925	Green Published, hybrid			2022-12-27	WOS:000276165900003
J	Fernandez-Messina, L; Ashiru, O; Boutet, P; Aguera-Gonzalez, S; Skepper, JN; Reyburn, HT; Vales-Gomez, M				Fernandez-Messina, Lola; Ashiru, Omodele; Boutet, Philippe; Aguera-Gonzalez, Sonia; Skepper, Jeremy N.; Reyburn, Hugh T.; Vales-Gomez, Mar			Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN-RELATED MOLECULES; CLASS-I; EXPRESSION; NK; RECEPTOR; RELEASE; MICA; PROTEINS; IMMUNORECEPTOR; CYTOTOXICITY	Tumor cells release NKG2D ligands to evade NKG2D-mediated immune surveillance. The purpose of our investigation was to explore the cellular mechanisms of release used by various members of the ULBP family. Using biochemical and cellular approaches in both transfectant systems and tumor cell lines, this paper shows that ULBP1, ULBP2, and ULBP3 are released from cells with different kinetics and by distinct mechanisms. Whereas ULBP2 is mainly shed by metalloproteases, ULBP3 is abundantly released as part of membrane vesicles known as exosomes. Interestingly, exosomal ULBP3 protein is much more potent for down-modulation of the NKG2D receptor than soluble ULBP2 protein. This is the first report showing functionally relevant differences in the biochemistry of the three members of the ULBP family and confirms that in depth study of the biochemical features of individual NKG2D ligands will be necessary to understand and manipulate the biology of these proteins for therapy.	[Fernandez-Messina, Lola; Ashiru, Omodele; Boutet, Philippe; Aguera-Gonzalez, Sonia; Reyburn, Hugh T.; Vales-Gomez, Mar] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Skepper, Jeremy N.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QP, England	University of Cambridge; University of Cambridge	Vales-Gomez, M (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	mv231@cam.ac.uk	Ashiru, Omodele/AAD-1193-2020; Fernández-Messina, Lola/ABH-4496-2020; Vales-Gomez, Mar/ABG-7808-2020; Reyburn, Hugh T/B-4338-2009; Valés-Gómez, Mar/F-5351-2012	Fernández-Messina, Lola/0000-0002-2163-8746; Vales-Gomez, Mar/0000-0001-7424-3206; Reyburn, Hugh T/0000-0003-2855-1595; Valés-Gómez, Mar/0000-0001-7424-3206	Medical Research Council; Medical Research Council [G0601165, G9800943] Funding Source: researchfish; MRC [G0601165, G9800943] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by the Medical Research Council.	Aguera-Gonzalez S, 2009, J IMMUNOL, V182, P4800, DOI 10.4049/jimmunol.0800713; Apps R, 2008, HUM REPROD, V23, P2535, DOI 10.1093/humrep/den223; Boissel N, 2006, J IMMUNOL, V176, P5108, DOI 10.4049/jimmunol.176.8.5108; Borchers MT, 2006, AM J PHYSIOL-LUNG C, V291, pL222, DOI 10.1152/ajplung.00327.2005; Boutet P, 2009, J IMMUNOL, V182, P49, DOI 10.4049/jimmunol.182.1.49; Castriconi R, 2003, P NATL ACAD SCI USA, V100, P4120, DOI 10.1073/pnas.0730640100; Clayton A, 2008, J IMMUNOL, V180, P7249, DOI 10.4049/jimmunol.180.11.7249; Clayton A, 2007, CANCER RES, V67, P7458, DOI 10.1158/0008-5472.CAN-06-3456; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; DELALUNA S, 1992, METHOD ENZYMOL, V216, P376; Doubrovina ES, 2003, J IMMUNOL, V171, P6891, DOI 10.4049/jimmunol.171.12.6891; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eleme K, 2004, J EXP MED, V199, P1005, DOI 10.1084/jem.20032194; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Holdenrieder S, 2006, CANCER IMMUNOL IMMUN, V55, P1584, DOI 10.1007/s00262-006-0167-1; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Jinushi M, 2003, INT J CANCER, V104, P354, DOI 10.1002/ijc.10966; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Lopez-Botet M, 2004, TISSUE ANTIGENS, V63, P195, DOI 10.1111/j.1399-0039.2004.00210.x; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Nice TJ, 2009, J EXP MED, V206, P287, DOI 10.1084/jem.20081335; Onda H, 2001, BIOCHEM BIOPH RES CO, V285, P235, DOI 10.1006/bbrc.2001.5149; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; Raffaghello L, 2004, NEOPLASIA, V6, P558, DOI 10.1593/neo.04316; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Vales-Gomez M, 2008, CANCER RES, V68, P1546, DOI 10.1158/0008-5472.CAN-07-2973; Vales-Gomez Mar, 2003, BMC Immunol, V4, P4, DOI 10.1186/1471-2172-4-4; Vetter CS, 2004, BRIT J CANCER, V91, P1495, DOI 10.1038/sj.bjc.6602123; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Waldhauer I, 2008, CANCER RES, V68, P6368, DOI 10.1158/0008-5472.CAN-07-6768; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wills MR, 2005, J IMMUNOL, V175, P7457, DOI 10.4049/jimmunol.175.11.7457; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206; Wu JD, 2009, CLIN CANCER RES, V15, P632, DOI 10.1158/1078-0432.CCR-08-1305; Zwirner NW, 1999, HUM IMMUNOL, V60, P323, DOI 10.1016/S0198-8859(98)00128-1	46	119	121	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8543	8551		10.1074/jbc.M109.045906	http://dx.doi.org/10.1074/jbc.M109.045906			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080967	Green Published, hybrid			2022-12-27	WOS:000275553700006
J	Osakabe, Y; Mizuno, S; Tanaka, H; Maruyama, K; Osakabe, K; Todaka, D; Fujita, Y; Kobayashi, M; Shinozaki, K; Yamaguchi-Shinozaki, K				Osakabe, Yuriko; Mizuno, Shinji; Tanaka, Hidenori; Maruyama, Kyonoshin; Osakabe, Keishi; Todaka, Daisuke; Fujita, Yasunari; Kobayashi, Masatomo; Shinozaki, Kazuo; Yamaguchi-Shinozaki, Kazuko			Overproduction of the Membrane-bound Receptor-like Protein Kinase 1, RPK1, Enhances Abiotic Stress Tolerance in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN GENE NETWORK; ABSCISIC-ACID; FATTY-ACID; OXIDATIVE STRESS; PLANT HORMONE; WATER-STRESS; DROUGHT; COLD; DEHYDRATION; VERSATILE	RPK1 (receptor-like protein kinase 1) localizes to the plasma membrane and functions as a regulator of abscisic acid (ABA) signaling in Arabidopsis. In our current study, we investigated the effect of RPK1 disruption and overproduction upon plant responses to drought stress. Transgenic Arabidopsis overexpressing the RPK1 protein showed increased ABA sensitivity in their root growth and stomatal closure and also displayed less transpirational water loss. In contrast, a mutant lacking RPK1 function, rpk1-1, was found to be resistant to ABA during these processes and showed increased water loss. RPK1 overproduction in these transgenic plants thus increased their tolerance to drought stress. We performed microarray analysis of RPK1 transgenic plants and observed enhanced expression of several stress-responsive genes, such as Cor15a, Cor15b, and rd29A, in addition to H2O2-responsive genes. Consistently, the expression levels of ABA/stress-responsive genes in rpk1-1 had decreased compared with wild type. The results suggest that the overproduction of RPK1 enhances both the ABA and drought stress signaling pathways. Furthermore, the leaves of the rpk1-1 plants exhibit higher sensitivity to oxidative stress upon ABA-pretreatment, whereas transgenic plants overproducing RPK1 manifest increased tolerance to this stress. Our current data suggest therefore that RPK1 overproduction controls reactive oxygen species homeostasis and enhances both water and oxidative stress tolerance in Arabidopsis.	[Osakabe, Yuriko; Tanaka, Hidenori; Todaka, Daisuke; Yamaguchi-Shinozaki, Kazuko] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Mizuno, Shinji; Maruyama, Kyonoshin; Fujita, Yasunari; Yamaguchi-Shinozaki, Kazuko] JIRCAS, Biol Resources Div, Tsukuba, Ibaraki 3058686, Japan; [Mizuno, Shinji] Chiba Univ, Grad Sch Sci & Technol, Chiba 2638522, Japan; [Osakabe, Keishi] Natl Inst Agrobiol Sci, Dept Plant Biotechnol, Tsukuba, Ibaraki 3058602, Japan; [Kobayashi, Masatomo] RIKEN Bioresource Ctr, Expt Plant Div, Tsukuba, Ibaraki 3050074, Japan; [Shinozaki, Kazuo] RIKEN Plant Sci Ctr, Gene Discovery Res Grp, Kanagawa 2300045, Japan	University of Tokyo; Japan International Research Center for Agricultural Sciences; Chiba University; National Institute of Agrobiological Sciences - Japan; RIKEN; RIKEN	Yamaguchi-Shinozaki, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akys@mail.ecc.u-tokyo.ac.jp	Kobayashi, Masatomo/A-5945-2016; Mizuno, Shinji/HGC-6716-2022; Fujita, Yasunari/P-9861-2018; Yamaguchi-Shinozaki, Kazuko/K-9004-2015; åè, æé/ABH-5084-2020; Shinozaki, Kazuo/AAB-4945-2019; Osakabe, Yuriko/Y-2507-2019; Osakabe, Yuriko/GRI-9818-2022; Shinozaki, Kazuo/G-4202-2013; Maruyama, Kyonoshin/I-9191-2012	Fujita, Yasunari/0000-0002-5036-8319; Yamaguchi-Shinozaki, Kazuko/0000-0002-0249-8258; Shinozaki, Kazuo/0000-0002-6317-9867; Osakabe, Yuriko/0000-0001-5503-1427; Osakabe, Yuriko/0000-0001-5503-1427; Shinozaki, Kazuo/0000-0002-6317-9867; Maruyama, Kyonoshin/0000-0001-7725-0380; Tanaka, Hidenori/0000-0003-0266-1745	Japan Society for the Promotion of Science [21580125]; Ministry of Agriculture, Forestry and Fisheries, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries, Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work was supported by Japan Society for the Promotion of Science Grant-in aid for Scientific Research C 21580125 (to Y.O.) and by the Ministry of Agriculture, Forestry and Fisheries, Japan.	Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Dievart A, 2004, DEVELOPMENT, V131, P251, DOI 10.1242/dev.00998; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Franke R, 2007, CURR OPIN PLANT BIOL, V10, P252, DOI 10.1016/j.pbi.2007.04.004; Gendron JM, 2007, CURR OPIN PLANT BIOL, V10, P436, DOI 10.1016/j.pbi.2007.08.015; Goepfert S, 2007, CURR OPIN PLANT BIOL, V10, P245, DOI 10.1016/j.pbi.2007.04.007; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Hirayama T, 2007, TRENDS PLANT SCI, V12, P343, DOI 10.1016/j.tplants.2007.06.013; Hong SW, 1997, PLANT PHYSIOL, V113, P1203, DOI 10.1104/pp.113.4.1203; Iuchi S, 2000, PLANT PHYSIOL, V123, P553, DOI 10.1104/pp.123.2.553; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kondo T, 2006, SCIENCE, V313, P845, DOI 10.1126/science.1128439; Kwak JM, 2006, PLANT PHYSIOL, V141, P323, DOI 10.1104/pp.106.079004; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Li S, 2006, PLOS BIOL, V4, P1732, DOI 10.1371/journal.pbio.0040312; Lim PO, 2007, PLANT J, V52, P1140, DOI 10.1111/j.1365-313X.2007.03317.x; Lopez MA, 2008, CURR OPIN PLANT BIOL, V11, P420, DOI 10.1016/j.pbi.2008.05.002; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; Matsubayashi Y, 2002, SCIENCE, V296, P1470, DOI 10.1126/science.1069607; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Mizuno S, 2007, PLANT J, V50, P751, DOI 10.1111/j.1365-313X.2007.03083.x; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nodine MD, 2007, DEV CELL, V12, P943, DOI 10.1016/j.devcel.2007.04.003; Osakabe Y, 2005, PLANT CELL, V17, P1105, DOI 10.1105/tpc.104.027474; Osakabe Y, 2002, BIOCHEM BIOPH RES CO, V293, P806, DOI 10.1016/S0006-291X(02)00286-3; Pandey S, 2009, CELL, V136, P136, DOI 10.1016/j.cell.2008.12.026; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sakuma Y, 2006, P NATL ACAD SCI USA, V103, P18822, DOI 10.1073/pnas.0605639103; Schippers JHM, 2008, PLANT CELL, V20, P2909, DOI 10.1105/tpc.107.056341; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Shockey JM, 2002, PLANT PHYSIOL, V129, P1710, DOI 10.1104/pp.003269; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Umezawa T, 2006, PLANT J, V46, P171, DOI 10.1111/j.1365-313X.2006.02683.X; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Weber H, 2002, TRENDS PLANT SCI, V7, P217, DOI 10.1016/S1360-1385(02)02250-1; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263	57	95	106	1	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9190	9201		10.1074/jbc.M109.051938	http://dx.doi.org/10.1074/jbc.M109.051938			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089852	Green Published, hybrid			2022-12-27	WOS:000275553700068
J	Chandra, A; Chen, L; Liang, HY; Madura, K				Chandra, Abhishek; Chen, Li; Liang, Huiyan; Madura, Kiran			Proteasome Assembly Influences Interaction with Ubiquitinated Proteins and Shuttle Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PARTICLE; SACCHAROMYCES-CEREVISIAE; CORE PARTICLE; MITOCHONDRIAL MORPHOLOGY; TERMINAL DOMAIN; SUBSTRATE ENTRY; BINDING PROTEIN; 20S PROTEASOMES; 26S PROTEASOME; SUBUNIT RPN11	A major fraction of intracellular protein degradation is mediated by the proteasome. Successful degradation of these substrates requires ubiquitination and delivery to the proteasome followed by protein unfolding and disassembly of the multiubiquitin chain. Enzymes, such as Rpn11, dismantle multiubiquitin chains, and mutations can affect proteasome assembly and activity. We report that different rpn11 mutations can affect proteasome interaction with ubiquitinated proteins. Moreover, proteasomes are unstable in rpn11-1 and do not form productive interactions with multiubiquitinated proteins despite high levels in cell extracts. However, increased levels of ubiquitinated proteins were found associated with shuttle factors. In contrast to rpn11-1, proteasomes expressing a catalytically inactive mutant (rpn11(AXA)) were more stable and bound very high amounts of ubiquitinated substrates. Expression of the carboxyl-terminal domain of Rpn11 partially suppressed the growth and proteasome stability defects of rpn11-1. These results indicate that ubiquitinated substrates are preferentially delivered to intact proteasome.	[Chandra, Abhishek; Chen, Li; Liang, Huiyan; Madura, Kiran] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Madura, K (corresponding author), SPH 383,683 Hoes Lane, Piscataway, NJ 08854 USA.	maduraki@umdnj.edu	Chandra, Abhishek/AAG-8781-2020	Chandra, Abhishek/0000-0001-9423-9669	National Institutes of Health [CA83875, GM083321]; NATIONAL CANCER INSTITUTE [R01CA083875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83875 and GM083321 (to K. M.).	BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chuang SM, 2005, GENETICS, V171, P1477, DOI 10.1534/genetics.105.046888; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Glickman MH, 1999, MOL BIOL REP, V26, P21, DOI 10.1023/A:1006928316738; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Lambertson D, 1999, GENETICS, V153, P69; Le Tallec B, 2007, MOL CELL, V27, P660, DOI 10.1016/j.molcel.2007.06.025; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Park S, 2009, NATURE, V459, P866, DOI 10.1038/nature08065; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Ramos PC, 2008, STRUCTURE, V16, P1296, DOI 10.1016/j.str.2008.07.001; Rinaldi T, 1998, MOL BIOL CELL, V9, P2917, DOI 10.1091/mbc.9.10.2917; Rinaldi T, 2004, BIOCHEM J, V381, P275, DOI 10.1042/BJ20040008; Rinaldi T, 2002, GENE, V286, P43, DOI 10.1016/S0378-1119(01)00799-5; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rosenzweig R, 2008, BIOCHEM SOC T, V36, P807, DOI 10.1042/BST0360807; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; vanNocker S, 1996, MOL CELL BIOL, V16, P6020; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014	40	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8330	8339		10.1074/jbc.M109.076786	http://dx.doi.org/10.1074/jbc.M109.076786			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061387	Green Published, hybrid			2022-12-27	WOS:000275413800049
J	Kalthoff, S; Ehmer, U; Freiberg, N; Manns, MP; Strassburg, CP				Kalthoff, Sandra; Ehmer, Ursula; Freiberg, Nicole; Manns, Michael P.; Strassburg, Christian P.			Interaction between Oxidative Stress Sensor Nrf2 and Xenobiotic-activated Aryl Hydrocarbon Receptor in the Regulation of the Human Phase II Detoxifying UDP-glucuronosyltransferase 1A10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTIONAL ACTIVATION; SUPEROXIDE-DISMUTASE; MEDIATED EXPRESSION; GENE-EXPRESSION; DEFICIENT MICE; AH RECEPTOR; HUMAN COLON; GLUCURONIDATION; PROTEINS	The defense against oxidative stress is a critical feature that prevents cellular and DNA damage. UDP-glucuronosyltransferases (UGTs) catalyze the glucuronidation of xenobiotics, mutagens, and reactive metabolites and thus act as indirect antioxidants. Aim of this study was to elucidate the regulation of UGTs expressed in the mucosa of the gastrointestinal tract by xenobiotics and the main mediator of antioxidant defense, Nrf2 (nuclear factor erythroid 2-related factor 2). Xenobiotic (XRE) and antioxidant (ARE) response elements were detected in the promoters of UGT1A8, UGT1A9, and UGT1A10. Reporter gene experiments demonstrated XRE-mediated induction by dioxin in addition to tert-butylhydroquinone (ARE)-mediated induction of UGT1A8 and UGT1A10, which are expressed in extrahepatic tissue in humans in vivo. The responsible XRE and ARE motifs were identified by mutagenesis. Small interfering RNA knockdown, electrophoretic mobility shifts, and supershifts identified a functional interaction of Nrf2 and the aryl hydrocarbon receptor (AhR). Induction of UGT1A8 and UGT1A10 requires Nrf2 and AhR. It proceeds by utilizing XRE- as well as ARE-binding motifs. In summary, we demonstrate the coordinated AhR- and Nrf2-dependent transcriptional regulation of human UGT1As. Cellular protection by glucuronidation is thus inducible by xenobiotics via AhR and by oxidative metabolites via Nrf2 linking glucuronidation to cellular protection and defense against oxidative stress.	[Kalthoff, Sandra; Ehmer, Ursula; Freiberg, Nicole; Manns, Michael P.; Strassburg, Christian P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany	Hannover Medical School	Strassburg, CP (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	strassburg.christian@mh-hannover.de			Deutsche Forschungsgemeinschaft [SFB621 C3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB621 C3.	Auten RL, 2006, AM J PHYSIOL-LUNG C, V290, pL32, DOI 10.1152/ajplung.00133.2005; BREIMER LH, 1990, MOL CARCINOGEN, V3, P188, DOI 10.1002/mc.2940030405; Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Cheng ZQ, 1998, ARCH BIOCHEM BIOPHYS, V356, P301, DOI 10.1006/abbi.1998.0781; Dellinger RW, 2007, CARCINOGENESIS, V28, P2412, DOI 10.1093/carcin/bgm164; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Erichsen TJ, 2008, TOXICOL APPL PHARM, V230, P252, DOI 10.1016/j.taap.2008.02.020; Goetz ME, 2008, CANCER LETT, V266, P73, DOI 10.1016/j.canlet.2008.02.035; Gregory PA, 2004, MOL PHARMACOL, V65, P953, DOI 10.1124/mol.65.4.953; Ho YS, 2004, J BIOL CHEM, V279, P32804, DOI 10.1074/jbc.M404800200; Holtzclaw WD, 2004, ADV ENZYME REGUL, V44, P335, DOI 10.1016/j.advenzreg.2003.11.013; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Iyer LV, 2003, TOXICOL SCI, V73, P36, DOI 10.1093/toxsci/kfg066; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Koo HC, 2005, AM J PHYSIOL-LUNG C, V288, pL718, DOI 10.1152/ajplung.00456.2003; Lankisch TO, 2008, ARCH TOXICOL, V82, P573, DOI 10.1007/s00204-008-0347-1; Marini MG, 1997, J BIOL CHEM, V272, P16490, DOI 10.1074/jbc.272.26.16490; Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200; Mojarrabi B, 1998, BIOCHEM BIOPH RES CO, V247, P704, DOI 10.1006/bbrc.1998.8843; Munzel PA, 2003, BIOCHEM PHARMACOL, V66, P841, DOI 10.1016/S0006-2952(03)00389-7; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nishiyama T, 2008, ARCH BIOCHEM BIOPHYS, V478, P75, DOI 10.1016/j.abb.2008.06.013; Petrulis JR, 2002, CHEM-BIOL INTERACT, V141, P25, DOI 10.1016/S0009-2797(02)00064-9; QUATTROCHI LC, 1993, MOL PHARMACOL, V43, P504; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Reddy VP, 2009, J ALZHEIMERS DIS, V16, P763, DOI 10.3233/JAD-2009-1013; Segal BH, 2007, AM J PHYSIOL-LUNG C, V292, pL760, DOI 10.1152/ajplung.00281.2006; Strassburg C, 2008, CRIT REV CL LAB SCI, V45, P485, DOI 10.1080/10408360802374624 ; Strassburg CP, 1997, CANCER RES, V57, P2979; Strassburg CP, 1998, J BIOL CHEM, V273, P8719, DOI 10.1074/jbc.273.15.8719; Vasiliou V, 1995, BIOCHEM PHARMACOL, V50, P2057, DOI 10.1016/0006-2952(95)02108-6; Venkatraman M, 2008, BIOL PHARM BULL, V31, P1639, DOI 10.1248/bpb.31.1639; Venugopal R, 1998, ONCOGENE, V17, P3145, DOI 10.1038/sj.onc.1202237; Videan EN, 2009, COMPARATIVE MED, V59, P287; WARD JF, 1994, INT J RADIAT BIOL, V66, P427, DOI 10.1080/09553009414551401; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115; Yu X, 2005, MUTAT RES-FUND MOL M, V591, P93, DOI 10.1016/j.mrfmmm.2005.04.017	40	87	91	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					5993	6002		10.1074/jbc.M109.075770	http://dx.doi.org/10.1074/jbc.M109.075770			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20053997	Green Published, hybrid			2022-12-27	WOS:000275367500002
J	Hasan, MR; Rahman, M; Jaques, S; Purwantini, E; Daniels, L				Hasan, Mohammad Rubayet; Rahman, Mahbuba; Jaques, Sandford; Purwantini, Endang; Daniels, Lacy			Glucose 6-Phosphate Accumulation in Mycobacteria IMPLICATIONS FOR A NOVEL F-420-DEPENDENT ANTI-OXIDANT DEFENSE SYSTEM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE-STRESS; TUBERCULOSIS; SMEGMATIS; IDENTIFICATION; DEHYDROGENASE; PURIFICATION; BACTERIA; GENE; MACROPHAGES; METABOLISM	Glucose 6-phosphate (G6P) is a metabolic intermediate with many possible cellular fates. In mycobacteria, G6P is a substrate for an enzyme, F-420-dependent glucose-6-phosphate dehydrogenase (Fgd), found in few bacterial genera. Intracellular G6P levels in six Mycobacterium sp. were remarkably higher (similar to 17-130-fold) than Escherichia coli and Bacillus megaterium. The high G6P level in Mycobacterium smegmatis may result from 10-25-fold higher activity of the gluconeogenic enzyme fructose-1,6-bisphosphatase when grown on glucose, glycerol, or acetate compared with B. megaterium and E. coli. In M. smegmatis this coincided with up-regulation of the first gluconeogenic enzyme, phosphoenolpyruvate carboxykinase, when acetate was the carbon source, suggesting a cellular program for maintaining high G6P levels. G6P was depleted in cells under oxidative stress induced by redox cycling agents plumbagin and menadione, whereas an fgd mutant of M. smegmatis used G6P less well under such conditions. The fgd mutant was more sensitive to these agents and, in contrast to wild type, was defective in its ability to reduce extracellular plumbagin and menadione. These data suggest that intracellular G6P in mycobacteria serves as a source of reducing power and, with the mycobacteria-specific Fgd-F-420 system, plays a protective role against oxidative stress.	[Hasan, Mohammad Rubayet; Rahman, Mahbuba; Jaques, Sandford; Daniels, Lacy] Texas A&M Hlth Sci Ctr, Irma Lerma Rangel Coll Pharm, Dept Pharmaceut Sci, Kingsville, TX 78363 USA; [Purwantini, Endang] Virginia Tech, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Virginia Polytechnic Institute & State University	Daniels, L (corresponding author), Texas A&M Hlth Sci Ctr, Irma Lerma Rangel Coll Pharm, Dept Pharmaceut Sci, 1010 W Ave B, Kingsville, TX 78363 USA.	ldaniels@tamhsc.edu	Rahman, Mahbuba/AAR-2085-2020; Hasan, Mohammad/AAR-2093-2020	Rahman, Mahbuba/0000-0003-4586-4067; Hasan, Mohammad/0000-0002-4658-7949	National Institutes of Health [2R42GM073965-02A1]; Texas Advanced Research Program [000089-0023-2006]; United States Department of Agriculture [2006-34188-17123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R42GM073965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Advanced Research Program; United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R42GM073965-02A1. This work was also supported by Texas Advanced Research Program Grant 000089-0023-2006 and United States Department of Agriculture Agreement 2006-34188-17123.	Albers E, 2007, APPL ENVIRON MICROB, V73, P4839, DOI 10.1128/AEM.00425-07; Bergmeyer H., 1985, METHODS ENZYMATIC AN, VVI; BERGMEYER HU, 1985, METHODS ENZYMATIC AN, V7; Berrington WR, 2007, IMMUNOL REV, V219, P167, DOI 10.1111/j.1600-065X.2007.00545.x; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; DANIELS L, 1985, SYST APPL MICROBIOL, V6, P12, DOI 10.1016/S0723-2020(85)80004-7; de Orduna Ramon Mira, 2000, Journal of Biotechnology, V77, P209; DERETIC V, 1995, MOL MICROBIOL, V17, P889, DOI 10.1111/j.1365-2958.1995.mmi_17050889.x; DIETZLER DN, 1979, J BIOL CHEM, V254, P8308; Dominguez H, 1998, EUR J BIOCHEM, V254, P96, DOI 10.1046/j.1432-1327.1998.2540096.x; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; EIRICH LD, 1979, J BACTERIOL, V140, P20, DOI 10.1128/JB.140.1.20-27.1979; Guerra-Lopez D, 2007, MICROBIOL-SGM, V153, P2724, DOI 10.1099/mic.0.2006/009241-0; Gupta S, 2005, IUBMB LIFE, V57, P149, DOI 10.1080/15216540500090611; HARTZELL PL, 1985, BIOCHEM BIOPH RES CO, V133, P884, DOI 10.1016/0006-291X(85)91218-5; HASSAN HM, 1979, ARCH BIOCHEM BIOPHYS, V196, P385, DOI 10.1016/0003-9861(79)90289-3; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JONES JB, 1980, J BIOL CHEM, V255, P1049; Liu KY, 2003, MICROBIOL-SGM, V149, P1829, DOI 10.1099/mic.0.26234-0; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; MOAT AG, 1995, MICROBIAL PHYSL; Mukhopadhyay B, 2000, BBA-GEN SUBJECTS, V1475, P191, DOI 10.1016/S0304-4165(00)00064-7; Mukhopadhyay B, 2001, J BIOL CHEM, V276, P16137, DOI 10.1074/jbc.M008960200; Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x; NARAOKA T, 1984, BIOCHIM BIOPHYS ACTA, V797, P377, DOI 10.1016/0304-4165(84)90260-5; Nathan C., 2004, TUBERCULOSIS, V84, P215; O Gaora P, 1998, METH MOL B, V101, P261; Paget T, 2004, MICROBIOL-SGM, V150, P1231, DOI 10.1099/mic.0.26836-0; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; Purwantini E, 1998, J BACTERIOL, V180, P2212, DOI 10.1128/JB.180.8.2212-2219.1998; PURWANTINI E, 1992, ANAL BIOCHEM, V205, P342, DOI 10.1016/0003-2697(92)90446-E; Purwantini E, 1997, FEMS MICROBIOL LETT, V146, P129, DOI 10.1016/S0378-1097(96)00465-X; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Shankar S, 1997, MOL MICROBIOL, V24, P477, DOI 10.1046/j.1365-2958.1997.3491724.x; SHERMAN DR, 1995, P NATL ACAD SCI USA, V92, P6625, DOI 10.1073/pnas.92.14.6625; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tuckman D, 1997, J BACTERIOL, V179, P2724, DOI 10.1128/jb.179.8.2724-2730.1997; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WIDDEL F, 1989, ARCH MICROBIOL, V152, P322, DOI 10.1007/BF00425168; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924	43	47	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 18	2010	285	25					19135	19144		10.1074/jbc.M109.074310	http://dx.doi.org/10.1074/jbc.M109.074310			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	610JG	20075070	hybrid, Green Published			2022-12-27	WOS:000278727800023
J	Luo, SL; Akondi, KB; Zhangsun, DT; Wu, Y; Zhu, XP; Hu, YY; Christensen, S; Dowell, C; Daly, NL; Craik, DJ; Wang, CIA; Lewis, RJ; Alewood, PF; McIntosh, JM				Luo, Sulan; Akondi, Kalyana Bharati; Zhangsun, Dongting; Wu, Yong; Zhu, Xiaopeng; Hu, Yuanyan; Christensen, Sean; Dowell, Cheryl; Daly, Norelle L.; Craik, David J.; Wang, Ching-I. Anderson; Lewis, Richard J.; Alewood, Paul F.; McIntosh, J. Michael			Atypical alpha-Conotoxin LtIA from Conus litteratus Targets a Novel Microsite of the alpha 3 beta 2 Nicotinic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; NACHR SUBTYPE SELECTIVITY; ACETYLCHOLINE-RECEPTORS; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; BINDING PROTEIN; HOMOLOG ACHBP; CDNA CLONING; PEPTIDE; SUBUNIT	Different nicotinic acetylcholine receptor (nAChR) subtypes are implicated in learning, pain sensation, and disease states, including Parkinson disease and nicotine addiction. alpha-Conotoxins are among the most selective nAChR ligands. Mechanistic insights into the structure, function, and receptor interaction of alpha-conotoxins may serve as a platform for development of new therapies. Previously characterized alpha-conotoxins have a highly conserved Ser-Xaa-Pro motif that is crucial for potent nAChR interaction. This study characterized the novel alpha-conotoxin LtIA, which lacks this highly conserved motif but potently blocked alpha 3 beta 2 nAChRs with a 9.8 nM IC50 value. The off-rate of LtIA was rapid relative to Ser-Xaa-Pro-containing alpha-conotoxin MII. Nevertheless, pre-blockof alpha 3 beta 2 nAChRs with LtIA prevented the slowly reversible block associated with MII, suggesting overlap in their binding sites. nAChR beta subunit ligand-binding interface mutations were used to examine the > 1000-fold selectivity difference of LtIA for alpha 3 beta 2 versus alpha 3 beta 4 nAChRs. Unlike MII, LtIA had a > 900-fold increased IC50 value on alpha 3 beta 2(F119Q) versus wild type nAChRs, whereas T59K and V111I beta 2 mutants had little effect. Molecular docking simulations suggested that LtIA had a surprisingly shallow binding site on the alpha 3 beta 2 nAChR that includes beta 2 Lys-79. The K79A mutant disrupted LtIA binding but was without effect on an LtIA analog where the Ser-Xaa-Pro motif is present, consistent with distinct binding modes.	[Luo, Sulan] Hainan Univ, Ctr Expt Biotechnol, Ocean Coll, Coll Mat & Chem Engn,Minist Educ,Key Lab Trop Bio, Haikou Hainan 570228, Peoples R China; [Akondi, Kalyana Bharati; Daly, Norelle L.; Craik, David J.; Wang, Ching-I. Anderson; Lewis, Richard J.; Alewood, Paul F.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Akondi, Kalyana Bharati; Daly, Norelle L.; Craik, David J.; Wang, Ching-I. Anderson; Lewis, Richard J.; Alewood, Paul F.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Christensen, Sean; Dowell, Cheryl; McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Christensen, Sean; Dowell, Cheryl; McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT 84112 USA	Hainan University; University of Queensland; University of Queensland; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Luo, SL (corresponding author), Hainan Univ, Ctr Expt Biotechnol, Ocean Coll, Coll Mat & Chem Engn,Minist Educ,Key Lab Trop Bio, Haikou Hainan 570228, Peoples R China.	luosulan2003@163.com	Daly, Norelle L/D-4302-2013; Craik, David/B-1695-2010; Lewis, Richard J/E-8674-2013; Lewis, Richard/T-8763-2019; Alewood, Paul F/J-2412-2014	Daly, Norelle L/0000-0002-4697-6602; Craik, David/0000-0003-0007-6796; Lewis, Richard J/0000-0003-3470-923X; Lewis, Richard/0000-0003-3470-923X; Alewood, Paul/0000-0001-7454-6522	Ministry of Science and Technology of China [2007AA02Z114]; Major New Drug Discovery [2009ZX09103-644]; International Key Project of Science and Technology Collaboration [2005DFA30600]; National Natural Science Foundation of China [30860368]; Key Scientific and Technical Innovation Project; Ministry of Education of China [705043]; National Institutes of Health [MH53631, GM48677]; Australian Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053631, R29MH053631] Funding Source: NIH RePORTER	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Major New Drug Discovery; International Key Project of Science and Technology Collaboration; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific and Technical Innovation Project; Ministry of Education of China(Ministry of Education, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by State High Tech Research and Development Project (863) of the Ministry of Science and Technology of China Grant 2007AA02Z114, Major New Drug Discovery Project 2009ZX09103-644, International Key Project of Science and Technology Collaboration Grant 2005DFA30600, National Natural Science Foundation of China Grant 30860368, Cultivation Fund of the Key Scientific and Technical Innovation Project, and Ministry of Education of China Grant 705043. This work was also supported by National Institutes of Health Grants MH53631 and GM48677 (to J. M. M.), and Australian Research Council grants (to P. F. A., D. J. C., and N. L. D.). A preliminary account of part of this work was presented in the patent literature (Chinese Patents CN ZL200410103563. X (November 5, 2008) and CN 200810182970.2-A (December 12, 2008)).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Armishaw CJ, 2005, CURR PROTEIN PEPT SC, V6, P221, DOI 10.2174/1389203054065437; Azam L, 2008, J BIOL CHEM, V283, P11625, DOI 10.1074/jbc.M710288200; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Celie PHN, 2005, J BIOL CHEM, V280, P26457, DOI 10.1074/jbc.M414476200; Chi SW, 2006, BIOCHEM BIOPH RES CO, V345, P248, DOI 10.1016/j.bbrc.2006.04.099; Clark RJ, 2006, J BIOL CHEM, V281, P23254, DOI 10.1074/jbc.M604550200; Craik DJ, 2007, ACS CHEM BIOL, V2, P457, DOI 10.1021/cb700091j; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; Dowell C, 2003, J NEUROSCI, V23, P8445; Dutertre S, 2005, J BIOL CHEM, V280, P30460, DOI 10.1074/jbc.M504229200; Dutertre S, 2004, J MOL RECOGNIT, V17, P339, DOI 10.1002/jmr.683; Dutertre S, 2004, EUR J BIOCHEM, V271, P2327, DOI 10.1111/j.1432-1033.2004.04147.x; Dutertre S, 2007, EMBO J, V26, P3858, DOI 10.1038/sj.emboj.7601785; Ellison M, 2007, CHEM REC, V7, P341, DOI 10.1002/tcr.20131; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gehrmann J, 1998, J MOL BIOL, V278, P401, DOI 10.1006/jmbi.1998.1701; Gotti C, 2006, CURR PHARM DESIGN, V12, P407, DOI 10.2174/138161206775474486; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hill JM, 1998, BIOCHEMISTRY-US, V37, P15621, DOI 10.1021/bi981535w; Hogg RC, 1999, J BIOL CHEM, V274, P36559, DOI 10.1074/jbc.274.51.36559; Jin AH, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-28; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lopez-Vera E, 2007, FEBS J, V274, P3972, DOI 10.1111/j.1742-4658.2007.05931.x; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Loughnan ML, 2004, J MED CHEM, V47, P1234, DOI 10.1021/jm031010o; Luo S, 1999, BIOCHEMISTRY-US, V38, P14542, DOI 10.1021/bi991252j; Luo SQ, 1998, J NEUROSCI, V18, P8571; Luo SL, 2006, PEPTIDES, V27, P2640, DOI 10.1016/j.peptides.2006.05.002; Luo S, 2006, J PEPT SCI, V12, P693, DOI 10.1002/psc.781; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; McIntosh JM, 2002, J BIOL CHEM, V277, P33610, DOI 10.1074/jbc.M205102200; Olivera BM, 2008, CHANNELS, V2, P143, DOI 10.4161/chan.2.2.6276; Olivera BM, 2007, MOL INTERV, V7, P251, DOI 10.1124/mi.7.5.7; Peng C, 2008, PEPTIDES, V29, P1700, DOI 10.1016/j.peptides.2008.05.028; Quiram PA, 2000, J BIOL CHEM, V275, P4889, DOI 10.1074/jbc.275.7.4889; Ritchie DW, 2000, PROTEINS, V39, P178, DOI 10.1002/(SICI)1097-0134(20000501)39:2<178::AID-PROT8>3.3.CO;2-Y; Sandall DW, 2003, BIOCHEMISTRY-US, V42, P6904, DOI 10.1021/bi034043e; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shiembob DL, 2006, BIOCHEMISTRY-US, V45, P11200, DOI 10.1021/bi0611715; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Vincler M, 2006, P NATL ACAD SCI USA, V103, P17880, DOI 10.1073/pnas.0608715103; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wonnacott S, 2006, J MOL NEUROSCI, V30, P137, DOI 10.1385/JMN:30:1:137; Zhangsun D, 2006, CHEM BIOL DRUG DES, V68, P256, DOI 10.1111/j.1747-0285.2006.00443.x	57	48	59	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12355	12366		10.1074/jbc.M109.079012	http://dx.doi.org/10.1074/jbc.M109.079012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20145249	Green Published, hybrid			2022-12-27	WOS:000276787100064
J	Schopfer, FJ; Cole, MP; Groeger, AL; Chen, CS; Khoo, NKH; Woodcock, SR; Golin-Bisello, F; Motanya, UN; Li, Y; Zhang, JF; Garcia-Barrio, MT; Rudolph, TK; Rudolph, V; Bonacci, G; Baker, PRS; Xu, HE; Batthyany, CI; Chen, YE; Hallis, TM; Freeman, BA				Schopfer, Francisco J.; Cole, Marsha P.; Groeger, Alison L.; Chen, Chen-Shan; Khoo, Nicholas K. H.; Woodcock, Steven R.; Golin-Bisello, Franca; Motanya, U. Nkiru; Li, Yong; Zhang, Jifeng; Garcia-Barrio, Minerva T.; Rudolph, Tanja K.; Rudolph, Volker; Bonacci, Gustavo; Baker, Paul R. S.; Xu, H. Eric; Batthyany, Carlos I.; Chen, Y. Eugene; Hallis, Tina M.; Freeman, Bruce A.			Covalent Peroxisome Proliferator-activated Receptor gamma Adduction by Nitro-fatty Acids SELECTIVE LIGAND ACTIVITY AND ANTI-DIABETIC SIGNALING ACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; INSULIN-RESISTANCE; THIAZOLIDINEDIONES; MELLITUS; IDENTIFICATION; ROSIGLITAZONE; DERIVATIVES; GENERATION; PROTEINS; OBESITY	The peroxisome proliferator-activated receptor-gamma (PPAR gamma) binds diverse ligands to transcriptionally regulate metabolism and inflammation. Activators of PPAR gamma include lipids and anti-hyperglycemic drugs such as thiazolidinediones (TZDs). Recently, TZDs have raised concern after being linked with increased risk of peripheral edema, weight gain, and adverse cardiovascular events. Most reported endogenous PPAR gamma ligands are intermediates of lipid metabolism and oxidation that bind PPAR gamma with very low affinity. In contrast, nitro derivatives of unsaturated fatty acids (NO2-FA) are endogenous products of nitric oxide ((NO)-N-center dot) and nitrite (NO2-)-mediated redox reactions that activate PPAR gamma at nanomolar concentrations. We report that NO2-FA act as partial agonists of PPAR gamma and covalently bind PPAR gamma at Cys-285 via Michael addition. NO2-FA show selective PPAR gamma modulator characteristics by inducing coregulator protein interactions, PPAR gamma-dependent expression of key target genes, and lipid accumulation is distinctively different from responses induced by the TZD rosiglitazone. Administration of this class of signaling mediators to ob/ob mice revealed that NO2-FA lower insulin and glucose levels without inducing adverse side effects such as the increased weight gain induced by TZDs.	[Schopfer, Francisco J.; Cole, Marsha P.; Groeger, Alison L.; Chen, Chen-Shan; Khoo, Nicholas K. H.; Woodcock, Steven R.; Golin-Bisello, Franca; Motanya, U. Nkiru; Rudolph, Tanja K.; Bonacci, Gustavo; Baker, Paul R. S.; Freeman, Bruce A.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Rudolph, Tanja K.; Rudolph, Volker] Univ Heart Ctr Hamburg, Dept Cardiol, D-20246 Hamburg, Germany; [Batthyany, Carlos I.] Inst Pasteur Montevideo, Montevideo 11400, Uruguay; [Li, Yong; Xu, H. Eric] Van Andel Res Inst, Lab Struct Sci, Grand Rapids, MI 49503 USA; [Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Med Ctr, Dept Internal Med, Ctr Cardiovasc, Ann Arbor, MI 48109 USA; [Hallis, Tina M.] Invitrogen Discovery Sci, Madison, WI 53719 USA; [Garcia-Barrio, Minerva T.] Morehouse Sch Med, Cardiovasc Res Inst, Atlanta, GA 30310 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Hamburg; University Medical Center Hamburg-Eppendorf; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Van Andel Institute; University of Michigan System; University of Michigan; Morehouse School of Medicine	Freeman, BA (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	freerad@pitt.edu	Freeman, Bruce A/H-9342-2012; Woodcock, Steven/AAE-9199-2020; Schopfer, Francisco Jose/AAE-8125-2020; Xu, H. Eric/ABD-7487-2021; Schopfer, Francisco/AAW-6505-2021	Schopfer, Francisco Jose/0000-0001-9526-695X; Batthyany, Carlos/0000-0002-0627-1982; Xu, H. Eric/0000-0002-6829-8144	National Institutes of Health [R01 HL58115, R01 HL64937, P30 DK046204-15, T32DK007052-34, DK071662, DK066202, HL089301, HL68878, HL089544, HL75397]; The Hartwell Foundation; American Diabetes Association [7-08-JF-52]; American Heart Association [0665418U, 0840025N]; Deutsche Forschungsgemeinschaft; Deutsche Herzstiftung; Jay and Betty Van Andel Foundation; Complexa, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075397, R01HL089544, R37HL058115, R01HL089301, R01HL064937, R01HL068878, R01HL058115, K99HL095769] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK046204, T32DK007052, R01DK071662, R01DK066202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Hartwell Foundation; American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Herzstiftung; Jay and Betty Van Andel Foundation; Complexa, Inc; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL58115 and R01 HL64937 (to B. A. F.), P30 DK046204-15 and T32DK007052-34 (to M. P. C.), DK071662 and DK066202 (to H. E. X.), HL089301 (to H. E. X. and to Y.L.), and HL68878, HL089544, and HL75397. This work was also supported by The Hartwell Foundation (M. P. C.), American Diabetes Association Grant 7-08-JF-52 (to F. J. S.), American Heart Association Grants 0665418U (to F. J. S.) and 0840025N (to Y. E. C.), Deutsche Forschungsgemeinschaft (to T. K. R.), Deutsche Herzstiftung (to V. R.), and Jay and Betty Van Andel Foundation (to H. E. X.). B. A. F. acknowledges financial interest in Complexa, Inc.	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Baker LMS, 2007, J BIOL CHEM, V282, P31085, DOI 10.1074/jbc.M704085200; Baker PRS, 2005, J BIOL CHEM, V280, P42464, DOI 10.1074/jbc.M504212200; Baker PRS, 2004, P NATL ACAD SCI USA, V101, P11577, DOI 10.1073/pnas.0402587101; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; BOUVIER G, 1994, J LEUKOCYTE BIOL, V55, P729, DOI 10.1002/jlb.55.6.729; Carmona MC, 2007, DIABETES, V56, P2797, DOI 10.2337/db06-1734; Cerghizan Anca, 2007, Exp Clin Cardiol, V12, P83; Cui T, 2006, J BIOL CHEM, V281, P35686, DOI 10.1074/jbc.M603357200; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Freeman BA, 2008, J BIOL CHEM, V283, P15515, DOI 10.1074/jbc.R800004200; Guan YF, 2005, NAT MED, V11, P861, DOI 10.1038/nm1278; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hu X, 2006, ACTA PHARMACOL SIN, V27, P1346, DOI 10.1111/j.1745-7254.2006.00427.x; Itoh T, 2008, NAT STRUCT MOL BIOL, V15, P924, DOI 10.1038/nsmb.1474; Kansanen E, 2009, J BIOL CHEM, V284, P33233, DOI 10.1074/jbc.M109.064873; Kelley EE, 2008, J BIOL CHEM, V283, P36176, DOI 10.1074/jbc.M802402200; Khanderia U, 2008, ANN PHARMACOTHER, V42, P1466, DOI 10.1345/aph.1K666; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li Y, 2008, J BIOL CHEM, V283, P9168, DOI 10.1074/jbc.M800104200; Li Y, 2008, NAT STRUCT MOL BIOL, V15, P865, DOI 10.1038/nsmb.1447; McGuire DK, 2008, CIRCULATION, V117, P440, DOI 10.1161/CIRCULATIONAHA.107.704080; Nettles KW, 2008, NAT STRUCT MOL BIOL, V15, P893, DOI 10.1038/nsmb0908-893; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rudolph V, 2010, CARDIOVASC RES, V85, P155, DOI 10.1093/cvr/cvp275; Rudolph V, 2009, J BIOL CHEM, V284, P1461, DOI 10.1074/jbc.M802298200; Schopfer FJ, 2009, FREE RADICAL BIO MED, V46, P1250, DOI 10.1016/j.freeradbiomed.2008.12.025; Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102; Shiraki T, 2006, BIOCHEM J, V393, P749, DOI 10.1042/BJ20050930; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tsikas D, 2009, LIPIDS, V44, P855, DOI 10.1007/s11745-009-3332-4; Tsikas D, 2009, J CHROMATOGR B, V877, P2895, DOI 10.1016/j.jchromb.2008.12.062; Villacorta L, 2007, AM J PHYSIOL-HEART C, V293, pH770, DOI 10.1152/ajpheart.00261.2007; Waku T, 2009, J MOL BIOL, V385, P188, DOI 10.1016/j.jmb.2008.10.039; Wigren J, 2003, J ENDOCRINOL, V177, P207, DOI 10.1677/joe.0.1770207; Woodcock SR, 2006, ORG LETT, V8, P3931, DOI 10.1021/ol0613463; Young PW, 1998, J PHARMACOL EXP THER, V284, P751; Zhang F, 2007, PPAR RES, V2007, DOI 10.1155/2007/32696	42	132	144	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12321	12333		10.1074/jbc.M109.091512	http://dx.doi.org/10.1074/jbc.M109.091512			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20097754	Green Published, hybrid			2022-12-27	WOS:000276787100061
J	Whibley, C; Odell, AF; Nedelko, T; Balaburski, G; Murphy, M; Liu, ZP; Stevens, L; Walker, JH; Routledge, M; Hollstein, M				Whibley, Catherine; Odell, Adam F.; Nedelko, Tatiana; Balaburski, Gregor; Murphy, Maureen; Liu, Zhipei; Stevens, Louisa; Walker, John H.; Routledge, Michael; Hollstein, Monica			Wild-type and Hupki (Human p53 Knock-in) Murine Embryonic Fibroblasts p53/ARF PATHWAY DISRUPTION IN SPONTANEOUS ESCAPE FROM SENESCENCE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENES; CELLULAR SENESCENCE; HUMAN CANCER; LUNG-TUMORS; CELLS; MUTATIONS; MOUSE; DNA; IMMORTALIZATION; MICE	Research on cell senescence and immortalization of murine embryonic fibroblasts (MEFs) has revealed important clues about genetic control of senescence in humans. To investigate senescence and genetic alterations in the p53 pathway that lead to senescence bypass in culture, we compared the behavior of MEFs from wild-type mice with MEFs from Hupki mice, which harbor a humanized p53 gene. We found that humanizing the p53 gene in mice preserved major features of the MEF senescence/immortalization process. In both genotypes, a significant proportion of spontaneously arising cell lines had sustained either a p53 point mutation or p19/ARF biallelic deletion. The p53 mutations selected for during Hupki MEF immortalization have been found in human tumors and are classified in the yeast transactivation assay as transcriptionally defunct, suggesting that disabling this component of p53 activity is crucial in senescence bypass. Surprisingly, in spontaneously immortalized cell lines from both wild-type and Hupki MEFs, the predominant type of p53 mutation was a G to C transversion, rather than the G to T substitutions expected from the raised oxygen levels characteristic of standard culture conditions. Over half of the cell lines did not reveal evidence of p53 mutation or loss of p19/ARF and retained a robust wild-type p53 response to DNA damage, supporting the inference from senescence bypass screens that alternative genetic routes to immortalization occur.	[Whibley, Catherine; Stevens, Louisa; Routledge, Michael; Hollstein, Monica] Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Odell, Adam F.; Walker, John H.] Univ Leeds, LIGHT Labs, Fac Biol Sci, Leeds LS2 9JT, W Yorkshire, England; [Balaburski, Gregor; Murphy, Maureen] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA; [Nedelko, Tatiana; Hollstein, Monica] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Liu, Zhipei] Max Planck Inst Heart & Lung Dis, D-61231 Bad Nauheim, Germany	University of Leeds; University of Leeds; Fox Chase Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Max Planck Society	Hollstein, M (corresponding author), Univ Leeds, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England.	m.hollstein@leeds.ac.uk	Odell, Adam/J-1386-2012; Routledge, Michael N/N-7413-2017	Routledge, Michael N/0000-0001-9139-2182; Murphy, Maureen/0000-0001-7644-7296	Cancer Research UK; Yorkshire Cancer Research; Biotechnology and Biological Sciences Research Council [BB/D524875/1] Funding Source: researchfish; BBSRC [BB/D524875/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA102184] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); Yorkshire Cancer Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Cancer Research UK and by Yorkshire Cancer Research.	Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; BOND JA, 1995, CANCER RES, V55, P2404; BROSH R, 2010, NAT REV CANCER, V6, P17; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; COLLINS AR, 1993, CARCINOGENESIS, V14, P1733, DOI 10.1093/carcin/14.9.1733; Cook WD, 2000, ONCOGENE, V19, P3434, DOI 10.1038/sj.onc.1203653; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dirac AMG, 2003, J BIOL CHEM, V278, P11731, DOI 10.1074/jbc.C300023200; Esteller M, 2000, CANCER RES, V60, P129; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Hainaut P, 2000, ADV CANCER RES, V77, P81; HARVEY DM, 1991, GENE DEV, V5, P2375, DOI 10.1101/gad.5.12b.2375; Hergenhahn M, 2004, CELL CYCLE, V3, P738; HERMAN JG, 1995, CANCER RES, V55, P4525; HIRABAYASHI Y, 1985, J IMMUNOL METHODS, V82, P253, DOI 10.1016/0022-1759(85)90357-6; Jaworski M, 2005, CARCINOGENESIS, V26, P1829, DOI 10.1093/carcin/bgi142; Johnson TM, 2008, P NATL ACAD SCI USA, V105, P1215, DOI 10.1073/pnas.0706764105; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Leal JFM, 2008, ONCOGENE, V27, P1961, DOI 10.1038/sj.onc.1210846; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liu ZP, 2005, CANCER RES, V65, P2583, DOI 10.1158/0008-5472.CAN-04-3675; Liu ZP, 2004, P NATL ACAD SCI USA, V101, P2963, DOI 10.1073/pnas.0308607101; Luo JL, 2001, ONCOGENE, V20, P320, DOI 10.1038/sj.onc.1204080; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Maslov AY, 2009, BBA-GEN SUBJECTS, V1790, P963, DOI 10.1016/j.bbagen.2009.03.020; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nedelko T, 2009, INT J CANCER, V124, P987, DOI 10.1002/ijc.24006; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; OSTLING O, 1984, BIOCHEM BIOPH RES CO, V123, P291, DOI 10.1016/0006-291X(84)90411-X; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Randle DH, 2001, P NATL ACAD SCI USA, V98, P9654, DOI 10.1073/pnas.171217498; Reinbold M, 2008, ONCOGENE, V27, P2788, DOI 10.1038/sj.onc.1210932; RITTLING SR, 1992, ONCOGENE, V7, P935; Roussel MF, 2002, CANCER CELL, V2, P434, DOI 10.1016/S1535-6108(02)00216-7; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Tam AS, 2003, CARCINOGENESIS, V24, P121, DOI 10.1093/carcin/24.1.121; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Vijg J, 2002, MECH AGEING DEV, V123, P907, DOI 10.1016/S0047-6374(02)00028-3; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; vom Brocke J, 2009, MUTAGENESIS, V24, P17, DOI 10.1093/mutage/gen049; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; WynfordThomas D, 1996, J PATHOL, V180, P118, DOI 10.1002/(SICI)1096-9896(199610)180:2<118::AID-PATH673>3.0.CO;2-I; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	55	26	26	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11326	11335		10.1074/jbc.M109.064444	http://dx.doi.org/10.1074/jbc.M109.064444			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20118236	hybrid, Green Published			2022-12-27	WOS:000276286200039
J	Chen, SL; Liu, DM; Finley, RL; Greenberg, ML				Chen, Shuliang; Liu, Dongmei; Finley, Russell L., Jr.; Greenberg, Miriam L.			Loss of Mitochondrial DNA in the Yeast Cardiolipin Synthase crd1 Mutant Leads to Up-regulation of the Protein Kinase Swe1p That Regulates the G(2)/M Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUPPRESSES TEMPERATURE SENSITIVITY; NUCLEAR GENE-EXPRESSION; CYTOCHROME-C REDUCTASE; CELL-DIVISION CYCLE; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; RESPIRATORY-CHAIN; PHOSPHATIDYLGLYCEROLPHOSPHATE SYNTHASE; OXIDATIVE-PHOSPHORYLATION; SEPTIN ORGANIZATION	The anionic phospholipid cardiolipin and its precursor phosphatidylglycerol are synthesized and localized in the mitochondrial inner membrane of eukaryotes. They are required for structural integrity and optimal activities of a large number of mitochondrial proteins and complexes. Previous studies showed that loss of anionic phospholipids leads to cell inviability in the absence of mitochondrial DNA. However, the mechanism linking loss of anionic phospholipids to petite lethality was unclear. To elucidate the mechanism, we constructed a crd1 Delta rho degrees mutant, which is viable and mimics phenotypes of pgs1 Delta in the petite background. We found that loss of cardiolipin in rho degrees cells leads to elevated expression of Swe1p, a morphogenesis checkpoint protein. Moreover, the retrograde pathway is activated in crd1 Delta rho degrees cells, most likely due to the exacerbation of mitochondrial dysfunction. Interestingly, the expression of SWE1 is dependent on retrograde regulation as elevated expression of SWE1 is suppressed by deletion of RTG2 or RTG3. Taken together, these findings indicate that activation of the retrograde pathway leads to up-regulation of SWE1 in crd1 Delta rho degrees cells. These results suggest that anionic phospholipids are required for processes that are essential for normal cell division in rho degrees cells.	[Chen, Shuliang; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Liu, Dongmei; Finley, Russell L., Jr.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	mlgreen@sun.science.wayne.edu	Chen, Shuliang/N-9498-2013	Chen, Shuliang/0000-0002-7175-7604; Finley, Russ/0000-0003-1144-6887	National Institutes of Health [HL62263]; Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062263] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barth Syndrome Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL62263. This work was also supported by a grant from the Barth Syndrome Foundation.	Amberg DC, 1998, MOL BIOL CELL, V9, P3259, DOI 10.1091/mbc.9.12.3259; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Berger KH, 1997, J CELL BIOL, V136, P545, DOI 10.1083/jcb.136.3.545; Beyer K, 1996, BIOCHEMISTRY-US, V35, P15784, DOI 10.1021/bi9610055; Boldogh IR, 2001, TRAFFIC, V2, P368, DOI 10.1034/j.1600-0854.2001.002006368.x; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; BURGESS SM, 1994, J CELL BIOL, V126, P1375, DOI 10.1083/jcb.126.6.1375; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Cabib E, 2004, ARCH BIOCHEM BIOPHYS, V426, P201, DOI 10.1016/j.abb.2004.02.030; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; Casamayor A, 2003, MOL CELL BIOL, V23, P2762, DOI 10.1128/MCB.23.8.2762-2777.2003; Chang SC, 1998, J BIOL CHEM, V273, P9829, DOI 10.1074/jbc.273.16.9829; Chang SC, 1998, J BIOL CHEM, V273, P14933, DOI 10.1074/jbc.273.24.14933; Chelstowska A, 1999, YEAST, V15, P1377, DOI 10.1002/(SICI)1097-0061(19990930)15:13<1377::AID-YEA473>3.0.CO;2-0; Chen SL, 2008, MOL MICROBIOL, V68, P1061, DOI 10.1111/j.1365-2958.2008.06216.x; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; DeMarini DJ, 1997, J CELL BIOL, V139, P75, DOI 10.1083/jcb.139.1.75; DeVay RM, 2009, J CELL BIOL, V186, P793, DOI 10.1083/jcb.200906098; DEVIN AB, 1990, YEAST, V6, P231, DOI 10.1002/yea.320060308; DREES M, 1988, BIOCHEMISTRY-US, V27, P8584, DOI 10.1021/bi00423a012; Dzugasova V, 1998, CURR GENET, V34, P297, DOI 10.1007/s002940050399; Epstein CB, 2001, MOL BIOL CELL, V12, P297, DOI 10.1091/mbc.12.2.297; GAYNOR PM, 1991, J BACTERIOL, V173, P6124, DOI 10.1128/jb.173.19.6124-6131.1991; GBELSKA Y, 1983, EUR J BIOCHEM, V130, P281, DOI 10.1111/j.1432-1033.1983.tb07148.x; Gebert N, 2009, CURR BIOL, V19, P2133, DOI 10.1016/j.cub.2009.10.074; Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Gomez B, 1999, BIOCHEMISTRY-US, V38, P9031, DOI 10.1021/bi990603r; Hasek Jiri, 2006, Methods Mol Biol, V313, P85; HAYERHARTL M, 1992, EUR J BIOCHEM, V209, P423, DOI 10.1111/j.1432-1033.1992.tb17305.x; Hermann GJ, 1998, ANNU REV CELL DEV BI, V14, P265, DOI 10.1146/annurev.cellbio.14.1.265; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; JANITOR M, 1993, CURR GENET, V24, P307, DOI 10.1007/BF00336781; Jensen RE, 2000, MICROSC RES TECHNIQ, V51, P573, DOI 10.1002/1097-0029(20001215)51:6<573::AID-JEMT7>3.0.CO;2-2; Jia YK, 1997, MOL CELL BIOL, V17, P1110, DOI 10.1128/MCB.17.3.1110; Jiang F, 1997, MOL MICROBIOL, V26, P481, DOI 10.1046/j.1365-2958.1997.5841950.x; Jiang F, 1999, MOL MICROBIOL, V31, P373, DOI 10.1046/j.1365-2958.1999.01181.x; Jiang F, 2000, J BIOL CHEM, V275, P22387, DOI 10.1074/jbc.M909868199; Kirchman PA, 1999, GENETICS, V152, P179; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Koltovaya NA, 1998, YEAST, V14, P133, DOI 10.1002/(SICI)1097-0061(19980130)14:2<133::AID-YEA206>3.0.CO;2-0; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Koshkin V, 2002, BIOCHEM J, V364, P317, DOI 10.1042/bj3640317; Koshkin V, 2000, BIOCHEM J, V347, P687, DOI 10.1042/0264-6021:3470687; LEW DJ, 1995, J CELL BIOL, V129, P739, DOI 10.1083/jcb.129.3.739; LIAO XS, 1991, MOL CELL BIOL, V11, P38, DOI 10.1128/MCB.11.1.38; LISOWSKY T, 1994, CURR GENET, V26, P15, DOI 10.1007/BF00326299; LISOWSKY T, 1992, MOL GEN GENET, V232, P58, DOI 10.1007/BF00299137; Liu ZC, 2003, MOL CELL, V12, P401, DOI 10.1016/S1097-2765(03)00285-5; Liu ZC, 1999, MOL CELL BIOL, V19, P6720; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; MCCONNELL SJ, 1992, J CELL BIOL, V118, P385, DOI 10.1083/jcb.118.2.385; McNulty JJ, 2005, CURR BIOL, V15, P2190, DOI 10.1016/j.cub.2005.11.039; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; NEWLON CS, 1975, CELL, V5, P423; NEWLON CS, 1979, MOL GEN GENET, V169, P189, DOI 10.1007/BF00271670; PARIKH VS, 1987, SCIENCE, V235, P576, DOI 10.1126/science.3027892; Pfeiffer K, 2003, J BIOL CHEM, V278, P52873, DOI 10.1074/jbc.M308366200; Poyton RO, 1996, ANNU REV BIOCHEM, V65, P563, DOI 10.1146/annurev.bi.65.070196.003023; Pruyne D, 2000, J CELL SCI, V113, P365; Pruyne D, 2000, J CELL SCI, V113, P571; Richman TJ, 1999, J BIOL CHEM, V274, P16861, DOI 10.1074/jbc.274.24.16861; ROBERTS RL, 1983, MOL CELL BIOL, V3, P922, DOI 10.1128/MCB.3.5.922; ROBINSON NC, 1990, BIOCHEMISTRY-US, V29, P8962, DOI 10.1021/bi00490a012; ROTHERMEL BA, 1995, J BIOL CHEM, V270, P29476, DOI 10.1074/jbc.270.49.29476; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schmidt M, 2003, MOL BIOL CELL, V14, P2128, DOI 10.1091/mbc.E02-08-0547; Sedlak E, 1999, BIOCHEMISTRY-US, V38, P14966, DOI 10.1021/bi9914053; Sekito T, 2000, MOL BIOL CELL, V11, P2103, DOI 10.1091/mbc.11.6.2103; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; SOGO LF, 1994, J CELL BIOL, V126, P1361, DOI 10.1083/jcb.126.6.1361; STEWART LC, 1991, J CELL BIOL, V115, P1249, DOI 10.1083/jcb.115.5.1249; SUBIK J, 1974, FEBS LETT, V42, P309, DOI 10.1016/0014-5793(74)80753-2; Suzuki M, 2004, NAT CELL BIOL, V6, P861, DOI 10.1038/ncb1162; Traven A, 2001, J BIOL CHEM, V276, P4020, DOI 10.1074/jbc.M006807200; Tuller G, 1998, FEBS LETT, V421, P15, DOI 10.1016/S0014-5793(97)01525-1; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Vaz FM, 2003, J BIOL CHEM, V278, P43089, DOI 10.1074/jbc.M305956200; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Yaffe MP, 1999, SCIENCE, V283, P1493, DOI 10.1126/science.283.5407.1493; YU CA, 1980, BIOCHEMISTRY-US, V19, P5715, DOI 10.1021/bi00566a008; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200; Zhao M, 1998, J BIOL CHEM, V273, P2402, DOI 10.1074/jbc.273.4.2402; Zhong Q, 2005, MOL BIOL CELL, V16, P665, DOI 10.1091/mbc.E04-09-0808; Zhong Q, 2003, J BIOL CHEM, V278, P33978, DOI 10.1074/jbc.M305242200; Zhong Q, 2007, J BIOL CHEM, V282, P15946, DOI 10.1074/jbc.M701055200	95	29	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10397	10407		10.1074/jbc.M110.100784	http://dx.doi.org/10.1074/jbc.M110.100784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20086012	Green Published, hybrid			2022-12-27	WOS:000276264600025
J	Li, LT; Murdock, G; Bagley, D; Jia, XA; Ward, DM; Kaplan, J				Li, Liangtao; Murdock, Grace; Bagley, Dustin; Jia, Xuan; Ward, Diane McVey; Kaplan, Jerry			Genetic Dissection of a Mitochondria-Vacuole Signaling Pathway in Yeast Reveals a Link between Chronic Oxidative Stress and Vacuolar Iron Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATOR; AFT1; IDENTIFICATION; DEFICIENCY; REGULON; STORAGE	Deletion of two homologous genes, MRS3 and MRS4, that encode mitochondrial iron transporters affects the activity of the vacuolar iron importer Ccc1. Ccc1 levels are decreased in Delta mrs3 Delta mrs4 cells, but the activity of the transporter is increased, resulting is reduced cytosolic iron. Overexpression of CCC1 in Delta mrs3 Delta mrs4 cells results in a severe growth defect due to decreased cytosolic iron, referred to as the mitochondria-vacuole signaling (MVS) phenotype. Mutants were identified that suppress the MVS growth defect, and FRA1 was identified as a gene that suppresses the MVS phenotype. Overexpression of FRA1 suppresses altered transition metal metabolism in Delta mrs3 Delta mrs4 cells, whereas deletion of FRA1 is synthetically lethal with Delta mrs3 Delta mrs4. Fra1 binds to Tsa1, which encodes a thioredoxin-dependent peroxidase. Deletion of TSA1 or TRR1 is synthetically lethal in Delta mrs3 Delta mrs4 cells, suggesting that Delta mrs3 Delta mrs4 cells generate reactive oxygen metabolites. The generation of reactive oxygen metabolites in Delta mrs3 Delta mrs4 cells was confirmed by use of the reporter molecule 2',7'-dichlorodihydrofluorescein diacetate. These results suggest that mitochondria-induced oxidant damage is responsible for activating Ccc1 and that Fra1 and Tsa1 can reduce oxidant damage.	[Li, Liangtao; Murdock, Grace; Bagley, Dustin; Jia, Xuan; Ward, Diane McVey; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu			National Institutes of Health [DK052380, DK035034]; Center of Excellence in Molecular Hematology [5P30DK72437]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052380, P30DK072437, R01DK030534] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence in Molecular Hematology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK052380 and DK035034 (to J. K.). This work was also supported by Center of Excellence in Molecular Hematology Grant 5P30DK72437.	AMBERG DC, 1995, YEAST, V11, P1275, DOI 10.1002/yea.320111307; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Felice MR, 2005, J BIOL CHEM, V280, P22181, DOI 10.1074/jbc.M414663200; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Lesuisse E, 2005, GENETICS, V169, P107, DOI 10.1534/genetics.104.035873; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; Mense SM, 2006, CELL RES, V16, P681, DOI 10.1038/sj.cr.7310086; Milgrom E, 2007, J BIOL CHEM, V282, P7125, DOI 10.1074/jbc.M608293200; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200; Puig S, 2008, CELL METAB, V7, P555, DOI 10.1016/j.cmet.2008.04.010; Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Tuttle MS, 2003, J BIOL CHEM, V278, P1273, DOI 10.1074/jbc.M209631200; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; YAMAGUCHIIWAI Y, 1995, EMBO J, V14, P1231, DOI 10.1002/j.1460-2075.1995.tb07106.x	22	28	28	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10232	10242		10.1074/jbc.M109.096859	http://dx.doi.org/10.1074/jbc.M109.096859			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139087	Green Published, hybrid			2022-12-27	WOS:000276264600007
J	Tang, GM; Perng, MD; Wilk, S; Quinlan, R; Goldman, JE				Tang, Guomei; Perng, Ming D.; Wilk, Sherwin; Quinlan, Roy; Goldman, James E.			Oligomers of Mutant Glial Fibrillary Acidic Protein (GFAP) Inhibit the Proteasome System in Alexander Disease Astrocytes, and the Small Heat Shock Protein alpha B-Crystallin Reverses the Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEDIATE-FILAMENT; STRESS-RESPONSE; 26S PROTEASOME; RAT-BRAIN; MUTATIONS; TRANSCRIPTION; ACCUMULATION; DEGRADATION; ACTIVATION; EXPRESSION	The accumulation of the intermediate filament protein, glial fibrillary acidic protein (GFAP), in astrocytes of Alexander disease (AxD) impairs proteasome function in astrocytes. We have explored the molecular mechanism that underlies the proteasome inhibition. We find that both assembled and unassembled wild type (wt) and R239C mutant GFAP protein interacts with the 20 S proteasome complex and that the R239C AxD mutation does not interfere with this interaction. However, the R239C GFAP accumulates to higher levels and forms more protein aggregates than wt protein. These aggregates bind components of the ubiquitin-proteasome system and, thus, may deplete the cytosolic stores of these proteins. We also find that the R239C GFAP has a greater inhibitory effect on proteasome system than wt GFAP. Using a ubiquitin-independent degradation assay in vitro, we observed that the proteasome cannot efficiently degrade unassembled R239C GFAP, and the interaction of R239C GFAP with proteasomes actually inhibits proteasomal protease activity. The small heat shock protein, alpha B-crystallin, which accumulates massively in AxD astrocytes, reverses the inhibitory effects of R239C GFAP on proteasome activity and promotes degradation of the mutant GFAP, apparently by shifting the size of the mutant protein from larger oligomers to smaller oligomers and monomers. These observations suggest that oligomeric forms of GFAP are particularly effective at inhibiting proteasome activity.	[Tang, Guomei; Goldman, James E.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Perng, Ming D.; Quinlan, Roy] Univ Durham, Sch Biol & Med Sci, Durham DH1 3LE, England; [Wilk, Sherwin] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Columbia University; Durham University; Icahn School of Medicine at Mount Sinai	Goldman, JE (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, 630 W 168th St,P&S Rm 15-420, New York, NY 10032 USA.	jeg5@columbia.edu	Quinlan, Roy/A-1348-2012	Quinlan, Roy/0000-0003-0644-4123	National Institutes of Health [PO1NS42803, P30-HD03352]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS042803] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1NS42803 and P30-HD03352.	Alvarez-Castelao B, 2005, FEBS LETT, V579, P4797, DOI 10.1016/j.febslet.2005.07.060; Arcangeletti C, 1997, J STRUCT BIOL, V119, P35, DOI 10.1006/jsbi.1997.3871; BANAYSCHWARTZ M, 1992, AGE, V15, P51, DOI 10.1007/BF02435024; Boelens WC, 2001, BBA-PROTEIN STRUCT M, V1544, P311, DOI 10.1016/S0167-4838(00)00243-0; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Dachsel JC, 2005, FEBS LETT, V579, P3913, DOI 10.1016/j.febslet.2005.06.003; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; DESA MFG, 1988, J CELL BIOL, V107, P1517, DOI 10.1083/jcb.107.4.1517; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Gregori L, 1997, J BIOL CHEM, V272, P58; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Hagemann TL, 2006, J NEUROSCI, V26, P11162, DOI 10.1523/JNEUROSCI.3260-06.2006; Hsiao VC, 2005, J CELL SCI, V118, P2057, DOI 10.1242/jcs.02339; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Koyama Y, 1999, AM J PATHOL, V154, P1563, DOI 10.1016/S0002-9440(10)65409-0; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Li R, 2005, ANN NEUROL, V57, P310, DOI 10.1002/ana.20406; MALLOCH GDA, 1987, J NEUROCHEM, V48, P299, DOI 10.1111/j.1471-4159.1987.tb13162.x; Middeldorp J, 2009, FASEB J, V23, P2710, DOI 10.1096/fj.08-127696; NICHOLL ID, 1994, EMBO J, V13, P945, DOI 10.1002/j.1460-2075.1994.tb06339.x; OLINKCOUX M, 1994, J CELL SCI, V107, P353; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411; Snyder H, 2003, J BIOL CHEM, V278, P11753, DOI 10.1074/jbc.M208641200; Tang GM, 2008, HUM MOL GENET, V17, P1540, DOI 10.1093/hmg/ddn042; Tang GM, 2006, J BIOL CHEM, V281, P38634, DOI 10.1074/jbc.M604942200; Tian RJ, 2006, AM J PATHOL, V168, P888, DOI 10.2353/ajpath.2006.051028; WENZEL T, 1995, NAT STRUCT BIOL, V2, P199, DOI 10.1038/nsb0395-199; Wilk S., 2001, CURR PROTOC PROTEIN; Wolburg H, 2005, NEUROGLIA, V2, P19, DOI [10.1093/acprof:oso/9780195152227.001.0001/acprof-9780195152227-chapter-2, DOI 10.1093/ACPROF:OSO/9780195152227.003]; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001	33	67	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10527	10537		10.1074/jbc.M109.067975	http://dx.doi.org/10.1074/jbc.M109.067975			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110364	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000276264600039
J	Jiang, SX; Whitehead, S; Aylsworth, A; Slinn, J; Zurakowski, B; Chan, K; Li, JJ; Hou, ST				Jiang, Susan X.; Whitehead, Shawn; Aylsworth, Amy; Slinn, Jacqueline; Zurakowski, Bogdan; Chan, Kenneth; Li, Jianjun; Hou, Sheng T.			Neuropilin 1 Directly Interacts with Fer Kinase to Mediate Semaphorin 3A-induced Death of Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR E2F1; CEREBRAL-ISCHEMIA; SYMPATHETIC NEURONS; GLUTAMATE TOXICITY; SIGNALING PATHWAY; MASS-SPECTROMETRY; TISSUE-SECTIONS; AXON RETRACTION; FOCAL ISCHEMIA; SPINAL-CORD	Neuropilins (NRPs) are receptors for the major chemorepulsive axonal guidance cue semaphorins (Sema). The interaction of Sema3A/NRP1 during development leads to the collapse of growth cones. Here we show that Sema3A also induces death of cultured cortical neurons through NRP1. A specific NRP1 inhibitory peptide ameliorated Sema3A-evoked cortical axonal retraction and neuronal death. Moreover, Sema3A was also involved in cerebral ischemia-induced neuronal death. Expression levels of Sema3A and NRP1, but not NRP2, were significantly increased early during brain reperfusion following transient focal cerebral ischemia. NRP1 inhibitory peptide delivered to the ischemic brain was potently neuroprotective and prevented the loss of motor functions in mice. The integrity of the injected NRP1 inhibitory peptide into the brain remained unchanged, and the intact peptide permeated the ischemic hemisphere of the brain as determined using MALDI-MS-based imaging. Mechanistically, NRP1-mediated axonal collapse and neuronal death is through direct and selective interaction with the cytoplasmic tyrosine kinase Fer. Fer RNA interference effectively attenuated Sema 3A-induced neurite retraction and neuronal death in cortical neurons. More importantly, down-regulation of Fer expression using Fer-specific RNA interference attenuated cerebral ischemia-induced brain damage. Together, these studies revealed a previously unknown function of NRP1 in signaling Sema3A-evoked neuronal death through Fer in cortical neurons.	[Jiang, Susan X.; Whitehead, Shawn; Aylsworth, Amy; Slinn, Jacqueline; Zurakowski, Bogdan; Hou, Sheng T.] Natl Res Council Canada, Inst Biol Sci, Expt NeuroTherapeut Lab, Ottawa, ON K1A 0R6, Canada; [Chan, Kenneth; Li, Jianjun] Natl Res Council Canada, Inst Biol Sci, Mass Spectrometry Glycoanal Lab, Ottawa, ON K1A 0R6, Canada; [Aylsworth, Amy; Hou, Sheng T.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	National Research Council Canada; National Research Council Canada; University of Ottawa	Hou, ST (corresponding author), Natl Res Council Canada, Inst Biol Sci, Expt NeuroTherapeut Lab, Bldg M54,1200 Montreal Rd, Ottawa, ON K1A 0R6, Canada.	sheng.hou@nrc-cnrc.gc.ca	Hou, Sheng Tao/O-3202-2018; Whitehead, Shawn/E-3772-2016; Hou, Sheng Tao/AAM-7756-2020	Whitehead, Shawn/0000-0003-4728-8067; Hou, Sheng Tao/0000-0001-9736-342X	Heart and Stroke Foundation of Ontario [NA5393, T5760]; Canadian Institutes of Health Research [CCI85680]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Heart and Stroke Foundation of Ontario Grants NA5393 and T5760 and by Canadian Institutes of Health Research Grant CCI85680 (to S.T.H.).	Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Beck H, 2002, J NEUROPATH EXP NEUR, V61, P339, DOI 10.1093/jnen/61.4.339; Ben-Zvi A, 2008, J NEUROSCI, V28, P12427, DOI 10.1523/JNEUROSCI.3573-08.2008; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Chen G, 2008, NAT NEUROSCI, V11, P36, DOI 10.1038/nn2018; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; De Winter F, 2002, ADV EXP MED BIOL, V515, P115; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Ding S, 2007, BIOCHEM BIOPH RES CO, V356, P857, DOI 10.1016/j.bbrc.2007.03.073; Fujita H, 2001, BRAIN RES, V914, P1, DOI 10.1016/S0006-8993(01)02765-2; Gagliardini V, 1999, MOL CELL NEUROSCI, V14, P301, DOI 10.1006/mcne.1999.0787; Gallo G, 2006, J CELL SCI, V119, P3413, DOI 10.1242/jcs.03084; Giger RJ, 1998, PROG BRAIN RES, V117, P133; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; Hou ST, 2008, INT REV CEL MOL BIO, V267, P125, DOI 10.1016/S1937-6448(08)00603-5; Hou ST, 2008, BIOCHEM BIOPH RES CO, V367, P109, DOI 10.1016/j.bbrc.2007.12.103; Hou ST, 2006, J NEUROSCI, V26, P2241, DOI 10.1523/JNEUROSCI.4485-05.2006; Hou ST, 2000, J NEUROCHEM, V75, P91, DOI 10.1046/j.1471-4159.2000.0750091.x; Jiang SX, 2007, MOL CELL BIOL, V27, P1696, DOI 10.1128/MCB.01760-06; Jiang SX, 2005, J BIOL CHEM, V280, P33811, DOI 10.1074/jbc.M503113200; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; MacManus JP, 1999, NEUROREPORT, V10, P2711, DOI 10.1097/00001756-199909090-00004; MacManus JP, 2003, J CEREBR BLOOD F MET, V23, P1020, DOI 10.1097/01.WCB.0000084249.20114.FA; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Pasterkamp RJ, 1998, EXP NEUROL, V153, P313, DOI 10.1006/exnr.1998.6886; Pasterkamp RJ, 2001, BRAIN RES REV, V35, P36, DOI 10.1016/S0165-0173(00)00050-3; Pasterkamp RJ, 1998, PROG BRAIN RES, V117, P151; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Rohner TC, 2005, MECH AGEING DEV, V126, P177, DOI 10.1016/j.mad.2004.09.032; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; Shapovalova Z, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-133; Shirvan A, 1999, J NEUROCHEM, V73, P961, DOI 10.1046/j.1471-4159.1999.0730961.x; Shirvan A, 2002, J BIOL CHEM, V277, P49799, DOI 10.1074/jbc.M204793200; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Trim PJ, 2008, ANAL CHEM, V80, P8628, DOI 10.1021/ac8015467; WAKADE TD, 1995, J PHYSIOL-LONDON, V488, P123, DOI 10.1113/jphysiol.1995.sp020951; Weaver JGR, 2005, J CLIN INVEST, V115, P1828, DOI 10.1172/JCI22954; Williams G, 2005, J NEUROCHEM, V92, P1180, DOI 10.1111/j.1471-4159.2004.02950.x; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	49	36	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9908	9918		10.1074/jbc.M109.080689	http://dx.doi.org/10.1074/jbc.M109.080689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20133938	Green Published, hybrid			2022-12-27	WOS:000276165900061
J	Martinez, E; Hamberg, M; Busquets, M; Diaz, P; Manresa, A; Oliw, EH				Martinez, Eriel; Hamberg, Mats; Busquets, Montse; Diaz, Pilar; Manresa, Angeles; Oliw, Ernst H.			Biochemical Characterization of the Oxygenation of Unsaturated Fatty Acids by the Dioxygenase and Hydroperoxide Isomerase of Pseudomonas aeruginosa 42A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLEIC-ACID; LINOLEIC-ACID; 7,10-DIHYDROXY-8(E)-OCTADECENOIC ACID; MASS-SPECTROMETRY; RICINOLEIC ACID; STERIC ANALYSIS; LIPOXYGENASE; IDENTIFICATION; OXIDATION; COMPOUND	We have studied oxygenation of fatty acids by cell extract of Pseudomonas aeruginosa 42A2. Oleic acid ((9Z)-18:1) was transformed to (10S)-hydroperoxy-(8E)-octadecenoic acid ((10S)-HPOME) and to (7S, 10S)-dihydroxy-(8E)-octadecenoic acid (7,10-DiHOME). Experiments under oxygen-18 showed that 7,10-DiHOME contained oxygen from air and was formed sequentially from (10S)-HPOME by isomerization. (10R)-HPOME was not isomerized. The (10S)-dioxygenase and hydroperoxide isomerase activities co-eluted on ion exchange chromatography and on gel filtration with an apparent molecular size of similar to 50 kDa. 16: 1n-7, 18: 2n-6, and 20: 1n-11 were also oxygenated to 7,10-dihydroxy fatty acids, and (8Z)-18: 1 was oxygenated to 6,9-dihydroxy-(7E)-octadecenoic acid. A series of fatty acids with the double bond positioned closer to ((6Z)-18: 1, (5Z, 9Z)- 18: 2) or more distant from the carboxyl group ((11Z)-, (13Z)-, and (15Z)- 18: 1) were poor substrates. The oxygenation mechanism was studied with [7S-H-2] 18: 1n-9, [7R-H-2] 18: 2n-6, and [8R-H-2] 18: 2n-6 as substrates. The pro-R hydrogen at C-8 was lost in the biosynthesis of (10S)- HPODE, whereas the pro-S hydrogen was lost and the pro-R hydrogen was retained at C-7 during biosynthesis of the 7,10-dihydroxy metabolites. Analysis of the fatty acid composition of P. aeruginosa revealed relatively large amounts of (9E/Z)- 16: 1 and (11E/Z)- 18: 1 and only traces of 18: 1n-9. We found that (11Z)- 18: 1 (vaccenic acid) was transformed to (11S, 14S)- dihydroxy-(12E)-octadecenoic acid and to a mixture of 11- and 12-HPOME, possibly due to reverse orientation of (11Z)- 18: 1 at the active site compared with oleic acid. The reaction mechanism of the hydroperoxide isomerase suggests catalytic similarities to cytochrome P450.	[Martinez, Eriel; Oliw, Ernst H.] Uppsala Biomed Ctr, Div Biochem Pharmacol, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; [Martinez, Eriel; Manresa, Angeles] Univ Barcelona, Microbiol Lab, Fac Farm, E-08028 Barcelona, Spain; [Diaz, Pilar] Univ Barcelona, Microbiol Lab, Fac Biol, E-08028 Barcelona, Spain; [Busquets, Montse] Univ Barcelona, Dept Bioquim & Biol Mol, E-08028 Barcelona, Spain; [Hamberg, Mats] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	University of Barcelona; University of Barcelona; University of Barcelona; Karolinska Institutet	Oliw, EH (corresponding author), Uppsala Biomed Ctr, Div Biochem Pharmacol, Dept Pharmaceut Biosci, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se	; Diaz, Pilar/I-2465-2014	Manresa, Angeles/0000-0003-2337-9060; Diaz, Pilar/0000-0003-4008-0669; Hamberg, Mats/0000-0002-8910-7810; Oliw, Ernst/0000-0002-7986-8130	Comision Interministerial de Ciencia y Tecnologia, Spain (CICYT) [CTQ2007-60749/PPQ]; Vetenskapsradet Natur och Teknik; Comissio Interdepartamental de Recerca i Tecnologia [2005GR00143]; Vetenskapsradet Medicin [3X-06523]; Formas [222-2005-1733]; Knut and Alice Wallenberg Foundation [2004.0123]	Comision Interministerial de Ciencia y Tecnologia, Spain (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Vetenskapsradet Natur och Teknik; Comissio Interdepartamental de Recerca i Tecnologia; Vetenskapsradet Medicin; Formas(Swedish Research Council Formas); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	Supported by a scholarship from Comision Interministerial de Ciencia y Tecnologia, Spain (CICYT) Project CTQ2007-60749/PPQ.; Supported by Vetenskapsradet Natur och Teknik.; Supported by CICYT Project CTQ2007-60749/PPQ and Comissio Interdepartamental de Recerca i Tecnologia Project 2005GR00143.; Supported by Vetenskapsradet Medicin (project 3X-06523), Formas (222-2005-1733), and The Knut and Alice Wallenberg Foundation (2004.0123).	Bae JH, 2007, APPL MICROBIOL BIOT, V75, P435, DOI 10.1007/s00253-006-0832-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brash AR, 2009, PHYTOCHEMISTRY, V70, P1522, DOI 10.1016/j.phytochem.2009.08.005; Brodhun F, 2009, J BIOL CHEM, V284, P11792, DOI 10.1074/jbc.M809152200; Chacon JN, 2000, CHEM PHYS LIPIDS, V107, P107, DOI 10.1016/S0009-3084(00)00157-2; Clapp CH, 2001, J AM CHEM SOC, V123, P747, DOI 10.1021/ja0032071; El-Kattan Ayman F, 2008, Drug Metab Lett, V2, P120, DOI 10.2174/187231208784041004; Gardner HW, 1999, J AM OIL CHEM SOC, V76, P1151, DOI 10.1007/s11746-999-0088-1; Garscha U, 2008, J CHROMATOGR B, V872, P90, DOI 10.1016/j.jchromb.2008.07.013; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; Garscha U, 2009, J BIOL CHEM, V284, P13755, DOI 10.1074/jbc.M808665200; Guerrero A, 1997, BBA-LIPID LIPID MET, V1347, P75, DOI 10.1016/S0005-2760(97)00056-8; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; HAMBERG M, 1971, ANAL BIOCHEM, V43, P515, DOI 10.1016/0003-2697(71)90282-X; Hou CT, 2009, NEW BIOTECHNOL, V26, P2, DOI 10.1016/j.nbt.2009.05.001; HOU CT, 1991, J AM OIL CHEM SOC, V68, P99, DOI 10.1007/BF02662326; Kim H, 2000, J AM OIL CHEM SOC, V77, P95, DOI 10.1007/s11746-000-0015-7; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; Kuo TM, 2004, CURR MICROBIOL, V49, P261, DOI 10.1007/s00284-004-4296-5; Kuo TM, 2001, CURR MICROBIOL, V43, P198, DOI 10.1007/s002840010287; Kuo TM, 1998, J AM OIL CHEM SOC, V75, P875, DOI 10.1007/s11746-998-0240-3; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; MERCADE E, 1988, J AM OIL CHEM SOC, V65, P1915, DOI 10.1007/BF02546006; NING D, 2009, BIODEGRADAT IN PRESS; OLIW EH, 1994, PROG LIPID RES, V33, P329, DOI 10.1016/0163-7827(94)90029-9; Oliw EH, 2001, BIOCHEM PHARMACOL, V62, P407, DOI 10.1016/S0006-2952(01)00683-9; Porta H, 2001, MICROBIOL-SGM, V147, P3199, DOI 10.1099/00221287-147-12-3199; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; Smith WL, 2008, TRENDS BIOCHEM SCI, V33, P27, DOI 10.1016/j.tibs.2007.09.013; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Vidal-Mas J, 2005, ANTON LEEUW INT J G, V87, P245, DOI 10.1007/s10482-004-4021-1; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; Yetkin G, 2006, AM J INFECT CONTROL, V34, P188, DOI 10.1016/j.ajic.2005.11.010	35	39	41	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9339	9345		10.1074/jbc.M109.078147	http://dx.doi.org/10.1074/jbc.M109.078147			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20075076	hybrid, Green Published			2022-12-27	WOS:000276165900005
J	Qian, C; Liu, JN; Tang, FY; Yuan, DW; Guo, ZG; Zhang, J				Qian, Chen; Liu, Jian-Ning; Tang, Fengyuan; Yuan, Dawen; Guo, Zhigang; Zhang, Jing			A Novel Strategy for Proteome-wide Ligand Screening Using Cross-linked Phage Matrices	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY LIGANDS; PEPTIDE LIGAND; SELECTION; ANTIBODY; LIBRARIES; DISPLAY; TECHNOLOGY; FRAGMENTS	To find a suitable ligand from a complex antigen system is still a mission to be accomplished. Here we have explored a novel "library against proteome" panning strategy for ligand screening and antigen purification from a complex system using phage-displayed antibody technology. Human plasma proteome was targeted for phage library panning. During the process, the panning was carried out in solution, using a biotin/streptavidin beads separation system, for three rounds. Nine monoclonal phages, bound tightly to a number of unknown plasma proteins, were selected from the last round, six of which were directly employed as cross-linked matrices to purify their corresponding antigens from the plasma. The proteins isolated by G5 and E1 matrices were identified as amyloid protein and apolipoprotein A-I precursor, respectively. The results demonstrated that it was feasible to simultaneously obtain a number of ligand phages for various antigens, including low abundant proteins in a non-comparative proteome-wide system.	[Qian, Chen; Liu, Jian-Ning; Tang, Fengyuan; Yuan, Dawen; Zhang, Jing] Nanjing Univ, Inst Mol Med, Nanjing 210093, Peoples R China; [Qian, Chen; Liu, Jian-Ning; Tang, Fengyuan; Yuan, Dawen; Zhang, Jing] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; [Liu, Jian-Ning; Guo, Zhigang; Zhang, Jing] E China Normal Univ, Inst Mol & Expt Therapeut, Shanghai 200062, Peoples R China	Nanjing University; Nanjing University; East China Normal University	Zhang, J (corresponding author), Nanjing Univ, Inst Mol Med, 22 Hankou Rd, Nanjing 210093, Peoples R China.	jingzhang2001@gmail.com			Ministry of Education, China [20060284042, 20060284045]	Ministry of Education, China(Ministry of Education, China)	The work was supported by the Ministry of Education, China (Grants 20060284042 and 20060284045).	Adamson SR, 1998, DEV BIOL STAND, V93, P89; Amatschek K, 2000, HRC-J HIGH RES CHROM, V23, P47; Bowley DR, 2009, P NATL ACAD SCI USA, V106, P1380, DOI 10.1073/pnas.0812291106; Breccia JD, 2003, ENZYME MICROB TECH, V33, P244, DOI 10.1016/S0141-0229(03)00118-2; Furuta M, 2002, J BIOCHEM, V132, P245, DOI 10.1093/oxfordjournals.jbchem.a003217; GIROT P, 1990, J CHROMATOGR, V510, P213, DOI 10.1016/S0021-9673(01)93755-0; Goletz S, 2002, J MOL BIOL, V315, P1087, DOI 10.1006/jmbi.2001.5314; Hage DS, 1999, CLIN CHEM, V45, P593; Hammond DJ, 1998, CHROMATOGRAPHIA, V47, P475, DOI 10.1007/BF02466484; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; HELLMAN U, 1995, ANAL BIOCHEM, V224, P451, DOI 10.1006/abio.1995.1070; Hoogenboom HR, 1999, EUR J BIOCHEM, V260, P774, DOI 10.1046/j.1432-1327.1999.00214.x; Hortin GL, 2006, CLIN CHEM, V52, P1223, DOI 10.1373/clinchem.2006.069252; Huang PY, 1999, BIOTECHNOL BIOENG, V63, P633, DOI 10.1002/(SICI)1097-0290(19990620)63:6<633::AID-BIT1>3.0.CO;2-C; Hust M, 2004, TRENDS BIOTECHNOL, V22, P8, DOI 10.1016/j.tibtech.2003.10.011; Kay B. K, 1996, PHAGE DISPLAY PEPTID; Kelley BD, 2004, J CHROMATOGR A, V1038, P121, DOI 10.1016/j.chroma.2004.03.041; Kouzmitcheva GA, 2001, CLIN DIAGN LAB IMMUN, V8, P150, DOI 10.1128/CDLI.8.1.150-160.2001; KRETZSCHMAR T, 1995, ANAL BIOCHEM, V224, P413, DOI 10.1006/abio.1995.1059; LABROU N, 1994, J BIOTECHNOL, V36, P95, DOI 10.1016/0168-1656(94)90047-7; Labrou NE, 2003, J CHROMATOGR B, V790, P67, DOI 10.1016/S1570-0232(03)00098-9; Liu B, 2002, J MOL BIOL, V315, P1063, DOI 10.1006/jmbi.2001.5276; McConnell SJ, 1999, BIOTECHNIQUES, V26, P208, DOI 10.2144/99262bm06; Nord K, 2001, EUR J BIOCHEM, V268, P4269, DOI 10.1046/j.1432-1327.2001.02344.x; Samoylova TI, 2004, BIOTECHNIQUES, V37, P254, DOI 10.2144/04372RR02; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Smith GP, 1998, J IMMUNOL METHODS, V215, P151, DOI 10.1016/S0022-1759(98)00087-8; StausbolGron B, 1996, FEBS LETT, V391, P71, DOI 10.1016/0014-5793(96)00703-X; Su Z G, 1991, Chin J Biotechnol, V7, P161	29	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9367	9372		10.1074/jbc.M109.059857	http://dx.doi.org/10.1074/jbc.M109.059857			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118230	hybrid, Green Published			2022-12-27	WOS:000276165900008
J	Kieken, F; Sharma, M; Jovic, M; Giridharan, SSP; Naslavsky, N; Caplan, S; Sorgen, PL				Kieken, Fabien; Sharma, Mahak; Jovic, Marko; Giridharan, Sai Srinivas Panapakkam; Naslavsky, Naava; Caplan, Steve; Sorgen, Paul L.			Mechanism for the Selective Interaction of C-terminal Eps15 Homology Domain Proteins with Specific Asn-Pro-Phe-containing Partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE SUBSTRATE; EARLY ENDOSOMAL TRANSPORT; EH-DOMAIN; PLASMA-MEMBRANE; MAMMALIAN-CELLS; ENDOCYTOSIS; RME-1; IDENTIFICATION; RECOGNITION; COMPARTMENT	Epidermal growth factor receptor tyrosine kinase substrate 15 (Eps15) homology (EH)-domain proteins can be divided into two classes: those with an N-terminal EH-domain(s), and the C-terminal Eps15 homology domain-containing proteins (EHDs). Whereas many N-terminal EH-domain proteins regulate internalization events, the best characterized C-terminal EHD, EHD1, regulates endocytic recycling. Because EH-domains interact with the tripeptide Asn-Pro-Phe (NPF), it is of critical importance to elucidate the molecular mechanisms that allow EHD1 and its paralogs to interact selectively with a subset of the hundreds of NPF-containing proteins expressed in mammalian cells. Here, we capitalize on our findings that C-terminal EH-domains possess highly positively charged interaction surfaces and that many NPF-containing proteins that interact with C-terminal (but not N-terminal) EH-domains are followed by acidic residues. Using the recently identified EHD1 interaction partner molecule interacting with CasL (MICAL)-Like 1 (MICAL-L1) as a model, we have demonstrated that only the first of its two NPF motifs is required for EHD1 binding. Because only this first NPF is followed by acidic residues, we have utilized glutathione S-transferase pulldowns, two-hybrid analysis, and NMR to demonstrate that the flanking acidic residues "fine tune" the binding affinity to EHD1. Indeed, our NMR solution structure of the EHD1 EH-domain in complex with the MICAL-L1 NPFEEEEED peptide indicates that the first two flanking Glu residues lie in a position favorable to form salt bridges with Lys residues within the EH-domain. Our data provide a novel explanation for the selective interaction of C-terminal EH-domains with specific NPF-containing proteins and allow for the prediction of new interaction partners with C-terminal EHDs.	[Caplan, Steve] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; Univ Nebraska, Med Ctr, Eppley Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Caplan, S (corresponding author), Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, 985870 Nebraska Med Ctr, Omaha, NE 68198 USA.	scaplan@unmc.edu; psorgen@unmc.edu	giridharan, sai srinivas panapakkam/X-9083-2019	Jovic, Marko/0000-0002-0310-7730; Sharma, Mahak/0000-0002-4117-4790	National Institutes of Health [GM072631, GM074876, P20RR018759]; University of Nebraska Medical Center Eppley Cancer Center; Nebraska Health and Human Services [LB506, 2009-38, 2010-05]; American Heart Association; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072631, R01GM074876, R01GM087455] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Medical Center Eppley Cancer Center; Nebraska Health and Human Services; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM072631 (to P. L. S.), GM074876 (to S. C.), and P20RR018759 (to M.J. and N.N.). This work was also supported by the University of Nebraska Medical Center Eppley Cancer Center (P. L. S. and S. C.), Nebraska Health and Human Services Grants LB506 and 2009-38 (to P. L. S.) and LB506 and 2010-05 (to S. C.), and by an American Heart Association predoctoral fellowship (to M.	Barbosa MDFS, 1996, NATURE, V382, P262, DOI 10.1038/382262a0; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Confalonieri S, 2002, FEBS LETT, V513, P24, DOI 10.1016/S0014-5793(01)03241-0; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; FAZIOLI F, 1993, MOL CELL BIOL, V13, P5814, DOI 10.1128/MCB.13.9.5814; Gao GH, 2006, BIOCHEMISTRY-US, V45, P1785, DOI 10.1021/bi051856p; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Gokool S, 2007, TRAFFIC, V8, P1873, DOI 10.1111/j.1600-0854.2007.00652.x; Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Miliaras NB, 2004, CELL BIOCHEM BIOPHYS, V41, P295, DOI 10.1385/CBB:41:2:295; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Nishimura N, 2008, J MED INVESTIG, V55, P9, DOI 10.2152/jmi.55.9; Paoluzi S, 1998, EMBO J, V17, P6541, DOI 10.1093/emboj/17.22.6541; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Rapaport D, 2006, TRAFFIC, V7, P52, DOI 10.1111/j.1600-0854.2005.00359.x; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Sharma M, 2008, TRAFFIC, V9, P995, DOI 10.1111/j.1600-0854.2008.00732.x; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; WONG WT, 1995, P NATL ACAD SCI USA, V92, P9530, DOI 10.1073/pnas.92.21.9530; Zhang XY, 2005, J BIOL CHEM, V280, P20356, DOI 10.1074/jbc.M500511200	36	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8687	8694		10.1074/jbc.M109.045666	http://dx.doi.org/10.1074/jbc.M109.045666			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20106972	Green Published, hybrid			2022-12-27	WOS:000275553700021
J	Kamimura, Y; Devreotes, PN				Kamimura, Yoichiro; Devreotes, Peter N.			Phosphoinositide-dependent Protein Kinase (PDK) Activity Regulates Phosphatidylinositol 3,4,5-Trisphosphate-dependent and -independent Protein Kinase B Activation and Chemotaxis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM-DISCOIDEUM; MEDIATES CHEMOTAXIS; CELL POLARITY; LEADING-EDGE; AKT/PKB; PHOSPHORYLATION; PATHWAYS; RECEPTOR; INSULIN; TORC2	Chemotactic cells must sense shallow extracellular gradients and produce localized intracellular responses. We previously showed that the temporal and spatial activation of two protein kinase B (PKB) homologues, PkbA and PkbR1, in Dictyostelium discoideum by phosphorylation of activation loops (ALs) and hydrophobic motifs had important roles in chemotaxis. We found that hydrophobic motif phosphorylation depended on regulation of TorC2 (target of rapamycin complex 2); however, the regulation of AL phosphorylation remains to be determined at a molecular level. Here, we show that two PDK (phosphoinositide-dependent protein kinase) homologues, PdkA and PdkB, function as the key AL kinases. Cells lacking both PdkA and PdkB are defective in PKB activation, chemotaxis, and fruiting body formation upon nutrient deprivation. The pleckstrin homology domain of PdkA is sufficient to localize it to the membrane, but transient activation of PdkA is independent of PIP3 as well as TorC2 and dispensable for full function. These results confirm the importance of the TorC2-PDK-PKB pathway in chemotaxis and point to a novel mechanism of regulation of PDKs by chemoattractant.	[Kamimura, Yoichiro; Devreotes, Peter N.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Devreotes, PN (corresponding author), 725 N Wolfe St,Wood Bas Sci Bldg,Rm 114, Baltimore, MD 21205 USA.	pnd@jhmi.edu	Kamimura, Yoichiro/M-2585-2017		National Institutes of Health [GM 28007, GM 34933]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM028007, R01GM034933, R01GM028007] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 28007 and GM 34933 (to P. N. D.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bayascas JR, 2008, CELL CYCLE, V7, P2978, DOI 10.4161/cc.7.19.6810; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Chen LF, 2007, DEV CELL, V12, P603, DOI 10.1016/j.devcel.2007.03.005; Chen MY, 1997, GENE DEV, V11, P3218, DOI 10.1101/gad.11.23.3218; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Fergus GJ, 2007, NAT CELL BIOL, V9, P86, DOI 10.1038/ncb1517; Franca-Koh J, 2006, CURR OPIN GENET DEV, V16, P333, DOI 10.1016/j.gde.2006.06.001; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Inoue T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003068; Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068; Kamimura Y, 2009, METHODS MOL BIOL, V571, P255, DOI 10.1007/978-1-60761-198-1_17; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342; Meili R, 2000, CURR BIOL, V10, P708, DOI 10.1016/S0960-9822(00)00536-4; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; van Haastert PJM, 2007, J CELL BIOL, V177, P809, DOI 10.1083/jcb.200701134	25	29	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7938	7946		10.1074/jbc.M109.089235	http://dx.doi.org/10.1074/jbc.M109.089235			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075071	hybrid, Green Published			2022-12-27	WOS:000275413800011
J	Penno, A; Reilly, MM; Houlden, H; Laura, M; Rentsch, K; Niederkofler, V; Stoeckli, ET; Nicholson, G; Eichler, F; Brown, RH; von Eckardstein, A; Hornemann, T				Penno, Anke; Reilly, Mary M.; Houlden, Henry; Laura, Matilde; Rentsch, Katharina; Niederkofler, Vera; Stoeckli, Esther T.; Nicholson, Garth; Eichler, Florian; Brown, Robert H., Jr.; von Eckardstein, Arnold; Hornemann, Thorsten			Hereditary Sensory Neuropathy Type 1 Is Caused by the Accumulation of Two Neurotoxic Sphingolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PALMITOYLTRANSFERASE; CERAMIDE SYNTHASE; NERVOUS-SYSTEM; CELL-SURFACE; IN-VIVO; HSAN-I; SPTLC1; METABOLISM; MUTATIONS; 1-PHOSPHATE	HSAN1 is an inherited neuropathy found to be associated with several missense mutations in the SPTLC1 subunit of serine palmitoyltransferase (SPT). SPT catalyzes the condensation of serine and palmitoyl-CoA, the initial step in the de novo synthesis of sphingolipids. Here we show that the HSAN1 mutations induce a shift in the substrate specificity of SPT, which leads to the formation of the two atypical deoxy-sphingoid bases (DSBs) 1-deoxy-sphinganine and 1-deoxymethyl-sphinganine. Both metabolites lack the C-1 hydroxyl group of sphinganine and can therefore neither be converted to complex sphingolipids nor degraded. Consequently, they accumulate in the cell, as demonstrated in HEK293 cells over-expressing mutant SPTLC1 and lymphoblasts of HSAN1 patients. Elevated DSB levels were also found in the plasma of HSAN1 patients and confirmed in three groups of HSAN1 patients with different SPTLC1mutations. The DSBs show pronounced neurotoxic effects on neurite formation in cultured sensory neurons. The neurotoxicity co-occurs with a disturbed neurofilament structure in neurites when cultured in the presence of DSBs. Based on these observations, we conclude that HSAN1 is caused by a gain of function mutation, which results in the formation of two atypical and neurotoxic sphingolipid metabolites.	[Penno, Anke; Rentsch, Katharina; von Eckardstein, Arnold; Hornemann, Thorsten] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Penno, Anke; von Eckardstein, Arnold; Hornemann, Thorsten] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8093 Zurich, Switzerland; [Reilly, Mary M.; Houlden, Henry; Laura, Matilde] Natl Hosp Neurol & Neurosurg, MRC, Ctr Neuromuscular Dis, London WC1N 3BG, England; [Reilly, Mary M.; Houlden, Henry; Laura, Matilde] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Niederkofler, Vera; Stoeckli, Esther T.] Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; [Nicholson, Garth] Concord Repatriat Gen Hosp, Mol Med Lab, Sydney, NSW 2139, Australia; [Nicholson, Garth] Concord Repatriat Gen Hosp, Australian & New Zealand Army Corps Res Inst, Sydney, NSW 2139, Australia; [Eichler, Florian; Brown, Robert H., Jr.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Neurosci,Day Lab Neuromuscular Res, Boston, MA 02115 USA; [Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA	University of Zurich; University Zurich Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Zurich; Concord Repatriation General Hospital; Concord Repatriation General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester	Hornemann, T (corresponding author), Univ Zurich Hosp, Inst Clin Chem, Raemistr 100, CH-8091 Zurich, Switzerland.	thorsten.hornemann@usz.ch	Houlden, Henry J/C-1532-2008	Houlden, Henry J/0000-0002-2866-7777; Stoeckli, Esther/0000-0002-8485-0648; Reilly, Mary/0000-0003-0686-905X; Nicholson, Garth/0000-0001-9694-066X	National Institutes of Health through the NINDS [K08NS52550]; Deater Foundation; MRC; Muscular Dystrophy Campaign; Hartmann Muller Foundation; Herzog-Egli Foundation; Olga Mayenfisch Foundation; Foundation for Scientific Research (University of Zurich); German Society for Clinical Chemistry; Laboratory Medicine (DGKL); European Commission [LSHM-CT-2006-037631]; MRC [G0601943, G0802760] Funding Source: UKRI; Medical Research Council [G0802760, G0601943] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS052550, R01NS072446] Funding Source: NIH RePORTER	National Institutes of Health through the NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Deater Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Hartmann Muller Foundation; Herzog-Egli Foundation; Olga Mayenfisch Foundation; Foundation for Scientific Research (University of Zurich); German Society for Clinical Chemistry; Laboratory Medicine (DGKL); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant K08NS52550 (to F. E.) through the NINDS. This work was also supported by grants from the Deater Foundation (to R. H. B. and F. E.) and from the MRC (to M. M. R. and H. H.) and the Muscular Dystrophy Campaign (to M. M. R. and M. L.). The work undertaken at the University Hospital of Zurich and was supported by grants from the Hartmann Muller Foundation, the Herzog-Egli Foundation, the Olga Mayenfisch Foundation, and the Foundation for Scientific Research (University of Zurich) as well as the German Society for Clinical Chemistry and Laboratory Medicine (DGKL) and the European Commission (LSHM-CT-2006-037631).	Auer-Grumbach M, 2006, NEUROMOL MED, V8, P147, DOI 10.1385/NMM:8:1:147; Auer-Grumbach M, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-7; Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Bejaoui K, 2002, J CLIN INVEST, V110, P1301, DOI 10.1172/JCI200216450; Bi H, 2007, NEUROPATHOLOGY, V27, P429, DOI 10.1111/j.1440-1789.2007.00808.x; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; Cuadros R, 2000, CANCER LETT, V152, P23, DOI 10.1016/S0304-3835(99)00428-0; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Dedov VN, 2004, BBA-MOL BASIS DIS, V1688, P168, DOI 10.1016/j.bbadis.2003.12.005; Du L, 2008, J IND MICROBIOL BIOT, V35, P455, DOI 10.1007/s10295-008-0316-y; Eichler FS, 2009, J NEUROSCI, V29, P14646, DOI 10.1523/JNEUROSCI.2536-09.2009; Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200; Geraldes R, 2004, J NEUROL SCI, V227, P35, DOI 10.1016/j.jns.2004.08.002; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hornemann T, 2009, NEUROGENETICS, V10, P135, DOI 10.1007/s10048-008-0168-7; Houlden H, 2006, BRAIN, V129, P411, DOI 10.1093/brain/awh712; Humpf HU, 1998, J BIOL CHEM, V273, P19060, DOI 10.1074/jbc.273.30.19060; Klein CJ, 2005, J NEUROL NEUROSUR PS, V76, P1022, DOI 10.1136/jnnp.2004.050062; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Milstien S, 2007, ACTA PAEDIATR, V96, P40, DOI 10.1111/j.1651-2227.2007.00206.x; Okada T, 2009, CELL SIGNAL, V21, P7, DOI 10.1016/j.cellsig.2008.07.011; Riley RT, 1999, NAT TOXINS, V7, P407, DOI 10.1002/1522-7189(199911/12)7:6<407::AID-NT84>3.0.CO;2-0; Rotthier A, 2009, BRAIN, V132, P2699, DOI 10.1093/brain/awp198; Salcedo M, 2007, APOPTOSIS, V12, P395, DOI 10.1007/s10495-006-0573-z; Sanchez AM, 2008, EUR J PHARMACOL, V584, P237, DOI 10.1016/j.ejphar.2008.02.011; Stoeckli ET, 1996, DEV BIOL, V177, P15, DOI 10.1006/dbio.1996.0141; Tani M, 2007, CELL SIGNAL, V19, P229, DOI 10.1016/j.cellsig.2006.07.001; Verhoeven K, 2004, NEUROLOGY, V62, P1001, DOI 10.1212/01.WNL.0000115388.10828.5C; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	33	230	235	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11178	11187		10.1074/jbc.M109.092973	http://dx.doi.org/10.1074/jbc.M109.092973			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20097765	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000276286200023
J	Simon, GM; Cravatt, BF				Simon, Gabriel M.; Cravatt, Benjamin F.			Activity-based Proteomics of Enzyme Superfamilies: Serine Hydrolases as a Case Study	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACTIVITY-BASED PROBES; IN-VIVO; FUNCTIONAL PROTEOMICS; COMPLEX PROTEOMES; POSTTRANSLATIONAL MODIFICATIONS; ACTIVITY PROFILES; INHIBITORS; IDENTIFICATION; REVEALS; 2-ARACHIDONOYLGLYCEROL	Genome sequencing projects have uncovered thousands of uncharacterized enzymes in eukaryotic and prokaryotic organisms. Deciphering the physiological functions of enzymes requires tools to profile and perturb their activities in native biological systems. Activity-based protein profiling has emerged as a powerful chemoproteomic strategy to achieve these objectives through the use of chemical probes that target large swaths of enzymes that share active-site features. Here, we review activity-based protein profiling and its implementation to annotate the enzymatic proteome, with particular attention given to probes that target serine hydrolases, a diverse superfamily of enzymes replete with many uncharacterized members.	[Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Cravatt, BF (corresponding author), Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA.	cravatt@scripps.edu			National Institutes of Health [CA087660, CA132630, DA025285]; ARCS Foundation; Koshland Graduate Fellowship in Enzyme Biochemistry; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R01CA087660, R37CA087660, R01CA132630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARCS Foundation; Koshland Graduate Fellowship in Enzyme Biochemistry; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants CA087660, CA132630, and DA025285. This work was also supported by the ARCS Foundation and a Koshland Graduate Fellowship in Enzyme Biochemistry (to G. M. S.) and by the Skaggs Institute for Chemical Biology. This is the fourth of six articles in the "Chemical Biology Meets Biological Chemistry Minireview Series." This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Ahn K, 2007, BIOCHEMISTRY-US, V46, P13019, DOI 10.1021/bi701378g; Alexander JP, 2005, CHEM BIOL, V12, P1179, DOI 10.1016/j.chembiol.2005.08.011; Bachovchin DA, 2009, NAT BIOTECHNOL, V27, P387, DOI 10.1038/nbt.1531; Berger Alicia B, 2004, Am J Pharmacogenomics, V4, P371, DOI 10.2165/00129785-200404060-00004; Bertone P, 2005, FEBS J, V272, P5400, DOI 10.1111/j.1742-4658.2005.04970.x; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Bottcher T, 2008, J AM CHEM SOC, V130, P14400, DOI 10.1021/ja8051365; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Cohen MS, 2007, NAT CHEM BIOL, V3, P156, DOI 10.1038/nchembio859; Collins SR, 2009, NAT METHODS, V6, P721, DOI 10.1038/nmeth1009-721; Cravatt BF, 2008, ANNU REV BIOCHEM, V77, P383, DOI 10.1146/annurev.biochem.75.101304.124125; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Doucet A, 2008, MOL CELL PROTEOMICS, V7, P1925, DOI 10.1074/mcp.R800012-MCP200; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Greenbaum D, 2002, MOL CELL PROTEOMICS, V1, P60, DOI 10.1074/mcp.T100003-MCP200; Greenbaum D, 2000, CHEM BIOL, V7, P569, DOI 10.1016/S1074-5521(00)00014-4; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; Guengerich FP, 2005, BIOCHEM BIOPH RES CO, V338, P465, DOI 10.1016/j.bbrc.2005.08.079; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jessani N, 2005, ANGEW CHEM INT EDIT, V44, P2400, DOI 10.1002/anie.200463098; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Joyce JA, 2004, CANCER CELL, V5, P443, DOI 10.1016/S1535-6108(04)00111-4; Kaschani F, 2009, MOL CELL PROTEOMICS, V8, P1082, DOI 10.1074/mcp.M800494-MCP200; Kato D, 2005, NAT CHEM BIOL, V1, P33, DOI 10.1038/nchembio707; Kidd D, 2001, BIOCHEMISTRY-US, V40, P4005, DOI 10.1021/bi002579j; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Leung D, 2003, NAT BIOTECHNOL, V21, P687, DOI 10.1038/nbt826; Li WW, 2007, J AM CHEM SOC, V129, P9594, DOI 10.1021/ja073650c; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, P NATL ACAD SCI USA, V106, P20270, DOI 10.1073/pnas.0909411106; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Madsen MA, 2006, J BIOL CHEM, V281, P15997, DOI 10.1074/jbc.M601223200; Mahrus S, 2005, CHEM BIOL, V12, P567, DOI 10.1016/j.chembiol.2005.03.006; Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Meier JL, 2009, ACS CHEM BIOL, V4, P948, DOI 10.1021/cb9002128; Morak M, 2009, J LIPID RES, V50, P1281, DOI 10.1194/jlr.M800566-JLR200; Muccioli GG, 2007, J NEUROSCI, V27, P2883, DOI 10.1523/JNEUROSCI.4830-06.2007; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Okerberg ES, 2005, P NATL ACAD SCI USA, V102, P4996, DOI 10.1073/pnas.0501205102; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Sadaghiani AM, 2007, CURR OPIN CHEM BIOL, V11, P20, DOI 10.1016/j.cbpa.2006.11.030; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Shin S, 2002, EMBO J, V21, P2509, DOI 10.1093/emboj/21.11.2509; Sieber SA, 2006, NAT CHEM BIOL, V2, P274, DOI 10.1038/nchembio781; Speers AE, 2005, J AM CHEM SOC, V127, P10018, DOI 10.1021/ja0532842; Staub I, 2009, J AM CHEM SOC, V131, P6271, DOI 10.1021/ja901304n; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Tagore DM, 2009, NAT CHEM BIOL, V5, P23, DOI 10.1038/nchembio.126; Weerapana E, 2008, NAT CHEM BIOL, V4, P405, DOI 10.1038/nchembio.91; Zhao YM, 2009, PROTEOMICS, V9, P4632, DOI 10.1002/pmic.200900398	60	213	215	4	60	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11051	11055		10.1074/jbc.R109.097600	http://dx.doi.org/10.1074/jbc.R109.097600			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147750	hybrid, Green Published			2022-12-27	WOS:000276286200006
J	Yun, HM; Baik, JH; Kang, I; Jin, C; Rhim, H				Yun, Hyung-Mun; Baik, Ja-Hyun; Kang, Insug; Jin, Changbae; Rhim, Hyewhon			Physical Interaction of Jab1 with Human Serotonin 6 G-protein-coupled Receptor and Their Possible Roles in Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATE AP-1 ACTIVITY; HUMAN 5-HT6 RECEPTOR; CYTOPLASMIC LOCALIZATION; ACTIVATOR PROTEIN-1; COP9 SIGNALOSOME; ENERGY-TRANSFER; DEGRADATION; ANTAGONIST; EXPRESSION; BINDING	The 5-HT6 receptor (5-HT6R) is one of the most recently cloned serotonin receptors, and it plays important roles in Alzheimer disease, depression, and learning and memory disorders. However, unlike the other serotonin receptors, the cellular mechanisms of 5-HT6R are poorly elucidated relative to its significance in human brain diseases. Here, using a yeast two-hybrid assay, we found that the human 5-HT6R interacts with Jun activation domain-binding protein-1 (Jab1). We also confirmed a physical interaction between 5-HT6R and Jab1 using glutathione S-transferase pulldown, fluorescence resonance energy transfer, co-immunoprecipitation, and immunocyto(histo)-chemistry assays. The manipulation of Jab1 expression using Jab1 small interference RNA decreased 5-HT6R-mediated activity and cell membrane expression of 5-HT6R, whereas overexpression of Jab1 produced no significant effect. In addition, we demonstrated that the activation of 5-HT6R induced the translocation of Jab1 into the nucleus and increased c-Jun phosphorylation and the interaction between Jab1 and c-Jun. Furthermore, we found that 5-HT6R and Jab1 were up-regulated in middle cerebral artery occlusion-induced focal cerebral ischemic rats and in cultured cells exposed to hypoxic insults, suggesting possible protective roles for 5-HT6R and Jab1. These findings suggest that Jab1 provides a novel signal transduction pathway for 5-HT6R and may play an important role in 5-HT6R mediated behavior changes in the brain.	[Yun, Hyung-Mun; Rhim, Hyewhon] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [Yun, Hyung-Mun; Baik, Ja-Hyun] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea; [Kang, Insug] Kyung Hee Univ, Coll Med, Seoul 130702, South Korea; [Jin, Changbae] Korea Inst Sci & Technol, Doping Control Ctr, Seoul 136791, South Korea	Korea Institute of Science & Technology (KIST); Korea University; Kyung Hee University; Korea Institute of Science & Technology (KIST)	Rhim, H (corresponding author), Korea Inst Sci & Technol, Div Life Sci, 39-1 Hawholgok Dong, Seoul 136791, South Korea.	hrhim@kist.re.kr			Korea Science and Engineering Foundation [20090079000, 2009-0081531]; Ministry of Education, Science, and Technology, Korea [2009K001265]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science, and Technology, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Korea Science and Engineering Foundation Grant 20090079000, Pioneer Grant 2009-0081531, and the Brain Research Center of the 21st Century Frontier Research Program (Grant 2009K001265 to H. R.) from Ministry of Education, Science, and Technology, Korea.	Ahn J, 2009, ENDOCR J, V56, P707, DOI 10.1507/endocrj.K08E-372; Bae MK, 2002, J BIOL CHEM, V277, P9, DOI 10.1074/jbc.C100442200; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Bockaert J, 2006, CELL TISSUE RES, V326, P553, DOI 10.1007/s00441-006-0286-1; Branchek TA, 2000, ANNU REV PHARMACOL, V40, P319, DOI 10.1146/annurev.pharmtox.40.1.319; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen CH, 2007, J NEUROCHEM, V102, P1831, DOI 10.1111/j.1471-4159.2007.04652.x; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Cope Gregory A., 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-1; Dawson LA, 2001, NEUROPSYCHOPHARMACOL, V25, P662, DOI 10.1016/S0893-133X(01)00265-2; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Foley AG, 2004, NEUROPSYCHOPHARMACOL, V29, P93, DOI 10.1038/sj.npp.1300332; Fukumoto A, 2006, FEBS LETT, V580, P5836, DOI 10.1016/j.febslet.2006.09.042; Hayashi M, 2005, J CLIN ENDOCR METAB, V90, P1712, DOI 10.1210/jc.2004-1547; Hsu MC, 2008, MODERN PATHOL, V21, P609, DOI [10.1038/modpathol.2008.23, 10.1038/mpath.2008.23]; Hwang CY, 2004, ONCOGENE, V23, P8868, DOI 10.1038/sj.onc.1208116; Kang HT, 2005, BIOCHEM BIOPH RES CO, V329, P684, DOI 10.1016/j.bbrc.2005.02.040; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kim HJ, 2008, COMB CHEM HIGH T SCR, V11, P316, DOI 10.2174/138620708784246059; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kohen R, 1996, J NEUROCHEM, V66, P47; Larsen M, 2005, ADV EXP MED BIOL, V566, P203; Lee EW, 2006, MOL CELLS, V22, P133; Li SH, 2000, J BIOL CHEM, V275, P13386, DOI 10.1074/jbc.275.18.13386; Liu MT, 2009, J NEUROSCI, V29, P9683, DOI 10.1523/JNEUROSCI.1145-09.2009; Luo WB, 2006, J BIOL CHEM, V281, P7927, DOI 10.1074/jbc.M510784200; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Mitchell ES, 2005, PHARMACOL THERAPEUT, V108, P320, DOI 10.1016/j.pharmthera.2005.05.001; Oh W, 2006, J BIOL CHEM, V281, P30166, DOI 10.1074/jbc.M602651200; Oh W, 2006, J BIOL CHEM, V281, P17457, DOI 10.1074/jbc.M601857200; Oono K, 2004, NEUROCHEM INT, V45, P765, DOI 10.1016/j.neuint.2004.01.003; Osoegawa A, 2006, CANCER, V107, P154, DOI 10.1002/cncr.21961; Riemer C, 2003, J MED CHEM, V46, P1273, DOI 10.1021/jm021085c; ROTH BL, 1994, J PHARMACOL EXP THER, V268, P1403; Schechter Lee E, 2005, NeuroRx, V2, P590, DOI 10.1602/neurorx.2.4.590; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3188, DOI 10.1073/pnas.052712699; Svenningsson P, 2007, J NEUROSCI, V27, P4201, DOI 10.1523/JNEUROSCI.3110-06.2007; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; Upton N, 2008, NEUROTHERAPEUTICS, V5, P458, DOI 10.1016/j.nurt.2008.05.008; WARD RP, 1995, NEUROSCIENCE, V64, P1105, DOI 10.1016/0306-4522(94)00439-C; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004; Wesolowska A, 2007, BEHAV PHARMACOL, V18, P439, DOI 10.1097/FBP.0b013e3282d28f9c; Wesolowska A, 2007, NEUROPHARMACOLOGY, V52, P1274, DOI 10.1016/j.neuropharm.2007.01.007; WOOLLEY ML, 2004, CURR DRUG TARGETS CN, V33, P59; Yun HM, 2007, J BIOL CHEM, V282, P5496, DOI 10.1074/jbc.M606215200	48	47	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10016	10029		10.1074/jbc.M109.068759	http://dx.doi.org/10.1074/jbc.M109.068759			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093369	Green Published, hybrid			2022-12-27	WOS:000276165900070
J	Curnis, F; Cattaneo, A; Longhi, R; Sacchi, A; Gasparri, AM; Pastorino, F; Di Matteo, P; Traversari, C; Bachi, A; Ponzoni, M; Rizzardi, GP; Corti, A				Curnis, Flavio; Cattaneo, Angela; Longhi, Renato; Sacchi, Angelina; Gasparri, Anna Maria; Pastorino, Fabio; Di Matteo, Paola; Traversari, Catia; Bachi, Angela; Ponzoni, Mirco; Rizzardi, Gian-Paolo; Corti, Angelo			Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; TARGETING AGENT VTA; AMINOPEPTIDASE N; FACTOR-ALPHA; PHASE-II; PATIENTS PTS; VASCULATURE; PEPTIDES; DELIVERY; BINDING	Various NGR-containing peptides have been exploited for targeted delivery of drugs to CD13-positive tumor neovasculature. Recent studies have shown that compounds containing this motif can rapidly deamidate and generate isoaspartate-glycinearginine (isoDGR), a ligand of alpha v beta 3-integrin that can be also exploited for drug delivery to tumors. We have investigated the role of NGR and isoDGR peptide scaffolds on their biochemical and biological properties. Peptides containing the cyclic CNGRC sequence could bind CD13-positive endothelial cells more efficiently than those containing linear GNGRG. Peptide degradation studies showed that cyclic peptides mostly undergo NGR-to-isoDGR transition and CD13/integrin switching, whereas linear peptides mainly undergo degradation reactions involving the alpha-amino group, which generate non-functional six/seven-membered ring compounds, unable to bind alpha v beta 3, and small amount of isoDGR. Structure-activity studies showed that cyclic isoDGR could bind alpha v beta 3 with an affinity >100-fold higher than that of linear isoDGR and inhibited endothelial cell adhesion and tumor growth more efficiently. Cyclic isoDGR could also bind other integrins (alpha v beta 5, alpha v beta 6, alpha v beta 8, and alpha 5 beta 1), although with 10-100-fold lower affinity. Peptide linearization caused loss of affinity for all integrins and loss of specificity, whereas alpha-amino group acetylation increased the affinity for all tested integrins, but caused loss of specificity. These results highlight the critical role of molecular scaffold on the biological properties of NGR/isoDGR peptides. These findings may have important implications for the design and development of anticancer drugs or tumor neovasculature-imaging compounds, and for the potential function of different NGR/isoDGR sites in natural proteins.	[Curnis, Flavio; Cattaneo, Angela; Sacchi, Angelina; Gasparri, Anna Maria; Bachi, Angela; Corti, Angelo] Ist Sci San Raffaele, Div Mol Oncol, I-20132 Milan, Italy; [Curnis, Flavio; Cattaneo, Angela; Sacchi, Angelina; Gasparri, Anna Maria; Bachi, Angela; Corti, Angelo] Ist Sci San Raffaele, IIT Network Res Unit Mol Neurosci, I-20132 Milan, Italy; [Longhi, Renato] CNR, Ist Chim Riconoscimento Mol, I-20131 Milan, Italy; [Pastorino, Fabio; Ponzoni, Mirco] G Gaslini Childrens Hosp, Lab Oncol, I-16148 Genoa, Italy; [Di Matteo, Paola; Traversari, Catia; Rizzardi, Gian-Paolo] MolMed SpA, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Istituto Italiano di Tecnologia - IIT; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Corti, A (corresponding author), Ist Sci San Raffaele, Div Mol Oncol, Via Olgettina 58, I-20132 Milan, Italy.	corti.angelo@hsr.it	Pastorino, Fabio/I-4491-2018; Corti, Angelo/F-7046-2012; Ponzoni, Mirco/J-7713-2016; Pastorino, Fabio/Z-6245-2019; Curnis, Flavio/AAK-3542-2020; Gasparri, Anna Maria/AAN-5071-2020; bachi, angela/B-3527-2015	Pastorino, Fabio/0000-0002-8312-808X; Corti, Angelo/0000-0002-0893-6191; Ponzoni, Mirco/0000-0002-6164-4286; Pastorino, Fabio/0000-0002-8312-808X; Curnis, Flavio/0000-0002-7231-9569; Gasparri, Anna Maria/0000-0002-1757-8699; bachi, angela/0000-0003-4842-6556; SACCHI, ANGELINA/0000-0002-6594-0277; Subba, Rajkrishna/0000-0003-0051-0062	Associazione Italiana per la Ricerca sul Cancro (AIRC); Alleanza Contro il Cancro (ISS)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Alleanza Contro il Cancro (ISS)	This work was supported in part by the Associazione Italiana per la Ricerca sul Cancro (AIRC) and Alleanza Contro il Cancro (ISS).	Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Bieker R, 2009, BLOOD, V113, P5019, DOI 10.1182/blood-2008-04-150318; Buehler A, 2006, ARTERIOSCL THROM VAS, V26, P2681, DOI 10.1161/01.ATV.0000245807.65714.0b; Ceresoli GL, 2008, ANN ONCOL, V19, P119; Citterio G, 2008, ANN ONCOL, V19, P178; Colombo G, 2002, J BIOL CHEM, V277, P47891, DOI 10.1074/jbc.M207500200; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Curnis F, 2000, NAT BIOTECHNOL, V18, P1185, DOI 10.1038/81183; Curnis F, 2005, CANCER RES, V65, P2906, DOI 10.1158/0008-5472.CAN-04-4282; Curnis F, 2002, J CLIN INVEST, V110, P475, DOI 10.1172/JCI200215223; Curnis F, 2002, CANCER RES, V62, P867; Curnis F, 2008, CANCER RES, V68, P7073, DOI 10.1158/0008-5472.CAN-08-1272; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Dehart MP, 2007, J PHARM SCI-US, V96, P2667, DOI 10.1002/jps.20905; Di Matteo P, 2006, MOL IMMUNOL, V43, P1509, DOI 10.1016/j.molimm.2005.10.009; Dirksen A, 2004, ORG LETT, V6, P4857, DOI 10.1021/ol048084u; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Gasparri A, 1999, CANCER RES, V59, P2917; Gasparri AM, 2008, MOL CANCER THER, V7, P3859, DOI 10.1158/1535-7163.MCT-08-0538; GEIGER T, 1987, J BIOL CHEM, V262, P785; Grifman M, 2001, MOL THER, V3, P964, DOI 10.1006/mthe.2001.0345; Holle L, 2004, ONCOL REP, V11, P613; Liu LQ, 2000, J VIROL, V74, P5320, DOI 10.1128/JVI.74.11.5320-5328.2000; LURA R, 1988, BIOCHEMISTRY-US, V27, P7671, DOI 10.1021/bi00420a015; Majhen D, 2006, BIOCHEM BIOPH RES CO, V348, P278, DOI 10.1016/j.bbrc.2006.07.051; Meng J, 2007, CYTOTHERAPY, V9, P60, DOI 10.1080/14653240601094322; Meng JR, 2006, J BIOCHEM, V140, P299, DOI 10.1093/jb/mvj152; Moffatt S, 2005, HUM GENE THER, V16, P57, DOI 10.1089/hum.2005.16.57; Moffatt S, 2006, INT J PHARMACEUT, V321, P143, DOI 10.1016/j.ijpharm.2006.05.007; Ostendorp M, 2008, CANCER RES, V68, P7676, DOI 10.1158/0008-5472.CAN-08-0689; Pasqualini R, 2000, CANCER RES, V60, P722; Pastorino F, 2003, CANCER RES, V63, P7400; Pastorino F, 2006, CANCER RES, V66, P10073, DOI 10.1158/0008-5472.CAN-06-2117; Rimassa L, 2008, ANN ONCOL, V19, P136; Sacchi A, 2004, CANCER RES, V64, P7150, DOI 10.1158/0008-5472.CAN-04-1445; Spitaleri A, 2008, J BIOL CHEM, V283, P19757, DOI 10.1074/jbc.M710273200; Takahashi S, 2007, J CELL BIOL, V178, P167, DOI 10.1083/jcb.200703021; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; von Wallbrunn A, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2839046; Yokoyama Y, 2005, CANCER-AM CANCER SOC, V104, P321, DOI 10.1002/cncr.21149; Zarovni N, 2004, HUM GENE THER, V15, P373, DOI 10.1089/104303404322959524; Zhang Z, 2005, PEPTIDES, V26, P2182, DOI 10.1016/j.peptides.2005.03.049	42	75	80	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9114	9123		10.1074/jbc.M109.044297	http://dx.doi.org/10.1074/jbc.M109.044297			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20064928	hybrid, Green Published			2022-12-27	WOS:000275553700061
J	David, Y; Ziv, T; Admon, A; Navon, A				David, Yael; Ziv, Tamar; Admon, Arie; Navon, Ami			The E2 Ubiquitin-conjugating Enzymes Direct Polyubiquitination to Preferred Lysines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-DEGRADATION; ANAPHASE-PROMOTING COMPLEX; STRUCTURAL BASIS; CHAIN LINKAGES; E3 LIGASE; MULTIUBIQUITIN CHAIN; HECT DOMAIN; DNA-REPAIR; PROTEASOME; DETERMINANTS	The ubiquitin-proteasome pathway plays a crucial role in many cellular processes by degrading substrates tagged by polyubiquitin chains, linked mostly through lysine 48 of ubiquitin. Although polymerization of ubiquitin via its six other lysine residues exists in vivo as part of various physiological pathways, the molecular mechanisms that determine the type of polyubiquitin chains remained largely unknown. We under took a systematic, in vitro, approach to evaluate the role of E2 enzymes in determining the topology of polyubiquitin. Because this study was performed in the absence of an E3 enzyme, our data indicate that the E2 enzymes are capable of directing the ubiquitination process to distinct subsets of ubiquitin lysines, depending on the specific E2 utilized. Moreover, our findings are in complete agreement with prior analyses of lysine preference assigned to certain E2s in the context of E3 (in vitro and in vivo). Finally, our findings support the rising notion that the functional unit of E2 is a dimer. To our knowledge, this is the first systematic indication for the involvement of E2 enzymes in specifying polyubiquitin chain assembly.	[David, Yael; Ziv, Tamar; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Admon, Arie] Technion Israel Inst Technol, Dept Biol, IL-31096 Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology	Navon, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	ami.navon@weizmann.ac.il		Ziv, Tamar/0000-0003-4299-7454; Admon, Arie/0000-0003-0504-3950	Israel Science Foundation [916/05]	Israel Science Foundation(Israel Science Foundation)	Supported by Israel Science Foundation Grant 916/05.	Ardley HC, 2005, ESSAYS BIOCHEM, V41, P15, DOI 10.1042/EB0410015; Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Ben-Saadon R, 2006, MOL CELL, V24, P701, DOI 10.1016/j.molcel.2006.10.022; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; BUSCH H, 1981, MOL CELL BIOCHEM, V40, P173; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Duncan LM, 2006, EMBO J, V25, P1635, DOI 10.1038/sj.emboj.7601056; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Eletr ZM, 2007, J MOL BIOL, V369, P419, DOI 10.1016/j.jmb.2007.03.026; Eletr ZM, 2005, NAT STRUCT MOL BIOL, V12, P933, DOI 10.1038/nsmb984; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Fujimuro M, 2005, BIOL PHARM BULL, V28, P2315, DOI 10.1248/bpb.28.2315; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; GOLDBERG AL, 1995, SCIENCE, V268, P522, DOI 10.1126/science.7725095; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; HERSHKO A, 1981, J BIOL CHEM, V256, P1525; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2006, CELL, V124, P27, DOI 10.1016/j.cell.2005.12.025; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HC, 2009, MOL CELL BIOL, V29, P3307, DOI 10.1128/MCB.00240-09; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kravtsova-Ivantsiv Y, 2009, MOL CELL, V33, P496, DOI 10.1016/j.molcel.2009.01.023; Lewis MJ, 2006, J BIOMOL NMR, V34, P89, DOI 10.1007/s10858-005-5583-6; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; McKenna S, 2003, J BIOL CHEM, V278, P13151, DOI 10.1074/jbc.M212353200; Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ordureau A, 2008, BIOCHEM J, V409, P43, DOI 10.1042/BJ20071365; Park Y, 2009, J BIOL CHEM, V284, P1540, DOI 10.1074/jbc.M807554200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2002, NATURE, V419, P120, DOI 10.1038/419120a; Raimondo D, 2008, BIOCHEM PHARMACOL, V76, P1620, DOI 10.1016/j.bcp.2008.08.026; Rape M, 2004, NATURE, V432, P588, DOI 10.1038/nature03023; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; SILVER ET, 1992, EMBO J, V11, P3091, DOI 10.1002/j.1460-2075.1992.tb05381.x; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Varelas X, 2003, MOL CELL BIOL, V23, P5388, DOI 10.1128/MCB.23.15.5388-5400.2003; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wen R, 2006, PLANT MOL BIOL, V61, P241, DOI 10.1007/s11103-006-0007-x; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041	58	118	143	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8595	8604		10.1074/jbc.M109.089003	http://dx.doi.org/10.1074/jbc.M109.089003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20061386	Green Published, hybrid			2022-12-27	WOS:000275553700011
J	Gopalakrishnan, J; Guichard, P; Smith, AH; Schwarz, H; Agard, DA; Marco, S; Avidor-Reiss, T				Gopalakrishnan, Jayachandran; Guichard, Paul; Smith, Andrew H.; Schwarz, Heinz; Agard, David A.; Marco, Sergio; Avidor-Reiss, Tomer			Self-assembling SAS-6 Multimer Is a Core Centriole Building Block	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASAL BODY; INTRAFLAGELLAR TRANSPORT; CENTROSOME DUPLICATION; 9-FOLD SYMMETRY; HUMAN-CELLS; DROSOPHILA; BIOGENESIS; PROTEIN; CYCLE; PROCENTRIOLE	Centrioles are conserved microtubule-based organelles with 9-fold symmetry that are essential for cilia and mitotic spindle formation. A conserved structure at the onset of centriole assembly is a "cartwheel" with 9-fold radial symmetry and a central tubule in its core. It remains unclear how the cartwheel is formed. The conserved centriole protein, SAS-6, is a cartwheel component that functions early in centriole formation. Here, combining biochemistry and electron microscopy, we characterize SAS-6 and show that it self-assembles into stable tetramers, which serve as building blocks for the central tubule. These results suggest that SAS-6 self-assembly may be an initial step in the formation of the cartwheel that provides the 9-fold symmetry. Electron microscopy of centrosomes identified 25-nm central tubules with repeating subunits and show that SAS-6 concentrates at the core of the cartwheel. Recombinant and native SAS-6 self-oligomerizes into tetramers with similar to 6-nm subunits, and these tetramers are components of the centrosome, suggesting that tetramers are the building blocks of the central tubule. This is further supported by the observation that elevated levels of SAS-6 in Drosophila cells resulted in higher order structures resembling central tubule morphology. Finally, in the presence of embryonic extract, SAS-6 tetramers assembled into high density complexes, providing a starting point for the eventual in vitro reconstruction of centrioles.	[Gopalakrishnan, Jayachandran; Smith, Andrew H.; Avidor-Reiss, Tomer] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Guichard, Paul; Marco, Sergio] Inst Curie, Ctr Rech, F-91405 Orsay, France; [Guichard, Paul; Marco, Sergio] INSERM, U759, F-91405 Orsay, France; [Schwarz, Heinz] Max Planck Inst Entwicklungsbiol, D-72076 Tubingen, Germany; [Agard, David A.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	Harvard University; Harvard Medical School; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Avidor-Reiss, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	tomer_avidor-reiss@hms.harvard.edu	Guichard, Paul/AAL-8603-2020; marco, SERGIO/E-4875-2017; Avidor-Reiss, Tomer/AAK-6153-2020; marco garrido, sergio/F-5876-2013	Guichard, Paul/0000-0002-0363-1049; Avidor-Reiss, Tomer/0000-0003-0918-526X; Smith, Andrew/0000-0002-9710-0096	William F. Milton and Stewart Trust	William F. Milton and Stewart Trust	This work was supported in part by a grant from the bequest of the William F. Milton and Stewart Trust Pilot Projects.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALVEY PL, 1986, CELL BIOL INT REP, V10, P589, DOI 10.1016/0309-1651(86)90136-0; ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Azimzadeh J., 2004, CENTROSOMES DEV DIS, P93; Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231; Badano JL, 2005, NAT REV GENET, V6, P194, DOI 10.1038/nrg1557; Blachon S, 2008, GENETICS, V180, P2081, DOI 10.1534/genetics.108.095141; Callaini G, 1997, EXP CELL RES, V234, P183, DOI 10.1006/excr.1997.3618; CAVALIER.T, 1974, J CELL SCI, V16, P529; CROWTHER RA, 1971, J MOL BIOL, V60, P123, DOI 10.1016/0022-2836(71)90452-9; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; DIPPELL RV, 1968, P NATL ACAD SCI USA, V61, P461, DOI 10.1073/pnas.61.2.461; Fernandez JJ, 2003, J STRUCT BIOL, V144, P152, DOI 10.1016/j.jsb.2003.09.010; Gonzalez C, 1998, J CELL SCI, V111, P2697; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Moritz M, 1998, J CELL BIOL, V142, P775, DOI 10.1083/jcb.142.3.775; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PHILLIPS DM, 1967, J CELL BIOL, V33, P73, DOI 10.1083/jcb.33.1.73; Riparbelli MG, 2009, CELL MOTIL CYTOSKEL, V66, P1100, DOI 10.1002/cm.20417; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rodrigues-Martins A, 2008, CELL CYCLE, V7, P11, DOI 10.4161/cc.7.1.5226; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Rogers GC, 2008, MOL BIOL CELL, V19, P3163, DOI 10.1091/mbc.E07-10-1069; Rosenbaum J, 2002, CURR BIOL, V12, pR125, DOI 10.1016/S0960-9822(02)00703-0; SATIR P, 1964, J THEOR BIOL, V7, P123, DOI 10.1016/0022-5193(64)90045-1; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; VOROBJEV IA, 1982, J CELL BIOL, V93, P938, DOI 10.1083/jcb.93.3.938	37	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8759	8770		10.1074/jbc.M109.092627	http://dx.doi.org/10.1074/jbc.M109.092627			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20083610	Green Published, hybrid			2022-12-27	WOS:000275553700028
J	Christensen, B; Schack, L; Klaning, E; Sorensen, ES				Christensen, Brian; Schack, Lotte; Klaning, Eva; Sorensen, Esben S.			Osteopontin Is Cleaved at Multiple Sites Close to Its Integrin-binding Motifs in Milk and Is a Novel Substrate for Plasmin and Cathepsin D	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSLATIONAL MODIFICATIONS; SECRETED PHOSPHOPROTEINS; IN-VITRO; THROMBIN; IDENTIFICATION; PHOSPHORYLATION; PROTEINS; FRAGMENT; URINE; ALPHA(9)BETA(1)	Osteopontin (OPN) is a highly modified integrin-binding protein present in most tissues and body fluids where it has been implicated in numerous biological processes. A significant regulation of OPN function is mediated through phosphorylation and proteolytic processing. Proteolytic cleavage by thrombin and matrix metalloproteinases close to the integrin-binding Arg-Gly-Asp sequence modulates the function of OPN and its integrin binding properties. In this study, seven N-terminal OPN fragments originating from proteolytic cleavage have been characterized from human milk. Identification of the cleavage sites revealed that all fragments contained the Arg-Gly-Asp(145) sequence and were generated by cleavage of the Leu(151)-Arg(152),Arg(152)- Ser(153), Ser(153)-Lys(154), Lys(154)-Ser(155), Ser(155)-Lys(156), Lys(156)-Lys(157), or Phe(158)-Arg(159) peptide bonds. Six cleavages cannot be ascribed to thrombin or matrix metalloproteinase activity, whereas the cleavage at Arg(152)-Ser(153) matches thrombin specificity for OPN. The principal protease in milk, plasmin, hydrolyzed the same peptide bond as thrombin, but its main cleavage site was identified to be Lys(154)-Ser(155). Another endogenous milk protease, cathepsin D, cleaved the Leu(151)-Arg(152) bond. OPN fragments corresponding to plasmin activity were also identified in urine showing that plasmin cleavage of OPN is not restricted to milk. Plasmin, but not cathepsin D, cleavage of OPN increased cell adhesion mediated by the alpha(V)beta(3)- or alpha(5)beta(1)-integrins. Similar cellular adhesion was mediated by plasmin and thrombin-cleaved OPN showing that plasmin can be a potent regulator of OPN activity. These data show that OPN is highly susceptible to cleavage near its integrin-binding motifs, and the protein is a novel substrate for plasmin and cathepsin D.	[Christensen, Brian; Schack, Lotte; Klaning, Eva; Sorensen, Esben S.] Univ Aarhus, Dept Mol Biol, Prot Chem Lab, DK-8000 Aarhus C, Denmark	Aarhus University	Sorensen, ES (corresponding author), Univ Aarhus, Dept Mol Biol, Prot Chem Lab, Sci Pk,Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	ess@mb.au.dk		Sorensen, Esben Skipper/0000-0002-7050-3354	The Carlsberg Foundation; Novo Nordisk Foundation; The Danish Dairy Research Foundation; Arla Foods amba; The Milk Protein Research Consortium	The Carlsberg Foundation(Carlsberg Foundation); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); The Danish Dairy Research Foundation; Arla Foods amba; The Milk Protein Research Consortium	This work was supported by grants from The Carlsberg Foundation, The Novo Nordisk Foundation, The Danish Dairy Research Foundation, Arla Foods amba, and The Milk Protein Research Consortium.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Barry ST, 2000, BIOCHEM BIOPH RES CO, V267, P764, DOI 10.1006/bbrc.1999.2032; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Cao YH, 2000, INT J MOL MED, V5, P547; Chatterton DEW, 2004, TRENDS FOOD SCI TECH, V15, P373, DOI 10.1016/j.tifs.2003.12.004; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; Christensen B, 2007, J BIOL CHEM, V282, P19463, DOI 10.1074/jbc.M703055200; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Ferranti P, 2004, J DAIRY RES, V71, P74, DOI 10.1017/S0022029903006599; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Heegaard CW, 1997, J PEDIATR GASTR NUTR, V25, P159, DOI 10.1097/00005176-199708000-00006; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kelly AL, 2006, INT DAIRY J, V16, P563, DOI 10.1016/j.idairyj.2005.10.019; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P15326, DOI 10.1073/pnas.0903704106; Kitamoto Y, 2004, ANN CLIN BIOCHEM, V41, P133, DOI 10.1258/000456304322880023; Koldas M, 2001, THROMB RES, V102, P221, DOI 10.1016/S0049-3848(01)00257-2; KORYCKADAHL M, 1983, J DAIRY SCI, V66, P704, DOI 10.3168/jds.S0022-0302(83)81848-7; LINDBERG T, 1982, PEDIATR RES, V16, P479, DOI 10.1203/00006450-198206000-00016; Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396; Nemir M, 2000, J BIOL CHEM, V275, P969, DOI 10.1074/jbc.275.2.969; Oda T, 2008, NEPHROL DIAL TRANSPL, V23, P2254, DOI 10.1093/ndt/gfm937; Ohba T, 1996, J RHEUMATOL, V23, P1505; Palmer DJ, 2006, PROTEOMICS, V6, P2208, DOI 10.1002/pmic.200500558; Piwnica D, 2006, MOL ENDOCRINOL, V20, P3263, DOI 10.1210/me.2006-0044; Schack L, 2009, J DAIRY SCI, V92, P5378, DOI 10.3168/jds.2009-2360; Schack L, 2009, J IMMUNOL, V182, P6943, DOI 10.4049/jimmunol.0900065; Schnolzer M, 1996, ELECTROPHORESIS, V17, P945, DOI 10.1002/elps.1150170517; SCHONHEYDER F., 1942, Acta Physiologica Scandinavica, V4, P309, DOI 10.1111/j.1748-1716.1942.tb01464.x; SENGER DR, 1989, BIOCHIM BIOPHYS ACTA, V996, P43, DOI 10.1016/0167-4838(89)90092-7; SENGER DR, 1988, CANCER RES, V48, P5770; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; SHIRAGA H, 1992, P NATL ACAD SCI USA, V89, P426, DOI 10.1073/pnas.89.1.426; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; Sohar N, 2002, BIOL CHEM, V383, P865, DOI 10.1515/BC.2002.093; SORENSEN ES, 1995, PROTEIN SCI, V4, P2040, DOI 10.1002/pro.5560041009; Sorensen S, 2003, PROTEIN EXPRES PURIF, V30, P238, DOI 10.1016/S1046-5928(03)00102-5; SORENSEN S, 1995, UROL RES, V23, P327, DOI 10.1007/BF00300022; Taguchi O, 1996, CLIN CHIM ACTA, V244, P69, DOI 10.1016/0009-8981(95)06196-7; Takafuji V, 2007, ONCOGENE, V26, P6361, DOI 10.1038/sj.onc.1210463; VAZIRI ND, 1984, AM J MED, V77, P433, DOI 10.1016/0002-9343(84)90098-6; VETVICKA V, 1993, BIOCHEM MOL BIOL INT, V30, P921; VINAZZER H, 1988, Haemostasis, V18, P41; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; WEINSTEI.MJ, 1972, BIOCHIM BIOPHYS ACTA, V258, P577, DOI 10.1016/0005-2744(72)90250-1; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; ZHANG R, 1990, J BIOL CHEM, V265, P15375	51	86	89	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7929	7937		10.1074/jbc.M109.075010	http://dx.doi.org/10.1074/jbc.M109.075010			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071328	Green Published, hybrid			2022-12-27	WOS:000275413800010
J	Kiesler, P; Haynes, PA; Shi, LF; Kao, PN; Wysocki, VH; Vercelli, D				Kiesler, Patricia; Haynes, Paul A.; Shi, Lingfang; Kao, Peter N.; Wysocki, Vicki H.; Vercelli, Donata			NF45 and NF90 Regulate HS4-dependent Interleukin-13 Transcription in T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; RANGE INTRACHROMOSOMAL INTERACTIONS; LOCUS-CONTROL REGION; GENE-EXPRESSION; CYTOKINE GENES; MESSENGER-RNA; SUBSEQUENT DEVELOPMENT; HYPERSENSITIVE SITE; STATISTICAL-MODEL; PROMOTER ANALYSIS	Expression of the cytokine interleukin-13 (IL13) is critical for Th2 immune responses and Th2-mediated allergic diseases. Activation of human IL13 expression involves chromatin remodeling and formation of multiple DNase I-hypersensitive sites throughout the locus. Among these, HS4 is detected in the distal IL13 promoter in both naive and polarized CD4(+) T cells. We show herein that HS4 acts as a position-independent, orientation-dependent positive regulator of IL13 proximal promoter activity in transiently transfected, activated human CD4(+) Jurkat T cells and primary murine Th2 cells. The 3'-half of HS4 (HS4-3') was responsible for IL13 up-regulation and bound nuclear factor (NF) 90 and NF45, as demonstrated by DNA affinity chromatography coupled with tandem mass spectrometry, chromatin immunoprecipitation, and gel shift analysis. Notably, the CTGTT NF45/NF90-binding motif within HS4-3' was critical for HS4-dependent upregulation of IL13 expression. Moreover, transfection of HS4-IL13 reporter vectors into primary, in vitro differentiated Th2 cells from wild-type, NF45(+/-), or NF90(+/-) mice showed that HS4 activity was exquisitely dependent on the levels of endogenous NF45 (and to a lesser degree NF90), because HS4-dependent IL13 expression was virtually abrogated in NF45(+/-) cells and reduced in NF90(+/-) cells. Collectively, our results identify NF45 and NF90 as novel regulators of HS4-dependent human IL13 transcription in response to T cell activation.	Univ Arizona, Funct Genom Lab, Arizona Resp Ctr, Tucson, AZ 85719 USA; [Haynes, Paul A.] Univ Arizona, Dept Biochem, Tucson, AZ 85719 USA; [Wysocki, Vicki H.] Univ Arizona, Dept Chem, Tucson, AZ 85719 USA; [Vercelli, Donata] Univ Arizona, Dept Cell Biol, Tucson, AZ 85719 USA; Univ Arizona, Arizona Ctr Biol Complex Dis, Tucson, AZ 85719 USA; [Vercelli, Donata] Univ Arizona, Inst Bio5, Tucson, AZ 85719 USA; [Shi, Lingfang; Kao, Peter N.] Stanford Univ, Med Ctr, Dept Pulm & Crit Care Med, Stanford, CA 94305 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; Stanford University	Vercelli, D (corresponding author), 1657 E Helen St,Rm 339,Thomas W Keating Biores Bl, Tucson, AZ 85719 USA.	donata@arc.arizona.edu		Haynes, Paul/0000-0003-1472-8249; Wysocki, Vicki/0000-0003-0495-2538	NHLBI [HL66391]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039624] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant HL66391 (to D. V.) from NHLBI.	Andon NL, 2002, PROTEOMICS, V2, P1156, DOI 10.1002/1615-9861(200209)2:9<1156::AID-PROT1156>3.0.CO;2-4; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Boyes J, 1996, EMBO J, V15, P2496, DOI 10.1002/j.1460-2075.1996.tb00607.x; Cameron L, 2006, J IMMUNOL, V177, P8633, DOI 10.4049/jimmunol.177.12.8633; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Casolaro V, 2008, J ALLERGY CLIN IMMUN, V121, P853, DOI 10.1016/j.jaci.2007.12.1166; Cooper B, 2003, J AM SOC MASS SPECTR, V14, P736, DOI 10.1016/S1044-0305(03)00125-9; CORTHESY B, 1994, J BIOL CHEM, V269, P20682; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dolganov G, 1996, BLOOD, V87, P3316, DOI 10.1182/blood.V87.8.3316.bloodjournal8783316; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Ghaffar O, 1997, AM J RESP CELL MOL, V17, P17, DOI 10.1165/ajrcmb.17.1.2696; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Guan DY, 2008, MOL CELL BIOL, V28, P4629, DOI 10.1128/MCB.00120-08; KAO PN, 1994, J BIOL CHEM, V269, P20691; Keen JC, 2006, IMMUNOLOGY, V117, P29, DOI 10.1111/j.1365-2567.2005.02260.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khaled WT, 2007, DEVELOPMENT, V134, P2739, DOI 10.1242/dev.003194; Kishikawa H, 2001, J IMMUNOL, V167, P4414, DOI 10.4049/jimmunol.167.8.4414; Kuwano Y, 2008, MOL CELL BIOL, V28, P4562, DOI 10.1128/MCB.00165-08; Lange J, 2003, CLIN EXP ALLERGY, V33, P1537, DOI 10.1046/j.1365-2222.2003.01789.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lavenu-Bombled C, 2002, J BIOL CHEM, V277, P18313, DOI 10.1074/jbc.M110013200; Lee GR, 2005, NAT IMMUNOL, V6, P42, DOI 10.1038/ni1148; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lordan JL, 2002, J IMMUNOL, V169, P407, DOI 10.4049/jimmunol.169.1.407; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Neaville WA, 2003, J ALLERGY CLIN IMMUN, V112, P740, DOI 10.1016/S0091-6749(03)01868-2; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Novac O, 2001, MOL BIOL CELL, V12, P3386, DOI 10.1091/mbc.12.11.3386; Ohshima Y, 2002, PEDIATR RES, V51, P195, DOI 10.1203/00006450-200202000-00012; Pei Y, 2008, J IMMUNOL, V180, P222, DOI 10.4049/jimmunol.180.1.222; Qian WJ, 2005, J PROTEOME RES, V4, P53, DOI 10.1021/pr0498638; Reichman TW, 2002, MOL CELL BIOL, V22, P343, DOI 10.1128/MCB.22.1.343-356.2002; Ribeiro-do-Couto LM, 2001, EUR J IMMUNOL, V31, P3394, DOI 10.1002/1521-4141(200111)31:11<3394::AID-IMMU3394>3.0.CO;2-B; Santangelo S, 2002, J IMMUNOL, V169, P1893, DOI 10.4049/jimmunol.169.4.1893; Shi LF, 2007, J EXP MED, V204, P971, DOI 10.1084/jem.20052078; Shi LF, 2007, NUCLEIC ACIDS RES, V35, P2302, DOI 10.1093/nar/gkm117; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Strempel JM, 2007, J BIOL CHEM, V282, P3738, DOI 10.1074/jbc.M606615200; Tao WA, 2005, NAT METHODS, V2, P591, DOI 10.1038/NMETH776; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Webster RB, 2007, J BIOL CHEM, V282, P700, DOI 10.1074/jbc.M609501200; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhao GH, 2005, EXP CELL RES, V305, P312, DOI 10.1016/j.yexcr.2004.12.030	53	48	51	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8256	8267		10.1074/jbc.M109.041004	http://dx.doi.org/10.1074/jbc.M109.041004			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20051514	Green Published, hybrid			2022-12-27	WOS:000275413800044
J	Yang, YW; Hua, QX; Liu, J; Shimizu, EH; Choquette, MH; Mackin, RB; Weiss, MA				Yang, Yanwu; Hua, Qing-xin; Liu, Jin; Shimizu, Eri H.; Choquette, Meredith H.; Mackin, Robert B.; Weiss, Michael A.			Solution Structure of Proinsulin CONNECTING DOMAIN FLEXIBILITY AND PROHORMONE PROCESSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-STRUCTURE DETERMINATION; RECEPTOR-BINDING SURFACE; NMR-SPECTROSCOPY; SECONDARY STRUCTURE; DIABETES-MELLITUS; BACKBONE DYNAMICS; XPLOR-NIH; PROTEIN; INSULIN; DESIGN	The folding of proinsulin, the single-chain precursor of insulin, ensures native disulfide pairing in pancreatic beta-cells. Mutations that impair folding cause neonatal diabetes mellitus. Although the classical structure of insulin is well established, proinsulin is refractory to crystallization. Here, we employ heteronuclear NMR spectroscopy to characterize a monomeric analogue. Proinsulin contains a native-like insulin moiety (A- and B-domains); the tethered connecting (C) domain (as probed by {H-1}-(15)Nnuclear Overhauser enhancements) is progressively less ordered. Although the BC junction is flexible, residues near the CA junction exhibit alpha-helical-like features. Relative to canonical alpha-helices, however, segmental C-13(alpha/beta) chemical shifts are attenuated, suggesting that this junction and contiguous A-chain residues are molten. We propose that flexibility at each C-domain junction facilitates prohormone processing. Studies of protease SPC3 (PC1/3) suggest that C-domain sequences contribute to cleavage site selection. The structure of proinsulin provides a foundation for studies of insulin biosynthesis and its impairment in monogenic forms of diabetes mellitus.	[Yang, Yanwu; Hua, Qing-xin; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Liu, Jin; Shimizu, Eri H.; Choquette, Meredith H.; Mackin, Robert B.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Case Western Reserve University; Creighton University	Yang, YW (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	yanwu.yang@ase.edu; maw21@case.edu	liu, jin/A-9012-2010		National Institutes of Health [DK052085]; National Institutes of Health and American Diabetes Association [DK040949, DK0697604]; American Heart Association [0530067N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040949, R01DK074176, R01DK052085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health and American Diabetes Association; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK052085 (to R.B.M.) and Grants DK040949 and DK0697604 from the National Institutes of Health and American Diabetes Association (to M.A.W.). This work was also supported by American Heart Association Grant 0530067N (to Y.Y.).	BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Lipkind G, 1999, BIOCHEMISTRY-US, V38, P890, DOI 10.1021/bi981556q; Liu M, 2009, J BIOL CHEM, V284, P35259, DOI 10.1074/jbc.M109.046888; Mackin RB, 2003, PROTEIN EXPRES PURIF, V27, P210, DOI 10.1016/S1046-5928(02)00643-5; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Omichinski JG, 1997, NAT STRUCT BIOL, V4, P122, DOI 10.1038/nsb0297-122; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STEINER DF, 1967, T NEW YORK ACAD SCI, V30, P60, DOI 10.1111/j.2164-0947.1967.tb02452.x; STONE MJ, 1992, BIOCHEMISTRY-US, V31, P4394, DOI 10.1021/bi00133a003; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; TAYLOR NA, 1992, BIOCHEM J, V286, P619, DOI 10.1042/bj2860619; WEISS MA, 1990, BIOCHEMISTRY-US, V29, P8389, DOI 10.1021/bi00488a028; Weiss MA, 2000, BIOCHEMISTRY-US, V39, P15429, DOI 10.1021/bi001905s; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; Yang YW, 2010, J BIOL CHEM, V285, P10806, DOI 10.1074/jbc.M109.067850	35	52	55	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7847	7851		10.1074/jbc.C109.084921	http://dx.doi.org/10.1074/jbc.C109.084921			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20106974	Green Published, hybrid			2022-12-27	WOS:000275413800001
J	Loeb, V; Yakunin, E; Saada, A; Sharon, R				Loeb, Virginie; Yakunin, Eugenia; Saada, Ann; Sharon, Ronit			The Transgenic Overexpression of alpha-Synuclein and Not Its Related Pathology Associates with Complex I Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; FATTY-ACIDS; CELL-DEATH; NEURODEGENERATIVE DISEASES; MITOCHONDRIAL LOCALIZATION; DOPAMINERGIC-NEURONS; RESPIRATORY-CHAIN; OXIDATIVE STRESS; PROTEIN DJ-1; MICE	alpha-Synuclein (alpha S) is a protein involved in the cytopathology and genetics of Parkinson disease and is thought to affect mitochondrial complex I activity. Previous studies have shown that mitochondrial toxins and specifically inhibitors of complex I activity enhance alpha S pathogenesis. Here we show that alpha S overexpression specifically inhibits complex I activity in dopaminergic cells and in A53T alpha S transgenic mouse brains. Importantly, our results indicate that the inhibitory effect on complex I activity is not associated with alpha S-related pathology. Specifically, complex I activity measured in purified mitochondria from A53T alpha S transgenic mouse brains was not affected by mouse age; Parkinson disease-like symptoms; levels of alpha S soluble oligomers; levels of insoluble, lipid-associated alpha S; or alpha S intraneuronal depositions in vivo. Likewise, no correlation was found between complex I activity and polyunsaturated fatty acid-induced alpha S depositions in Lewy body-like inclusions in cultured dopaminergic cells. We further show that the effect of alpha S on complex I activity is not due to altered mitochondrial protein levels or affected complex I assembly. Based on the results herein, we suggest that alpha S expression negatively regulates complex I activity as part of its normal, physiological role.	Hebrew Univ Jerusalem, Dept Biochem & Mol Biol, Inst Med Res, IL-91120 Jerusalem, Israel; [Saada, Ann] Hadassah Hebrew Univ, Hadassah Med Ctr, Metab Dis Unit, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center		ronitsh@ekmd.huji.ac.il	Saada, Ann/J-6864-2017	Saada, Ann/0000-0003-2951-0656	National Institutes of Health [R01 NS051318]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 NS051318.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Barsoum MJ, 2006, EMBO J, V25, P3900, DOI 10.1038/sj.emboj.7601253; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Beach TG, 2008, ACTA NEUROPATHOL, V116, P277, DOI 10.1007/s00401-008-0409-8; Ben Gedalya T, 2009, TRAFFIC, V10, P218, DOI 10.1111/j.1600-0854.2008.00853.x; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Duda JE, 2000, J NEUROSCI RES, V61, P121, DOI 10.1002/1097-4547(20000715)61:2<121::AID-JNR1>3.0.CO;2-4; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gitler AD, 2008, P NATL ACAD SCI USA, V105, P145, DOI 10.1073/pnas.0710685105; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Gupta A, 2008, ANN NEUROL, V64, pS3, DOI 10.1002/ana.21573; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hirsch EC, 1999, MOVEMENT DISORD, V14, P383, DOI 10.1002/1531-8257(199903)14:2<383::AID-MDS1037>3.0.CO;2-F; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; LANGSTON JW, 1983, NEW ENGL J MED, V309, P310; Larsen KE, 2006, J NEUROSCI, V26, P11915, DOI 10.1523/JNEUROSCI.3821-06.2006; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Li WX, 2004, J NEUROSCI, V24, P7400, DOI 10.1523/JNEUROSCI.1370-04.2004; Manning-Bog AB, 2003, J NEUROSCI, V23, P3095; Manning-Bog AB, 2002, J BIOL CHEM, V277, P1641, DOI 10.1074/jbc.C100560200; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Martins LM, 2004, MOL CELL BIOL, V24, P9848, DOI 10.1128/MCB.24.22.9848-9862.2004; Meuer K, 2007, CELL DEATH DIFFER, V14, P651, DOI 10.1038/sj.cdd.4402087; MIZUNO Y, 1989, BIOCHEM BIOPH RES CO, V163, P1450, DOI 10.1016/0006-291X(89)91141-8; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Nair VD, 2006, J BIOL CHEM, V281, P39550, DOI 10.1074/jbc.M603950200; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Norris EH, 2007, AM J PATHOL, V170, P658, DOI 10.2353/ajpath.2007.060359; Parihar MS, 2008, CELL MOL LIFE SCI, V65, P1272, DOI 10.1007/s00018-008-7589-1; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; RAGAN CI, 1987, SUBFRACTIONATION MIT, P80; Saada A, 2004, ANAL BIOCHEM, V335, P66, DOI 10.1016/j.ab.2004.08.015; Schagger H, 2001, METHOD CELL BIOL, V65, P231, DOI 10.1016/S0091-679X(01)65014-3; SCHAPIRA AH, 1989, LANCET, V333, P1269, DOI DOI 10.1016/S0140-6736(89)92366-0; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Shavali S, 2008, NEUROSCI LETT, V439, P125, DOI 10.1016/j.neulet.2008.05.005; Sherer TB, 2003, EXP NEUROL, V179, P9, DOI 10.1006/exnr.2002.8072; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Song DD, 2004, EXP NEUROL, V186, P158, DOI 10.1016/S0014-4886(03)00342-X; Specht CG, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-11; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tatton WG, 2003, ANN NEUROL, V53, pS61, DOI 10.1002/ana.10489; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; Vila M, 2008, J NEUROCHEM, V107, P317, DOI 10.1111/j.1471-4159.2008.05604.x; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Zhang L, 2005, HUM MOL GENET, V14, P2063, DOI 10.1093/hmg/ddi211; Zhang L, 2008, BRAIN RES, V1244, P40, DOI 10.1016/j.brainres.2008.08.067	68	89	89	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7334	7343		10.1074/jbc.M109.061051	http://dx.doi.org/10.1074/jbc.M109.061051			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053987	Green Published, hybrid			2022-12-27	WOS:000275415600045
J	Di Giovanni, S; Eleuteri, S; Paleologou, KE; Yin, GW; Zweckstetter, M; Carrupt, PA; Lashuel, HA				Di Giovanni, Saviana; Eleuteri, Simona; Paleologou, Katerina E.; Yin, Guowei; Zweckstetter, Markus; Carrupt, Pierre-Alain; Lashuel, Hilal A.			Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of alpha-Synuclein and beta-Amyloid and Protect against Amyloid-induced Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; IN-VITRO; CEREBROSPINAL-FLUID; INCLUSION FORMATION; CAFFEIC ACID; AGGREGATION; DOPAMINE; FIBRILLIZATION	Parkinson disease (PD) is the second most common neurodegenerative disorder after Alzheimer disease (AD). There is considerable consensus that the increased production and/or aggregation of alpha-synuclein (alpha-syn) plays a central role in the pathogenesis of PD and related synucleinopathies. Current therapeutic strategies for treating PD offer mainly transient symptomatic relief and aim at the restitution of dopamine levels to counterbalance the loss of dopaminergic neurons. Therefore, the identification and development of drug-like molecules that block alpha-synuclein aggregation and prevent the loss of dopaminergic neurons are desperately needed to treat or slow the progression of PD. Here, we show that entacapone and tolcapone are potent inhibitors of alpha-syn and beta-amyloid (A beta) oligomerization and fibrillogenesis, and they also protect against extracellular toxicity induced by the aggregation of both proteins. Comparison of the anti-aggregation properties of entacapone and tolcapone with the effect of five other catechol-containing compounds, dopamine, pyrogallol, gallic acid, caffeic acid, and quercetin on the oligomerization and fibrillization of alpha-syn and A beta, demonstrate that the catechol moiety is essential for the anti-amyloidogenic activity. Our findings present the first characterization of the anti-amyloidogenic properties of tolcapone and entacapone against both alpha-synuclein and A beta 42 and highlight the potential of this class of nitro-catechol compounds as anti-amyloidogenic agents. Their inhibitory properties, mode of action, and structural properties suggest that they constitute promising lead compounds for further optimization.	[Di Giovanni, Saviana; Eleuteri, Simona; Paleologou, Katerina E.; Lashuel, Hilal A.] Swiss Fed Inst Technol, Lab Mol Neurobiol & Neuroprote, CH-1015 Lausanne, Switzerland; [Eleuteri, Simona] Univ Bologna, Dipartimento Biol Evoluzionist Sperimentale, I-40126 Bologna, Italy; [Yin, Guowei; Zweckstetter, Markus] Max Planck Inst Biophys Chem, NMR Based Struct Biol, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Deutsch Forsch Sgemeinschaft Res Ctr Mol Physiol, Gottingen, Germany; [Carrupt, Pierre-Alain] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland; [Carrupt, Pierre-Alain] Univ Lausanne, CH-1211 Geneva 4, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Bologna; Max Planck Society; University of Geneva; University of Lausanne	Lashuel, HA (corresponding author), Swiss Fed Inst Technol, Lab Mol Neurobiol & Neuroprote, SV BMI LMNN AI2351, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Carrupt, Pierre-Alain/C-4854-2008; Lashuel, Hilal/M-3500-2017	Zweckstetter, Markus/0000-0002-2536-6581	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation; Strauss Foundation; Max Planck Society; Deutsche Forschungsgemeinschaft Heisenberg Scholarship [ZW 71/2-1, 3-1]	Swiss Federal Institute of Technology Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Strauss Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft Heisenberg Scholarship(German Research Foundation (DFG))	This work was supported by the Swiss Federal Institute of Technology Lausanne, grants from the Swiss National Science Foundation and the Strauss Foundation, and by the Max Planck Society and through Deutsche Forschungsgemeinschaft Heisenberg Scholarship ZW 71/2-1 and 3-1 ( to M.Z.).	Ahn KJ, 2006, J NEUROCHEM, V97, P265, DOI 10.1111/j.1471-4159.2006.03731.x; Albani D, 2004, FASEB J, V18, P1713, DOI 10.1096/fj.04-1621fje; Ansari MA, 2009, J NUTR BIOCHEM, V20, P269, DOI 10.1016/j.jnutbio.2008.03.002; Antonini Angelo, 2008, Neuropsychiatr Dis Treat, V4, P1; Armagan A, 2008, HUM EXP TOXICOL, V27, P547, DOI 10.1177/0960327108092293; Assal F, 1998, LANCET, V352, P958, DOI 10.1016/S0140-6736(05)61511-5; Ban JY, 2008, BIOL PHARM BULL, V31, P149, DOI 10.1248/bpb.31.149; Bastianetto S, 2006, EUR J NEUROSCI, V23, P55, DOI 10.1111/j.1460-9568.2005.04532.x; Bertolini F, 2007, J PHARM SCI-US, V96, P2931, DOI 10.1002/jps.20881; Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102; Boelsterli UA, 2006, CURR DRUG METAB, V7, P715, DOI 10.2174/138920006778520606; Bonifacio MJ, 2007, CNS DRUG REV, V13, P352, DOI 10.1111/j.1527-3458.2007.00020.x; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Cappai R, 2005, FASEB J, V19, P1377, DOI 10.1096/fj.04-3437fje; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chen L, 2005, NAT NEUROSCI, V8, P657, DOI 10.1038/nn1443; Chung KKK, 2003, J NEUROL, V250, P15, DOI 10.1007/s00415-003-1304-9; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, ANN NY ACAD SCI, V920, P42; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Craik D J, 1997, Methods Mol Biol, V60, P195; Damier P, 2008, EUR J NEUROL, V15, P643, DOI 10.1111/j.1468-1331.2008.02165.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Di Stefano A, 2009, EXPERT OPIN DRUG DEL, V6, P389, DOI [10.1517/17425240902870405, 10.1517/17425240902870405 ]; Dodo K, 2008, BIOORGAN MED CHEM, V16, P7975, DOI 10.1016/j.bmc.2008.07.063; Dore S, 1997, P NATL ACAD SCI USA, V94, P4772, DOI 10.1073/pnas.94.9.4772; Du HN, 2003, BIOCHEMISTRY-US, V42, P8870, DOI 10.1021/bi034028+; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; El-Agnaf OMA, 1998, NEUROREPORT, V9, P3925, DOI 10.1097/00001756-199812010-00029; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Feng Y, 2009, NEUROTOXICOLOGY, V30, P986, DOI 10.1016/j.neuro.2009.08.013; Fernandez CO, 2004, EMBO J, V23, P2039, DOI 10.1038/sj.emboj.7600211; Forloni G, 2000, ANN NEUROL, V47, P632, DOI 10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.3.CO;2-E; Forsberg M, 2003, J PHARMACOL EXP THER, V304, P498, DOI 10.1124/jpet.102.042846; Fradinger EA, 2008, P NATL ACAD SCI USA, V105, P14175, DOI 10.1073/pnas.0807163105; Goddard T. D, 2003, SPARKY, V3; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Grzesiek S, 1996, BIOCHEMISTRY-US, V35, P10256, DOI 10.1021/bi9611164; Haefeli WE, 2007, J NEUROL, V254, P29, DOI 10.1007/s00415-007-4006-x; Han YH, 2008, INT J MOL MED, V21, P721; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Herrera FE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003394; Horwich A, 2002, J CLIN INVEST, V110, P1221, DOI 10.1172/JCI200216781; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Johnson KS, 2005, J AGR FOOD CHEM, V53, P10120, DOI 10.1021/jf051942w; Klegeris A, 2008, NEUROBIOL AGING, V29, P739, DOI 10.1016/j.neurobiolaging.2006.11.013; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lapish CC, 2009, PSYCHOPHARMACOLOGY, V202, P521, DOI 10.1007/s00213-008-1342-1; Lashuel HA, 2002, J BIOL CHEM, V277, P42881, DOI 10.1074/jbc.M206593200; Learmonth DA, 2004, J MED CHEM, V47, P6207, DOI 10.1021/jm040848o; Lee EN, 2004, BIOCHEMISTRY-US, V43, P3704, DOI 10.1021/bi0356707; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2008, BIOCHEM BIOPH RES CO, V372, P423, DOI 10.1016/j.bbrc.2008.05.045; Lees AJ, 2007, J NEUROL NEUROSUR PS, V78, P944, DOI 10.1136/jnnp.2006.097154; Li HT, 2005, FEBS J, V272, P3661, DOI 10.1111/j.1742-4658.2005.04792.x; Li J, 2004, FASEB J, V18, P962, DOI 10.1096/fj.03-0770fje; Li J, 2001, BIOCHEMISTRY-US, V40, P11604, DOI 10.1021/bi010616g; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Losic D, 2006, J STRUCT BIOL, V155, P104, DOI 10.1016/j.jsb.2006.02.013; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McLaurin J, 2000, J BIOL CHEM, V275, P18495, DOI 10.1074/jbc.M906994199; Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004; Naiki H, 1996, LAB INVEST, V74, P374; NISSINEN E, 1992, N-S ARCH PHARMACOL, V346, P262; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Novaroli L, 2006, HELV CHIM ACTA, V89, P144, DOI 10.1002/hlca.200690007; Novaroli L, 2005, CHIMIA, V59, P315, DOI 10.2533/000942905777676407; Ono K, 2007, J NEUROSCI RES, V85, P1547, DOI 10.1002/jnr.21271; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Recchia A, 2004, FASEB J, V18, P617, DOI 10.1096/fj.03-0338rev; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Sommer David B, 2008, Expert Rev Neurother, V8, P1829, DOI 10.1586/14737175.8.12.1829; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sul D, 2009, LIFE SCI, V84, P257, DOI 10.1016/j.lfs.2008.12.001; Sung JY, 2001, J BIOL CHEM, V276, P27441, DOI 10.1074/jbc.M101318200; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Truong DD, 2009, CLIN INTERV AGING, V4, P109; Wang YJ, 2009, NEUROTOX RES, V15, P3, DOI 10.1007/s12640-009-9000-x; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yamin G, 2005, BIOCHEMISTRY-US, V44, P9096, DOI 10.1021/bi048778a; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhu M, 2004, J BIOL CHEM, V279, P26846, DOI 10.1074/jbc.M403129200	91	96	98	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					14941	14954		10.1074/jbc.M109.080390	http://dx.doi.org/10.1074/jbc.M109.080390			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20150427	hybrid, Green Published			2022-12-27	WOS:000277399000015
J	Smith, MA; Mack, V; Ebneth, A; Moraes, I; Felicetti, B; Wood, M; Schonfeld, D; Mather, O; Cesura, A; Barker, J				Smith, Myron A.; Mack, Volker; Ebneth, Andreas; Moraes, Isabel; Felicetti, Brunella; Wood, Michael; Schonfeld, Dorian; Mather, Owen; Cesura, Andrea; Barker, John			The Structure of Mammalian Serine Racemase EVIDENCE FOR CONFORMATIONAL CHANGES UPON INHIBITOR BINDING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; NMDA-RECEPTORS; GLYCINE; BRAIN; ACTIVATION; DEHYDRATASE; COMPLEX; PROTEIN	Serine racemase is responsible for the synthesis of D-serine, an endogenous co-agonist for N-methyl-D-aspartate receptor-type glutamate receptors (NMDARs). This pyridoxal 5'-phosphate-dependent enzyme is involved both in the reversible conversion of L- to D-serine and serine catabolism by alpha,beta-elimination of water, thereby regulating D-serine levels. Because D-serine affects NMDAR signaling throughout the brain, serine racemase is a promising target for the treatment of disorders related to NMDAR dysfunction. To provide a molecular basis for rational drug design the x-ray crystal structures of human and rat serine racemase were determined at 1.5- and 2.1-angstrom resolution, respectively, and in the presence and absence of the orthosteric inhibitor malonate. The structures revealed a fold typical of beta-family pyridoxal 5'-phosphate enzymes, with both a large domain and a flexible small domain associated into a symmetric dimer, and indicated a ligand-induced rearrangement of the small domain that organizes the active site for specific turnover of the substrate.	[Smith, Myron A.; Mack, Volker; Ebneth, Andreas; Moraes, Isabel; Felicetti, Brunella; Wood, Michael; Schonfeld, Dorian; Mather, Owen; Cesura, Andrea; Barker, John] Evotec, Dept Struct Biol & Biol, Abingdon OX14 4SA, Oxon, England	Evotec	Smith, MA (corresponding author), Evotec, Dept Struct Biol & Biol, 114 Milton Pk, Abingdon OX14 4SA, Oxon, England.	myron.smith@evotec.com	Moraes, Isabel/AAK-7872-2021	Moraes, Isabel/0000-0002-7427-5467				Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balan L, 2009, P NATL ACAD SCI USA, V106, P7589, DOI 10.1073/pnas.0809442106; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; Brown DG, 2006, CURR TOP MED CHEM, V6, P749, DOI 10.2174/156802606777057571; Chaffey H, 2008, CURR ANAESTHES CRIT, V19, P183, DOI [DOI 10.1016/J.CACC.2008.05.004, DOI 10.1016/j.cacc.2008.05.004]; Chen HJ, 2009, STRUCTURE, V17, P517, DOI 10.1016/j.str.2009.02.013; Cook SP, 2002, J BIOL CHEM, V277, P27782, DOI 10.1074/jbc.M111814200; DeLano W.L., 2003, PYMOL REFERENCE MANU; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; Goto M, 2009, J BIOL CHEM, V284, P25944, DOI 10.1074/jbc.M109.010470; Hoffman HE, 2009, PROTEIN EXPRES PURIF, V63, P62, DOI 10.1016/j.pep.2008.09.003; Inoue R, 2008, J NEUROSCI, V28, P14486, DOI 10.1523/JNEUROSCI.5034-08.2008; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; MATSUI T, 1995, J NEUROCHEM, V65, P454; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGATA Y, 1992, EXPERIENTIA, V48, P753, DOI 10.1007/BF02124295; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Schell MJ, 1997, J NEUROSCI, V17, P1604; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Strisovsky K, 2005, BIOCHEMISTRY-US, V44, P13091, DOI 10.1021/bi051201o; Sun L, 2005, PROTEIN SCI, V14, P791, DOI 10.1110/ps.041179105; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100; Yoshimura T, 2008, FEBS J, V275, P3527, DOI 10.1111/j.1742-4658.2008.06516.x	35	68	73	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12873	12881		10.1074/jbc.M109.050062	http://dx.doi.org/10.1074/jbc.M109.050062			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20106978	hybrid, Green Published			2022-12-27	WOS:000276787800045
J	Herman, MA; She, PX; Peroni, OD; Lynch, CJ; Kahn, BB				Herman, Mark A.; She, Pengxiang; Peroni, Odile D.; Lynch, Christopher J.; Kahn, Barbara B.			Adipose Tissue Branched Chain Amino Acid (BCAA) Metabolism Modulates Circulating BCAA Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; S6 KINASE; LEUCINE; EXPRESSION; MECHANISMS; PATHWAY; ENZYMES; OBESITY; MUSCLE; CONTRIBUTES	Whereas the role of adipose tissue in glucose and lipid homeostasis is widely recognized, its role in systemic protein and amino acid metabolism is less well-appreciated. In vitro and ex vivo experiments suggest that adipose tissue can metabolize substantial amounts of branched chain amino acids (BCAAs). However, the role of adipose tissue in regulating BCAA metabolism in vivo is controversial. Interest in the contribution of adipose tissue to BCAA metabolism has been renewed with recent observations demonstrating down-regulation of BCAA oxidation enzymes in adipose tissue in obese and insulin-resistant humans. Using gene set enrichment analysis, we observe alterations in adipose-tissue BCAA enzyme expression caused by adipose-selective genetic alterations in the GLUT4 glucose-transporter expression. We show that the rate of adipose tissue BCAA oxidation per mg of tissue from normal mice is higher than in skeletal muscle. In mice overexpressing GLUT4 specifically in adipose tissue, we observe coordinate down-regulation of BCAA metabolizing enzymes selectively in adipose tissue. This decreases BCAA oxidation rates in adipose tissue, but not in muscle, in association with increased circulating BCAA levels. To confirm the capacity of adipose tissue to modulate circulating BCAA levels in vivo, we demonstrate that transplantation of normal adipose tissue into mice that are globally defective in peripheral BCAA metabolism reduces circulating BCAA levels by 30% (fasting)-50% (fed state). These results demonstrate for the first time the capacity of adipose tissue to catabolize circulating BCAAs in vivo and that coordinate regulation of adiposetissue BCAA enzymes may modulate circulating BCAA levels.	[Herman, Mark A.; Peroni, Odile D.; Kahn, Barbara B.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Herman, Mark A.; Peroni, Odile D.; Kahn, Barbara B.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [She, Pengxiang; Lynch, Christopher J.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kahn, BB (corresponding author), 330 Brookline Ave, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Lynch, Christopher J./E-6875-2010; Herman, Mark/H-3232-2012	Lynch, Christopher J./0000-0003-2453-5838; Herman, Mark/0000-0001-6979-103X	National Institutes of Health [R01DK43051, P30DK57521, K08DK076726, R01DK062880]; Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, R01DK062880, R01DK043051, K08DK076726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Picower Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK43051 and P30DK57521 (to B.B.K.), Grant K08DK076726 (to M.A.H.), and Grant R01DK062880 (to C.J.L.). This work was also supported by a grant from the Picower Foundation (to B.B.K.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; BLOCK KP, 1987, AM J PHYSIOL, V252, pE396, DOI 10.1152/ajpendo.1987.252.3.E396; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; CROFFORD OB, 1964, P SOC EXP BIOL MED, V117, P11, DOI 10.3181/00379727-117-29483; FAJANS SS, 1965, NEW ENGL J MED, V272, P1224, DOI 10.1056/NEJM196506102722308; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fell DA, 2005, J EXP BOT, V56, P267, DOI 10.1093/jxb/eri011; FRAYN KN, 1991, CLIN SCI, V80, P471, DOI 10.1042/cs0800471; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; GOODMAN HM, 1977, AM J PHYSIOL, V233, pE97, DOI 10.1152/ajpendo.1977.233.2.E97; GOODMAN HM, 1986, PROBLEMS POTENTIAL B, P173; Greiwe JS, 2001, AM J PHYSIOL-ENDOC M, V281, pE466, DOI 10.1152/ajpendo.2001.281.3.E466; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; HARRIS RA, 1988, METHOD ENZYMOL, V166, P114; Harris RA, 2004, BIOCHEM BIOPH RES CO, V313, P391, DOI 10.1016/j.bbrc.2003.11.007; Harris RA, 2001, J NUTR, V131, p841S, DOI 10.1093/jn/131.3.841S; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; HUTSON SM, 1987, J BIOL CHEM, V262, P9629; ICHIHARA A, 1966, J BIOCHEM-TOKYO, V59, P160, DOI 10.1093/oxfordjournals.jbchem.a128277; Joshi MA, 2006, BIOCHEM J, V400, P153, DOI 10.1042/BJ20060869; Kowalski TJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE613, DOI 10.1152/ajpendo.1997.273.3.E613; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lynch CJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE854, DOI 10.1152/ajpendo.00153.2003; Lynch CJ, 2002, AM J PHYSIOL-ENDOC M, V283, pE824, DOI 10.1152/ajpendo.00085.2002; MEIKLE AW, 1972, AM J PHYSIOL, V222, P1246, DOI 10.1152/ajplegacy.1972.222.5.1246; Mitsubuchi H, 2005, J NUTR, V135, p1565S, DOI 10.1093/jn/135.6.1565S; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Norton LE, 2006, J NUTR, V136, p533S, DOI 10.1093/jn/136.2.533S; ODESSEY R, 1986, PROBLEMS POTENTIAL B, P49; Pietilainen KH, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050051; POPOV KM, 1995, ARCH BIOCHEM BIOPHYS, V316, P148, DOI 10.1006/abbi.1995.1022; ROSENTHA.J, 1974, AM J PHYSIOL, V226, P411, DOI 10.1152/ajplegacy.1974.226.2.411; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; She PX, 2007, AM J PHYSIOL-ENDOC M, V293, pE1552, DOI 10.1152/ajpendo.00134.2007; She P, 2007, CELL METAB, V6, P181, DOI 10.1016/j.cmet.2007.08.003; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SNELL K, 1977, BIOCHEM BIOPH RES CO, V77, P925, DOI 10.1016/S0006-291X(77)80066-1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suryawan A, 1998, AM J CLIN NUTR, V68, P72, DOI 10.1093/ajcn/68.1.72; Sweatt AJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE64, DOI 10.1152/ajpendo.00276.2003; TISCHLER ME, 1980, J BIOL CHEM, V255, P8074; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; WAHREN J, 1976, J CLIN INVEST, V57, P987, DOI 10.1172/JCI108375; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; ZINNEMAN HH, 1966, DIABETES, V15, P5, DOI 10.2337/diab.15.1.5	49	257	263	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11348	11356		10.1074/jbc.M109.075184	http://dx.doi.org/10.1074/jbc.M109.075184			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20093359	Green Published, hybrid			2022-12-27	WOS:000276286200041
J	Filosto, S; Fry, W; Knowlton, AA; Goldkorn, T				Filosto, Simone; Fry, William; Knowlton, Anne A.; Goldkorn, Tzipora			Neutral Sphingomyelinase 2 (nSMase2) Is a Phosphoprotein Regulated by Calcineurin (PP2B)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG EPITHELIAL-CELLS; KINASE-C-DELTA; NECROSIS-FACTOR-ALPHA; ACID SPHINGOMYELINASE; CIGARETTE-SMOKE; CYCLOSPORINE-A; UP-REGULATION; P38 MAPK; MEDIATED PHOSPHORYLATION	We previously reported that exposure of human airway epithelial cells to oxidative stress increased ceramide generation via specific activation of neutral sphingomyelinase2 (nSMase2). Here we show that nSMase2 is a phosphoprotein exclusively phosphorylated at serine residues. The level of nSMase2 phosphorylation can be modulated by treatment with anisomycin or phorbol 12-myristate 13-acetate (PMA/12-O-tetradecanoylphorbol-13-acetate), suggesting that p38 mitogen-activated protein kinase (MAPK) and protein kinases Cs are upstream of nSMase2 phosphorylation. Oxidative stress enhances both the activity and phosphorylation of nSMase2. Strikingly, we show here that nSMase2 is bound directly by the phosphatase calcineurin (CaN), which acts as an on/off switch for nSMase2 phosphorylation in the presence or absence of oxidative stress. Specifically, CaN is being inhibited/degraded and therefore does not bind nSMase2 under oxidative stress, and a mutant nSMase2 that lacks the CaN binding site exhibits constitutively elevated phosphorylation and increased activity relative to wild type nSMase2. Importantly, the phosphorylation and activity of the mutant no longer responds to oxidative stress, confirming that CaN is the critical link that allows oxidative stress to modulate nSMase2 phosphorylation and function.	[Filosto, Simone; Fry, William; Knowlton, Anne A.; Goldkorn, Tzipora] Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Dept Internal Med, Davis, CA 95616 USA	University of California System; University of California Davis	Goldkorn, T (corresponding author), Univ Calif Davis, Sch Med, Genome & Biomed Sci Facil, Dept Internal Med, Rm 6321,451 E Hlth Sci Dr, Davis, CA 95616 USA.	ttgoldkorn@ucdavis.edu		Filosto, Simone/0000-0002-7854-998X	National Institutes of Health [HL-71871, HL-66189]; Tobacco-related Disease Research Program [17RT-0131]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071871, R01HL066189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-related Disease Research Program(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-71871 and HL-66189 (to T. G.) and Tobacco-related Disease Research Program Grant 17RT-0131 (to T. G.).	Aramburu J, 1998, MOL CELL, V1, P627, DOI 10.1016/S1097-2765(00)80063-5; Bezombes C, 1998, FASEB J, V12, P101, DOI 10.1096/fasebj.12.1.101; Bogumil R, 2000, EUR J BIOCHEM, V267, P1407, DOI 10.1046/j.1432-1327.2000.01133.x; Braz JC, 2003, J CLIN INVEST, V111, P1475, DOI 10.1172/JCI200317295; Castillo SS, 2007, EXP CELL RES, V313, P2680, DOI 10.1016/j.yexcr.2007.04.002; Castillo SS, 2007, EXP CELL RES, V313, P816, DOI 10.1016/j.yexcr.2006.12.001; Chan C, 2000, AM J RESP CELL MOL, V22, P460, DOI 10.1165/ajrcmb.22.4.3376; Chen Y, 2001, AM J RESP CELL MOL, V25, P409, DOI 10.1165/ajrcmb.25.4.4413; CIFONE MG, 1994, J EXP MED, V180, P1547, DOI 10.1084/jem.180.4.1547; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Clarke CJ, 2007, J BIOL CHEM, V282, P1384, DOI 10.1074/jbc.M609216200; Dave V, 2004, J BIOL CHEM, V279, P34578, DOI 10.1074/jbc.M404296200; Eckstein LA, 2005, INVEST OPHTH VIS SCI, V46, P782, DOI 10.1167/iovs.04-1022; Elias JA, 2005, NAT MED, V11, P471, DOI 10.1038/nm0505-471; Elias Jack A, 2006, Proc Am Thorac Soc, V3, P494, DOI 10.1513/pats.200603-068MS; Goggel R, 2004, NAT MED, V10, P155, DOI 10.1038/nm977; Goldkorn T, 2005, ANTIOXID REDOX SIGN, V7, P119, DOI 10.1089/ars.2005.7.119; Goldkorn T, 1998, J CELL SCI, V111, P3209; HALL BH, 1990, BROOKINGS PAP ECO AC, P85; Hamai H, 2009, J LIPID RES, V50, P1101, DOI 10.1194/jlr.M800427-JLR200; Hardin SC, 1998, BIOTECHNIQUES, V24, P344, DOI 10.2144/98243bm01; Heit I, 2001, ONCOGENE, V20, P5143, DOI 10.1038/sj.onc.1204657; Henson PM, 2008, AM J PHYSIOL-LUNG C, V294, pL601, DOI 10.1152/ajplung.00320.2007; Henson Peter M, 2006, Proc Am Thorac Soc, V3, P713, DOI 10.1513/pats.200605-104SF; Hofmann K, 2000, P NATL ACAD SCI USA, V97, P5895, DOI 10.1073/pnas.97.11.5895; Ikeda T, 2009, IUBMB LIFE, V61, P644, DOI 10.1002/iub.193; JAYADEV S, 1995, J BIOL CHEM, V270, P2047, DOI 10.1074/jbc.270.5.2047; Jung JY, 2008, ARCH ORAL BIOL, V53, P1042, DOI 10.1016/j.archoralbio.2008.03.008; Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Lavrentiadou SN, 2001, AM J RESP CELL MOL, V25, P676, DOI 10.1165/ajrcmb.25.6.4321; Lawler JF, 1998, J BIOL CHEM, V273, P5053, DOI 10.1074/jbc.273.9.5053; Lee JE, 2007, J NEUROCHEM, V100, P1703, DOI 10.1111/j.1471-4159.2006.04340.x; Levy M, 2006, BIOCHEM BIOPH RES CO, V344, P900, DOI 10.1016/j.bbrc.2006.04.013; Levy M, 2009, AM J PHYSIOL-LUNG C, V297, pL125, DOI 10.1152/ajplung.00031.2009; Lim HW, 2001, J BIOL CHEM, V276, P15913, DOI 10.1074/jbc.M100452200; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Magnasco A, 2008, CURR CLIN PHARMACOL, V3, P166, DOI 10.2174/157488408785747674; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Melgert BN, 2007, CLIN EXP ALLERGY, V37, P1798, DOI 10.1111/j.1365-2222.2007.02843.x; MERRILL AH, 1990, BIOCHIM BIOPHYS ACTA, V1044, P1, DOI 10.1016/0005-2760(90)90211-F; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; OKAZAKI T, 1994, J BIOL CHEM, V269, P4070; Park JS, 2007, TISSUE ENG REGEN MED, V4, P347; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Petrache I, 2008, AM J PHYSIOL-LUNG C, V295, pL44, DOI 10.1152/ajplung.00448.2007; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Rahman I, 2005, MUTAT RES-FUND MOL M, V579, P58, DOI 10.1016/j.mrfmmm.2005.02.025; Rahman Irfan, 2008, Ther Adv Respir Dis, V2, P351, DOI 10.1177/1753465808098224; Ravid T, 2003, AM J PHYSIOL-LUNG C, V284, pL1082, DOI 10.1152/ajplung.00172.2002; Rennard Stephen I, 2006, Proc Am Thorac Soc, V3, P703, DOI 10.1513/pats.200605-121SF; ROBINSON CB, 1991, J TISSUE CULTURE MET, V13, P95; Rodriguez A, 2009, MOL CELL, V33, P616, DOI 10.1016/j.molcel.2009.01.030; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Spurzem JR, 2005, SEMIN RESP CRIT CARE, V26, P142, DOI 10.1055/s-2005-869535; Szijgyarto Z, 2007, INT J MOL MED, V20, P359; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; WIEGMANN K, 1994, CELL, V78, P1005, DOI 10.1016/0092-8674(94)90275-5; Wright JL, 2008, AM J PHYSIOL-LUNG C, V295, pL1, DOI 10.1152/ajplung.90200.2008; Xiong W, 2006, BRAIN RES, V1085, P68, DOI 10.1016/j.brainres.2006.02.015; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zeidan YH, 2008, FASEB J, V22, P183, DOI 10.1096/fj.07-8967com; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zimmerman GA, 2004, TRENDS MOL MED, V10, P245, DOI 10.1016/j.molmed.2004.03.009	67	45	47	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10213	10222		10.1074/jbc.M109.069963	http://dx.doi.org/10.1074/jbc.M109.069963			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20106976	Green Published, hybrid			2022-12-27	WOS:000276264600005
J	Pewzner-Jung, Y; Brenner, O; Braun, S; Laviad, EL; Ben-Dor, S; Feldmesser, E; Horn-Saban, S; Amann-Zalcenstein, D; Raanan, C; Berkutzki, T; Erez-Roman, R; Ben-David, O; Levy, M; Holzman, D; Park, H; Nyska, A; Merrill, AH; Futerman, AH				Pewzner-Jung, Yael; Brenner, Ori; Braun, Svantje; Laviad, Elad L.; Ben-Dor, Shifra; Feldmesser, Ester; Horn-Saban, Shirley; Amann-Zalcenstein, Daniela; Raanan, Calanit; Berkutzki, Tamara; Erez-Roman, Racheli; Ben-David, Oshrit; Levy, Michal; Holzman, Dorin; Park, Hyejung; Nyska, Abraham; Merrill, Alfred H., Jr.; Futerman, Anthony H.			A Critical Role for Ceramide Synthase 2 in Liver Homeostasis II. INSIGHTS INTO MOLECULAR CHANGES LEADING TO HEPATOPATHY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGEVITY ASSURANCE GENE-1; FUMONISIN B-1; HUMAN HEAD; EXPRESSION; INHIBITOR; APOPTOSIS; TOXICITY; SPHINGOLIPIDS; ACCUMULATION; SENSITIVITY	We have generated a mouse that cannot synthesize very long acyl chain (C22-C24) ceramides (Pewzner-Jung, Y., Park, H., Laviad, E. L., Silva, L. C., Lahiri, S., Stiban, J., Erez-Roman, R., Brugger, B., Sachsenheimer, T., Wieland, F. T., Prieto, M., Merrill, A. H., and Futerman, A. H. (2010) J. Biol. Chem. 285, 10902-10910) due to ablation of ceramide synthase 2 (CerS2). As a result, significant changes were observed in the sphingolipid profile of livers from these mice, including elevated C16-ceramide and sphinganine levels. We now examine the functional consequences of these changes. CerS2 null mice develop severe nonzonal hepatopathy from about 30 days of age, the age at which CerS2 expression peaks in wild type mice, and display increased rates of hepatocyte apoptosis and proliferation. In older mice there is extensive and pronounced hepatocellular anisocytosis with widespread formation of nodules of regenerative hepatocellular hyperplasia. Progressive hepatomegaly and noninvasive hepatocellular carcinoma are also seen from similar to 10 months of age. Even though CerS2 is found at equally high mRNA levels in kidney and liver, there are no changes in renal function and no pathological changes in the kidney. High throughput analysis of RNA expression in liver revealed up-regulation of genes associated with cell cycle regulation, protein transport, cell-cell interactions and apoptosis, and down-regulation of genes associated with intermediary metabolism, such as lipid and steroid metabolism, adipocyte signaling, and amino acid metabolism. In addition, levels of the cell cycle regulator, the cyclin dependent-kinase inhibitor p21(WAF1/CIP1), were highly elevated, which occurs by at least two mechanisms, one of which may involve p53. We propose a functional rationale for the synthesis of sphingolipids with very long acyl chains in liver homeostasis and in cell physiology.	[Pewzner-Jung, Yael; Braun, Svantje; Laviad, Elad L.; Erez-Roman, Racheli; Ben-David, Oshrit; Levy, Michal; Holzman, Dorin; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Brenner, Ori; Raanan, Calanit; Berkutzki, Tamara] Weizmann Inst Sci, Dept Vet Resources, IL-76100 Rehovot, Israel; [Ben-Dor, Shifra; Feldmesser, Ester; Horn-Saban, Shirley; Amann-Zalcenstein, Daniela] Weizmann Inst Sci, Dept Biol Serv, IL-76100 Rehovot, Israel; [Nyska, Abraham] Tel Aviv Univ, Timrat & Sackler Sch Med, IL-69978 Ramat Aviv, Israel; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	BEN-DOR, SHIFRA/M-6718-2019; Pewzner, Faivish/I-6225-2017	BEN-DOR, SHIFRA/0000-0001-9604-1939; Pewzner, Faivish/0000-0002-7490-8121; Merrill, Alfred/0000-0002-6673-968X; Stiban, Johnny/0000-0002-3748-9976; Futerman, Anthony/0000-0003-0013-0115	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by Israel Science Foundation Grant 1404/07 and by The Minerva Foundation.	Albrecht JH, 1997, HEPATOLOGY, V25, P557, DOI 10.1002/hep.510250311; Amacher DE, 1998, FOOD CHEM TOXICOL, V36, P831, DOI 10.1016/S0278-6915(98)00066-0; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bannasch P, 2003, TOXICOL PATHOL, V31, P566, DOI 10.1080/01926230390224700; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bondy GS, 1997, FOOD CHEM TOXICOL, V35, P981, DOI 10.1016/S0278-6915(97)87267-5; Ciacci-Zanella JR, 1998, FOOD CHEM TOXICOL, V36, P791, DOI 10.1016/S0278-6915(98)00034-9; Cotran R. S., 1999, ROBBINS PATHOLOGIC B, V6th; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DESCHL U, 2001, INT CLASSIFICATION R; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dragan YP, 2001, TOXICOL SCI, V61, P6, DOI 10.1093/toxsci/61.1.6; Flock G, 2007, DIABETES, V56, P3006, DOI 10.2337/db07-0697; Flowers MT, 2008, PHYSIOL GENOMICS, V33, P361, DOI 10.1152/physiolgenomics.00139.2007; Goodman DG., 1994, GUIDES TOXICOLOGIC P; GREAVES P, 2000, HISTOPATHOLOGY PRECL, P448; Hailey JR, 2005, TOXICOL PATHOL, V33, P165, DOI 10.1080/01926230590888324; HARADA T, 1999, PATHOLOGY MOUSE; HARADA T, 1999, LIVER GALLBLADDER; Hojjati MR, 2005, BBA-MOL CELL BIOL L, V1737, P44, DOI 10.1016/j.bbalip.2005.08.006; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; HOWARD PC, 2001, TOXICOLOGY CARCINOGE; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jin JF, 2008, J BIOL CHEM, V283, P26509, DOI 10.1074/jbc.M801597200; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Katzenellenbogen M, 2006, CANCER RES, V66, P4001, DOI 10.1158/0008-5472.CAN-05-2937; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Leuenberger N, 2009, J CLIN INVEST, V119, P3138, DOI 10.1172/JCI39019; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Merrill AH, 1996, TRENDS CELL BIOL, V6, P218, DOI 10.1016/0962-8924(96)10021-0; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Min JX, 2007, MOL CANCER RES, V5, P801, DOI 10.1158/1541-7786.MCR-07-0100; Panjarian S, 2008, PROSTAG OTH LIPID M, V86, P41, DOI 10.1016/j.prostaglandins.2008.02.004; Perkins ND, 2002, CELL CYCLE, V1, P39, DOI 10.4161/cc.1.1.98; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Riley RT, 2006, TOXICOL SCI, V92, P335, DOI 10.1093/toxsci/kfj198; Saddoughi Sahar A., 2008, V49, P413, DOI 10.1007/978-1-4020-8831-5_16; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Senkal CE, 2007, MOL CANCER THER, V6, P712, DOI 10.1158/1535-7163.MCT-06-0558; Sonnino S, 2009, GLYCOCONJUGATE J, V26, P615, DOI 10.1007/s10719-008-9215-8; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; SULLARDS MC, 2001, SCI STKE, V86; Tennant B.C., 1999, CLIN CHEM LAB ANIMAL; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Voss KA, 2001, ENVIRON HEALTH PERSP, V109, P259, DOI 10.2307/3435017; Walker T, 2009, MOL PHARMACOL, V76, P342, DOI 10.1124/mol.109.056523; Wang X, 2009, J CELL BIOL, V184, P143, DOI 10.1083/jcb.200807176; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yamashita T, 1999, P NATL ACAD SCI USA, V96, P9142, DOI 10.1073/pnas.96.16.9142; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; [No title captured]	62	169	170	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10911	10923		10.1074/jbc.M109.077610	http://dx.doi.org/10.1074/jbc.M109.077610			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110366	Green Published, hybrid			2022-12-27	WOS:000276264600076
J	Yu, WF; Kong, TQ; Beaudry, S; Tran, M; Negoro, H; Yanamadala, V; Denker, BM				Yu, Wanfeng; Kong, Tianqing; Beaudry, Sarah; Tran, Mei; Negoro, Hideyuki; Yanamadala, Vijay; Denker, Bradley M.			Polycystin-1 Protein Level Determines Activity of the G alpha(12)/JNK Apoptosis Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; EPITHELIAL-CELLS; ALPHA-SUBUNITS; E-CADHERIN; PKD1; PROLIFERATION; ACTIVATION; RESISTANCE; MIGRATION; JUNCTION	Mutations in PKD1 are the most common cause of autosomal dominant polycystic kidney disease (ADPKD). The protein product of PKD1 (polycystin-1 (PC1)) is a large transmembrane protein with a short intracellular C terminus that interacts with numerous signaling molecules, including G alpha(12). Cyst formation in ADPKD results from numerous cellular defects, including abnormal cilia, changes in polarity, and dysregulated apoptosis and proliferation. Recently, we reported increased apoptosis in Madin-Darby canine kidney (MDCK) cells through G alpha(12) stimulation of JNK and degradation of the anti-apoptotic protein Bcl-2 (Yanamadala, V., Negoro, H., Gunaratnam, L., Kong, T., and Denker, B. M. (2007) J. Biol. Chem. 282, 24352-24363). Herein, we confirm this pathway in G alpha(12)-silenced MDCK cells and utilize MDCK cell lines harboring either overexpressed or silenced PC1 to demonstrate that PC1 expression levels determine activity of the JNK/Bcl-2 apoptosis pathway. PC1-overexpressing MDCK cells were resistant to thrombin/alpha(12)-stimulated apoptosis, JNK activation, and Bcl-2 degradation. In contrast, PC1-silenced MDCK cells displayed enhanced thrombin-induced apoptosis, JNK activity, and Bcl-2 degradation. In pulldown experiments, PC1 bound to G alpha(12), but not the related G alpha(13) subunit, and thrombin-stimulated MDCK cells led to increased interaction of G alpha(12) with the PC1 C terminus. In transient transfection assays, a PC1 C-terminal mutant lacking the G protein-binding domain was uncoupled from PC1-inhibited apoptosis. PC1 expression levels may be increased or decreased in ADPKD, and these findings suggest a mechanism in which levels of PC1 expression modulate G alpha(12)/JNK-stimulated apoptosis. Taken together, these findings are consistent with a set point model in which PC1 expression levels regulate specific G protein signaling pathways important to cyst development.	[Yu, Wanfeng; Kong, Tianqing; Beaudry, Sarah; Tran, Mei; Negoro, Hideyuki; Yanamadala, Vijay; Denker, Bradley M.] Brigham & Womens Hosp, Harvard Inst Med, Div Renal, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Denker, BM (corresponding author), Brigham & Womens Hosp, Harvard Inst Med, Div Renal, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	bdenker@rics.bwh.harvard.edu	yu, wanfeng/G-2915-2013		National Institutes of Health [P50 DK074030, GM55223]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK074030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055223, R29GM055223] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P50 DK074030 (Polycystic Kidney Center; Project 1) and GM55223 (to B. M. D.).	Ando-Akatsuka Y, 1999, J CELL PHYSIOL, V179, P115, DOI 10.1002/(SICI)1097-4652(199905)179:2<115::AID-JCP1>3.0.CO;2-T; Basavanna U, 2007, BIOCHEM BIOPH RES CO, V359, P367, DOI 10.1016/j.bbrc.2007.05.114; Battini L, 2006, J AM SOC NEPHROL, V17, P3049, DOI 10.1681/ASN.2006030234; Boca M, 2007, MOL BIOL CELL, V18, P4050, DOI 10.1091/mbc.E07-02-0142; Boca M, 2006, J AM SOC NEPHROL, V17, P637, DOI 10.1681/ASN.2005050534; Boletta A, 2000, MOL CELL, V6, P1267, DOI 10.1016/S1097-2765(00)00123-4; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; DENKER BM, 1995, BIOCHEMISTRY-US, V34, P5544, DOI 10.1021/bi00016a028; Kelly P, 2007, BIOCHEMISTRY-US, V46, P6677, DOI 10.1021/bi700235f; Kim E, 1999, P NATL ACAD SCI USA, V96, P6371, DOI 10.1073/pnas.96.11.6371; Kong TQ, 2009, MOL BIOL CELL, V20, P4596, DOI 10.1091/mbc.E09-03-0220; Landry Y, 2006, CURR MED CHEM, V13, P51, DOI 10.2174/092986706775197953; Lanoix J, 1996, ONCOGENE, V13, P1153; Low SH, 2006, DEV CELL, V10, P57, DOI 10.1016/j.devcel.2005.12.005; Luo Y, 2003, MOL CELL BIOL, V23, P2600, DOI 10.1128/MCB.23.7.2600-2607.2003; Meigs TE, 2002, J BIOL CHEM, V277, P24594, DOI 10.1074/jbc.M201984200; Meyer TN, 2003, AM J PHYSIOL-CELL PH, V285, pC1281, DOI 10.1152/ajpcell.00548.2002; Meyer TN, 2002, J BIOL CHEM, V277, P24855, DOI 10.1074/jbc.C200240200; NEER EJ, 1994, PROTEIN SCI, V3, P3; Nishio S, 2005, J CLIN INVEST, V115, P910, DOI 10.1172/JCI200522850; Ong ACM, 1999, AM J PATHOL, V154, P1721, DOI 10.1016/S0002-9440(10)65428-4; Parnell SC, 1998, BIOCHEM BIOPH RES CO, V251, P625, DOI 10.1006/bbrc.1998.9514; Parnell SC, 2002, J BIOL CHEM, V277, P19566, DOI 10.1074/jbc.M201875200; QUICK MW, 1994, J BIOL CHEM, V269, P30164; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Sabath E, 2008, J CELL SCI, V121, P814, DOI 10.1242/jcs.014878; Streets AJ, 2009, J CELL SCI, V122, P1410, DOI 10.1242/jcs.045021; Thivierge C, 2006, MOL CELL BIOL, V26, P1538, DOI 10.1128/MCB.26.4.1538-1548.2006; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; Ward CJ, 1996, P NATL ACAD SCI USA, V93, P1524, DOI 10.1073/pnas.93.4.1524; WOO D, 1995, NEW ENGL J MED, V333, P18, DOI 10.1056/NEJM199507063330104; Yanamadala V, 2007, J BIOL CHEM, V282, P24352, DOI 10.1074/jbc.M702804200; Yanamadala V, 2009, CURR MOL MED, V9, P527, DOI 10.2174/156652409788488784; Yuasa T, 2004, GENOMICS, V84, P126, DOI 10.1016/j.ygeno.2004.02.008; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	35	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10243	10251		10.1074/jbc.M109.070821	http://dx.doi.org/10.1074/jbc.M109.070821			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20106977	Green Published, hybrid			2022-12-27	WOS:000276264600008
J	Novakovic, B; Wong, NC; Sibson, M; Ng, HK; Morley, R; Manuelpillai, U; Down, T; Rakyan, VK; Beck, S; Hiendleder, S; Roberts, CT; Craig, JM; Saffery, R				Novakovic, Boris; Wong, Nick C.; Sibson, Mandy; Ng, Hong-Kiat; Morley, Ruth; Manuelpillai, Ursula; Down, Thomas; Rakyan, Vardhman K.; Beck, Stephan; Hiendleder, Stefan; Roberts, Claire T.; Craig, Jeffrey M.; Saffery, Richard			DNA Methylation-mediated Down-regulation of DNA Methyltransferase-1 (DNMT1) Is Coincident with, but Not Essential for, Global Hypomethylation in Human Placenta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA EXPRESSION; 5-METHYLCYTOSINE CONTENT; CHORIOCARCINOMA CELLS; REPETITIVE DNA; NORMAL-TISSUES; LUNG-CANCER; CPG ISLANDS; GENE; HYPERMETHYLATION; OVEREXPRESSION	The genome of extraembryonic tissue, such as the placenta, is hypomethylated relative to that in somatic tissues. However, the origin and role of this hypomethylation remains unclear. The DNA methyltransferases DNMT1, -3A, and -3B are the primary mediators of the establishment and maintenance of DNA methylation in mammals. In this study, we investigated promoter methylation-mediated epigenetic down-regulation of DNMT genes as a potential regulator of global methylation levels in placental tissue. Although DNMT3A and -3B promoters lack methylation in all somatic and extraembryonic tissues tested, we found specific hypermethylation of the maintenance DNA methyltransferase (DNMT1) gene and found hypomethylation of the DNMT3L gene in full term and first trimester placental tissues. Bisulfite DNA sequencing revealed monoallelic methylation of DNMT1, with no evidence of imprinting (parent of origin effect). In vitro reporter experiments confirmed that DNMT1 promoter methylation attenuates transcriptional activity in trophoblast cells. However, global hypomethylation in the absence of DNMT1 down-regulation is apparent in non-primate placentas and in vitro derived human cytotrophoblast stem cells, suggesting that DNMT1 down-regulation is not an absolute requirement for genomic hypomethylation in all instances. These data represent the first demonstration of methylation-mediated regulation of the DNMT1 gene in any system and demonstrate that the unique epigenome of the human placenta includes down-regulation of DNMT1 with concomitant hypomethylation of the DNMT3L gene. This strongly implicates epigenetic regulation of the DNMT gene family in the establishment of the unique epigenetic profile of extraembryonic tissue in humans.	[Novakovic, Boris; Wong, Nick C.; Sibson, Mandy; Ng, Hong-Kiat; Morley, Ruth; Craig, Jeffrey M.; Saffery, Richard] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Novakovic, Boris; Craig, Jeffrey M.; Saffery, Richard] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Manuelpillai, Ursula] Monash Univ, Monash Inst Med Res, Clayton, Vic 3168, Australia; [Down, Thomas] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QR, England; [Down, Thomas] Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; [Rakyan, Vardhman K.] Inst Cell & Mol Sci Barts & London, London E1 2AT, England; [Beck, Stephan] UCL, Inst Canc, London WC1E 6BT, England; [Hiendleder, Stefan] Univ Adelaide, JS Davies Epigenet & Genet Grp, Adelaide, SA 5005, Australia; [Roberts, Claire T.] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Monash University; University of Cambridge; University of Cambridge; University of London; Queen Mary University London; University of London; University College London; University of Adelaide; University of Adelaide	Saffery, R (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	richard.saffery@mcri.edu.au	Novakovic, Boris/D-8018-2013; Saffery, Richard/GLS-1976-2022; Hiendleder, Stefan/J-8008-2012; Craig, Jeffrey M/B-3484-2012; Wong, Nick Wong/AAF-8627-2021; Roberts, Claire/A-1205-2007	Novakovic, Boris/0000-0002-5623-9008; Saffery, Richard/0000-0002-9510-4181; Craig, Jeffrey M/0000-0003-3979-7849; Wong, Nick Wong/0000-0003-4393-7541; Roberts, Claire/0000-0002-9250-2192	National Health and Medical Research Council (NHMRC) (Australia); Wellcome Trust [084071]	National Health and Medical Research Council (NHMRC) (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission)	Supported by a National Health and Medical Research Council (NHMRC) (Australia) Dora Lush scholarship.; Supported by NHMRC research fellowships.; Supported by Wellcome Trust Grant 084071.	Aapola U, 2000, GENOMICS, V65, P293, DOI 10.1006/geno.2000.6168; Al-Nasiry S, 2006, HUM REPROD, V21, P193, DOI 10.1093/humrep/dei272; Arai E, 2006, INT J CANCER, V119, P288, DOI 10.1002/ijc.21807; Arima T, 2006, DEV BIOL, V297, P361, DOI 10.1016/j.ydbio.2006.05.003; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bigey P, 2000, GENE, V242, P407, DOI 10.1016/S0378-1119(99)00501-6; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; Brueckner B, 2007, CANCER J, V13, P17, DOI 10.1097/PPO.0b013e31803c7245; Campbell PM, 2003, CARCINOGENESIS, V24, P17, DOI 10.1093/carcin/24.1.17; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Chalitchagorn K, 2004, ONCOGENE, V23, P8841, DOI 10.1038/sj.onc.1208137; CHAPMAN V, 1984, NATURE, V307, P284, DOI 10.1038/307284a0; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Cotton AM, 2009, HUM MOL GENET, V18, P3544, DOI 10.1093/hmg/ddp299; Cui M, 2009, MOL BIOL REP, V36, P2201, DOI 10.1007/s11033-008-9435-9; Etoh T, 2004, AM J PATHOL, V164, P689, DOI 10.1016/S0002-9440(10)63156-2; Fan H, 2009, WORLD J GASTROENTERO, V15, P2020, DOI 10.3748/wjg.15.2020; FEINBERG AP, 1988, CANCER RES, V48, P1159; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; Fuke C, 2004, ANN HUM GENET, V68, P196, DOI 10.1046/j.1529-8817.2004.00081.x; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; GAMASOSA MA, 1983, BIOCHIM BIOPHYS ACTA, V740, P212, DOI 10.1016/0167-4781(83)90079-9; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P3087, DOI 10.1093/nar/11.10.3087; Guilleret I, 2009, EPIGENETICS-US, V4, P62, DOI 10.4161/epi.4.1.7471; Harun R, 2006, HUM REPROD, V21, P1349, DOI 10.1093/humrep/del017; Hata K, 2002, DEVELOPMENT, V129, P1983; Hemberger M, 2007, CELL MOL LIFE SCI, V64, P2422, DOI 10.1007/s00018-007-7113-z; Hermann A, 2004, J BIOL CHEM, V279, P48350, DOI 10.1074/jbc.M403427200; Jackson K, 2004, CANCER BIOL THER, V3, P1225, DOI 10.4161/cbt.3.12.1222; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Kinney SRM, 2008, MOL CANCER RES, V6, P1365, DOI 10.1158/1541-7786.MCR-08-0040; Lin RK, 2007, LUNG CANCER, V55, P205, DOI 10.1016/j.lungcan.2006.10.022; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Medstrand P, 2005, CYTOGENET GENOME RES, V110, P342, DOI 10.1159/000084966; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Okahara G, 2004, GENOMICS, V84, P982, DOI 10.1016/j.ygeno.2004.09.004; Pavan L, 2003, CARCINOGENESIS, V24, P1325, DOI 10.1093/carcin/bgg074; Peng DF, 2006, CARCINOGENESIS, V27, P1160, DOI 10.1093/carcin/bgi361; Rahnama F, 2006, ENDOCRINOLOGY, V147, P5275, DOI 10.1210/en.2006-0288; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Reiss D, 2007, NUCLEIC ACIDS RES, V35, P4743, DOI 10.1093/nar/gkm455; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Saikawa Y, 2004, ONCOL REP, V12, P527; SANFORD J, 1984, NUCLEIC ACIDS RES, V12, P2823, DOI 10.1093/nar/12.6.2823; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Sato N, 2003, JNCI-J NATL CANCER I, V95, P327, DOI 10.1093/jnci/95.4.327; Serman L, 2007, PLACENTA, V28, P803, DOI 10.1016/j.placenta.2007.04.001; Slack A, 1999, EUR J BIOCHEM, V264, P191, DOI 10.1046/j.1432-1327.1999.00603.x; Slack A, 2001, GENE, V268, P87, DOI 10.1016/S0378-1119(01)00427-9; Spada F, 2007, J CELL BIOL, V176, P565, DOI 10.1083/jcb.200610062; Suetake I, 2004, J BIOL CHEM, V279, P27816, DOI 10.1074/jbc.M400181200; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Tsien F, 2002, CYTOGENET GENOME RES, V98, P13, DOI 10.1159/000068543; Vallbohmer D, 2006, CLIN LUNG CANCER, V8, P39, DOI 10.3816/CLC.2006.n.031; Wagschal A, 2006, CYTOGENET GENOME RES, V113, P90, DOI 10.1159/000090819; Widschwendter M, 2004, CANCER RES, V64, P4472, DOI 10.1158/0008-5472.CAN-04-0238; Wong NC, 2008, CANCER LETT, V268, P56, DOI 10.1016/j.canlet.2008.03.033; Wong NC, 2006, PLOS GENET, V2, P172, DOI 10.1371/journal.pgen.0020017; Yaqinuddin A, 2009, J UROLOGY, V182, P756, DOI 10.1016/j.juro.2009.03.082	61	70	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9583	9593		10.1074/jbc.M109.064956	http://dx.doi.org/10.1074/jbc.M109.064956			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20071334	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000276165900031
J	Lin, YM; Wu, SJ; Chang, TW; Wang, CF; Suen, CS; Hwang, MJ; Chang, MDT; Chen, YT; Liao, YD				Lin, Yu-Min; Wu, Shih-Jung; Chang, Ting-Wei; Wang, Chiu-Feng; Suen, Ching-Shu; Hwang, Ming-Jing; Chang, Margaret Dah-Tsyr; Chen, Yuan-Tsong; Liao, You-Di			Outer Membrane Protein I of Pseudomonas aeruginosa Is a Target of Cationic Antimicrobial Peptide/Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HOST-DEFENSE; LIPOPROTEIN; PEPTIDES; EXPRESSION; PATHOGENS; RNASE-7; BINDING; MODEL; SKIN	Cationic antimicrobial peptides/proteins (AMPs) are important components of the host innate defense mechanisms against invading microorganisms. Here we demonstrate that OprI (outer membrane protein I) of Pseudomonas aeruginosa is responsible for its susceptibility to human ribonuclease 7 (hRNase 7) and alpha-helical cationic AMPs, instead of surface lipopolysaccharide, which is the initial binding site of cationic AMPs. The antimicrobial activities of hRNase 7 and alpha-helical cationic AMPs against P. aeruginosa were inhibited by the addition of exogenous OprI or anti-OprI antibody. On modification and internalization of OprI by hRNase 7 into cytosol, the bacterial membrane became permeable to metabolites. The lipoprotein was predicted to consist of an extended loop at the N terminus for hRNase 7/lipopolysaccharide binding, a trimeric alpha-helix, and a lysine residue at the C terminus for cell wall anchoring. Our findings highlight a novel mechanism of antimicrobial activity and document a previously unexplored target of alpha-helical cationic AMPs, which may be used for screening drugs to treat antibiotic-resistant bacterial infection.	[Lin, Yu-Min; Wu, Shih-Jung; Chang, Ting-Wei; Wang, Chiu-Feng; Suen, Ching-Shu; Hwang, Ming-Jing; Chen, Yuan-Tsong; Liao, You-Di] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Lin, Yu-Min; Chang, Margaret Dah-Tsyr] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu 300, Taiwan; [Wu, Shih-Jung; Chen, Yuan-Tsong] Natl Taiwan Univ, Coll Med, Inst Microbiol, Taipei 106, Taiwan; [Chang, Ting-Wei; Liao, You-Di] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Taiwan University; National Yang Ming Chiao Tung University	Liao, YD (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan.	ydliao@ibms.sinica.edu.tw	Hwang, Ming-jing/E-9210-2012; Liao, You-Di/S-7018-2018	Hwang, Ming-jing/0000-0002-9657-5663; Liao, You-Di/0000-0001-5527-4736	National Science Council [NSC95-2311-B-001-067-MY3]; Academia Sinica (Taiwan)	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica (Taiwan)(Academia Sinica - Taiwan)	This work was supported by National Science Council Grant NSC95-2311-B-001-067-MY3 and funds from the Academia Sinica (Taiwan).	Boix E, 2007, MOL BIOSYST, V3, P317, DOI 10.1039/b617527a; Bowdish DME, 2005, CURR PROTEIN PEPT SC, V6, P35, DOI 10.2174/1389203053027494; Brogden KA, 2001, ANTIMICROB AGENTS CH, V45, P331, DOI 10.1128/AAC.45.1.331-334.2001; Brown JH, 2001, P NATL ACAD SCI USA, V98, P8496, DOI 10.1073/pnas.131219198; Brown KL, 2006, CURR OPIN IMMUNOL, V18, P24, DOI 10.1016/j.coi.2005.11.004; Cote-Sierra J, 1998, GENE, V221, P25, DOI 10.1016/S0378-1119(98)00437-5; DUCHENE M, 1989, J BACTERIOL, V171, P4130; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Falla TJ, 1996, J BIOL CHEM, V271, P19298, DOI 10.1074/jbc.271.32.19298; FUNG J, 1978, J BACTERIOL, V133, P1467, DOI 10.1128/JB.133.3.1467-1471.1978; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Giamarellou H, 2002, J ANTIMICROB CHEMOTH, V49, P229, DOI 10.1093/jac/49.2.229; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Harder J, 2002, J BIOL CHEM, V277, P46779, DOI 10.1074/jbc.M207587200; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Huang YC, 2007, J BIOL CHEM, V282, P4626, DOI 10.1074/jbc.M607321200; INOUYE M, 1974, P NATL ACAD SCI USA, V71, P2396, DOI 10.1073/pnas.71.6.2396; INOUYE M, 1972, J BIOL CHEM, V247, P8154; INOUYE S, 1976, J BACTERIOL, V127, P555, DOI 10.1128/JB.127.1.555-563.1976; Liu J, 2003, BIOCHEMISTRY-US, V42, P5657, DOI 10.1021/bi026828a; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MIZUNO T, 1979, J BIOCHEM-TOKYO, V85, P115, DOI 10.1093/oxfordjournals.jbchem.a132300; PETERSON AA, 1987, ANTIMICROB AGENTS CH, V31, P230, DOI 10.1128/AAC.31.2.230; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; ROSENBERG HF, 1995, J BIOL CHEM, V270, P30234; Schroder JM, 2006, CELL MOL LIFE SCI, V63, P469, DOI 10.1007/s00018-005-5364-0; Shu W, 2000, J MOL BIOL, V299, P1101, DOI 10.1006/jmbi.2000.3776; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Tack BF, 2002, EUR J BIOCHEM, V269, P1181, DOI 10.1046/j.0014-2956.2002.02751.x; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Yang CWO, 2007, J ALLERGY CLIN IMMUN, V120, P870, DOI 10.1016/j.jaci.2007.06.017; Zanetti M, 2005, CURR ISSUES MOL BIOL, V7, P179, DOI 10.21775/cimb.007.179; Zavascki AP, 2007, J ANTIMICROB CHEMOTH, V60, P1206, DOI 10.1093/jac/dkm357; Zhang JZ, 2003, NUCLEIC ACIDS RES, V31, P602, DOI 10.1093/nar/gkg157	34	67	74	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8985	8994		10.1074/jbc.M109.078725	http://dx.doi.org/10.1074/jbc.M109.078725			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20100832	Green Published, hybrid			2022-12-27	WOS:000275553700050
J	Pi, JB; Leung, L; Xue, P; Wang, WP; Hou, YY; Liu, DX; Yehuda-Shnaidman, E; Lee, C; Lau, J; Kurtz, TW; Chan, JY				Pi, Jingbo; Leung, Laura; Xue, Peng; Wang, Weiping; Hou, Yongyong; Liu, Dianxin; Yehuda-Shnaidman, Einav; Lee, Candy; Lau, Jackie; Kurtz, Theodore W.; Chan, Jefferson Y.			Deficiency in the Nuclear Factor E2-related Factor-2 Transcription Factor Results in Impaired Adipogenesis and Protects against Diet-induced Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; HIGH-FAT DIET; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; OXIDATIVE STRESS; UNCOUPLING PROTEINS; ECTOPIC EXPRESSION; C/EBP-ALPHA; BINDING; GENE	Nuclear factor E2-related factor 2 (Nrf2) is a cap-n-collar basic leucine zipper (CNC-bZIP) transcription factor that is well established as a master regulator of phase II detoxification and antioxidant gene expression and is strongly expressed in tissues involved in xenobiotic metabolism including liver and kidney. Nrf2 is also abundantly expressed in adipose tissue; however, the exact function of Nrf2 in adipocyte biology is unclear. In the current study we show that targeted knock-out of Nrf2 in mice decreases adipose tissue mass, promotes formation of small adipocytes, and protects against weight gain and obesity otherwise induced by a high fat diet. In mouse embryonic fibroblasts, 3T3-L1 cells, and human subcutaneous preadipocytes, selective deficiency of Nrf2 impairs adipocyte differentiation. Deficiency of Nrf2 also leads to decreased expression of peroxisome proliferator-activated receptor gamma (PPAR gamma), CCAAT enhancer-binding protein alpha (C/EBP alpha), and their downstream targets during adipocyte differentiation. Conversely, activation of Nrf2 in 3T3-L1 cells by stable knockdown of its negative regulator Keap1 enhances and accelerates hormone-induced adipocyte differentiation. Transfection of Nrf2 stimulates Ppar gamma promoter activity, and stable knockdown of Keap1 enhances PPAR gamma expression in 3T3-L1 cells. In addition, chromatin immunoprecipitation studies show that Nrf2 associates with consensus binding sites for Nrf2 in the Ppar gamma promoter. These findings demonstrate a novel biologic role for Nrf2 beyond its participation in detoxification and antioxidant pathways and place Nrf2 within the limited network of transcription factors that control adipocyte differentiation by regulating expression of PPAR gamma.	[Pi, Jingbo; Xue, Peng; Hou, Yongyong; Liu, Dianxin; Yehuda-Shnaidman, Einav] Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA; [Leung, Laura; Wang, Weiping; Lee, Candy; Lau, Jackie; Chan, Jefferson Y.] Univ Calif Irvine, Dept Lab Med & Pathol, Irvine, CA 92697 USA; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	The Hamner Institutes for Health Sciences; University of California System; University of California Irvine; University of California System; University of California San Francisco	Pi, JB (corresponding author), Hamner Inst Hlth Sci, Div Translat Biol, Res Triangle Pk, NC 27709 USA.	jpi@thehamner.org; jchan@uci.edu	xue, peng/K-4159-2015; Liu, Dianxin/O-5053-2018; PI, JINGBO/GWC-2514-2022; Longo, Kenneth A/A-5631-2010	Liu, Dianxin/0000-0003-2282-7386; PI, JINGBO/0000-0003-0227-8041; 	National Institutes of Health [DK76788, ES016005, CA091907]; NATIONAL CANCER INSTITUTE [R01CA091907, R56CA091907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK076788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK76788 and ES016005 (to J.P.) and CA091907 (to J.Y.C.).	CAO ZD, 1991, GENE DEV, V5, P1538, DOI 10.1101/gad.5.9.1538; Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943; Cho HY, 2005, FREE RADICAL BIO MED, V38, P325, DOI 10.1016/j.freeradbiomed.2004.10.013; CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593; Clarke SL, 1997, BIOCHEM BIOPH RES CO, V240, P99, DOI 10.1006/bbrc.1997.7627; Darlington GJ, 1998, J BIOL CHEM, V273, P30057, DOI 10.1074/jbc.273.46.30057; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Gummersbach C, 2009, DIFFERENTIATION, V77, P115, DOI 10.1016/j.diff.2008.09.009; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Leung L, 2003, J BIOL CHEM, V278, P48021, DOI 10.1074/jbc.M308439200; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Pi JB, 2009, ENDOCRINOLOGY, V150, P3040, DOI 10.1210/en.2008-1642; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Shao DL, 1997, J BIOL CHEM, V272, P21473, DOI 10.1074/jbc.272.34.21473; Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07; Shin S, 2009, EUR J PHARMACOL, V620, P138, DOI 10.1016/j.ejphar.2009.08.022; Surwit RS, 1998, P NATL ACAD SCI USA, V95, P4061, DOI 10.1073/pnas.95.7.4061; Tanaka Y, 2008, J PHARMACOL EXP THER, V325, P655, DOI 10.1124/jpet.107.135822; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang WP, 2007, J BIOL CHEM, V282, P24670, DOI 10.1074/jbc.M700159200; Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8; WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Yoshinari K, 2006, DRUG METAB DISPOS, V34, P1081, DOI 10.1124/dmd.105.007286; Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	32	204	219	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9292	9300		10.1074/jbc.M109.093955	http://dx.doi.org/10.1074/jbc.M109.093955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089859	Green Published, hybrid			2022-12-27	WOS:000275553700077
J	Huang, YZ; McNamara, JO				Huang, Yang Z.; McNamara, James O.			Mutual Regulation of Src Family Kinases and the Neurotrophin Receptor TrkB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE KINASE; AUTOPHOSPHORYLATION SITES; SIGNAL-TRANSDUCTION; ACTIVATION; TRANSACTIVATION; PLASTICITY; TARGET; DOMAIN; ROLES	The neurotrophin receptor tyrosine kinase TrkB is critical to diverse biological processes. We investigated the interplay of Src family kinases (SFKs) and TrkB to better understand mechanisms of TrkB signaling in physiological and pathological conditions. We compared and contrasted the role of SFKs in TrkB signaling following activation of TrkB by two mechanisms, its transactivation by zinc, and its activation by its prototypic neurotrophin ligand, brain-derived neurotrophic factor (BDNF). Using biochemical, pharmacological, and chemical genetic studies of cultured rodent neurons, we found that zinc promotes preferential phosphorylation of Tyr-705/Tyr-706 of TrkB by a SFK-dependent but TrkB kinase-independent mechanism, a signaling event critical for transactivation of TrkB by zinc. By contrast, SFK activity is not essential for BDNF-mediated activation of TrkB, yet SFK activity is increased as a consequence of TrkB activation by BDNF. Moreover, BDNF-induced phosphorylation of Tyr-705/Tyr-706 of TrkB was inhibited by SFK inhibitors, implicating a regulatory role of SFKs in TrkB activation by BDNF. In sum, SFKs are activated by TrkB and, in turn, SFKs can promote TrkB activation. We propose models depicting the mutual regulation of SFKs and TrkB following activation of TrkB by zinc and BDNF.	[McNamara, James O.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [McNamara, James O.] Duke Univ, Med Ctr, Dept Med Neurol, Durham, NC 27710 USA; [McNamara, James O.] Duke Univ, Med Ctr, Dept Pharmacol & Mol Canc Biol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	McNamara, JO (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, 401 Bryan Res Bldg, Durham, NC 27710 USA.	jmc@neuro.duke.edu			NINDS [NS056217]; Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056217] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Epilepsy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS056217 (to J.O.M.) from NINDS. This work was also supported by an Epilepsy Foundation postdoctoral fellowship (to Y.Z.H.).	Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen X, 2005, NEURON, V46, P13, DOI 10.1016/j.neuron.2005.03.009; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Cunningham ME, 1997, J BIOL CHEM, V272, P10957; De Koninck Y, 2007, CURR OPIN PHARMACOL, V7, P93, DOI 10.1016/j.coph.2006.11.005; Desmet CJ, 2006, CELL MOL LIFE SCI, V63, P755, DOI 10.1007/s00018-005-5490-8; Dietz DM, 2009, PHARMACOPSYCHIATRY, V42, pS69, DOI 10.1055/s-0029-1202847; GUITON M, 1994, J BIOL CHEM, V269, P30370; GULTON M, 1995, BIOCHEM SOC T, V23, pS176; He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Huang YZ, 2008, NEURON, V57, P546, DOI 10.1016/j.neuron.2007.11.026; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Iwasaki Y, 1998, J NEUROCHEM, V71, P106; Lee FS, 2002, CYTOKINE GROWTH F R, V13, P11, DOI 10.1016/S1359-6101(01)00024-7; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McCarty JH, 1998, ONCOGENE, V16, P1691, DOI 10.1038/sj.onc.1201688; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; MCNAMARA JO, 2006, SCI STKE, pRE12, DOI DOI 10.1126/STKE.3562006RE12; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Pereira DB, 2007, J NEUROSCI, V27, P4859, DOI 10.1523/JNEUROSCI.4587-06.2007; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Segal RA, 1996, J BIOL CHEM, V271, P20175, DOI 10.1074/jbc.271.33.20175; Wu WD, 2002, J BIOL CHEM, V277, P24252, DOI 10.1074/jbc.M200437200; Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336	27	49	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8207	8217		10.1074/jbc.M109.091041	http://dx.doi.org/10.1074/jbc.M109.091041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064930	Green Published, hybrid			2022-12-27	WOS:000275413800039
J	Skjoedt, MO; Hummelshoj, T; Palarasah, Y; Honore, C; Koch, C; Skjodt, K; Garred, P				Skjoedt, Mikkel-Ole; Hummelshoj, Tina; Palarasah, Yaseelan; Honore, Christian; Koch, Claus; Skjodt, Karsten; Garred, Peter			A Novel Mannose-binding Lectin/Ficolin-associated Protein Is Highly Expressed in Heart and Skeletal Muscle Tissues and Inhibits Complement Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECTIN; MBL; IDENTIFICATION; LOCALIZATION; DEFICIENCY; PROTEASE-2; PATHWAY; FICOLIN; SITES	The human lectin complement pathway involves circulating complexes consisting of mannose-binding lectin (MBL) or three ficolins (ficolin-1, -2, and -3) in association with three MBL/ficolin-associated serine proteases (MASP) (MASP-1, -2, and -3) and a nonenzymatic sMAP. MASP-1 and MASP-3 (MASP1 iso-forms 1 and 2, respectively) are splice variants of the MASP1 gene, whereas MASP-2 and sMAP are splice variants of the MASP2 gene. We have identified a novel serum protein of 45 kDa that is associated with MBL and the ficolins. This protein is named MBL/ficolin-associated protein 1 (MAP-1 corresponding to MASP1 isoform 3). The transcript generating MAP-1 (MASP1_v3) contains exons 1-8 and a novel exon encoding an in-frame stop codon. The corresponding protein lacks the serine protease domains but contains most of the common heavy chain of MASP-1 and MASP-3. Additionally MAP-1 contains 17 unique C-terminal amino acids. By use of quantitative PCR and MAP-1-specific immunohistochemistry, we found that MAP-1 is highly expressed in myocardial and skeletal muscle tissues as well as in liver hepatocytes with a different expression profile than that observed for MASP-1 and MASP-3. MAP-1 co-precipitated from human serum with MBL, ficolin-2, and ficolin-3, and recombinant MAP-1 was able to inhibit complement C4 deposition via both the ficolin-3 and MBL pathway. In conclusion we have identified a novel 45-kDa serum protein derived from the MASP1 gene, which is highly expressed in striated muscle tissues. It is found in complex with MBL and ficolins and may function as a potent inhibitor of the complement system in vivo.	[Garred, Peter] Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Lab Mol Med,Fac Hlth Sci,Sect 7631, DK-2100 Copenhagen, Denmark; [Skjoedt, Mikkel-Ole; Palarasah, Yaseelan; Koch, Claus; Skjodt, Karsten; Garred, Peter] Univ So Denmark, Fac Hlth Sci, Inst Med Biol, Res Unit Immunol & Microbiol, DK-5000 Odense, Denmark	Rigshospitalet; University of Copenhagen; University of Southern Denmark	Garred, P (corresponding author), Univ Copenhagen Hosp, Rigshosp, Dept Clin Immunol, Lab Mol Med,Fac Hlth Sci,Sect 7631, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	garred@post5.tele.dk		Palarasah, Yaseelan/0000-0002-9337-0232; Garred, Peter/0000-0002-2876-8586; Skjodt, Karsten/0000-0002-9161-8185; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Honore, Christian/0000-0003-4846-1319	Rigshospitalet; The Capital Region of Denmark; The Novo Nordisk Research Foundation; The Lundbeck Foundation; The John and Birthe Meyer Foundation; The Carlsberg Foundation	Rigshospitalet; The Capital Region of Denmark; The Novo Nordisk Research Foundation; The Lundbeck Foundation(Lundbeckfonden); The John and Birthe Meyer Foundation; The Carlsberg Foundation(Carlsberg Foundation)	This work was supported by Rigshospitalet, The Capital Region of Denmark, The Novo Nordisk Research Foundation, The Lundbeck Foundation, The John and Birthe Meyer Foundation, and The Carlsberg Foundation.	Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Endo Y, 2007, IMMUNOBIOLOGY, V212, P371, DOI 10.1016/j.imbio.2006.11.014; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Girija UV, 2007, J IMMUNOL, V179, P455, DOI 10.4049/jimmunol.179.1.455; House AE, 2008, J BIOL CHEM, V283, P1217, DOI 10.1074/jbc.R700031200; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Krarup A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000623; Krarup A, 2008, BBA-PROTEINS PROTEOM, V1784, P1294, DOI 10.1016/j.bbapap.2008.03.020; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; MATSUSHITA M, 1992, J EXP MED, V176, P1497, DOI 10.1084/jem.176.6.1497; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Naito H, 1999, J BIOCHEM-TOKYO, V126, P1004, DOI 10.1093/oxfordjournals.jbchem.a022543; Seyfarth J, 2006, MOL IMMUNOL, V43, P962, DOI 10.1016/j.molimm.2005.06.033; Skjoedt MO, 2010, DEV COMP IMMUNOL, V34, P59, DOI 10.1016/j.dci.2009.08.004; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2007, ADV EXP MED BIOL, V598, P93; Teillet F, 2008, J BIOL CHEM, V283, P25715, DOI 10.1074/jbc.M803551200; Teillet F, 2007, J IMMUNOL, V178, P5710, DOI 10.4049/jimmunol.178.9.5710; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thielens NM, 2001, J IMMUNOL, V166, P5068, DOI 10.4049/jimmunol.166.8.5068; Turner MW, 2003, MOL IMMUNOL, V40, P423, DOI 10.1016/S0161-5890(03)00155-X; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406	28	112	120	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8234	8243		10.1074/jbc.M109.065805	http://dx.doi.org/10.1074/jbc.M109.065805			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20053996	hybrid, Green Published			2022-12-27	WOS:000275413800042
J	Tian, YY; Luo, AP; Cai, YR; Su, Q; Ding, F; Chen, HY; Liu, ZH				Tian, Yanyan; Luo, Aiping; Cai, Yiran; Su, Qin; Ding, Fang; Chen, Hongyan; Liu, Zhihua			MicroRNA-10b Promotes Migration and Invasion through KLF4 in Human Esophageal Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR-4; HUMAN BREAST-CANCER; TUMOR-SUPPRESSOR; DOWN-REGULATION; COLORECTAL-CANCER; MESSENGER-RNA; MICRO-RNA; EXPRESSION; CARCINOMA; GROWTH	Recently, microRNAs have emerged as regulators of cancer metastasis through acting on multiple signaling pathways involved in metastasis. In this study, we have analyzed the level of miR-10b and cell motility and invasiveness in several human esophageal squamous cell carcinoma cell lines. Our results reveal a significant correlation of miR-10b level with cell motility and invasiveness. Overexpression of miR-10b in KYSE140 cells increased cell motility and invasiveness, whereas inhibition of miR-10b in EC9706 cells reduced cell invasiveness, although it did not alter cell motility. Additionally, we identified KLF4, a known tumor suppressor gene that has been reported to suppress esophageal cancer cell migration and invasion, as a direct target of miR-10b. Furthermore, overexpression of miR-10b in KYSE140 and KYSE450 cells led to a reduction of endogenous KLF4 protein, whereas silencing of miR-10b in EC9706 cells caused up-regulation of KLF4 protein. Coexpression of miR-10b and KLF4 in KYSE140 cells and coexpression of small interfering RNA for KLF4 mRNA and miR-10b-AS in EC9706 cells partially abrogated the effect of miR-10b on cell migration and invasion. Finally, analyses of the miR-10b level in 40 human esophageal cancer samples and their paired normal adjacent tissues revealed an elevated expression of miR-10b in 95% (38 of 40) of cancer tissues, although no significant correlation of the miR-10b level with clinical metastasis status was observed in these samples.	[Liu, Zhihua] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China; [Cai, Yiran; Su, Qin] Chinese Acad Med Sci, Inst Canc, Dept Pathol, Beijing 100021, Peoples R China; [Cai, Yiran; Su, Qin] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100021, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, ZH (corresponding author), Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100021, Peoples R China.	liuzh@cicams.ac.cn			National Basic Research Program of China [2006CB910407]; National Natural Science Foundation of China [30721001]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grant 2006CB910407 and National Natural Science Foundation of China Grant 30721001.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bianchi F, 2004, CLIN CANCER RES, V10, P6023, DOI 10.1158/1078-0432.CCR-04-0619; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Gee HE, 2008, NATURE, V455, DOI 10.1038/nature07362; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hiyoshi Y, 2009, CLIN CANCER RES, V15, P1915, DOI 10.1158/1078-0432.CCR-08-2545; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; KANDA Y, 1994, INT J CANCER, V58, P291, DOI 10.1002/ijc.2910580224; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Myers C, 2002, AM J PATHOL, V161, P2099, DOI 10.1016/S0002-9440(10)64488-4; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SHIMADA Y, 1992, CANCER, V69, P277, DOI 10.1002/1097-0142(19920115)69:2<277::AID-CNCR2820690202>3.0.CO;2-C; Tan YL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-12; Tanzer A, 2005, J EXP ZOOL PART B, V304B, P75, DOI 10.1002/jez.b.21021; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yasunaga J, 2004, CANCER RES, V64, P6002, DOI 10.1158/0008-5472.CAN-04-1422; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang LY, 2006, CLIN CANCER RES, V12, P1639, DOI 10.1158/1078-0432.CCR-05-1858; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345	54	247	271	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7986	7994		10.1074/jbc.M109.062877	http://dx.doi.org/10.1074/jbc.M109.062877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075075	hybrid, Green Published			2022-12-27	WOS:000275413800016
J	Sakudoh, T; Iizuka, T; Narukawa, J; Sezutsu, H; Kobayashi, I; Kuwazaki, S; Banno, Y; Kitamura, A; Sugiyama, H; Takada, N; Fujimoto, H; Kadono-Okuda, K; Mita, K; Tamura, T; Yamamoto, K; Tsuchida, K				Sakudoh, Takashi; Iizuka, Tetsuya; Narukawa, Junko; Sezutsu, Hideki; Kobayashi, Isao; Kuwazaki, Seigo; Banno, Yutaka; Kitamura, Akitoshi; Sugiyama, Hiromu; Takada, Naoko; Fujimoto, Hirofumi; Kadono-Okuda, Keiko; Mita, Kazuei; Tamura, Toshiki; Yamamoto, Kimiko; Tsuchida, Kozo			A CD36-related Transmembrane Protein Is Coordinated with an Intracellular Lipid-binding Protein in Selective Carotenoid Transport for Cocoon Coloration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILKWORM BOMBYX-MORI; B TYPE-I; HIGH-DENSITY-LIPOPROTEIN; LINKAGE MAP; SR-BI; MAPPING ANALYSIS; CELLULAR UPTAKE; GENE FAMILY; RECEPTOR; DROSOPHILA	The transport pathway of specific dietary carotenoids from the midgut lumen to the silk gland in the silkworm, Bombyx mori, is a model system for selective carotenoid transport because several genetic mutants with defects in parts of this pathway have been identified that manifest altered cocoon pigmentation. In the wild-type silkworm, which has both genes, Yellow blood (Y) and Yellow cocoon (C), lutein is transferred selectively from the hemolymph lipoprotein to the silk gland cells where it is accumulated into the cocoon. The Y gene encodes an intracellular carotenoid-binding protein (CBP) containing a lipid-binding domain known as the steroidogenic acute regulatory protein-related lipid transfer domain. Positional cloning and transgenic rescue experiments revealed that the C gene encodes Cameo2, a transmembrane protein gene belonging to the CD36 family genes, some of which, such as the mammalian SR-BI and the fruit fly ninaD, are reported as lipoprotein receptors or implicated in carotenoid transport for visual system. In C mutant larvae, Cameo2 expression was strongly repressed in the silk gland in a specific manner, resulting in colorless silk glands and white cocoons. The developmental profile of Cameo2 expression, CBP expression, and lutein pigmentation in the silk gland of the yellow cocoon strain were correlated. We hypothesize that selective delivery of lutein to specific tissue requires the combination of two components: 1) CBP as a carotenoid transporter in cytosol and 2) Cameo2 as a transmembrane receptor on the surface of the cells.	[Sakudoh, Takashi; Takada, Naoko; Fujimoto, Hirofumi; Tsuchida, Kozo] Natl Inst Infect Dis, Div Radiol Protect & Biol, Shinjuku Ku, Tokyo 1628640, Japan; [Iizuka, Tetsuya; Sezutsu, Hideki; Kobayashi, Isao; Tamura, Toshiki] Natl Inst Agrobiol Sci, Transgen Silkworm Res Ctr, Tsukuba, Ibaraki 3058634, Japan; [Narukawa, Junko; Kuwazaki, Seigo; Kadono-Okuda, Keiko; Mita, Kazuei; Yamamoto, Kimiko] Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki 3058634, Japan; [Banno, Yutaka] Kyushu Univ, Fukuoka 8128581, Japan; [Kitamura, Akitoshi] Fuji Chem Ind Co Ltd, Div Life Sci, Toyama 9300397, Japan; [Sugiyama, Hiromu] Natl Inst Infect Dis, Dept Parasitol, Shinjuku Ku, Tokyo 1628640, Japan	National Institute of Infectious Diseases (NIID); National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan; Kyushu University; National Institute of Infectious Diseases (NIID)	Tsuchida, K (corresponding author), 1-23-1 Toyama,Shinjuku, Tokyo 1628640, Japan.	kozo@nih.go.jp	Kobayashi, Isao/E-3338-2010	Sezutsu, Hideki/0000-0001-8886-1611	Kieikai Research Foundation (Japan); Futaba Electronics Memorial Foundation (Japan); Japan Society for the Promotion of Science; Ministry of Agriculture, Forestry and Fisheries (Japan); Ministry of Education, Culture, Sports, Science, and Technology (Japan)	Kieikai Research Foundation (Japan); Futaba Electronics Memorial Foundation (Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Agriculture, Forestry and Fisheries (Japan)(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science, and Technology (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Kieikai Research Foundation (Japan), the Futaba Electronics Memorial Foundation (Japan), a grant-in-aid for scientific research from the Japan Society for the Promotion of Science, the Insect Technology Project of the Ministry of Agriculture, Forestry and Fisheries (Japan), and the National Bioresource Project (Silkworm) of the Ministry of Education, Culture, Sports, Science, and Technology (Japan).	Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Azhar S, 2002, MOL CELL ENDOCRINOL, V195, P1, DOI 10.1016/S0303-7207(02)00222-8; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Connelly MA, 2009, MOL CELL ENDOCRINOL, V300, P83, DOI 10.1016/j.mce.2008.09.011; During A, 2008, J LIPID RES, V49, P1715, DOI 10.1194/jlr.M700580-JLR200; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Franc NC, 1999, SCIENCE, V284, P1991, DOI 10.1126/science.284.5422.1991; FUJIMOTO N, 1943, J SERIC SCI JAP, V14, P276; Fujimoto N., 1949, J SERIC SCI JAPAN, V18, P82; Goldberg IJ, 1996, J LIPID RES, V37, P693; GOODWIN TW, 1986, ANNU REV NUTR, V6, P273, DOI 10.1146/annurev.nu.06.070186.001421; Gopalapillai R, 2006, J LIPID RES, V47, P1005, DOI 10.1194/jlr.M500462-JLR200; Gruarin P, 2000, BIOCHEM BIOPH RES CO, V275, P446, DOI 10.1006/bbrc.2000.3333; Hara Wajiro, 2007, Journal of Insect Biotechnology and Sericology, V76, P149; Harizuka M., 1948, J SERIC SCI JAPAN, V17, P1; HARIZUKA MASAKI, 1953, BULL SERICUL EXPT STA [JAPAN], V14, P141; Hoosdally SJ, 2009, J BIOL CHEM, V284, P16277, DOI 10.1074/jbc.M109.007849; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Ikemoto M, 2000, P NATL ACAD SCI USA, V97, P6538, DOI 10.1073/pnas.100114397; Imamura M, 2003, GENETICS, V165, P1329; Ishii K., 1917, SAKURAKAI ZASSHI, V1, P113; Jin X, 2008, P NATL ACAD SCI USA, V105, P10996, DOI 10.1073/pnas.0803309105; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Loane E, 2008, SURV OPHTHALMOL, V53, P68, DOI 10.1016/j.survophthal.2007.10.008; Manunta C., 1937, Archivio Zoologico Italiano Torino, V24, P385; MARTINEZ LO, 2007, HIGH DENSITY LIPOPRO, P307; Miao XX, 2005, P NATL ACAD SCI USA, V102, P16303, DOI 10.1073/pnas.0507794102; Mita K, 2003, P NATL ACAD SCI USA, V100, P14121, DOI 10.1073/pnas.2234984100; Moussa M, 2008, J NUTR, V138, P1432, DOI 10.1093/jn/138.8.1432; Nakajima M., 1963, B FAC AGR TOKYO, V8, P1; Nichols Z, 2008, INSECT BIOCHEM MOLEC, V38, P398, DOI 10.1016/j.ibmb.2007.11.003; Niwa R, 2005, INSECT MOL BIOL, V14, P563, DOI 10.1111/j.1365-2583.2005.00587.x; OKU M, 1934, B AGR CHEM SOC JAPAN, V10, P1258; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; Sakudoh T, 2005, BIOCHEM BIOPH RES CO, V336, P1125, DOI 10.1016/j.bbrc.2005.08.241; Sakudoh T, 2007, P NATL ACAD SCI USA, V104, P8941, DOI 10.1073/pnas.0702860104; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; SPITSBERG VL, 1995, EUR J BIOCHEM, V230, P872, DOI 10.1111/j.1432-1033.1995.tb20630.x; Sturtevant AH, 1915, AM NAT, V49, P42, DOI 10.1086/279453; Su X, 2009, TRENDS ENDOCRIN MET, V20, P72, DOI 10.1016/j.tem.2008.11.001; Tabunoki H, 2002, J BIOL CHEM, V277, P32133, DOI 10.1074/jbc.M204507200; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Tanaka H, 2008, INSECT BIOCHEM MOLEC, V38, P1087, DOI 10.1016/j.ibmb.2008.09.001; Tatematsu K, 2010, TRANSGENIC RES, V19, P473, DOI 10.1007/s11248-009-9328-2; Tazima Y, 1964, GENETICS SILKWORM; Tsuchida K, 2004, J INSECT PHYSIOL, V50, P975, DOI 10.1016/j.jinsphys.2004.08.001; Tsuchida K, 2004, J INSECT PHYSIOL, V50, P363, DOI 10.1016/j.jinsphys.2004.02.006; Tsuchida K, 1998, INSECT BIOCHEM MOLEC, V28, P927, DOI 10.1016/S0965-1748(98)00036-8; Uda H, 1919, GENETICS, V4, P395; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; VANDERHORST DJ, 2004, COMPREHENSIVE INSECT, P225; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Voolstra O, 2006, BIOCHEMISTRY-US, V45, P13429, DOI 10.1021/bi060701u; Wang T, 2007, J CELL BIOL, V177, P305, DOI 10.1083/jcb.200610081; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Yamamoto K, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r21; Yamamoto K, 2006, GENETICS, V173, P151, DOI 10.1534/genetics.105.053801; Zhao YP, 2008, INSECT SCI, V15, P399, DOI 10.1111/j.1744-7917.2008.00226.x	64	64	74	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7739	7751		10.1074/jbc.M109.074435	http://dx.doi.org/10.1074/jbc.M109.074435			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053988	hybrid, Green Published			2022-12-27	WOS:000275415600082
J	Liu, WH; Yuen, EY; Yan, Z				Liu, Wenhua; Yuen, Eunice Y.; Yan, Zhen			The Stress Hormone Corticosterone Increases Synaptic alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors via Serum- and Glucocorticoid-inducible Kinase (SGK) Regulation of the GDI-Rab4 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP-DISSOCIATION INHIBITOR; GTP-BINDING PROTEIN; RAB PROTEINS; PREFRONTAL CORTEX; EARLY ENDOSOMES; GLUTAMATERGIC TRANSMISSION; ENDOCYTIC PATHWAY; CURRENT AMPLITUDE; TRAFFICKING; PLASTICITY	Corticosterone, the major stress hormone, plays an important role in regulating neuronal functions of the limbic system, although the cellular targets and molecular mechanisms of corticosteroid signaling are largely unknown. Here we show that a short treatment of corticosterone significantly increases alpha-amino- 3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR)-mediated synaptic transmission and AMPAR membrane trafficking in pyramidal neurons of prefrontal cortex, a key region involved in cognition and emotion. This enhancing effect of corticosterone is through a mechanism dependent on Rab4, the small GTPase-controlling receptor recycling between early endosome and plasma membrane. Guanosine nucleotide dissociation inhibitor (GDI), which regulates the cycle of Rab proteins between membrane and cytosol, forms an increased complex with Rab4 after corticosterone treatment. Corticosterone also triggers an increased GDI phosphorylation at Ser-213 by the serum- and glucocorticoid-inducible kinase (SGK). Moreover, AMPAR synaptic currents and surface expression and their regulation by corticosterone are altered by mutating Ser-213 on GDI. These results suggest that corticosterone, via SGK phosphorylation of GDI at Ser-213, increases the formation of GDI-Rab4 complex, facilitating the functional cycle of Rab4 and Rab4-mediated recycling of AMPARs to the synaptic membrane. It provides a potential mechanism underlying the role of corticosteroid stress hormone in up-regulating excitatory synaptic efficacy in cortical neurons.	[Liu, Wenhua; Yuen, Eunice Y.; Yan, Zhen] SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, Buffalo, NY 14214 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Yan, Z (corresponding author), SUNY Buffalo, Dept Physiol & Biophys, Sch Med & Biomed Sci, 124 Sherman Hall, Buffalo, NY 14214 USA.	zhenyan@buffalo.edu		Liu, Wenhua/0000-0003-0903-8497	National Institutes of Health [084233]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant MH 084233 (to Z.Y.).	ARAKI S, 1990, J BIOL CHEM, V265, P13007; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Brown TC, 2007, J NEUROSCI, V27, P13311, DOI 10.1523/JNEUROSCI.4258-07.2007; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chameau P, 2007, J NEUROPHYSIOL, V97, P5, DOI 10.1152/jn.00821.2006; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Funder JW, 1997, ANNU REV MED, V48, P231, DOI 10.1146/annurev.med.48.1.231; Gerges NZ, 2004, J BIOL CHEM, V279, P43870, DOI 10.1074/jbc.M404982200; Groc L, 2008, NAT NEUROSCI, V11, P868, DOI 10.1038/nn.2150; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Joels M, 2009, BRAIN RES, V1293, P91, DOI 10.1016/j.brainres.2009.03.036; Karst H, 2005, J NEUROPHYSIOL, V94, P3479, DOI 10.1152/jn.00143.2005; Kaufer D, 2004, NAT NEUROSCI, V7, P947, DOI 10.1038/nn1296; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2001, Sci STKE, V2001, pre17, DOI 10.1126/stke.2001.108.re17; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lu NZ, 2006, PHARMACOL REV, V58, P782, DOI 10.1124/pr.58.4.9; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Martin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004714; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mohrmann K, 2002, J BIOL CHEM, V277, P32029, DOI 10.1074/jbc.M203064200; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Odley A, 2004, P NATL ACAD SCI USA, V101, P7082, DOI 10.1073/pnas.0308335101; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; PFEFFER SR, 1995, J BIOL CHEM, V270, P17057, DOI 10.1074/jbc.270.29.17057; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Schalk I, 1996, NATURE, V381, P42, DOI 10.1038/381042a0; Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123; Shisheva A, 1999, BIOCHEMISTRY-US, V38, P11711, DOI 10.1021/bi990200r; Shisheva A, 1997, BIOCHEMISTRY-US, V36, P6564, DOI 10.1021/bi970202g; SHISHEVA A, 1994, MOL CELL BIOL, V14, P3459, DOI 10.1128/MCB.14.5.3459; STEELEMORTIMER O, 1993, FEBS LETT, V329, P313, DOI 10.1016/0014-5793(93)80244-O; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X; VANDERSLUIJS P, 1991, P NATL ACAD SCI USA, V88, P6313, DOI 10.1073/pnas.88.14.6313; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; YANG CZ, 1994, J BIOL CHEM, V269, P31891; Yuen EY, 2009, P NATL ACAD SCI USA, V106, P14075, DOI 10.1073/pnas.0906791106; Yuen EY, 2009, J NEUROSCI, V29, P550, DOI 10.1523/JNEUROSCI.5050-08.2009; Yuen EY, 2005, J NEUROSCI, V25, P5488, DOI 10.1523/JNEUROSCI.1187-05.2005; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhong P, 2008, J PHYSIOL-LONDON, V586, P4465, DOI 10.1113/jphysiol.2008.155143	46	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6101	6108		10.1074/jbc.M109.050229	http://dx.doi.org/10.1074/jbc.M109.050229			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20051515	Green Published, hybrid			2022-12-27	WOS:000275367500013
J	Moulton, VR; Tsokos, GC				Moulton, Vaishali R.; Tsokos, George C.			Alternative Splicing Factor/Splicing Factor 2 Regulates the Expression of the zeta Subunit of the Human T Cell Receptor-associated CD3 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRE-MESSENGER-RNA; SR PROTEINS; 3'-UNTRANSLATED REGION; FACTOR ASF/SF2; FACTOR SF2/ASF; CHAIN; TRANSLATION; ACTIVATION; STABILITY	T cells from patients with systemic lupus erythematosus express decreased levels of the T cell receptor-associated CD3 zeta chain, a feature directly linked to their aberrant function. The decrease in CD3 zeta protein expression is in part due to decreased levels of functional wild type isoform of the 3'-untranslated region (UTR) of CD3 zeta mRNAwith concomitant increased levels of an unstable alternatively spliced isoform. In order to identify factors involved in the post-transcriptional regulation of CD3 zeta, we performed mass spectrometric analysis of Jurkat T cell nuclear proteins "pulled down" by a CD3 zeta 3'-UTR oligonucleotide, which identified the splicing protein alternative splicing factor/splicing factor 2 (ASF/SF2). We show for the first time that ASF/SF2 binds specifically to the 3'-UTR of CD3 zeta and regulates expression of CD3 zeta protein by limiting the production of the alternatively spliced isoform. During activation of human T cells, an increase in the wild type CD3 zeta mRNAis associated with increased expression of ASF/SF2. Finally, we show a significant correlation between ASF/SF2 and CD3 zeta protein levels in T cells from systemic lupus erythematosus patients. Thus, our results identify ASF/SF2 as a novel factor in the regulation of alternative splicing of the 3'-UTR of CD3 zeta and protein expression in human T cells.	[Moulton, Vaishali R.; Tsokos, George C.] Harvard Univ, Sch Med, Dept Med, Div Rheumatol,Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsokos, GC (corresponding author), 3 Blackfan Circle,CLS-928, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360	National Institutes of Health [RO1 AI42269]; Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 AI42269 (to G.C.T.) and an Arthritis Foundation grant (to V.R.M.).	Bakkour N, 2007, PLOS PATHOG, V3, P1530, DOI 10.1371/journal.ppat.0030159; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; CACERES JF, 1994, SCIENCE, V265, P1706, DOI 10.1126/science.8085156; Caceres JF, 1998, GENE DEV, V12, P55, DOI 10.1101/gad.12.1.55; Chalfant CE, 2001, J BIOL CHEM, V276, P44848, DOI 10.1074/jbc.M106291200; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chowdhury B, 2005, J BIOL CHEM, V280, P18959, DOI 10.1074/jbc.M501048200; Chowdhury B, 2006, J IMMUNOL, V177, P8248, DOI 10.4049/jimmunol.177.11.8248; Cohen RA, 2008, CLIN IMMUNOL, V128, P1, DOI 10.1016/j.clim.2008.04.004; Dauksaite V, 2002, J BIOL CHEM, V277, P12579, DOI 10.1074/jbc.M107867200; Enyedy EJ, 2001, ARTHRITIS RHEUM, V44, P1114, DOI 10.1002/1529-0131(200105)44:5<1114::AID-ANR192>3.0.CO;2-B; JENSEN JP, 1992, J IMMUNOL, V148, P2563; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Krishnan S, 2003, J IMMUNOL, V171, P3325, DOI 10.4049/jimmunol.171.7.3325; Lemaire R, 1999, EUR J IMMUNOL, V29, P823, DOI 10.1002/(SICI)1521-4141(199903)29:03<823::AID-IMMU823>3.0.CO;2-C; Lemaire R, 2002, GENE DEV, V16, P594, DOI 10.1101/gad.939502; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Massiello A, 2006, J LIPID RES, V47, P892, DOI 10.1194/jlr.C600003-JLR200; Michlewski G, 2008, MOL CELL, V30, P179, DOI 10.1016/j.molcel.2008.03.013; Mole S, 2009, J PATHOL, V219, P383, DOI 10.1002/path.2608; Mole S, 2009, J VIROL, V83, P357, DOI 10.1128/JVI.01414-08; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; Moulton VR, 2008, J BIOL CHEM, V283, P20037, DOI 10.1074/jbc.M710434200; Nambiar MP, 2003, ARTHRITIS RHEUM, V48, P1948, DOI 10.1002/art.11072; Nambiar MP, 2003, LUPUS, V12, P46, DOI 10.1191/0961203303lu281oa; Nambiar MP, 2001, J AUTOIMMUN, V16, P133, DOI 10.1006/jaut.2000.0475; Neugebauer KM, 2000, ARTHRITIS RHEUM, V43, P1768, DOI 10.1002/1529-0131(200008)43:8<1768::AID-ANR13>3.0.CO;2-9; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Pang M, 1998, ARTHRITIS RHEUM, V41, P1456, DOI 10.1002/1529-0131(199808)41:8<1456::AID-ART16>3.0.CO;2-0; Poole BD, 2009, AUTOIMMUN REV, V8, P337, DOI 10.1016/j.autrev.2008.12.008; Ropers D, 2004, J BIOL CHEM, V279, P29963, DOI 10.1074/jbc.M404452200; Sanchez-Lockhart M, 2004, J IMMUNOL, V173, P7120, DOI 10.4049/jimmunol.173.12.7120; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tenbrock K, 2002, J IMMUNOL, V169, P4147, DOI 10.4049/jimmunol.169.8.4147; Tyson-Capper AJ, 2005, J BIOL CHEM, V280, P34521, DOI 10.1074/jbc.M505344200; Wang JG, 2006, J IMMUNOL, V176, P2105, DOI 10.4049/jimmunol.176.4.2105; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WEISSMAN AM, 1988, P NATL ACAD SCI USA, V85, P9709, DOI 10.1073/pnas.85.24.9709; Xiao SH, 1998, EMBO J, V17, P6359, DOI 10.1093/emboj/17.21.6359	41	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12490	12496		10.1074/jbc.M109.091660	http://dx.doi.org/10.1074/jbc.M109.091660			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20118245	Green Published, hybrid			2022-12-27	WOS:000276787800005
J	Saha, A; Lee, YC; Zhang, ZJ; Chandra, G; Su, SB; Mukherjee, AB				Saha, Arjun; Lee, Yi-Ching; Zhang, Zhongjian; Chandra, Goutam; Su, Shao-Bo; Mukherjee, Anil B.			Lack of an Endogenous Anti-inflammatory Protein in Mice Enhances Colonization of B16F10 Melanoma Cells in the Lungs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; CANCER-CELLS; MICROENVIRONMENTAL REGULATION; SURFACE RECEPTOR; BINDING PROTEINS; METASTASIS; INFLAMMATION; UTEROGLOBIN; EXPRESSION; DISEASE	Emerging evidence indicates a link between inflammation and cancer metastasis, but the molecular mechanism(s) remains unclear. Uteroglobin (UG), a potent anti-inflammatory protein, is constitutively expressed in the lungs of virtually all mammals. UG-knock-out (UG-KO) mice, which are susceptible to pulmonary inflammation, and B16F10 melanoma cells, which preferentially metastasize to the lungs, provide the components of a model system to determine how inflammation and metastasis are linked. We report here that B16F10 cells, injected into the tail vein of UG-KO mice, form markedly elevated numbers of tumor colonies in the lungs compared with their wild type littermates. Remarkably, UG-KO mouse lungs overexpress two calcium-binding proteins, S100A8 and S100A9, whereas B16F10 cells express the receptor for advanced glycation end products (RAGE), which is a known receptor for these proteins. Moreover, S100A8 and S100A9 are potent chemoattractants for RAGE-expressing B16F10 cells, and pretreatment of these cells with a blocking antibody to RAGE suppressed migration and invasion. Interestingly, in UG-KO mice S100A8/S100A9 concentrations in blood are lowest in tail vein and highest in the lungs, which most likely guide B16F10 cells to migrate to the lungs. Further, B16F10 cells treated with S100A8 or S100A9 overexpress matrix metalloproteinases, which are known to promote tumor invasion. Most notably, the metastasized B16F10 cells in UG-KO mouse lungs express MMP-2, MMP-9, and MMP-14 as well as furin, a pro-protein convertase that activates MMPs. Taken together, our results suggest that a lack of an anti-inflammatory protein leads to increased pulmonary colonization of melanoma cells and identify RAGE as a potential anti-metastatic drug target.	[Mukherjee, Anil B.] Eunice Kennedy Shriver NICHD, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Su, Shao-Bo] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Sun Yat Sen University	Mukherjee, AB (corresponding author), Eunice Kennedy Shriver NICHD, Sect Dev Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA.	mukherja@exchange.nih.gov	Chandra, Goutam/AAC-7319-2022; Lee, Yi-Ching/AAE-6900-2022	Chandra, Goutam/0000-0002-6485-8562; Lee, Yi-Ching/0000-0002-7734-5619	Eunice Kennedy Shriver NICHD, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000910] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the Eunice Kennedy Shriver NICHD, National Institutes of Health.	Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boyd JH, 2008, CIRC RES, V102, P1239, DOI 10.1161/CIRCRESAHA.107.167544; BROERS JLV, 1992, LAB INVEST, V66, P337; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Couzin J, 2003, SCIENCE, V299, P1002, DOI 10.1126/science.299.5609.1002; DONATO R, 1986, CELL CALCIUM, V7, P123, DOI 10.1016/0143-4160(86)90017-5; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FIDLER IJ, 1975, CANCER RES, V35, P218; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Hedley BD, 2009, ADV CANCER RES, V102, P67, DOI 10.1016/S0065-230X(09)02003-X; Heizmann C. W., 2007, V45, P93; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hofmann UB, 2000, J INVEST DERMATOL, V115, P337, DOI 10.1046/j.1523-1747.2000.00068.x; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kundu GC, 1998, J BIOL CHEM, V273, P22819, DOI 10.1074/jbc.273.35.22819; LINNOILA RI, 1992, AM J CLIN PATHOL, V97, P233, DOI 10.1093/ajcp/97.2.233; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; Liotta LA, 2003, NAT GENET, V33, P10, DOI 10.1038/ng0103-10; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Mandal AK, 2004, J EXP MED, V199, P1317, DOI 10.1084/jem.20031666; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Marx J, 2004, SCIENCE, V306, P966, DOI 10.1126/science.306.5698.966; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Moss NM, 2009, J BIOL CHEM, V284, P19791, DOI 10.1074/jbc.M109.020362; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Nacken W, 2003, MICROSC RES TECHNIQ, V60, P569, DOI 10.1002/jemt.10299; NEEPER M, 1992, J BIOL CHEM, V267, P14998; PERI A, 1993, J CLIN INVEST, V92, P2099, DOI 10.1172/JCI116810; Ra HJ, 2007, MATRIX BIOL, V26, P587, DOI 10.1016/j.matbio.2007.07.001; Rafii S, 2006, NAT CELL BIOL, V8, P1321, DOI 10.1038/ncb1206-1321; RAY MK, 1993, BIOCHEM BIOPH RES CO, V197, P163, DOI 10.1006/bbrc.1993.2455; Saha A, 2008, FEBS LETT, V582, P3823, DOI 10.1016/j.febslet.2008.10.015; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shames DS, 2007, CURR MOL MED, V7, P85, DOI 10.2174/156652407779940413; Szabo E, 1998, CELL GROWTH DIFFER, V9, P475; Warembourg M, 2000, J NEUROSCI METH, V104, P27, DOI 10.1016/S0165-0270(00)00320-4; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Yang YP, 2004, J BIOL CHEM, V279, P29336, DOI 10.1074/jbc.C400162200; Zhang ZJ, 1997, SCIENCE, V276, P1408, DOI 10.1126/science.276.5317.1408; Zhang ZJ, 1999, P NATL ACAD SCI USA, V96, P3963, DOI 10.1073/pnas.96.7.3963	48	52	56	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10822	10831		10.1074/jbc.M109.083550	http://dx.doi.org/10.1074/jbc.M109.083550			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118237	Green Published, hybrid			2022-12-27	WOS:000276264600067
J	Fujiwara, K; Maita, N; Hosaka, H; Okamura-Ikeda, K; Nakagawa, A; Taniguchi, H				Fujiwara, Kazuko; Maita, Nobuo; Hosaka, Harumi; Okamura-Ikeda, Kazuko; Nakagawa, Atsushi; Taniguchi, Hisaaki			Global Conformational Change Associated with the Two-step Reaction Catalyzed by Escherichia coli Lipoate-Protein Ligase A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINE CLEAVAGE SYSTEM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; H-PROTEIN; THERMOPLASMA-ACIDOPHILUM; SYNTHETASE; COMPLEX; IDENTIFICATION; SUPERFAMILY; LIPOYLATION	Lipoate-protein ligase A (LplA) catalyzes the attachment of lipoic acid to lipoate-dependent enzymes by a two-step reaction: first the lipoate adenylation reaction and, second, the lipoate transfer reaction. We previously determined the crystal structure of Escherichia coli LplA in its unliganded form and a binary complex with lipoic acid (Fujiwara, K., Toma, S., Okamura-Ikeda, K., Motokawa, Y., Nakagawa, A., and Taniguchi, H. (2005) J Biol. Chem. 280, 33645-33651). Here, we report two new LplA structures, LplA.lipoyl-5'-AMP and LplA.octyl-5'-AMP.apoH-protein complexes, which represent the post-lipoate adenylation intermediate state and the pre-lipoate transfer intermediate state, respectively. These structures demonstrate three large scale conformational changes upon completion of the lipoate adenylation reaction: movements of the adenylate-binding and lipoate-binding loops to maintain the lipoyl-5'-AMP reaction intermediate and rotation of the C-terminal domain by about 180 degrees. These changes are prerequisites for LplA to accommodate apoprotein for the second reaction. The Lys(133) residue plays essential roles in both lipoate adenylation and lipoate transfer reactions. Based on structural and kinetic data, we propose a reaction mechanism driven by conformational changes.	[Fujiwara, Kazuko; Maita, Nobuo; Okamura-Ikeda, Kazuko; Taniguchi, Hisaaki] Univ Tokushima, Inst Enzyme Res, Tokushima 7708503, Japan; [Hosaka, Harumi; Nakagawa, Atsushi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Tokushima University; Osaka University	Fujiwara, K (corresponding author), Univ Tokushima, Inst Enzyme Res, Kuramotocho 3 Chome, Tokushima 7708503, Japan.	fujiwara@ier.tokushima-u.ac.jp	Nakagawa, Atsushi/D-4329-2009; Maita, Nobuo/J-1443-2012; Nakagawa, Atsushi/M-5731-2019; Taniguchi, Hisaaki/I-9171-2012	Nakagawa, Atsushi/0000-0002-1700-7861; Maita, Nobuo/0000-0003-2260-5783; Nakagawa, Atsushi/0000-0002-1700-7861; 	Japan Society for the Promotion of Science [18570108, 19370041]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research 18570108 (C) and 19370041 (B) and by the National Projects on Protein Structural and Functional Analyses of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Bagautdinov B, 2005, J MOL BIOL, V353, P322, DOI 10.1016/j.jmb.2005.08.032; Bagautdinov B, 2008, J BIOL CHEM, V283, P14739, DOI 10.1074/jbc.M709116200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Beringer M, 2007, MOL CELL, V26, P311, DOI 10.1016/j.molcel.2007.03.015; Branchini BR, 2000, BIOCHEMISTRY-US, V39, P5433, DOI 10.1021/bi9928804; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Conti E, 1997, EMBO J, V16, P4174, DOI 10.1093/emboj/16.14.4174; Conti E, 1996, STRUCTURE, V4, P287, DOI 10.1016/S0969-2126(96)00033-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUJIWARA K, 1992, J BIOL CHEM, V267, P20011; Fujiwara K, 1996, J BIOL CHEM, V271, P12932, DOI 10.1074/jbc.271.22.12932; Fujiwara K, 2005, J BIOL CHEM, V280, P33645, DOI 10.1074/jbc.M505010200; FUJIWARA K, 1986, J BIOL CHEM, V261, P8836; Fujiwara K, 2007, J MOL BIOL, V371, P222, DOI 10.1016/j.jmb.2007.05.059; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hisanaga Y, 2004, J BIOL CHEM, V279, P31717, DOI 10.1074/jbc.M400100200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Horswill AR, 2002, BIOCHEMISTRY-US, V41, P2379, DOI 10.1021/bi015647q; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; KHORANA HG, 1959, J AM CHEM SOC, V81, P4657, DOI 10.1021/ja01526a052; Kim DJ, 2005, J BIOL CHEM, V280, P38081, DOI 10.1074/jbc.M507284200; Kochan G, 2009, J MOL BIOL, V388, P997, DOI 10.1016/j.jmb.2009.03.064; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; May JJ, 2002, P NATL ACAD SCI USA, V99, P12120, DOI 10.1073/pnas.182156699; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; OKAMURAIKEDA K, 1993, EUR J BIOCHEM, V216, P539, DOI 10.1111/j.1432-1033.1993.tb18172.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARES S, 1995, ACTA CRYSTALLOGR D, V51, P1041, DOI 10.1107/S0907444995006421; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; REED LJ, 1990, J BIOL CHEM, V265, P8971; Reger AS, 2008, BIOCHEMISTRY-US, V47, P8016, DOI 10.1021/bi800696y; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WILSON KP, 1992, P NATL ACAD SCI USA, V89, P9257, DOI 10.1073/pnas.89.19.9257; Wood ZA, 2006, J MOL BIOL, V357, P509, DOI 10.1016/j.jmb.2005.12.066; Yonus H, 2008, J BIOL CHEM, V283, P32484, DOI 10.1074/jbc.M800557200	41	27	28	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9971	9980		10.1074/jbc.M109.078717	http://dx.doi.org/10.1074/jbc.M109.078717			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089862	Green Published, hybrid			2022-12-27	WOS:000276165900066
J	Lu, X; Bennet, B; Mu, E; Rabinowitz, J; Kang, YB				Lu, Xin; Bennet, Bryson; Mu, Euphemia; Rabinowitz, Joshua; Kang, Yibin			Metabolomic Changes Accompanying Transformation and Acquisition of Metastatic Potential in a Syngeneic Mouse Mammary Tumor Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER METASTASIS; MASS-SPECTROMETRY; METABOLITES; CELLS; BONE; MICE	Breast cancer is the most common cancer type for women in the western world. Despite decades of research, the molecular processes associated with breast cancer progression are still inadequately defined. Here, we focus on the systematic alteration of metabolism by using the state of the art metabolomic profiling techniques to investigate the changes of 157 metabolites during the progression of normal mouse mammary epithelial cells to an isogenic series of mammary tumor cell lines with increasing metastatic potentials. Our results suggest a two-step metabolic progression hypothesis during the acquisition of tumorigenic and metastatic abilities. Metabolite changes accompanying tumor progression are identified in the intracellular and secreted forms in several pathways, including glycolysis, the tricarboxylic acid cycle, the pentose phosphate pathway, fatty acid and nucleotide biosynthesis, and the GSH-dependent antioxidative pathway. These results suggest possible biomarkers of breast cancer progression as well as opportunities of interrupting tumor progression through the targeting of metabolic pathways.	[Kang, Yibin] Princeton Univ, Dept Mol Biol, Champalimaud Metastasis Program, Princeton, NJ 08544 USA; [Bennet, Bryson; Rabinowitz, Joshua] Princeton Univ, Lewis Sigler Inst Integrat Gen, Princeton, NJ 08544 USA; [Bennet, Bryson; Rabinowitz, Joshua] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Kang, Yibin] Canc Inst New Jersey, Breast Canc Program, New Brunswick, NJ 08903 USA	Princeton University; Princeton University; Princeton University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Kang, YB (corresponding author), Princeton Univ, Dept Mol Biol, Champalimaud Metastasis Program, Princeton, NJ 08544 USA.	ykang@princeton.edu	lu, xuemin/A-8741-2011; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Kang, Yibin/0000-0002-1626-6730	National Institutes of Health [R01CA134519, R21CA128620]; Brewster Foundation; Department of Defense [BC051647]; Princeton University; NATIONAL CANCER INSTITUTE [R21CA128620, R01CA134519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brewster Foundation; Department of Defense(United States Department of Defense); Princeton University(Princeton University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health R01 Grant R01CA134519 (to Y.K.) and R21 Grant R21CA128620 (to J.R.). This work was also supported by the Brewster Foundation and a Department of Defense Era of Hope Scholar Award BC051647.; Recipient of a Harold W. Dodds Fellowship from Princeton University.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bajad SU, 2006, J CHROMATOGR A, V1125, P76, DOI 10.1016/j.chroma.2006.05.019; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Filomeni G, 2002, FASEB J, V16, P64, DOI 10.1096/fj.02-0105fje; Filomeni G, 2002, BIOCHEM PHARMACOL, V64, P1057, DOI 10.1016/S0006-2952(02)01176-0; Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kang YB, 2005, EXPERT REV MOL DIAGN, V5, P385, DOI 10.1586/14737159.5.3.385; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kang Yibin, 2006, Breast Dis, V26, P129; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Lu X, 2007, J MAMMARY GLAND BIOL, V12, P153, DOI 10.1007/s10911-007-9047-3; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Luo B, 2007, J CHROMATOGR A, V1147, P153, DOI 10.1016/j.chroma.2007.02.034; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Munger J, 2006, PLOS PATHOG, V2, P1165, DOI 10.1371/journal.ppat.0020132; OWENS RB, 1974, J NATL CANCER I, V53, P261, DOI 10.1093/jnci/53.1.261; Richardson AD, 2008, BREAST CANCER RES TR, V110, P297, DOI 10.1007/s10549-007-9732-3; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Zu XL, 2004, BIOCHEM BIOPH RES CO, V313, P459, DOI 10.1016/j.bbrc.2003.11.136	26	73	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9317	9321		10.1074/jbc.C110.104448	http://dx.doi.org/10.1074/jbc.C110.104448			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20139083	Green Published, hybrid			2022-12-27	WOS:000276165900002
J	Pitsawong, W; Sucharitakul, J; Prongjit, M; Tan, TC; Spadiut, O; Haltrich, D; Divne, C; Chaiyen, P				Pitsawong, Warintra; Sucharitakul, Jeerus; Prongjit, Methinee; Tan, Tien-Chye; Spadiut, Oliver; Haltrich, Dietmar; Divne, Christina; Chaiyen, Pimchai			A Conserved Active-site Threonine Is Important for Both Sugar and Flavin Oxidations of Pyranose 2-Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER FLAVOPROTEIN; TRAMETES-MULTICOLOR; KINETIC MECHANISM; OXYGEN REACTIVITY; CRYSTAL-STRUCTURE; REDOX PROPERTIES; OXIDASE; SUBSTRATE; FLAVOENZYMES; BINDING	Pyranose 2-oxidase (P2O) catalyzes the oxidation by O-2 of D-glucose and several aldopyranoses to yield the 2-ketoaldoses and H2O2. Based on crystal structures, in one rotamer conformation, the threonine hydroxyl of Thr(169) forms H-bonds to the flavin-N5/O4 locus, whereas, in a different rotamer, it may interact with either sugar or other parts of the P2O center dot sugar complex. Transient kinetics of wild-type (WT) and Thr(169)-> S/N/G/A replacement variants show that D-Glc binds to T169S, T169N, and WT with the same K-d (45-47 mM), and the hydride transfer rate constants (k(red)) are similar (15.3-9.7 s(-1) at 4 degrees C). k(red) of T169G with D-glucose (0.7 s(-1), 4 degrees C) is significantly less than that of WT but not as severely affected as in T169A (k(red) of 0.03 s(-1) at 25 degrees C). Transient kinetics of WT and mutants using D-galactose show that P2O binds D-galactose with a one-step binding process, different from binding of D- glucose. In T169S, T169N, and T169G, the overall turnover with D- Gal is faster than that of WT due to an increase of kred. In the crystal structure of T169S, Ser(169) O gamma assumes a position identical to that of O gamma 1 in Thr(169); in T169G, solvent molecules may be able to rescue H-bonding. Our data suggest that a competent reductive half-reaction requires a side chain at position 169 that is able to form an H-bond within the ES complex. During the oxidative half-reaction, all mutants failed to stabilize a C4a-hydroperoxyflavin intermediate, thus suggesting that the precise position and geometry of the Thr(169) side chain are required for intermediate stabilization.	[Pitsawong, Warintra; Prongjit, Methinee; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Pitsawong, Warintra; Prongjit, Methinee; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok 10300, Thailand; [Tan, Tien-Chye; Spadiut, Oliver; Divne, Christina] Albanova Univ Ctr, Royal Inst Technol, Div Glycosci, SE-10691 Stockholm, Sweden; [Haltrich, Dietmar] Bodenkultur Univ Nat Resource & Appl Life Sci, Dept Food Sci & Technol, A-1190 Vienna, Austria	Mahidol University; Mahidol University; Chulalongkorn University; Royal Institute of Technology	Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.	scpcy@mahidol.ac.th	pitsawong, warintra/G-1760-2018; Chaiyen, Pimchai/A-8236-2010; Chaiyen, Pimchai/R-5052-2019; Divne, Christina/E-8646-2010; Haltrich, Dietmar/N-2624-2019	pitsawong, warintra/0000-0001-5438-1783; Chaiyen, Pimchai/0000-0002-8533-1604; Divne, Christina/0000-0002-5805-2693; Haltrich, Dietmar/0000-0002-8722-8176	Thailand Research Fund [BRG5180002, MRG4980117]; Royal Golden Jubilee Ph.D. program [PHD/0151/2547]; Faculty of Science, Mahidol University; Faculty of Dentistry Chulalongkorn University; Development and Promotion of Science and Technology Talent Project, Thailand; Swedish Research Council Formas; Swedish Research Council Vetenskapsradet; Carl Tryggers Foundation; Swedish Foundation for Strategic Research through the Swedish Center for Biomimetic Fiber Engineering; Austrian Research Foundation [L213-B11]	Thailand Research Fund(Thailand Research Fund (TRF)); Royal Golden Jubilee Ph.D. program(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Faculty of Dentistry Chulalongkorn University(Chulalongkorn University); Development and Promotion of Science and Technology Talent Project, Thailand; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council Vetenskapsradet(Swedish Research Council); Carl Tryggers Foundation; Swedish Foundation for Strategic Research through the Swedish Center for Biomimetic Fiber Engineering; Austrian Research Foundation(Austrian Science Fund (FWF))	This work was supported in part by the Thailand Research Fund through Grants BRG5180002 (to P. C.), MRG4980117 (to J. S.), and PHD/0151/2547 of the Royal Golden Jubilee Ph.D. program (to M. P.) and by the Faculty of Science, Mahidol University (to P. C.) and from the Faculty of Dentistry Chulalongkorn University (to J. S.).; Supported by the Development and Promotion of Science and Technology Talent Project, Thailand.; Supported by the Swedish Research Council Formas, the Swedish Research Council Vetenskapsradet, the Carl Tryggers Foundation, and the Swedish Foundation for Strategic Research through the Swedish Center for Biomimetic Fiber Engineering ( through Biomime).; Supported by a grant from the Austrian Research Foundation (Fonds zur Forderung der wissenschaftlichen Forschung Translational Project L213-B11).	Albrecht M, 2003, BIOINFORMATICS, V19, P1216, DOI 10.1093/bioinformatics/btg140; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Bannwarth M, 2006, BIOCHEMISTRY-US, V45, P6587, DOI 10.1021/bi052465d; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P2612, DOI 10.1021/bi962325r; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; Forneris F, 2008, BIOCHEMISTRY-US, V47, P978, DOI 10.1021/bi701886t; Fraaije MW, 2000, TRENDS BIOCHEM SCI, V25, P126, DOI 10.1016/S0968-0004(99)01533-9; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; GIBSON QH, 1964, J BIOL CHEM, V239, P3927; Halada P, 2003, ANAL BIOCHEM, V314, P235, DOI 10.1016/S0003-2697(02)00661-9; Hallberg BM, 2004, J MOL BIOL, V341, P781, DOI 10.1016/j.jmb.2004.06.033; Heroux A, 2009, BIOCHEMISTRY-US, V48, P3407, DOI 10.1021/bi8023042; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kujawa M, 2006, J BIOL CHEM, V281, P35104, DOI 10.1074/jbc.M604718200; Leitner C, 2001, APPL ENVIRON MICROB, V67, P3636, DOI 10.1128/AEM.67.8.3636-3644.2001; Mallett TC, 1998, BIOCHEMISTRY-US, V37, P8790, DOI 10.1021/bi9803630; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Orville AM, 2009, BIOCHEMISTRY-US, V48, P720, DOI 10.1021/bi801918u; Palfey B. A., 1998, COMPREHENSIVE BIOL C, VIII, P83; Prongjit M, 2009, BIOCHEMISTRY-US, V48, P4170, DOI 10.1021/bi802331r; Quaye O, 2008, BIOCHEMISTRY-US, V47, P243, DOI 10.1021/bi7017943; Roberts DL, 1996, P NATL ACAD SCI USA, V93, P14355, DOI 10.1073/pnas.93.25.14355; Rungsrisuriyachai K, 2009, ARCH BIOCHEM BIOPHYS, V483, P10, DOI 10.1016/j.abb.2008.12.018; Salaheddin Clara, 2009, Biotechnology Journal, V4, P535, DOI 10.1002/biot.200800265; Spadiut O, 2009, FEBS J, V276, P776, DOI 10.1111/j.1742-4658.2008.06823.x; Spadiut O, 2008, BIOCATAL BIOTRANSFOR, V26, P120, DOI 10.1080/10242420701789320; Spadiut Oliver, 2009, Biotechnology Journal, V4, P525, DOI 10.1002/biot.200800260; Sucharitakul J, 2008, BIOCHEMISTRY-US, V47, P8485, DOI 10.1021/bi801039d; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van den Heuvel RHH, 2000, J BIOL CHEM, V275, P14799, DOI 10.1074/jbc.275.20.14799; Yang KY, 2007, BIOCHEMISTRY-US, V46, P2289, DOI 10.1021/bi0616293; Yue QK, 1999, BIOCHEMISTRY-US, V38, P4277, DOI 10.1021/bi982497j	34	49	50	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9697	9705		10.1074/jbc.M109.073247	http://dx.doi.org/10.1074/jbc.M109.073247			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089849	Green Published, hybrid			2022-12-27	WOS:000276165900042
J	Klenk, C; Schulz, S; Calebiro, D; Lohse, MJ				Klenk, Christoph; Schulz, Stefan; Calebiro, Davide; Lohse, Martin J.			Agonist-regulated Cleavage of the Extracellular Domain of Parathyroid Hormone Receptor Type 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							(PTH)/PTH-RELATED PEPTIDE RECEPTOR; HUMAN THYROTROPIN RECEPTOR; PROTEIN-COUPLED-RECEPTOR; PTH-RELATED PEPTIDE; MATRIX METALLOPROTEINASES; 4-AMINOPHENYLMERCURIC ACETATE; PHARMACOLOGICAL CHAPERONES; BIOLOGICAL-ACTIVITY; CELL-SURFACE; KINASE-C	The receptor for parathyroid hormone (PTHR) is a main regulator of calcium homeostasis and bone maintenance. As a member of class B of G protein-coupled receptors, it harbors a large extracellular domain, which is required for ligand binding. Here, we demonstrate that the PTHR extracellular domain is cleaved by a protease belonging to the family of extracellular metalloproteinases. We show that the cleavage takes place in a region of the extracellular domain that belongs to an unstructured loop connecting the ligand-binding parts and that the N-terminal 10-kDa fragment is connected to the receptor core by a disulfide bond. Cleaved receptor revealed reduced protein stability compared with noncleaved receptor, suggesting degradation of the whole receptor. In the presence of the agonistic peptides PTH(1-34), PTH(1-14), or PTH(1-31), the processing of the PTHR extracellular domain was inhibited, and receptor protein levels were stabilized. A processed form of the PTHR was also detected in human kidney. These findings suggest a new model of PTHR processing and regulation of its stability.	[Klenk, Christoph; Calebiro, Davide; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Calebiro, Davide; Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, Deutsch Forsch Gemeinschaft Res Ctr Expt Biomed, D-97078 Wurzburg, Germany; [Schulz, Stefan] Univ Jena, Dept Pharmacol & Toxicol, D-07743 Jena, Germany	University of Wurzburg; University of Wurzburg; Friedrich Schiller University of Jena	Klenk, C (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	klenk@toxi.uni-wuerzburg.de	Schulz, Stefan/A-6928-2017; Lohse, Martin J/A-7160-2012; Klenk, Christoph/E-5158-2014	Schulz, Stefan/0000-0002-5997-8885; Lohse, Martin J/0000-0002-0599-3510; Klenk, Christoph/0000-0001-5199-7144; calebiro, davide/0000-0002-3811-1553	Deutsche Forschungsgemeinschaft; European Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the European Research Council (to M. J. L.).	ABOUSAMRA AB, 1992, P NATL ACAD SCI USA, V89, P2732, DOI 10.1073/pnas.89.7.2732; Andersen TL, 2004, BONE, V35, P1107, DOI 10.1016/j.bone.2004.06.019; Bisello A, 1996, BIOCHEMISTRY-US, V35, P15890, DOI 10.1021/bi962111+; Castro M, 2005, P NATL ACAD SCI USA, V102, P16084, DOI 10.1073/pnas.0503942102; Castro M, 2002, ENDOCRINOLOGY, V143, P3854, DOI 10.1210/en.2002-220232; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Delaisse JM, 2000, CLIN CHIM ACTA, V291, P223, DOI 10.1016/S0009-8981(99)00230-2; Foord SM, 2005, PHARMACOL REV, V57, P279, DOI 10.1124/pr.57.2.5; Galazka G, 1996, BIOCHEMISTRY-US, V35, P11221, DOI 10.1021/bi960618e; GARDELLA TJ, 1994, ENDOCRINOLOGY, V135, P1186, DOI 10.1210/en.135.3.1186; Gensure RC, 2005, BIOCHEM BIOPH RES CO, V328, P666, DOI 10.1016/j.bbrc.2004.11.069; Geoffroy V, 2004, J BONE MINER RES, V19, P811, DOI 10.1359/JBMR.040119; GOLDRING SR, 1985, BIOCHEMISTRY-US, V24, P513, DOI 10.1021/bi00323a040; Grauschopf U, 2000, BIOCHEMISTRY-US, V39, P8878, DOI 10.1021/bi0001426; JOUISHOMME H, 1994, J BONE MINER RES, V9, P943; KARPF DB, 1988, ENDOCRINOLOGY, V123, P2611, DOI 10.1210/endo-123-6-2611; Kawashima-Ohya Y, 1998, ENDOCRINOLOGY, V139, P2120, DOI 10.1210/en.139.4.2120; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; LEE CW, 1994, ENDOCRINOLOGY, V135, P1488, DOI 10.1210/en.135.4.1488; LOOSFELT H, 1992, P NATL ACAD SCI USA, V89, P3765, DOI 10.1073/pnas.89.9.3765; Luck MD, 1999, MOL ENDOCRINOL, V13, P670, DOI 10.1210/me.13.5.670; Luo XH, 2004, J BONE MINER METAB, V22, P19, DOI 10.1007/s00774-003-0442-6; LUPP A, 2010, EUR J ENDOC IN PRESS; Merciris D, 2007, BONE, V40, P75, DOI 10.1016/j.bone.2006.07.013; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Offermanns S, 1996, MOL ENDOCRINOL, V10, P566, DOI 10.1210/me.10.5.566; Peeters-Joris C, 1998, BBA-MOL CELL RES, V1405, P14, DOI 10.1016/S0167-4889(98)00094-9; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Pines M, 1996, BONE, V18, P381, DOI 10.1016/8756-3282(96)00008-7; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Santavicca M, 1996, BIOCHEM J, V315, P953, DOI 10.1042/bj3150953; SCHIPANI E, 1993, ENDOCRINOLOGY, V132, P2157, DOI 10.1210/en.132.5.2157; Shimizu N, 2001, J BIOL CHEM, V276, P49003, DOI 10.1074/jbc.M106827200; Tanaka K, 1999, J BIOL CHEM, V274, P33979, DOI 10.1074/jbc.274.48.33979; TREGEAR GW, 1973, ENDOCRINOLOGY, V93, P1349, DOI 10.1210/endo-93-6-1349; Trifilieff A, 2002, BRIT J PHARMACOL, V135, P1655, DOI 10.1038/sj.bjp.0704616; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; WADSWORTH HL, 1990, SCIENCE, V249, P1423, DOI 10.1126/science.2169649	42	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8665	8674		10.1074/jbc.M109.058685	http://dx.doi.org/10.1074/jbc.M109.058685			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080964	Green Published, hybrid			2022-12-27	WOS:000275553700019
J	Liao, S; Tung, ETK; Zheng, W; Chong, K; Xu, YY; Dai, P; Guo, YY; Bartlam, M; Yuen, KY; Rao, ZH				Liao, Shuang; Tung, Edward T. K.; Zheng, Wei; Chong, Ken; Xu, Yuanyuan; Dai, Peng; Guo, Yingying; Bartlam, Mark; Yuen, Kwok-Yung; Rao, Zihe			Crystal Structure of the Mp1p Ligand Binding Domain 2 Reveals Its Function as a Fatty Acid-binding Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS PENICILLIUM-MARNEFFEI; CELL-WALL MANNOPROTEIN; GLYOXYLATE CYCLE; MACROPHAGE; ABUNDANT	Penicillium marneffei is a dimorphic, pathogenic fungus in Southeast Asia that mostly afflicts immunocompromised individuals. As the only dimorphic member of the genus, it goes through a phase transition from a mold to yeast form, which is believed to be a requisite for its pathogenicity. Mp1p, a cell wall antigenic mannoprotein existing widely in yeast, hyphae, and conidia of the fungus, plays a vital role in host immune response during infection. To understand the function of Mp1p, we have determined the x-ray crystal structure of its ligand binding domain 2 (LBD2) to 1.3 angstrom. The structure reveals a dimer between the two molecules. The dimer interface forms a ligand binding cavity, in which electron density was observed for a palmitic acid molecule interacting with LBD2 indirectly through hydrogen bonding networks via two structural water molecules. Isothermal titration calorimetry experiments measured the ligand binding affinity (K-d) of Mp1p at the micromolar level. Mutations of ligand-binding residues, namely S313A and S332A, resulted in a 9-fold suppression of ligand binding affinity. Analytical ultracentrifugation assays demonstrated that both LBD2 and Mp1p are mostly monomeric in vitro, no matter with or without ligand, and our dimeric crystal structure of LBD2 might be the result of crystal packing. Based on the conformation of the ligand-binding pocket in the dimer structure, a model for the closed, monomeric form of LBD2 is proposed. Further structural analysis indicated the biological importance of fatty acid binding of Mp1p for the survival and pathogenicity of the conditional pathogen.	[Tung, Edward T. K.; Yuen, Kwok-Yung] Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China; [Liao, Shuang; Zheng, Wei; Xu, Yuanyuan; Dai, Peng; Guo, Yingying; Rao, Zihe] Tsinghua Univ, Struct Biol Lab, Beijing 100084, Peoples R China; [Liao, Shuang; Chong, Ken; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Macromol, Beijing 100101, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	University of Hong Kong; Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University	Yuen, KY (corresponding author), Univ Hong Kong, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk; raozh@xtal.tsinghua.edu.cn	Rao, Zihe/HCH-6944-2022	Bartlam, Mark/0000-0001-5173-5080; Liao, Shuang/0000-0002-1016-6149; Yuen, Kwok-yung/0000-0002-2083-1552	Ministry of Science and Technology 973 [006CB10901, 2007CB914301]; 863 Project [2006AA02A322]; International Cooperation Project [2006DFB32420]	Ministry of Science and Technology 973(National Basic Research Program of China); 863 Project; International Cooperation Project	This work was supported by Ministry of Science and Technology 973 Project Grants 2006CB10901 and 2007CB914301) and 863 Project Grant 2006AA02A322, and International Cooperation Project Grant 2006DFB32420.	Appelberg R, 2006, J LEUKOCYTE BIOL, V79, P1117, DOI 10.1189/jlb.0206079; Balendiran GK, 2000, J BIOL CHEM, V275, P27045; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Canovas D, 2006, MOL MICROBIOL, V62, P1725, DOI 10.1111/j.1365-2958.2006.05477.x; Cao L, 1998, INFECT IMMUN, V66, P966, DOI 10.1128/IAI.66.3.966-973.1998; Cao L, 1998, J CLIN MICROBIOL, V36, P3028, DOI 10.1128/JCM.36.10.3028-3031.1998; Cao L, 1999, J CLIN MICROBIOL, V37, P981, DOI 10.1128/JCM.37.4.981-986.1999; Darios F, 2007, J PHYSIOL-LONDON, V585, P699, DOI 10.1113/jphysiol.2007.136812; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Jordanova R, 2005, J BIOL CHEM, V280, P41429, DOI 10.1074/jbc.M504474200; Lorenz MC, 2002, EUKARYOT CELL, V1, P657, DOI 10.1128/EC.1.5.657-662.2002; Mazumdar J, 2007, EUKARYOT CELL, V6, P1727, DOI 10.1128/EC.00255-07; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OTWINOWSKI Z, 1997, PROCESSING XRAY DIFF, P307; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Roncal T, 2003, RES MICROBIOL, V154, P539, DOI 10.1016/S0923-2508(03)00168-2; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schymkowitz JWH, 2001, NAT STRUCT BIOL, V8, P888, DOI 10.1038/nsb1001-888; Wenk MR, 2006, FEBS LETT, V580, P5541, DOI 10.1016/j.febslet.2006.07.007; Wong SSY, 2001, J CLIN MICROBIOL, V39, P4535, DOI 10.1128/JCM.39.12.4535-4540.2001; Woo PCY, 2007, J CLIN MICROBIOL, V45, P3647, DOI 10.1128/JCM.00619-07; Yuen K, 2003, ARCH MICROBIOL, V179, P339, DOI 10.1007/s00203-003-0533-8	24	8	9	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9211	9220		10.1074/jbc.M109.057760	http://dx.doi.org/10.1074/jbc.M109.057760			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20053994	Green Published, hybrid			2022-12-27	WOS:000275553700070
J	Maier-Peuschel, M; Frolich, N; Dees, C; Hommers, LG; Hoffmann, C; Nikolaev, VO; Lohse, MJ				Maier-Peuschel, Monika; Froelich, Nadine; Dees, Christian; Hommers, Leif G.; Hoffmann, Carsten; Nikolaev, Viacheslav O.; Lohse, Martin J.			A Fluorescence Resonance Energy Transfer-based M-2 Muscarinic Receptor Sensor Reveals Rapid Kinetics of Allosteric Modulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; ACETYLCHOLINE-RECEPTORS; LIVING CELLS; MOLECULAR-BASIS; ACTIVATION; BINDING; LIGANDS; GALLAMINE; AGONIST; SITE	Allosteric modulators have been identified for several G protein-coupled receptors, most notably muscarinic receptors. To study their mechanism of action, we made use of a recently developed technique to generate fluorescence resonance energy transfer (FRET)-based sensors to monitor G protein-coupled receptor activation. Cyan fluorescent protein was fused to the C terminus of the M-2 muscarinic receptor, and a specific binding sequence for the small fluorescent compound fluorescein arsenical hairpin binder, FlAsH, was inserted into the third intracellular loop; the latter site was labeled in intact cells by incubation with FlAsH. We then measured FRET between the donor cyan fluorescent protein and the acceptor FlAsH in intact cells and monitored its changes in real time. Agonists such as acetylcholine and carbachol induced rapid changes in FRET, indicative of agonist-induced conformational changes. Removal of the agonists or addition of an antagonist caused a reversal of this signal with rate constants between 400 and 1100 ms. The allosteric ligands gallamine and dimethyl-W84 caused no changes in FRET when given alone, but increased FRET when given in the presence of an agonist, compatible with an inactivation of the receptors. The kinetics of these effects were very rapid, with rate constants of 80-100 ms and approximate to 200 ms for saturating concentrations of gallamine and dimethyl-W84, respectively. Because these speeds are significantly faster than the responses to antagonists, these data indicate that gallamine and dimethyl-W84 are allosteric ligands and actively induce a conformation of the M-2 receptor with a reduced affinity for its agonists.	[Nikolaev, Viacheslav O.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; Univ Wurzburg, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Nikolaev, VO (corresponding author), Univ Wurzburg, Inst Pharmacol & Toxicol, Versbacher Str 9, D-97078 Wurzburg, Germany.	nikolaev@toxi.uni-wuerzburg.de	Lohse, Martin J/A-7160-2012; Nikolaev, Vyacheslav/AAT-7746-2020	Lohse, Martin J/0000-0002-0599-3510; 	Deutsche Forschungsgemeinschaft; European Research Council	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the European Research Council (to M. J. L.).	Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Birdsall NJM, 2005, MINI-REV MED CHEM, V5, P523, DOI 10.2174/1389557054023251; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Christopoulos A, 2004, BIOCHEM SOC T, V32, P873, DOI 10.1042/BST0320873; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Grossmuller M, 2006, N-S ARCH PHARMACOL, V372, P267, DOI 10.1007/s00210-005-0023-4; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hoffmann C, 2008, J BIOL CHEM, V283, P30933, DOI 10.1074/jbc.M801472200; Holzgrabe U, 2000, Pharm Acta Helv, V74, P149, DOI 10.1016/S0031-6865(99)00028-X; Hommers LG, 2003, J BIOL CHEM, V278, P1037, DOI 10.1074/jbc.M205325200; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; Jakubik J, 1997, MOL PHARMACOL, V52, P172, DOI 10.1124/mol.52.1.172; Kostenis E, 1997, BIOCHEMISTRY-US, V36, P1487, DOI 10.1021/bi962554d; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; LAZARENO S, 1989, BRIT J PHARMACOL, V98, P309, DOI 10.1111/j.1476-5381.1989.tb16896.x; Li JH, 2007, J BIOL CHEM, V282, P26284, DOI 10.1074/jbc.M704875200; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lohse MJ, 2007, ADV PROTEIN CHEM, V74, P167, DOI 10.1016/S0065-3233(07)74005-6; MAGGIO R, 1993, FEBS LETT, V319, P195, DOI 10.1016/0014-5793(93)80066-4; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; May LT, 2003, CURR OPIN PHARMACOL, V3, P551, DOI 10.1016/S1471-4892(03)00107-3; Mohr K, 2003, RECEPTOR CHANNEL, V9, P229, DOI 10.1080/10606820308264; NARAYANAN TK, 1986, NEUROCHEM RES, V11, P1397, DOI 10.1007/BF00966219; Nikolaev VO, 2006, J BIOL CHEM, V281, P24506, DOI 10.1074/jbc.M603266200; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; PEARCE BD, 1988, NEUROSCI LETT, V88, P281, DOI 10.1016/0304-3940(88)90224-8; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; STOCKTON JM, 1983, MOL PHARMACOL, V23, P551; SZILAGYI M, 1993, PHARMACOLOGY, V47, P223, DOI 10.1159/000139101; Trankle C, 2005, MOL PHARMACOL, V68, P1597, DOI 10.1124/mol.105.017707; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; Trankle C, 1997, LIFE SCI, V60, P1995, DOI 10.1016/S0024-3205(97)00164-1; Vilardaga JP, 2008, NAT CHEM BIOL, V4, P126, DOI 10.1038/nchembio.64; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	43	60	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8793	8800		10.1074/jbc.M109.098517	http://dx.doi.org/10.1074/jbc.M109.098517			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20083608	Green Published, hybrid			2022-12-27	WOS:000275553700031
J	Kim, S; Kim, Y; Lee, J; Chung, J				Kim, Sunhong; Kim, Yongsung; Lee, Jiwoon; Chung, Jongkyeong			Regulation of FOXO1 by TAK1-Nemo-like Kinase Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEMO-LIKE-KINASE; FORKHEAD TRANSCRIPTION FACTOR; PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; NUCLEAR EXCLUSION; GENE-EXPRESSION; MAP KINASE; PHOSPHORYLATION; NLK; COACTIVATOR	The FOXO family of forkhead transcription factors has a variety of important functions in stress response, metabolism, cell cycle, apoptosis, longevity, etc. The transcriptional activity and subcellular localization of FOXO are tightly regulated by post-translational modifications, including phosphorylation by various kinases. Here, we report that the transforming growth factor-beta-activated kinase (TAK1)-Nemo-like kinase (NLK) pathway negatively regulates FOXO1. We show that NLK binds and phosphorylates FOXO1 at Pro-directed Ser/Thr residues in the transactivation domain. The phosphorylation by TAK1-NLK pathway inhibits the transcriptional activity of FOXO1 and excludes FOXO1 from the nucleus, which is independent of phosphatidylinositol 3-kinase/Akt pathway. Consistently, knockdown of TAK1-NLK pathway dephosphorylates FOXO1 and decreases phospho-Ser-329 FOXO1 level. It also induces translocation of FOXO1 into the nucleus and leads to an increase in mRNA levels of FOXO target genes and poly(ADPribose) polymerase cleavage. In addition, we show the interaction between NLK and FOXO1 is evolutionarily conserved in Drosophila. Collectively, these findings provide the first evidence that TAK1-NLK pathway is a novel regulator of FOXO1.	[Chung, Jongkyeong] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Sunhong] Korea Res Inst Biosci & Biotechnol, Ctr Mol Canc Res, Chungbuk 363883, South Korea; [Kim, Yongsung; Lee, Jiwoon; Chung, Jongkyeong] Korea Adv Inst Sci & Technol, Natl Creat Res Initiat, Ctr Cell Growth Regulat, Taejon 305701, South Korea; [Kim, Yongsung; Lee, Jiwoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Chung, J (corresponding author), Seoul Natl Univ, Sch Biol Sci, San 56-1, Seoul 151742, South Korea.	jchung63@snu.ac.kr			Ministry of Education, Science and Technology [R16-2001-002-01001-0]; National Research Foundation of Korea	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea)	This work was supported by National Creative Research Initiatives Grant R16-2001-002-01001-0 from the Ministry of Education, Science and Technology and National Research Foundation of Korea.	Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; CHOI KW, 1994, CELL, V78, P125, DOI 10.1016/0092-8674(94)90579-7; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Ishitani T, 2003, MOL CELL BIOL, V23, P1379, DOI 10.1128/MCB.23.4.1379-1389.2003; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kim Y, 2008, BIOCHEM BIOPH RES CO, V377, P975, DOI 10.1016/j.bbrc.2008.10.104; Kortenjann M, 2001, EUR J IMMUNOL, V31, P3580, DOI 10.1002/1521-4141(200112)31:12<3580::AID-IMMU3580>3.0.CO;2-N; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Meneghini MD, 1999, NATURE, V399, P793, DOI 10.1038/21666; Miyata Y, 1999, BIOCHEM BIOPH RES CO, V266, P291, DOI 10.1006/bbrc.1999.1705; Ohkawara B, 2004, GENE DEV, V18, P381, DOI 10.1101/gad.1166904; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Smit L, 2004, J BIOL CHEM, V279, P17232, DOI 10.1074/jbc.M307801200; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Thorpe CJ, 2004, DEVELOPMENT, V131, P2899, DOI 10.1242/dev.01171; von Groote-Bidlingmaier F, 2003, BIOCHEM BIOPH RES CO, V300, P764, DOI 10.1016/S0006-291X(02)02914-5; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Zeng YA, 2007, DEVELOPMENT, V134, P2061, DOI 10.1242/dev.02853	28	37	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8122	8129		10.1074/jbc.M110.101824	http://dx.doi.org/10.1074/jbc.M110.101824			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061393	Green Published, hybrid			2022-12-27	WOS:000275413800030
J	Krapf, D; Arcelay, E; Wertheimer, EV; Sanjay, A; Pilder, SH; Salicioni, AM; Visconti, PE				Krapf, Dario; Arcelay, Enid; Wertheimer, Eva V.; Sanjay, Archana; Pilder, Stephen H.; Salicioni, Ana M.; Visconti, Pablo E.			Inhibition of Ser/Thr Phosphatases Induces Capacitation-associated Signaling in the Presence of Src Kinase Inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; MOUSE SPERMATOZOA; ACROSOME REACTION; SPERM PROTEINS; OKADAIC ACID; CALYCULIN-A; EGG WATER; CAMP; PKA; 2A	Signaling events leading to mammalian sperm capacitation rely on activation/deactivation of proteins by phosphorylation. This cascade includes soluble adenylyl cyclase, an atypical bicarbonate-stimulated adenylyl cyclase, and is mediated by protein kinase A and the subsequent stimulation of protein tyrosine phosphorylation. Recently, it has been proposed that the capacitation- associated increase in tyrosine phosphorylation is governed by Src tyrosine kinase activity. This conclusion was based mostly on the observation that Src is present in sperm and that the Src kinase family inhibitor SU6656 blocked the capacitation-associated increase in tyrosine phosphorylation. Results in the present manuscript confirmed these observations and provided evidence that these inhibitors were also able to inhibit protein kinase A phosphorylation, sperm motility, and in vitro fertilization. However, the block of capacitation- associated parameters was overcome when sperm were incubated in the presence of Ser/Thr phosphatase inhibitors such as okadaic acid and calyculin-A at concentrations reported to affect only PP2A. Altogether, these data indicate that Src is not directly involved in the observed increase in tyrosine phosphorylation. More importantly, this work presents strong evidence that capacitation is regulated by two parallel pathways. One of them requiring activation of protein kinase A and the second one involving inactivation of Ser/Thr phosphatases.	[Krapf, Dario; Arcelay, Enid; Wertheimer, Eva V.; Salicioni, Ana M.; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; [Sanjay, Archana; Pilder, Stephen H.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA	University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Visconti, PE (corresponding author), 427W Integrated Sci Bldg,661 N Pleasant St, Amherst, MA 01003 USA.	pvisconti@vasci.umass.edu	Salicioni, Ana Maria/ABD-8384-2021	Salicioni, Ana Maria/0000-0002-8951-3587; Krapf, Dario/0000-0001-7607-1954	National Institutes of Health [HD38082, HD44044]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044044, R01HD038082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants HD38082 and HD44044 (to P.E.V.).	Arcelay E, 2008, INT J DEV BIOL, V52, P463, DOI 10.1387/ijdb.072555ea; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baker MA, 2009, DEV BIOL, V333, P57, DOI 10.1016/j.ydbio.2009.06.022; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; BIALOJAN C, 1988, BIOCHEM J, V256, P283, DOI 10.1042/bj2560283; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHENG HC, 1992, J BIOL CHEM, V267, P9248; Cheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004861; CHERNOFF J, 1983, J BIOL CHEM, V258, P7852; COHEN P, 1989, J BIOL CHEM, V264, P21435; Etkovitz N, 2009, DEV BIOL, V334, P447, DOI 10.1016/j.ydbio.2009.08.002; Goto N, 2009, J REPROD DEVELOP, V55, P327, DOI 10.1262/jrd.20170; Hao ZL, 2004, MOL HUM REPROD, V10, P433, DOI 10.1093/molehr/gah052; Harrison RAP, 2004, MOL REPROD DEV, V67, P337, DOI 10.1002/mrd.20028; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hu XH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-74; Huang ZH, 2004, BIOL REPROD, V70, P439, DOI 10.1095/biolreprod.103.020024; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Kaneto M, 2008, MOL REPROD DEV, V75, P1045, DOI 10.1002/mrd.20839; Krapf D, 2007, DEV BIOL, V306, P516, DOI 10.1016/j.ydbio.2007.03.030; Krapf D, 2006, BIOL CELL, V98, P403, DOI 10.1042/BC20050051; Krapf D, 2009, BIOL REPROD, V80, P311, DOI 10.1095/biolreprod.108.071076; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson C, 2008, BIOL REPROD, V79, P657, DOI 10.1095/biolreprod.108.070367; Litvin TN, 2003, J BIOL CHEM, V278, P15922, DOI 10.1074/jbc.M212475200; MACKINTOSH C, 1990, FEBS LETT, V264, P187, DOI 10.1016/0014-5793(90)80245-E; Mallozzi C, 2005, FREE RADICAL BIO MED, V38, P1625, DOI 10.1016/j.freeradbiomed.2005.02.021; Mao LM, 2005, J BIOL CHEM, V280, P12602, DOI 10.1074/jbc.M411709200; Mitchell LA, 2008, MOL HUM REPROD, V14, P235, DOI 10.1093/molehr/gan007; MOORE GD, 1994, DEVELOPMENT, V120, P3313; Morgan DJ, 2008, P NATL ACAD SCI USA, V105, P20740, DOI 10.1073/pnas.0810971105; O'Flaherty C, 2004, MOL HUM REPROD, V10, P355, DOI 10.1093/molehr/gah046; Pawson T, 2007, ONCOGENE, V26, P1268, DOI 10.1038/sj.onc.1210255; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Salicioni Ana M, 2007, Soc Reprod Fertil Suppl, V65, P245; Si YM, 1999, BIOL REPROD, V61, P240, DOI 10.1095/biolreprod61.1.240; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; SRINIVASAN M, 1994, J BIOL CHEM, V269, P12514; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Vanichviriyakit R, 2004, MOL REPROD DEV, V69, P356, DOI 10.1002/mrd.20138; Varano G, 2008, HUM REPROD, V23, P2652, DOI 10.1093/humrep/den314; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Vijayaraghavan Srinivasan, 2007, Soc Reprod Fertil Suppl, V63, P111; VillaMoruzzi E, 1996, BIOCHEM BIOPH RES CO, V219, P863, DOI 10.1006/bbrc.1996.0337; Visconti PE, 1997, DEV BIOL, V192, P351, DOI 10.1006/dbio.1997.8768; Visconti PE, 1999, BIOL REPROD, V61, P76, DOI 10.1095/biolreprod61.1.76; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Visconti PE, 2002, J REPROD IMMUNOL, V53, P133, DOI 10.1016/S0165-0378(01)00103-6; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; Yanagimachi R., 1994, P189; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964	56	110	115	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7977	7985		10.1074/jbc.M109.085845	http://dx.doi.org/10.1074/jbc.M109.085845			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068039	hybrid, Green Published			2022-12-27	WOS:000275413800015
J	Li, FW; Patra, KP; Yowell, CA; Dame, JB; Chin, K; Vinetz, JM				Li, Fengwu; Patra, Kailash P.; Yowell, Charles A.; Dame, John B.; Chin, Karen; Vinetz, Joseph M.			Apical Surface Expression of Aspartic Protease Plasmepsin 4, a Potential Transmission-blocking Target of the Plasmodium Ookinete	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VECTOR ANOPHELES-GAMBIAE; FOOD VACUOLE PLASMEPSINS; MALARIA PARASITE; MOSQUITO MIDGUT; INFECTING MAN; FALCIPARUM; PROTEINS; CTRP; IDENTIFICATION; GALLINACEUM	To invade its definitive host, the mosquito, the malaria parasite must cross the midgut peritrophic matrix that is composed of chitin cross-linked by chitin-binding proteins and then develop into an oocyst on the midgut basal lamina. Previous evidence indicates that Plasmodium ookinete-secreted chitinase is important in midgut invasion. The mechanistic role of other ookinete-secreted enzymes in midgut invasion has not been previously examined. De novo mass spectrometry sequencing of a protein obtained by benzamidine affinity column of Plasmodium gallinaceum ookinete axenic culture supernatant demonstrated the presence of an ookinete-secreted plasmepsin, an aspartic protease previously only known to be present in the digestive vacuole of asexual stage malaria parasites. This plasmepsin, the ortholog of Plasmodium falciparum plasmepsin 4, was designated PgPM4. PgPM4 and PgCHT2 (the P. gallinaceum ortholog of P. falciparum chitinase PfCHT1) are both localized on the ookinete apical surface, and both are present in micronemes. Aspartic protease inhibitors (peptidomimetic and natural product), calpain inhibitors, and anti-PgPM4 monoclonal antibodies significantly reduced parasite infectivity for mosquitoes. These results suggest that plasmepsin 4, previously known only to function in the digestive vacuole of asexual blood stage Plasmodium, plays a role in how the ookinete interacts with the mosquito midgut interactions as it becomes an oocyst. These data are the first to delineate a role for an aspartic protease in mediating Plasmodium invasion of the mosquito and demonstrate the potential for plasmepsin 4 as a malaria transmission-blocking vaccine target.	[Vinetz, Joseph M.] Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis,George Palade Labs, La Jolla, CA 92093 USA; [Yowell, Charles A.; Dame, John B.] Univ Florida, Coll Vet Med, Dept Pathobiol, Gainesville, FL 32608 USA	University of California System; University of California San Diego; State University System of Florida; University of Florida	Vinetz, JM (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, Div Infect Dis,George Palade Labs, 9500 Gilman Dr 0741,Rm 125, La Jolla, CA 92093 USA.	jvinetz@ucsd.edu		Vinetz, Joseph/0000-0001-8344-2004; Dame, John B./0000-0002-5772-5454	USPHS [AI45999]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045999] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI45999 from the USPHS.	Abraham EG, 2004, J BIOL CHEM, V279, P5573, DOI 10.1074/jbc.M307582200; Banerjee R, 2003, MOL BIOCHEM PARASIT, V129, P157, DOI 10.1016/S0166-6851(03)00119-1; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Bonilla JA, 2007, MOL MICROBIOL, V65, P64, DOI 10.1111/j.1365-2958.2007.05768.x; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Coombs GH, 2001, TRENDS PARASITOL, V17, P532, DOI 10.1016/S1471-4922(01)02037-2; Dame JB, 2003, MOL BIOCHEM PARASIT, V130, P1, DOI 10.1016/S0166-6851(03)00137-3; De Vries L, 1998, MOL BIOL CELL, V9, P1123, DOI 10.1091/mbc.9.5.1123; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; FRANCIS SE, 1994, EMBO J, V13, P306, DOI 10.1002/j.1460-2075.1994.tb06263.x; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Haque TS, 1999, J MED CHEM, V42, P1428, DOI 10.1021/jm980641t; Kaneko O, 2006, PARASITOL INT, V55, P227, DOI 10.1016/j.parint.2006.04.003; Kaslow DC, 2002, CHEM IMMUNOL, V80, P287; KAUSHAL DC, 1984, MOL BIOCHEM PARASIT, V11, P145, DOI 10.1016/0166-6851(84)90061-6; Langer RC, 2002, INFECT IMMUN, V70, P102, DOI 10.1128/IAI.70.1.102-106.2002; Le Bonniec S, 1999, J BIOL CHEM, V274, P14218, DOI 10.1074/jbc.274.20.14218; Li FW, 2005, J INFECT DIS, V192, P878, DOI 10.1086/432552; Li FW, 2004, J BIOL CHEM, V279, P26635, DOI 10.1074/jbc.M401385200; Li T, 2004, MOL BIOCHEM PARASIT, V135, P101, DOI 10.1016/j.molbiopara.2004.01.010; Limviroj W, 2002, J PARASITOL, V88, P664, DOI 10.1645/0022-3395(2002)088[0664:IEMOOP]2.0.CO;2; Malkin EM, 2005, VACCINE, V23, P3131, DOI 10.1016/j.vaccine.2004.12.019; Moskalyk LA, 1996, INSECT MOL BIOL, V5, P261, DOI 10.1111/j.1365-2583.1996.tb00100.x; Nezami A, 2002, BIOCHEMISTRY-US, V41, P2273, DOI 10.1021/bi0117549; Patra KP, 2008, PROTEOMICS, V8, P2492, DOI 10.1002/pmic.200700727; ROSENTHAL PJ, 1995, EXP PARASITOL, V80, P272, DOI 10.1006/expr.1995.1033; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Saul A, 2007, CURR OPIN INFECT DIS, V20, P476, DOI 10.1097/QCO.0b013e3282a95e12; SHAHABUDDIN M, 1995, EXP PARASITOL, V80, P212, DOI 10.1006/expr.1995.1026; Shen ZC, 1997, J BIOL CHEM, V272, P28895, DOI 10.1074/jbc.272.46.28895; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; Templeton TJ, 2000, MOL MICROBIOL, V36, P1, DOI 10.1046/j.1365-2958.2000.01821.x; Tomas AM, 2001, EMBO J, V20, P3975, DOI 10.1093/emboj/20.15.3975; Tsai YL, 2001, INFECT IMMUN, V69, P4048, DOI 10.1128/IAI.69.6.4048-4054.2001; Vinetz JM, 1999, P NATL ACAD SCI USA, V96, P14061, DOI 10.1073/pnas.96.24.14061; Vinetz JM, 2005, CURR TOP MICROBIOL, V295, P357; WINGER LA, 1988, PARASITE IMMUNOL, V10, P193, DOI 10.1111/j.1365-3024.1988.tb00214.x; Wyatt DM, 2002, FEBS LETT, V513, P159, DOI 10.1016/S0014-5793(02)02241-X; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007; Yuda M, 2001, MOL BIOCHEM PARASIT, V116, P65, DOI 10.1016/S0166-6851(01)00304-8	41	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8076	8083		10.1074/jbc.M109.063388	http://dx.doi.org/10.1074/jbc.M109.063388			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20056606	Green Published, hybrid			2022-12-27	WOS:000275413800025
J	Cai, JJ; Crotty, TM; Reichert, E; Carraway, KL; Stafforini, DM; Topham, MK				Cai, Jinjin; Crotty, Tracy M.; Reichert, Ethan; Carraway, Kermit L., III; Stafforini, Diana M.; Topham, Matthew K.			Diacylglycerol Kinase delta and Protein Kinase C alpha Modulate Epidermal Growth Factor Receptor Abundance and Degradation through Ubiquitin-specific Protease 8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOWN-REGULATION; MEDIATED ENDOCYTOSIS; EGFR MUTATIONS; LUNG-CANCER; ACTIVATION; PHOSPHORYLATION; INTERNALIZATION; UBPY; ZETA; TRAFFICKING	Many human epithelial cancers are characterized by abnormal activation of the epidermal growth factor receptor (EGFR), which is often caused by its excessive expression in tumor cells. The abundance of EGFR is modulated, in part, by its ubiquitination, which targets it for degradation. The components responsible for adding ubiquitin to EGFR are well characterized, but this is a reversible process, and the mechanisms that modulate the removal of ubiquitin from the EGFR are not well known. We found that de-ubiquitination of EGFR was regulated by diacylglycerol kinase delta (DGK delta), a lipid kinase that terminates diacylglycerol signaling. In DGK delta-deficient cells, ubiquitination of EGFR was enhanced, which attenuated the steady-state levels of EGFR and promoted its ligand-induced degradation. These effects were not caused by changes in the ubiquitinating apparatus, but instead were due to reduced expression of the deubiquitinase, ubiquitin-specific protease 8 (USP8). Depletion of protein kinase C alpha (PKC alpha), a target of diacylglycerol, rescued the levels of USP8 and normalized EGFR degradation in DGK delta-deficient cells. Moreover, the effects of PKC alpha were caused by its inhibition of Akt, which stabilizes USP8. Our data indicate a novel mechanism where DGK delta and PKC delta modulate the levels of ubiquitinated EGFR through Akt and USP8.	[Cai, Jinjin; Crotty, Tracy M.; Reichert, Ethan; Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Cai, Jinjin; Topham, Matthew K.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Stafforini, Diana M.; Topham, Matthew K.] Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; [Carraway, Kermit L., III] Univ Calif Davis, Ctr Canc, Sacramento, CA 95817 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California Davis	Topham, MK (corresponding author), 2000 E Circle Hope, Salt Lake City, UT 84112 USA.	matt.topham@hci.utah.edu	cai, jinjin/I-7005-2012		National Institutes of Health [R01-CA95463, P01-CA73992, R01-CA123541]; Huntsman Cancer Foundation; R. Harold Burton Foundation; Cancer Center Support [P30-CA042014]; NATIONAL CANCER INSTITUTE [R01CA095463, P01CA073992, R01CA123541, P30CA042014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntsman Cancer Foundation; R. Harold Burton Foundation; Cancer Center Support; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-CA95463 (to M. K. T.), P01-CA73992 to D. M. S.), and R01-CA123541 (to K. L. C.). This work was also supported by the Huntsman Cancer Foundation, the R. Harold Burton Foundation, and by the Cancer Center Support Grant P30-CA042014 for support of core facilities.	Bacchiocchi R, 2005, BLOOD, V106, P2175, DOI 10.1182/blood-2005-01-0316; Baldanzi G, 2004, ONCOGENE, V23, P4828, DOI 10.1038/sj.onc.1207633; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; BEGUINOT L, 1985, P NATL ACAD SCI USA, V82, P2774, DOI 10.1073/pnas.82.9.2774; Buchanan FG, 2007, CANCER RES, V67, P9380, DOI 10.1158/0008-5472.CAN-07-0710; Cao ZW, 2007, MOL CELL BIOL, V27, P2180, DOI 10.1128/MCB.01245-06; Chianale F, 2007, MOL BIOL CELL, V18, P4859, DOI 10.1091/mbc.E07-02-0177; Crotty T, 2006, P NATL ACAD SCI USA, V103, P15485, DOI 10.1073/pnas.0604104103; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Guan LJ, 2007, J BIOL CHEM, V282, P14213, DOI 10.1074/jbc.M610513200; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Imai S, 2009, BBA-MOL CELL BIOL L, V1791, P246, DOI 10.1016/j.bbalip.2009.01.024; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LUND KA, 1990, J BIOL CHEM, V265, P20517; Luo B, 2003, J CELL BIOL, V160, P929, DOI 10.1083/jcb.200208120; Luo B, 2003, J BIOL CHEM, V278, P39542, DOI 10.1074/jbc.M307153200; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Mizuno E, 2007, EXP CELL RES, V313, P3624, DOI 10.1016/j.yexcr.2007.07.028; Niendorf S, 2007, MOL CELL BIOL, V27, P5029, DOI 10.1128/MCB.01566-06; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; Sakane F, 1996, J BIOL CHEM, V271, P8394, DOI 10.1074/jbc.271.14.8394; Schmidt MHH, 2005, NAT REV MOL CELL BIO, V6, P907, DOI 10.1038/nrm1762; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Topham MK, 2001, J CELL BIOL, V152, P1135, DOI 10.1083/jcb.152.6.1135; Torrance CJ, 2000, NAT MED, V6, P1024, DOI 10.1038/79534; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Yasuda S, 2009, J BIOL CHEM, V284, P29559, DOI 10.1074/jbc.M109.043604; Zhong XP, 2003, NAT IMMUNOL, V4, P882, DOI 10.1038/ni958	37	19	19	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6952	6959		10.1074/jbc.M109.055731	http://dx.doi.org/10.1074/jbc.M109.055731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20064931	hybrid, Green Published			2022-12-27	WOS:000275415600008
J	Grygoruk, A; Fei, H; Daniels, RW; Miller, BR; DiAntonio, A; Krantz, DE				Grygoruk, Anna; Fei, Hao; Daniels, Richard W.; Miller, Bradley R.; DiAntonio, Aaron; Krantz, David E.			A Tyrosine-based Motif Localizes a Drosophila Vesicular Transporter to Synaptic Vesicles in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSE CORE VESICLES; CENTRAL-NERVOUS-SYSTEM; CLONAL CELL-LINES; ACETYLCHOLINE TRANSPORTER; MONOAMINE TRANSPORTER-2; GLUTAMATE TRANSPORTER; PC12 CELLS; NEUROTRANSMITTER CANDIDATES; DOPAMINERGIC-NEURONS; AMINE TRANSPORTER	Vesicular neurotransmitter transporters must localize to synaptic vesicles (SVs) to allow regulated neurotransmitter release at the synapse. However, the signals required to localize vesicular proteins to SVs in vivo remain unclear. To address this question we have tested the effects of mutating proposed trafficking domains in Drosophila orthologs of the vesicular monoamine and glutamate transporters, DVMAT-A and DVGLUT. We show that a tyrosine-based motif (YXXY) is important both for DVMAT-A internalization from the cell surface in vitro, and localization to SVs in vivo. In contrast, DVGLUT deletion mutants that lack a putative C-terminal trafficking domain show more modest defects in both internalization in vitro and trafficking to SVs in vivo. Our data show for the first time that mutation of a specific trafficking motif can disrupt localization to SVs in vivo and suggest possible differences in the sorting of VMATs versus VGLUTs to SVs at the synapse.	Univ Calif Los Angeles, David Geffen Sch Med,Dept Psychiat & Biobehav Sci, Semel Inst Neurosci & Human Behav, Hatos Ctr Neuropharmacol, Los Angeles, CA 90095 USA; [Daniels, Richard W.; Miller, Bradley R.; DiAntonio, Aaron] Washington Univ, Dept Dev Biol, Sch Med, St Louis, MO 63110 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Washington University (WUSTL)	Krantz, DE (corresponding author), Gonda Goldschmied Neurosci & Genet Res Ctr, 695 S Charles E Young Dr, Los Angeles, CA 90095 USA.	dkrantz@ucla.edu	Miller, Bradley/G-7426-2014	DiAntonio, Aaron/0000-0002-7262-0968	National Institute of Mental Health [MH076900]; National Institutes of Health [ES015747]; NIEHS [ES016732]; National Institute on Drug Abuse [DA020812]; NIDDK [NS051453]; UCLA Molecular and Cellular and Neurobiology Training [T32MH019384]; Achievement Reward for College Scientists Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015747, P01ES016732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019384, R01MH076900] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020812] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); UCLA Molecular and Cellular and Neurobiology Training; Achievement Reward for College Scientists Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institute of Mental Health Grant MH076900, National Institutes of Health Grants ES015747 (to D. E. K.) and ES016732 (to M. F. Chesselet) from NIEHS, National Institute on Drug Abuse Grant DA020812, and National Institutes of Health Grant NS051453 from NIDDK (to A. D.). This work was also supported by UCLA Molecular and Cellular and Neurobiology Training Grant T32MH019384 and the Achievement Reward for College Scientists Foundation (to A. G.).	Barbosa J, 2002, J NEUROCHEM, V82, P1221, DOI 10.1046/j.1471-4159.2002.01068.x; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BUTTERWORTH FM, 1995, MUTAT RES-GENET TOX, V342, P61, DOI 10.1016/0165-1218(95)90090-X; Caudle WM, 2007, J NEUROSCI, V27, P8138, DOI 10.1523/JNEUROSCI.0319-07.2007; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Chen CXQ, 2005, NEUROBIOL DIS, V19, P419, DOI 10.1016/j.nbd.2005.01.014; Colgan L, 2007, TRAFFIC, V8, P512, DOI 10.1111/j.1600-0854.2007.00555.x; Daniels RW, 2008, J COMP NEUROL, V508, P131, DOI 10.1002/cne.21670; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; De Gois S, 2006, CELL MOL NEUROBIOL, V26, P679, DOI 10.1007/s10571-006-9054-8; Edwards R H, 1992, Curr Opin Neurobiol, V2, P586, DOI 10.1016/0959-4388(92)90023-E; Eiden LE, 2004, PFLUG ARCH EUR J PHY, V447, P636, DOI 10.1007/s00424-003-1100-5; Estes PS, 1996, J NEUROSCI, V16, P5443; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Fei H, 2008, TRAFFIC, V9, P1425, DOI 10.1111/j.1600-0854.2008.00771.x; Fei H, 2007, J NEUROCHEM, V101, P1662, DOI 10.1111/j.1471-4159.2007.04518.x; Ferreira LT, 2005, J NEUROCHEM, V94, P957, DOI 10.1111/j.1471-4159.2005.03244.x; Fleckenstein AE, 2003, EUR J PHARMACOL, V479, P283, DOI 10.1016/j.ejphar.2003.08.077; Fleckenstein AE, 2009, NEUROPHARMACOLOGY, V56, P133, DOI 10.1016/j.neuropharm.2008.07.002; Fumagalli F, 1999, J NEUROSCI, V19, P2424; Gainetdinov RR, 1998, J NEUROCHEM, V70, P1973; GREENSPAN RJ, 1997, FLY PUSHING THEORY P, P3; Greer CL, 2005, J NEUROBIOL, V64, P239, DOI 10.1002/neu.20146; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Jahn R, 2007, TRAFFIC, V8, P1121, DOI 10.1111/j.1600-0854.2007.00615.x; Kim MH, 2004, J BIOL CHEM, V279, P12580, DOI 10.1074/jbc.M310681200; Kim MH, 2000, J BIOL CHEM, V275, P6175, DOI 10.1074/jbc.275.9.6175; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Larsen KE, 2002, J NEUROSCI, V22, P8951; Li HY, 2005, NEURON, V48, P619, DOI 10.1016/j.neuron.2005.09.033; Little KY, 2003, AM J PSYCHIAT, V160, P47, DOI 10.1176/appi.ajp.160.1.47; LIU Y, 1992, P NATL ACAD SCI USA, V89, P9074, DOI 10.1073/pnas.89.19.9074; LIU YJ, 1992, CELL, V70, P539, DOI 10.1016/0092-8674(92)90425-C; LIU YJ, 1994, J CELL BIOL, V127, P1419, DOI 10.1083/jcb.127.5.1419; Liu YJ, 1997, J CELL BIOL, V139, P907, DOI 10.1083/jcb.139.4.907; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; REGNIERVIGOUROUX A, 1991, EMBO J, V10, P3589, DOI 10.1002/j.1460-2075.1991.tb04925.x; Reimer RJ, 2004, PFLUG ARCH EUR J PHY, V447, P629, DOI 10.1007/s00424-003-1087-y; Romero-Calderon R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000245; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; Salazar G, 2005, J CELL SCI, V118, P1911, DOI 10.1242/jcs.02319; Sandoval V, 2002, J NEUROSCI, V22, P8705; Sang TK, 2007, J NEUROSCI, V27, P981, DOI 10.1523/JNEUROSCI.4810-06.2007; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; UITEI K, 1995, NEUROSCI LETT, V195, P187, DOI 10.1016/0304-3940(95)11815-E; UITEI K, 1994, NEUROSCI LETT, V174, P85, DOI 10.1016/0304-3940(94)90125-2; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; Varoqui H, 1998, J BIOL CHEM, V273, P9094, DOI 10.1074/jbc.273.15.9094; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Waites CL, 2001, J CELL BIOL, V152, P1159, DOI 10.1083/jcb.152.6.1159; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Yao J, 2007, J NEUROCHEM, V100, P1387, DOI 10.1111/j.1471-4159.2006.04326.x; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150; Zubieta JK, 2000, AM J PSYCHIAT, V157, P1619, DOI 10.1176/appi.ajp.157.10.1619; Zubieta JK, 2001, BIOL PSYCHIAT, V49, P110, DOI 10.1016/S0006-3223(00)00981-1	64	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6867	6878		10.1074/jbc.M109.073064	http://dx.doi.org/10.1074/jbc.M109.073064			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053989	Green Published, hybrid			2022-12-27	WOS:000275415600001
J	Preston, P; Wartosch, L; Gunzel, D; Fromm, M; Kongsuphol, P; Ousingsawat, J; Kunzelmann, K; Barhanin, J; Warth, R; Jentsch, TJ				Preston, Patricia; Wartosch, Lena; Guenzel, Dorothee; Fromm, Michael; Kongsuphol, Patthara; Ousingsawat, Jiraporn; Kunzelmann, Karl; Barhanin, Jacques; Warth, Richard; Jentsch, Thomas J.			Disruption of the K+ Channel beta-Subunit KCNE3 Reveals an Important Role in Intestinal and Tracheal Cl- Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNELS; I-KS; CHLORIDE SECRETION; MOUSE MODEL; MEMBRANE-PROTEIN; CHROMANOL 293B; USSING CHAMBER; CAUSE JERVELL; RABBIT COLON; CONDUCTANCE	The KCNE3 beta-subunit constitutively opens outwardly rectifying KCNQ1 (Kv7.1) K+ channels by abolishing their voltage-dependent gating. The resulting KCNQ1/KCNE3 heteromers display enhanced sensitivity to K+ channel inhibitors like chromanol 293B. KCNE3 was also suggested to modify biophysical properties of several other K+ channels, and a mutation in KCNE3 was proposed to underlie forms of human periodic paralysis. To investigate physiological roles of KCNE3, we now disrupted its gene in mice. kcne3(-/-) mice were viable and fertile and displayed neither periodic paralysis nor other obvious skeletal muscle abnormalities. KCNQ1/KCNE3 heteromers are present in basolateral membranes of intestinal and tracheal epithelial cells where they might facilitate transepithelial Cl- secretion through basolateral recycling of K+ ions and by increasing the electrochemical driving force for apical Cl- exit. Indeed, cAMP-stimulated electrogenic Cl- secretion across tracheal and intestinal epithelia was drastically reduced in kcne3(-/-) mice. Because the abundance and subcellular localization of KCNQ1 was unchanged in kcne3(-/-) mice, the modification of biophysical properties of KCNQ1 by KCNE3 is essential for its role in intestinal and tracheal transport. Further, these results suggest KCNE3 as a potential modifier gene in cystic fibrosis.	[Jentsch, Thomas J.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Guenzel, Dorothee; Fromm, Michael; Kunzelmann, Karl] Charite, Inst Klin Physiol, D-12203 Berlin, Germany; [Kongsuphol, Patthara; Ousingsawat, Jiraporn; Warth, Richard] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany; [Barhanin, Jacques] CNRS, F-06108 Nice 2, France; [Barhanin, Jacques] Univ Nice Sophia Antipolis, F-06108 Nice 2, France; [Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Regensburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP)	Jentsch, TJ (corresponding author), Leibniz Inst Mol Pharmacol, Robert Rossle Str 10, D-13125 Berlin, Germany.	Jentsch@fmp-berlin.de	Warth, Richard/N-7119-2014; Fromm, Michael/K-6203-2013	Warth, Richard/0000-0001-6084-0659; Fromm, Michael/0000-0003-4497-7983; Gunzel, Dorothee/0000-0002-7998-7164; Jentsch, Thomas/0000-0002-3509-2553; Preston Ferrer, patricia/0000-0002-7456-2693; Kunzelmann, Karl/0000-0002-4583-7037	Prix Louis Jeantet de Medecine; Deutsche Forschungsgemeinschaft [SFB699-A6]	Prix Louis Jeantet de Medecine; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by the Prix Louis Jeantet de Medecine (to T. J. J.) and Deutsche Forschungsgemeinschaft Grant SFB699-A6 (to K. K.).	Abbott GW, 2006, FASEB J, V20, P293, DOI 10.1096/fj.05-5070com; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Amasheh S, 2009, BIOCHEM BIOPH RES CO, V378, P45, DOI 10.1016/j.bbrc.2008.10.164; Arrighi I, 2001, P NATL ACAD SCI USA, V98, P8792, DOI 10.1073/pnas.141233398; Bachmann A, 2001, N-S ARCH PHARMACOL, V363, P590, DOI 10.1007/s002100100410; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; CLARKE LL, 1992, SCIENCE, V257, P1125, DOI 10.1126/science.257.5073.1125; Da Silva MRD, 2002, J CLIN ENDOCR METAB, V87, P4881, DOI 10.1210/jc.2002-020698; Dedek K, 2001, PFLUG ARCH EUR J PHY, V442, P896, DOI 10.1007/s004240100609; Diener M, 1996, BRIT J PHARMACOL, V118, P1477, DOI 10.1111/j.1476-5381.1996.tb15563.x; Drici MD, 1998, CIRC RES, V83, P95, DOI 10.1161/01.RES.83.1.95; Farthing Michael J G, 2004, Curr Gastroenterol Rep, V6, P177, DOI 10.1007/s11894-004-0001-x; Flores CA, 2007, J PHYSIOL-LONDON, V583, P705, DOI 10.1113/jphysiol.2007.134387; Fontaine B, 2008, ADV GENET, V63, P3, DOI 10.1016/S0065-2660(08)01001-8; Gitter AH, 1997, J BIOCHEM BIOPH METH, V35, P81, DOI 10.1016/S0165-022X(97)00028-6; Grahammer F, 2001, J BIOL CHEM, V276, P42268, DOI 10.1074/jbc.M105014200; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; Greger R, 1997, COMP BIOCHEM PHYS A, V118, P271, DOI 10.1016/S0300-9629(96)00304-0; Gunzel D, 2006, AM J PHYSIOL-REG I, V290, pR1496, DOI 10.1152/ajpregu.00470.2005; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1012, DOI 10.1212/01.WNL.0000119392.29624.88; Jurkat-Rott K, 2007, NEUROTHERAPEUTICS, V4, P216, DOI 10.1016/j.nurt.2007.02.001; Kottgen M, 2003, J CLIN INVEST, V111, P371, DOI 10.1172/JCI200316711; KUNZELMANN K, 1995, PFLUG ARCH EUR J PHY, V431, P1, DOI 10.1007/BF00374371; Lange PF, 2006, NATURE, V440, P220, DOI 10.1038/nature04535; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Lerche C, 2007, MOL PHARMACOL, V71, P1503, DOI 10.1124/mol.106.031682; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Liao TJ, 2005, AM J PHYSIOL-CELL PH, V289, pC564, DOI 10.1152/ajpcell.00561.2004; LOHRMANN E, 1995, PFLUG ARCH EUR J PHY, V429, P517, DOI 10.1007/BF00704157; Lundquist AL, 2006, GENOMICS, V87, P119, DOI 10.1016/j.ygeno.2005.09.004; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; MacVinish LJ, 2001, MOL PHARMACOL, V60, P753; MacVinish LJ, 1998, J PHYSIOL-LONDON, V510, P237, DOI 10.1111/j.1469-7793.1998.237bz.x; Matthews JB, 1998, J CLIN INVEST, V101, P2072, DOI 10.1172/JCI1042; McCrossan ZA, 2003, J NEUROSCI, V23, P8077; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Ohno S, 2009, HUM MUTAT, V30, P557, DOI 10.1002/humu.20834; Reynolds A, 2007, J PHYSIOL-LONDON, V582, P507, DOI 10.1113/jphysiol.2007.129718; Rickheit G, 2008, EMBO J, V27, P2907, DOI 10.1038/emboj.2008.203; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; Sanguinetti MC, 2000, TRENDS PHARMACOL SCI, V21, P199, DOI 10.1016/S0165-6147(00)01475-9; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Sternberg D, 2003, NEUROLOGY, V61, P857, DOI 10.1212/01.WNL.0000082392.66713.E3; Stockmann M, 1999, PFLUG ARCH EUR J PHY, V438, P107, DOI 10.1007/s004240050886; STRABEL D, 1995, EUR J PHARMACOL, V274, P181, DOI 10.1016/0014-2999(94)00728-P; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; Suessbrich H, 1996, FEBS LETT, V396, P271, DOI 10.1016/0014-5793(96)01113-1; SUGIMOTO T, 1990, J MEMBRANE BIOL, V113, P39, DOI 10.1007/BF01869604; TAKUMI T, 1988, SCIENCE, V242, P1042, DOI 10.1126/science.3194754; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tinel N, 2000, FEBS LETT, V480, P137, DOI 10.1016/S0014-5793(00)01918-9; Tyson J, 1997, HUM MOL GENET, V6, P2179, DOI 10.1093/hmg/6.12.2179; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Vetter DE, 1996, NEURON, V17, P1251, DOI 10.1016/S0896-6273(00)80255-X; Warth R, 2002, PFLUG ARCH EUR J PHY, V443, P822, DOI 10.1007/s00424-001-0751-3; Warth R, 1996, PFLUG ARCH EUR J PHY, V432, P81, DOI 10.1007/s004240050108; Warth R, 1999, PFLUG ARCH EUR J PHY, V438, P437, DOI 10.1007/s004240051059; WELSH MJ, 1982, SCIENCE, V218, P1219, DOI 10.1126/science.6293054; Zdebik AA, 2004, J BIOL CHEM, V279, P22276, DOI 10.1074/jbc.M309899200; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839	72	74	75	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7165	7175		10.1074/jbc.M109.047829	http://dx.doi.org/10.1074/jbc.M109.047829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051516	Green Published, hybrid			2022-12-27	WOS:000275415600030
J	Rohrl, J; Yang, D; Oppenheim, JJ; Hehlgans, T				Roehrl, Johann; Yang, De; Oppenheim, Joost J.; Hehlgans, Thomas			Specific Binding and Chemotactic Activity of mBD4 and Its Functional Orthologue hBD2 to CCR6-expressing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-DEFENSINS; HUMAN BETA-DEFENSIN-3; DENDRITIC CELLS; EXPRESSION; IMMUNITY; KERATINOCYTES; INDUCTION; PEPTIDES; IMMATURE; INNATE	beta-Defensins are small antimicrobial polypeptides that are mainly expressed by epithelial cells and play an important role in the antimicrobial innate immune response. In addition to the direct microbicidal effects of these polypeptides, members of the beta-defensin super family have the capacity to promote local innate inflammatory and systemic adaptive immune responses, which are in part mediated by the CC-chemokine receptor CCR6. Here we report the expression of recombinant mBD4 and its human orthologue hBD2 fused to the constant domain of human IgG(1) to obtain correct folding and to increase stability and solubility using the Drosophila S2 expression system. Purified recombinant mBD4:Ig and hBD2: Ig fusion proteins retained potent antimicrobial activity against Gram-negative and Gram-positive bacteria. Furthermore, these beta-defensin fusion proteins showed specific binding to CCR6-expressing cells as revealed by flow cytometry. Interestingly, although hBD2: Ig bound to both human and mouse CCR6-expressing cells, mBD4: Ig did only bind to mCCR6-expressing cells but not to hCCR6-expressing cells. Both beta-defensin fusion proteins demonstrated chemotactic activity for cells expressing the mouse CC-chemokine receptor CCR6. The chemokine ligand CCL20 competed with the beta-defensin fusion proteins for specific binding to CCR6 as analyzed by fluorescence-activated cell sorter analysis. Both beta-defensin fusion proteins demonstrated chemotactic activity for cells expressing the mouse CCR6 receptor, but mBD4: Ig did not induce chemotactic activity of cells expressing human CCR6. This result supports our finding that mBD4 does not interact with human CCR6-expressing cells. Further evidence for specific interaction of the beta-defensin fusion proteins with CCR6-expressing cells is demonstrated by the observation that CCL20 and beta-defensin fusion proteins desensitize each other in inducing chemotactic activity. In addition both mBD4: Ig and hBD2: Ig demonstrated CCR6-independent chemotaxis of freshly isolated mouse resident peritoneal cells and human peripheral blood mononuclear cells, indicating the interaction with another chemotaxis-inducing receptor. Thus, the beta-defensin fusion proteins used in this study retained their biological activity and are a feasible tool to identify and analyze specific beta-defensin receptor interactions.	[Hehlgans, Thomas] Univ Regensburg, Inst Immunol, D-93042 Regensburg, Germany; [Yang, De; Oppenheim, Joost J.] NCI Frederick, Mol Immunoregulat Lab, Canc & Inflammat Program, Ctr Canc Res,Div Basic Sci,NIH, Frederick, MD 21702 USA	University of Regensburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Hehlgans, T (corresponding author), Univ Regensburg, Inst Immunol, Franz Josef Strauss Allee 11, D-93042 Regensburg, Germany.	thomas.hehlgans@klinik.uni-regensburg.de			Bayerische Forschungsstifung [PDOK-62-08]; NATIONAL CANCER INSTITUTE [ZIABC009369] Funding Source: NIH RePORTER	Bayerische Forschungsstifung; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by Bayerische Forschungsstifung Grant PDOK-62-08 (to T.H.).	Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Chong KT, 2008, VIROLOGY, V380, P136, DOI 10.1016/j.virol.2008.07.024; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x; Harder J, 2004, J INVEST DERMATOL, V123, P522, DOI 10.1111/j.0022-202X.2004.23234.x; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Hinrichsen K, 2008, ANTIMICROB AGENTS CH, V52, P1876, DOI 10.1128/AAC.01308-07; Ishimoto H, 2006, EUR RESPIR J, V27, P253, DOI 10.1183/09031936.06.00105904; Jia HP, 2000, J BIOL CHEM, V275, P33314, DOI 10.1074/jbc.M006603200; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; PIERS KL, 1993, GENE, V134, P7, DOI 10.1016/0378-1119(93)90168-3; Rivas-Santiago B, 2006, J INFECT DIS, V194, P697, DOI 10.1086/506454; Roehrl J, 2008, J BIOL CHEM, V283, P5414, DOI 10.1074/jbc.M709103200; Soruri A, 2007, EUR J IMMUNOL, V37, P2474, DOI 10.1002/eji.200737292; Taylor K, 2008, J BIOL CHEM, V283, P6631, DOI 10.1074/jbc.M709238200; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Vargues T, 2009, PROTEIN PEPTIDE LETT, V16, P668, DOI 10.2174/092986609788490122; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yin CY, 2006, INT J ANTIMICROB AG, V28, P352, DOI 10.1016/j.ijantimicag.2006.08.003	25	57	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7028	7034		10.1074/jbc.M109.091090	http://dx.doi.org/10.1074/jbc.M109.091090			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20068036	Green Published, hybrid			2022-12-27	WOS:000275415600016
J	Wernick, NLB; De Luca, H; Kam, WR; Lencer, WI				Wernick, Naomi L. B.; De Luca, Heidi; Kam, Wendy R.; Lencer, Wayne I.			N-terminal Extension of the Cholera Toxin A1-chain Causes Rapid Degradation after Retrotranslocation from Endoplasmic Reticulum to Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRO-TRANSLOCATION; AAA-ATPASE; PATHWAY; DESTRUCTION; SUBSTRATE; TRANSPORT; PROTEINS; DISORDER; SUBUNIT; CELLS	Cholera toxin travels from the plasma membrane to the endoplasmic reticulum of host cells, where a portion of the toxin, the A1-chain, is unfolded and targeted to a protein-conducting channel for retrotranslocation to the cytosol. Unlike most retrotranslocation substrates, the A1-chain escapes degradation by the proteasome and refolds in the cytosol to induce disease. How this occurs remains poorly understood. Here, we show that an unstructured peptide appended to the N terminus of the A1-chain renders the toxin functionally inactive. Cleavage of the peptide extension prior to cell entry rescues toxin half-life and function. The loss of toxicity is explained by rapid degradation by the proteasome after retrotranslocation to the cytosol. Degradation of the mutant toxin does not follow the N-end rule but depends on the two Lys residues at positions 4 and 17 of the native A1-chain, consistent with polyubiquitination at these sites. Thus, retrotranslocation and refolding of the wild-type A1-chain must proceed in a way that protects these Lys residues from attack by E3 ligases.	[Wernick, Naomi L. B.; De Luca, Heidi; Kam, Wendy R.; Lencer, Wayne I.] Childrens Hosp Boston, Gastrointestinal Cell Biol Lab, Boston, MA 02115 USA; [Lencer, Wayne I.] Harvard Digest Dis Ctr, Boston, MA 02115 USA; [Wernick, Naomi L. B.; De Luca, Heidi; Kam, Wendy R.; Lencer, Wayne I.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Lencer, WI (corresponding author), Childrens Hosp Boston, Gastrointestinal Cell Biol Lab, 300 Longwood Ave,Enders 720, Boston, MA 02115 USA.	wayne.lencer@childrens.harvard.edu		Lencer, Wayne/0000-0001-7346-2730	National Institutes of Health [RO1 DK48106, F32 DK078426]; Harvard Digestive Diseases Center [P30 DK034854]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084424, F32DK078426, P30DK034854, R01DK048106] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 DK48106 (to W.I.L.) and F32 DK078426 (N.L.B.W.). This work was also supported by Harvard Digestive Diseases Center Grant P30 DK034854.	Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Bernardi KM, 2010, MOL BIOL CELL, V21, P140, DOI 10.1091/mbc.E09-07-0586; Dixit G, 2008, EXP BIOL MED, V233, P163, DOI 10.3181/0705-RM-132; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; JOBLING MG, 1991, MOL MICROBIOL, V5, P1755, DOI 10.1111/j.1365-2958.1991.tb01925.x; Kothe M, 2005, J BIOL CHEM, V280, P28127, DOI 10.1074/jbc.M503138200; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; LENCER WI, 1995, P NATL ACAD SCI USA, V92, P10094, DOI 10.1073/pnas.92.22.10094; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lencer WI, 1997, J BIOL CHEM, V272, P15562, DOI 10.1074/jbc.272.24.15562; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; Pande AH, 2007, J MOL BIOL, V374, P1114, DOI 10.1016/j.jmb.2007.10.025; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schmitz A, 2000, J CELL BIOL, V148, P1203, DOI 10.1083/jcb.148.6.1203; SPANGLER BD, 1992, MICROBIOL REV, V56, P622, DOI 10.1128/MMBR.56.4.622-647.1992; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; WALTER P, 1983, METHOD ENZYMOL, V96, P84; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a	29	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6145	6152		10.1074/jbc.M109.062067	http://dx.doi.org/10.1074/jbc.M109.062067			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20056601	Green Published, hybrid			2022-12-27	WOS:000275367500018
J	Beleford, D; Rattan, R; Chien, J; Shridhar, V				Beleford, Daniah; Rattan, Ramandeep; Chien, Jeremy; Shridhar, Viji			High Temperature Requirement A3 (HtrA3) Promotes Etoposide- and Cisplatin-induced Cytotoxicity in Lung Cancer Cell Lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE-PROTEASE OMI/HTRA2; OVARIAN-CANCER; APOPTOSIS; INHIBITOR; PROTEINS; DEATH; XIAP; IDENTIFICATION; MITOCHONDRIA; CHEMOTHERAPY	Lung cancer is the leading cause of cancer-related deaths worldwide. Here we show for the first time that HtrA3 is a mitochondrial stress-response factor that promotes cytotoxicity to etoposide and cisplatin in lung cancer cell lines. Exogenous expression of wild type HtrA3 domain variants significantly attenuated cell survival with etoposide and cisplatin treatment in lung cancer cell lines H157 and A549 compared with expression of protease inactive mutants (S305A) or vector control. Conversely, HtrA3 suppression promoted cell survival with etoposide and cisplatin treatment in lung cancer cell lines Hop62 and HCC827. Survival was attenuated by re-expression of wild type HtrA3 variants during treatment but not by protease inactive mutants or vector control. HtrA3 also co-fractionated and co-localized with mitochondrial markers with both endogenous and exogenous expression in normal lung and lung cancer cell lines but was translocated from mitochondria following etoposide treatment. Moreover, HtrA3 translocation from mitochondria correlated with an increase in cell death that was attenuated by either HtrA3 suppression or Bcl-2 overexpression. Taken together, these results suggest that HtrA3 may be a previously uncharacterized mitochondrial cell death effector whose serine protease function may be crucial to modulating etoposide-and cisplatin-induced cytotoxicity in lung cancer cell lines.	[Beleford, Daniah; Rattan, Ramandeep; Chien, Jeremy; Shridhar, Viji] Mayo Clin, Coll Med, Dept Expt Pathol, Rochester, MN 55905 USA	Mayo Clinic	Shridhar, V (corresponding author), Mayo Clin, Coll Med, Dept Expt Pathol, Stabile 2-47,200 1st St SW, Rochester, MN 55905 USA.	shridhar.vijayalakshmi@mayo.edu	Seal, Sudipta/A-7698-2012; Chien, Jeremy/AID-8939-2022	Chien, Jeremy/0000-0003-4744-8374	Edith and Bernard Waterman Foundation; Mayo Foundation	Edith and Bernard Waterman Foundation; Mayo Foundation	This work was supported by the Edith and Bernard Waterman Foundation and the Mayo Foundation (to V. S.).	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Babcock M, 1997, SCIENCE, V276, P1709, DOI 10.1126/science.276.5319.1709; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bunn Paul A Jr, 2004, Clin Lung Cancer, V6, P85; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chandra D, 2002, J BIOL CHEM, V277, P50842, DOI 10.1074/jbc.M207622200; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Chien J, 2009, MOL CELL BIOL, V29, P4177, DOI 10.1128/MCB.00035-09; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Chien J, 2006, J CLIN INVEST, V116, P1994, DOI 10.1172/JCI27698; Cilenti L, 2005, AM J PHYSIOL-RENAL, V288, pF371, DOI 10.1152/ajprenal.00154.2004; Ciombor Kristen Keon, 2006, Curr Treat Options Oncol, V7, P59, DOI 10.1007/s11864-006-0032-7; CLAROS MG, 1995, COMPUT APPL BIOSCI, V11, P441; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Damiani LA, 2008, CANCER RES, V68, P9005, DOI 10.1158/0008-5472.CAN-08-1276; Dinser R, 2009, J TISSUE ENG REGEN M, V3, P124, DOI 10.1002/term.148; Ferraldeschi R, 2007, DRUGS, V67, P2135, DOI 10.2165/00003495-200767150-00003; Fischer B, 2008, REV RECENT CLIN TRIA, V3, P40, DOI 10.2174/157488708783330503; Gallego MA, 2008, ONCOGENE, V27, P1981, DOI 10.1038/sj.onc.1210833; Gandhi S, 2006, BRAIN, V129, P1720, DOI 10.1093/brain/awl114; Gibson TJ, 1996, TRENDS NEUROSCI, V19, P465, DOI 10.1016/S0166-2236(96)20054-2; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Hann CL, 2008, ONCOLOGY-NY, V22, P1486; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Hirsch FR, 2005, J CLIN ONCOL, V23, P3186, DOI 10.1200/JCO.2005.14.209; James R, 2004, MOL CELL NEUROSCI, V26, P112, DOI 10.1016/j.mcn.2004.01.013; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Koutnikova H, 1997, NAT GENET, V16, P345, DOI 10.1038/ng0897-345; Kroemer G, 1997, NAT MED, V3, P614, DOI 10.1038/nm0697-614; Li CX, 2007, MOL BIOL CELL, V18, P3081, DOI 10.1091/mbc.E07-02-0172; Li YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001397; Lingle WL, 2000, CURR TOP DEV BIOL, V49, P313; Machtay M, 2004, J THORAC CARDIOV SUR, V127, P108, DOI 10.1016/j.jtcvs.2003.07.027; Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200; Martins LM, 2002, CELL DEATH DIFFER, V9, P699, DOI 10.1038/sj.cdd.4401044; Meng XW, 2006, CURR OPIN CELL BIOL, V18, P668, DOI 10.1016/j.ceb.2006.10.008; Millar JK, 2005, MOL CELL NEUROSCI, V30, P477, DOI 10.1016/j.mcn.2005.08.021; MINNA J, 2008, HARRISONS PRINCIPLES; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Nie GY, 2003, BIOCHEM J, V371, P39, DOI 10.1042/BJ20021569; Rosell R, 2006, CURR OPIN PHARMACOL, V6, P323, DOI 10.1016/j.coph.2006.01.011; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Sanborn Rachel E, 2008, Thorac Surg Clin, V18, P423, DOI 10.1016/j.thorsurg.2008.08.004; Seong YM, 2004, J BIOL CHEM, V279, P37588, DOI 10.1074/jbc.M401408200; Srinivasula SM, 2003, J BIOL CHEM, V278, P31469, DOI 10.1074/jbc.C300240200; Staub J, 2007, ONCOGENE, V26, P4969, DOI 10.1038/sj.onc.1210300; Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; van Loo G, 2002, CELL DEATH DIFFER, V9, P20, DOI 10.1038/sj.cdd.4400970; Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903; Zhang JM, 2009, AM J RESP CELL MOL, V40, P135, DOI 10.1165/rcmb.2007-0277OC	58	42	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12011	12027		10.1074/jbc.M109.097790	http://dx.doi.org/10.1074/jbc.M109.097790			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20154083	Green Published, hybrid			2022-12-27	WOS:000276787100030
J	Jablonska, E; Markart, P; Zakrzewicz, D; Preissner, KT; Wygrecka, M				Jablonska, Ewa; Markart, Philipp; Zakrzewicz, Dariusz; Preissner, Klaus T.; Wygrecka, Malgorzata			Transforming Growth Factor-beta 1 Induces Expression of Human Coagulation Factor XII via Smad3 and JNK Signaling Pathways in Human Lung Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY-DISTRESS-SYNDROME; GROWTH-FACTOR-BETA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; IDIOPATHIC PULMONARY-FIBROSIS; TGF-BETA; HAGEMAN-FACTOR; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; PROTEOLYTIC ACTIVATION; PROCOLLAGEN PRODUCTION	Coagulation factor XII ( FXII) is a liver-derived serine protease involved in fibrinolysis, coagulation, and inflammation. The regulation of FXII expression is largely unknown. Transforming growth factor-beta 1 (TGF-beta 1) is a multifunctional cytokine that has been linked to several pathological processes, including tissue fibrosis by modulating procoagulant and fibrinolytic activities. This study investigated whether TGF-beta 1 may regulate FXII expression in human lung fibroblasts. Treatment of human lung fibroblasts with TGF-beta 1 resulted in a time-dependent increase in FXII production, activation of p44/42, p38, JNK, and Akt, and phosphorylation and translocation into the nucleus of Smad3. However, TGF-beta 1-induced FXII expression was repressed only by the JNK inhibitor and JNK and Smad3 antisense oligonucleotides but not by MEK, p38, or phosphoinositide 3-kinase blockers. JNK inhibition had no effect on TGF-beta 1-induced Smad3 phosphorylation, association with Smad4, and its translocation into the nucleus but strongly suppressed Smad3-DNA complex formation. FXII promoter analysis revealed that the -299/+1 region was sufficient for TGF-beta 1 to induce FXII expression. Sequence analysis of this region detected a potential Smad-binding element at position -272/-269 (SBE-(-272/-269)). Chromatin immunoprecipitation and streptavidin pulldown assays demonstrated TGF-beta 1-dependent Smad3 binding to SBE-(-272/-269). Mutation or deletion of SBE-(-272/-269) substantially reduced TGF-beta 1-mediated activation of the FXII promoter. Clinical relevance was demonstrated by elevated FXII levels and its co-localization with fibroblasts in the lungs of patients with acute respiratory distress syndrome. Our results show that JNK/Smad3 pathway plays a critical role in TGF-beta 1-induced FXII expression in human lung fibroblasts and implicate its possible involvement in pathological conditions characterized by elevated TGF-beta 1 levels.	[Jablonska, Ewa; Zakrzewicz, Dariusz; Preissner, Klaus T.; Wygrecka, Malgorzata] Univ Giessen, Dept Biochem, Fac Med, D-35392 Giessen, Germany; [Markart, Philipp] Univ Giessen, Dept Internal Med, Fac Med, D-35392 Giessen, Germany	Justus Liebig University Giessen; Justus Liebig University Giessen	Wygrecka, M (corresponding author), Univ Giessen, Dept Biochem, Fac Med, Friedrichstr 24, D-35392 Giessen, Germany.	malgorzata.wygrecka@innere.med.uni-giessen.de	Wygrecka, Malgorzata/AAZ-3679-2020; Jabłońska, Ewa/T-3878-2018; Jablonska, Ewa/W-2303-2018	Wygrecka, Malgorzata/0000-0002-3656-2932; Jabłońska, Ewa/0000-0001-7899-7830; Jablonska, Ewa/0000-0002-5445-4249; Zakrzewicz, Dariusz/0000-0003-3292-9706	German Research Foundation [KFO 118]; Excellence Cluster "Cardiopulmonary System"	German Research Foundation(German Research Foundation (DFG)); Excellence Cluster "Cardiopulmonary System"(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant KFO 118 and the Excellence Cluster "Cardiopulmonary System."	BERNARD GR, 1994, J CRIT CARE, V9, P72, DOI 10.1016/0883-9441(94)90033-7; Blanc-Brude OP, 2005, EXP CELL RES, V304, P16, DOI 10.1016/j.yexcr.2004.10.021; Bogatkevich GS, 2001, J BIOL CHEM, V276, P45184, DOI 10.1074/jbc.M106441200; Bonniaud P, 2005, J IMMUNOL, V175, P5390, DOI 10.4049/jimmunol.175.8.5390; BRISEID K, 1991, THROMB RES, V61, P123, DOI 10.1016/0049-3848(91)90239-S; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; BURKHARDT A, 1989, AM REV RESPIR DIS, V140, P513, DOI 10.1164/ajrccm/140.2.513; CAO SX, 1989, P NATL ACAD SCI USA, V86, P5306, DOI 10.1073/pnas.86.14.5306; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; Chambers RC, 2000, J BIOL CHEM, V275, P35584, DOI 10.1074/jbc.M003188200; Chesnutt AN, 1997, AM J RESP CRIT CARE, V156, P840, DOI 10.1164/ajrccm.156.3.9701124; CHIEN P, 1988, J CLIN INVEST, V82, P1554, DOI 10.1172/JCI113765; Cichon S, 2006, AM J HUM GENET, V79, P1098, DOI 10.1086/509899; Citarella F, 1997, BLOOD, V90, P1501, DOI 10.1182/blood.V90.4.1501.1501_1501_1507; Citarella F, 1996, STEROIDS, V61, P270, DOI 10.1016/0039-128X(96)00037-2; CITARELLA F, 1993, BIOCHIM BIOPHYS ACTA, V1172, P197, DOI 10.1016/0167-4781(93)90294-N; COLMAN RW, 1986, CRC CR REV ONCOL-HEM, V5, P57, DOI 10.1016/S1040-8428(86)80053-1; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Colman RW, 1999, THROMB HAEMOSTASIS, V82, P1568; Das F, 2008, J CELL PHYSIOL, V214, P513, DOI 10.1002/jcp.21236; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Dhainaut JF, 2003, CRIT CARE MED, V31, pS258, DOI 10.1097/01.CCM.0000057901.92381.75; Engel ME, 1999, J BIOL CHEM, V274, P37413, DOI 10.1074/jbc.274.52.37413; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; FARSETTI A, 1995, ENDOCRINOLOGY, V136, P5076, DOI 10.1210/en.136.11.5076; Farsetti A, 1998, ENDOCRINOLOGY, V139, P4581, DOI 10.1210/en.139.11.4581; Felts SJ, 1997, ONCOGENE, V14, P1679, DOI 10.1038/sj.onc.1201006; FINE A, 1987, J BIOL CHEM, V262, P3897; FUKUDA Y, 1987, AM J PATHOL, V126, P171; GARZON RJ, 1994, MOL CELL BIOL, V14, P934, DOI 10.1128/MCB.14.2.934; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; GORDON EM, 1985, BLOOD, V66, P602; GORDON EM, 1988, J LAB CLIN MED, V111, P52; GORDON EM, 1980, J LAB CLIN MED, V96, P762; GORDON EM, 1991, J LAB CLIN MED, V117, P353; Gordon EM, 1996, P NATL ACAD SCI USA, V93, P2174, DOI 10.1073/pnas.93.5.2174; Goulet S, 2007, J CELL PHYSIOL, V210, P167, DOI 10.1002/jcp.20836; GRINNEL F, 1980, EXPERIENTIA, V36, P505, DOI 10.1007/BF01965766; Gunther A, 2000, AM J RESP CRIT CARE, V161, P454; Gunther A, 2000, THROMB HAEMOSTASIS, V83, P853; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Hua XX, 1998, GENE DEV, V12, P3084, DOI 10.1101/gad.12.19.3084; IDELL S, 1992, AM J PHYSIOL, V263, pL487, DOI 10.1152/ajplung.1992.263.4.L487; IDELL S, 1991, AM J PHYSIOL, V261, pL240, DOI 10.1152/ajplung.1991.261.4.L240; IDELL S, 1989, J CLIN INVEST, V84, P695, DOI 10.1172/JCI114217; IDELL S, 1994, AM J PHYSIOL-LUNG C, V267, pL693, DOI 10.1152/ajplung.1994.267.6.L693; Imokawa S, 1997, AM J RESP CRIT CARE, V156, P631, DOI 10.1164/ajrccm.156.2.9608094; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; KIM SJ, 1989, J BIOL CHEM, V264, P7041; KOTANI I, 1995, THROMB RES, V77, P493, DOI 10.1016/0049-3848(95)00025-9; Kutz SM, 2001, J CELL SCI, V114, P3905; Liberati NT, 1999, P NATL ACAD SCI USA, V96, P4844, DOI 10.1073/pnas.96.9.4844; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Liu QH, 2008, PERITON DIALYSIS INT, V28, pS88; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MARTIN C, 1995, CHEST, V107, P196, DOI 10.1378/chest.107.1.196; Meduri G U, 1995, Semin Respir Infect, V10, P154; Meduri GU, 1998, AM J RESP CRIT CARE, V158, P1432; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Mori S, 2004, ONCOGENE, V23, P7416, DOI 10.1038/sj.onc.1207981; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Neth P, 2001, THROMB HAEMOSTASIS, V85, P1043, DOI 10.1055/s-0037-1615961; OLMAN MA, 1995, J CLIN INVEST, V96, P1621, DOI 10.1172/JCI118201; Pelaia G, 2007, J CELL PHYSIOL, V210, P489, DOI 10.1002/jcp.20884; Piwien-Pilipuk G, 2002, J BIOL CHEM, V277, P44557, DOI 10.1074/jbc.M206886200; Qing J, 2004, MOL CELL BIOL, V24, P1411, DOI 10.1128/MCB.24.3.1411-1425.2004; RATNOFF OD, 1991, J LAB CLIN MED, V117, P343; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; SCHMEIDLERSAPIRO KT, 1991, P NATL ACAD SCI USA, V88, P4382, DOI 10.1073/pnas.88.10.4382; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; SEEGER W, 1993, AM J RESP CELL MOL, V9, P213, DOI 10.1165/ajrcmb/9.2.213; SENIOR RM, 1986, J CLIN INVEST, V77, P1014, DOI 10.1172/JCI112353; Shen X, 1998, MOL BIOL CELL, V9, P3309, DOI 10.1091/mbc.9.12.3309; TOOSSI Z, 1992, P NATL ACAD SCI USA, V89, P11969, DOI 10.1073/pnas.89.24.11969; Utsugi M, 2003, AM J RESP CELL MOL, V28, P754, DOI 10.1165/rcmb.4892; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; Wygrecka M, 2004, THROMB HAEMOSTASIS, V92, P529, DOI 10.1160/TH04-02-0126; Wygrecka M, 2007, THORAX, V62, P880, DOI 10.1136/thx.2006.069658; Wygrecka M, 2007, J BIOL CHEM, V282, P21671, DOI 10.1074/jbc.M610748200; Yoshida K, 2005, AM J PATHOL, V166, P1029, DOI 10.1016/S0002-9440(10)62324-3; Yu L, 2002, EMBO J, V21, P3749, DOI 10.1093/emboj/cdf366	84	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11638	11651		10.1074/jbc.M109.045963	http://dx.doi.org/10.1074/jbc.M109.045963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20142324	hybrid, Green Published			2022-12-27	WOS:000276286200069
J	Demma, M; Maxwell, E; Ramos, R; Liang, LZ; Li, C; Hesk, D; Rossman, R; Mallams, A; Doll, R; Liu, M; Seidel-Dugan, C; Bishop, WR; Dasmahapatra, B				Demma, Mark; Maxwell, Eugene; Ramos, Robert; Liang, Lianzhu; Li, Cheng; Hesk, David; Rossman, Randall; Mallams, Alan; Doll, Ronald; Liu, Ming; Seidel-Dugan, Cynthia; Bishop, W. Robert; Dasmahapatra, Bimalendu			SCH529074, a Small Molecule Activator of Mutant p53, Which Binds p53 DNA Binding Domain (DBD), Restores Growth-suppressive Function to Mutant p53 and Interrupts HDM2-mediated Ubiquitination of Wild Type p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE DOMAIN; TRANSCRIPTION ACTIVATION; CRYSTAL-STRUCTURE; RESCUE; MDM2; CP-31398; RESTORATION; PEPTIDE; P63; CONFORMATION	Abrogation of p53 function occurs in almost all human cancers, with more than 50% of cancers harboring inactivating mutations in p53 itself. Mutation of p53 is indicative of highly aggressive cancers and poor prognosis. The vast majority of mutations in p53 occur in its core DNA binding domain (DBD) and result in inactivation of p53 by reducing its thermodynamic stability at physiological temperature. Here, we report a small molecule, SCH529074, that binds specifically to the p53 DBD in a saturable manner with an affinity of 1-2 mu M. Binding restores wild type function to many oncogenic mutant forms of p53. This small molecule reactivates mutant p53 by acting as a chaperone, in a manner similar to that previously reported for the peptide CDB3. Binding of SCH529074 to the p53 DBD is specifically displaced by an oligonucleotide with a sequence derived from the p53-response element. In addition to reactivating mutant p53, SCH529074 binding inhibits ubiquitination of p53 by HDM2. We have also developed a novel variant of p53 by changing a single amino acid in the core domain of p53 (N268R), which abolishes binding of SCH529074. This amino acid change also inhibits HDM2-mediated ubiquitination of p53. Our novel findings indicate that through its interaction with p53 DBD, SCH529074 restores DNA binding activity to mutant p53 and inhibits HDM2-mediated ubiquitination.	[Demma, Mark; Maxwell, Eugene; Ramos, Robert; Liang, Lianzhu; Liu, Ming; Seidel-Dugan, Cynthia; Bishop, W. Robert; Dasmahapatra, Bimalendu] Schering Plough Res Inst, Dept Tumor Biol, Kenilworth, NJ 07033 USA; [Li, Cheng; Hesk, David; Rossman, Randall; Mallams, Alan; Doll, Ronald] Schering Plough Res Inst, Dept Chem, Kenilworth, NJ 07033 USA	Merck & Company; Schering-Plough Research Institute; Merck & Company; Schering-Plough Research Institute	Demma, M (corresponding author), Merck Res Labs, 2015 Galloping Hill Rd, Kenilworth, NJ 07033 USA.	Mark.Demma@spcorp.com						ABARZUA P, 1995, CANCER RES, V55, P3490; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bullock AN, 2000, ONCOGENE, V19, P1245, DOI 10.1038/sj.onc.1203434; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; Camus S, 2003, FEBS LETT, V536, P220, DOI 10.1016/S0014-5793(03)00054-1; Canadillas JMP, 2006, P NATL ACAD SCI USA, V103, P2109, DOI 10.1073/pnas.0510941103; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Demma MJ, 2004, J BIOL CHEM, V279, P45887, DOI 10.1074/jbc.M401854200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Friedler A, 2004, J MOL BIOL, V336, P187, DOI 10.1016/j.jmb.2003.12.005; Friedler A, 2003, J BIOL CHEM, V278, P24108, DOI 10.1074/jbc.M302458200; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; GANNON JV, 1990, EMBO J, V9, P1595, DOI 10.1002/j.1460-2075.1990.tb08279.x; Helton ES, 2008, ONCOGENE, V27, P2843, DOI 10.1038/sj.onc.1210948; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Klein C, 2001, J BIOL CHEM, V276, P37390, DOI 10.1074/jbc.M103801200; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lane DR, 2003, DRUG DISCOV TODAY, V8, P347, DOI 10.1016/S1359-6446(03)02669-2; Little NA, 2001, ONCOGENE, V20, P4576, DOI 10.1038/sj.onc.1204615; Luu Y, 2002, EXP CELL RES, V276, P214, DOI 10.1006/excr.2002.5526; Meyer-Ficca ML, 2004, ANAL BIOCHEM, V334, P9, DOI 10.1016/j.ab.2004.07.011; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Nicholls CD, 2002, J BIOL CHEM, V277, P12937, DOI 10.1074/jbc.M108815200; Nie LH, 2007, J BIOL CHEM, V282, P14616, DOI 10.1074/jbc.M610515200; Nikolova PV, 2000, EMBO J, V19, P370, DOI 10.1093/emboj/19.3.370; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Pan YP, 2006, BIOCHEMISTRY-US, V45, P3925, DOI 10.1021/bi052242n; Rehman A, 2005, BREAST CANCER RES, V7, pR765, DOI 10.1186/bcr1290; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Sang MX, 2006, BIOCHEM BIOPH RES CO, V347, P327, DOI 10.1016/j.bbrc.2006.06.079; Selivanova G, 1999, MOL CELL BIOL, V19, P3395; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; SKINNER RH, 1994, ANAL BIOCHEM, V223, P259, DOI 10.1006/abio.1994.1582; Soussi T, 1996, J MOL BIOL, V260, P623, DOI 10.1006/jmbi.1996.0425; Soussi T, 2001, NAT REV CANCER, V1, P233, DOI 10.1038/35106009; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; VOJTESEK B, 1995, ONCOGENE, V10, P389; Wallace M, 2006, MOL CELL, V23, P251, DOI 10.1016/j.molcel.2006.05.029; Wang WG, 2003, MOL CELL BIOL, V23, P2171, DOI 10.1128/MCB.23.6.2171-2181.2003; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Willis A. C., 2002, Current Molecular Medicine (Hilversum), V2, P329, DOI 10.2174/1566524023362474; Wischhusen J, 2003, ONCOGENE, V22, P8233, DOI 10.1038/sj.onc.1207198; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zalcenstein A, 2006, ONCOGENE, V25, P359, DOI 10.1038/sj.onc.1209061	52	72	75	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10198	10212		10.1074/jbc.M109.083469	http://dx.doi.org/10.1074/jbc.M109.083469			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20124408	Green Published, hybrid			2022-12-27	WOS:000276264600004
J	Eby, JC; Ciesla, WP; Hamman, W; Donato, GM; Pickles, RJ; Hewlett, EL; Lencer, WI				Eby, Joshua C.; Ciesla, William P.; Hamman, Wendy; Donato, Gina M.; Pickles, Raymond J.; Hewlett, Erik L.; Lencer, Wayne I.			Selective Translocation of the Bordetella pertussis Adenylate Cyclase Toxin across the Basolateral Membranes of Polarized Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INEFFICIENT GENE-TRANSFER; PORE-FORMING TOXIN; TARGET-CELLS; HEMOLYTIC ACTIVITIES; IN-VIVO; BACILLUS-ANTHRACIS; AIRWAY EPITHELIUM; DEPENDENT MANNER; AC TOXIN; SECRETION	The catalytic domain of Bordetella pertussis adenylate cyclase toxin (ACT) translocates directly across the plasma membrane of mammalian cells to induce toxicity by the production of cAMP. Here, we use electrophysiology to examine the translocation of toxin into polarized epithelial cells that model the mucosal surfaces of the host. We find that both polarized T84 cell monolayers and human airway epithelial cultures respond to nanomolar concentrations of ACT when applied to basolateral membranes, with little or no response to toxin applied apically. The induction of toxicity is rapid and fully explained by increases in intracellular cAMP, consistent with toxin translocation directly across the basolateral membrane. Intoxication of T84 cells occurs in the absence of CD11b/CD18 or evidence of another specific membrane receptor, and it is not dependent on post-translational acylation of the toxin or on host cell membrane potential, both previously reported to be required for toxin action. Thus, elements of the basolateral membrane render epithelial cells highly sensitive to the entry of ACT in the absence of a specific receptor for toxin binding.	[Eby, Joshua C.; Donato, Gina M.; Hewlett, Erik L.] Univ Virginia, Sch Med, Div Infect Dis & Int Hlth, Dept Med, Charlottesville, VA 22908 USA; [Ciesla, William P.; Hamman, Wendy; Lencer, Wayne I.] Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Ciesla, William P.; Hamman, Wendy; Lencer, Wayne I.] Harvard Univ, Sch Med, Harvard Digest Dis Ctr, Boston, MA 02115 USA; [Pickles, Raymond J.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of Virginia; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Hewlett, EL (corresponding author), Univ Virginia, Sch Med, Div Infect Dis & Int Hlth, Dept Med, Box 800419, Charlottesville, VA 22908 USA.	eh2v@virginia.edu		Lencer, Wayne/0000-0001-7346-2730	National Institutes of Health [AI18000, 5 T32 A1007046-30, DK48106, DK34854]; SCCOR [5 P50 HL084934]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI081900, R01AI018000, T32AI007046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048106, R37DK048106, P30DK034854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCCOR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI18000 (to E. L. H.), 5 T32 A1007046-30 (to J. C. E.), DK48106 (to W. I. L.), DK34854 (to W. I. L.), and SCCOR 5 P50 HL084934 (to R. J. P.).	Abrami L, 2000, TRENDS MICROBIOL, V8, P168, DOI 10.1016/S0966-842X(00)01722-4; Abrami L, 2003, INFECT IMMUN, V71, P739, DOI 10.1128/IAI.71.2.739-746.2003; Atapattu DN, 2007, INFECT IMMUN, V75, P4719, DOI 10.1128/IAI.00534-07; Barrett KE, 1997, AM J PHYSIOL-CELL PH, V272, pC1069, DOI 10.1152/ajpcell.1997.272.4.C1069; BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991; Basar T, 2001, J BIOL CHEM, V276, P348, DOI 10.1074/jbc.M006463200; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Bassinet L, 2004, INFECT IMMUN, V72, P5530, DOI 10.1128/IAI.72.9.5530-5533.2004; Beauregard KE, 1999, INFECT IMMUN, V67, P3026, DOI 10.1128/IAI.67.6.3026-3030.1999; Bejerano M, 1999, MOL MICROBIOL, V31, P381, DOI 10.1046/j.1365-2958.1999.01183.x; BENZ R, 1994, J BIOL CHEM, V269, P27231; Clarke LL, 1997, AM J PHYSIOL-LUNG C, V272, pL1084, DOI 10.1152/ajplung.1997.272.6.L1084; CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574; DHARMSATHAPHORN K, 1990, METHOD ENZYMOL, V192, P354; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fiser R, 2007, J BIOL CHEM, V282, P2808, DOI 10.1074/jbc.M609979200; Fong KP, 2006, CELL MICROBIOL, V8, P1753, DOI 10.1111/j.1462-5822.2006.00746.x; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GOLDHAMMER AR, 1981, EUR J BIOCHEM, V115, P605; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; GORDON VM, 1989, J BIOL CHEM, V264, P14792; Gray M, 1998, J BIOL CHEM, V273, P18260, DOI 10.1074/jbc.273.29.18260; Gray MC, 1999, INFECT IMMUN, V67, P4393, DOI 10.1128/IAI.67.9.4393-4399.1999; Gray MC, 2001, J BACTERIOL, V183, P5904, DOI 10.1128/JB.183.20.5904-5910.2001; Groathouse NA, 2003, INFECT IMMUN, V71, P7208, DOI 10.1128/IAI.71.12.7208-7210.2003; GRUBB BR, 1994, NATURE, V371, P802, DOI 10.1038/371802a0; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; HANSKI E, 1985, J BIOL CHEM, V260, P5526; Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x; HEWLETT EL, 1993, J BIOL CHEM, V268, P7842; Ingalls RR, 1997, J IMMUNOL, V159, P433; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Knapp O, 2008, BBA-BIOMEMBRANES, V1778, P260, DOI 10.1016/j.bbamem.2007.09.026; Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9; Lee SJ, 1999, INFECT IMMUN, V67, P2090, DOI 10.1128/IAI.67.5.2090-2095.1999; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; LISANTI MP, 1988, P NATL ACAD SCI USA, V85, P9557, DOI 10.1073/pnas.85.24.9557; Lovell MA, 1998, ARCH PEDIAT ADOL MED, V152, P925; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Mallory, 1912, J MED RES, V27, P115; Moal VLL, 2006, CLIN MICROBIOL REV, V19, P315, DOI 10.1128/CMR.19.2.315-337.2006; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Osicka R, 2000, INFECT IMMUN, V68, P247; OTERO AS, 1995, J BIOL CHEM, V270, P9695, DOI 10.1074/jbc.270.17.9695; Ou G, 2009, SCAND J IMMUNOL, V69, P150, DOI 10.1111/j.1365-3083.2008.02208.x; Paddock CD, 2008, CLIN INFECT DIS, V47, P328, DOI 10.1086/589753; PEARSON RD, 1987, J IMMUNOL, V139, P2749; Pickles RJ, 1998, J VIROL, V72, P6014, DOI 10.1128/JVI.72.7.6014-6023.1998; Pickles RJ, 2000, J VIROL, V74, P6050, DOI 10.1128/JVI.74.13.6050-6057.2000; Rufo PA, 1997, J CLIN INVEST, V100, P3111, DOI 10.1172/JCI119866; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; Sawal M, 2009, PEDIATR PULM, V44, P970, DOI 10.1002/ppul.21082; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Schuck S, 2004, J CELL SCI, V117, P5955, DOI 10.1242/jcs.01596; Soane MC, 2000, RESP MED, V94, P791, DOI 10.1053/rmed.2000.0823; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Stonebraker JR, 2004, J VIROL, V78, P13755, DOI 10.1128/JVI.78.24.13755-13768.2004; STROHMEIER GR, 1995, J BIOL CHEM, V270, P2387, DOI 10.1074/jbc.270.5.2387; SZABO G, 1994, J BIOL CHEM, V269, P22496; TUOMANEN EI, 1983, J INFECT DIS, V148, P125, DOI 10.1093/infdis/148.1.125; VOJLOVAVODOLANO.J, 2009, FASEB J, V23, P2831; Vojtova J, 2006, MICROSC RES TECHNIQ, V69, P119, DOI 10.1002/jemt.20277; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983; WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x; WOLFF J, 1973, J BIOL CHEM, V248, P350	66	33	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10662	10670		10.1074/jbc.M109.089219	http://dx.doi.org/10.1074/jbc.M109.089219			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139088	Green Published, hybrid			2022-12-27	WOS:000276264600053
J	Hanelt, I; Lochte, S; Sundermann, L; Elbers, K; Vor der Bruggen, M; Bakker, EP				Haenelt, Inga; Loechte, Sara; Sundermann, Lea; Elbers, Katharina; Vor der Brueggen, Marc; Bakker, Evert P.			Gain of Function Mutations in Membrane Region M-2C2 of KtrB Open a Gate Controlling K+ Transport by the KtrAB System from Vibrio alginolyticus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID SUBSTITUTIONS; ESCHERICHIA-COLI K-12; POTASSIUM-TRANSPORT; GLYCINE RESIDUES; KDPFABC COMPLEX; HIGH-AFFINITY; CHANNEL; SELECTIVITY; PROTEIN; ADAPTATION	KtrB, the K+-translocating subunit of the Na+-dependent bacterial K+ uptake system KtrAB, consists of four M1PM2 domains, in which M-1 and M-2 are transmembrane helices and P indicates a p-loop that folds back from the external medium into the cell membrane. The transmembrane stretch M-2C is, with its 40 residues, unusually long. It consists of three parts, the hydrophobic helices M-2C1 and M-2C3, which are connected by a nonhelical M-2C2 region, containing conserved glycine, alanine, serine, threonine, and lysine residues. Several point mutations in M-2C2 led to a huge gain of function of K+ uptake by KtrB from the bacterium Vibrio alginolyticus. This effect was exclusively due to an increase in V-max for K+ transport. Na+ translocation by KtrB was not affected. Partial to complete deletions of M-2C2 also led to enhanced Vmax values for K+ uptake via KtrB. However, several deletion variants also exhibited higher Km values for K+ uptake and at least one deletion variant, KtrB(Delta 326-328), also transported Na+ faster. The presence of KtrA did not suppress any of these effects. For the deletion variants, this was due to a diminished binding of KtrA to KtrB. PhoA studies indicated that M-2C2 forms a flexible structure within the membrane allowing M-2C3 to be directed either to the cytoplasm or (artificially) to the periplasm. These data are interpreted to mean (i) that region M-2C2 forms a flexible gate controlling K+ translocation at the cytoplasmic side of KtrB, and (ii) that M-2C2 is required for the interaction between KtrA and KtrB.	[Haenelt, Inga; Loechte, Sara; Sundermann, Lea; Elbers, Katharina; Vor der Brueggen, Marc; Bakker, Evert P.] Univ Osnabruck, Abt Mikrobiol, D-49076 Osnabruck, Germany	University Osnabruck	Hanelt, I (corresponding author), Univ Osnabruck, Abt Mikrobiol, Barbarastr 11, D-49076 Osnabruck, Germany.	haenelt@biologie.uni-osnabrueck.de	Hänelt, Inga/N-2982-2016	Hänelt, Inga/0000-0003-1495-3163	Deutsche Forschungsgemeinschaft;  [SFB431]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by SFB431, Teilprojekt P6 from the Deutsche Forschungsgemeinschaft.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; Bertrand J, 2004, J BACTERIOL, V186, P5519, DOI 10.1128/JB.186.16.5519-5522.2004; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; CALAMIA J, 1990, P NATL ACAD SCI USA, V87, P4937, DOI 10.1073/pnas.87.13.4937; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Drew D, 2002, P NATL ACAD SCI USA, V99, P2690, DOI 10.1073/pnas.052018199; DULLEY JR, 1975, ANAL BIOCHEM, V64, P136, DOI 10.1016/0003-2697(75)90415-7; Durell SR, 2000, BIOPHYS J, V78, P188, DOI 10.1016/S0006-3495(00)76584-2; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Durell SR, 1999, BIOPHYS J, V77, P789, DOI 10.1016/S0006-3495(99)76932-8; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; EPSTEIN W, 1986, FEMS MICROBIOL LETT, V39, P73; Fersht A. R., 1985, ENZYME STRUCTURE MEC, P475; Gadsby DC, 2009, NAT REV MOL CELL BIO, V10, P344, DOI 10.1038/nrm2668; Gadsby DC, 2004, NATURE, V427, P795, DOI 10.1038/427795a; GIFFARD PM, 1985, J BACTERIOL, V164, P904, DOI 10.1128/JB.164.2.904-910.1985; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Kawano M, 2000, J BACTERIOL, V182, P2507, DOI 10.1128/JB.182.9.2507-2512.2000; Kroning N, 2007, J BIOL CHEM, V282, P14018, DOI 10.1074/jbc.M609084200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kuo MMC, 2005, FEMS MICROBIOL REV, V29, P961, DOI 10.1016/j.femsre.2005.03.003; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; MILLER JH, 1972, EXPT MOL GENETICS, P401; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Sakuma T, 1998, BBA-BIOENERGETICS, V1363, P231, DOI 10.1016/S0005-2728(97)00102-3; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; STUMPE S, 1996, HDB BIOL PHYS, V2, P473; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; van der Laan M, 2002, J BACTERIOL, V184, P5491, DOI 10.1128/JB.184.19.5491-5494.2002; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	43	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10318	10327		10.1074/jbc.M109.089870	http://dx.doi.org/10.1074/jbc.M109.089870			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20097755	Green Published, hybrid			2022-12-27	WOS:000276264600016
J	Hui, XY; Li, HY; Zhou, ZG; Lam, KSL; Xiao, Y; Wu, DH; Ding, K; Wang, Y; Vanhoutte, PM; Xu, AM				Hui, Xiaoyan; Li, Huiying; Zhou, Zhiguang; Lam, Karen S. L.; Xiao, Yang; Wu, Donghai; Ding, Ke; Wang, Yu; Vanhoutte, Paul M.; Xu, Aimin			Adipocyte Fatty Acid-binding Protein Modulates Inflammatory Responses in Macrophages through a Positive Feedback Loop Involving c-Jun NH2-terminal Kinases and Activator Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; HORMONE-SENSITIVE LIPASE; HUMAN THP-1 MACROPHAGES; FOAM CELL-FORMATION; INSULIN-RESISTANCE; SIGNAL-TRANSDUCTION; METABOLIC SYNDROME; MAP KINASES; OBESITY; AP2	Adipocyte fatty acid-binding protein (A-FABP) has emerged as an important mediator of inflammation in macrophages. Macrophage-selective ablation of A-FABP alone is sufficient to prevent the development of high cholesterol diet-induced atherosclerosis in apoE-deficient mice. However, the precise mechanisms whereby A-FABP modulates inflammation remain elusive. Here, we report that A-FABP forms a finely tuned positive loop between JNK and activator protein-1 (AP-1) to exacerbate lipopolysaccharide (LPS)-induced inflammatory responses in macrophages. Real time PCR and luciferase reporter analysis showed that LPS induced A-FABP expression through transcriptional activation. This effect was mediated by JNK, which promoted the recruitment of c-Jun to a highly conserved AP-1 consensus binding motif located within the proximal region of the A-FABP promoter. LPS-induced transactivation of the A-FABP gene was diminished by either pharmacological inhibition of JNK or knocking down c-Jun or by mutating the AP-1 recognition site within the proximal region (-122 to -116 bp) of the A-FABP promoter. Conversely, the LPS-evoked phosphorylation of JNK, activation of AP-1, and production of pro-inflammatory cytokines were markedly attenuated by pharmacological or genetic suppression of A-FABP in macrophages. Furthermore, the LPS-induced elevation in A-FABP expression could also be prevented by the selective A-FABP inhibitor BMS309403. These findings support the notion that pharmacological inhibition of A-FABP represents a valid strategy for treating inflammation-related disorders such as atherosclerosis.	[Hui, Xiaoyan; Lam, Karen S. L.; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Li, Huiying; Wang, Yu; Vanhoutte, Paul M.; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Hui, Xiaoyan; Li, Huiying; Lam, Karen S. L.; Wang, Yu; Vanhoutte, Paul M.; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Zhou, Zhiguang; Xiao, Yang] Cent S Univ, Xiangya Hosp 2, Inst Metab & Endocrinol, Metab Syndrome Res Ctr,Diabet Ctr, Changsha 410011, Peoples R China; [Wu, Donghai; Ding, Ke] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; Central South University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Xu, AM (corresponding author), L8-40,New Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	Ding, Ke/B-3257-2010; Xu, Aimin/D-3291-2013; HUI, Xiaoyan Hannah/M-5175-2019	Xu, Aimin/0000-0002-0668-033X; HUI, Xiaoyan Hannah/0000-0002-7525-5812; Ding, Ke/0000-0001-9016-812X; wang, yu/0000-0001-8697-2940; Zhou, Zhiguang/0000-0002-0374-1838; ding, ke/0000-0001-8167-0476	Research Grants Council of Hong Kong; National Natural Science Foundation of China [N_HKU 735/08, 30831160518]; Collaborative Research Fund [HKU 2/07C]	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Research Fund	This work was supported by Research Grants Council of Hong Kong, the National Natural Science Foundation of China Joint Research Scheme (Projects N_HKU 735/08 and 30831160518), and the Collaborative Research Fund (HKU 2/07C) from the Research Grants Council of Hong Kong.	Bennett BL, 2003, CURR OPIN PHARMACOL, V3, P420, DOI 10.1016/S1471-4892(03)00068-7; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; CABRE A, 2009, J LIPID RES     0411, DOI DOI 10.1194/JLR.M800626-JLR200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deng WG, 2003, J IMMUNOL, V171, P6581, DOI 10.4049/jimmunol.171.12.6581; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Erbay E, 2009, NAT MED, V15, P1383, DOI 10.1038/nm.2067; Fu YC, 2002, ATHEROSCLEROSIS, V165, P259, DOI 10.1016/S0021-9150(02)00305-2; Fu YC, 2000, J LIPID RES, V41, P2017; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Hertzel AV, 2009, J MED CHEM, V52, P6024, DOI 10.1021/jm900720m; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kazemi MR, 2005, ARTERIOSCL THROM VAS, V25, P1220, DOI 10.1161/01.ATV.0000159163.52632.1b; Lamounier-Zepter V, 2009, CIRC RES, V105, P326, DOI 10.1161/CIRCRESAHA.109.200501; Lin A, 2003, BIOESSAYS, V25, P17, DOI 10.1002/bies.10204; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Milner KL, 2009, HEPATOLOGY, V49, P1926, DOI 10.1002/hep.22896; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pelton PD, 1999, BIOCHEM BIOPH RES CO, V261, P456, DOI 10.1006/bbrc.1999.1071; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RANSONE LJ, 1990, ANNU REV CELL BIOL, V6, P539, DOI 10.1146/annurev.cellbio.6.1.539; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Sabio G, 2008, SCIENCE, V322, P1539, DOI 10.1126/science.1160794; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shum BOV, 2006, J CLIN INVEST, V116, P2183, DOI 10.1172/JCI24767; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Sulsky R, 2007, BIOORG MED CHEM LETT, V17, P3511, DOI 10.1016/j.bmcl.2006.12.044; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Thompson BR, 2009, J BIOL CHEM, V284, P13473, DOI 10.1074/jbc.M900075200; Uysal KT, 2000, ENDOCRINOLOGY, V141, P3388, DOI 10.1210/en.141.9.3388; Vigouroux C, 2003, AIDS, V17, P1503, DOI 10.1097/00002030-200307040-00011; WAHLI B, 2002, GUT, V50, P658; Wang QF, 2000, MOL CELL BIOL, V20, P9203, DOI 10.1128/MCB.20.24.9203-9211.2000; Wu Kenneth K., 2006, V338, P281; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2006, CLIN CHEM, V52, P405, DOI 10.1373/clinchem.2005.062463; Xu AM, 2004, FEBS LETT, V572, P129, DOI 10.1016/j.febslet.2004.07.020; Yeung DCY, 2009, DIABETES CARE, V32, P132, DOI 10.2337/dc08-1333; Zheng CJ, 1999, J BIOL CHEM, V274, P28966, DOI 10.1074/jbc.274.41.28966	48	122	138	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10273	10280		10.1074/jbc.M109.097907	http://dx.doi.org/10.1074/jbc.M109.097907			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145251	Green Published, hybrid			2022-12-27	WOS:000276264600011
J	Iwai, K; Naganuma, A; Kuge, S				Iwai, Kenta; Naganuma, Akira; Kuge, Shusuke			Peroxiredoxin Ahp1 Acts as a Receptor for Alkylhydroperoxides to Induce Disulfide Bond Formation in the Cad1 Transcription Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-PEROXIDE; SACCHAROMYCES-CEREVISIAE; 2-CYS PEROXIREDOXIN; OXIDATIVE STRESS; THIOL PEROXIDASE; YAP1; PROTEIN; OXYR; ACTIVATION	Reactive oxygen species (ROS) generated during cellular metabolism are toxic to cells. As a result, cells must be able to identify ROS as a stress signal and induce stress response pathways that protect cells from ROS toxicity. Recently, peroxiredoxin (Prx)-induced relays of disulfide bond formation have been identified in budding yeast, namely the disulfide bond formation of Yap1, a crucial transcription factor for oxidative stress response, by a specific Prx Gpx3 and by a major Prx Tsa1. Here, we show that an atypical-type Prx Ahp1 can act as a receptor for alkylhydroperoxides, resulting in activation of the Cad1 transcription factor that is homologous to Yap1. We demonstrate that Ahp1 is required for the formation of intermolecular Cad1 disulfide bond(s) in both an in vitro redox system and in cells treated with alkylhydroperoxide. Furthermore, we found that Cad1-dependent transcriptional activation of the HSP82 gene is dependent on Ahp1. Our results suggest that, although the Gpx3-Yap1 pathway contributes more strongly to resistance than the Ahp1-Cad1 pathway, the Ahp1-induced activation of Cad1 can function as a defense system against stress induced by alkylhydroperoxides, possibly including lipid peroxides. Thus, the Prx family of proteins have an important role in determining peroxide response signals and in transmitting the signals to specific target proteins by inducing disulfide bond formation.	[Iwai, Kenta; Naganuma, Akira; Kuge, Shusuke] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Mol & Biochem Toxicol, Sendai, Miyagi 9800861, Japan	Tohoku University	Kuge, S (corresponding author), Tohoku Pharmaceut Univ, Dept Microbiol, Aoba Ku, 4-4-1 Komatsujima, Sendai, Miyagi 9818558, Japan.	skuge@mail.pharm.tohoku.ac.jp	NAGANUMA, AKIRA/V-2918-2019		Ministry of Education, Culture, Sports, Science, and Technology, Japan [20059003, 21200069]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-aid for Exploratory Research, a Grant-in-aid for Scientific Research on Priority Areas (Life of Proteins, KAKENHI 20059003), and a Grant-in-aid for Scientific Research on Innovative Areas (KAKENHI 21200069) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Avery AM, 2004, J BIOL CHEM, V279, P46652, DOI 10.1074/jbc.M408340200; Azevedo D, 2007, FEBS LETT, V581, P187, DOI 10.1016/j.febslet.2006.11.083; Bilsland E, 2004, MOL MICROBIOL, V53, P1743, DOI 10.1111/j.1365-2958.2004.04238.x; Bozonet SM, 2005, J BIOL CHEM, V280, P23319, DOI 10.1074/jbc.M502757200; Cohen BA, 2002, MOL BIOL CELL, V13, P1608, DOI 10.1091/mbc.01-10-0472; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; DUNN B, 1997, CURRENT PROTOCOLS MO; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Frankel EN, 1996, J AGR FOOD CHEM, V44, P131, DOI 10.1021/jf950374p; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lee J, 1999, J BIOL CHEM, V274, P4537, DOI 10.1074/jbc.274.8.4537; Lee SY, 2008, BIOCHEM BIOPH RES CO, V367, P67, DOI 10.1016/j.bbrc.2007.12.105; Okazaki S, 2005, ANTIOXID REDOX SIGN, V7, P327, DOI 10.1089/ars.2005.7.327; Okazaki S, 2007, MOL CELL, V27, P675, DOI 10.1016/j.molcel.2007.06.035; Park SG, 2000, J BIOL CHEM, V275, P5723, DOI 10.1074/jbc.275.8.5723; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; Tanaka T, 2005, J BIOL CHEM, V280, P42078, DOI 10.1074/jbc.M508622200; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Veal EA, 2003, J BIOL CHEM, V278, P30896, DOI 10.1074/jbc.M303542200; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wong CM, 2004, J BIOL CHEM, V279, P23207, DOI 10.1074/jbc.M402095200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	27	29	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10597	10604		10.1074/jbc.M109.090142	http://dx.doi.org/10.1074/jbc.M109.090142			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145245	Green Published, hybrid			2022-12-27	WOS:000276264600047
J	Pavlov, E; Aschar-Sobbi, R; Campanella, M; Turner, RJ; Gomez-Garcia, MR; Abramov, AY				Pavlov, Evgeny; Aschar-Sobbi, Roozbeh; Campanella, Michelangelo; Turner, Raymond J.; Gomez-Garcia, Maria R.; Abramov, Andrey Y.			Inorganic Polyphosphate and Energy Metabolism in Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; ESCHERICHIA-COLI; OXIDATIVE PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; RESPIRATORY ENZYMES; SENSITIVITY; EXPRESSION; MEMBRANE; DEATH; CHAIN	Inorganic polyphosphate (poly P) is a polymer made from as few as 10 to several hundred phosphate molecules linked by phosphoanhydride bonds similar to ATP. Poly P is ubiquitous in all mammalian organisms, where it plays multiple physiological roles. The metabolism of poly P in mammalian organisms is not well understood. We have examined the mechanism of poly P production and the role of this polymer in cell energy metabolism. Poly P levels in mitochondria and intact cells were estimated using a fluorescent molecular probe, 4',6-diamidino-2-phenylindole. Poly P levels were dependent on the metabolic state of the mitochondria. Poly P levels were increased by substrates of respiration and in turn reduced by mitochondrial inhibitor(rotenone) or an uncoupler(carbonyl cyanide p-trifluoromethoxyphenylhydrazone). Oligomycin, an inhibitor of mitochondrial ATP-synthase, blocked the production of poly P. Enzymatic depletion of poly P from cells significantly altered the rate of ATP metabolism. We propose the existence of a feedback mechanism where poly P production and cell energy metabolism regulate each other.	[Abramov, Andrey Y.] UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Pavlov, Evgeny; Aschar-Sobbi, Roozbeh] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; [Turner, Raymond J.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 4N1, Canada; [Gomez-Garcia, Maria R.] Stanford Univ, Dept Plant Biol, Carnegie Inst Sci, Stanford, CA 94305 USA; [Campanella, Michelangelo] Univ London, Royal Vet Coll, London NW1 0TU, England; [Campanella, Michelangelo] UCL, Consortium Mitochondrial Res, London WC1E 6BT, England	University of London; University College London; University of Calgary; University of Calgary; Carnegie Institution for Science; Stanford University; University of London; University of London Royal Veterinary College; University of London; University College London	Abramov, AY (corresponding author), UCL Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England.	a.abramov@ucl.ac.uk	Abramov, Andrey/AAC-6712-2019; Turner, Raymond J./M-3961-2015; Abramov, Andrey Y/H-9053-2012	Abramov, Andrey/0000-0002-7646-7235; Turner, Raymond J./0000-0002-9263-0776; Abramov, Andrey Y/0000-0002-7646-7235	Clinical Research and Development Committee; Heart and Stroke Foundation of Alberta	Clinical Research and Development Committee; Heart and Stroke Foundation of Alberta	This work was supported by a Clinical Research and Development Committee Research Funding grant and the Heart and Stroke Foundation of Alberta.	Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Abramov AY, 2005, J NEUROSCI, V25, P9176, DOI 10.1523/JNEUROSCI.1632-05.2005; AKIYAMA M, 1993, J BIOL CHEM, V268, P633; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Ault-Riche D, 1998, J BACTERIOL, V180, P1841; BEAUVOIT B, 1991, BIOCHEMISTRY-US, V30, P11212, DOI 10.1021/bi00111a004; Beca S, 2009, ARCH BIOCHEM BIOPHYS, V490, P110, DOI 10.1016/j.abb.2009.08.014; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; CHANCE B, 1955, J BIOL CHEM, V217, P383; CHANCE B, 1955, J BIOL CHEM, V217, P429; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; HAROLD FM, 1966, BACTERIOL REV, V30, P772, DOI 10.1128/MMBR.30.4.772-794.1966; Hooley P, 2008, TRENDS BIOCHEM SCI, V33, P577, DOI 10.1016/j.tibs.2008.09.007; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kulaev I, 1999, J BIOSCI BIOENG, V88, P111, DOI 10.1016/S1389-1723(99)80189-3; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LYNN WS, 1963, BIOCHEM BIOPH RES CO, V11, P367, DOI 10.1016/0006-291X(63)90124-4; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Pavlov E, 2005, BIOPHYS J, V88, P2614, DOI 10.1529/biophysj.104.057281; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Reusch RN, 1997, FEBS LETT, V412, P592, DOI 10.1016/S0014-5793(97)00863-6; SILVERMAN HS, 1994, AM J PHYSIOL, V266, pC222, DOI 10.1152/ajpcell.1994.266.1.C222; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; TIJSSEN JPF, 1982, BIOCHIM BIOPHYS ACTA, V721, P394, DOI 10.1016/0167-4889(82)90094-5; Vagabov VM, 2000, BIOCHEMISTRY-MOSCOW+, V65, P349; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100	28	123	126	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9420	9428		10.1074/jbc.M109.013011	http://dx.doi.org/10.1074/jbc.M109.013011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20124409	hybrid, Green Published			2022-12-27	WOS:000276165900014
J	Shen, YQ; Chen, CS; Ichikawa, H; Goldberg, GS				Shen, Yongquan; Chen, Chen-Shan; Ichikawa, Hitoshi; Goldberg, Gary S.			Src Induces Podoplanin Expression to Promote Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GAP JUNCTIONAL COMMUNICATION; PLATELET-AGGREGATION; TRANSFORMED-CELLS; PHOSPHORYLATION SITES; PULMONARY METASTASIS; TUMOR INVASION; CAS; GROWTH; CANCER	Nontransformed cells can force tumor cells to assume a normal morphology and phenotype by the process of contact normalization. Transformed cells must escape this process to become invasive and malignant. However, mechanisms underlying contact normalization have not been elucidated. Here, we have identified genes that are affected by contact normalization of Src-transformed cells. Tumor cells must migrate to become invasive and malignant. Src must phosphorylate the adaptor protein Cas (Crk-associated substrate) to promote tumor cell motility. We report here that Src utilizes Cas to induce podoplanin (Pdpn) expression to promote tumor cell migration. Pdpn is a membrane-bound extracellular glycoprotein that associates with endogenous ligands to promote tumor cell migration leading to cancer invasion and metastasis. In fact, Pdpn expression accounted for a major part of the increased migration seen in Src-transformed cells. Moreover, nontransformed cells suppressed Pdpn expression in adjacent Src-transformed cells. Of > 39,000 genes, Pdpn was one of only 23 genes found to be induced by transforming Src activity and suppressed by contact normalization of Src-transformed cells. In addition, we found 16 genes suppressed by Src and induced by contact normalization. These genes encode growth factor receptors, adaptor proteins, and products that have not yet been annotated and may play important roles in tumor cell growth and migration.	[Shen, Yongquan; Chen, Chen-Shan; Goldberg, Gary S.] Univ Med & Dent New Jersey, Dept Mol Biol, Stratford, NJ 08084 USA; [Chen, Chen-Shan] Univ Med & Dent New Jersey, Grad Sch Biomed Sci, Stratford, NJ 08084 USA; [Ichikawa, Hitoshi] Natl Canc Ctr, Res Inst, Canc Transcriptome Project, Chuo Ku, Tokyo 1040045, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Cancer Center - Japan	Goldberg, GS (corresponding author), Univ Med & Dent New Jersey, Dept Mol Biol, Stratford, NJ 08084 USA.	gary.goldberg@umdnj.edu			National Institutes of Health [CA88085]; Department of Molecular Biology; Research Foundation of the University of Medicine and Dentistry of New Jersey; Ministry of Education, Culture, Sports, Science and Technology of Japan; NATIONAL CANCER INSTITUTE [R13CA088085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Molecular Biology; Research Foundation of the University of Medicine and Dentistry of New Jersey; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA88085 (to G. S. G.). This work was also supported by the Department of Molecular Biology, the Research Foundation of the University of Medicine and Dentistry of New Jersey, and by a grant-in-aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to H. I.).	Alexander DB, 2004, CANCER RES, V64, P1347, DOI 10.1158/0008-5472.CAN-03-2558; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Brabek J, 2005, MOL CANCER RES, V3, P307, DOI 10.1158/1541-7786.MCR-05-0015; Brune V, 2008, J EXP MED, V205, P2251, DOI 10.1084/jem.20080809; Cavanna T, 2007, J CELL SCI, V120, P606, DOI 10.1242/jcs.000273; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; Durchdewald M, 2008, CANCER RES, V68, P6877, DOI 10.1158/0008-5472.CAN-08-0299; Glick AB, 2005, SEMIN CANCER BIOL, V15, P75, DOI 10.1016/j.semcancer.2004.08.008; Goldberg GS, 2003, J BIOL CHEM, V278, P46533, DOI 10.1074/jbc.M307526200; Goldberg GS, 2002, J BIOL CHEM, V277, P36725, DOI 10.1074/jbc.M109797200; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; Kato Y, 2008, CANCER SCI, V99, P54, DOI 10.1111/j.1349-7006.2007.00634.x; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; Kunita A, 2007, AM J PATHOL, V170, P1337, DOI 10.2353/ajpath.2007.060790; Li X, 2009, ONCOGENE, V28, P4272, DOI 10.1038/onc.2009.278; Li X, 2008, CANCER SCI, V99, P1326, DOI 10.1111/j.1349-7006.2008.00816.x; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; Nakazawa Y, 2008, BLOOD, V112, P1730, DOI 10.1182/blood-2007-11-124693; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Patwardhan P, 2006, J BIOL CHEM, V281, P20689, DOI 10.1074/jbc.M602311200; Rubin H, 2006, BIOESSAYS, V28, P515, DOI 10.1002/bies.20403; Rubin H, 2008, ADV CANCER RES, V100, P159, DOI 10.1016/S0065-230X(08)00006-7; Rubin H, 2007, ADV CANCER RES, V98, P117, DOI 10.1016/S0065-230X(06)98004-X; Schenone S, 2007, CURR MED CHEM, V14, P2495, DOI 10.2174/092986707782023622; Scholl FG, 1999, J CELL SCI, V112, P4601; Shao Q, 2005, CANCER RES, V65, P2705, DOI 10.1158/0008-5472.CAN-04-2367; Shen YQ, 2007, J BIOL CHEM, V282, P18914, DOI 10.1074/jbc.M608980200; Shen YQ, 2006, CANCER RES, V66, P1543, DOI 10.1158/0008-5472.CAN-05-3152; Watanabe T, 2005, CANCER SCI, V96, P498, DOI 10.1111/j.1349-7006.2005.00073.x; Werbowetski-Ogilvie TE, 2006, CANCER RES, V66, P1464, DOI 10.1158/0008-5472.CAN-05-1913; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	35	44	45	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9649	9656		10.1074/jbc.M109.047696	http://dx.doi.org/10.1074/jbc.M109.047696			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20123990	Green Published, hybrid			2022-12-27	WOS:000276165900038
J	Weis, F; Moullintraffort, L; Heichette, C; Chretien, D; Garnier, C				Weis, Felix; Moullintraffort, Laura; Heichette, Claire; Chretien, Denis; Garnier, Cyrille			The 90-kDa Heat Shock Protein Hsp90 Protects Tubulin against Thermal Denaturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE DYNAMIC INSTABILITY; IN-VITRO; MOLECULAR CHAPERONE; SIGNAL-TRANSDUCTION; SUBSTRATE-BINDING; TERMINAL DOMAIN; KINASE-ACTIVITY; CO-CHAPERONE; CELLS; OLIGOMERIZATION	Hsp90 and tubulin are among the most abundant proteins in the cytosol of eukaryotic cells. Although Hsp90 plays key roles in maintaining its client proteins in their active state, tubulin is essential for fundamental processes such as cell morphogenesis and division. Several studies have suggested a possible connection between Hsp90 and the microtubule cytoskeleton. Because tubulin is a labile protein in its soluble form, we investigated whether Hsp90 protects it against thermal denaturation. Both proteins were purified from porcine brain, and their interaction was characterized in vitro by using spectrophotometry, sedimentation assays, video-enhanced differential interference contrast light microscopy, and native polyacrylamide gel electrophoresis. Our results show that Hsp90 protects tubulin against thermal denaturation and keeps it in a state compatible with microtubule polymerization. We demonstrate that Hsp90 cannot resolve tubulin aggregates but that it likely binds early unfolding intermediates, preventing their aggregation. Protection was maximal at a stoichiometry of two molecules of Hsp90 for one of tubulin. This protection does not require ATP binding and hydrolysis by Hsp90, but it is counteracted by geldanamycin, a specific inhibitor of Hsp90.	[Weis, Felix; Moullintraffort, Laura; Heichette, Claire; Chretien, Denis; Garnier, Cyrille] Univ Rennes 1, CNRS, UMR 6026, IFR Genet Fonct Agron & Sante 140, F-35042 Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes	Garnier, C (corresponding author), Univ Rennes 1, CNRS, UMR 6026, IFR Genet Fonct Agron & Sante 140, Campus Beaulieu Batiment 13,263 Ave Gen Leclerc, F-35042 Rennes, France.	cyrille.garnier@univ-rennes1.fr		Weis, Felix/0000-0002-8137-3532; Chretien, Denis/0000-0001-8261-4396; GARNIER, Cyrille/0000-0002-5715-8218; Le Breton, Laura/0000-0002-5599-3244	Ligue contre le Cancer; Region Bretagne; Rennes Metropole	Ligue contre le Cancer(Ligue nationale contre le cancer); Region Bretagne(Region Bretagne); Rennes Metropole(Region Bretagne)	This work was supported by a Ligue contre le Cancer grant (to C.G. awarded by the Conseil Scientifique Interregional Grand-Ouest), a Region Bretagne Ph.D. grant (to L.M.), and Rennes Metropole (to D.C.).	Andersen SSL, 1997, J CELL BIOL, V139, P975, DOI 10.1083/jcb.139.4.975; Arnal I, 2004, CURR BIOL, V14, P2086, DOI 10.1016/j.cub.2004.11.055; Ashford AJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P205; BORNENS M, 1987, CELL MOTIL CYTOSKEL, V8, P238, DOI 10.1002/cm.970080305; Chretien D, 1997, J STRUCT BIOL, V120, P117, DOI 10.1006/jsbi.1997.3928; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; COSS RA, 1982, CANCER RES, V42, P1059; Czar MJ, 1996, EUR J CELL BIOL, V70, P322; Day RM, 2003, CELL STRESS CHAPERON, V8, P183, DOI 10.1379/1466-1268(2003)008<0183:ASHCPF>2.0.CO;2; Debec A, 1997, BIOL CELL, V89, P67, DOI 10.1016/S0248-4900(99)80082-3; Garnier C, 1998, BIOCHEM BIOPH RES CO, V250, P414, DOI 10.1006/bbrc.1998.9319; Garnier C, 1998, BIOCHEM BIOPH RES CO, V249, P197, DOI 10.1006/bbrc.1998.9108; Garnier C, 2002, BIOCHEMISTRY-US, V41, P11770, DOI 10.1021/bi025650p; Garnier C, 2001, EUR J BIOCHEM, V268, P2402, DOI 10.1046/j.1432-1327.2001.02121.x; GASKIN F, 1982, METHOD ENZYMOL, V85, P433; Giustiniani J, 2009, CELL SIGNAL, V21, P529, DOI 10.1016/j.cellsig.2008.12.004; HENEGOUWEN PMPVE, 1987, EXP CELL RES, V171, P367, DOI 10.1016/0014-4827(87)90169-8; HICKEY E, 1986, GENE, V43, P147, DOI 10.1016/0378-1119(86)90018-1; HILLER G, 1978, CELL, V14, P795, DOI 10.1016/0092-8674(78)90335-5; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; KIM DH, 1992, J CELL PHYSIOL, V153, P353, DOI 10.1002/jcp.1041530215; KNOX JD, 1991, EXP CELL RES, V194, P275, DOI 10.1016/0014-4827(91)90365-2; LAEMMLI UK, 1970, NATURE, V227, P685; Liang P, 1997, J CELL SCI, V110, P1431; MALAWISTA SE, 1982, J CELL BIOL, V95, P960, DOI 10.1083/jcb.95.3.960; Manna T, 2008, BIOCHEMISTRY-US, V47, P779, DOI 10.1021/bi701912g; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Marcu MG, 2000, JNCI-J NATL CANCER I, V92, P242, DOI 10.1093/jnci/92.3.242; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MIYATA Y, 1992, J BIOL CHEM, V267, P7042; MOZOVILLARIAS A, 1991, EUR BIOPHYS J, V19, P295, DOI 10.1007/BF00183318; Muller L, 2004, J BIOL CHEM, V279, P48846, DOI 10.1074/jbc.M407687200; Nemoto TK, 2004, BIOCHEMISTRY-US, V43, P7628, DOI 10.1021/bi036235f; Nemoto TK, 2001, BIOCHEM J, V354, P663, DOI 10.1042/0264-6021:3540663; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; Nollen EAA, 2002, J CELL SCI, V115, P2809; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Phillips JJ, 2007, J MOL BIOL, V372, P1189, DOI 10.1016/j.jmb.2007.04.059; Pratt WB, 1998, P SOC EXP BIOL MED, V217, P420; Radanyi C, 2009, CANCER LETT, V274, P88, DOI 10.1016/j.canlet.2008.09.001; REDMOND T, 1989, EUR J CELL BIOL, V50, P66; Richter K, 2001, J CELL PHYSIOL, V188, P281, DOI 10.1002/jcp.1131; SANCHEZ ER, 1988, MOL ENDOCRINOL, V2, P756, DOI 10.1210/mend-2-8-756; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Scheibel T, 1999, P NATL ACAD SCI USA, V96, P1297, DOI 10.1073/pnas.96.4.1297; Schnaider T, 2000, CELL STRESS CHAPERON, V5, P52, DOI 10.1379/1466-1268(2000)005<0052:THSIGS>2.0.CO;2; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Thorne ME, 2004, BIOCHEM BIOPH RES CO, V323, P1163, DOI 10.1016/j.bbrc.2004.08.215; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; VIDAIR CA, 1995, J CELL PHYSIOL, V163, P194, DOI 10.1002/jcp.1041630122; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Williams NE, 1997, J CELL SCI, V110, P1665; Yamada S, 2003, EUR J BIOCHEM, V270, P146, DOI 10.1046/j.1432-1033.2003.03375.x; YONEZAWA N, 1988, EUR J BIOCHEM, V177, P1, DOI 10.1111/j.1432-1033.1988.tb14337.x; Young JC, 1997, FEBS LETT, V418, P139, DOI 10.1016/S0014-5793(97)01363-X; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201	59	53	55	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9525	9534		10.1074/jbc.M109.096586	http://dx.doi.org/10.1074/jbc.M109.096586			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110359	Green Published, hybrid			2022-12-27	WOS:000276165900026
J	Landles, C; Sathasivam, K; Weiss, A; Woodman, B; Moffitt, H; Finkbeiner, S; Sun, BH; Gafni, J; Ellerby, LM; Trottier, Y; Richards, WG; Osmand, A; Paganetti, P; Bates, GP				Landles, Christian; Sathasivam, Kirupa; Weiss, Andreas; Woodman, Ben; Moffitt, Hilary; Finkbeiner, Steve; Sun, Banghua; Gafni, Juliette; Ellerby, Lisa M.; Trottier, Yvon; Richards, William G.; Osmand, Alex; Paganetti, Paolo; Bates, Gillian P.			Proteolysis of Mutant Huntingtin Produces an Exon 1 Fragment That Accumulates as an Aggregated Protein in Neuronal Nuclei in Huntington Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN MOUSE MODEL; N-TERMINAL FRAGMENTS; TRANSGENIC MICE; POLYGLUTAMINE AGGREGATION; DEPENDENT PROTEOLYSIS; WILD-TYPE; LENGTH; CLEAVAGE; BRAIN; LOCALIZATION	Huntingtin proteolysis has been implicated in the molecular pathogenesis of Huntington disease (HD). Despite an intense effort, the identity of the pathogenic smallest N-terminal fragment has not been determined. Using a panel of anti-huntingtin antibodies, we employed an unbiased approach to generate proteolytic cleavage maps of mutant and wild-type huntingtin in the HdhQ150 knock-in mouse model of HD. We identified 14 prominent N-terminal fragments, which, in addition to the full-length protein, can be readily detected in cytoplasmic but not nuclear fractions. These fragments were detected at all ages and are not a consequence of the pathogenic process. We demonstrated that the smallest fragment is an exon 1 huntingtin protein, known to contain a potent nuclear export signal. Prior to the onset of behavioral phenotypes, the exon 1 protein, and possibly other small fragments, accumulate in neuronal nuclei in the form of a detergent insoluble complex, visualized as diffuse granular nuclear staining in tissue sections. This methodology can be used to validate the inhibition of specific proteases as therapeutic targets for HD by pharmacological or genetic approaches.	[Landles, Christian; Sathasivam, Kirupa; Woodman, Ben; Moffitt, Hilary; Bates, Gillian P.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Weiss, Andreas; Paganetti, Paolo] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Finkbeiner, Steve] Univ Calif San Francisco, Gladstone Inst Neurol Dis, Taube Koret Ctr Huntingtons Dis Res, San Francisco, CA 94158 USA; [Finkbeiner, Steve] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Finkbeiner, Steve] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Sun, Banghua; Richards, William G.] Dept Metab Disorders, Thousand Oaks, CA 91320 USA; [Gafni, Juliette; Ellerby, Lisa M.] Buck Inst Age Res, Novato, CA 94945 USA; [Trottier, Yvon] CNRS, INSERM Uds, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; [Osmand, Alex] Univ Tennessee, Dept Med, Grad Sch Med, Knoxville, TN 37920 USA	University of London; King's College London; Novartis; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Buck Institute for Research on Aging; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Tennessee System; University of Tennessee Health Science Center	Bates, GP (corresponding author), Kings Coll London, Sch Med, Dept Med & Mol Genet, Guys Hosp, 8th Floor Tower Wing, London SE1 9RT, England.	gillian.bates@kcl.ac.uk	Bates, Gillian P/E-1146-2012; Trottier, Yvon/H-8852-2016; Paganetti, Paolo/AAF-8039-2020	Bates, Gillian P/0000-0002-4041-6305; Landles, Christian/0000-0001-9715-6447; Paganetti, Paolo/0000-0003-1896-6324; Trottier, Yvon/0000-0001-7230-4810	National Institutes of Health [NS40251]; Huntington's Disease Society of America Coalition for the Cure; CHDI Foundation; Hereditary Disease Foundation; Medical Research Council [G9800001]; MRC [G9800001, G0801314] Funding Source: UKRI; Medical Research Council [G0801314] Funding Source: researchfish; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huntington's Disease Society of America Coalition for the Cure; CHDI Foundation; Hereditary Disease Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS40251 (to L. M. E.). This work was also supported by the Huntington's Disease Society of America Coalition for the Cure (to G. P. B.), the CHDI Foundation, the Hereditary Disease Foundation (to A. O.), and the Medical Research Council (Grant G9800001).	BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Davies SW, 1999, METHOD ENZYMOL, V309, P687; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gafni J, 2004, J BIOL CHEM, V279, P20211, DOI 10.1074/jbc.M401267200; Goldberg YP, 1996, NAT GENET, V13, P442, DOI 10.1038/ng0896-442; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Harjes P, 2003, TRENDS BIOCHEM SCI, V28, P425, DOI 10.1016/S0968-0004(03)00168-3; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martindale D, 1998, NAT GENET, V18, P150, DOI 10.1038/ng0298-150; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Osmand AP, 2006, METHOD ENZYMOL, V412, P106, DOI 10.1016/S0076-6879(06)12008-X; Paganetti P, 2009, CHEMBIOCHEM, V10, P1678, DOI 10.1002/cbic.200900131; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Smith DL, 2001, NEUROBIOL DIS, V8, P1017, DOI 10.1006/nbdi.2001.0438; Sun B, 2002, NEUROBIOL DIS, V11, P111, DOI 10.1006/nbdi.2002.0539; Tanaka Y, 2006, NEUROBIOL DIS, V21, P381, DOI 10.1016/j.nbd.2005.07.014; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wang J, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-1; Warby SC, 2008, HUM MOL GENET, V17, P2390, DOI 10.1093/hmg/ddn139; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wellington CL, 2002, J NEUROSCI, V22, P7862; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Zhou H, 2003, J CELL BIOL, V163, P109, DOI 10.1083/jcb.200306038	41	224	229	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8808	8823		10.1074/jbc.M109.075028	http://dx.doi.org/10.1074/jbc.M109.075028			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086007	Green Published, hybrid			2022-12-27	WOS:000275553700033
J	Li, GD; Chiara, DC; Cohen, JB; Olsen, RW				Li, Guo-Dong; Chiara, David C.; Cohen, Jonathan B.; Olsen, Richard W.			Numerous Classes of General Anesthetics Inhibit Etomidate Binding to gamma-Aminobutyric Acid Type A (GABA(A)) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLCHOLINE-RECEPTOR; SITES; PROPOFOL; ALCOHOL; GLYCINE; PHARMACOLOGY; ISOFLURANE; SUBTYPES; DISTINCT; MODELS	Enhancement of gamma-aminobutyric acid type A receptor (GABA(A)R)-mediated inhibition is a property of most general anesthetics and a candidate for a molecular mechanism of anesthesia. Intravenous anesthetics, including etomidate, propofol, barbiturates, and neuroactive steroids, as well as volatile anesthetics and long-chain alcohols, all enhance GABA(A)R function at anesthetic concentrations. The implied existence of a receptor site for anesthetics on the GABA(A)R protein was supported by identification, using photoaffinity labeling, of a binding site for etomidate within the GABA(A)R transmembrane domain at the beta-alpha subunit interface; the etomidate analog [H-3]azietomidate photolabeled in a pharmacologically specific manner two amino acids, alpha 1Met-236 in the M1 helix and beta Met-286 in the M3 helix (Li, G. D., Chiara, D. C., Sawyer, G. W., Husain, S. S., Olsen, R. W., and Cohen, J. B. (2006) J. Neurosci. 26, 11599-11605). Here, we use [H-3]azietomidate photolabeling of bovine brain GABA(A)Rs to determine whether other structural classes of anesthetics interact with the etomidate binding site. Photolabeling was inhibited by anesthetic concentrations of propofol, barbiturates, and the volatile agent isoflurane, at low millimolar concentrations, but not by octanol or ethanol. Inhibition by barbiturates, which was pharmacologically specific and stereospecific, and by propofol was only partial, consistent with allosteric interactions, whereas isoflurane inhibition was nearly complete, apparently competitive. Protein sequencing showed that propofol inhibited to the same extent the photolabeling of alpha 1Met-236 and beta Met-286. These results indicate that several classes of general anesthetics modulate etomidate binding to the GABA(A)R: isoflurane binds directly to the site with millimolar affinity, whereas propofol and barbiturates inhibit binding but do not bind in a mutually exclusive manner with etomidate.	[Li, Guo-Dong; Olsen, Richard W.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School	Li, GD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	guodongli@mednet.ucla.edu; rolsen@mednet.ucla.edu			National Institutes of Health [GM 58448]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 58448 ( to R.W.O., J.B.C., and Keith W. Miller).	Altomare C, 2003, EUR J PHARM SCI, V20, P17, DOI 10.1016/S0928-0987(03)00161-1; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Bonin RP, 2008, PHARMACOL BIOCHEM BE, V90, P105, DOI 10.1016/j.pbb.2007.12.011; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Hall AC, 2004, ANESTH ANALG, V98, P1297, DOI 10.1213/01.ANE.0000111108.78745.AD; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Harrison NL, 2000, GABA IN THE NERVOUS SYSTEM: THE VIEW AT FIFTY YEARS, P167; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; HillVenning C, 1997, BRIT J PHARMACOL, V120, P749, DOI 10.1038/sj.bjp.0700927; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Husain SS, 2003, J MED CHEM, V46, P1257, DOI 10.1021/jm020465v; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jenkins A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-06-j0002.2001; Jia F, 2008, J PHARMACOL EXP THER, V324, P1127, DOI 10.1124/jpet.107.134569; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Krasowski MD, 1998, J PHARMACOL EXP THER, V284, P934; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Krasowski MD, 2001, NEUROPHARMACOLOGY, V41, P952, DOI 10.1016/S0028-3908(01)00141-1; LEEBLUNDBERG F, 1982, MOL PHARMACOL, V21, P320; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2009, J BIOL CHEM, V284, P11771, DOI 10.1074/jbc.C900016200; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; OLSEN RW, 1986, MOL CELLULAR MECHANI, P165; Reynolds DS, 2003, J NEUROSCI, V23, P8608; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; STEWART DS, 2009, SOC NEUR OCT 17 21 2; TICKU MK, 1978, LIFE SCI, V22, P1643, DOI 10.1016/0024-3205(78)90061-9; TICKU MK, 1986, MOL CELLULAR MECHANI, P179; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; WONG EHF, 1984, EUR J PHARMACOL, V102, P205, DOI 10.1016/0014-2999(84)90252-8; Yamakura T, 2001, ANNU REV PHARMACOL, V41, P23, DOI 10.1146/annurev.pharmtox.41.1.23	39	71	72	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8615	8620		10.1074/jbc.M109.074708	http://dx.doi.org/10.1074/jbc.M109.074708			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20083606	hybrid, Green Published			2022-12-27	WOS:000275553700013
J	Buescher, JL; Phiel, CJ				Buescher, Jessica L.; Phiel, Christopher J.			A Noncatalytic Domain of Glycogen Synthase Kinase-3 (GSK-3) Is Essential for Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; DIFFERENTIAL REGULATION; SUBSTRATE-SPECIFICITY; TAU-PHOSPHORYLATION; MICROTUBULE-BINDING; STRUCTURAL BASIS; XENOPUS EMBRYOS; 3-BETA; DISEASE	Glycogen synthase kinase-3 (GSK-3) isoforms, GSK-3 alpha and GSK-3 beta, are serine/threonine kinases involved in numerous cellular processes and diverse diseases, including Alzheimer disease, cancer, and diabetes. GSK-3 isoforms function redundantly in some settings, while, in others, they exhibit distinct activities. Despite intensive investigation into the physiological roles of GSK-3 isoforms, the basis for their differential activities remains unresolved. A more comprehensive understanding of the mechanistic basis for GSK-3 isoform-specific functions could lead to the development of isoform-specific inhibitors. Here, we describe a structure-function analysis of GSK-3 alpha and GSK-3 beta in mammalian cells. We deleted the noncatalytic N and C termini in both GSK-3 isoforms and generated point mutations of key regulatory residues. We examined the effect of these mutations on GSK-3 activity toward Tau, activity in Wnt signaling, interaction with Axin, and GSK-3 alpha/beta Tyr(279/216) phosphorylation. We found that the N termini of both GSK-3 isoforms were dispensable, whereas progressive C-terminal deletions resulted in protein misfolding exhibited by deficient activity, impaired ability to interact with Axin, and a loss of Tyr(279/216) phosphorylation. Our data predict that small molecules targeting the divergent C terminus may lead to isoform-specific GSK-3 inhibition through destabilization of the GSK-3 structure.	[Phiel, Christopher J.] Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, Columbus, OH 43205 USA; Ohio State Univ, Coll Med, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Phiel, CJ (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Mol & Human Genet, 700 Childrens Dr W432, Columbus, OH 43205 USA.	phiel.1@osu.edu			National Institutes of Health NIA [R01AG031883]; NATIONAL INSTITUTE ON AGING [R01AG031883] Funding Source: NIH RePORTER	National Institutes of Health NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grant R01AG031883 (to C.J.P.) from NIA.	Aoki M, 2004, ACTA CRYSTALLOGR D, V60, P439, DOI [10.1107/S090744490302938X, 10.1107/S090744490302938x]; Avila J, 2006, FEBS LETT, V580, P2922, DOI 10.1016/j.febslet.2006.02.067; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cole A, 2004, BIOCHEM J, V377, P249, DOI 10.1042/BJ20031259; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dajani R, 2003, EMBO J, V22, P494, DOI 10.1093/emboj/cdg068; Ding VW, 2000, J BIOL CHEM, V275, P32475, DOI 10.1074/jbc.M005342200; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOMINGUEZ I, 1995, P NATL ACAD SCI USA, V92, P8498, DOI 10.1073/pnas.92.18.8498; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; FIOL CJ, 1990, J BIOL CHEM, V265, P6061; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fraser E, 2002, J BIOL CHEM, V277, P2176, DOI 10.1074/jbc.M109462200; GOODE N, 1992, J BIOL CHEM, V267, P16878; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hagen T, 2002, J BIOL CHEM, V277, P23330, DOI 10.1074/jbc.M201364200; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; HUGHES K, 1993, EMBO J, V12, P803, DOI 10.1002/j.1460-2075.1993.tb05715.x; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Koivisto L, 2006, EXP CELL RES, V312, P2791, DOI 10.1016/j.yexcr.2006.05.009; Lau KF, 1999, J PEPT RES, V54, P85, DOI 10.1034/j.1399-3011.1999.00083.x; Liang MH, 2006, J BIOL CHEM, V281, P30479, DOI 10.1074/jbc.M607468200; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacAulay K, 2007, CELL METAB, V6, P329, DOI 10.1016/j.cmet.2007.08.013; MacDonald BT, 2008, J BIOL CHEM, V283, P16115, DOI 10.1074/jbc.M800327200; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; OTVOS L, 1994, J NEUROSCI RES, V39, P669, DOI 10.1002/jnr.490390607; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; PIERCE SB, 1995, DEVELOPMENT, V121, P755; ter Haar E, 2001, NAT STRUCT BIOL, V8, P593, DOI 10.1038/89624; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x	40	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7957	7963		10.1074/jbc.M109.091603	http://dx.doi.org/10.1074/jbc.M109.091603			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080974	hybrid, Green Published			2022-12-27	WOS:000275413800013
J	Seeger, MA; Rice, SE				Seeger, Mark A.; Rice, Sarah E.			Microtubule-associated Protein-like Binding of the Kinesin-1 Tail to Microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAVY-CHAIN; TERMINAL DOMAIN; MOTOR PROTEIN; TRANSPORT; TUBULIN; DYNEIN; LOCALIZATION; MOLECULE; SITES; TAU	The kinesin-1 molecular motor contains an ATP-dependent microtubule-binding site in its N-terminal head domain and an ATP-independent microtubule-binding site in its C-terminal tail domain. Here we demonstrate that a kinesin-1 tail fragment associates with microtubules with submicromolar affinity. Binding is largely electrostatic in nature, and is facilitated by a region of basic amino acids in the tail and the acidic E-hook at the C terminus of tubulin. The tail binds to a site on tubulin that is independent of the head domain-binding site but overlaps with the binding site of the microtubule-associated protein Tau. Surprisingly, the kinesin tail domain stimulates microtubule assembly and stability in a manner similar to Tau. The biological function of this strong kinesin tail-microtubule interaction remains to be seen, but it is likely to play an important role in kinesin regulation due to the close proximity of the microtubule- binding region to the conserved regulatory and cargobinding domains of the tail.	[Seeger, Mark A.; Rice, Sarah E.] Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA	Northwestern University	Rice, SE (corresponding author), 303 E Chicago Ave,Ward 8-321, Chicago, IL 60611 USA.	s-rice@northwestern.edu	Gelfand, Vladimir I/D-2545-2013	Gelfand, Vladimir I/0000-0002-6361-2798; Seeger, Mark/0000-0001-8149-947X	National Institutes of Health [GM072656]; Northwestern University Molecular Biophysics Training Program [5T32 GM008382]; Northwestern University Malkin Scholarship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072656, T32GM008382] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University Molecular Biophysics Training Program; Northwestern University Malkin Scholarship Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM072656 (to S. E. R.), Northwestern University Molecular Biophysics Training Program Grant 5T32 GM008382 (to M. A. S.), and the Northwestern University Malkin Scholarship Program (to M. A. S.).	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; Cai DW, 2007, BIOPHYS J, V92, P4137, DOI 10.1529/biophysj.106.100206; Cai Q, 2005, J CELL BIOL, V170, P959, DOI 10.1083/jcb.200506042; Coy DL, 1999, NAT CELL BIOL, V1, P288, DOI 10.1038/13001; Dietrich KA, 2008, P NATL ACAD SCI USA, V105, P8938, DOI 10.1073/pnas.0803575105; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Hackney DD, 2009, BIOCHEMISTRY-US, V48, P3448, DOI 10.1021/bi8022575; Hackney DD, 2000, NAT CELL BIOL, V2, P257, DOI 10.1038/35010525; Hammond JW, 2008, TRAFFIC, V9, P725, DOI 10.1111/j.1600-0854.2008.00722.x; HOLLENBECK PJ, 1989, J CELL BIOL, V108, P2335, DOI 10.1083/jcb.108.6.2335; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Karabay A, 2003, BIOCHEM BIOPH RES CO, V305, P523, DOI 10.1016/S0006-291X(03)00827-1; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; Karabay A, 1999, BIOCHEM BIOPH RES CO, V258, P39, DOI 10.1006/bbrc.1999.0572; LEE JC, 1978, BIOCHEMISTRY-US, V17, P2783, DOI 10.1021/bi00607a013; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Marx A, 2006, J MUSCLE RES CELL M, V27, P125, DOI 10.1007/s10974-005-9051-4; NAVONE F, 1992, J CELL BIOL, V117, P1263, DOI 10.1083/jcb.117.6.1263; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; RODIONOV VI, 1990, J BIOL CHEM, V265, P5702; Sakamoto R, 2005, MOL BIOL CELL, V16, P483, DOI 10.1091/mbc.E04-07-0553; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; Stock MF, 1999, J BIOL CHEM, V274, P14617, DOI 10.1074/jbc.274.21.14617; Straube A, 2006, MOL BIOL CELL, V17, P907, DOI 10.1091/mbc.E05-06-0542; WILLIAMS RC, 1982, METHOD ENZYMOL, V85, P376; Yonekura H, 2006, BIOCHEM BIOPH RES CO, V343, P420, DOI 10.1016/j.bbrc.2006.02.169	35	47	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8155	8162		10.1074/jbc.M109.068247	http://dx.doi.org/10.1074/jbc.M109.068247			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071331	Green Published, hybrid			2022-12-27	WOS:000275413800034
J	Wang, JD; Chen, JJ				Wang, Jiadong; Chen, Junjie			SIRT1 Regulates Autoacetylation and Histone Acetyltransferase Activity of TIP60	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; ACTIVATES ATM; P53; ACETYLATION; COMPLEX; FOXO	The histone acetyltransferase TIP60, a frequent target of monoallelic loss in human carcinomas, can acetylate many substrates, including histones and p53, and thus promote apoptosis following UV radiation. Here we showed that TIP60 is autoacetylated in response to UV damage, which is critically important for TIP60 activation. Mechanistically we demonstrated that TIP60 autoacetylation leads to the dissociation of TIP60 oligomer and enhances its interaction with substrates. Moreover, we identified SIRT1 that specifically deacetylates TIP60 and negatively regulates TIP60 activity in vivo. Taken together, our data reveal TIP60 autoacetylation as a key step in the control of its histone acetyltransferase activity and function in response to DNA damage.	[Wang, Jiadong; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jchen8@mdanderson.org			National Institutes of Health [CA089239, CA092312, CA100109]; NATIONAL CANCER INSTITUTE [R01CA100109, R01CA092312, R01CA089239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA089239, CA092312, and CA100109 (to J.C.).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Carter S, 2009, CURR OPIN GENET DEV, V19, P18, DOI 10.1016/j.gde.2008.11.010; Chailleux C, 2010, BIOCHEM J, V426, P365, DOI 10.1042/BJ20091329; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; HOFER B, 1994, GENE, V144, P9, DOI 10.1016/0378-1119(94)90196-1; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim TW, 2009, NAT CELL BIOL, V11, P1254, DOI 10.1038/ncb1970; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kranz D, 2008, J CELL BIOL, V182, P197, DOI 10.1083/jcb.200712014; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yamagata K, 2009, BIOCHEM BIOPH RES CO, V390, P1355, DOI 10.1016/j.bbrc.2009.10.156; Yuan Z, 2007, MOL CELL, V27, P149, DOI 10.1016/j.molcel.2007.05.029	31	79	87	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11458	11464		10.1074/jbc.M109.087585	http://dx.doi.org/10.1074/jbc.M109.087585			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20100829	Green Published, hybrid			2022-12-27	WOS:000276286200052
J	Nakano, H; Funasaka, T; Hashizume, C; Wong, RW				Nakano, Hiroshi; Funasaka, Tatsuyoshi; Hashizume, Chieko; Wong, Richard W.			Nucleoporin Translocated Promoter Region (Tpr) Associates with Dynein Complex, Preventing Chromosome Lagging Formation during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-PORE COMPLEX; SPINDLE-ASSEMBLY CHECKPOINT; COILED-COIL PROTEIN; MICROTUBULE MOTOR DYNEIN; COHESIN SUBUNIT SMC1; MESSENGER-RNA EXPORT; INTRACELLULAR-TRANSPORT; MITOTIC SPINDLES; KINETOCHORE; ENVELOPE	Gain or loss of whole chromosomes is often observed in cancer cells and is thought to be due to aberrant chromosome segregation during mitosis. Proper chromosome segregation depends on a faithful interaction between spindle microtubules and kinetochores. Several components of the nuclear pore complex/nucleoporins play critical roles in orchestrating the rapid remodeling events that occur during mitosis. Our recent studies revealed that the nucleoporin, Rae1, plays critical roles in maintaining spindle bipolarity. Here, we show association of another nucleoporin, termed Tpr (translocated promoter region), with the molecular motors dynein and dynactin, which both orchestrate with the spindle checkpoints Mad1 and Mad2 during cell division. Overexpression of Tpr enhanced multinucleated cell formation. RNA interference-mediated knockdown of Tpr caused a severe lagging chromosome phenotype and disrupted spindle checkpoint proteins expression and localization. Next, we performed a series of rescue and dominant negative experiments to confirm that Tpr orchestrates proper chromosome segregation through interaction with dynein light chain. Our data indicate that Tpr functions as a spatial and temporal regulator of spindle checkpoints, ensuring the efficient recruitment of checkpoint proteins to the molecular motor dynein to promote proper anaphase formation.	[Wong, Richard W.] Kanazawa Univ, Frontier Sci Org, Canc Res Inst 1F, Kanazawa, Ishikawa 9201192, Japan; Kanazawa Univ, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan	Kanazawa University; Kanazawa University	Wong, RW (corresponding author), Kanazawa Univ, Frontier Sci Org, Canc Res Inst 1F, Kanazawa, Ishikawa 9201192, Japan.	rwong@staff.kanazawa-u.ac.jp	Wong, Richard W./E-9155-2011	Hashizume, Chieko/0000-0002-5937-3915	Special Coordination Funds for Promoting Science and Technology (SCF); Ministry of Education, Culture, Sports, Science and Technology, Japan; Takeda Science Foundation; Astellas Foundation; Novartis Foundation (Japan)	Special Coordination Funds for Promoting Science and Technology (SCF)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Astellas Foundation(Astellas Pharmaceuticals); Novartis Foundation (Japan)(Novartis)	This work was supported by the Program for Improvement of Research Environment for Young Researchers from the Special Coordination Funds for Promoting Science and Technology (SCF), grants-in-aid for young scientists (B), from (Ministry of Education, Culture, Sports, Science and Technology), Japan, and by grants from the Takeda Science Foundation, the Astellas Foundation for research on metabolic disorders, and The Novartis Foundation (Japan) (to R. W. W.).	Bangs P, 1998, J CELL BIOL, V143, P1801, DOI 10.1083/jcb.143.7.1801; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; BYRD DA, 1994, J CELL BIOL, V127, P1515, DOI 10.1083/jcb.127.6.1515; Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515; Cordes VC, 1998, EXP CELL RES, V245, P43, DOI 10.1006/excr.1998.4246; De Souza CP, 2009, MOL BIOL CELL, V20, P2146, DOI 10.1091/mbc.E08-08-0878; Debler EW, 2009, NAT STRUCT MOL BIOL, V16, P457, DOI 10.1038/nsmb0509-457; Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; Funasaka T, 2005, FASEB J, V19, P1422, DOI 10.1096/fj.05-3699com; Galy V, 2006, CURR BIOL, V16, P1748, DOI 10.1016/j.cub.2006.06.067; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hase ME, 2001, MOL BIOL CELL, V12, P2433, DOI 10.1091/mbc.12.8.2433; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Kuznetsov NV, 2002, CHROMOSOMA, V111, P236, DOI 10.1007/s00412-002-0208-2; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lim RYH, 2008, INT REV CEL MOL BIO, V267, P299, DOI 10.1016/S1937-6448(08)00632-1; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883; Merdes A, 2000, J CELL BIOL, V149, P851, DOI 10.1083/jcb.149.4.851; MITCHELL PJ, 1992, ONCOGENE, V7, P383; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nguyen CL, 2008, CANCER RES, V68, P8715, DOI 10.1158/0008-5472.CAN-08-1303; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029; Orjalo AV, 2006, MOL BIOL CELL, V17, P3806, DOI 10.1091/mbc.E05-11-1061; Peschard P, 2007, ONCOGENE, V26, P1276, DOI 10.1038/sj.onc.1210201; Qi HY, 2004, MOL BIOL CELL, V15, P4854, DOI 10.1091/mbc.E04-07-0579; Rao CV, 2009, CARCINOGENESIS, V30, P1469, DOI 10.1093/carcin/bgp081; Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; VALLEE R, 1993, P NATL ACAD SCI USA, V90, P8769, DOI 10.1073/pnas.90.19.8769; Wojcik E, 2001, NAT CELL BIOL, V3, P1001, DOI 10.1038/ncb1101-1001; Wong RW, 2008, P NATL ACAD SCI USA, V105, P15441, DOI 10.1073/pnas.0807660105; Wong RW, 2006, P NATL ACAD SCI USA, V103, P19783, DOI 10.1073/pnas.0609582104; Wong RW, 2010, CELL CYCLE, V9, P198, DOI 10.4161/cc.9.1.10431; Wong RWC, 2002, P NATL ACAD SCI USA, V99, P14500, DOI 10.1073/pnas.222371099; Xu SL, 2009, SEMIN CELL DEV BIOL, V20, P620, DOI 10.1016/j.semcdb.2009.03.003; Xu XM, 2007, PLANT CELL, V19, P1537, DOI 10.1105/tpc.106.049239; Yang ZY, 2005, MOL CELL BIOL, V25, P4062, DOI 10.1128/MCB.25.10.4062-4074.2005	50	65	68	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10841	10849		10.1074/jbc.M110.105890	http://dx.doi.org/10.1074/jbc.M110.105890			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133940	hybrid, Green Published			2022-12-27	WOS:000276264600069
J	Nian, ZQ; Sun, ZQ; Yu, LX; Toh, SY; Sang, JL; Li, P				Nian, Zongqian; Sun, Zhiqi; Yu, Luxin; Toh, Shen Yon; Sang, Jianli; Li, Peng			Fat-specific Protein 27 Undergoes Ubiquitin-dependent Degradation Regulated by Triacylglycerol Synthesis and Lipid Droplet Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; WHITE ADIPOSE-TISSUE; POSTTRANSLATIONAL REGULATION; INSULIN SENSITIVITY; DEFICIENT MICE; MOUSE-LIVER; CIDEA; STORAGE; ADIPOCYTES; EXPRESSION	The fat-specific protein 27 (Fsp27), a protein localized to lipid droplets (LDs), plays an important role in controlling lipid storage and mitochondrial activity in adipocytes. Fsp27-null mice display increased energy expenditure and are resistant to high fat diet-induced obesity and diabetes. However, little is known about how the Fsp27 protein is regulated. Here, we show that Fsp27 stability is controlled by the ubiquitin-dependent proteasomal degradation pathway in adipocytes. The ubiquitination of Fsp27 is regulated by three lysine residues located in the C-terminal region. Substitution of these lysine residues with alanines greatly increased Fsp27 stability and enhanced lipid storage in adipocytes. Furthermore, Fsp27 was stabilized and rapidly accumulated following treatment with beta-agonists that induce lipolysis and fatty acid re-esterification in adipocytes. More importantly, Fsp27 stabilization was dependent on triacylglycerol synthesis and LD formation, because knockdown of diacylglycerol acyltransferase in adipocytes significantly reduced Fsp27 accumulation in adipocytes. Finally, we observed that increased Fsp27 during beta-agonist treatment preferentially associated with LDs. Taken together, our data revealed that Fsp27 can be stabilized by free fatty acid availability, triacylglycerol synthesis, and LD formation. The stabilization of Fsp27 when free fatty acids are abundant further enhances lipid storage, providing positive feedback to regulate lipid storage in adipocytes.	[Nian, Zongqian; Sun, Zhiqi; Li, Peng] Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Yu, Luxin; Sang, Jianli] Beijing Normal Univ, Coll Life Sci, Beijing 100875, Peoples R China; [Toh, Shen Yon] Inst Mol & Cell Biol, Singapore 138673, Singapore	Tsinghua University; Beijing Normal University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Li, P (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	li-peng@mail.tsinghua.edu.cn	Sun, Zhiqi/E-9303-2012	Sun, Zhiqi/0000-0002-2792-2158; Toh, Shen Yon/0000-0002-6421-0862	National Natural Science Foundation of China [30530350, 30925017]; Ministry of Education of China [704002]; Ministry of Science and Technology of China [2006CB503909, 2007CB914404]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation of China (Grants 30530350 and 30925017 to P. L.), the Ministry of Education of China (Grant 704002 to P. L.), and the National Basic Research program of China (Grants 2006CB503909 and 2007CB914404) from the Ministry of Science and Technology of China. This work was also supported by the Program for Changjiang Scholars and the Innovative Research Team in University from the Ministry of Education in China.	Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 2000, BBA-MOL CELL BIOL L, V1483, P251, DOI 10.1016/S1388-1981(99)00179-1; Brasaemle DL, 1997, J BIOL CHEM, V272, P9378; Chan SC, 2007, BIOCHEM J, V408, P259, DOI 10.1042/BJ20070690; CROZE EM, 1984, J CELL PHYSIOL, V119, P46, DOI 10.1002/jcp.1041190109; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; EGAN JJ, 1992, P NATL ACAD SCI USA, V89, P8537, DOI 10.1073/pnas.89.18.8537; Gong JY, 2009, CURR OPIN LIPIDOL, V20, P121, DOI 10.1097/MOL.0b013e328328d0bb; Joost HG, 2000, METH MOL B, V155, P77; Keller P, 2008, J BIOL CHEM, V283, P14355, DOI 10.1074/jbc.M708323200; Kovsan J, 2007, J BIOL CHEM, V282, P21704, DOI 10.1074/jbc.M702223200; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Li JZ, 2007, DIABETES, V56, P2523, DOI 10.2337/db07-0040; Londos C, 1999, ANN NY ACAD SCI, V892, P155, DOI 10.1111/j.1749-6632.1999.tb07794.x; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; MAYOREK N, 1985, J BIOL CHEM, V260, P6528; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Orlicky DJ, 2008, J CELL SCI, V121, P2921, DOI 10.1242/jcs.026153; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Suzuki R, 2005, J BIOL CHEM, V280, P3331, DOI 10.1074/jbc.M410955200; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Viswakarma N, 2007, J BIOL CHEM, V282, P18613, DOI 10.1074/jbc.M701983200; Xu GH, 2006, BBA-MOL CELL BIOL L, V1761, P83, DOI 10.1016/j.bbalip.2005.12.005; Xu GH, 2005, J BIOL CHEM, V280, P42841, DOI 10.1074/jbc.M506569200; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Yu ST, 2003, J BIOL CHEM, V278, P498, DOI 10.1074/jbc.M210062200; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	31	51	59	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9604	9615		10.1074/jbc.M109.043786	http://dx.doi.org/10.1074/jbc.M109.043786			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089860	Green Published, hybrid			2022-12-27	WOS:000276165900033
J	Trazzi, S; Steger, M; Mitrugno, VM; Bartesaghi, R; Ciani, E				Trazzi, Stefania; Steger, Martin; Mitrugno, Valentina Maria; Bartesaghi, Renata; Ciani, Elisabetta			CB1 Cannabinoid Receptors Increase Neuronal Precursor Proliferation through AKT/Glycogen Synthase Kinase-3 beta/beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE CELLS; MESSENGER-RNA EXPRESSION; ENDOCANNABINOID SYSTEM; RAT-BRAIN; ACTIVATION; DIFFERENTIATION; PATHWAY; MOUSE; INVOLVEMENT; INHIBITORS	The endocannabinoid system is involved in the regulation of many physiological effects in the central and peripheral nervous system. Recent findings have demonstrated the presence of a functional endocannabinoid system within neuronal progenitors located in the hippocampus and ventricular/subventricular zone that participates in the regulation of cell proliferation. It is presently unknown whether the endocannabinoid system exerts a widespread effect on neuronal precursors from different neurogenic regions, and very little is known about the signaling by which it regulates neuronal precursor proliferation. Herein, we demonstrate the presence of cannabinoid CB1 receptors in granule cell precursors (GCPs) during early cerebellar development. Activation of CB1 receptors by HU-210 promoted GCP proliferation in vitro, an effect that was prevented by a selective CB1 antagonist. Accordingly, in vivo experiments showed that GCP proliferation was increased by chronic HU-210 treatment and that in CB1-deficient mice cell proliferation was significantly lower than in wild-type littermates, indicating that the endocannabinoid system is physiologically involved in regulation of GCP proliferation. The pro-proliferative effect of cannabinoids in GCPs was mediated through the CB1/AKT/glycogen synthase kinase-3 beta/beta-catenin pathway. Involvement of this pathway was also observed in cultures of neuronal precursors from the subventricular zone, suggesting that this pathway may be a general mechanism by which endocannabinoids regulate proliferation of neuronal precursors. These observations suggest that endocannabinoids constitute a new family of lipid signaling cues that may exert a widespread effect on neuronal precursor proliferation during brain development.	[Trazzi, Stefania; Steger, Martin; Mitrugno, Valentina Maria; Bartesaghi, Renata; Ciani, Elisabetta] Univ Bologna, Dept Human & Gen Physiol, I-40126 Bologna, Italy; [Ciani, Elisabetta] S Orsola Malpighi Univ Hosp, Ctr Appl Biomed Res, I-40138 Bologna, Italy	University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna	Ciani, E (corresponding author), Univ Bologna, Dept Human & Gen Physiol, Piazza Porta San Donato 2, I-40126 Bologna, Italy.	elisabetta.ciani@unibo.it	Ciani, Elisabetta/AAL-6462-2020	ciani, elisabetta/0000-0003-3130-5168; Trazzi, Stefania/0000-0003-2623-2769				Aguado T, 2005, FASEB J, V19, P1704, DOI 10.1096/fj.05-3995fje; Altman J., 1982, CEREBELLUM NEW VISTA, V47, P8; Behesti H, 2009, INT J BIOCHEM CELL B, V41, P435, DOI 10.1016/j.biocel.2008.06.017; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Berrendero F, 1998, DEVELOPMENT, V125, P3179; Bianchi P, 2010, BRAIN PATHOL, V20, P106, DOI 10.1111/j.1750-3639.2008.00246.x; Bouaboula M, 1997, J BIOL CHEM, V272, P22330, DOI 10.1074/jbc.272.35.22330; Breivogel CS, 2004, NEUROPHARMACOLOGY, V47, P81, DOI 10.1016/j.neuropharm.2004.02.017; Brown SP, 2004, J NEUROSCI, V24, P5623, DOI 10.1523/JNEUROSCI.0918-04.2004; Buckley NE, 1998, NEUROSCIENCE, V82, P1131; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Chenn A, 2003, CEREB CORTEX, V13, P599, DOI 10.1093/cercor/13.6.599; Childers SR, 1998, DRUG ALCOHOL DEPEN, V51, P173, DOI 10.1016/S0376-8716(98)00075-1; Contestabile A, 2005, J BIOL CHEM, V280, P33541, DOI 10.1074/jbc.M413323200; Contestabile A, 2009, BRAIN PATHOL, V19, P224, DOI 10.1111/j.1750-3639.2008.00168.x; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dalton GD, 2009, CNS NEUROL DISORD-DR, V8, P422, DOI 10.2174/187152709789824615; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Downer EJ, 2007, BRAIN RES, V1175, P39, DOI 10.1016/j.brainres.2007.07.076; Fernandez-Ruiz J, 2000, TRENDS NEUROSCI, V23, P14, DOI 10.1016/S0166-2236(99)01491-5; Fernandez-Ruiz JJ, 1999, LIFE SCI, V65, P725, DOI 10.1016/S0024-3205(99)00295-7; GALLO V, 1982, P NATL ACAD SCI-BIOL, V79, P7919, DOI 10.1073/pnas.79.24.7919; Galve-Roperh I, 2000, NAT MED, V6, P313, DOI 10.1038/73171; Glass M, 1997, NEUROSCIENCE, V77, P299, DOI 10.1016/S0306-4522(96)00428-9; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HOWLETT AC, 1995, ANNU REV PHARMACOL, V35, P607, DOI 10.1146/annurev.pharmtox.35.1.607; Israsena N, 2004, DEV BIOL, V268, P220, DOI 10.1016/j.ydbio.2003.12.024; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Jin KL, 2004, MOL PHARMACOL, V66, P204, DOI 10.1124/mol.66.2.204; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; KOPPEL H, 1983, NEUROPATH APPL NEURO, V9, P207, DOI 10.1111/j.1365-2990.1983.tb00108.x; Li J, 2005, BIOL REPROD, V72, P700, DOI 10.1095/biolreprod.104.033837; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lundholt BK, 2005, J BIOMOL SCREEN, V10, P20, DOI 10.1177/108705710429989; Mairet-Coello G, 2009, J NEUROSCI, V29, P775, DOI 10.1523/JNEUROSCI.1700-08.2009; MARES V, 1970, BRAIN RES, V23, P343, DOI 10.1016/0006-8993(70)90061-2; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1994, BIOCHEM PHARMACOL, V48, P1537, DOI 10.1016/0006-2952(94)90197-X; Mechoulam R, 2002, Sci STKE, V2002, pre5, DOI 10.1126/stke.2002.129.re5; Molina-Holgado E, 2002, J NEUROSCI, V22, P9742, DOI 10.1523/jneurosci.22-22-09742.2002; Molina-Holgado F, 2007, EUR J NEUROSCI, V25, P629, DOI 10.1111/j.1460-9568.2007.05322.x; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Ozaita A, 2007, J NEUROCHEM, V102, P1105, DOI 10.1111/j.1471-4159.2007.04642.x; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Porter AC, 2001, PHARMACOL THERAPEUT, V90, P45, DOI 10.1016/S0163-7258(01)00130-9; Pozzoli G, 2006, J NEUROSCI RES, V83, P1058, DOI 10.1002/jnr.20794; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rueda D, 2000, MOL PHARMACOL, V58, P814, DOI 10.1124/mol.58.4.814; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; Sanchez C, 1998, MOL PHARMACOL, V54, P834, DOI 10.1124/mol.54.5.834; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sim-Selley Laura J., 2003, Critical Reviews in Neurobiology, V15, P91, DOI 10.1615/CritRevNeurobiol.v15.i2.10; Skaper SD, 1996, P NATL ACAD SCI USA, V93, P3984, DOI 10.1073/pnas.93.9.3984; Toledo EM, 2008, PROG NEUROBIOL, V86, P281, DOI 10.1016/j.pneurobio.2008.08.001; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Vallano ML, 2006, NEUROPHARMACOLOGY, V50, P651, DOI 10.1016/j.neuropharm.2005.11.012; Viti J, 2003, J NEUROSCI, V23, P5919; Vogt PK, 1999, CELL GROWTH DIFFER, V10, P777; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Weiss S, 1996, J NEUROSCI, V16, P7599; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; ZHENG TM, 1994, P NATL ACAD SCI USA, V91, P10952, DOI 10.1073/pnas.91.23.10952; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	73	60	62	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10098	10109		10.1074/jbc.M109.043711	http://dx.doi.org/10.1074/jbc.M109.043711			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20083607	hybrid, Green Published			2022-12-27	WOS:000276165900077
J	Zhang, X; Chen, XJ; Jia, CX; Geng, X; Du, XN; Zhang, HL				Zhang, Xuan; Chen, Xingjuan; Jia, Caixia; Geng, Xian; Du, Xiaona; Zhang, Hailin			Depolarization Increases Phosphatidylinositol (PI) 4,5-Bisphosphate Level and KCNQ Currents through PI 4-Kinase Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED INHIBITION; PROTEIN-COUPLED RECEPTOR; POTASSIUM CHANNELS; SYMPATHETIC NEURONS; ION CHANNELS; MODULATION; PHOSPHOINOSITIDES; HYDROLYSIS; ACTIVATION; PATHWAYS	A growing body of evidence shows that membrane phosphatidylinositol 4,5-bisphosphates (PtdIns(4,5)P-2, PIP2) play an important role in cell signaling. The presence of PIP2 is fundamentally important for maintaining the functions of a large number of ion channels and transporters, and for other cell processes such as vesicle trafficking, mobility, and endo-and exocytosis. PIP2 levels in the membrane are dynamically modulated, which is an important signaling mechanism for modulation of PIP2-dependent cellular processes. In this study, we describe a novel mechanism of membrane PIP2 modulation. Membrane depolarization induces an elevation in membrane PIP2, and subsequently increases functions of PIP2-sensitive KCNQ potassium channels expressed in Xenopus oocytes. Further evidence suggests that the depolarization-induced elevation of membrane PIP2 occurs through increased activity of PI4 kinase. With increased recognition of the importance of PIP2 in cell function, the effect of membrane depolarization in PIP2 metabolism is destined to have important physiological implications.	[Zhang, Xuan; Chen, Xingjuan; Jia, Caixia; Geng, Xian; Du, Xiaona; Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China	Hebei Medical University	Zhang, HL (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang 050017, Hebei, Peoples R China.	zhanghl@hebmu.edu.cn	chen, xingjuan/V-4064-2019	chen, xingjuan/0000-0002-7380-8399	National Natural Science Foundation of China [30730031, 30500112]; National Basic Research Program [2007CB512100]; National Science Fund for Distinguished Young Scholars of China [30325038]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars)	This work was supported by the National Natural Science Foundation of China (30730031, to H.Z., 30500112, to X. D.) and the National Basic Research Program (2007CB512100).; Recipient of National Science Fund for Distinguished Young Scholars of China (30325038).	Araya R, 2003, J GEN PHYSIOL, V121, P3, DOI 10.1085/jgp.20028671; Ben-Chaim Y, 2003, J BIOL CHEM, V278, P22482, DOI 10.1074/jbc.M301146200; Ben-Chaim Y, 2006, NATURE, V444, P106, DOI 10.1038/nature05259; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Du XO, 2004, J BIOL CHEM, V279, P37271, DOI 10.1074/jbc.M403413200; Ford CP, 2003, J NEUROSCI, V23, P4931, DOI 10.1523/jneurosci.23-12-04931.2003; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jia QZ, 2007, J NEUROSCI, V27, P2503, DOI 10.1523/JNEUROSCI.2911-06.2007; Jia ZF, 2008, J GEN PHYSIOL, V131, P575, DOI 10.1085/jgp.200709924; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Martinez-Pinna J, 2005, J BIOL CHEM, V280, P1490, DOI 10.1074/jbc.M407783200; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; NAKANISHI S, 1995, P NATL ACAD SCI USA, V92, P5317, DOI 10.1073/pnas.92.12.5317; Nasuhoglu C, 2002, AM J PHYSIOL-CELL PH, V283, pC223, DOI 10.1152/ajpcell.00486.2001; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; Wood MJ, 2000, BIOPHYS J, V79, P2535, DOI 10.1016/S0006-3495(00)76494-0; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Yamamoto M, 2006, J BIOL CHEM, V281, P32630, DOI 10.1074/jbc.M605928200; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	32	15	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9402	9409		10.1074/jbc.M109.068205	http://dx.doi.org/10.1074/jbc.M109.068205			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106968	hybrid, Green Published			2022-12-27	WOS:000276165900012
J	Bintintan, I; Meyers, G				Bintintan, Ioana; Meyers, Gregor			A New Type of Signal Peptidase Cleavage Site Identified in an RNA Virus Polyprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRAL-DIARRHEA-VIRUS; SWINE-FEVER VIRUS; GLYCOPROTEIN E-RNS; BREFELDIN-A; PESTIVIRUS GLYCOPROTEIN; SECRETORY PROTEINS; INTRACELLULAR-TRANSPORT; MONOCLONAL-ANTIBODIES; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION	Pestiviruses, a group of enveloped positive strand RNA viruses belonging to the family Flaviviridae, express their genes via a polyprotein that is subsequently processed by proteases. The structural protein region contains typical signal peptidase cleavage sites. Only the site at the C terminus of the glycoprotein E-rns is different because it does not contain a hydrophobic transmembrane region but an amphipathic helix functioning as the Erns membrane anchor. Despite the absence of a hydrophobic region, the site between the C terminus of E-rns and E1, the protein located downstream in the polyprotein, is cleaved by signal peptidase, as demonstrated by mutagenesis and inhibitor studies. Thus, E(rns)E1 is processed at a novel type of signal peptidase cleavage site showing a different membrane topology. Prevention of glycosylation or introduction of mutations into the C-terminal region of E-rns severely impairs processing, presumably by preventing proper membrane interaction or disturbing a conformation critical for the protein to be accepted as a substrate by signal peptidase.	[Bintintan, Ioana; Meyers, Gregor] Friedrich Loeffler Inst, Inst Immunol, D-72001 Tubingen, Germany	Friedrich Loeffler Institute	Meyers, G (corresponding author), Friedrich Loeffler Inst, Inst Immunol, Paul Ehrlich Str 28, D-72001 Tubingen, Germany.	gregor.meyers@fli.bund.de			Deutsche Forschungsgemeinschaft [Me1367/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant Me1367/4.	BOLIN S, 1988, ARCH VIROL, V99, P117, DOI 10.1007/BF01311029; Casanova CL, 2006, MOL BIOCHEM PARASIT, V149, P144, DOI 10.1016/j.molbiopara.2006.05.005; CHOO KH, 2008, BMC BIOINFORMATI S12, V9, pS15; COLLETT MS, 1989, J GEN VIROL, V70, P253, DOI 10.1099/0022-1317-70-2-253; COLLETT MS, 1988, VIROLOGY, V165, P200, DOI 10.1016/0042-6822(88)90673-3; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DONIS RO, 1988, J GEN VIROL, V69, P77, DOI 10.1099/0022-1317-69-1-77; Elbers K, 1996, J VIROL, V70, P4131, DOI 10.1128/JVI.70.6.4131-4135.1996; Fetzer C, 2005, J VIROL, V79, P11901, DOI 10.1128/JVI.79.18.11901-11913.2005; FUJIWARA T, 1988, J BIOL CHEM, V263, P18545; Harada T, 2000, J VIROL, V74, P9498, DOI 10.1128/JVI.74.20.9498-9506.2000; Hausmann Y, 2004, J VIROL, V78, P5507, DOI 10.1128/JVI.78.10.5507-5512.2004; Heimann M, 2006, J VIROL, V80, P1915, DOI 10.1128/JVI.80.4.1915-1921.2006; HEINZ FX, 2000, VIRUS TAXONOMY, P859; HORIUCHI H, 1988, J BIOCHEM-TOKYO, V103, P408, DOI 10.1093/oxfordjournals.jbchem.a122284; HULST MM, 1994, VIROLOGY, V200, P558, DOI 10.1006/viro.1994.1218; Iqbal M, 2004, J VIROL, V78, P136, DOI 10.1128/JVI.78.1.136-145.2004; Jackson R C, 1980, Ann N Y Acad Sci, V343, P391, DOI 10.1111/j.1749-6632.1980.tb47268.x; JACKSON RC, 1977, P NATL ACAD SCI USA, V74, P5598, DOI 10.1073/pnas.74.12.5598; Karla A, 2005, J BIOL CHEM, V280, P6731, DOI 10.1074/jbc.M413019200; Kessler S W, 1981, Methods Enzymol, V73, P442; KONIG M, 1995, J VIROL, V69, P6479; Lackner T, 2005, J VIROL, V79, P9746, DOI 10.1128/JVI.79.15.9746-9755.2005; Langedijk JPM, 2002, J BIOL CHEM, V277, P5308, DOI 10.1074/jbc.M104147200; LAU JTY, 1983, J BIOL CHEM, V258, P5255; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Lively MO, 1989, CURR OPIN CELL BIOL, V1, P1188, DOI 10.1016/S0955-0674(89)80070-5; LIVELY MO, 1994, METHOD ENZYMOL, V244, P301; Magkouras I, 2008, J GEN VIROL, V89, P2501, DOI 10.1099/vir.0.2008/003749-0; Martoglio B, 2003, BIOCHEM SOC T, V31, P1243; Matzener P, 2009, VIRUS RES, V140, P15, DOI 10.1016/j.virusres.2008.10.015; Meyer C, 2002, J VIROL, V76, P8494, DOI 10.1128/JVI.76.16.8494-8503.2002; Meyers G, 1999, J VIROL, V73, P10224, DOI 10.1128/JVI.73.12.10224-10235.1999; Meyers G, 1996, J VIROL, V70, P8606, DOI 10.1128/JVI.70.12.8606-8613.1996; Meyers G, 1996, J VIROL, V70, P1588, DOI 10.1128/JVI.70.3.1588-1595.1996; Meyers G, 2007, J VIROL, V81, P3327, DOI 10.1128/JVI.02372-06; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; NILSSON I, 1994, J CELL BIOL, V126, P1127, DOI 10.1083/jcb.126.5.1127; Nilsson I, 2003, J BIOL CHEM, V278, P29389, DOI 10.1074/jbc.M212310200; Nilsson I, 2002, FEBS LETT, V516, P106, DOI 10.1016/S0014-5793(02)02511-5; ODA K, 1987, FEBS LETT, V214, P135, DOI 10.1016/0014-5793(87)80028-5; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Reimann I, 2007, VIROLOGY, V366, P377, DOI 10.1016/j.virol.2007.05.006; RUMENAPF T, 1993, J VIROL, V67, P3288; Sambrook J., 2001, MOL CLONING LAB MANU; SCHNEIDER R, 1993, SCIENCE, V261, P1169, DOI 10.1126/science.8356450; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Shmulevitz M, 2000, EMBO J, V19, P902, DOI 10.1093/emboj/19.5.902; Tautz N, 1997, J VIROL, V71, P5415, DOI 10.1128/JVI.71.7.5415-5422.1997; Tews BA, 2007, J BIOL CHEM, V282, P32730, DOI 10.1074/jbc.M706803200; THIEL HJ, 1991, J VIROL, V65, P4705, DOI 10.1128/JVI.65.9.4705-4712.1991; van Geest M, 1999, J BIOL CHEM, V274, P2816, DOI 10.1074/jbc.274.5.2816; von Heijne G, 1998, NATURE, V396, P111, DOI 10.1038/24036; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; VONHEIJNE G, 1984, J MOL BIOL, V173, P243, DOI 10.1016/0022-2836(84)90192-X; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; VONHEIJNE G, 1985, J MOL BIOL, V184, P99, DOI 10.1016/0022-2836(85)90046-4; Wegelt A, 2009, J GEN VIROL, V90, P2462, DOI 10.1099/vir.0.012559-0; Weihofen A, 2000, J BIOL CHEM, V275, P30951, DOI 10.1074/jbc.M005980200; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; WEILAND E, 1990, J VIROL, V64, P3563, DOI 10.1128/JVI.64.8.3563-3569.1990; WEILAND E, 1992, J VIROL, V66, P3677, DOI 10.1128/JVI.66.6.3677-3682.1992; Weiland F, 1999, J GEN VIROL, V80, P1157, DOI 10.1099/0022-1317-80-5-1157; Widjojoatmodjo MN, 2000, J VIROL, V74, P2973, DOI 10.1128/JVI.74.7.2973-2980.2000; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Windisch JM, 1996, J VIROL, V70, P352, DOI 10.1128/JVI.70.1.352-358.1996; WISKERCHEN M, 1991, J VIROL, V65, P4508, DOI 10.1128/JVI.65.8.4508-4514.1991; WYATT LS, 1995, VIROLOGY, V210, P202, DOI 10.1006/viro.1995.1332; Xu JA, 1997, J VIROL, V71, P5312, DOI 10.1128/JVI.71.7.5312-5322.1997	70	29	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8572	8584		10.1074/jbc.M109.083394	http://dx.doi.org/10.1074/jbc.M109.083394			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093364	Green Published, hybrid			2022-12-27	WOS:000275553700009
J	Joshi, B; Li, L; Nabi, IR				Joshi, Bharat; Li, Lei; Nabi, Ivan R.			A Role for KAI1 in Promotion of Cell Proliferation and Mammary Gland Hyperplasia by the gp78 Ubiquitin Ligase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOCRINE MOTILITY FACTOR; RETICULUM-ASSOCIATED DEGRADATION; TRANSGENIC MOUSE MODEL; FACTOR-RECEPTOR; ENDOPLASMIC-RETICULUM; METASTATIC-DISEASE; CARCINOMA CELLS; PROTEIN LIGASE; HUMAN BREAST; EXPRESSION	Expression of gp78, an E3 ubiquitin ligase in endoplasmic reticulum-associated degradation, is associated with tumor malignancy. To study gp78 overexpression in mammary gland development and tumorigenicity, we generated murine mammary tumor virus (MMTV) long terminal repeat-driven gp78 transgenic mice. Embryos carrying the gp78 transgene cassette were implanted in FVB surrogate mothers, and two founders with high copy integration showed elevated gp78 expression at both transcript and protein levels at the virgin stage and at 12 days gestation. Transgenic mammary glands showed increased ductal branching, dense alveolar lobule formation, and secondary terminal end bud development. Bromodeoxyuridine staining showed increased proliferation in hyperplastic ductal regions at the virgin stage and at 12 days gestation compared with wild type mice. Reduced expression of the metastasis suppressor KAI1, a gp78 endoplasmic reticulum-associated degradation substrate, demonstrates that gp78 ubiquitin ligase activity is increased in MMTV-gp78 mammary gland. Similarly, metastatic MDA-435 cells exhibit increased gp78 expression, decreased KAI1 expression, and elevated proliferation compared with nonmetastatic MCF7 cells whose proliferation was enhanced upon knockdown of KAI1. Importantly, stable gp78 knockdown HEK293 cells showed increased KAI1 expression and reduced proliferation that was rescued upon KAI1 knockdown, demonstrating that gp78 regulation of cell proliferation is mediated by KAI1. Mammary tumorigenesis was not observed in repeatedly pregnant MMTV-long terminal repeat-gp78 transgenic mice over a period of 18 months post-birth. Elevated gp78 ubiquitin ligase activity is therefore not sufficient for mammary tumorigenesis. However, the hyperplastic phenotype observed in mammary glands of MMTV-gp78 transgenic mice identifies a novel role for gp78 expression in enhancing mammary epithelial cell proliferation and nontumorigenic ductal outgrowth.	[Joshi, Bharat; Li, Lei; Nabi, Ivan R.] Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Nabi, IR (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Inst Life Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	irnabi@interchange.ubc.ca	Nabi, Ivan/GWZ-5144-2022	Nabi, Ivan/0000-0002-0670-0513	Canadian Institutes of Health Research [CIHR MOP-64333, MT-15132]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Grants CIHR MOP-64333 and MT-15132.	Bandyopadhyay S, 2006, NAT MED, V12, P933, DOI 10.1038/nm1444; Chiu CG, 2008, EXPERT REV ANTICANC, V8, P207, DOI 10.1586/14737140.8.2.207; Choi UJ, 2009, CELL BIOCHEM FUNCT, V27, P40, DOI 10.1002/cbf.1532; Christgen M, 2008, INT J CANCER, V123, P2239, DOI 10.1002/ijc.23806; Fairbank M, 2009, MOL BIOSYST, V5, P793, DOI 10.1039/b820820b; Fang S, 2003, SEMIN CANCER BIOL, V13, P5, DOI 10.1016/S1044-579X(02)00095-0; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Guo XZ, 2005, ONCOL REP, V14, P59; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hirono Y, 1996, BRIT J CANCER, V74, P2003, DOI 10.1038/bjc.1996.667; Jackson P, 2005, INT J BIOCHEM CELL B, V37, P530, DOI 10.1016/j.biocel.2004.08.009; JANSSEN PJ, 1994, J HISTOCHEM CYTOCHEM, V42, P1169, DOI 10.1177/42.8.8027537; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Kojic LD, 2007, J BIOL CHEM, V282, P29305, DOI 10.1074/jbc.M704069200; Li BL, 1998, ONCOGENE, V16, P997, DOI 10.1038/sj.onc.1201621; Liang JS, 2003, J BIOL CHEM, V278, P23984, DOI 10.1074/jbc.M302683200; LIOTTA LA, 1986, P NATL ACAD SCI USA, V83, P3302, DOI 10.1073/pnas.83.10.3302; MARUYAMA K, 1995, INT J CANCER, V64, P316, DOI 10.1002/ijc.2910640506; MATSUI Y, 1990, CELL, V61, P1147, DOI 10.1016/0092-8674(90)90077-R; Medina D, 2000, J MAMMARY GLAND BIOL, V5, P393, DOI 10.1023/A:1009529928422; Miranti CK, 2009, CELL SIGNAL, V21, P196, DOI 10.1016/j.cellsig.2008.08.023; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; NABI IR, 1990, CANCER RES, V50, P409; Nagai Y, 1996, DERMATOLOGY, V192, P8, DOI 10.1159/000246304; NAKAMORI S, 1994, CANCER-AM CANCER SOC, V74, P1855, DOI 10.1002/1097-0142(19941001)74:7<1855::AID-CNCR2820740705>3.0.CO;2-1; OTTO T, 1994, CANCER RES, V54, P3120; Registre M, 2004, BIOCHEM BIOPH RES CO, V320, P1316, DOI 10.1016/j.bbrc.2004.06.089; Ruseva Z, 2009, EXP CELL RES, V315, P1759, DOI 10.1016/j.yexcr.2009.01.007; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; SILLETTI S, 1993, BIOCHEM BIOPH RES CO, V194, P446, DOI 10.1006/bbrc.1993.1840; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sridhar SC, 2006, ONCOGENE, V25, P2367, DOI 10.1038/sj.onc.1209269; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Tsutsumi S, 2003, CANCER RES, V63, P242; van Rossum AGSH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-58; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	38	27	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8830	8839		10.1074/jbc.M109.074344	http://dx.doi.org/10.1074/jbc.M109.074344			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089858	Green Published, hybrid			2022-12-27	WOS:000275553700035
J	Hommers, LG; Klenk, C; Dees, C; Bunemann, M				Hommers, Leif G.; Klenk, Christoph; Dees, Christian; Buenemann, Moritz			G Proteins in Reverse Mode RECEPTOR-MEDIATED GTP RELEASE INHIBITS G PROTEIN AND EFFECTOR FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED RECEPTORS; LIVING CELLS; K+ CHANNEL; SUBUNIT DISSOCIATION; HIGH-AFFINITY; ACTIVATION; LOCALIZATION; NUCLEOTIDES; GUANOSINE; MECHANISM	Active G protein-coupled receptors activate heterotrimeric G alpha beta gamma proteins by catalyzing the exchange of GDP by GTP at the G alpha subunit. A paradoxical attenuation of G(o) protein-activated inwardly rectifying potassium channels (GIRK) upon stimulation of native cells with high concentrations of agonist is known. However, a deactivation of activated G(o) proteins by active receptors has not been experimentally studied in intact cells. We monitored GIRK currents and G(o) protein activation by means of fluorescence resonance energy transfer (FRET) in parallel. The results suggested that GIRK currents were paradoxically attenuated due to an inactivation of G(o) proteins by active alpha(2A)-adrenergic receptors. To study the mechanisms, G(o) protein activation and receptor-G protein interactions were analyzed as a function of nucleotide type and nucleotide concentrations by means of FRET, while controlling intracellular nucleotides upon permeabilization of the cell membrane. Results suggested a receptor-catalyzed dissociation of GTP from activated heterotrimeric G alpha beta gamma. Consequently, nucleotide-free G proteins were sequestrated in heterotrimeric conformation at the active receptor, thus attenuating downstream signaling in an agonist-dependent manner.	[Hommers, Leif G.; Klenk, Christoph; Dees, Christian; Buenemann, Moritz] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany	University of Wurzburg	Bunemann, M (corresponding author), Karl von Frisch Str 1, D-35043 Marburg, Germany.	moritz.buenemann@staff.uni-marburg.de	Klenk, Christoph/E-5158-2014	Klenk, Christoph/0000-0001-5199-7144	Deutsch Forschungsgemeinschaft [SFB 487 TP A10]	Deutsch Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsch Forschungsgemeinschaft Grant SFB 487 TP A10 (to M. B.).	ASANO T, 1995, J BIOCHEM-TOKYO, V117, P183, DOI 10.1093/oxfordjournals.jbchem.a124707; BIERNBAUM MS, 1979, J GEN PHYSIOL, V74, P649, DOI 10.1085/jgp.74.6.649; Bjarnadottir TK, 2006, GENOMICS, V88, P263, DOI 10.1016/j.ygeno.2006.04.001; Bornheimer SJ, 2004, P NATL ACAD SCI USA, V101, P15899, DOI 10.1073/pnas.0407009101; Bosche LI, 2003, J PHYSIOL-LONDON, V550, P707, DOI 10.1113/jphysiol.2003.041962; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BREITWIESER GE, 1988, J GEN PHYSIOL, V91, P469, DOI 10.1085/jgp.91.4.469; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Chidiac P, 1998, BIOCHEM PHARMACOL, V55, P549, DOI 10.1016/S0006-2952(97)00361-4; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; HILF G, 1992, EUR J BIOCHEM, V204, P725, DOI 10.1111/j.1432-1033.1992.tb16687.x; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; KAGAWA H, 1980, J BIOL CHEM, V255, P7106; Leaney JL, 2004, AM J PHYSIOL-CELL PH, V287, pC182, DOI 10.1152/ajpcell.00540.2003; LEFKOWITZ RJ, 1981, ADV CYCLIC NUCL PROT, V14, P145; LEVITZKI A, 1988, SCIENCE, V241, P800, DOI 10.1126/science.2841758; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MACKINNON AC, 1989, BRIT J PHARMACOL, V98, P1143, DOI 10.1111/j.1476-5381.1989.tb12658.x; NEUBIG RR, 1994, FASEB J, V8, P939, DOI 10.1096/fasebj.8.12.8088459; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Qin K, 2008, FASEB J, V22, P2920, DOI 10.1096/fj.08-105775; Rosenzweig DH, 2007, J NEUROSCI, V27, P5484, DOI 10.1523/JNEUROSCI.1421-07.2007; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Tsien Roger Y., 1993, Trends in Cell Biology, V3, P242, DOI 10.1016/0962-8924(93)90124-J; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838	33	12	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8227	8233		10.1074/jbc.M109.015388	http://dx.doi.org/10.1074/jbc.M109.015388			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075078	Green Published, hybrid			2022-12-27	WOS:000275413800041
J	Roy, A; Zhou, XD; Chong, MZ; D'hoedt, D; Foo, CS; Rajagopalan, N; Nirthanan, S; Bertrand, D; Sivaraman, J; Kini, RM				Roy, Amrita; Zhou, Xingding; Chong, Ming Zhi; D'hoedt, Dieter; Foo, Chun Shin; Rajagopalan, Nandhakishore; Nirthanan, Selvanayagam; Bertrand, Daniel; Sivaraman, J.; Kini, R. Manjunatha			Structural and Functional Characterization of a Novel Homodimeric Three-finger Neurotoxin from the Venom of Ophiophagus hannah (King Cobra)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; KRAIT BUNGARUS-CANDIDUS; DENDROPHILA MANGROVE CATSNAKE; SITE-DIRECTED MUTAGENESIS; KAPPA-BUNGAROTOXIN; PHARMACOLOGICAL CHARACTERIZATION; POSTSYNAPTIC NEUROTOXIN; ALPHA-NEUROTOXINS; CRYSTAL-STRUCTURE; MUSCARINIC RECEPTORS	Snake venoms are a mixture of pharmacologically active proteins and polypeptides that have led to the development of molecular probes and therapeutic agents. Here, we describe the structural and functional characterization of a novel neurotoxin, haditoxin, from the venom of Ophiophagus hannah (King cobra). Haditoxin exhibited novel pharmacology with antagonism toward muscle (alpha beta gamma delta) and neuronal (alpha(7), alpha(3)beta(2), and alpha(4)beta(2)) nicotinic acetylcholine receptors (nAChRs) with highest affinity for alpha(7)-nAChRs. The high resolution (1.5 angstrom) crystal structure revealed haditoxin to be a homodimer, like kappa-neurotoxins, which target neuronal alpha(3)beta(2)- and alpha(4)beta(2)-nAChRs. Interestingly however, the monomeric subunits of haditoxin were composed of a three-finger protein fold typical of curaremimetic shortchain alpha-neurotoxins. Biochemical studies confirmed that it existed as a non-covalent dimer species in solution. Its structural similarity to short-chain alpha-neurotoxins and kappa-neurotoxins notwithstanding, haditoxin exhibited unique blockade of alpha(7)-nAChRs (IC50 180 nM), which is recognized by neither shortchain alpha-neurotoxins nor alpha-neurotoxins. This is the first report of a dimeric short-chain alpha-neurotoxin interacting with neuronal alpha(7)-nAChRs as well as the first homodimeric three-finger toxin to interact with muscle nAChRs.	[Kini, R. Manjunatha] Natl Univ Singapore, Fac Sci, Dept Biol Sci, Prot Sci Lab, Singapore 117543, Singapore; [D'hoedt, Dieter; Bertrand, Daniel] Univ Geneva, Fac Med, Dept Neurosci, CH-1211 Geneva 4, Switzerland; [Nirthanan, Selvanayagam] Griffith Univ, Sch Med Sci, Griffith, Qld 4222, Australia; [Nirthanan, Selvanayagam] Natl Univ Singapore, Sch Med, Dept Pharmacol, Singapore 117597, Singapore; [Kini, R. Manjunatha] Virginia Commonwealth Univ, Med Coll Virginia, Dept Biochem & Mol Biophys, Richmond, VA 23298 USA	National University of Singapore; University of Geneva; Griffith University; National University of Singapore; Virginia Commonwealth University	Kini, RM (corresponding author), Natl Univ Singapore, Fac Sci, Dept Biol Sci, Prot Sci Lab, Singapore 117543, Singapore.	dbskinim@nus.edu.sg	Nirthanan, Selvanayagam/ABI-4281-2020; Sivaraman, J/H-8028-2012; Kini, Manjunatha/H-8029-2012	J, Sivaraman/0000-0001-9781-5326; Kini, Manjunatha/0000-0002-6100-3251; Nirthanan, S. Niru/0000-0001-9888-8447				Aird SD, 1999, TOXICON, V37, P609, DOI 10.1016/S0041-0101(98)00199-8; Antil S, 1999, J BIOL CHEM, V274, P34851, DOI 10.1074/jbc.274.49.34851; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Barlow A, 2009, P ROY SOC B-BIOL SCI, V276, P2443, DOI 10.1098/rspb.2009.0048; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bulbring E, 1997, BRIT J PHARMACOL, V120, P3; CHANGEUX JP, 1990, TRENDS PHARMACOL SCI, V11, P485, DOI 10.1016/0165-6147(90)90049-E; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; CHIAPPINELLI VA, 1989, BIOCHEMISTRY-US, V28, P8543, DOI 10.1021/bi00447a041; CHIAPPINELLI VA, 1985, J BIOL CHEM, V260, P6182; COBORN J, 1991, ATLAS SNAKES WORLD, P452; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; Coulson FR, 2004, J PHARMACOL EXP THER, V308, P760, DOI 10.1124/jpet.103.057570; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; Dellisanti CD, 2007, NAT NEUROSCI, V10, P953, DOI 10.1038/nn1942; DEWAN JC, 1994, BIOCHEMISTRY-US, V33, P13147, DOI 10.1021/bi00248a026; DEWEILLE JR, 1991, P NATL ACAD SCI USA, V88, P2437, DOI 10.1073/pnas.88.6.2437; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endo T., 1991, P165; FIORDALISI JJ, 1994, BIOCHEMISTRY-US, V33, P3872, DOI 10.1021/bi00179a011; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; GINSBORG BL, 1960, BRIT J PHARM CHEMOTH, V15, P410, DOI 10.1111/j.1476-5381.1960.tb01264.x; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grant GA, 1998, BIOCHEMISTRY-US, V37, P12166, DOI 10.1021/bi981227y; GRANT GA, 1985, BIOCHEMISTRY-US, V24, P1532, DOI 10.1021/bi00327a036; Grant GA, 1997, BIOCHEMISTRY-US, V36, P3353, DOI 10.1021/bi9629687; Grutter T, 2001, TRENDS BIOCHEM SCI, V26, P459, DOI 10.1016/S0968-0004(01)01921-1; Harvey AL, 2002, NEUROCHEM RES, V27, P1543, DOI 10.1023/A:1021660708187; Harvey AL, 2002, TRENDS PHARMACOL SCI, V23, P201, DOI 10.1016/S0165-6147(02)02012-6; Harvey AL., 1991, SNAKE TOXINS, P1; HERZ JM, 1989, J BIOL CHEM, V264, P12439; Hogg RC, 2008, J NEUROSCI METH, V169, P65, DOI 10.1016/j.jneumeth.2007.11.028; JIANG M, 1987, TOXICON, V25, P1019, DOI 10.1016/0041-0101(87)90167-X; KATZ B, 1957, J PHYSIOL-LONDON, V138, P63, DOI 10.1113/jphysiol.1957.sp005838; Kini RM, 2002, CLIN EXP PHARMACOL P, V29, P815, DOI 10.1046/j.1440-1681.2002.03725.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar TKS, 1997, J BIOMOL STRUCT DYN, V15, P431, DOI 10.1080/07391102.1997.10508957; Kuruppu S, 2005, BIOCHEM PHARMACOL, V70, P794, DOI 10.1016/j.bcp.2005.06.003; Langley JN, 1907, J PHYSIOL-LONDON, V36, P347; Laothong C, 2001, TOXICON, V39, P1353, DOI 10.1016/S0041-0101(01)00087-3; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Lumsden NG, 2005, TOXICON, V45, P329, DOI 10.1016/j.toxicon.2004.11.003; Mackessy SP, 2006, TOXICON, V47, P537, DOI 10.1016/j.toxicon.2006.01.007; MCDOWELL RS, 1992, BIOCHEMISTRY-US, V31, P4766, DOI 10.1021/bi00135a004; MEHRTENS J, 1987, LIVING SNAKES WORLD, P245; MENEZ A, 1980, BIOCHEMISTRY-US, V19, P4166, DOI 10.1021/bi00559a005; Nirthanan S, 2004, J PHARMACOL SCI, V94, P1, DOI 10.1254/jphs.94.1; Nirthanan S, 2003, BRIT J PHARMACOL, V139, P832, DOI 10.1038/sj.bjp.0705299; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; Ohno M, 1998, PROG NUCLEIC ACID RE, V59, P307; Olianas MC, 1999, J PHARMACOL EXP THER, V288, P164; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; OSWALD RE, 1991, BIOCHEMISTRY-US, V30, P4901, DOI 10.1021/bi00234a010; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pahari S, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-175; Pahari S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-115; Palma E, 1996, J PHYSIOL-LONDON, V491, P151, DOI 10.1113/jphysiol.1996.sp021203; Pawlak J, 2006, J BIOL CHEM, V281, P29030, DOI 10.1074/jbc.M605850200; Pawlak J, 2009, FASEB J, V23, P534, DOI 10.1096/fj.08-113555; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pung YF, 2005, J BIOL CHEM, V280, P13137, DOI 10.1074/jbc.M414137200; Rajagopalan N, 2007, FASEB J, V21, P3685, DOI 10.1096/fj.07-8658com; Ricciardi A, 2000, J BIOL CHEM, V275, P18302, DOI 10.1074/jbc.275.24.18302; Servent D, 2000, EUR J PHARMACOL, V393, P197, DOI 10.1016/S0014-2999(00)00095-9; Servent D, 1998, TOXICOL LETT, V103, P199, DOI 10.1016/S0378-4274(98)00307-5; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; Starkov V G, 2009, Bioorg Khim, V35, P15; STAROS JV, 1982, BIOCHEMISTRY-US, V21, P3950, DOI 10.1021/bi00260a008; Tan LC, 2006, NEUROPHARMACOLOGY, V51, P782, DOI 10.1016/j.neuropharm.2006.05.020; Taylor P, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P271; Teixeira-Clerc F, 2002, J BIOL CHEM, V277, P25741, DOI 10.1074/jbc.M200534200; Torres AM, 2001, BIOCHEM J, V360, P539, DOI 10.1042/0264-6021:3600539; TREMEAU O, 1995, J BIOL CHEM, V270, P9362, DOI 10.1074/jbc.270.16.9362; Tsetlin V, 1999, EUR J BIOCHEM, V264, P281, DOI 10.1046/j.1432-1327.1999.00623.x; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; WARRELL DA, 1983, BRIT MED J, V286, P678, DOI 10.1136/bmj.286.6366.678; Weiser M, 1997, N-S ARCH PHARMACOL, V356, P671, DOI 10.1007/PL00005104; WOLF KM, 1988, BRAIN RES, V439, P249, DOI 10.1016/0006-8993(88)91481-3	83	60	63	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8302	8315		10.1074/jbc.M109.074161	http://dx.doi.org/10.1074/jbc.M109.074161			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071329	Green Published, hybrid			2022-12-27	WOS:000275413800047
J	Tajima, M; Crane, JM; Verkman, AS				Tajima, Masato; Crane, Jonathan M.; Verkman, A. S.			Aquaporin-4 (AQP4) Associations and Array Dynamics Probed by Photobleaching and Single-molecule Analysis of Green Fluorescent Protein-AQP4 Chimeras	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORTHOGONAL ARRAYS; WATER CHANNELS; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANES; KNOCKOUT MICE; SPINAL-CORD; BRAIN; DIFFUSION; CELLS; ISOFORMS	The plasma membrane assembly of aquaporin-4 (AQP4) water channels into orthogonal arrays of particles (OAPs) involves interactions of AQP4 N-terminal domains. To study in live cells the site of OAP assembly, the size and dynamics of plasma membrane OAPs, and the heterotetrameric associations of AQP4, we constructed green fluorescent protein (GFP)-labeled AQP4 "long" (M1) and "short" (M23) isoforms in which GFP was inserted at the cytoplasm-facing N or C terminus or between Val-141 and Val-142 in the second extracellular loop of AQP4. The C-terminal and extracellular loop GFP insertions did not interfere with the rapid unrestricted membrane diffusion of GFP-labeled M1 or the restricted diffusion and OAP assembly of GFP-labeled M23. Photobleaching of brefeldin A-treated cells showed comparable and minimally restricted diffusion of M1 and M23, indicating that OAP assembly occurs post-endoplasmic reticulum. Single-molecule step photobleaching and intensity analysis of GFP-labeled M1 in the absence versus presence of excess unlabeled M1 or M23 with an OAP-disrupting mutation indicated heterotetrameric AQP4 association. Time-lapse total internal reflection fluorescence imaging of M23 in live cells at 37 degrees C indicated that OAPs diffuse slowly (D similar to 10(-12) cm(2)/s) and rearrange over tens of minutes. Our biophysical measurements in live cells thus reveal extensive AQP4 monomer-monomer and tetramertetramer interactions.	[Verkman, A. S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [EB00415, HL73856, DK35124, EY13574, DK72517]; Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415, R01EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, P30DK072517, R01DK035124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guthy-Jackson Charitable Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants EB00415, HL73856, DK35124, EY13574, and DK72517 and by a grant from the Guthy-Jackson Charitable Foundation.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; Crane JM, 2008, BIOPHYS J, V94, P702, DOI 10.1529/biophysj.107.115121; Crane JM, 2009, J BIOL CHEM, V284, P35850, DOI 10.1074/jbc.M109.071670; Crane JM, 2009, BIOPHYS J, V97, P3010, DOI 10.1016/j.bpj.2009.09.017; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100; Haggie PM, 2008, J BIOL CHEM, V283, P23510, DOI 10.1074/jbc.C800100200; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Levin MH, 2001, J BIOL CHEM, V276, P21331, DOI 10.1074/jbc.M101901200; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Moe SE, 2008, GENOMICS, V91, P367, DOI 10.1016/j.ygeno.2007.12.003; Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sugiyama Y, 2005, NAT METHODS, V2, P677, DOI 10.1038/NMETH783; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Umenishi F, 2000, BIOPHYS J, V78, P1024, DOI 10.1016/S0006-3495(00)76661-6; Verbavatz JM, 1997, J CELL SCI, V110, P2855; Verkman AS, 2006, BBA-BIOMEMBRANES, V1758, P1085, DOI 10.1016/j.bbamem.2006.02.018; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; WOLBURG H, 1995, J BRAIN RES, V36, P239; Yang BX, 1996, J BIOL CHEM, V271, P4577	27	34	36	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8163	8170		10.1074/jbc.M109.093948	http://dx.doi.org/10.1074/jbc.M109.093948			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071343	Green Published, hybrid			2022-12-27	WOS:000275413800035
J	Naik, AK; Lieber, MR; Raghavan, SC				Naik, Abani Kanta; Lieber, Michael R.; Raghavan, Sathees C.			Cytosines, but Not Purines, Determine Recombination Activating Gene (RAG)-induced Breaks on Heteroduplex DNA Structures IMPLICATIONS FOR GENOMIC INSTABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR BREAKPOINT REGION; V(D)J RECOMBINATION; CHROMOSOMAL TRANSLOCATIONS; RAG2 PROTEINS; STRUCTURE REQUIREMENTS; STAGE SPECIFICITY; SIGNAL SEQUENCES; HUMAN-DISEASE; CODING ENDS; IN-VITRO	The sequence specificity of the recombination activating gene (RAG) complex during V(D)J recombination has been well studied. RAGs can also act as structure-specific nuclease; however, little is known about the mechanism of its action. Here, we show that in addition to DNA structure, sequence dictates the pattern and efficiency of RAG cleavage on altered DNA structures. Cytosine nucleotides are preferentially nicked by RAGs when present at single-stranded regions of heteroduplex DNA. Although unpaired thymine nucleotides are also nicked, the efficiency is many fold weaker. Induction of single- or double-strand breaks by RAGs depends on the position of cytosines and whether it is present on one or both of the strands. Interestingly, RAGs are unable to induce breaks when adenine or guanine nucleotides are present at single- strand regions. The nucleotide present immediately next to the bubble sequence could also affect RAG cleavage. Hence, we propose "C(d)C(S)C(S)" (d, double-stranded; s, single-stranded) as a consensus sequence for RAG-induced breaks at single-/double-strand DNA transitions. Such a consensus sequence motif is useful for explaining RAG cleavage on other types of DNA structures described in the literature. Therefore, the mechanism of RAG cleavage described here could explain facets of chromosomal rearrangements specific to lymphoid tissues leading to genomic instability.	Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Lieber, Michael R.] Univ So Calif, Norris Comprehens Canc Ctr, Dept Pathol, Los Angeles, CA 90089 USA	Indian Institute of Science (IISC) - Bangalore; University of Southern California		sathees@biochem.iisc.ernet.in	Naik, Abani K/D-1254-2013	Naik, Abani K/0000-0001-9032-1147; Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345	Department of Science and Technology, India [SR/SO/BB-051/2007]; Indian Institute of Science	Department of Science and Technology, India(Department of Science & Technology (India)); Indian Institute of Science(Indian Institute of Science (IISC) - Bangalore)	This work was supported in part by grants from the Department of Science and Technology, India (SR/SO/BB-051/2007), and an Indian Institute of Science startup grant ( to S. C. R.).	Agrawal A, 1997, CELL, V89, P43, DOI 10.1016/S0092-8674(00)80181-6; Bacolla A, 2004, J BIOL CHEM, V279, P47411, DOI 10.1074/jbc.R400028200; Besmer E, 1998, MOL CELL, V2, P817, DOI 10.1016/S1097-2765(00)80296-8; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; Franco S, 2006, DNA REPAIR, V5, P1030, DOI 10.1016/j.dnarep.2006.05.024; Fugmann SD, 2000, ANNU REV IMMUNOL, V18, P495, DOI 10.1146/annurev.immunol.18.1.495; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Grawunder U, 1997, NUCLEIC ACIDS RES, V25, P1375, DOI 10.1093/nar/25.7.1375; Greenbaum JA, 2007, GENOME RES, V17, P940, DOI 10.1101/gr.5602807; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Jones JM, 2001, P NATL ACAD SCI USA, V98, P12926, DOI 10.1073/pnas.221471198; Jung D, 2004, CELL, V116, P299, DOI 10.1016/S0092-8674(04)00039-X; Jung D, 2006, ANNU REV IMMUNOL, V24, P541, DOI 10.1146/annurev.immunol.23.021704.115830; Kuzminov A, 2001, P NATL ACAD SCI USA, V98, P8241, DOI 10.1073/pnas.131009198; Lewis SM, 1997, MOL CELL BIOL, V17, P3125, DOI 10.1128/MCB.17.6.3125; LEWIS SM, 1994, ADV IMMUNOL, V56, P27, DOI 10.1016/S0065-2776(08)60450-2; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; Ma YM, 2005, DNA REPAIR, V4, P845, DOI 10.1016/j.dnarep.2005.04.013; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Marculescu R, 2002, J EXP MED, V195, P85, DOI 10.1084/jem.20011578; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Mills KD, 2003, IMMUNOL REV, V194, P77, DOI 10.1034/j.1600-065X.2003.00060.x; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Naik AK, 2008, DNA REPAIR, V7, P1384, DOI 10.1016/j.dnarep.2008.04.010; Nambiar M, 2008, BBA-REV CANCER, V1786, P139, DOI 10.1016/j.bbcan.2008.07.005; Nishihara T, 2004, MOL CELL BIOL, V24, P3692, DOI 10.1128/MCB.24.9.3692-3702.2004; Oettinger MA, 2004, IMMUNOL REV, V200, P165, DOI 10.1111/j.0105-2896.2004.00172.x; Raghavan SC, 2007, FRONT BIOSCI, V12, P4402, DOI 10.2741/2397; Raghavan SC, 2007, DNA REPAIR, V6, P751, DOI 10.1016/j.dnarep.2006.12.016; Raghavan SC, 2006, BIOESSAYS, V28, P480, DOI 10.1002/bies.20353; Raghavan SC, 2005, MOL CELL BIOL, V25, P6475, DOI 10.1128/MCB.25.15.6475-6484.2005; Raghavan SC, 2005, J BIOL CHEM, V280, P22749, DOI 10.1074/jbc.M502952200; Raghavan SC, 2005, MOL CELL BIOL, V25, P5904, DOI 10.1128/MCB.25.14.5904-5919.2005; Raghavan SC, 2004, CELL CYCLE, V3, P762; Raghavan SC, 2004, NATURE, V428, P88, DOI 10.1038/nature02355; Raghavan SC, 2001, J BIOL CHEM, V276, P29126, DOI 10.1074/jbc.M103797200; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Rooney S, 2004, IMMUNOL REV, V200, P115, DOI 10.1111/j.0105-2896.2004.00165.x; Roth DB, 2003, NAT REV IMMUNOL, V3, P656, DOI 10.1038/nri1152; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; ROTH DB, 1993, P NATL ACAD SCI USA, V90, P10788, DOI 10.1073/pnas.90.22.10788; Rval P, 2008, NUCLEIC ACIDS RES, V36, P2060, DOI 10.1093/nar/gkn049; Sadofsky MJ, 2004, IMMUNOL REV, V200, P83, DOI 10.1111/j.0105-2896.2004.00164.x; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; Schatz David G., 2004, Cell, VS116, pS103, DOI 10.1016/S0092-8674(04)00042-X; Schatz DG, 2005, CURR TOP MICROBIOL, V290, P49; Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225; Shockett PE, 1999, MOL CELL BIOL, V19, P4159; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; Swanson PC, 2004, IMMUNOL REV, V200, P90, DOI 10.1111/j.0105-2896.2004.00159.x; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Wells RD, 2007, TRENDS BIOCHEM SCI, V32, P271, DOI 10.1016/j.tibs.2007.04.003; Yu KF, 1999, MOL CELL BIOL, V19, P8094; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919	56	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7587	7597		10.1074/jbc.M109.089631	http://dx.doi.org/10.1074/jbc.M109.089631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051517	Green Published, hybrid			2022-12-27	WOS:000275415600070
J	Albert, A; Yunta, C; Arranz, R; Pena, A; Salido, E; Valpuesta, JM; Martin-Benito, J				Albert, Armando; Yunta, Cristina; Arranz, Rocio; Pena, Alvaro; Salido, Eduardo; Valpuesta, Jose Maria; Martin-Benito, Jaime			Structure of GroEL in Complex with an Early Folding Intermediate of Alanine Glyoxylate Aminotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY HYPEROXALURIA TYPE-1; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; CHAPERONIN GROEL; VISUALIZATION; CONFORMATION; MUTATION; IMAGES; ACTIN	Primary hyperoxaluria type 1 is a rare autosomal recessive disease caused by mutations in the alanine glyoxylate aminotransferase gene (AGXT). We have previously shown that P11L and I340M polymorphisms together with I244T mutation (AGXT-LTM) represent a conformational disease that could be amenable to pharmacological intervention. Thus, the study of the folding mechanism of AGXT is crucial to understand the molecular basis of the disease. Here, we provide biochemical and structural data showing that AGXT-LTM is able to form non-native folding intermediates. The three-dimensional structure of a complex between the bacterial chaperonin GroEL and a folding intermediate of AGXT-LTM mutant has been solved by cryoelectron microscopy. The electron density map shows the protein substrate in a non-native extended conformation that crosses the GroEL central cavity. Addition of ATP to the complex induces conformational changes on the chaperonin and the internalization of the protein substrate into the folding cavity. The structure provides a three-dimensional picture of an in vivo early ATP-dependent step of the folding reaction cycle of the chaperonin and supports a GroEL functional model in which the chaperonin promotes folding of the AGXT-LTM mutant protein through forced unfolding mechanism.	[Albert, Armando] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estructural, E-28006 Madrid, Spain; [Yunta, Cristina; Salido, Eduardo] Univ La Laguna, Hosp Univ Canarias, Inst Tecnol Biomed, Ctr Invest Biomed Red Enfermedades Raras, E-38320 Tenerife, Spain; [Arranz, Rocio; Pena, Alvaro; Valpuesta, Jose Maria; Martin-Benito, Jaime] Campus Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de la Laguna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Albert, A (corresponding author), CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estructural, Serrano 119, E-28006 Madrid, Spain.	xalbert@iqfr.csic.es	Valpuesta, José M/T-1977-2017; Albert, Armando/J-2373-2012; Salido, Eduardo C/I-2232-2015; Valpuesta, Jose M/AAA-6002-2019	Valpuesta, José M/0000-0001-7468-8053; Albert, Armando/0000-0002-0026-6816; Salido, Eduardo C/0000-0001-9599-9854; Martin-Benito Romero, Jaime/0000-0002-8541-4709; Arranz, Rocio/0000-0001-5321-0915	Spanish "Plan Nacional" (Ministerio de Ciencia e Innovacion) [BFU2008-00368/BMC, BFU2007-62382/BMC, SAF2007-62343]; "Factoria de Cristalizacion" Consolider Ingenio 2010	Spanish "Plan Nacional" (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Factoria de Cristalizacion" Consolider Ingenio 2010(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants BFU2008-00368/BMC (to A. A.), BFU2007-62382/BMC (to J.M.V.), and SAF2007-62343 (to E. S.) from the Spanish "Plan Nacional" (Ministerio de Ciencia e Innovacion) and "Factoria de Cristalizacion" Consolider Ingenio 2010 (to A. A.).	BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Carrell RW, 1997, LANCET, V350, P134, DOI 10.1016/S0140-6736(97)02073-4; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Chacon P, 2002, J MOL BIOL, V317, P375, DOI 10.1006/jmbi.2002.5438; Chen DH, 2006, STRUCTURE, V14, P1711, DOI 10.1016/j.str.2006.09.010; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; DeLano W.L, PYMOL MOL GRAPHICS S; Elad N, 2008, J STRUCT BIOL, V162, P108, DOI 10.1016/j.jsb.2007.11.007; Fenton WA, 2003, Q REV BIOPHYS, V36, P229, DOI 10.1017/S0033583503003883; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hoppe B, 2009, KIDNEY INT, V75, P1264, DOI 10.1038/ki.2009.32; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Llorca O, 2001, EMBO J, V20, P4065, DOI 10.1093/emboj/20.15.4065; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Madan D, 2008, J BIOL CHEM, V283, P32003, DOI 10.1074/jbc.M802898200; MARABINI R, 1994, BIOPHYS J, V66, P1804, DOI 10.1016/S0006-3495(94)80974-9; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Saibil HR, 2002, TRENDS BIOCHEM SCI, V27, P627, DOI 10.1016/S0968-0004(02)02211-9; Sambrook J., 2001, MOL CLONING LAB MANU; Santana A, 2003, P NATL ACAD SCI USA, V100, P7277, DOI 10.1073/pnas.1131968100; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Williams EL, 2009, HUM MUTAT, V30, P910, DOI 10.1002/humu.21021; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhang XX, 2003, J MOL BIOL, V331, P643, DOI 10.1016/S0022-2836(03)00791-5	33	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6371	6376		10.1074/jbc.M109.062471	http://dx.doi.org/10.1074/jbc.M109.062471			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20056599	Green Published, hybrid			2022-12-27	WOS:000275367500041
J	Freire-De-Lima, L; Alisson-Silva, F; Carvalho, ST; Takiya, CM; Rodrigues, MM; DosReis, GA; Mendonca-Previato, L; Previato, JO; Todeschini, AR				Freire-de-Lima, Leonardo; Alisson-Silva, Frederico; Carvalho, Sebastiao T.; Takiya, Christina M.; Rodrigues, Mauricio M.; DosReis, George A.; Mendonca-Previato, Lucia; Previato, Jose O.; Todeschini, Adriane R.			Trypanosoma cruzi Subverts Host Cell Sialylation and May Compromise Antigen-specific CD8(+) T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-SIALIDASE; CHAGAS-DISEASE; LYMPHOCYTES; MICE; BINDING; MEMORY; ACID; CD43; GLYCOSYLATION; ACTIVATION	Upon activation, cytotoxic CD8(+) T lymphocytes are desialylated exposing beta-galactose residues in a physiological change that enhances their effector activity and that can be monitored on the basis of increased binding of the lectin peanut agglutinin. Herein, we investigated the impact of sialylation mediated by trans-sialidase, a specific and unique Trypanosoma transglycosylase for sialic acid, on CD8(+) T cell response of mice infected with T. cruzi. Our data demonstrate that T. cruzi uses its trans-sialidase enzyme to resialylate the CD8(+) T cell surface, thereby dampening antigen-specific CD8(+) T cell response that might favor its own persistence in the mammalian host. Binding of the monoclonal antibody S7, which recognizes sialic acid-containing epitopes on the 115-kDa isoform of CD43, was augmented on CD8(+) T cells from ST3Gal-I-deficient infected mice, indicating that CD43 is one sialic acid acceptor for trans-sialidase activity on the CD8(+) T cell surface. The cytotoxic activity of antigen-experienced CD8(+) T cells against the immunodominant trans-sialidase synthetic peptide IYNVGQVSI was decreased following active trans-sialidase-mediated resialylation in vitro and in vivo. Inhibition of the parasite's native trans-sialidase activity during infection strongly decreased CD8(+) T cell sialylation, reverting it to the glycosylation status expected in the absence of parasite manipulation increasing mouse survival. Taken together, these results demonstrate, for the first time, that T. cruzi subverts sialylation to attenuate CD8(+) T cell interactions with peptide-major histocompatibility complex class I complexes. CD8(+) T cell resialylation may represent a sophisticated strategy to ensure lifetime host parasitism.	[Freire-de-Lima, Leonardo; Alisson-Silva, Frederico; Carvalho, Sebastiao T.; DosReis, George A.; Mendonca-Previato, Lucia; Previato, Jose O.; Todeschini, Adriane R.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ilha Fundao, BR-21949900 Rio De Janeiro, Brazil; [Takiya, Christina M.] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Ctr Ciencias Saude, Ilha Fundao, BR-21949900 Rio De Janeiro, Brazil; [Rodrigues, Mauricio M.] Univ Fed Sao Paulo, Ctr Interdisciplinar Terapia Gen, BR-04044010 Sao Paulo, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal de Sao Paulo (UNIFESP)	Todeschini, AR (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Ilha Fundao, Cidade Univ, BR-21949900 Rio De Janeiro, Brazil.	adrianet@biof.ufrj.br	Todeschini, Adriane Regina/ABC-9165-2020; Todeschini, Adriane/AAG-8128-2020; Rodrigues, Mauricio M./B-8512-2012; Takiya, Christina/AAU-5959-2021; da Silva, Frederico/AAY-4758-2021; da Silva, Frederico/X-7822-2018; Freire-de-Lima, Leonardo/I-1894-2012	Todeschini, Adriane Regina/0000-0002-6049-2751; Takiya, Christina/0000-0002-8019-628X; da Silva, Frederico/0000-0001-6717-2518; da Silva, Frederico/0000-0001-6717-2518; Freire-de-Lima, Leonardo/0000-0003-3013-3173; DosReis, George/0000-0002-8924-4727; Previato, Jose Osvaldo/0000-0002-9233-9954; Mendonca Previato, Lucia/0000-0003-3927-3244	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Programa de Apoio ao Desenvolvimento Cientifico e Tecnologico (PADCT)/World Bank/CNPq; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/PRONEX); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); CAPES/Cooperacao Universitaria e Cientifica com o Brasil (Cofecub); National Institute for Science and Technology in Vaccines	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programa de Apoio ao Desenvolvimento Cientifico e Tecnologico (PADCT)/World Bank/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/PRONEX)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES/Cooperacao Universitaria e Cientifica com o Brasil (Cofecub)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Institute for Science and Technology in Vaccines	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Programa de Apoio ao Desenvolvimento Cientifico e Tecnologico (PADCT)/World Bank/CNPq, Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ/PRONEX), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), CAPES/Cooperacao Universitaria e Cientifica com o Brasil (Cofecub), and the National Institute for Science and Technology in Vaccines.	Akha AAS, 2006, IMMUNOLOGY, V119, P187, DOI 10.1111/j.1365-2567.2006.02420.x; Amado M, 2004, J BIOL CHEM, V279, P36689, DOI 10.1074/jbc.M405629200; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; CHERVENAK R, 1982, THYMUS, V4, P61; CHUENKOVA M, 1995, J EXP MED, V181, P1693, DOI 10.1084/jem.181.5.1693; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CREMONA ML, 1995, GENE, V160, P123, DOI 10.1016/0378-1119(95)00175-6; Daniels MA, 2001, IMMUNITY, V15, P1051, DOI 10.1016/S1074-7613(01)00252-7; Dias WB, 2008, CELL MICROBIOL, V10, P88, DOI 10.1111/j.1462-5822.2007.01017.x; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; Galvan M, 1998, J IMMUNOL, V161, P641; Garcia GG, 2005, EUR J IMMUNOL, V35, P622, DOI 10.1002/eji.200425538; Garg N, 1997, J IMMUNOL, V158, P3293; Harrington LE, 2000, J EXP MED, V191, P1241, DOI 10.1084/jem.191.7.1241; JONES AT, 1994, J IMMUNOL, V153, P3426; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kao C, 2005, INT IMMUNOL, V17, P1607, DOI 10.1093/intimm/dxh340; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Moody AM, 2003, J BIOL CHEM, V278, P7240, DOI 10.1074/jbc.M210468200; Moody AM, 2001, CELL, V107, P501, DOI 10.1016/S0092-8674(01)00577-3; Morrot A, 2004, IMMUNOL REV, V201, P291, DOI 10.1111/j.0105-2896.2004.00175.x; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; Ostberg JR, 1998, IMMUNOL TODAY, V19, P546, DOI 10.1016/S0167-5699(98)01343-7; Pace KE, 1999, J IMMUNOL, V163, P3801; Pappu BP, 2004, J IMMUNOL, V173, P275, DOI 10.4049/jimmunol.173.1.275; PEREIRA MEA, 1976, CARBOHYD RES, V51, P107; PREVIATO J O, 1990, Memorias do Instituto Oswaldo Cruz, V85, P38; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9; Priatel JJ, 2000, IMMUNITY, V12, P273, DOI 10.1016/S1074-7613(00)80180-6; Rossi M A, 1995, Sao Paulo Med J, V113, P750; Tarleton RL, 2007, CURR OPIN IMMUNOL, V19, P430, DOI 10.1016/j.coi.2007.06.003; TARLETON RL, 1990, J IMMUNOL, V144, P717; Todeschin AR, 2002, J BIOL CHEM, V277, P45962, DOI 10.1074/jbc.M203185200; Todeschini AR, 2004, J BIOL CHEM, V279, P5323, DOI 10.1074/jbc.M310663200; Todeschini AR, 2002, J IMMUNOL, V168, P5192, DOI 10.4049/jimmunol.168.10.5192; Todeschini AR, 2000, GLYCOBIOLOGY, V10, P213, DOI 10.1093/glycob/10.2.213; Tyler KM, 2001, INT J PARASITOL, V31, P472, DOI 10.1016/S0020-7519(01)00153-9; Tzelepis F, 2006, INFECT IMMUN, V74, P2477, DOI 10.1128/IAI.74.4.2477-2481.2006; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; Tzelepis F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000393; VANDEKERCKHOVE F, 1992, GLYCOBIOLOGY, V2, P541, DOI 10.1093/glycob/2.6.541; Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656; WANG WC, 1988, J BIOL CHEM, V263, P4576	44	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13388	13396		10.1074/jbc.M109.096305	http://dx.doi.org/10.1074/jbc.M109.096305			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20106975	Green Published, hybrid			2022-12-27	WOS:000276987700010
J	Chen, XQ; Zhu, HL; Yuan, M; Fu, J; Zhou, YQ; Ma, L				Chen, Xiaoqing; Zhu, Huiling; Yuan, Man; Fu, Jie; Zhou, Yuqing; Ma, Lan			G-protein-coupled Receptor Kinase 5 Phosphorylates p53 and Inhibits DNA Damage-induced Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOXYL-TERMINUS; OPIOID RECEPTOR; DESENSITIZATION; GRK5; EXPRESSION; LOCALIZATION; PURIFICATION; PATHWAY; GROWTH; MEMBER	G-protein-coupled receptor kinases (GRKs) are an important family of Ser/Thr kinases that specifically phosphorylate and desensitize the activated receptor in response to environmental stimulation. Here we identify p53, a key tumor suppressor, as a novel GRK substrate in vivo, revealing a previously unknown function of GRKs in regulation of genome stability. Knockdown GRK5 in osteosarcoma cells inhibits DNA damage-induced apoptosis via a p53-mediated mechanism. Furthermore, GRK5, but not GRK2 or GRK6, phosphorylates p53 at Thr-55, which promotes the degradation of p53, leading to inhibition of p53-dependent apoptotic response to genotoxic damage. Consistently, the increase of p53 and irradiation-induced apoptosis were observed in GRK5-deficient mice. These results demonstrate GRK5 as a novel kinase of p53, as well as a negative regulator of p53-mediated signal transduction.	[Ma, Lan] Fudan Univ, State Key Lab Med Neurobiol & Pharmacol, Res Ctr, Shanghai Med Coll, Shanghai 200032, Peoples R China; Fudan Univ, Inst Brain Sci, Shanghai 200032, Peoples R China; [Fu, Jie] Jiao Tong Univ, Hosp 6, Dept Radiat Oncol, Shanghai 200233, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Ma, L (corresponding author), Fudan Univ, State Key Lab Med Neurobiol & Pharmacol, Res Ctr, Shanghai Med Coll, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	lanma@fudan.edu.cn	Zhou, Yu/HHN-3071-2022; Ma, Lan/B-9295-2009	Ma, Lan/0000-0001-9034-5472	Ministry of Science and Technology [2009ZX09303-006, 2009ZX09301-011, 2009CB522000]; Natural Science Foundation of China [30830042, 30821002]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants from the Ministry of Science and Technology (Grants 2009ZX09303-006, 2009ZX09301-011, and 2009CB522000) and Natural Science Foundation of China (Grants 30830042 and 30821002).	Aramori I, 1997, EMBO J, V16, P4606, DOI 10.1093/emboj/16.15.4606; Barthet G, 2009, EMBO J, V28, P2706, DOI 10.1038/emboj.2009.215; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; Chen YJ, 2008, MOL BIOL CELL, V19, P2973, DOI 10.1091/mbc.E07-10-1058; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Freedman NJ, 2002, J BIOL CHEM, V277, P48261, DOI 10.1074/jbc.M204431200; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Gainetdinov RR, 1999, NEURON, V24, P1029, DOI 10.1016/S0896-6273(00)81048-X; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GILGOMEZ G, 2003, METH MOL B, V282, P131; Hall RA, 1999, J BIOL CHEM, V274, P24328, DOI 10.1074/jbc.274.34.24328; Jaber M, 1996, P NATL ACAD SCI USA, V93, P12974, DOI 10.1073/pnas.93.23.12974; Jiang X, 2009, P NATL ACAD SCI USA, V106, P10183, DOI 10.1073/pnas.0812105106; Johnson LR, 2004, MOL CELL BIOL, V24, P10169, DOI 10.1128/MCB.24.23.10169-10179.2004; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; KUNAPULI P, 1994, J BIOL CHEM, V269, P10209; KUNAPULI P, 1993, P NATL ACAD SCI USA, V90, P5588, DOI 10.1073/pnas.90.12.5588; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li HH, 2004, MOL CELL, V13, P867, DOI 10.1016/S1097-2765(04)00123-6; Li JL, 2003, J BIOL CHEM, V278, P30219, DOI 10.1074/jbc.M302385200; Martini JS, 2008, P NATL ACAD SCI USA, V105, P12457, DOI 10.1073/pnas.0803153105; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 1999, J BIOL CHEM, V274, P29381, DOI 10.1074/jbc.274.41.29381; PREMONT RT, 1994, J BIOL CHEM, V269, P6832; Pronin AN, 1998, J BIOL CHEM, V273, P31510, DOI 10.1074/jbc.273.47.31510; Pronin AN, 2000, J BIOL CHEM, V275, P26515, DOI 10.1074/jbc.M003542200; Pronin AN, 1997, J BIOL CHEM, V272, P18273, DOI 10.1074/jbc.272.29.18273; Pronin AN, 1997, J BIOL CHEM, V272, P3806, DOI 10.1074/jbc.272.6.3806; Rockman HA, 1996, P NATL ACAD SCI USA, V93, P9954, DOI 10.1073/pnas.93.18.9954; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Suo Z, 2007, NEUROBIOL AGING, V28, P1873, DOI 10.1016/j.neurobiolaging.2006.08.013; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tiberi M, 1996, J BIOL CHEM, V271, P3771; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; Yi XP, 2005, ANAT REC PART A, V282A, P13, DOI 10.1002/ar.a.20143; Zhao J, 1997, BIOCHEM BIOPH RES CO, V238, P71, DOI 10.1006/bbrc.1997.7242	43	63	70	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12823	12830		10.1074/jbc.M109.094243	http://dx.doi.org/10.1074/jbc.M109.094243			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20124405	Green Published, hybrid			2022-12-27	WOS:000276787800040
J	Stuelsatz, P; Pouzoulet, F; Lamarre, Y; Dargelos, E; Poussard, S; Leibovitch, S; Cottin, P; Veschambre, P				Stuelsatz, Pascal; Pouzoulet, Frederic; Lamarre, Yann; Dargelos, Elise; Poussard, Sylvie; Leibovitch, Serge; Cottin, Patrick; Veschambre, Philippe			Down-regulation of MyoD by Calpain 3 Promotes Generation of Reserve Cells in C2C12 Myoblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; MUSCLE-SPECIFIC CALPAIN; ADULT SKELETAL-MUSCLE; CREATINE-KINASE GENE; KAPPA-B PATHWAY; SATELLITE CELLS; IN-VIVO; DNA-BINDING; UBIQUITIN PATHWAY; TRANSGENIC MICE	Calpain 3 is a calcium-dependent cysteine protease that is primarily expressed in skeletal muscle and is implicated in limb girdle muscular dystrophy type 2A. To date, its best characterized function is located within the sarcomere, but this protease is found in other cellular compartments, which suggests that it exerts multiple roles. Here, we present evidence that calpain 3 is involved in the myogenic differentiation process. In the course of in vitro culture of myoblasts to fully differentiated myotubes, a population of quiescent undifferentiated "reserve cells" are maintained. These reserve cells are closely related to satellite cells responsible for adult muscle regeneration. In the present work, we observe that reserve cells express higher levels of endogenous Capn3 mRNA than proliferating myoblasts. We show that calpain 3 participates in the establishment of the pool of reserve cells by decreasing the transcriptional activity of the key myogenic regulator MyoD via proteolysis independently of the ubiquitin-proteasome degradation pathway. Our results identify calpain 3 as a potential new player in the muscular regeneration process by promoting renewal of the satellite cell compartment.	[Cottin, Patrick; Veschambre, Philippe] Univ Bordeaux 1, Unite Proteolyse Croissance & Dev Musculaire, INRA, USC 2009, F-33405 Talence, France; [Leibovitch, Serge] INRA UM II, Lab Genom Fonct & Myogenese, Differenciat Cellulaire & Croissance UMR866, F-34060 Montpellier, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; Universite de Montpellier	Veschambre, P (corresponding author), Univ Bordeaux 2, CNRS, UMR 5164, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	veschambre@enscbp.fr	stuelsatz, pascal/F-5735-2015; Lamarre, Yann/ABC-2074-2020; stuelsatz, pascal/AAQ-8778-2020	stuelsatz, pascal/0000-0001-7679-6410; Pouzoulet, Frederic/0000-0003-4819-2876; Philippe, Veschambre/0000-0001-6094-6795	Institut National de la Recherche Agronomique; Region Aquitaine; Association Francaise contre les Myopathies	Institut National de la Recherche Agronomique; Region Aquitaine(Region Nouvelle-Aquitaine); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This work was supported by grants from the Institut National de la Recherche Agronomique, the Region Aquitaine, and the "Association Francaise contre les Myopathies."	Abu Hatoum O, 1998, MOL CELL BIOL, V18, P5670, DOI 10.1128/MCB.18.10.5670; AURADE F, 1994, DIFFERENTIATION, V55, P185, DOI 10.1046/j.1432-0436.1994.5530185.x; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Baroffio A, 1995, DIFFERENTIATION, V59, P259, DOI 10.1046/j.1432-0436.1995.5940259.x; Batonnet S, 2004, J BIOL CHEM, V279, P5413, DOI 10.1074/jbc.M310315200; Batonnet-Pichon S, 2006, EXP CELL RES, V312, P3999, DOI 10.1016/j.yexcr.2006.09.001; Beckmann JS, 2008, NEUROMUSCULAR DISORD, V18, P913, DOI 10.1016/j.nmd.2008.08.005; Benayoun B, 2008, FASEB J, V22, P1521, DOI 10.1096/fj.07-8701com; Benchaouir R, 2004, EXP CELL RES, V294, P254, DOI 10.1016/j.yexcr.2003.11.005; BRUSTIS JJ, 1994, EUR J CELL BIOL, V64, P320; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; BUSKIN JN, 1989, MOL CELL BIOL, V9, P2627, DOI 10.1128/MCB.9.6.2627; Chae J, 2001, NEUROMUSCULAR DISORD, V11, P547, DOI 10.1016/S0960-8966(01)00197-3; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Ciechanover A, 1999, MOL BIOL REP, V26, P59, DOI 10.1023/A:1006964122190; Combaret L, 2003, INT J BIOCHEM CELL B, V35, P676, DOI 10.1016/S1357-2725(02)00357-6; Cooper RN, 1999, J CELL SCI, V112, P2895; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cornelison DDW, 2000, DEV BIOL, V224, P122, DOI 10.1006/dbio.2000.9682; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; Duquet A, 2006, EMBO REP, V7, P1140, DOI 10.1038/sj.embor.7400820; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Hayashi C, 2008, J BIOL CHEM, V283, P14801, DOI 10.1074/jbc.M708262200; Herasse M, 1999, MOL CELL BIOL, V19, P4047; Huang YC, 2008, HUM MOL GENET, V17, P1855, DOI 10.1093/hmg/ddn081; Huang YC, 2005, EUR J HUM GENET, V13, P721, DOI 10.1038/sj.ejhg.5201414; Huebsch KA, 2005, HUM MOL GENET, V14, P2801, DOI 10.1093/hmg/ddi313; Kitzmann M, 1999, MOL CELL BIOL, V19, P3167; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kramerova I, 2005, HUM MOL GENET, V14, P2125, DOI 10.1093/hmg/ddi217; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kramerova I, 2008, HUM MOL GENET, V17, P3271, DOI 10.1093/hmg/ddn223; Kramerova I, 2007, BBA-MOL BASIS DIS, V1772, P128, DOI 10.1016/j.bbadis.2006.07.002; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Ojima K, 2007, J BIOL CHEM, V282, P14493, DOI 10.1074/jbc.M610806200; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ono Y, 2008, FEBS LETT, V582, P691, DOI 10.1016/j.febslet.2008.01.044; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poussard S, 1996, CELL GROWTH DIFFER, V7, P1461; Puri PL, 1997, EMBO J, V16, P369, DOI 10.1093/emboj/16.2.369; Rey MA, 2002, FEBS LETT, V532, P401, DOI 10.1016/S0014-5793(02)03722-5; Reynaud EG, 1999, MOL CELL BIOL, V19, P7621; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Sabourin LA, 1999, J CELL BIOL, V144, P631, DOI 10.1083/jcb.144.4.631; Sartorelli V, 1999, MOL CELL, V4, P725, DOI 10.1016/S1097-2765(00)80383-4; Seale P, 2004, DEV BIOL, V275, P287, DOI 10.1016/j.ydbio.2004.07.034; Shield MA, 1996, MOL CELL BIOL, V16, P5058; SMITH CK, 1994, J CELL PHYSIOL, V159, P379, DOI 10.1002/jcp.1041590222; Song A, 1998, MOL CELL BIOL, V18, P4994, DOI 10.1128/MCB.18.9.4994; SORIMACHI H, 1990, BIOL CHEM H-S, V371, P171; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; Sorimachi H, 1995, J BIOL CHEM, V270, P31158, DOI 10.1074/jbc.270.52.31158; SORIMACHI H, 1992, BIOCHIM BIOPHYS ACTA, V1160, P55, DOI 10.1016/0167-4838(92)90037-E; Spencer MJ, 2002, P NATL ACAD SCI USA, V99, P8874, DOI 10.1073/pnas.132269299; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Taveau M, 2003, MOL CELL BIOL, V23, P9127, DOI 10.1128/MCB.23.24.9127-9135.2003; Tintignac LA, 2000, EXP CELL RES, V259, P300, DOI 10.1006/excr.2000.4973; Tintignac LAJ, 2004, MOL CELL BIOL, V24, P1809, DOI 10.1128/MCB.24.4.1809-1821.2004; Tompa P, 2004, J BIOL CHEM, V279, P20775, DOI 10.1074/jbc.M313873200; WEINTRAUB H, 1990, P NATL ACAD SCI USA, V87, P5623, DOI 10.1073/pnas.87.15.5623; Yablonka-Reuveni Z, 2008, J Anim Sci, V86, pE207; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	71	36	38	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12670	12683		10.1074/jbc.M109.063966	http://dx.doi.org/10.1074/jbc.M109.063966			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20139084	Green Published, hybrid			2022-12-27	WOS:000276787800026
J	Lachkar, S; Lebois, M; Steinmetz, MO; Guichet, A; Lal, N; Curmi, PA; Sobel, A; Ozon, S				Lachkar, Sylvie; Lebois, Marion; Steinmetz, Michel O.; Guichet, Antoine; Lal, Neha; Curmi, Patrick A.; Sobel, Andre; Ozon, Sylvie			Drosophila Stathmins Bind Tubulin Heterodimers with High and Variable Stoichiometries	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAGE-SPECIFIC EXPRESSION; FAMILY PROTEINS; NERVOUS-SYSTEM; IN-VITRO; PHYLOGENETIC CONSERVATION; SUBCELLULAR-LOCALIZATION; SCG10-LIKE PROTEIN; PHOSPHOPROTEIN P19; CELL REGULATIONS; GOLGI-COMPLEX	In vertebrates, stathmins form a family of proteins possessing two tubulin binding repeats (TBRs), which each binds one soluble tubulin heterodimer. The stathmins thus sequester two tubulins in a phosphorylation-dependent manner, providing a link between signal transduction and microtubule dynamics. In Drosophila, we show here that a single stathmin gene (stai) encodes a family of D-stathmin proteins. Two of the D-stathmins are maternally deposited and then restricted to germ cells, and the other two are detected in the nervous system during embryo development. Like in vertebrates, the nervous system-enriched stathmins contain an N-terminal domain involved in subcellular targeting. All the D-stathmins possess a domain containing three or four predicted TBRs, and we demonstrate here, using complementary biochemical and biophysical methods, that all four predicted TBR domains actually bind tubulin. D-stathmins can indeed bind up to four tubulins, the resulting complex being directly visualized by electron microscopy. Phylogenetic analysis shows that the presence of regulated multiple tubulin sites is a conserved characteristic of stathmins in invertebrates and allows us to predict key residues in stathmin for the binding of tubulin. Altogether, our results reveal that the single Drosophila stathmin gene codes for a stathmin family similar to the multigene vertebrate one, but with particular tubulin binding properties.	[Sobel, Andre] UPMC, INSERM, Inst Moulin, UMR S 839, F-75005 Paris, France; [Lachkar, Sylvie; Lebois, Marion; Lal, Neha; Sobel, Andre; Ozon, Sylvie] INSERM, U839, F-75005 Paris, France; [Lebois, Marion; Lal, Neha] Univ Paris Diderot, CNRS, Inst Jacques Monod, UMR 7592, F-75013 Paris, France; [Curmi, Patrick A.] Univ Evry Val Essonne, INSERM, U829, F-91025 Evry, France; [Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Sobel, A (corresponding author), UPMC, INSERM, Inst Moulin, UMR S 839, 17 Rue Fer Moulin, F-75005 Paris, France.	andre.sobel@inserm.fr	CURMI, Patrick/G-4036-2013; Steinmetz, Michel O/AAA-3349-2022	Steinmetz, Michel O/0000-0001-6157-3687; CURMI, Patrick A./0000-0001-5045-8501	INSERM; Universite Pierre et Marie Curie (UPMC); Association pour la Recherche Contre le Cancer; Association Francaise Contre les Myopathies; Association pour la Recherche sur la Sclerose en Plaque; Agence Nationale pour la Recherche	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Pierre et Marie Curie (UPMC); Association pour la Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise Contre les Myopathies(Association Francaise contre les Myopathies); Association pour la Recherche sur la Sclerose en Plaque; Agence Nationale pour la Recherche(French National Research Agency (ANR))	This work was supported by INSERM, the Universite Pierre et Marie Curie (UPMC), the Association pour la Recherche Contre le Cancer, the Association Francaise Contre les Myopathies, the Association pour la Recherche sur la Sclerose en Plaque, and the Agence Nationale pour la Recherche.	AMAT JA, 1991, DEV BRAIN RES, V60, P205, DOI 10.1016/0165-3806(91)90049-O; Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Balogh A, 1996, EXP CELL RES, V224, P8, DOI 10.1006/excr.1996.0106; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Charbaut E, 2005, J CELL SCI, V118, P2313, DOI 10.1242/jcs.02349; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Chauvin S, 2008, BIOL CELL, V100, P577, DOI 10.1042/BC20070119; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; DiPaolo G, 1997, J BIOL CHEM, V272, P5175, DOI 10.1074/jbc.272.8.5175; DOYE V, 1992, DIFFERENTIATION, V50, P89, DOI 10.1111/j.1432-0436.1992.tb00489.x; Gavet O, 2002, J NEUROSCI RES, V68, P535, DOI 10.1002/jnr.10234; Giampietro C, 2005, ENDOCRINOLOGY, V146, P1825, DOI 10.1210/en.2004-0972; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Guillaume E, 2001, MOL REPROD DEV, V60, P439, DOI 10.1002/mrd.1108; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Koppel J, 1999, MOL REPROD DEV, V53, P306; Larsson N, 1999, J CELL BIOL, V146, P1289, DOI 10.1083/jcb.146.6.1289; Lawler S, 1998, FEBS LETT, V421, P55, DOI 10.1016/S0014-5793(97)01519-6; Liedtke W, 2002, AM J PATHOL, V160, P469, DOI 10.1016/S0002-9440(10)64866-3; Lutjens R, 2000, EUR J NEUROSCI, V12, P2224, DOI 10.1046/j.1460-9568.2000.00112.x; Maekawa S, 2001, J BIOCHEM-TOKYO, V129, P691, DOI 10.1093/oxfordjournals.jbchem.a002908; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; MAUCUER A, 1990, FEBS LETT, V264, P275, DOI 10.1016/0014-5793(90)80266-L; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; MELHEM RF, 1991, BIOCHEM BIOPH RES CO, V179, P1649, DOI 10.1016/0006-291X(91)91764-4; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Ohkawa N, 2007, J CELL SCI, V120, P1447, DOI 10.1242/jcs.001461; Ozon S, 1998, J NEUROCHEM, V70, P2386; Ozon S, 1999, J NEUROSCI RES, V56, P553, DOI 10.1002/(SICI)1097-4547(19990601)56:5<553::AID-JNR11>3.0.CO;2-J; Ozon S, 1997, EUR J BIOCHEM, V248, P794, DOI 10.1111/j.1432-1033.1997.t01-2-00794.x; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Poulain FE, 2008, J NEUROSCI, V28, P7387, DOI 10.1523/JNEUROSCI.1942-08.2008; Poulain FE, 2007, MOL CELL NEUROSCI, V34, P137, DOI 10.1016/j.mcn.2006.10.012; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SCHUBART UK, 1992, DIFFERENTIATION, V51, P21, DOI 10.1111/j.1432-0436.1992.tb00676.x; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STEIN R, 1988, DEV BIOL, V127, P316, DOI 10.1016/0012-1606(88)90318-1; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X	52	14	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11667	11680		10.1074/jbc.M109.096727	http://dx.doi.org/10.1074/jbc.M109.096727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145240	Green Published, hybrid			2022-12-27	WOS:000276286200071
J	Aihara, T; Nakamura, M; Ueki, S; Hara, H; Miki, M; Arata, T				Aihara, Tomoki; Nakamura, Motoyoshi; Ueki, Shoji; Hara, Hideyuki; Miki, Masao; Arata, Toshiaki			Switch Action of Troponin on Muscle Thin Filament as Revealed by Spin Labeling and Pulsed EPR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; HUMAN CARDIAC TROPONIN; ELECTRON-PARAMAGNETIC-RESONANCE; RABBIT SKELETAL TROPONIN; REGULATORY DOMAIN; CONFORMATIONAL-CHANGES; STRUCTURAL TRANSITION; TROPOMYOSIN COMPLEX; INHIBITORY REGION; TERMINAL REGION	We have used pulsed electron-electron double resonance (PELDOR) spectroscopy to measure the distance between spin labels at Cys(133) of the regulatory region of TnI (TnI133) and a native or genetically substituted cysteine of TnC (TnC44, TnC61, or TnC98). In the +Ca2+ state, the TnC44-TnI133-T distance was 42 angstrom, with a narrow distribution (half-width of 9 angstrom), suggesting that the regulatory region binds the N-lobe of TnC. Distances for TnC61-TnI133 and TnC98-TnI133 were also determined to be 38 angstrom (width of 12 angstrom) and 22 angstrom (width of 3.4 angstrom), respectively. These values were all consistent with recently published crystal structure (Vinogradova, M. V., Stone, D. B., Malanina, G. G., Karatzaferi, C., Cooke, R., Mendelson, R. A., and Fletterick, R. J. (2005) Proc. Natl Acad. Sci. U. S. A. 102, 50385043). Similar distances were obtained with the same spin pairs on a reconstituted thin filament in the +Ca2+ state. In the -Ca2+ state, the distances displayed broad distributions, suggesting that the regulatory region of TnI was physically released from the N-lobe of TnC and consequently fluctuated over a variety of distances on a large scale (20-80 angstrom). The interspin distance appeared longer on the filament than on troponin alone, consistent with the ability of the region to bind actin. These results support a concept that the regulatory region of TnI, as a molecular switch, binds to the exposed hydrophobic patch of TnC and traps the inhibitory region of TnI away from actin in Ca2+ activation of muscle.	Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; [Hara, Hideyuki] Bruker Biospin, Kanagawa 2150022, Japan; [Miki, Masao] Univ Fukui, Grad Sch Engn Sci, Div Appl Chem & Biotechnol, Fukui 9108507, Japan	Osaka University; Bruker Corporation; Bruker BioSpin GmbH; University of Fukui	Arata, T (corresponding author), Machikaneyama Cho 1-1, Osaka 5600043, Japan.	arata@bio.sci.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology; Japanese Science and Technology Cooperation, Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Science and Technology Cooperation, Japan	This work was supported by grants-in-aid for Special Coordination Funds (to T. A. and M. M.) and Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, and Core Research for Evolutional Science and Technology program from Japanese Science and Technology Cooperation, Japan (to T. A.).	Aihara T, 2006, BIOCHEM BIOPH RES CO, V340, P462, DOI 10.1016/j.bbrc.2005.12.030; Bacchiocchi C, 2002, BIOPHYS J, V82, P1524, DOI 10.1016/S0006-3495(02)75505-7; Blumenschein TMA, 2005, J BIOL CHEM, V280, P21924, DOI 10.1074/jbc.M500574200; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; CHONG PCS, 1982, J BIOL CHEM, V257, P2549; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; EBASHI S, 1968, J BIOCHEM-TOKYO, V64, P465, DOI 10.1093/oxfordjournals.jbchem.a128918; EBASHI S, 1974, J BIOCHEM-TOKYO, V75, P211, DOI 10.1093/oxfordjournals.jbchem.a130379; Ebashi S, 1968, Prog Biophys Mol Biol, V18, P123, DOI 10.1016/0079-6107(68)90023-0; Ferguson RE, 2003, MOL CELL, V11, P865, DOI 10.1016/S1097-2765(03)00096-0; Fujiwara S, 2007, J MOL BIOL, V367, P16, DOI 10.1016/j.jmb.2006.12.072; Gergely J, 1998, ADV EXP MED BIOL, V453, P169; HERZBERG O, 1986, J BIOL CHEM, V261, P2638; Kimura-Sakiyama C, 2008, J MOL BIOL, V376, P80, DOI 10.1016/j.jmb.2007.10.078; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; LEVINE BA, 1988, EUR J BIOCHEM, V172, P389, DOI 10.1111/j.1432-1033.1988.tb13899.x; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Luo Y, 1997, BIOCHEMISTRY-US, V36, P11027, DOI 10.1021/bi962461w; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; Matsuo N, 2002, J BIOCHEM, V131, P375, DOI 10.1093/oxfordjournals.jbchem.a003112; Maytum R, 2008, J BIOL CHEM, V283, P1902, DOI 10.1074/jbc.M708593200; Mchaourab HS, 1996, BIOCHEMISTRY-US, V35, P7692, DOI 10.1021/bi960482k; McKay RT, 1997, J BIOL CHEM, V272, P28494, DOI 10.1074/jbc.272.45.28494; McKay RT, 1999, BIOCHEMISTRY-US, V38, P5478; Miki M, 1998, J BIOCHEM-TOKYO, V123, P1104; MIKI M, 1990, EUR J BIOCHEM, V187, P155, DOI 10.1111/j.1432-1033.1990.tb15289.x; Miki M, 1998, J BIOCHEM-TOKYO, V123, P324; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Nakamura M, 2005, J MOL BIOL, V348, P127, DOI 10.1016/j.jmb.2005.02.018; Narita A, 2001, J MOL BIOL, V308, P241, DOI 10.1006/jmbi.2001.4598; OJIMA T, 1988, J BIOCHEM-TOKYO, V104, P9, DOI 10.1093/oxfordjournals.jbchem.a122429; PARK HS, 1994, BIOPHYS J, V66, P2062, DOI 10.1016/S0006-3495(94)81000-8; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; POTTER JD, 1976, J BIOL CHEM, V251, P7551; Ramos CHI, 1999, J BIOL CHEM, V274, P18189, DOI 10.1074/jbc.274.26.18189; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; ROSENFELD SS, 1985, J BIOL CHEM, V260, P252; Slupsky CM, 1995, BIOCHEMISTRY-US, V34, P15953, DOI 10.1021/bi00049a010; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Sun YB, 2006, P NATL ACAD SCI USA, V103, P17771, DOI 10.1073/pnas.0605430103; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; TALBOT JA, 1981, J BIOL CHEM, V256, P2798; TAO T, 1989, BIOCHEMISTRY-US, V28, P5902, DOI 10.1021/bi00440a029; TONOMURA Y, 1969, BIOCHEMISTRY-US, V8, P2171, DOI 10.1021/bi00833a058; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; Ueki S, 2005, BIOCHEMISTRY-US, V44, P411, DOI 10.1021/bi048110w; Vassylyev DG, 1998, P NATL ACAD SCI USA, V95, P4847, DOI 10.1073/pnas.95.9.4847; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; WAKABAYASHI T, 1975, J MOL BIOL, V93, P477, DOI 10.1016/0022-2836(75)90241-7; Wang H, 2008, BIOPHYS J, V94, P4358, DOI 10.1529/biophysj.107.121129; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535; ZOT HG, 1987, J MUSCLE RES CELL M, V8, P428, DOI 10.1007/BF01578432	57	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10671	10677		10.1074/jbc.M109.082925	http://dx.doi.org/10.1074/jbc.M109.082925			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139080	hybrid, Green Published			2022-12-27	WOS:000276264600054
J	Lee, KY; Yang, K; Cohn, MA; Sikdar, N; D'Andrea, AD; Myung, K				Lee, Kyoo-young; Yang, Kailin; Cohn, Martin A.; Sikdar, Nilabja; D'Andrea, Alan D.; Myung, Kyungjae			Human ELG1 Regulates the Level of Ubiquitinated Proliferating Cell Nuclear Antigen (PCNA) through Its Interactions with PCNA and USP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPLICATION-FACTOR-C; DNA-POLYMERASE-ETA; GENOME STABILITY; COHESION ESTABLISHMENT; MONOUBIQUITINATED PCNA; COMPLEX-FORMATION; S-PHASE; INSTABILITY; DAMAGE; FORMS	The level of monoubiquitinated proliferating cell nuclear antigen (PCNA) is closely linked with DNA damage bypass to protect cells from a high level of mutagenesis. However, it remains unclear how the level of monoubiquitinated PCNA is regulated. Here, we demonstrate that human ELG1 protein, which comprises an alternative replication factor C (RFC) complex and plays an important role in preserving genomic stability, as an interacting partner for the USP1 (ubiquitin-specific protease 1)-UAF1 (USP1-associated factor 1) complex, a deubiquitinating enzyme complex for PCNA and FANCD2. ELG1 protein interacts with PCNAs that are localized at stalled replication forks. ELG1 knockdown specifically resulted in an increase in the level of PCNA monoubiquitination without affecting the level of FANCD2 ubiquitination. It is a novel function of ELG1 distinct from its role as an alternative RFC complex because knockdowns of any other RFC subunits or other alternative RFCs did not affect PCNA monoubiquitination. Lastly, we identified a highly conserved N-terminal domain in ELG1 that was responsible for the USP1-UAF1 interaction as well as the activity to down-regulate PCNA monoubiquitination. Taken together, ELG1 specifically directs USP1-UAF1 complex for PCNA deubiquitination.	[Lee, Kyoo-young; Sikdar, Nilabja; Myung, Kyungjae] NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bethesda, MD 20892 USA; [Yang, Kailin; Cohn, Martin A.; D'Andrea, Alan D.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Myung, K (corresponding author), NHGRI, Genome Instabil Sect, Genet & Mol Biol Branch, NIH, Bldg 49,Rm 4A22, Bethesda, MD 20892 USA.	kmyung@nhgri.nih.gov	Yang, Kailin/L-2205-2013; Classen, Scott/AAY-8176-2020; Lee, Kyoo-young/AAG-3144-2019; Yang, Kailin/D-7966-2013	Yang, Kailin/0000-0001-5968-6738; Cohn, Martin/0000-0002-2988-3009	National Institutes of Health [RO1-HL52725, RO1-DK43889, PO1-CA092584]; National Institutes of Health, National Human Genome Research Institute, Intramural Research Program [HG012003-07]; Korean Government [KRF-2007-357C00092]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG012003, Z01HG012003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health, National Human Genome Research Institute, Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Korean Government(Korean Government); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL52725, RO1-DK43889, and PO1-CA092584 (to A. D.) and National Institutes of Health, National Human Genome Research Institute, Intramural Research Program Grant HG012003-07 (to K. M.). This work was also supported by Korea Research Foundation Grant KRF-2007-357C00092 funded by the Korean Government (to K. Y. L.).	Banerjee S, 2004, EUKARYOT CELL, V3, P1557, DOI 10.1128/EC.3.6.1557-1566.2004; Banerjee S, 2007, BIOCHEM BIOPH RES CO, V362, P546, DOI 10.1016/j.bbrc.2007.07.126; Bellaoui M, 2003, EMBO J, V22, P4304, DOI 10.1093/emboj/cdg406; Ben-Aroya S, 2003, P NATL ACAD SCI USA, V100, P9906, DOI 10.1073/pnas.1633757100; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BRAVO R, 1987, J CELL BIOL, V105, P1549, DOI 10.1083/jcb.105.4.1549; Brown S, 2009, CELL CYCLE, V8, P689, DOI 10.4161/cc.8.5.7707; Bylund GO, 2005, MOL CELL BIOL, V25, P5445, DOI 10.1128/MCB.25.13.5445-5455.2005; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Davidson MB, 2008, DNA REPAIR, V7, P1221, DOI 10.1016/j.dnarep.2008.04.001; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Ishizaki K, 1996, MUTAT RES-DNA REPAIR, V364, P43, DOI 10.1016/0921-8777(96)00020-1; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kanellis P, 2003, CURR BIOL, V13, P1583, DOI 10.1016/S0960-9822(03)00578-5; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim JM, 2009, DEV CELL, V16, P314, DOI 10.1016/j.devcel.2009.01.001; Lee KY, 2008, MOL CELLS, V26, P5; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Merkle CJ, 2003, J BIOL CHEM, V278, P30051, DOI 10.1074/jbc.M211591200; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; Sikdar N, 2009, CELL CYCLE, V8, P3199, DOI 10.4161/cc.8.19.9752; Uhlmann F, 1997, J BIOL CHEM, V272, P10065; Uhlmann F, 1997, J BIOL CHEM, V272, P10058; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	34	105	107	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10362	10369		10.1074/jbc.M109.092544	http://dx.doi.org/10.1074/jbc.M109.092544			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20147293	hybrid, Green Published			2022-12-27	WOS:000276264600021
J	Colombo, G; Margosio, B; Ragona, L; Neves, M; Bonifacio, S; Annis, DS; Stravalaci, M; Tomaselli, S; Giavazzi, R; Rusnati, M; Presta, M; Zetta, L; Mosher, DF; Ribatti, D; Gobbi, M; Taraboletti, G				Colombo, Giorgio; Margosio, Barbara; Ragona, Laura; Neves, Marco; Bonifacio, Silvia; Annis, Douglas S.; Stravalaci, Matteo; Tomaselli, Simona; Giavazzi, Raffaella; Rusnati, Marco; Presta, Marco; Zetta, Lucia; Mosher, Deane F.; Ribatti, Domenico; Gobbi, Marco; Taraboletti, Giulia			Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors AN INTEGRATED STRATEGY FOR THE DEVELOPMENT OF NEW ANTIANGIOGENIC COMPOUNDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; MOLECULAR-DYNAMICS; HOT-SPOT; ANGIOGENESIS; PEPTIDE; BINDING; RECEPTOR; FRAGMENT; DESIGN; SHEPHERDIN	Endogenous inhibitors of angiogenesis, such as thrombospondin-1 (TSP-1), are promising sources of therapeutic agents to treat angiogenesis-driven diseases, including cancer. TSP-1 regulates angiogenesis through different mechanisms, including binding and sequestration of the angiogenic factor fibroblast growth factor-2 (FGF-2), through a site located in the calcium binding type III repeats. We hypothesized that the FGF-2 binding sequence of TSP-1 might serve as a template for the development of inhibitors of angiogenesis. Using a peptide array approach followed by binding assays with synthetic peptides and recombinant proteins, we identified a FGF-2 binding sequence of TSP-1 in the 15-mer sequence DDDDDNDKIPD-DRDN. Molecular dynamics simulations, taking the full flexibility of the ligand and receptor into account, and nuclear magnetic resonance identified the relevant residues and conformational determinants for the peptide-FGF interaction. This information was translated into a pharmacophore model used to screen the NCI2003 small molecule databases, leading to the identification of three small molecules that bound FGF-2 with affinity in the submicromolar range. The lead compounds inhibited FGF-2-induced endothelial cell proliferation in vitro and affected angiogenesis induced by FGF-2 in the chicken chorioallantoic membrane assay. These small molecules, therefore, represent promising leads for the development of antiangiogenic agents. Altogether, this study demonstrates that new biological insights obtained by integrated multidisciplinary approaches can be used to develop small molecule mimics of endogenous proteins as therapeutic agents.	[Margosio, Barbara; Bonifacio, Silvia; Giavazzi, Raffaella; Taraboletti, Giulia] Mario Negri Inst Pharmacol Res, Dept Oncol, I-24125 Bergamo, Italy; [Colombo, Giorgio; Neves, Marco; Taraboletti, Giulia] CNR, Ist Chim Riconoscimento Mol, I-20131 Milan, Italy; [Ragona, Laura; Tomaselli, Simona; Zetta, Lucia] CNR, Ist Studio Macromol, I-20133 Milan, Italy; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Biomol Chem, Madison, WI 53706 USA; [Annis, Douglas S.; Mosher, Deane F.] Univ Wisconsin, Dept Med, Madison, WI 53706 USA; [Stravalaci, Matteo; Gobbi, Marco] Mario Negri Inst Pharmacol Res, Dept Mol Pharmacol & Biochem, I-20156 Milan, Italy; [Rusnati, Marco; Presta, Marco] Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy; [Ribatti, Domenico] Univ Bari, Dept Human Anat & Histol, I-70124 Bari, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto per lo Studio delle Macromolecole (ISMAC-CNR); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Brescia; Universita degli Studi di Bari Aldo Moro	Taraboletti, G (corresponding author), Mario Negri Inst Pharmacol Res, Dept Oncol, Via Gavazzeni,11, I-24125 Bergamo, Italy.	giulia.taraboletti@marionegri.it	Stravalaci, Matteo/AAB-8963-2019; tomaselli, simona/A-6075-2012; Rusnati, Marco/F-1168-2010; Neves, Marco/K-6630-2012; Giavazzi, Raffaella/J-7424-2018; Gobbi, Marco/J-2638-2016; Giavazzi, Raffaella/ABB-9768-2020; Colombo, Giorgio/A-2730-2012; Presta, Marco/B-4345-2010; Taraboletti, Giulia/J-4089-2018; Ragona, Laura/AAB-9691-2020	Stravalaci, Matteo/0000-0002-5636-4204; tomaselli, simona/0000-0002-8627-6838; Rusnati, Marco/0000-0001-9968-5908; Gobbi, Marco/0000-0003-1014-6225; Giavazzi, Raffaella/0000-0001-5249-8208; Colombo, Giorgio/0000-0002-1318-668X; Taraboletti, Giulia/0000-0001-8780-5001; Ragona, Laura/0000-0003-3893-7117; Neves, Marco/0000-0003-0525-7318; PRESTA, Marco/0000-0002-4398-8376	National Institutes of Health [HL054462]; Associazione Italiana per la Ricerca sul Cancro; Fondazione Cariplo; Italian Ministry of Health [GR2007, onc_ord 25/07]; European Union [IP-FP7-HEALTH-2007-ADAMANT, 201342]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054462] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); Italian Ministry of Health(Ministry of Health, Italy); European Union(European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL054462, the Associazione Italiana per la Ricerca sul Cancro, Fondazione Cariplo, and the Italian Ministry of Health (GR2007 and onc_ord 25/07), and European Union IP-FP7-HEALTH-2007-ADAMANT, 201342.	Annis DS, 2007, J BIOL CHEM, V282, P27067, DOI 10.1074/jbc.M703804200; Armstrong LC, 2003, MATRIX BIOL, V22, P63, DOI 10.1016/S0945-053X(03)00005-2; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Berg T, 2003, ANGEW CHEM INT EDIT, V42, P2462, DOI 10.1002/anie.200200558; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Bravman T, 2006, ANAL BIOCHEM, V358, P281, DOI 10.1016/j.ab.2006.08.005; Calero S, 2004, CHEM BIODIVERS, V1, P505, DOI 10.1002/cbdv.200490044; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Carlson CB, 2005, NAT STRUCT MOL BIOL, V12, P910, DOI 10.1038/nsmb997; Carlson HA, 2008, J MED CHEM, V51, P6432, DOI 10.1021/jm8006504; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Esteras-Chopo A, 2008, J MOL BIOL, V383, P266, DOI 10.1016/j.jmb.2008.07.076; Fernandez-Tornero C, 2003, J BIOL CHEM, V278, P21774, DOI 10.1074/jbc.M212833200; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frembgen-Kesner T, 2006, J MOL BIOL, V359, P202, DOI 10.1016/j.jmb.2006.03.021; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Gyurkocza B, 2006, J NATL CANCER I, V98, P1068, DOI 10.1093/jnci/djj300; Hannah BLA, 2004, J BIOL CHEM, V279, P51915, DOI 10.1074/jbc.M409632200; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; HOGG PJ, 1994, THROMB HAEMOSTASIS, V72, P787; Iruela-Arispe ML, 2004, INT J BIOCHEM CELL B, V36, P1070, DOI 10.1016/j.biocel.2004.01.025; Kazerounian S, 2008, CELL MOL LIFE SCI, V65, P700, DOI 10.1007/s00018-007-7486-z; Kvansakul M, 2004, EMBO J, V23, P1223, DOI 10.1038/sj.emboj.7600166; Leali D, 2009, CURR PHARM DESIGN, V15, P3577, DOI 10.2174/138161209789206962; LEALI D, 2009, J CELL MOL IN PRESS; Lerner MG, 2007, J CHEM INF MODEL, V47, P2358, DOI 10.1021/ci700167n; Majluf-Cruz A, 2000, J LAB CLIN MED, V136, P292, DOI 10.1067/mlc.2000.109407; Manetti F, 1998, BIOORGAN MED CHEM, V6, P947, DOI 10.1016/S0968-0896(98)00052-2; Margosio B, 2003, BLOOD, V102, P4399, DOI 10.1182/blood-2003-03-0893; Margosio B, 2008, INT J BIOCHEM CELL B, V40, P700, DOI 10.1016/j.biocel.2007.10.002; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meli M, 2006, J MED CHEM, V49, P7721, DOI 10.1021/jm060836y; MILNE GWA, 1994, J CHEM INF COMP SCI, V34, P1219, DOI 10.1021/ci00021a032; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Ragona L, 2009, BIOCHEM BIOPH RES CO, V382, P26, DOI 10.1016/j.bbrc.2009.02.092; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Robinson JA, 2008, DRUG DISCOV TODAY, V13, P944, DOI 10.1016/j.drudis.2008.07.008; Slootstra JW, 1996, MOL DIVERS, V1, P87, DOI 10.1007/BF01721323; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Sulochana KN, 2007, CURR PHARM DESIGN, V13, P2074; Taraboletti G, 1997, CELL GROWTH DIFFER, V8, P471; TARABOLETTI G, 1990, J CELL BIOL, V111, P765, DOI 10.1083/jcb.111.2.765; Taraboletti G., 2009, RECENT ADV ANGIOGENE, P112; Thanos CD, 2006, P NATL ACAD SCI USA, V103, P15422, DOI 10.1073/pnas.0607058103; Watkins NA, 2003, BLOOD, V102, P718, DOI 10.1182/blood-2002-11-3497; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Whitty A, 2006, NAT CHEM BIOL, V2, P112, DOI 10.1038/nchembio0306-112; Zhang XF, 2007, MICROVASC RES, V74, P90, DOI 10.1016/j.mvr.2007.04.007	54	61	65	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8733	8742		10.1074/jbc.M109.085605	http://dx.doi.org/10.1074/jbc.M109.085605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20056600	Green Published, hybrid			2022-12-27	WOS:000275553700026
J	Hargreaves, VV; Shell, SS; Mazur, DJ; Hess, MT; Kolodner, RD				Hargreaves, Victoria V.; Shell, Scarlet S.; Mazur, Dan J.; Hess, Martin T.; Kolodner, Richard D.			Interaction between the Msh2 and Msh6 Nucleotide-binding Sites in the Saccharomyces cerevisiae Msh2-Msh6 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA MISMATCH REPAIR; ESCHERICHIA-COLI MUTS; MISPAIR-BINDING; ATPASE ACTIVITY; RECOGNITION COMPLEX; DOMINANT MUTATIONS; CRYSTAL-STRUCTURE; PROTEIN MUTS; GENE-PRODUCT; ALPHA	Indirect evidence has suggested that the Msh2-Msh6 mispair-binding complex undergoes conformational changes upon binding of ATP and mispairs, resulting in the formation of Msh2-Msh6 sliding clamps and licensing the formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes. Here, we have studied eight mutant Msh2-Msh6 complexes with defective responses to nucleotide binding and/or mispair binding and used them to study the conformational changes required for sliding clamp formation and ternary complex assembly. ATP binding to the Msh6 nucleotide-binding site results in a conformational change that allows binding of ATP to the Msh2 nucleotide-binding site, although ATP binding to the two nucleotide-binding sites appears to be uncoupled in some mutant complexes. The formation of Msh2-Msh6-Mlh1-Pms1 ternary complexes requires ATP binding to only the Msh6 nucleotide-binding site, whereas the formation of Msh2- Msh6 sliding clamps requires ATP binding to both the Msh2 and Msh6 nucleotide-binding sites. In addition, the properties of the different mutant complexes suggest that distinct conformational states mediated by communication between the Msh2 and Msh6 nucleotide-binding sites are required for the formation of ternary complexes and sliding clamps.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego	Kolodner, RD (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rkolodner@ucsd.edu	Classen, Scott/AAY-8176-2020		National Institutes of Health [GM50006, CA92584]; NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050006] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM50006 and CA92584.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Alani E, 2003, J BIOL CHEM, V278, P16088, DOI 10.1074/jbc.M213193200; Amin NS, 2001, MOL CELL BIOL, V21, P5142, DOI 10.1128/MCB.21.15.5142-5155.2001; Antony E, 2006, DNA REPAIR, V5, P153, DOI 10.1016/j.dnarep.2005.08.016; Antony E, 2003, BIOCHEMISTRY-US, V42, P7682, DOI 10.1021/bi034602h; Blackwell LJ, 2001, J BIOL CHEM, V276, P33233, DOI 10.1074/jbc.M105076200; Bowers J, 1999, J BIOL CHEM, V274, P16115, DOI 10.1074/jbc.274.23.16115; Das Gupta R, 2000, NAT GENET, V24, P53, DOI 10.1038/71684; Drotschmann K, 2001, J BIOL CHEM, V276, P46225, DOI 10.1074/jbc.C100450200; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Gradia S, 1997, CELL, V91, P995, DOI 10.1016/S0092-8674(00)80490-0; Gradia S, 1999, MOL CELL, V3, P255, DOI 10.1016/S1097-2765(00)80316-0; GRILLEY M, 1989, J BIOL CHEM, V264, P1000; Hall MC, 1999, J BIOL CHEM, V274, P1306, DOI 10.1074/jbc.274.3.1306; Hess MT, 2006, P NATL ACAD SCI USA, V103, P558, DOI 10.1073/pnas.0510078103; Hess MT, 2002, J BIOL CHEM, V277, P25545, DOI 10.1074/jbc.M202282200; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2000, STRUCTURE, V8, pR237, DOI 10.1016/S0969-2126(00)00545-1; Huang ME, 2005, MOL CELL, V17, P709, DOI 10.1016/j.molcel.2005.02.008; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Jiricny J, 2006, NAT REV MOL CELL BIO, V7, P335, DOI 10.1038/nrm1907; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Marsischky GT, 1999, J BIOL CHEM, V274, P26668, DOI 10.1074/jbc.274.38.26668; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; MARTINEZ S, 2010, P NATL ACAD IN PRESS; Mazur DJ, 2006, MOL CELL, V22, P39, DOI 10.1016/j.molcel.2006.02.010; Mendillo ML, 2009, P NATL ACAD SCI USA, V106, P22223, DOI 10.1073/pnas.0912250106; Mendillo ML, 2005, J BIOL CHEM, V280, P22245, DOI 10.1074/jbc.M407545200; Natrajan G, 2003, NUCLEIC ACIDS RES, V31, P4814, DOI 10.1093/nar/gkg677; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; PROLLA TA, 1994, SCIENCE, V265, P1091, DOI 10.1126/science.8066446; Raschle M, 2002, J BIOL CHEM, V277, P21810, DOI 10.1074/jbc.M108787200; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; Shell SS, 2007, P NATL ACAD SCI USA, V104, P10956, DOI 10.1073/pnas.0704148104; Shell SS, 2007, MOL CELL, V26, P565, DOI 10.1016/j.molcel.2007.04.024; SU SS, 1986, P NATL ACAD SCI USA, V83, P5057, DOI 10.1073/pnas.83.14.5057; Tian L, 2009, J BIOL CHEM, V284, P11557, DOI 10.1074/jbc.M900908200; Tran PT, 2000, MOL CELL BIOL, V20, P6390, DOI 10.1128/MCB.20.17.6390-6398.2000; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018; WELSH KM, 1987, J BIOL CHEM, V262, P15624; Wilson T, 1999, J BIOL CHEM, V274, P21659, DOI 10.1074/jbc.274.31.21659	49	43	43	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9301	9310		10.1074/jbc.M109.096388	http://dx.doi.org/10.1074/jbc.M109.096388			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089866	Green Published, hybrid			2022-12-27	WOS:000275553700078
J	Turk, EM; Caprara, MG				Turk, Edward M.; Caprara, Mark G.			Splicing of Yeast aI5 beta Group I Intron Requires SUV3 to Recycle MRS1 via Mitochondrial Degradosome-promoted Decay of Excised Intron Ribonucleoprotein (RNP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD-BOX PROTEIN; JUNCTION RESOLVASE YDC2; NUCLEAR GENE; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; POSTTRANSCRIPTIONAL PROCESSES; HELICASE; TRANSCRIPTION; SEQUENCE; CHAPERONE	Yeast Suv3p is a member of the DEXH/D box family of RNA helicases and is a critical component of the mitochondrial degradosome, which also includes a 3' --> 5' exonuclease, Dss1p. Defects in the degradosome result in accumulation of aberrant transcripts, unprocessed transcripts, and excised group I introns. In addition, defects in SUV3 result in decreased splicing of the aI5 beta and bI3 group I introns. Whereas a role for Suv3p in RNA degradation is well established, the function of Suv3p in splicing of group I introns has remained elusive. It has been particularly challenging to determine if Suv3p effects group I intron splicing through RNA degradation as part of the degradosome, or has a direct role in splicing as a chaperone, because nearly all perturbations of SUV3 or DSS1 result in loss of the mitochondrial genome. Here we utilized the suv3-1 allele, which is defective in RNA metabolism and yet maintains a stable mitochondrial genome, to investigate the role of Suv3p in splicing of the aI5 beta group I intron. We provide genetic evidence that Mrs1p is a limiting cofactor for aI5 beta splicing, and this evidence also suggests that Suv3p activity is required to recycle the excised aI5 beta ribonucleoprotein. We also show that Suv3p acts indirectly as a component of the degradosome to promote aI5 beta splicing. We present a model whereby defects in Suv3p result in accumulation of stable, excised group I intron ribonucleoproteins, which result in sequestration of Mrs1p, and a concomitant reduction in splicing of aI5 beta.	[Turk, Edward M.; Caprara, Mark G.] Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Turk, EM (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	emt11@case.edu			National Institutes of Health [F32GM078969, T32HD007104, GM-62853]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078969, R01GM062853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants F32GM078969 and T32HD007104 (to E. M. T.) and GM-62853 (to M. G. C.).	Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Ahn JS, 2003, J BIOL CHEM, V278, P29121, DOI 10.1074/jbc.M302314200; Amiott EA, 2006, MOL CELL, V22, P329, DOI 10.1016/j.molcel.2006.03.031; Bassi GS, 2003, BIOCHEMISTRY-US, V42, P9980, DOI 10.1021/bi0346906; Bassi GS, 2002, P NATL ACAD SCI USA, V99, P128, DOI 10.1073/pnas.012579299; Bifano AL, 2008, J MOL BIOL, V383, P667, DOI 10.1016/j.jmb.2008.08.070; BOUSQUET I, 1990, CURR GENET, V18, P117, DOI 10.1007/BF00312599; Brachmann CB, 1998, YEAST, V14, P115; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; CAPRARA MG, 2010, SKI2 LIKE D IN PRESS; Ceschini S, 2001, EMBO J, V20, P6601, DOI 10.1093/emboj/20.23.6601; Cliften PF, 2000, MOL CELL BIOL, V20, P7013, DOI 10.1128/MCB.20.18.7013-7023.2000; CONRADWEBB H, 1990, NUCLEIC ACIDS RES, V18, P1369, DOI 10.1093/nar/18.6.1369; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; DMOCHOWSKA A, 1995, CURR GENET, V28, P108, DOI 10.1007/BF00315775; Dmochowska A, 1999, ACTA BIOCHIM POL, V46, P155, DOI 10.18388/abp.1999_4193; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 1998, MOL GEN GENET, V260, P108, DOI 10.1007/s004380050876; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Golden BL, 2005, NAT STRUCT MOL BIOL, V12, P82, DOI 10.1038/nsmb868; GOLIK P, 1995, CURR GENET, V28, P217, DOI 10.1007/BF00309780; Hoffmann B, 2008, J MOL BIOL, V377, P1024, DOI 10.1016/j.jmb.2008.01.038; Hua SB, 1997, PLASMID, V38, P91, DOI 10.1006/plas.1997.1305; Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101; Kaspar BJ, 2008, NUCLEIC ACIDS RES, V36, P2958, DOI 10.1093/nar/gkn045; KREIKE J, 1986, CURR GENET, V11, P185, DOI 10.1007/BF00420605; KREIKE J, 1987, EMBO J, V6, P2123, DOI 10.1002/j.1460-2075.1987.tb02479.x; Labbe S, 1999, METHOD ENZYMOL, V306, P145; LAMBOWITZ AM, 1999, RNA WORLD, V2, P451; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Margossian SP, 1996, TRENDS BIOCHEM SCI, V21, P392, DOI 10.1016/S0968-0004(96)90129-2; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Mohr S, 2006, P NATL ACAD SCI USA, V103, P3569, DOI 10.1073/pnas.0600332103; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f; Rogowska AT, 2006, MOL BIOL CELL, V17, P1184, DOI 10.1091/mbc.E05-08-0796; Schafer B, 2005, GENE, V354, P80, DOI 10.1016/j.gene.2005.03.032; SERAPHIN B, 1988, EMBO J, V7, P1455, DOI 10.1002/j.1460-2075.1988.tb02963.x; SERAPHIN B, 1989, NATURE, V337, P84, DOI 10.1038/337084a0; Shadel GS, 2004, TRENDS GENET, V20, P513, DOI 10.1016/j.tig.2004.08.005; SHADEL GS, 1993, J BIOL CHEM, V268, P16083; Sigala B, 2003, EUR J BIOCHEM, V270, P2837, DOI 10.1046/j.1432-1033.2003.03661.x; STEPIEN PP, 1992, P NATL ACAD SCI USA, V89, P6813, DOI 10.1073/pnas.89.15.6813; VALENCIK ML, 1989, EMBO J, V8, P3899, DOI 10.1002/j.1460-2075.1989.tb08569.x; Wardleworth BN, 2000, J BIOL CHEM, V275, P23725, DOI 10.1074/jbc.M002612200; Wegierski T, 1998, ACTA BIOCHIM POL, V45, P935, DOI 10.18388/abp.1998_4352; Woodson SA, 2005, CURR OPIN STRUC BIOL, V15, P324, DOI 10.1016/j.sbi.2005.05.007; ZHU H, 1989, MOL CELL BIOL, V9, P1507, DOI 10.1128/MCB.9.4.1507	51	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8585	8594		10.1074/jbc.M109.090761	http://dx.doi.org/10.1074/jbc.M109.090761			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20064926	hybrid, Green Published			2022-12-27	WOS:000275553700010
J	Zhou, YB; Tzeng, WP; Wong, HC; Ye, YM; Jiang, J; Chen, YY; Huang, Y; Suppiah, S; Frey, TK; Yang, JJ				Zhou, Yubin; Tzeng, Wen-Pin; Wong, Hing-Cheung; Ye, Yiming; Jiang, Jie; Chen, Yanyi; Huang, Yun; Suppiah, Suganthi; Frey, Teryl K.; Yang, Jenny J.			Calcium-dependent Association of Calmodulin with the Rubella Virus Nonstructural Protease Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING DOMAIN; ENERGY-TRANSFER; CAPSID PROTEIN; CLEAVAGE SITE; INTACT-CELLS; HIV-1 GP160; TROPONIN-C; AFFINITY; REPLICATION; SEQUENCE	The rubella virus (RUBV) nonstructural (NS) protease domain, a Ca2+- and Zn2+-binding papain-like cysteine protease domain within the nonstructural replicase polyprotein precursor, is responsible for the self-cleavage of the precursor into two mature products, P150 and P90, that compose the replication complex that mediates viral RNA replication; the NS protease resides at the C terminus of P150. Here we report the Ca2+-dependent, stoichiometric association of calmodulin (CaM) with the RUBV NS protease. Co-immunoprecipitation and pull-down assays coupled with site-directed mutagenesis demonstrated that both the P150 protein and a 110-residue minidomain within NS protease interacted directly with Ca2+/CaM. The specific interaction was mapped to a putative CaM-binding domain. A 32-mer peptide (residues 1152-1183, denoted as RUBpep) containing the putative CaM-binding domain was used to investigate the association of RUBV NS protease with CaM or its N- and C-terminal subdomains. We found that RUBpep bound to Ca2+/CaM with a dissociation constant of 100-300 nM. The C-terminal subdomain of CaM preferentially bound to RUBpep with an affinity 12.5-fold stronger than the N-terminal subdomain. Fluorescence, circular dichroism and NMR spectroscopic studies revealed a "wrapping around" mode of interaction between RUBpep and Ca2+/CaM with substantially more helical structure in RUBpep and a global structural change in CaM upon complex formation. Using a site-directed mutagenesis approach, we further demonstrated that association of CaM with the CaM-binding domain in the RUBV NS protease was necessary for NS protease activity and infectivity.	[Tzeng, Wen-Pin; Suppiah, Suganthi; Frey, Teryl K.] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Wong, Hing-Cheung; Jiang, Jie; Chen, Yanyi; Huang, Yun; Yang, Jenny J.] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Ye, Yiming] Ctr Dis Control & Prevent, Prote Lab, Biotechnol Core Facil Branch, Atlanta, GA 30333 USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; Centers for Disease Control & Prevention - USA	Frey, TK (corresponding author), Georgia State Univ, Dept Biol, 50 Decatur St, Atlanta, GA 30303 USA.	tfrey@gsu.edu; chejjy@langate.gsu.edu	Zhou, Yubin/D-4748-2011; Chen, Yanyi/H-7096-2013	Zhou, Yubin/0000-0001-7962-0517; Chen, Yanyi/0000-0002-7755-0882; Huang, Yun/0000-0001-5950-9168	National Institutes of Health, NIAID [R01 AI21389]; National Institutes of Health [R01 GM62999, R01 GM081749]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062999, R01GM081749] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or part, by National Institutes of Health Grants R01 AI21389 from NIAID (to T. K. F. and J. J. Y.) and R01 GM62999 and R01 GM081749 (to J. J. Y.).	Balog EM, 2003, J BIOL CHEM, V278, P15615, DOI 10.1074/jbc.M209180200; Barth A, 1998, J BIOL CHEM, V273, P2174, DOI 10.1074/jbc.273.4.2174; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; BRITTAIN HG, 1976, J AM CHEM SOC, V98, P8255, DOI 10.1021/ja00441a060; BRUNO J, 1992, BIOCHEMISTRY-US, V31, P7016, DOI 10.1021/bi00146a002; Chami M, 2006, BBA-MOL CELL RES, V1763, P1344, DOI 10.1016/j.bbamcr.2006.09.025; Chen HH, 2006, ARCH VIROL, V151, P1841, DOI 10.1007/s00705-006-0744-9; Chen JP, 1996, J VIROL, V70, P4707, DOI 10.1128/JVI.70.7.4707-4713.1996; FREY TK, 1994, ADV VIRUS RES, V44, P69, DOI 10.1016/S0065-3527(08)60328-0; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; IKURA M, 1992, CELL CALCIUM, V13, P391, DOI 10.1016/0143-4160(92)90052-T; JOHNSON JD, 1983, BIOCHEM J, V211, P473, DOI 10.1042/bj2110473; LAPORTE DC, 1981, BIOCHEMISTRY-US, V20, P3965, DOI 10.1021/bi00517a004; Liang YY, 2001, VIROLOGY, V282, P307, DOI 10.1006/viro.2001.0862; LING KY, 1994, EUR J BIOCHEM, V222, P433, DOI 10.1111/j.1432-1033.1994.tb18882.x; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Liu X, 2000, J VIROL, V74, P5949, DOI 10.1128/JVI.74.13.5949-5956.2000; Matsubara M, 2005, PROTEIN SCI, V14, P494, DOI 10.1110/ps.04969605; Micoli KJ, 2006, VIROLOGY, V344, P468, DOI 10.1016/j.virol.2005.08.033; Micoli KJ, 2000, J BIOL CHEM, V275, P1233, DOI 10.1074/jbc.275.2.1233; Nelson MR, 1998, BIOMETALS, V11, P297, DOI 10.1023/A:1009253808876; Newman RA, 2008, PROTEINS, V71, P1792, DOI 10.1002/prot.21861; Pellecchia M, 1999, NAT STRUCT BIOL, V6, P336; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; Pugachev KV, 1997, J VIROL, V71, P562, DOI 10.1128/JVI.71.1.562-568.1997; Radding W, 2000, AIDS RES HUM RETROV, V16, P1519, DOI 10.1089/088922200750006047; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Ruiz MC, 2000, CELL CALCIUM, V28, P137, DOI 10.1054/ceca.2000.0142; Scheschonka A, 2008, J BIOL CHEM, V283, P5577, DOI 10.1074/jbc.M709505200; SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304; Sham SWS, 2008, AIDS RES HUM RETROV, V24, P607, DOI 10.1089/aid.2007.0202; SRINIVAS SK, 1993, J BIOL CHEM, V268, P22895; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Tzeng WP, 2006, J VIROL, V80, P3966, DOI 10.1128/JVI.80.8.3966-3974.2006; Tzeng WP, 2003, J VIROL, V77, P9502, DOI 10.1128/JVI.77.17.9502-9510.2003; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; WALLACE RW, 1982, J BIOL CHEM, V257, P1845; WANG CLA, 1982, J BIOL CHEM, V257, P8372; WANG CLA, 1981, BIOCHEMISTRY-US, V20, P2439, DOI 10.1021/bi00512a012; WANG CLA, 1982, EUR J BIOCHEM, V124, P7, DOI 10.1111/j.1432-1033.1982.tb05900.x; WANG CLA, 1984, BIOCHEMISTRY-US, V23, P6410, DOI 10.1021/bi00321a020; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Ye YM, 2005, J AM CHEM SOC, V127, P3743, DOI 10.1021/ja042786x; YUAN T, 1995, BIOCHEMISTRY-US, V34, P10690, DOI 10.1021/bi00033a045; Yuan T, 2001, BIOPOLYMERS, V58, P50, DOI 10.1002/1097-0282(200101)58:1<50::AID-BIP60>3.0.CO;2-S; ZHONG LX, 1992, P NATL ACAD SCI USA, V89, P4462, DOI 10.1073/pnas.89.10.4462; Zhou YB, 2007, J BIOL CHEM, V282, P35005, DOI 10.1074/jbc.M707728200; Zhou YB, 2007, J VIROL, V81, P7517, DOI 10.1128/JVI.00605-07; Zhou YB, 2009, BIOCHEM J, V417, P477, DOI 10.1042/BJ20081468	54	7	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8855	8868		10.1074/jbc.M109.097063	http://dx.doi.org/10.1074/jbc.M109.097063			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086014	Green Published, hybrid			2022-12-27	WOS:000275553700037
J	Fourquet, S; Guerois, R; Biard, D; Toledano, MB				Fourquet, Simon; Guerois, Raphael; Biard, Denis; Toledano, Michel B.			Activation of NRF2 by Nitrosative Agents and H2O2 Involves KEAP1 Disulfide Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; TRANSCRIPTION FACTOR NRF2; UBIQUITIN LIGASE COMPLEX; CUL3-BASED E3 LIGASE; OXIDATIVE STRESS; PROTEASOMAL DEGRADATION; CYSTEINE RESIDUES; ADAPTIVE RESPONSE; PHASE-2 RESPONSE; GENE-EXPRESSION	The NRF2 transcription factor regulates a major environmental and oxidative stress response. NRF2 is itself negatively regulated by KEAP1, the adaptor of a Cul3-ubiquitin ligase complex that marks NRF2 for proteasomal degradation by ubiquitination. Electrophilic compounds activate NRF2 primarily by inhibiting KEAP1-dependent NRF2 degradation, through alkylation of specific cysteines. We have examined the impact on KEAP1 of reactive oxygen and nitrogen species, which are also NRF2 inducers. We found that in untreated cells, a fraction of KEAP1 carried a long range disulfide linking Cys(226) and Cys(613). Exposing cells to hydrogen peroxide, to the nitric oxide donor spermine NONOate, to hypochlorous acid, or to S-nitrosocysteine further increased this disulfide and promoted formation of a disulfide linking two KEAP1 molecules via Cys(151). None of these oxidants, except S-nitrocysteine, caused KEAP1 S-nitrosylation. A cysteine mutant preventing KEAP1 intermolecular disulfide formation also prevented NRF2 stabilization in response to oxidants, whereas those preventing intramolecular disulfide formation were functionally silent. Further, simultaneously inactivating the thioredoxin and glutathione pathways led both to major constitutive KEAP1 oxidation and NRF2 stabilization. We propose that KEAP1 intermolecular disulfide formation via Cys(151) underlies the activation of NRF2 by reactive oxygen and nitrogen species.	[Toledano, Michel B.] CEA Saclay, LSOC, IBITECS, F-91191 Gif Sur Yvette, France; [Guerois, Raphael] CEA Saclay, CNRS, IBITECS, URA 2096, F-91191 Gif Sur Yvette, France; [Guerois, Raphael] CEA Saclay, SB2MS, IBITECS, F-91191 Gif Sur Yvette, France; [Biard, Denis] CNRS, CEA, DSV, iRCM,INSERM,Inst A Lwoff,U935, F-94801 Villejuif, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Toledano, MB (corresponding author), CEA Saclay, LSOC, IBITECS, Bat 142, F-91191 Gif Sur Yvette, France.	michel.toledano@cea.fr	, raph/AAF-4380-2019	BIARD, Denis Serge Francois/0000-0001-9697-4392	ARC; ANR; Region Ile-de-France; Programme Toxicologie Nucleaire fellowship	ARC(Australian Research Council); ANR(French National Research Agency (ANR)); Region Ile-de-France(Region Ile-de-France); Programme Toxicologie Nucleaire fellowship	This work was supported by funds from ARC, ANR, and Region Ile-de-France DIM SEnT (to M. B. T.) and by a Programme Toxicologie Nucleaire fellowship (to S. F.).	Ashino T, 2008, MOL IMMUNOL, V45, P2106, DOI 10.1016/j.molimm.2007.10.011; Biard DSF, 2005, MOL CANCER RES, V3, P519, DOI 10.1158/1541-7786.MCR-05-0044; Buckley BJ, 2008, FREE RADICAL BIO MED, V44, P692, DOI 10.1016/j.freeradbiomed.2007.10.055; Buckley BJ, 2003, BIOCHEM BIOPH RES CO, V307, P973, DOI 10.1016/S0006-291X(03)01308-1; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dhakshinamoorthy S, 2004, J BIOL CHEM, V279, P20096, DOI 10.1074/jbc.M312492200; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Dinkova-Kostova AT, 2005, BIOCHEMISTRY-US, V44, P6889, DOI 10.1021/bi047434h; Dinkova-Kostova AT, 2005, CHEM RES TOXICOL, V18, P1779, DOI 10.1021/tx050217c; Eggler AL, 2009, BIOCHEM J, V422, P171, DOI 10.1042/BJ20090471; Eggler AL, 2005, P NATL ACAD SCI USA, V102, P10070, DOI 10.1073/pnas.0502402102; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Holland R, 2008, CHEM RES TOXICOL, V21, P2051, DOI 10.1021/tx800226m; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Ito N, 2009, GENES CELLS, V14, P167, DOI 10.1111/j.1365-2443.2008.01259.x; Itoh K, 2004, MOL CELL BIOL, V24, P36, DOI 10.1128/MCB.24.1.36-45.2004; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Itoh K, 2003, GENES CELLS, V8, P379, DOI 10.1046/j.1365-2443.2003.00640.x; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kobayashi M, 2009, MOL CELL BIOL, V29, P493, DOI 10.1128/MCB.01080-08; Levonen AL, 2004, BIOCHEM J, V378, P373, DOI 10.1042/BJ20031049; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Nguyen T, 2003, J BIOL CHEM, V278, P4536, DOI 10.1074/jbc.M207293200; Oh JY, 2008, BIOCHEM J, V411, P297, DOI [10.1042/BJ20071189, 10.1042/bj20071189]; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Rachakonda G, 2008, CHEM RES TOXICOL, V21, P705, DOI 10.1021/tx700302s; Sakurai T, 2006, CHEM RES TOXICOL, V19, P1196, DOI 10.1021/tx0601105; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Satoh T, 2008, J NEUROCHEM, V104, P1116, DOI 10.1111/j.1471-4159.2007.05039.x; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Schubot FD, 2006, BIOCHEM BIOPH RES CO, V351, P1, DOI 10.1016/j.bbrc.2006.09.167; Sekhar KR, 2010, TOXICOL APPL PHARM, V244, P21, DOI 10.1016/j.taap.2009.06.016; Stamler JS, 2002, CURR OPIN CHEM BIOL, V6, P779, DOI 10.1016/S1367-5931(02)00383-6; Stewart D, 2003, J BIOL CHEM, V278, P2396, DOI 10.1074/jbc.M209195200; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Vert JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-520; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wilson LA, 2005, FASEB J, V19, P2085, DOI 10.1096/fj.05-4401fje; Yamamoto T, 2008, MOL CELL BIOL, V28, P2758, DOI 10.1128/MCB.01704-07; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhu LX, 2008, AM J PHYSIOL-LUNG C, V294, pL469, DOI 10.1152/ajplung.00310.2007; Zipper LM, 2002, J BIOL CHEM, V277, P36544, DOI 10.1074/jbc.M206530200	51	268	279	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8463	8471		10.1074/jbc.M109.051714	http://dx.doi.org/10.1074/jbc.M109.051714			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061377	hybrid, Green Published			2022-12-27	WOS:000275413800061
J	Hsu, SC; Chen, CH; Tsai, SH; Kawasaki, H; Hung, CH; Chu, YT; Chang, HW; Zhou, YF; Fu, JR; Plunkett, B; Su, SN; Vieths, S; Lee, RT; Lee, YC; Huang, SK				Hsu, Shih-Chang; Chen, Chien-Ho; Tsai, Shih-Han; Kawasaki, Hirokazu; Hung, Chih-Hsing; Chu, Yu-Te; Chang, Hui-Wen; Zhou, Yufeng; Fu, Jinrong; Plunkett, Beverly; Su, Song-Nan; Vieths, Stefan; Lee, Reiko T.; Lee, Yuan C.; Huang, Shau-Ku			Functional Interaction of Common Allergens and a C-type Lectin Receptor, Dendritic Cell-specific ICAM3-grabbing Non-integrin (DC-SIGN), on Human Dendritic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; OLIGOSACCHARIDES; RECOGNITION; GLYCOPROTEIN; PROTEINS; PATHWAY; DER-P-1; INNATE; LIGAND; ROLES	Fucosylated glycans on pathogens are known to shape the immune response through their interaction with pattern recognition receptors, such as C-type lectin receptors (CLRs), on dendritic cells (DCs). Similar fucosylated structures are also commonly found in a variety of allergens, but their functional significance remains unclear. To test a hypothesis that allergen-associated glycans serve as the molecular patterns in functional interaction with CLRs, an enzyme-linked immunosorbent assay-based binding assay was performed to determine the binding activity of purified allergens and allergen extracts. THP-1 cells and monocyte-derived DCs (MDDCs) were investigated as a model for testing the functional effects of allergen-CLR interaction using enzyme-linked immunosorbent assay, Western blotting, and flow cytometry. Significant and saturable bindings of allergens and allergen extracts with variable binding activities to DC- specific ICAM3-grabbing non-integrin (DCSIGN) and its related receptor, L-SIGN, were found. These include bovine serum albumin coupled with a common glycoform (fucosylated glycan lacking the alpha 1,3-linked mannose) of allergens and a panel of purified allergens, including BG60 (Cyn dBG-60; Bermuda grass pollen) and Der p2 (house dust mite). The binding activity was calcium-dependent and inhibitable by fucose and Lewis-x trisaccharides (Lex). In THP-1 cells and human MDDCs, BG60-DC-SIGN interaction led to the activation of Raf-1 and ERK kinases and the induction of tumor necrosis factor-alpha expression. This effect could be blocked, in part, by Raf-1 inhibitor or anti-DC-SIGN antibodies and was significantly reduced in cells with DC-SIGN knockdown. These results suggest that allergens are able to interact with DC- SIGN and induce tumor necrosis factor-alpha expression in MDDCs via, in part, Raf-1 signaling pathways.	[Hsu, Shih-Chang; Kawasaki, Hirokazu; Zhou, Yufeng; Fu, Jinrong; Plunkett, Beverly; Huang, Shau-Ku] Johns Hopkins Asthma & Allergy Ctr, Baltimore, MD 21224 USA; [Chen, Chien-Ho; Tsai, Shih-Han] Taipei Med Univ, Dept Med Technol, Taipei 110, Taiwan; [Hung, Chih-Hsing] Kaohsiung Med Univ, Dept Pediat, Kaohsiung 807, Taiwan; [Hung, Chih-Hsing; Huang, Shau-Ku] Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung 807, Taiwan; [Huang, Shau-Ku] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung 807, Taiwan; [Hung, Chih-Hsing; Chu, Yu-Te; Chang, Hui-Wen] Kaohsiung Med Univ Hosp, Dept Pediat, Kaohsiung 807, Taiwan; [Su, Song-Nan] Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Vieths, Stefan] Paul Ehrlich Inst, Dept Allergol, D-63225 Langen, Germany; [Lee, Reiko T.; Lee, Yuan C.] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine; Taipei Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Paul Ehrlich Institute; Johns Hopkins University	Huang, SK (corresponding author), Johns Hopkins Asthma & Allergy Ctr, 5501 Hopkins Bayview Circle, Baltimore, MD 21224 USA.	skhuang@jhmi.edu	zhou, yufeng/G-6429-2010; Hsu, Shih-Chang/I-4277-2012; Huang, Shau-Ku/F-5509-2010	Hsu, Shih-Chang/0000-0003-1010-1182; zhou, Yufeng/0000-0002-6050-4951	National Institutes of Health [AI052468, AI073610]; Center of Excellence For Environmental Medicine, Kaohsiung Medical University [KMU-EM-98-4.1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073610, R01AI052468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Excellence For Environmental Medicine, Kaohsiung Medical University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI052468 and AI073610. This work was also supported by Center of Excellence For Environmental Medicine, Kaohsiung Medical University Grant KMU-EM-98-4.1.	Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Cambi A, 2005, CURR OPIN IMMUNOL, V17, P345, DOI 10.1016/j.coi.2005.05.011; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Foster B, 2003, J ALLERGY CLIN IMMUN, V112, P1132, DOI 10.1016/j.jaci.2003.09.011; Fotisch K, 2001, GLYCOCONJUGATE J, V18, P373, DOI 10.1023/A:1014860030380; Furmonaviciene R, 2007, CLIN EXP ALLERGY, V37, P231, DOI 10.1111/j.1365-2222.2007.02651.x; Geijtenbeek TBH, 2004, ANNU REV IMMUNOL, V22, P33, DOI 10.1146/annurev.immunol.22.012703.104558; Gringhuis SI, 2007, IMMUNITY, V26, P605, DOI 10.1016/j.immuni.2007.03.012; Gringhuis SI, 2009, NAT IMMUNOL, V10, P1081, DOI 10.1038/ni.1778; Hsu SC, 2007, J ALLERGY CLIN IMMUN, V119, P1522, DOI 10.1016/j.jaci.2007.01.034; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Kawaguchi M, 2007, J ALLERGY CLIN IMMUN, V119, P1408, DOI 10.1016/j.jaci.2007.02.036; Kawasaki N, 1997, ANAL BIOCHEM, V250, P260, DOI 10.1006/abio.1997.2233; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Lauer I, 2004, BIOCHEM J, V383, P327, DOI 10.1042/BJ20041062; LEE YC, 1976, BIOCHEMISTRY-US, V15, P3956, DOI 10.1021/bi00663a008; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; McGreal EP, 2005, CURR OPIN IMMUNOL, V17, P18, DOI 10.1016/j.coi.2004.12.001; Ohsuga H, 1996, J BIOL CHEM, V271, P26653, DOI 10.1074/jbc.271.43.26653; Okano M, 2004, CLIN EXP ALLERGY, V34, P770, DOI 10.1111/j.1365-2222.2004.1948.x; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; van Kooyk Y, 2008, NAT IMMUNOL, V9, P593, DOI 10.1038/ni.f.203; van Liempt E, 2006, FEBS LETT, V580, P6123, DOI 10.1016/j.febslet.2006.10.009; van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451; Wicklein D, 2004, BIOL CHEM, V385, P397, DOI 10.1515/BC.2004.044	30	71	76	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7903	7910		10.1074/jbc.M109.058370	http://dx.doi.org/10.1074/jbc.M109.058370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080962	hybrid, Green Published			2022-12-27	WOS:000275413800007
J	Jiang, XL; Yu, Y; Yang, HW; Agar, NYR; Frado, L; Johnson, MD				Jiang, Xiuli; Yu, Yi; Yang, Hong Wei; Agar, Nathalie Y. R.; Frado, Laura; Johnson, Mark D.			The Imprinted Gene PEG3 Inhibits Wnt Signaling and Regulates Glioma Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER GENE; WNT/BETA-CATENIN PATHWAY; BETA-CATENIN; APOPTOSIS; P53; PHOSPHORYLATION; IDENTIFICATION; EXPRESSION; MEDIATOR; BEHAVIOR	The imprinted gene PEG3 confers parenting and sexual behaviors, alters growth and development, and regulates apoptosis. However, a molecular mechanism that can account for the diverse functions of Peg3/Pw1 is not known. To elucidate Peg3-regulated pathways, we performed a functional screen in zebrafish. Enforced overexpression of PEG3 mRNA during zebrafish embryogenesis decreased beta-catenin protein expression and inhibited Wnt-dependent tail development. Peg3/Pw1 also inhibited Wnt signaling in human cells by binding to beta-catenin and promoting its degradation via a p53/Siah1-dependent, GSK3 beta-independent proteasomal pathway. The inhibition of the Wnt pathway by Peg3/Pw1 suggested a role in tumor suppression. Hypermethylation of the PEG3 promoter in primary human gliomas led to a loss of imprinting and decreased PEG3 mRNA expression that correlated with tumor grade. The decrease in Peg3/Pw1 protein expression increased beta-catenin, promoted proliferation, and inhibited p53-dependent apoptosis in human CD133(+) glioma stem cells. Thus, mammalian imprinting utilizes Peg3/Pw1 to co-opt the Wnt pathway, thereby regulating development and glioma growth.	[Johnson, Mark D.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Johnson, MD (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02215 USA.	mjohnson27@partners.org			National Institutes of Health [K08 NS43482, 1DP2OD002319-01]; American Brain Tumor Association; Sontag Distinguished Scientist award; Hagerty Fund research award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS043482, R01NS062219] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Brain Tumor Association; Sontag Distinguished Scientist award; Hagerty Fund research award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant K08 NS43482 and National Institutes of Health Director's New Innovator Award 1DP2OD002319-01 (to M. D. J.). This work was also supported by an American Brain Tumor Association fellowship (to X. J.), a Sontag Distinguished Scientist award, and a Hagerty Fund research award (to M. D. J.).	Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Coletti D, 2002, EMBO J, V21, P631, DOI 10.1093/emboj/21.4.631; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Deng YB, 2000, P NATL ACAD SCI USA, V97, P12050, DOI 10.1073/pnas.97.22.12050; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Edelstein LC, 2005, GENE, V359, P1, DOI 10.1016/j.gene.2005.06.022; Huang ML, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-221; Johnson MD, 2004, J BIOL CHEM, V279, P26685, DOI 10.1074/jbc.M401274200; Johnson MD, 2002, J BIOL CHEM, V277, P23000, DOI 10.1074/jbc.M201907200; Kapsimali M, 2004, DEVELOPMENT, V131, P5923, DOI 10.1242/dev.01453; Kim J, 2000, GENOMICS, V64, P114, DOI 10.1006/geno.1999.6112; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kohda T, 2001, GENES CELLS, V6, P237, DOI 10.1046/j.1365-2443.2001.00412.x; Ledgerwood EC, 2000, LAB INVEST, V80, P1509, DOI 10.1038/labinvest.3780160; Li HL, 2007, P NATL ACAD SCI USA, V104, P3591, DOI 10.1073/pnas.0609303104; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Maegawa S, 2001, MOL CARCINOGEN, V31, P1, DOI 10.1002/mc.1034; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nicolas N, 2005, DEV BIOL, V281, P171, DOI 10.1016/j.ydbio.2005.02.022; Okamoto K, 1997, P NATL ACAD SCI USA, V94, P5367, DOI 10.1073/pnas.94.10.5367; Pantoja C, 2005, CANCER RES, V65, P26; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Relaix F, 1998, NAT GENET, V18, P287, DOI 10.1038/ng0398-287; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Sadot E, 2002, J CELL SCI, V115, P2771; Santelli E, 2005, J BIOL CHEM, V280, P34278, DOI 10.1074/jbc.M506707200; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Swaney WT, 2008, BEHAV NEUROSCI, V122, P963, DOI 10.1037/a0012706; Swaney WT, 2007, P NATL ACAD SCI USA, V104, P6084, DOI 10.1073/pnas.0609471104; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Wang ZH, 2003, CANCER RES, V63, P5234; Yamaguchi A, 2002, J BIOL CHEM, V277, P623, DOI 10.1074/jbc.M107435200; Yu Y, 2007, CANCER RES, V67, P130, DOI 10.1158/0008-5472.CAN-06-2478; Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208	37	93	97	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8472	8480		10.1074/jbc.M109.069450	http://dx.doi.org/10.1074/jbc.M109.069450			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064927	Green Published, hybrid			2022-12-27	WOS:000275413800062
J	Price, NT; Jackson, VN; Muller, J; Moffat, K; Matthews, KL; Orton, T; Zammit, VA				Price, Nigel T.; Jackson, Vicky N.; Mueller, Juerger; Moffat, Kevin; Matthews, Karen L.; Orton, Tim; Zammit, Victor A.			Alternative Exon Usage in the Single CPT1 Gene of Drosophila Generates Functional Diversity in the Kinetic Properties of the Enzyme DIFFERENTIAL EXPRESSION OF ALTERNATIVELY SPLICED VARIANTS IN DROSOPHILA TISSUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARNITINE PALMITOYLTRANSFERASE-I; MALONYL-COA SENSITIVITY; CRYSTAL-STRUCTURE; RAT-LIVER; STRUCTURAL MODEL; SUBSTRATE SELECTIVITY; MUSCLE ISOFORMS; ACETYLTRANSFERASE; OCTANOYLTRANSFERASE; IDENTIFICATION	The Drosophila melanogaster genome contains only one CPT1 gene (Jackson, V. N., Cameron, J. M., Zammit, V. A., and Price, N. T. (1999) Biochem. J. 341, 483-489). We have now extended our original observation to all insect genomes that have been sequenced, suggesting that a single CPT1 gene is a universal feature of insect genomes. We hypothesized that insects may be able to generate kinetically distinct variants by alternative splicing of their single CPT1 gene. Analysis of the insect genomes revealed that (a) the single CPT1 gene in each and every insect genome contains two alternative exons and (ii) in all cases, the putative alternative splicing site occurs within a small region corresponding to 21 amino acid residues that are known to be essential for the binding of substrates and of malonyl-CoA in mammalian CPT1A. We performed PCR analyses of mRNA from different Drosophila tissues; both of the anticipated splice variants of CPT1 mRNA were found to be expressed in all of the tissues tested (both in larvae and adults), with the expression level for one of the splice variants being significantly different between flight muscle and the fat body of adult Drosophila. Heterologous expression of the full-length cDNAs corresponding to the two putative variants of Drosophila CPT1 in the yeast Pichia pastoris revealed two important differences between the properties of the two variants: (i) their affinity (K-0.5) for one of the substrates, palmitoyl-CoA, differed by 5-fold, and (ii) the sensitivity to inhibition by malonyl-CoA at fixed, higher palmitoyl-CoA concentrations was 2-fold different and associated with different kinetics of inhibition. These data indicate that alternative splicing that specifically affects a structurally crucial region of the protein is an important mechanism through which functional diversity of CPT1 kinetics is generated from the single gene that occurs in insects.	[Price, Nigel T.; Jackson, Vicky N.; Mueller, Juerger; Matthews, Karen L.; Orton, Tim; Zammit, Victor A.] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Moffat, Kevin] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick	Zammit, VA (corresponding author), Univ Warwick, Warwick Med Sch, Gibbett Hill Rd, Coventry CV4 7AL, W Midlands, England.	v.a.zammit@warwick.ac.uk		Muller, Jurgen/0000-0002-5487-0736	British Heart Foundation	British Heart Foundation(British Heart Foundation)	This work was supported by the British Heart Foundation.	Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Buglino J, 2004, J BIOL CHEM, V279, P30634, DOI 10.1074/jbc.M404011200; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Candy DJ, 1997, COMP BIOCHEM PHYS B, V117, P497, DOI 10.1016/S0305-0491(97)00212-5; Celniker SE, 2002, GENOME BIOL, V3, DOI DOI 10.1186/GB-2002-3-12-RESEARCH0079; Gobin S, 2002, HUM GENET, V111, P179, DOI 10.1007/s00439-002-0752-0; Hsiao YS, 2004, J BIOL CHEM, V279, P31584, DOI 10.1074/jbc.M403484200; Hsiao YS, 2006, J BIOL CHEM, V281, P28480, DOI 10.1074/jbc.M602622200; Hsiao YS, 2006, BIOCHEM BIOPH RES CO, V346, P974, DOI 10.1016/j.bbrc.2006.06.006; Jackson VN, 2000, J BIOL CHEM, V275, P38410, DOI 10.1074/jbc.M007722200; Jackson VN, 1999, BIOCHEM J, V341, P483, DOI 10.1042/0264-6021:3410483; Jackson VN, 2000, J BIOL CHEM, V275, P19560, DOI 10.1074/jbc.M002177200; Jackson VN, 2001, BIOCHEMISTRY-US, V40, P14629, DOI 10.1021/bi011632g; Jogl G, 2004, ANN NY ACAD SCI, V1033, P17, DOI 10.1196/annals.1320.002; Jogl G, 2005, J BIOL CHEM, V280, P738, DOI 10.1074/jbc.M409894200; Jogl G, 2003, CELL, V112, P113, DOI 10.1016/S0092-8674(02)01228-X; Knudsen J, 2000, J NUTR, V130, p294S, DOI 10.1093/jn/130.2.294S; Lawson D, 2007, NUCLEIC ACIDS RES, V35, pD503, DOI 10.1093/nar/gkl960; Lopez-Vinas E, 2007, J BIOL CHEM, V282, P18212, DOI 10.1074/jbc.M700885200; Morillas M, 2004, BIOCHEM J, V379, P777, DOI 10.1042/BJ20031373; Morillas M, 2003, J BIOL CHEM, V278, P9058, DOI 10.1074/jbc.M209999200; Morillas M, 2002, J BIOL CHEM, V277, P11473, DOI 10.1074/jbc.M111628200; Morillas M, 2000, FEBS LETT, V466, P183, DOI 10.1016/S0014-5793(99)01788-3; Morillas M, 2001, J BIOL CHEM, V276, P45001, DOI 10.1074/jbc.M106920200; PANDE SV, 1989, BIOCHEM CELL BIOL, V67, P671, DOI 10.1139/o89-100; Park EA, 1998, BIOCHEM J, V330, P217; Price NT, 2003, BIOCHEM J, V372, P871, DOI 10.1042/BJ20030086; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; van der Leij FR, 2000, MOL GENET METAB, V71, P139, DOI 10.1006/mgme.2000.3055; van der Leij FR, 2002, J BIOL CHEM, V277, P26994, DOI 10.1074/jbc.M203189200; Wang DC, 1998, GENOMICS, V48, P314, DOI 10.1006/geno.1997.5184; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Yamazaki N, 1997, FEBS LETT, V409, P401, DOI 10.1016/S0014-5793(97)00561-9; Yu GS, 1998, J BIOL CHEM, V273, P32901, DOI 10.1074/jbc.273.49.32901; Zammit VA, 1999, BIOCHEM J, V343, P505, DOI 10.1042/0264-6021:3430505; Zammit VA, 2001, BIOCHEM SOC T, V29, P287, DOI 10.1042/BST0290287	40	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7857	7865		10.1074/jbc.M109.072892	http://dx.doi.org/10.1074/jbc.M109.072892			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061394	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000275413800003
J	Antipova, O; Orgel, JPRO				Antipova, Olga; Orgel, Joseph P. R. O.			In Situ D-periodic Molecular Structure of Type II Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING; CONFORMATIONAL-ANALYSIS; EXTRACELLULAR-MATRIX; DIFFRACTION PATTERN; FIBRIL STRUCTURE; C-TELOPEPTIDES; SEQUENCE DATA; CARTILAGE; SPECTROSCOPY; LAMPREY	Collagens are essential components of extracellular matrices in multicellular animals. Fibrillar type II collagen is the most prominent component of articular cartilage and other cartilage-like tissues such as notochord. Its in situ macromolecular and packing structures have not been fully characterized, but an understanding of these attributes may help reveal mechanisms of tissue assembly and degradation (as in osteo- and rheumatoid arthritis). In some tissues such as lamprey notochord, the collagen fibrillar organization is naturally crystalline and may be studied by x-ray diffraction. We used diffraction data from native and derivative notochord tissue samples to solve the axial, D-periodic structure of type II collagen via multiple isomorphous replacement. The electron density maps and heavy atom data revealed the conformation of the nonhelical telopeptides and the overall D-periodic structure of collagen type II in native tissues, data that were further supported by structure prediction and transmission electron microscopy. These results help to explain the observed differences in collagen type I and type II fibrillar architecture and indicate the collagen type II cross-link organization, which is crucial for fibrillogenesis. Transmission electron microscopy data show the close relationship between lamprey and mammalian collagen fibrils, even though the respective larger scale tissue architecture differs.	[Antipova, Olga] IIT, BioCAT, Chicago, IL 60616 USA; IIT, Ctr Mol Study Condensed Soft Matter CoSM Ctr, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA; IIT, CSRRI, Chicago, IL 60616 USA; IIT, Dept Biol Chem & Phys Sci, Chicago, IL 60616 USA	Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology; Illinois Institute of Technology	Antipova, O (corresponding author), IIT, BioCAT, Chicago, IL 60616 USA.	antiolg@iit.edu; orgel@iit.edu			National Science Foundation [MCB-0644015]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630, P41RR007707] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was also supported by the National Science Foundation (Grant MCB-0644015 CAREER).	Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; Barrea RA, 2009, J SYNCHROTRON RADIAT, V16, P76, DOI 10.1107/S0909049508039782; Bos KJ, 2001, J MOL BIOL, V306, P1011, DOI 10.1006/jmbi.2000.4429; BRADSHAW JP, 1989, J MOL BIOL, V205, P685, DOI 10.1016/0022-2836(89)90314-8; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; BRODSKY B, 1994, J MOL BIOL, V243, P38, DOI 10.1006/jmbi.1994.1628; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Christopher NA, 1996, COMPUT CHEM, V20, P339, DOI 10.1016/0097-8485(95)00075-5; EIKENBERRY EF, 1984, J MOL BIOL, V176, P261, DOI 10.1016/0022-2836(84)90424-8; EYRE DR, 1984, ANNU REV BIOCHEM, V53, P717, DOI 10.1146/annurev.bi.53.070184.003441; Fischetti R, 2004, J SYNCHROTRON RADIAT, V11, P399, DOI 10.1107/S0909049504016760; Garnero P, 2009, BONE, V44, P461, DOI 10.1016/j.bone.2008.11.006; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gineyts E, 2000, BIOCHEM J, V345, P481, DOI 10.1042/0264-6021:3450481; HELSETH DL, 1981, J BIOL CHEM, V256, P7118; Holmes DF, 2006, P NATL ACAD SCI USA, V103, P17249, DOI 10.1073/pnas.0608417103; HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7; HULMES DJS, 1977, J MOL BIOL, V110, P643, DOI 10.1016/S0022-2836(77)80082-X; KADLER K, 1995, PROTEIN PROFILE, V2, P491; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; KADLER KE, 1987, J BIOL CHEM, V262, P15696; LIU XH, 1993, J BIOMOL STRUCT DYN, V11, P541, DOI 10.1080/07391102.1993.10508014; MARTIN GR, 1961, BIOCHIM BIOPHYS ACTA, V53, P599, DOI 10.1016/0006-3002(61)90227-X; MEEK KM, 1979, J BIOL CHEM, V254, P710; MOW VC, 1997, STRUCTURE FUNCTION A, P113; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JPRO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007028; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; Ortolani F, 2000, BIOPOLYMERS, V54, P448; Ortolani F., 1993, Bollettino Societa Italiana Biologia Sperimentale, V69, P107; OTTER A, 1993, BIOPOLYMERS, V33, P1443, DOI 10.1002/bip.360330914; OTTER A, 1988, BIOCHEMISTRY-US, V27, P3560, DOI 10.1021/bi00410a006; Park H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-599; PASTEELS J, 1958, TRAITE ZOOL, V13, P106; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; PETRUSKA JA, 1964, P NATL ACAD SCI USA, V51, P871, DOI 10.1073/pnas.51.5.871; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Phillips WC, 2002, J SYNCHROTRON RADIAT, V9, P36; Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4; PIEZ KA, 1961, BIOCHIM BIOPHYS ACTA, V53, P596, DOI 10.1016/0006-3002(61)90226-8; Prockop D.J., 1976, BIOCH COLLAGENS, P163; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Rajkumar G, 2007, J APPL CRYSTALLOGR, V40, P178, DOI 10.1107/S0021889806048643; ROBINS SP, 1983, BIOCHEM J, V215, P175, DOI 10.1042/bj2150175; Schmitt FO, 1942, J CELL COMPAR PHYSL, V20, P11, DOI 10.1002/jcp.1030200103; SCOTT JE, 1988, BIOCHEM J, V253, P607, DOI 10.1042/bj2530607; SCOTT JE, 1993, DERMATAN SULPHATE PR, P165; Scott John E., 1993, Biochemical Society Transactions, V21, p123S; SCOTT PG, 1986, BIOCHEM BIOPH RES CO, V138, P1348, DOI 10.1016/S0006-291X(86)80431-4; Shintani S, 2000, J MOL EVOL, V51, P363, DOI 10.1007/s002390010098; Weast R.C., HDB CHEM PHYS; WESS TJ, 1995, J MOL BIOL, V248, P487, DOI 10.1006/jmbi.1995.0236; Yu EW, 2001, P NATL ACAD SCI USA, V98, P9517, DOI 10.1073/pnas.161239298; Zhang GJ, 2006, P NATL ACAD SCI USA, V103, P3180, DOI 10.1073/pnas.0508313103	55	46	47	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7087	7096		10.1074/jbc.M109.060400	http://dx.doi.org/10.1074/jbc.M109.060400			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056598	Green Published, hybrid			2022-12-27	WOS:000275415600022
J	Cordoba-Canero, D; Dubois, E; Ariza, RR; Doutriaux, MP; Roldan-Arjona, T				Cordoba-Canero, Dolores; Dubois, Emeline; Ariza, Rafael R.; Doutriaux, Marie-Pascale; Roldan-Arjona, Teresa			Arabidopsis Uracil DNA Glycosylase (UNG) Is Required for Base Excision Repair of Uracil and Increases Plant Sensitivity to 5-Fluorouracil	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTIAL-PURIFICATION; ESCHERICHIA-COLI; DEAMINATED CYTOSINE; ABASIC SITES; DAMAGE; CONSEQUENCES; NUCLEAR; CELLS; SMUG1; PATCH	Uracil in DNA arises by misincorporation of dUMP during replication and by hydrolytic deamination of cytosine. This common lesion is actively removed through a base excision repair (BER) pathway initiated by a uracil DNA glycosylase (UDG) activity that excises the damage as a free base. UDGs are classified into different families differentially distributed across eubacteria, archaea, yeast, and animals, but remain to be unambiguously identified in plants. We report here the molecular characterization of AtUNG (Arabidopsis thaliana uracil DNA glycosylase), a plant member of the Family-1 of UDGs typified by Escherichia coli Ung. AtUNG exhibits the narrow substrate specificity and single-stranded DNA preference that are characteristic of Ung homologues. Cell extracts from atung(-/-) mutants are devoid of UDG activity, and lack the capacity to initiate BER on uracil residues. AtUNG-deficient plants do not display any apparent phenotype, but show increased resistance to 5-fluorouracil (5-FU), a cytostatic drug that favors dUMP misincorporation into DNA. The resistance of atung(-/-) mutants to 5-FU is accompanied by the accumulation of uracil residues in DNA. These results suggest that AtUNG excises uracil in vivo but generates toxic AP sites when processing abundant U: A pairs in dTTP-depleted cells. Altogether, our findings point to AtUNG as the major UDG activity in Arabidopsis.	[Cordoba-Canero, Dolores; Ariza, Rafael R.; Roldan-Arjona, Teresa] Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain; [Cordoba-Canero, Dolores; Ariza, Rafael R.; Roldan-Arjona, Teresa] Maimonides Inst Biomed Res IMIBIC, Cordoba 14071, Spain; [Dubois, Emeline; Doutriaux, Marie-Pascale] Univ Paris 11, Inst Biotechnol Plantes, CNRS, UMR8618, F-91405 Orsay, France	Universidad de Cordoba; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Roldan-Arjona, T (corresponding author), Univ Cordoba, Dept Genet, Edif Gregor Mendel,Campus Rabanales S-N, E-14071 Cordoba, Spain.	ge2roarm@uco.es	Roldan-Arjona, Teresa/H-5976-2015; Cordoba Canero, Dolores/H-8450-2018	Roldan-Arjona, Teresa/0000-0003-2842-3956; Cordoba Canero, Dolores/0000-0002-9659-4928; Dubois, Emeline/0000-0002-2515-9128	Ministerio de Educacion y Ciencia, Spain [BFU2007-60956/BMC]; Junta de Andalucia, Spain [P07-CVI-02770]	Ministerio de Educacion y Ciencia, Spain(Spanish Government); Junta de Andalucia, Spain(Junta de Andalucia)	This work was supported by funds from the Ministerio de Educacion y Ciencia, Spain ( Grant Number BFU2007-60956/BMC) and from the Junta de Andalucia, Spain ( Grant Number P07-CVI-02770).	Andersen S, 2005, CARCINOGENESIS, V26, P547, DOI 10.1093/carcin/bgh347; Aravind L, 2000, GENOME BIOL, V1, P1, DOI DOI 10.1186/GB-2000-1-4-RESEARCH0007; Bennett SE, 2004, P NATL ACAD SCI USA, V101, P6391, DOI 10.1073/pnas.0401031101; BENSEN RJ, 1987, PLANT PHYSIOL, V83, P149, DOI 10.1104/pp.83.1.149; BLAISDELL P, 1983, J BIOL CHEM, V258, P1603; BONES AM, 1993, PHYSIOL PLANTARUM, V88, P682, DOI 10.1111/j.1399-3054.1993.tb01389.x; Chung JH, 2003, NUCLEIC ACIDS RES, V31, P2045, DOI 10.1093/nar/gkg319; Cordoba-Canero D, 2009, PLANT J, V60, P716, DOI 10.1111/j.1365-313X.2009.03994.x; Dianov GL, 2003, MUTAT RES-FUND MOL M, V531, P157, DOI 10.1016/j.mrfmmm.2003.09.003; Drohat AC, 1999, BIOCHEMISTRY-US, V38, P11866, DOI 10.1021/bi9910878; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Fan JS, 2005, FREE RADICAL BIO MED, V38, P1121, DOI 10.1016/j.freeradbiomed.2005.01.012; Fortini P, 2007, DNA REPAIR, V6, P398, DOI 10.1016/j.dnarep.2006.10.008; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Guillet M, 2003, MOL CELL BIOL, V23, P8386, DOI 10.1128/MCB.23.22.8386-8394.2003; Guillet M, 2006, NUCLEIC ACIDS RES, V34, P2056, DOI 10.1093/nar/gkl139; GUTIERREZ C, 1987, MUTAT RES, V181, P111, DOI 10.1016/0027-5107(87)90293-4; Izumi T, 2003, TOXICOLOGY, V193, P43, DOI 10.1016/S0300-483X(03)00289-0; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; LINDAHL T, 1974, P NATL ACAD SCI USA, V71, P3649, DOI 10.1073/pnas.71.9.3649; MOL CD, 1995, CELL, V80, P869, DOI 10.1016/0092-8674(95)90290-2; Nakamura N, 2008, MUTAGENESIS, V23, P407, DOI 10.1093/mutage/gen030; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 1997, NUCLEIC ACIDS RES, V25, P750, DOI 10.1093/nar/25.4.750; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Pettersen HS, 2007, NUCLEIC ACIDS RES, V35, P3879, DOI 10.1093/nar/gkm372; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Stivers JT, 2004, SCIENCE, V306, p2042A, DOI 10.1126/science.1104396; Sutherland Betsy M, 2006, Methods Mol Biol, V314, P251; TALPAERTBORLE M, 1982, EUR J BIOCHEM, V124, P435; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Visnes T, 2008, DNA REPAIR, V7, P1869, DOI 10.1016/j.dnarep.2008.07.012; Wyatt MD, 2009, CELL MOL LIFE SCI, V66, P788, DOI 10.1007/s00018-008-8557-5	37	28	30	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7475	7483		10.1074/jbc.M109.067173	http://dx.doi.org/10.1074/jbc.M109.067173			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056608	Green Published, hybrid			2022-12-27	WOS:000275415600059
J	Hwang, CY; Holl, J; Rajan, D; Lee, Y; Kim, S; Um, M; Kwon, KS; Song, B				Hwang, Chae Young; Holl, Jens; Rajan, Devi; Lee, Younglang; Kim, Susan; Um, Moonkyoung; Kwon, Ki-Sun; Song, Byeongwoon			Hsp70 Interacts with the Retroviral Restriction Factor TRIM5 alpha and Assists the Folding of TRIM5 alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; CYTOPLASMIC BODIES; CHAPERONE SUPPRESSION; ANDROGEN RECEPTOR; MOLECULAR-CLONING; EMBRYONIC-CELLS; MONKEY CELLS; OLD-WORLD; PROTEIN	Tripartite motif (TRIM) protein TRIM5 alpha has been shown to restrict human immunodeficiency virus, type 1 infection in Old World monkey cells at the early post-entry step by poorly understood mechanisms. Currently, the physiological function of TRIM5 alpha is not known. In this study, we showed that transiently overexpressed TRIM5 alpha causes a morphological change in HEK293T cells. A proteomics analysis of the protein complexes that were pulled down with hemagglutinin-tagged TRIM5 alpha suggested that the heat shock protein 70 (Hsp70) may serve as a TRIM5 alpha-binding partner. The interaction between Hsp70 and TRIM5 alpha was confirmed by co-localization and co-immunoprecipitation assays. Co-expression of Hsp70 reversed the TRIM5 alpha-induced morphological change in HEK293T cells. Another heat shock protein Hsc70 also bound to TRIM5 alpha, but unlike Hsp70, Hsc70 was not able to reverse the TRIM5 alpha-induced morphological change, suggesting that Hsp70 specifically reverses the morphological change caused by TRIM5 alpha. Studies using a series of TRIM5 alpha deletion mutants demonstrate that, although the PRYSPRY domain is critical for binding to Hsp70, the entire TRIM5 alpha structure is necessary to induce the morphological change of cells. When the ATPase domain of Hsp70 was mutated, the mutated Hsp70 could not counteract the morphological change induced by TRIM5 alpha, indicating that the catalytic activity of Hsp70 protein is important for this function. Co-expression of Hsp70 elevated the levels of TRIM5 alpha in the detergent-soluble fraction with a concomitant decrease in the detergent-insoluble fraction. Together these results suggest that Hsp70 plays critical roles in the cellular management against the TRIM5 alpha-induced cellular insults.	[Song, Byeongwoon] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Hwang, Chae Young; Lee, Younglang; Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Lab Cell Signaling, Aging Res Ctr, Taejon 305333, South Korea; [Lee, Younglang] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Um, Moonkyoung] Boston Biomed Res Inst, Watertown, MA 02472 USA	Emory University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Boston Biomedical Research Institute	Song, B (corresponding author), Emory Univ, Sch Med, Dept Pediat, 2015 Uppergate Dr, Atlanta, GA 30322 USA.	bsong4@emory.edu			Campbell Foundation; Emory University Research Committee; Emory Egleston Children's Research Center; Emory Center for AIDS Research [P30AI050409]; Korea Research Council of Fundamental Science and Technology [M10642040003]; National Research Foundation of Korea [M10503010002]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI050409] Funding Source: NIH RePORTER	Campbell Foundation; Emory University Research Committee; Emory Egleston Children's Research Center; Emory Center for AIDS Research; Korea Research Council of Fundamental Science and Technology; National Research Foundation of Korea(National Research Foundation of Korea); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Campbell Foundation Award, Emory University Research Committee Award, Emory Egleston Children's Research Center Award, and Emory Center for AIDS Research Award P30AI050409 (to B. S.), and partially supported by the Korea Research Council of Fundamental Science and Technology Award M10642040003 and National Research Foundation of Korea Award fM10503010002 (to K.-S.K.).	Agostini I, 2000, EXP CELL RES, V259, P398, DOI 10.1006/excr.2000.4992; Asaoka K, 2005, BIOCHEM BIOPH RES CO, V338, P1950, DOI 10.1016/j.bbrc.2005.10.173; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bailey CK, 2002, HUM MOL GENET, V11, P515, DOI 10.1093/hmg/11.5.515; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Campbell EM, 2007, MOL BIOL CELL, V18, P2102, DOI 10.1091/mbc.E06-12-1075; ChelbiAlix MK, 1995, LEUKEMIA, V9, P2027; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Diaz-Griffero F, 2006, VIROLOGY, V349, P300, DOI 10.1016/j.virol.2005.12.040; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Frydman J, 1996, SCIENCE, V272, P1497, DOI 10.1126/science.272.5267.1497; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gongora C, 2000, J INTERF CYTOK RES, V20, P955, DOI 10.1089/10799900050198390; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Hatziioannou T, 2004, J VIROL, V78, P6005, DOI 10.1128/JVI.78.11.6005-6012.2004; Himathongkham S, 1996, VIROLOGY, V219, P485, DOI 10.1006/viro.1996.0276; Hofmann W, 1999, J VIROL, V73, P10020, DOI 10.1128/JVI.73.12.10020-10028.1999; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kobayashi Y, 2000, J BIOL CHEM, V275, P8772, DOI 10.1074/jbc.275.12.8772; Liberek K, 2008, EMBO J, V27, P328, DOI 10.1038/sj.emboj.7601970; Marsh JL, 2000, HUM MOL GENET, V9, P13, DOI 10.1093/hmg/9.1.13; Mische CC, 2005, J VIROL, V79, P14446, DOI 10.1128/JVI.79.22.14446-14450.2005; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Orimo A, 2000, GENOMICS, V69, P143, DOI 10.1006/geno.2000.6318; Owens CA, 2003, J VIROL, V77, P726, DOI 10.1128/JVI.77.1.726-731.2003; Owens CM, 2004, J VIROL, V78, P5423, DOI 10.1128/JVI.78.10.5423-5437.2004; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; SHIBATA R, 1995, J GEN VIROL, V76, P2723, DOI 10.1099/0022-1317-76-11-2723; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Xu LX, 2003, EXP CELL RES, V288, P84, DOI 10.1016/S0014-4827(03)00187-3; Yamauchi K, 2008, FEBS J, V275, P1540, DOI 10.1111/j.1742-4658.2008.06313.x; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	54	10	16	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7827	7837		10.1074/jbc.M109.040618	http://dx.doi.org/10.1074/jbc.M109.040618			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20053985	Green Published, hybrid			2022-12-27	WOS:000275415600090
J	Ouchi, N; Asaumi, Y; Ohashi, K; Higuchi, A; Sono-Romanelli, S; Oshima, Y; Walsh, K				Ouchi, Noriyuki; Asaumi, Yasuhide; Ohashi, Koji; Higuchi, Akiko; Sono-Romanelli, Saki; Oshima, Yuichi; Walsh, Kenneth			DIP2A Functions as a FSTL1 Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; ACTIVATED PROTEIN-KINASE; FOLLISTATIN-LIKE 1; EXPRESSION; AKT; ANGIOGENESIS; GROWTH; GENE; REVASCULARIZATION; CLONING	FSTL1 is an extracellular glycoprotein whose functional significance in physiological and pathological processes is incompletely understood. Recently, we have shown that FSTL1 acts as a muscle-derived secreted factor that is up-regulated by Akt activation and ischemic stress and that FSTL1 exerts favorable actions on the heart and vasculature. Here, we sought to identify the receptor that mediates the cellular actions of FSTL1. We identified DIP2A as a novel FSTL1-binding partner from the membrane fraction of endothelial cells. Co-immunoprecipitation assays revealed a direct physical interaction between FSTL1 and DIP2A. DIP2A was present on the cell surface of endothelial cells, and knockdown of DIP2A by small interfering RNA reduced the binding of FSTL1 to cells. In cultured endothelial cells, knockdown of DIP2A by small interfering RNA diminished FSTL1-stimulated survival, migration, and differentiation into network structures and inhibited FSTL1-induced Akt phosphorylation. In cultured cardiac myocytes, ablation of DIP2A reduced the protective actions of FSTL1 on hypoxia/reoxygenation-induced apoptosis and suppressed FSTL1-induced Akt phosphorylation. These data indicate that DIP2A functions as a novel receptor that mediates the cardiovascular protective effects of FSTL1.	[Ouchi, Noriyuki; Asaumi, Yasuhide; Ohashi, Koji; Higuchi, Akiko; Sono-Romanelli, Saki; Oshima, Yuichi; Walsh, Kenneth] Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, Boston, MA 02118 USA	Boston University	Walsh, K (corresponding author), Boston Univ, Sch Med, Mol Cardiol Whitaker Cardiovasc Inst, 715 Albany St,W611, Boston, MA 02118 USA.	kxwalsh@bu.edu	OUCHI, Noriyuki/I-7306-2014; OHASHI, Koji/I-7307-2014	Walsh, Kenneth/0000-0001-7580-2276; Asaumi, Yasuhide/0000-0002-9009-7234	National Institutes of Health [HL77774, HL86785, AG15052, HL81587]; Banyu Life Science Foundation International	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Banyu Life Science Foundation International(Banyu Life Science Foundation International)	This work was supported, in whole or in part, by National Institutes of Health Grants HL77774, HL86785, AG15052, and HL81587 (to K. W.). This work was also supported by grants from Banyu Life Science Foundation International (to Y. A.).	Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Chan QKY, 2009, CARCINOGENESIS, V30, P114, DOI 10.1093/carcin/bgn215; Fujio Y, 2000, CIRCULATION, V101, P660, DOI 10.1161/01.CIR.101.6.660; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Hambrock HO, 2004, J BIOL CHEM, V279, P11727, DOI 10.1074/jbc.M309318200; Kawabata D, 2004, ARTHRITIS RHEUM-US, V50, P660, DOI 10.1002/art.20023; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kureishi Y, 2000, NAT MED, V6, P1004, DOI 10.1038/79510; Le Luduec JB, 2008, AM J TRANSPLANT, V8, P2297, DOI 10.1111/j.1600-6143.2008.02398.x; Mashimo J, 1997, CANCER LETT, V113, P213, DOI 10.1016/S0304-3835(97)04700-9; Miyamae T, 2006, J IMMUNOL, V177, P4758, DOI 10.4049/jimmunol.177.7.4758; Mukhopadhyay M, 2002, GENE, V293, P59, DOI 10.1016/S0378-1119(02)00694-7; Nagase T, 1996, DNA Res, V3, P17, DOI 10.1093/dnares/3.1.17; Ohashi K, 2009, MOL CELL BIOL, V29, P3487, DOI 10.1128/MCB.00126-09; Oshima Y, 2008, CIRCULATION, V117, P3099, DOI 10.1161/CIRCULATIONAHA.108.767673; Ouchi N, 2005, CIRC RES, V96, P838, DOI 10.1161/01.RES.0000163633.10240.3b; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ouchi N, 2008, J BIOL CHEM, V283, P32802, DOI 10.1074/jbc.M803440200; Pimentel DR, 2001, CIRC RES, V89, P453, DOI 10.1161/hh1701.096615; SHIBANUMA M, 1993, EUR J BIOCHEM, V217, P13, DOI 10.1111/j.1432-1033.1993.tb18212.x; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Shiojima I, 2006, GENE DEV, V20, P3347, DOI 10.1101/gad.1492806; STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2; Sumitomo K, 2000, CANCER LETT, V155, P37, DOI 10.1016/S0304-3835(00)00407-9; Takemura Y, 2007, J CLIN INVEST, V117, P375, DOI 10.1172/JCI29709	25	91	97	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7127	7134		10.1074/jbc.M109.069468	http://dx.doi.org/10.1074/jbc.M109.069468			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20054002	hybrid, Green Published			2022-12-27	WOS:000275415600026
J	Rachid, S; Revermann, O; Dauth, C; Kazmaier, U; Muller, R				Rachid, Shwan; Revermann, Ole; Dauth, Christina; Kazmaier, Uli; Mueller, Rolf			Characterization of a Novel Type of Oxidative Decarboxylase Involved in the Biosynthesis of the Styryl Moiety of Chondrochloren from an Acylated Tyrosine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYBRID PEPTIDE SYNTHETASES; CRYSTAL-STRUCTURE; MOLECULAR CHARACTERIZATION; POLYKETIDE; SYNTHASE; CATALYZES; PHENYLALANINE; CONSTRUCTION; MECHANISM; MODULE	Myxobacteria are soil-dwelling bacteria notable for several unique behavioral features, such as cellular movement by gliding and the formation of multicellular fruiting bodies. More recently they have gained recognition as producers of several unique polyketide and nonribosomal polypeptide metabolites with potential therapeutic value. The biosynthesis of these compounds often involves highly unusual mechanisms including the formation of the chloro-hydroxy-styryl moiety of the chondrochloren antibiotic produced by Chondromyces crocatus Cm c5. Here it is shown that the final product of the chondrochloren megasynthetase is the novel natural product pre-chondrochloren, a carboxylated and saturated derivative of chondrochloren. This compound was isolated from strains harboring mutants of a hypothetical oxidative decarboxylase (CndG) identified in the chondrochloren gene cluster. CndG was heterologously expressed in Escherichia coli and shown to be an FAD-dependent oxidative decarboxylase. Biochemical characterization of the protein was achieved using the intermediate described above as the substrate and yielded chondrochloren by oxidative decarboxylation. It was also demonstrated that the CndG post-assembly line modification of pre-chondrochloren is essential for the biological activity of chondrochloren.	[Rachid, Shwan; Revermann, Ole; Mueller, Rolf] Univ Saarland, Dept Pharmaceut Biotechnol, D-66041 Saarbrucken, Germany; [Rachid, Shwan; Revermann, Ole; Mueller, Rolf] Univ Saarland, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res, D-66041 Saarbrucken, Germany; [Dauth, Christina; Kazmaier, Uli] Univ Saarland, Dept Organ Chem, D-66041 Saarbrucken, Germany	Saarland University; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University	Muller, R (corresponding author), Univ Saarland, Dept Pharmaceut Biotechnol, POB 151150, D-66041 Saarbrucken, Germany.	rom@mx.uni-saarland.de	Kazmaier, Uli/D-2947-2018; Müller, Rolf/B-1559-2008	Müller, Rolf/0000-0002-1042-5665; Rachid, Shwan/0000-0003-0834-5153	Bundesministerium fur Bildung und Forschung; Deutsche Forschungsgemeinschaft	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Bundesministerium fur Bildung und Forschung and the Deutsche Forschungsgemeinschaft.	Altena K, 2000, APPL ENVIRON MICROB, V66, P2565, DOI 10.1128/AEM.66.6.2565-2571.2000; Blaesse M, 2003, ACTA CRYSTALLOGR D, V59, P1414, DOI 10.1107/S0907444903011831; Brady SF, 2003, ORG LETT, V5, P121, DOI 10.1021/ol0267681; Brady SF, 2002, J AM CHEM SOC, V124, P9968, DOI 10.1021/ja0268985; Chang ZX, 2002, GENE, V296, P235, DOI 10.1016/S0378-1119(02)00860-0; Duerfahrt T, 2003, EUR J BIOCHEM, V270, P4555, DOI 10.1046/j.1432-1033.2003.03858.x; Flatt PM, 2006, J NAT PROD, V69, P938, DOI 10.1021/np050523q; Hoyer KM, 2007, CHEM BIOL, V14, P13, DOI 10.1016/j.chembiol.2006.10.011; Jansen R, 2003, EUR J ORG CHEM, V2003, P2684, DOI 10.1002/ejoc.200200699; Kaminaga Y, 2006, J BIOL CHEM, V281, P23357, DOI 10.1074/jbc.M602708200; Khosla C, 2007, ANNU REV BIOCHEM, V76, P195, DOI 10.1146/annurev.biochem.76.053105.093515; Kieser T., 2000, PRACTICAL STREPTOMYC, P162; Kupke T, 2000, J BIOL CHEM, V275, P31838, DOI 10.1074/jbc.M004273200; Liu AM, 2006, BIOCHEMISTRY-US, V45, P10407, DOI 10.1021/bi061031v; Majer F, 2002, J BACTERIOL, V184, P1234, DOI 10.1128/JB.184.5.1234-1243.2002; Martynowski D, 2006, BIOCHEMISTRY-US, V45, P10412, DOI 10.1021/bi060903q; McCubbin JA, 2006, ORG LETT, V8, P2993, DOI 10.1021/ol0609356; Mootz HD, 2000, P NATL ACAD SCI USA, V97, P5848, DOI 10.1073/pnas.100075897; Muller R, 2004, CHEM BIOL, V11, P4, DOI 10.1016/S1074-5521(04)00006-7; Rachid S, 2006, CHEM BIOL, V13, P667, DOI 10.1016/j.chembiol.2006.06.002; Rachid S, 2009, CHEM BIOL, V16, P70, DOI 10.1016/j.chembiol.2008.11.005; Rangarajan ES, 2004, PROTEIN SCI, V13, P3006, DOI 10.1110/ps.04953004; Reichenbach H, 2000, SPR DESKT EDIT CHEM, P149; Rix U, 2002, NAT PROD REP, V19, P542, DOI 10.1039/b103920m; Salomon CE, 2004, NAT PROD REP, V21, P105, DOI 10.1039/b301384g; Sambrook J., 2001, MOL CLONING LAB MANU; Samel SA, 2008, MOL BIOSYST, V4, P387, DOI 10.1039/b717538h; Shen B, 2003, CURR OPIN CHEM BIOL, V7, P285, DOI 10.1016/S1367-5931(03)00020-6; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; Walsh CT, 2008, ACCOUNTS CHEM RES, V41, P4, DOI 10.1021/ar7000414; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Walsh CT, 2004, SCIENCE, V303, P1805, DOI 10.1126/science.1094318; Wenzel SC, 2006, ANGEW CHEM INT EDIT, V45, P2296, DOI 10.1002/anie.200503737; Wenzel SC, 2005, CURR OPIN CHEM BIOL, V9, P447, DOI 10.1016/j.cbpa.2005.08.001; Wenzel SC, 2009, IDRUGS, V12, P220; Xu J, 2005, MICROBIOL-SGM, V151, P2515, DOI 10.1099/mic.0.28138-0; Yoshida M, 2004, J BACTERIOL, V186, P6855, DOI 10.1128/JB.186.20.6855-6863.2004; Zhou H, 2008, P NATL ACAD SCI USA, V105, P6249, DOI 10.1073/pnas.0800657105	38	10	10	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12482	12489		10.1074/jbc.M109.079707	http://dx.doi.org/10.1074/jbc.M109.079707			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20080978	Green Published, hybrid			2022-12-27	WOS:000276787800004
J	Arab, A; Wang, J; Bausch, K; von Schmadel, K; Bode, C; Hehrlein, C				Arab, Amina; Wang, Jin; Bausch, Kathrin; von Schmaedel, Katharina; Bode, Christoph; Hehrlein, Christoph			Transient Hyperoxic Reoxygenation Reduces Cytochrome c Oxidase Activity by Increasing Superoxide Dismutase and Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBRAL-ISCHEMIA; CELL-SURVIVAL; OXYGEN; RESPIRATION; DISEASE; MITOCHONDRIA; REPERFUSION; INHIBITION; HYPOXIA; O-2	Oxygen therapies have been shown to be cytoprotective in a dose-dependent fashion. Previously, we have characterized the protective effects of moderate hyperoxia on cell viability of ischemic human cardiomyocytes and their mitochondrial membrane potential by transient addition of oxygenated perfluorocarbons to the cell medium. Now, we report that the activity and expression of cytochrome c oxidase (COX) after prolonged ischemia depend on the amount of oxygen delivered during reoxygenation. Transient hyperoxia during reoxygenation results in a decrease of COX activity by 62 +/- 15% and COX expression by 67 +/- 5%, when hyperoxic tensions of approximate to 300 mm Hg are reached in the cell medium. This decrease in COX expression is prevented by the inhibition of inducible nitric-oxide synthase (iNOS). Immunoblot analysis of ischemic human cardiomyocytes revealed that hyperoxic reoxygenation causes a 2-fold increase of iNOS, leading to a rise in nitric oxide production by 140 +/- 45%. Hyperoxic reoxygenation is further responsible for a 2-fold activation of hydrogen peroxide production and an increase in cytosolic superoxide dismutase expression by 35 +/- 10%. NADPH availability has no effect on the hyperoxia-induced decrease of superoxide. Overall, these results indicate that transient hyperoxic reoxygenation in optimal concentrations increases the level of nitric oxide by activation of iNOS and superoxide dismutase, thereby inducing respiration arrest in mitochondria of ischemic cardiomyocytes.	[Arab, Amina; Wang, Jin; Bausch, Kathrin; von Schmaedel, Katharina; Bode, Christoph; Hehrlein, Christoph] Univ Freiburg, Dept Cardiol, D-79106 Freiburg, Germany	University of Freiburg	Arab, A (corresponding author), Hugstetterstr 55, D-79106 Freiburg, Germany.	amina.arab@uniklinik-freiburg.de		Bausch, Kathrin/0000-0002-6253-0854				Arab A, 2008, J PHARMACOL EXP THER, V325, P417, DOI 10.1124/jpet.107.133710; BARTH E, 1992, J MOL CELL CARDIOL, V24, P669, DOI 10.1016/0022-2828(92)93381-S; Beltran B, 2000, P NATL ACAD SCI USA, V97, P14602, DOI 10.1073/pnas.97.26.14602; BROWN GC, 1994, FEBS LETT, V356, P295, DOI 10.1016/0014-5793(94)01290-3; Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401; Cassina A, 1996, ARCH BIOCHEM BIOPHYS, V328, P309, DOI 10.1006/abbi.1996.0178; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chen HJ, 2001, AM J PHYSIOL-HEART C, V281, pH1035, DOI 10.1152/ajpheart.2001.281.3.H1035; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; Demchenko IT, 2002, CIRC RES, V91, P1031, DOI 10.1161/01.RES.0000043500.03647.81; Eschenfelder CC, 2008, CEREBROVASC DIS, V25, P193, DOI 10.1159/000113856; Evtodienko YV, 1996, FEBS LETT, V393, P86, DOI 10.1016/0014-5793(96)00875-7; Foglieni C, 2001, HISTOCHEM CELL BIOL, V115, P223; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Helms AK, 2005, CEREBROVASC DIS, V20, P417, DOI 10.1159/000088979; Husain M, 2008, J BIOL CHEM, V283, P7682, DOI 10.1074/jbc.M708845200; JOHNSON G, 1990, J PHARMACOL EXP THER, V252, P35; Merante F, 1998, AM J PHYSIOL-HEART C, V275, pH1673, DOI 10.1152/ajpheart.1998.275.5.H1673; OMAR HA, 1991, CIRC RES, V69, P601, DOI 10.1161/01.RES.69.3.601; PAGANO PJ, 1995, AM J PHYSIOL-HEART C, V268, pH2274, DOI 10.1152/ajpheart.1995.268.6.H2274; Reznik ON, 2008, TRANSPL P, V40, P1027, DOI 10.1016/j.transproceed.2008.03.053; Riess JG, 2005, ARTIF CELL BLOOD SUB, V33, P47, DOI 10.1081/BIO-200046659; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Victor VM, 2009, CIRC RES, V104, P1178, DOI 10.1161/CIRCRESAHA.109.197228; WINK DA, 1993, P NATL ACAD SCI USA, V90, P9813, DOI 10.1073/pnas.90.21.9813; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	30	6	6	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11172	11177		10.1074/jbc.M109.053181	http://dx.doi.org/10.1074/jbc.M109.053181			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20086011	hybrid, Green Published			2022-12-27	WOS:000276286200022
J	Saita, E; Iino, R; Suzuki, T; Feniouk, BA; Kinosita, K; Yoshida, M				Saita, Ei-ichiro; Iino, Ryota; Suzuki, Toshiharu; Feniouk, Boris A.; Kinosita, Kazuhiko, Jr.; Yoshida, Masasuke			Activation and Stiffness of the Inhibited States of F-1-ATPase Probed by Single-molecule Manipulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; COLI ATP SYNTHASE; C-TERMINAL DOMAIN; EPSILON-SUBUNIT; ESCHERICHIA-COLI; THERMOPHILIC F-1-ATPASE; F0F1-ATP SYNTHASE; MITOCHONDRIAL F1-ATPASE; ENDOGENOUS INHIBITOR; NUCLEOTIDE-BINDING	F-1-ATPase (F-1), a soluble portion of FoF1-ATP synthase (FoF1), is an ATP-driven motor in which gamma epsilon subunits rotate in the alpha(3)beta(3) cylinder. Activity of F1 and FoF1 from Bacillus PS3 is attenuated by the epsilon subunit in an inhibitory extended form. In this study we observed ATP-dependent transition of epsilon in single F-1 molecules from extended form to hairpin form by fluorescence resonance energy transfer. The results justify the previous bulk experiments and ensure that fraction of F-1 with hairpin epsilon directly determines the fraction of active F-1 at any ATP concentration. Next, mechanical activation and stiffness of epsilon-inhibited F-1 were examined by the forced rotation of magnetic beads attached to epsilon. Compared with ADP inhibition, which is another manner of inhibition, rotation by a larger angle was required for the activation from epsilon inhibition when the beads were forced to rotate to ATP hydrolysis direction, and more torque was required to reach the same rotation angle when beads were forced to rotate to ATP synthesis direction. The results imply that if FoF1 is resting in the epsilon-inhibited state, F-o motor must transmit to gamma a torque larger than expected from thermodynamic equilibrium to initiate ATP synthesis.	[Saita, Ei-ichiro; Suzuki, Toshiharu; Feniouk, Boris A.; Yoshida, Masasuke] Japan Sci & Technol Corp, ICORP ATP Synth Regulat Project, Tokyo 1350064, Japan; [Iino, Ryota] Osaka Univ, Inst Sci & Ind Res, Osaka 5670047, Japan; [Kinosita, Kazuhiko, Jr.] Waseda Univ, Fac Sci & Engn, Dept Phys, Shinjuku Ku, Tokyo 1698555, Japan; [Yoshida, Masasuke] Kyoto Sangyo Univ, Fac Engn, Kyoto 6038555, Japan	Japan Science & Technology Agency (JST); Osaka University; Waseda University; Kyoto Sangyo University	Yoshida, M (corresponding author), Japan Sci & Technol Corp, ICORP ATP Synth Regulat Project, Aomi 2-3-6, Tokyo 1350064, Japan.	myoshida@res.titech.ac.jp	Iino, Ryota/B-7746-2011; Feniouk, Boris/F-2380-2012	Iino, Ryota/0000-0003-0110-5704; Feniouk, Boris/0000-0003-0474-7411				Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Ariga T, 2007, NAT STRUCT MOL BIOL, V14, P841, DOI 10.1038/nsmb1296; Bandyopadhyay S, 2005, BIOCHEMISTRY-US, V44, P2441, DOI 10.1021/bi047694z; BOYER PD, 1993, BIOCHIM BIOPHYS ACTA, V1140, P215, DOI 10.1016/0005-2728(93)90063-L; Bulygin VV, 2004, J BIOL CHEM, V279, P35616, DOI 10.1074/jbc.M405012200; Bulygin VV, 1998, J BIOL CHEM, V273, P31765, DOI 10.1074/jbc.273.48.31765; CARMELI C, 1972, BIOCHIM BIOPHYS ACTA, V267, P86, DOI 10.1016/0005-2728(72)90140-5; Cipriano DJ, 2006, J BIOL CHEM, V281, P501, DOI 10.1074/jbc.M509986200; Diez M, 2004, NAT STRUCT MOL BIOL, V11, P135, DOI 10.1038/nsmb718; DROBINSKAYA IY, 1985, FEBS LETT, V182, P419, DOI 10.1016/0014-5793(85)80346-X; DUNCAN TM, 1995, P NATL ACAD SCI USA, V92, P10964, DOI 10.1073/pnas.92.24.10964; DUNHAM KR, 1981, J BIOL CHEM, V256, P44; Feniouk Boris A., 2008, V45, P279, DOI 10.1007/400_2007_043; Feniouk BA, 2007, J BIOL CHEM, V282, P764, DOI 10.1074/jbc.M606321200; Fischer S, 2000, J BIOL CHEM, V275, P30157, DOI 10.1074/jbc.275.39.30157; FUNG DC, 1995, NATURE, V375, P809, DOI 10.1038/375809a0; Gabel CV, 2003, P NATL ACAD SCI USA, V100, P8748, DOI 10.1073/pnas.1533395100; Ganti S, 2007, J BIOENERG BIOMEMBR, V39, P99, DOI 10.1007/s10863-006-9066-6; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Iino R, 2005, J BIOL CHEM, V280, P40130, DOI 10.1074/jbc.M506160200; Iino R, 2009, J BIOL CHEM, V284, P17457, DOI 10.1074/jbc.M109.003798; JAULT JM, 1993, J BIOL CHEM, V268, P1558; JUNGE W, 1970, EUR J BIOCHEM, V14, P582, DOI 10.1111/j.1432-1033.1970.tb00327.x; Kato S, 2007, J BIOL CHEM, V282, P37618, DOI 10.1074/jbc.M707509200; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 1999, J BIOL CHEM, V274, P33991, DOI 10.1074/jbc.274.48.33991; Kato-Yamada Y, 2003, J BIOL CHEM, V278, P36013, DOI 10.1074/jbc.M306140200; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; Kinosita K Jr, 2000, Essays Biochem, V35, P3; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Masaike T, 2006, BIOCHEM BIOPH RES CO, V342, P800, DOI 10.1016/j.bbrc.2006.02.017; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Nakanishi-Matsui M, 2006, J BIOL CHEM, V281, P4126, DOI 10.1074/jbc.M510090200; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Noji H, 2001, J BIOL CHEM, V276, P25480, DOI 10.1074/jbc.M102200200; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Spetzler D, 2006, BIOCHEMISTRY-US, V45, P3117, DOI 10.1021/bi052363n; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Tsumuraya M, 2009, FEBS LETT, V583, P1121, DOI 10.1016/j.febslet.2009.02.038; Tsunoda SP, 1999, J BIOL CHEM, V274, P5701, DOI 10.1074/jbc.274.9.5701; Turina P, 2003, EMBO J, V22, P418, DOI 10.1093/emboj/cdg073; TURINA P, 1992, J BIOL CHEM, V267, P11057; Ueno H, 2005, P NATL ACAD SCI USA, V102, P1333, DOI 10.1073/pnas.0407857102; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; VanWalraven HS, 1996, FEBS LETT, V379, P309, DOI 10.1016/0014-5793(95)01536-1; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Weber J, 1999, J BIOL CHEM, V274, P19124, DOI 10.1074/jbc.274.27.19124; Wilkens S, 1998, J BIOL CHEM, V273, P26645, DOI 10.1074/jbc.273.41.26645; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Zharova TV, 2006, BIOCHEMISTRY-US, V45, P14552, DOI 10.1021/bi061520v	56	27	28	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11411	11417		10.1074/jbc.M109.099143	http://dx.doi.org/10.1074/jbc.M109.099143			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154086	hybrid, Green Published			2022-12-27	WOS:000276286200047
J	Bradford, J; Shin, JY; Roberts, M; Wang, CE; Sheng, GQ; Li, SH; Li, XJ				Bradford, Jennifer; Shin, Ji-Yeon; Roberts, Meredith; Wang, Chuan-En; Sheng, Guoqing; Li, Shihua; Li, Xiao-Jiang			Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOSODIUM-L-GLUTAMATE; INTRANUCLEAR INCLUSIONS; MOUSE MODEL; EXPRESSION; ASTROCYTES; NEURODEGENERATION; ACCUMULATION; PATHOGENESIS; PROTEIN; RATS	Huntington disease (HD) is caused by an expansion of the polyglutamine (polyQ) repeat (> 37Q) in huntingtin (htt), and age of onset is inversely correlated with the length of the polyQ repeat. Mutant htt with expanded polyQ is ubiquitously expressed in various types of cells, including glia, but causes selective neurodegeneration. Our recent study demonstrated that expression of the N-terminal mutant htt with a large polyQ repeat (160Q) in astrocytes is sufficient to induce neurological symptoms in mice (Bradford, J., Shin, J. Y., Roberts, M., Wang, C. E., Li, X.-J., and Li, S. H. (2009) Proc. Natl. Acad. Sci. U. S. A. 106, 22480-22485). Because glia-neuron interactions are critical for maintaining the normal function and survival of neurons in the brain and because mutant htt is more abundant in neurons than in glial cells, it is important to investigate whether glial htt can still contribute to HD pathology when mutant htt is abundantly expressed in neuronal cells. We generated transgenic mice that express mutant htt with 98Q in astrocytes. Unlike our recently generated htt-160Q transgenic mice, htt-98Q mice do not show obvious neurological phenotypes, suggesting that the length of the polyQ repeat determines the severity of glial dysfunction. However, htt-98Q mice show increased susceptibility to glutamate-induced seizure. Mice expressing mutant htt in astrocytes were mated with N171-82Q mice that express mutant htt primarily in neuronal cells. Double transgenic mice expressing mutant htt in both neuronal and glial cells display more severe neurological symptoms and earlier death than N171-82Q mice. These findings indicate a role of glial mutant htt in exacerbating HD neuropathology and underscore the importance of improving glial function in treating HD.	[Bradford, Jennifer; Shin, Ji-Yeon; Roberts, Meredith; Wang, Chuan-En; Sheng, Guoqing; Li, Shihua; Li, Xiao-Jiang] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA	Emory University	Li, XJ (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	xli2@emory.edu			National Institutes of Health [NS36232, AG19206, AG031153, NS045016]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041669, R01NS045016, R01NS036232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019206, R01AG031153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants NS36232 (to X.-J.L.), AG19206 (to X.-J.L.), AG031153 (to S. H. L.), and NS045016 (to S. H. L.).	ARAUZCONTRERAS J, 1984, GEN PHARMACOL-VASC S, V15, P391, DOI 10.1016/0306-3623(84)90036-3; Arzberger T, 1997, J NEUROPATH EXP NEUR, V56, P440, DOI 10.1097/00005072-199704000-00013; Behrens PF, 2002, BRAIN, V125, P1908, DOI 10.1093/brain/awf180; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Brenner Michael, 1996, Methods (Orlando), V10, P351, DOI 10.1006/meth.1996.0113; Chou SY, 2008, J NEUROSCI, V28, P3277, DOI 10.1523/JNEUROSCI.0116-08.2008; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; FeriaVelasco A, 1995, ARCH MED RES, V26, pS127; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Gu XF, 2005, NEURON, V46, P433, DOI 10.1016/j.neuron.2005.03.025; Gu XF, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-8; Hassel B, 2008, NEUROCHEM RES, V33, P232, DOI 10.1007/s11064-007-9463-1; Hayase T, 2001, J PHARM PHARMACOL, V53, P1525, DOI 10.1211/0022357011777891; Hebb MO, 1999, FASEB J, V13, P1099, DOI 10.1096/fasebj.13.9.1099; Heng MY, 2008, NEUROBIOL DIS, V32, P1, DOI 10.1016/j.nbd.2008.06.005; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; Li SH, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-19; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Lievens JC, 2001, NEUROBIOL DIS, V8, P807, DOI 10.1006/nbdi.2001.0430; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Singhrao SK, 1998, EXP NEUROL, V150, P213, DOI 10.1006/exnr.1998.6778; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Yu ZX, 2003, J NEUROSCI, V23, P2193	34	108	114	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10653	10661		10.1074/jbc.M109.083287	http://dx.doi.org/10.1074/jbc.M109.083287			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145253	hybrid, Green Published			2022-12-27	WOS:000276264600052
J	Lee, SY; Choi, HK; Kim, ST; Chung, S; Park, MK; Cho, JH; Ho, WK; Cho, H				Lee, Seul-Yi; Choi, Hyun-Kyung; Kim, Seong-Tae; Chung, Sungkwon; Park, Myoung Kyu; Cho, Jung-Hwa; Ho, Won-Kyung; Cho, Hana			Cholesterol Inhibits M-type K+ Channels via Protein Kinase C-dependent Phosphorylation in Sympathetic Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED INHIBITION; POTASSIUM CHANNELS; DIETARY-CHOLESTEROL; MEMBRANE CHOLESTEROL; TRANSPORT PROTEINS; ARACHIDONIC-ACID; KCNQ CHANNELS; SMOOTH-MUSCLE; MODULATION; CURRENTS	M-type (KCNQ) potassium channels play an important role in regulating the action potential firing in neurons. Here, we investigated the effect of cholesterol on M current in superior cervical ganglion (SCG) sympathetic neurons, using the patch clamp technique. M current was inhibited in a dose-dependent manner by cholesterol loading with a methyl-beta-cyclodextrin-cholesterol complex. This effect was prevented when membrane cholesterol level was restored by including empty methyl-beta-cyclodextrin in the pipette solution. Dialysis of cells with AMP-PNP instead of ATP prevented cholesterol action on M currents. Protein kinase C (PKC) inhibitor, calphostin C, abolished cholesterol-induced inhibition whereas the PKC activator, PDBu, mimicked the inhibition of M currents by cholesterol. The in vitro kinase assay showed that KCNQ2 subunits of M channel can be phosphorylated by PKC. A KCNQ2 mutant that is defective in phosphorylation by PKC failed to show current inhibition not only by PDBu but also by cholesterol. These results indicate that cholesterol-induced inhibition of M currents is mediated by PKC phosphorylation. The inhibition of M currents by PDBu and cholesterol was completely blocked by PIP2 loading, indicating that the decrease in PIP2-channel interaction underlies M channel inhibition by PKC-mediated phosphorylation. We conclude that cholesterol specifically regulates M currents in SCG neurons via PKC activation.	[Cho, Hana] Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon 440746, South Korea; [Choi, Hyun-Kyung; Kim, Seong-Tae] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Cho, Jung-Hwa; Ho, Won-Kyung] Seoul Natl Univ, Coll Med, Dept Physiol, WCU Neurocyt Program Project, Seoul 110799, South Korea; [Cho, Jung-Hwa; Ho, Won-Kyung] Neurosci Res Inst, Seoul 110799, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Seoul National University (SNU)	Cho, H (corresponding author), Sungkyunkwan Univ, Sch Med, Dept Physiol, Suwon 440746, South Korea.	hanacho@med.skku.ac.kr	CHUNG, SUNGKWON/ABF-8293-2021; Ho, Won-Kyung/J-2798-2012; Kim, Seong-Tae/A-9917-2013	Lee, Seul-Yi/0000-0002-9360-131X	Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A080604]	Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea (A080604).	Armstrong D, 2008, BIOPHYS J, V94, P4700, DOI 10.1529/biophysj.107.121426; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Brown SG, 2005, AM J PHYSIOL-CELL PH, V289, pC543, DOI 10.1152/ajpcell.00025.2005; Cho H, 2006, MOL CELLS, V22, P97; Christian AE, 1997, J LIPID RES, V38, P2264; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; EPAND RM, 1990, TRENDS PHARMACOL SCI, V11, P317, DOI 10.1016/0165-6147(90)90234-Y; FRANCIS GS, 1993, CIRCULATION, V87, P40; Gamper N, 2004, J NEUROSCI, V24, P10980, DOI 10.1523/JNEUROSCI.3869-04.2004; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Guo J, 2008, MOL MEMBR BIOL, V25, P216, DOI 10.1080/09687680701805541; Hamilton JA, 2003, CURR OPIN LIPIDOL, V14, P263, DOI 10.1097/00041433-200306000-00006; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Higashida H, 2005, NEUROSCI RES, V51, P231, DOI 10.1016/j.neures.2004.11.009; Hilgemann D W, 2001, Sci STKE, V2001, pre19, DOI 10.1126/stke.2001.111.re19; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hilgemann DW, 2004, SCIENCE, V304, P223, DOI 10.1126/science.1097439; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jia ZF, 2008, J GEN PHYSIOL, V131, P575, DOI 10.1085/jgp.200709924; Karten B, 2002, J NEUROCHEM, V83, P1154, DOI 10.1046/j.1471-4159.2002.01220.x; KIM JA, 1991, J LIPID RES, V32, P1125; Libby P, 2000, BBA-MOL CELL BIOL L, V1529, P299, DOI 10.1016/S1388-1981(00)00161-X; Liu BY, 2008, AM J PHYSIOL-CELL PH, V295, pC81, DOI 10.1152/ajpcell.00028.2008; Liu LW, 2001, AM J PHYSIOL-CELL PH, V280, pC1293, DOI 10.1152/ajpcell.2001.280.5.C1293; Liu YB, 2003, CIRC RES, V92, P1145, DOI 10.1161/01.RES.0000072999.51484.92; Luo TY, 2004, J BIOMED SCI, V11, P339, DOI [10.1007/BF02254438, 10.1159/000077102]; MANGER WM, 1982, ADV CARDIOL, P71; Mann RK, 2000, BBA-MOL CELL BIOL L, V1529, P188, DOI 10.1016/S1388-1981(00)00148-7; MARRION NV, 1994, PFLUG ARCH EUR J PHY, V426, P296, DOI 10.1007/BF00374785; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; McNamara DJ, 2000, BBA-MOL CELL BIOL L, V1529, P310, DOI 10.1016/S1388-1981(00)00156-6; Melenovsky V, 2003, AM J CARDIOL, V92, P337, DOI 10.1016/S0002-9149(03)00643-X; Mohler ER, 2007, BIOCHEM BIOPH RES CO, V358, P317, DOI 10.1016/j.bbrc.2007.04.138; Morikage N, 2006, CIRC RES, V99, P299, DOI 10.1161/01.RES.0000235877.33682.e9; Nakajo K, 2005, J PHYSIOL-LONDON, V569, P59, DOI 10.1113/jphysiol.2005.094995; Robbins J, 2006, J NEUROSCI, V26, P7950, DOI 10.1523/JNEUROSCI.2138-06.2006; Romanenko VG, 2002, BIOPHYS J, V83, P3211, DOI 10.1016/S0006-3495(02)75323-X; Sander D, 2001, NEUROLOGY, V57, P833, DOI 10.1212/WNL.57.5.833; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Shen WX, 2005, J NEUROSCI, V25, P7449, DOI 10.1523/JNEUROSCI.1381-05.2005; Sirikci O, 1996, ATHEROSCLEROSIS, V126, P253, DOI 10.1016/0021-9150(96)05909-6; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Sohn JW, 2007, J PHYSIOL-LONDON, V582, P1037, DOI 10.1113/jphysiol.2007.137265; Sohn JW, 2007, J PHYSIOL-LONDON, V580, P411, DOI 10.1113/jphysiol.2006.125914; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stoffel-Wagner B, 2001, EUR J ENDOCRINOL, V145, P669, DOI 10.1530/eje.0.1450669; Suh BC, 2002, NEURON, V35, P507, DOI 10.1016/S0896-6273(02)00790-0; Sun Y, 2009, CIRC RES, V104, P455, DOI 10.1161/CIRCRESAHA.108.182568; Tabas I, 2002, J CLIN INVEST, V110, P583, DOI 10.1172/JCI200216381; Tillman TS, 2003, CELL BIOCHEM BIOPHYS, V38, P161, DOI 10.1385/CBB:38:2:161; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Winks JS, 2005, J NEUROSCI, V25, P3400, DOI 10.1523/JNEUROSCI.3231-04.2005; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5; Zaika O, 2006, J PHYSIOL-LONDON, V575, P49, DOI 10.1113/jphysiol.2006.114074; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	58	22	23	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10939	10950		10.1074/jbc.M109.048868	http://dx.doi.org/10.1074/jbc.M109.048868			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123983	Green Published, hybrid			2022-12-27	WOS:000276264600078
J	Kracun, S; Chaptal, V; Abramson, J; Khakh, BS				Kracun, Sebastian; Chaptal, Vincent; Abramson, Jeff; Khakh, Baljit S.			Gated Access to the Pore of a P2X Receptor STRUCTURAL IMPLICATIONS FOR CLOSED-OPEN TRANSITIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-RESIDUES; 2ND TRANSMEMBRANE DOMAIN; CYSTEINE ACCESSIBILITY METHOD; ION-CHANNEL STRUCTURE; ZINC-BINDING SITE; ATP RECEPTOR; ACETYLCHOLINE-RECEPTOR; CATION PERMEABILITY; CYTOSOLIC DOMAIN; POLAR RESIDUES	P2X receptors are ligand-gated cation channels that transition from closed to open states upon binding ATP. The crystal structure of the closed zebrafish P2X4.1 receptor directly reveals that the ion-conducting pathway is formed by three transmembrane domain 2 (TM2) alpha-helices, each being provided by the three subunits of the trimer. However, the transitions in TM2 that accompany channel opening are incompletely understood and remain unresolved. In this study, we quantified gated access to Cd2+ at substituted cysteines in TM2 of P2X2 receptors in the open and closed states. Our data for the closed state are consistent with the zebrafish P2X4.1 structure, with isoleucines and threonines (Ile-332 and Thr-336) positioned one helical turn apart lining the channel wall on approach to the gate. Our data for the open state reveal gated access to deeper parts of the pore (Thr-339, Val-343, Asp-349, and Leu-353), suggesting the closed channel gate is between Thr-336 and Thr-339. We also found unexpected interactions between native Cys-348 and D349C that result in tight Cd2+ binding deep within the intracellular vestibule in the open state. Interpreted with a P2X2 receptor structural model of the closed state, our data suggest that the channel gate opens near Thr-336/Thr-339 and is accompanied by movement of the pore-lining regions, which narrow toward the cytosolic end of TM2 in the open state. Such transitions would relieve the barrier to ion flow and render the intracellular vestibule less splayed during channel opening in the presence of ATP.	[Kracun, Sebastian; Chaptal, Vincent; Abramson, Jeff; Khakh, Baljit S.] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Khakh, Baljit S.] Univ Calif Los Angeles, Dept Neurobiol, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Khakh, BS (corresponding author), Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA.	bkhakh@mednet.ucla.edu		chaptal, vincent/0000-0003-2603-0294	National Institutes of Health [GM070925-04]; UCLA; American Physiological Society; Stein-Oppenheimer Foundation Endowment Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844, R01GM070925] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA(University of California System); American Physiological Society; Stein-Oppenheimer Foundation Endowment Award; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a National Institutes of Health Grant GM070925-04. This work was also supported by unrestricted funds from UCLA (to B. S. K.), by a S&R Foundation Ryuji Ueno Award for Ion Channels or Barrier Function Research from the American Physiological Society and by a Stein-Oppenheimer Foundation Endowment Award (to B. S. K.).	Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Burnstock G, 2009, ACTA PHYSIOL, V195, P415, DOI 10.1111/j.1748-1716.2009.01957.x; Burnstock G, 2007, PHYSIOL REV, V87, P659, DOI 10.1152/physrev.00043.2006; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; Chaumont S, 2004, J BIOL CHEM, V279, P29628, DOI 10.1074/jbc.M403940200; Chaumont S, 2008, P NATL ACAD SCI USA, V105, P12063, DOI 10.1073/pnas.0803008105; Clyne JD, 2002, J PHYSIOL-LONDON, V539, P347, DOI 10.1113/jphysiol.2001.013244; Clyne JD, 2002, J NEUROSCI, V22, P3873, DOI 10.1523/JNEUROSCI.22-10-03873.2002; Ding S, 1999, J MEMBRANE BIOL, V172, P215, DOI 10.1007/s002329900598; Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695; Dokmanic I, 2008, ACTA CRYSTALLOGR D, V64, P257, DOI 10.1107/S090744490706595X; Duckwitz W, 2006, J BIOL CHEM, V281, P39561, DOI 10.1074/jbc.M606113200; Egan TM, 2006, PFLUG ARCH EUR J PHY, V452, P501, DOI 10.1007/s00424-006-0078-1; Egan TM, 1998, J NEUROSCI, V18, P2350; Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004; Eickhorst AN, 2002, J GEN PHYSIOL, V120, P119, DOI 10.1085/jgp.20028535; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ennion SJ, 2002, MOL PHARMACOL, V61, P303, DOI 10.1124/mol.61.2.303; Evans RJ, 2009, EUR BIOPHYS J BIOPHY, V38, P319, DOI 10.1007/s00249-008-0275-2; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Fountain SJ, 2008, J BIOL CHEM, V283, P15122, DOI 10.1074/jbc.M801512200; Fountain SJ, 2007, NATURE, V448, P200, DOI 10.1038/nature05926; Fountain SJ, 2009, PURINERG SIGNAL, V5, P269, DOI 10.1007/s11302-008-9127-x; Fujiwara Y, 2009, J GEN PHYSIOL, V133, P93, DOI 10.1085/jgp.200810002; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Guerlet G, 2008, BIOCHEM BIOPH RES CO, V375, P405, DOI 10.1016/j.bbrc.2008.08.030; Haines WR, 2001, J NEUROSCI, V21, P5885, DOI 10.1523/JNEUROSCI.21-16-05885.2001; Haines WR, 2001, J BIOL CHEM, V276, P32793, DOI 10.1074/jbc.M104216200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang LH, 2003, J NEUROSCI, V23, P8903; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Keceli B, 2009, J PHYSIOL-LONDON, V587, P5801, DOI 10.1113/jphysiol.2009.182824; Kellenberger S, 2005, J BIOL CHEM, V280, P7739, DOI 10.1074/jbc.M409955200; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kubo Y, 2009, J PHYSIOL-LONDON, V587, P5317, DOI 10.1113/jphysiol.2009.179309; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; MACKINNON R, 1995, NEURON, V14, P889, DOI 10.1016/0896-6273(95)90327-5; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagaya N, 2005, J BIOL CHEM, V280, P25982, DOI 10.1074/jbc.M504545200; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 1996, CIBA F SYMP, V198, P91; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Perozo E, 2002, NOVART FDN SYMP, V245, P146; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; RHODES G, 1993, CRYSTALLOGRAPHY MADE, P237; Richler E, 2008, NAT METHODS, V5, P87, DOI 10.1038/NMETH1144; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samways DSK, 2008, J BIOL CHEM, V283, P5110, DOI 10.1074/jbc.M708713200; Sheng SH, 2005, J BIOL CHEM, V280, P8513, DOI 10.1074/jbc.M413880200; Shinozaki Y, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000103; Spencer RH, 2002, ANNU REV BIOPH BIOM, V31, P207, DOI 10.1146/annurev.biophys.31.082901.134329; Stoop R, 1999, MOL PHARMACOL, V56, P973, DOI 10.1124/mol.56.5.973; Takeda AN, 2007, J BIOL CHEM, V282, P31928, DOI 10.1074/jbc.M700733200; Tittle RK, 2008, J NEUROSCI, V28, P11131, DOI 10.1523/JNEUROSCI.2763-08.2008; Tittle RK, 2007, J BIOL CHEM, V282, P19526, DOI 10.1074/jbc.M701604200; Torres GE, 1998, FEBS LETT, V425, P19, DOI 10.1016/S0014-5793(98)00179-3; Torres GE, 1998, BIOCHEMISTRY-US, V37, P14845, DOI 10.1021/bi981209g; Torres GE, 1999, J BIOL CHEM, V274, P22359, DOI 10.1074/jbc.274.32.22359; Unwin N, 2000, PHILOS T R SOC B, V355, P1813, DOI 10.1098/rstb.2000.0737; VALERA S, 1994, NATURE, V371, P519; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Young MT, 2010, TRENDS BIOCHEM SCI, V35, P83, DOI 10.1016/j.tibs.2009.09.006; Zhou Z, 1998, BIOCHEM BIOPH RES CO, V252, P541, DOI 10.1006/bbrc.1998.9689	74	56	57	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10110	10121		10.1074/jbc.M109.089185	http://dx.doi.org/10.1074/jbc.M109.089185			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093367	hybrid, Green Published			2022-12-27	WOS:000276165900078
J	May, V; Lutz, E; MacKenzie, C; Schutz, KC; Dozark, K; Braas, KM				May, Victor; Lutz, Eve; MacKenzie, Christopher; Schutz, Kristin C.; Dozark, Kate; Braas, Karen M.			Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/PAC(1)HOP1 Receptor Activation Coordinates Multiple Neurotrophic Signaling Pathways Akt ACTIVATION THROUGH PHOSPHATIDYLINOSITOL 3-KINASE gamma AND VESICLE ENDOCYTOSIS FOR NEURONAL SURVIVAL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBELLAR GRANULE NEURONS; DEPENDENT PROTEIN-KINASE; NERVE GROWTH-FACTOR; RAT SYMPATHETIC NEURONS; CYCLIC-AMP; PACAP RECEPTOR; PAC(1) RECEPTOR; NEUROPEPTIDE-Y; MAP KINASE; PC12 CELLS	MAPK and Akt pathways are predominant mediators of trophic signaling for many neuronal systems. Among the vasoactive intestinal peptide/secretin/glucagon family of related peptides, pituitary adenylate cyclase-activating polypeptide (PACAP) binding to specific PAC(1) receptor isoforms can engage multiple signaling pathways and promote neuroprotection through mechanisms that are not well understood. Using a primary sympathetic neuronal system, the current studies demonstrate that PACAP activation of PAC(1)HOP1 receptors engages both MAPK and Akt neurotrophic pathways in an integrated program to facilitate neuronal survival after growth factor withdrawal. PACAP not only stimulated prosurvival ERK1/2 and ERK5 activation but also abrogated SAPK/JNK and p38 MAPK signaling in parallel. In contrast to the potent and rapid effects of PACAP in ERK1/2 phosphorylation, PACAP stimulated Akt phosphorylation in a late phase of PAC(1)HOP1 receptor signaling. From inhibitor and immunoprecipitation analyses, the PACAP/PAC(1)HOP1 receptor-mediated Akt responses did not represent transactivation mechanisms but appeared to depend on G alpha(q)/phosphatidylinositol 3-kinase gamma activity and vesicular internalization pathways. Phosphatidylinositol 3-kinase gamma-selective inhibitors blocked PACAP-stimulated Akt phosphorylation in primary neuronal cultures and in PAC(1)HOP1-overexpressing cell lines; RNA interference-mediated knockdown of the receptor effectors attenuated PACAP-mediated Akt activation. Similarly, perturbation of endocytic pathways also blocked Akt phosphorylation. Between ERK and Akt pathways, PACAP-stimulated Akt signaling was the primary cascade that attenuated cultured neuron apoptosis after growth factor withdrawal. The partitioning of PACAP-mediated Akt signaling in endosomes may be a key mechanism contributing to the high spatial and temporal specificity in signal transduction necessary for survival pathways.	[May, Victor; Schutz, Kristin C.; Dozark, Kate; Braas, Karen M.] Univ Vermont, Coll Med, Dept Anat & Neurobiol, Burlington, VT 05405 USA; [May, Victor; Schutz, Kristin C.; Dozark, Kate; Braas, Karen M.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Lutz, Eve; MacKenzie, Christopher] Univ Strathclyde, Royal Coll, Strathclyde Inst Pharm & Biomed Sci, Glasgow G1 1XW, Lanark, Scotland	University of Vermont; University of Vermont; University of Strathclyde	May, V (corresponding author), Univ Vermont, Coll Med, Dept Anat & Neurobiol, 149 Beaumont Ave, Burlington, VT 05405 USA.	victor.may@uvm.edu			National Institutes of Health [HD27468, NS37179]; Wellcome Trust; National Institutes of Health National Center for Research Resources [P20RR16435]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027468] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037179] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants HD27468 and NS37179.; Supported by Wellcome Trust.; The use of the Molecular Biology Core Facility, supported by National Institutes of Health National Center for Research Resources Grant P20RR16435, is also gratefully acknowledged.	Arimura A, 1998, JPN J PHYSIOL, V48, P301, DOI 10.2170/jjphysiol.48.301; Barrie AP, 1997, J BIOL CHEM, V272, P19666, DOI 10.1074/jbc.272.32.19666; BASILLE M, 1994, DEV BRAIN RES, V82, P81, DOI 10.1016/0165-3806(94)90150-3; Beaudet MM, 2000, J NEUROSCI, V20, P7353; Bouschet T, 2003, J BIOL CHEM, V278, P4778, DOI 10.1074/jbc.M204652200; Braas KM, 1999, J BIOL CHEM, V274, P27702, DOI 10.1074/jbc.274.39.27702; Brandenburg CA, 1997, J NEUROSCI, V17, P4045; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Campard PK, 1997, DNA CELL BIOL, V16, P323, DOI 10.1089/dna.1997.16.323; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Carey RG, 2002, J NEUROSCI, V22, P1583, DOI 10.1523/JNEUROSCI.22-05-01583.2002; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chang JY, 1997, NEUROCHEM INT, V31, P161, DOI 10.1016/S0197-0186(96)00145-3; Choi EK, 2004, FEBS LETT, V559, P141, DOI 10.1016/S0014-5793(04)00058-4; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; David C, 2005, J MOL NEUROSCI, V27, P91, DOI 10.1385/JMN:27:01:91; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DiCicco-Bloom E, 2000, DEV BIOL, V219, P197, DOI 10.1006/dbio.2000.9604; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; Fessart D, 2005, MOL ENDOCRINOL, V19, P491, DOI 10.1210/me.2004-0246; Filippa N, 1999, MOL CELL BIOL, V19, P4989; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Garcia-Regalado A, 2008, MOL BIOL CELL, V19, P4188, DOI 10.1091/mbc.E07-10-1089; Gayer CP, 2009, J BIOL CHEM, V284, P2001, DOI 10.1074/jbc.M804576200; Girard BM, 2004, REGUL PEPTIDES, V123, P107, DOI 10.1016/j.regpep.2004.05.024; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; Hansel DE, 2001, J NEUROSCI, V21, P4625, DOI 10.1523/JNEUROSCI.21-13-04625.2001; HASHIMOTO H, 1993, NEURON, V11, P333, DOI 10.1016/0896-6273(93)90188-W; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; HOSOYA M, 1993, BIOCHEM BIOPH RES CO, V194, P133, DOI 10.1006/bbrc.1993.1795; Hunker CM, 2006, ARCH BIOCHEM BIOPHYS, V449, P130, DOI 10.1016/j.abb.2006.01.020; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; INAGAKI N, 1994, P NATL ACAD SCI USA, V91, P2679, DOI 10.1073/pnas.91.7.2679; ISHIHARA T, 1992, NEURON, V8, P811, DOI 10.1016/0896-6273(92)90101-I; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Johnson-Farley NN, 2005, J NEUROCHEM, V92, P72, DOI 10.1111/j.1471-4159.2004.02832.x; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kerchner KR, 2004, J BIOL CHEM, V279, P44554, DOI 10.1074/jbc.M406071200; Laburthe M, 2002, RECEPTOR CHANNEL, V8, P137, DOI 10.1080/10606820290005191; Lee FS, 2002, J BIOL CHEM, V277, P9096, DOI 10.1074/jbc.M107421200; Lioudyno M, 1998, J NEUROSCI RES, V51, P243, DOI 10.1002/(SICI)1097-4547(19980115)51:2<243::AID-JNR13>3.0.CO;2-9; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; Lu NR, 1998, J NEUROSCI RES, V53, P651, DOI 10.1002/(SICI)1097-4547(19980915)53:6<651::AID-JNR3>3.0.CO;2-4; Luttrell LM, 1999, SCIENCE, V283, P655, DOI 10.1126/science.283.5402.655; LUTZ EM, 1993, FEBS LETT, V334, P3, DOI 10.1016/0014-5793(93)81668-P; Lutz EM, 2006, MOL CELL NEUROSCI, V31, P193, DOI 10.1016/j.mcn.2005.09.008; Ma YC, 2002, CELL MOL LIFE SCI, V59, P456, DOI 10.1007/s00018-002-8438-2; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; MASUO Y, 1994, NEUROSCI LETT, V170, P43, DOI 10.1016/0304-3940(94)90234-8; May V, 2002, J NEUROSCI, V22, P6980; MAY V, 1995, J NEUROSCI, V15, P4580; MAY V, 1995, J NEUROCHEM, V65, P978; MAY V, 1989, ENDOCRINOLOGY, V124, P157, DOI 10.1210/endo-124-1-157; McCulloch DA, 2002, BIOCHEM SOC T, V30, P441, DOI 10.1042/bst0300441; Mei FC, 2002, J BIOL CHEM, V277, P11497, DOI 10.1074/jbc.M110856200; Morio H, 1996, BRAIN RES, V741, P82, DOI 10.1016/S0006-8993(96)00920-1; Murga C, 1998, J BIOL CHEM, V273, P19080, DOI 10.1074/jbc.273.30.19080; Mustafa T, 2007, J BIOL CHEM, V282, P8079, DOI 10.1074/jbc.M609638200; Nicot A, 2001, P NATL ACAD SCI USA, V98, P4758, DOI 10.1073/pnas.071465398; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Pomel V, 2006, J MED CHEM, V49, P3857, DOI 10.1021/jm0601598; Prasad SVN, 2002, J CELL BIOL, V158, P563, DOI 10.1083/jcb.200202113; Przywara DA, 1998, J NEUROCHEM, V71, P1889; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Shuto Y, 1996, REGUL PEPTIDES, V67, P79, DOI 10.1016/S0167-0115(96)00116-4; Silveira MS, 2002, J BIOL CHEM, V277, P16075, DOI 10.1074/jbc.M110106200; SPENGLER D, 1993, NATURE, V365, P170, DOI 10.1038/365170a0; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Tabuchi A, 2003, J NEUROSCI RES, V71, P504, DOI 10.1002/jnr.10505; Vaudry D, 2000, PHARMACOL REV, V52, P269; Vaudry D, 1998, NEUROSCIENCE, V84, P801, DOI 10.1016/S0306-4522(97)00545-9; Vaudry D, 1999, P NATL ACAD SCI USA, V96, P9415, DOI 10.1073/pnas.96.16.9415; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang ZP, 2006, MOL CELL BIOL, V26, P2130, DOI 10.1128/MCB.26.6.2130-2145.2006; Waschek JA, 1998, P NATL ACAD SCI USA, V95, P9602, DOI 10.1073/pnas.95.16.9602; Waschek JA, 1996, ANN NY ACAD SCI, V805, P290; Waters CM, 2005, CELL SIGNAL, V17, P263, DOI 10.1016/j.cellsig.2004.07.011; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	88	64	65	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9749	9761		10.1074/jbc.M109.043117	http://dx.doi.org/10.1074/jbc.M109.043117			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093365	Green Published, hybrid			2022-12-27	WOS:000276165900047
J	Reineke, EL; Liu, Y; Kao, HY				Reineke, Erin L.; Liu, Yu; Kao, Hung-Ying			Promyelocytic Leukemia Protein Controls Cell Migration in Response to Hydrogen Peroxide and Insulin-like Growth Factor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-BODY FORMATION; TUMOR-SUPPRESSOR PML; BREAST-CANCER; INTEGRIN EXPRESSION; RECEPTOR-ALPHA; BODIES; APOPTOSIS; DEGRADATION; MECHANISMS; MEMBRANE	Promyelocytic leukemia protein (PML) was originally identified as part of a chromosomal translocation that contributes to the development of acute promyelocytic leukemia (APL). Since its discovery, PML has been found to play diverse roles in different cellular processes. Notably, PML has anti-proliferative and pro-apoptotic activity that supports its role as a tumor suppressor. We have previously shown that the peptidyl-prolyl isomerase Pin1 is able to affect cell proliferation and hydrogen peroxide (H2O2)-mediated cell death through modulation of the steady-state levels of PML. We have extended these studies to show that the interaction between PML and Pin1 is targeted by multiple extracellular signals in the cell. We show that H2O2 up-regulates and IGF-1 down-regulates PML expression in a Pin1 dependent manner. Interestingly, we found that H2O2- and IGF1-mediated alteration in PML accumulation regulate MDA-MB231 cell migration. Furthermore, we show that the control of cell migration by PML, and thus H2O2 and IGF-1, results from PML-dependent decreased expression of integrin beta 1 (ITGB1). Knockdown of Pin1 leads to decreased cell migration, lower levels of ITGB1 expression and resistance to IGF-1- and H2O2-induced changes in cell migration and ITGB1 expression. Taken together, our work identifies PML as a common target for H2O2 and IGF-1 and supports a novel tumor suppressive role for PML in controlling cell migration through the expression of ITGB1.	Case Western Reserve Univ, Dept Biochem, Sch Med, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; Univ Hosp Cleveland, Cleveland, OH 44106 USA	Case Western Reserve University; University Hospitals of Cleveland	Kao, HY (corresponding author), 10900 Euclid Ave, Cleveland, OH 44106 USA.	hxk43@cwru.edu			National Institutes of Health [R01 DK078965, R01 HL093269]; Pardee Foundation; Aging Cancer Research Program at the Case Comprehensive Cancer Center [P20 CA103736]; NATIONAL CANCER INSTITUTE [P20CA103736] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078965] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Foundation; Aging Cancer Research Program at the Case Comprehensive Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole of in part, by National Institutes of Health Grants R01 DK078965 and HL093269. This work was also supported by grants from the Pardee Foundation and the Aging Cancer Research Program at the Case Comprehensive Cancer Center (P20 CA103736).	Bartucci M, 2001, CANCER RES, V61, P6747; Baserga R, 1997, VITAM HORM, V53, P65, DOI 10.1016/S0083-6729(08)60704-9; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; Bernardi R, 2008, ONCOGENE, V27, P6299, DOI 10.1038/onc.2008.305; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Berry MG, 2004, EJSO, V30, P484, DOI 10.1016/j.ejso.2004.01.016; Borden KLB, 2002, MOL CELL BIOL, V22, P5259, DOI 10.1128/MCB.22.15.5259-5269.2002; Buschbeck M, 2007, ONCOGENE, V26, P3415, DOI 10.1038/sj.onc.1210128; Ching RW, 2005, J CELL SCI, V118, P847, DOI 10.1242/jcs.01700; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Fierro FA, 2008, J MOL BIOL, V377, P1082, DOI 10.1016/j.jmb.2008.01.085; Gao CZ, 2008, MOL CELL BIOL, V28, P5658, DOI 10.1128/MCB.00874-08; Gui GPH, 1996, EUR J SURG ONCOL, V22, P254, DOI 10.1016/S0748-7983(96)80013-8; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; He DL, 1997, CANCER RES, V57, P1868; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jensen K, 2001, ONCOGENE, V20, P7223, DOI 10.1038/sj.onc.1204765; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Larsson O, 2005, BRIT J CANCER, V92, P2097, DOI 10.1038/sj.bjc.6602627; LeRoith D, 2003, CANCER LETT, V195, P127, DOI 10.1016/S0304-3835(03)00159-9; Maul GG, 2000, J STRUCT BIOL, V129, P278, DOI 10.1006/jsbi.2000.4239; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; OYAOHTA Y, 1995, MUTAT RES-FUND MOL M, V326, P99, DOI 10.1016/0027-5107(95)00153-A; Rego EM, 2001, J EXP MED, V193, P521, DOI 10.1084/jem.193.4.521; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Surmacz E, 2004, J EXP CLIN CANC RES, V23, P385; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Tsiper MV, 2002, J CELL SCI, V115, P1005; VIRADOR VM, 2008, MOL CARCINOG; Wang ZG, 1998, SCIENCE, V279, P1547; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; You H, 2002, J CELL BIOCHEM, V84, P211, DOI 10.1002/jcb.10037; Zhang H, 2009, J BIOL CHEM, V284, P2867, DOI 10.1074/jbc.M807526200; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020; ZUTTER MM, 1993, AM J PATHOL, V142, P1439	38	31	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9485	9492		10.1074/jbc.M109.063362	http://dx.doi.org/10.1074/jbc.M109.063362			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100838	hybrid, Green Published			2022-12-27	WOS:000276165900022
J	Borras, L; Gunde, T; Tietz, J; Bauer, U; Hulmann-Cottier, V; Grimshaw, JPA; Urech, DM				Borras, Leo; Gunde, Tea; Tietz, Julia; Bauer, Ulrich; Hulmann-Cottier, Valerie; Grimshaw, John P. A.; Urech, David M.			Generic Approach for the Generation of Stable Humanized Single-chain Fv Fragments from Rabbit Monoclonal Antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTI-P185HER2 ANTIBODY; POSTERIOR SEGMENT; PROTEIN STABILITY; V-H; PHAGE; IMPROVEMENT; REPERTOIRE; FRAMEWORKS; LIBRARIES; AFFINITY	Despite their favorable pharmacokinetic properties, single-chain Fv antibody fragments (scFvs) are not commonly used as therapeutics, mainly due to generally low stabilities and poor production yields. In this work, we describe the identification and optimization of a human scFv scaffold, termed FW1.4, which is suitable for humanization and stabilization of a broad variety of rabbit antibody variable domains. A motif consisting of five structurally relevant framework residues that are highly conserved in rabbit variable domains was introduced into FW1.4 to generate a generically applicable scFv scaffold, termed FW1.4gen. Grafting of complementarity determining regions (CDRs) from 15 different rabbit monoclonal antibodies onto FW1.4 and their derivatives resulted in humanized scFvs with binding affinities in the range from 4.7 x 10(-9) to 1.5 x 10(-11) M. Interestingly, minimalistic grafting of CDRs onto FW1.4gen, without any substitutions in the framework regions, resulted in affinities ranging from 5.7 x 10(-10) to < 1.8 x 10(-12) M. When compared with progenitor rabbit scFvs, affinities of most humanized scFvs were similar. Moreover, in contrast to progenitor scFvs, which were difficult to produce, biophysical properties of the humanized scFvs were significantly improved, as exemplified by generally good production yields in a generic refolding process and by apparent melting temperatures between 53 and 86 degrees C. Thus, minimalistic grafting of rabbit CDRs on the FW1.4gen scaffold presents a simple and reproducible approach to humanize and stabilize rabbit variable domains.	[Borras, Leo; Gunde, Tea; Tietz, Julia; Bauer, Ulrich; Hulmann-Cottier, Valerie; Grimshaw, John P. A.; Urech, David M.] ESBATech, ALCON Biomed Res Unit, CH-8952 Schlieren, Switzerland		Urech, DM (corresponding author), Wagistr 21, CH-8952 Schlieren, Switzerland.	david.urech@esbatech.com						Adair John R., 1994, Human Antibodies and Hybridomas, V5, P41; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; Demarest SJ, 2006, PROTEIN ENG DES SEL, V19, P325, DOI 10.1093/protein/gzl016; der Maur Adrian Auf, 2004, Methods (Amsterdam), V34, P215; EIGENBROT C, 1993, J MOL BIOL, V229, P969, DOI 10.1006/jmbi.1993.1099; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Ewert S, 2003, BIOCHEMISTRY-US, V42, P1517, DOI 10.1021/bi026448p; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fuh G, 2006, J BIOL CHEM, V281, P6625, DOI 10.1074/jbc.M507783200; Furrer E, 2009, INVEST OPHTH VIS SCI, V50, P771, DOI 10.1167/iovs.08-2370; Huang YJ, 2007, HYBRIDOMA, V26, P387, DOI 10.1089/hyb.2007.0517; Hurle Mark R., 1994, Current Opinion in Biotechnology, V5, P428, DOI 10.1016/0958-1669(94)90053-1; Jermutus L, 2001, P NATL ACAD SCI USA, V98, P75, DOI 10.1073/pnas.011311398; Jespers L, 2004, NAT BIOTECHNOL, V22, P1161, DOI 10.1038/nbt1000; Jung S, 1999, J MOL BIOL, V294, P163, DOI 10.1006/jmbi.1999.3196; KABAT EA, 1991, J IMMUNOL, V147, P1709; KETTLEBOROUGH CA, 1991, PROTEIN ENG, V4, P773, DOI 10.1093/protein/4.7.773; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; Kodituwakku AP, 2003, IMMUNOL CELL BIOL, V81, P163, DOI 10.1046/j.1440-1711.2003.01152.x; Lanning D, 2000, IMMUNOL REV, V175, P214, DOI 10.1034/j.1600-065X.2000.017516.x; Luo GX, 2003, J IMMUNOL METHODS, V275, P31, DOI 10.1016/S0022-1759(02)00542-2; Monsellier E, 2006, J MOL BIOL, V362, P580, DOI 10.1016/j.jmb.2006.07.044; Mountain A, 1992, Biotechnol Genet Eng Rev, V10, P1; Ottiger M, 2009, INVEST OPHTH VIS SCI, V50, P779, DOI 10.1167/iovs.08-2372; Presta LG, 1997, CANCER RES, V57, P4593; Proba K, 1998, J MOL BIOL, V275, P245, DOI 10.1006/jmbi.1997.1457; Rader C, 2000, J BIOL CHEM, V275, P13668, DOI 10.1074/jbc.275.18.13668; Sidhu SS, 2004, J MOL BIOL, V338, P299, DOI 10.1016/j.jmb.2004.02.050; Steinberger P, 2000, J BIOL CHEM, V275, P36073, DOI 10.1074/jbc.M002765200; Steipe B, 2004, METHOD ENZYMOL, V388, P176; STEIPE B, 1994, J MOL BIOL, V240, P188, DOI 10.1006/jmbi.1994.1434; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; URECH DM, 2009, ANN RHEUM DIS; Willuda J, 1999, CANCER RES, V59, P5758; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265	37	37	81	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9054	9066		10.1074/jbc.M109.072876	http://dx.doi.org/10.1074/jbc.M109.072876			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20056614	Green Published, hybrid			2022-12-27	WOS:000275553700056
J	Rothery, RA; Bertero, MG; Spreter, T; Bouromand, N; Strynadka, NCJ; Weiner, JH				Rothery, Richard A.; Bertero, Michela G.; Spreter, Thomas; Bouromand, Nasim; Strynadka, Natalie C. J.; Weiner, Joel H.			Protein Crystallography Reveals a Role for the FS0 Cluster of Escherichia coli Nitrate Reductase A (NarGHI) in Enzyme Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; BIS(MOLYBDOPTERIN GUANINE DINUCLEOTIDE)MOLYBDENUM; IRON-SULFUR MOLYBDOENZYME; SITE-DIRECTED MUTAGENESIS; MOLYBDENUM COFACTOR; ELECTRON-TRANSFER; DIMETHYLSULFOXIDE REDUCTASE; CATALYTIC SUBUNIT; FORMATE DEHYDROGENASES; RESPIRATORY COMPLEX	We have used site-directed mutagenesis, EPR spectroscopy, redox potentiometry, and protein crystallography to monitor assembly of the FS0 [4Fe-4S] cluster and molybdo-bis(pyranopterin guanine dinucleotide) cofactor (Mo-bisPGD) of the Escherichia coli nitrate reductase A (NarGHI) catalytic subunit (NarG). Cys and Ser mutants of NarG-His(49) both lack catalytic activity, with only the former assembling FS0 and Mo-bisPGD. Importantly, both prosthetic groups are absent in the NarG-H49S mutant. EPR spectroscopy of the Cys mutant reveals that the E-m value of the FS0 cluster is decreased by at least 500 mV, preventing its participation in electron transfer to the MobisPGD cofactor. To demonstrate that decreasing the FS0 cluster E-m results in decreased enzyme activity, we mutated a critical Arg residue (NarG-Arg(94)) in the vicinity of FS0 to a Ser residue. In this case, the E-m of FS0 is decreased by 115 mV, with a concomitant decrease in enzyme turnover to similar to 30% of the wild type. Analysis of the structure of the NarG-H49S mutant reveals two important aspects of NarGHI maturation: (i) apomolybdo-NarGHI is able to bind GDP moieties at their respective P and Q sites in the absence of the Mo-bisPGD cofactor, and (ii) a critical segment of residues in NarG, (49)HGVNCTG(55), must be correctly positioned to ensure holoenzyme maturation.	[Rothery, Richard A.; Bouromand, Nasim; Weiner, Joel H.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Bertero, Michela G.; Spreter, Thomas; Strynadka, Natalie C. J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of Alberta; University of British Columbia	Weiner, JH (corresponding author), Univ Alberta, Dept Biochem, 474 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	joel.weiner@UAlberta.ca		Bertero, Michela/0000-0002-2012-6706; Rothery, Richard/0000-0003-3265-1783	National Institutes of Health [GMO68451-01]; Canadian Institutes of Health Research [MOP15292]; Canada Foundation for Innovation; Alberta Heritage Foundation for Medical Research	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	This work was supported, in whole or in part, by National Institutes of Health Grant GMO68451-01. This work was also supported by Canadian Institutes of Health Research Grant MOP15292, the Canada Foundation for Innovation, and the Alberta Heritage Foundation for Medical Research.	Bennett BD, 2009, NAT CHEM BIOL, V5, P593, DOI 10.1038/nchembio.186; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; Bertero MG, 2005, J BIOL CHEM, V280, P14836, DOI 10.1074/jbc.M410457200; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Blasco F, 1998, MOL MICROBIOL, V28, P435, DOI 10.1046/j.1365-2958.1998.00795.x; BLASCO F, 1989, MOL GEN GENET, V218, P249, DOI 10.1007/BF00331275; Blasco F, 2001, CELL MOL LIFE SCI, V58, P179, DOI 10.1007/PL00000846; BLASCO F, 1992, MOL MICROBIOL, V6, P221, DOI 10.1111/j.1365-2958.1992.tb02003.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buc J, 1995, EUR J BIOCHEM, V234, P766, DOI 10.1111/j.1432-1033.1995.766_a.x; Chan CS, 2006, BIOCHEM BIOPH RES CO, V343, P244, DOI 10.1016/j.bbrc.2006.02.133; Cheng VWT, 2006, J BIOL CHEM, V281, P27662, DOI 10.1074/jbc.M604900200; Daizadeh I, 2002, MOL BIOL EVOL, V19, P406, DOI 10.1093/oxfordjournals.molbev.a004095; Duderstadt RE, 1999, FEBS LETT, V454, P21, DOI 10.1016/S0014-5793(99)00766-8; Gladyshev VN, 1996, J BIOL CHEM, V271, P8095, DOI 10.1074/jbc.271.14.8095; Gonzalez PJ, 2006, J BIOL INORG CHEM, V11, P609, DOI 10.1007/s00775-006-0110-0; Guigliarelli B, 1996, BIOCHEMISTRY-US, V35, P4828, DOI 10.1021/bi952459p; HAGEN WR, 1992, ADV INORG CHEM, V38, P165, DOI 10.1016/S0898-8838(08)60064-1; HEINZINGER NK, 1995, J BACTERIOL, V177, P2813, DOI 10.1128/jb.177.10.2813-2820.1995; Hettmann T, 2003, BIOCHEM BIOPH RES CO, V310, P40, DOI 10.1016/j.bbrc.2003.08.114; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, MET IONS BIOL SYST, V39, P187; Hilton JC, 1996, ARCH BIOCHEM BIOPHYS, V325, P139, DOI 10.1006/abbi.1996.0017; Hinsley AP, 2002, MICROBIOL-SGM, V148, P3631, DOI 10.1099/00221287-148-11-3631; Ize B, 2009, MICROBIOL-SGM, V155, P3992, DOI 10.1099/mic.0.033647-0; Jepson BJN, 2007, J BIOL CHEM, V282, P6425, DOI 10.1074/jbc.M607353200; JOHNSON JL, 1990, P NATL ACAD SCI USA, V87, P3190, DOI 10.1073/pnas.87.8.3190; JOHNSON JL, 1982, P NATL ACAD SCI-BIOL, V79, P6856, DOI 10.1073/pnas.79.22.6856; Jormakka M, 2002, SCIENCE, V295, P1863, DOI 10.1126/science.1068186; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kloer DP, 2006, STRUCTURE, V14, P1377, DOI 10.1016/j.str.2006.07.001; KRAFFT T, 1992, EUR J BIOCHEM, V206, P503, DOI 10.1111/j.1432-1033.1992.tb16953.x; Lanciano P, 2007, J PHYS CHEM B, V111, P13632, DOI 10.1021/jp075243t; Lanciano P, 2007, J BIOL CHEM, V282, P17468, DOI 10.1074/jbc.M700994200; Li HM, 2009, CAN J MICROBIOL, V55, P179, DOI [10.1139/W08-111, 10.1139/w08-111]; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Magalon A, 1998, BIOCHEMISTRY-US, V37, P7363, DOI 10.1021/bi972858f; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MORPETH FF, 1985, BIOCHEMISTRY-US, V24, P40, DOI 10.1021/bi00322a007; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Moura JJG, 2004, J BIOL INORG CHEM, V9, P791, DOI 10.1007/s00775-004-0573-9; Neumann M, 2009, J BIOL CHEM, V284, P21891, DOI 10.1074/jbc.M109.008565; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palmer T, 1996, MOL MICROBIOL, V20, P875, DOI 10.1111/j.1365-2958.1996.tb02525.x; PASCAL MC, 1982, MOL GEN GENET, V188, P103, DOI 10.1007/BF00333001; ROTHERY RA, 1991, BIOCHEMISTRY-US, V30, P8296, DOI 10.1021/bi00098a003; Rothery RA, 1998, BIOCHEM J, V332, P35, DOI 10.1042/bj3320035; Rothery RA, 2001, BIOCHEMISTRY-US, V40, P5260, DOI 10.1021/bi002393k; Rothery RA, 1998, J BIOL CHEM, V273, P7462, DOI 10.1074/jbc.273.13.7462; Rothery RA, 1999, BIOCHEMISTRY-US, V38, P12747, DOI 10.1021/bi990533o; Rothery RA, 2004, BIOCHEMISTRY-US, V43, P5324, DOI 10.1021/bi049938l; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Sambasivarao D, 2000, J BIOL CHEM, V275, P22526, DOI 10.1074/jbc.M909289199; Sargent F, 2007, MICROBIOL-SGM, V153, P633, DOI 10.1099/mic.0.2006/004762-0; Temple CA, 2000, J BIOL CHEM, V275, P40202, DOI 10.1074/jbc.M007407200; Trieber CA, 1996, J BIOL CHEM, V271, P4620; TRIEBER CA, 1994, J BIOL CHEM, V269, P7103; Turner RJ, 2004, CAN J MICROBIOL, V50, P225, DOI 10.1139/W03-117; Vergnes A, 2004, J BIOL CHEM, V279, P41398, DOI 10.1074/jbc.M407087200; Watts CA, 2005, BIOCHEM SOC T, V33, P173, DOI 10.1042/BST0330173; WEINER JH, 1992, BIOCHIM BIOPHYS ACTA, V1102, P1, DOI 10.1016/0167-4838(92)90493-W; Weiner JH, 1998, CELL, V93, P93, DOI 10.1016/S0092-8674(00)81149-6; Wittekindt C, 2009, J AM CHEM SOC, V131, P8134, DOI 10.1021/ja900352t	66	27	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8801	8807		10.1074/jbc.M109.066027	http://dx.doi.org/10.1074/jbc.M109.066027			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20053990	Green Published, hybrid			2022-12-27	WOS:000275553700032
J	Wanngren, J; Franberg, J; Svensson, AI; Laudon, H; Olsson, F; Winblad, B; Liu, F; Naslund, J; Lundkvist, J; Karlstrom, H				Wanngren, Johanna; Franberg, Jenny; Svensson, Annelie I.; Laudon, Hanna; Olsson, Fredrik; Winblad, Bengt; Liu, Frank; Naslund, Jan; Lundkvist, Johan; Karlstrom, Helena			The Large Hydrophilic Loop of Presenilin 1 Is Important for Regulating beta-Secretase Complex Assembly and Dictating the Amyloid beta Peptide (A beta) Profile without Affecting Notch Processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL FRAGMENTS; GAMMA-SECRETASE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; TALKING POINT; IN-VIVO; ENDOPROTEOLYSIS; MUTATIONS; INHIBITOR; CLEAVAGE	gamma-Secretase is an enzyme complex that mediates both Notch signaling and beta-amyloid precursor protein (APP) processing, resulting in the generation of Notch intracellular domain, APP intracellular domain, and the amyloid beta peptide (A beta), the latter playing a central role in Alzheimer disease (AD). By a hitherto undefined mechanism, the activity of gamma-secretase gives rise to A beta peptides of different lengths, where A beta 42 is considered to play a particular role in AD. In this study we have examined the role of the large hydrophilic loop (amino acids 320-374, encoded by exon 10) of presenilin 1 (PS1), the catalytic subunit of gamma-secretase, for gamma-secretase complex formation and activity on Notch and APP processing. Deletion of exon 10 resulted in impaired PS1 endoproteolysis, gamma-secretase complex formation, and had a differential effect on A beta-peptide production. Although the production of A beta 38, A beta 39, and A beta 40 was severely impaired, the effect on A beta 42 was affected to a lesser extent, implying that the production of the AD-related A beta 42 peptide is separate from the production of the A beta 38, A beta 39, and A beta 40 peptides. Interestingly, formation of the intracellular domains of both APP and Notch was intact, implying a differential cleavage activity between the epsilon/S3 and gamma sites. The most C-terminal amino acids of the hydrophilic loop were important for regulating APP processing. In summary, the large hydrophilic loop of PS1 appears to differentially regulate the relative production of different A beta peptides without affecting Notch processing, two parameters of significance when considering gamma-secretase as a target for pharmaceutical intervention in AD.	[Wanngren, Johanna; Franberg, Jenny; Svensson, Annelie I.; Laudon, Hanna; Winblad, Bengt; Karlstrom, Helena] Karolinska Inst, Dept Neurobiol Caring Sci & Soc, KI Alzheimer Dis Res Ctr, SE-14186 Stockholm, Sweden; [Olsson, Fredrik; Naslund, Jan; Lundkvist, Johan] AstraZeneca Cent Nervous Syst, Pain Res Area, Div Mol Pharmacol, SE-15185 Sodertalje, Sweden; [Liu, Frank] AstraZeneca, Div Neurosci Biol, Wilmington, DE 19850 USA	Karolinska Institutet; AstraZeneca; AstraZeneca	Karlstrom, H (corresponding author), Karolinska Inst, Dept Neurobiol Caring Sci & Soc, 5th Floor, SE-14157 Stockholm, Sweden.	Helena.Karlstrom@ki.se		Karlstrom, Helena/0000-0002-0498-2473	Swedish Brain Power; Wallenberg Stiftelsen; Loo och Hans Ostermans Stiftelse; Magnus Bergvalls Stiftlelse; Fonden for Alderforskning vid Karolinska Institutet; Stiftelsen for Gamla Tjanarinnor; Gun och Bertil Stohnes Stiftelse	Swedish Brain Power; Wallenberg Stiftelsen; Loo och Hans Ostermans Stiftelse; Magnus Bergvalls Stiftlelse; Fonden for Alderforskning vid Karolinska Institutet; Stiftelsen for Gamla Tjanarinnor; Gun och Bertil Stohnes Stiftelse	This work was supported by grants from Swedish Brain Power, Wallenberg Stiftelsen, Loo och Hans Ostermans Stiftelse, Magnus Bergvalls Stiftlelse, Fonden for Alderforskning vid Karolinska Institutet, Stiftelsen for Gamla Tjanarinnor, and Gun och Bertil Stohnes Stiftelse.	Bentahir M, 2006, J NEUROCHEM, V96, P732, DOI 10.1111/j.1471-4159.2005.03578.x; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Bergman A, 2004, J BIOL CHEM, V279, P45564, DOI 10.1074/jbc.M407717200; Bergman A, 2004, J BIOL CHEM, V279, P16744, DOI 10.1074/jbc.M313999200; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Deng Y, 2006, J NEUROSCI, V26, P3845, DOI 10.1523/JNEUROSCI.5384-05.2006; Dillen K, 2006, INT REV CYTOL, V254, P215, DOI 10.1016/S0074-7696(06)54005-7; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Farmery MR, 2003, J BIOL CHEM, V278, P24277, DOI 10.1074/jbc.M211992200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Henricson A, 2005, FEBS J, V272, P2727, DOI 10.1111/j.1742-4658.2005.04691.x; Hyde LA, 2006, J PHARMACOL EXP THER, V319, P1133, DOI 10.1124/jpet.106.111716; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; Karlstrom H, 2002, J BIOL CHEM, V277, P6763, DOI 10.1074/jbc.C100649200; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; Kumar-Singh S, 2006, HUM MUTAT, V27, P686, DOI 10.1002/humu.20336; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Laudon H, 2004, J NEUROCHEM, V89, P44, DOI 10.1046/j.1471-4159.2003.02298.x; Milano J, 2004, TOXICOL SCI, V82, P341, DOI 10.1093/toxsci/kfh254; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; Podlisny MB, 1997, NEUROBIOL DIS, V3, P325, DOI 10.1006/nbdi.1997.0129; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Spasic D, 2006, J BIOL CHEM, V281, P26569, DOI 10.1074/jbc.M600592200; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Stromberg K, 2005, J NEUROCHEM, V95, P880, DOI 10.1111/j.1471-4159.2005.03415.x; Taniguchi Y, 2002, P NATL ACAD SCI USA, V99, P4014, DOI 10.1073/pnas.052017699; TERANISHI Y, 2010, J CELL MOL IN PRESS; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Wolfe MS, 2007, EMBO REP, V8, P136, DOI 10.1038/sj.embor.7400896; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Xia XF, 2002, P NATL ACAD SCI USA, V99, P8760, DOI 10.1073/pnas.132045399; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Zhao B, 2008, J BIOL CHEM, V283, P2927, DOI 10.1074/jbc.M708870200	43	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8527	8536		10.1074/jbc.M109.055590	http://dx.doi.org/10.1074/jbc.M109.055590			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20106965	hybrid, Green Accepted, Green Published			2022-12-27	WOS:000275553700004
J	Balcer, HI; Daugherty-Clarke, K; Goode, BL				Balcer, Heath I.; Daugherty-Clarke, Karen; Goode, Bruce L.			The p40/ARPC1 Subunit of Arp2/3 Complex Performs Multiple Essential Roles in WASp-regulated Actin Nucleation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; SACCHAROMYCES-CEREVISIAE; CONFORMATIONAL-CHANGES; INDIVIDUAL SUBUNITS; WASP/SCAR PROTEINS; IN-VIVO; YEAST; BINDING; NUCLEOTIDE; DOMAIN	The Arp2/3 complex is a conserved seven-subunit actin-nucleating machine activated by WASp (Wiskott Aldrich syndrome protein). Despite its central importance in a broad range of cellular processes, many critical aspects of the mechanism of the Arp2/3 complex have yet to be resolved. In particular, some of the individual subunits in the complex have not been assigned clear functional roles, including p40/ARPC1. Here, we dissected the structure and function of Saccharomyces cerevisiae p40/ARPC1, which is encoded by the essential ARC40 gene, by analyzing 39 integrated alleles that target its conserved surfaces. We identified three distinct sites on p40/ARPC1 required for function in vivo: one site contacts p19/ARPC4, one contacts p15/ARPC5, and one site resides in an extended structural "arm" of p40/ARPC1. Using a novel strategy, we purified the corresponding lethal mutant Arp2/3 complexes from yeast and compared their actin nucleation activities. Lethal mutations at the contact with p19/ARPC4 specifically impaired WASp-induced nucleation. In contrast, lethal mutations at the contact with p15/ARPC5 led to unregulated ("leaky") nucleation in the absence of WASp. Lethal mutations in the extended arm drastically reduced nucleation, and the same mutations disrupted the ability of the purified p40/ARPC1 arm domain to bind the VCA domain of WASp. Together, these data indicate that p40/ARPC1 performs at least three distinct, essential functions in regulating Arp2/3 complex-mediated actin assembly: 1) suppression of spontaneous nucleation by the Arp2/3 complex, which requires proper contacts with p15/ARPC5; 2) propagation of WASp activation signals via contacts with p19/ARPC2; and 3) direct facilitation of actin nucleation through interactions of the extended arm with the VCA domain of WASp.	[Goode, Bruce L.] Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA	Brandeis University	Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, 415 South St, Waltham, MA 02454 USA.	goode@brandeis.edu			National Institutes of Health [GM63691, GM083137]; March of Dimes [MOD 1-FY07-508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083137, T32GM007596, R01GM063691] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM63691 and GM083137 (to B. G.). This work was also supported by March of Dimes Grant MOD 1-FY07-508.	[Anonymous], 1991, Methods Enzymol, V194, P1; Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X; Beltzner CC, 2004, J MOL BIOL, V336, P551, DOI 10.1016/j.jmb.2003.12.017; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; D'Agostino JL, 2005, GENETICS, V171, P35, DOI 10.1534/genetics.105.040634; Daugherty KM, 2008, J BIOL CHEM, V283, P16950, DOI 10.1074/jbc.M800783200; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Goley ED, 2004, MOL CELL, V16, P269, DOI 10.1016/j.molcel.2004.09.018; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; KELLEHER JF, 1995, J CELL BIOL, V131, P385, DOI 10.1083/jcb.131.2.385; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kozminski KG, 2000, MOL BIOL CELL, V11, P339, DOI 10.1091/mbc.11.1.339; Lappalainen P, 1997, EMBO J, V16, P5520, DOI 10.1093/emboj/16.18.5520; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3; Martin AC, 2005, J CELL BIOL, V168, P315, DOI 10.1083/jcb.200408177; Moreau V, 1996, J CELL BIOL, V134, P117, DOI 10.1083/jcb.134.1.117; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pan F, 2004, J BIOL CHEM, V279, P54629, DOI 10.1074/jbc.M402357200; POLLARD TD, 1984, FEBS LETT, V170, P94, DOI 10.1016/0014-5793(84)81376-9; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X; Rouiller I, 2008, J CELL BIOL, V180, P887, DOI 10.1083/jcb.200709092; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stradal TEB, 2004, TRENDS CELL BIOL, V14, P303, DOI 10.1016/j.tcb.2004.04.007; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Winter DC, 1999, P NATL ACAD SCI USA, V96, P7288, DOI 10.1073/pnas.96.13.7288; Wolven AK, 2000, J CELL BIOL, V150, P895, DOI 10.1083/jcb.150.4.895; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zalevsky J, 2001, J BIOL CHEM, V276, P3468, DOI 10.1074/jbc.M006407200	34	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8481	8491		10.1074/jbc.M109.054957	http://dx.doi.org/10.1074/jbc.M109.054957			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071330	Green Published, hybrid			2022-12-27	WOS:000275413800063
J	Brocker, MJ; Watzlich, D; Saggu, M; Lendzian, F; Moser, J; Jahn, D				Broecker, Markus J.; Waetzlich, Denise; Saggu, Miguel; Lendzian, Friedhelm; Moser, Juergen; Jahn, Dieter			Biosynthesis of (Bacterio) chlorophylls ATP-DEPENDENT TRANSIENT SUBUNIT INTERACTION AND ELECTRON TRANSFER OF DARK OPERATIVE PROTOCHLOROPHYLLIDE OXIDOREDUCTASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGENASE IRON PROTEIN; ADP-ALUMINUM FLUORIDE; AZOTOBACTER-VINELANDII; PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; FE-PROTEIN; 4FE-4S CLUSTER; BCHN-BCHB; STATE; REDUCTION; MGATP	Dark operative protochlorophyllide oxidoreductase (DPOR) catalyzes the light-independent two-electron reduction of protochlorophyllide a to form chlorophyllide a, the last common precursor of chlorophyll a and bacteriochlorophyll a biosynthesis. During ATP-dependent DPOR catalysis the homodimeric ChlL(2) subunit carrying a [4Fe-4S] cluster transfers electrons to the corresponding heterotetrameric catalytic subunit (ChlN/ChlB)(2), which also possesses a redox active [4Fe-4S] cluster. To investigate the transient interaction of both subcomplexes and the resulting electron transfer reactions, the ternary DPOR enzyme holocomplex comprising subunits ChlN, ChlB, and ChlL from the cyanobacterium Prochlorococcus marinus was trapped as an octameric (ChlN/ChlB)(2)(ChlL(2))(2) complex after incubation with the nonhydrolyzable ATP analogs adenosine 5'(gamma-thio) triphosphate, adenosine 5'-(beta,gamma-imido) triphosphate, or MgADP in combination with AlF4-. Aitionally, a mutant ChlL(2) protein, with a deleted Leu(153) in the switch II region also allowed for the formation of a stable octameric complex. Furthermore, efficient complex formation required the presence of protochlorophyllide. Electron paramagnetic resonance spectroscopy of ternary DPOR complexes revealed a reduced [4Fe-4S] cluster located on ChlL(2), indicating that complete ATP hydrolysis is a prerequisite for intersubunit electron transfer. Circular dichroism spectroscopic experiments indicated nucleotide-dependent conformational changes for ChlL(2) after ATP binding. A nucleotide-dependent switch mechanism triggering ternary complex formation and electron transfer was concluded. From these results a detailed redox cycle for DPOR catalysis was deduced.	Tech Univ Carolo Wilhelmina Braunschweig, Inst Mikrobiol, D-38106 Braunschweig, Germany; [Saggu, Miguel; Lendzian, Friedhelm] Tech Univ Berlin, Inst Chem, Max Volmer Lab, D-10623 Berlin, Germany	Braunschweig University of Technology; Technical University of Berlin		j.moser@tu-bs.de	Saggu, Miguel/B-1224-2009	Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	Apel K, 2001, ADV PHOTOSYNTH, V11, P235; Beale SI, 1999, PHOTOSYNTH RES, V60, P43, DOI 10.1023/A:1006297731456; Belyaeva OB, 2001, BIOCHEMISTRY-MOSCOW+, V66, P173, DOI 10.1023/A:1002891531118; BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x; Boll M, 2001, BIOCHEMISTRY-US, V40, P7612, DOI 10.1021/bi002771l; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Chiu HJ, 2001, BIOCHEMISTRY-US, V40, P641, DOI 10.1021/bi001645e; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; Duyvis MG, 1998, BIOCHEMISTRY-US, V37, P17345, DOI 10.1021/bi981509y; Duyvis MG, 1996, FEBS LETT, V380, P233, DOI 10.1016/0014-5793(96)00019-1; EBERTH A, 2009, CURRENT PROTOCOLS CE, V43; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Erickson JA, 1999, BIOCHEMISTRY-US, V38, P14279, DOI 10.1021/bi991389+; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; Fujita Y, 1996, PLANT CELL PHYSIOL, V37, P411, DOI 10.1093/oxfordjournals.pcp.a028962; Guo ML, 2002, J AM CHEM SOC, V124, P12100, DOI 10.1021/ja026478f; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; Heyes DJ, 2003, NAT STRUCT BIOL, V10, P491, DOI 10.1038/nsb929; Heyes DJ, 2002, P NATL ACAD SCI USA, V99, P11145, DOI 10.1073/pnas.182274199; HORIO M, 1988, P NATL ACAD SCI USA, V85, P3580, DOI 10.1073/pnas.85.10.3580; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; HOWARD JB, 1994, ANNU REV BIOCHEM, V63, P235, DOI 10.1146/annurev.bi.63.070194.001315; Igarashi RY, 2003, CRIT REV BIOCHEM MOL, V38, P351, DOI 10.1080/10409230390242380; Kelman Z, 1999, P NATL ACAD SCI USA, V96, P14783, DOI 10.1073/pnas.96.26.14783; LANZILOTTA WN, 1995, BIOCHEMISTRY-US, V34, P15646, DOI 10.1021/bi00048a007; Leslie AGW, 1999, BIOCHEM SOC T, V27, P37, DOI 10.1042/bst0270037; MARUTA S, 1993, J BIOL CHEM, V268, P7093; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; MOSS GP, 1987, PURE APPL CHEM, V59, P779, DOI 10.1351/pac198759060779; Nomata J, 2008, FEBS LETT, V582, P1346, DOI 10.1016/j.febslet.2008.03.018; RAINBIRD RM, 1984, PLANT PHYSIOL, V75, P49, DOI 10.1104/pp.75.1.49; Rees DC, 2000, CURR OPIN CHEM BIOL, V4, P559, DOI 10.1016/S1367-5931(00)00132-0; Renner KA, 1996, BIOCHEMISTRY-US, V35, P5353, DOI 10.1021/bi960441o; RUDIGER W, 2003, PORPHYRIN HDB, V13, P71; Ryle MJ, 1996, J BIOL CHEM, V271, P1551, DOI 10.1074/jbc.271.3.1551; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P4766, DOI 10.1021/bi960026w; Ryle MJ, 1996, BIOCHEMISTRY-US, V35, P9424, DOI 10.1021/bi9608572; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schoefs B, 2001, PHOTOSYNTH RES, V70, P257, DOI 10.1023/A:1014769707404; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Watzlich D, 2009, J BIOL CHEM, V284, P15530, DOI 10.1074/jbc.M901331200; Walther J, 2009, FEMS MICROBIOL LETT, V290, P156, DOI 10.1111/j.1574-6968.2008.01413.x	50	40	40	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8268	8277		10.1074/jbc.M109.087874	http://dx.doi.org/10.1074/jbc.M109.087874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075073	hybrid, Green Published			2022-12-27	WOS:000275413800045
J	Shankar, H; Michal, A; Kern, RC; Kang, DS; Gurevich, VV; Benovic, JL				Shankar, Haripriya; Michal, Allison; Kern, Ronald C.; Kang, Dong Soo; Gurevich, Vsevolod V.; Benovic, Jeffrey L.			Non-visual Arrestins Are Constitutively Associated with the Centrosome and Regulate Centrosome Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; GAMMA-TUBULIN COMPLEXES; POLO-LIKE KINASE; BETA-ARRESTIN; BRCA1-DEPENDENT UBIQUITINATION; BETA(2)-ADRENERGIC RECEPTOR; CHROMOSOMAL INSTABILITY; PROSTATE-CANCER; PRIMARY CILIUM; RING COMPLEX	In addition to regulating receptor activity, non-visual arrestins function as scaffolds for numerous intracellular signaling cascades and as regulators of gene transcription. Here we report that the two non-visual arrestins, arrestin2 and arrestin3, localize to the centrosome, a key organelle involved in microtubule nucleation and bipolar mitotic spindle assembly. Both arrestins co-localized with the centrosomal marker gamma-tubulin during interphase and mitosis and were found in purified centrosome preparations. In vitro binding assays demonstrated that both arrestins directly interact with gamma-tubulin. Knockdown of either arrestin by RNA interference resulted in multinucleation, centrosome amplification, and mitotic defects, although only the loss of arrestin2 triggered aberrant microtubule nucleation. Importantly, overexpression of wild type arrestin rescued the multinucleation phenotype and restored normal centrosome number in arrestin siRNA-transfected cells. Moreover, overexpression of arrestin2 or -3 rescued the multinucleation defect observed in MDA-MB-231 breast cancer cells. Taken together, our data reveal that non-visual arrestins are novel centrosomal components and regulate normal centrosome function.	[Benovic, Jeffrey L.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Gurevich, Vsevolod V.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Jefferson University; Vanderbilt University	Benovic, JL (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, 233 S 10th St, Philadelphia, PA 19107 USA.	benovic@mail.jci.tju.edu	Gurevich, Vsevolod/A-3236-2008	Gurevich, Vsevolod/0000-0002-3950-5351	National Institutes of Health [GM047417, GM077561]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077561, R01GM047417, R37GM047417] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM047417 (to J. L. B.) and GM077561 (to V. V. G.).	Bae I, 2005, CELL CYCLE, V4, P1641, DOI 10.4161/cc.4.11.2152; BAILLY E, 1989, EMBO J, V8, P3985, DOI 10.1002/j.1460-2075.1989.tb08581.x; BENOVIC JL, 1987, P NATL ACAD SCI USA, V84, P8879, DOI 10.1073/pnas.84.24.8879; Bornens M, 2002, CURR OPIN CELL BIOL, V14, P25, DOI 10.1016/S0955-0674(01)00290-3; Bornens M, 1999, METHOD CELL BIOL, V61, P13; Boularan C, 2007, P NATL ACAD SCI USA, V104, P18061, DOI 10.1073/pnas.0705550104; Cho HS, 2005, J BIOL CHEM, V280, P805, DOI 10.1074/jbc.M408163200; Cho H, 2007, J CELL BIOL, V178, P245, DOI 10.1083/jcb.200604114; D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Doxsey S, 1998, NAT GENET, V20, P104, DOI 10.1038/2392; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; FELIX MA, 1994, J CELL BIOL, V124, P19, DOI 10.1083/jcb.124.1.19; Feng Y, 1999, BIOCHEM J, V339, P435, DOI 10.1042/0264-6021:3390435; Ferguson SSG, 1996, SCIENCE, V271, P363, DOI 10.1126/science.271.5247.363; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; GALLANT P, 1992, J CELL BIOL, V117, P213, DOI 10.1083/jcb.117.1.213; Gillies L, 2009, CELL SIGNAL, V21, P675, DOI 10.1016/j.cellsig.2009.01.023; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; GOULD RR, 1977, J CELL BIOL, V73, P601, DOI 10.1083/jcb.73.3.601; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Hanson SM, 2007, J MOL BIOL, V368, P375, DOI 10.1016/j.jmb.2007.02.053; Hinchcliffe EH, 2001, SCIENCE, V291, P1547, DOI 10.1126/science.1056866; Hsu LC, 2001, CANCER RES, V61, P7713; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; KELLOGG DR, 1994, ANNU REV BIOCHEM, V63, P639, DOI 10.1146/annurev.bi.63.070194.003231; Khodjakov A, 2001, J CELL BIOL, V153, P237, DOI 10.1083/jcb.153.1.237; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Krupnick JG, 1997, J BIOL CHEM, V272, P18125, DOI 10.1074/jbc.272.29.18125; Lange BMH, 2000, EMBO J, V19, P1252, DOI 10.1093/emboj/19.6.1252; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Luttrell LM, 2001, P NATL ACAD SCI USA, V98, P2449, DOI 10.1073/pnas.041604898; Ma L, 2007, J CELL SCI, V120, P213, DOI 10.1242/jcs.03338; Mayor T, 1999, FEBS LETT, V452, P92, DOI 10.1016/S0014-5793(99)00534-7; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Milano SK, 2006, J BIOL CHEM, V281, P9812, DOI 10.1074/jbc.M512703200; Molla-Herman A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003728; Mundell SJ, 1999, BIOCHEMISTRY-US, V38, P8723, DOI 10.1021/bi990361v; Mundt KE, 1997, BIOCHEM BIOPH RES CO, V239, P377, DOI 10.1006/bbrc.1997.7378; Neuhaus EM, 2006, J CELL SCI, V119, P3047, DOI 10.1242/jcs.03046; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Orsini MJ, 1998, J BIOL CHEM, V273, P34616, DOI 10.1074/jbc.273.51.34616; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Pihan GA, 2001, CANCER RES, V61, P2212; Quintyne NJ, 2002, J CELL BIOL, V159, P245, DOI 10.1083/jcb.200203089; Reagan-Shaw S, 2005, FASEB J, V19, P611, DOI 10.1096/fj.04-2910fje; Sankaran S, 2005, MOL CELL BIOL, V25, P8656, DOI 10.1128/MCB.25.19.8656-8668.2005; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; STEARNS T, 1994, CELL, V76, P623, DOI 10.1016/0092-8674(94)90503-7; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; TUGENDREICH S, 1995, CELL, V81, P261, DOI 10.1016/0092-8674(95)90336-4; White RA, 2000, MICROSC RES TECHNIQ, V49, P451, DOI 10.1002/(SICI)1097-0029(20000601)49:5<451::AID-JEMT7>3.0.CO;2-9; Xiao K, 2007, P NATL ACAD SCI USA, V104, P12011, DOI 10.1073/pnas.0704849104; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416; Yang AH, 2003, J NEUROSCI, V23, P10454; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0; Zimmerman W, 1999, CURR OPIN CELL BIOL, V11, P122, DOI 10.1016/S0955-0674(99)80015-5; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	65	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8316	8329		10.1074/jbc.M109.062521	http://dx.doi.org/10.1074/jbc.M109.062521			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20056609	hybrid, Green Published			2022-12-27	WOS:000275413800048
J	Tanno, M; Kuno, A; Yano, T; Miura, T; Hisahara, S; Ishikawa, S; Shimamoto, K; Horio, Y				Tanno, Masaya; Kuno, Atsushi; Yano, Toshiyuki; Miura, Tetsuji; Hisahara, Shin; Ishikawa, Satoko; Shimamoto, Kazuaki; Horio, Yoshiyuki			Induction of Manganese Superoxide Dismutase by Nuclear Translocation and Activation of SIRT1 Promotes Cell Survival in Chronic Heart Failure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE ACTIVATORS; OXIDATIVE STRESS; DEACETYLASE ACTIVITY; HISTONE DEACETYLASE; DISEASE; MICE; CARDIOMYOPATHY; RESVERATROL; SIRTUINS; PROTEIN	Oxidative stress plays a pivotal role in chronic heart failure. SIRT1, an NAD(+)-dependent histone/protein deacetylase, promotes cell survival under oxidative stress when it is expressed in the nucleus. However, adult cardiomyocytes predominantly express SIRT1 in the cytoplasm, and its function has not been elucidated. The purpose of this study was to investigate the functional role of SIRT1 in the heart and the potential use of SIRT1 in therapy for heart failure. We investigated the subcellular localization of SIRT1 in cardiomyocytes and its impact on cell survival. SIRT1 accumulated in the nucleus of cardiomyocytes in the failing hearts of TO-2 hamsters, postmyocardial infarction rats, and a dilated cardiomyopathy patient but not in control healthy hearts. Nuclear but not cytoplasmic SIRT1-induced manganese superoxide dismutase (Mn-SOD), which was further enhanced by resveratrol, and increased the resistance of C2C12 myoblasts to oxidative stress. Resveratrol's enhancement of MnSOD levels depended on the level of nuclear SIRT1, and it suppressed the cell death induced by antimycin A or angiotensin II. The cell-protective effects of nuclear SIRT1 or resveratrol were canceled by the Mn-SOD small interfering RNA or SIRT1 small interfering RNA. The oral administration of resveratrol to TO-2 hamsters increased Mn-SOD levels in cardiomyocytes, suppressed fibrosis, preserved cardiac function, and significantly improved survival. Thus, Mn-SOD induced by resveratrol via nuclear SIRT1 reduced oxidative stress and participated in cardiomyocyte protection. SIRT1 activators such as resveratrol could be novel therapeutic tools for the treatment of chronic heart failure.	[Horio, Yoshiyuki] Sapporo Med Univ, Dept Pharmacol, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Tanno, Masaya; Kuno, Atsushi; Yano, Toshiyuki; Miura, Tetsuji; Ishikawa, Satoko; Shimamoto, Kazuaki] Sapporo Med Univ, Dept Internal Med 2, Sapporo, Hokkaido 0608556, Japan; [Hisahara, Shin] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Horio, Y (corresponding author), Sapporo Med Univ, Dept Pharmacol, Chuo Ku, S1,W17, Sapporo, Hokkaido 0608556, Japan.	horio@sapmed.ac.jp	Hisahara, Shin/AAS-8094-2021	Horio, Yoshiyuki/0000-0002-5021-5929; KUNO, ATSUSHI/0000-0001-6873-1297	Grant-in-aid for scientific research [20590869]; National Project; Knowledge Cluster Initiative; Ministry of Education, Culture, Sports, Science and Technology of Japan; Sapporo Medical University; Sapporo Medical University Foundation; Northern Advancement Center for Science and Technology	Grant-in-aid for scientific research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Project; Knowledge Cluster Initiative(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sapporo Medical University; Sapporo Medical University Foundation; Northern Advancement Center for Science and Technology	This work was supported in part by a Grant-in-aid for scientific research (20590869), a grant from a National Project, "Knowledge Cluster Initiative," (2nd stage, "Sapporo Biocluster Bio-S") and Program for developing the supporting system for upgrading the education and research from the Ministry of Education, Culture, Sports, Science and Technology of Japan, grants from The Special Fund for Medical Research from Sapporo Medical University and the Sapporo Medical University Foundation for Promotion of Medical Science, and the Northern Advancement Center for Science and Technology.	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Casper RF, 1999, MOL PHARMACOL, V56, P784; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dorn GW, 2005, J CLIN INVEST, V115, P527, DOI 10.1172/JCI200524178; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Hisahara S, 2008, P NATL ACAD SCI USA, V105, P15599, DOI 10.1073/pnas.0800612105; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; LI YB, 1995, NAT GENET, V11, P376, DOI 10.1038/ng1295-376; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McMullen JR, 2007, P NATL ACAD SCI USA, V104, P612, DOI 10.1073/pnas.0606663104; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Robb EL, 2008, BIOCHEM BIOPH RES CO, V372, P254, DOI 10.1016/j.bbrc.2008.05.028; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sakamoto A, 1997, P NATL ACAD SCI USA, V94, P13873, DOI 10.1073/pnas.94.25.13873; Sentman ML, 2006, J BIOL CHEM, V281, P6904, DOI 10.1074/jbc.M510764200; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Valenti L, 2004, J MED GENET, V41, P946, DOI 10.1136/jmg.2004.019588; van der Horst A, 2004, J BIOL CHEM, V279, P28873, DOI 10.1074/jbc.M401138200; Yen HC, 1996, J CLIN INVEST, V98, P1253, DOI 10.1172/JCI118909	36	281	297	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8375	8382		10.1074/jbc.M109.090266	http://dx.doi.org/10.1074/jbc.M109.090266			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20089851	Green Published, hybrid			2022-12-27	WOS:000275413800053
J	Xiong, LW; Kleerekoper, QK; Wang, X; Putkey, JA				Xiong, Liang-Wen; Kleerekoper, Quinn K.; Wang, Xu; Putkey, John A.			Intra- and Interdomain Effects Due to Mutation of Calcium-binding Sites in Calmodulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; CARDIAC TROPONIN-C; CA2+ BINDING; GLOBULAR DOMAINS; TERMINAL DOMAIN; APO-CALMODULIN; CHANNELS; PROTEINS; PEP-19; MECHANISM	The IQ-motif protein PEP-19, binds to the C-domain of calmodulin (CaM) with significantly different k(on) and k(off) rates in the presence and absence of Ca2+, which could play a role in defining the levels of free CaM during Ca2+ transients. The initial goal of the current study was to determine whether Ca2+ binding to sites III or IV in the C-domain of CaM was responsible for affecting the kinetics of binding PEP-19. EF-hand Ca2+ binding sites were selectively inactivated by the common strategy of changing Asp to Ala at the X-coordination position. Although Ca2+ binding to both sites III and IV appeared necessary for native-like interactions with PEP-19, the data also indicated that the mutations caused undesirable structural alterations as evidenced by significant changes in amide chemical shifts for apoCaM. Mutations in the C-domain also affected chemical shifts in the unmodified N-domain, and altered the Ca2+ binding properties of the N-domain. Conversion of Asp(93) to Ala caused the greatest structural perturbations, possibly due to the loss of stabilizing hydrogen bonds between the side chain of Asp(93) and backbone amides in apo loop III. Thus, although these mutations inhibit binding of Ca2+, the mutated CaM may not be able to support potentially important native-like activity of the apoprotein. This should be taken into account when designing CaM mutants for expression in cell culture.	[Putkey, John A.] Univ Texas Houston, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA; Univ Texas Houston, Houston Med Sch, Struct Biol Ctr, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Putkey, JA (corresponding author), Univ Texas Houston, Houston Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	john.putkey@uth.tmc.edu		Wang, Xu/0000-0002-8266-098X	National Institutes of Health [GM069611, NS038310]; American Heart Association [09GRATN2280427]; Robert A. Welch Foundation [AU1144]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038310] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM069611 and NS038310, American Heart Association Grant 09GRATN2280427, and Robert A. Welch Foundation Grant AU1144.	Bayley PM, 1996, PROTEIN SCI, V5, P1215, DOI 10.1002/pro.5560050701; Chen YG, 2007, J AM CHEM SOC, V129, P2414, DOI 10.1021/ja067791a; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dodd R, 2008, J BIOL CHEM, V283, P26911, DOI 10.1074/jbc.M801434200; DOTSON DG, 1993, J BIOL CHEM, V268, P24067; Erhardt JA, 2000, NEUROREPORT, V11, P3719, DOI 10.1097/00001756-200011270-00026; Evans TIA, 2009, PROTEINS, V76, P47, DOI 10.1002/prot.22317; Evenas J, 1998, BIOCHEMISTRY-US, V37, P13744, DOI 10.1021/bi9806448; Evenas J, 1997, BIOCHEMISTRY-US, V36, P3448, DOI 10.1021/bi9628275; Fallon JL, 2003, STRUCTURE, V11, P1303, DOI 10.1016/j.str.2003.09.004; Fefeu S, 2000, BIOCHEMISTRY-US, V39, P15920, DOI 10.1021/bi001772a; Gagne SM, 1997, BIOCHEMISTRY-US, V36, P4386, DOI 10.1021/bi963076+; HAIECH J, 1991, J BIOL CHEM, V266, P3427; Joseph JD, 2002, EUKARYOT CELL, V1, P119, DOI 10.1128/EC.01.1.119-125.2002; Kanazawa Y, 2008, NEUROSCIENCE, V154, P473, DOI 10.1016/j.neuroscience.2008.03.044; Kasri NN, 2006, J BIOL CHEM, V281, P8332, DOI 10.1074/jbc.M510971200; Kasri NN, 2004, MOL PHARMACOL, V66, P276, DOI 10.1124/mol.66.2.276; Kasri NN, 2003, J BIOL CHEM, V278, P27548, DOI 10.1074/jbc.M302026200; Kleerekoper QK, 2009, J BIOL CHEM, V284, P7455, DOI 10.1074/jbc.M808067200; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lambers TT, 2004, J BIOL CHEM, V279, P28855, DOI 10.1074/jbc.M313637200; LEACHMAN SA, 1992, J BIOL CHEM, V267, P4930; Lee A, 2003, P NATL ACAD SCI USA, V100, P16059, DOI 10.1073/pnas.2237000100; LEUNG LLK, 1984, J CLIN INVEST, V74, P1764, DOI 10.1172/JCI111595; Li L, 2005, J BIOL CHEM, V280, P13097, DOI 10.1074/jbc.M410642200; LINSE S, 1991, J BIOL CHEM, V266, P8050; Lundstrom P, 2005, P NATL ACAD SCI USA, V102, P16984, DOI 10.1073/pnas.0504361102; Mahajan A, 2008, BIOPHYS J, V94, P411, DOI 10.1529/biophysj.106.98590; MARTIN SR, 1992, EUR J BIOCHEM, V205, P1107, DOI 10.1111/j.1432-1033.1992.tb16879.x; MAUNE JF, 1992, J BIOL CHEM, V267, P5286; NADIF KN, 2005, MOL PHARM, V68, P241; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Rabl CR, 2002, BIOPHYS CHEM, V101, P553, DOI 10.1016/S0301-4622(02)00150-3; Ravindran A, 2008, P NATL ACAD SCI USA, V105, P8154, DOI 10.1073/pnas.0711624105; Ravindran A, 2009, CHANNELS, V3, P25, DOI 10.4161/chan.3.1.7498; REINACH FC, 1986, NATURE, V322, P80, DOI 10.1038/322080a0; RENNER M, 1993, P NATL ACAD SCI USA, V90, P6493, DOI 10.1073/pnas.90.14.6493; SHENG ZL, 1990, J BIOL CHEM, V265, P21554; Slemmon JR, 1996, J BIOL CHEM, V271, P15911, DOI 10.1074/jbc.271.27.15911; Spratt DE, 2007, BBA-PROTEINS PROTEOM, V1774, P1351, DOI 10.1016/j.bbapap.2007.07.019; Stroffekova K, 2008, PFLUG ARCH EUR J PHY, V455, P873, DOI 10.1007/s00424-007-0344-x; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; VanScyoc WS, 2002, BIOPHYS J, V83, P2767, DOI 10.1016/S0006-3495(02)75286-7; Vermassen E, 2004, BIOCHEM BIOPH RES CO, V319, P888, DOI 10.1016/j.bbrc.2004.05.071; Wei F, 2003, J NEUROSCI, V23, P8402; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	54	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8094	8103		10.1074/jbc.M109.065243	http://dx.doi.org/10.1074/jbc.M109.065243			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20048169	hybrid, Green Published			2022-12-27	WOS:000275413800027
J	Oliveira, L; Cuervo, A; Tavares, P				Oliveira, Leonor; Cuervo, Ana; Tavares, Paulo			Direct Interaction of the Bacteriophage SPP1 Packaging ATPase with the Portal Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION; FUNCTIONAL DOMAINS; TERMINASE ENZYME; LARGE SUBUNIT; DNA; MOTOR; NUCLEASE; REGION; FORMS; GENE	DNA packaging in tailed bacteriophages and other viruses requires assembly of a complex molecular machine at a specific vertex of the procapsid. This machine is composed of the portal protein that provides a tunnel for DNA entry, an ATPase that fuels DNA translocation (large terminase subunit), and most frequently, a small terminase subunit. Here we characterized the interaction between the terminase ATPase subunit of bacteriophage SPP1 (gp2) and the procapsid portal vertex. We found, by affinity pulldown assays with purified proteins, that gp2 interacts with the portal protein, gp6, independently of the terminase small subunit gp1, DNA, or ATP. The gp2-procapsid interaction via the portal protein depends on gp2 concentration and requires the presence of divalent cations. Competition experiments showed that isolated gp6 can only inhibit gp2-procapsid interactions and DNA packaging at gp6: procapsid molar ratios above 10-fold. Assays with gp6 carrying mutations in distinct regions of its structure that affect the portal-induced stimulation of ATPase and DNA packaging revealed that none of these mutations impedes gp2-gp6 binding. Our results demonstrate that the SPP1 packaging ATPase binds directly to the portal and that the interaction is stronger with the portal embedded in procapsids. Identification of mutations in gp6 that allow for assembly of the ATPase-portal complex but impair DNA packaging support an intricate cross-talk between the two proteins for activity of the DNA translocation motor.	[Oliveira, Leonor] CNRS 2472, Inst Federatif Rech 1157, Unite Virol Mol & Struct, Unite Mixte Rech, F-91190 Gif Sur Yvette, France; IFR 115, F-91190 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Oliveira, L (corresponding author), CNRS 2472, Inst Federatif Rech 1157, Unite Virol Mol & Struct, Unite Mixte Rech, Batiment 14B,Ave Terrasse, F-91190 Gif Sur Yvette, France.	oliveira@vms.cnrs-gif.fr		Cuervo, Ana/0000-0001-9414-503X; Tavares, Paulo/0000-0002-2566-4546	CNRS; Agence Nationale de la Recherche [ANR-06-BLAN-0168]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS institutional funding and by Agence Nationale de la Recherche Grant ANR-06-BLAN-0168.	Agirrezabala X, 2005, J MOL BIOL, V347, P895, DOI 10.1016/j.jmb.2005.02.005; Alam TI, 2008, MOL MICROBIOL, V69, P1180, DOI 10.1111/j.1365-2958.2008.06344.x; BAZINET C, 1985, ANNU REV MICROBIOL, V39, P109; BLACK LW, 1989, ANNU REV MICROBIOL, V43, P267, DOI 10.1146/annurev.micro.43.1.267; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camacho AG, 2003, J BIOL CHEM, V278, P23251, DOI 10.1074/jbc.M301805200; Casjens S, 1988, BACTERIOPHAGES, P15; Catalano Carlos Enrique, 2005, P1; CHAI S, 1992, J MOL BIOL, V224, P87, DOI 10.1016/0022-2836(92)90578-8; CHAI SH, 1995, J MOL BIOL, V252, P386, DOI 10.1006/jmbi.1995.0505; Cuervo A, 2007, J BIOL CHEM, V282, P18907, DOI 10.1074/jbc.M701808200; DEMEDICIS E, 1986, APPL ENVIRON MICROB, V52, P567; Droge A, 2000, J MOL BIOL, V296, P103, DOI 10.1006/jmbi.1999.3449; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Gual A, 1998, VIROLOGY, V242, P279, DOI 10.1006/viro.1997.9017; Gual A, 2000, J BIOL CHEM, V275, P35311, DOI 10.1074/jbc.M004309200; GUO PX, 1987, J MOL BIOL, V197, P219, DOI 10.1016/0022-2836(87)90120-3; HAIMA P, 1987, MOL GEN GENET, V209, P335, DOI 10.1007/BF00329663; Harlow E., 1988, ANTIBODIES LAB MANUA; Isidro A, 2004, VIROLOGY, V322, P253, DOI 10.1016/j.virol.2004.02.012; Isidro A, 2004, MOL MICROBIOL, V51, P949, DOI 10.1046/j.1365-2958.2003.03880.x; Jekow P, 1999, EUR J BIOCHEM, V264, P724, DOI 10.1046/j.1432-1327.1999.00601.x; Koti JS, 2008, J MOL BIOL, V381, P1114, DOI 10.1016/j.jmb.2008.04.034; Lebedev AA, 2007, EMBO J, V26, P1984, DOI 10.1038/sj.emboj.7601643; Lin HC, 1999, J MOL BIOL, V289, P249, DOI 10.1006/jmbi.1999.2781; Lurz R, 2001, J MOL BIOL, V310, P1027, DOI 10.1006/jmbi.2001.4800; Morais MC, 2008, STRUCTURE, V16, P1267, DOI 10.1016/j.str.2008.05.010; MORITA M, 1995, J MOL BIOL, V245, P635, DOI 10.1006/jmbi.1994.0052; MORITA M, 1993, VIROLOGY, V193, P748, DOI 10.1006/viro.1993.1183; Newcomb WW, 2001, J VIROL, V75, P10923, DOI 10.1128/JVI.75.22.10923-10932.2001; Oliveira L, 2005, J MOL BIOL, V353, P529, DOI 10.1016/j.jmb.2005.08.063; Oliveira L, 2006, J BIOL CHEM, V281, P21914, DOI 10.1074/jbc.M603314200; Orlova EV, 2003, EMBO J, V22, P1255, DOI 10.1093/emboj/cdg123; Rao VB, 2008, ANNU REV GENET, V42, P647, DOI 10.1146/annurev.genet.42.110807.091545; Simpson AA, 2000, NATURE, V408, P745, DOI 10.1038/35047129; Smith DE, 2001, NATURE, V413, P748, DOI 10.1038/35099581; Smits C, 2009, EMBO REP, V10, P592, DOI 10.1038/embor.2009.53; STUDIER FW, 1991, J MOL BIOL, V219, P37, DOI 10.1016/0022-2836(91)90855-Z; Sun SY, 2007, MOL CELL, V25, P943, DOI 10.1016/j.molcel.2007.02.013; Sun S, 2008, CELL, V135, P1251, DOI 10.1016/j.cell.2008.11.015; TAVARES P, 1992, J MOL BIOL, V225, P81, DOI 10.1016/0022-2836(92)91027-M; VALPUESTA JM, 1994, Q REV BIOPHYS, V27, P107, DOI 10.1017/S0033583500004510; YEO A, 1995, J MOL BIOL, V245, P141, DOI 10.1006/jmbi.1994.0013	43	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7366	7373		10.1074/jbc.M109.061010	http://dx.doi.org/10.1074/jbc.M109.061010			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056615	hybrid, Green Published			2022-12-27	WOS:000275415600049
J	Hao, WS; Chang, CPB; Tsao, CC; Xu, J				Hao, Wenshan; Chang, Chao-Pei Betty; Tsao, Cheng-Chung; Xu, Jun			Oligomycin-induced Bioenergetic Adaptation in Cancer Cells with Heterogeneous Bioenergetic Organization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NITRIC-OXIDE; GLYCOLYSIS; METABOLISM; AMPK; 6-PHOSPHOFRUCTO-2-KINASE; PHOSPHORYLATION; PROLIFERATION; TRANSLOCATION; STIMULATION	Cancer cells constantly adapt to oxidative phosphorylation (OXPHOS) suppression resulting from hypoxia or mitochondria defects. Under the OXPHOS suppression, AMP-activated protein kinase (AMPK) regulates global metabolism adjustments, but its activation has been found to be transient. Whether cells can maintain cellular ATP homeostasis and survive beyond the transient AMPK activation is not known. Here, we study the bioenergetic adaptation to the OXPHOS inhibitor oligomycin in a group of cancer cells. We found that oligomycin at 100 ng/ml completely inhibits OXPHOS activity in 1 h and induces various levels of glycolysis gains by 6 h, from which we calculate the bioenergetic organizations of cancer cells. In glycolysis-dominant cells, oligomycin does not induce much energy stress as measured by glycolysis acceleration, ATP imbalance, AMPK activation, AMPK substrate acetyl-CoA carboxylase phosphorylation at Ser(79), and cell growth inhibition. In OXPHOS-dependent LKB1 wild type cells, oligomycin induces 5-8% ATP drops and transient AMPK activation during the initial 1-2 h. After AMPK activation is completed, oligomycin-induced increase of acetyl-CoA carboxylase phosphorylation at Ser(79) is still detected, and cellular ATP is back at preoligomycin treatment levels by sustained elevation of glycolysis. Cell growth, however, is inhibited without an increase in cell death and alteration in cell cycle distribution. In OXPHOS-dependent LKB1-null cells, no AMPK activation by oligomycin is detected, yet cells still show a similar adaptation. We also demonstrate that the adaptation to oligomycin does not invoke activation of hypoxia-induced factor. Our data suggest that cancer cells may grow and survive persistent OXPHOS suppression through an as yet unidentified regulatory mechanism.	[Hao, Wenshan; Chang, Chao-Pei Betty; Tsao, Cheng-Chung; Xu, Jun] Wyeth Res, Dept Oncol, Pearl River, NY 10965 USA	Pfizer	Hao, WS (corresponding author), Wyeth Res, Dept Oncol, 401 Middletown Rd 200-4614, Pearl River, NY 10965 USA.	ytwhao@yahoo.com						Almeida A, 2001, P NATL ACAD SCI USA, V98, P15294, DOI 10.1073/pnas.261560998; Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Capuano F, 1997, J BIOENERG BIOMEMBR, V29, P379, DOI 10.1023/A:1022402915431; Cuezva JM, 2002, CANCER RES, V62, P6674; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Hardie DG, 2000, CURR BIOL, V10, pR757, DOI 10.1016/S0960-9822(00)00744-2; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lopez-Rios F, 2007, CANCER RES, V67, P9013, DOI 10.1158/0008-5472.CAN-07-1678; Marsin AS, 2000, CURR BIOL, V10, P1247, DOI 10.1016/S0960-9822(00)00742-9; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Russell RR, 1999, AM J PHYSIOL-HEART C, V277, pH643, DOI 10.1152/ajpheart.1999.277.2.H643; Samudio I, 2008, CANCER RES, V68, P5198, DOI 10.1158/0008-5472.CAN-08-0555; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	24	88	92	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12647	12654		10.1074/jbc.M109.084194	http://dx.doi.org/10.1074/jbc.M109.084194			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20110356	Green Published, hybrid			2022-12-27	WOS:000276787800023
J	Zhang, Y; Raudah, S; Teo, H; Teo, GWS; Fan, RL; Sun, XM; Orner, BP				Zhang, Yu; Raudah, Siti; Teo, Huihian; Teo, Gwenda W. S.; Fan, Rongli; Sun, Xiaoming; Orner, Brendan P.			Alanine-shaving Mutagenesis to Determine Key Interfacial Residues Governing the Assembly of a Nano-cage Maxi-ferritin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; HOT-SPOTS; PROTEIN CAGES; H-CHAIN; BUILDING-BLOCKS; VIRUS-PARTICLES; HORSE SPLEEN; HELIX; DNA; BACTERIOFERRITIN	The fundamental process of protein self-assembly is governed by protein-protein interactions between subunits, which combine to form structures that are often on the nano-scale. The nano-cage protein, bacterioferritin from Escherichia coli, a maxi-ferritin made up of 24 subunits, was chosen as the basis for an alanine-shaving mutagenesis study to discover key amino acid residues at symmetry-related protein-protein interfaces that control protein stability and self-assembly. By inspection of these interfaces and "virtual alanine scanning," nine mutants were designed, expressed, purified, and characterized using transmission electron microscopy, size exclusion chromatography, dynamic light scattering, native PAGE, and temperature-dependent CD. Many of the selected amino acids act as hot spot residues. Four of these (Arg-30, which is located at the two-fold axis, and Arg-61, Tyr-114, and Glu-128, which are located at the three-fold axis), when individually mutated to alanine, completely shut down detectable solution formation of 24-mer, favoring a cooperatively folded dimer, suggesting that they may be oligomerization "switch residues." Furthermore, two residues, Arg-30 and Arg-61, when changed to alanine form mutants that are more thermodynamically stable than the native protein. This investigation into the structure and energetics of this self-assembling nano-cage protein not only can act as a jumping off point for the eventual design of novel protein nanostructures but can also help to understand the role that structure plays on the function of this important class of proteins.	[Zhang, Yu; Raudah, Siti; Teo, Huihian; Teo, Gwenda W. S.; Fan, Rongli; Sun, Xiaoming; Orner, Brendan P.] Nanyang Technol Univ, Div Chem & Biol Chem, Sch Phys & Math Sci, Singapore 637371, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Orner, BP (corresponding author), Nanyang Technol Univ, Div Chem & Biol Chem, Sch Phys & Math Sci, 21 Nanyang Link, Singapore 637371, Singapore.	orner@ntu.edu.sg	Lazim, Raudah/N-2119-2018	ZHANG, YU/0000-0002-2614-5975	School of Physical and Mathematical Sciences (SPMS); Singapore Ministry of Education Academic Research Fund Tier 1 [RG 53/06]	School of Physical and Mathematical Sciences (SPMS); Singapore Ministry of Education Academic Research Fund Tier 1(Ministry of Education, Singapore)	This work was supported by a School of Physical and Mathematical Sciences (SPMS) start up grant and Singapore Ministry of Education Academic Research Fund Tier 1 Grant RG 53/06.	ALMIRON M, 1992, GENE DEV, V6, P2646, DOI 10.1101/gad.6.12b.2646; ANDREWS SC, 1993, EUR J BIOCHEM, V213, P329, DOI 10.1111/j.1432-1033.1993.tb17766.x; Bellapadrona G, 2009, J BIOL CHEM, V284, P19101, DOI 10.1074/jbc.M109.014670; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Bromley EHC, 2008, ACS CHEM BIOL, V3, P38, DOI 10.1021/cb700249v; Butts CA, 2009, P NATL ACAD SCI USA, V106, P6501, DOI 10.1073/pnas.0810590106; Calhoun JR, 2008, J AM CHEM SOC, V130, P9188, DOI 10.1021/ja801657y; Chamberlain AK, 2004, J MOL BIOL, V339, P471, DOI 10.1016/j.jmb.2004.03.072; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; Dautant A, 1998, ACTA CRYSTALLOGR D, V54, P16, DOI 10.1107/S0907444997006811; Destito G, 2007, CHEM BIOL, V14, P1152, DOI 10.1016/j.chembiol.2007.08.015; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Fan RL, 2009, BIOCHEMISTRY-US, V48, P5623, DOI 10.1021/bi900387t; Fletcher S, 2007, CURR TOP MED CHEM, V7, P922, DOI 10.2174/156802607780906735; GERL M, 1988, BIOCHEMISTRY-US, V27, P4089, DOI 10.1021/bi00411a027; Grant RA, 1998, NAT STRUCT BIOL, V5, P294, DOI 10.1038/nsb0498-294; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Hill RB, 2000, ACCOUNTS CHEM RES, V33, P745, DOI 10.1021/ar970004h; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Ingrassia R, 2006, J BIOCHEM, V139, P881, DOI 10.1093/jb/mvj101; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; JIN L, 1994, PROTEIN SCI, V3, P2351, DOI 10.1002/pro.5560031219; Kennedy D, 2005, SCIENCE, V309, P75, DOI 10.1126/science.309.5731.75; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; KORTEMME T, 2004, SCI STKE, P12, DOI DOI 10.1126/STKE.2192004P12; Levi S, 2005, BEST PRACT RES CL HA, V18, P265, DOI 10.1016/j.beha.2004.08.021; LEVI S, 1989, BIOCHEM J, V264, P381, DOI 10.1042/bj2640381; Liu XF, 2003, P NATL ACAD SCI USA, V100, P3653, DOI 10.1073/pnas.0636928100; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; LUZZAGO A, 1989, EMBO J, V8, P569, DOI 10.1002/j.1460-2075.1989.tb03411.x; Moreira IS, 2007, PROTEINS, V68, P803, DOI 10.1002/prot.21396; Papapostolou D, 2007, P NATL ACAD SCI USA, V104, P10853, DOI 10.1073/pnas.0700801104; Pieraccini S, 2009, NAT CHEM, V1, P642, DOI [10.1038/nchem.401, 10.1038/NCHEM.401]; Ren Y, 2007, BIOCONJUGATE CHEM, V18, P836, DOI 10.1021/bc060361p; SEGREST JP, 1992, J LIPID RES, V33, P141; Seringhaus M, 2007, SCIENCE, V315, P40, DOI 10.1126/science.315.5808.40; STEFANINI S, 1987, BIOCHEMISTRY-US, V26, P1831, DOI 10.1021/bi00381a007; Tong GJ, 2009, J AM CHEM SOC, V131, P11174, DOI 10.1021/ja903857f; Turk JA, 2001, J ORG CHEM, V66, P8328, DOI 10.1021/jo0106849; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Vidal R, 2003, J NEUROL SCI, V207, P110, DOI 10.1016/S0022-510X(02)00435-5; Wang Q, 2002, ANGEW CHEM INT EDIT, V41, P459; Young L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh058; Zandman-Goddard G, 2007, AUTOIMMUN REV, V6, P457, DOI 10.1016/j.autrev.2007.01.016	45	41	43	3	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12078	12086		10.1074/jbc.M109.092445	http://dx.doi.org/10.1074/jbc.M109.092445			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20139406	hybrid, Green Published			2022-12-27	WOS:000276787100037
J	Henderson, MJ; Vij, N; Zeitlin, PL				Henderson, Mark J.; Vij, Neeraj; Zeitlin, Pamela L.			Ubiquitin C-terminal Hydrolase-L1 Protects Cystic Fibrosis Transmembrane Conductance Regulator from Early Stages of Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; GREEN FLUORESCENT PROTEIN; CELL-CYCLE ANALYSIS; DEUBIQUITINATING ENZYMES; DOWN-REGULATION; QUALITY-CONTROL; L1 GENE; CFTR; DISEASE; UCH-L1	Delta F508 cystic fibrosis transmembrane conductance regulator (CFTR) degradation involves ubiquitin modification and efficient proteasomal targeting of the nascent misfolded protein. We show that a deubiquitinating enzyme, ubiquitin C-terminal hydrolase-L1 (UCH-L1), is highly expressed in cystic fibrosis (CF) airway epithelial cells in vitro and in vivo. We hypothesized that the elevation in UCH-L1 in CF cells represents a cellular adaptation to counterbalance excessive proteasomal degradation. The bronchial epithelial cell lines IB3-1 (CF, high UCH-L1 expression) and S9 (non-CF, low UCH-L1 expression) were transiently transfected with wild type (WT) or Delta F508 CFTR, WTUCH-L1 or small interfering RNA-UCH-L1, and a variety of ubiquitin mutants. We observed a positive correlation between UCH-L1 expression and steady state levels of WT- or Delta F508CFTR, and this stabilizing effect was confined to the early stages of CFTR synthesis. Immunolocalization of UCH-L1 by confocal microscopy revealed a partial co-localization with a ribosomal subunit and the endoplasmic reticulum. The UCH-L1-associated increase in CFTR levels was correlated with an increase in ubiquitinated CFTR (CFTR-Ub). Co-transfection with mutant ubiquitins and treatment with proteasome inhibitors suggested that UCH-L1 was reducing the proteasomal targeting of CFTR during synthesis by shortening conjugated polyubiquitin chains. Although not sufficient by itself to rescue mutant CFTR therapeutically, the elevation of UCH-L1 and its effect on CFTR processing provides insight into its potential roles in CF and other diseases.	[Henderson, Mark J.; Vij, Neeraj; Zeitlin, Pamela L.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Zeitlin, PL (corresponding author), 200 N wolfe St,Rm 3051, Baltimore, MD 21287 USA.	pzeitlin@jhmi.edu		Henderson, Mark/0000-0001-8590-7338; Zeitlin, Pamela/0000-0002-2719-1834	National Institutes of Health [R01 HL59410, BAA-HL-0204]; CTSA [UL1 RR 025005]; Cystic Fibrosis Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059410, R03HL096931] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL59410, BAA-HL-0204, and CTSA UL1 RR 025005 (to P.L.Z.). This work was also supported by a Cystic Fibrosis Foundation grant (to N.V.).	Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Ardley HC, 2004, J NEUROCHEM, V90, P379, DOI 10.1111/j.1471-4159.2004.02485.x; Arndt V, 2005, MOL BIOL CELL, V16, P5891, DOI 10.1091/mbc.E05-07-0660; Caballero OL, 2002, ONCOGENE, V21, P3003, DOI 10.1038/sj.onc.1205390; Carlson EJ, 2006, EMBO J, V25, P4557, DOI 10.1038/sj.emboj.7601307; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Farinha CA, 2005, MOL CELL BIOL, V25, P5242, DOI 10.1128/MCB.25.12.5242-5252.2005; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200; GRUENERT DC, 1988, P NATL ACAD SCI USA, V85, P5951, DOI 10.1073/pnas.85.16.5951; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Iwai K, 2009, EMBO REP, V10, P706, DOI 10.1038/embor.2009.144; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kalejta RF, 1999, EXP CELL RES, V248, P322, DOI 10.1006/excr.1999.4427; Kalejta RF, 1997, CYTOMETRY, V29, P286, DOI 10.1002/(SICI)1097-0320(19971201)29:4<286::AID-CYTO4>3.0.CO;2-8; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Maraganore DM, 1999, NEUROLOGY, V53, P1858, DOI 10.1212/WNL.53.8.1858; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Miyoshi Y, 2006, CANCER SCI, V97, P523, DOI 10.1111/j.1349-7006.2006.00202.x; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Moyer BD, 1998, J BIOL CHEM, V273, P21759, DOI 10.1074/jbc.273.34.21759; Naze P, 2002, NEUROSCI LETT, V328, P1, DOI 10.1016/S0304-3940(02)00231-8; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pollard HB, 2006, MOL CELL PROTEOMICS, V5, P1628, DOI 10.1074/mcp.M600091-MCP200; Qu BH, 1997, J BIOENERG BIOMEMBR, V29, P483, DOI 10.1023/A:1022439108101; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rolen U, 2006, MOL CARCINOGEN, V45, P260, DOI 10.1002/mc.20177; Rubenstein RC, 2000, AM J PHYSIOL-CELL PH, V278, pC259, DOI 10.1152/ajpcell.2000.278.2.C259; Sato S, 1998, J BIOL CHEM, V273, P7189, DOI 10.1074/jbc.273.13.7189; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Singh OV, 2008, MOL CELL PROTEOMICS, V7, P1099, DOI 10.1074/mcp.M700303-MCP200; Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200; Swaminathan S, 1999, MOL BIOL CELL, V10, P2583, DOI 10.1091/mbc.10.8.2583; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tokumaru Y, 2008, INT J CANCER, V123, P753, DOI 10.1002/ijc.23354; Tokunaga Fuminori, 2009, Tanpakushitsu Kakusan Koso, V54, P635; Van Oene M, 2000, J BIOL CHEM, V275, P19577, DOI 10.1074/jbc.M002186200; Vij N, 2006, J BIOL CHEM, V281, P17369, DOI 10.1074/jbc.M600509200; Wang B, 2008, CELL, V133, P1080, DOI 10.1016/j.cell.2008.04.042; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; WARD CL, 1994, J BIOL CHEM, V269, P25710; WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Xue SF, 2006, BRAIN RES, V1087, P28, DOI 10.1016/j.brainres.2006.02.121; Youker RT, 2004, MOL BIOL CELL, V15, P4787, DOI 10.1091/mbc.E04-07-0584; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; ZEITLIN PL, 1992, P NATL ACAD SCI USA, V89, P344, DOI 10.1073/pnas.89.1.344; ZEITLIN PL, 1991, AM J RESP CELL MOL, V4, P313, DOI 10.1165/ajrcmb/4.4.313	61	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11314	11325		10.1074/jbc.M109.044057	http://dx.doi.org/10.1074/jbc.M109.044057			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147297	Green Published, hybrid			2022-12-27	WOS:000276286200038
J	Hliscs, M; Sattler, JM; Tempel, W; Artz, JD; Dong, AP; Hui, R; Matuschewski, K; Schuler, H				Hliscs, Marion; Sattler, Julia M.; Tempel, Wolfram; Artz, Jennifer D.; Dong, Aiping; Hui, Raymond; Matuschewski, Kai; Schuler, Herwig			Structure and Function of a G-actin Sequestering Protein with a Vital Role in Malaria Oocyst Development inside the Mosquito Vector	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLASE-ASSOCIATED PROTEIN; N-TERMINAL DOMAIN; DICTYOSTELIUM-DISCOIDEUM; ADENYLATE-CYCLASE; CRYSTAL-STRUCTURE; SRV2/CAP COMPLEX; REGULATES ACTIN; CAP; OLIGOMERIZATION; PROFILIN	Cyclase-associated proteins (CAPs) are evolutionary conserved G-actin-binding proteins that regulate microfilament turnover. CAPs have a modular structure consisting of an N-terminal adenylate cyclase binding domain, a central proline-rich segment, and a C-terminal actin binding domain. Protozoan parasites of the phylum Apicomplexa, such as Cryptosporidium and the malaria parasite Plasmodium, express small CAP orthologs with homology to the C-terminal actin binding domain (C-CAP). Here, we demonstrate by reverse genetics that C-CAP is dispensable for the pathogenic Plasmodium blood stages. However, c-cap(-) parasites display a complete defect in oocyst development in the insect vector. By trans-species complementation we show that the Cryptosporidium parvum ortholog complements the Plasmodium gene functions. Purified recombinant C. parvum C-CAP protein binds actin monomers and prevents actin polymerization. The crystal structure of C. parvum C-CAP shows two monomers with a right-handed beta-helical fold intercalated at their C termini to form the putative physiological dimer. Our results reveal a specific vital role for an apicomplexan G-actin-binding protein during sporogony, the parasite replication phase that precedes formation of malaria transmission stages. This study also exemplifies how Plasmodium reverse genetics combined with biochemical and structural analyses of orthologous proteins can offer a fast track toward systematic gene characterization in apicomplexan parasites.	[Hliscs, Marion; Matuschewski, Kai] Max Planck Inst Infect Biol, Parasitol Unit, D-10117 Berlin, Germany; [Hliscs, Marion; Sattler, Julia M.; Matuschewski, Kai; Schuler, Herwig] Heidelberg Univ, Sch Med, Dept Parasitol, D-69120 Heidelberg, Germany; [Tempel, Wolfram; Artz, Jennifer D.; Dong, Aiping; Hui, Raymond] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Schuler, Herwig] Karolinska Inst, Struct Genom Consortium, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Max Planck Society; Ruprecht Karls University Heidelberg; University of Toronto; Structural Genomics Consortium; Karolinska Institutet	Matuschewski, K (corresponding author), Max Planck Inst Infect Biol, Parasitol Unit, Charitepl 1, D-10117 Berlin, Germany.	matuschewski@mpiib-berlin.mpg.de; herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011; Artz, Jennifer/G-5515-2014	Schuler, Herwig/0000-0003-4059-3501; Matuschewski, Kai/0000-0001-6147-8591; Artz, Jennifer/0000-0003-0500-6156	Deutsche Forschungsgemeinschaft [SCHU1561/1-2]; European Commission [BioMalPar 23]; Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Joachim Siebeneicher Foundation; Chica and Heinz Schaller Foundation	This work was supported by the Deutsche Forschungsgemeinschaft (SCHU1561/1-2) (to H. S.), and by grants from the European Commission (BioMalPar 23), the Joachim Siebeneicher Foundation, and the Chica and Heinz Schaller Foundation (to K. M.).	Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Baum B, 2000, CURR BIOL, V10, P964, DOI 10.1016/S0960-9822(00)00640-0; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Bertling E, 2004, MOL BIOL CELL, V15, P2324, DOI 10.1091/mbc.E04-01-0048; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Chaudhary K, 2005, NAT BIOTECHNOL, V23, P1089, DOI 10.1038/nbt0905-1089; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 1996, MOL CELL BIOL, V16, P548; GERST JE, 1991, MOL CELL BIOL, V11, P1248, DOI 10.1128/MCB.11.3.1248; GIESELMANN R, 1992, FEBS LETT, V298, P149, DOI 10.1016/0014-5793(92)80043-G; Gottwald U, 1996, MOL BIOL CELL, V7, P261, DOI 10.1091/mbc.7.2.261; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; Jenkins J, 2001, PROG BIOPHYS MOL BIO, V77, P111, DOI 10.1016/S0079-6107(01)00013-X; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Ksiazek D, 2003, STRUCTURE, V11, P1171, DOI 10.1016/S0969-2126(03)00180-1; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Noegel AA, 1999, J CELL SCI, V112, P3195; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paunola E, 2002, FEBS LETT, V513, P92, DOI 10.1016/S0014-5793(01)03242-2; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Schuler H, 2006, TRAFFIC, V7, P1433, DOI 10.1111/j.1600-0854.2006.00484.x; Schuler H, 2005, MOL BIOL CELL, V16, P4013, DOI 10.1091/mbc.E05-02-0086; SINDEN RE, 2005, MOL APPROACHES MALAR, P110; Vedadi M, 2007, MOL BIOCHEM PARASIT, V151, P100, DOI 10.1016/j.molbiopara.2006.10.011; VOJTEK A, 1991, CELL, V66, P497, DOI 10.1016/0092-8674(81)90013-1; Weiss VH, 2000, NAT STRUCT BIOL, V7, P1165; Winzeler EA, 2008, NATURE, V455, P751, DOI 10.1038/nature07361; Yusof AM, 2006, J MOL BIOL, V362, P1072, DOI 10.1016/j.jmb.2006.08.008; Yusof AM, 2005, PROTEINS, V58, P255, DOI 10.1002/prot.20314; Zelicof A, 1996, J BIOL CHEM, V271, P18243, DOI 10.1074/jbc.271.30.18243	41	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11572	11583		10.1074/jbc.M109.054916	http://dx.doi.org/10.1074/jbc.M109.054916			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20083609	Green Published, hybrid			2022-12-27	WOS:000276286200063
J	Hong, MP; Vu, K; Bautos, J; Gelli, A				Hong, Min-Pyo; Vu, Kiem; Bautos, Jennifer; Gelli, Angie			Cch1 Restores Intracellular Ca2+ in Fungal Cells during Endoplasmic Reticulum Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENOMIC ANALYSIS; PLASMA-MEMBRANE; CALCIUM-ENTRY; CRAC CHANNELS; STORE; PROTEIN; GROWTH; HOMOLOG; INFLUX	Pathogens endure and proliferate during infection by exquisitely coping with the many stresses imposed by the host to prevent pathogen survival. Recent evidence has shown that fungal pathogens and yeast respond to insults to the endoplasmic reticulum (ER) by initiating Ca2(+) influx across their plasma membrane. Although the high affinity Ca2(+) channel, Cch1, and its subunit Mid1, have been suggested as the protein complex responsible for mediating Ca2(+) influx, a direct demonstration of the gating mechanism of the Cch1 channel remains elusive. In this first mechanistic study of Cch1 channel activity we show that the Cch1 channel from the model human fungal pathogen, Cryptococcus neoformans, is directly activated by the depletion of intracellular Ca2(+) stores. Electrophysiological analysis revealed that agents that enable ER Ca2(+) store depletion promote the development of whole cell inward Ca2(+) currents through Cch1 that are effectively blocked by La3(+) and dependent on the presence of Mid1. Cch1 is permeable to both Ca2(+) and Ba2(+); however, unexpectedly, in contrast to Ca2(+) currents, Ba2(+) currents are steeply voltage-dependent. Cch1 maintains a strong Ca2(+) selectivity even in the presence of high concentrations of monovalent ions. Single channel analysis indicated that Cch1 channel conductance is small, similar to that reported for the Ca2(+) current I-CRAC. This study demonstrates that Cch1 functions as a store-operated Ca2(+)-selective channel that is gated by intracellular Ca2(+) depletion. The inability of cryptococcal cells that lacked the Cch1-Mid1 channel to survive ER stress suggests that Cch1 and its co-regulator, Mid1, are critical players in the restoration of Ca2(+) homeostasis.	[Hong, Min-Pyo; Vu, Kiem; Bautos, Jennifer; Gelli, Angie] Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA	University of California System; University of California Davis	Gelli, A (corresponding author), Genome & Biomed Sci Facil, 451 Hlth Sci Dr, Davis, CA 95616 USA.	acgelli@ucdavis.edu	Vu, Kiem/GQZ-3955-2022; Gelli, Angie/F-1764-2018		National Institutes of Health [AI054477, AI078848]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078848, R01AI054477] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI054477 and AI078848 ( to A. G.).	Bakowski D, 2007, CELL CALCIUM, V42, P333, DOI 10.1016/j.ceca.2007.01.005; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bonilla M, 2002, EMBO J, V21, P2343, DOI 10.1093/emboj/21.10.2343; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Davidson RC, 2000, FUNGAL GENET BIOL, V29, P38, DOI 10.1006/fgbi.1999.1180; Durell SR, 2004, BIOPHYS J, V87, P2116, DOI 10.1529/biophysj.104.040618; Edlind T, 2002, MOL MICROBIOL, V46, P257, DOI 10.1046/j.1365-2958.2002.03165.x; Fan W, 2007, INFECT IMMUN, V75, P3394, DOI 10.1128/IAI.01977-06; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Hallen HE, 2008, EUKARYOT CELL, V7, P415, DOI 10.1128/EC.00248-07; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; Hogan PG, 2007, TRENDS BIOCHEM SCI, V32, P235, DOI 10.1016/j.tibs.2007.03.009; IIDA H, 1994, MOL CELL BIOL, V14, P8259, DOI 10.1128/MCB.14.12.8259; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; Kauffman CA, 2006, CURR OPIN MICROBIOL, V9, P483, DOI 10.1016/j.mib.2006.08.001; Kaur R, 2004, ANTIMICROB AGENTS CH, V48, P1600, DOI 10.1128/AAC.48.5.1600-1613.2004; Kerschbaum HH, 1999, SCIENCE, V283, P836, DOI 10.1126/science.283.5403.836; Liu M, 2008, EUKARYOT CELL, V7, P1118, DOI 10.1128/EC.00116-08; Liu M, 2006, EUKARYOT CELL, V5, P1788, DOI 10.1128/EC.00158-06; Locke EG, 2000, MOL CELL BIOL, V20, P6686, DOI 10.1128/MCB.20.18.6686-6694.2000; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu BX, 2007, CELL, V129, P371, DOI 10.1016/j.cell.2007.02.041; MARKS PW, 1991, ANAL BIOCHEM, V193, P61, DOI 10.1016/0003-2697(91)90044-T; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Vu K, 2009, ANAL BIOCHEM, V393, P234, DOI 10.1016/j.ab.2009.06.039; Yoshimura H, 2004, EXP CELL RES, V293, P185, DOI 10.1016/j.yexcr.2003.09.020; Zelter A, 2004, FUNGAL GENET BIOL, V41, P827, DOI 10.1016/j.fgb.2004.05.001; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	40	44	44	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10951	10958		10.1074/jbc.M109.056218	http://dx.doi.org/10.1074/jbc.M109.056218			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123986	Green Published, hybrid			2022-12-27	WOS:000276264600079
J	Lin, L; Gardsvoll, H; Huai, Q; Huang, MD; Ploug, M				Lin, Lin; Gardsvoll, Henrik; Huai, Qing; Huang, Mingdong; Ploug, Michael			Structure-based Engineering of Species Selectivity in the Interaction between Urokinase and Its Receptor IMPLICATION FOR PRECLINICAL CANCER THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULAR-BINDING SITE; PLASMINOGEN-ACTIVATOR; ANTHRAX TOXIN; COMBINATORIAL CHEMISTRY; FUNCTIONAL EPITOPE; LIGAND-BINDING; DEFICIENT MICE; TUMOR-CELLS; IN-VIVO; VITRONECTIN	The high affinity interaction between the urokinase-type plasminogen activator (uPA) and its glycolipid-anchored receptor (uPAR) is decisive for cell surface-associated plasminogen activation. Because plasmin activity controls fibrinolysis in a variety of pathological conditions, including cancer and wound healing, several intervention studies have focused on targeting the uPA.uPAR interaction in vivo. Evaluations of such studies in xenotransplanted tumor models are, however, complicated by the pronounced species selectivity in this interaction. We now report the molecular basis underlying this difference by solving the crystal structure for the murine uPA.uPAR complex and demonstrate by extensive surface plasmon resonance studies that the kinetic rate constants for this interaction can be swapped completely between these orthologs by exchanging only two residues. This study not only discloses the structural basis required for a successful rational design of the species selectivity in the uPA.uPAR interaction, which is highly relevant for functional studies in mouse models, but it also suggests the possible development of general inhibitors that will target the uPA.uPAR interaction across species barriers.	[Lin, Lin; Huai, Qing; Huang, Mingdong] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Gardsvoll, Henrik; Ploug, Michael] Rigshosp, Copenhagen Bioctr, Finsen Lab, Sect 3735, DK-2200 Copenhagen N, Denmark; [Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Fujian, Peoples R China	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Rigshospitalet; Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS	Huang, MD (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA.	mhuang1@bidmc.harvard.edu; m-ploug@finsenlab.dk	Huang, Mingdong/J-4278-2017	Huang, Mingdong/0000-0003-0085-9141; Ploug, Michael/0000-0003-2215-4265	National Institutes of Health [HL08658]; Danish National Research Foundation; National Natural Science Foundation of China [30625011, 30811130467]; Lundbeck Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL008658, R01HL086584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish National Research Foundation(Danmarks Grundforskningsfond); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant HL08658. This work was also supported by the Danish National Research Foundation and the National Natural Science Foundation of China (Grants 30625011 and 30811130467, from the Danish-Chinese Centre for Proteases and Cancer), and the Lundbeck Foundation. The work is based in part on research conducted at National Synchrotron Light Source, Brookhaven National Laboratory (beam lines x12b and x29).	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; APPELLA E, 1987, J BIOL CHEM, V262, P4437; Barinka C, 2006, J MOL BIOL, V363, P482, DOI 10.1016/j.jmb.2006.08.063; Bolon I, 2004, AM J PATHOL, V164, P2299, DOI 10.1016/S0002-9440(10)63786-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; DeLano WL, 2004, PYMOL MOL GRAPHICS S; ELLIS V, 1989, J BIOL CHEM, V264, P2185; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTREICHER A, 1989, J BIOL CHEM, V264, P1180; Frandsen TL, 2001, CANCER RES, V61, P532; Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x; Gardsvoll H, 1999, J BIOL CHEM, V274, P37995, DOI 10.1074/jbc.274.53.37995; Gardsvoll H, 2004, PROTEIN EXPRES PURIF, V34, P284, DOI 10.1016/j.pep.2003.12.002; Gardsvoll H, 2007, J BIOL CHEM, V282, P13561, DOI 10.1074/jbc.M610184200; Gardsvoll H, 2006, J BIOL CHEM, V281, P19260, DOI 10.1074/jbc.M513583200; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; HANSEN AP, 1994, BIOCHEMISTRY-US, V33, P4847, DOI 10.1021/bi00182a013; HEISS MM, 1995, NAT MED, V1, P1035, DOI 10.1038/nm1095-1035; Hillig T, 2008, J BIOL CHEM, V283, P15217, DOI 10.1074/jbc.C700214200; Huai Q, 2006, SCIENCE, V311, P656, DOI 10.1126/science.1121143; Huai Q, 2008, NAT STRUCT MOL BIOL, V15, P422, DOI 10.1038/nsmb.1404; Illemann M, 2009, INT J CANCER, V124, P1860, DOI 10.1002/ijc.24166; Jacobsen B, 2007, PROTEIN EXPRES PURIF, V52, P286, DOI 10.1016/j.pep.2006.08.011; Jo M, 2009, AM J PATHOL, V175, P190, DOI 10.2353/ajpath.2009.081053; Jogi A, 2007, J THROMB HAEMOST, V5, P1936, DOI 10.1111/j.1538-7836.2007.02653.x; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kjaergaard M, 2008, FRONT BIOSCI-LANDMRK, V13, P5441, DOI 10.2741/3092; Kjaergaard M, 2007, PROTEIN SCI, V16, P1934, DOI 10.1110/ps.072949607; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li ZB, 2008, CLIN CANCER RES, V14, P4758, DOI 10.1158/1078-0432.CCR-07-4434; Liu SH, 2003, P NATL ACAD SCI USA, V100, P657, DOI 10.1073/pnas.0236849100; Liu SH, 2001, J BIOL CHEM, V276, P17976, DOI 10.1074/jbc.M011085200; Llinas P, 2005, EMBO J, V24, P1655, DOI 10.1038/sj.emboj.7600635; Madsen CD, 2007, J CELL BIOL, V177, P927, DOI 10.1083/jcb.200612058; May AE, 1998, J EXP MED, V188, P1029, DOI 10.1084/jem.188.6.1029; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nielsen BS, 2007, INT J CANCER, V120, P2086, DOI 10.1002/ijc.22340; PLOUG M, 1994, FEBS LETT, V349, P163, DOI 10.1016/0014-5793(94)00674-1; Ploug M, 1998, J BIOL CHEM, V273, P13933, DOI 10.1074/jbc.273.22.13933; Ploug M, 2001, BIOCHEMISTRY-US, V40, P12157, DOI 10.1021/bi010662g; PLOUG M, 1991, J BIOL CHEM, V266, P1926; Ploug M, 1998, BIOCHEMISTRY-US, V37, P3612, DOI 10.1021/bi972787k; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rijneveld AW, 2002, J IMMUNOL, V168, P3507, DOI 10.4049/jimmunol.168.7.3507; Romer J, 2004, CURR PHARM DESIGN, V10, P2359, DOI 10.2174/1381612043383962; Solberg H, 2001, J HISTOCHEM CYTOCHEM, V49, P237, DOI 10.1177/002215540104900211; Stephens RW, 1999, JNCI-J NATL CANCER I, V91, P869, DOI 10.1093/jnci/91.10.869; Su YP, 2007, CANCER RES, V67, P3329, DOI 10.1158/0008-5472.CAN-06-4642; Tressler RJ, 1999, APMIS, V107, P168, DOI 10.1111/j.1699-0463.1999.tb01540.x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VASSALLI JD, 1985, J CELL BIOL, V100, P86, DOI 10.1083/jcb.100.1.86; WALTZ DA, 1994, J BIOL CHEM, V269, P14746; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Zhou HM, 2000, EMBO J, V19, P4817, DOI 10.1093/emboj/19.17.4817	55	69	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10982	10992		10.1074/jbc.M109.093492	http://dx.doi.org/10.1074/jbc.M109.093492			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133942	Green Published, hybrid			2022-12-27	WOS:000276264600082
J	Marat, AL; McPherson, PS				Marat, Andrea L.; McPherson, Peter S.			The Connecdenn Family, Rab35 Guanine Nucleotide Exchange Factors Interfacing with the Clathrin Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; SYNAPTIC VESICLE ENDOCYTOSIS; BETA-2 APPENDAGE; RAB6-INTERACTING PROTEIN-1; ALPHA-APPENDAGE; BINDING-PROTEIN; ADAPTER PROTEIN; LDL RECEPTOR; DENN DOMAIN; AP-2	Rabs constitute the largest family of monomeric GTPases, yet for the majority of Rabs relatively little is known about their activation and recruitment to vesicle-trafficking pathways. We recently identified connecdenn (DENND1A), which contains an N-terminal DENN (differentially expressed in neoplastic versus normal cells) domain, a common and evolutionarily ancient protein module. Through its DENN domain, connecdenn functions enzymatically as a guanine-nucleotide exchange factor (GEF) for Rab35. Here we identify two additional connecdenn family members and demonstrate that all connecdenns function as Rab35 GEFs, albeit with different levels of activity. The DENN domain of connecdenn 1 and 2 binds Rab35, whereas connecdenn 3 does not, indicating that Rab35 binding and activation are separable functions. Through their highly divergent C termini, each of the connecdenns binds to clathrin and to the clathrin adaptor AP-2. Interestingly, all three connecdenns use different mechanisms to bind AP-2. Characterization of connecdenn 2 reveals binding to the beta 2-ear of AP-2 on a site that overlaps with that used by the autosomal recessive hypercholesterolemia protein and beta arrestin, although the sequence used by connecdenn 2 is unique. Loss of connecdenn 2 function through small interference RNA knockdown results in an enlargement of early endosomes, similar to what is observed upon loss of Rab35 activity. Our studies reveal connecdenn DENN domains as generalized GEFs for Rab35 and identify a new AP-2-binding motif, demonstrating a complex link between the clathrin machinery and Rab35 activation.	[Marat, Andrea L.; McPherson, Peter S.] McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	McPherson, PS (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	peter.mcpherson@mcgill.ca		Marat, Andrea/0000-0001-8571-4253	Natural Sciences and Engineering Research Council [197316]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Grant 197316 from the Natural Sciences and Engineering Research Council (to P. S. M.).	Allaire PD, 2006, J NEUROSCI, V26, P13202, DOI 10.1523/JNEUROSCI.4608-06.2006; Allaire PD, 2010, MOL CELL, V37, P370, DOI 10.1016/j.molcel.2009.12.037; Azzedine H, 2003, AM J HUM GENET, V72, P1141, DOI 10.1086/375034; Blondeau F, 2000, HUM MOL GENET, V9, P2223, DOI 10.1093/oxfordjournals.hmg.a018913; Brett TJ, 2002, STRUCTURE, V10, P797, DOI 10.1016/S0969-2126(02)00784-0; Burtey A, 2007, TRAFFIC, V8, P914, DOI 10.1111/j.1600-0854.2007.00578.x; Chevallier J, 2009, FEBS LETT, V583, P1096, DOI 10.1016/j.febslet.2009.03.012; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Drake MT, 2001, J BIOL CHEM, V276, P28700, DOI 10.1074/jbc.M104226200; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Esters H, 2001, J MOL BIOL, V310, P141, DOI 10.1006/jmbi.2001.4735; Falbel TG, 2003, DEVELOPMENT, V130, P4011, DOI 10.1242/dev.00619; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Garcia CK, 2001, SCIENCE, V292, P1394, DOI 10.1126/science.1060458; Girard Martine, 2005, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0313s26; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Harsay E, 2007, MOL BIOL CELL, V18, P1203, DOI 10.1091/mbc.E06-11-1035; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Hussain NK, 2001, NAT CELL BIOL, V3, P927, DOI 10.1038/ncb1001-927; Kang DS, 2009, J BIOL CHEM, V284, P29860, DOI 10.1074/jbc.M109.023366; Katoh M, 2004, INT J ONCOL, V24, P743; Kim YM, 2002, J BIOL CHEM, V277, P30760, DOI 10.1074/jbc.M204528200; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Levivier E, 2001, BIOCHEM BIOPH RES CO, V287, P688, DOI 10.1006/bbrc.2001.5652; Liao YH, 1999, J BIOL CHEM, V274, P37815, DOI 10.1074/jbc.274.53.37815; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; LICHY JH, 1992, CELL GROWTH DIFFER, V3, P541; Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219; Miserey-Lenkei S, 2007, TRAFFIC, V8, P1385, DOI 10.1111/j.1600-0854.2007.00612.x; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Morgan JR, 2000, J NEUROSCI, V20, P8667; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Patino-Lopez G, 2008, J BIOL CHEM, V283, P18323, DOI 10.1074/jbc.M800056200; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Ritter B, 2004, TOP CURR GENET, V10, P9; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Ritter B, 2003, EMBO REP, V4, P1089, DOI 10.1038/sj.embor.7400004; Saito K, 2002, J BIOL CHEM, V277, P3412, DOI 10.1074/jbc.M106276200; Santini F, 2000, J CELL SCI, V113, P2463; Sato M, 2008, EMBO J, V27, P1183, DOI 10.1038/emboj.2008.54; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Senderek J, 2003, HUM MOL GENET, V12, P349, DOI 10.1093/hmg/ddg030; Soutar AK, 2003, ARTERIOSCL THROM VAS, V23, P1963, DOI 10.1161/01.ATV.0000094410.66558.9A; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Walseng E, 2008, J BIOL CHEM, V283, P14717, DOI 10.1074/jbc.M801070200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	59	65	76	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10627	10637		10.1074/jbc.M109.050930	http://dx.doi.org/10.1074/jbc.M109.050930			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20154091	Green Published, hybrid			2022-12-27	WOS:000276264600050
J	Venkataramani, V; Rossner, C; Iffland, L; Schweyer, S; Tamboli, IY; Walter, J; Wirths, O; Bayer, TA				Venkataramani, Vivek; Rossner, Christian; Iffland, Lara; Schweyer, Stefan; Tamboli, Irfan Y.; Walter, Jochen; Wirths, Oliver; Bayer, Thomas A.			Histone Deacetylase Inhibitor Valproic Acid Inhibits Cancer Cell Proliferation via Down-regulation of the Alzheimer Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NEUROBLASTOMA-CELLS; BETA-PROTEIN; IN-VIVO; INCREASED EXPRESSION; RNA INTERFERENCE; SODIUM VALPROATE; GENE-EXPRESSION; CARCINOMA-CELLS; ALPHA-SECRETASE; GROWTH	The beta-amyloid precursor protein (APP) represents a type I transmembrane glycoprotein that is ubiquitously expressed. In the brain, it is a key player in the molecular pathogenesis of Alzheimer disease. Its physiological function is however less well understood. Previous studies showed that APP is up-regulated in prostate, colon, pancreatic tumor, and oral squamous cell carcinoma. In this study, we show that APP has an essential role in growth control of pancreatic and colon cancer. Abundant APP staining was found in human pancreatic adenocarcinoma and colon cancer tissue. Interestingly, treating pancreatic and colon cancer cells with valproic acid (VPA, 2-propylpentanoic acid), a known histone deacetylase (HDAC) inhibitor, leads to up-regulation of GRP78, an endoplasmic reticulum chaperone immunoglobulin-binding protein. GRP78 is involved in APP maturation and inhibition of tumor cell growth by down-regulation of APP and secreted soluble APP alpha. Trichostatin A, a pan-HDAC inhibitor, also lowered APP and increased GRP78 levels. In contrast, treating cells with valpromide, a VPA derivative lacking HDAC inhibitory properties, had no effect on APP levels. VPA did not modify the level of epidermal growth factor receptor, another type I transmembrane protein, and APLP2, a member of the APP family, demonstrating the specificity of the VPA effect on APP. Small interfering RNA-mediated knockdown of APP also resulted in significantly decreased cell growth. Based on these observations, the data suggest that APP downregulation via HDAC inhibition provides a novel mechanism for pancreatic and colon cancer therapy.	[Venkataramani, Vivek; Rossner, Christian; Iffland, Lara; Wirths, Oliver; Bayer, Thomas A.] Univ Goettingen, Dept Mol Psychiat, Alzheimer PhD Grad Sch, D-37075 Gottingen, Germany; [Schweyer, Stefan] Univ Goettingen, Dept Pathol, D-37075 Gottingen, Germany; [Tamboli, Irfan Y.; Walter, Jochen] Univ Bonn, Dept Mol Cell Biol, D-53127 Bonn, Germany	University of Gottingen; University of Gottingen; University of Bonn	Bayer, TA (corresponding author), Univ Med, Div Mol Psychiat, Von Siebold Str 5, D-37075 Gottingen, Germany.	tbayer@gwdg.de	Wirths, Oliver/C-7342-2019; Wang, Caihong/T-5837-2019; Rossner, Christian/R-1901-2016; Walter, Jochen/B-3677-2014	Wirths, Oliver/0000-0002-4115-0334; Wang, Caihong/0000-0002-6808-3709; Rossner, Christian/0000-0002-3428-3542; Walter, Jochen/0000-0002-4678-2912; Venkataramani, Vivek/0000-0002-6771-365X	Alzheimer Forschung Initiative e.V.; European Commission [MEST-CT-2005-020013]	Alzheimer Forschung Initiative e.V.; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Alzheimer Forschung Initiative e.V. (to O. W.) and the European Commission (Marie Curie Early Stage Training, MEST-CT-2005-020013 (NEURAD)).	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; Bayer TA, 2001, BRAIN PATHOL, V11, P1; Bayer TA, 1999, MOL PSYCHIATR, V4, P524, DOI 10.1038/sj.mp.4000552; Beher D, 1996, J BIOL CHEM, V271, P1613, DOI 10.1074/jbc.271.3.1613; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Blaheta RA, 2002, MED RES REV, V22, P492, DOI 10.1002/med.10017; Blaheta RA, 2005, MED RES REV, V25, P383, DOI 10.1002/med.20027; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Botelho MG, 2010, J INVEST DERMATOL, V130, P1400, DOI 10.1038/jid.2009.296; Caille I, 2004, DEVELOPMENT, V131, P2173, DOI 10.1242/dev.01103; Chavez-Blanco A, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-2; Chen CL, 2006, J PHARMACOL EXP THER, V319, P533, DOI 10.1124/jpet.106.106658; Christensen DZ, 2008, ACTA NEUROPATHOL, V116, P647, DOI 10.1007/s00401-008-0451-6; Cinatl J, 1997, ANTI-CANCER DRUG, V8, P958, DOI 10.1097/00001813-199711000-00007; Cohen G, 2006, CANCER RES, V66, P5656, DOI 10.1158/0008-5472.CAN-05-0308; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Duenas-Gonzalez A, 2008, CANCER TREAT REV, V34, P206, DOI 10.1016/j.ctrv.2007.11.003; Duncan S, 2007, CURR OPIN NEUROL, V20, P175, DOI 10.1097/WCO.0b013e32805866fb; DYRKS T, 1992, FEBS LETT, V309, P20, DOI 10.1016/0014-5793(92)80730-5; Erhuma M, 2007, INT J CANCER, V120, P2393, DOI 10.1002/ijc.22252; Glaser KB, 2003, BIOCHEM BIOPH RES CO, V310, P529, DOI 10.1016/j.bbrc.2003.09.043; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gralle M, 2009, J BIOL CHEM, V284, P15016, DOI 10.1074/jbc.M808755200; GRAY CW, 1993, NEUROREPORT, V4, P811, DOI 10.1097/00001756-199306000-00054; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansel DE, 2003, CANCER RES, V63, P7032; Henry Thomas R, 2003, Psychopharmacol Bull, V37 Suppl 2, P5; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hoffmann J, 2000, EUR J CELL BIOL, V79, P905, DOI 10.1078/0171-9335-00117; Hooper NM, 2002, CURR MED CHEM, V9, P1107, DOI 10.2174/0929867023370121; Hoshino T, 2007, BIOCHEM J, V402, P581, DOI 10.1042/BJ20061318; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; JIN LW, 1994, J NEUROSCI, V14, P5461; Khabele D, 2007, CANCER BIOL THER, V6, P795, DOI 10.4161/cbt.6.5.4007; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Knupfer MM, 1998, ANTICANCER RES, V18, P3585; Ko SY, 2004, INT J CANCER, V111, P727, DOI 10.1002/ijc.20328; Kudo T, 2006, BIOCHEM BIOPH RES CO, V344, P525, DOI 10.1016/j.bbrc.2006.03.173; Lagace DC, 2004, J BIOL CHEM, V279, P18851, DOI 10.1074/jbc.M312795200; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; LOSCHER W, 1985, NEUROPHARMACOLOGY, V24, P427, DOI 10.1016/0028-3908(85)90028-0; Meng JY, 2001, INT J CANCER, V92, P31, DOI 10.1002/1097-0215(200102)9999:9999<::AID-IJC1155>3.3.CO;2-8; MOBLEY WC, 1988, P NATL ACAD SCI USA, V85, P9811, DOI 10.1073/pnas.85.24.9811; Mote PL, 1998, MECH AGEING DEV, V104, P149, DOI 10.1016/S0047-6374(98)00064-5; NINOMIYA H, 1993, J CELL BIOL, V121, P879, DOI 10.1083/jcb.121.4.879; Ott MO, 2001, DEV GENES EVOL, V211, P355; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Pietrzik CU, 1998, P NATL ACAD SCI USA, V95, P1770, DOI 10.1073/pnas.95.4.1770; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; RADINSKY R, 1995, CLIN CANCER RES, V1, P19; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; Roe CM, 2010, NEUROLOGY, V74, P106, DOI 10.1212/WNL.0b013e3181c91873; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Rossner S, 1998, PROG NEUROBIOL, V56, P541, DOI 10.1016/S0301-0082(98)00044-6; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Sakai T, 2006, CELL BIOL INT, V30, P952, DOI 10.1016/j.cellbi.2006.06.018; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295, DOI 10.1074/jbc.271.31.18295; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; Senese S, 2007, MOL CELL BIOL, V27, P4784, DOI 10.1128/MCB.00494-07; SERRANO J, 2010, ONCOGENE        0125, DOI DOI 10.1038/ONC.2009.503; Shi YY, 2007, BIOORG MED CHEM LETT, V17, P4491, DOI 10.1016/j.bmcl.2007.06.006; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Small D H, 1999, J Alzheimers Dis, V1, P275; Sondag CM, 2004, J BIOL CHEM, V279, P14456, DOI 10.1074/jbc.M313747200; Stettner M, 2007, MOL CANCER THER, V6, P2626, DOI 10.1158/1535-7163.MCT-07-0197; Stockhausen MT, 2005, BRIT J CANCER, V92, P751, DOI 10.1038/sj.bjc.6602309; Takayama KI, 2009, CANCER RES, V69, P137, DOI 10.1158/0008-5472.CAN-08-3633; Tamboli IY, 2005, J BIOL CHEM, V280, P28110, DOI 10.1074/jbc.M414525200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tomita S, 1998, J BIOL CHEM, V273, P6277, DOI 10.1074/jbc.273.11.6277; Valentini A, 2007, CANCER BIOL THER, V6, P185, DOI 10.4161/cbt.6.2.3578; Van Broeck B, 2007, NEURODEGENER DIS, V4, P349, DOI 10.1159/000105156; Villa A, 2001, J NEUROCHEM, V77, P1077, DOI 10.1046/j.1471-4159.2001.00315.x; Wang JF, 1999, MOL PHARMACOL, V55, P521; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; Wirths O, 2007, BRAIN RES, V1152, P209, DOI 10.1016/j.brainres.2007.03.029; Witt O, 2009, CANCER LETT, V280, P123, DOI 10.1016/j.canlet.2009.02.038; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Xia QH, 2006, CANCER RES, V66, P7237, DOI 10.1158/0008-5472.CAN-05-0487; YAMAMOTO K, 1994, J NEUROBIOL, V25, P585, DOI 10.1002/neu.480250510; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	87	99	106	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10678	10689		10.1074/jbc.M109.057836	http://dx.doi.org/10.1074/jbc.M109.057836			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145244	Green Published, hybrid			2022-12-27	WOS:000276264600055
J	Walls, KC; Ghosh, AP; Franklin, AV; Klocke, BJ; Ballestas, M; Shacka, JJ; Zhang, JH; Roth, KA				Walls, Ken C.; Ghosh, Arindam P.; Franklin, Aimee V.; Klocke, Barbara J.; Ballestas, Mary; Shacka, John J.; Zhang, Jianhua; Roth, Kevin A.			Lysosome Dysfunction Triggers Atg7-dependent Neural Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; AUTOPHAGIC CELL-DEATH; DEFICIENT MICE; BCL-2 FAMILY; DEPENDENT APOPTOSIS; CASPASE ACTIVATION; MEDIATED CLEAVAGE; P53; BRAIN; 3-KINASE	Macroautophagy (autophagy) is a process wherein bulk cytosolic proteins and damaged organelles are sequestered and degraded via the lysosome. Alterations in autophagy-associated proteins have been shown to cause neural tube closure defects, neurodegeneration, and tumor formation. Normal lysosome function is critical for autophagy completion and when altered may lead to an accumulation of autophagic vacuoles (AVs) and caspase activation. The tumor suppressor p53 is highly expressed in neural precursor cells (NPCs) and has an important role in the regulation of both autophagy and apoptosis. We hypothesized that altered lysosome function would lead to NPC death via an interaction between autophagy-and apoptosis-associated proteins. To test our hypothesis, we utilized FGF2-expanded NPCs and the neural stem cell line, C17.2, in combination with the lysosomotropic agent chloroquine (CQ) and the vacuolar ATPase inhibitor bafilomycin A1 (Baf A1). Both CQ and Baf A1 caused concentration-and time-dependent AV accumulation, p53 phosphorylation, increased damage regulator autophagy modulator levels, caspase-3 activation, and cell death. Short hairpin RNA knockdown of Atg7, but not Beclin1, expression significantly inhibited CQ-and Baf A1-induced cell death, indicating that Atg7 is an upstream mediator of lysosome dysfunction-induced cell death. Cell death and/or caspase-3 activation was also attenuated by protein synthesis inhibition, p53 deficiency, or Bax deficiency, indicating involvement of the intrinsic apoptotic death pathway. In contrast to lysosome dysfunction, starvation-induced AV accumulation was inhibited by either Atg7 or Beclin1 knockdown, and Atg7 knockdown had no effect on starvation-induced death. These findings indicate that Atg7-and Beclin1-induced autophagy plays a cytoprotective role during starvation but that Atg7 has a unique pro-apoptotic function in response to lysosome dysfunction.	[Walls, Ken C.; Ghosh, Arindam P.; Franklin, Aimee V.; Klocke, Barbara J.; Shacka, John J.; Zhang, Jianhua; Roth, Kevin A.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Walls, Ken C.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Ghosh, Arindam P.] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Ballestas, Mary] Univ Alabama Birmingham, Dept Pediat & Infect Dis, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Walls, KC (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	kcwalls@uab.edu; karoth@uab.edu	zhang, jianhua/D-3404-2009	Ballestas, Mary/0000-0003-0660-9477; Roth, Kevin/0000-0002-0643-995X; Zhang, Jianhua/0000-0002-2128-9574	National Institutes of Health [NS35107, NS41962, CA134773]; NATIONAL CANCER INSTITUTE [R01CA134773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035107, P30NS057098, R01NS041962, P30NS047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS35107, NS41962, and CA134773.	Akhtar RS, 2006, CELL DEATH DIFFER, V13, P1727, DOI 10.1038/sj.cdd.4401879; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Canu N, 2005, J NEUROCHEM, V92, P1228, DOI 10.1111/j.1471-4159.2004.02956.x; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Cho DH, 2009, CANCER LETT, V274, P95, DOI 10.1016/j.canlet.2008.09.004; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Clarke PGH, 2002, TRENDS PHARMACOL SCI, V23, P308, DOI 10.1016/S0165-6147(02)02041-2; Codogno P, 2006, NAT CELL BIOL, V8, P1045, DOI 10.1038/ncb1006-1045; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Eizenberg O, 1996, MOL CELL BIOL, V16, P5178; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Geng Y, 2007, J NEUROPATH EXP NEUR, V66, P66, DOI 10.1097/nen.0b013e31802d4ab4; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Guillon-Munos A, 2005, APOPTOSIS, V10, P1031, DOI 10.1007/s10495-005-0741-6; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hoyer-Hansen M, 2005, CELL DEATH DIFFER, V12, P1297, DOI 10.1038/sj.cdd.4401651; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Noguchi KK, 2008, CELL DEATH DIFFER, V15, P1582, DOI 10.1038/cdd.2008.97; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Saftig P, 1997, J BIOL CHEM, V272, P18628, DOI 10.1074/jbc.272.30.18628; Shacka JJ, 2006, CELL DEATH DIFFER, V13, P1299, DOI 10.1038/sj.cdd.4401974; Shacka JJ, 2006, AUTOPHAGY, V2, P228, DOI 10.4161/auto.2703; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Shacka JJ, 2007, J NEUROSCI, V27, P2081, DOI 10.1523/JNEUROSCI.5577-06.2007; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Tasdemir E, 2008, NAT CELL BIOL, V10, P676, DOI 10.1038/ncb1730; Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826; Uchiyama Y, 2008, AUTOPHAGY, V4, P404, DOI 10.4161/auto.5598; Wagner M, 2005, NAT CELL BIOL, V7, P212, DOI 10.1038/ncb0305-212; Walls KC, 2007, AUTOPHAGY, V3, P222, DOI 10.4161/auto.3822; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Windelborn JA, 2008, J NEUROCHEM, V106, P56, DOI 10.1111/j.1471-4159.2008.05349.x; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zaidi AU, 2001, J NEUROPATH EXP NEUR, V60, P937, DOI 10.1093/jnen/60.10.937	51	67	69	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10497	10507		10.1074/jbc.M110.103747	http://dx.doi.org/10.1074/jbc.M110.103747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20123985	hybrid, Green Published			2022-12-27	WOS:000276264600036
J	Awad, S; Ryan, D; Prochasson, P; Owen-Hughes, T; Hassan, AH				Awad, Salma; Ryan, Daniel; Prochasson, Philippe; Owen-Hughes, Tom; Hassan, Ahmed H.			The Snf2 Homolog Fun30 Acts as a Homodimeric ATP-dependent Chromatin-remodeling Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATOR; DNA TRANSLOCATION; PROTEIN COMPLEXES; CHROMOSOME-I; HISTONE; NUCLEOSOME; BINDING; GENES; IDENTIFICATION	The Saccharomyces cerevisiae Fun30 (Function unknown now 30) protein shares homology with an extended family of Snf2-related ATPases. Here we report the purification of Fun30 principally as a homodimer with a molecular mass of about 250 kDa. Biochemical characterization of this complex reveals that it has ATPase activity stimulated by both DNA and chromatin. Consistent with this, it also binds to both DNA and chromatin. The Fun30 complex also exhibits activity in ATP-dependent chromatin remodeling assays. Interestingly, its activity in histone dimer exchange is high relative to the ability to reposition nucleosomes. Fun30 also possesses a weakly conserved CUE motif suggesting that it may interact specifically with ubiquitinylated proteins. However, in vitro Fun30 was found to have no specificity in its interaction with ubiquitinylated histones.	[Awad, Salma; Hassan, Ahmed H.] United Arab Emirates Univ, Dept Biochem, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Awad, Salma; Ryan, Daniel; Owen-Hughes, Tom] Univ Dundee, Wellcome Trust Ctr Gene Regulat & Express, Sch Life Sci, Dundee DD1 5EH, Scotland; [Prochasson, Philippe] Stowers Inst Med Res, Kansas City, MO 64110 USA	United Arab Emirates University; University of Dundee; Stowers Institute for Medical Research	Hassan, AH (corresponding author), United Arab Emirates Univ, Dept Biochem, Fac Med & Hlth Sci, POB 17666, Al Ain, U Arab Emirates.	ahmedh@uaeu.ac.ae	Hassan, Ahmed/AAB-7241-2019	Owen-Hughes, Tom/0000-0002-0618-8185; Ryan, Daniel/0000-0001-9842-2620; Al-Marzouqi, Ahmed/0000-0003-4586-5676; Mahmoud, Salma/0000-0003-1475-9483	United Arabs Emirates University Faculty of Medicine and Health Sciences [NP/05/14]; Terry Fox Funds for Cancer Research; Wellcome Trust [064414]	United Arabs Emirates University Faculty of Medicine and Health Sciences; Terry Fox Funds for Cancer Research; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by United Arabs Emirates University Faculty of Medicine and Health Sciences Grant NP/05/14, a grant from the Terry Fox Funds for Cancer Research (to A. H. H.), and by Wellcome Trust Senior Fellowship 064414 (to T. O.-H.).	Adra CN, 2000, GENOMICS, V69, P162, DOI 10.1006/geno.2000.6281; BARTON AB, 1994, J BACTERIOL, V176, P1872, DOI 10.1128/jb.176.7.1872-1880.1994; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; CLARK MW, 1992, YEAST, V8, P133, DOI 10.1002/yea.320080208; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Dillingham MS, 2000, BIOCHEMISTRY-US, V39, P205, DOI 10.1021/bi992105o; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Flaus A, 2003, MOL CELL BIOL, V23, P7767, DOI 10.1128/MCB.23.21.7767-7779.2003; Flaus A, 2006, NUCLEIC ACIDS RES, V34, P2887, DOI 10.1093/nar/gkl295; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Hartley PD, 2009, CELL, V137, P445, DOI 10.1016/j.cell.2009.02.043; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Hassan AH, 2006, J BIOL CHEM, V281, P18126, DOI 10.1074/jbc.M602851200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Okazaki N, 2008, J MOL BIOL, V382, P257, DOI 10.1016/j.jmb.2008.07.031; Ouspenski II, 1999, NUCLEIC ACIDS RES, V27, P3001, DOI 10.1093/nar/27.15.3001; Papamichos-Chronakis M, 2006, GENE DEV, V20, P2437, DOI 10.1101/gad.1440206; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Racki LR, 2008, CURR OPIN GENET DEV, V18, P137, DOI 10.1016/j.gde.2008.01.007; SCHOOR M, 1993, DEV DYNAM, V197, P227, DOI 10.1002/aja.1001970307; Schoor M, 1999, MECH DEVELOP, V85, P73, DOI 10.1016/S0925-4773(99)00090-8; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; SOININEN R, 1992, MECH DEVELOP, V39, P111, DOI 10.1016/0925-4773(92)90030-N; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Suter B, 2004, GENETICS, V167, P579, DOI 10.1534/genetics.103.024851; Thastrom A, 2004, BIOCHEMISTRY-US, V43, P736, DOI 10.1021/bi0302043; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Zofall M, 2004, MOL CELL BIOL, V24, P10047, DOI 10.1128/MCB.24.22.10047-10057.2004	38	55	58	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9477	9484		10.1074/jbc.M109.082149	http://dx.doi.org/10.1074/jbc.M109.082149			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20075079	Green Published, hybrid			2022-12-27	WOS:000276165900021
J	Courel, M; Soler-Jover, A; Rodriguez-Flores, JL; Mahata, SK; Elias, S; Montero-Hadjadje, M; Anouar, Y; Giuly, RJ; O'Connor, DT; Taupenot, L				Courel, Maiete; Soler-Jover, Alex; Rodriguez-Flores, Juan L.; Mahata, Sushil K.; Elias, Salah; Montero-Hadjadje, Maiete; Anouar, Youssef; Giuly, Richard J.; O'Connor, Daniel T.; Taupenot, Laurent			Pro-hormone Secretogranin II Regulates Dense Core Secretory Granule Biogenesis in Catecholaminergic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CHROMOGRANIN-A; REFLECTION FLUORESCENCE MICROSCOPY; NERVE GROWTH-FACTOR; PC12 CELLS; MEMBRANE-BINDING; NEUROPEPTIDE-Y; NEUROENDOCRINE CELLS; TARGETED ABLATION; VESICLE MEMBRANE; CHROMAFFIN CELLS	Processes underlying the formation of dense core secretory granules (DCGs) of neuroendocrine cells are poorly understood. Here, we present evidence that DCG biogenesis is dependent on the secretory protein secretogranin (Sg) II, a member of the granin family of pro-hormone cargo of DCGs in neuroendocrine cells. Depletion of SgII expression in PC12 cells leads to a decrease in both the number and size of DCGs and impairs DCG trafficking of other regulated hormones. Expression of SgII fusion proteins in a secretory-deficient PC12 variant rescues a regulated secretory pathway. SgII-containing dense core vesicles share morphological and physical properties with bona fide DCGs, are competent for regulated exocytosis, and maintain an acidic luminal pH through the V-type H+-translocating ATPase. The granulogenic activity of SgII requires a pH gradient along this secretory pathway. We conclude that SgII is a critical factor for the regulation of DCG biogenesis in neuroendocrine cells, mediating the formation of functional DCGs via its pH-dependent aggregation at the trans-Golgi network.	[Courel, Maiete; Soler-Jover, Alex; Rodriguez-Flores, Juan L.; Mahata, Sushil K.; O'Connor, Daniel T.; Taupenot, Laurent] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Courel, Maiete; Elias, Salah; Montero-Hadjadje, Maiete; Anouar, Youssef] Univ Rouen, INSERM, U982, F-76821 Mont St Aignan, France; [Giuly, Richard J.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Mahata, Sushil K.; O'Connor, Daniel T.; Taupenot, Laurent] Vet Affairs San Diego Healthcare Syst, San Diego, CA 92093 USA	University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Courel, M (corresponding author), Univ Rouen, INSERM, U982, F-76821 Mont St Aignan, France.	mcourel@univ-rouen.fr; doconnor@ucsd.edu; ltaupenot@gmail.com	Mahata, Sushil/AAF-8781-2021; Rodriguez-Flores, Juan L/AAJ-7565-2020; Montero-Hadjadje, Maite/AAC-5692-2019; Anouar, Youssef/F-9683-2017	Rodriguez-Flores, Juan L/0000-0002-0394-8062; Montero-Hadjadje, Maite/0000-0001-8859-893X; Taupenot, Laurent/0000-0003-2316-3825; Elias, Salah/0000-0003-1005-438X	National Institutes of Health [HL58120, DK60702, DK59628]; Fondation pour la Recherche Medicale; National Kidney Foundation; Comissionat per Universitat I Recerca of the Departament d'Innovacio, Universitats i Empresa of the Autonomous Government of Catalonia; American Heart Association [0855181F]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK059628, R01DK060702] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Kidney Foundation; Comissionat per Universitat I Recerca of the Departament d'Innovacio, Universitats i Empresa of the Autonomous Government of Catalonia; American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We appreciate the technical assistance of Timo Meerloo during the immunoelectron microscopy (laboratory of Marilyn Farquhar, University of California, San Diego). Digital imaging was performed at the Cancer Center Shared Resource Facilities (University of California, San Diego) and at the National Center for Microscopy and Imaging Research CMIR (funded in part by grants from the National Institutes of Health).; This work was supported, in whole or in part, by National Institutes of Health Grants HL58120, DK60702, and DK59628. This work was also supported by postdoctoral research fellowships from the Fondation pour la Recherche Medicale and the National Kidney Foundation (to M. C.), the Comissionat per Universitat I Recerca of the Departament d'Innovacio, Universitats i Empresa of the Autonomous Government of Catalonia (to A. S.-J.), and by American Heart Association Grant 0855181F.	Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; ASHLEY RH, 1994, EUR BIOPHYS J BIOPHY, V23, P263, DOI 10.1007/BF00213576; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200; Brun C, 2006, FASEB J, V20, P732, DOI 10.1096/fj.05-4338fje; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CARNELL L, 1994, J CELL BIOL, V127, P693, DOI 10.1083/jcb.127.3.693; CHANAT E, 1991, J CELL BIOL, V115, P1505, DOI 10.1083/jcb.115.6.1505; Chen YQ, 2008, J AM COLL CARDIOL, V52, P1468, DOI 10.1016/j.jacc.2008.07.047; Corradi N, 1996, J BIOL CHEM, V271, P27116, DOI 10.1074/jbc.271.43.27116; Courel M, 2008, J BIOL CHEM, V283, P11807, DOI 10.1074/jbc.M709832200; Courel M, 2006, J BIOL CHEM, V281, P38038, DOI 10.1074/jbc.M604037200; D'Alessandro R, 2008, J NEUROCHEM, V105, P1369, DOI 10.1111/j.1471-4159.2008.05259.x; Day R, 2003, TRENDS ENDOCRIN MET, V14, P10, DOI 10.1016/S1043-2760(02)00011-5; Egger M, 2007, FASEB J, V21, P2906, DOI 10.1096/fj.06-7440com; El Meskini R, 2001, ENDOCRINOLOGY, V142, P864, DOI 10.1210/endo.142.2.7929; Eskeland NL, 1996, J CLIN INVEST, V98, P148, DOI 10.1172/JCI118760; FISCHERCOLBRIE R, 1987, ANN NY ACAD SCI, V493, P120, DOI 10.1111/j.1749-6632.1987.tb27189.x; Fisher RJ, 1999, PFLUG ARCH EUR J PHY, V437, P754, DOI 10.1007/s004240050842; GERDES HH, 1989, J BIOL CHEM, V264, P12009; GORR SU, 1988, BONE MINER, V4, P17; Grundschober C, 2002, J BIOL CHEM, V277, P36715, DOI 10.1074/jbc.M203777200; HAIGH JR, 1989, BIOCHEM J, V257, P499, DOI 10.1042/bj2570499; Han L, 2008, MOL ENDOCRINOL, V22, P1935, DOI 10.1210/me.2008-0006; Han WP, 1999, J NEUROSCI, V19, P900; Heidrich FM, 2008, CIRC RES, V102, P1230, DOI 10.1161/CIRCRESAHA.107.166033; Hendy GN, 2006, MOL ENDOCRINOL, V20, P1935, DOI 10.1210/me.2005-0398; Hosaka M, 2004, J BIOL CHEM, V279, P3627, DOI 10.1074/jbc.M310104200; Hosaka M, 2002, MOL BIOL CELL, V13, P3388, DOI 10.1091/mbc.02-03-0040; Hotta K, 2009, J ENDOCRINOL, V202, P111, DOI 10.1677/JOE-08-0531; Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200; Inomoto C, 2007, J HISTOCHEM CYTOCHEM, V55, P487, DOI 10.1369/jhc.6A7110.2007; Kaipio K, 2005, BIOCHEM BIOPH RES CO, V337, P633, DOI 10.1016/j.bbrc.2005.09.093; Kaipio K, 2009, NEUROSCI LETT, V450, P181, DOI 10.1016/j.neulet.2008.11.018; Kim T, 2006, MOL BIOL CELL, V17, P789, DOI 10.1091/mbc.E05-08-0755; Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005; Kim T, 2002, ANN NY ACAD SCI, V971, P323, DOI 10.1111/j.1749-6632.2002.tb04487.x; Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Mahapatra NR, 2008, BIOCHEMISTRY-US, V47, P7167, DOI 10.1021/bi7019996; Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354; Mahapatra NR, 2004, J BIOL CHEM, V279, P51107, DOI 10.1074/jbc.M408742200; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; MCCAFFERY JM, 1995, METHOD ENZYMOL, V257, P259; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Montero-Hadjadje M, 2009, J BIOL CHEM, V284, P12420, DOI 10.1074/jbc.M805607200; Montesinos MS, 2008, J NEUROSCI, V28, P3350, DOI 10.1523/JNEUROSCI.5292-07.2008; Morvan J, 2008, HISTOCHEM CELL BIOL, V129, P243, DOI 10.1007/s00418-008-0377-z; Mosley CA, 2007, BIOCHEMISTRY-US, V46, P10999, DOI 10.1021/bi700704r; MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Pance A, 1999, J NEUROCHEM, V73, P21, DOI 10.1046/j.1471-4159.1999.0730021.x; Pance A, 2006, J NEUROCHEM, V99, P1435, DOI 10.1111/j.1471-4159.2006.04190.x; Park HY, 2002, BIOCHEMISTRY-US, V41, P1259, DOI 10.1021/bi0156963; Park JJ, 2008, MOL ENDOCRINOL, V22, P2583, DOI 10.1210/me.2008-0209; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Prasad P, 2008, J IMMUNOL, V181, P5024, DOI 10.4049/jimmunol.181.7.5024; Reaves BJ, 1996, J CELL SCI, V109, P749; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Schoonderwoert VTG, 2000, EUR J BIOCHEM, V267, P5646, DOI 10.1046/j.1432-1327.2000.01648.x; Silva AP, 2003, REGUL PEPTIDES, V116, P71, DOI 10.1016/S0167-0115(03)00191-5; Stettler H, 2009, BIOCHEM J, V418, P81, DOI 10.1042/BJ20071382; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Tanaka S, 1997, J HISTOCHEM CYTOCHEM, V45, P425, DOI 10.1177/002215549704500310; Taupenot L, 2005, J BIOL CHEM, V280, P3885, DOI 10.1074/jbc.M408197200; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Taupenot L, 2002, J CELL SCI, V115, P4827, DOI 10.1242/jcs.00140; TAUPENOT L, 2007, CURR PROTOC CELL B S, V36; Taylor CV, 2000, J BIOL CHEM, V275, P22905, DOI 10.1074/jbc.M001232200; TISCHLER AS, 1978, LAB INVEST, V39, P77; TOOZE SA, 1991, FEBS LETT, V285, P220, DOI 10.1016/0014-5793(91)80805-D; TOOZE SA, 1991, J CELL BIOL, V115, P1491, DOI 10.1083/jcb.115.6.1491; Tsuboi T, 2007, GENES CELLS, V12, P511, DOI 10.1111/j.1365-2443.2007.01070.x; TWISS JL, 1995, J NEUROCHEM, V64, P550; Urbe S, 1998, J CELL BIOL, V143, P1831, DOI 10.1083/jcb.143.7.1831; VIDEEN JS, 1992, J BIOL CHEM, V267, P3066; VOORBERG J, 1993, EMBO J, V12, P749, DOI 10.1002/j.1460-2075.1993.tb05709.x; Wen G, 2007, HUM MOL GENET, V16, P1752, DOI 10.1093/hmg/ddm123; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Xiong J, 2005, P ANN INT IEEE EMBS, P7529; Yajima A, 2008, J PEPT SCI, V14, P773, DOI 10.1002/psc.991; Yoo SH, 2007, BIOCHEMISTRY-US, V46, P14663, DOI 10.1021/bi701339m; YOO SH, 1995, BIOCHEMISTRY-US, V34, P8680, DOI 10.1021/bi00027a017; Yoo SH, 1996, J BIOL CHEM, V271, P17041, DOI 10.1074/jbc.271.29.17041; Yoo SH, 2002, J BIOL CHEM, V277, P16011, DOI 10.1074/jbc.M105594200; YOO SH, 1993, BIOCHEMISTRY-US, V32, P8213, DOI 10.1021/bi00083a023	87	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10030	10043		10.1074/jbc.M109.064196	http://dx.doi.org/10.1074/jbc.M109.064196			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20061385	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000276165900071
J	Lee, JY; Lee, YG; Lee, J; Yang, KJ; Kim, AR; Kim, JY; Won, MH; Park, J; Yoo, BC; Kim, S; Cho, WJ; Cho, JY				Lee, Ji Yeon; Lee, Yong Gyu; Lee, Jaehwi; Yang, Keum-Jin; Kim, Ae Ra; Kim, Joo Young; Won, Moo-Ho; Park, Jongsun; Yoo, Byong Chul; Kim, Sanghee; Cho, Won-Jea; Cho, Jae Youl			Akt Cys-310-targeted Inhibition by Hydroxylated Benzene Derivatives Is Tightly Linked to Their Immunosuppressive Effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; MACROPHAGE INFLAMMATORY RESPONSE; NITRIC-OXIDE PRODUCTION; TYROSINE PHOSPHORYLATION; PHENOLIC ANTIOXIDANTS; REACTIVE METABOLITE; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; HYDROQUINONE	The hydroxylated benzene metabolite hydroquinone (HQ) is mainly generated from benzene, an important industrial chemical, and is also a common dietary component. Although numerous reports have addressed the tumorigenesis-inducing effects of HQ, few papers have explored its molecular regulatory mechanism in immunological responses. In this study we characterized Akt (protein kinase B)-targeted regulation by HQ and its derivatives, in suppressing inflammatory responses using cellular, molecular, biochemical, and immunopharmacological approaches. HQ down-regulated inflammatory responses such as NO production, surface levels of pattern recognition receptors, and cytokine gene expression with IC50 values that ranged from 5 to 10 mu M. HQ inhibition was mediated by blocking NF-kappa B activation via suppression of its translocation pathway, which is composed of Akt, I kappa B alpha kinase beta, and I kappa B alpha. Of the targets in this pathway, HQ directly targeted and bound to the sulfhydryl group of Cys-310 of Akt and sequentially interrupted the phosphorylation of both Thr-308 and Ser-473 by mediation of beta-mercaptoethanol, according to the liquid chromatography/mass spectroscopy analysis of the interaction of HQ with an Akt-derived peptide. Therefore, our data suggest that Akt and its target site Cys-310 can be considered as a prime molecular target of HQ-mediated immunosuppression and for novel anti Akt-targeted immunosuppressive drugs.	[Lee, Ji Yeon; Lee, Yong Gyu; Kim, Ae Ra; Kim, Joo Young; Cho, Jae Youl] Kangwon Natl Univ, Sch Biosci & Biotechnol, Chunchon 200701, South Korea; [Lee, Ji Yeon; Lee, Yong Gyu; Kim, Ae Ra; Kim, Joo Young; Cho, Jae Youl] Kangwon Natl Univ, Inst Biosci & Biotechnol, Chunchon 200701, South Korea; [Lee, Jaehwi] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Yang, Keum-Jin; Park, Jongsun] Chungnam Natl Univ, Dept Pharmacol, Daejeon Reg Canc Ctr, Canc Res Inst,Coll Med, Taejon 310010, South Korea; [Won, Moo-Ho] Hallym Univ, Coll Med, Dept Anat & Neurobiol, Chucheon 200702, South Korea; [Won, Moo-Ho] Hallym Univ, Coll Med, Inst Neurodegenerat & Neuroregenerat, Chucheon 200702, South Korea; [Kim, Sanghee] Seoul Natl Univ, Coll Pharm, Seoul 151741, South Korea; [Yoo, Byong Chul] Natl Canc Ctr, Res Inst & Hosp, Goyang 410769, South Korea; [Cho, Won-Jea] Chonnam Natl Univ, Coll Pharm, Kwangju 500757, South Korea	Kangwon National University; Kangwon National University; Chung Ang University; Chungnam National University; Hallym University; Hallym University; Seoul National University (SNU); National Cancer Center - Korea (NCC); Chonnam National University	Cho, JY (corresponding author), Kangwon Natl Univ, Sch Biosci & Biotechnol, 192-1 Hyoja 2 Dong, Chunchon 200701, South Korea.	jaecho@kangwon.ac.kr	Park, Jongsun/E-7465-2010	Park, Jongsun/0000-0002-4690-1854; Kim, Sanghee/0000-0001-9125-9541	Ministry of Commerce, Industry and Energy (MOCIE); Korea Industrial Technology Foundation (KOTEF) through the Human Resource Training Project for Regional Innovation	Ministry of Commerce, Industry and Energy (MOCIE)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korea Industrial Technology Foundation (KOTEF) through the Human Resource Training Project for Regional Innovation	This work was supported by the Ministry of Commerce, Industry and Energy (MOCIE) and Korea Industrial Technology Foundation (KOTEF) through the Human Resource Training Project for Regional Innovation (to J.Y.C.).	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Boatman RJ, 2004, ARCH TOXICOL, V78, P443, DOI 10.1007/s00204-004-0563-2; Butchar JP, 2006, CURR PHARM DESIGN, V12, P4143, DOI 10.2174/138161206778743574; Byeon SE, 2008, J MICROBIOL BIOTECHN, V18, P1984, DOI 10.4014/jmb.0800.189; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Cho JY, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/298010; Cho JY, 2004, PHARMACOL RES, V49, P423, DOI 10.1016/j.phrs.2003.11.003; Cho JY, 2000, BIOL PHARM BULL, V23, P1243; Choi JM, 2008, ARCH PHARM RES, V31, P337, DOI 10.1007/s12272-001-1161-1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Donald A, 2007, J MED CHEM, V50, P2289, DOI 10.1021/jm0700924; Enkvist E, 2006, J MED CHEM, V49, P7150, DOI 10.1021/jm0605942; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Hartnett JC, 2008, BIOORG MED CHEM LETT, V18, P2194, DOI 10.1016/j.bmcl.2007.12.040; Heerding DA, 2008, J MED CHEM, V51, P5663, DOI 10.1021/jm8004527; Huang X, 2003, STRUCTURE, V11, P21, DOI 10.1016/S0969-2126(02)00937-1; Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518; Jeong SJ, 2005, ONCOGENE, V24, P6719, DOI 10.1038/sj.onc.1208825; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Jung KK, 2006, LIFE SCI, V79, P2022, DOI 10.1016/j.lfs.2006.06.048; Kim AR, 2005, J PHARM PHARMACOL, V57, P475, DOI 10.1211/0022357055731; Kim BH, 2008, ACTA PHARMACOL SIN, V29, P113, DOI 10.1111/j.1745-7254.2008.00725.x; Kim E, 2005, IMMUNOL LETT, V99, P24, DOI 10.1016/j.imlet.2004.11.025; Kleiner HE, 1998, CHEM RES TOXICOL, V11, P1283, DOI 10.1021/tx980134e; Kobori M, 2007, BRIT J PHARMACOL, V150, P209, DOI 10.1038/sj.bjp.0706972; KOSHIHARA Y, 1988, BIOCHEM PHARMACOL, V37, P2161, DOI 10.1016/0006-2952(88)90576-X; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; LAU SS, 1995, DRUG METAB DISPOS, V23, P1136; LEE BL, 1993, J CHROMATOGR-BIOMED, V619, P259, DOI 10.1016/0378-4347(93)80115-K; Lee JY, 2008, N-S ARCH PHARMACOL, V377, P111, DOI 10.1007/s00210-008-0266-y; Lee MH, 2002, IMMUNOLOGY, V106, P496, DOI 10.1046/j.1365-2567.2002.01451.x; Lee YG, 2008, BRIT J PHARMACOL, V154, P852, DOI 10.1038/bjp.2008.136; Lee YG, 2009, INT J BIOCHEM CELL B, V41, P811, DOI 10.1016/j.biocel.2008.08.011; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Li Q, 1996, TOXICOL APPL PHARM, V139, P317, DOI 10.1006/taap.1996.0171; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Ma Q, 2003, MOL PHARMACOL, V64, P211, DOI 10.1124/mol.64.2.211; Ma Q, 2002, J BIOL CHEM, V277, P2477, DOI 10.1074/jbc.M106685200; Malyshev I. Yu., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P1, DOI 10.2174/1568008033340342; MANNING BW, 1994, TOXICOL APPL PHARM, V126, P214, DOI 10.1006/taap.1994.1110; Martelli AM, 2006, LEUKEMIA, V20, P911, DOI 10.1038/sj.leu.2404245; Motobu M, 2006, PHYTOTHER RES, V20, P359, DOI 10.1002/ptr.1860; Ozes ON, 1999, NATURE, V401, P82; Palaniyar N, 2002, IMMUNOBIOLOGY, V205, P575, DOI 10.1078/0171-2985-00156; Park J, 2001, J BIOL CHEM, V276, P37459, DOI 10.1074/jbc.M105916200; Poet TS, 2004, TOXICOL SCI, V82, P9, DOI 10.1093/toxsci/kfh229; Pyatt DW, 2000, CELL BIOL TOXICOL, V16, P41, DOI 10.1023/A:1007644620655; Qureshi N, 2005, IMMUNOL RES, V31, P243, DOI 10.1385/IR:31:3:243; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Rouse MB, 2009, BIOORG MED CHEM LETT, V19, P1508, DOI 10.1016/j.bmcl.2009.01.002; Sethi G, 2008, BIOCHEM PHARMACOL, V76, P1404, DOI 10.1016/j.bcp.2008.05.023; Shao D, 2008, INFLAMM RES, V57, P601, DOI 10.1007/s00011-008-8053-2; Toral-Barza L, 2007, MOL CANCER THER, V6, P3028, DOI 10.1158/1535-7163.MCT-07-0211; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Xu WR, 2004, ONCOL REP, V12, P501; Yang HC, 2007, ARCH PHARM RES, V30, P955, DOI 10.1007/BF02993963; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang KJ, 2008, J BIOL CHEM, V283, P1480, DOI 10.1074/jbc.M706361200; Yoo ES, 2004, J PHARM PHARMACOL, V56, P503, DOI 10.1211/0022357023042; Yoshimura A, 2006, CANCER SCI, V97, P439, DOI 10.1111/j.1349-7006.2006.00197.x	62	55	56	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9932	9948		10.1074/jbc.M109.074872	http://dx.doi.org/10.1074/jbc.M109.074872			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20054000	Green Published, hybrid			2022-12-27	WOS:000276165900063
J	Shimada, M; Nakadai, T; Fukuda, A; Hisatake, K				Shimada, Miho; Nakadai, Tomoyoshi; Fukuda, Aya; Hisatake, Koji			cAMP-response Element-binding Protein (CREB) Controls MSK1-mediated Phosphorylation of Histone H3 at the c-fos Promoter in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHORBOL ESTER BINDING; STRESS-INDUCED PHOSPHORYLATION; EARLY GENE INDUCTION; S6 KINASE-B; MAP KINASE; TRANSCRIPTIONAL ACTIVATION; CHROMOSOMAL-PROTEINS; DNA-BINDING; MITOTIC PHOSPHORYLATION; TARGET GENES	The rapid induction of the c-fos gene correlates with phosphorylations of histone H3 and HMGN1 by mitogen- and stress-activated protein kinases. We have used a cell-free system to dissect the mechanism by which MSK1 phosphorylates histone H3 within the c-fos chromatin. Here, we show that the reconstituted c-fos chromatin presents a strong barrier to histone H3 phosphorylation by MSK1; however, the activators (serum response factor, Elk-1, cAMP-response element-binding protein (CREB), and ATF1) bound on their cognate sites recruit MSK1 to phosphorylate histone H3 at Ser-10 within the chromatin. This activator-dependent phosphorylation of histone H3 is enhanced by HMGN1 and occurs preferentially near the promoter region. Among the four activators, CREB plays a predominant role in MSK1-mediated phosphorylation of histone H3, and the phosphorylation of Ser-133 in CREB is essential for this process. Mutational analyses of MSK1 show that its N-terminal inhibition domain is critical for the kinase to phosphorylate chromatin-embedded histone H3 in a CREB-dependent manner, indicating the presence of an intricate regulatory network for MSK1-mediated phosphorylation of histone H3.	[Shimada, Miho; Nakadai, Tomoyoshi] Saitama Med Univ, Dept Mol Biol, Fac Med, Saitama 3500495, Japan; [Fukuda, Aya; Hisatake, Koji] Univ Tsukuba, Dept Biochem, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Fukuda, Aya; Hisatake, Koji] Univ Tsukuba, Inst Basic Med Sci, Tsukuba, Ibaraki 3058575, Japan	Saitama Medical University; University of Tsukuba; University of Tsukuba	Hisatake, K (corresponding author), 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	kojihisa@md.tsukuba.ac.jp		Hisatake, Koji/0000-0002-5795-3115	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid for scientific research (to M.S., T.N., A.F., and K.H.) and special coordination funds for promoting science and technology (to A. F.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Alepuz PM, 2003, EMBO J, V22, P2433, DOI 10.1093/emboj/cdg243; Alepuz PM, 2001, MOL CELL, V7, P767, DOI 10.1016/S1097-2765(01)00221-0; An WJ, 2002, MOL CELL, V9, P811, DOI 10.1016/S1097-2765(02)00497-5; Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Arthur JSC, 2008, FRONT BIOSCI-LANDMRK, V13, P5866, DOI 10.2741/3122; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; BARRATT MJ, 1994, P NATL ACAD SCI USA, V91, P4781, DOI 10.1073/pnas.91.11.4781; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bustin M, 2001, TRENDS BIOCHEM SCI, V26, P431, DOI 10.1016/S0968-0004(01)01855-2; Chadee DN, 1999, J BIOL CHEM, V274, P24914, DOI 10.1074/jbc.274.35.24914; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; Clayton AL, 2003, FEBS LETT, V546, P51, DOI 10.1016/S0014-5793(03)00451-4; Darragh J, 2005, BIOCHEM J, V390, P749, DOI 10.1042/BJ20050196; de Nadal E, 2004, NATURE, V427, P370, DOI 10.1038/nature02258; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; DeManno DA, 1999, MOL ENDOCRINOL, V13, P91, DOI 10.1210/me.13.1.91; Ding HF, 1997, MOL CELL BIOL, V17, P5843, DOI 10.1128/MCB.17.10.5843; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; Dyson MH, 2005, J CELL SCI, V118, P2247, DOI 10.1242/jcs.02373; Edmunds JW, 2006, SCIENCE, V313, P449, DOI 10.1126/science.1131158; EDWARDS DR, 1992, EMBO J, V11, P2415, DOI 10.1002/j.1460-2075.1992.tb05306.x; Flynn P, 1998, J BIOL CHEM, V273, P2698, DOI 10.1074/jbc.273.5.2698; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fukuda A, 2009, J BIOL CHEM, V284, P23472, DOI 10.1074/jbc.M109.013656; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Gupta P, 2002, J BIOL CHEM, V277, P50550, DOI 10.1074/jbc.M209799200; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; James SR, 1996, BIOCHEM J, V315, P709, DOI 10.1042/bj3150709; KAZANIETZ MG, 1995, J BIOL CHEM, V270, P21852, DOI 10.1074/jbc.270.37.21852; Li JW, 2002, MOL CELL BIOL, V22, P5688, DOI 10.1128/MCB.22.16.5688-5697.2002; Lim JH, 2004, MOL CELL, V15, P573, DOI 10.1016/j.molcel.2004.08.006; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; New L, 1999, J BIOL CHEM, V274, P1026, DOI 10.1074/jbc.274.2.1026; Nowak SJ, 2000, GENE DEV, V14, P3003, DOI 10.1101/gad.848800; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; ONO Y, 1989, P NATL ACAD SCI USA, V86, P4868, DOI 10.1073/pnas.86.13.4868; PARANJAPE SM, 1995, GENE DEV, V9, P1978, DOI 10.1101/gad.9.16.1978; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; POSTNIKOV YV, 1995, J MOL BIOL, V252, P423, DOI 10.1006/jmbi.1995.0508; Price MA, 1996, PHILOS T ROY SOC B, V351, P551, DOI 10.1098/rstb.1996.0054; Prigent C, 2003, J CELL SCI, V116, P3677, DOI 10.1242/jcs.00735; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Prymakowska-Bosak M, 2001, MOL CELL BIOL, V21, P5169, DOI 10.1128/MCB.21.15.5169-5178.2001; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Sharma N, 2007, J BIOL CHEM, V282, P19872, DOI 10.1074/jbc.M701435200; Smith KJ, 2004, STRUCTURE, V12, P1067, DOI 10.1016/j.str.2004.02.040; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Thomson S, 1999, SEMIN CELL DEV BIOL, V10, P205, DOI 10.1006/scdb.1999.0302; Thomson S, 2004, MOL CELL, V15, P585, DOI 10.1016/j.molcel.2004.08.002; Tomas-Zuber M, 2001, J BIOL CHEM, V276, P5892, DOI 10.1074/jbc.M005822200; Tomas-Zuber M, 2000, J BIOL CHEM, V275, P23549, DOI 10.1074/jbc.M002586200; Trieschmann L, 1998, P NATL ACAD SCI USA, V95, P5468, DOI 10.1073/pnas.95.10.5468; TRIESCHMANN L, 1995, EMBO J, V14, P1478, DOI 10.1002/j.1460-2075.1995.tb07134.x; Vermeulen L, 2009, TRENDS BIOCHEM SCI, V34, P311, DOI 10.1016/j.tibs.2009.02.007; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang HM, 2008, NUCLEIC ACIDS RES, V36, P2594, DOI 10.1093/nar/gkn099; Zhang Y, 2004, J BIOL CHEM, V279, P21866, DOI 10.1074/jbc.M400099200	72	20	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9390	9401		10.1074/jbc.M109.057745	http://dx.doi.org/10.1074/jbc.M109.057745			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089855	hybrid, Green Submitted, Green Published			2022-12-27	WOS:000276165900011
J	Tsakraklides, V; Bell, SP				Tsakraklides, Vasiliki; Bell, Stephen P.			Dynamics of Pre-replicative Complex Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORIGIN RECOGNITION COMPLEX; XENOPUS EGG EXTRACTS; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; ATP-HYDROLYSIS; BUDDING YEAST; MCM PROTEINS; INITIATION PROTEINS; CELL-CYCLE; IN-VITRO	The pre-replicative complex (pre-RC) is formed at all potential origins of replication through the action of the origin recognition complex (ORC), Cdc6, Cdt1, and the Mcm2-7 complex. The end result of pre-RC formation is the loading of the Mcm2-7 replicative helicase onto origin DNA. We examined pre-RC formation in vitro and found that it proceeds through separable binding events. Origin-bound ORC recruits Cdc6, and this ternary complex then promotes helicase loading in the presence of a pre-formed Mcm2-7-Cdt1 complex. Using a stepwise pre-RC assembly assay, we investigated the fate of pre-RC components during later stages of the reaction. We determined that helicase loading is accompanied by dissociation of ORC, Cdc6, and Cdt1 from origin DNA. This dissociation requires ATP hydrolysis at a late stage of pre-RC assembly. Our results indicate that pre-RC formation is a dynamic process.	[Tsakraklides, Vasiliki; Bell, Stephen P.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Bell, Stephen P.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Bell, SP (corresponding author), 77 Massachusetts Ave,Rm 68-630, Cambridge, MA 02139 USA.	spbell@mit.edu		Bell, Stephen/0000-0002-2876-610X; Tsakraklides, Vasiliki/0000-0003-1998-1075	National Institutes of Health [GM52339]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052339] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM52339 (to S.P.B.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; BELL SP, 1995, CURR OPIN GENET DEV, V5, P162, DOI 10.1016/0959-437X(95)80003-4; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Bowers JL, 2004, MOL CELL, V16, P967, DOI 10.1016/j.molcel.2004.11.038; Chen S, 2007, GENE DEV, V21, P2897, DOI 10.1101/gad.1596807; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gibson DG, 2006, GENES CELLS, V11, P557, DOI 10.1111/j.1365-2443.2006.00967.x; Kan JS, 2008, J BIOL CHEM, V283, P33803, DOI 10.1074/jbc.C800182200; Kawasaki Y, 2006, GENES CELLS, V11, P745, DOI 10.1111/j.1365-2443.2006.00975.x; Klemm RD, 1997, CELL, V88, P493, DOI 10.1016/S0092-8674(00)81889-9; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Randell JCW, 2006, MOL CELL, V21, P29, DOI 10.1016/j.molcel.2005.11.023; RAO H, 1995, P NATL ACAD SCI USA, V92, P2224, DOI 10.1073/pnas.92.6.2224; Rowles A, 1999, J CELL SCI, V112, P2011; Schwacha A, 2001, MOL CELL, V8, P1093, DOI 10.1016/S1097-2765(01)00389-6; Seki T, 2000, P NATL ACAD SCI USA, V97, P14115, DOI 10.1073/pnas.97.26.14115; Semple JW, 2006, EMBO J, V25, P5150, DOI 10.1038/sj.emboj.7601391; Speck C, 2005, NAT STRUCT MOL BIOL, V12, P965, DOI 10.1038/nsmb1002; Speck C, 2007, J BIOL CHEM, V282, P11705, DOI 10.1074/jbc.M700399200; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Waga S, 2006, J BIOL CHEM, V281, P10926, DOI 10.1074/jbc.M600299200	29	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9437	9443		10.1074/jbc.M109.072504	http://dx.doi.org/10.1074/jbc.M109.072504			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097898	hybrid, Green Published			2022-12-27	WOS:000276165900016
J	Ochi, A; Makabe, K; Kuwajima, K; Hori, H				Ochi, Anna; Makabe, Koki; Kuwajima, Kunihiro; Hori, Hiroyuki			Flexible Recognition of the tRNA G18 Methylation Target Site by TrmH Methyltransferase through First Binding and Induced Fit Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEEP TREFOIL KNOT; ACID-SEQUENCE MOTIFS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; AQUIFEX-AEOLICUS; GM18 METHYLTRANSFERASE; SUBSTRATE-SPECIFICITY; ACTIVE-SITE; PROTEIN; ENZYME	Transfer RNA (Gm18) methyltransferase (TrmH) catalyzes methyl transfer from S-adenosyl-L-methionine to a conserved G18 in tRNA. We investigated the recognition mechanism of Thermus thermophilus TrmH for its guanosine target. Thirteen yeast tRNAPhe mutant transcripts were prepared in which the modification site and/or other nucleotides in the D-loop were substituted by dG, inosine, or other nucleotides. We then conducted methyl transfer kinetic studies, gel shift assays, and inhibition experiments using these tRNA variants. Sites of methylation were confirmed with RNA sequencing or primer extension. Although the G18G19 sequence is not essential for methylation by TrmH, disruption of G18G19 severely reduces the efficiency of methyl transfer. There is strict recognition of guanosine by TrmH, in that methylation occurs at the adjacent G19 when the G18 is replaced by dG or adenosine. The fact that TrmH methylates guanosine in D-loops from 4 to 12 nucleotides in length suggests that selection of the position of guanosine within the D-loop is relatively flexible. Our studies also demonstrate that the oxygen 6 atom of the guanine base is a positive determinant for TrmH recognition. The recognition process of TrmH for substrate is inducible and product-inhibited, in that tRNAs containing Gm18 are excluded by TrmH. In contrast, substitution of G18 with dG18 results in the formation of a more stable TrmH-tRNA complex. To address the mechanism, we performed the stopped-flow pre-steady state kinetic analysis. The result clearly showed that the binding of TrmH to tRNA is composed of at least three steps, the first bi-molecular binding and the subsequent two uni-molecular induced-fit processes.	[Ochi, Anna; Hori, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan; [Hori, Hiroyuki] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan; [Makabe, Koki; Kuwajima, Kunihiro] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Makabe, Koki; Kuwajima, Kunihiro] Inst Mol Sci, Okazaki, Aichi 4448787, Japan	Ehime University; Ehime University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS)	Hori, H (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Bunkyo 3, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Hori, Hiroyuki/AAB-3911-2021		Japan Society for the Promotion of Science [21-10011, 20034041, 19350087]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Research Fellowship for Young Scientists 21-10011 (to A.O.), Grant-in-aid for Science Research on Priority Areas 20034041 (to H. H.), and Grant-in-aid for Science Research 19350087 (to H. H.) from the Japan Society for the Promotion of Science.	Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Alsallaq R, 2008, PROTEINS, V71, P320, DOI 10.1002/prot.21679; Anantharaman V, 2002, J MOL MICROB BIOTECH, V4, P71; BRISSETTE P, 1989, ANAL BIOCHEM, V181, P234, DOI 10.1016/0003-2697(89)90235-2; BYSTROM AS, 1982, MOL GEN GENET, V188, P440, DOI 10.1007/BF00330046; Cavaille J, 1999, RNA, V5, P66, DOI 10.1017/S1355838299981475; Chitester BJ, 2002, ARCH BIOCHEM BIOPHYS, V406, P73, DOI 10.1016/S0003-9861(02)00409-5; Christian T, 2004, J MOL BIOL, V339, P707, DOI 10.1016/j.jmb.2004.04.025; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; DONISKELLER H, 1977, NUCLEIC ACIDS RES, V4, P2527, DOI 10.1093/nar/4.8.2527; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Elkins PA, 2003, J MOL BIOL, V333, P931, DOI 10.1016/j.jmb.2003.09.011; Forouhar F, 2003, PROTEINS, V53, P329, DOI 10.1002/prot.10510; GARCIA GR, 1998, MODIFICATION EDITING, P555; Goto-Ito S, 2008, PROTEINS, V72, P1274, DOI 10.1002/prot.22019; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; HOLMES WM, 1992, J BIOL CHEM, V267, P13440; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; HORI H, 1989, J BIOCHEM-TOKYO, V106, P798, DOI 10.1093/oxfordjournals.jbchem.a122933; Hori H, 2002, GENES CELLS, V7, P259, DOI 10.1046/j.1365-2443.2002.00520.x; Hori H, 1998, J BIOL CHEM, V273, P25721, DOI 10.1074/jbc.273.40.25721; KEITH G, 1995, BIOCHIMIE, V77, P142, DOI 10.1016/0300-9084(96)88118-1; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KOREN R, 1976, BIOCHEMISTRY-US, V15, P1165, DOI 10.1021/bi00650a032; KUMAGAI I, 1982, J BIOL CHEM, V257, P7388; Kuratani M, 2008, J MOL BIOL, V375, P1064, DOI 10.1016/j.jmb.2007.11.023; Lim K, 2003, PROTEINS, V51, P56, DOI 10.1002/prot.10323; Liu JY, 2003, PROTEINS, V53, P326, DOI 10.1002/prot.10479; Mosbacher TG, 2005, J MOL BIOL, V345, P535, DOI 10.1016/j.jmb.2004.10.051; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; Nureki O, 2002, ACTA CRYSTALLOGR D, V58, P1129, DOI 10.1107/S0907444902006601; Okamoto H, 2004, J BIOL CHEM, V279, P49151, DOI 10.1074/jbc.M408209200; Persson BC, 1997, NUCLEIC ACIDS RES, V25, P4093, DOI 10.1093/nar/25.20.4093; Pleshe E, 2005, ACTA CRYSTALLOGR F, V61, P722, DOI 10.1107/S1744309105022980; Purta E, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-23; Redlak M, 1997, BIOCHEMISTRY-US, V36, P8699, DOI 10.1021/bi9701538; Renalier MH, 2005, RNA, V11, P1051, DOI 10.1261/rna.2110805; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Urbonavicius J, 2002, J BACTERIOL, V184, P5348, DOI 10.1128/JB.184.19.5348-5357.2002; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Watanabe K, 2006, J BIOL CHEM, V281, P34630, DOI 10.1074/jbc.M606141200; Zarembinski TI, 2003, PROTEINS, V50, P177, DOI 10.1002/prot.10311	46	28	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9018	9029		10.1074/jbc.M109.065698	http://dx.doi.org/10.1074/jbc.M109.065698			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20053984	hybrid, Green Published			2022-12-27	WOS:000275553700053
J	Pena, F; Jansens, A; van Zadelhoff, G; Braakman, I				Pena, Florentina; Jansens, Annemieke; van Zadelhoff, Guus; Braakman, Ineke			Calcium as a Crucial Cofactor for Low Density Lipoprotein Receptor Folding in the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH REPEAT; FAMILIAL HYPERCHOLESTEROLEMIA MUTATIONS; PROTEIN-DISULFIDE-ISOMERASE; LIGAND-BINDING MODULES; LDL RECEPTOR; MONOCLONAL-ANTIBODIES; INTRACELLULAR-TRANSPORT; INFLUENZA HEMAGGLUTININ; 3-DIMENSIONAL STRUCTURE; QUALITY-CONTROL	The family of low density lipoprotein (LDL) receptors mediate uptake of a plethora of ligands from the circulation and couple this to signaling, thereby performing a crucial role in physiological processes including embryonic development, cancer development, homeostasis of lipoproteins, viral infection, and neuronal plasticity. Structural integrity of individual ectodomain modules in these receptors depends on calcium, and we showed before that the LDL receptor folds its modules late after synthesis via intermediates with abundant non-native disulfide bonds and structure. Using a radioactive pulse-chase approach, we here show that for proper LDL receptor folding, calcium had to be present from the very early start of folding, which suggests at least some native, essential coordination of calcium ions at the still largely non-native folding phase. As long as the protein was in the endoplasmic reticulum (ER), its folding was reversible, which changed only upon both proper incorporation of calcium and exit from the ER. Coevolution of protein folding with the high calcium concentration in the ER may be the basis for the need for this cation throughout the folding process even though calcium is only stably integrated in native repeats at a later stage.	[Pena, Florentina; Jansens, Annemieke; van Zadelhoff, Guus; Braakman, Ineke] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands	Utrecht University	Braakman, I (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	i.braakman@uu.nl	Jansens, A./L-4409-2015; van Zadelhoff, Guus/F-2260-2010	Pena, Florentina/0000-0002-7127-9219; Braakman, Ineke/0000-0003-1592-4364	Netherlands Heart Foundation; EuroSCOPE; Netherlands Organization for Scientific Research-Chemical Division; Federation of European Biochemical Societies and Marie Curie	Netherlands Heart Foundation(Netherlands Heart Foundation); EuroSCOPE; Netherlands Organization for Scientific Research-Chemical Division; Federation of European Biochemical Societies and Marie Curie	This work was supported by grants from The Netherlands Heart Foundation (to I. B. and A.J.), EuroSCOPE (to I. B. and F. P.), The Netherlands Organization for Scientific Research-Chemical Division (to I. B. and F. P.), and Federation of European Biochemical Societies and Marie Curie (to F. P.).	Abdul-Aziz D, 2005, BIOCHEMISTRY-US, V44, P5075, DOI 10.1021/bi047575j; Arias-Moreno X, 2008, J BIOL CHEM, V283, P13627, DOI 10.1074/jbc.M800755200; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; BAKSH S, 1991, J BIOL CHEM, V266, P21458; BAUMANN O, 1991, P NATL ACAD SCI USA, V88, P741, DOI 10.1073/pnas.88.3.741; Beglova N, 2005, TRENDS BIOCHEM SCI, V30, P309, DOI 10.1016/j.tibs.2005.03.007; BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BIERI S, 1995, FEBS LETT, V371, P341, DOI 10.1016/0014-5793(95)00939-7; Bieri S, 1998, BIOCHEMISTRY-US, V37, P10994, DOI 10.1021/bi980452c; Biswas C, 2007, BIOCHEM J, V405, P233, DOI 10.1042/BJ20061867; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; Boswell EJ, 2004, J BIOL CHEM, V279, P30611, DOI 10.1074/jbc.M401412200; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; BRAAKMAN I, 1992, EMBO J, V11, P1717, DOI 10.1002/j.1460-2075.1992.tb05223.x; Brockmeier A, 2006, BIOCHEMISTRY-US, V45, P12906, DOI 10.1021/bi0614378; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BROWN MS, 1974, SCIENCE, V185, P61, DOI 10.1126/science.185.4145.61; Chandrashekar R, 1998, P NATL ACAD SCI USA, V95, P531, DOI 10.1073/pnas.95.2.531; Combettes L, 1996, EMBO J, V15, P2086, DOI 10.1002/j.1460-2075.1996.tb00562.x; Conte IL, 2007, BIOCHEMISTRY-US, V46, P4671, DOI 10.1021/bi6026456; Cooper GR, 1997, BIOCHEM J, V325, P601, DOI 10.1042/bj3250601; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; Corbett EF, 2000, J BIOL CHEM, V275, P27177; CUMMINGS RD, 1983, J BIOL CHEM, V258, P5261; DALY NL, 1995, BIOCHEMISTRY-US, V34, P14474, DOI 10.1021/bi00044a025; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Guest PC, 1997, BIOCHEM J, V323, P445, DOI 10.1042/bj3230445; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Huang W, 1999, J BIOL CHEM, V274, P14130, DOI 10.1074/jbc.274.20.14130; Jansens A, 2002, SCIENCE, V298, P2401, DOI 10.1126/science.1078376; Jansens Annemieke, 2003, Methods Mol Biol, V232, P133; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; JOSEPH SK, 1986, J BIOL CHEM, V261, P4658; KITA T, 1981, P NATL ACAD SCI-BIOL, V78, P2268, DOI 10.1073/pnas.78.4.2268; Koduri V, 2001, BIOCHEMISTRY-US, V40, P12801, DOI 10.1021/bi011344k; Kurniawan ND, 2001, J MOL BIOL, V311, P341, DOI 10.1006/jmbi.2001.4867; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; LODISH HF, 1992, J BIOL CHEM, V267, P12753; Lucero HA, 1999, J BIOL CHEM, V274, P3243, DOI 10.1074/jbc.274.5.3243; MACER DRJ, 1988, J CELL SCI, V91, P61; Malby S, 2001, BIOCHEMISTRY-US, V40, P2555, DOI 10.1021/bi002322l; May Petra, 2003, Sci STKE, V2003, pPE12, DOI 10.1126/stke.2003.176.pe12; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Molinari M, 2004, MOL CELL, V13, P125, DOI 10.1016/S1097-2765(03)00494-5; MONTERO M, 1995, EMBO J, V14, P5467, DOI 10.1002/j.1460-2075.1995.tb00233.x; Nguyen AT, 2006, J LIPID RES, V47, P1399, DOI 10.1194/jlr.M600130-JLR200; NIGAM SK, 1994, J BIOL CHEM, V269, P1744; North CL, 1999, BIOCHEMISTRY-US, V38, P3926, DOI 10.1021/bi9821622; North CL, 2000, BIOCHEMISTRY-US, V39, P2564, DOI 10.1021/bi992087a; Nuss JE, 2008, BIOCHEM BIOPH RES CO, V365, P355, DOI 10.1016/j.bbrc.2007.10.194; Obermoeller LM, 1998, J BIOL CHEM, V273, P22374, DOI 10.1074/jbc.273.35.22374; Papp S, 2003, J CELL BIOL, V160, P475, DOI 10.1083/jcb.200207136; PFEIFFER DR, 1976, BIOCHEMISTRY-US, V15, P935, DOI 10.1021/bi00650a001; Pieren M, 2005, J BIOL CHEM, V280, P28265, DOI 10.1074/jbc.M501020200; Rancy PC, 2008, BIOCHEMISTRY-US, V47, P12047, DOI 10.1021/bi801604x; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; SCHNEIDER WJ, 1979, P NATL ACAD SCI USA, V76, P5577, DOI 10.1073/pnas.76.11.5577; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; SHORT AD, 1993, J BIOL CHEM, V268, P25887; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; TATU U, 1993, EMBO J, V12, P2151, DOI 10.1002/j.1460-2075.1993.tb05863.x; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; TSE FW, 1994, P NATL ACAD SCI USA, V91, P9750, DOI 10.1073/pnas.91.21.9750; VANDRIEL IR, 1987, J BIOL CHEM, V262, P17443; VANROGGEN JFG, 1995, ARTERIOSCL THROM VAS, V15, P765, DOI 10.1161/01.ATV.15.6.765; Willnow TE, 1999, NAT CELL BIOL, V1, pE157, DOI 10.1038/14109; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yu XM, 2003, J VIROL, V77, P7517, DOI 10.1128/JVI.77.13.7517-7526.2003	75	27	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8656	8664		10.1074/jbc.M110.105718	http://dx.doi.org/10.1074/jbc.M110.105718			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089850	Green Published, hybrid			2022-12-27	WOS:000275553700018
J	Cote, MC; Lavoie, JR; Houle, F; Poirier, A; Rousseau, S; Huot, J				Cote, Maxime C.; Lavoie, Jessie R.; Houle, Francois; Poirier, Andree; Rousseau, Simon; Huot, Jacques			Regulation of Vascular Endothelial Growth Factor-induced Endothelial Cell Migration by LIM Kinase 1-mediated Phosphorylation of Annexin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; METASTASIS-ASSOCIATED PROTEINS; P38 MAP KINASE; FOCAL ADHESION KINASE; ACTIN-BASED MOTILITY; CANCER-CELLS; RECEPTOR; ANGIOGENESIS; STRESS; IDENTIFICATION	In this study, we obtained evidence indicating that annexin 1 is a new target of the p38/MAPKAP kinase-2 pathway and that it regulates endothelial cell migration in response to vascular endothelial growth factor (VEGF). These conclusions are supported by a series of substantiating experiments. First, by two-dimensional gel electrophoresis and mass spectrometry, we identified annexin 1 as a protein whose phosphorylation is induced by VEGF and is impaired by inhibiting p38. Second, using in vitro kinase assays and in vivo phosphorylation assays, we found that VEGF-mediated activation of LIM kinase 1 downstream of the p38 pathway triggers the phosphorylation of annexin 1. Third, VEGF-induced cell migration and tube formation in Matrigel are inhibited following small interfering RNA-mediated knockdown of annexin 1. Fourth, both processes are rescued in cells expressing an annexin 1 construct insensitive to the small interfering RNA knockdown. Finally, the VEGF/annexin 1-mediated cell migration is impaired by inhibiting p38. We therefore conclude that phosphorylation of annexin 1 regulates the angiogenic effect that is associated with the activation of the p38/LIM kinase 1 axis by VEGF.	[Cote, Maxime C.; Lavoie, Jessie R.; Houle, Francois; Poirier, Andree; Huot, Jacques] Univ Laval, Canc Res Ctr, Quebec City, PQ G1R 2J6, Canada; [Rousseau, Simon] McGill Univ, Meakins Inst, Montreal, PQ H2X 2P2, Canada	Laval University; McGill University	Huot, J (corresponding author), Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Hotel Dieu Quebec,Canc Res Ctr, 9 Rue McMahon, Quebec City, PQ G1R 2J6, Canada.	Jacques.Huot@fmed.ulaval.ca	Rousseau, Simon/A-1800-2009	Rousseau, Simon/0000-0002-8773-575X	The Canadian Institutes of Health Research; Heart Stroke Foundation of Canada	The Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was supported by grants from The Canadian Institutes of Health Research and the Heart Stroke Foundation of Canada (Qc).	Alldridge LC, 2003, EXP CELL RES, V290, P93, DOI 10.1016/S0014-4827(03)00310-0; Alldridge LC, 1999, J BIOL CHEM, V274, P37620, DOI 10.1074/jbc.274.53.37620; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bai XF, 2004, WORLD J GASTROENTERO, V10, P1466; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; CAMPOSGONZALEZ R, 1990, CELL MOTIL CYTOSKEL, V15, P34, DOI 10.1002/cm.970150106; Chouinard N, 2002, BIOCHEM J, V365, P133, DOI 10.1042/BJ20020072; Cicek M, 2004, CLIN EXP METASTAS, V21, P149, DOI 10.1023/B:CLIN.0000024729.19084.f0; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; Endo M, 2003, J NEUROSCI, V23, P2527; Evans IM, 2008, CELL SIGNAL, V20, P1375, DOI 10.1016/j.cellsig.2008.03.002; FLOWER RJ, 1994, TRENDS PHARMACOL SCI, V15, P71, DOI 10.1016/0165-6147(94)90281-X; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; HUOT J, 1995, EUR J BIOCHEM, V227, P416, DOI 10.1111/j.1432-1033.1995.tb20404.x; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Jiang DF, 2003, PROTEOMICS, V3, P724, DOI 10.1002/pmic.200300411; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Le Boeuf F, 2006, MOL BIOL CELL, V17, P3508, DOI 10.1091/mbc.E05-12-1158; Liao SH, 2009, PROTEOMICS, V9, P3901, DOI 10.1002/pmic.200800922; Lim LHK, 2007, FASEB J, V21, P968, DOI 10.1096/fj.06-7464rev; Martin GR, 2008, AM J PHYSIOL-GASTR L, V294, pG764, DOI 10.1152/ajpgi.00531.2007; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; New L, 1998, EMBO J, V17, P3372, DOI 10.1093/emboj/17.12.3372; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rescher U, 2002, J IMMUNOL, V169, P1500, DOI 10.4049/jimmunol.169.3.1500; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Ritchie RH, 2005, BRIT J PHARMACOL, V145, P495, DOI 10.1038/sj.bjp.0706211; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Rousseau S, 2000, TRENDS CARDIOVAS MED, V10, P321, DOI 10.1016/S1050-1738(01)00072-X; Rousseau S, 2006, CELL SIGNAL, V18, P1897, DOI 10.1016/j.cellsig.2006.02.006; Roviezzo F, 2002, J PHYSIOL PHARMACOL, V53, P541; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Skouteris GG, 1996, J BIOL CHEM, V271, P27266, DOI 10.1074/jbc.271.44.27266; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Solito E, 2003, ENDOCRINOLOGY, V144, P1164, DOI 10.1210/en.2002-220592; STOKOE D, 1993, BIOCHEM J, V296, P843, DOI 10.1042/bj2960843; Taher MM, 2000, BIOCHEMISTRY-US, V39, P1709, DOI 10.1021/bi9921079; Tong QS, 2006, EXP CELL RES, V312, P3559, DOI 10.1016/j.yexcr.2006.07.024; Traverso V, 1998, J CELL SCI, V111, P1405; Wu WG, 2002, CLIN EXP METASTAS, V19, P319, DOI 10.1023/A:1015515119300; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100	53	35	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8013	8021		10.1074/jbc.M109.098665	http://dx.doi.org/10.1074/jbc.M109.098665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061392	hybrid, Green Published			2022-12-27	WOS:000275413800019
J	Hsu, MF; Meng, TC				Hsu, Ming-Fo; Meng, Tzu-Ching			Enhancement of Insulin Responsiveness by Nitric Oxide-mediated Inactivation of Protein-tyrosine Phosphatases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; RAT SKELETAL-MUSCLE; S-NITROSYLATION; IN-VIVO; REVERSIBLE OXIDATION; GLUCOSE-TRANSPORT; MICE LACKING; RESISTANCE; SYNTHASE; HYPERTENSION	NO synthesis is a prerequisite for proper insulin sensitivity in insulin-targeted tissues; however, the molecular basis for this process remains unclear. Using a gain-of-function model of endothelial nitric-oxide synthase (eNOS)-transfected COS-7 cells, we have shown a critical role of NO in insulin responsiveness, as evidenced by an NO-dependent increase of tyrosine phosphorylation levels of the insulin receptor and its downstream effectors insulin receptor substrate-1 and PKB/AKT. We hypothesized that NO-induced inactivation of endogenous protein-tyrosine phosphatases (PTPs) would enhance insulin receptor-mediated signaling. To test this hypothesis, we devised a new method of the PTP labeling using a cysteine sulfhydryl-reacted probe. Under the acidic conditions employed in this study, the probe recognized the reduced and active forms but not the S-nitrosylated and inactive forms of endogenous PTPs. Our data suggest that phosphatases SHP-1, SHP-2, and PTP1B, but not TC-PTP, are likely S-nitrosylated at the active site cysteine residue concomitantly with a burst of NO production in signaling response to insulin stimulation. These results were further confirmed by phosphatase activity assays. We investigated further the role of NO as a regulator of insulin signaling by RNA interference that ablates endogenous eNOS expression in endothelial MS-1 cells. We have shown that eNOS-dependent NO production is essential for the activation of insulin signaling. Our findings demonstrate that NO mediates enhancement of insulin responsiveness via the inhibition of insulin receptor phosphatases.	[Meng, Tzu-Ching] Acad Sinica, Inst Biol Chem, Taipei 11529, Taiwan; Natl Taiwan Univ, Coll Life Sci, Taiwan & Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Meng, TC (corresponding author), Acad Sinica, Inst Biol Chem, 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	tcmeng@gate.sinica.edu.tw	Meng, Tzu-Ching/G-5426-2019	Meng, Tzu-Ching/0000-0001-7693-2021	Taiwan National Science Council [97-3112-B-002-005, 98-3112-B-001-028]; Academia Sinica	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by Taiwan National Science Council Grants 97-3112-B-002-005 and 98-3112-B-001-028). This work was also supported by funding from Academia Sinica (to T.-C. M.).	Asante-Appiah E, 2003, AM J PHYSIOL-ENDOC M, V284, pE663, DOI 10.1152/ajpendo.00462.2002; Balon TW, 1997, J APPL PHYSIOL, V82, P359, DOI 10.1152/jappl.1997.82.1.359; BARON AD, 1995, AM J PHYSIOL-ENDOC M, V269, pE709, DOI 10.1152/ajpendo.1995.269.4.E709; Barrett DM, 2005, J BIOL CHEM, V280, P14453, DOI 10.1074/jbc.M411523200; CASELLI A, 1994, J BIOL CHEM, V269, P24878; Chen YY, 2007, METHODS, V42, P243, DOI 10.1016/j.ymeth.2007.03.002; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Duplain H, 2001, CIRCULATION, V104, P342, DOI 10.1161/01.CIR.104.3.342; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Engeli S, 2004, J LIPID RES, V45, P1640, DOI 10.1194/jlr.M300322-JLR200; Forrester MT, 2007, J BIOL CHEM, V282, P13977, DOI 10.1074/jbc.M609684200; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Greco TM, 2006, P NATL ACAD SCI USA, V103, P7420, DOI 10.1073/pnas.0600729103; Hao G, 2006, P NATL ACAD SCI USA, V103, P1012, DOI 10.1073/pnas.0508412103; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Higaki Y, 2001, DIABETES, V50, P241, DOI 10.2337/diabetes.50.2.241; Iwakiri Y, 2006, P NATL ACAD SCI USA, V103, P19777, DOI 10.1073/pnas.0605907103; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; Kuncewicz T, 2003, MOL CELL PROTEOMICS, V2, P156, DOI 10.1074/mcp.M300003-MCP200; Li S, 2003, ARCH BIOCHEM BIOPHYS, V410, P269, DOI 10.1016/S0003-9861(02)00696-3; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Meng TC, 2004, J BIOL CHEM, V279, P37716, DOI 10.1074/jbc.M404606200; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; Ouwens DM, 2001, MOL CELL ENDOCRINOL, V175, P131, DOI 10.1016/S0303-7207(01)00389-6; Roy D, 1998, AM J PHYSIOL-ENDOC M, V274, pE692, DOI 10.1152/ajpendo.1998.274.4.E692; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Shankar RR, 2000, DIABETES, V49, P684, DOI 10.2337/diabetes.49.5.684; Tang SG, 2001, DIABETES, V50, P83, DOI 10.2337/diabetes.50.1.83; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Young ME, 1997, BIOCHEM J, V322, P223, DOI 10.1042/bj3220223; Yu CX, 2005, MOL PHARMACOL, V68, P847, DOI 10.1124/mol.104.010504; Zeng GY, 1996, J CLIN INVEST, V98, P894, DOI 10.1172/JCI118871; Zeng GY, 2000, CIRCULATION, V101, P1539, DOI 10.1161/01.CIR.101.13.1539; ZHANG ZY, 1993, BIOCHEMISTRY-US, V32, P9340, DOI 10.1021/bi00087a012	42	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7919	7928		10.1074/jbc.M109.057513	http://dx.doi.org/10.1074/jbc.M109.057513			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064934	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000275413800009
J	Hu, W; Xu, RJ; Sun, W; Szulc, ZM; Bielawski, J; Obeid, LM; Mao, CG				Hu, Wei; Xu, Ruijuan; Sun, Wei; Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui			Alkaline Ceramidase 3 (ACER3) Hydrolyzes Unsaturated Long-chain Ceramides, and Its Down-regulation Inhibits Both Cell Proliferation and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; MOLECULAR-CLONING; ACID CERAMIDASE; FUNCTIONAL-CHARACTERIZATION; MITOCHONDRIAL CERAMIDASE; SACCHAROMYCES-CEREVISIAE; FARBER-DISEASE; CANCER CELLS; SPHINGOSINE; GENERATION	Ceramides with different fatty acyl chains may vary in their physiological or pathological roles; however, it remains unclear how cellular levels of individual ceramide species are regulated. Here, we demonstrate that our previously cloned human alkaline ceramidase 3 (ACER3) specifically controls the hydrolysis of ceramides carrying unsaturated long acyl chains, unsaturated long-chain (ULC) ceramides. In vitro, ACER3 only hydrolyzed C-18:1-, C-20:1-, C-20:4-ceramides, dihydroceramides, and phytoceramides. In cells, ACER3 overexpression decreased C-18:1- and C-20:1-ceramides and dihydroceramides, whereas ACER3 knockdown by RNA interference had the opposite effect, suggesting that ACER3 controls the catabolism of ULC ceramides and dihydroceramides. ACER3 knockdown inhibited cell proliferation and up-regulated the cyclin-dependent kinase inhibitor p21(CIP1/WAF1). Blocking p21(CIP1/WAF1) up-regulation attenuated the inhibitory effect of ACER3 knockdown on cell proliferation, suggesting that ACER3 knockdown inhibits cell proliferation because of p21(CIP1/WAF1) up-regulation. ACER3 knockdown inhibited cell apoptosis in response to serum deprivation. ACER3 knockdown up-regulated the expression of the alkaline ceramidase 2 (ACER2), and the ACER2 up-regulation decreased non-ULC ceramide species while increasing both sphingosine and its phosphate. Collectively, these data suggest that ACER3 catalyzes the hydrolysis of ULC ceramides and dihydroceramides and that ACER3 coordinates with ACER2 to regulate cell proliferation and survival.	[Mao, Cungui] Med Univ S Carolina, Div Gen Internal Med, Dept Med, Charleston, SC 29425 USA; [Szulc, Zdzislaw M.; Bielawski, Jacek; Obeid, Lina M.; Mao, Cungui] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Hosp, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Mao, CG (corresponding author), Med Univ S Carolina, Div Gen Internal Med, Dept Med, 114 Doughty St,Rm 646,STB,POB 250779, Charleston, SC 29425 USA.	maoc@musc.edu	xu, rui/GRX-5734-2022	obeid, lina/0000-0002-0734-0847	National Institutes of Health [P20RR017677, R01CA104834, R01GM062887]; Veterans Affairs Merit award; NATIONAL CANCER INSTITUTE [R01CA104834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20RR017677 (to C.M.), R01CA104834 (to C.M.), and R01GM062887 (to L.M.O.). This work was also supported by a Veterans Affairs Merit award (to L.M.O.).	Alesse E, 1998, CELL DEATH DIFFER, V5, P381, DOI 10.1038/sj.cdd.4400358; Alvarez SE, 2007, TRENDS ENDOCRIN MET, V18, P300, DOI 10.1016/j.tem.2007.07.005; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; CHEN WW, 1982, BIOCHIM BIOPHYS ACTA, V718, P185, DOI 10.1016/0304-4165(82)90218-5; Colombaioni L, 2002, NEUROCHEM INT, V40, P327, DOI 10.1016/S0197-0186(01)00090-0; Cuvillier O, 2002, BBA-MOL CELL BIOL L, V1585, P153, DOI 10.1016/S1388-1981(02)00336-0; Ehlert Karoline, 2007, Pediatr Rheumatol Online J, V5, P15; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 1999, J BIOL CHEM, V274, P27948, DOI 10.1074/jbc.274.39.27948; el Bawab Samer, 2002, Subcell Biochem, V36, P187; Furland NE, 2007, J BIOL CHEM, V282, P18141, DOI 10.1074/jbc.M700708200; Hanna AN, 2001, MOL BIOL CELL, V12, P3618, DOI 10.1091/mbc.12.11.3618; Holman DH, 2008, CANCER CHEMOTH PHARM, V61, P231, DOI 10.1007/s00280-007-0465-0; Hwang YH, 2005, BIOCHEM BIOPH RES CO, V331, P37, DOI 10.1016/j.bbrc.2005.03.134; Jafrezou JP, 2001, FASEB J, V15, P123, DOI 10.1096/fj.00-0305com; Koch J, 1996, J BIOL CHEM, V271, P33110, DOI 10.1074/jbc.271.51.33110; Kohama T, 1998, J BIOL CHEM, V273, P23722, DOI 10.1074/jbc.273.37.23722; Liu H, 2000, J BIOL CHEM, V275, P19513, DOI 10.1074/jbc.M002759200; Magnoni C, 2002, TOXICOL IN VITRO, V16, P349, DOI 10.1016/S0887-2333(02)00024-3; Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876; Mao CG, 2001, J BIOL CHEM, V276, P26577, DOI 10.1074/jbc.M102818200; Mao CG, 2003, J BIOL CHEM, V278, P31184, DOI 10.1074/jbc.M303875200; Mao CG, 2000, J BIOL CHEM, V275, P31369, DOI 10.1074/jbc.M003683200; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; MERRILL AH, 1988, ANAL BIOCHEM, V171, P373, DOI 10.1016/0003-2697(88)90500-3; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; MOMOI T, 1982, BIOCHEM J, V205, P419, DOI 10.1042/bj2050419; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Phillips DC, 2007, CELL DEATH DIFFER, V14, P1780, DOI 10.1038/sj.cdd.4402198; Plummer G, 2005, BIOCHEM J, V385, P685, DOI 10.1042/BJ20040929; Sun W, 2008, J INVEST DERMATOL, V128, P389, DOI 10.1038/sj.jid.5701025; Usta J, 2001, BIOCHEMISTRY-US, V40, P9657, DOI 10.1021/bi010535k; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Wang J, 2007, WORLD J GASTROENTERO, V13, P1129, DOI 10.3748/wjg.v13.i7.1129; Wassall SR, 2008, CHEM PHYS LIPIDS, V153, P57, DOI 10.1016/j.chemphyslip.2008.02.010; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	42	63	63	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7964	7976		10.1074/jbc.M109.063586	http://dx.doi.org/10.1074/jbc.M109.063586			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068046	hybrid, Green Published			2022-12-27	WOS:000275413800014
J	Sawada, K; Ariki, S; Kojima, T; Saito, A; Yamazoe, M; Nishitani, C; Shimizu, T; Takahashi, M; Mitsuzawa, H; Yokota, S; Sawada, N; Fujii, N; Takahashi, H; Kuroki, Y				Sawada, Kaku; Ariki, Shigeru; Kojima, Takashi; Saito, Atsushi; Yamazoe, Masami; Nishitani, Chiaki; Shimizu, Takeyuki; Takahashi, Motoko; Mitsuzawa, Hiroaki; Yokota, Shin-ichi; Sawada, Norimasa; Fujii, Nobuhiro; Takahashi, Hiroki; Kuroki, Yoshio			Pulmonary Collectins Protect Macrophages against Pore-forming Activity of Legionella pneumophila and Suppress Its Intracellular Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-RECOGNITION DOMAIN; LEGIONNAIRES-DISEASE; SURFACTANT PROTEINS; PHAGOSOME TRAFFICKING; ALVEOLAR MACROPHAGES; CELLULAR-RESPONSE; D BINDS; PHAGOCYTOSIS; BACTERIUM; PHOSPHATIDYLINOSITOL	Pulmonary collectins, surfactant proteins A (SP-A) and D (SP-D), play important roles in innate immunity of the lung. Legionella pneumophila is a bacterial respiratory pathogen that can replicate within macrophages and causes opportunistic infections. L. pneumophila possesses cytolytic activity, resulting from insertion of pores in the macrophage membrane upon contact. We examined whether pulmonary collectins play protective roles against L. pneumophila infection. SP-A and SP-D bound to L. pneumophila and its lipopolysaccharide (LPS) and inhibited the bacterial growth in a Ca2+-dependent manner. The addition of LPS in the culture blocked the inhibitory effects on L. pneumophila growth by the collectins, indicating the importance of LPS-collectin interaction. When differentiated THP-1 cells were infected with L. pneumophila in the presence of SP-A and SP-D, the number of permeable cells was significantly decreased, indicating that pulmonary collectins inhibit pore-forming activity of L. pneumophila. The number of live bacteria within the macrophages on days 1-4 after infection was significantly decreased when infection was performed in the presence of pulmonary collectins. The phagocytosis experiments with the pH-sensitive dye-labeled bacteria revealed that pulmonary collectins promoted bacterial localization to an acidic compartment. In addition, SP-A and SP-D significantly increased the number of L. pneumophila co-localized with LAMP-1. These results indicate that pulmonary collectins protect macrophages against contact-dependent cytolytic activity of L. pneumophila and suppress intracellular growth of the phagocytosed bacteria. The promotion of lysosomal fusion with Legionella-containing phagosomes constitutes a likely mechanism of L. pneumophila growth suppression by the collectins.	[Kuroki, Yoshio] Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Kojima, Takashi; Sawada, Norimasa] Sapporo Med Univ, Sch Med, Dept Pathol, Sapporo, Hokkaido 0608556, Japan; [Yokota, Shin-ichi; Fujii, Nobuhiro] Sapporo Med Univ, Sch Med, Dept Microbiol, Sapporo, Hokkaido 0608556, Japan; [Mitsuzawa, Hiroaki] Sapporo Med Univ, Sch Med, Dept Otolaryngol, Sapporo, Hokkaido 0608556, Japan; [Sawada, Kaku; Saito, Atsushi; Yamazoe, Masami; Takahashi, Hiroki] Sapporo Med Univ, Sch Med, Dept Internal Med 3, Sapporo, Hokkaido 0608556, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Kuroki, Y (corresponding author), Sapporo Med Univ, Sch Med, Dept Biochem, Chuo Ku, South 1,West 17, Sapporo, Hokkaido 0608556, Japan.	kurokiy@sapmed.ac.jp	Saito, Atsushi/M-7382-2018; Yokota, Shin-ichi/K-8139-2019; Ariki, Shigeru/E-3861-2014; Takahashi, Motoko/I-3154-2013	Saito, Atsushi/0000-0003-3430-884X; Yokota, Shin-ichi/0000-0002-0831-3429; Ariki, Shigeru/0000-0001-5838-499X; Takahashi, Motoko/0000-0002-2112-6142	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20790574, 20390232, 19041062]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-aid for Scientific Research 20790574 (to S. A.) and 20390232 and 19041062 (to Y.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	AUSBEL FM, 1992, CURRENT PROTOCOLS MO; BASTACKY J, 1995, J APPL PHYSIOL, V79, P1615, DOI 10.1152/jappl.1995.79.5.1615; BAUGHMAN RP, 1993, AM REV RESPIR DIS, V147, P653, DOI 10.1164/ajrccm/147.3.653; Beharka AA, 2002, J IMMUNOL, V169, P3565, DOI 10.4049/jimmunol.169.7.3565; Chiba H, 1999, BIOCHEMISTRY-US, V38, P7321, DOI 10.1021/bi990353e; DAY AJ, 1994, BIOCHEM SOC T, V22, P83, DOI 10.1042/bst0220083; Ferguson JS, 1999, J IMMUNOL, V163, P312; Gardai SJ, 2003, CELL, V115, P13, DOI 10.1016/S0092-8674(03)00758-X; GEERTSMA MF, 1994, AM J PHYSIOL-LUNG C, V267, pL578, DOI 10.1152/ajplung.1994.267.5.L578; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; HONDA Y, 1995, AM J RESP CRIT CARE, V152, P1860, DOI 10.1164/ajrccm.152.6.8520747; HORWITZ MA, 1980, J CLIN INVEST, V66, P441, DOI 10.1172/JCI109874; HORWITZ MA, 1983, J EXP MED, V158, P2108, DOI 10.1084/jem.158.6.2108; Kabha K, 1997, AM J PHYSIOL-LUNG C, V272, pL344, DOI 10.1152/ajplung.1997.272.2.L344; KAUFMANN AF, 1981, AM J EPIDEMIOL, V114, P337, DOI 10.1093/oxfordjournals.aje.a113200; Kirby JE, 1998, MOL MICROBIOL, V27, P323, DOI 10.1046/j.1365-2958.1998.00680.x; Kudo K, 2004, J IMMUNOL, V172, P7592, DOI 10.4049/jimmunol.172.12.7592; KUROKI Y, 1985, BIOCHIM BIOPHYS ACTA, V836, P201; KUROKI Y, 1994, J BIOL CHEM, V269, P25943; Kuroki Y, 2007, CELL MICROBIOL, V9, P1871, DOI 10.1111/j.1462-5822.2007.00953.x; Kuronuma K, 2004, J BIOL CHEM, V279, P21421, DOI 10.1074/jbc.M312490200; LeVine AM, 1997, J IMMUNOL, V158, P4336; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; MARRA A, 1992, P NATL ACAD SCI USA, V89, P9607, DOI 10.1073/pnas.89.20.9607; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; MCDADE JE, 1977, NEW ENGL J MED, V297, P1197, DOI 10.1056/NEJM197712012972202; McIntosh JC, 1996, AM J RESP CELL MOL, V15, P509, DOI 10.1165/ajrcmb.15.4.8879185; Murakami S, 2002, J BIOL CHEM, V277, P6830, DOI 10.1074/jbc.M106671200; Nagae H, 1997, CLIN CHIM ACTA, V266, P157, DOI 10.1016/S0009-8981(97)00124-1; Nie XM, 2008, BIOCHEMISTRY-US, V47, P12878, DOI 10.1021/bi8010175; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; PHELPS DS, 1991, AM REV RESPIR DIS, V143, P1072, DOI 10.1164/ajrccm/143.5_Pt_1.1072; Piboonpocanun S, 2005, J BIOL CHEM, V280, P9, DOI 10.1074/jbc.M411570200; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Sano H, 1999, J IMMUNOL, V163, P387; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Shin S, 2008, CELL MICROBIOL, V10, P1209, DOI 10.1111/j.1462-5822.2008.01145.x; Tino MJ, 1999, AM J PHYSIOL-LUNG C, V276, pL164, DOI 10.1152/ajplung.1999.276.1.L164; Tino MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL677, DOI 10.1152/ajplung.1996.270.4.L677; UCHIDA K, 1987, AGR BIOL CHEM TOKYO, V51, P3107; VANDEGRAAF EA, 1992, J LAB CLIN MED, V120, P252; Whitsett JA, 2002, NEW ENGL J MED, V347, P2141, DOI 10.1056/NEJMra022387; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yamada C, 2006, J BIOL CHEM, V281, P21771, DOI 10.1074/jbc.M513041200; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Zuckman DM, 1999, MOL MICROBIOL, V32, P990, DOI 10.1046/j.1365-2958.1999.01410.x	49	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8434	8443		10.1074/jbc.M109.074765	http://dx.doi.org/10.1074/jbc.M109.074765			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20056602	Green Published, hybrid			2022-12-27	WOS:000275413800058
J	Cuddapah, VA; Sontheimer, H				Cuddapah, Vishnu Anand; Sontheimer, Harald			Molecular Interaction and Functional Regulation of ClC-3 by Ca2+/Calmodulin-dependent Protein Kinase II (CaMKII) in Human Malignant Glioma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNEL REGULATION; BK CHANNELS; CELL-VOLUME; HYPOTONIC ACTIVATION; HUMAN GLIOBLASTOMA; ACTIN-FILAMENTS; PLASMA-MEMBRANE; CL-CHANNEL; RAT-BRAIN; EXPRESSION	Glioblastoma multiforme is the most common and lethal primary brain cancer in adults. Tumor cells diffusely infiltrate the brain making focal surgical and radiation treatment challenging. The invasion of glioma cells into normal brain is facilitated by the activity of ion channels aiding dynamic regulation of cell volume. Recent studies have specifically implicated ClC-3, a voltage-gated chloride channel, in this process. However, the interaction between ClC-3 activity and cell movement is poorly understood. Here, we demonstrate that ClC-3 is highly expressed on the plasma membrane of human glioma cells where its activity is regulated through phosphorylation via Ca2+/calmodulin-dependent protein kinase II (CaMKII). Intracellular infusion of autoactivated CaMKII via patch pipette enhanced chloride currents 3-fold, and this regulation was inhibited by autocamtide-2 related inhibitory peptide, a CaMKII-specific inhibitor. CaMKII modulation of chloride currents was also lost upon stable small hairpin RNA knockdown of ClC-3 channels indicating a specific interaction of ClC-3 and CaMKII. In ClC-3-expressing cells, inhibition of CaMKII reduced glioma invasion to the same extent as direct inhibition of ClC-3. The importance of the molecular interaction of ClC-3 and CaMKII is further supported by our finding that CaMKII co-localizes and co-immunoprecipitates with ClC-3. ClC-3 and CaMKII also co-immunoprecipitate in tissue biopsies from patients diagnosed with grade IV glioblastoma. These tumor samples show 10-fold higher ClC-3 protein expression than nonmalignant brain. These data suggest that CaMKII is a molecular link translating intracellular calcium changes, which are intrinsically associated with glioma migration, to changes in ClC-3 conductance required for cell movement.	[Sontheimer, Harald] Univ Alabama, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama, Ctr Glial Biol Med, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sontheimer, H (corresponding author), Univ Alabama, Dept Neurobiol, 1719 6th Ave S,CIRC 410, Birmingham, AL 35294 USA.	sontheimer@uab.edu		Sontheimer, Harald/0000-0002-5843-9871; Cuddapah, Vishnu/0000-0002-4606-673X	National Institutes of Health [RO1-NS-31234, RO1-NS-36692]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031234, R01NS036692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-NS-31234 and RO1-NS-36692 (to H. S.).	Arreola J, 2002, J PHYSIOL-LONDON, V545, P207, DOI 10.1113/jphysiol.2002.021980; Berdiev BK, 1996, J BIOL CHEM, V271, P17704, DOI 10.1074/jbc.271.30.17704; BERNSTEIN JJ, 1989, J NEUROSCI RES, V22, P134, DOI 10.1002/jnr.490220205; Bordey A, 2000, J MEMBRANE BIOL, V176, P31, DOI 10.1007/s002320001073; CANTIELLO HF, 1991, AM J PHYSIOL, V261, P882; CHAN HC, 1994, J BIOL CHEM, V269, P32464; Deriy LV, 2009, CELL METAB, V10, P316, DOI 10.1016/j.cmet.2009.08.012; Duan D, 1999, J GEN PHYSIOL, V113, P57, DOI 10.1085/jgp.113.1.57; Duan D, 1997, NATURE, V390, P417, DOI 10.1038/37151; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Gong WQ, 2004, CELL PHYSIOL BIOCHEM, V14, P213, DOI 10.1159/000080330; Grueter CE, 2008, BIOCHEMISTRY-US, V47, P1760, DOI 10.1021/bi701755q; Habela CW, 2008, J NEUROSCI, V28, P9205, DOI 10.1523/JNEUROSCI.1897-08.2008; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P1241, DOI 10.1074/jbc.M407030200; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; KAWASAKI M, 1994, NEURON, V12, P597, DOI 10.1016/0896-6273(94)90215-1; Komuro H, 1996, NEURON, V17, P275, DOI 10.1016/S0896-6273(00)80159-2; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Li XH, 2002, AM J PHYSIOL-CELL PH, V282, pC1483, DOI 10.1152/ajpcell.00504.2001; Liu JX, 2006, NAT NEUROSCI, V9, P41, DOI 10.1038/nn1602; Liu Q, 2007, J NEUROSCI, V27, P10404, DOI 10.1523/JNEUROSCI.5634-06.2007; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Mamelak AN, 2006, J CLIN ONCOL, V24, P3644, DOI 10.1200/JCO.2005.05.4569; Mao JW, 2008, BIOCHEM PHARMACOL, V75, P1706, DOI 10.1016/j.bcp.2008.01.008; Mao JW, 2009, BIOCHEM PHARMACOL, V77, P159, DOI 10.1016/j.bcp.2008.10.009; Maritzen T, 2008, J NEUROSCI, V28, P10587, DOI 10.1523/JNEUROSCI.3750-08.2008; McCloskey DT, 2007, J BIOL CHEM, V282, P16871, DOI 10.1074/jbc.M700379200; Mitchell J, 2008, CURR BIOL, V18, P1600, DOI 10.1016/j.cub.2008.08.073; Olsen ML, 2003, J NEUROSCI, V23, P5572; Qian JS, 2009, CELL PHYSIOL BIOCHEM, V24, P461, DOI 10.1159/000257485; Ransom CB, 2002, GLIA, V38, P281, DOI 10.1002/glia.10064; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; Robinson NC, 2004, J PHYSIOL-LONDON, V556, P353, DOI 10.1113/jphysiol.2003.058032; Ronde P, 2000, BBA-MOL CELL RES, V1498, P273, DOI 10.1016/S0167-4889(00)00102-6; Rossow CF, 2006, ACTA PHYSIOL, V187, P5, DOI 10.1111/j.1748-1716.2006.01550.x; Salazar G, 2004, J BIOL CHEM, V279, P25430, DOI 10.1074/jbc.M402331200; Shimada K, 2000, AM J PHYSIOL-GASTR L, V279, pG268, DOI 10.1152/ajpgi.2000.279.2.G268; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Sun XX, 2004, J BIOL CHEM, V279, P10206, DOI 10.1074/jbc.M310728200; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Tang YB, 2008, CELL PROLIFERAT, V41, P775, DOI 10.1111/j.1365-2184.2008.00551.x; Vessey JP, 2004, BIOCHEM CELL BIOL, V82, P708, DOI 10.1139/O04-107; Volk APD, 2008, J BIOL CHEM, V283, P34315, DOI 10.1074/jbc.M803141200; Wang GX, 2004, AM J PHYSIOL-HEART C, V287, pH533, DOI 10.1152/ajpheart.00228.2003; Wang XQ, 2006, NEURON, V52, P321, DOI 10.1016/j.neuron.2006.08.035; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Xiong DZ, 2009, CLIN EXP PHARMACOL P, V36, P386, DOI 10.1111/j.1440-1681.2008.05069.x; Yamamoto-Mizuma S, 2004, J PHYSIOL-LONDON, V557, P439, DOI 10.1113/jphysiol.2003.059261; Ye ZC, 1999, CANCER RES, V59, P4383; Zhao ZF, 2007, J BIOL CHEM, V282, P29022, DOI 10.1074/jbc.M703506200	60	96	108	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11188	11196		10.1074/jbc.M109.097675	http://dx.doi.org/10.1074/jbc.M109.097675			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139089	Green Published, hybrid			2022-12-27	WOS:000276286200024
J	Gao, YS; Hubbert, CC; Yao, TP				Gao, Ya-Sheng; Hubbert, Charlotte C.; Yao, Tso-Pang			The Microtubule-associated Histone Deacetylase 6 (HDAC6) Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATE ENDOSOMES; ALPHA-TUBULIN; ACETYLATION; CELLS; TRANSPORT; DYNEIN; MORPHOGENESIS; INHIBITION; LYSOSOMES; CANCER	Histone deacetylase 6 (HDAC6) is a microtubule-associated deacetylase with tubulin deacetylase activity, and it binds dynein motors. Recent studies revealed that microtubule acetylation affects the affinity and processivity of microtubule motors. These unique properties implicate a role for HDAC6 in intracellular organelle transport. Here, we show that HDAC6 associates with the endosomal compartments and controls epidermal growth factor receptor (EGFR) trafficking and degradation. We found that loss of HDAC6 promoted EGFR degradation. Mechanistically, HDAC6deficiency did not cause aberrant EGFR internalization and recycling. Rather, it resulted in accelerated segregation of EGFR from early endosomes and premature delivery of EGFR to the late endosomal and lysosomal compartments. The deregulated EGFR endocytic trafficking was accompanied by an increase in microtubule-dependent movement of EGFR-bearing vesicles, revealing a novel regulation of EGFR vesicular trafficking and degradation by the microtubule deacetylase HDAC6.	[Gao, Ya-Sheng; Hubbert, Charlotte C.; Yao, Tso-Pang] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Yao, TP (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, C325 LSRC,Box 3813,Res Dr, Durham, NC 27710 USA.	yao00001@mc.duke.edu			National Institutes of Health [NS053825]; Department of Defense [PC 050119]; DAMD [17-01-1-0054]; Leukemia and Lymphoma Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); DAMD; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part, by National Institutes of Health Grant NS053825. This work was also supported by Department of Defense Grants PC 050119 (to Y.-s.G.) and DAMD 17-01-1-0054 and the Leukemia and Lymphoma Society (to T.-P.Y.).	ANIENTO F, 1993, J CELL BIOL, V123, P1373, DOI 10.1083/jcb.123.6.1373; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gao YS, 2001, J CELL BIOL, V152, P877, DOI 10.1083/jcb.152.5.877; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kamemura K, 2008, BIOCHEM BIOPH RES CO, V374, P84, DOI 10.1016/j.bbrc.2008.06.092; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lee YS, 2008, CANCER RES, V68, P7561, DOI 10.1158/0008-5472.CAN-08-0188; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Merrifield CJ, 1999, NAT CELL BIOL, V1, P72, DOI 10.1038/9048; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rusan NM, 2001, MOL BIOL CELL, V12, P971, DOI 10.1091/mbc.12.4.971; SORKIN A, 1991, J CELL BIOL, V112, P55, DOI 10.1083/jcb.112.1.55; Taunton J, 2000, J CELL BIOL, V148, P519, DOI 10.1083/jcb.148.3.519; Yarden Y, 2001, EUR J CANCER, V37, pS3; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	28	116	127	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11219	11226		10.1074/jbc.M109.042754	http://dx.doi.org/10.1074/jbc.M109.042754			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20133936	Green Published, hybrid			2022-12-27	WOS:000276286200027
J	Young, TS; Schultz, PG				Young, Travis S.; Schultz, Peter G.			Beyond the Canonical 20 Amino Acids: Expanding the Genetic Lexicon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SITE-SPECIFIC INCORPORATION; TRANSFER-RNA SYNTHETASE; IN-VIVO INCORPORATION; EFFICIENT INCORPORATION; MAMMALIAN-CELLS; PROTEINS; CODE; BINDING; SUPPRESSOR; GENERATION	The ability to genetically encode unnatural amino acids beyond the common 20 has allowed unprecedented control over the chemical structures of recombinantly expressed proteins. Orthogonal aminoacyl-tRNA synthetase/tRNA pairs have been used together with nonsense, rare, or 4-bp codons to incorporate >50 unnatural amino acids into proteins in Escherichia coli, Saccharomyces cerevisiae, Pichia pastoris, and mammalian cell lines. This has allowed the expression of proteins containing amino acids with novel side chains, including fluorophores, post-translational modifications, metal ion chelators, photocaged and photocross-linking moieties, uniquely reactive functional groups, and NMR, IR, and x-ray crystallographic probes.	[Young, Travis S.; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Schultz, PG (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	schultz@scripps.edu			National Institutes of Health [R01GM062159]; United States Department of Energy [DE-FG03-00ER46051]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM062159 and Division of Materials Sciences Award DE-FG03-00ER46051 from the United States Department of Energy. This is the second of six articles in the "Chemical Biology Meets Biological Chemistry Minireview Series." This minireview will be reprinted in the 2010 Minireview Compendium, which will be available in January, 2011.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Anderson JC, 2003, BIOCHEMISTRY-US, V42, P9598, DOI 10.1021/bi034550w; Bose M, 2006, J AM CHEM SOC, V128, P388, DOI 10.1021/ja055467u; Brustad E, 2008, ANGEW CHEM INT EDIT, V47, P8220, DOI 10.1002/anie.200803240; Brustad EM, 2008, J AM CHEM SOC, V130, P17664, DOI 10.1021/ja807430h; Cellitti SE, 2008, J AM CHEM SOC, V130, P9268, DOI 10.1021/ja801602q; Chen PR, 2009, ANGEW CHEM INT EDIT, V48, P4052, DOI 10.1002/anie.200900683; Chen S, 2007, J MOL BIOL, V371, P112, DOI 10.1016/j.jmb.2007.05.017; Chin JW, 2003, SCIENCE, V301, P964, DOI 10.1126/science.1084772; Chin JW, 2003, CHEM BIOL, V10, P511, DOI 10.1016/S1074-5521(03)00123-6; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Deiters A, 2005, BIOORG MED CHEM LETT, V15, P1521, DOI 10.1016/j.bmcl.2004.12.065; Deiters A, 2006, ANGEW CHEM INT EDIT, V45, P2728, DOI 10.1002/anie.200600264; EDWARDS H, 1990, MOL CELL BIOL, V10, P1633, DOI 10.1128/MCB.10.4.1633; Groff D, 2009, ANGEW CHEM INT EDIT, V48, P3478, DOI 10.1002/anie.200806239; Grunewald J, 2009, P NATL ACAD SCI USA, V106, P4337, DOI 10.1073/pnas.0900507106; Guo JT, 2008, ANGEW CHEM INT EDIT, V47, P722, DOI 10.1002/anie.200704074; Guo JT, 2009, ANGEW CHEM INT EDIT, V48, P9148, DOI 10.1002/anie.200904035; Guo JT, 2008, ANGEW CHEM INT EDIT, V47, P6399, DOI 10.1002/anie.200802336; Hino N, 2005, NAT METHODS, V2, P201, DOI 10.1038/NMETH739; Huang LY, 2008, BIOCHEMISTRY-US, V47, P5638, DOI 10.1021/bi701866e; Kiga D, 2002, P NATL ACAD SCI USA, V99, P9715, DOI 10.1073/pnas.142220099; Lee HS, 2008, J AM CHEM SOC, V130, P13194, DOI 10.1021/ja804653f; Lee HS, 2009, J AM CHEM SOC, V131, P12921, DOI 10.1021/ja904896s; Lee HS, 2009, J AM CHEM SOC, V131, P2481, DOI 10.1021/ja808340b; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Lemke EA, 2007, NAT CHEM BIOL, V3, P769, DOI 10.1038/nchembio.2007.44; LIU CC, 2010, ANN REV BIO IN PRESS, V79; Liu CC, 2006, NAT BIOTECHNOL, V24, P1436, DOI 10.1038/nbt1254; Liu CC, 2009, J AM CHEM SOC, V131, P9616, DOI 10.1021/ja902985e; Liu CC, 2008, P NATL ACAD SCI USA, V105, P17688, DOI 10.1073/pnas.0809543105; Liu DR, 1997, P NATL ACAD SCI USA, V94, P10092, DOI 10.1073/pnas.94.19.10092; Liu WS, 2007, NAT METHODS, V4, P239, DOI 10.1038/NMETH1016; Martin AB, 1999, TRENDS CELL BIOL, V9, pM24, DOI 10.1016/S0962-8924(99)01682-7; MENDEL D, 1995, ANNU REV BIOPH BIOM, V24, P435, DOI 10.1146/annurev.bb.24.060195.002251; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; NOREN CJ, 1989, SCIENCE, V244, P182, DOI 10.1126/science.2649980; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Pastrnak M, 2000, HELV CHIM ACTA, V83, P2277, DOI 10.1002/1522-2675(20000906)83:9<2277::AID-HLCA2277>3.0.CO;2-L; Peters FB, 2009, CHEM BIOL, V16, P148, DOI 10.1016/j.chembiol.2009.01.013; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sakamoto K, 2002, NUCLEIC ACIDS RES, V30, P4692, DOI 10.1093/nar/gkf589; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15060, DOI 10.1021/ja076043y; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Turner JM, 2006, P NATL ACAD SCI USA, V103, P6483, DOI 10.1073/pnas.0601756103; Wang JY, 2006, J AM CHEM SOC, V128, P8738, DOI 10.1021/ja062666k; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Wang L, 2001, CHEM BIOL, V8, P883, DOI 10.1016/S1074-5521(01)00063-1; Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077; Wang L, 2003, P NATL ACAD SCI USA, V100, P56, DOI 10.1073/pnas.0234824100; Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507; Wang Q, 2008, J AM CHEM SOC, V130, P6066, DOI 10.1021/ja800894n; Wang WY, 2007, NAT NEUROSCI, V10, P1063, DOI 10.1038/nn1932; Wu N, 2004, J AM CHEM SOC, V126, P14306, DOI 10.1021/ja040175z; Xie JM, 2007, ANGEW CHEM INT EDIT, V46, P9239, DOI 10.1002/anie.200703397; Xie JM, 2007, ACS CHEM BIOL, V2, P474, DOI 10.1021/cb700083w; Ye SX, 2009, NAT CHEM BIOL, V5, P397, DOI 10.1038/nchembio.167; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Young TS, 2009, BIOCHEMISTRY-US, V48, P2643, DOI 10.1021/bi802178k	61	238	265	9	164	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11039	11044		10.1074/jbc.R109.091306	http://dx.doi.org/10.1074/jbc.R109.091306			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147747	hybrid, Green Published			2022-12-27	WOS:000276286200004
J	Matsushita, S; Nakata, H; Kubo, Y; Tateyama, M				Matsushita, Shinichi; Nakata, Hiroyasu; Kubo, Yoshihiro; Tateyama, Michihiro			Ligand-induced Rearrangements of the GABA(B) Receptor Revealed by Fluorescence Resonance Energy Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; METABOTROPIC GLUTAMATE-RECEPTOR; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; EXTRACELLULAR REGIONS; ALLOSTERIC MODULATION; ACTIVATION MECHANISM; HEPTAHELICAL DOMAIN; STRUCTURAL BASIS; LIVING CELLS	The gamma-aminobutyric acid type B receptor (GABA(B)R), one of the family C G-protein-coupled receptor members, exists as a heterodimer comprised of subunits GB1 and GB2. To clarify the ligand-induced activation mechanism of the GABA(B)R, each subunit was fused with either Cerulean or enhanced yellow fluorescent protein at its intracellular loop, and fluorescence resonance energy transfer (FRET) changes upon agonist application were monitored. As a result, FRET decreases were observed between GB1a loop 2 and GB2 loop 2 and between GB1a loop 2 and GB2 loop 1, suggesting the dissociation of intracellular domains during the receptor activation. Both intersubunit FRET pairs were expected to faithfully capture the activation of the original receptor as their pharmacological properties were highly similar to that of the wild-type receptor. However, the intrasubunit data suggest that the receptor activation does not involve major structural changes within the transmembrane domain of each subunit. By combining the results obtained from two different levels, it was concluded that the GABA(B)R activation by agonist is associated with an asymmetrical intersubunit rearrangement of GB1a and GB2 on the membrane. This type of activation mode, an intersubunit rearrangement without apparent intrahelical structural changes, appears commonly shared by the GABA(B)R and the metabotropic glutamate receptor 1 alpha, another family C G-protein-coupled receptor previously studied by our group. Nevertheless, the directions of intracellular domain movements and its asymmetry observed here highlight the qualitative difference between the two receptors.	[Matsushita, Shinichi; Kubo, Yoshihiro; Tateyama, Michihiro] Natl Inst Physiol Sci, Div Biophys & Neurobiol, Dept Mol Physiol, Okazaki, Aichi 4448585, Japan; [Matsushita, Shinichi; Kubo, Yoshihiro; Tateyama, Michihiro] Grad Univ Adv Studies, Sch Life Sci, Dept Physiol Sci, Okazaki, Aichi 4448585, Japan; [Kubo, Yoshihiro; Tateyama, Michihiro] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Nakata, Hiroyasu] Tokyo Metropolitan Inst Neurosci, Dept Immunol & Signal Transduct, Tokyo 1838526, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science	Tateyama, M (corresponding author), 38 Nishigonaka, Okazaki, Aichi 4448585, Japan.	tateyama@nips.ac.jp	Centeno, Patricia Pacios/O-8368-2016	Kubo, Yoshihiro/0000-0001-6707-0837	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by research grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to M. T. and Y. K.) and from the Japan Society for the Promotion of Science (to Y. K.).	Binet V, 2004, J BIOL CHEM, V279, P29085, DOI 10.1074/jbc.M400930200; Binet V, 2007, J BIOL CHEM, V282, P12154, DOI 10.1074/jbc.M611071200; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brauner-Osborne H, 1999, BRIT J PHARMACOL, V128, P1370, DOI 10.1038/sj.bjp.0702914; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 2000, MOL PHARMACOL, V57, P419, DOI 10.1124/mol.57.3.419; Gether U, 2002, PHARMACOL TOXICOL, V91, P304, DOI 10.1034/j.1600-0773.2002.910607.x; Hoffmann C, 2008, BRIT J PHARMACOL, V153, pS358, DOI 10.1038/sj.bjp.0707615; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jensen AD, 2001, J BIOL CHEM, V276, P9279, DOI 10.1074/jbc.M004871200; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; Lohse MJ, 2008, TRENDS PHARMACOL SCI, V29, P159, DOI 10.1016/j.tips.2007.12.002; Lu ZL, 2002, TRENDS PHARMACOL SCI, V23, P140, DOI 10.1016/S0165-6147(00)01973-8; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14643, DOI 10.1073/pnas.251554798; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Nomura R, 2008, J BIOL CHEM, V283, P4665, DOI 10.1074/jbc.M705202200; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Parmentier ML, 2002, TRENDS PHARMACOL SCI, V23, P268, DOI 10.1016/S0165-6147(02)02016-3; Pin JP, 2005, FEBS J, V272, P2947, DOI 10.1111/j.1742-4658.2005.04728.x; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Tateyama M, 2004, NAT STRUCT MOL BIOL, V11, P637, DOI 10.1038/nsmb770; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Urwyler S, 2005, NEUROPHARMACOLOGY, V48, P343, DOI 10.1016/j.neuropharm.2004.10.013; Urwyler S, 2001, MOL PHARMACOL, V60, P963, DOI 10.1124/mol.60.5.963; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wess J, 2008, TRENDS PHARMACOL SCI, V29, P616, DOI 10.1016/j.tips.2008.08.006; Yamashita T, 2008, J NEUROCHEM, V106, P850, DOI 10.1111/j.1471-4159.2008.05443.x; Yanagawa M, 2009, MOL PHARMACOL, V76, P201, DOI 10.1124/mol.109.056549	37	29	30	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10291	10299		10.1074/jbc.M109.077990	http://dx.doi.org/10.1074/jbc.M109.077990			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20129919	Green Published, hybrid			2022-12-27	WOS:000276264600013
J	Chen, PW; Lin, SJ; Tsai, SC; Lin, JH; Chen, MR; Wang, JT; Lee, CP; Tsai, CH				Chen, Po-Wen; Lin, Sue-Jane; Tsai, Shu-Chun; Lin, Jiun-Han; Chen, Mei-Ru; Wang, Jiin-Tarng; Lee, Chung-Pei; Tsai, Ching-Hwa			Regulation of Microtubule Dynamics through Phosphorylation on Stathmin by Epstein-Barr Virus Kinase BGLF4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASOPHARYNGEAL CARCINOMA-CELLS; HERPES-SIMPLEX-VIRUS; PROTEIN-KINASE; ONCOPROTEIN 18; PHYLOGENETIC CONSERVATION; MULTISITE PHOSPHORYLATION; VIRAL TRANSPORT; LEUKEMIC-CELLS; VACCINIA VIRUS; IDENTIFICATION	Stathmin is an important microtubule (MT)-destabilizing protein, and its activity is differently attenuated by phosphorylation at one or more of its four phosphorylatable serine residues (Ser-16, Ser-25, Ser-38, and Ser-63). This phosphorylation of stathmin plays important roles in mitotic spindle formation. We observed increasing levels of phosphorylated stathmin in Epstein-Barr virus (EBV)-harboring lymphoblastoid cell lines (LCLs) and nasopharyngeal carcinoma (NPC) cell lines during the EBV lytic cycle. These suggest that EBV lytic products may be involved in the regulation of stathmin phosphorylation. BGLF4 is an EBV-encoded kinase and has similar kinase activity to cdc2, an important kinase that phosphorylates serine residues 25 and 38 of stathmin during mitosis. Using an siRNA approach, we demonstrated that BGLF4 contributes to the phosphorylation of stathmin in EBV-harboring NPC. Moreover, we confirmed that BGLF4 interacts with and phosphorylates stathmin using an in vitro kinase assay and an in vivo two-dimensional electrophoresis assay. Interestingly, unlike cdc2, BGLF4 was shown to phosphorylate non-proline directed serine residues of stathmin (Ser-16) and it mediated phosphorylation of stathmin predominantly at serines 16, 25, and 38, indicating that BGLF4 can down-regulate the activity of stathmin. Finally, we demonstrated that the pattern of MT organization was changed in BGLF4-expressing cells, possibly through phosphorylation of stathmin. In conclusion, we have shown that a viral Ser/Thr kinase can directly modulate the activity of stathmin and this contributes to alteration of cellular MT dynamics and then may modulate the associated cellular processes.	[Chen, Po-Wen; Tsai, Shu-Chun; Lin, Jiun-Han; Chen, Mei-Ru; Wang, Jiin-Tarng; Lee, Chung-Pei; Tsai, Ching-Hwa] Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Taipei 10051, Taiwan; [Lin, Sue-Jane] Chang Gung Univ, Res Ctr Emerging Viral Infect, Tao Yuan 333, Taiwan; [Lin, Sue-Jane] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan 333, Taiwan	National Taiwan University; Chang Gung University; Chang Gung University	Tsai, CH (corresponding author), Natl Taiwan Univ, Grad Inst Microbiol, Coll Med, Rm 714,1,1st Sect,Jen Ai Rd, Taipei 10051, Taiwan.	chtsai@ntu.edu.tw		CHEN, MEI-RU/0000-0002-7007-8036	National Health Research Institute [NHRI-EX98-9726BI, NHRI-EX99-9726BI]; National Science Council [NSC97-2320-B-002-003, NSC98-3112-B-002-033, NSC99-3112-B-002-022]; Frontier and Innovative Research of National Taiwan University [97R0331]; National Taiwan University	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Frontier and Innovative Research of National Taiwan University(National Taiwan University); National Taiwan University(National Taiwan University)	This work was supported by the National Health Research Institute (NHRI-EX98-9726BI and NHRI-EX99-9726BI), National Science Council (Grants NSC97-2320-B-002-003, NSC98-3112-B-002-033, and NSC99-3112-B-002-022), Frontier and Innovative Research of National Taiwan University (97R0331), and a research training fellowship from the National Taiwan University.	Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4; Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382; Asai R, 2009, J GEN VIROL, V90, P1575, DOI 10.1099/vir.0.010462-0; Baik SY, 2007, CELL PROLIFERAT, V40, P268, DOI 10.1111/j.1365-2184.2007.00429.x; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Cassimeris L, 1999, CURR OPIN CELL BIOL, V11, P134, DOI 10.1016/S0955-0674(99)80017-9; Chang Y, 1999, J VIROL, V73, P8857, DOI 10.1128/JVI.73.10.8857-8866.1999; CHEE MS, 1989, J GEN VIROL, V70, P1151, DOI 10.1099/0022-1317-70-5-1151; Chua HH, 2007, J VIROL, V81, P2459, DOI 10.1128/JVI.02289-06; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Cudmore S, 1997, TRENDS MICROBIOL, V5, P142, DOI 10.1016/S0966-842X(97)01011-1; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; DiPaolo G, 1997, FEBS LETT, V416, P149, DOI 10.1016/S0014-5793(97)01188-5; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; Gavet O, 1998, J CELL SCI, V111, P3333; Gershburg E, 2004, J VIROL, V78, P12140, DOI 10.1128/JVI.78.22.12140-12146.2004; Gershburg E, 2008, BBA-PROTEINS PROTEOM, V1784, P203, DOI 10.1016/j.bbapap.2007.08.009; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Holmfeldt P, 2001, MOL BIOL CELL, V12, P73, DOI 10.1091/mbc.12.1.73; Holmfeldt P, 2006, MOL BIOL CELL, V17, P2921, DOI 10.1091/mbc.e06-02-0165; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Hsu TY, 2005, J GEN VIROL, V86, P317, DOI 10.1099/vir.0.80556-0; Joshi HC, 1998, CURR OPIN CELL BIOL, V10, P35, DOI 10.1016/S0955-0674(98)80084-7; Kawaguchi Y, 2003, REV MED VIROL, V13, P331, DOI 10.1002/rmv.402; Kawaguchi Y, 2003, J VIROL, V77, P2359, DOI 10.1128/JVI.77.4.2359-2368.2003; KOPPEL J, 1990, J BIOL CHEM, V265, P3703; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Lawler S, 1998, CURR BIOL, V8, pR212, DOI 10.1016/S0960-9822(98)70128-9; Lee CP, 2007, J VIROL, V81, P5166, DOI 10.1128/JVI.00120-07; Lee CP, 2008, J VIROL, V82, P11913, DOI 10.1128/JVI.01100-08; Lin XC, 2009, INT J CANCER, V124, P1020, DOI 10.1002/ijc.23767; LUO XN, 1994, J BIOL CHEM, V269, P10312; Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; MARKLUND U, 1994, J BIOL CHEM, V269, P30626; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MAUCUER A, 1993, J BIOL CHEM, V268, P16420; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Sankar S, 2006, CELL SIGNAL, V18, P982, DOI 10.1016/j.cellsig.2005.08.006; SCHULZE E, 1988, NATURE, V334, P356, DOI 10.1038/334356a0; SMITH RF, 1989, J VIROL, V63, P450, DOI 10.1128/JVI.63.1.450-455.1989; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Suomalainen M, 2001, EMBO J, V20, P1310, DOI 10.1093/emboj/20.6.1310; Tsai CH, 1997, J BIOMED SCI, V4, P69, DOI 10.1007/BF02255596; Wang JT, 2009, J VIROL, V83, P1856, DOI 10.1128/JVI.01099-08; Wang JT, 2005, J GEN VIROL, V86, P3215, DOI 10.1099/vir.0.81313-0; Yan GG, 2006, PROTEOMICS, V6, P1810, DOI 10.1002/pmic.200500156; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhu J, 2009, J VIROL, V83, P5219, DOI 10.1128/JVI.02378-08	60	25	28	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10053	10063		10.1074/jbc.M109.044420	http://dx.doi.org/10.1074/jbc.M109.044420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110360	hybrid, Green Published			2022-12-27	WOS:000276165900073
J	Courtois, ET; Castillo, CG; Seiz, EG; Ramos, M; Bueno, C; Liste, I; Martinez-Serrano, A				Courtois, Elise T.; Castillo, Claudia G.; Seiz, Emma G.; Ramos, Milagros; Bueno, Carlos; Liste, Isabel; Martinez-Serrano, Alberto			In Vitro and in Vivo Enhanced Generation of Human A9 Dopamine Neurons from Neural Stem Cells by Bcl-X-L	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-HYDROXYLASE EXPRESSION; MESENCEPHALIC PRECURSOR CELLS; FETAL VENTRAL MESENCEPHALON; LONG-TERM PROLIFERATION; PARKINSONS-DISEASE; PROGENITOR CELLS; ALPHA-SYNUCLEIN; DIFFERENTIATION; DEATH; LINE	Human neural stem cells derived from the ventral mesencephalon (VM) are powerful research tools and candidates for cell therapies in Parkinson disease. Previous studies with VM dopaminergic neuron (DAn) precursors indicated poor growth potential and unstable phenotypical properties. Using the model cell line hVM1 (human ventral mesencephalic neural stem cell line 1; a new human fetal VM stem cell line), we have found that Bcl-X-L enhances the generation of DAn from VM human neural stem cells. Mechanistically, Bcl-X-L not only exerts the expected antiapoptotic effect but also induces pro-neural (NGN2 and NEUROD1) and dopamine-related transcription factors, resulting in a high yield of DAn with the correct phenotype of substantia nigra pars compacta (SNpc). The expression of key genes directly involved in VM/SNpc dopaminergic patterning, differentiation, and maturation (EN1, LMX1B, PITX3, NURR1, VMAT2, GIRK2, and dopamine transporter) is thus enhanced by Bcl-X-L. These effects on neurogenesis occur in parallel to a decrease in glia generation. These in vitro Bcl-X-L effects are paralleled in vivo, after transplantation in hemiparkinsonian rats, where hVM1-Bcl-X-L cells survive, integrate, and differentiate into DAn, alleviating behavioral motor asymmetry. Bcl-X-L then allows for human fetal VM stem cells to stably generate mature SNpc DAn both in vitro and in vivo and is thus proposed as a helpful factor for the development of cell therapies for neurodegenerative conditions, Parkinson disease in particular.	[Courtois, Elise T.; Castillo, Claudia G.; Seiz, Emma G.; Ramos, Milagros; Liste, Isabel; Martinez-Serrano, Alberto] Autonomous Univ Madrid, Ctr Mol Biol Severo Ochoa, CSIC, Dept Mol Biol, E-28049 Madrid, Spain; [Bueno, Carlos] Univ Miguel Hernandez Elche, Inst Neurosci, Alicante 03550, Spain; [Castillo, Claudia G.] Univ San Luis Potosi, Dept Biochem, Fac Med, San Luis Potosi 782, Mexico	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Universidad Miguel Hernandez de Elche; Universidad Autonoma de San Luis Potosi	Martinez-Serrano, A (corresponding author), Autonomous Univ Madrid, Ctr Mol Biol Severo Ochoa, CSIC, Dept Mol Biol, C Nicolas Cabrera 1, E-28049 Madrid, Spain.	amserrano@cbm.uam.es	Martínez-Serrano, Alberto/J-8146-2014	RAMOS GOMEZ, MILAGROS/0000-0001-5798-9508; Martinez Serrano, Alberto/0000-0003-3927-6699; Courtois, Elise/0000-0002-8749-2719; Liste, Isabel/0000-0002-3294-9558	European Union [QLK3-CT-2001-02120 DANCE, CP-FP-214706-2 EXCELL]; Spanish Ministry of Science and Technology [SAF2001-0841, SAF2004-03405]; Spanish Ministry of Science and Innovation [BIO2007-66807]; Carlos III Institute of Health [RETICS TerCel RD06/0010/0009]; La Caixa Foundation [BM05-22-0]; Comunidad Auto noma de Madrid [GR/SAL/0115/2004]; Foundation Ramon Areces to the Center of Molecular Biology Severo Ochoa	European Union(European Commission); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Institute of Health(Instituto de Salud Carlos III); La Caixa Foundation(La Caixa Foundation); Comunidad Auto noma de Madrid(Comunidad de Madrid); Foundation Ramon Areces to the Center of Molecular Biology Severo Ochoa	This work was supported by European Union Grants QLK3-CT-2001-02120 DANCE and CP-FP-214706-2 EXCELL, Spanish Ministry of Science and Technology Grants SAF2001-0841 and SAF2004-03405, Spanish Ministry of Science and Innovation Grant BIO2007-66807, Carlos III Institute of Health Grant RETICS TerCel RD06/0010/0009, La Caixa Foundation Grant BM05-22-0), and Comunidad Auto noma de Madrid Grant GR/SAL/0115/2004. This work was also supported by an institutional grant from Foundation Ramon Areces to the Center of Molecular Biology Severo Ochoa.	Alavian KN, 2008, MOVEMENT DISORD, V23, P319, DOI 10.1002/mds.21640; Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128; Andersson EKI, 2007, EXP CELL RES, V313, P1172, DOI 10.1016/j.yexcr.2006.12.014; Aouadi M, 2006, STEM CELLS, V24, P1399, DOI 10.1634/stemcells.2005-0398; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Caldwell MA, 1998, EXP NEUROL, V152, P1, DOI 10.1006/exnr.1998.6815; Chang MY, 2007, MOL CELL BIOL, V27, P4293, DOI 10.1128/MCB.00031-07; Christophersen NS, 2006, BRAIN RES BULL, V70, P457, DOI 10.1016/j.brainresbull.2006.07.001; Chung S, 2006, STEM CELLS, V24, P1583, DOI 10.1634/stemcells.2005-0558; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Duval D, 2006, CELL DEATH DIFFER, V13, P564, DOI 10.1038/sj.cdd.4401789; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2007, FASEB J, V21, P8, DOI 10.1096/fj.06-5912hyp; GONZALEZGARCIA M, 1995, P NATL ACAD SCI USA, V92, P4304, DOI 10.1073/pnas.92.10.4304; Haughn L, 2003, J BIOL CHEM, V278, P25158, DOI 10.1074/jbc.M212849200; Hedlund E, 2008, STEM CELLS, V26, P1526, DOI 10.1634/stemcells.2007-0996; Hong S, 2008, J NEUROCHEM, V104, P316, DOI 10.1111/j.1471-4159.2007.04952.x; Itoh T, 2003, J NEUROCHEM, V85, P1500, DOI 10.1046/j.1471-4159.2003.01795.x; Jensen JB, 2006, MOL NEUROBIOL, V34, P153, DOI 10.1385/MN:34:3:153; Jensen P, 2007, J NEUROSCI RES, V85, P1884, DOI 10.1002/jnr.21327; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Khan Z, 2007, EXP CELL RES, V313, P2958, DOI 10.1016/j.yexcr.2007.05.004; Kim HJ, 2007, EXP NEUROL, V203, P394, DOI 10.1016/j.expneurol.2006.08.029; Ko JY, 2009, MOL THER, V17, P1761, DOI 10.1038/mt.2009.148; Lindvall O, 2009, TRENDS PHARMACOL SCI, V30, P260, DOI 10.1016/j.tips.2009.03.001; Liste I, 2007, CELL DEATH DIFFER, V14, P1880, DOI 10.1038/sj.cdd.4402205; Liste I, 2004, J NEUROSCI, V24, P10786, DOI 10.1523/JNEUROSCI.3208-04.2004; Lotharius J, 2005, J NEUROSCI, V25, P6329, DOI 10.1523/JNEUROSCI.1746-05.2005; Lotharius J, 2002, J BIOL CHEM, V277, P38884, DOI 10.1074/jbc.M205518200; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Morizane A, 2008, CELL TISSUE RES, V331, P323, DOI 10.1007/s00441-007-0541-0; Morrow BA, 2007, EXP NEUROL, V204, P802, DOI 10.1016/j.expneurol.2007.01.009; Ostenfeld T, 2002, DEV BRAIN RES, V134, P43, DOI 10.1016/S0165-3806(01)00291-7; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Paul G, 2007, MOL CELL NEUROSCI, V34, P390, DOI 10.1016/j.mcn.2006.11.010; Ravindran G, 2008, BIOCHEM BIOPH RES CO, V373, P258, DOI 10.1016/j.bbrc.2008.06.022; Rawal N, 2007, CELL DEATH DIFFER, V14, P381, DOI 10.1038/sj.cdd.4402010; Rubio FJ, 2000, MOL CELL NEUROSCI, V16, P1, DOI 10.1006/mcne.2000.0854; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Shim JW, 2004, J NEUROSCI, V24, P843, DOI 10.1523/JNEUROSCI.3977-03.2004; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; SPECTOR S, 1965, J PHARMACOL EXP THER, V147, P86; Stefanis L, 2005, NEUROSCIENTIST, V11, P50, DOI 10.1177/1073858404271087; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Suzuki A, 1998, BRAIN RES, V801, P59, DOI 10.1016/S0006-8993(98)00523-X; Svendsen CN, 1996, EXP NEUROL, V137, P376, DOI 10.1006/exnr.1996.0039; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Thompson L, 2005, J NEUROSCI, V25, P6467, DOI 10.1523/JNEUROSCI.1676-05.2005; Trouillas M, 2008, CELL DEATH DIFFER, V15, P1450, DOI 10.1038/cdd.2008.63; Vila M, 2003, NAT REV NEUROSCI, V4, P365, DOI 10.1038/nrn1100; Villa A, 2004, EXP CELL RES, V294, P559, DOI 10.1016/j.yexcr.2003.11.025; Villa A, 2000, EXP NEUROL, V161, P67, DOI 10.1006/exnr.1999.7237; Villa A, 2009, EXP CELL RES, V315, P1860, DOI 10.1016/j.yexcr.2009.03.011; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Yi SH, 2008, MOL THER, V16, P1873, DOI 10.1038/mt.2008.189; Zhang KZ, 1996, P NATL ACAD SCI USA, V93, P4504, DOI 10.1073/pnas.93.9.4504	60	47	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9881	9897		10.1074/jbc.M109.054312	http://dx.doi.org/10.1074/jbc.M109.054312			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106970	Green Published, hybrid			2022-12-27	WOS:000276165900059
J	Golczak, M; Kiser, PD; Lodowski, DT; Maeda, A; Palczewski, K				Golczak, Marcin; Kiser, Philip D.; Lodowski, David T.; Maeda, Akiko; Palczewski, Krzysztof			Importance of Membrane Structural Integrity for RPE65 Retinoid Isomerization Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VISUAL CYCLE; PIGMENT-EPITHELIUM; BINDING-PROTEIN; IN-VITRO; PHOSPHOLIPASE A(2); BIOCHEMICAL-CHARACTERIZATION; ISOMEROHYDROLASE ACTIVITY; SELECTIVE SOLUBILIZATION; DEHYDROGENASE TYPE-1; MICROSOMAL PROTEIN	Regeneration of visual chromophore in the vertebrate visual cycle involves the retinal pigment epithelium-specific protein RPE65, the key enzyme catalyzing the cleavage and isomerization of all-trans-retinyl fatty acid esters to 11-cis-retinol. Although RPE65 has no predicted membrane spanning domains, this protein predominantly associates with microsomal fractions isolated from bovine retinal pigment epithelium (RPE). We have re-examined the nature of RPE65 interactions with native microsomal membranes by using extraction and phase separation experiments. We observe that hydrophobic interactions are the dominant forces that promote RPE65 association with these membranes. These results are consistent with the crystallographic model of RPE65, which features a large lipophilic surface that surrounds the entrance to the catalytic site of this enzyme and likely interacts with the hydrophobic core of the endoplasmic reticulum membrane. Moreover, we report a critical role for phospholipid membranes in preserving the retinoid isomerization activity and physical properties of RPE65. Isomerase activity measured in bovine RPE was highly sensitive to phospholipase A(2) treatment, but the observed decline in 11-cis-retinol production did not directly reflect inhibition by products of lipid hydrolysis. Instead, a direct correlation between the kinetics of phospholipid hydrolysis and retinoid isomerization suggests that the lipid membrane structure is critical for RPE65 enzymatic activity. We also provide evidence that RPE65 operates in a multiprotein complex with retinol dehydrogenase 5 and retinal G protein-coupled receptor in RPE microsomes. Modifications in the phospholipid environment affecting interactions with these protein components may be responsible for the alterations in retinoid metabolism observed in phospholipid-depleted RPE microsomes. Thus, our results indicate that the enzymatic activity of native RPE65 strongly depends on its membrane binding and phospholipid environment.	[Golczak, Marcin; Kiser, Philip D.; Lodowski, David T.; Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Akiko] Case Western Reserve Univ, Sch Med, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			National Institutes of Health [EY019478, EY009339, K08 EY019031, P30 EY11373]; Foundation Fighting Blindness, Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NEI [T32EY007157]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Science [Y1-GM-1104]; U.S. Department of Energy [DE-AC02-06CH11357]; NATIONAL EYE INSTITUTE [T32EY007157, R01EY009339, R01EY019478, P30EY011373, K08EY019031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness, Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY019478, EY009339, K08 EY019031, and P30 EY11373. This work was also supported by Foundation Fighting Blindness, Research to Prevent Blindness Foundation, and Ohio Lions Eye Research Foundation.; Supported by National Institutes of Health Visual Sciences Training Program Grant T32EY007157 from NEI.; We thank Dr. Janna Kiselar from the Center for Proteomics and Bioinformatics at Case Western Reserve University for assistance with MS instruments. We thank the staff at the APS 23-ID-D beamline for technical assistance. GM/CA CAT has been funded, in whole or in part, with federal funds from the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Science (Y1-GM-1104). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under Contract No. DE-AC02-06CH11357. We also thank Dr. Leslie T. Webster, Jr., and members of the Palczewski laboratory (Case Western Reserve University) for valuable comments about the manuscript.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; BARRY RJ, 1989, J BIOL CHEM, V264, P9231; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BAVIK CO, 1992, J BIOL CHEM, V267, P23035; BAVIK CO, 1993, J BIOL CHEM, V268, P20540; Bell JD, 1996, BIOCHEMISTRY-US, V35, P4945, DOI 10.1021/bi952274i; Bereta G, 2008, BIOCHEMISTRY-US, V47, P9856, DOI 10.1021/bi800905v; BERNSTEIN PS, 1987, J BIOL CHEM, V262, P16848; BERNSTEIN PS, 1987, P NATL ACAD SCI USA, V84, P1849, DOI 10.1073/pnas.84.7.1849; Booth PJ, 2005, CURR OPIN STRUC BIOL, V15, P435, DOI 10.1016/j.sbi.2005.06.002; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BURACK WR, 1995, BIOCHEMISTRY-US, V34, P14819, DOI 10.1021/bi00045a024; Chernomordik L, 1996, CHEM PHYS LIPIDS, V81, P203, DOI 10.1016/0009-3084(96)02583-2; Choo DW, 1998, FEBS LETT, V440, P195, DOI 10.1016/S0014-5793(98)01459-8; COOKE GM, 1985, J BIOL CHEM, V260, P7489; Crabb JW, 1998, METH MOL B, V89, P91; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forneris F, 2008, SCIENCE, V321, P213, DOI 10.1126/science.1151118; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; HAMEL CP, 1993, J BIOL CHEM, V268, P15751; HAMEL CP, 1993, J NEUROSCI RES, V34, P414, DOI 10.1002/jnr.490340406; Hemati N, 2005, MOL VIS, V11, P1151; Imanishi Y, 2004, J CELL BIOL, V164, P373, DOI 10.1083/jcb.200311079; Jahng WJ, 2002, BIOCHEMISTRY-US, V41, P6311, DOI 10.1021/bi015710b; Jang GF, 2001, J BIOL CHEM, V276, P32456, DOI 10.1074/jbc.M104949200; JENSEN JW, 1989, BIOCHEMISTRY-US, V28, P851, DOI 10.1021/bi00428a066; Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042; KATSUTA K, 1978, BIOCHIM BIOPHYS ACTA, V507, P271, DOI 10.1016/0005-2736(78)90422-4; KINTER M, 2000, PROTEIN SEQUENCING I, P147, DOI DOI 10.1002/0471721980; Kiser PD, 2009, P NATL ACAD SCI USA, V106, P17325, DOI 10.1073/pnas.0906600106; Ma JX, 2001, INVEST OPHTH VIS SCI, V42, P1429; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200; Moise AR, 2007, J BIOL CHEM, V282, P2081, DOI 10.1074/jbc.M608315200; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikolaeva O, 2009, FEBS J, V276, P3020, DOI 10.1111/j.1742-4658.2009.07021.x; Ogg D, 2005, J BIOL CHEM, V280, P3789, DOI 10.1074/jbc.M412463200; ORegan MH, 1996, NEUROSCI LETT, V202, P201, DOI 10.1016/0304-3940(95)12238-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Penefsky H. S., 1971, METHOD ENZYMOL, V22, P204; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; RYDSTROM J, 1976, BIOCHIM BIOPHYS ACTA, V455, P24, DOI 10.1016/0005-2736(76)90151-6; SIMON A, 1995, J BIOL CHEM, V270, P1107, DOI 10.1074/jbc.270.34.19979; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; STUBBS CD, 1984, BIOCHIM BIOPHYS ACTA, V779, P89, DOI 10.1016/0304-4157(84)90005-4; Takahashi Y, 2009, J BIOL CHEM, V284, P3211, DOI 10.1074/jbc.M807248200; Tatulian SA, 2001, BIOPHYS J, V80, P789, DOI 10.1016/S0006-3495(01)76058-4; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; VESELY DL, 1981, SCIENCE, V213, P359, DOI 10.1126/science.6113689; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wendt KU, 1999, J MOL BIOL, V286, P175, DOI 10.1006/jmbi.1998.2470; Wenzel A, 2005, J BIOL CHEM, V280, P29874, DOI 10.1074/jbc.M503603200; Xu H, 2008, J PROTEOME RES, V7, P138, DOI 10.1021/pr070363z; Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016; Yuan Q, 2010, J BIOL CHEM, V285, P988, DOI 10.1074/jbc.M109.025643; Zhang M, 2004, J BIOL CHEM, V279, P51482, DOI 10.1074/jbc.M409051200; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	65	49	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9667	9682		10.1074/jbc.M109.063941	http://dx.doi.org/10.1074/jbc.M109.063941			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100834	Green Published, hybrid			2022-12-27	WOS:000276165900040
J	Kummer, C; Petrich, BG; Rose, DM; Ginsberg, MH				Kummer, Christiane; Petrich, Brian G.; Rose, David M.; Ginsberg, Mark H.			A Small Molecule That Inhibits the Interaction of Paxillin and alpha 4 Integrin Inhibits Accumulation of Mononuclear Leukocytes at a Site of Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; T-CELL MIGRATION; CYTOPLASMIC DOMAIN; CONTROLLED TRIAL; LD MOTIFS; BINDING; PROTEIN; ACTIVATION; LEUPAXIN; DISEASE	Extracellular antagonists of alpha 4 integrin are an effective therapy for several autoimmune and inflammatory diseases; however, these agents that directly block ligand binding may exhibit mechanism-based toxicities. Inhibition of alpha 4 integrin signaling by mutations of alpha 4 that block paxillin binding inhibits inflammation while limiting mechanism-based toxicities. Here, we test a pharmacological approach by identifying small molecules that inhibit the alpha 4 integrin-paxillin interaction. By screening a large (similar to 40,000-compound) chemical library, we identified a noncytotoxic inhibitor of this interaction that impaired integrin alpha 4-mediated but not alpha L beta 2-mediated Jurkat T cell migration. The identified compound had no effect on alpha 4-mediated migration in cells bearing the alpha 4(Y991A) mutation that disrupts the alpha 4-paxillin interaction, establishing the specificity of its action. Administration of this compound to mice led to impaired recruitment of mononuclear leukocytes to a site of inflammation in vivo, whereas an isomer that does not inhibit the alpha 4-paxillin interaction had no effect on alpha 4-mediated cell migration, cell spreading, or recruitment of leukocytes to an inflammatory site. Thus, a small molecule inhibitor that interferes with alpha 4 integrin signaling reduces alpha 4-mediated T cell migration in vivo, thus providing proof of principle for inhibition of alpha 4 integrin signaling as a target for the pharmacological reduction of inflammation.	[Kummer, Christiane; Petrich, Brian G.; Rose, David M.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Ginsberg, MH (corresponding author), Univ Calif San Diego, Dept Med, Leichtag Bldg,Rm 181,9500 Gilman Dr,Dept 0726, La Jolla, CA 92093 USA.	mhginsberg@ucsd.edu			National Institutes of Health [AR27214, NS059433, AR52367]; Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR027214, R01AR027214, R01AR052367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059433] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR27214 and NS059433 (to M. H. G.) and AR52367 (to D. M. R.). This work was also supported by an Arthritis Foundation postdoctoral fellowship (to C. K.).	Ambroise Y, 2002, CHEM BIOL, V9, P1219, DOI 10.1016/S1074-5521(02)00246-6; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown MC, 1996, J CELL BIOL, V135, P1109, DOI 10.1083/jcb.135.4.1109; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; Feral CC, 2006, J CLIN INVEST, V116, P715, DOI 10.1172/JCI26091; Ghosh S, 2003, EXPERT OPIN BIOL TH, V3, P995, DOI 10.1517/eobt.3.6.995.21264; Goldfinger LE, 2003, J CELL BIOL, V162, P731, DOI 10.1083/jcb.200304031; Gordon FH, 2001, GASTROENTEROLOGY, V121, P268, DOI 10.1053/gast.2001.26260; Gupta A, 2003, J BONE MINER RES, V18, P669, DOI 10.1359/jbmr.2003.18.4.669; Han JW, 2003, J BIOL CHEM, V278, P34845, DOI 10.1074/jbc.M304691200; James WG, 2003, J IMMUNOL, V170, P520, DOI 10.4049/jimmunol.170.1.520; Jongewaard IN, 1996, CELL ADHES COMMUN, V3, P487, DOI 10.3109/15419069609081025; Lipsky BP, 1998, J BIOL CHEM, V273, P11709, DOI 10.1074/jbc.273.19.11709; Liu S, 1999, NATURE, V402, P676, DOI 10.1038/45264; Liu SC, 2002, J BIOL CHEM, V277, P20887, DOI 10.1074/jbc.M110928200; Liu SC, 2000, J BIOL CHEM, V275, P22736, DOI 10.1074/jbc.M000388200; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Ramos JW, 2000, MOL BIOL CELL, V11, P2863, DOI 10.1091/mbc.11.9.2863; Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130; Rose DM, 2003, J IMMUNOL, V170, P5912, DOI 10.4049/jimmunol.170.12.5912; Rose DM, 2001, J IMMUNOL, V167, P2824, DOI 10.4049/jimmunol.167.5.2824; Sahu SN, 2007, AM J PHYSIOL-CELL PH, V292, pC2288, DOI 10.1152/ajpcell.00503.2006; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Sheridan C, 2005, NAT REV DRUG DISCOV, V4, P357, DOI 10.1038/nrd1743; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Smolen JS, 2003, NAT REV DRUG DISCOV, V2, P473, DOI 10.1038/nrd1109; Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Turner CE, 2000, J CELL SCI, V113, P4139; TURNER CE, 1994, J CELL SCI, V107, P1583; von Andrian UH, 2003, NEW ENGL J MED, V348, P68, DOI 10.1056/NEJMe020157; YANG JT, 1995, DEVELOPMENT, V121, P549; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	37	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9462	9469		10.1074/jbc.M109.066993	http://dx.doi.org/10.1074/jbc.M109.066993			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097761	Green Published, hybrid			2022-12-27	WOS:000276165900019
J	Shimizu, E; Selvamurugan, N; Westendorf, JJ; Olson, EN; Partridge, NC				Shimizu, Emi; Selvamurugan, Nagarajan; Westendorf, Jennifer J.; Olson, Eric N.; Partridge, Nicola C.			HDAC4 Represses Matrix Metalloproteinase-13 Transcription in Osteoblastic Cells, and Parathyroid Hormone Controls This Repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT COLLAGENASE-3 PROMOTER; II HISTONE DEACETYLASES; ACTIVATOR PROTEIN-1; CLEIDOCRANIAL DYSPLASIA; BONE-DEVELOPMENT; RUNX2; DIFFERENTIATION; EXPRESSION; BINDING; CBFA1	Parathyroid hormone (PTH) is a hormone regulating bone remodeling through its actions on both bone formation and bone resorption. Previously we reported that PTH induces matrix metalloproteinase-13 (MMP-13) transcription in osteoblastic cells. Here, we show that histone deacetylase 4 (HDAC4) interacts with Runx2, binds the MMP-13 promoter, and suppresses MMP-13 gene transcription in the rat osteoblastic cell line, UMR 106-01. PTH induces the rapid cAMP-dependent protein kinase-dependent release of HDAC4 from the MMP-13 promoter and subsequent transcription of MMP-13. Knock-out of HDAC4 either by siRNA in vitro or by gene deletion in vivo leads to an increase in MMP-13 expression, and overexpression of HDAC4 decreases the PTH induction of MMP-13. All of these observations indicate that HDAC4 represses MMP-13 gene transcription in bone. Moreover, PTH stimulates HDAC4 gene expression and enzymatic activity at times corresponding to the reassociation of HDAC4 with the MMP-13 promoter and a decline in its transcription. Thus, HDAC4 is a basal repressor of MMP-13 transcription, and PTH regulates HDAC4 to control MMP-13 promoter activity. These data identify a novel and discrete mechanism of regulating HDAC4 levels and, subsequently, gene expression.	[Shimizu, Emi; Partridge, Nicola C.] NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, New York, NY 10010 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN 55905 USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Selvamurugan, Nagarajan] Sri Ramaswamy Mem Univ, Sch Bioengn, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	New York University; Mayo Clinic; Mayo Clinic; SRM Institute of Science & Technology Chennai; University of Texas System; University of Texas Southwestern Medical Center Dallas	Partridge, NC (corresponding author), NYU, Coll Dent, Dept Basic Sci & Craniofacial Biol, 345 E 24th St, New York, NY 10010 USA.	ncp234@nyu.edu	Selvamurugan, Nagarajan/P-7894-2016	Selvamurugan, Nagarajan/0000-0003-3713-1920; Partridge, Nicola/0000-0002-5406-4814	National Institutes of Health [DK47420]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK047420, R01DK047420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK47420 (to N. C. P.).	Boumah CE, 2009, MOL ENDOCRINOL, V23, P1255, DOI 10.1210/me.2008-0217; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; HOCK JM, 1992, J BONE MINER RES, V7, P65, DOI 10.1002/jbmr.5650070110; HOCK JM, 1988, ENDOCRINOLOGY, V122, P2899, DOI 10.1210/endo-122-6-2899; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Johansson N, 1997, DEV DYNAM, V208, P387, DOI 10.1002/(SICI)1097-0177(199703)208:3<387::AID-AJA9>3.0.CO;2-E; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Lee SK, 1999, ENDOCRINOLOGY, V140, P3552, DOI 10.1210/en.140.8.3552; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; Liu F, 2006, MOL BIOL CELL, V17, P585, DOI 10.1091/mbc.E05-08-0775; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARTRIDGE NC, 1987, ENDOCRINOLOGY, V120, P1956, DOI 10.1210/endo-120-5-1956; Porte D, 1999, ONCOGENE, V18, P667, DOI 10.1038/sj.onc.1202333; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; SCOTT DK, 1992, MOL ENDOCRINOL, V6, P2153, DOI 10.1210/me.6.12.2153; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvamurugan N, 2000, J BIOL CHEM, V275, P5037, DOI 10.1074/jbc.275.7.5037; STREWLER GJ, 1987, J CLIN INVEST, V80, P1803, DOI 10.1172/JCI113275; Tuckermann JP, 2000, J BONE MINER RES, V15, P1257, DOI 10.1359/jbmr.2000.15.7.1257; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang AH, 2000, MOL CELL BIOL, V20, P6904, DOI 10.1128/MCB.20.18.6904-6912.2000; Weir EC, 1996, J BONE MINER RES, V11, P1474; Westendorf JJ, 2007, J CELL BIOCHEM, V102, P332, DOI 10.1002/jcb.21486; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; Winchester SK, 2000, J BIOL CHEM, V275, P23310, DOI 10.1074/jbc.M003004200; Yamagiwa H, 1999, BONE, V25, P197, DOI 10.1016/S8756-3282(99)00157-X; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zhao WG, 1999, J CLIN INVEST, V103, P517, DOI 10.1172/JCI5481	36	65	68	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9616	9626		10.1074/jbc.M109.094862	http://dx.doi.org/10.1074/jbc.M109.094862			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097749	hybrid, Green Published			2022-12-27	WOS:000276165900034
J	Szymanski, MR; Jezewska, MJ; Bujalowski, W				Szymanski, Michal R.; Jezewska, Maria J.; Bujalowski, Wlodzimierz			The Escherichia coli PriA Helicase Specifically Recognizes Gapped DNA Substrates EFFECT OF THE TWO NUCLEOTIDE-BINDING SITES OF THE ENZYME ON THE RECOGNITION PROCESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; STALLED REPLICATION FORKS; NUCLEOTIDE-BINDING SITES; PHI X174-TYPE PRIMOSOME; SWINE-FEVER VIRUS; QUANTITATIVE-ANALYSIS; NUCLEIC-ACID; HEXAMERIC HELICASE; PLASMID RSF1010; LARGE LIGANDS	Energetics and specificity of interactions between the Escherichia coli PriA helicase and the gapped DNAs have been studied, using the quantitative fluorescence titration and analytical ultracentrifugation methods. The gap complex has a surprisingly low minimum total site size, corresponding to similar to 7 nucleotides of the single-stranded DNA (ssDNA), as compared with the site size of similar to 20 nucleotides of the enzyme-ssDNA complex. The dramatic difference in stoichiometries indicates that the enzyme predominantly engages the strong DNA-binding subsite in interactions with the gap and assumes a very different orientation in the gap complex, as compared with the complex with the ssDNA. The helicase binds the ssDNA gaps with 4-5 nucleotides with the highest affinity, which is similar to 3 and similar to 2 orders of magnitude larger than the affinities for the ssDNA and double-stranded DNA, respectively. In the gap complex, the protein does not engage in cooperative interactions with the enzyme predominantly associated with the surrounding dsDNA. Binding of nucleoside triphosphate to the strong and weak nucleotide-binding sites of the helicase eliminates the selectivity of the enzyme for the size of the gap, whereas saturation of both sites with ADP leads to amplified affinity for the ssDNA gap containing 5 nucleotides and engagement of an additional protein area in interactions with the nucleic acid.	[Bujalowski, Wlodzimierz] Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Dept Obstet & Gynecol,Sealy Ctr Struct Biol, Galveston, TX 77555 USA; Univ Texas Galveston, Med Branch, Sealy Ctr Canc Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bujalowski, W (corresponding author), Univ Texas Galveston, Med Branch, Dept Biochem & Mol Biol, Dept Obstet & Gynecol,Sealy Ctr Struct Biol, 301 Univ Blvd, Galveston, TX 77555 USA.	wbujalow@utmb.edu		Szymanski, Michal/0000-0001-9452-8508	National Institutes of Health [GM46679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46679 (to W. B.).	ALLEN GC, 1993, J BIOL CHEM, V268, P19204; BAKER BM, 1978, BIOPOLYMERS, V17, P1361, DOI 10.1002/bip.1978.360170519; Bujalowski W, 2006, CHEM REV, V106, P556, DOI 10.1021/cr040462l; BUJALOWSKI W, 1995, BIOCHEMISTRY-US, V34, P8513, DOI 10.1021/bi00027a001; BUJALOWSKI W, 1994, J BIOL CHEM, V269, P31350; BUJALOWSKI W, 1989, BIOPOLYMERS, V28, P1637, DOI 10.1002/bip.360280912; Bujalowski W., 2000, SPECTROPHOTOMETRY SP, P141; CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P591; Delagoutte E, 2003, Q REV BIOPHYS, V36, P1, DOI 10.1017/S0033583502003864; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; EPSTEIN IR, 1978, BIOPHYS CHEM, V8, P327, DOI 10.1016/0301-4622(78)80015-5; Galletto R, 2004, J MOL BIOL, V343, P83, DOI 10.1016/j.jmb.2004.07.055; Galletto R, 2004, J MOL BIOL, V343, P101, DOI 10.1016/j.jmb.2004.07.056; Galletto R, 2004, BIOCHEMISTRY-US, V43, P11002, DOI 10.1021/bi049378q; Galletto R, 2003, J MOL BIOL, V329, P441, DOI 10.1016/S0022-2836(03)00435-2; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Heller RC, 2005, MOL CELL, V17, P733, DOI 10.1016/j.molcel.2005.01.019; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; Heller RC, 2007, DNA REPAIR, V6, P945, DOI 10.1016/j.dnarep.2007.02.014; Jezewska MJ, 2007, BIOCHEMISTRY-US, V46, P12909, DOI 10.1021/bi700677j; Jezewska MJ, 1996, J BIOL CHEM, V271, P4261; Jezewska MJ, 1996, BIOCHEMISTRY-US, V35, P2117, DOI 10.1021/bi952344l; Jezewska MJ, 1998, J BIOL CHEM, V273, P9058, DOI 10.1074/jbc.273.15.9058; Jezewska MJ, 1998, BIOCHEMISTRY-US, V37, P3116, DOI 10.1021/bi972564u; Jezewska MJ, 2006, J MOL BIOL, V356, P121, DOI 10.1016/j.jmb.2005.10.061; Jezewska MJ, 2004, J MOL BIOL, V343, P115, DOI 10.1016/j.jmb.2004.08.021; Jezewska MJ, 2003, BIOCHEMISTRY-US, V42, P11864, DOI 10.1021/bi030111l; Jezewska MJ, 2002, J BIOL CHEM, V277, P20316, DOI 10.1074/jbc.M200918200; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; Jezewska MJ, 2000, J BIOL CHEM, V275, P27865; Jezewska MJ, 2000, BIOCHEMISTRY-US, V39, P10454, DOI 10.1021/bi001113y; Jones JM, 2001, J MOL BIOL, V312, P935, DOI 10.1006/jmbi.2001.4930; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; LASKEN RS, 1988, J BIOL CHEM, V263, P5512; LEDNEVA RK, 1978, NUCLEIC ACIDS RES, V5, P4225, DOI 10.1093/nar/5.11.4225; LEE EH, 1990, P NATL ACAD SCI USA, V87, P4620, DOI 10.1073/pnas.87.12.4620; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; Liu J, 1996, J BIOL CHEM, V271, P15656, DOI 10.1074/jbc.271.26.15656; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; LOHMAN TM, 1991, METHOD ENZYMOL, V208, P258; LOW RL, 1981, P NATL ACAD SCI-BIOL, V78, P1436, DOI 10.1073/pnas.78.3.1436; Lucius AL, 2006, BIOCHEMISTRY-US, V45, P7217, DOI 10.1021/bi051827e; Lucius AL, 2006, BIOCHEMISTRY-US, V45, P7237, DOI 10.1021/bi0518287; Lucius AL, 2006, BIOCHEMISTRY-US, V45, P7202, DOI 10.1021/bi051826m; Marcinowicz A, 2008, J MOL BIOL, V375, P386, DOI 10.1016/j.jmb.2007.06.051; Marcinowicz A, 2007, BIOCHEMISTRY-US, V46, P13279, DOI 10.1021/bi700729k; Marians KJ, 2000, PROG NUCLEIC ACID RE, V63, P39; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Ng JY, 1996, J BIOL CHEM, V271, P15649, DOI 10.1074/jbc.271.26.15649; North SH, 2005, MOL MICROBIOL, V56, P1601, DOI 10.1111/j.1365-2958.2005.04639.x; NURSE P, 1990, P NATL ACAD SCI USA, V87, P4615, DOI 10.1073/pnas.87.12.4615; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X; Roychowdhury A, 2009, BIOCHEMISTRY-US, V48, P6712, DOI 10.1021/bi900050x; Sandler SJ, 2001, MOL MICROBIOL, V41, P697, DOI 10.1046/j.1365-2958.2001.02547.x; Sasaki K, 2007, EMBO J, V26, P2584, DOI 10.1038/sj.emboj.7601697; SCHEKMAN R, 1975, J BIOL CHEM, V250, P5859; TOLMAN GL, 1974, BIOCHEMISTRY-US, V13, P4869, DOI 10.1021/bi00721a001; WICKNER S, 1974, P NATL ACAD SCI USA, V71, P4120, DOI 10.1073/pnas.71.10.4120; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3	60	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9683	9696		10.1074/jbc.M109.094789	http://dx.doi.org/10.1074/jbc.M109.094789			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089865	hybrid, Green Published			2022-12-27	WOS:000276165900041
J	Gu, XG; Glushka, J; Yin, YB; Xu, Y; Denny, T; Smith, J; Jiang, YN; Bar-Peled, M				Gu, Xiaogang; Glushka, John; Yin, Yanbin; Xu, Ying; Denny, Timothy; Smith, James; Jiang, Yingnan; Bar-Peled, Maor			Identification of a Bifunctional UDP-4-keto-pentose/UDP-xylose Synthase in the Plant Pathogenic Bacterium Ralstonia solanacearum Strain GMI1000, a Distinct Member of the 4,6-Dehydratase and Decarboxylase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-SPECIFIC POLYSACCHARIDE; UDP-GLUCURONIC ACID; BETA-D-XYLOSYLTRANSFERASE; ESCHERICHIA-COLI; D-XYLOSE; STRUCTURAL-CHARACTERIZATION; PSEUDOMONAS-AERUGINOSA; STREPTOMYCES-FRADIAE; FUNCTIONAL CLONING; 4-AMINO-4-DEOXY-L-ARABINOSE	The UDP-sugar interconverting enzymes involved in UDPGlcA metabolism are well described in eukaryotes but less is known in prokaryotes. Here we identify and characterize a gene (RsU4kpxs) from Ralstonia solanacearum str. GMI1000, which encodes a dual function enzyme not previously described. One activity is to decarboxylate UDP-glucuronic acid to UDP-beta-L-threo-pentopyranosyl-4 ''-ulose in the presence of NAD(+). The second activity converts UDP-beta-L-threo-pentopyranosyl-4 ''-ulose and NADH to UDP-xylose and NAD(+), albeit at a lower rate. Our data also suggest that following decarboxylation, there is stereospecific protonation at the C5 pro-R position. The identification of the R. solanacearum enzyme enables us to propose that the ancestral enzyme of UDP-xylose synthase and UDP-apiose/UDP-xylose synthase was diverged to two distinct enzymatic activities in early bacteria. This separation gave rise to the current UDP-xylose synthase in animal, fungus, and plant as well as to the plant Uaxs and bacterial ArnA and U4kpxs homologs.	[Gu, Xiaogang; Glushka, John; Smith, James; Jiang, Yingnan; Bar-Peled, Maor] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Yin, Yanbin; Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Denny, Timothy] Univ Georgia, Dept Plant Pathogen, Athens, GA 30602 USA; [Bar-Peled, Maor] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Bar-Peled, M (corresponding author), CCRC 315 Riverbend Rd, Athens, GA 30602 USA.	peled@ccrc.uga.edu	gu, xiaogang/F-7440-2015; Yin, Yanbin/C-9788-2010; Yin, Yanbin/AAH-2665-2020	Yin, Yanbin/0000-0001-7667-881X; Yin, Yanbin/0000-0001-7667-881X	National Science Foundation [IOB-0453664]; Office of Biological and Environmental Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103390] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation Grant IOB-0453664 (to M. B.-P.) and in part by the BioEnergy Science Center, which is supported by the Office of Biological and Environmental Research in the Department of Energy Office of Science.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bakker H, 2009, J BIOL CHEM, V284, P2576, DOI 10.1074/jbc.M804394200; Breazeale SD, 2005, J BIOL CHEM, V280, P14154, DOI 10.1074/jbc.M414265200; Breazeale SD, 2003, J BIOL CHEM, V278, P24731, DOI 10.1074/jbc.M304043200; Breazeale SD, 2002, J BIOL CHEM, V277, P2886, DOI 10.1074/jbc.M109377200; CHERNIAK R, 1994, INFECT IMMUN, V62, P1507, DOI 10.1128/IAI.62.5.1507-1512.1994; Forsberg LS, 2008, J BIOL CHEM, V283, P16037, DOI 10.1074/jbc.M709615200; Gatzeva-Topalova PZ, 2004, BIOCHEMISTRY-US, V43, P13370, DOI 10.1021/bi048551f; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Gu XG, 2004, PLANT PHYSIOL, V136, P4256, DOI 10.1104/pp.104.052365; Gu XG, 2009, J BIOCHEM, V146, P527, DOI 10.1093/jb/mvp099; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guyett P, 2009, CARBOHYD RES, V344, P1072, DOI 10.1016/j.carres.2009.03.026; Harper AD, 2002, PLANT PHYSIOL, V130, P2188, DOI 10.1104/pp.009654; Hwang HY, 2002, P NATL ACAD SCI USA, V99, P14218, DOI 10.1073/pnas.172522199; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Klutts JS, 2008, J BIOL CHEM, V283, P14327, DOI 10.1074/jbc.M708927200; KNIREL YA, 1987, EUR J BIOCHEM, V167, P549, DOI 10.1111/j.1432-1033.1987.tb13372.x; KOCHAROVA NA, 1993, CARBOHYD RES, V250, P275, DOI 10.1016/0008-6215(93)84006-R; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Ma LY, 2007, J BACTERIOL, V189, P8353, DOI 10.1128/JB.00620-07; Melancon CE, 2007, BIOCHEMISTRY-US, V46, P577, DOI 10.1021/bi061907y; MOHNEN D, 2008, BIOSYNTHESIS PLANT C, P1; Mohnen D, 2008, CURR OPIN PLANT BIOL, V11, P266, DOI 10.1016/j.pbi.2008.03.006; Molhoj M, 2003, PLANT J, V35, P693, DOI 10.1046/j.1365-313X.2003.01841.x; O'Neill M. A., 2003, PLANT CELL WALL, P1, DOI DOI 10.1002/9781119312994.APR0067; Pauly M, 2000, ANAL BIOCHEM, V278, P69, DOI 10.1006/abio.1999.4411; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Shashkov AS, 1999, CARBOHYD RES, V319, P199, DOI 10.1016/S0008-6215(99)00132-9; Tello M, 2008, CHEMBIOCHEM, V9, P1295, DOI 10.1002/cbic.200800021; Vaishnav VV, 1998, CARBOHYD RES, V306, P315, DOI 10.1016/S0008-6215(97)10058-1; Varbanets LD, 2003, MICROBIOLOGY+, V72, P12, DOI 10.1023/A:1022261619561; Veshtort M, 2006, J MAGN RESON, V178, P248, DOI 10.1016/j.jmr.2005.07.018; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Williams GJ, 2005, J BIOL CHEM, V280, P23000, DOI 10.1074/jbc.M501534200; Xu XJ, 2004, CARBOHYD RES, V339, P1631, DOI 10.1016/j.carres.2004.04.006; Zdorovenko EL, 2008, BIOMACROMOLECULES, V9, P2215, DOI 10.1021/bm800326u	39	28	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9030	9040		10.1074/jbc.M109.066803	http://dx.doi.org/10.1074/jbc.M109.066803			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20118241	Green Published, hybrid			2022-12-27	WOS:000275553700054
J	Honsho, M; Asaoku, S; Fujiki, Y				Honsho, Masanori; Asaoku, Shunsuke; Fujiki, Yukio			Posttranslational Regulation of Fatty Acyl-CoA Reductase 1, Far1, Controls Ether Glycerophospholipid Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALKYL-DIHYDROXYACETONEPHOSPHATE SYNTHASE; RHIZOMELIC CHONDRODYSPLASIA PUNCTATA; CHO-CELL MUTANT; PLASMALOGEN BIOSYNTHESIS; LIPID BIOSYNTHESIS; ACYLTRANSFERASE; RAT; IDENTIFICATION; PURIFICATION; OXIDOREDUCTASE	Plasmalogens are a major subclass of ethanolamine and choline glycerophospholipids in which a long chain fatty alcohol is attached at the sn-1 position through a vinyl ether bond. This ether-linked alkyl bond is formed in peroxisomes by replacement of a fatty acyl chain in the intermediate 1-acyl-dihydroxyacetone phosphate with a fatty alcohol in a reaction catalyzed by alkyl dihydroxyacetone phosphate synthase. Here, we demonstrate that the enzyme fatty acyl-CoA reductase 1 (Far1) supplies the fatty alcohols used in the formation of ether-linked alkyl bonds. Far1 activity is elevated in plasmalogen-deficient cells, and conversely, the levels of this enzyme are restored to normal upon plasmalogen supplementation. Down-regulation of Far1 activity in response to plasmalogens is achieved by increasing the rate of degradation of peroxisomal Far1 protein. Supplementation of normal cells with ethanolamine and 1-O-hexadecylglycerol, which are intermediates in plasmalogen biosynthesis, accelerates degradation of Far1. Taken together, our results indicate that ether lipid biosynthesis in mammalian cells is regulated by a negative feedback mechanism that senses cellular plasmalogen levels and appropriately increases or decreases Far1.	[Fujiki, Yukio] Kyushu Univ, Fac Sci, Dept Biol, Grad Sch,Higashi Ku, Fukuoka 8128581, Japan; [Asaoku, Shunsuke; Fujiki, Yukio] Kyushu Univ, Grad Sch Syst Life Sci, Higashi Ku, Fukuoka 8128581, Japan; [Fujiki, Yukio] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan	Kyushu University; Kyushu University; Japan Science & Technology Agency (JST)	Fujiki, Y (corresponding author), Kyushu Univ, Fac Sci, Dept Biol, Grad Sch,Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	yfujiki@kyudai.jp		Honsho, Masanori/0000-0001-6165-4516	Science and Technology Agency of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Foundation for Applied Enzymology	Science and Technology Agency of Japan(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Foundation for Applied Enzymology	This work was supported in part by a CREST grant from the Science and Technology Agency of Japan (to Y.F.); grants-in-aid for scientific research (to M. H. and Y.F.) and a grant from the Global Center of Excellence Program from The Ministry of Education, Culture, Sports, Science, and Technology of Japan; a grant from the Japan Foundation for Applied Enzymology (to Y.F.).	BISHOP JE, 1981, J BIOL CHEM, V256, P9542; Bleijerveld OB, 2004, BIOCHEM J, V379, P711, DOI 10.1042/BJ20031422; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BURDETT K, 1991, J BIOL CHEM, V266, P12201; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; DAS AK, 1988, FEBS LETT, V227, P187, DOI 10.1016/0014-5793(88)80895-0; DAVIS PA, 1981, ARCH BIOCHEM BIOPHYS, V211, P20, DOI 10.1016/0003-9861(81)90424-0; de Vet ECJM, 1999, J LIPID RES, V40, P1998; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hajra AK, 2000, J BIOL CHEM, V275, P9441, DOI 10.1074/jbc.275.13.9441; Honsho M, 2008, BBA-MOL CELL RES, V1783, P1857, DOI 10.1016/j.bbamcr.2008.05.018; JAMES PF, 1990, P NATL ACAD SCI USA, V87, P6102, DOI 10.1073/pnas.87.16.6102; Kuerschner L, 2005, NAT METHODS, V2, P39, DOI 10.1038/NMETH728; LEE T, 1979, J BIOL CHEM, V254, P2892; LEE TC, 1980, BIOCHIM BIOPHYS ACTA, V619, P420, DOI 10.1016/0005-2760(80)90091-0; Liu DL, 2005, J LIPID RES, V46, P727, DOI 10.1194/jlr.M400364-JLR200; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; Nagan N, 1997, P NATL ACAD SCI USA, V94, P4475, DOI 10.1073/pnas.94.9.4475; Nagan N, 1998, BIOCHEM J, V332, P273, DOI 10.1042/bj3320273; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Nishimukai M, 2003, LIPIDS, V38, P1227, DOI 10.1007/s11745-003-1183-9; RIZZO WB, 1993, BIOCHEM MED METAB B, V50, P93, DOI 10.1006/bmmb.1993.1050; Rizzo WB, 1998, MOL GENET METAB, V65, P63, DOI 10.1006/mgme.1998.2728; Rosenberger TA, 2002, J LIPID RES, V43, P59; Shimozawa N, 1999, J HUM GENET, V44, P123, DOI 10.1007/s100380050123; Tamura S, 1998, P NATL ACAD SCI USA, V95, P4350, DOI 10.1073/pnas.95.8.4350; Tanaka A, 2006, EXP CELL RES, V312, P1671, DOI 10.1016/j.yexcr.2006.01.028; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; WEBBER KO, 1993, ARCH BIOCHEM BIOPHYS, V300, P88, DOI 10.1006/abbi.1993.1013; Yang JY, 2003, FEBS LETT, V546, P247, DOI 10.1016/S0014-5793(03)00581-7; Zheng H, 2006, J LIPID RES, V47, P633, DOI 10.1194/jlr.M500493-JLR200	31	81	85	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8537	8542		10.1074/jbc.M109.083311	http://dx.doi.org/10.1074/jbc.M109.083311			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071337	hybrid, Green Published			2022-12-27	WOS:000275553700005
J	Nguyen, HM; Goldin, AL				Nguyen, Hai M.; Goldin, Alan L.			Sodium Channel Carboxyl-terminal Residue Regulates Fast Inactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; ALPHA-SUBUNIT; RAT-BRAIN; EF-HAND; ARRHYTHMOGENIC MECHANISM; MOLECULAR-MECHANISMS; MESSENGER-RNAS; LQT-3 MUTATION; DOMAIN; CALMODULIN	The Na(v)1.2 and Na(v)1.3 voltage-gated sodium channel isoforms demonstrate distinct differences in their kinetics and voltage dependence of fast inactivation when expressed in Xenopus oocytes. Co-expression of the auxiliary beta 1 subunit accelerated inactivation of both the Na(v)1.2 and Na(v)1.3 isoforms, but it did not eliminate the differences, demonstrating that this property is inherent in the alpha subunit. By constructing chimeric channels between Na(v)1.2 and Na(v)1.3, we demonstrate that the carboxyl terminus is responsible for the differences. The Na(v)1.2 carboxyl terminus caused faster inactivation in the Na(v)1.3 backbone, and the Na(v)1.3 carboxyl terminus caused slower inactivation in the Na(v)1.2 channel. Through analysis of truncated channels, we identified a homologous 60-amino acid region within the carboxyl terminus of the Na(v)1.2 and the Na(v)1.3 channels that is responsible for this modulation of fast inactivation. Site-directed replacement of Na(v)1.3 lysine 1826 in this region to its Na(v)1.2 analogue glutamic acid 1880 (K1826E) shifted the voltage dependence of inactivation toward that of Na(v)1.2. The K1826E mutation also accelerated the inactivation kinetics to a level comparable with that of Na(v)1.2. The reverse Na(v)1.2 E1880K mutation exhibited much slower inactivation kinetics and depolarized inactivation voltage dependence. A complementary mutation located within the inactivation linker of Na(v)1.3 (K1453E) caused inactivation changes mirroring those caused by the K1826E mutation in Na(v)1.3. Therefore, we have identified a homologous carboxyl-terminal residue that regulates the kinetics and voltage dependence of fast inactivation in sodium channels, possibly via a charge-dependent interaction with the inactivation linker.	Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Goldin, AL (corresponding author), B240 Med Sci 1, Irvine, CA 92697 USA.	agoldin@uci.edu	Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	National Institutes of Health [NS26729, NS48336]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048336, R01NS026729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS26729 and NS48336.	Abriel H, 2001, CIRC RES, V88, P740, DOI 10.1161/hh0701.089668; An RH, 1998, CIRC RES, V83, P141, DOI 10.1161/01.RES.83.2.141; [Anonymous], [No title captured]; AULD VJ, 1988, NEURON, V1, P449, DOI 10.1016/0896-6273(88)90176-6; BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; Bendahhou S, 1999, J PHYSIOL-LONDON, V518, P337, DOI 10.1111/j.1469-7793.1999.0337p.x; BENNETT PB, 1995, NATURE, V376, P683, DOI 10.1038/376683a0; Bezzina C, 1999, CIRC RES, V85, P1206; Biswas S, 2008, J GEN PHYSIOL, V131, P197, DOI 10.1085/jgp.200709863; BRYSCH W, 1991, EXP BRAIN RES, V86, P562; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Chagot B, 2009, J BIOL CHEM, V284, P6436, DOI 10.1074/jbc.M807747200; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Clancy CE, 2002, CIRCULATION, V105, P1208, DOI 10.1161/hc1002.105183; Cormier JW, 2002, J BIOL CHEM, V277, P9233, DOI 10.1074/jbc.M110204200; Deschenes I, 2000, CARDIOVASC RES, V46, P55, DOI 10.1016/S0008-6363(00)00006-7; Deschenes I, 2002, CIRC RES, V90, pE49, DOI 10.1161/01.RES.0000012502.92751.E6; Deschenes I, 2001, J MEMBRANE BIOL, V183, P103, DOI 10.1007/s00232-001-0058-5; Felts PA, 1997, MOL BRAIN RES, V45, P71, DOI 10.1016/S0169-328X(96)00241-0; Fujiwara T, 2003, BRAIN, V126, P531, DOI 10.1093/brain/awg053; FURUYAMA T, 1993, MOL BRAIN RES, V17, P169, DOI 10.1016/0169-328X(93)90087-6; Glaaser IW, 2006, J BIOL CHEM, V281, P24015, DOI 10.1074/jbc.M605473200; GOLDIN AL, 1991, METHOD CELL BIOL, V36, P487; Green DS, 1998, J PHYSIOL-LONDON, V510, P685, DOI 10.1111/j.1469-7793.1998.685bj.x; Hains BC, 2002, J NEUROSCI RES, V70, P546, DOI 10.1002/jnr.10402; Hille B., 2001, ION CHANNELS EXCITAB, P75; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; JOHO RH, 1990, MOL BRAIN RES, V7, P105, DOI 10.1016/0169-328X(90)90087-T; Keating MT, 1996, SCIENCE, V272, P681, DOI 10.1126/science.272.5262.681; Kim J, 2004, J BIOL CHEM, V279, P45004, DOI 10.1074/jbc.M407286200; Kontis KJ, 1997, J GEN PHYSIOL, V110, P391, DOI 10.1085/jgp.110.4.391; Kuhn FJP, 1999, J GEN PHYSIOL, V114, P167, DOI 10.1085/jgp.114.2.167; Makita N, 1998, FEBS LETT, V423, P5, DOI 10.1016/S0014-5793(98)00033-7; Mantegazza M, 2001, P NATL ACAD SCI USA, V98, P15348, DOI 10.1073/pnas.211563298; Miloushev VZ, 2009, J BIOL CHEM, V284, P6446, DOI 10.1074/jbc.M807401200; Morgan K, 2000, P NATL ACAD SCI USA, V97, P2308, DOI 10.1073/pnas.030362197; Mori M, 2003, BIOCHEM BIOPH RES CO, V307, P290, DOI 10.1016/S0006-291X(03)01183-5; Mori M, 2000, BIOCHEMISTRY-US, V39, P1316, DOI 10.1021/bi9912600; Motoike HK, 2004, J GEN PHYSIOL, V123, P155, DOI 10.1085/jgp.200308929; Nabbout R, 2003, NEUROLOGY, V60, P1961, DOI 10.1212/01.WNL.0000069463.41870.2F; OLEARY ME, 1995, J GEN PHYSIOL, V106, P641, DOI 10.1085/jgp.106.4.641; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; PATTON DE, 1991, NEURON, V7, P637, DOI 10.1016/0896-6273(91)90376-B; Potet F, 2009, J BIOL CHEM, V284, P8846, DOI 10.1074/jbc.M806871200; Qu Y, 2001, MOL CELL NEUROSCI, V18, P570, DOI 10.1006/mcne.2001.1039; Rivolta I, 2001, J BIOL CHEM, V276, P30623, DOI 10.1074/jbc.M104471200; Shah VN, 2006, P NATL ACAD SCI USA, V103, P3592, DOI 10.1073/pnas.0507397103; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Splawski I, 2002, SCIENCE, V297, P1333, DOI 10.1126/science.1073569; Tan BH, 2007, CARDIOVASC RES, V76, P409, DOI 10.1016/j.cardiores.2007.08.006; Theoharis NT, 2008, BIOCHEMISTRY-US, V47, P112, DOI 10.1021/bi7013129; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; Veldkamp MW, 2000, CIRC RES, V86, pE91, DOI 10.1161/01.RES.86.9.e91; Wallace RH, 2001, AM J HUM GENET, V68, P859, DOI 10.1086/319516; WANG Q, 1995, HUM MOL GENET, V4, P1603, DOI 10.1093/hmg/4.9.1603; Wehrens XHT, 2000, CIRCULATION, V102, P584; Wingo TL, 2004, NAT STRUCT MOL BIOL, V11, P219, DOI 10.1038/nsmb737	59	18	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9077	9089		10.1074/jbc.M109.054940	http://dx.doi.org/10.1074/jbc.M109.054940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089854	Green Published, hybrid			2022-12-27	WOS:000275553700058
J	Swanson, MD; Winter, HC; Goldstein, IJ; Markovitz, DM				Swanson, Michael D.; Winter, Harry C.; Goldstein, Irwin J.; Markovitz, David M.			A Lectin Isolated from Bananas Is a Potent Inhibitor of HIV Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN GP120; INFECTIOUS MOLECULAR CLONE; HEPATITIS-C VIRUS; CYANOVIRIN-N; PLANT-LECTINS; CARBOHYDRATE-BINDING; ANTIBODY 2G12; IN-VITRO; V3 LOOP	BanLec is a jacalin-related lectin isolated from the fruit of bananas, Musa acuminata. This lectin binds to high mannose carbohydrate structures, including those found on viruses containing glycosylated envelope proteins such as human immunodeficiency virus type-1 (HIV-1). Therefore, we hypothesized that BanLec might inhibit HIV-1 through binding of the glycosylated HIV-1 envelope protein, gp120. We determined that BanLec inhibits primary and laboratory-adapted HIV-1 isolates of different tropisms and subtypes. BanLec possesses potent anti-HIV activity, with IC50 values in the low nanomolar to picomolar range. The mechanism for BanLec-mediated antiviral activity was investigated by determining if this lectin can directly bind the HIV-1 envelope protein and block entry of the virus into the cell. Anenzyme-linked immunosorbent assay confirmed direct binding of BanLec to gp120 and indicated that BanLec can recognize the high mannose structures that are recognized by the monoclonal antibody 2G12. Furthermore, BanLec is able to block HIV-1 cellular entry as indicated by temperature-sensitive viral entry studies and by the decreased levels of the strong-stop product of early reverse transcription seen in the presence of BanLec. Thus, our data indicate that BanLec inhibits HIV-1 infection by binding to the glycosylated viral envelope and blocking cellular entry. The relative anti-HIV activity of BanLec compared favorably to other anti-HIV lectins, such as snowdrop lectin and Griffithsin, and to T-20 and mara-viroc, two anti-HIV drugs currently in clinical use. Based on these results, BanLec is a potential component for an anti-viral microbicide that could be used to prevent the sexual transmission of HIV-1.	[Markovitz, David M.] Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA; [Swanson, Michael D.; Markovitz, David M.] Univ Michigan, Med Ctr, Program Immunol, Ann Arbor, MI 48109 USA; [Markovitz, David M.] Univ Michigan, Med Ctr, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA; [Winter, Harry C.; Goldstein, Irwin J.] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Markovitz, DM (corresponding author), Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, 5220 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	dmarkov@umich.edu			National Institutes of Health [R01 AI062248]; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062248] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI062248 (of D. M. M.). This work was also supported by a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; BACK NKT, 1994, VIROLOGY, V199, P431, DOI 10.1006/viro.1994.1141; BALZARINI J, 1991, ANTIMICROB AGENTS CH, V35, P410, DOI 10.1128/AAC.35.3.410; Balzarini J, 2004, ANTIMICROB AGENTS CH, V48, P3858, DOI 10.1128/AAC.48.10.3858-3870.2004; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Balzarini O, 2005, LANCET INFECT DIS, V5, P726, DOI 10.1016/S1473-3099(05)70271-1; Barrientos LG, 2004, J INFECT DIS, V189, P1440, DOI 10.1086/382658; Barrientos LG, 2003, ANTIVIR RES, V58, P47, DOI 10.1016/S0166-3542(02)00183-3; Bertaux C, 2007, VIROLOGY, V366, P40, DOI 10.1016/j.virol.2007.04.008; Boyd MR, 1997, ANTIMICROB AGENTS CH, V41, P1521, DOI 10.1128/AAC.41.7.1521; Buffa V, 2009, J GEN VIROL, V90, P234, DOI 10.1099/vir.0.004358-0; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; CHESEBRO B, 1991, J INFECT DIS, V163, P64, DOI 10.1093/infdis/163.1.64; CHESEBRO B, 1991, J VIROL, V65, P5782, DOI 10.1128/JVI.65.11.5782-5789.1991; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Clevestig P, 2006, J GEN VIROL, V87, P607, DOI 10.1099/vir.0.81510-0; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; Crosby R, 2005, J AM COLL HEALTH, V54, P143, DOI 10.3200/JACH.54.3.143-148; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gavrovic-Jankulovic M, 2008, INT J BIOCHEM CELL B, V40, P929, DOI 10.1016/j.biocel.2007.10.033; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; GEYER H, 1988, J BIOL CHEM, V263, P11760; Gray ES, 2007, J VIROL, V81, P10769, DOI 10.1128/JVI.01106-07; Gupta GR, 2002, BRIT MED J, V324, P183, DOI 10.1136/bmj.324.7331.183; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Jeyaprakash AA, 2004, J MOL BIOL, V338, P757, DOI 10.1016/j.jmb.2004.03.040; Keyaerts E, 2007, ANTIVIR RES, V75, P179, DOI 10.1016/j.antiviral.2007.03.003; KOSHTE VL, 1990, BIOCHEM J, V272, P721, DOI 10.1042/bj2720721; Kothe DL, 2006, VIROLOGY, V352, P438, DOI 10.1016/j.virol.2006.05.011; Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; Lis H., 2003, LECTINS; MATTHEWS TJ, 1987, P NATL ACAD SCI USA, V84, P5424, DOI 10.1073/pnas.84.15.5424; Meagher JL, 2005, GLYCOBIOLOGY, V15, P1033, DOI 10.1093/glycob/cwi088; Mkrtchyan SR, 2005, J VIROL, V79, P11161, DOI 10.1128/JVI.79.17.11161-11169.2005; Mo HQ, 2001, EUR J BIOCHEM, V268, P2609, DOI 10.1046/j.1432-1327.2001.02148.x; Mori T, 2005, J BIOL CHEM, V280, P9345, DOI 10.1074/jbc.M411122200; Nakamura-Tsuruta S, 2008, FEBS J, V275, P1227, DOI 10.1111/j.1742-4658.2008.06282.x; O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000; O'Keefe BR, 2009, P NATL ACAD SCI USA, V106, P6099, DOI 10.1073/pnas.0901506106; Peumans WJ, 2000, PLANTA, V211, P546, DOI 10.1007/s004250000307; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Randolph ME, 2007, ARCH SEX BEHAV, V36, P844, DOI 10.1007/s10508-007-9213-0; Saidi H, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-28; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Schmidtmayerova H, 1998, J VIROL, V72, P4633, DOI 10.1128/JVI.72.6.4633-4642.1998; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Singh DD, 2005, GLYCOBIOLOGY, V15, P1025, DOI 10.1093/glycob/cwi087; Smee DF, 2008, ANTIVIR RES, V80, P266, DOI 10.1016/j.antiviral.2008.06.003; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; TOOHEY K, 1995, VIROLOGY, V213, P70, DOI 10.1006/viro.1995.1547; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Tsai CC, 2003, AIDS RES HUM RETROV, V19, P535, DOI 10.1089/088922203322230897; Tsai CC, 2004, AIDS RES HUM RETROV, V20, P11, DOI 10.1089/088922204322749459; UNAIDS, 2008, REP GLOB AIDS EP; Underhill K, 2007, BMJ-BRIT MED J, V335, P248, DOI 10.1136/bmj.39245.446586.BE; VANDAMME EJM, 1987, FEBS LETT, V215, P140, DOI 10.1016/0014-5793(87)80129-1; Warrilow D, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-77; Warrilow D, 2008, J VIROL, V82, P1425, DOI 10.1128/JVI.01808-07; WATTS C, 2002, MICROBICIDES; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Witvrouw M, 2005, J VIROL, V79, P7777, DOI 10.1128/JVI.79.12.7777-7784.2005; Zappe H, 2008, ADV DRUG DELIVER REV, V60, P79, DOI 10.1016/j.addr.2007.05.016; Ziolkowska NE, 2006, STRUCTURE, V14, P1127, DOI 10.1016/j.str.2006.05.017	73	134	141	1	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8646	8655		10.1074/jbc.M109.034926	http://dx.doi.org/10.1074/jbc.M109.034926			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080975	hybrid, Green Published			2022-12-27	WOS:000275553700017
J	Zhao, PS; Nguyen, CH; Chidiac, P				Zhao, Peishen; Nguyen, Chau H.; Chidiac, Peter			The Proline-rich N-terminal Domain of G18 Exhibits a Novel G Protein Regulatory Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; DISSOCIATION INHIBITOR ACTIVITY; GUANINE-NUCLEOTIDE EXCHANGE; G-ALPHA SUBUNITS; GOLOCO MOTIF; STRUCTURAL DETERMINANTS; SIGNAL INTEGRATION; BINDING PROTEIN; RECEPTOR; PINS	The protein G18 (also known as AGS4 or GPSM3) contains three conserved GoLoco/GPR domains in its central and C-terminal regions that bind to inactive G alpha(i), whereas the N-terminal region has not been previously characterized. We investigated whether this domain might itself regulate G protein activity by assessing the abilities of G18 and mutants thereof to modulate the nucleotide binding and hydrolytic properties of G alpha(i1) and G alpha(o). Surprisingly, in the presence of fluoroaluminate (AlF4-) both G proteins bound strongly to full-length G18 (G18wt) and to its isolated N-terminal domain (G18 Delta C) but not to its GoLoco region (Delta NG18). Thus, it appears that its N-terminal domain promotes G18 binding to fluoroaluminate-activated G alpha(i/o). Neither G18wt nor any G18 mutant affected the GTPase activity of G alpha(i1) or G alpha(o). In contrast, complex effects were noted with respect to nucleotide binding. As inferred by the binding of [S-35]GTP gamma S (guanosine 5'-O-[gamma-thio]triphosphate) to G alpha(i1), the isolated GoLoco region as expected acted as a guanine nucleotide dissociation inhibitor, whereas the N-terminal region exhibited a previously unknown guanine nucleotide exchange factor effect on this G protein. On the other hand, the N terminus inhibited [S-35]GTP gamma S binding to G alpha(o), albeit to a lesser extent than the effect of the GoLoco region on G alpha(i1). Taken together, our results identify the N-terminal region of G18 as a novel G protein-interacting domain that may have distinct regulatory effects within the G(i/o) subfamily, and thus, it could potentially play a role in differentiating signals between these related G proteins.	[Chidiac, Peter] Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Chidiac, P (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada.	peter.chidiac@schulich.uwo.ca	Zhao, Peishen/AFQ-6840-2022; Chidiac, Peter/L-5906-2015	Chidiac, Peter/0000-0001-8365-6109	Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by the Canadian Institutes of Health Research. Holds a Career Investigator Award from the Heart and Stroke Foundation of Ontario.	Abramow-Newerly M, 2006, CELL SIGNAL, V18, P2209, DOI 10.1016/j.cellsig.2006.05.011; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Blumer JB, 2007, PHARMACOL THERAPEUT, V113, P488, DOI 10.1016/j.pharmthera.2006.11.001; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cao XQ, 2004, J BIOL CHEM, V279, P27567, DOI 10.1074/jbc.M312786200; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cladman W, 2002, MOL PHARMACOL, V62, P654, DOI 10.1124/mol.62.3.654; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Garbay C, 2000, BIOCHEM PHARMACOL, V60, P1165, DOI 10.1016/S0006-2952(00)00428-7; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh M, 2003, J BIOL CHEM, V278, P34747, DOI 10.1074/jbc.C300271200; Gruen JR, 2001, FRONT BIOSCI-LANDMRK, V6, pD960, DOI 10.2741/Gruen; Guo XZ, 2009, CELL RES, V19, P838, DOI 10.1038/cr.2009.54; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; HIGASHIJIMA T, 1990, J BIOL CHEM, V265, P14176; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Jordan JD, 1999, J BIOL CHEM, V274, P21507, DOI 10.1074/jbc.274.31.21507; Kerr DS, 2008, MOL CELL NEUROSCI, V38, P341, DOI 10.1016/j.mcn.2008.03.006; Kimple Randall J, 2002, Mol Interv, V2, P88, DOI 10.1124/mi.2.2.88; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Kinoshita-Kawada M, 2004, MOL BRAIN RES, V132, P73, DOI 10.1016/j.molbrainres.2004.09.007; Kopein D, 2009, MOL BIOL CELL, V20, P3865, DOI 10.1091/mbc.E09-01-0021; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Luo Y, 1999, J BIOL CHEM, V274, P10685, DOI 10.1074/jbc.274.16.10685; Mahon MJ, 2006, MOL ENDOCRINOL, V20, P136, DOI 10.1210/me.2005-0169; Mao H, 2004, J BIOL CHEM, V279, P26314, DOI 10.1074/jbc.M401800200; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Moulds JM, 2001, FRONT BIOSCI-LANDMRK, V6, pD986, DOI 10.2741/Moulds; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Oshiro T, 2002, J BIOL CHEM, V277, P38618, DOI 10.1074/jbc.M203453200; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; STRITTMATTER SM, 1991, J BIOL CHEM, V266, P22465; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Thomas CJ, 2008, J BIOL CHEM, V283, P23150, DOI 10.1074/jbc.M802422200; Watson N, 1996, NATURE, V383, P172, DOI 10.1038/383172a0; Willard FS, 2006, CELL SIGNAL, V18, P1226, DOI 10.1016/j.cellsig.2005.10.003; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Wiser O, 2006, NEURON, V50, P561, DOI 10.1016/j.neuron.2006.03.046; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505	52	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9008	9017		10.1074/jbc.M109.057174	http://dx.doi.org/10.1074/jbc.M109.057174			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097748	hybrid, Green Published			2022-12-27	WOS:000275553700052
J	Sridharan, H; Zhao, C; Krug, RM				Sridharan, Haripriya; Zhao, Chen; Krug, Robert M.			Species Specificity of the NS1 Protein of Influenza B Virus NS1 BINDS ONLY HUMAN AND NON-HUMAN PRIMATE UBIQUITIN-LIKE ISG15 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL MOLECULE; STIMULATED GENE-15; UBIQUITIN E2; ISG15; CONJUGATION; ENZYME; IDENTIFICATION; TARGETS; LIGASE; HERC5	Influenza B viruses, which cause a highly contagious respiratory disease every year, are restricted to humans, but the basis for this restriction had not been determined. Here we provide one explanation for this restriction: the species specificity exhibited by the NS1 protein of influenza B virus (NS1B protein). This viral protein combats a major host antiviral response by binding the interferon-alpha/beta-induced, ubiquitin-like ISG15 protein and inhibiting its conjugation to an array of proteins. We demonstrate that the NS1B protein exhibits species-specific binding; it binds human and non-human primate ISG15 but not mouse or canine ISG15. In both transfection assays and virus-infected cells, the NS1B protein binds and relocalizes only human and non-human primate ISG15 from the cytoplasm to nuclear speckles. Human and non-human primate ISG15 proteins consist of two ubiquitin-like domains separated by a short hinge linker of five amino acids. Remarkably, this short hinge plays a large role in the species-specific binding by the NS1B protein. The hinge of human and non-human primate ISG15, which has a sequence that differs from that of other mammalian ISG15 proteins, including mouse and canine ISG15, is absolutely required for binding the NS1B protein. Consequently, the ISG15 proteins of humans and non-human primates are the only mammalian ISG15 proteins that would bind NS1B.	[Sridharan, Haripriya; Zhao, Chen; Krug, Robert M.] Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Krug, RM (corresponding author), Univ Texas Austin, Sect Mol Genet & Microbiol, Inst Cellular & Mol Biol, 2500 Speedway,MBB 2-122, Austin, TX 78712 USA.	rkrug@mail.utexas.edu	Zhao, Chen/A-9987-2011		National Institutes of Health [AI11772]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI011772, R01AI011772] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI11772 (to R.M.K.).	[Anonymous], FIELDS VIROLOGY; Chang YG, 2008, J BIOL CHEM, V283, P13370, DOI 10.1074/jbc.M800162200; Dastur A, 2006, J BIOL CHEM, V281, P4334, DOI 10.1074/jbc.M512830200; Giannakopoulos NV, 2005, BIOCHEM BIOPH RES CO, V336, P496, DOI 10.1016/j.bbrc.2005.08.132; Guerra S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000096; Hoffmann E, 2002, P NATL ACAD SCI USA, V99, P11411, DOI 10.1073/pnas.172393399; Hsiang TY, 2009, J VIROL, V83, P5971, DOI 10.1128/JVI.01667-08; Huber VC, 2008, VACCINE, V26, P5381, DOI 10.1016/j.vaccine.2008.07.086; Kim KI, 2004, MOL CELL BIOL, V24, P9592, DOI 10.1128/MCB.24.21.9592-9600.2004; Lai C, 2009, J VIROL, V83, P1147, DOI 10.1128/JVI.00105-08; Lamb R.A., 2001, FIELDS VIROLOGY, P1487; Lenschow DJ, 2007, P NATL ACAD SCI USA, V104, P1371, DOI 10.1073/pnas.0607038104; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Malakhova OA, 2008, J BIOL CHEM, V283, P8783, DOI 10.1074/jbc.C800030200; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Okumura A, 2006, P NATL ACAD SCI USA, V103, P1440, DOI 10.1073/pnas.0510518103; Okumura A, 2008, P NATL ACAD SCI USA, V105, P3974, DOI 10.1073/pnas.0710629105; Schneider J, 2009, J VIROL, V83, P701, DOI 10.1128/JVI.01858-08; Wong JJY, 2006, P NATL ACAD SCI USA, V103, P10735, DOI 10.1073/pnas.0600397103; Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhao C, 2005, P NATL ACAD SCI USA, V102, P10200, DOI 10.1073/pnas.0504754102	23	56	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7852	7856		10.1074/jbc.C109.095703	http://dx.doi.org/10.1074/jbc.C109.095703			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20093371	Green Published, hybrid			2022-12-27	WOS:000275413800002
J	Gregory, KJ; Hall, NE; Tobin, AB; Sexton, PM; Christopoulos, A				Gregory, Karen J.; Hall, Nathan E.; Tobin, Andrew B.; Sexton, Patrick M.; Christopoulos, Arthur			Identification of Orthosteric and Allosteric Site Mutations in M-2 Muscarinic Acetylcholine Receptors That Contribute to Ligand-selective Signaling Bias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND EXTRACELLULAR LOOP; CONSERVED DISULFIDE BOND; TRANSMEMBRANE DOMAIN; CONFORMATIONAL-CHANGES; AMINO-ACIDS; SCANNING MUTAGENESIS; DIRECTED MUTAGENESIS; SUBTYPE SELECTIVITY; FUNCTIONAL SELECTIVITY; N-DESMETHYLCLOZAPINE	Muscarinic acetylcholine receptors contain at least one allosteric site that is topographically distinct from the acetylcholine, orthosteric binding site. Although studies have investigated the basis of allosteric modulation at these receptors, less is known about putative allosteric ligands that activate the receptor in their own right. We generated M-2 muscarinic acetylcholine receptor mutations in either the orthosteric site in transmembrane helices 3 and 6 (TM3 and -6) or part of an allosteric site involving the top of TM2, the second extracellular (E2) loop, and the top of TM7 and investigated their effects on the binding and function of the novel selective (putative allosteric) agonists (AC-42 (4-n-butyl-1-(4-(2-methylphenyl)-4-oxo-1-butyl) piperidine HCl), 77-LH-28-1 (1-(3-(4-butyl-1-piperidinyl)propyl)-3,3-dihydro-2(1H)-quinolinone), and N-desmethylclozapine) as well as the bitopic orthosteric/allosteric ligand, McN-A-343 (4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethylammonium). Four classes of agonists were identified, depending on their response to the mutations, suggesting multiple, distinct modes of agonist-receptor interaction. Interestingly, with the exception of 77-LH-28-1, allosteric site mutations had no effect on the affinity of any of the agonists tested, but some mutations in the E2 loop influenced the efficacy of both orthosteric and novel selective agonists, highlighting a role for this region of the receptor in modulating activation status. Two point mutations (Y104(3.33)A (Ballesteros and Weinstein numbers in superscript) in the orthosteric and Y177A in the allosteric site) unmasked ligand-selective and signaling pathway-selective effects, providing evidence for the existence of pathway-specific receptor conformations. Molecular modeling of 77-LH-28-1 and N-desmethylclozapine yielded novel binding poses consistent with the possibility that the functional selectivity of such agents may arise from a bitopic mechanism.	[Gregory, Karen J.; Hall, Nathan E.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Gregory, Karen J.; Hall, Nathan E.; Sexton, Patrick M.; Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Tobin, Andrew B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England	Monash University; Monash University; University of Leicester	Christopoulos, A (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, 399 Royal Pde, Parkville, Vic 3052, Australia.	arthur.christopoulos@med.monash.edu.au	Sexton, Patrick M/B-1319-2008; Christopoulos, Arthur/B-6207-2013	Sexton, Patrick M/0000-0001-8902-2473; Christopoulos, Arthur/0000-0003-4442-3294; Gregory, Karen/0000-0002-3833-2137; Hall, Nathan/0000-0001-8942-0498	National Health and Medical Research Council (NHMRC) of Australia [519461]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) of Australia Program Grant 519461.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Allman K, 2000, MOL PHARMACOL, V58, P175, DOI 10.1124/mol.58.1.175; Antony J, 2009, FASEB J, V23, P442, DOI 10.1096/fj.08-114751; Avlani V, 2004, J PHARMACOL EXP THER, V308, P1062, DOI 10.1124/jpet.103.059840; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; BAIG A, 2005, P BR PHARM SOC, V3, pP119; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BLACK JW, 1983, PROC R SOC SER B-BIO, V220, P141, DOI 10.1098/rspb.1983.0093; BLUML K, 1994, J BIOL CHEM, V269, P18870; Buller S, 2002, MOL PHARMACOL, V61, P160, DOI 10.1124/mol.61.1.160; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christopoulos A, 1998, TRENDS PHARMACOL SCI, V19, P351, DOI 10.1016/S0165-6147(98)01240-1; CLARK AL, 1976, BRIT J PHARMACOL, V58, P323, DOI 10.1111/j.1476-5381.1976.tb07708.x; CURTIS CAM, 1989, J BIOL CHEM, V264, P489; DAVIDSON FF, 1994, P NATL ACAD SCI USA, V91, P4029, DOI 10.1073/pnas.91.9.4029; Eglen RM, 2001, TRENDS PHARMACOL SCI, V22, P409, DOI 10.1016/S0165-6147(00)01737-5; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; ELLIS J, 1993, MOL PHARMACOL, V44, P583; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Gether U, 1997, EMBO J, V16, P6737, DOI 10.1093/emboj/16.22.6737; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Gnagey AL, 1999, MOL PHARMACOL, V56, P1245, DOI 10.1124/mol.56.6.1245; Gregory KJ, 2007, CURR NEUROPHARMACOL, V5, P157, DOI 10.2174/157015907781695946; Han SJ, 2005, J BIOL CHEM, V280, P24870, DOI 10.1074/jbc.M500379200; Heitz F, 1999, EUR J PHARMACOL, V380, P183, DOI 10.1016/S0014-2999(99)00439-2; HILF G, 1992, CELL SIGNAL, V4, P787, DOI 10.1016/0898-6568(92)90059-H; Hoffmann C, 1999, J BIOL CHEM, V274, P14639, DOI 10.1074/jbc.274.21.14639; Holst B, 2009, MOL PHARMACOL, V75, P44, DOI 10.1124/mol.108.049189; Huang XP, 2007, MOL PHARMACOL, V71, P759, DOI 10.1124/mol.106.028944; Huang XP, 2005, MOL PHARMACOL, V68, P769, DOI 10.1124/mol.105.014043; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Hulme EC, 2003, RECEPTOR CHANNEL, V9, P215, DOI 10.1080/10606820308261; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; JAKUBIK J, 1995, J PHARMACOL EXP THER, V274, P1077; Javitch JA, 1997, J BIOL CHEM, V272, P18546, DOI 10.1074/jbc.272.30.18546; Jones CK, 2008, J NEUROSCI, V28, P10422, DOI 10.1523/JNEUROSCI.1850-08.2008; Klco JM, 2005, NAT STRUCT MOL BIOL, V12, P320, DOI 10.1038/nsmb913; Kleinau G, 2007, J BIOL CHEM, V282, P518, DOI 10.1074/jbc.M606176200; Langmead CJ, 2008, BRIT J PHARMACOL, V154, P1104, DOI 10.1038/bjp.2008.152; Langmead CJ, 2006, TRENDS PHARMACOL SCI, V27, P475, DOI 10.1016/j.tips.2006.07.009; Langmead CJ, 2006, MOL PHARMACOL, V69, P236, DOI 10.1124/mol.105.017814; Lanzafame AA, 2003, RECEPTOR CHANNEL, V9, P241, DOI 10.1080/10606820390217078; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; LEACH K, 2010, NEUROPSYCHO IN PRESS; Lebon G, 2009, MOL PHARMACOL, V75, P331, DOI 10.1124/mol.108.050963; LEPPIK RA, 1994, MOL PHARMACOL, V45, P983; Li JH, 2007, J BIOL CHEM, V282, P26284, DOI 10.1074/jbc.M704875200; Lu ZL, 2001, J BIOL CHEM, V276, P34098, DOI 10.1074/jbc.M104217200; Lu ZL, 1999, J BIOL CHEM, V274, P7309, DOI 10.1074/jbc.274.11.7309; LULLMANN H, 1969, EUR J PHARMACOL, V6, P241, DOI 10.1016/0014-2999(69)90181-2; MATSUI H, 1995, MOL PHARMACOL, V47, P88; May LT, 2007, MOL PHARMACOL, V72, P463, DOI 10.1124/mol.107.037630; Nawaratne V, 2008, MOL PHARMACOL, V74, P1119, DOI 10.1124/mol.108.049353; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Proska J, 1996, EUR J PHARMACOL, V305, P201, DOI 10.1016/0014-2999(96)00169-0; Scarselli M, 2007, J BIOL CHEM, V282, P7385, DOI 10.1074/jbc.M610394200; SCHWARZ RD, 1995, LIFE SCI, V56, P923, DOI 10.1016/0024-3205(95)00029-6; Spalding TA, 2002, MOL PHARMACOL, V61, P1297, DOI 10.1124/mol.61.6.1297; Spalding TA, 1998, J BIOL CHEM, V273, P21563, DOI 10.1074/jbc.273.34.21563; Spalding TA, 2006, MOL PHARMACOL, V70, P1974, DOI 10.1124/mol.106.024901; STRADER CD, 1988, J BIOL CHEM, V263, P10267; Sur C, 2003, P NATL ACAD SCI USA, V100, P13674, DOI 10.1073/pnas.1835612100; Trankle C, 1999, MOL PHARMACOL, V56, P962, DOI 10.1124/mol.56.5.962; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; TUCEK S, 1990, MOL PHARMACOL, V38, P674; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Valant C, 2009, MOL INTERV, V9, P125, DOI 10.1124/mi.9.3.6; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Ward SDC, 2002, J BIOL CHEM, V277, P2247, DOI 10.1074/jbc.M107647200; Ward SDC, 1999, MOL PHARMACOL, V56, P1031, DOI 10.1124/mol.56.5.1031; Ward SDC, 2006, BIOCHEMISTRY-US, V45, P676, DOI 10.1021/bi051503q; Werry TD, 2005, J NEUROCHEM, V93, P1603, DOI 10.1111/j.1471-4159.2005.03161.x; Werry TD, 2006, CURR PHARM DESIGN, V12, P1683, DOI 10.2174/138161206776873725; WESS J, 1991, EMBO J, V10, P3729, DOI 10.1002/j.1460-2075.1991.tb04941.x; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; Zahn K, 2002, J PHARMACOL EXP THER, V301, P720, DOI 10.1124/jpet.301.2.720	80	125	128	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7459	7474		10.1074/jbc.M109.094011	http://dx.doi.org/10.1074/jbc.M109.094011			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051519	Green Published, hybrid			2022-12-27	WOS:000275415600058
J	Varela, D; Penna, A; Simon, F; Eguiguren, AL; Leiva-Salcedo, E; Cerda, O; Sala, F; Stutzin, A				Varela, Diego; Penna, Antonello; Simon, Felipe; Luisa Eguiguren, Ana; Leiva-Salcedo, Elias; Cerda, Oscar; Sala, Francisco; Stutzin, Andres			P2X4 Activation Modulates Volume-sensitive Outwardly Rectifying Chloride Channels in Rat Hepatoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED ANION CHANNELS; ATP RELEASE; PURINERGIC RECEPTORS; AGONIST BINDING; CA2+; KINASE; EFFLUX; CONTRIBUTES; MECHANISM; APOPTOSIS	Volume-sensitive outwardly rectifying (VSOR) Cl- channels are critical for the regulatory volume decrease (RVD) response triggered upon cell swelling. Recent evidence indicates that H2O2 plays an essential role in the activation of these channels and that H2O2 per se activates the channels under isotonic iso-volumic conditions. However, a significant difference in the time course for current onset between H2O2-induced and hypotonicity-mediated VSOR Cl- activation is observed. In several cell types, cell swelling induced by hypotonic challenges triggers the release of ATP to the extracellular medium, which in turn, activates purinergic receptors and modulates cell volume regulation. In this study, we have addressed the effect of purinergic receptor activation on H2O2-induced and hypotonicity-mediated VSOR Cl- current activation. Here we show that rat hepatoma cells (HTC) exposed to a 33% hypotonic solution responded by rapidly activating VSOR Cl- current and releasing ATP to the extracellular medium. In contrast, cells exposed to 200 mu M H2O2 VSOR Cl- current onset was significantly slower, and ATP release was not detected. In cells exposed to either 11% hypotonicity or 200 mu M H2O2, exogenous addition of ATP in the presence of extracellular Ca2+ resulted in a decrease in the half-time for VSOR Cl- current onset. Conversely, in cells that overexpress a dominant-negative mutant of the ionotropic receptor P2X4 challenged with a 33% hypotonic solution, the half-time for VSOR Cl- current onset was significantly slowed down. Our results indicate that, at high hypotonic imbalances, swelling-induced ATP release activates the purinergic receptor P2X4, which in turn modulates the time course of VSOR Cl- current onset in a extracellular Ca2+-dependent manner.	[Stutzin, Andres] Univ Chile, CEMC, Fac Med, Santiago 8380453, Chile; [Simon, Felipe] Univ Andres Bello, Dept Ciencias Biol, Fac Ciencias Biol, Santiago 8370134, Chile; [Simon, Felipe] Univ Andres Bello, Fac Med, Santiago 8370134, Chile; [Sala, Francisco] Univ Miguel Hernandez, Inst Neurociencias Alicante, CSIC, St Joan Dalcant, Spain; [Stutzin, Andres] Univ Chile, ICBM, Fac Med, Santiago 8380453, Chile	Universidad de Chile; Universidad Andres Bello; Universidad Andres Bello; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Universidad de Chile	Varela, D (corresponding author), Univ Chile, CEMC, Fac Med, Santiago 8380453, Chile.	dvarela@bitmed.med.uchile.cl	Penna, Antonello/O-6694-2019; Varela, Diego/AAG-7489-2019; Stutzin, Andrés/I-7605-2013; Cerda, Oscar/N-3895-2018	Penna, Antonello/0000-0002-8626-4415; Varela, Diego/0000-0002-9352-414X; Stutzin, Andrés/0000-0002-7264-066X; Cerda, Oscar/0000-0003-2873-5722; Simon, Felipe/0000-0002-2653-9798; Sala, Francisco/0000-0002-2080-7683	FONDAP-Fondecyt, Chile [15010006]	FONDAP-Fondecyt, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP)	This work was supported by FONDAP-Fondecyt 15010006, Chile.	ALVAREZLEEFMANS FJ, 1995, METH NEUROSCI, V27, P361; Barriere H, 2003, J MEMBRANE BIOL, V193, P153, DOI 10.1007/s00232-003-2014-z; Cheema TA, 2007, J PHARMACOL EXP THER, V320, P1068, DOI 10.1124/jpet.106.115741; Crepel V, 1998, J NEUROSCI, V18, P1196; Darby M, 2003, J NEUROPHYSIOL, V89, P1870, DOI 10.1152/jn.00510.2002; Emmett DS, 2008, HEPATOLOGY, V47, P698, DOI 10.1002/hep.22035; Feranchak AP, 1998, J BIOL CHEM, V273, P14906, DOI 10.1074/jbc.273.24.14906; Fernandez-Fernandez JM, 2002, AM J PHYSIOL-CELL PH, V283, pC1705, DOI 10.1152/ajpcell.00245.2002; Fitz J Gregory, 2007, Trans Am Clin Climatol Assoc, V118, P199; Friis MB, 2005, J PHYSIOL-LONDON, V567, P427, DOI 10.1113/jphysiol.2005.087130; Gatof D, 2004, AM J PHYSIOL-GASTR L, V286, pG538, DOI 10.1152/ajpgi.00355.2003; Hazama A, 1999, J GEN PHYSIOL, V114, P525, DOI 10.1085/jgp.114.4.525; Hisadome K, 2002, J GEN PHYSIOL, V119, P511, DOI 10.1085/jgp.20028540; Hoffmann EK, 2000, CELL PHYSIOL BIOCHEM, V10, P273, DOI 10.1159/000016356; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; IWATA K, 1995, J CHROMATOGR B, V667, P339, DOI 10.1016/0378-4347(95)00042-H; Junankar PR, 2002, J BIOL CHEM, V277, P40324, DOI 10.1074/jbc.M204712200; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; MCCARTY NA, 1992, PHYSIOL REV, V72, P1037, DOI 10.1152/physrev.1992.72.4.1037; Mongin AA, 2005, AM J PHYSIOL-CELL PH, V288, pC204, DOI 10.1152/ajpcell.00330.2004; Moore AL, 2002, J BIOL CHEM, V277, P34030, DOI 10.1074/jbc.M205945200; Mori S, 2002, BRAIN RES, V957, P1, DOI 10.1016/S0006-8993(02)03574-6; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Nilius B, 1999, J PHYSIOL-LONDON, V516, P67, DOI 10.1111/j.1469-7793.1999.067aa.x; Okada Y, 2001, J PHYSIOL-LONDON, V532, P3, DOI 10.1111/j.1469-7793.2001.0003g.x; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Pedersen SF, 1998, J MEMBRANE BIOL, V163, P97, DOI 10.1007/s002329900374; Chaves LAP, 2008, PFLUG ARCH EUR J PHY, V457, P493, DOI 10.1007/s00424-008-0525-2; Roe MW, 2001, J BIOL CHEM, V276, P30871, DOI 10.1074/jbc.M102362200; Roman RM, 1999, AM J PHYSIOL-GASTR L, V276, pG1391, DOI 10.1152/ajpgi.1999.276.6.G1391; Shen MR, 2000, J PHYSIOL-LONDON, V529, P385, DOI 10.1111/j.1469-7793.2000.00385.x; Shi CJ, 1999, J PHYSIOL-LONDON, V521, P57, DOI 10.1111/j.1469-7793.1999.00057.x; Shimizu T, 2004, P NATL ACAD SCI USA, V101, P6770, DOI 10.1073/pnas.0401604101; Stutzin A, 2006, ACTA PHYSIOL, V187, P27, DOI 10.1111/j.1748-1716.2006.01537.x; Stutzin A, 1999, AM J PHYSIOL-CELL PH, V277, pC392, DOI 10.1152/ajpcell.1999.277.3.C392; Stutzin A, 1997, AM J PHYSIOL-CELL PH, V273, pC999, DOI 10.1152/ajpcell.1997.273.3.C999; Szabo I, 1998, P NATL ACAD SCI USA, V95, P6169, DOI 10.1073/pnas.95.11.6169; Szucs G, 1996, PFLUG ARCH EUR J PHY, V431, P467, DOI 10.1007/s004240050023; THOMPSON EB, 1966, P NATL ACAD SCI USA, V56, P296, DOI 10.1073/pnas.56.1.296; TILLY BC, 1994, AM J PHYSIOL-CELL PH, V267, pC1271, DOI 10.1152/ajpcell.1994.267.5.C1271; Varela D, 2004, ADV EXP MED BIOL, V559, P141; Varela D, 2004, J BIOL CHEM, V279, P13301, DOI 10.1074/jbc.C400020200; Varela D, 2002, J PHYSIOL-LONDON, V544, P363, DOI 10.1113/jphysiol.2002.026096; Varela D, 2007, CELL PHYSIOL BIOCHEM, V20, P773, DOI 10.1159/000110437; Vazquez-Juarez E, 2008, PFLUG ARCH EUR J PHY, V455, P859, DOI 10.1007/s00424-007-0343-y; Voets T, 1999, P NATL ACAD SCI USA, V96, P5298, DOI 10.1073/pnas.96.9.5298; Wang Y, 1996, P NATL ACAD SCI USA, V93, P12020, DOI 10.1073/pnas.93.21.12020; Yan ZH, 2005, MOL PHARMACOL, V67, P1078, DOI 10.1124/mol.104.010108; Yan ZH, 2006, J BIOL CHEM, V281, P32649, DOI 10.1074/jbc.M512791200; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x	51	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7566	7574		10.1074/jbc.M109.063693	http://dx.doi.org/10.1074/jbc.M109.063693			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056605	hybrid, Green Published			2022-12-27	WOS:000275415600068
J	Cha, SK; Huang, CL				Cha, Seung-Kuy; Huang, Chou-Long			WNK4 Kinase Stimulates Caveola-mediated Endocytosis of TRPV5 Amplifying the Dynamic Range of Regulation of the Channel by Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPERKALEMIC HYPERTENSION; CA2+ REABSORPTION; MOLECULAR PATHOGENESIS; PARATHYROID-HORMONE; COORDINATED CONTROL; TISSUE KALLIKREIN; PLASMA-MEMBRANE; ADAPTER PROTEIN; EPS15 HOMOLOGY; BLOOD-PRESSURE	WNK4 (with-no-lysine (K) kinase-4) is present in the distal nephron of the kidney and plays an important role in the regulation of renal ion transport. The epithelial Ca2+ channel TRPV5 (transient receptor potential vanilloid 5) is the gatekeeper of transcellular Ca2+ reabsorption in the distal nephron. Previously, we reported that activation of protein kinase C (PKC) increases cell-surface abundance of TRPV5 by inhibiting caveola-mediated endocytosis of the channel. Here, we report that WNK4 decreases cell-surface abundance of TRPV5 by enhancing its endocytosis. Deletion analysis revealed that stimulation of endocytosis of TRPV5 involves amino acids outside the kinase domain of WNK4. We also investigated interplay between WNK4 and PKC regulation of TRPV5. The maximal level of TRPV5 current density stimulated by the PKC activator 1-oleoyl-acetyl-sn- glycerol (OAG) is the same with or without WNK4. The relative increase of TRPV5 current stimulated by OAG, however, is greater in the presence of WNK4 compared with that without WNK4 (similar to 215% increase versus 60% increase above the level without OAG). Moreover, the rate of increase of TRPV5 by OAG is faster with WNK4 than without WNK4. The enhanced increase of TRPV5 in the presence of WNK4 is also observed when PKC is activated by parathyroid hormones. Thus, WNK4 exerts tonic inhibition of TRPV5 by stimulating caveola-mediated endocytosis. The lower basal TRPV5 level in the presence of WNK4 allows amplification of the stimulation of channel by PKC. This interaction between WNK4 and PKC regulation of TRPV5 may be important for physiological regulation of renal Ca2+ reabsorption by parathyroid hormones or the tissue kallikrein in vivo.	[Cha, Seung-Kuy; Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, Dallas, TX 75390 USA; [Huang, Chou-Long] Univ Texas SW Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Huang, CL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Div Nephrol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	chou-long.huang@utsouthwestern.edu			National Institutes of Health [DK-20543, DK-85726]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085726, P01DK020543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK-20543 and DK-85726.	Achard JM, 2003, AM J MED, V114, P495, DOI 10.1016/S0002-9343(03)00054-8; BHOOLA KD, 1992, PHARMACOL REV, V44, P1; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; Deal C, 2003, CLEV CLIN J MED, V70, P585, DOI 10.3949/ccjm.70.7.585; Delaloy C, 2003, MOL CELL BIOL, V23, P9208, DOI 10.1128/MCB.23.24.9208-9221.2003; Ellison DH, 2003, J AM SOC NEPHROL, V14, P538, DOI 10.1681/ASN.V142538; FIGUEROA CD, 1988, HISTOCHEMISTRY, V89, P437, DOI 10.1007/BF00492599; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; He GC, 2007, J CLIN INVEST, V117, P1078, DOI 10.1172/JCI30087; Hecquet C, 2000, MOL PHARMACOL, V58, P828, DOI 10.1124/mol.58.4.828; Hoenderop JGJ, 1999, KIDNEY INT, V55, P225, DOI 10.1046/j.1523-1755.1999.00228.x; Hoenderop JGJ, 2002, ANNU REV PHYSIOL, V64, P529, DOI 10.1146/annurev.physiol.64.081501.155921; Holden S, 2004, GENE, V335, P109, DOI 10.1016/j.gene.2004.03.009; Huang CL, 2008, CURR OPIN NEPHROL HY, V17, P519, DOI 10.1097/MNH.0b013e32830dd580; Jiang Y, 2008, BIOCHEM BIOPH RES CO, V375, P225, DOI 10.1016/j.bbrc.2008.08.010; Jiang Y, 2007, AM J PHYSIOL-RENAL, V292, pF545, DOI 10.1152/ajprenal.00187.2006; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kahle KT, 2004, P NATL ACAD SCI USA, V101, P2064, DOI 10.1073/pnas.0308434100; Kahle KT, 2003, NAT GENET, V35, P372, DOI 10.1038/ng1271; Klein IK, 2009, J BIOL CHEM, V284, P25953, DOI 10.1074/jbc.M109.035071; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Lalioti MD, 2006, NAT GENET, V38, P1124, DOI 10.1038/ng1877; Lambers TT, 2006, KIDNEY INT, V69, P650, DOI 10.1038/sj.ki.5000169; Lazrak A, 2006, P NATL ACAD SCI USA, V103, P1615, DOI 10.1073/pnas.0510609103; Mayan H, 2004, J CLIN ENDOCR METAB, V89, P4025, DOI 10.1210/jc.2004-0037; McMahon KA, 2009, EMBO J, V28, P1001, DOI 10.1038/emboj.2009.46; O'Reilly M, 2003, J AM SOC NEPHROL, V14, P2447, DOI 10.1097/01.ASN.0000089830.97681.3B; Predescu SA, 2003, MOL BIOL CELL, V14, P4997, DOI 10.1091/mbc.e03-01-0041; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; SCHAMBELAN M, 1981, KIDNEY INT, V19, P716, DOI 10.1038/ki.1981.72; Sengar AS, 1999, EMBO J, V18, P1159, DOI 10.1093/emboj/18.5.1159; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; van Abel M, 2005, KIDNEY INT, V68, P1708, DOI 10.1111/j.1523-1755.2005.00587.x; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wilson FH, 2003, P NATL ACAD SCI USA, V100, P680, DOI 10.1073/pnas.242735399; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Yamabhai M, 1998, J BIOL CHEM, V273, P31401, DOI 10.1074/jbc.273.47.31401; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Yang SS, 2007, CELL METAB, V5, P331, DOI 10.1016/j.cmet.2007.03.009	44	29	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6604	6611		10.1074/jbc.M109.056044	http://dx.doi.org/10.1074/jbc.M109.056044			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20061383	Green Published, hybrid			2022-12-27	WOS:000275367500065
J	Kumawat, K; Pathak, SK; Spetz, AL; Kundu, M; Basu, J				Kumawat, Kuldeep; Pathak, Sushil Kumar; Spetz, Anna-Lena; Kundu, Manikuntala; Basu, Joyoti			Exogenous Nef Is an Inhibitor of Mycobacterium tuberculosis-induced Tumor Necrosis Factor-alpha Production and Macrophage Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-SURFACE EXPRESSION; HUMAN MONOCYTIC CELLS; HIV-1 NEF; GENE-EXPRESSION; DOWN-REGULATION; T-CELLS; C-JUN; HUMAN MONOCYTES/MACROPHAGES; TRANSCRIPTION FACTORS	Human immunodeficiency virus-1 (HIV-1) impairs tumor necrosis factor-alpha (TNF-alpha)-mediated macrophage apoptosis induced by Mycobacterium tuberculosis (Mtb). HIV Nef protein plays an important role in the pathogenesis of AIDS. We have tested the hypothesis that exogenous Nef is a factor that inhibits TNF-alpha production/apoptosis in macrophages infected with Mtb. We demonstrate that Mtb and Nef individually trigger TNF-alpha production in macrophages. However, TNF-alpha production is dampened when the two are present simultaneously, probably through cross-regulation of the individual signaling pathways leading to activation of the TNF-alpha promoter. Mtb induced TNF-alpha production is abrogated upon mutation of the Ets, Egr, Sp1, CRE, or AP1 binding sites on the TNF-alpha promoter, whereas Nef-mediated promoter activation depends only on the CRE and AP1 binding sites, pointing to differences in the mechanisms of activation of the promoter. Mtb-dependent promoter activation depends on the mitogen-activated kinase (MAPK) kinase kinase ASK1 and on MEK/ERK signaling. Nef inhibits ASK1/p38 MAPK-dependent Mtb-induced TNF-alpha production probably by inhibiting binding of ATF2 to the TNF-alpha promoter. It also inhibits MEK/ERK-dependent Mtb-induced binding of FosB to the promoter. Nef-driven TNF-alpha production occurs in an ASK1-independent, Rac1/PAK1/p38 MAPK-dependent, and MEK/ERK-independent manner. The signaling pathways used by Mtb and Nef to trigger TNF-alpha production are therefore distinctly different. In addition to attenuating Mtb-dependent TNF-alpha promoter activation, Nef also reduces Mtb-dependent TNF-alpha mRNA stability probably through its ability to inhibit ASK1/p38 MAPK signaling. These results provide new insight into how HIV Nef probably exacerbates tuberculosis infection by virtue of its ability to dampen Mtb-induced TNF-alpha production.	[Kumawat, Kuldeep; Pathak, Sushil Kumar; Kundu, Manikuntala; Basu, Joyoti] Bose Inst, Dept Chem, Kolkata 700009, India; [Spetz, Anna-Lena] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Huddinge, Sweden	Department of Science & Technology (India); Bose Institute; Karolinska Institutet; Karolinska University Hospital	Basu, J (corresponding author), Bose Inst, Dept Chem, 93-1 APC Rd, Kolkata 700009, India.	joyoti@vsnl.com	Spetz, Anna-Lena/C-3543-2016	Spetz, Anna-Lena/0000-0003-3964-9512	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by a grant from the Swedish Research Council (to J.B. and A.-L.S.).	Barthel R, 2003, MOL CELL BIOL, V23, P526, DOI 10.1128/MCB.23.2.526-533.2003; Basak C, 2005, J BIOL CHEM, V280, P4279, DOI 10.1074/jbc.M412820200; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Brambilla A, 1999, VIROLOGY, V259, P349, DOI 10.1006/viro.1999.9783; Brook M, 2000, FEBS LETT, V483, P57, DOI 10.1016/S0014-5793(00)02084-6; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Chaudhry A, 2005, J IMMUNOL, V175, P4566, DOI 10.4049/jimmunol.175.7.4566; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; de Jong BC, 2004, ANNU REV MED, V55, P283, DOI 10.1146/annurev.med.55.091902.103753; Dean JLE, 2003, J BIOL CHEM, V278, P39470, DOI 10.1074/jbc.M306345200; Falvo JV, 2000, MOL CELL BIOL, V20, P2239, DOI 10.1128/MCB.20.6.2239-2247.2000; Federico M, 2001, BLOOD, V98, P2752, DOI 10.1182/blood.V98.9.2752; Fujii Y, 1996, FEBS LETT, V393, P93, DOI 10.1016/0014-5793(96)00859-9; Geist LJ, 1997, AM J RESP CELL MOL, V16, P31, DOI 10.1165/ajrcmb.16.1.8998076; Geleziunas R, 2001, NATURE, V410, P834, DOI 10.1038/35071111; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Greenway AL, 2003, J BIOSCIENCES, V28, P323, DOI 10.1007/BF02970151; Hayashi N, 2002, PROTEIN SCI, V11, P529, DOI 10.1110/ps.23702; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Hung CH, 2007, CELL HOST MICROBE, V1, P121, DOI 10.1016/j.chom.2007.03.004; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Kundu M, 2009, NAT IMMUNOL, V10, P918, DOI 10.1038/ni.1754; Lama J, 1999, CURR BIOL, V9, P622, DOI 10.1016/S0960-9822(99)80284-X; Ma W, 2009, J BIOL CHEM, V284, P7578, DOI 10.1074/jbc.M710013200; Mahlknecht U, 2001, TRENDS IMMUNOL, V22, P256, DOI 10.1016/S1471-4906(01)01898-1; Maiti D, 2001, J BIOL CHEM, V276, P329, DOI 10.1074/jbc.M002650200; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Matsukawa J, 2004, J BIOCHEM, V136, P261, DOI 10.1093/jb/mvh134; Michel N, 2005, CURR BIOL, V15, P714, DOI 10.1016/j.cub.2005.02.058; MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101; Muratori C, 2009, CELL HOST MICROBE, V6, P218, DOI 10.1016/j.chom.2009.06.009; NEWELL CL, 1994, J LEUKOCYTE BIOL, V56, P27, DOI 10.1002/jlb.56.1.27; Novotny V, 1998, NUCLEIC ACIDS RES, V26, P5480, DOI 10.1093/nar/26.23.5480; Nunn P, 2005, NAT REV IMMUNOL, V5, P819, DOI 10.1038/nri1704; Olivetta E, 2006, EXP CELL RES, V312, P890, DOI 10.1016/j.yexcr.2005.12.003; Olivetta E, 2003, J IMMUNOL, V170, P1716, DOI 10.4049/jimmunol.170.4.1716; PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0; Patel NR, 2007, J IMMUNOL, V179, P6973, DOI 10.4049/jimmunol.179.10.6973; Pathak SK, 2005, J BIOL CHEM, V280, P42794, DOI 10.1074/jbc.M506471200; POPE RM, 1994, J CLIN INVEST, V94, P1449, DOI 10.1172/JCI117482; Qiao XG, 2006, NAT IMMUNOL, V7, P302, DOI 10.1038/ni1302; Raabe T, 1998, J BIOL CHEM, V273, P974, DOI 10.1074/jbc.273.2.974; Rajasingh J, 2006, FASEB J, V20, P2112, DOI 10.1096/fj.06-6084fje; Renkema GH, 2000, FRONT BIOSCI-LANDMRK, V5, pD268, DOI 10.2741/Renkema; Ross TM, 1999, CURR BIOL, V9, P613, DOI 10.1016/S0960-9822(99)80283-8; Schindler M, 2003, J VIROL, V77, P10548, DOI 10.1128/JVI.77.19.10548-10556.2003; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; SPINA CA, 1994, J EXP MED, V179, P115, DOI 10.1084/jem.179.1.115; Stolp B, 2009, CELL HOST MICROBE, V6, P174, DOI 10.1016/j.chom.2009.06.004; Swantek JL, 1997, MOL CELL BIOL, V17, P6274, DOI 10.1128/MCB.17.11.6274; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Tsai EY, 1996, MOL CELL BIOL, V16, P5232; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Varin A, 2003, J BIOL CHEM, V278, P2219, DOI 10.1074/jbc.M209622200; Vigerust DJ, 2005, J LEUKOCYTE BIOL, V77, P522, DOI 10.1189/jlb.0804454; Wolf D, 2001, NAT MED, V7, P1217, DOI 10.1038/nm1101-1217; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753; Yao J, 1997, J BIOL CHEM, V272, P17795, DOI 10.1074/jbc.272.28.17795	62	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12629	12637		10.1074/jbc.M109.073320	http://dx.doi.org/10.1074/jbc.M109.073320			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20068037	hybrid, Green Published			2022-12-27	WOS:000276787800021
J	Cornu, M; Modi, H; Kawamori, D; Kulkarni, RN; Joffraud, M; Thorens, B				Cornu, Marion; Modi, Honey; Kawamori, Dan; Kulkarni, Rohit N.; Joffraud, Magali; Thorens, Bernard			Glucagon-like Peptide-1 Increases beta-Cell Glucose Competence and Proliferation by Translational Induction of Insulin-like Growth Factor-1 Receptor Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CAMP; SECRETION; EXOCYTOSIS; HORMONES; MASS; SURVIVAL; LOCALIZATION; PANCREAS; RELEASE	Glucagon-like peptide-1 (GLP-1) protects beta-cells against apoptosis, increases their glucose competence, and induces their proliferation. We previously demonstrated that the antiapoptotic effect was mediated by an increase in insulin-like growth factor-1 receptor (IGF-1R) expression and signaling, which was dependent on autocrine secretion of insulin-like growth factor 2 (IGF-2). Here, we further investigated how GLP-1 induces IGF-1R expression and whether the IGF-2/IGF-1R autocrine loop is also involved in mediating GLP-1-increase in glucose competence and proliferation. We show that GLP-1 up-regulated IGF-1R expression by a protein kinase Adependent translational control mechanism, whereas isobutylmethylxanthine, which led to higher intracellular accumulation of cAMP than GLP-1, increased both IGF-1R transcription and translation. We then demonstrated, using MIN6 cells and primary islets, that the glucose competence of these cells was dependent on the level of IGF-1R expression and on IGF-2 secretion. We showed that GLP-1-induced primary beta-cell proliferation was suppressed by Igf-1r gene inactivation and by IGF-2 immunoneutralization or knockdown. Together our data show that regulation of beta-cell number and function by GLP-1 depends on the cAMP/protein kinase A mediated-induction of IGF-1R expression and the increased activity of an IGF-2/ IGF-1R autocrine loop.	[Cornu, Marion; Modi, Honey; Joffraud, Magali; Thorens, Bernard] Univ Lausanne, Dept Physiol, CH-1015 Lausanne, Switzerland; [Cornu, Marion; Modi, Honey; Joffraud, Magali; Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Kawamori, Dan; Kulkarni, Rohit N.] Joslin Diabet Ctr, Dept Cellular & Mol Physiol, Boston, MA 02215 USA; [Kawamori, Dan; Kulkarni, Rohit N.] Harvard Univ, Sch Med, Boston, MA 02139 USA	University of Lausanne; University of Lausanne; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Thorens, B (corresponding author), Univ Lausanne, Dept Physiol, Genopode Bldg, CH-1015 Lausanne, Switzerland.	Bernard.Thorens@unil.ch			National Institutes of Health [RO1 DK67536]; Swiss National Science Foundation [31003A-113525]; Juvenile Diabetes Research Foundation [7-2005-1158]; European Community [LSHM-CT-2006 518153]; Juvenile Diabetes Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067536] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Community(European Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK67536 (to R. N. K.). This work was also supported by Swiss National Science Foundation Grant 31003A-113525, Juvenile Diabetes Research Foundation Program Project 7-2005-1158, the Integrated Project Eurodia LSHM-CT-2006 518153 Framework Programme 6 of the European Community (to B. T.), and a Juvenile Diabetes Research Foundation Fellowship (to D. K.).	Abderrahmani A, 2006, EMBO J, V25, P977, DOI 10.1038/sj.emboj.7601008; Arnette D, 2003, J BIOL CHEM, V278, P32517, DOI 10.1074/jbc.M301174200; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Buchanan CM, 2001, BIOCHEM J, V360, P431, DOI 10.1042/0264-6021:3600431; Buteau J, 1999, DIABETOLOGIA, V42, P856, DOI 10.1007/s001250051238; Buteau J, 2006, DIABETES, V55, P1190, DOI 10.2337/db05-0825; CHRISTOFORI G, 1995, NAT GENET, V10, P196, DOI 10.1038/ng0695-196; Cornu M, 2009, DIABETES, V58, P1816, DOI 10.2337/db09-0063; Dickson LM, 2004, AM J PHYSIOL-ENDOC M, V287, pE192, DOI 10.1152/ajpendo.00031.2004; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Egan JM, 2003, DIABETES-METAB RES, V19, P115, DOI 10.1002/dmrr.357; Fujimoto K, 2002, J BIOL CHEM, V277, P50497, DOI 10.1074/jbc.M210146200; Gomez E, 2002, J BIOL CHEM, V277, P48146, DOI 10.1074/jbc.M209165200; GOTOH M, 1987, TRANSPLANTATION, V43, P725, DOI 10.1097/00007890-198705000-00024; Hoog A, 1997, ULTRASTRUCT PATHOL, V21, P457, DOI 10.3109/01913129709021946; Iezzi M, 2000, FEBS LETT, V474, P66, DOI 10.1016/S0014-5793(00)01572-6; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Kang GX, 2001, J PHYSIOL-LONDON, V536, P375, DOI 10.1111/j.1469-7793.2001.0375c.xd; Kashima Y, 2001, J BIOL CHEM, V276, P46046, DOI 10.1074/jbc.M108378200; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Kulkarni RN, 2005, REV ENDOCR METAB DIS, V6, P199, DOI 10.1007/s11154-005-3051-y; Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872; MAAKE C, 1993, CELL TISSUE RES, V273, P249, DOI 10.1007/BF00312826; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Park S, 2006, J BIOL CHEM, V281, P1159, DOI 10.1074/jbc.M508307200; Perfetti R, 2000, ENDOCRINOLOGY, V141, P4600, DOI 10.1210/en.141.12.4600; PIPELEERS DG, 1985, ENDOCRINOLOGY, V117, P824, DOI 10.1210/endo-117-3-824; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; SCHUIT FC, 1985, ENDOCRINOLOGY, V117, P834, DOI 10.1210/endo-117-3-834; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; WIDMANN C, 1994, MOL PHARMACOL, V45, P1029; Xuan SH, 2002, J CLIN INVEST, V110, P1011, DOI 10.1172/JCI200215276	36	68	77	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10538	10545		10.1074/jbc.M109.091116	http://dx.doi.org/10.1074/jbc.M109.091116			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20145256	hybrid, Green Published			2022-12-27	WOS:000276264600040
J	Bavencoffe, A; Gkika, D; Kondratskyi, A; Beck, B; Borowiec, AS; Bidaux, G; Busserolles, J; Eschalier, A; Shuba, Y; Skryma, R; Prevarskaya, N				Bavencoffe, Alexis; Gkika, Dimitra; Kondratskyi, Artem; Beck, Benjamin; Borowiec, Anne-Sophie; Bidaux, Gabriel; Busserolles, Jerome; Eschalier, Alain; Shuba, Yaroslav; Skryma, Roman; Prevarskaya, Natalia			The Transient Receptor Potential Channel TRPM8 Is Inhibited via the alpha 2A Adrenoreceptor Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIPHERAL-NERVE INJURY; PRIMARY SENSORY NEURONS; COLD RECEPTOR; NEUROPATHIC PAIN; MENTHOL; ACTIVATION; MICE; IDENTIFICATION; EXPRESSION; MECHANISM	The transient receptor potential channel melastatin member 8 (TRPM8) is expressed in sensory neurons, where it constitutes the main receptor of environmental innocuous cold (10-25 degrees C). Among several types of G protein-coupled receptors expressed in sensory neurons, G(i)-coupled alpha 2A-adrenoreceptor (alpha 2A-AR), is known to be involved in thermoregulation; however, the underlying molecular mechanisms remain poorly understood. Here we demonstrated that stimulation of alpha 2A-AR inhibited TRPM8 in sensory neurons from rat dorsal root ganglia (DRG). In addition, using specific pharmacological and molecular tools combined with patch-clamp current recordings, we found that in heterologously expressed HEK-293 (human embryonic kidney) cells, TRPM8 channel is inhibited by the G(i) protein/adenylate cyclase (AC)/cAMP/protein kinase A (PKA) signaling cascade. We further identified the TRPM8 S9 and T17 as two key PKA phosphorylation sites regulating TRPM8 channel activity. We therefore propose that inhibition of TRPM8 through the alpha 2A-AR signaling cascade could constitute a new mechanism of modulation of thermosensation in both physiological and pathological conditions.	[Bavencoffe, Alexis; Gkika, Dimitra; Beck, Benjamin; Borowiec, Anne-Sophie; Bidaux, Gabriel; Skryma, Roman; Prevarskaya, Natalia] Univ Sci & Technol Lille, INSERM, U800, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France; [Kondratskyi, Artem; Shuba, Yaroslav] Natl Acad Sci Ukraine, Bogomoletz Inst Physiol, Kiev, Ukraine; [Kondratskyi, Artem; Shuba, Yaroslav] Natl Acad Sci Ukraine, Int Ctr Mol Physiol, Kiev, Ukraine; [Busserolles, Jerome; Eschalier, Alain] Univ Auvergne, INSERM, U766, Fac Med, F-63001 Clermont Ferrand, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; National Academy of Sciences Ukraine; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA)	Prevarskaya, N (corresponding author), Univ Sci & Technol Lille, INSERM, U800, Equipe Labellisee Ligue Natl Canc, F-59655 Villeneuve Dascq, France.	natacha.prevarskaya@univ-lille1.fr	Busserolles, Jerome/K-4232-2014; Gkika, Dimitra/S-3054-2019; ESCHALIER, Alain/L-9957-2015; Shuba, Yaroslav/AAT-6758-2021; Busserolles, Jerome/AAJ-1196-2020; Bidaux, Gabriel/F-1294-2016	Busserolles, Jerome/0000-0001-7542-9520; Gkika, Dimitra/0000-0001-8612-0836; Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Kondratskyi, Artem/0000-0003-3290-0524; Beck, Benjamin/0000-0001-8162-7566; Prevarskaya, natacha/0000-0003-0316-197X; Bidaux, Gabriel/0000-0002-6162-3223	INSERM; la Ligue Nationale contre le Cancer; le Ministere de l'Education Nationale; la Region Nord/Pas-de-Calais; INTAS [05-1000008-8223]; Institut National du Cancer (INCa)	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); la Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); le Ministere de l'Education Nationale; la Region Nord/Pas-de-Calais(Region Hauts-de-France); INTAS(INTASEuropean Commission); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France)	This work was supported by grants from INSERM, la Ligue Nationale contre le Cancer, le Ministere de l'Education Nationale, la Region Nord/Pas-de-Calais, and INTAS 05-1000008-8223.; Supported by a post-doctoral fellowship from the Institut National du Cancer (INCa).	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Beck B, 2007, CELL CALCIUM, V41, P285, DOI 10.1016/j.ceca.2006.07.002; Birder LA, 1999, J PHYSIOL-LONDON, V515, P533, DOI 10.1111/j.1469-7793.1999.533ac.x; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Cho HJ, 1997, NEUROREPORT, V8, P3119, DOI 10.1097/00001756-199709290-00022; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Chung MK, 2007, NEURON, V54, P345, DOI 10.1016/j.neuron.2007.04.025; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; CONKLIN BR, 1992, J BIOL CHEM, V267, P31; Cortright DN, 2007, BBA-MOL BASIS DIS, V1772, P978, DOI 10.1016/j.bbadis.2007.03.003; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Duflo F, 2002, ANESTHESIOLOGY, V97, P636, DOI 10.1097/00000542-200209000-00018; Hocker J, 2008, ANESTHESIOLOGY, V109, P95, DOI 10.1097/ALN.0b013e31817c02fc; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Madrid R, 2006, J NEUROSCI, V26, P12512, DOI 10.1523/JNEUROSCI.3752-06.2006; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pinchenko VO, 2005, BBA-GEN SUBJECTS, V1724, P1, DOI 10.1016/j.bbagen.2005.04.008; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Ramos BP, 2006, LEARN MEMORY, V13, P770, DOI 10.1101/lm.298006; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T., 2007, V179, P329; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang HB, 2005, NEURON, V46, P9, DOI 10.1016/j.neuron.2005.03.011; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007	33	50	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9410	9419		10.1074/jbc.M109.069377	http://dx.doi.org/10.1074/jbc.M109.069377			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20110357	Green Published, hybrid			2022-12-27	WOS:000276165900013
J	Ceru, S; Konjar, S; Maher, K; Repnik, U; Krizaj, I; Bencina, M; Renko, M; Nepveu, A; Zerovnik, E; Turk, B; Kopitar-Jerala, N				Ceru, Slavko; Konjar, Spela; Maher, Katarina; Repnik, Urska; Krizaj, Igor; Bencina, Mojca; Renko, Miha; Nepveu, Alain; Zerovnik, Eva; Turk, Boris; Kopitar-Jerala, Natasa			Stefin B Interacts with Histones and Cathepsin L in the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; LYSOSOMAL CYSTEINE PROTEASES; CDP/CUX TRANSCRIPTION FACTOR; CROSS-CLASS INHIBITION; CYSTATIN-B; ENDOSOMAL PROTEOLYSIS; HUMAN GENOME; CELL-CYCLE; S-PHASE; EPM1	Stefin B (cystatin B) is an endogenous inhibitor of cysteine proteinases localized in the nucleus and the cytosol. Loss-of-function mutations in the stefin B gene (CSTB) gene were reported in patients with Unverricht-Lundborg disease (EPM1). We have identified an interaction between stefin B and nucleosomes, specifically with histones H2A.Z, H2B, and H3. In synchronized T98G cells, stefin B co-immunoprecipitated with histone H3, predominantly in the G(1) phase of the cell cycle. Stefin B-deficient mouse embryonic fibroblasts entered S phase earlier than wild type mouse embryonic fibroblasts. In contrast, increased expression of stefin B in the nucleus delayed cell cycle progression in T98G cells. The delay in cell cycle progression was associated with the inhibition of cathepsin L in the nucleus, as judged from the decreased cleavage of the CUX1 transcription factor. In vitro, inhibition of cathepsin L by stefin B was potentiated in the presence of histones, whereas histones alone did not affect the cathepsin L activity. Interaction of stefin B with the Met-75 truncated form of cathepsin L in the nucleus was confirmed by fluorescence resonance energy transfer experiments in the living cells. Stefin B could thus play an important role in regulating the proteolytic activity of cathepsin L in the nucleus, protecting such as transcription factors from its proteolytic processing.	[Ceru, Slavko; Konjar, Spela; Maher, Katarina; Repnik, Urska; Renko, Miha; Zerovnik, Eva; Turk, Boris; Kopitar-Jerala, Natasa] Jozef Stefan Inst, Dept Biochem, SI-1000 Ljubljana, Slovenia; [Ceru, Slavko; Konjar, Spela; Maher, Katarina; Repnik, Urska; Renko, Miha; Zerovnik, Eva; Turk, Boris; Kopitar-Jerala, Natasa] Jozef Stefan Inst, Dept Biol Mol & Struct, SI-1000 Ljubljana, Slovenia; [Krizaj, Igor] Jozef Stefan Inst, Dept Mol & Biomed Sci, SI-1000 Ljubljana, Slovenia; [Bencina, Mojca] Natl Inst Chem, Dept Biotechnol, SI-1000 Ljubljana, Slovenia; [Nepveu, Alain] McGill Univ, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; National Institute of Chemistry - Slovenia; McGill University	Kopitar-Jerala, N (corresponding author), Jozef Stefan Inst, Dept Biochem, SI-1000 Ljubljana, Slovenia.	natasa.kopitar@ijs.si	Zerovnik, Eva/AAB-6498-2022; /AAB-8315-2020; Konjar, Špela/AAU-6390-2020	Turk, Boris/0000-0002-9007-5764	Slovenian Research Agency [J3-9324, J3-0612, P-0140]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This work was supported by Slovenian Research Agency Grants J3-9324 and J3-0612 (to N.K.J.) and Grant P-0140 (to V.T. and B.T.).	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Alakurtti K, 2005, EUR J HUM GENET, V13, P208, DOI 10.1038/sj.ejhg.5201300; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bromme D, 1999, BIOCHEMISTRY-US, V38, P2377, DOI 10.1021/bi982175f; Bulynko YA, 2006, MOL CELL BIOL, V26, P4172, DOI 10.1128/MCB.00135-06; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DOLINAR M, 1995, BIOL CHEM H-S, V376, P385; Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055; ELDRIDGE R, 1983, LANCET, V2, P838, DOI 10.1016/s0140-6736(83)90749-3; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Goulet B, 2004, MOL CELL, V14, P207, DOI 10.1016/S1097-2765(04)00209-6; Goulet B, 2007, MOL CANCER RES, V5, P899, DOI 10.1158/1541-7786.MCR-07-0160; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; HANNIGAN G, 1986, EMBO J, V5, P1607, DOI 10.1002/j.1460-2075.1986.tb04403.x; Hiwasa T, 1996, CANCER LETT, V99, P87, DOI 10.1016/0304-3835(95)04041-2; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Hwang SR, 2005, BIOCHEMISTRY-US, V44, P7757, DOI 10.1021/bi050053z; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Istomina NE, 2003, MOL CELL BIOL, V23, P6455, DOI 10.1128/MCB.23.18.6455-6468.2003; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; KASTELIC L, 1994, CANCER LETT, V82, P81, DOI 10.1016/0304-3835(94)90149-X; Kopitar-Jerala NA, 2005, FEBS LETT, V579, P2149, DOI 10.1016/j.febslet.2005.03.002; Kopitar-Jerala N, 2006, FEBS LETT, V580, P6295, DOI 10.1016/j.febslet.2006.10.055; KOPITARJERALA N, 1993, BIOCHIM BIOPHYS ACTA, V1164, P75, DOI 10.1016/0167-4838(93)90114-7; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lalioti MD, 1997, AM J HUM GENET, V60, P342; Lalioti MD, 1997, NATURE, V386, P847, DOI 10.1038/386847a0; Lehesjoki AE, 2003, EMBO J, V22, P3473, DOI 10.1093/emboj/cdg338; Lenarcic B, 1999, J BIOL CHEM, V274, P563, DOI 10.1074/jbc.274.2.563; MACHLEIDT W, 1989, FEBS LETT, V243, P234, DOI 10.1016/0014-5793(89)80135-8; Maubach G, 2008, MOL BIOL CELL, V19, P4238, DOI 10.1091/mbc.E08-03-0291; Mellgren RL, 1997, BIOCHEM BIOPH RES CO, V236, P555, DOI 10.1006/bbrc.1997.7003; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; Ong PC, 2007, J BIOL CHEM, V282, P36980, DOI 10.1074/jbc.M706991200; Pennacchio LA, 1998, NAT GENET, V20, P251, DOI 10.1038/3059; Pennacchio LA, 1996, SCIENCE, V271, P1731, DOI 10.1126/science.271.5256.1731; Pol E, 2003, BBA-PROTEINS PROTEOM, V1645, P105, DOI 10.1016/S1570-9639(02)00526-5; Puente XS, 2003, NAT REV GENET, V4, P544, DOI 10.1038/nrg1111; Qiu ZZ, 2006, J VIROL, V80, P5768, DOI 10.1128/JVI.00442-06; Rabzelj S, 2005, PROTEIN SCI, V14, P2713, DOI 10.1110/ps.051609705; Reinheckel T, 2005, J CELL SCI, V118, P3387, DOI 10.1242/jcs.02469; Reinheckel T, 2001, BIOL CHEM, V382, P735, DOI 10.1515/BC.2001.089; Riccio M, 2001, EXP CELL RES, V262, P84, DOI 10.1006/excr.2000.5085; Sansregret L, 2006, MOL CELL BIOL, V26, P2441, DOI 10.1128/MCB.26.6.2441-2455.2006; Santamaria I, 1998, CANCER RES, V58, P1624; Schick C, 1998, BIOCHEMISTRY-US, V37, P5258, DOI 10.1021/bi972521d; Schmid CD, 2007, CELL, V131, P831, DOI 10.1016/j.cell.2007.11.017; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; STEIN GH, 1979, J CELL PHYSIOL, V99, P43, DOI 10.1002/jcp.1040990107; STUBBS MT, 1990, EMBO J, V9, P1939, DOI 10.1002/j.1460-2075.1990.tb08321.x; Turk V, 2001, EMBO J, V20, P4629, DOI 10.1093/emboj/20.17.4629; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Yasothornsrikul S, 2003, P NATL ACAD SCI USA, V100, P9590, DOI 10.1073/pnas.1531542100; Zapata-Hommer O, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-5; Zimmermann T, 2002, FEBS LETT, V531, P245, DOI 10.1016/S0014-5793(02)03508-1	59	66	67	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10078	10086		10.1074/jbc.M109.034793	http://dx.doi.org/10.1074/jbc.M109.034793			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20075068	Green Published, hybrid			2022-12-27	WOS:000276165900075
J	Choi, BH; Feng, L; Yoon, HS				Choi, Bo-Hwa; Feng, Lin; Yoon, Ho Sup			FKBP38 Protects Bcl-2 from Caspase-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-INDUCED APOPTOSIS; MOLECULAR CHARACTERIZATION; FK-506 BINDING-PROTEIN-38; S-NITROSYLATION; TARGETS BCL-2; PROTEASOME; INHIBITOR; FAMILY; EXPRESSION; REGULATOR	The cellular processes that regulate Bcl-2 at the posttranslational levels are as important as those that regulate bcl-2 synthesis. Previously we demonstrated that the suppression of FK506-binding protein 38 (FKBP38) contributes to the instability of Bcl-2 or leaves Bcl-2 unprotected from degradation in an unknown mechanism. Here, we studied the underlying molecular mechanism mediating this process. We first showed that Bcl-2 binding-defective mutants of FKBP38 fail to accumulate Bcl-2 protein. We demonstrated that the FKBP38-mediated Bcl-2 stability is specific as the levels of other anti-apoptotic proteins such as Bcl-XL and Mcl-1 remained unaffected. FKBP38 enhanced the Bcl-2 stability under the blockade of de novo protein synthesis, indicating it is posttranslational. We showed that the overexpression of FKBP38 attenuates reduction rate of Bcl-2, thus resulting in an increment of the intracellular Bcl-2 level, contributing to the resistance of apoptotic cell death induced by the treatment of kinetin riboside, an anticancer drug. Caspase inhibitors markedly induced the accumulation of Bcl-2. In caspase-3-activated cells, the knockdown of endogenous FKBP38 by small interfering RNA resulted in Bcl-2 down-regulation as well, which was significantly recovered by the treatment with caspase inhibitors or overexpression of FKBP38. Finally we presented that the Bcl-2 cleavage by caspase-3 is blocked when Bcl-2 binds to FKBP38 through the flexible loop. Taken together, these results suggest that FKBP38 is a key player in regulating the function of Bcl-2 by antagonizing caspase-dependent degradation through the direct interaction with the flexible loop domain of Bcl-2, which contains the caspase cleavage site.	[Choi, Bo-Hwa; Feng, Lin; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Yoon, HS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.	hsyoon@ntu.edu.sg	Yoon, Ho Sup/A-2193-2011; Feng, Lin/G-5147-2013	Yoon, Ho Sup/0000-0002-8243-3904; Feng, Lin/0000-0002-3878-3608	A*STAR-Biomedical Research Council of Singapore [04/1/22/12/362]	A*STAR-Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by A*STAR-Biomedical Research Council of Singapore Grant 04/1/22/12/362.	Amundson SA, 2000, CANCER RES, V60, P6101; Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; Baliga BC, 2002, HEMATOL ONCOL, V20, P63, DOI 10.1002/hon.685; Barth S, 2007, MOL CELL BIOL, V27, P3758, DOI 10.1128/MCB.01324-06; Blanc C, 2000, CANCER RES, V60, P4386; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; Bulgakov OV, 2004, DEVELOPMENT, V131, P2149, DOI 10.1242/dev.01122; Buolamwini JK, 1999, CURR OPIN CHEM BIOL, V3, P500, DOI 10.1016/S1367-5931(99)80073-8; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chen M, 2007, J BIOL CHEM, V282, P33888, DOI 10.1074/jbc.M702969200; Cheng EHY, 1997, SCIENCE, V278, P1966, DOI 10.1126/science.278.5345.1966; Choi BH, 2008, CANCER LETT, V261, P37, DOI 10.1016/j.canlet.2007.11.014; Cliff MJ, 2006, STRUCTURE, V14, P415, DOI 10.1016/j.str.2005.12.009; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Edlich F, 2005, EMBO J, V24, P2688, DOI 10.1038/sj.emboj.7600739; Edlich F, 2007, J BIOL CHEM, V282, P15341, DOI 10.1074/jbc.M611594200; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Fong S, 2003, P NATL ACAD SCI USA, V100, P14253, DOI 10.1073/pnas.2332307100; Grandgirard D, 1998, EMBO J, V17, P1268, DOI 10.1093/emboj/17.5.1268; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; Haendeler J, 1996, EUR J PHARMACOL, V317, P407, DOI 10.1016/S0014-2999(96)00759-5; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Kang CB, 2005, BIOCHEM BIOPH RES CO, V337, P30, DOI 10.1016/j.bbrc.2005.09.023; Kang CB, 2005, FEBS LETT, V579, P1469, DOI 10.1016/j.febslet.2005.01.053; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kirsch DG, 1999, J BIOL CHEM, V274, P21155, DOI 10.1074/jbc.274.30.21155; Ling YH, 2002, MOL CANCER THER, V1, P841; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367; Paradis E, 1996, J NEUROSCI, V16, P7533; Pedersen KM, 1999, ELECTROPHORESIS, V20, P249, DOI 10.1002/(SICI)1522-2683(19990201)20:2<249::AID-ELPS249>3.0.CO;2-F; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Ramsey AJ, 2000, J BIOL CHEM, V275, P17857, DOI 10.1074/jbc.M001625200; Reed John C., 1995, Current Opinion in Oncology, V7, P541, DOI 10.1097/00001622-199511000-00012; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Snyder SH, 1998, NEURON, V21, P283, DOI 10.1016/S0896-6273(00)80538-3; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06	47	32	33	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9770	9779		10.1074/jbc.M109.032466	http://dx.doi.org/10.1074/jbc.M109.032466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20139069	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000276165900049
J	Juliana, C; Fernandes-Alnemri, T; Wu, JH; Datta, P; Solorzano, L; Yu, JW; Meng, R; Quong, AA; Latz, E; Scott, CP; Alnemri, ES				Juliana, Christine; Fernandes-Alnemri, Teresa; Wu, Jianghong; Datta, Pinaki; Solorzano, Leobaldo; Yu, Je-Wook; Meng, Rong; Quong, Andrew A.; Latz, Eicke; Scott, Charles P.; Alnemri, Emad S.			Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CYSTEINE PROTEASE INHIBITORS; NALP3 INFLAMMASOME; VINYL SULFONES; CASPASE-1 ACTIVATION; CELL-DEATH; SESQUITERPENE LACTONES; NLRP3 INFLAMMASOME; ASC PYROPTOSOME; MECHANISM	Activation of the inflammasome generates the pro-inflammatory cytokines interleukin-1 beta and -18, which are important mediators of inflammation. Abnormal activation of the inflammasome leads to many inflammatory diseases, including gout, silicosis, neurodegeneration, and genetically inherited periodic fever syndromes. Therefore, identification of small molecule inhibitors that target the inflammasome is an important step toward developing effective therapeutics for the treatment of inflammation. Here, we show that the herbal NF-kappa B inhibitory compound parthenolide inhibits the activity of multiple inflammasomes in macrophages by directly inhibiting the protease activity of caspase-1. Additional investigations of other NF-kappa B inhibitors revealed that the synthetic I kappa B kinase-beta inhibitor Bay 11-7082 and structurally related vinyl sulfone compounds selectively inhibit NLRP3 inflammasome activity in macrophages independent of their inhibitory effect on NF-kappa B activity. In vitro assays of the effect of parthenolide and Bay 11-7082 on the ATPase activity of NLRP3 demonstrated that both compounds inhibit the ATPase activity of NLRP3, suggesting that the inhibitory effect of these compounds on inflammasome activity could be mediated in part through their effect on the ATPase activity of NLRP3. Our results thus elucidate the molecular mechanism for the therapeutic anti-inflammatory activity of parthenolide and identify vinyl sulfones as a new class of potential therapeutics that target the NLRP3 inflammasome.	[Juliana, Christine; Fernandes-Alnemri, Teresa; Wu, Jianghong; Datta, Pinaki; Solorzano, Leobaldo; Yu, Je-Wook; Scott, Charles P.; Alnemri, Emad S.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Meng, Rong; Quong, Andrew A.] Thomas Jefferson Univ, Dept Canc Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Latz, Eicke] Univ Massachusetts, Dept Immunol & Infect Dis, Sch Med, Worcester, MA 01605 USA; [Latz, Eicke] Univ Bonn, Inst Innate Immun, D-53012 Bonn, Germany	Jefferson University; Jefferson University; University of Massachusetts System; University of Massachusetts Worcester; University of Bonn	Alnemri, ES (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	E_Alnemri@mail.jci.tju.edu	Alnemri, Emad S/B-4526-2010; Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666; Juliana, Christine/0000-0002-4314-1407; Yu, Je-Wook/0000-0001-5943-4071	National Institutes of Health [AG14357, AR055398]; National Research Service Award [T32-CA09678];  [1R01AI083713];  [R01HL093262]; NATIONAL CANCER INSTITUTE [T32CA009678] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055398] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG014357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG14357 and AR055398 (to E. S. A.) and Grants 1R01AI083713 and R01HL093262 (to E. L.).; Supported by National Research Service Award T32-CA09678.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Chu J, 2009, J LEUKOCYTE BIOL, V86, P1227, DOI 10.1189/jlb.0309164; Dinarello CA, 1998, ANN NY ACAD SCI, V856, P1, DOI 10.1111/j.1749-6632.1998.tb08307.x; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; FAROOQUI MYH, 1983, CHEM-BIOL INTERACT, V47, P363, DOI 10.1016/0009-2797(83)90170-9; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2008, METHOD ENZYMOL, V442, P251, DOI [10.1016/S0076-6S79(08)01413-4, 10.1016/S0076-6879(08)01413-4]; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2009, J INNATE IMMUN, V1, P607, DOI 10.1159/000227263; Frankel BA, 2004, J AM CHEM SOC, V126, P3404, DOI 10.1021/ja0390294; Garcia-Pineres AJ, 2004, LIFE SCI, V75, P841, DOI 10.1016/j.lfs.2004.01.024; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; HALL IH, 1980, J PHARM SCI, V69, P537, DOI 10.1002/jps.2600690516; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hehner SP, 1999, J IMMUNOL, V163, P5617; Heinrich M, 1998, ANNU REV PHARMACOL, V38, P539, DOI 10.1146/annurev.pharmtox.38.1.539; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Joly S, 2009, J IMMUNOL, V183, P3578, DOI 10.4049/jimmunol.0901323; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kerr ID, 2009, J BIOL CHEM, V284, P25697, DOI 10.1074/jbc.M109.014340; Kiuchi H, 2009, J UROLOGY, V181, P2339, DOI 10.1016/j.juro.2009.01.015; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Liu SJ, 2008, J AM CHEM SOC, V130, P8251, DOI 10.1021/ja711125p; Lopez-Franco O, 2006, ARTERIOSCL THROM VAS, V26, P1864, DOI 10.1161/01.ATV.0000229659.94020.53; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; MASRI MS, 1988, J PROTEIN CHEM, V7, P49, DOI 10.1007/BF01025413; Meadows DC, 2006, MED RES REV, V26, P793, DOI 10.1002/med.20074; Meng GX, 2009, IMMUNITY, V30, P860, DOI 10.1016/j.immuni.2009.04.012; PALMER JT, 1995, J MED CHEM, V38, P3193, DOI 10.1021/jm00017a002; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Scheidt KA, 1998, BIOORGAN MED CHEM, V6, P2477, DOI 10.1016/S0968-0896(98)80022-9; Schinella GR, 1998, J PHARM PHARMACOL, V50, P1069, DOI 10.1111/j.2042-7158.1998.tb06924.x; Sheehan M, 2002, MOL PHARMACOL, V61, P953, DOI 10.1124/mol.61.5.953; SOROOSH P, 2009, IMMUNITY, V30, P875; Yu JW, 2007, MOL CELL, V28, P214, DOI 10.1016/j.molcel.2007.08.029; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	46	373	408	4	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9792	9802		10.1074/jbc.M109.082305	http://dx.doi.org/10.1074/jbc.M109.082305			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093358	hybrid, Green Published			2022-12-27	WOS:000276165900051
J	Chan, MWC; Chaudary, F; Lee, W; Copeland, JW; McCulloch, CA				Chan, Matthew W. C.; Chaudary, Faiza; Lee, Wilson; Copeland, John W.; McCulloch, Christopher A.			Force-induced Myofibroblast Differentiation through Collagen Receptors Is Dependent on Mammalian Diaphanous (mDia)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; SMOOTH MUSCLE ACTIN; MECHANICAL STRETCH; STRESS FIBER; RHO; ACTIVATION; BINDING; CELLS; COACTIVATOR; FIBROBLASTS	The development of fibrosis promotes the differentiation of myofibroblasts, pro-fibrotic cells, which contribute to tissue dysfunction. Myofibroblast differentiation is dependent on actin assembly, which in response to force, is mediated by various actin-binding proteins including the mammalian Diaphanous-related formins (mDia). We examined the role of mDia in the mechano-sensing pathway that leads to force-induced expression of alpha-smooth muscle actin (SMA), a marker and critical determinant of myofibroblast differentiation. In cells treated with siRNA to knockdown mDia and then subjected to tensile force using collagen-coated magnetite beads attached to beta 1 integrins, actin assembly was inhibited at bead contact sites. Force-induced nuclear translocation of MRTF-A, a transcriptional co-activator of SMA, was reduced 50% by mDia knockdown. The expression of the transcriptional co-activator of SMA, serum response factor, was reduced by 50% after siRNA knockdown of mDia or by 100% in cells transfected with catalytically inactive mDia. Force-induced activation of the SMA promoter and SMA expression were blocked by knockdown of siRNA of mDia. In anchored collagen gel assays to measure myofibroblast-mediated contraction, knockdown of mDia reduced contraction by 50%. We conclude that mDia plays an important role in the development of force-induced transcriptional activation of SMA and myofibroblast differentiation.	[Chan, Matthew W. C.; Chaudary, Faiza; Lee, Wilson; McCulloch, Christopher A.] Univ Toronto, CIHR Grp Matrix Dynam, Toronto, ON M5S 3E2, Canada; [Copeland, John W.] Univ Ottawa, Ottawa, ON K1H 8M5, Canada	University of Toronto; University of Ottawa	Chan, MWC (corresponding author), Rm 243,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	matthew.chan@utoronto.ca			CIHR [MGP-37783]; Heart and Stroke Foundation [T-6022]; Canada Research Chair (Tier I)	CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Canada Research Chair (Tier I)(Canada Research Chairs)	This work was supported by CIHR Operating Grant MGP-37783, a CIHR resource grant, and Heart and Stroke Foundation Grant T-6022 (to C.A.M.).; Supported by a Canada Research Chair (Tier I).	Arora PD, 2005, MOL BIOL CELL, V16, P5175, DOI 10.1091/mbc.E05-07-0648; Arora PD, 2004, MOL BIOL CELL, V15, P588, DOI 10.1091/mbc.E03-07-0468; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Browning CL, 1998, DEV BIOL, V194, P18, DOI 10.1006/dbio.1997.8808; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chan MWC, 2009, J CELL SCI, V122, P2769, DOI 10.1242/jcs.044008; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Dickinson RB, 2004, BIOPHYS J, V87, P2838, DOI 10.1529/biophysj.104.045211; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; GLOGAUER M, 1995, AM J PHYSIOL-CELL PH, V269, pC1093, DOI 10.1152/ajpcell.1995.269.5.C1093; Glogauer M, 1997, J CELL SCI, V110, P11; Glogauer M, 1998, J BIOL CHEM, V273, P1689, DOI 10.1074/jbc.273.3.1689; Glogauer M, 1998, PFLUG ARCH EUR J PHY, V435, P320; GULLBERG D, 1992, EMBO J, V11, P3865, DOI 10.1002/j.1460-2075.1992.tb05479.x; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Hinz B, 2003, CURR OPIN BIOTECH, V14, P538, DOI 10.1016/j.copbio.2003.08.006; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; LESLIE KO, 1991, AM J PATHOL, V139, P207; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; MacKenna DA, 1998, J CLIN INVEST, V101, P301, DOI 10.1172/JCI1026; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Mouilleron S, 2008, EMBO J, V27, P3198, DOI 10.1038/emboj.2008.235; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Palazzo AF, 2004, SCIENCE, V303, P836, DOI 10.1126/science.1091325; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Sotiropoulos A, 1999, CELL, V98, P159, DOI 10.1016/S0092-8674(00)81011-9; Sun Y, 1996, CARDIOVASC RES, V31, P518; Syuto T, 2009, WOUND REPAIR REGEN, V17, P589, DOI 10.1111/j.1524-475X.2009.00510.x; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Unsworth KE, 2004, CELL MICROBIOL, V6, P1041, DOI 10.1111/j.1462-5822.2004.00417.x; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Walsh N, 2008, J PROTEOMICS, V71, P561, DOI 10.1016/j.jprot.2008.09.002; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang JX, 2002, J BIOL CHEM, V277, P22889, DOI 10.1074/jbc.M203130200; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	41	41	41	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9273	9281		10.1074/jbc.M109.075218	http://dx.doi.org/10.1074/jbc.M109.075218			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071339	Green Published, hybrid			2022-12-27	WOS:000275553700075
J	Shina, MC; Unal, C; Eichinger, L; Muller-Taubenberger, A; Schleicher, M; Steinert, M; Noegel, AA				Shina, Maria C.; Uenal, Can; Eichinger, Ludwig; Mueller-Taubenberger, Annette; Schleicher, Michael; Steinert, Michael; Noegel, Angelika A.			A Coronin7 Homolog with Functions in Actin-driven Processes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM-DISCOIDEUM; MONOCLONAL-ANTIBODIES; CAENORHABDITIS-ELEGANS; LEGIONELLA-PNEUMOPHILA; BINDING PROTEINS; F-ACTIN; CHEMOTACTIC STIMULATION; ENDOCYTIC PATHWAY; CELL MOTILITY; MYOSIN-II	Dictyostelium discoideum Coronin7 (DdCRN7) together with human Coronin7 (CRN7) and Pod-1 of Drosophila melanogaster and Caenorhabditis elegans belong to the coronin family of WD-repeat domain-containing proteins. Coronin7 proteins are characterized by two WD-repeat domains that presumably fold into two beta-propeller structures. DdCRN7 shares highest homology with human CRN7, a protein with roles in membrane trafficking. DdCRN7 is present in the cytosol and accumulates in cell surface projections during movement and phago- and pinocytosis. Cells lacking CRN7 have altered chemotaxis and phagocytosis. Furthermore, loss of CRN7 affects the infection process by the pathogen Legionella pneumophila and allows a more efficient internalization of bacteria. To provide a mechanism for CNR7 action, we studied actin-related aspects. We could show that CRN7 binds directly to F-actin and protects actin filaments from depolymerization. CRN7 also associated with F-actin in vivo. It was present in the Triton X-100-insoluble cytoskeleton, colocalized with F-actin, and its distribution was sensitive to drugs affecting the actin cytoskeleton. We propose that the CRN7 role in chemotaxis and phagocytosis is through its effect on the actin cytoskeleton.	[Shina, Maria C.; Eichinger, Ludwig; Noegel, Angelika A.] Univ Cologne, Fac Med, Ctr Mol Med Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Uenal, Can] Univ Wurzburg, Inst Mol Infect Biol, D-97080 Wurzburg, Germany; [Mueller-Taubenberger, Annette; Schleicher, Michael] Univ Munich, Inst Anat & Cell Biol, D-80336 Munich, Germany; [Mueller-Taubenberger, Annette; Schleicher, Michael] Univ Munich, Ctr Integrated Prot Sci, D-80336 Munich, Germany; [Steinert, Michael] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany	University of Cologne; University of Wurzburg; University of Munich; University of Munich; Braunschweig University of Technology	Noegel, AA (corresponding author), Univ Cologne, Fac Med, Ctr Biochem, Joseph Stelzmann Str 52, D-50931 Cologne, Germany.	noegel@uni-koeln.de	Müller-Taubenberger, Annette/AAG-8538-2020; Eichinger, Ludwig/AAJ-8895-2021; Müller-Taubenberger, Annette/AAM-3671-2021; Ünal, Can M./H-3796-2012	Müller-Taubenberger, Annette/0000-0003-1163-9232; Eichinger, Ludwig/0000-0003-1594-6117; Unal, Can/0000-0003-4710-9567	Deutsche Forschungsgemeinschaft [SFB 670]; Koln Fortune	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Koln Fortune	This work was supported by grants from the Deutsche Forschungsgemeinschaft, SFB 670, and Koln Fortune.	ADACHI H, 1994, BIOCHEM BIOPH RES CO, V205, P1808, DOI 10.1006/bbrc.1994.2880; Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013; BERTHOLDT G, 1985, CELL DIFFER DEV, V16, P187, DOI 10.1016/0045-6039(85)90516-0; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; CLAVIEZ M, 1982, EMBO J, V1, P1017, DOI 10.1002/j.1460-2075.1982.tb01287.x; Cornillon S, 2000, J BIOL CHEM, V275, P34287, DOI 10.1074/jbc.M006725200; Cosson P, 2008, CURR OPIN MICROBIOL, V11, P271, DOI 10.1016/j.mib.2008.05.005; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; DHARMAWARDHANE S, 1989, CELL MOTIL CYTOSKEL, V13, P57, DOI 10.1002/cm.970130107; EICHINGER L, 1992, BIOCHEMISTRY-US, V31, P4779, DOI 10.1021/bi00135a006; EICHINGER L, 1991, J CELL BIOL, V112, P665, DOI 10.1083/jcb.112.4.665; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Fajardo M, 2004, MICROBIOL-SGM, V150, P2825, DOI 10.1099/mic.0.27111-0; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Fey P, 2002, J CELL BIOL, V159, P1109, DOI 10.1083/jcb.200206067; FIRTEL RA, 1972, J MOL BIOL, V66, P339, DOI 10.1016/0022-2836(72)90419-6; Galkin VE, 2008, J MOL BIOL, V376, P607, DOI 10.1016/j.jmb.2007.12.007; Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83; HALL AL, 1988, J CELL BIOCHEM, V37, P285, DOI 10.1002/jcb.240370304; HAUGWITZ M, 1991, J CELL SCI, V100, P481; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jeon TJ, 2007, J CELL BIOL, V176, P1021, DOI 10.1083/jcb.200607072; JEPRAS RI, 1985, J HYG-CAMBRIDGE, V95, P29, DOI 10.1017/S0022172400062252; Jin T, 2009, IMMUNOL RES, V43, P118, DOI 10.1007/s12026-008-8056-7; Jung E, 1996, EMBO J, V15, P1238, DOI 10.1002/j.1460-2075.1996.tb00465.x; Korneeva NL, 1996, EUR J CELL BIOL, V71, P351; KREFFT M, 1989, J CELL SCI, V93, P199; Maniak M, 2003, CURR BIOL, V13, pR917, DOI 10.1016/j.cub.2003.11.014; Maniak M, 2003, TRAFFIC, V4, P1, DOI 10.1034/j.1600-0854.2003.40101.x; Maniak M, 2002, INT REV CYTOL, V221, P257; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Maniak M, 2001, BBA-GEN SUBJECTS, V1525, P197, DOI 10.1016/S0304-4165(01)00105-2; MCROBBIE SJ, 1983, BIOCHEM BIOPH RES CO, V115, P351, DOI 10.1016/0006-291X(83)91011-2; Mohri K, 2004, J BIOL CHEM, V279, P31697, DOI 10.1074/jbc.M403351200; Mondal S, 2008, J CELL BIOL, V181, P747, DOI 10.1083/jcb.200710111; Morgan Reginald O., 2008, V48, P41, DOI 10.1007/978-0-387-09595-0_5; Niewohner J, 1997, J CELL BIOL, V138, P349, DOI 10.1083/jcb.138.2.349; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Rivero Francisco, 2006, V346, P423; Rothenberg ME, 2003, NEURON, V39, P779, DOI 10.1016/S0896-6273(03)00508-7; Rybakin V, 2008, CELL MOL LIFE SCI, V65, P2419, DOI 10.1007/s00018-008-8278-9; Rybakin V, 2004, FEBS LETT, V573, P161, DOI 10.1016/j.febslet.2004.07.066; Rybakin V, 2006, J BIOL CHEM, V281, P31070, DOI 10.1074/jbc.M604680200; SCHLEICHER M, 1988, J CELL SCI, V90, P59; SCHLEICHER M, 1988, DEV GENET, V9, P521, DOI 10.1002/dvg.1020090428; SIMPSON PA, 1984, J CELL BIOL, V99, P287, DOI 10.1083/jcb.99.1.287; Solomon JM, 2000, INFECT IMMUN, V68, P2939, DOI 10.1128/IAI.68.5.2939-2947.2000; Solomon JM, 2003, INFECT IMMUN, V71, P3578, DOI 10.1128/IAI.71.6.3578-3586.2003; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Tagawa A, 2001, DEV BIOL, V233, P412, DOI 10.1006/dbio.2001.0234; THILO L, 1980, P NATL ACAD SCI-BIOL, V77, P1015, DOI 10.1073/pnas.77.2.1015; TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0; Voegtli WC, 2003, J BIOL CHEM, V278, P34373, DOI 10.1074/jbc.M302773200; VOGEL G, 1980, J CELL BIOL, V86, P456; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989	59	19	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9249	9261		10.1074/jbc.M109.083725	http://dx.doi.org/10.1074/jbc.M109.083725			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071332	hybrid, Green Published			2022-12-27	WOS:000275553700073
J	Zhang, P; Zheng, Y; Shi, J; Zhang, YX; Liu, SL; Liu, YX; Zheng, DX				Zhang, Peng; Zheng, Yong; Shi, Juan; Zhang, Yaxi; Liu, Shilian; Liu, Yanxin; Zheng, Dexian			Targeting a Novel N-terminal Epitope of Death Receptor 5 Triggers Tumor Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; AGONISTIC MONOCLONAL-ANTIBODY; RESISTANT CANCER-CELLS; KAPPA-B; TUMORICIDAL ACTIVITY; CRYSTAL-STRUCTURE; DECOY RECEPTOR; LIGAND TRAIL; IN-VIVO; C-FLIP	Tumor necrosis factor-related apoptosis-inducing ligand receptors death receptor (DR) 4 and DR5 are potential targets for antibody-based cancer therapy. Activation of the proapoptotic DR5 in various cancer cells triggers the extrinsic and/or intrinsic pathway of apoptosis. It has been shown that there are several functional domains in the DR5 extracellular domain. The cysteine-rich domains of DR5 have a conservative role in tumor necrosis factor-related apoptosis-inducing ligand-DR5-mediated apoptosis, and the pre-ligand assembly domain within the N1-cap contributes to the ligand-independent formation of receptor complexes. However, the role of the N-terminal region (NTR) preceding the N1-cap of DR5 remains unclear. In this study, we demonstrate that NTR could mediate DR5 activation that transmits an apoptotic signal when bound to a specific agonistic monoclonal antibody. A novel epitope in the NTR of DR5 was identified by peptide array. Antibodies against the antigenic determinant showed high affinities for DR5 and triggered caspase activation in a time-dependent manner, suggesting the NTR of DR5 might function as a potential death-inducing region. Moreover, permutation analysis showed that Leu(6) was pivotal for the interaction of DR5 and the agonistic antibody. Synthetic wild-type epitopes eliminated the cytotoxicity of all three agonistic monoclonal antibodies, AD5-10, Adie-1, and Adie-2. These results indicate that the NTR of DR5 could be a potential target site for the development of new strategies for cancer immunotherapy. Also, our findings expand the current knowledge about DR5 extracellular functional domains and provide insights into the mechanism of DR5-mediated cell death.	[Zhang, Peng; Shi, Juan; Zhang, Yaxi; Liu, Shilian; Liu, Yanxin; Zheng, Dexian] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100005, Peoples R China; [Zhang, Peng; Shi, Juan; Zhang, Yaxi; Liu, Shilian; Liu, Yanxin; Zheng, Dexian] Peking Union Med Coll, Beijing 100005, Peoples R China; [Zheng, Yong] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Liu, YX (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	liuyx2000@tom.com; zhengdx@pumc.edu.cn	Zhang, Peng/N-4773-2016	Zheng, Dexian/0000-0003-3966-1212	Natural Science Foundation of China [30623009, 30721063, 30772495, 30972684]; State Key Basic Research Program of China [2007CB507404, 2006CB504200]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by Natural Science Foundation of China Grants 30623009, 30721063, 30772495, and 30972684 and State Key Basic Research Program of China Grants 2007CB507404 and 2006CB504200.	Adams C, 2008, CELL DEATH DIFFER, V15, P751, DOI 10.1038/sj.cdd.4402306; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Bodmer JL, 2000, NAT CELL BIOL, V2, P241, DOI 10.1038/35008667; Cha SS, 2000, J BIOL CHEM, V275, P31171, DOI 10.1074/jbc.M004414200; Chen CF, 2009, CELL RES, V19, P984, DOI 10.1038/cr.2009.60; Chen F, 2009, CANCER SCI, V100, P940, DOI 10.1111/j.1349-7006.2009.01119.x; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Chuntharapai A, 2001, J IMMUNOL, V166, P4891, DOI 10.4049/jimmunol.166.8.4891; Clancy L, 2005, P NATL ACAD SCI USA, V102, P18099, DOI 10.1073/pnas.0507329102; Degli-Esposti MA, 1997, IMMUNITY, V7, P813, DOI 10.1016/S1074-7613(00)80399-4; DegliEsposti MA, 1997, J EXP MED, V186, P1165, DOI 10.1084/jem.186.7.1165; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Guo YB, 2005, J BIOL CHEM, V280, P41940, DOI 10.1074/jbc.M503621200; Han J, 2008, J BIOL CHEM, V283, P19665, DOI 10.1074/jbc.M710169200; Harper N, 2001, J BIOL CHEM, V276, P34743, DOI 10.1074/jbc.M105693200; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hoffmann I, 2001, J CELL BIOL, V155, P133, DOI 10.1083/jcb.200106148; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hotte SJ, 2008, CLIN CANCER RES, V14, P3450, DOI 10.1158/1078-0432.CCR-07-1416; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kim MR, 2001, FEBS LETT, V505, P179, DOI 10.1016/S0014-5793(01)02816-2; Kuang AA, 2000, J BIOL CHEM, V275, P25065, DOI 10.1074/jbc.C000284200; Li B, 2006, J MOL BIOL, V361, P522, DOI 10.1016/j.jmb.2006.06.042; Lin Y, 2000, MOL CELL BIOL, V20, P6638, DOI 10.1128/MCB.20.18.6638-6645.2000; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Marini P, 2006, ONCOGENE, V25, P5145, DOI 10.1038/sj.onc.1209516; MATSUDA S, 1993, P NATL ACAD SCI USA, V90, P10803, DOI 10.1073/pnas.90.22.10803; Mayaan E, 2007, J COMPUT CHEM, V28, P495, DOI 10.1002/jcc.20474; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Miyashita T, 2004, CLIN EXP IMMUNOL, V137, P430, DOI 10.1111/j.1365-2249.2004.02534.x; Mongkolsapaya J, 1999, NAT STRUCT BIOL, V6, P1048; Muhlethaler-Mottet A, 2004, ONCOGENE, V23, P5415, DOI 10.1038/sj.onc.1207704; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Park KJ, 2007, CANCER RES, V67, P7327, DOI 10.1158/0008-5472.CAN-06-4766; Plummer R, 2007, CLIN CANCER RES, V13, P6187, DOI 10.1158/1078-0432.CCR-07-0950; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Rowinsky EK, 2005, J CLIN ONCOL, V23, P9394, DOI 10.1200/JCO.2005.02.2889; Shi J, 2006, CANCER RES, V66, P11946, DOI 10.1158/0008-5472.CAN-06-1227; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Takeda K, 2004, J EXP MED, V199, P437, DOI 10.1084/jem.20031457; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Wang P, 2007, CELL SIGNAL, V19, P2237, DOI 10.1016/j.cellsig.2007.06.001; Wang X, 2008, MOL CANCER THER, V7, P1156, DOI 10.1158/1535-7163.MCT-07-2183; Wassenaar TA, 2008, PROTEINS, V70, P333, DOI 10.1002/prot.21541; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Yada A, 2008, ANN ONCOL, V19, P1060, DOI 10.1093/annonc/mdn015; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	53	8	12	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8953	8966		10.1074/jbc.M109.070680	http://dx.doi.org/10.1074/jbc.M109.070680			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20106985	Green Published, hybrid			2022-12-27	WOS:000275553700047
J	Pacholec, M; Bleasdale, JE; Chrunyk, B; Cunningham, D; Flynn, D; Garofalo, RS; Griffith, D; Griffor, M; Loulakis, P; Pabst, B; Qiu, XY; Stockman, B; Thanabal, V; Varghese, A; Ward, J; Withka, J; Ahn, K				Pacholec, Michelle; Bleasdale, John E.; Chrunyk, Boris; Cunningham, David; Flynn, Declan; Garofalo, Robert S.; Griffith, David; Griffor, Matt; Loulakis, Pat; Pabst, Brandon; Qiu, Xiayang; Stockman, Brian; Thanabal, Venkataraman; Varghese, Alison; Ward, Jessica; Withka, Jane; Ahn, Kay			SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYL-COA SYNTHETASE; SMALL-MOLECULE ACTIVATORS; CALORIE RESTRICTION; INSULIN-RESISTANCE; HISTONE/PROTEIN DEACETYLASES; SACCHAROMYCES-CEREVISIAE; INCREASED DOSAGE; CELL-SURVIVAL; P53; MECHANISM	Sirtuins catalyze NAD(+)-dependent protein deacetylation and are critical regulators of transcription, apoptosis, metabolism, and aging. There are seven human sirtuins (SIRT1-7), and SIRT1 has been implicated as a key mediator of the pathways downstream of calorie restriction that have been shown to delay the onset and reduce the incidence of age-related diseases such as type 2 diabetes. Increasing SIRT1 activity, either by transgenic overexpression of the Sirt1 gene in mice or by pharmacological activation by small molecule activators resveratrol and SRT1720, has shown beneficial effects in rodent models of type 2 diabetes, indicating that SIRT1 may represent an attractive therapeutic target. Herein, we have assessed purported SIRT1 activators by employing biochemical assays utilizing native substrates, including a p53-derived peptide substrate lacking a fluorophore as well as the purified native full-length protein substrates p53 and acetyl-CoA synthetase1. SRT1720, its structurally related compounds SRT2183 and SRT1460, and resveratrol do not lead to apparent activation of SIRT1 with native peptide or full-length protein substrates, whereas they do activate SIRT1 with peptide substrate containing a covalently attached fluorophore. Employing NMR, surface plasmon resonance, and isothermal calorimetry techniques, we provide evidence that these compounds directly interact with fluorophore-containing peptide substrates. Furthermore, we demonstrate that SRT1720 neither lowers plasma glucose nor improves mitochondrial capacity in mice fed a high fat diet. SRT1720, SRT2183, SRT1460, and resveratrol exhibit multiple off-target activities against receptors, enzymes, transporters, and ion channels. Taken together, we conclude that SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1.	[Griffith, David; Pabst, Brandon] Pfizer Global Res & Dev, Dept Cardiovasc Metab & Endocrine Dis, Groton, CT 06340 USA; [Chrunyk, Boris; Cunningham, David; Griffor, Matt; Loulakis, Pat; Qiu, Xiayang; Stockman, Brian; Thanabal, Venkataraman; Varghese, Alison; Withka, Jane] Pfizer Global Res & Dev, Dept Biol Struct, Groton, CT 06340 USA	Pfizer; Pfizer		kay.ahn@pfizer.com		Stockman, Brian/0000-0002-8520-9588				Albani D, 2010, J ALZHEIMERS DIS, V19, P11, DOI 10.3233/JAD-2010-1215; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barzilai N, 1998, J CLIN INVEST, V101, P1353, DOI 10.1172/JCI485; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; CHEN L, 2010, J INORG BIO IN PRESS; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Facchini FS, 2001, J CLIN ENDOCR METAB, V86, P3574, DOI 10.1210/jc.86.8.3574; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; GRACIASANCHO J, CARDIOVASC RES, V85, P514; Groebe DR, 2006, DRUG DISCOV TODAY, V11, P632, DOI 10.1016/j.drudis.2006.05.010; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Heilbronn LK, 2005, OBES RES, V13, P574, DOI 10.1038/oby.2005.61; ISHIKAWA M, 1995, TOHOKU J EXP MED, V175, P55, DOI 10.1620/tjem.175.55; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; North BJ, 2007, TRENDS BIOCHEM SCI, V32, P1, DOI 10.1016/j.tibs.2006.11.002; Ramadori G, 2009, ENDOCRINOLOGY, V150, P5326, DOI 10.1210/en.2009-0528; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sauve AA, 2004, CURR MED CHEM, V11, P807, DOI 10.2174/0929867043455675; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Segel I.H., 1993, ENZYME KINETICS, P227; Smith BC, 2008, CHEM BIOL, V15, P1002, DOI 10.1016/j.chembiol.2008.09.009; Smith BC, 2007, J AM CHEM SOC, V129, P5802, DOI 10.1021/ja070162w; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; SULAIMAN M, 2010, AM J PHYSL IN PRESS; Sun Xiu Zhu, 2003, Methods Mol Biol, V234, P17; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; UM JH, 2010, DIABETES IN PRESS; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang YH, 2003, J BIOL CHEM, V278, P25568, DOI 10.1074/jbc.M212574200; Yamazaki Y, 2009, AM J PHYSIOL-ENDOC M, V297, pE1179, DOI 10.1152/ajpendo.90997.2008	48	711	749	2	88	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8340	8351		10.1074/jbc.M109.088682	http://dx.doi.org/10.1074/jbc.M109.088682			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061378	hybrid, Green Published			2022-12-27	WOS:000275413800050
J	Hagenbuchner, J; Ausserlechner, MJ; Porto, V; David, R; Meister, B; Bodner, M; Villunger, A; Geiger, K; Obexer, P				Hagenbuchner, Judith; Ausserlechner, Michael J.; Porto, Verena; David, Reinhard; Meister, Bernhard; Bodner, Martin; Villunger, Andreas; Geiger, Kathrin; Obexer, Petra			The Anti-apoptotic Protein BCL2L1/Bcl-xL Is Neutralized by Pro-apoptotic PMAIP1/Noxa in Neuroblastoma, Thereby Determining Bortezomib Sensitivity Independent of Prosurvival MCL1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME INHIBITOR BORTEZOMIB; BH3-ONLY PROTEINS; LEUKEMIA-CELLS; CASPASE ACTIVATION; BCL-2 PROTEINS; GROWTH; DEATH; P53; NOXA; PUMA	Neuroblastoma is the most frequent extracranial solid tumor in children. Here, we report that the proteasome inhibitor bortezomib (PS-341, Velcade) activated the pro-apoptotic BH3-only proteins PMAIP1/Noxa and BBC3/Puma and induced accumulation of anti-apoptotic MCL1 as well as repression of anti-apoptotic BCL2L1/Bcl-xL. Retroviral expression of Bcl-xL, but not of MCL1, prevented apoptosis by bortezomib. Gene knockdown of Noxa by shRNA technology significantly reduced apoptosis, whereas Puma knockdown did not affect cell death kinetics. Immunoprecipitation revealed that endogenous Noxa associated with both, Bcl-xL and MCL1, suggesting that in neuronal cells Noxa can neutralize Bcl-xL, explaining the pronounced protective effect of Bcl-xL. Tetracycline-regulated Noxa expression did not trigger cell death per se but sensitized to bortezomib treatment in a dose-dependent manner. This implies that the induction of Noxa is necessary but not sufficient for bortezomib-induced apoptosis. We conclude that MCL1 steady-state expression levels do not affect sensitivity to proteasome-inhibitor treatment in neuronal tumor cells, and that both the repression of Bcl-xL and the activation of Noxa are necessary for bortezomib-induced cell death.	[Obexer, Petra] Med Univ Innsbruck, Pediat Oncol Res Lab, Tyrolean Canc Res Inst, A-6020 Innsbruck, Austria; [Hagenbuchner, Judith; Obexer, Petra] Med Univ Innsbruck, Dept Pediat 4, A-6020 Innsbruck, Austria; [Ausserlechner, Michael J.; Meister, Bernhard; Bodner, Martin] Med Univ Innsbruck, Dept Pediat 2, A-6020 Innsbruck, Austria; [Villunger, Andreas] Med Univ Innsbruck, Dept Dev Immunol, Bioctr, A-6020 Innsbruck, Austria	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck	Obexer, P (corresponding author), Med Univ Innsbruck, Pediat Oncol Res Lab, Tyrolean Canc Res Inst, Innrain 66, A-6020 Innsbruck, Austria.	Petra.Obexer@i-med.ac.at		Hagenbuchner, Judith/0000-0003-1396-3407; Bodner, Martin/0000-0002-3870-9862; Ausserlechner, Michael/0000-0002-1015-2302	Kinderkrebshilfe Tirol und Vorarlberg; Sudtiroler Krebshilfe-Vereinigung; SVP-Frauen-Initiative; Kinderkrebshilfe Sudtirol-Regenbogen; OeNB Anniversary Fund [11436, 12582]; COMET Center ONCOTYROL; Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK); Tyrolean Cancer Society; Dept. of Health-Care, Autonomy of South Tyrol.	Kinderkrebshilfe Tirol und Vorarlberg; Sudtiroler Krebshilfe-Vereinigung; SVP-Frauen-Initiative; Kinderkrebshilfe Sudtirol-Regenbogen; OeNB Anniversary Fund; COMET Center ONCOTYROL; Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK); Tyrolean Cancer Society; Dept. of Health-Care, Autonomy of South Tyrol.	This work was supported by grants from the Kinderkrebshilfe Tirol und Vorarlberg, the Sudtiroler Krebshilfe-Vereinigung, the SVP-Frauen-Initiative, the Kinderkrebshilfe Sudtirol-Regenbogen, the OeNB Anniversary Fund (Projects 11436 and 12582), and the COMET Center ONCOTYROL. The Tyrolean Cancer Research Institute and this study were supported by the Tiroler Landeskrankenanstalten Ges.m.b.H. (TILAK), the Tyrolean Cancer Society, and by the Dept. of Health-Care, Autonomy of South Tyrol.	Adams Julian, 2002, Breast Dis, V15, P61; Armstrong Michael B, 2008, J Exp Ther Oncol, V7, P135; Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Ausserlechner MJ, 2005, LEUKEMIA, V19, P1051, DOI 10.1038/sj.leu.2403729; Ausserlechner MJ, 2004, CELL DEATH DIFFER, V11, P165, DOI 10.1038/sj.cdd.4401328; Blaney SM, 2004, J CLIN ONCOL, V22, P4804, DOI 10.1200/JCO.2004.12.185; Brignole C, 2006, J NATL CANCER I, V98, P1142, DOI 10.1093/jnci/djj309; Bui NT, 2001, J CELL BIOL, V152, P753, DOI 10.1083/jcb.152.4.753; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Ding WX, 2007, MOL CANCER THER, V6, P1062, DOI 10.1158/1535-7163.MCT-06-0541; DOLE MG, 1995, CANCER RES, V55, P2576; Engels IH, 2000, ONCOGENE, V19, P4563, DOI 10.1038/sj.onc.1203824; Fennell DA, 2008, ONCOGENE, V27, P1189, DOI 10.1038/sj.onc.1210744; Gomez-Bougie P, 2007, CANCER RES, V67, P5418, DOI 10.1158/0008-5472.CAN-06-4322; He Q, 2004, ONCOGENE, V23, P2554, DOI 10.1038/sj.onc.1207351; Hemann MT, 2004, P NATL ACAD SCI USA, V101, P9333, DOI 10.1073/pnas.0403286101; Jagannath S, 2004, BRIT J HAEMATOL, V127, P165, DOI 10.1111/j.1365-2141.2004.05188.x; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nencioni A, 2005, BLOOD, V105, P3255, DOI 10.1182/blood-2004-10-3984; Nikrad M, 2005, MOL CANCER THER, V4, P443; Obexer P, 2007, CELL DEATH DIFFER, V14, P534, DOI 10.1038/sj.cdd.4402017; Obexer P, 2009, J BIOL CHEM, V284, P30933, DOI 10.1074/jbc.M109.051441; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Orlowski RZ, 2008, CLIN CANCER RES, V14, P1649, DOI 10.1158/1078-0432.CCR-07-2218; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Satou Y, 2004, LEUKEMIA, V18, P1357, DOI 10.1038/sj.leu.2403400; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Zaman F, 2007, CANCER RES, V67, P10078, DOI 10.1158/0008-5472.CAN-06-3982; Zhu HB, 2005, ONCOGENE, V24, P4993, DOI 10.1038/sj.onc.1208683	36	60	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6904	6912		10.1074/jbc.M109.038331	http://dx.doi.org/10.1074/jbc.M109.038331			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20051518	hybrid, Green Published			2022-12-27	WOS:000275415600004
J	Thomas, CP; Morgan, LT; Maskrey, BH; Murphy, RC; Kuhn, H; Hazen, SL; Goodall, AH; Hamali, HA; Collins, PW; O'Donnell, VB				Thomas, Christopher P.; Morgan, Lloyd T.; Maskrey, Benjamin H.; Murphy, Robert C.; Kuehn, Hartmut; Hazen, Stanley L.; Goodall, Alison H.; Hamali, Hassan A.; Collins, Peter W.; O'Donnell, Valerie B.			Phospholipid-esterified Eicosanoids Are Generated in Agonist-activated Human Platelets and Enhance Tissue Factor-dependent Thrombin Generation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PEPTIDE; OXIDIZED PHOSPHOLIPIDS; LIPID-PEROXIDATION; PROCOAGULANT ACTIVITY; COAGULANT ACTIVITY; ARACHIDONIC-ACID; GLYCOPROTEIN-VI; SCOTT-SYNDROME; LIPOXYGENASE; PHOSPHATIDYLETHANOLAMINE	Here, a group of specific lipids, comprising phosphatidylethanolamine (PE)- or phosphatidylcholine (PC)-esterified 12S-hydroxyeicosatetraenoic acid (12S-HETE), generated by 12-lipoxygenase was identified and characterized. 12S-HETE-PE/PCs were formed within 5 min of activation by thrombin, ionophore, or collagen. Esterified HETE levels generated in response to thrombin were 5.85 +/- 1.42 (PE) or 18.35 +/- 4.61 (PC), whereas free was 65.5 +/- 17.6 ng/4 x 10(7) cells (n = 5 separate donors, mean +/- S.E.). Their generation was stimulated by triggering protease-activated receptors-1 and -4 and signaling via Ca2+ mobilization secretory phospholipase A2, platelet-activating factor-acetylhydrolase, src tyrosine kinases, and protein kinase C. Stable isotope labeling showed that they form predominantly by esterification that occurs on the same time scale as free acid generation. Unlike free 12S-HETE that is secreted, esterified HETEs remain cell-associated, with HETE-PEs migrating to the outside of the plasma membrane. 12-Lipoxygenase inhibition attenuated externalization of native PE and phosphatidylserine and HETE-PEs. Platelets from a patient with the bleeding disorder, Scott syndrome, did not externalize HETE-PEs, and liposomes supplemented with HETE-PC dose-dependently enhanced tissue factor-dependent thrombin generation in vitro. This suggests a role for these novel lipids in promoting coagulation. Thus, oxidized phospholipids form by receptor/agonist mechanisms, not merely as an undesirable consequence of vascular and inflammatory disease.	[Thomas, Christopher P.; Morgan, Lloyd T.; Maskrey, Benjamin H.; O'Donnell, Valerie B.] Cardiff Univ, Dept Infect Immunol & Biochem, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Collins, Peter W.] Cardiff Univ, Dept Hematol, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Murphy, Robert C.] Univ Colorado Denver, Dept Pharmacol, Aurora, CO 80045 USA; [Kuehn, Hartmut] Humboldt Univ, Inst Biochem, D-10117 Berlin, Germany; [Hazen, Stanley L.] Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Goodall, Alison H.; Hamali, Hassan A.] Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Leicester LE3 9QP, Leics, England	Cardiff University; Cardiff University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Humboldt University of Berlin; Cleveland Clinic Foundation; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	O'Donnell, VB (corresponding author), Cardiff Univ, Dept Infect Immunol & Biochem, Sch Med, Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	o-donnellvb@cardiff.ac.uk	O'Donnell, Valerie/C-6948-2012; Thomas, Christopher P/R-5243-2016; Murphy, Robert/AAO-5349-2020; Hazen, Stanley L/ABD-5845-2021	Thomas, Christopher P/0000-0001-5840-8613; Murphy, Robert/0000-0002-9430-6515; /0000-0003-4089-8460; Hamali, Hassan A./0000-0003-3791-460X; Goodall, Alison/0000-0002-7883-9645	Lipid MAPS Large Scale Collaborative; National Institutes of Health [GM069338, P01 HL087018-020001]; Wellcome Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER	Lipid MAPS Large Scale Collaborative; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by the Lipid MAPS Large Scale Collaborative Grant, National Institutes of Health GM069338 (to R. C. M.), National Institutes of Health Grant P01 HL087018-020001 (to S. L. H.), and by the Wellcome Trust (V.B.O., C. P. T., and B. H. M.).	ARONSON DL, 1977, J CLIN INVEST, V60, P1410, DOI 10.1172/JCI108902; Bochkov VN, 2007, THROMB HAEMOSTASIS, V97, P348, DOI 10.1160/TH06-08-0474; BRASH AR, 1986, PROSTAG LEUKOTR ESS, V23, P149, DOI 10.1016/0262-1746(86)90178-2; Butterfield DA, 2002, FREE RADICAL BIO MED, V32, P1050, DOI 10.1016/S0891-5849(02)00794-3; Coffey MJ, 2004, FEBS LETT, V576, P165, DOI 10.1016/j.febslet.2004.09.007; COMFURIUS P, 1990, BIOCHIM BIOPHYS ACTA, V1026, P153, DOI 10.1016/0005-2736(90)90058-V; COMFURIUS P, 1985, BIOCHIM BIOPHYS ACTA, V815, P143, DOI 10.1016/0005-2736(85)90485-7; COOK WJ, 1976, BIOCHEM BIOPH RES CO, V68, P143, DOI 10.1016/0006-291X(76)90021-8; FAILI A, 1994, BRIT J HAEMATOL, V88, P149, DOI 10.1111/j.1365-2141.1994.tb04990.x; Falls LA, 2000, BIOCHEMISTRY-US, V39, P13216, DOI 10.1021/bi0009789; Greaves M, 2000, BRIT J HAEMATOL, V109, P704, DOI 10.1046/j.1365-2141.2000.02069.x; Hayashi T, 2007, FREE RADICAL BIO MED, V43, P1552, DOI 10.1016/j.freeradbiomed.2007.08.013; Klein S, 2001, ARTERIOSCL THROM VAS, V21, P1695; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kuhn H, 1999, FEBS LETT, V449, P7, DOI 10.1016/S0014-5793(99)00396-8; Leitinger N, 1999, P NATL ACAD SCI USA, V96, P12010, DOI 10.1073/pnas.96.21.12010; Maskrey BH, 2007, J BIOL CHEM, V282, P20151, DOI 10.1074/jbc.M611776200; Morgan AH, 2009, J BIOL CHEM, V284, P21185, DOI 10.1074/jbc.M109.021634; Mori J, 2008, J BIOL CHEM, V283, P35419, DOI 10.1074/jbc.M806895200; MOUNIER C, 1993, EUR J BIOCHEM, V216, P169, DOI 10.1111/j.1432-1033.1993.tb18129.x; Murphy R. C, 2002, MASS SPECTROMETRY PH; Nirodi CS, 2004, P NATL ACAD SCI USA, V101, P1840, DOI 10.1073/pnas.0303950101; Paradies G, 1999, FREE RADICAL BIO MED, V27, P42, DOI 10.1016/S0891-5849(99)00032-5; PARRY DH, 1980, BRIT J HAEMATOL, V44, P323, DOI 10.1111/j.1365-2141.1980.tb01215.x; Pickering W, 2008, J THROMB HAEMOST, V6, P1122, DOI 10.1111/j.1538-7836.2008.02957.x; Podrez EA, 2007, NAT MED, V13, P1086, DOI 10.1038/nm1626; Rolla R, 2007, CLIN EXP IMMUNOL, V149, P63, DOI 10.1111/j.1365-2249.2007.03404.x; SCHEWE T, 1975, FEBS LETT, V60, P149, DOI 10.1016/0014-5793(75)80439-X; Schnurr K, 1996, FREE RADICAL BIO MED, V20, P11, DOI 10.1016/0891-5849(95)02012-8; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2000, FREE RADICAL BIO MED, V28, P1751, DOI 10.1016/S0891-5849(00)00233-1; TAKAHASHI Y, 1993, EUR J BIOCHEM, V218, P165, DOI 10.1111/j.1432-1033.1993.tb18362.x; Tyurin VA, 2008, J NEUROCHEM, V107, P1614, DOI 10.1111/j.1471-4159.2008.05728.x; von Schlieffen E, 2009, ARTERIOSCL THROM VAS, V29, P356, DOI 10.1161/ATVBAHA.108.173799; WEISS HJ, 1994, SEMIN HEMATOL, V31, P312; WEISS HJ, 1979, AM J MED, V67, P206, DOI 10.1016/0002-9343(79)90392-9; Witztum JL, 1998, CURR OPIN LIPIDOL, V9, P441, DOI 10.1097/00041433-199810000-00008; YUAN YP, 1995, BLOOD, V86, P4166, DOI 10.1182/blood.V86.11.4166.bloodjournal86114166; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zwaal RFA, 2004, BBA-MOL CELL BIOL L, V1636, P119, DOI 10.1016/j.bbalip.2003.07.003	40	101	104	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6891	6903		10.1074/jbc.M109.078428	http://dx.doi.org/10.1074/jbc.M109.078428			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20061396	Green Published, hybrid			2022-12-27	WOS:000275415600003
J	Safavi-Hemami, H; Bulaj, G; Olivera, BM; Williamson, NA; Purcell, AW				Safavi-Hemami, Helena; Bulaj, Grzegorz; Olivera, Baldomero M.; Williamson, Nicholas A.; Purcell, Anthony W.			Identification of Conus Peptidylprolyl Cis-Trans Isomerases (PPIases) and Assessment of Their Role in the Oxidative Folding of Conotoxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN DISULFIDE-ISOMERASE; HUMAN CYCLOPHILIN; CYCLOSPORINE-A; POSTTRANSLATIONAL MODIFICATIONS; FK506-BINDING PROTEIN; CHEMICAL-SYNTHESIS; PROLYL ISOMERASE; BINDING-PROTEIN; VENOM DUCT; PEPTIDES	Peptidylprolyl cis-trans isomerases (PPIases) are ubiquitous proteins that catalyze the cis-trans isomerization of prolines. A number of proteins, such as Drosophila rhodopsin and the human immunodeficiency viral protein HIV-1 Gag, have been identified as endogenous substrates for PPIases. However, very little is known about the interaction of PPIases with small, disulfide-rich peptides. Marine cone snails synthesize a wide array of cysteine-rich peptides, called conotoxins, many of which contain one or more prolines or hydroxyprolines. To identify whether PPIase-associated cis-trans isomerization of these residues affects the oxidative folding of conotoxins, we identified, sequenced, and expressed three functionally active isoforms of PPIase from the venom gland of Conus novaehollandiae, and we characterized their ability to facilitate oxidative folding of conotoxins in vitro. Three conotoxins, namely mu-GIIIA, mu-SIIIA, and omega-MVIIC, derived from two distinct toxin gene families were assayed. Conus PPIase significantly increased the rate of appearance of the native form of mu-GIIIA, a peptide containing three hydroxyprolines. In contrast, the presence of PPIase had no effect on the folding of mu-SIIIA and omega-MVIIC, peptides containing no or one proline residue, respectively. We further showed that an endoplasmic reticulum-resident PPIase isoform facilitated folding of mu-GIIIA more efficiently than two cytosolic isoforms. This is the first study to demonstrate PPIase-assisted folding of conotoxins, small disulfide-rich peptides with unique structural properties.	[Safavi-Hemami, Helena; Williamson, Nicholas A.; Purcell, Anthony W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia; [Bulaj, Grzegorz] Univ Utah, Dept Med Chem, Salt Lake City, UT 84108 USA; [Olivera, Baldomero M.] Univ Utah, Dept Biol, Salt Lake City, UT 84108 USA	University of Melbourne; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Purcell, AW (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Melbourne, Vic 3010, Australia.	apurcell@unimelb.edu.au	Purcell, Anthony/AAH-1942-2019; Safavi-Hemami, Helena/E-7624-2015; Williamson, Nicholas A/O-9812-2016	Purcell, Anthony/0000-0003-0532-8331; Safavi-Hemami, Helena/0000-0002-1984-2721; Williamson, Nicholas A/0000-0002-2173-3452				Arevalo-Rodriguez M, 2004, FRONT BIOSCI-LANDMRK, V9, P2420, DOI 10.2741/1405; Armishaw C, 2009, J BIOL CHEM, V284, P9498, DOI 10.1074/jbc.M806136200; ATHERTON E, 1989, SOLID PHASE PEPTIDE, P134; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; Balbach J., 2000, MECH PROTEIN FOLDING, P212; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Buczek O, 2005, CELL MOL LIFE SCI, V62, P3067, DOI 10.1007/s00018-005-5283-0; Buczek O, 2004, BIOCHEMISTRY-US, V43, P1093, DOI 10.1021/bi0354233; Buczek O, 2005, J BIOL CHEM, V280, P4247, DOI 10.1074/jbc.M405835200; Bugli F, 1998, PROTEIN EXPRES PURIF, V12, P340, DOI 10.1006/prep.1997.0852; Bulaj G, 2006, BIOCHEMISTRY-US, V45, P7404, DOI 10.1021/bi060159+; Bulaj G, 2003, P NATL ACAD SCI USA, V100, P14562, DOI 10.1073/pnas.2335845100; Bulaj G, 2008, ANTIOXID REDOX SIGN, V10, P141, DOI 10.1089/ars.2007.1856; BUSH KT, 1994, BIOCHEM J, V303, P705, DOI 10.1042/bj3030705; Craig AG, 2001, TOXICON, V39, P809, DOI 10.1016/S0041-0101(00)00211-7; DAVIS JM, 1989, J BIOL CHEM, V264, P8956; DeLa Cruz R, 2003, J PEPT RES, V61, P202, DOI 10.1034/j.1399-3011.2003.t01-1-00048.x; di Luccio E, 2001, BIOCHEM J, V358, P681, DOI 10.1042/0264-6021:3580681; Dolinski K, 1997, P NATL ACAD SCI USA, V94, P13093, DOI 10.1073/pnas.94.24.13093; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FISCHER G, 1984, BIOMED BIOCHIM ACTA, V43, P1101; Fuller E, 2005, FEBS J, V272, P1727, DOI 10.1111/j.1742-4658.2005.04602.x; Galat A, 2003, CURR TOP MED CHEM, V3, P1315, DOI 10.2174/1568026033451862; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; Gourlay LJ, 2007, J BIOL CHEM, V282, P24851, DOI 10.1074/jbc.M702714200; Gowd KH, 2007, MOL BIOSYST, V3, P554, DOI 10.1039/b705382g; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hanoulle X, 2009, J BIOL CHEM, V284, P13589, DOI 10.1074/jbc.M809244200; HARRISON RK, 1992, J AM CHEM SOC, V114, P3464, DOI 10.1021/ja00035a046; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Hill JM, 1996, BIOCHEMISTRY-US, V35, P8824, DOI 10.1021/bi960073o; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Jakubowski JA, 2006, TOXICON, V47, P688, DOI 10.1016/j.toxicon.2006.01.021; KALLEN J, 1991, NATURE, V353, P276, DOI 10.1038/353276a0; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KE HM, 1991, P NATL ACAD SCI USA, V88, P9483, DOI 10.1073/pnas.88.21.9483; Kim J, 2008, J CELL SCI, V121, P3636, DOI 10.1242/jcs.028654; LANCELIN JM, 1991, BIOCHEMISTRY-US, V30, P6908, DOI 10.1021/bi00242a014; Laxa M, 2007, BIOCHEM J, V401, P287, DOI 10.1042/BJ20061092; Le Gall F, 1999, TOXICON, V37, P985, DOI 10.1016/S0041-0101(98)00227-X; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lopez-Vera E, 2008, BIOCHEMISTRY-US, V47, P1741, DOI 10.1021/bi701934m; Loughnan ML, 2004, J MED CHEM, V47, P1234, DOI 10.1021/jm031010o; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Mann M, 2003, NAT BIOTECHNOL, V21, P255, DOI 10.1038/nbt0303-255; Motohashi K, 2003, J BIOL CHEM, V278, P31848, DOI 10.1074/jbc.M304258200; NIGAM SK, 1993, BIOCHEM J, V294, P511, DOI 10.1042/bj2940511; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; Olivera BM, 2006, J BIOL CHEM, V281, P31173, DOI 10.1074/jbc.R600020200; Olivera BM, 1997, MOL BIOL CELL, V8, P2101, DOI 10.1091/mbc.8.11.2101; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PANTIN CFA, 1946, NOTES MICROSCOPICAL, P75; Pisarewicz K, 2005, J AM CHEM SOC, V127, P6207, DOI 10.1021/ja050088m; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; RASSOW J, 1995, MOL CELL BIOL, V15, P2654; Rycyzyn MA, 2002, P NATL ACAD SCI USA, V99, P6790, DOI 10.1073/pnas.092160699; Schindler T, 1996, EUR J BIOCHEM, V241, P516, DOI 10.1111/j.1432-1033.1996.00516.x; SCHONBRUNNER ER, 1992, P NATL ACAD SCI USA, V89, P4510, DOI 10.1073/pnas.89.10.4510; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; Stanley TB, 1997, FEBS LETT, V407, P85, DOI 10.1016/S0014-5793(97)00299-8; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Townsend A, 2009, INT J PEPT RES THER, V15, P195, DOI 10.1007/s10989-009-9173-4; Walewska A, 2009, ANGEW CHEM INT EDIT, V48, P2221, DOI 10.1002/anie.200806085; Wang ZQ, 2007, FEBS J, V274, P4778, DOI 10.1111/j.1742-4658.2007.06003.x; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187	68	29	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12735	12746		10.1074/jbc.M109.078691	http://dx.doi.org/10.1074/jbc.M109.078691			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20147296	Green Published, hybrid			2022-12-27	WOS:000276787800032
J	Graham, BH; Li, ZH; Alesii, EP; Versteken, P; Lee, C; Wang, J; Craigen, WJ				Graham, Brett H.; Li, Zhihong; Alesii, Erminio P.; Versteken, Patrik; Lee, Cynthia; Wang, Jennifer; Craigen, William J.			Neurologic Dysfunction and Male Infertility in Drosophila porin Mutants A NEW MODEL FOR MITOCHONDRIAL DYSFUNCTION AND DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ANION CHANNEL; GENE DISRUPTION PROJECT; BEHAVIORAL MUTANTS; SENSITIVE MUTANTS; OUTER-MEMBRANE; ALPHA-SUBUNIT; CYTOCHROME-C; MELANOGASTER; PROTEIN; EXPRESSION	Voltage-dependent anion channels (VDACs) are a family of small pore-forming proteins of the mitochondrial outer membrane found in all eukaryotes. VDACs play an important role in the regulated flux of metabolites between the cytosolic and mitochondrial compartments, and three distinct mammalian isoforms have been identified. Animal and cell culture experiments suggest that the various isoforms act in disparate roles such as apoptosis, synaptic plasticity, learning, muscle bioenergetics, and reproduction. In Drosophila melanogaster, porin is the ubiquitously expressed VDAC isoform. Through imprecise excision of a P element insertion in the porin locus, a series of hypomorphic alleles have been isolated, and analyses of flies homozygous for these mutant alleles reveal phenotypes remarkably reminiscent of mouse VDAC mutants. These include partial lethality, defects of mitochondrial respiration, abnormal muscle mitochondrial morphology, synaptic dysfunction, and male infertility, which are features often observed in human mitochondrial disorders. Furthermore, the observed synaptic dysfunction at the neuromuscular junction in porin mutants is associated with a paucity of mitochondria in presynaptic termini. The similarity of VDAC mutant phenotypes in the fly and mouse clearly indicate a fundamental conservation of VDAC function. The establishment and validation of a new in vivo model for VDAC function in Drosophila should provide a valuable tool for further genetic dissection of VDAC role(s) in mitochondrial biology and disease, and as a model of mitochondrial disorders potentially amenable to the development of treatment strategies.	[Graham, Brett H.; Li, Zhihong; Alesii, Erminio P.; Lee, Cynthia; Wang, Jennifer; Craigen, William J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Craigen, William J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Versteken, Patrik] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Versteken, Patrik] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium	Baylor College of Medicine; Baylor College of Medicine; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven	Graham, BH (corresponding author), Rm T536,BCM225,1 Baylor Plaza, Houston, TX 77030 USA.	bgraham@bcm.edu	Verstreken, Patrik/AAC-7591-2022; Graham, Brett/R-8685-2018	Verstreken, Patrik/0000-0002-5073-5393; Graham, Brett/0000-0001-8451-8154	National Institutes of Health [K08 HD44808, R01 NS0423193]; March of Dimes [FY-99-323]; Fund for Scientific Research Flanders (FWO) [G.0747.09]; Research Fund Katholieke Universiteit Leuven; Marie Curie Excellence [MEXT-CT-2006-042267]; Baylor College of Medicine Mental Retardation Developmental Disabilities Research Center (MRDDRC) [HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K08HD044808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Fund for Scientific Research Flanders (FWO)(FWO); Research Fund Katholieke Universiteit Leuven; Marie Curie Excellence(European Commission); Baylor College of Medicine Mental Retardation Developmental Disabilities Research Center (MRDDRC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants K08 HD44808 (to B. H. G.) and R01 NS0423193 (to W. J. C.). This work was also supported by March of Dimes FY-99-323 (to W. J. C.), Fund for Scientific Research Flanders (FWO, G.0747.09) (to P. V.), Research Fund Katholieke Universiteit Leuven (P. V.), a Marie Curie Excellence Grant (MEXT-CT-2006-042267) (to P. V.), The Baylor College of Medicine Mental Retardation Developmental Disabilities Research Center (MRDDRC HD024064), and VIB (to P. V.).	Anflous K, 2001, J BIOL CHEM, V276, P1954, DOI 10.1074/jbc.M006587200; Anflous-Pharayra K, 2007, BBA-BIOENERGETICS, V1767, P136, DOI 10.1016/j.bbabio.2006.11.013; Arama E, 2006, EMBO J, V25, P232, DOI 10.1038/sj.emboj.7600920; Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; BELLEN HJ, 2000, DROSOPHILA PROTOCOLS, P175; BENZER S, 1971, J AMER MED ASSOC, V218, P1015, DOI 10.1001/jama.218.7.1015; BlachlyDyson E, 1997, MOL CELL BIOL, V17, P5727, DOI 10.1128/MCB.17.10.5727; BLACHLYDYSON E, 1993, J BIOL CHEM, V268, P1835; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; GANETZKY B, 1982, J NEUROPHYSIOL, V47, P501, DOI 10.1152/jn.1982.47.3.501; Gincel D, 2001, BIOCHEM J, V358, P147, DOI 10.1042/0264-6021:3580147; Graham BH, 2005, MOL GENET METAB, V85, P308, DOI 10.1016/j.ymgme.2005.03.009; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Guarino F, 2006, BIOCHEM BIOPH RES CO, V346, P665, DOI 10.1016/j.bbrc.2006.05.172; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; HOMYK T, 1977, GENETICS, V87, P105; HOMYK T, 1980, MOL GEN GENET, V177, P553; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Huizing M, 1996, PEDIATR RES, V39, P760, DOI 10.1203/00006450-199605000-00003; Jacobs H, 1998, MOL GEN GENET, V259, P383, DOI 10.1007/s004380050826; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; Komarov AG, 2004, BIOPHYS J, V86, P152, DOI 10.1016/S0006-3495(04)74093-X; Kuebler D, 2000, J NEUROPHYSIOL, V83, P998, DOI 10.1152/jn.2000.83.2.998; Lee J, 2002, J NEUROSCI, V22, P11065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LO MVC, 1981, J GEN PHYSIOL, V77, P155, DOI 10.1085/jgp.77.2.155; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; McQuibban GA, 2006, CURR BIOL, V16, P982, DOI 10.1016/j.cub.2006.03.062; Messina A, 1996, FEBS LETT, V384, P9, DOI 10.1016/0014-5793(96)00268-2; Oliva M, 2002, MOL GENET GENOMICS, V267, P746, DOI 10.1007/s010438-002-0714-1; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2; Rahmani Z, 1998, EUR J HUM GENET, V6, P337, DOI 10.1038/sj.ejhg.5200198; RAMASWAMI M, 1989, P NATL ACAD SCI USA, V86, P2079, DOI 10.1073/pnas.86.6.2079; ROBERTSON HM, 1988, GENETICS, V118, P461; Rostovtseva T, 1996, J BIOL CHEM, V271, P28006, DOI 10.1074/jbc.271.45.28006; ROYDEN CS, 1987, CELL, V51, P165, DOI 10.1016/0092-8674(87)90144-9; Ryerse J, 1997, BBA-BIOMEMBRANES, V1327, P204, DOI 10.1016/S0005-2736(97)00059-X; Sampson MJ, 2001, J BIOL CHEM, V276, P39206, DOI 10.1074/jbc.M104724200; Sampson MJ, 1997, J BIOL CHEM, V272, P18966, DOI 10.1074/jbc.272.30.18966; Santel A, 2008, IUBMB LIFE, V60, P448, DOI 10.1002/iub.71; SCHUBIGER M, 1994, NEURON, V12, P373, DOI 10.1016/0896-6273(94)90278-X; Shimizu S, 1999, NATURE, V399, P483, DOI 10.1038/20959; SORGATO MC, 1993, CRIT REV BIOCHEM MOL, V28, P127; Spradling AC, 1999, GENETICS, V153, P135; Tong JJY, 2007, BIOL BULL-US, V212, P169, DOI 10.2307/25066594; Trotta N, 2004, J NEUROBIOL, V60, P328, DOI 10.1002/neu.20017; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Walker DW, 2004, P NATL ACAD SCI USA, V101, P10290, DOI 10.1073/pnas.0403767101; Wang XN, 2009, CELL, V136, P163, DOI 10.1016/j.cell.2008.11.046; Weeber EJ, 2002, J BIOL CHEM, V277, P18891, DOI 10.1074/jbc.M201649200; Wu SL, 1999, BBA-MOL CELL RES, V1452, P68, DOI 10.1016/S0167-4889(99)00120-2; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zhang YQ, 1999, GENETICS, V153, P891	62	31	31	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11143	11153		10.1074/jbc.M109.080317	http://dx.doi.org/10.1074/jbc.M109.080317			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20110367	hybrid, Green Published			2022-12-27	WOS:000276286200019
J	Han, WN; Ming, M; He, TC; He, YY				Han, Weinong; Ming, Mei; He, Tong-Chuan; He, Yu-Ying			Immunosuppressive Cyclosporin A Activates AKT in Keratinocytes through PTEN Suppression IMPLICATIONS IN SKIN CARCINOGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; CANCER-RISK; TRANSPLANT RECIPIENTS; RAPAMYCIN; GROWTH; TRANSFORMATION; INDUCTION; SIROLIMUS; APOPTOSIS; KIDNEY	Non-melanoma skin cancer, the most common neoplasia after solid organ transplantation, causes serious morbidity and mortality and is related to sun exposure. Cyclosporin A (CsA) has been used widely to prevent rejection in organ transplantation. The mechanism of CsA action in causing cancer was thought to be well understood via immunosuppression. Here, we show that CsA promotes primary skin tumor growth in immune-deficient mice and keratinocyte growth in vitro. In addition, CsA enhances keratinocyte survival from removal of extracellular matrix or UVB radiation. At the molecular level, CsA increases AKT activation after serum treatment and UVB irradiation. Furthermore we found that expression of PTEN, the negative regulator of AKT activation, is significantly reduced post-CsA in human HaCaT and A431 cells and in mouse skin in vivo. CsA-induced PTEN down-regulation occurs at the transcription level and is epidermal growth factor receptor-dependent. Such PTEN suppression is required for increased AKT activation. Inhibition of AKT activation abolishes CsA-promoted growth and survival, indicating that AKT hyperactivation is essential for both growth and survival of CsA-treated cells. In addition, mTOR signaling as a known AKT downstream pathway is required for CsA-enhanced growth and survival. Taken together, we have identified the PTEN/AKT pathway as new molecular targets of CsA in epidermal keratinocytes, suggesting a previously unknown mechanism in CsA-enhanced skin carcinogenesis. Our findings challenge assumptions about how CsA-associated tumors arise in skin.	[Han, Weinong; Ming, Mei; He, Yu-Ying] Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA; [He, Tong-Chuan] Univ Chicago, Dept Surg, Chicago, IL 60637 USA	University of Chicago; University of Chicago	He, YY (corresponding author), Univ Chicago, Dept Med, Dermatol Sect, Chicago, IL 60637 USA.	yyhe@medicine.bsd.uchicago.edu			American Skin Association; Wendy Will Case Cancer Fund; University of Chicago Comprehensive Cancer Center [P30 CA014599]; Clinical and Translational Science Award [UL1RR024999]; University of Chicago; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016936] Funding Source: NIH RePORTER	American Skin Association; Wendy Will Case Cancer Fund; University of Chicago Comprehensive Cancer Center; Clinical and Translational Science Award; University of Chicago(University of Chicago); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the American Skin Association, the Wendy Will Case Cancer Fund, University of Chicago Comprehensive Cancer Center Grant P30 CA014599, Clinical and Translational Science Award UL1RR024999, and the University of Chicago "Friends of Dermatology" endowment fund.	Allardice GM, 2003, BRIT J CANCER, V89, P505, DOI 10.1038/sj.bjc.6601139; Berg D, 2002, J AM ACAD DERMATOL, V47, P1, DOI 10.1067/mjd.2002.125579; BODE AM, 2003, SCI STKE, pRE2; Boehm JS, 2005, MOL CELL BIOL, V25, P6464, DOI 10.1128/MCB.25.15.6464-6474.2005; Bowden GT, 2004, NAT REV CANCER, V4, P23, DOI 10.1038/nrc1253; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Dal Maso L, 2009, BRIT J CANCER, V100, P840, DOI 10.1038/sj.bjc.6604923; Dantal J, 1998, LANCET, V351, P623, DOI 10.1016/S0140-6736(97)08496-1; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dean PG, 2004, TRANSPLANTATION, V77, P1555, DOI 10.1097/01.TP.0000123082.31092.53; DEGRUIJL FR, 1993, CANCER RES, V53, P53; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Ekici Y, 2007, TRANSPL P, V39, P1201, DOI 10.1016/j.transproceed.2007.04.013; Engels EA, 2008, INT J CANCER, V123, P187, DOI 10.1002/ijc.23487; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Goedert JJ, 1998, LANCET, V351, P1833, DOI 10.1016/S0140-6736(97)09028-4; Goren I, 2009, J INVEST DERMATOL, V129, P752, DOI 10.1038/jid.2008.230; Groetzner J, 2004, J HEART LUNG TRANSPL, V23, P632, DOI 10.1016/S1053-2498(03)00309-7; Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128; He YY, 2008, PHOTOCHEM PHOTOBIOL, V84, P69, DOI 10.1111/j.1751-1097.2007.00199.x; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; He YY, 2006, ONCOGENE, V25, P3680, DOI 10.1038/sj.onc.1209384; He YY, 2006, ONCOGENE, V25, P1521, DOI 10.1038/sj.onc.1209184; He YY, 2004, J INVEST DERMATOL, V122, P533, DOI 10.1046/j.0022-202X.2003.22123.x; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Jensen P, 1999, J AM ACAD DERMATOL, V40, P177, DOI 10.1016/S0190-9622(99)70185-4; Kim HK, 2008, NEOPLASIA, V10, P1411, DOI 10.1593/neo.08804; Kraemer KH, 1997, P NATL ACAD SCI USA, V94, P11, DOI 10.1073/pnas.94.1.11; LEHMAN TA, 1993, CARCINOGENESIS, V14, P833, DOI 10.1093/carcin/14.5.833; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Luan FL, 2003, KIDNEY INT, V63, P917, DOI 10.1046/j.1523-1755.2003.00805.x; Luan FL, 2002, TRANSPLANTATION, V73, P1565, DOI 10.1097/00007890-200205270-00008; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; NAKAZAWA H, 1994, P NATL ACAD SCI USA, V91, P360, DOI 10.1073/pnas.91.1.360; Noonan FP, 2001, NATURE, V413, P271, DOI 10.1038/35095108; SETLOW RB, 1993, P NATL ACAD SCI USA, V90, P6666, DOI 10.1073/pnas.90.14.6666; Shair KHY, 2008, CANCER RES, V68, P6997, DOI 10.1158/0008-5472.CAN-08-1178; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Suzuki A, 2003, CANCER RES, V63, P674; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Vasudevan KM, 2007, CANCER RES, V67, P10343, DOI 10.1158/0008-5472.CAN-07-1827; Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113; Wishart MJ, 2002, TRENDS CELL BIOL, V12, P579, DOI 10.1016/S0962-8924(02)02412-1; Wulff BC, 2008, J INVEST DERMATOL, V128, P2467, DOI 10.1038/jid.2008.121; Yarosh DB, 2005, J INVEST DERMATOL, V125, P1020, DOI 10.1111/j.0022-202X.2005.23858.x	50	51	52	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11369	11377		10.1074/jbc.M109.028142	http://dx.doi.org/10.1074/jbc.M109.028142			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154081	Green Published, hybrid			2022-12-27	WOS:000276286200043
J	Jung, HJ; Shim, JS; Lee, J; Song, YM; Park, KC; Choi, SH; Kim, ND; Yoon, JH; Mungai, PT; Schumacker, PT; Kwon, HJ				Jung, Hye Jin; Shim, Joong Sup; Lee, Jiyong; Song, Young Mi; Park, Ki Chung; Choi, Seung Hoon; Kim, Nam Doo; Yoon, Jeong Hyeok; Mungai, Paul T.; Schumacker, Paul T.; Kwon, Ho Jeong			Terpestacin Inhibits Tumor Angiogenesis by Targeting UQCRB of Mitochondrial Complex III and Suppressing Hypoxia-induced Reactive Oxygen Species Production and Cellular Oxygen Sensing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME BC(1) COMPLEX; ELECTRON-TRANSFER; ENANTIOSELECTIVE SYNTHESIS; SUPEROXIDE-PRODUCTION; HEART-MITOCHONDRIA; DOMAIN MOVEMENT; 14-KDA SUBUNIT; CANCER-CELLS; Q-CYCLE; IDENTIFICATION	Cellular oxygen sensing is required for hypoxia-inducible factor-1 alpha stabilization, which is important for tumor cell survival, proliferation, and angiogenesis. Here we find that terpestacin, a small molecule previously identified in a screen of microbial extracts, binds to the 13.4-kDa subunit (UQCRB) of mitochondrial Complex III, resulting in inhibition of hypoxia-induced reactive oxygen species generation. Consequently, such inhibition blocks hypoxia-inducible factor activation and tumor angiogenesis in vivo, without inhibiting mitochondrial respiration. Overexpression of UQCRB or its suppression using RNA interference demonstrates that it plays a crucial role in the oxygen sensing mechanism that regulates responses to hypoxia. These findings provide a novel molecular basis of terpestacin targeting UQCRB of Complex III in selective suppression of tumor progression.	[Jung, Hye Jin; Shim, Joong Sup; Lee, Jiyong; Song, Young Mi; Kwon, Ho Jeong] Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, Seoul 120749, South Korea; [Park, Ki Chung; Choi, Seung Hoon] Yonsei Univ, Coll Med, Dept Surg, Seoul 120752, South Korea; [Kim, Nam Doo; Yoon, Jeong Hyeok] Equispharm Inc, Drug Design Team, Gyeonggi, South Korea; [Mungai, Paul T.; Schumacker, Paul T.] Northwestern Univ, Dept Pediat, Chicago, IL 60611 USA	Yonsei University; Yonsei University; Yonsei University Health System; Northwestern University	Kwon, HJ (corresponding author), Yonsei Univ, Dept Biotechnol, Coll Life Sci & Biotechnol, Translat Res Ctr Prot Funct Control, 134 Shinchon Dong, Seoul 120749, South Korea.	kwonhj@yonsei.ac.kr	Shim, Joong Sup/O-2848-2016; Park, Ki Cheong/ABD-3136-2020; Lee, Jiyong/B-4894-2017; 권, 호정/AAS-3642-2021; Shim, Joong Sup/G-8383-2011	Shim, Joong Sup/0000-0003-0167-7307; Shim, Joong Sup/0000-0003-0167-7307; Lee, Jiyong/0000-0002-4455-3358; Park, Ki Cheong/0000-0002-3435-3985; Schumacker, Paul T/0000-0001-9591-2034	National R & D Program for Cancer Control, Ministry of Health Welfare; Translational Research Center for Protein Function Control, KRF [2009-0083522]; Korean Government [2009-0092964]; Brain Korea 21 project of the Republic of Korea; National Institutes of Health [HL35440, HL079650]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079650, R01HL035440] Funding Source: NIH RePORTER	National R & D Program for Cancer Control, Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Translational Research Center for Protein Function Control, KRF(National Research Foundation of Korea); Korean Government(Korean Government); Brain Korea 21 project of the Republic of Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National R & D Program for Cancer Control, Ministry of Health & Welfare, the Translational Research Center for Protein Function Control, KRF Grant 2009-0083522, the National Research Foundation of Korea Grant funded by Korean Government Grant 2009-0092964, and the Brain Korea 21 project of the Republic of Korea. This work was supported, in whole or in part, by National Institutes of Health Grants HL35440 and HL079650 (to P. T. S. and P. T. M.).	Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Borisov Vitaliy B, 2004, Ital J Biochem, V53, P34; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Chan J, 2004, J AM CHEM SOC, V126, P10682, DOI 10.1021/ja0470968; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Darrouzet E, 2001, TRENDS BIOCHEM SCI, V26, P445, DOI 10.1016/S0968-0004(01)01897-7; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Folkman J, 1992, Semin Cancer Biol, V3, P65; Garcia-Maceira P, 2009, ONCOGENE, V28, P313, DOI 10.1038/onc.2008.398; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Haut S, 2003, HUM GENET, V113, P118, DOI 10.1007/s00439-003-0946-0; HEMRIKA W, 1994, EUR J BIOCHEM, V220, P569, DOI 10.1111/j.1432-1033.1994.tb18657.x; Hong Soon-Sun, 2004, Cancer Res Treat, V36, P343, DOI 10.4143/crt.2004.36.6.343; Hwang KY, 2008, NEUROSCI LETT, V444, P264, DOI 10.1016/j.neulet.2008.08.057; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jia HL, 2007, CLIN CANCER RES, V13, P1133, DOI 10.1158/1078-0432.CCR-06-1025; Jung HJ, 2003, J ANTIBIOT, V56, P492, DOI 10.7164/antibiotics.56.492; Kwon HJ, 2003, CURR MED CHEM, V10, P717, DOI 10.2174/0929867033457755; Lin X, 2008, P NATL ACAD SCI USA, V105, P174, DOI 10.1073/pnas.0706585104; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; MULDER W, 1994, BBA-GENE STRUCT EXPR, V1219, P719, DOI 10.1016/0167-4781(94)90235-6; Myers AG, 2002, J AM CHEM SOC, V124, P4230, DOI 10.1021/ja020072l; OKA M, 1993, J ANTIBIOT, V46, P367, DOI 10.7164/antibiotics.46.367; Park HJ, 2005, J BIOCHEM MOL BIOL, V38, P232, DOI 10.5483/BMBRep.2005.38.2.232; Piggott AM, 2008, CHEMBIOCHEM, V9, P524, DOI 10.1002/cbic.200700608; Rottenberg H, 2009, J BIOL CHEM, V284, P19203, DOI 10.1074/jbc.M109.017376; Satake S, 1998, BIOL CELL, V90, P161, DOI 10.1016/S0248-4900(98)80337-7; Schreiber SL, 1998, BIOORGAN MED CHEM, V6, P1127, DOI 10.1016/S0968-0896(98)00126-6; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shim JS, 2004, CHEM BIOL, V11, P1455, DOI 10.1016/j.chembiol.2004.08.015; Shim JS, 2005, EXP MOL MED, V37, P365, DOI 10.1038/emm.2005.46; Spector JA, 2001, AM J PHYSIOL-CELL PH, V280, pC72, DOI 10.1152/ajpcell.2001.280.1.C72; SUZUKI H, 1988, BIOCHEM BIOPH RES CO, V156, P987, DOI 10.1016/S0006-291X(88)80941-0; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; TURRENS JF, 1985, ARCH BIOCHEM BIOPHYS, V237, P408, DOI 10.1016/0003-9861(85)90293-0; Ulanovskaya OA, 2008, NAT CHEM BIOL, V4, P418, DOI 10.1038/nchembio.94; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	42	83	88	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11584	11595		10.1074/jbc.M109.087809	http://dx.doi.org/10.1074/jbc.M109.087809			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145250	Green Published, hybrid			2022-12-27	WOS:000276286200064
J	Nair, U; Cao, Y; Xie, ZP; Klionsky, DJ				Nair, Usha; Cao, Yang; Xie, Zhiping; Klionsky, Daniel J.			Roles of the Lipid-binding Motifs of Atg18 and Atg21 in the Cytoplasm to Vacuole Targeting Pathway and Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-ACTIVATING ENZYME; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; VESICLE FORMATION; BUDDING YEAST; PREAUTOPHAGOSOMAL STRUCTURE; NONSPECIFIC AUTOPHAGY; MEMBRANE RECRUITMENT; SELECTIVE AUTOPHAGY; SECRETORY PATHWAY	Atg18 and Atg21 are homologous WD-40 repeat proteins that bind phosphoinositides via a novel conserved Phe-Arg-Arg-Gly motif and function in autophagy-related pathways. Atg18 is required for the cytoplasm to vacuole targeting (Cvt) pathway and autophagy, whereas Atg21 is only required for the Cvt pathway. Currently, the functions of both proteins are poorly understood. Here, we examined the relationship between the phosphatidylinositol 3-phosphate (PtdIns(3)P)-binding abilities of Atg18 and Atg21 and autophagy by expressing variants of these proteins that have mutations in their phosphoinositide-binding motifs. Cells expressing PtdIns(3)P-binding mutants of both these proteins showed highly reduced autophagy. Furthermore, the localization of components of two related ubiquitin-like protein conjugation systems, Atg8 and Atg16, to the phagophore assembly site is affected. Consistent with the aberrant localization of the above Atg proteins, precursor Ape1, a cargo of the Cvt pathway and autophagy, is partially protease-sensitive in starvation conditions. This finding suggests a requirement for the PtdIns( 3) P binding capability of Atg18 and Atg21 in efficient completion of the sequestering autophagic vesicles. Finally, using a multiple knock-out strain, we found that Atg18 and Atg21 facilitate the recruitment of Atg8-PE to the site of autophagosome formation and protect it from premature cleavage by Atg4, which represents a key aspect of post-translational autophagy regulation. Taken together, our results suggest that PtdIns( 3) P binding by at least Atg18 or Atg21 is required for robust autophagic activity and that the PtdIns(3)P-binding motifs of Atg18 and Atg21 can compensate for one another in the recruitment of Atg components that are dependent on PtdIns( 3) P for their phagophore assembly site association.	[Nair, Usha; Cao, Yang; Xie, Zhiping; Klionsky, Daniel J.] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Nair, Usha; Cao, Yang; Xie, Zhiping; Klionsky, Daniel J.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Klionsky, Daniel J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Klionsky, DJ (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	klionsky@umich.edu	Xie, Zhiping/A-1306-2015	Xie, Zhiping/0000-0001-5816-6159	National Institutes of Health [GM53396]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053396] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53396 (to D.J.K.).	Achsel T, 1998, MOL CELL BIOL, V18, P6756, DOI 10.1128/MCB.18.11.6756; Barth H, 2002, FEBS LETT, V512, P173, DOI 10.1016/S0014-5793(02)02252-4; Barth H, 2001, FEBS LETT, V508, P23, DOI 10.1016/S0014-5793(01)03016-2; Burd CG, 1998, MOL CELL, V2, P157, DOI 10.1016/S1097-2765(00)80125-2; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Cao Y, 2008, J CELL BIOL, V182, P703, DOI 10.1083/jcb.200801035; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Denisenko ON, 1997, MOL CELL BIOL, V17, P4707, DOI 10.1128/MCB.17.8.4707; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Efe JA, 2007, MOL BIOL CELL, V18, P4232, DOI 10.1091/mbc.E07-04-0301; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Guan J, 2001, MOL BIOL CELL, V12, P3821, DOI 10.1091/mbc.12.12.3821; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; He CC, 2006, J CELL BIOL, V175, P925, DOI 10.1083/jcb.200606084; Hu YM, 1998, P NATL ACAD SCI USA, V95, P4386, DOI 10.1073/pnas.95.8.4386; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; James P, 1996, GENETICS, V144, P1425; Kametaka S, 1998, J BIOL CHEM, V273, P22284, DOI 10.1074/jbc.273.35.22284; Kamura T, 1998, GENE DEV, V12, P3872, DOI 10.1101/gad.12.24.3872; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kim J, 2002, J BIOL CHEM, V277, P763, DOI 10.1074/jbc.M109134200; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287; Krick R, 2008, AUTOPHAGY, V4, P896, DOI 10.4161/auto.6801; Krick R, 2006, FEBS LETT, V580, P4632, DOI 10.1016/j.febslet.2006.07.041; Li D, 2001, CELL MOL LIFE SCI, V58, P2085, DOI 10.1007/PL00000838; LI QW, 1994, J BIOL CHEM, V269, P31777; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Meiling-Wesse K, 2004, J BIOL CHEM, V279, P37741, DOI 10.1074/jbc.M401066200; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mizushima N, 1999, EMBO J, V18, P3888, DOI 10.1093/emboj/18.14.3888; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Noda T, 2000, J CELL BIOL, V148, P465, DOI 10.1083/jcb.148.3.465; Obara K, 2006, MOL BIOL CELL, V17, P1527, DOI 10.1091/mbc.E05-09-0841; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Obara K, 2008, GENES CELLS, V13, P537, DOI 10.1111/j.1365-2443.2008.01188.x; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Reggiori F, 2005, MOL BIOL CELL, V16, P5843, DOI 10.1091/mbc.E05-07-0629; Reggiori F, 2004, MOL BIOL CELL, V15, P2189, DOI 10.1091/mbc.E03-07-0479; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tanida I, 1999, MOL BIOL CELL, V10, P1367, DOI 10.1091/mbc.10.5.1367; Tanida I, 2002, J BIOL CHEM, V277, P13739, DOI 10.1074/jbc.M200385200; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292	61	92	100	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11476	11488		10.1074/jbc.M109.080374	http://dx.doi.org/10.1074/jbc.M109.080374			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154084	Green Published, hybrid			2022-12-27	WOS:000276286200054
J	Chapot-Chartier, MP; Vinogradov, E; Sadovskaya, I; Andre, G; Mistou, MY; Trieu-Cuot, P; Furlan, S; Bidnenko, E; Courtin, P; Pechoux, C; Hols, P; Dufrene, YF; Kulakauskas, S				Chapot-Chartier, Marie-Pierre; Vinogradov, Evgeny; Sadovskaya, Irina; Andre, Guillaume; Mistou, Michel-Yves; Trieu-Cuot, Patrick; Furlan, Sylviane; Bidnenko, Elena; Courtin, Pascal; Pechoux, Christine; Hols, Pascal; Dufrene, Yves F.; Kulakauskas, Saulius			Cell Surface of Lactococcus lactis Is Covered by a Protective Polysaccharide Pellicle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; GRAM-POSITIVE BACTERIA; COMPLETE GENOME SEQUENCE; ACID BACTERIA; GENE-CLUSTER; EXOPOLYSACCHARIDE BIOSYNTHESIS; MOLECULAR CHARACTERIZATION; STREPTOCOCCUS-AGALACTIAE; FUNCTIONAL-ANALYSIS; TEICHOIC-ACIDS	In Gram-positive bacteria, the functional role of surface polysaccharides (PS) that are not of capsular nature remains poorly understood. Here, we report the presence of a novel cell wall PS pellicle on the surface of Lactococcus lactis. Spontaneous PS-negative mutants were selected using semi-liquid growth conditions, and all mutations were mapped in a single chromosomal locus coding for PS biosynthesis. PS molecules were shown to be composed of hexasaccharide phosphate repeating units that are distinct from other bacterial PS. Using complementary atomic force and transmission electron microscopy techniques, we showed that the PS layer forms an outer pellicle surrounding the cell. Notably, we found that this cell wall layer confers a protective barrier against host phagocytosis by murine macrophages. Altogether, our results suggest that the PS pellicle could represent a new cell envelope structural component of Gram-positive bacteria.	[Chapot-Chartier, Marie-Pierre; Mistou, Michel-Yves; Furlan, Sylviane; Bidnenko, Elena; Courtin, Pascal; Kulakauskas, Saulius] INRA, Micalis UMR1319, F-78352 Jouy En Josas, France; [Vinogradov, Evgeny] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Sadovskaya, Irina] Univ Lille Nord France, F-59000 Lille, France; [Sadovskaya, Irina] Univ Littoral Cote dOpale, UMT 08, LR2B, F-62327 Boulogne, France; [Andre, Guillaume; Dufrene, Yves F.] Catholic Univ Louvain, Unite Chim Interfaces, B-1348 Louvain, Belgium; [Mistou, Michel-Yves; Trieu-Cuot, Patrick] Inst Pasteur, CNRS, Unite Biol Bacteries Pathogenes Gram Positif, URA 2172, F-75724 Paris, France; [Pechoux, Christine] INRA, Genom & Physiol Lactat UR1196, F-78350 Jouy En Josas, France; [Hols, Pascal] Catholic Univ Louvain, Unite Genet, Inst Sci Vie, B-1348 Louvain, Belgium	INRAE; UDICE-French Research Universities; Universite Paris Saclay; National Research Council Canada; Universite de Lille - ISITE; Universite de Lille; Universite du Littoral-Cote-d'Opale; Universite Catholique Louvain; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Catholique Louvain	Kulakauskas, S (corresponding author), INRA, Micalis UMR1319, F-78352 Jouy En Josas, France.	saulius.kulakauskas@jouy.inra.fr	Mistou, Michel-Yves/AAY-2688-2021	Mistou, Michel-Yves/0000-0001-9732-3970; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Vinogradov, Evgeny/0000-0002-5364-1376; Dufrene, Yves/0000-0002-7289-4248	INRA	INRA	This work was supported in part by INRA (to M.-P. C.-C., M.-Y.M., S. F., E. B., P. C., C. P., and S. K.).	Areschoug Thomas, 2008, V15, P45, DOI 10.1159/000135685; Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; CERNING J, 1990, FEMS MICROBIOL LETT, V87, P113, DOI 10.1111/j.1574-6968.1990.tb04883.x; Chandry PS, 1997, MOL MICROBIOL, V26, P49, DOI 10.1046/j.1365-2958.1997.5491926.x; Chapot-Chartier MP, 1994, INT DAIRY J, V4, P251, DOI 10.1016/0958-6946(94)90016-7; Chen PM, 2008, MICROBES INFECT, V10, P293, DOI 10.1016/j.micinf.2007.12.006; CHEN PS, 1956, ANAL CHEM, V28, P1758; Chia JS, 2001, INFECT IMMUN, V69, P6987, DOI 10.1128/IAI.69.11.6987-6998.2001; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Corthesy B, 2007, J NUTR, V137, p781S, DOI 10.1093/jn/137.3.781S; Dabour N, 2005, APPL ENVIRON MICROB, V71, P7414, DOI 10.1128/AEM.71.11.7414-7425.2005; Dabour N, 2006, J DAIRY SCI, V89, P95, DOI 10.3168/jds.S0022-0302(06)72073-2; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; DUBOIS M, 1956, ANAL CHEM, V28, P356; Dufrene YF, 2008, NAT REV MICROBIOL, V6, P674, DOI 10.1038/nrmicro1948; Dufrene YF, 2008, NAT PROTOC, V3, P1132, DOI 10.1038/nprot.2008.101; Dupont K, 2004, APPL ENVIRON MICROB, V70, P5825, DOI 10.1128/AEM.70.10.5825-5832.2004; ENGHOFER E, 1979, CARBOHYD RES, V76, P233, DOI 10.1016/0008-6215(79)80022-1; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; Francius G, 2008, ACS NANO, V2, P1921, DOI 10.1021/nn800341b; GASSON MJ, 1983, J BACTERIOL, V154, P1; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; Le Gouellec A, 2008, J BACTERIOL, V190, P4501, DOI 10.1128/JB.00376-08; Mercier C, 2000, FEMS MICROBIOL LETT, V187, P47, DOI 10.1111/j.1574-6968.2000.tb09135.x; Mercier C, 2002, MOL MICROBIOL, V46, P235, DOI 10.1046/j.1365-2958.2002.03160.x; Meyrand M, 2007, MICROBIOL-SGM, V153, P3275, DOI 10.1099/mic.0.2007/005835-0; Mifune J, 2009, APPL ENVIRON MICROB, V75, P4668, DOI 10.1128/AEM.00487-09; Morlot C, 2003, MOL MICROBIOL, V50, P845, DOI 10.1046/j.1365-2958.2003.03767.x; Naumova IB, 1997, BIOCHEMISTRY-MOSCOW+, V62, P809; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; POOLEY HM, 1972, J BACTERIOL, V109, P423, DOI 10.1128/JB.109.1.423-431.1972; Roberts IS, 1996, ANNU REV MICROBIOL, V50, P285, DOI 10.1146/annurev.micro.50.1.285; Sadovskaya I, 2004, CARBOHYD RES, V339, P1467, DOI 10.1016/j.carres.2004.03.017; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Segura M, 2004, INFECT IMMUN, V72, P5322, DOI 10.1128/IAI.72.9.5322-5330.2004; Stenutz R, 2006, FEMS MICROBIOL REV, V30, P382, DOI 10.1111/j.1574-6976.2006.00016.x; Stukalov O, 2008, APPL ENVIRON MICROB, V74, P5457, DOI 10.1128/AEM.02075-07; Sutcliffe IC, 2008, MICROBIOL-SGM, V154, P1354, DOI 10.1099/mic.0.2007/014522-0; Toukach P, 2007, NUCLEIC ACIDS RES, V35, pD280, DOI 10.1093/nar/gkl883; van Kranenburg R, 1999, J BACTERIOL, V181, P6347, DOI 10.1128/JB.181.20.6347-6353.1999; vanKranenburg R, 1997, MOL MICROBIOL, V24, P387, DOI 10.1046/j.1365-2958.1997.3521720.x; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Veiga P, 2006, MOL MICROBIOL, V62, P1713, DOI 10.1111/j.1365-2958.2006.05474.x; Vlieg JETV, 2006, CURR OPIN BIOTECH, V17, P183, DOI 10.1016/j.copbio.2006.02.007; Wegmann U, 2007, J BACTERIOL, V189, P3256, DOI 10.1128/JB.01768-06; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Zechini B, 2006, DIAGN MICR INFEC DIS, V56, P325, DOI 10.1016/j.diagmicrobio.2006.04.011	49	125	130	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10464	10471		10.1074/jbc.M109.082958	http://dx.doi.org/10.1074/jbc.M109.082958			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20106971	Green Published, hybrid			2022-12-27	WOS:000276264600032
J	Chen, XW; Chern, M; Canlas, PE; Jiang, CY; Ruan, DL; Cao, PJ; Ronald, PC				Chen, Xuewei; Chern, Mawsheng; Canlas, Patrick E.; Jiang, Caiying; Ruan, Deling; Cao, Peijian; Ronald, Pamela C.			A Conserved Threonine Residue in the Juxtamembrane Domain of the XA21 Pattern Recognition Receptor Is Critical for Kinase Autophosphorylation and XA21-mediated Immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORYZAE PV. ORYZAE; DISEASE-RESISTANCE GENE; NEGATIVE REGULATOR; STRUCTURAL BASIS; RICE; PHOSPHORYLATION; BINDING; INNATE; FLS2; IDENTIFICATION	Despite the key role that pattern recognition receptors (PRRs) play in regulating immunity in plants and animals, the mechanism of activation of the associated non-arginine-aspartate (non-RD) kinases is unknown. The rice PRR XA21 recognizes the pathogen-associated molecular pattern, Ax21 (activator of XA21-mediated immunity). Here we show that the XA21 juxtamembrane (JM) domain is required for kinase autophosphorylation. Threonine 705 in the XA21 JM domain is essential for XA21 autophosphorylation in vitro and XA21-mediated innate immunity in vivo. The replacement of Thr705 by an alanine or glutamic acid abolishes XA21 autophosphorylation and eliminates interactions between XA21 and four XA21-binding proteins in yeast and rice. Although threonine residues analogous to Thr705 of XA21 are present in the JM domains of most RD and non-RD plant receptor-like kinases, this residue is not required for autophosphorylation of the Arabidopsis RD RLK BRI1 (brassinosteroid insensitive 1). The threonine 705 of XA21 is conserved only in the JM domains of plant RLKs but not in those of fly, human, or mouse suggesting distinct regulatory mechanisms. These results contribute to growing knowledge regarding the mechanism by which non-RD RLKs function in plant.	[Chen, Xuewei; Chern, Mawsheng; Canlas, Patrick E.; Jiang, Caiying; Ruan, Deling; Cao, Peijian; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA	University of California System; University of California Davis	Ronald, PC (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu	Ronald, Pamela/AAK-7664-2020; Cao, Peijian/U-6776-2019		National Institutes of Health [GM055962]; United States Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative [2004-35317-14867]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM055962 (to P. C. R.). This work was also supported in part by the United States Department of Agriculture Cooperative State Research, Education and Extension Service-National Research Initiative-Applied Plant Genomics Program RiceCAP Grant 2004-35317-14867 (to P. C. R.).	Agosti V, 2009, EXP HEMATOL, V37, P159, DOI 10.1016/j.exphem.2008.10.009; Aifa S, 2006, PROTEINS, V62, P1036, DOI 10.1002/prot.20780; Aifa S, 2006, BIOCHEM BIOPH RES CO, V347, P381, DOI 10.1016/j.bbrc.2006.05.200; Andaya CB, 2003, PHYSIOL MOL PLANT P, V62, P203, DOI 10.1016/S0885-5765(03)00060-2; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Brueggeman R, 2002, P NATL ACAD SCI USA, V99, P9328, DOI 10.1073/pnas.142284999; Chen XW, 2006, PLANT J, V46, P794, DOI 10.1111/j.1365-313X.2006.02739.x; Chern M, 2005, PLANT J, V43, P623, DOI 10.1111/j.1365-313X.2005.02485.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gual P, 2005, BIOCHIMIE, V87, P99, DOI 10.1016/j.biochi.2004.10.019; Heiss E, 2006, BLOOD, V108, P1542, DOI 10.1182/blood-2005-07-008896; Hubbard SR, 2001, MOL CELL, V8, P481, DOI 10.1016/S1097-2765(01)00350-1; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; Jung KH, 2008, NAT REV GENET, V9, P91, DOI 10.1038/nrg2286; Lee SW, 2006, P NATL ACAD SCI USA, V103, P18395, DOI 10.1073/pnas.0605508103; Lee SW, 2009, SCIENCE, V326, P850, DOI 10.1126/science.1173438; Liu GZ, 2002, J BIOL CHEM, V277, P20264, DOI 10.1074/jbc.M110999200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Peng Y, 2008, MOL PLANT, V1, P446, DOI 10.1093/mp/ssn024; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Sun XL, 2004, PLANT J, V37, P517, DOI 10.1046/j.1365-313X.2003.01976.x; Thakur M, 2008, J BIOL CHEM, V283, P8023, DOI 10.1074/jbc.M707535200; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang YS, 2006, PLANT CELL, V18, P3635, DOI 10.1105/tpc.106.046730; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Werling D, 2003, VET IMMUNOL IMMUNOP, V91, P1, DOI 10.1016/S0165-2427(02)00228-3; Xu WH, 2006, PLANT J, V45, P740, DOI 10.1111/j.1365-313X.2005.02638.x; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304	43	49	55	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10454	10463		10.1074/jbc.M109.093427	http://dx.doi.org/10.1074/jbc.M109.093427			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118235	hybrid, Green Published			2022-12-27	WOS:000276264600031
J	Methner, DNR; Mayfield, RD				Methner, D. Nicole Riherd; Mayfield, R. Dayne			Ethanol Alters Endosomal Recycling of Human Dopamine Transporters	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROLOGOUSLY EXPRESSING CELLS; VENTRAL TEGMENTAL AREA; SURFACE EXPRESSION; PLASMA-MEMBRANE; MONOAMINE TRANSPORTERS; FUNCTIONAL REGULATION; NUCLEUS-ACCUMBENS; GLUCOSE-UPTAKE; UP-REGULATION; AMPHETAMINE	Dynamic membrane trafficking of the monoamine dopamine transporter (DAT) regulates dopaminergic signaling. Various intrinsic and pharmacological modulators can alter this trafficking. Previously we have shown ethanol potentiates in vitro DAT function and increases surface expression. However, the mechanism underlying these changes is unclear. In the present study, we found ethanol directly regulates DAT function by altering endosomal recycling of the transporter. We defined ethanol action on transporter regulation by [H-3]DA uptake functional analysis combined with biochemical and immunological assays in stably expressing DAT HEK-293 cells. Shortterm ethanol exposure potentiated DAT function in a concentration-, but not time-dependent manner. This potentiation was accompanied by a parallel increase in DAT surface expression. Ethanol had no effect on function or surface localization of the ethanol-insensitive mutant (G130T DAT), suggesting a trafficking-dependent mechanism in mediating the ethanol sensitivity of the transporter. The ethanol-induced increase in DAT surface expression occurred without altering the overall size of DAT endosomal recycling pools. We found ethanol increased the DAT membrane insertion rate while having no effect on internalization of the transporter. Ethanol had no effect on the surface expression or trafficking of the endogenously expressing transferrin receptor, suggesting ethanol does not have a nonspecific effect on endosomal recycling. These results define a novel trafficking mechanism by which ethanol regulates DAT function.	[Methner, D. Nicole Riherd; Mayfield, R. Dayne] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Mayfield, RD (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, MBB1-124,2500 Speedway, Austin, TX 78712 USA.	dayne.mayfield@mail.utexas.edu						Binda F, 2008, MOL PHARMACOL, V74, P1101, DOI 10.1124/mol.108.048447; Boudanova E, 2008, NEUROPHARMACOLOGY, V54, P605, DOI 10.1016/j.neuropharm.2007.11.007; Brodie MS, 1998, ALCOHOL CLIN EXP RES, V22, P236, DOI 10.1111/j.1530-0277.1998.tb03644.x; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Chen NH, 2007, J NEUROCHEM, V101, P377, DOI 10.1111/j.1471-4159.2006.04384.x; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Conti AC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005697; Cruz-Muros I, 2009, NEUROBIOL AGING, V30, P973, DOI 10.1016/j.neurobiolaging.2007.09.009; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Duan SM, 1999, J NEUROSCI, V19, P10193; Egana LA, 2009, J NEUROSCI, V29, P4592, DOI 10.1523/JNEUROSCI.4559-08.2009; Garzon M, 2006, J COMP NEUROL, V498, P821, DOI 10.1002/cne.21082; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Hersch SM, 1997, J COMP NEUROL, V388, P211; Holton KL, 2005, NAT NEUROSCI, V8, P881, DOI 10.1038/nn1478; Imoukhuede PI, 2009, BIOPHYS J, V96, P2949, DOI 10.1016/j.bpj.2008.11.070; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; Jayanthi LD, 2005, AAPS J, V7, pE728, DOI 10.1208/aapsj070373; Johnson LA, 2005, NEUROPHARMACOLOGY, V49, P750, DOI 10.1016/j.neuropharm.2005.08.018; Kahlig KM, 2006, MOL PHARMACOL, V70, P542, DOI 10.1124/mol.106.023952; LIN AMY, 1993, NEUROSCI LETT, V164, P71, DOI 10.1016/0304-3940(93)90860-N; Lin AMY, 1997, BRAIN RES, V756, P287, DOI 10.1016/S0006-8993(97)00229-1; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; Maiya R, 2007, GENES BRAIN BEHAV, V6, P97, DOI 10.1111/j.1601-183X.2006.00236.x; Maiya R, 2002, J BIOL CHEM, V277, P30724, DOI 10.1074/jbc.M204914200; Mayfield RD, 2001, J NEUROCHEM, V79, P1070, DOI 10.1046/j.1471-4159.2001.00656.x; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miller GW, 1997, ANN NEUROL, V41, P530, DOI 10.1002/ana.410410417; Miranda M, 2004, J BIOL CHEM, V279, P30760, DOI 10.1074/jbc.M312774200; Mochizuki H, 2005, NEUROCHEM INT, V46, P93, DOI 10.1016/j.neuint.2004.08.008; Nelson N, 1998, J NEUROCHEM, V71, P1785; Riherd DN, 2008, ALCOHOL, V42, P499, DOI 10.1016/j.alcohol.2008.04.009; RITZ MC, 1988, PROG NEURO-PSYCHOPH, V12, P233, DOI 10.1016/0278-5846(88)90040-1; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; SULZER D, 1993, J NEUROCHEM, V60, P527, DOI 10.1111/j.1471-4159.1993.tb03181.x; Tomas M, 2003, J NEUROCHEM, V87, P220, DOI 10.1046/j.1471-4159.2003.01993.x; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Wang D, 2005, J BIOL CHEM, V280, P18703, DOI 10.1074/jbc.M500381200; Whitworth TL, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0003.2002; Whitworth TL, 2001, BIOCHEM SOC T, V29, P736, DOI 10.1042/BST0290736; Whitworth TL, 2001, J BIOL CHEM, V276, P42932, DOI 10.1074/jbc.M107638200; YOSHIMOTO K, 1992, ALCOHOL, V9, P17, DOI 10.1016/0741-8329(92)90004-T; Yu B, 2000, AM J PHYSIOL-ENDOC M, V279, pE1358, DOI 10.1152/ajpendo.2000.279.6.E1358; Zhou JZ, 2004, J NEUROSCI, V24, P6301, DOI 10.1523/JNEUROSCI.1404-04.2004	49	12	13	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10310	10317		10.1074/jbc.M109.029561	http://dx.doi.org/10.1074/jbc.M109.029561			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133946	Green Published, hybrid			2022-12-27	WOS:000276264600015
J	Liu, X; Shu, S; Hong, MSS; Yu, B; Korn, ED				Liu, Xiong; Shu, Shi; Hong, Myoung-Soon S.; Yu, Bin; Korn, Edward D.			Mutation of Actin Tyr-53 Alters the Conformations of the DNase I-binding Loop and the Nucleotide-binding Cleft	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DICTYOSTELIUM MYOSIN-II; TYROSINE PHOSPHORYLATION; MONOMERIC ACTIN; CRYSTAL-STRUCTURES; SUBDOMAIN 2; CELLS; DISCOIDEUM; FILAMENT; DYNAMICS; STATE	All but 11 of the 323 known actin sequences have Tyr at position 53, and the 11 exceptions have the conservative substitution Phe, which raises the following questions. What is the critical role(s) of Tyr-53, and, if it can be replaced by Phe, why has this happened so infrequently? We compared the properties of purified endogenous Dictyostelium actin and mutant constructs with Tyr-53 replaced by Phe, Ala, Glu, Trp, and Leu. The Y53F mutant did not differ significantly from endogenous actin in any of the properties assayed, but the Y53A and Y53E mutants differed substantially; affinity for DNase I was reduced, the rate of nucleotide exchange was increased, the critical concentration for polymerization was increased, filament elongation was inhibited, and polymerized actin was in the form of small oligomers and imperfect filaments. Growth and/or development of cells expressing these actin mutants were also inhibited. The Trp and Leu mutations had lesser but still significant effects on cell phenotype and the biochemical properties of the purified actins. We conclude that either Tyr or Phe is required to maintain the functional conformations of the DNase I-binding loop (D-loop) in both G- and F-actin, and that the conformation of the D-loop affects not only the properties that directly involve the D-loop (binding to DNase I and polymerization) but also allosterically modifies the conformation of the nucleotide-binding cleft, thus increasing the rate of nucleotide exchange. The apparent evolutionary "preference" for Tyr at position 53 may be the result of Tyr allowing dynamic modification of the D-loop conformation by phosphorylation (Baek, K., Liu, X., Ferron, F., Shu, S., Korn, E. D., and Dominguez, R. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 11748-11753) with effects similar, but not identical, to those of the Ala and Glu mutations.	[Liu, Xiong; Shu, Shi; Hong, Myoung-Soon S.; Yu, Bin; Korn, Edward D.] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Korn, ED (corresponding author), NHLBI, Cell Biol Lab, NIH, Bldg 50,Rm 2517,9000 Rockville Pike, Bethesda, MD 20892 USA.	edk@nih.gov	Korn, Edward D/F-9929-2012	Korn, Edward/0000-0003-3867-6295	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006035, ZIAHL000506] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baek K, 2008, P NATL ACAD SCI USA, V105, P11748, DOI 10.1073/pnas.0805852105; Chu JW, 2005, P NATL ACAD SCI USA, V102, P13111, DOI 10.1073/pnas.0503732102; Gauthier ML, 1997, CELL SIGNAL, V9, P79, DOI 10.1016/S0898-6568(96)00113-1; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Holmes KC, 2009, NATURE, V457, P389, DOI 10.1038/457389a; HOWARD PK, 1993, SCIENCE, V259, P241, DOI 10.1126/science.7678470; Ito K, 1999, BIOPHYS J, V76, P985, DOI 10.1016/S0006-3495(99)77262-0; Joseph JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002654; JUNGBLUTH A, 1994, J CELL SCI, V107, P117; JUNGBLUTH A, 1995, FEBS LETT, V375, P87, DOI 10.1016/0014-5793(95)01165-B; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kameyama K, 2000, NATURE, V407, P37, DOI 10.1038/35024149; Kanzawa N, 2006, PLANT CELL PHYSIOL, V47, P531, DOI 10.1093/pcp/pcj022; KHAITLINA SY, 1993, EUR J BIOCHEM, V218, P911, DOI 10.1111/j.1432-1033.1993.tb18447.x; KHAITLINA SY, 1991, FEBS LETT, V279, P49, DOI 10.1016/0014-5793(91)80247-Z; Khaitlina SY, 2002, BIOPHYS J, V82, P321, DOI 10.1016/S0006-3495(02)75397-6; Kim E, 1995, BIOPHYS J, V69, P2024, DOI 10.1016/S0006-3495(95)80072-X; Kishi Y, 1998, J CELL SCI, V111, P2923; LAEMMLI UK, 1970, NATURE, V227, P685; Liu X, 2005, J BIOL CHEM, V280, P26974, DOI 10.1074/jbc.M504453200; Liu X, 2000, BIOCHEM BIOPH RES CO, V271, P75, DOI 10.1006/bbrc.2000.2582; Liu X, 2006, P NATL ACAD SCI USA, V103, P13694, DOI 10.1073/pnas.0606321103; Moraczewska J, 1996, BIOCHEM J, V317, P605, DOI 10.1042/bj3170605; Nair UB, 2008, J MOL BIOL, V384, P848, DOI 10.1016/j.jmb.2008.09.082; Oda T, 2009, NATURE, V457, P441, DOI 10.1038/nature07685; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Pfaendtner J, 2009, P NATL ACAD SCI USA, V106, P12723, DOI 10.1073/pnas.0902092106; POLLARD TD, 1973, J BIOL CHEM, V248, P4682; ROMANS P, 1985, J MOL BIOL, V186, P337, DOI 10.1016/0022-2836(85)90109-3; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sameshima M, 2001, J STRUCT BIOL, V136, P7, DOI 10.1006/jsbi.2001.4424; Schuler H, 2005, FEBS LETT, V579, P655, DOI 10.1016/j.febslet.2004.12.037; SCHWEIGER A, 1992, J CELL SCI, V102, P601; SCHWYTER D, 1989, BIOCHEMISTRY-US, V28, P5889, DOI 10.1021/bi00440a027; SCHWYTER DH, 1990, J CELL BIOL, V111, P465, DOI 10.1083/jcb.111.2.465; SHETERLINE P, 1998, PROTEIN PROFILE ACTI, P44; STRZELECKAGOLASZEWSKA H, 1993, EUR J BIOCHEM, V211, P731, DOI 10.1111/j.1432-1033.1993.tb17603.x; Tropea Joseph E., 2009, V498, P297, DOI 10.1007/978-1-59745-196-3_19; VANDEKERCKHOVE J, 1980, NATURE, V284, P475, DOI 10.1038/284475a0; Yao XY, 1999, J BIOL CHEM, V274, P37443, DOI 10.1074/jbc.274.52.37443; Zheng XG, 2007, BIOPHYS J, V93, P1277, DOI 10.1529/biophysj.107.109215	43	16	16	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9729	9739		10.1074/jbc.M109.073452	http://dx.doi.org/10.1074/jbc.M109.073452			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100837	hybrid, Green Published			2022-12-27	WOS:000276165900045
J	Qadri, YJ; Song, YH; Fuller, CM; Benos, DJ				Qadri, Yawar J.; Song, Yuhua; Fuller, Catherine M.; Benos, Dale J.			Amiloride Docking to Acid-sensing Ion Channel-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; ACTIVATES NA+/H+ EXCHANGE; PROTEIN-LIGAND COMPLEXES; ALPHA-SUBUNIT; BINDING DOMAIN; IDENTIFICATION; PORE; ENAC; TRANSPORT; PSALMOTOXIN-1	Amiloride is a small molecule diuretic, which has been used to dissect sodium transport pathways in many different systems. This drug is known to interact with the epithelial sodium channel and acid-sensing ion channel proteins, as well as sodium/hydrogen antiporters and sodium/calcium exchangers. The exact structural basis for these interactions has not been elucidated as crystal structures of these proteins have been challenging to obtain, though some involved residues and domains have been mapped. This work examines the interaction of amiloride with acid-sensing ion channel-1, a protein whose structure is available using computational and experimental techniques. Using molecular docking software, amiloride and related molecules were docked to model structures of homomeric human ASIC-1 to generate potential interaction sites and predict which analogs would be more or less potent than amiloride. The predictions made were experimentally tested using whole-cell patch clamp. Drugs previously classified as NCX or NHE inhibitors are shown to also inhibit hASIC-1. Potential docking sites were re-examined against experimental data to remove spurious interaction sites. The voltage sensitivity of inhibitors was also examined. Using the aggregated data from these computational and experimental experiments, putative interaction sites for amiloride and hASIC-1 have been defined. Future work will experimentally verify these interaction sites, but at present this should allow for virtual screening of drug libraries at these putative interaction sites.	[Qadri, Yawar J.; Fuller, Catherine M.; Benos, Dale J.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Song, Yuhua] Univ Alabama Birmingham, Dept Biomed Engn, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, UAb Stn, Birmingham, AL 35294 USA.	benos@uab.edu	Fuller, Cathy/B-4046-2011	Qadri, Yawar/0000-0003-2138-4018	National Institutes of Health [DK37206]; AMA foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037206, R56DK037206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AMA foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK37206. This work was also supported by the AMA foundation.	Adams CM, 1999, J BIOL CHEM, V274, P15500, DOI 10.1074/jbc.274.22.15500; BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; BENOS DJ, 1976, J GEN PHYSIOL, V68, P43, DOI 10.1085/jgp.68.1.43; Benos DJ, 1999, J PHYSIOL-LONDON, V520, P631, DOI 10.1111/j.1469-7793.1999.00631.x; BICKING JB, 1965, J MED CHEM, V8, P638, DOI 10.1021/jm00329a017; Bondarava M, 2009, PFLUG ARCH EUR J PHY, V458, P675, DOI 10.1007/s00424-009-0649-z; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Garnovskaya MN, 2003, J BIOL CHEM, V278, P16908, DOI 10.1074/jbc.M209883200; Garnovskaya MN, 1997, J BIOL CHEM, V272, P7770, DOI 10.1074/jbc.272.12.7770; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hassell AM, 2007, ACTA CRYSTALLOGR D, V63, P72, DOI 10.1107/S0907444906047020; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Heyer LJ, 1999, GENOME RES, V9, P1106, DOI 10.1101/gr.9.11.1106; Hirsh AJ, 2008, J PHARMACOL EXP THER, V325, P77, DOI 10.1124/jpet.107.130443; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ismailov II, 1997, J BIOL CHEM, V272, P21075, DOI 10.1074/jbc.272.34.21075; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Jernigan NL, 2009, AM J PHYSIOL-LUNG C, V297, pL271, DOI 10.1152/ajplung.00020.2009; Ji HL, 2004, J BIOL CHEM, V279, P8428, DOI 10.1074/jbc.M312012200; Kapoor N, 2009, J BIOL CHEM, V284, P24526, DOI 10.1074/jbc.M109.037390; Kashlan OB, 2005, J BIOL CHEM, V280, P26206, DOI 10.1074/jbc.M503500200; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kelly O, 2003, AM J PHYSIOL-RENAL, V285, pF1279, DOI 10.1152/ajprenal.00094.2003; Kieber-Emmons T, 1999, J BIOL CHEM, V274, P9648, DOI 10.1074/jbc.274.14.9648; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; KLEYMAN TR, 1988, J MEMBRANE BIOL, V105, P1, DOI 10.1007/BF01871102; Kuduk SD, 2009, BIOORG MED CHEM LETT, V19, P2514, DOI 10.1016/j.bmcl.2009.03.029; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; LI XJ, 1995, MOL PHARMACOL, V47, P1133; PALMER LG, 1985, J MEMBRANE BIOL, V87, P191, DOI 10.1007/BF01871218; PALMER LG, 1989, BIOPHYS J, V55, P779, DOI 10.1016/S0006-3495(89)82876-0; Pietra F, 2009, J CHEM INF MODEL, V49, P972, DOI 10.1021/ci800463h; Qadri YJ, 2009, J BIOL CHEM, V284, P17625, DOI 10.1074/jbc.M109.003913; Reddy CS, 2006, COMPUT BIOL CHEM, V30, P120, DOI 10.1016/j.compbiolchem.2005.12.002; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Segal A, 2002, PFLUG ARCH EUR J PHY, V443, P882, DOI 10.1007/s00424-001-0773-x; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Stockand JD, 2008, IUBMB LIFE, V60, P620, DOI 10.1002/iub.89; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Tannous BA, 2009, MOL THER, V17, P810, DOI 10.1038/mt.2009.33; Team RDC, 2008, LANGUAGE ENV STAT CO; Teiwes J, 2007, AM J HYPERTENS, V20, P109, DOI 10.1016/j.amjhyper.2006.05.022; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang WZ, 2006, J BIOL CHEM, V281, P29369, DOI 10.1074/jbc.M605122200; Xiong ZG, 2008, CURR OPIN PHARMACOL, V8, P25, DOI 10.1016/j.coph.2007.09.001; Ye JH, 2007, BIOCHEM BIOPH RES CO, V355, P986, DOI 10.1016/j.bbrc.2007.02.061	51	26	26	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9627	9635		10.1074/jbc.M109.082735	http://dx.doi.org/10.1074/jbc.M109.082735			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20048170	hybrid, Green Published			2022-12-27	WOS:000276165900035
J	Zhu, HQ; Shan, LM; Schiller, PW; Mai, A; Peng, TQ				Zhu, Huaqing; Shan, Limei; Schiller, Peter W.; Mai, Antonello; Peng, Tianqing			Histone Deacetylase-3 Activation Promotes Tumor Necrosis Factor-alpha (TNF-alpha) Expression in Cardiomyocytes during Lipopolysaccharide Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B; MITOCHONDRIAL DYSFUNCTION; INHIBITORS; TRANSCRIPTION; RECEPTOR; OXIDASE; DEATH; GENE; OVEREXPRESSION; SPHINGOSINE	Lipopolysaccharides (LPS) induce tumor necrosis factor-alpha (TNF-alpha) production in cardiomyocytes, which contributes to myocardial depression during sepsis. However, the underlying mechanisms remain not fully understood. This study was undertaken to investigate the contribution of histone deacetylase (HDAC) to TNF- expression in cardiomyocytes and the signaling mechanism of LPS-induced HDAC activation. Here, we show for the first time that LPS increases HDAC activity and that inhibition of HDAC decreases LPS-stimulated TNF-alpha expression via the accumulation of NF-kappa B/p65 at the TNF-alpha promoter in cardiomyocytes. Using a positive screen, we have further identified HDAC3 as a specific member of the HDAC family able to regulate TNF-alpha production. Furthermore, our data reveal that LPS-induced HDAC activity is mediated through reactive oxygen species from mitochondria and c-Src signaling. In summary, this study demonstrates a novel signaling mechanism by which LPS via mitochondrial reactive oxygen species/c-Src/HDAC3 pathways mediate TNF-alpha expression in cardiomyocytes.	[Zhu, Huaqing; Shan, Limei; Peng, Tianqing] Univ Western Ontario, Lawson Hlth Res Inst, London, ON N6A 4G5, Canada; [Zhu, Huaqing; Shan, Limei; Peng, Tianqing] Univ Western Ontario, Dept Med, London, ON N6A 4G5, Canada; [Peng, Tianqing] Univ Western Ontario, Dept Pathol, London, ON N6A 4G5, Canada; [Zhu, Huaqing] Anhui Med Univ, Mol Biol Lab, Hefei 230032, Peoples R China; [Zhu, Huaqing] Anhui Med Univ, Dept Biochem, Hefei 230032, Peoples R China; [Schiller, Peter W.] Clin Res Inst Montreal, Lab Chem Biol & Peptide Res, Montreal, PQ H2W 1R7, Canada; [Mai, Antonello] Univ Roma La Sapienza, Inst Pasteur, Fdn Cenci Bolognetti, Dipartimento Chim & Tecnol Farmaco, I-00185 Rome, Italy	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Anhui Medical University; Anhui Medical University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Fondazione Cenci Bolognetti; Sapienza University Rome	Peng, TQ (corresponding author), VRL 6th Floor,A6-140,800 Commissioners Rd, London, ON N6A 4G5, Canada.	tpeng2@uwo.ca	Mai, Antonello/AAC-2144-2019; Peng, Tianqing/G-3340-2011	Mai, Antonello/0000-0001-9176-2382	Heart and Stroke Foundation of Ontario	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported by Grant-in-aid T6717 (to T.P.) from the Heart and Stroke Foundation of Ontario.	Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bode KA, 2007, IMMUNOLOGY, V122, P596, DOI 10.1111/j.1365-2567.2007.02678.x; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Choi Y, 2008, EXP MOL MED, V40, P574, DOI 10.3858/emm.2008.40.5.574; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Di Lisa F, 2009, BASIC RES CARDIOL, V104, P131, DOI 10.1007/s00395-009-0008-4; Doughan AK, 2008, CIRC RES, V102, P488, DOI 10.1161/CIRCRESAHA.107.162800; Duong V, 2008, MOL CANCER RES, V6, P1908, DOI 10.1158/1541-7786.MCR-08-0299; Gao ZG, 2006, J BIOL CHEM, V281, P4540, DOI 10.1074/jbc.M507784200; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Grandel U, 2000, CIRCULATION, V102, P2758, DOI 10.1161/01.CIR.102.22.2758; Hall G, 2005, AM J PHYSIOL-HEART C, V289, pH2103, DOI 10.1152/ajpheart.00393.2005; Han SB, 2009, ARCH PHARM RES, V32, P613, DOI 10.1007/s12272-009-1418-4; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kiernan R, 2003, J BIOL CHEM, V278, P2758, DOI 10.1074/jbc.M209572200; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Li Y, 2009, FREE RADICAL BIO MED, V46, P51, DOI 10.1016/j.freeradbiomed.2008.09.025; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; Mahlknecht U, 2004, J IMMUNOL, V173, P3979, DOI 10.4049/jimmunol.173.6.3979; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Mai A, 2003, J MED CHEM, V46, P4826, DOI 10.1021/jm034167p; Matteucci E, 2007, MOL CANCER RES, V5, P833, DOI 10.1158/1541-7786.MCR-07-0054; Nebbioso A, 2020, EMBO REP, V21, DOI [10.1038/embor.2009.88, 10.15252/embr.202051028]; Oral H, 1997, J BIOL CHEM, V272, P4836, DOI 10.1074/jbc.272.8.4836; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Peng TQ, 2004, FASEB J, V18, P293, DOI 10.1096/fj.04-2289fje; Peng TQ, 2005, CIRCULATION, V111, P1637, DOI 10.1161/01.CIR.0000160366.50210.E9; Peng TQ, 2003, CARDIOVASC RES, V59, P893, DOI 10.1016/S0008-6363(03)00509-1; Peng TQ, 2003, J BIOL CHEM, V278, P8099, DOI 10.1074/jbc.M207288200; Sato H, 2005, CARDIOVASC RES, V67, P714, DOI 10.1016/j.cardiores.2005.04.017; Schiller PW, 2000, EUR J MED CHEM, V35, P895, DOI 10.1016/S0223-5234(00)01171-5; Shang FJ, 2006, BIOCHEM BIOPH RES CO, V351, P947, DOI 10.1016/j.bbrc.2006.10.134; Shen X, 2006, DIABETES, V55, P798, DOI 10.2337/diabetes.55.03.06.db05-1039; Suuronen T, 2003, J NEUROCHEM, V87, P407, DOI 10.1046/j.1471-4159.2003.02004.x; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Tibaldi E, 2008, J CELL BIOCHEM, V104, P840, DOI 10.1002/jcb.21670; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Wosniak J, 2009, ANTIOXID REDOX SIGN, V11, P1265, DOI 10.1089/ars.2009.2392; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	40	68	76	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9429	9436		10.1074/jbc.M109.071274	http://dx.doi.org/10.1074/jbc.M109.071274			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097764	Green Published, hybrid			2022-12-27	WOS:000276165900015
J	Benos, DJ				Benos, Dale J.			Biochemistry in Medicine: Hypertension Minireview Series	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material									Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Benos, DJ (corresponding author), Univ Alabama, Dept Physiol & Biophys, UAb Stn, Birmingham, AL 35294 USA.	benos@uab.edu							0	0	0	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8507	8507		10.1074/jbc.R109.025072	http://dx.doi.org/10.1074/jbc.R109.025072			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20118247	Green Published, hybrid			2022-12-27	WOS:000275553700001
J	Bhalla-Gehi, R; Penuela, S; Churko, JM; Shao, Q; Laird, DW				Bhalla-Gehi, Ruchi; Penuela, Silvia; Churko, Jared M.; Shao, Qing; Laird, Dale W.			Pannexin1 and Pannexin3 Delivery, Cell Surface Dynamics, and Cytoskeletal Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; LATERAL MOBILITY; PLASMA-MEMBRANE; BREFELDIN-A; INTERLEUKIN-1-BETA RELEASE; CONNEXIN GENES; CHANNELS; TRAFFICKING; RECEPTORS; MIGRATION	Pannexins (Panx) are a class of integral membrane proteins that have been proposed to exhibit characteristics similar to those of connexin family members. In this study, we utilized Cx43-positive BICR-M1Rk cells to stably express Panx1, Panx3, or Panx1-green fluorescent protein (GFP) to assess their trafficking, cell surface dynamics, and interplay with the cytoskeletal network. Expression of a Sar1 dominant negative mutant revealed that endoplasmic reticulum to Golgi transport of Panx1 and Panx3 was mediated via COPII-dependent vesicles. Distinct from Cx43-GFP, fluorescence recovery after photo-bleaching studies revealed that both Panx1-GFP and Panx3GFP remained highly mobile at the cell surface. Unlike Cx43, Panx1-GFP exhibited no detectable interrelationship with microtubules. Conversely, cytochalasin B-induced disruption of microfilaments caused a severe loss of cell surface Panx1-GFP, a reduction in the recoverable fraction of Panx1-GFP that remained at the cell surface, and a decrease in Panx1-GFP vesicular transport. Furthermore, co-immunoprecipitation and co-sedimentation assays revealed actin as a novel binding partner of Panx1. Collectively, we conclude that although Panx1 and Panx3 share a common endoplasmic reticulum to Golgi secretory pathway to Cx43, their ultimate cell surface residency appears to be independent of cell contacts and the need for intact microtubules. Importantly, Panx1 has an interaction with actin microfilaments that regulates its cell surface localization and mobility.	[Bhalla-Gehi, Ruchi; Penuela, Silvia; Churko, Jared M.; Shao, Qing; Laird, Dale W.] Univ Western Ontario, Dept Anat & Cell Biol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Laird, DW (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Dent Sci Bldg, London, ON N6A 5C1, Canada.	Dale.Laird@schulich.uwo.ca	Penuela, Silvia/A-6961-2010; Laird, Dale W/AAL-2407-2020; Laird, Dale w/E-4176-2015	Penuela, Silvia/0000-0003-4829-5517; Laird, Dale W/0000-0002-4568-3285; 	Canadian Institutes of Health Research; National Sciences and Engineering Council of Canada studentship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Sciences and Engineering Council of Canada studentship	This work was supported by a Canadian Institutes of Health Research operating grant (to D.W.L.) and a National Sciences and Engineering Council of Canada studentship (to R.B.).	ANGELIDES KJ, 1988, J CELL BIOL, V106, P1911, DOI 10.1083/jcb.106.6.1911; Baranova A, 2004, GENOMICS, V83, P706, DOI 10.1016/j.ygeno.2003.09.025; Barbe MT, 2006, PHYSIOLOGY, V21, P103, DOI 10.1152/physiol.00048.2005; Boassa D, 2008, CELL COMMUN ADHES, V15, P119, DOI 10.1080/15419060802013885; Boassa D, 2007, J BIOL CHEM, V282, P31733, DOI 10.1074/jbc.M702422200; Bruzzone R, 2003, P NATL ACAD SCI USA, V100, P13644, DOI 10.1073/pnas.2233464100; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Bunse S, 2005, CELL COMMUN ADHES, V12, P231, DOI 10.1080/15419060500511834; Dahl G, 2006, IUBMB LIFE, V58, P409, DOI 10.1080/15216540600794526; DONALDSON JG, 1992, NATURE, V360, P350, DOI 10.1038/360350a0; Dong C, 2008, CELL SIGNAL, V20, P1035, DOI 10.1016/j.cellsig.2008.01.014; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Fan Dominic, 2002, J Exp Ther Oncol, V2, P286, DOI 10.1046/j.1359-4117.2002.01053.x; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; Hendriks R, 1999, J NEUROSCI RES, V58, P805, DOI 10.1002/(SICI)1097-4547(19991215)58:6<805::AID-JNR7>3.0.CO;2-V; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Johnson RG, 2002, EXP CELL RES, V275, P67, DOI 10.1006/excr.2002.5480; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; KLAUSNER RD, 1980, J BIOL CHEM, V255, P1286; Lai CPK, 2007, CANCER RES, V67, P1545, DOI 10.1158/0008-5472.CAN-06-1396; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; LAIRD DW, 1995, J CELL BIOL, V131, P1193, DOI 10.1083/jcb.131.5.1193; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Ma WH, 2009, J PHARMACOL EXP THER, V328, P409, DOI 10.1124/jpet.108.146365; Mayo C, 2008, INVEST OPHTH VIS SCI, V49, P4384, DOI 10.1167/iovs.08-1688; MUSIL LS, 1993, CELL, V74, P1065, DOI 10.1016/0092-8674(93)90728-9; NIGG EA, 1980, P NATL ACAD SCI-BIOL, V77, P4702, DOI 10.1073/pnas.77.8.4702; PALLER MS, 1994, J MEMBRANE BIOL, V142, P127; Panchin Y, 2000, CURR BIOL, V10, pR473, DOI 10.1016/S0960-9822(00)00576-5; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Penuela S, 2008, CELL COMMUN ADHES, V15, P133, DOI 10.1080/15419060802014115; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Penuela S, 2009, MOL BIOL CELL, V20, P4313, DOI 10.1091/mbc.E09-01-0067; POO MM, 1982, NATURE, V295, P332, DOI 10.1038/295332a0; Qin H, 2002, J BIOL CHEM, V277, P29132, DOI 10.1074/jbc.M200797200; Rorth P, 2009, ANNU REV CELL DEV BI, V25, P407, DOI 10.1146/annurev.cellbio.042308.113231; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sato K, 2004, J BIOCHEM, V136, P755, DOI 10.1093/jb/mvh184; Scemes E, 2007, NEURON GLIA BIOL, V3, P199, DOI 10.1017/S1740925X08000069; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Simek J, 2009, J CELL SCI, V122, P554, DOI 10.1242/jcs.036970; SRINIVASAN Y, 1990, J NEUROSCI, V10, P985; Taneja TK, 2009, HUM MOL GENET, V18, P2400, DOI 10.1093/hmg/ddp179; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Thompson RJ, 2006, SCIENCE, V312, P924, DOI 10.1126/science.1126241; Thompson RJ, 2008, SCIENCE, V322, P1555, DOI 10.1126/science.1165209; Unger VM, 1999, NOVART FDN SYMP, V219, P22; UNGER VM, 1999, NOVART FDN SYMP, V219, P31; WANG YJ, 1995, J CELL SCI, V108, P3501; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076	61	82	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9147	9160		10.1074/jbc.M109.082008	http://dx.doi.org/10.1074/jbc.M109.082008			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086016	Green Published, hybrid			2022-12-27	WOS:000275553700064
J	Zhang, M; Wang, MN; Tan, XH; Li, TF; Zhang, YE; Chen, D				Zhang, Ming; Wang, Meina; Tan, Xiaohong; Li, Tian-Fang; Zhang, Ying E.; Chen, Di			Smad3 Prevents beta-Catenin Degradation and Facilitates beta-Catenin Nuclear Translocation in Chondrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MESENCHYMAL STEM-CELLS; F-BOX PROTEIN; SIGNALING CROSS-TALK; TGF-BETA; UBIQUITIN LIGASE; CARCINOMA CELLS; WNT PATHWAYS; DIFFERENTIATION; BONE	Our previous study demonstrated that transforming growth factor (TGF)-beta activates beta-catenin signaling through Smad3 interaction with beta-catenin in chondrocytes. In the present studies, we further investigated the detailed molecular mechanism of the cross-talk between TGF-beta/Smad3 and Wnt/beta-catenin signaling pathways. We found that C-terminal Smad3 interacted with both the N-terminal region and the middle region of beta-catenin protein in a TGF-beta-dependent manner. Both Smad3 and Smad4 were required for the interaction with beta-catenin and protected beta-catenin from an ubiquitin-proteasome-dependent degradation. In addition, the formation of the Smad3-Smad4-beta-catenin protein complex also mediated beta-catenin nuclear translocation. This Smad3-mediated regulatory mechanism of beta-catenin protein stability enhanced the activity of beta-catenin to activate downstream target genes during chondrogenesis. Our findings demonstrate a novel mechanism between TGF-beta and Wnt/beta-catenin signaling pathways during chondrocyte development.	[Zhang, Ming; Wang, Meina; Tan, Xiaohong; Li, Tian-Fang; Chen, Di] Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA; [Zhang, Ying E.] NCI, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	University of Rochester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Chen, D (corresponding author), Univ Rochester, Med Ctr, Ctr Musculoskeletal Res, Dept Orthopaed & Rehabil, Rochester, NY 14642 USA.	di_chen@urmc.rochester.edu	Zhang, Ying E/G-3657-2015; Zhang, Ming/H-6467-2011; Wang, Meina/K-8915-2012	Zhang, Ying E/0000-0003-2753-7601; 	National Institutes of Health [R01 AR051189, R01 AR054465, K02 AR052411, R01 AR055915]; New York State Department of Health [N08G-070]; Empire State Stem Cell Board; NATIONAL CANCER INSTITUTE [ZIABC010419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR052411, R01AR054465, R01AR051189, R01AR055915] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health; Empire State Stem Cell Board; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR051189, R01 AR054465, K02 AR052411, and R01 AR055915 (to D. C.). This work was also supported by Grant N08G-070 (to D. C.) from the New York State Department of Health and the Empire State Stem Cell Board.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Ferguson CM, 2000, ENDOCRINOLOGY, V141, P4728, DOI 10.1210/en.141.12.4728; Furuhashi M, 2001, MOL CELL BIOL, V21, P5132, DOI 10.1128/MCB.21.15.5132-5141.2001; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Guo W, 2008, J BIOL CHEM, V283, P9136, DOI 10.1074/jbc.M708968200; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Haq S, 2003, P NATL ACAD SCI USA, V100, P4610, DOI 10.1073/pnas.0835895100; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hirota M, 2008, CELL SIGNAL, V20, P1632, DOI 10.1016/j.cellsig.2008.05.003; Ionescu AM, 2003, EXP CELL RES, V288, P198, DOI 10.1016/S0014-4827(03)00181-2; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Jian HY, 2006, GENE DEV, V20, P666, DOI 10.1101/gad.1388806; Jin EJ, 2006, INT J BIOCHEM CELL B, V38, P183, DOI 10.1016/j.biocel.2005.08.013; Kawakami Y, 2006, CURR OPIN CELL BIOL, V18, P723, DOI 10.1016/j.ceb.2006.10.007; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Labbe E, 2000, P NATL ACAD SCI USA, V97, P8358, DOI 10.1073/pnas.150152697; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Li TF, 2006, J BONE MINER RES, V21, P4, DOI 10.1359/JBMR.050911; Li TF, 2006, J BIOL CHEM, V281, P21296, DOI 10.1074/jbc.M600514200; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Mishra L, 2005, ONCOGENE, V24, P5775, DOI 10.1038/sj.onc.1208924; Monga SPS, 2002, CANCER RES, V62, P2064; Nakashima A, 2005, J BIOL CHEM, V280, P37660, DOI 10.1074/jbc.M504612200; Nishita M, 2000, NATURE, V403, P781, DOI 10.1038/35001602; Romero D, 2008, CARCINOGENESIS, V29, P1070, DOI 10.1093/carcin/bgn054; Serra R, 1997, J CELL BIOL, V139, P541, DOI 10.1083/jcb.139.2.541; Song LN, 2005, J BIOL CHEM, V280, P37853, DOI 10.1074/jbc.M503850200; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; Waldrip WR, 1998, CELL, V92, P797, DOI 10.1016/S0092-8674(00)81407-5; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Xiao Z, 2000, P NATL ACAD SCI USA, V97, P7853, DOI 10.1073/pnas.97.14.7853; Xiao Z, 2000, J BIOL CHEM, V275, P23425, DOI 10.1074/jbc.C000345200; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35; Zhou SH, 2004, J BONE MINER RES, V19, P463, DOI 10.1359/JBMR.0301239	42	71	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8703	8710		10.1074/jbc.M109.093526	http://dx.doi.org/10.1074/jbc.M109.093526			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20097766	Green Published, hybrid			2022-12-27	WOS:000275553700023
J	Sharma, A; Kaur, M; Kar, A; Ranade, SM; Saxena, S				Sharma, Aparna; Kaur, Manpreet; Kar, Ananya; Ranade, Sourabh M.; Saxena, Sandeep			Ultraviolet Radiation Stress Triggers the Down-regulation of Essential Replication Factor Mcm10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA POLYMERASE-ALPHA; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CHROMATIN ASSOCIATION; DAMAGE; ORIGINS; COMPLEX; PROTEOLYSIS; INITIATION; STABILITY	We report that upon UV radiation insult, mammalian cells specifically down-regulate Mcm10, a protein essential for the initiation and elongation phases of DNA replication. The levels of a majority of replication factors remain unaffected under this condition, implying that Mcm10 is a key node in the regulation of the replication machinery. High doses of ionizing gamma radiation and exposure to a combination of DNA-damaging chemicals do not decrease Mcm10 protein levels, demonstrating that Mcm10 down-regulation is triggered only by UV-specific damage. The decrease of Mcm10 protein levels is not caused by transcriptional inhibition or cleavage by apoptotic enzymes, but results from degradation by the 26 S proteasome. UV-triggered degradation of Mcm10 requires its linker or C-terminal domain. In addition, Mcm10 down-regulation is not limited to cells from a particular lineage. Therefore, our study reveals a mechanism by which mammalian cells effectively inhibit the replication machinery during stress to prevent it from drifting toward a catastrophic path of genomic instability.	[Sharma, Aparna; Kaur, Manpreet; Kar, Ananya; Ranade, Sourabh M.; Saxena, Sandeep] Natl Inst Immunol, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Saxena, S (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	sandeep@nii.res.in		Kar, Ananya/0000-0003-0966-0833	Department of Biotechnology and Science of Technology of the Government of India; NET fellowship	Department of Biotechnology and Science of Technology of the Government of India; NET fellowship	This work was supported by sanctioned projects from the Department of Biotechnology and Science of Technology of the Government of India and a NET fellowship (to A. S. and M. K.).	Chattopadhyay S, 2007, MOL BIOL CELL, V18, P4085, DOI 10.1091/mbc.E06-12-1148; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; Gentile M, 2003, NUCLEIC ACIDS RES, V31, P4779, DOI 10.1093/nar/gkg675; Hall JR, 2007, MOL BIOL CELL, V18, P3340, DOI 10.1091/mbc.E07-02-0173; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Homesley L, 2000, GENE DEV, V14, P913; Izumi M, 2004, J BIOL CHEM, V279, P32569, DOI 10.1074/jbc.M314017200; Izumi M, 2001, J BIOL CHEM, V276, P48526, DOI 10.1074/jbc.M107190200; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Koppen A, 2007, EUR J CANCER, V43, P2413, DOI 10.1016/j.ejca.2007.07.024; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Park JH, 2008, BIOCHEM BIOPH RES CO, V365, P575, DOI 10.1016/j.bbrc.2007.11.003; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Robertson PD, 2008, J BIOL CHEM, V283, P3338, DOI 10.1074/jbc.M706267200; SOLOMON NA, 1992, YEAST, V8, P273, DOI 10.1002/yea.320080405; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yoshida K, 2004, ONCOGENE, V23, P6250, DOI 10.1038/sj.onc.1207829; Zhang SF, 2007, J BIOL CHEM, V282, P15330, DOI 10.1074/jbc.M610356200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	21	16	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8352	8362		10.1074/jbc.M109.041129	http://dx.doi.org/10.1074/jbc.M109.041129			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20064936	Green Published, hybrid			2022-12-27	WOS:000275413800051
J	Ekberg, K; Palmgren, MG; Veierskov, B; Buch-Pedersen, MJ				Ekberg, Kira; Palmgren, Michael G.; Veierskov, Bjarke; Buch-Pedersen, Morten J.			A Novel Mechanism of P-type ATPase Autoinhibition Involving Both Termini of the Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE H+-ATPASE; PLANT PLASMA-MEMBRANE; SINGLE-POINT MUTATIONS; CRYSTAL-STRUCTURE; PROTON PUMP; FUNCTIONAL COMPLEMENTATION; REGULATORY DOMAIN; DELETION ANALYSIS; C-TERMINUS; CA2+ PUMP	The activity of many P-type ATPases is found to be regulated by interacting proteins or autoinhibitory elements located in Nor C-terminal extensions. An extended C terminus of fungal and plant P-type plasma membrane H+-ATPases has long been recognized to be part of a regulatory apparatus involving an autoinhibitory domain. Here we demonstrate that both the N and the C termini of the plant plasma membrane H+-ATPase are directly involved in controlling the pump activity state and that N-terminal displacements are coupled to secondary modifications taking place at the C-terminal end. This identifies the first group of P-type ATPases for which both ends of the polypeptide chain constitute regulatory domains, which together contribute to the autoinhibitory apparatus. This suggests an intricate mechanism of cis-regulation with both termini of the protein communicating to obtain the necessary control of the enzyme activity state.	[Ekberg, Kira; Palmgren, Michael G.; Veierskov, Bjarke; Buch-Pedersen, Morten J.] Univ Copenhagen, Plant Physiol & Anat Lab, Dept Plant Biol & Biotechnol, DK-1871 Frederiksberg, Denmark; Univ Copenhagen, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-1871 Frederiksberg, Denmark	University of Copenhagen; Danmarks Grundforskningsfond; University of Copenhagen	Buch-Pedersen, MJ (corresponding author), Univ Copenhagen, Plant Physiol & Anat Lab, Dept Plant Biol & Biotechnol, Thorvaldsensvej 40, DK-1871 Frederiksberg, Denmark.	mob@life.ku.dk	Palmgren, Michael/A-9808-2013; Veierskov, Bjarke/H-3024-2014	Palmgren, Michael/0000-0002-9982-6114; Veierskov, Bjarke/0000-0002-3676-5895				Axelsen KB, 1999, BIOCHEMISTRY-US, V38, P7227, DOI 10.1021/bi982482l; Buch-Pedersen MJ, 2000, J BIOL CHEM, V275, P39167, DOI 10.1074/jbc.M007537200; CID A, 1987, CURR GENET, V12, P105, DOI 10.1007/BF00434664; Corradi GR, 2007, J BIOL CHEM, V282, P35440, DOI 10.1074/jbc.M703377200; DeWitt ND, 1995, PLANT CELL, V7, P2053, DOI 10.1105/tpc.7.12.2053; DEWITT ND, 1991, PLANT J, V1, P121, DOI 10.1111/j.1365-313X.1991.00121.x; DEXAERDE AD, 1995, J BIOL CHEM, V270, P23828, DOI 10.1074/jbc.270.40.23828; Duby G, 2009, J BIOL CHEM, V284, P4213, DOI 10.1074/jbc.M807311200; ENYEDI A, 1993, J BIOL CHEM, V268, P10621; EWING NN, 1994, PLANT PHYSIOL, V106, P547, DOI 10.1104/pp.106.2.547; Fong YW, 2000, MOL CELL BIOL, V20, P5897, DOI 10.1128/MCB.20.16.5897-5907.2000; Fuglsang AT, 1999, J BIOL CHEM, V274, P36774, DOI 10.1074/jbc.274.51.36774; Gevaudant F, 2001, PLANTA, V212, P619, DOI 10.1007/s004250000438; HARPER JF, 1990, J BIOL CHEM, V265, P13601; Harper JF, 1998, J BIOL CHEM, V273, P1099, DOI 10.1074/jbc.273.2.1099; Hentzen AE, 1996, PLANT CELL PHYSIOL, V37, P650, DOI 10.1093/oxfordjournals.pcp.a028994; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Jahn TP, 2002, J BIOL CHEM, V277, P6353, DOI 10.1074/jbc.M109637200; Jonsen MD, 1996, MOL CELL BIOL, V16, P2065; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Lecchi S, 2005, BIOCHEMISTRY-US, V44, P16624, DOI 10.1021/bi051555f; Lecchi S, 2007, J BIOL CHEM, V282, P35471, DOI 10.1074/jbc.M706094200; Mason AB, 1998, BBA-BIOMEMBRANES, V1372, P261, DOI 10.1016/S0005-2736(98)00065-0; Maudoux O, 2000, J BIOL CHEM, V275, P17762, DOI 10.1074/jbc.M909690199; Moriau L, 1999, PLANT J, V19, P31, DOI 10.1046/j.1365-313X.1999.00495.x; Morsomme P, 1996, EMBO J, V15, P5513, DOI 10.1002/j.1460-2075.1996.tb00936.x; Morsomme P, 1998, J BIOL CHEM, V273, P34837, DOI 10.1074/jbc.273.52.34837; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Niittylae T, 2007, MOL CELL PROTEOMICS, V6, P1711, DOI 10.1074/mcp.M700164-MCP200; Nuhse TS, 2003, MOL CELL PROTEOMICS, V2, P1234, DOI 10.1074/mcp.T300006-MCP200; Olsson A, 1998, PLANT PHYSIOL, V118, P551, DOI 10.1104/pp.118.2.551; Ottmann C, 2007, MOL CELL, V25, P427, DOI 10.1016/j.molcel.2006.12.017; PALMGREN MG, 1993, FEBS LETT, V317, P216, DOI 10.1016/0014-5793(93)81279-9; PALMGREN MG, 1991, J BIOL CHEM, V266, P20470; Palmgren MG, 2001, ANNU REV PLANT PHYS, V52, P817, DOI 10.1146/annurev.arplant.52.1.817; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; PORTILLO F, 1989, FEBS LETT, V247, P381, DOI 10.1016/0014-5793(89)81375-4; Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; Svennelid F, 1999, PLANT CELL, V11, P2379, DOI 10.1105/tpc.11.12.2379; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; VENEMA K, 1995, J BIOL CHEM, V270, P19659, DOI 10.1074/jbc.270.33.19659; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341	43	51	52	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7344	7350		10.1074/jbc.M109.096123	http://dx.doi.org/10.1074/jbc.M109.096123			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20068040	Green Published, hybrid			2022-12-27	WOS:000275415600046
J	Shanahan, MT; Vidrich, A; Shirafuji, Y; Dubois, CL; Henschen-Edman, A; Hagen, SJ; Cohn, SM; Ouellette, AJ				Shanahan, Michael T.; Vidrich, Alda; Shirafuji, Yoshinori; Dubois, Claire L.; Henschen-Edman, Agnes; Hagen, Susan J.; Cohn, Steven M.; Ouellette, Andre J.			Elevated Expression of Paneth Cell CRS4C in Ileitis-prone SAMP1/YitFc Mice REGIONAL DISTRIBUTION, SUBCELLULAR LOCALIZATION, AND MECHANISM OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL HOST-DEFENSE; CYSTEINE-RICH PEPTIDES; MOUSE SMALL-INTESTINE; ALPHA-DEFENSINS; ANTIMICROBIAL PEPTIDES; MATRIX METALLOPROTEINASE-7; HUMAN-NEUTROPHILS; DISULFIDE ARRAY; GENE FAMILY; ACTIVATION	Paneth cells at the base of small intestinal crypts of Lieberkuhn secrete host defense peptides and proteins, including alpha-defensins, as mediators of innate immunity. Mouse Paneth cells also express alpha-defensin-related Defcr-rs genes that code for cysteine-rich sequence 4C (CRS4C) peptides that have a unique CPX triplet repeat motif. In ileitis-prone SAMP1/YitFc mice, Paneth cell levels of CRS4C mRNAs and peptides are induced more than a 1000-fold relative to non-prone strains as early as 4 weeks of age, with the mRNA and peptide levels highest in distal ileum and below detection in duodenum. CRS4C-1 peptides are found exclusively in Paneth cells where they occur only in dense core granules and thus are secreted to function in the intestinal lumen. CRS4C bactericidal peptide activity is membrane-disruptive in that it permeabilizes Escherichia coli and induces rapid microbial cell K+ efflux, but in a manner different from mouse alpha-defensin cryptdin-4. In in vitro studies, inactive pro-CRS4C-1 is converted to bactericidal CRS4C-1 peptide by matrix metalloproteinase-7 (MMP-7) proteolysis of the precursor proregion at the same residue positions that MMP-7 activates mouse pro-alpha-defensins. The absence of processed CRS4C in protein extracts of MMP-7-null mouse ileum demonstrates the in vivo requirement for intracellular MMP-7 in pro-CRS4C processing.	[Shanahan, Michael T.; Ouellette, Andre J.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Shirafuji, Yoshinori; Dubois, Claire L.; Ouellette, Andre J.] Univ Calif Irvine, Dept Pathol & Lab Med, Sch Med, Coll Hlth Sci, Irvine, CA 92697 USA; [Henschen-Edman, Agnes] Univ Calif Irvine, Dept Mol Biol & Biochem, Sch Biol Sci, Irvine, CA 92697 USA; [Vidrich, Alda; Cohn, Steven M.] Univ Virginia, Digest Hlth Ctr Excellence, Charlottesville, VA 22908 USA; [Hagen, Susan J.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of Virginia; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Ouellette, AJ (corresponding author), Univ So Calif, Dept Pathol & Lab Med, Keck Sch Med, USC Norris Canc Ctr, NRT-7514 Mailcode 9601,1450 Biggy St, Los Angeles, CA 90089 USA.	andre.ouellette@med.usc.edu			National Institutes of Health [R01 DK044632, R01 AI059346, R01 DK064751, P01 DK57880]; Human Frontiers Science Program; Molecular Biology and Morphology Cores of the University of Virginia National Institutes Diabetes and Digestive and Kidney Diseases/National Institutes of Health Digestive Diseases Research Core Center [P30 DK067629]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059346] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057880, R01DK044632, R01DK064751, P30DK067629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontiers Science Program(Human Frontier Science Program); Molecular Biology and Morphology Cores of the University of Virginia National Institutes Diabetes and Digestive and Kidney Diseases/National Institutes of Health Digestive Diseases Research Core Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK044632 and R01 AI059346 and by the Human Frontiers Science Program ( to A.J.O.) and by National Institutes of Health Grants R01 DK064751 and P01 DK57880 ( to S. M. C.) and through the Molecular Biology and Morphology Cores of the University of Virginia National Institutes Diabetes and Digestive and Kidney Diseases/National Institutes of Health Digestive Diseases Research Core Center Grant P30 DK067629.	Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Barnes SL, 2007, J IMMUNOL, V179, P7012, DOI 10.4049/jimmunol.179.10.7012; Baroncelli S, 2007, AIDS RES HUM RETROV, V23, P287, DOI 10.1089/aid.2006.0142; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Clarke LL, 2004, AM J PHYSIOL-GASTR L, V286, pG1050, DOI 10.1152/ajpgi.00393.2003; Elphick D, 2008, AM J PATHOL, V172, P702, DOI 10.2353/ajpath.2008.070755; Figueredo SM, 2009, J BIOL CHEM, V284, P6826, DOI 10.1074/jbc.M807024200; GANZ T, 1985, J CLIN INVEST, V76, P1427, DOI 10.1172/JCI112120; GANZ T, 1993, BLOOD, V82, P641; Ge YB, 1997, ARCH HISTOL CYTOL, V60, P133; Ghosh D, 2002, NAT IMMUNOL, V3, P583, DOI 10.1038/ni797; Hadjicharalambous C, 2008, BIOCHEMISTRY-US, V47, P12626, DOI 10.1021/bi800335e; HAGEN SJ, 1990, J ELECTRON MICR TECH, V16, P37, DOI 10.1002/jemt.1060160106; HARWIG SSL, 1993, ANAL BIOCHEM, V208, P382, DOI 10.1006/abio.1993.1065; Hornef MW, 2004, NAT IMMUNOL, V5, P836, DOI 10.1038/ni1094; Hristova K, 1996, BIOCHEMISTRY-US, V35, P11888, DOI 10.1021/bi961100d; HUTTNER KM, 1994, GENOMICS, V19, P448, DOI 10.1006/geno.1994.1093; HUTTNER KM, 1994, GENOMICS, V24, P99, DOI 10.1006/geno.1994.1586; Kamdar K, 2008, J BIOL CHEM, V283, P32361, DOI 10.1074/jbc.M805296200; Karlsson J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-37; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; LAMBERT PA, 1973, BIOCHEM BIOPH RES CO, V54, P796, DOI 10.1016/0006-291X(73)91494-0; LEHRER RI, 1988, J IMMUNOL METHODS, V108, P153, DOI 10.1016/0022-1759(88)90414-0; Lehrer RI, 2007, CURR OPIN HEMATOL, V14, P16, DOI 10.1097/00062752-200701000-00005; Maemoto A, 2004, J BIOL CHEM, V279, P44188, DOI 10.1074/jbc.M406154200; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Miszta A, 2008, J PEPT SCI, V14, P503, DOI 10.1002/psc.938; Mukherjee S, 2008, CELL MOL LIFE SCI, V65, P3019, DOI 10.1007/s00018-008-8182-3; Orlov DS, 2002, J MICROBIOL METH, V49, P325, DOI 10.1016/S0167-7012(01)00383-9; Ouellette AJ, 1999, INFECT IMMUN, V67, P6643; Ouellette AJ, 2000, J BIOL CHEM, V275, P33969, DOI 10.1074/jbc.M004062200; OUELLETTE AJ, 1994, INFECT IMMUN, V62, P5040, DOI 10.1128/IAI.62.11.5040-5047.1994; Ouellette AJ, 1996, FASEB J, V10, P1280, DOI 10.1096/fasebj.10.11.8836041; OUELLETTE AJ, 1990, J BIOL CHEM, V265, P9831; Patil A, 2004, PHYSIOL GENOMICS, V20, P1, DOI 10.1152/physiolgenomics.00150.2004; Porter EM, 1997, INFECT IMMUN, V65, P2389, DOI 10.1128/IAI.65.6.2389-2395.1997; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Putsep K, 2000, J BIOL CHEM, V275, P40478, DOI 10.1074/jbc.M007816200; Rajabi M, 2008, J BIOL CHEM, V283, P21509, DOI 10.1074/jbc.M801851200; RICE WG, 1987, BLOOD, V70, P757; Rivera-Nieves J, 2003, GASTROENTEROLOGY, V124, P972, DOI 10.1053/gast.2003.50148; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Satchell DP, 2003, PEPTIDES, V24, P1795, DOI 10.1016/j.peptides.2003.08.020; Satchell DP, 2003, J BIOL CHEM, V278, P13838, DOI 10.1074/jbc.M212115200; Schutte BC, 2002, ANNU REV PHYSIOL, V64, P709, DOI 10.1146/annurev.physiol.64.081501.134340; Selsted M E, 1993, Genet Eng (N Y), V15, P131; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; SELSTED ME, 1989, J BIOL CHEM, V264, P4003; Selsted ME, 2007, CURR PHARM DESIGN, V13, P3061, DOI 10.2174/138161207782110363; Shirafuji Y, 2003, J BIOL CHEM, V278, P7910, DOI 10.1074/jbc.M210600200; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Stappenbeck TS, 2009, GASTROENTEROLOGY, V137, P30, DOI 10.1053/j.gastro.2009.05.013; Tanabe H, 2004, INFECT IMMUN, V72, P1470, DOI 10.1128/IAI.72.3.1470-1478.2004; Tincu JA, 2003, J BIOL CHEM, V278, P13546, DOI 10.1074/jbc.M211332200; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Valore EV, 1996, J CLIN INVEST, V97, P1624, DOI 10.1172/JCI118588; VALORE EV, 1992, BLOOD, V79, P1538; Vidrich A, 2005, AM J PATHOL, V166, P1055, DOI 10.1016/S0002-9440(10)62326-7; Wang MSC, 1997, ANAL BIOCHEM, V253, P225, DOI 10.1006/abio.1997.2347; Weeks CS, 2006, J BIOL CHEM, V281, P28932, DOI 10.1074/jbc.M602041200; WHITE SH, 1995, CURR OPIN STRUC BIOL, V5, P521, DOI 10.1016/0959-440X(95)80038-7; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wu ZB, 2007, J MOL BIOL, V368, P537, DOI 10.1016/j.jmb.2007.02.040	69	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7493	7504		10.1074/jbc.M109.083220	http://dx.doi.org/10.1074/jbc.M109.083220			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056603	Green Published, hybrid			2022-12-27	WOS:000275415600061
J	Doxakis, E				Doxakis, Epaminondas			Post-transcriptional Regulation of alpha-Synuclein Expression by mir-7 and mir-153	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; GENE-EXPRESSION; MESSENGER-RNAS; MICRORNAS; TARGET; AGGREGATION; DEGRADATION; AUTOPHAGY; INSIGHTS; MONKEYS	Genetic and biochemical studies have established a central role for alpha-synuclein accumulation in the pathogenesis of Parkinson disease. Here, two microRNAs, namely mir-7 and mir-153, have been identified to regulate alpha-synuclein levels post-transcriptionally. These microRNAs bind specifically to the 3'-untranslated region of alpha-synuclein and down-regulate its mRNA and protein levels, with their effect being additive. They are expressed predominantly in the brain with a pattern that mirrors synuclein expression in different tissues as well as during neuronal development, indicating that they play a tuning role in the amount of alpha-synuclein produced. Overexpression of mir-7 and mir-153 significantly reduces endogenous alpha-synuclein levels, whereas inhibition of mir-7 and mir-153 enhances translation of a luciferase construct bearing the alpha-synuclein 3'-untranslated region in primary neurons. These findings reveal a significant additional mechanism by which alpha-synuclein is regulated and point toward new therapeutic regimes for lowering endogenous alpha-synuclein levels in patients with familial or sporadic Parkinson disease.	Acad Athens, Basic Neurosci Div, Biomed Res Fdn, Athens 11527, Greece	Academy of Athens	Doxakis, E (corresponding author), Acad Athens, Basic Neurosci Div, Biomed Res Fdn, Soranou Efesiou 4, Athens 11527, Greece.			Doxakis, Epaminondas/0000-0003-1305-0739	Biomedical Research Foundation, Academy of Athens	Biomedical Research Foundation, Academy of Athens	Recipient of seed funding from the Biomedical Research Foundation, Academy of Athens.	Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Behm-Ansmant I, 2006, COLD SPRING HARB SYM, V71, P523, DOI 10.1101/sqb.2006.71.013; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Chu YP, 2007, NEUROBIOL DIS, V25, P134, DOI 10.1016/j.nbd.2006.08.021; Doxakis E, 2004, CURR BIOL, V14, P1761, DOI 10.1016/j.cub.2004.09.050; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; EULALIO A, 2009, RNA, V32, P15; Ge LM, 1997, BIOTECHNIQUES, V22, P28, DOI 10.2144/97221bm03; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Lai EC, 2005, CURR BIOL, V15, pR458, DOI 10.1016/j.cub.2005.06.015; Lao KQ, 2006, BIOCHEM BIOPH RES CO, V343, P85, DOI 10.1016/j.bbrc.2006.02.106; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705; Sathyan P, 2007, J NEUROSCI, V27, P8546, DOI 10.1523/JNEUROSCI.1269-07.2007; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Vogiatzi T, 2008, J BIOL CHEM, V283, P23542, DOI 10.1074/jbc.M801992200; Walker SJ, 2006, ALCOHOL, V38, P1, DOI 10.1016/j.alcohol.2006.03.008; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Winkler S, 2007, NEUROLOGY, V69, P1745, DOI 10.1212/01.wnl.0000275524.15125.f4	36	345	366	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12726	12734		10.1074/jbc.M109.086827	http://dx.doi.org/10.1074/jbc.M109.086827			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20106983	Green Published, hybrid			2022-12-27	WOS:000276787800031
J	Garcia-Marcos, M; Ghosh, P; Ear, J; Farquhar, MG				Garcia-Marcos, Mikel; Ghosh, Pradipta; Ear, Jason; Farquhar, Marilyn G.			A Structural Determinant That Renders G alpha(i) Sensitive to Activation by GIV/Girdin Is Required to Promote Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; RECEPTOR-MEDIATED ACTIVATION; PROTEIN SIGNALING PROTEINS; ENDOGENOUS RGS PROTEINS; BREAST-CANCER CELLS; ADENYLYL-CYCLASE; LYSOPHOSPHATIDIC ACID; ALPHA-SUBUNITS; GTP HYDROLYSIS; CRYSTAL-STRUCTURE	Although several non-receptor activators of heterotrimeric G proteins have been identified, the structural features of G proteins that determine their interaction with such activators and the subsequent biological effects are poorly understood. Here we investigated the structural determinants in G alpha i(3) necessary for its regulation by GIV/girdin, a guanine-nucleotide exchange factor (GEF) that activates G alpha(i) subunits. Using G protein activity and in vitro pulldown assays we demonstrate that G alpha i(3) is a better substrate for GIV than the highly homologous G alpha(o). We identified Trp-258 in the G alpha(i) subunit as a novel structural determinant for GIV binding by comparing GIV binding to G alpha(i3)/G alpha(o) chimeras. Mutation of Trp-258 to the corresponding Phe in G alpha(o) decreased GIV binding in vitro and in cultured cells but did not perturb interaction with other G alpha-binding partners, i.e. G beta gamma, AGS3 (a guanine nucleotide dissociation inhibitor), GAIP/RGS19 (a GTPase-activating protein), and LPAR1 (a G protein-coupled receptor). Activation of G alpha(i3) by GIV was also dramatically reduced when Trp-258 was replaced with Tyr, Leu, Ser, His, Asp, or Ala, highlighting that Trp is required for maximal activation. Moreover, when mutant G alpha(i3) W258F was expressed in HeLa cells they failed to undergo cell migration and to enhance Akt signaling after growth factor or G protein-coupled receptor stimulation. Thus activation of G alpha(i3) by GIV is essential for biological functions associated with G alpha(i3) activation. In conclusion, we have discovered a novel structural determinant on G alpha(i) that plays a key role in defining the selectivity and efficiency of the GEF activity of GIV on G alpha(i) and that represents an attractive target site for designing small molecules to disrupt the G alpha(i)-GIV interface for therapeutic purposes.	[Farquhar, Marilyn G.] Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, La Jolla, CA 92093 USA; [Ghosh, Pradipta; Ear, Jason] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Farquhar, MG (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, George Palade Labs Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mfarquhar@ucsd.edu		Garcia-Marcos, Mikel/0000-0001-9513-4826	National Institutes of Health [DKI7780, CA100768]; Basque Government [BFI06.300]; Susan G. Komen Postdoctoral Fellowship [KG080079]; American Gastroenterology Association [T32 DK07202]; McNair Student Research Scholarship; NATIONAL CANCER INSTITUTE [R01CA100768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basque Government(Basque Government); Susan G. Komen Postdoctoral Fellowship(Susan G. Komen Breast Cancer Foundation); American Gastroenterology Association; McNair Student Research Scholarship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DKI7780 and CA100768 (to M. G. F.).; Supported by Basque Government Postdoctoral Fellowship BFI06.300 and Susan G. Komen Postdoctoral Fellowship KG080079.; Supported by a Research Scholar Award from the American Gastroenterology Association and by Training Grant T32 DK07202.; Recipient of a McNair Student Research Scholarship.	Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Anai M, 2005, J BIOL CHEM, V280, P18525, DOI 10.1074/jbc.M500586200; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Cavalli A, 2000, J BIOL CHEM, V275, P23693, DOI 10.1074/jbc.M910395199; Chen Z, 2005, NAT STRUCT MOL BIOL, V12, P191, DOI 10.1038/nsmb888; Cismowski MJ, 1999, NAT BIOTECHNOL, V17, P878, DOI 10.1038/12867; Clark MJ, 2003, J BIOL CHEM, V278, P9418, DOI 10.1074/jbc.M208885200; Clark MJ, 2004, J PHARMACOL EXP THER, V310, P215, DOI 10.1124/jpet.103.064824; CODINA J, 1994, J BIOL CHEM, V269, P29339; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; DeVries L, 1996, P NATL ACAD SCI USA, V93, P15203, DOI 10.1073/pnas.93.26.15203; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Fu Y, 2006, CIRC RES, V98, P659, DOI 10.1161/01.RES.0000207497.50477.60; Fu Y, 2004, METHOD ENZYMOL, V389, P229; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Grishina G, 1998, J BIOL CHEM, V273, P15053, DOI 10.1074/jbc.273.24.15053; Huang CF, 1997, P NATL ACAD SCI USA, V94, P6159, DOI 10.1073/pnas.94.12.6159; Huang XY, 2008, DIABETES, V57, P77, DOI 10.2337/db07-0599; Ishii I, 2000, MOL PHARMACOL, V58, P895, DOI 10.1124/mol.58.5.895; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Johnston CA, 2005, STRUCTURE, V13, P1069, DOI 10.1016/j.str.2005.04.007; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; KLEUSS C, 1994, P NATL ACAD SCI USA, V91, P9828, DOI 10.1073/pnas.91.21.9828; Krumins AM, 2002, METHOD ENZYMOL, V344, P673; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lane JR, 2008, J PHARMACOL EXP THER, V325, P319, DOI 10.1124/jpet.107.134296; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Malik S, 2005, MOL PHARMACOL, V68, P129, DOI 10.1124/mol.104.010116; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Mukhopadhyay S, 2002, METHOD ENZYMOL, V344, P350; Natochin M, 2005, J BIOL CHEM, V280, P30236, DOI 10.1074/jbc.M500722200; Nishimura A, 2006, GENES CELLS, V11, P487, DOI 10.1111/j.1365-2443.2006.00959.x; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Qiao M, 2007, CANCER RES, V67, P5293, DOI 10.1158/0008-5472.CAN-07-0877; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Slep KC, 2008, P NATL ACAD SCI USA, V105, P6243, DOI 10.1073/pnas.0801569105; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; Sunahara RK, 1997, SCIENCE, V278, P1943, DOI 10.1126/science.278.5345.1943; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Vazquez-Prado J, 2004, J BIOL CHEM, V279, P54283, DOI 10.1074/jbc.M410594200; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warner DR, 1999, P NATL ACAD SCI USA, V96, P4268, DOI 10.1073/pnas.96.8.4268; Willard FS, 2008, J BIOL CHEM, V283, P36698, DOI 10.1074/jbc.M804936200; Wise A, 1999, BIOCHEMISTRY-US, V38, P2272, DOI 10.1021/bi982054f; Ye XQ, 2002, BBA-MOL CELL BIOL L, V1585, P108, DOI 10.1016/S1388-1981(02)00330-X	61	59	63	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12765	12777		10.1074/jbc.M109.045161	http://dx.doi.org/10.1074/jbc.M109.045161			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20157114	Green Published, hybrid			2022-12-27	WOS:000276787800035
J	Donelan, W; Koya, V; Li, SW; Yang, LJ				Donelan, William; Koya, Vijay; Li, Shi-Wu; Yang, Li-Jun			Distinct Regulation of Hepatic Nuclear Factor 1 alpha by NKX6.1 in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; DNA-BINDING; FACTOR-I; MOLECULAR-GENETICS; INSULIN-SECRETION; P1 PROMOTER; EXPRESSION; GENES; HNF-1-ALPHA; HNF1	Hepatic nuclear factor 1 alpha (HNF1 alpha) is a key regulator of development and function in pancreatic beta cells and is specifically involved in regulation of glycolysis and glucose-stimulated insulin secretion. Abnormal expression of HNF1 alpha leads to development of MODY3 (maturity-onset diabetes of the young 3). We report that NK6 homeodomain 1 (NKX6.1) binds to a cis-regulatory element in the HNF1 alpha promoter and is a major regulator of this gene in beta cells. We identified an NKX6.1 recognition sequence in the distal region of the HNF1 alpha promoter and demonstrated specific binding of NKX6.1 in beta cells by electrophoretic mobility shift and chromatin immunoprecipitation assays. Site-directed mutagenesis of the NKX6.1 core-binding sequence eliminated NKX6.1-mediated activation and substantially decreased activity of the HNF1 alpha promoter in beta cells. Overexpression or small interfering RNA-mediated knockdown of the Nkx6.1 gene resulted in increased or diminished HNF1 alpha gene expression, respectively, in beta cells. We conclude that NKX6.1 is a novel regulator of HNF1 alpha in pancreatic beta cells. This novel regulatory mechanism for HNF1 alpha in beta cells may provide new molecular targets for the diagnosis of MODY3.	[Donelan, William; Koya, Vijay; Li, Shi-Wu; Yang, Li-Jun] Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Yang, LJ (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Coll Med, Dent Sci Bldg D6-28,1600 SW Archer Rd, Gainesville, FL 32610 USA.	yanglj@pathology.ufl.edu		Donelan, William/0000-0001-7742-8089	National Institutes of Health [DK071831, DK64054]; NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK064054, R01DK071831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DK071831 and DK64054 (to L.-J.Y.) from NIDDK.	BACH I, 1993, EMBO J, V12, P4229, DOI 10.1002/j.1460-2075.1993.tb06107.x; Ban N, 2002, DIABETES, V51, P1409, DOI 10.2337/diabetes.51.5.1409; BAUMHUETER S, 1990, GENE DEV, V4, P372, DOI 10.1101/gad.4.3.372; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Borowiec M, 2009, P NATL ACAD SCI USA, V106, P14460, DOI 10.1073/pnas.0906474106; DELLA MT, 2007, J PEDIAT, V83, pS178; Eeckhoute J, 2003, ENDOCRINOLOGY, V144, P1686, DOI 10.1210/en.2002-0024; Ellard S, 2008, DIABETOLOGIA, V51, P546, DOI 10.1007/s00125-008-0942-y; EMENS LA, 1992, P NATL ACAD SCI USA, V89, P7300, DOI 10.1073/pnas.89.16.7300; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; Fodor A, 2007, DIABETOLOGIA, V50, P121, DOI 10.1007/s00125-006-0509-8; FOULKES NS, 1992, CELL, V68, P411, DOI 10.1016/0092-8674(92)90178-F; Gauthier BR, 2007, BIOCHEM J, V403, P593, DOI 10.1042/BJ20070053; GREGORI C, 1993, NUCLEIC ACIDS RES, V21, P897, DOI 10.1093/nar/21.4.897; Hansen SK, 2002, J CLIN INVEST, V110, P827, DOI 10.1172/JCI200215085; Harries LW, 2008, DIABETES, V57, P1745, DOI 10.2337/db07-1742; Harries LW, 2006, HUM MOL GENET, V15, P2216, DOI 10.1093/hmg/ddl147; Hattersley A, 2006, PEDIATR DIABETES, V7, P352, DOI 10.1111/j.1399-5448.2006.00217.x; Hattersley AT, 2005, CLIN MED, V5, P476, DOI 10.7861/clinmedicine.5-5-476; Huang JM, 2008, DIABETES-METAB RES, V24, P533, DOI 10.1002/dmrr.870; Huang JM, 2009, EXP CELL RES, V315, P1200, DOI 10.1016/j.yexcr.2009.01.004; Ihara A, 2005, BIOCHEM BIOPH RES CO, V329, P984, DOI 10.1016/j.bbrc.2005.02.072; Iype T, 2004, MOL ENDOCRINOL, V18, P1363, DOI 10.1210/me.2004-0006; Jorgensen MC, 1999, FEBS LETT, V461, P287, DOI 10.1016/S0014-5793(99)01436-2; Koya V, 2008, DIABETES, V57, P757, DOI 10.2337/db07-1441; Kulkarni RN, 2004, SCIENCE, V303, P1311, DOI 10.1126/science.1095486; KUO CJ, 1990, P NATL ACAD SCI USA, V87, P9838, DOI 10.1073/pnas.87.24.9838; Lee YH, 1998, MOL CELL BIOL, V18, P3059, DOI 10.1128/MCB.18.5.3059; Luco RF, 2006, DIABETES, V55, P2202, DOI 10.2337/db05-1534; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Marchetti P, 2006, NUTR METAB CARDIOVAS, V16, pS3, DOI 10.1016/j.numecd.2005.10.017; McCarthy MI, 2008, DIABETES, V57, P2889, DOI 10.2337/db08-0343; MENDEL DB, 1991, J BIOL CHEM, V266, P677; Mirmira RG, 2000, J BIOL CHEM, V275, P14743, DOI 10.1074/jbc.275.19.14743; Mitchell SMS, 2002, MOL GENET METAB, V77, P35, DOI 10.1016/S1096-7192(02)00150-6; MIURA N, 1993, NUCLEIC ACIDS RES, V21, P3731, DOI 10.1093/nar/21.16.3731; Murphy R, 2008, NAT CLIN PRACT ENDOC, V4, P200, DOI 10.1038/ncpendmet0778; Nakhei H, 1998, NUCLEIC ACIDS RES, V26, P497, DOI 10.1093/nar/26.2.497; Oster A, 1998, J HISTOCHEM CYTOCHEM, V46, P707, DOI 10.1177/002215549804600602; Pearson ER, 2000, DIABETIC MED, V17, P543, DOI 10.1046/j.1464-5491.2000.00305.x; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Pontoglio M, 1997, MOL CELL BIOL, V17, P4948, DOI 10.1128/MCB.17.9.4948; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Ryffel GU, 2001, J MOL ENDOCRINOL, V27, P11, DOI 10.1677/jme.0.0270011; Sander M, 2000, DEVELOPMENT, V127, P5533; Satoh S, 2005, J BIOL CHEM, V280, P39827, DOI 10.1074/jbc.M507303200; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schisler JC, 2008, MOL CELL BIOL, V28, P3465, DOI 10.1128/MCB.01791-07; Shepherd M, 2003, DIABETES CARE, V26, P3191, DOI 10.2337/diacare.26.11.3191-a; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Taylor DG, 2005, BIOCHEMISTRY-US, V44, P11269, DOI 10.1021/bi050821m; TIAN JM, 1991, GENE DEV, V5, P2225, DOI 10.1101/gad.5.12a.2225; Uchizono Y, 2009, DIABETES RES CLIN PR, V84, P19, DOI 10.1016/j.diabres.2008.12.014; Watada H, 2000, J BIOL CHEM, V275, P34224, DOI 10.1074/jbc.M004981200; Weber H, 1996, INT J DEV BIOL, V40, P297; Wobser H, 2002, J BIOL CHEM, V277, P6413, DOI 10.1074/jbc.M108390200	57	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12181	12189		10.1074/jbc.M109.064238	http://dx.doi.org/10.1074/jbc.M109.064238			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20106981	Green Published, hybrid			2022-12-27	WOS:000276787100048
J	Choi, HS; Han, GS; Carman, GM				Choi, Hyeon-Son; Han, Gil-Soo; Carman, George M.			Phosphorylation of Yeast Phosphatidylserine Synthase by Protein Kinase A IDENTIFICATION OF SER46 AND SER47 AS MAJOR SITES OF PHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID BIOSYNTHESIS; TRANSCRIPTIONAL REGULATION; COORDINATE REGULATION; MEMBRANE INSERTION; GENETIC-REGULATION; STRUCTURAL GENE; MUTANT; INOSITOL	The CHO1-encoded phosphatidylserine synthase from Saccharomyces cerevisiae is phosphorylated and inhibited by protein kinase A in vitro. CHO1 alleles bearing Ser(46) -> Ala and/or Ser(47) -> Ala mutations were constructed and expressed in a cho1 Delta mutant lacking phosphatidylserine synthase. In vitro, the S46A/S47A mutation reduced the total amount of phosphorylation by 90% and abolished the inhibitory effect protein kinase A had on phosphatidylserine synthase activity. The enzyme phosphorylation by protein kinase A, which was time- and dose-dependent and dependent on the concentration of ATP, caused a electrophoretic mobility shift from a 27-kDa form to a 30-kDa form. The two electrophoretic forms of phosphatidylserine synthase were present in exponential phase cells, whereas only the 27-kDa form was present in stationary phase cells. In vivo labeling with P-32(i) and immune complex analysis showed that the 30-kDa form was predominantly phosphorylated when compared with the 27-kDa form. However, the S46A/S47A mutations abolished the protein kinase A-mediated electrophoretic mobility shift. The S46A/S47A mutations also caused a 55% reduction in the total amount of phosphatidylserine synthase in exponential phase cells and a 66% reduction in the amount of enzyme in stationary phase cells. In phospholipid composition analysis, cells expressing the S46A/S47A mutant enzyme exhibited a 57% decrease in phosphatidylserine and a 40% increase in phosphatidylinositol. These results indicate that phosphatidylserine synthase is phosphorylated on Ser(46) and Ser(47) by protein kinase A, which results in a higher amount of enzyme for the net effect of stimulating the synthesis of phosphatidylserine.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA; Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	carman@aesop.rutgers.edu			National Institutes of Health [GM-50679]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050679] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-50679.	ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BAELEE M, 1990, J BIOL CHEM, V265, P7221; BAELEE MS, 1984, J BIOL CHEM, V259, P857; BAILIS AM, 1992, NUCLEIC ACIDS RES, V20, P1411, DOI 10.1093/nar/20.6.1411; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2009, J LIPID RES, V50, pS69, DOI 10.1194/jlr.R800043-JLR200; CARMAN GM, 1992, METHOD ENZYMOL, V209, P298; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; Carman GM, 1996, J BIOL CHEM, V271, P13293, DOI 10.1074/jbc.271.23.13293; Chen M, 2007, BBA-MOL CELL BIOL L, V1771, P310, DOI 10.1016/j.bbalip.2006.05.017; Choi HS, 2004, J BIOL CHEM, V279, P12081, DOI 10.1074/jbc.M400297200; Choi HS, 2007, J BIOL CHEM, V282, P31217, DOI 10.1074/jbc.M705098200; CULBERTSON MR, 1975, GENETICS, V80, P23; Greenberg ML, 1996, MICROBIOL REV, V60, P1; HAID A, 1983, METHOD ENZYMOL, V96, P192; Harlow E., 1988, ANTIBODIES LAB MANUA; Henry S. A., 1982, MOL BIOL YEAST SACCH, P101; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; HOMANN MJ, 1987, J BACTERIOL, V169, P533, DOI 10.1128/jb.169.2.533-539.1987; HOMANN MJ, 1987, J BACTERIOL, V169, P3276, DOI 10.1128/jb.169.7.3276-3280.1987; Innis MA, 1990, PCR PROTOCOLS GUIDE, P3; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KIYONO K, 1987, J BIOCHEM-TOKYO, V102, P1089, DOI 10.1093/oxfordjournals.jbchem.a122147; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KOHLWEIN SD, 1988, J BACTERIOL, V170, P3778, DOI 10.1128/jb.170.8.3778-3781.1988; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMPING E, 1994, GENETICS, V137, P55; LARSON TJ, 1976, BIOCHEMISTRY-US, V15, P5212, DOI 10.1021/bi00669a003; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; LIEBERMAN I, 1956, J BIOL CHEM, V222, P765; MACDONALD JIS, 1994, J BIOL CHEM, V269, P10529; MCDONOUGH VM, 1995, J BIOL CHEM, V270, P18774, DOI 10.1074/jbc.270.32.18774; MORLOCK KR, 1988, J BACTERIOL, V170, P3561, DOI 10.1128/jb.170.8.3561-3566.1988; Natter K, 2005, MOL CELL PROTEOMICS, V4, P662, DOI 10.1074/mcp.M400123-MCP200; NIKAWA J, 1987, EUR J BIOCHEM, V167, P7, DOI 10.1111/j.1432-1033.1987.tb13297.x; Odell AF, 2005, J BIOL CHEM, V280, P37974, DOI 10.1074/jbc.M503646200; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; PALTAUF F, 1992, MOL CELLULAR BIOL YE, P415; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; POOLE MA, 1986, J BACTERIOL, V168, P668, DOI 10.1128/jb.168.2.668-672.1986; RATTRAY JBM, 1975, BACTERIOL REV, V39, P197, DOI 10.1128/MMBR.39.3.197-231.1975; Rose MD., 1990, METHODS YEAST GENETI; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SIKORSKI RS, 1989, GENETICS, V122, P19; SPERKAGOTTLIEB C, 1990, YEAST, V6, P331, DOI 10.1002/yea.320060406; TAYLOR FR, 1979, BIOCHIM BIOPHYS ACTA, V575, P204, DOI 10.1016/0005-2760(79)90022-5; THEVELEIN JM, 1994, YEAST, V10, P1753, DOI 10.1002/yea.320101308; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; Vance JE, 1998, TRENDS BIOCHEM SCI, V23, P423, DOI 10.1016/S0968-0004(98)01297-3; Wang Q, 2009, J VIROL, V83, P3668, DOI 10.1128/JVI.02063-08; Williams JG, 1998, J BIOL CHEM, V273, P13482, DOI 10.1074/jbc.273.22.13482; Yamashita S, 1997, BBA-LIPID LIPID MET, V1348, P228, DOI 10.1016/S0005-2760(97)00102-1; Yang JW, 2007, P NATL ACAD SCI USA, V104, P20055, DOI 10.1073/pnas.0708574104; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777	65	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11526	11536		10.1074/jbc.M110.100727	http://dx.doi.org/10.1074/jbc.M110.100727			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145252	hybrid, Green Published			2022-12-27	WOS:000276286200059
J	Lee, LW; Mapp, AK				Lee, Lori W.; Mapp, Anna K.			Transcriptional Switches: Chemical Approaches to Gene Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SMALL-MOLECULE INHIBITORS; THYROID-HORMONE RECEPTOR; BETA-PEPTIDE INHIBITORS; TRANSACTIVATION DOMAIN; NUCLEAR RECEPTOR; KIX DOMAIN; COACTIVATOR INTERACTION; BREAST-CANCER; PROTEIN-INTERACTION; ANDROGEN RECEPTOR	Given the role of transcriptional misregulation in the pathogenesis of human disease, there is enormous interest in the development of molecules that exogenously control transcription in a defined manner. The past decade has seen many exciting advancements in the identification of molecules that mimic or inhibit the interactions between natural transcriptional activators and their binding partners. In this minireview, we focus on four activator.target protein complexes, highlighting recent advances as well as challenges in the field.	[Lee, Lori W.; Mapp, Anna K.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Mapp, AK (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.	amapp@umich.edu	, Dr Anna Mapp/GPX-8261-2022					Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Ansari AZ, 2002, CURR OPIN CHEM BIOL, V6, P765, DOI 10.1016/S1367-5931(02)00377-0; Ard PG, 2002, MOL CELL BIOL, V22, P5650, DOI 10.1128/MCB.22.16.5650-5661.2002; Arndt HD, 2006, ANGEW CHEM INT EDIT, V45, P4552, DOI 10.1002/anie.200600285; Arnold LA, 2005, J BIOL CHEM, V280, P43048, DOI 10.1074/jbc.M506693200; Arnold LA, 2007, J MED CHEM, V50, P5269, DOI 10.1021/jm070556y; Asada S, 2003, J AM CHEM SOC, V125, P4992, DOI 10.1021/ja0292703; Asada S, 2002, P NATL ACAD SCI USA, V99, P12747, DOI 10.1073/pnas.202162199; Berg T, 2008, CURR OPIN CHEM BIOL, V12, P464, DOI 10.1016/j.cbpa.2008.07.023; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Best JL, 2004, P NATL ACAD SCI USA, V101, P17622, DOI 10.1073/pnas.0406374101; Black JC, 2006, MOL CELL, V23, P809, DOI 10.1016/j.molcel.2006.07.018; Block KM, 2009, J AM CHEM SOC, V131, P18078, DOI 10.1021/ja807601b; Buhrlage SJ, 2009, ACS CHEM BIOL, V4, P335, DOI 10.1021/cb900028j; Campbell KM, 2002, BIOCHEMISTRY-US, V41, P13956, DOI 10.1021/bi026222m; Chan HM, 2001, J CELL SCI, V114, P2363; Chang C, 2001, J BIOL CHEM, V276, P30956, DOI 10.1074/jbc.M102254200; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Chhabra A, 2007, ONCOL REP, V18, P953; Chi SW, 2005, J BIOL CHEM, V280, P38795, DOI 10.1074/jbc.M508578200; Darimont BD, 1998, GENE DEV, V12, P3343, DOI 10.1101/gad.12.21.3343; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; DeGregori J, 2002, BBA-REV CANCER, V1602, P131, DOI 10.1016/S0304-419X(02)00051-3; Dervan PB, 2003, CURR OPIN STRUC BIOL, V13, P284, DOI 10.1016/S0959-440X(03)00081-2; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Dervan Peter B., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P373, DOI 10.2174/1568011054222346; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Feau C, 2009, ACS CHEM BIOL, V4, P834, DOI 10.1021/cb900143a; Fishburn J, 2005, MOL CELL, V18, P369, DOI 10.1016/j.molcel.2005.03.029; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Goodman RH, 2000, GENE DEV, V14, P1553; Hainaut P, 2000, ADV CANCER RES, V77, P81; Harker EA, 2009, CHEMBIOCHEM, V10, P990, DOI 10.1002/cbic.200900049; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hu CQ, 2008, CURR MED CHEM, V15, P1720, DOI 10.2174/092986708784872375; Jung DJ, 2009, J AM CHEM SOC, V131, P4774, DOI 10.1021/ja900669k; Kristensen VN, 2005, CLIN CANCER RES, V11, p878S; Kritzer JA, 2005, J AM CHEM SOC, V127, P14584, DOI 10.1021/ja055050o; Kritzer JA, 2004, J AM CHEM SOC, V126, P9468, DOI 10.1021/ja031625a; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lee CW, 2009, BIOCHEMISTRY-US, V48, P2115, DOI 10.1021/bi802055v; Lee LW, 2009, BIOORG MED CHEM LETT, V19, P6233, DOI 10.1016/j.bmcl.2009.08.090; Li BBX, 2009, CHEMBIOCHEM, V10, P2721, DOI 10.1002/cbic.200900552; Ma QP, 2009, MOL ENDOCRINOL, V23, P213, DOI 10.1210/me.2008-0147; Majmudar CY, 2005, CURR OPIN CHEM BIOL, V9, P467, DOI 10.1016/j.cbpa.2005.08.012; Mapp AK, 2007, ACS CHEM BIOL, V2, P62, DOI 10.1021/cb600463w; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; McPhaul MJ, 2002, MOL CELL ENDOCRINOL, V198, P61, DOI 10.1016/S0303-7207(02)00369-6; Minter AR, 2004, J AM CHEM SOC, V126, P10504, DOI 10.1021/ja0473889; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PTASHNE M, 2002, GENES SIGNALS; Pupa SM, 2005, J CELL PHYSIOL, V205, P10, DOI 10.1002/jcp.20387; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Radhakrishnan I, 1999, J MOL BIOL, V287, P859, DOI 10.1006/jmbi.1999.2658; Reeves WM, 2005, MOL CELL BIOL, V25, P9092, DOI 10.1128/MCB.25.20.9092-9102.2005; Reik A, 2007, BIOTECHNOL BIOENG, V97, P1180, DOI 10.1002/bit.21304; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; Rowe SP, 2007, J AM CHEM SOC, V129, P10654, DOI 10.1021/ja0736865; Sarek G, 2007, J CLIN INVEST, V117, P1019, DOI 10.1172/JCI30945; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Shimogawa H, 2004, J AM CHEM SOC, V126, P3461, DOI 10.1021/ja038855+; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tovar C, 2006, P NATL ACAD SCI USA, V103, P1888, DOI 10.1073/pnas.0507493103; Vassilev LT, 2005, J MED CHEM, V48, P4491, DOI 10.1021/jm058174k; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Xiao XS, 2007, J COMB CHEM, V9, P592, DOI 10.1021/cc070023a; Xiao XS, 2007, ANGEW CHEM INT EDIT, V46, P2865, DOI 10.1002/anie.200604485; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038	80	35	36	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11033	11038		10.1074/jbc.R109.075044	http://dx.doi.org/10.1074/jbc.R109.075044			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147748	hybrid, Green Published			2022-12-27	WOS:000276286200003
J	Xie, HDQ; Liang, D; Leung, KW; Chen, VP; Zhu, KY; Chan, WKB; Choi, RCY; Massoulie, J; Tsim, KWK				Xie, Heidi Q.; Liang, Dong; Leung, K. Wing; Chen, Vicky P.; Zhu, Kevin Y.; Chan, Wallace K. B.; Choi, Roy C. Y.; Massoulie, Jean; Tsim, Karl W. K.			Targeting Acetylcholinesterase to Membrane Rafts A FUNCTION MEDIATED BY THE PROLINE-RICH MEMBRANE ANCHOR (PRiMA) IN NEURONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBULAR FORM ACETYLCHOLINESTERASE; CHARACTERIZING FAST MUSCLES; TERMINAL T-PEPTIDE; LIPID RAFTS; TRANSCRIPTIONAL REGULATION; DEPENDENT RECRUITMENT; GENE-EXPRESSION; MOLECULAR-FORMS; BRAIN; PROTEINS	In the mammalian brain, acetylcholinesterase (AChE) is anchored in cell membranes by a transmembrane protein PRiMA (proline-rich membrane anchor). We present evidence that at least part of the PRiMA-linked AChE is integrated in membrane microdomains called rafts. A significant proportion of PRiMA-linked AChE tetramers from rat brain was recovered in raft fractions; this proportion was markedly higher at low rather than at high concentrations of cold Triton X-100. The detergent-resistant fraction increased during brain development. In NG108-15 neuroblastoma cells transfected with cDNAs encoding AChE(T) and PRiMA, PRiMA-linked G(4) AChE was found in membrane rafts and showed the same sensitivity to cold Triton X-100 extraction as in the brain. The association of PRiMA-linked AChE with rafts was weaker than that of glycosylphosphatidylinositol-anchored G(2) AChE or G(4) Q(N)-H-C-linked AChE. It was found to depend on the presence of a cholesterol-binding motif, called CRAC ( cholesterol recognition/interaction amino acid consensus), located at the junction of transmembrane and cytoplasmic domains of both PRiMA I and II isoforms. The cytoplasmic domain of PRiMA, which differs between PRiMA I and PRiMA II, appeared to play some role in stabilizing the raft localization of G(4) AChE, because the Triton X-100-resistant fraction was smaller with the shorter PRiMA II isoform than that with the longer PRiMA I isoform.	[Xie, Heidi Q.; Leung, K. Wing; Chen, Vicky P.; Zhu, Kevin Y.; Chan, Wallace K. B.; Choi, Roy C. Y.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China; [Xie, Heidi Q.; Leung, K. Wing; Chen, Vicky P.; Zhu, Kevin Y.; Chan, Wallace K. B.; Choi, Roy C. Y.; Tsim, Karl W. K.] Hong Kong Univ Sci & Technol, Ctr Chinese Med, Kowloon, Hong Kong, Peoples R China; [Liang, Dong; Massoulie, Jean] Ecole Normale Super, CNRS, Neurobiol Lab, UMR 8544, F-75005 Paris, France	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Tsim, KWK (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China.	botsim@ust.hk	CHEN, VICKY/C-9223-2016	CHEN, VICKY/0000-0003-3753-7170; Tsim, Karl/0000-0003-4808-1674; Leung, Ka Wing/0000-0002-6137-3877	Research Grants Council of Hong Kong [N_HKUST629/07, 662407, 662608, F-HK21/06T]; Croucher Foundation [CAS-CF07/08.SC03]; CNRS; Ecole Normale Superieure; Association Francais Contre les Myopathies; French Ministry of Foreign Affairs	Research Grants Council of Hong Kong(Hong Kong Research Grants Council); Croucher Foundation; CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Normale Superieure; Association Francais Contre les Myopathies(Association Francaise contre les Myopathies); French Ministry of Foreign Affairs	This work was supported by Research Grants Council of Hong Kong Grants N_HKUST629/07, 662407, 662608, and F-HK21/06T, Croucher Foundation Grant CAS-CF07/08.SC03 (to K. W. K. T.), CNRS, Ecole Normale Superieure, Association Francais Contre les Myopathies, and French Ministry of Foreign Affairs (to J.M.).	Belbeoc'h S, 2003, EMBO J, V22, P3536, DOI 10.1093/emboj/cdg360; Brimijoin S, 1996, NEUROSCIENCE, V71, P555, DOI 10.1016/0306-4522(95)00457-2; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; CHATEL JM, 1993, P NATL ACAD SCI USA, V90, P2476, DOI 10.1073/pnas.90.6.2476; Choi RCY, 1997, NEUROSCI LETT, V236, P167, DOI 10.1016/S0304-3940(97)00789-1; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Epand RM, 2006, PROG LIPID RES, V45, P279, DOI 10.1016/j.plipres.2006.02.001; Falasca C, 2005, J BIOL CHEM, V280, P878, DOI 10.1074/jbc.M409201200; GISIGER V, 1988, J NEUROSCI RES, V19, P62, DOI 10.1002/jnr.490190110; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; Hering H, 2003, J NEUROSCI, V23, P3262; INESTROSA NC, 1994, NEUROSCI LETT, V173, P155, DOI 10.1016/0304-3940(94)90172-4; Inestrosa NC, 1998, J PHYSIOLOGY-PARIS, V92, P341, DOI 10.1016/S0928-4257(99)80002-3; JASMIN BJ, 1990, J NEUROSCI, V10, P1444; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; Leung KW, 2009, FEBS J, V276, P3031, DOI 10.1111/j.1742-4658.2009.07022.x; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Ma L, 2003, J NEUROSCI, V23, P3164; Massoulie J, 2002, NEUROSIGNALS, V11, P130, DOI 10.1159/000065054; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Massoulie J, 2006, J MOL NEUROSCI, V30, P233, DOI 10.1385/JMN:30:1:233; Mok MKW, 2009, NEUROSCI LETT, V461, P202, DOI 10.1016/j.neulet.2009.06.015; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Neumann-Giesen C, 2004, BIOCHEM J, V378, P509, DOI 10.1042/BJ20031100; Noureddine H, 2008, J BIOL CHEM, V283, P20722, DOI 10.1074/jbc.M801364200; Noureddine H, 2007, J BIOL CHEM, V282, P3487, DOI 10.1074/jbc.M607221200; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; Perrier NA, 2005, J NEUROCHEM, V94, P629, DOI 10.1111/j.1471-4159.2005.03140.x; Perrier NA, 2003, EUR J NEUROSCI, V18, P1837, DOI 10.1046/j.1460-9568.2003.02914.x; Perry C, 2002, ONCOGENE, V21, P8428, DOI 10.1038/sj.onc.1205945; Pick M, 2004, ANN NY ACAD SCI, V1018, P85, DOI 10.1196/annals.1296.010; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; ROTUNDO RL, 1988, J BIOL CHEM, V263, P19398; Saslowsky DE, 2002, J BIOL CHEM, V277, P26966, DOI 10.1074/jbc.M204669200; SCHNITZER JE, 1995, SCIENCE, V269, P1435, DOI 10.1126/science.7660128; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Shogomori H, 2003, BIOL CHEM, V384, P1259, DOI 10.1515/BC.2003.139; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Simon S, 1998, EMBO J, V17, P6178, DOI 10.1093/emboj/17.21.6178; Siow NL, 2005, CHEM-BIOL INTERACT, V157, P423, DOI 10.1016/j.cbi.2005.10.088; SMART EJ, 1995, P NATL ACAD SCI USA, V92, P10104, DOI 10.1073/pnas.92.22.10104; Sternfeld M, 1998, J NEUROSCI, V18, P1240; STYA M, 1983, J CELL BIOL, V97, P48, DOI 10.1083/jcb.97.1.48; Suzuki T, 2008, J NEUROCHEM, V104, P596, DOI 10.1111/j.1471-4159.2007.05035.x; WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121; Xie HQ, 2007, J BIOL CHEM, V282, P11765, DOI 10.1074/jbc.M608265200; Xie HQ, 2009, BRAIN RES, V1265, P13, DOI 10.1016/j.brainres.2009.01.065	53	45	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11537	11546		10.1074/jbc.M109.038711	http://dx.doi.org/10.1074/jbc.M109.038711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147288	hybrid, Green Published			2022-12-27	WOS:000276286200060
J	Jacobsen, KT; Adlerz, L; Multhaup, G; Iverfeldt, K				Jacobsen, Kristin T.; Adlerz, Linda; Multhaup, Gerd; Iverfeldt, Kerstin			Insulin-like Growth Factor-1 (IGF-1)-induced Processing of Amyloid-beta Precursor Protein (APP) and APP-like Protein 2 Is Mediated by Different Metalloproteinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; UP-REGULATION; KINASE-C; ECTODOMAIN; PHOSPHORYLATION; FAMILY; APLP2; EXPRESSION	alpha-Secretase cleavage of the amyloid precursor protein (APP) is of great interest because it prevents the formation of the Alzheimer-linked amyloid-beta peptide. APP belongs to a conserved gene family including the two paralogues APP-like protein (APLP) 1 and 2. Insulin-like growth factor-1 (IGF-1) stimulates the shedding of all three proteins. IGF-1-induced shedding of both APP and APLP1 is dependent on phosphatidylinositol 3-kinase (PI3-K), whereas APLP2 shedding is independent of this signaling pathway. Here, we used human neuroblastoma SH-SY5Y cells to investigate the involvement of protein kinase C (PKC) in the proteolytic processing of endogenously expressed members of the APP family. Processing was induced by IGF-1 or retinoic acid, another known stimulator of APP alpha-secretase shedding. Our results show that stimulation of APP and APLP1 processing involves multiple signaling pathways, whereas APLP2 processing is mainly dependent on PKC. Next, we wanted to investigate whether the difference in the regulation of APLP2 shedding compared with APP shedding could be due to involvement of different processing enzymes. We focused on the two major alpha-secretase candidates ADAM10 and TACE, which both are members of the ADAM(a disintegrin and metalloprotease) family. Shedding was analyzed in the presence of the ADAM10 inhibitor GI254023X, or after transfection with small interfering RNAs targeted against TACE. The results clearly demonstrate that different alpha-secretases are involved in IGF-1-induced processing. APP is mainly cleaved by ADAM10, whereas APLP2 processing is mediated by TACE. Finally, we also show that IGF-1 induces PKC-dependent phosphorylation of TACE.	[Jacobsen, Kristin T.; Adlerz, Linda; Iverfeldt, Kerstin] Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden; [Multhaup, Gerd] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Stockholm University; Free University of Berlin	Iverfeldt, K (corresponding author), Stockholm Univ, Dept Neurochem, SE-10691 Stockholm, Sweden.	kerstin@neurochem.su.se			Swedish Research Council; Salen Stiftelsen; Magn. Bergvalls Stiftelse; Alzheimerfonden; Langmanska kulturfonden; Deutsche Forschungsgemeinschaft	Swedish Research Council(Swedish Research CouncilEuropean Commission); Salen Stiftelsen; Magn. Bergvalls Stiftelse; Alzheimerfonden; Langmanska kulturfonden; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Swedish Research Council (to K. I.), Salen Stiftelsen (to K. I.), Magn. Bergvalls Stiftelse (to K. I.), Alzheimerfonden (to K. I. and L. A.), Langmanska kulturfonden (to K. I.), and the Deutsche Forschungsgemeinschaft (to G. M.).	Adlerz L, 2007, J BIOL CHEM, V282, P10203, DOI 10.1074/jbc.M611183200; ARAKI W, 1991, BIOCHEM BIOPH RES CO, V181, P265, DOI 10.1016/S0006-291X(05)81412-3; Beckman M, 1997, NEUROSCI LETT, V221, P73, DOI 10.1016/S0304-3940(96)13292-4; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Carro E, 2006, NEUROBIOL AGING, V27, P1250, DOI 10.1016/j.neurobiolaging.2005.06.015; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Cisse MA, 2007, J NEUROSCI, V27, P4083, DOI 10.1523/JNEUROSCI.5293-06.2007; DAVIS PD, 1992, J MED CHEM, V35, P994, DOI 10.1021/jm00084a004; Deuss M, 2008, CURR ALZHEIMER RES, V5, P187, DOI 10.2174/156720508783954686; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Heber S, 2000, J NEUROSCI, V20, P7951; Holback S, 2005, J NEUROCHEM, V95, P1059, DOI 10.1111/j.1471-4159.2005.03440.x; Holback S, 2008, BIOCHEM BIOPH RES CO, V365, P298, DOI 10.1016/j.bbrc.2007.10.167; Hong F, 2001, BIOCHEM BIOPH RES CO, V282, P816, DOI 10.1006/bbrc.2001.4644; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; Kaden D, 2009, J CELL SCI, V122, P368, DOI 10.1242/jcs.034058; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Le Gall SM, 2009, MOL BIOL CELL, V20, P1785, DOI 10.1091/mbc.E08-11-1135; Maniar R, 2005, MOL CELL BIOCHEM, V275, P15, DOI 10.1007/s11010-005-7264-x; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Minogue AM, 2009, BRAIN RES, V1262, P89, DOI 10.1016/j.brainres.2009.01.008; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nagano O, 2004, J CELL BIOL, V165, P893, DOI 10.1083/jcb.200310024; Needham BE, 2008, J PATHOL, V215, P155, DOI 10.1002/path.2343; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Paliga K, 1997, EUR J BIOCHEM, V250, P354, DOI 10.1111/j.1432-1033.1997.0354a.x; Reddy ABM, 2009, ENDOCRINOLOGY, V150, P63, DOI 10.1210/en.2008-0677; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Slack BE, 2001, BIOCHEM J, V357, P787, DOI 10.1042/0264-6021:3570787; Slack BE, 1997, BIOCHEM J, V327, P245, DOI 10.1042/bj3270245; Solano DC, 2000, FASEB J, V14, P1015, DOI 10.1096/fasebj.14.7.1015; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Steen E, 2005, J ALZHEIMERS DIS, V7, P63, DOI 10.3233/jad-2005-7107; Tsakadze NL, 2006, J BIOL CHEM, V281, P3157, DOI 10.1074/jbc.M510797200; WILKINSON SE, 1993, BIOCHEM J, V294, P335, DOI 10.1042/bj2940335; Xu KP, 2001, AM J PHYSIOL-CELL PH, V281, pC603, DOI 10.1152/ajpcell.2001.281.2.C603	43	29	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10223	10231		10.1074/jbc.M109.038224	http://dx.doi.org/10.1074/jbc.M109.038224			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139073	Green Published, hybrid			2022-12-27	WOS:000276264600006
J	Olson, ED; Nelson, J; Griffith, K; Nguyen, T; Streeter, M; Wilson-Ashworth, HA; Gelb, MH; Judd, AM; Bell, JD				Olson, Erin D.; Nelson, Jennifer; Griffith, Katalyn; Nguyen, Thaothanh; Streeter, Michael; Wilson-Ashworth, Heather A.; Gelb, Michael H.; Judd, Allan M.; Bell, John D.			Kinetic Evaluation of Cell Membrane Hydrolysis during Apoptosis by Human Isoforms of Secretory Phospholipase A(2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROUP-IIA; GROUP-X; GROUP-V; ARACHIDONIC-ACID; PHOSPHATIDYLCHOLINE VESICLES; INTERFACIAL BINDING; PHYSICAL-PROPERTIES; CORTICAL-NEURONS; GROUP-I; SUSCEPTIBILITY	Some isoforms of secretory phospholipase A(2) (sPLA(2)) distinguish between healthy and damaged or apoptotic cells. This distinction reflects differences in membrane physical properties. Because various sPLA(2) isoforms respond differently to properties of artificial membranes such as surface charge, they should also behave differently as these properties evolve during a dynamic physiological process such as apoptosis. To test this idea, S49 lymphoma cell death was induced by glucocorticoid (6-48 h) or calcium ionophore. Rates of membrane hydrolysis catalyzed by various concentrations of snake venom and human groups IIa, V, and X sPLA(2) were compared after each treatment condition. The data were analyzed using a model that evaluates the adsorption of enzyme to the membrane surface and subsequent binding of substrate to the active site. Results were compared temporally to changes in membrane biophysics and composition. Under control conditions, membrane hydrolysis was confined to the few unhealthy cells present in each sample. Increased hydrolysis during apoptosis and necrosis appeared to reflect substrate access to adsorbed enzyme for the snake venom and group X isoforms corresponding to weakened lipid-lipid interactions in the membrane. In contrast, apoptosis promoted initial adsorption of human groups V and IIa concurrent with phosphatidylserine exposure on the membrane surface. However, this observation was inadequate to explain the behavior of the groups V and IIa enzymes toward necrotic cells where hydrolysis was reduced or absent. Thus, a combination of changes in cell membrane properties during apoptosis and necrosis capacitates the cell for hydrolysis differently by each isoform.	[Olson, Erin D.; Nelson, Jennifer; Griffith, Katalyn; Nguyen, Thaothanh; Streeter, Michael; Judd, Allan M.; Bell, John D.] Brigham Young Univ, Dept Physiol & Dev Biol, Provo, UT 84602 USA; [Wilson-Ashworth, Heather A.] Utah Valley State Coll, Dept Biol, Orem, UT 84058 USA; [Gelb, Michael H.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Gelb, Michael H.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Brigham Young University; Utah System of Higher Education; Utah Valley University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bell, JD (corresponding author), Brigham Young Univ, Dept Physiol & Dev Biol, 302A MSRB, Provo, UT 84602 USA.	john_bell@byu.edu		gelb, michael/0000-0001-7000-5219	National Institutes of Health [GM073997]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL036235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM073997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM073997.	Atsumi G, 1997, BBA-LIPID LIPID MET, V1349, P43, DOI 10.1016/S0005-2760(97)00082-9; Bailey RW, 2007, BIOPHYS J, V93, P2350, DOI 10.1529/biophysj.107.104679; Bailey RW, 2009, BIOPHYS J, V96, P2709, DOI 10.1016/j.bpj.2008.12.3925; Baker SF, 1998, BIOCHEMISTRY-US, V37, P13203, DOI 10.1021/bi981223t; Baritaki S, 2007, ADV CANCER RES, V98, P149, DOI 10.1016/S0065-230X(06)98005-1; Beers SA, 2003, BIOCHEMISTRY-US, V42, P7326, DOI 10.1021/bi0343222; Beers SA, 2002, J BIOL CHEM, V277, P1788, DOI 10.1074/jbc.M109777200; BELL JD, 1989, J BIOL CHEM, V264, P225; BELL JD, 1992, BIOCHIM BIOPHYS ACTA, V1127, P208, DOI 10.1016/0005-2760(92)90279-5; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Chang MK, 2004, J EXP MED, V200, P1359, DOI 10.1084/jem.20031763; Cho WW, 1999, METH MOL B, V109, P31; Degousee N, 2002, J BIOL CHEM, V277, P5061, DOI 10.1074/jbc.M109083200; DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0; Fadeel B, 2004, ANTIOXID REDOX SIGN, V6, P269, DOI 10.1089/152308604322899332; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Fujimoto K, 1999, FEBS LETT, V446, P113, DOI 10.1016/S0014-5793(99)00204-5; GELB MH, 1995, ANNU REV BIOCHEM, V64, P653; Gimenez AP, 2004, J IMMUNOL, V173, P521, DOI 10.4049/jimmunol.173.1.521; Gwag BJ, 1999, NEUROSCIENCE, V90, P1339, DOI 10.1016/S0306-4522(98)00508-9; Han SK, 1998, BIOCHEM J, V331, P353, DOI 10.1042/bj3310353; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Harris FM, 2001, J BIOL CHEM, V276, P22722, DOI 10.1074/jbc.M010879200; Henshaw JB, 1998, BIOCHEMISTRY-US, V37, P10709, DOI 10.1021/bi9728809; Huhtinen HT, 2006, APMIS, V114, P127, DOI 10.1111/j.1600-0463.2006.apm_330.x; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V980, P23, DOI 10.1016/0005-2736(89)90195-8; Jensen LB, 2005, BIOPHYS J, V88, P2692, DOI 10.1529/biophysj.104.056457; Jourdheuil D, 1996, CAN J PHYSIOL PHARM, V74, P706, DOI 10.1139/cjpp-74-6-706; Kagan VE, 2002, J IMMUNOL, V169, P487, DOI 10.4049/jimmunol.169.1.487; Kinkaid AR, 1995, BIOCHEM SOC T, V23, pS556, DOI 10.1042/bst023556s; Koduri RS, 1998, J BIOL CHEM, V273, P32142, DOI 10.1074/jbc.273.48.32142; Koduri RS, 2002, J BIOL CHEM, V277, P5849, DOI 10.1074/jbc.M109699200; Koprivnjak T, 2002, J BIOL CHEM, V277, P47636, DOI 10.1074/jbc.M205104200; Kottilil S, 2001, CELL IMMUNOL, V214, P1, DOI 10.1006/cimm.2001.1876; KUDO I, 1993, BIOCHIM BIOPHYS ACTA, V1170, P217, DOI 10.1016/0005-2760(93)90003-R; LYONS AB, 1992, CYTOMETRY, V13, P809; MARAGANORE JM, 1984, J BIOL CHEM, V259, P3839; Markova M, 2005, ONCOGENE, V24, P6450, DOI 10.1038/sj.onc.1208791; Moulin M, 2007, APOPTOSIS, V12, P1703, DOI 10.1007/s10495-007-0096-2; MOWER DA, 1994, J IMMUNOL, V152, P4832; Murakami M, 1999, J BIOL CHEM, V274, P31435, DOI 10.1074/jbc.274.44.31435; Nielson KH, 2000, BBA-MOL CELL BIOL L, V1484, P163, DOI 10.1016/S1388-1981(00)00004-4; Pan YH, 2002, J BIOL CHEM, V277, P29086, DOI 10.1074/jbc.M202531200; Piris-Gimenez A, 2005, J IMMUNOL, V175, P6786, DOI 10.4049/jimmunol.175.10.6786; Raghavendra PB, 2007, MOL IMMUNOL, V44, P2292, DOI 10.1016/j.molimm.2006.11.009; SALGO MG, 1993, ARCH BIOCHEM BIOPHYS, V304, P123, DOI 10.1006/abbi.1993.1330; SEVANIAN A, 1988, BIOCHIM BIOPHYS ACTA, V961, P316, DOI 10.1016/0005-2760(88)90079-3; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Smith SK, 2001, J BIOL CHEM, V276, P22732, DOI 10.1074/jbc.M010880200; Tyurin VA, 2008, METHOD ENZYMOL, V442, P375, DOI [10.1017/S0076-6879(08)01419-5, 10.1016/S0076-6879(08)01419-5]; Tyurin VA, 2009, J CHROMATOGR B, V877, P2863, DOI 10.1016/j.jchromb.2009.03.007; Tyurin VA, 2008, J NEUROCHEM, V107, P1614, DOI 10.1111/j.1471-4159.2008.05728.x; VITALE M, 1993, HISTOCHEMISTRY, V100, P223, DOI 10.1007/BF00269095; Wilson HA, 1997, BBA-LIPID LIPID MET, V1349, P142, DOI 10.1016/S0005-2760(97)00089-1; Wilson HA, 1999, J BIOL CHEM, V274, P11494, DOI 10.1074/jbc.274.17.11494	56	23	23	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10993	11002		10.1074/jbc.M109.070797	http://dx.doi.org/10.1074/jbc.M109.070797			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139082	hybrid, Green Published			2022-12-27	WOS:000276264600083
J	Ratnakumar, S; Young, ET				Ratnakumar, Sooraj; Young, Elton T.			Snf1 Dependence of Peroxisomal Gene Expression Is Mediated by Adr1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS PIP2P; OLEATE-RESPONSIVE GENES; SACCHAROMYCES-CEREVISIAE; FATTY-ACID; BETA-OXIDATION; ADH2 EXPRESSION; IDENTIFY GENES; UP-REGULATION; OLEIC-ACID; PROTEIN	Eukaryotes utilize fatty acids by beta-oxidation, which occurs in the mitochondria and peroxisomes in higher organisms and in the peroxisomes in yeast. The AMP-activated protein kinase regulates this process in mammalian cells, and its homolog Snf1, together with the transcription factors Adr1, Oaf1, and Pip2, regulates peroxisome proliferation and beta-oxidation in yeast. A constitutive allele of Adr1 (Adr1(c)) lacking the glucose-and Snf1-regulated phosphorylation substrate Ser-230 was found to be Snf1-independent for regulation of peroxisomal genes. In addition, it could compensate for and even suppress the requirement for Oaf1 or Pip2 for gene induction. Peroxisomal genes were found to be regulated by oleate in the presence of glucose, as long as Adr1(c) was expressed, suggesting that the Oaf1/Pip2 heterodimer is Snf1-independent. Consistent with this observation, Oaf1 binding to promoters in the presence of oleate was not reduced in a snf1 Delta strain. Exploring the mechanism by which Adr1(c) permits Snf1-independent peroxisomal gene induction, we found that strength of promoter binding did not correlate with transcription, suggesting that stable binding is not a prerequisite for enhanced transcription. Instead, enhanced transcriptional activation and suppression of Oaf1, Pip2, and Snf1 by Adr1(c) may be related to the ability of Adr1(c) to suppress the requirement for and enhance the recruitment of transcriptional coactivators in a promoter- and growth medium-dependent manner.	[Ratnakumar, Sooraj; Young, Elton T.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Young, ET (corresponding author), Univ Washington, Dept Biochem, 1705 NE Pacific St, Seattle, WA 98195 USA.	ety@u.washington.edu			National Institutes of Health [GM26079]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM26079 (to E. T. Y.).	Baumgartner U, 1999, J BIOL CHEM, V274, P22208, DOI 10.1074/jbc.274.32.22208; BEMIS LT, 1988, MOL CELL BIOL, V8, P2125, DOI 10.1128/MCB.8.5.2125; Biddick RK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001436; Biddick RK, 2008, J BIOL CHEM, V283, P33101, DOI 10.1074/jbc.M805258200; CHERRY JR, 1989, CELL, V56, P409, DOI 10.1016/0092-8674(89)90244-4; CIRIACY M, 1979, MOL GEN GENET, V176, P427, DOI 10.1007/BF00333107; COLLART M, 1993, CURRENT PROTOCOLS MO; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; DENIS CL, 1986, MOL CELL BIOL, V6, P4026, DOI 10.1128/MCB.6.11.4026; DENIS CL, 1992, MOL CELL BIOL, V12, P1507, DOI 10.1128/MCB.12.4.1507; Dombek KM, 1997, MOL CELL BIOL, V17, P1450, DOI 10.1128/MCB.17.3.1450; DOMBEK KM, 1993, MOL CELL BIOL, V13, P4391, DOI 10.1128/MCB.13.7.4391; DONOVIEL MS, 1995, MOL CELL BIOL, V15, P3442; EINERHAND AWC, 1991, EUR J BIOCHEM, V200, P113, DOI 10.1111/j.1432-1033.1991.tb21056.x; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Gurvitz A, 2001, J BIOL CHEM, V276, P31825, DOI 10.1074/jbc.M105989200; Gurvitz A, 1997, MOL MICROBIOL, V26, P675, DOI 10.1046/j.1365-2958.1997.5931969.x; Gurvitz A, 1999, MOL GEN GENET, V262, P481; Gurvitz A, 2006, BBA-MOL CELL RES, V1763, P1392, DOI 10.1016/j.bbamcr.2006.07.011; Gurvitz Aner, 2000, Molecular Cell Biology Research Communications, V4, P81, DOI 10.1006/mcbr.2000.0261; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; Hiltunen JK, 2003, FEMS MICROBIOL REV, V27, P35, DOI 10.1016/S0168-6445(03)00017-2; ISHII H, 1980, BIOCHIM BIOPHYS ACTA, V617, P1, DOI 10.1016/0005-2760(80)90218-0; Kacherovsky N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003213; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Karpichev IV, 2008, J BIOL CHEM, V283, P10264, DOI 10.1074/jbc.M708215200; Karpichev IV, 1998, MOL CELL BIOL, V18, P6560, DOI 10.1128/MCB.18.11.6560; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Luo Y, 1996, J BIOL CHEM, V271, P12068, DOI 10.1074/jbc.271.20.12068; Naar AM, 2009, GENE DEV, V23, P419, DOI 10.1101/gad.1743009; Phelps C, 2006, P NATL ACAD SCI USA, V103, P7077, DOI 10.1073/pnas.0510080103; Ratnakumar S, 2009, GENETICS, V182, P735, DOI 10.1534/genetics.109.103432; REDDY JK, 1975, SCIENCE, V190, P787, DOI 10.1126/science.1198095; Rottensteiner H, 1997, EUR J BIOCHEM, V247, P776, DOI 10.1111/j.1432-1033.1997.00776.x; Rottensteiner H, 1996, EMBO J, V15, P2924, DOI 10.1002/j.1460-2075.1996.tb00655.x; Rottensteiner H, 2003, J BIOL CHEM, V278, P27605, DOI 10.1074/jbc.M304097200; Rottensteiner H, 2003, EUR J BIOCHEM, V270, P2013, DOI 10.1046/j.1432-1033.2003.03575.x; Saleem RA, 2008, J CELL BIOL, V181, P281, DOI 10.1083/jcb.200710009; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIMON M, 1991, MOL CELL BIOL, V11, P699, DOI 10.1128/MCB.11.2.699; SIMON M, 1992, YEAST, V8, P303, DOI 10.1002/yea.320080407; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JJ, 2002, J CELL BIOL, V158, P259, DOI 10.1083/jcb.200204059; Tachibana C, 2005, MOL CELL BIOL, V25, P2138, DOI 10.1128/MCB.25.6.2138-2146.2005; Tachibana C, 2007, J BIOL CHEM, V282, P37308, DOI 10.1074/jbc.M707363200; TAYLOR WE, 1990, P NATL ACAD SCI USA, V87, P4098, DOI 10.1073/pnas.87.11.4098; Thakur JK, 2009, J BIOL CHEM, V284, P4422, DOI 10.1074/jbc.M808263200; Trzcinska-Danielewicz J, 2008, BIOCHEM BIOPH RES CO, V374, P763, DOI 10.1016/j.bbrc.2008.07.105; VEENHUIS M, 1987, YEAST, V3, P77, DOI 10.1002/yea.320030204; Verdone L, 2002, EMBO J, V21, P1101, DOI 10.1093/emboj/21.5.1101; Walther K, 2001, MICROBIOL-SGM, V147, P2037, DOI 10.1099/00221287-147-8-2037; WANG TW, 1994, J BIOL CHEM, V269, P24480; Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200; Young ET, 2002, J BIOL CHEM, V277, P38095, DOI 10.1074/jbc.M206158200	57	35	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10703	10714		10.1074/jbc.M109.079848	http://dx.doi.org/10.1074/jbc.M109.079848			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139423	Green Published, hybrid			2022-12-27	WOS:000276264600057
J	Wang, QY; Yu, L; Yu, CA				Wang, Qiyu; Yu, Linda; Yu, Chang-An			Cross-talk between Mitochondrial Malate Dehydrogenase and the Cytochrome bc(1) Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE HEART-MITOCHONDRIA; ELECTRON-TRANSFER; PROCESSING PEPTIDASE; RESPIRATORY-CHAIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; C REDUCTASE; RECONSTITUTION; BINDING; SITE	The interactions between the mitochondrial cytochrome bc(1) complex and matrix-soluble proteins were studied by a precipitation pulldown technique. Purified, detergent-dispersed bc(1) complex was incubated with mitochondrial matrix proteins followed by dialysis in the absence of detergent. The interacting protein(s) was co-precipitated with bc(1) complex upon centrifugation. One of the matrix proteins pulled down by bc(1) complex was identified as mitochondrial malate dehydrogenase (MDH) by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and confirmed by Western blotting with anti-MDH antibody. Using a cross-linking technique, subunits I, II (core I and II), and V of the bc(1) complex were identified as the interacting sites for MDH. Incubating purified MDH with the detergent dispersed bc(1) complex results in an increase of the activities of both the bc(1) complex and MDH. The effect of the bc(1) complex on the activities of MDH is unidirectional (oxaloacetate 3 malate). These results suggest that the novel cross-talk between citric acid cycle enzymes and electron transfer chain complexes might play a regulatory role in mitochondrial bioenergetics.	[Wang, Qiyu; Yu, Linda; Yu, Chang-An] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater	Yu, CA (corresponding author), Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA.	cayuq@okstate.edu			National Institutes of Health [GM30721]; Oklahoma Agricultural Experiment Station, Oklahoma State University [1819, 2372]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030721, R37GM030721] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Agricultural Experiment Station, Oklahoma State University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM30721 (to C.-A.Y.). This work was also supported by Oklahoma Agricultural Experiment Station Projects 1819 and 2372 from the Oklahoma State University.	BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2000, ANNU REV BIOCHEM, V69, P1005, DOI 10.1146/annurev.biochem.69.1.1005; Deng K, 2001, J BIOL CHEM, V276, P6499, DOI 10.1074/jbc.M007128200; Deng KP, 1998, J BIOL CHEM, V273, P20752, DOI 10.1074/jbc.273.33.20752; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Gao XG, 2003, BIOCHEMISTRY-US, V42, P9067, DOI 10.1021/bi0341814; Gao XG, 2002, BIOCHEMISTRY-US, V41, P11692, DOI 10.1021/bi026252p; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Hunte C, 2002, BBA-BIOENERGETICS, V1555, P21, DOI 10.1016/S0005-2728(02)00249-9; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Kim H, 1998, P NATL ACAD SCI USA, V95, P8026, DOI 10.1073/pnas.95.14.8026; LINK TA, 1995, J BIOL CHEM, V270, P25001, DOI 10.1074/jbc.270.42.25001; Morgunov I, 1998, J BIOL CHEM, V273, P29540, DOI 10.1074/jbc.273.45.29540; MULLINAX TR, 1982, J BIOL CHEM, V257, P13233; OHNISHI T, 1980, J BIOL CHEM, V255, P3278; Ovadi Judit, 1994, Journal of Molecular Recognition, V7, P265, DOI 10.1002/jmr.300070405; SCHINDLER PW, 1975, EUR J BIOCHEM, V51, P579, DOI 10.1111/j.1432-1033.1975.tb03959.x; STUMPF DA, 1982, NEUROLOGY, V32, P221, DOI 10.1212/WNL.32.3.221; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; Tso SC, 2006, BBA-BIOENERGETICS, V1757, P1561, DOI 10.1016/j.bbabio.2006.06.010; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Weinberg JM, 2000, P NATL ACAD SCI USA, V97, P2826, DOI 10.1073/pnas.97.6.2826; Xia D, 1997, SCIENCE, V277, P60, DOI 10.1126/science.277.5322.60; Xia D, 2007, PHOTOSYNTH RES, V92, P17, DOI 10.1007/s11120-007-9155-3; YU C, 1980, BIOCHIM BIOPHYS ACTA, V591, P409, DOI 10.1016/0005-2728(80)90172-3; YU CA, 1972, J BIOL CHEM, V247, P1012; YU CA, 1982, BIOCHEMISTRY-US, V21, P4096, DOI 10.1021/bi00260a028; Yu LD, 2009, METHOD ENZYMOL, V456, P459, DOI 10.1016/S0076-6879(08)04425-X; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612	29	21	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10408	10414		10.1074/jbc.M109.085787	http://dx.doi.org/10.1074/jbc.M109.085787			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20075069	Green Published, hybrid			2022-12-27	WOS:000276264600026
J	Drozak, J; Veiga-da-Cunha, M; Vertommen, D; Stroobant, V; Van Schaftingen, E				Drozak, Jakub; Veiga-da-Cunha, Maria; Vertommen, Didier; Stroobant, Vincent; Van Schaftingen, Emile			Molecular Identification of Carnosine Synthase as ATP-grasp Domain-containing Protein 1 (ATPGD1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ALANYL; BRAIN; SYNTHETASE; HOMOCARNOSINE; MUSCLE; DIPEPTIDES; ANSERINE; PURIFICATION; DEFICIENCY; PEPTIDES	Carnosine (beta-alanyl-L-histidine) and homocarnosine (gamma-aminobutyryl-L-histidine) are abundant dipeptides in skeletal muscle and brain of most vertebrates and some invertebrates. The formation of both compounds is catalyzed by carnosine synthase, which is thought to convert ATP to AMP and inorganic pyrophosphate, and whose molecular identity is unknown. In the present work, we have purified carnosine synthase from chicken pectoral muscle about 1500-fold until only two major polypeptides of 100 and 90 kDa were present in the preparation. Mass spectrometry analysis of these polypeptides did not yield any meaningful candidate. Carnosine formation catalyzed by the purified enzyme was accompanied by a stoichiometric formation, not of AMP, but of ADP, suggesting that carnosine synthase belongs to the "ATP-grasp family" of ligases. A data base mining approach identified ATPGD1 as a likely candidate. As this protein was absent from chicken protein data bases, we reconstituted its sequence from a PCR-amplified cDNA and found it to fit with the 100-kDa polypeptide of the chicken carnosine synthase preparation. Mouse and human ATPGD1 were expressed in HEK293T cells, purified to homogeneity, and shown to catalyze the formation of carnosine, as confirmed by mass spectrometry, and of homocarnosine. Specificity studies carried out on all three enzymes were in agreement with published data. In particular, they acted with 15-25-fold higher catalytic efficiencies on beta-alanine than on gamma-aminobutyrate. The identification of the gene encoding carnosine synthase will help for a better understanding of the biological functions of carnosine and related dipeptides, which still remain largely unknown.	[Drozak, Jakub; Veiga-da-Cunha, Maria; Van Schaftingen, Emile] Catholic Univ Louvain, Physiol Chem Lab, Duve Inst, B-1200 Brussels, Belgium; [Vertommen, Didier] Catholic Univ Louvain, Hormone & Metab Res Unit, Duve Inst, B-1200 Brussels, Belgium; [Stroobant, Vincent] Catholic Univ Louvain, Ludwig Inst Canc Res, Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Van Schaftingen, E (corresponding author), Catholic Univ Louvain, Physiol Chem Lab, Duve Inst, Ave Hippocrate 75, B-1200 Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Van+Schaftingen, Emile/AAF-5532-2020	Drozak, Jakub/0000-0002-3601-3845; Van Schaftingen, Emile/0000-0002-6199-7647; Vertommen, Didier/0000-0001-7648-8282	Belgian Fonds National de la Recherche Scientifique; Interuniversity Attraction Pole Programme Belgian Science Policy Networks [P6/05, P6/28]; Region Wallonne; ASCO Industries; Fonds National de la Recherche Scientifique	Belgian Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Pole Programme Belgian Science Policy Networks; Region Wallonne; ASCO Industries; Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS)	This work was supported in part by grants from the Belgian Fonds National de la Recherche Scientifique, the Interuniversity Attraction Pole Programme Belgian Science Policy Networks P6/05 and P6/28, the DIANE centre of excellence program of the Region Wallonne, and by ASCO Industries.; Supported by a postdoctoral fellowship from the Fonds National de la Recherche Scientifique.	ACHESON SA, 1988, BIOCHEMISTRY-US, V27, P7371, DOI 10.1021/bi00419a030; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bauer K, 2005, NEUROCHEM RES, V30, P1339, DOI 10.1007/s11064-005-8806-z; Boldyrev A.A., 2007, CARNOSINE OXIDATIVE; Bonfanti L, 1999, PROG NEUROBIOL, V59, P333, DOI 10.1016/S0301-0082(99)00010-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN CE, 1980, BIOCHEM BIOPH RES CO, V92, P470, DOI 10.1016/0006-291X(80)90357-5; CAMERON JN, 1989, J EXP BIOL, V143, P543; CRUSH KG, 1970, COMP BIOCHEM PHYSIOL, V34, P3, DOI 10.1016/0010-406X(70)90049-6; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Galperin MY, 1997, PROTEIN SCI, V6, P2639; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83, DOI 10.1152/ajpendo.2000.278.1.E83; Gulewitsch W, 1900, BER DTSCH CHEM GES, V33, P1902, DOI 10.1002/cber.19000330275; Hipkiss AR, 2009, EXP GERONTOL, V44, P237, DOI 10.1016/j.exger.2008.11.001; HORINISHI H, 1978, J NEUROCHEM, V31, P909, DOI 10.1111/j.1471-4159.1978.tb00127.x; Jackson MC, 1996, INFLAMM RES, V45, P132, DOI 10.1007/BF02265166; KALYANKAR GD, 1959, J BIOL CHEM, V234, P3210; KISH SJ, 1979, J NEUROCHEM, V32, P1629, DOI 10.1111/j.1471-4159.1979.tb02272.x; KOHEN R, 1988, P NATL ACAD SCI USA, V85, P3175, DOI 10.1073/pnas.85.9.3175; KUMON A, 1970, BIOCHIM BIOPHYS ACTA, V200, P466, DOI 10.1016/0005-2795(70)90103-0; LIENHARD GE, 1973, J BIOL CHEM, V248, P1121; MARGOLIS FL, 1987, J NEUROCHEM, V48, P593, DOI 10.1111/j.1471-4159.1987.tb04134.x; MATSUOKA M, 1969, BIOCHIM BIOPHYS ACTA, V177, P169, DOI 10.1016/0304-4165(69)90083-X; Murakami T, 2009, EUR J PHARMACOL, V602, P73, DOI 10.1016/j.ejphar.2008.10.049; MURPHEY WH, 1973, PEDIATR RES, V7, P601, DOI 10.1203/00006450-197307000-00001; Nagase T, 2000, DNA RES, V7, P143, DOI 10.1093/dnares/7.2.143; Nakagawa Y, 1998, AM J HUM GENET, V63, P547, DOI 10.1086/301974; Sauerhofer S, 2007, DIABETES, V56, P2425, DOI 10.2337/db07-0177; SKAPER SD, 1973, J NEUROCHEM, V21, P1429, DOI 10.1111/j.1471-4159.1973.tb06027.x; STENESH JJ, 1960, BIOCHEM J, V77, P575, DOI 10.1042/bj0770575; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Uchisawa H, 2007, BBA-GEN SUBJECTS, V1770, P790, DOI 10.1016/j.bbagen.2006.12.010; van der Zee DC, 1999, SURG ENDOSC-ULTRAS, V13, P925, DOI 10.1007/s004649901136; Van Schaftingen E, 2009, J INHERIT METAB DIS, V32, P135, DOI 10.1007/s10545-008-1042-3; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; Willi SM, 1997, PEDIATR RES, V41, P210, DOI 10.1203/00006450-199702000-00009	37	132	139	6	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9346	9356		10.1074/jbc.M109.095505	http://dx.doi.org/10.1074/jbc.M109.095505			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097752	Green Published, hybrid			2022-12-27	WOS:000276165900006
J	Lionetti, V; Cantoni, S; Cavallini, C; Bianchi, F; Valente, S; Frascari, I; Olivi, E; Aquaro, GD; Bonavita, F; Scarlata, I; Maioli, M; Vaccari, V; Tassinari, R; Bartoli, A; Recchia, FA; Pasquinelli, G; Ventura, C				Lionetti, Vincenzo; Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Valente, Sabrina; Frascari, Irene; Olivi, Elena; Aquaro, Giovanni D.; Bonavita, Francesca; Scarlata, Ignazio; Maioli, Margherita; Vaccari, Valentina; Tassinari, Riccardo; Bartoli, Antonietta; Recchia, Fabio A.; Pasquinelli, Gianandrea; Ventura, Carlo			Hyaluronan Mixed Esters of Butyric and Retinoic Acid Affording Myocardial Survival and Repair without Stem Cell Transplantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; HISTONE DEACETYLASE; BONE-MARROW; IN-VITRO; GROWTH; AKT; EXPRESSION; VEGF; PROLIFERATION; ACTIVATION	Possible cardiac repair by adult stem cell transplantation is currently hampered by poor cell viability and delivery efficiency, uncertain differentiating fate in vivo, the needs of ex vivo cell expansion, and consequent delay in transplantation after the onset of heart attack. By the aid of magnetic resonance imaging, positron emission tomography, and immunohistochemistry, we show that injection of a hyaluronan mixed ester of butyric and retinoic acid (HBR) into infarcted rat hearts afforded substantial cardiovascular repair and recovery of myocardial performance. HBR restored cardiac [F-18]fluorodeoxyglucose uptake and increased capillary density and led to the recruitment of endogenous Stro-1-positive stem cells. A terminal deoxynucleotidyl-transferase-mediated dUTP nick end labeling assay demonstrated that HBR-treated hearts exhibited a decrease in the number of apoptotic cardiomyocytes. In isolated rat cardiomyocytes and Stro-1 stem cells, HBR enhanced the transcription of vascular endothelial growth factor, hepatocyte growth factor, kdr, akt, and pim-1. HBR also increased the secretion of vascular endothelial growth factor and hepatocyte growth factor, suggesting that the mixed ester may have recruited both myocardial and Stro-1 cells also. An increase in capillarogenesis was induced in vitro with medium obtained from HBR-exposed cells. In the infarcted myocardium, HBR injection increased histone H4 acetylation significantly. Acetyl-H4 immunoreactivity increased in rat cardiomyocytes and Stro-1 cells exposed to HBR, compared with untreated cells. In conclusion, efficient cardiac regenerative therapy can be afforded by HBR without the need of stem cell transplantation or vector-mediated gene delivery.	[Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Frascari, Irene; Olivi, Elena; Bonavita, Francesca; Scarlata, Ignazio; Vaccari, Valentina; Tassinari, Riccardo; Ventura, Carlo] Univ Bologna, Lab Mol Biol & Stem Cell Engn, Cardiovasc Dept, Natl Inst Biostruct & Biosyst,S Orsola Malpighi H, I-40138 Bologna, Italy; [Lionetti, Vincenzo; Recchia, Fabio A.] Scuola Super Sant Anna, Sector Med, I-56124 Pisa, Italy; [Cantoni, Silvia; Cavallini, Claudia; Bianchi, Francesca; Frascari, Irene; Olivi, Elena; Bonavita, Francesca; Scarlata, Ignazio; Vaccari, Valentina; Tassinari, Riccardo; Ventura, Carlo] Biosci Inst, RSM-47891 Falciano, San Marino; [Lionetti, Vincenzo; Aquaro, Giovanni D.] Consiglio Nazl Ric Fdn G Monasterio, Inst Clin Physiol, I-56124 Pisa, Italy; [Maioli, Margherita] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Bartoli, Antonietta] Univ Pisa, Dept Phys, I-56124 Pisa, Italy; [Recchia, Fabio A.] New York Med Coll, Dept Physiol, Valhalla, NY 10595 USA; [Valente, Sabrina; Pasquinelli, Gianandrea] Univ Bologna, Dept Hematol Oncol & Clin Pathol, I-40138 Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Scuola Superiore Sant'Anna; University of Sassari; University of Pisa; New York Medical College; University of Bologna	Ventura, C (corresponding author), Univ Bologna, Lab Mol Biol & Stem Cell Engn, Cardiovasc Dept, Natl Inst Biostruct & Biosyst,S Orsola Malpighi H, Via Massarenti 9, I-40138 Bologna, Italy.	carlo.ventura@unibo.it	Ventura, Carlo/AAV-3658-2020; Pasquinelli, Gianandrea/I-7088-2012; Recchia, Fabio/F-2315-2010; Lionetti, Vincenzo/AAN-1994-2020; Valente, Sabrina/ABI-1022-2020; Lionetti, Vincenzo/G-9528-2014; Lionetti, Vincenzo/AAH-9503-2020; aquaro, giovanni donato/AAB-8978-2019; Bianchi, Francesca/M-2205-2016; Cantoni, Silvia/H-3938-2011	Pasquinelli, Gianandrea/0000-0003-1506-1829; Lionetti, Vincenzo/0000-0002-0640-8651; Bianchi, Francesca/0000-0001-6732-0533; Scarlata, Ignazio/0000-0002-5490-7834; Cavallini, Claudia/0000-0002-8079-9697; MAIOLI, Margherita/0000-0003-0187-4968; Cantoni, Silvia/0000-0002-3866-3307; VALENTE, SABRINA/0000-0002-4090-291X; aquaro, giovanni donato/0000-0003-0915-915X	Regione Emilia Romagna; Fondazione Luisa Fanti Melloni, Bologna, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Tavola Valdese, Rome, Italy; "Compagnia di San Paolo," Torino, Italy	Regione Emilia Romagna(Regione Emilia Romagna); Fondazione Luisa Fanti Melloni, Bologna, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Tavola Valdese, Rome, Italy; "Compagnia di San Paolo," Torino, Italy(Compagnia di San Paolo)	This work was supported by Regione Emilia Romagna, Programma di Ricerca Regione-Universita 2007/2009, Area 1b "Medicina Rigenerativa," Italy; Fondazione Luisa Fanti Melloni, Bologna, Italy; Sintofarm S.p.A. (Guastalla, Reggio Emilia), Italy; Tavola Valdese, Rome, Italy; and and "Compagnia di San Paolo," Torino, Italy.	Ancelin M, 2004, LAB INVEST, V84, P502, DOI 10.1038/labinvest.3700053; Bonacchi M, 2009, J CELL MOL MED, V13, P3437, DOI 10.1111/j.1582-4934.2008.00503.x; Bonaros N, 2008, TRANSPLANTATION, V86, P1151, DOI 10.1097/TP.0b013e3181880f9e; Buckley AR, 2000, ANN NY ACAD SCI, V917, P522; Buckley AR, 1996, CELL GROWTH DIFFER, V7, P1713; Choi SC, 2008, STEM CELLS DEV, V17, P725, DOI 10.1089/scd.2007.0230; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; Fernandes VRS, 2007, RADIOLOGY, V245, P712, DOI 10.1148/radiol.2452061615; Forte G, 2006, STEM CELLS, V24, P23, DOI 10.1634/stemcells.2004-0176; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Granger A, 2008, FASEB J, V22, P3549, DOI 10.1096/fj.08-108548; Guzman MJ, 2008, J SURG RES, V150, P286, DOI 10.1016/j.jss.2007.12.772; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Higuchi T, 2007, J NUCL MED, V48, P288; Kaga S, 2006, J MOL CELL CARDIOL, V40, P138, DOI 10.1016/j.yjmcc.2005.09.009; Lai LH, 2003, DEVELOPMENT, V130, P6465, DOI 10.1242/dev.00887; Lee TM, 2007, AM J PHYSIOL-HEART C, V293, pH968, DOI 10.1152/ajpheart.00891.2006; Li YW, 2003, CIRCULATION, V107, P2499, DOI 10.1161/01.CIR.0000065579.19126.B8; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Markel TA, 2008, AM J PHYSIOL-HEART C, V295, pH2308, DOI 10.1152/ajpheart.00565.2008; Matsui T, 2002, J BIOL CHEM, V277, P22896, DOI 10.1074/jbc.M200347200; MILLAUER B, 1993, CELL, V72, P835, DOI 10.1016/0092-8674(93)90573-9; Muraski JA, 2007, NAT MED, V13, P1467, DOI 10.1038/nm1671; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Napoli C, 2007, TRENDS MOL MED, V13, P278, DOI 10.1016/j.molmed.2007.05.004; Noiseux N, 2006, MOL THER, V14, P840, DOI 10.1016/j.ymthe.2006.05.016; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Positano V, 2005, J CARDIOV MAGN RESON, V7, P487, DOI 10.1081/JCMR-200053630; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Saito A, 2007, ENDOCRINOLOGY, V148, P1412, DOI 10.1210/en.2006-0900; Santini V, 2007, CURR DRUG METAB, V8, P383, DOI 10.2174/138920007780655397; SHI H, 2006, J NUCL MED S1, V47, pP271; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Spinelli AE, 2007, NUCL INSTRUM METH A, V571, P215, DOI 10.1016/j.nima.2006.10.066; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Thirunavukkarasu M, 2008, J CELL MOL MED, V12, P1284, DOI 10.1111/j.1582-4934.2008.00269.x; Ventura C, 2004, J BIOL CHEM, V279, P23574, DOI 10.1074/jbc.M401869200; Ventura C, 2007, J BIOL CHEM, V282, P14243, DOI 10.1074/jbc.M609350200	39	43	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9949	9961		10.1074/jbc.M109.087254	http://dx.doi.org/10.1074/jbc.M109.087254			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20097747	Green Published, hybrid			2022-12-27	WOS:000276165900064
J	Fu, J; Taubman, MB				Fu, Jian; Taubman, Mark B.			Prolyl Hydroxylase EGLN3 Regulates Skeletal Myoblast Differentiation through an NF-kappa B-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; MUSCLE DIFFERENTIATION; MYOGENIC DIFFERENTIATION; TRANSCRIPTIONAL ACTIVITY; MICE LACKING; HIF-ALPHA; IKK-ALPHA; ACTIVATION; KINASE; INDUCTION	The egg-laying abnormal-9 (EGLN) prolyl hydroxylases have been shown to regulate the stability and thereby the activity of the alpha subunits of hypoxia-inducible factor (HIF) through its ability to catalyze their hydroxylation. We have previously shown that EGLN3 promotes differentiation of C2C12 skeletal myoblasts. However, the mechanism underlying this effect remains to be fully elucidated. Here, we report that exposure of C2C12 cells to dimethyl oxalylglycine (DMOG), desferrioxamine, and hypoxia, all inhibitors of prolyl hydroxylase activity, led to repression of C2C12 myogenic differentiation. Inactivation of HIF by expression of a HIF dominant-negative mutant or deletion of HIF-1 alpha by RNA interference did not affect the inhibitory effect of DMOG, suggesting that the effect of DMOG is HIF-independent. Pharmacologic inactivation of EGLN3 hydroxylase resulted in activation of the canonical NF-kappa B pathway. The inhibitory effect of DMOG on myogenic differentiation was markedly impaired in C2C12 cells expressing a dominant-negative mutant of I kappa B alpha. Exogenous expression of wild-type EGLN3, but not its catalytically inactive mutant, significantly inhibited NF-kappa B activation induced by overexpressed TRAF2 or I kappa B kinase 2. In contrast, deletion of EGLN3 by small interfering RNAs led to activation of NF-kappa B. These data suggest that EGLN3 is a negative regulator of NF-kappa B, and its prolyl hydroxylase activity is required for this effect. Furthermore, wild-type EGLN3, but not its catalytically inactive mutant, potentiated myogenic differentiation. This study demonstrates a novel role for EGLN3 in the regulation of NF-kappa B and suggests that it is involved in mediating myogenic differentiation, which is HIF-independent.	[Fu, Jian] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Fu, J (corresponding author), Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA.	jian_fu@urmc.rochester.edu						Baek JH, 2005, MOL CELL, V17, P503, DOI 10.1016/j.molcel.2005.01.011; Bakkar N, 2008, J CELL BIOL, V180, P787, DOI 10.1083/jcb.200707179; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernhardt WM, 2006, J AM SOC NEPHROL, V17, P1970, DOI 10.1681/ASN.2005121302; Biederer CH, 2000, J BIOL CHEM, V275, P26245, DOI 10.1074/jbc.M001430200; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; EDMONDSON DG, 1989, GENE DEV, V3, P628, DOI 10.1101/gad.3.5.628; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Fu J, 2003, J BIOL CHEM, V278, P52660, DOI 10.1074/jbc.M308036200; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kasiganesan H, 2007, ACTA PHYSIOL, V190, P163, DOI 10.1111/j.1748-1716.2007.01676.x; Koditz J, 2007, BLOOD, V110, P3610, DOI 10.1182/blood-2007-06-094441; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lee S, 2005, CANCER CELL, V8, P155, DOI 10.1016/j.ccr.2005.06.015; Lehtinen SK, 1996, BIOCHEM BIOPH RES CO, V229, P36, DOI 10.1006/bbrc.1996.1754; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Liang YX, 2002, J BIOL CHEM, V277, P20087, DOI 10.1074/jbc.M201766200; Liu J, 2006, MOL CELL, V21, P467, DOI 10.1016/j.molcel.2005.12.020; Lomb DJ, 2007, J NEUROCHEM, V103, P1897, DOI 10.1111/j.1471-4159.2007.04873.x; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mikhaylova O, 2008, MOL CELL BIOL, V28, P2701, DOI 10.1128/MCB.01231-07; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Munz B, 2002, MOL CELL BIOL, V22, P5879, DOI 10.1128/MCB.22.16.5879-5886.2002; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Ratan RR, 2007, J MOL MED, V85, P1331, DOI 10.1007/s00109-007-0283-1; Sakurai H, 2003, J BIOL CHEM, V278, P36916, DOI 10.1074/jbc.M301598200; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scortegagna M, 2008, BLOOD, V111, P3343, DOI 10.1182/blood-2007-10-115758; Shohet RV, 2007, J MOL MED, V85, P1309, DOI 10.1007/s00109-007-0279-x; Sitcheran R, 2003, GENE DEV, V17, P2368, DOI 10.1101/gad.1114503; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Wang HT, 2007, MOL CELL BIOL, V27, P4374, DOI 10.1128/MCB.02020-06; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105	54	58	60	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8927	8935		10.1074/jbc.M109.078600	http://dx.doi.org/10.1074/jbc.M109.078600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20089853	Green Published, hybrid			2022-12-27	WOS:000275553700044
J	Lu, TY; Lu, RM; Liao, MY; Yu, J; Chung, CH; Kao, CF; Wu, HC				Lu, Tung-Ying; Lu, Ruei-Min; Liao, Mei-Ying; Yu, John; Chung, Chu-Hung; Kao, Cheng-Fu; Wu, Han-Chung			Epithelial Cell Adhesion Molecule Regulation Is Associated with the Maintenance of the Undifferentiated Phenotype of Human Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EP-CAM; SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; DEVELOPMENTAL REGULATORS; H3K27 DEMETHYLASES; METHYLATION STATUS; MOUSE DEVELOPMENT; DNA METHYLATION; PROMOTER REGION; C-MYC	Human embryonic stem cells (hESCs) are unique pluripotent cells capable of self-renewal and differentiation into all three germ layers. To date, more cell surface markers capable of reliably identifying hESCs are needed. The epithelial cell adhesion molecule (EpCAM) is a type I transmembrane glycoprotein expressed in several progenitor cell populations and cancers. It has been used to enrich cells with tumor-initiating activity in xenograft transplantation studies. Here, we comprehensively profile the expression of EpCAM by immunofluorescence microscopy, Western blotting, and flow cytometry using an anti-EpCAM monoclonal antibody (mAb) OC98-1. We found EpCAM to be highly and selectively expressed by undifferentiated rather than differentiated hESCs. The protein and transcript level of EpCAM rapidly diminished as soon as hESC had differentiated. This silencing was closely and exclusively associated with the radical transformation of histone modification at the EpCAM promoter. Moreover, we demonstrated that the dynamic pattern of lysine 27 trimethylation of histone 3 was conferred by the interplay of SUZ12 and JMJD3, both of which were involved in maintaining hESC pluripotency. In addition, we used chromatin immunoprecipitation analysis to elucidate the direct regulation by EpCAM of several reprogramming genes, including c-MYC, OCT-4, NANOG, SOX2, and KLF4, to help maintain the undifferentiation of hESCs. Collectively, our results suggest that EpCAM might be used as a surface marker for hESC. The expression of EpCAM may be regulated by epigenetic mechanisms, and it is strongly associated with the maintenance of the undifferentiated state of hESCs.	[Lu, Tung-Ying; Lu, Ruei-Min; Liao, Mei-Ying; Yu, John; Chung, Chu-Hung; Kao, Cheng-Fu; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Yu, John; Wu, Han-Chung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lu, Tung-Ying; Wu, Han-Chung] Natl Taiwan Univ, Inst Pathol, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University	Kao, CF (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	ckao@gate.sinica.edu.tw; hcw0928@gate.sinica.edu.tw	Lu, Ruei-Min/ABF-4388-2021; yu, john/AAA-9255-2021; Kao, Cheng-Fu/AAE-8400-2022; YU, JOHN/G-8954-2012; Wu, Han-Chung/B-1209-2011	Lu, Ruei-Min/0000-0003-3792-5499; Kao, Cheng-Fu/0000-0002-8875-8152; Wu, Han-Chung/0000-0002-5185-1169; Yu, John/0000-0002-3237-4272	Academia Sinica and National Science Council (Taiwan) [NSC98-2323-B-001-001, NSC98-3111-B-001-004]	Academia Sinica and National Science Council (Taiwan)	This work was supported by Academia Sinica and National Science Council (Taiwan) Grants NSC98-2323-B-001-001 and NSC98-3111-B-001-004 ( to H.-C.W.).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anderson R, 1999, J REPROD FERTIL, V116, P379, DOI 10.1530/jrf.0.1160379; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Balzar M, 1999, J MOL MED, V77, P699, DOI 10.1007/s001099900038; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brimble SN, 2007, STEM CELLS, V25, P54, DOI 10.1634/stemcells.2006-0232; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chan KKK, 2009, STEM CELLS, V27, P2114, DOI 10.1002/stem.143; Chen YC, 2007, CLIN VACCINE IMMUNOL, V14, P404, DOI 10.1128/CVI.00249-06; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dan YY, 2006, P NATL ACAD SCI USA, V103, P9912, DOI 10.1073/pnas.0603824103; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huttner HB, 2008, STEM CELLS, V26, P698, DOI 10.1634/stemcells.2007-0639; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Jovic M, 2007, J CELL SCI, V120, P802, DOI 10.1242/jcs.03383; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Kolle G, 2009, STEM CELLS, V27, P2446, DOI 10.1002/stem.182; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Litvinov SV, 1997, J CELL BIOL, V139, P1337, DOI 10.1083/jcb.139.5.1337; LITVINOV SV, 1994, J CELL BIOL, V125, P437, DOI 10.1083/jcb.125.2.437; Litvinov SV, 1996, AM J PATHOL, V148, P865; Lu TY, 2009, J CELL BIOCHEM, V108, P315, DOI 10.1002/jcb.22256; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Munz M, 2004, ONCOGENE, V23, P5748, DOI 10.1038/sj.onc.1207610; Mutskov V, 2004, EMBO J, V23, P138, DOI 10.1038/sj.emboj.7600013; Ng VY, 2010, STEM CELLS, V28, P29, DOI 10.1002/stem.221; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schmelzer E, 2007, J EXP MED, V204, P1973, DOI 10.1084/jem.20061603; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shiah Shine-Gwo, 2009, Oral Oncol, V45, pe1, DOI 10.1016/j.oraloncology.2008.03.003; Spizzo G, 2007, CANCER LETT, V246, P253, DOI 10.1016/j.canlet.2006.03.002; Stingl J, 2005, J MAMMARY GLAND BIOL, V10, P49, DOI 10.1007/s10911-005-2540-7; Sundberg M, 2009, STEM CELL RES, V2, P113, DOI 10.1016/j.scr.2008.08.001; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tai KY, 2007, ONCOGENE, V26, P3989, DOI 10.1038/sj.onc.1210176; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trzpis M, 2007, AM J PATHOL, V171, P386, DOI 10.2353/ajpath.2007.070152; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamashita T, 2007, CANCER RES, V67, P10831, DOI 10.1158/0008-5472.CAN-07-0908; Yu GL, 2008, ONCOL REP, V20, P1061, DOI 10.3892/or_00000110; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	72	96	99	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8719	8732		10.1074/jbc.M109.077081	http://dx.doi.org/10.1074/jbc.M109.077081			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20064925	hybrid, Green Published			2022-12-27	WOS:000275553700025
J	Yu, JJ; Pan, L; Qin, XC; Chen, H; Xu, YL; Chen, YG; Tang, H				Yu, Junjing; Pan, Lei; Qin, Xincheng; Chen, Hua; Xu, Youli; Chen, Yeguang; Tang, Hong			MTMR4 Attenuates Transforming Growth Factor beta (TGF beta) Signaling by Dephosphorylating R-Smads in Endosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FYVE DOMAIN PROTEIN; RECEPTOR ACTIVATION; PHOSPHATASES; INTERNALIZATION; LOCALIZATION; INTERACTS; ENDOFIN; BINDING; ANCHOR; SARA	Homeostasis of Smad phosphorylation at its C-terminal SXS motif is essential for transforming growth factor beta (TGF beta) signaling. Whereas it is known that TGF beta signaling can be terminated by phosphatases, which dephosphorylate R-Smads in the nucleus, it is unclear whether there are any cytoplasmic phosphatase(s) that can attenuate R-Smad phosphorylation and nuclear translocation. Here we demonstrate that myotubularin-related protein 4 (MTMR4), a FYVE domain-containing dual-specificity protein phosphatase (DSP), attenuates TGF beta signaling by reducing the phosphorylation level of R-Smads in early endosomes. Co-immunoprecipitation experiments showed that endogenous MTMR4 interacts with phosphorylated R-Smads, and that this interaction is correlated with dephosphorylation of R-Smads. Further analysis showed that overexpression of MTMR4 resulted in the sequestration of activated Smad3 in the early endosomes, thus reducing its nuclear translocation. However, both point mutations at the conserved catalytic site of the phosphatase (MTMR4-C407S) and small interference RNA of endogenous Mtmr4 expression led to sustained Smad3 activation. This work therefore suggests that MTMR4 plays an important role in preventing the overactivation of TGF beta signaling by dephosphorylating activated R-Smads that have been trafficked to early endosomes.	[Tang, Hong] Chinese Acad Sci, Key Lab Infect & Immun, Inst Biophys, Beijing 100101, Peoples R China; [Yu, Junjing; Pan, Lei] Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China; [Chen, Hua; Chen, Yeguang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University	Tang, H (corresponding author), Chinese Acad Sci, Key Lab Infect & Immun, Inst Biophys, 15 Da Tun Rd, Beijing 100101, Peoples R China.	tanghong@moon.ibp.ac.cn	Chen, Ye-Guang/L-6998-2019	Pan, Lei/0000-0002-0500-8904	MOST [2006CB504300, 2007DFC30190, 2009CB522506, 2004CB720002, 2006CB910100]; NSFC [30428002]	MOST; NSFC(National Natural Science Foundation of China (NSFC))	This work was supported in part by grants from the National Basic Research Program of MOST (2006CB504300, 2007DFC30190, 2009CB522506) (to H. T.) and NSFC (30428002) and MOST (2004CB720002, 2006CB910100) (to Y. C.).	Aoki CA, 2005, AUTOIMMUN REV, V4, P450, DOI 10.1016/j.autrev.2005.03.006; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Chen YL, 2006, BIOCHEM BIOPH RES CO, V345, P106, DOI 10.1016/j.bbrc.2006.04.034; Chen YG, 2007, J BIOL CHEM, V282, P9688, DOI 10.1074/jbc.M611704200; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Itoh F, 2002, GENES CELLS, V7, P321, DOI 10.1046/j.1365-2443.2002.00519.x; Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1; Knockaert M, 2006, P NATL ACAD SCI USA, V103, P11940, DOI 10.1073/pnas.0605133103; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Lo RS, 1999, NAT CELL BIOL, V1, P472, DOI 10.1038/70258; Lorenzo O, 2006, J CELL SCI, V119, P2953, DOI 10.1242/jcs.03040; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Miura S, 2000, MOL CELL BIOL, V20, P9346, DOI 10.1128/MCB.20.24.9346-9355.2000; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Pierreux CE, 2000, MOL CELL BIOL, V20, P9041, DOI 10.1128/MCB.20.23.9041-9054.2000; Schilling SH, 2006, CELL, V125, P838, DOI 10.1016/j.cell.2006.05.015; Shi WB, 2007, J CELL SCI, V120, P1216, DOI 10.1242/jcs.03400; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Tang H, 1999, IMMUNITY, V11, P517, DOI 10.1016/S1074-7613(00)80127-2; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xu L, 2004, NAT REV MOL CELL BIO, V5, P209, DOI 10.1038/nrm1331; Zhao RX, 2001, EXP CELL RES, V265, P329, DOI 10.1006/excr.2001.5185; Zhao X, 2008, J BIOL CHEM, V283, P3272, DOI 10.1074/jbc.M708033200	37	37	38	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8454	8462		10.1074/jbc.M109.075036	http://dx.doi.org/10.1074/jbc.M109.075036			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061380	Green Published, hybrid			2022-12-27	WOS:000275413800060
J	Day, AM; Veal, EA				Day, Alison M.; Veal, Elizabeth A.			Hydrogen Peroxide-sensitive Cysteines in the Sty1 MAPK Regulate the Transcriptional Response to Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; CANDIDA-ALBICANS; SPC1 KINASE; PATHWAY; PHOSPHORYLATION; ROLES; GENE; EXPRESSION	MAPK are activated by and orchestrate responses to multiple, diverse stimuli. Although these responses involve the increased phosphorylation of substrate effector proteins, e. g. transcription factors, the mechanisms by which responses are tailored to particular stimuli are unclear. In the fission yeast Schizosaccharomyces pombe, the Sty1 MAPK is crucial for changes in gene expression that allow adaptation to many forms of environmental stress. Here, we have identified two cysteine residues in Sty1, Cys-153 and Cys-158, that are important for hydrogen peroxide-induced gene expression and oxidative stress resistance but not for other functions of Sty1. Many Sty1-dependent changes in gene expression are mediated by the Atf1 transcription factor. In response to stress, Sty1 increases Atf1 levels by (i) promoting increases in atf1 mRNA and by (ii) directly phosphorylating and stabilizing Atf1 protein. Although dispensable for phosphorylation and stabilization of Atf1 protein, we find that both Cys-153 and Cys-158 are required for increases in atf1 mRNA levels and Atf1-dependent gene expression in response to hydrogen peroxide but not osmotic stress. Indeed, our data indicate that oxidation of Sty1, by formation of a disulfide bond between Cys-153 and Cys-158, is important for maintaining atf1 mRNA stability at high concentrations of hydrogen peroxide. Together, these data reveal that redox regulation of cysteine thiols in Sty1 is involved in a stress-specific mechanism regulating transcriptional responses to oxidative stress. Intriguingly, the conservation of these cysteine residues in other MAPK raises the possibility that similar mechanisms may ensure appropriate responses to hydrogen peroxide in other eukaryotes.	[Day, Alison M.; Veal, Elizabeth A.] Med Sch Newcastle Upon Tyne, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Veal, EA (corresponding author), Med Sch Newcastle Upon Tyne, Inst Cell & Mol Biosci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	e.a.veal@ncl.ac.uk		Veal, Elizabeth/0000-0002-1152-5473	Medical Research Council Career Development; Biotechnology and Biological Sciences Research Council [BBF0230651]; BBSRC [BB/F023065/1] Funding Source: UKRI; MRC [G120/817] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F023065/1] Funding Source: researchfish; Medical Research Council [G120/817] Funding Source: researchfish	Medical Research Council Career Development(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Medical Research Council Career Development Award and Biotechnology and Biological Sciences Research Council Grant BBF0230651 ( to E. V.).	Alonso-Monge R, 1999, J BACTERIOL, V181, P3058, DOI 10.1128/JB.181.10.3058-3068.1999; APOLINARIO E, 1993, CURR GENET, V24, P491, DOI 10.1007/BF00351711; Bahn YS, 2005, MOL BIOL CELL, V16, P2285, DOI 10.1091/mbc.E04-11-0987; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; BASI G, 1993, GENE, V123, P131, DOI 10.1016/0378-1119(93)90552-E; Buck V, 2001, MOL BIOL CELL, V12, P407, DOI 10.1091/mbc.12.2.407; Chen DR, 2008, MOL BIOL CELL, V19, P308, DOI 10.1091/mbc.E07-08-0735; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Csank C, 1998, INFECT IMMUN, V66, P2713, DOI 10.1128/IAI.66.6.2713-2721.1998; Degols G, 1996, MOL CELL BIOL, V16, P2870; Degols G, 1997, MOL CELL BIOL, V17, P3356, DOI 10.1128/MCB.17.6.3356; Delaunay A, 2000, EMBO J, V19, P5157, DOI 10.1093/emboj/19.19.5157; Delaunay A, 2002, CELL, V111, P471, DOI 10.1016/S0092-8674(02)01048-6; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; GUPTA S, 1995, SCIENCE, V267, P389, DOI 10.1126/science.7824938; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Lawrence CL, 2007, J BIOL CHEM, V282, P5160, DOI 10.1074/jbc.M608526200; LIVINGSTONE C, 1995, EMBO J, V14, P1785, DOI 10.1002/j.1460-2075.1995.tb07167.x; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MILLAR JBA, 1995, GENE DEV, V9, P2117, DOI 10.1101/gad.9.17.2117; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nguyen AN, 2000, MOL BIOL CELL, V11, P1169, DOI 10.1091/mbc.11.4.1169; Nguyen AN, 1999, GENE DEV, V13, P1653, DOI 10.1101/gad.13.13.1653; PARKER R, 1991, METHOD ENZYMOL, V194, P415; Quinn J, 2002, MOL BIOL CELL, V13, P805, DOI 10.1091/mbc.01-06-0288; Rodriguez-Gabriel MA, 2003, EMBO J, V22, P6256, DOI 10.1093/emboj/cdg597; Rodriguez-Gabriel MA, 2006, MOL CELL BIOL, V26, P6347, DOI 10.1128/MCB.00286-06; Sambrook I, 1989, MOL CLONING LAB MANU; SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0; Shiozaki K, 1996, GENE DEV, V10, P2276, DOI 10.1101/gad.10.18.2276; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Toone WM, 1998, GENES CELLS, V3, P485, DOI 10.1046/j.1365-2443.1998.00211.x; Veal EA, 2002, J BIOL CHEM, V277, P35523, DOI 10.1074/jbc.M111548200; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vivancos AP, 2004, MOL MICROBIOL, V52, P1427, DOI 10.1111/j.1365-2958.2004.04065.x; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wilkinson MG, 1996, GENE DEV, V10, P2289, DOI 10.1101/gad.10.18.2289	44	38	39	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7505	7516		10.1074/jbc.M109.040840	http://dx.doi.org/10.1074/jbc.M109.040840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20061379	hybrid, Green Published			2022-12-27	WOS:000275415600062
J	McLaughlin, M; Alloza, I; Quoc, HP; Scott, CJ; Hirabayashi, Y; Vandenbroeck, K				McLaughlin, Martin; Alloza, Iraide; Quoc, Hung Pham; Scott, Christopher J.; Hirabayashi, Yasuhiko; Vandenbroeck, Koen			Inhibition of Secretion of Interleukin (IL)-12/IL-23 Family Cytokines by 4-Trifluoromethyl-celecoxib Is Coupled to Degradation via the Endoplasmic Reticulum Stress Protein HERP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NON-COXIB ANALOG; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; CELECOXIB; CELLS; CALCIUM; INTERLEUKIN-12-ALPHA-BETA; 2,5-DIMETHYL-CELECOXIB; INFLAMMATION; USTEKINUMAB	Interleukin-12 (IL-12), p80, and IL-23 are structurally related cytokines sharing a p40 subunit. We have recently demonstrated that celecoxib and its COX-2-independent analogue 4-trifluoromethyl-celecoxib (TFM-C) inhibit secretion but not transcription of IL-12 (p35/p40) and p80 (p40/p40). This is associated with a mechanism involving altered cytokine-chaperone interaction in the endoplasmic reticulum (ER). In the present study, we found that celecoxib and TFM-C also block secretion of IL-23 (p40/p19 heterodimers). Given the putative ER-centric mode of these compounds, we performed a comprehensive RTPCR analysis of 23 ER-resident chaperones/foldases and associated co-factors. This revealed that TFM-C induced 1.5-3-fold transcriptional up-regulation of calreticulin, GRP78, GRP94, GRP170, ERp72, ERp57, ERdj4, and ERp29. However, more significantly, a 7-fold up-regulation of homocysteine-inducible ER protein (HERP) was observed. HERP is part of a high molecular mass protein complex involved in ER-associated protein degradation (ERAD). Using co-immunoprecipitation assays, we show that TFM-C induces protein interaction of p80 and IL-23 with HERP. Both HERP siRNA knockdown and HERP overexpression coupled to cycloheximide chase assays revealed that HERP is necessary for degradation of intracellularly retained p80 by TFM-C. Thus, our data suggest that targeting cytokine folding in the ER by small molecule drugs could be therapeutically exploited to alleviate in appropriate inflammation in autoimmune conditions.	[McLaughlin, Martin; Alloza, Iraide; Quoc, Hung Pham; Vandenbroeck, Koen] Univ Pais Vasco UPV EHU, Neurogenom Lab, Zamudio 48170, Spain; [McLaughlin, Martin; Scott, Christopher J.] Queens Univ Belfast, Sch Pharm, Belfast BT9 7BL, Antrim, North Ireland; [Hirabayashi, Yasuhiko] Hikarigaoka Spellman Hosp, Dept Rheumatol, Miyagino Ku, Sendai, Miyagi 9830833, Japan; [Vandenbroeck, Koen] KERBASQUE, Basque Fdn Sci, Bilbao 48011, Spain	University of Basque Country; Queens University Belfast; Basque Foundation for Science	Vandenbroeck, K (corresponding author), Univ Pais Vasco UPV EHU, Neurogenom Lab, Parque Tecnol Bizkaia, Zamudio 48170, Spain.	k.vandenbroeck@ikerbasque.org	Vandenbroeck, Koen/D-6845-2012	Vandenbroeck, Koen/0000-0002-6967-6485; McLaughlin, Martin/0000-0002-9739-7133; Alloza, Iraide/0000-0002-8949-7732	Northern Ireland R&D Office for Health and Personal Social Services, Ikerbasque [RRG11.5 RSG/1726]; Basque Foundation for Science, Bilbao, Spain; Ministerio de Ciencia e Innovacion, Madrid, Spain [MEC-2008, SAF2008-00433]	Northern Ireland R&D Office for Health and Personal Social Services, Ikerbasque; Basque Foundation for Science, Bilbao, Spain; Ministerio de Ciencia e Innovacion, Madrid, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by Grants RRG11.5 RSG/1726 (to K. V.) from the Northern Ireland R&D Office for Health and Personal Social Services, Ikerbasque, the Basque Foundation for Science, Bilbao, Spain, and the Ministerio de Ciencia e Innovacion, Madrid, Spain (MEC-2008; SAF2008-00433).	Alloza I, 2006, MOL PHARMACOL, V69, P1579, DOI 10.1124/mol.105.020669; Alloza I, 2005, J PHARM PHARMACOL, V57, P213, DOI 10.1211/0022357055443; Alloza I, 2004, ANAL BIOCHEM, V324, P137, DOI 10.1016/j.ab.2003.09.017; Barnabe N, 1998, J BIOTECHNOL, V60, P67, DOI 10.1016/S0168-1656(97)00188-0; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Collison LW, 2008, IMMUNOL REV, V226, P248, DOI 10.1111/j.1600-065X.2008.00704.x; Cooper AM, 2007, TRENDS IMMUNOL, V28, P33, DOI 10.1016/j.it.2006.11.002; Grosch S, 2006, JNCI-J NATL CANCER I, V98, P736, DOI 10.1093/jnci/djj206; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Johnson AJ, 2002, BIOCHEM J, V366, P831, DOI 10.1042/BJ20020279; Kardosh A, 2008, CANCER RES, V68, P843, DOI 10.1158/0008-5472.CAN-07-5555; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Kroenke MA, 2008, J EXP MED, V205, P1535, DOI 10.1084/jem.20080159; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lee YK, 1999, MOL BIOL CELL, V10, P2209, DOI 10.1091/mbc.10.7.2209; Lehner I, 2003, ELECTROPHORESIS, V24, P1795, DOI 10.1002/elps.200305387; Leitzgen K, 1997, J BIOL CHEM, V272, P3117, DOI 10.1074/jbc.272.5.3117; Lenz B, 2006, EXP CELL RES, V312, P4049, DOI 10.1016/j.yexcr.2006.09.004; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; LI WWF, 1993, J BIOL CHEM, V268, P12003; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Lou JR, 2006, CANCER EPIDEM BIOMAR, V15, P1598, DOI 10.1158/1055-9965.EPI-06-0216; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mikols CL, 2006, AM J RESP CRIT CARE, V174, P461, DOI 10.1164/rccm.200512-1886OC; Namba T, 2007, MOL PHARMACOL, V71, P860, DOI 10.1124/mol.106.027698; Oka Y, 2007, TOHOKU J EXP MED, V212, P431, DOI 10.1620/tjem.212.431; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Paunovic V, 2008, RHEUMATOLOGY, V47, P771, DOI 10.1093/rheumatology/kem352; Pyrko P, 2008, BIOCHEM PHARMACOL, V75, P395, DOI 10.1016/j.bcp.2007.08.029; Pyrko P, 2007, MOL CANCER THER, V6, P1262, DOI 10.1158/1535-7163.MCT-06-0629; Russell TD, 2003, J IMMUNOL, V171, P6866, DOI 10.4049/jimmunol.171.12.6866; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; Schonthal AH, 2007, BRIT J CANCER, V97, P1465, DOI 10.1038/sj.bjc.6604049; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Steinman L, 2008, J EXP MED, V205, P1517, DOI 10.1084/jem.20072066; Torti DC, 2007, J AM ACAD DERMATOL, V57, P1059, DOI 10.1016/j.jaad.2007.07.016; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Vandenbroeck K, 2004, J PHARM PHARMACOL, V56, P145, DOI 10.1211/0022357022962; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	44	16	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					6960	6969		10.1074/jbc.M109.056614	http://dx.doi.org/10.1074/jbc.M109.056614			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20054003	hybrid, Green Published			2022-12-27	WOS:000275415600009
J	Gopal, S; Bober, A; Whiteford, JR; Multhaupt, HAB; Yoneda, A; Couchman, JR				Gopal, Sandeep; Bober, Adam; Whiteford, James R.; Multhaupt, Hinke A. B.; Yoneda, Atsuko; Couchman, John R.			Heparan Sulfate Chain Valency Controls Syndecan-4 Function in Cell Adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIRECTIONAL MIGRATION; CYTOPLASMIC DOMAIN; PKC-ALPHA; BINDING; PROTEIN; KINASE; PROTEOGLYCANS; LOCALIZATION; ACTIVATION; ACTIN	Fibroblasts null for the transmembrane proteoglycan, syndecan-4, have an altered actin cytoskeleton, compared with matching wild-type cells. They do not organize alpha-smooth muscle actin into bundles, but will do so when full-length syndecan-4 is re-expressed. This requires the central V region of the core protein cytoplasmic domain, though not interactions with PDZ proteins. A second key requirement is multiple heparan sulfate chains. Mutant syndecan-4 with no chains, or only one chain, failed to restore the wild-type phenotype, whereas those expressing two or three were competent. However, clustering of one-chain syndecan-4 forms with antibodies overcame the block, indicating that valency of interactions with ligands is a key component of syndecan-4 function. Measurements of focal contact/adhesion size and focal adhesion kinase phosphorylation correlated with syndecan-4 status and alpha-smooth muscle actin organization, being reduced where syndecan-4 function was compromised by a lack of multiple heparan sulfate chains.	[Couchman, John R.] Univ Copenhagen, Dept Biomed Sci, Bioctr, DK-2200 Copenhagen N, Denmark; [Bober, Adam; Whiteford, James R.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Natl Heart & Lung Inst, London SW7 2AZ, England	University of Copenhagen; Imperial College London	Couchman, JR (corresponding author), Univ Copenhagen, Dept Biomed Sci, Bioctr, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	john.couchman@bric.ku.dk		Gopal, Sandeep/0000-0002-6706-6747; Whiteford, James/0000-0002-8967-7389	Wellcome Trust [065940]; Danish National Research Foundation; Haensch Foundation; Wilhelm Pedersen Fonden through the Novo Nordisk Fonden; Department of Biomedical Sciences at the University of Copenhagen; Molecular Medicine Ph.D. program at the University of Copenhagen; Medical Research Council UK (MRC); Versus Arthritis [19207] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Haensch Foundation; Wilhelm Pedersen Fonden through the Novo Nordisk Fonden; Department of Biomedical Sciences at the University of Copenhagen; Molecular Medicine Ph.D. program at the University of Copenhagen; Medical Research Council UK (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Versus Arthritis(Versus Arthritis)	This work was supported initially by Wellcome Trust Programme Grant 065940 (to J. R. C.), then by the Danish National Research Foundation, Haensch Foundation, Wilhelm Pedersen Fonden through the Novo Nordisk Fonden, and the Department of Biomedical Sciences at the University of Copenhagen (to J. R. C.).; Supported by the Molecular Medicine Ph.D. program at the University of Copenhagen.; Supported by a Medical Research Council UK (MRC) studentship.	Bass MD, 2007, J CELL BIOL, V177, P527, DOI 10.1083/jcb.200610076; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Dovas A, 2006, J CELL SCI, V119, P2837, DOI 10.1242/jcs.03020; Echtermeyer F, 1999, J CELL SCI, V112, P3433; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Ishiguro K, 2000, J BIOL CHEM, V275, P5249, DOI 10.1074/jbc.275.8.5249; Keum E, 2004, BIOCHEM J, V378, P1007, DOI 10.1042/BJ20031734; Lim ST, 2003, J BIOL CHEM, V278, P13795, DOI 10.1074/jbc.M208300200; Longley RL, 1999, J CELL SCI, V112, P3421; Mahalingam Y, 2007, J BIOL CHEM, V282, P3221, DOI 10.1074/jbc.M604938200; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; MIEKKA SI, 1982, THROMB RES, V27, P1, DOI 10.1016/0049-3848(82)90272-9; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Okina E, 2009, SCAND J MED SCI SPOR, V19, P479, DOI 10.1111/j.1600-0838.2009.00941.x; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; Shin J, 2001, BIOCHEMISTRY-US, V40, P8471, DOI 10.1021/bi002750r; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; SHWORAK NW, 1994, J BIOL CHEM, V269, P21204; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tumova S, 2000, J BIOL CHEM, V275, P9410, DOI 10.1074/jbc.275.13.9410; Whiteford JR, 2008, J BIOL CHEM, V283, P29322, DOI 10.1074/jbc.M803505200; Whiteford JR, 2007, EXP CELL RES, V313, P3902, DOI 10.1016/j.yexcr.2007.08.002; Whiteford JR, 2006, J BIOL CHEM, V281, P32156, DOI 10.1074/jbc.M605553200; Wilcox-Adelman SA, 2002, J BIOL CHEM, V277, P32970, DOI 10.1074/jbc.M201283200; Woods A, 2000, ARCH BIOCHEM BIOPHYS, V374, P66, DOI 10.1006/abbi.1999.1607; Yamada S, 2007, GLYCOBIOLOGY, V17, P886, DOI 10.1093/glycob/cwm051; Zimmermann P, 2001, MOL BIOL CELL, V12, P339, DOI 10.1091/mbc.12.2.339	36	56	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 7	2010	285	19					14247	14258		10.1074/jbc.M109.056945	http://dx.doi.org/10.1074/jbc.M109.056945			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	591KQ	20154082	hybrid, Green Published			2022-12-27	WOS:000277299700021
J	Moon, SH; Lin, L; Zhang, XN; Nguyen, TA; Darlington, Y; Waldman, AS; Lu, XB; Donehower, LA				Moon, Sung-Hwan; Lin, Lin; Zhang, Xinna; Nguyen, Thuy-Ai; Darlington, Yolanda; Waldman, Alan S.; Lu, Xiongbin; Donehower, Lawrence A.			Wild-type p53-induced Phosphatase 1 Dephosphorylates Histone Variant gamma-H2AX and Suppresses DNA Double Strand Break Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-RESPONSE; MAMMALIAN CHROMOSOMES; PROTEIN PHOSPHATASE; GENOMIC INSTABILITY; TUMOR-SUPPRESSOR; WIP1; ATM; PPM1D; MDC1; H2AX	In response to DNA double strand breaks, the histone variant H2AX at the break site is phosphorylated at serine 139 by DNA damage sensor kinases such as ataxia telangiectasia-mutated, forming gamma-H2AX. This phosphorylation event is critical for sustained recruitment of other proteins to repair the break. After repair, restoration of the cell to a prestress state is associated with gamma-H2AX dephosphorylation and dissolution of gamma-H2AX-associated damage foci. The phosphatases PP2A and PP4 have previously been shown to dephosphorylate gamma-H2AX. Here, we demonstrate that the wild-type p53-induced phosphatase 1 (WIP1) also dephosphorylates gamma-H2AX at serine 139 in vitro and in vivo. Overexpression of WIP1 reduces formation of gamma-H2AX foci in response to ionizing and ultraviolet radiation and blocks recruitment of MDC1 (mediator of DNA damage checkpoint 1) and 53BP1 (p53 binding protein 1) to DNA damage foci. Finally, these inhibitory effects of WIP1 on gamma-H2AX are accompanied by WIP1 suppression of DNA double strand break repair. Thus, WIP1 has a homeostatic role in reversing the effects of ataxia telangiectasia-mutated phosphorylation of H2AX.	[Moon, Sung-Hwan; Donehower, Lawrence A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Nguyen, Thuy-Ai; Darlington, Yolanda; Donehower, Lawrence A.] Baylor Coll Med, Interdepartmental Grad Program Cell & Mol Biol, Houston, TX 77030 USA; [Lin, Lin; Zhang, Xinna; Waldman, Alan S.; Lu, Xiongbin] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Lu, Xiongbin] Univ S Carolina, Ctr Colon Canc Res, Columbia, SC 29208 USA; [Donehower, Lawrence A.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Baylor College of Medicine	Lu, XB (corresponding author), Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	xlu@biol.sc.edu; larryd@bcm.tmc.edu	Nguyen, Thuy-Ai/Q-4082-2019	Nguyen, Thuy-Ai/0000-0001-8778-0078	NCI [CA100420]; Department of Defense Breast Cancer Research Program; National Institutes of Health Grant [CA136549]; NATIONAL CANCER INSTITUTE [R01CA136549, R01CA100420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081472] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense Breast Cancer Research Program(United States Department of Defense); National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100420 from the NCI (to L. A. D.).; Supported by grants from the Department of Defense Breast Cancer Research Program.; Supported by the Center for Colon Cancer Research at the University of South Carolina and by National Institutes of Health Grant CA136549. To whom correspondence may be addressed: Dept. of Biological Sciences, University of South Carolina, Columbia, SC 29208. Fax: 803-777-4002; E-mail: xlu@biol.sc.edu.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Bakkenist CJ, 2004, TRENDS CELL BIOL, V14, P339, DOI 10.1016/j.tcb.2004.05.001; Bannister LA, 2004, DNA REPAIR, V3, P465, DOI 10.1016/j.dnarep.2004.01.001; Barford D, 1996, TRENDS BIOCHEM SCI, V21, P407, DOI 10.1016/S0968-0004(96)10060-8; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Collis SJ, 2005, ONCOGENE, V24, P949, DOI 10.1038/sj.onc.1208332; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Jackson MD, 2001, CHEM REV, V101, P2313, DOI 10.1021/cr000247e; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, CELL CYCLE, V3, P1363, DOI 10.4161/cc.3.11.1241; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Modesti M, 2001, CURR BIOL, V11, pR229, DOI 10.1016/S0960-9822(01)00112-9; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nannenga B, 2006, MOL CARCINOGEN, V45, P594, DOI 10.1002/mc.20195; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Smith JA, 2007, MOL CELL BIOL, V27, P7816, DOI 10.1128/MCB.00455-07; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; van Gent DC, 2001, NAT REV GENET, V2, P196, DOI 10.1038/35056049; YAGINUMA Y, 1991, CANCER RES, V51, P6506; Yamaguchi H, 2005, BIOCHEMISTRY-US, V44, P5285, DOI 10.1021/bi0476634; Yamaguchi H, 2007, BIOCHEMISTRY-US, V46, P12594, DOI 10.1021/bi701096s; Yoda A, 2008, J BIOL CHEM, V283, P18969, DOI 10.1074/jbc.M800560200	56	84	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12935	12947		10.1074/jbc.M109.071696	http://dx.doi.org/10.1074/jbc.M109.071696			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20118229	Green Published, hybrid			2022-12-27	WOS:000276787800052
J	Zavialov, AV; Yu, XD; Spillmann, D; Lauvau, G; Zavialov, AV				Zavialov, Anton V.; Yu, Xiaodi; Spillmann, Dorothe; Lauvau, Gregoire; Zavialov, Andrey V.			Structural Basis for the Growth Factor Activity of Human Adenosine Deaminase ADA2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMATIONAL-CHANGE; CELL-SURFACE; DROSOPHILA; FAMILY; GENE; PURIFICATION; RECEPTORS; REVEALS; BINDING	Two distinct adenosine deaminases, ADA1 and ADA2, are found in humans. ADA1 has an important role in lymphocyte function and inherited mutations in ADA1 result in severe combined immunodeficiency. The recently isolated ADA2 belongs to the novel family of adenosine deaminase growth factors (ADGFs), which play an important role in tissue development. The crystal structures of ADA2 and ADA2 bound to a transition state analogue presented here reveal the structural basis of the catalytic/signaling activity of ADGF/ ADA2 proteins. In addition to the catalytic domain, the structures discovered two ADGF/ADA2-specific domains of novel folds that mediate the protein dimerization and binding to the cell surface receptors. This complex architecture is in sharp contrast with that of monomeric single domain ADA1. An extensive glycosylation and the presence of a conserved disulfide bond and a signal peptide in ADA2 strongly suggest that ADA2, in contrast to ADA1, is specifically designed to act in the extracellular environment. The comparison of catalytic sites of ADA2 and ADA1 demonstrates large differences in the arrangement of the substrate-binding pockets. These structural differences explain the substrate and inhibitor specificity of adenosine deaminases and provide the basis for a rational design of ADA2-targeting drugs to modulate the immune system responses in pathophysiological conditions.	Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, SE-75324 Uppsala, Sweden; [Spillmann, Dorothe] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Lauvau, Gregoire] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, INSERM, U924, F-06560 Valbonne, France; [Lauvau, Gregoire] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA; [Zavialov, Andrey V.] Singapore Immunol Network SIgN, Lab Immune Regulat, Singapore 138648, Singapore	Swedish University of Agricultural Sciences; Uppsala University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Yeshiva University; Albert Einstein College of Medicine; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)		anton.zavialov@molbio.slu.se; Andrey_Zaviyalov@immunol.a-star.edu.sg	Zavialov, Anton V./C-7664-2015	Zavialov, Anton V./0000-0001-6191-5931	Swedish Research Council [K2008-58X-20689-01-3]; FORMAS [221-2007-1057]; European Molecular Biology Organization [ALT-978-2005]; Human Frontier of Science Program (HFSP) [LT00395-2006-L]; INSERM (Avenir); HFSP [CDA0040-2005C]	Swedish Research Council(Swedish Research CouncilEuropean Commission); FORMAS(Swedish Research Council Formas); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier of Science Program (HFSP)(Human Frontier Science Program); INSERM (Avenir)(Institut National de la Sante et de la Recherche Medicale (Inserm)); HFSP(Human Frontier Science Program)	This work was supported by grants from the Swedish Research Council (K2008-58X-20689-01-3) and FORMAS (221-2007-1057) (to Ant. V. Z.), European Molecular Biology Organization Grant ALT-978-2005 and Human Frontier of Science Program (HFSP) Long Term Fellowship LT00395-2006-L (to And. V. Z.), and grants from INSERM (Avenir) and HFSP carrier development award (CDA0040-2005C) (to G. L.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; Canals M, 2004, J NEUROCHEM, V88, P726, DOI 10.1046/j.1471-4159.2003.02200.x; Charlab R, 2001, GENE, V267, P13, DOI 10.1016/S0378-1119(01)00393-6; Dillman Robert O, 2004, Expert Rev Anticancer Ther, V4, P27, DOI 10.1586/14737140.4.1.27; Dolezal T, 2005, PLOS BIOL, V3, P1213, DOI 10.1371/journal.pbio.0030201; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Franco R, 2007, CRIT REV IMMUNOL, V27, P495, DOI 10.1615/CritRevImmunol.v27.i6.10; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hershfield MS, 2005, EUR J IMMUNOL, V35, P25, DOI 10.1002/eji.200425738; Homma K, 1996, J BIOL CHEM, V271, P13770, DOI 10.1074/jbc.271.23.13770; Homma KJ, 2001, J BIOL CHEM, V276, P43761, DOI 10.1074/jbc.M105088200; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Iijima R, 2008, J BIOL CHEM, V283, P2255, DOI 10.1074/jbc.M709279200; Iwaki-Egawa S, 2004, COMP BIOCHEM PHYS B, V137, P247, DOI 10.1016/j.cbpc.2003.11.010; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinoshita T, 2005, BIOCHEMISTRY-US, V44, P10562, DOI 10.1021/bi050529e; Kinoshita T, 2008, BIOCHEM BIOPH RES CO, V373, P53, DOI 10.1016/j.bbrc.2008.05.180; Larson ET, 2008, J MOL BIOL, V381, P975, DOI 10.1016/j.jmb.2008.06.048; Maier SA, 2005, J MOL EVOL, V61, P776, DOI 10.1007/s00239-005-0046-y; Maier SA, 2001, GENE, V280, P27, DOI 10.1016/S0378-1119(01)00762-4; Matsushita T, 2000, J BIOL CHEM, V275, P36934, DOI 10.1074/jbc.M003455200; Meins M, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.5.e62; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NIEDZWICKI JG, 1991, J ACQ IMMUN DEF SYND, V4, P178; Petersen F, 1999, J BIOL CHEM, V274, P12376, DOI 10.1074/jbc.274.18.12376; Riazi MA, 2000, GENOMICS, V64, P277, DOI 10.1006/geno.1999.6099; Sachchidanand, 2002, J BIOL CHEM, V277, P50629, DOI 10.1074/jbc.M208956200; UNGERER JPJ, 1992, CLIN CHEM, V38, P1322; Weihofen WA, 2004, J BIOL CHEM, V279, P43330, DOI 10.1074/jbc.M405001200; WILSON DK, 1993, BIOCHEMISTRY-US, V32, P1689, DOI 10.1021/bi00058a001; WILSON DK, 1991, SCIENCE, V252, P1278, DOI 10.1126/science.1925539; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zavialov AV, 2005, BIOCHEM J, V391, P51, DOI 10.1042/BJ20050683; Zurovec M, 2002, P NATL ACAD SCI USA, V99, P4403, DOI 10.1073/pnas.062059699	36	79	83	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					12367	12377		10.1074/jbc.M109.083527	http://dx.doi.org/10.1074/jbc.M109.083527			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147294	hybrid, Green Published			2022-12-27	WOS:000276787100065
J	Dodge-Kafka, KL; Bauman, A; Mayer, N; Henson, E; Heredia, L; Ahn, J; McAvoy, T; Nairn, AC; Kapiloff, MS				Dodge-Kafka, Kimberly L.; Bauman, Andrea; Mayer, Nicole; Henson, Edward; Heredia, Lorena; Ahn, Jung; McAvoy, Thomas; Nairn, Angus C.; Kapiloff, Michael S.			cAMP-stimulated Protein Phosphatase 2A Activity Associated with Muscle A Kinase-anchoring Protein (mAKAP) Signaling Complexes Inhibits the Phosphorylation and Activity of the cAMP-specific Phosphodiesterase PDE4D3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC MYOCYTE HYPERTROPHY; CHANNEL RYANODINE RECEPTOR; ACTIVATION; HEART; COMPARTMENTATION; CALCIUM; CONTRACTION; INVOLVEMENT	The concentration of the second messenger cAMP is tightly controlled in cells by the activity of phosphodiesterases. We have previously described how the protein kinase A-anchoring protein mAKAP serves as a scaffold for the cAMP-dependent protein kinase PKA and the cAMP-specific phosphodiesterase PDE4D3 in cardiac myocytes. PKA and PDE4D3 constitute a negative feedback loop whereby PKA-catalyzed phosphorylation and activation of PDE4D3 attenuate local cAMP levels. We now show that protein phosphatase 2A (PP2A) associated with mAKAP complexes is responsible for reversing the activation of PDE4D3 by catalyzing the dephosphorylation of PDE4D3 serine residue 54. Mapping studies reveal that a C-terminal mAKAP domain (residues 2085-2319) binds PP2A. Binding to mAKAP is required for PP2A function, such that deletion of the C-terminal domain enhances both base-line and forskolin-stimulated PDE4D3 activity. Interestingly, PP2A holoenzyme associated with mAKAP complexes in the heart contains the PP2A targeting subunit B56 delta. Like PDE4D3, B56 delta is a PKA substrate, and PKA phosphorylation of mAKAP-bound B56 delta enhances phosphatase activity 2-fold in the complex. Accordingly, expression of a B56 delta mutant that cannot be phosphorylated by PKA results in increased PDE4D3 phosphorylation. Taken together, our findings demonstrate that PP2A associated with mAKAP complexes promotes PDE4D3 dephosphorylation, serving both to inhibit PDE4D3 in unstimulated cells and also to mediate a cAMP-induced positive feedback loop following adenylyl cyclase activation and B56 delta phosphorylation. In general, PKA.PP2A.mAKAP complexes exemplify how protein kinases and phosphatases may participate in molecular signaling complexes to dynamically regulate localized intracellular signaling.	[Dodge-Kafka, Kimberly L.; Mayer, Nicole] Univ Connecticut, Ctr Hlth, Pat & Jim Calhoun Ctr Cardiol, Farmington, CT 06030 USA; [Bauman, Andrea] Oregon Hlth & Sci Univ, Casey Eye Inst, Portland, OR 97239 USA; [Henson, Edward; Heredia, Lorena; Kapiloff, Michael S.] Univ Miami, Miller Sch Med, Dept Pediat, Interdisciplinary Stem Cell Inst, Miami, FL 33101 USA; [Henson, Edward; Heredia, Lorena; Kapiloff, Michael S.] Univ Miami, Miller Sch Med, Dept Med, Interdisciplinary Stem Cell Inst, Miami, FL 33101 USA; [Ahn, Jung] Ewha Womans Univ, Sch Med, Dept Biochem, Seoul 158710, South Korea; [McAvoy, Thomas] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; [Nairn, Angus C.] Yale Univ, Dept Psychiat, New Haven, CT 06511 USA	University of Connecticut; Oregon Health & Science University; University of Miami; University of Miami; Ewha Womans University; Rockefeller University; Yale University	Dodge-Kafka, KL (corresponding author), Univ Connecticut, Ctr Hlth, MC3946,EGO28,263 Farmington Ave, Farmington, CT 06032 USA.	dodge@uchc.edu		Kapiloff, Michael/0000-0002-7005-6953; McAvoy, Thomas/0000-0002-1917-5797; Nairn, Angus/0000-0002-7075-0195; Ahn, Jung-Hyuck/0000-0001-9589-3881	National Institutes of Health [HL82705, HL075398, DA10044, MH074866]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075398, R01HL082705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants HL82705 (to K. L. D.- K.), HL075398 (to M. S. K.), and DA10044 and MH074866 (to A. C. N.).	Ahn JH, 2007, P NATL ACAD SCI USA, V104, P2979, DOI 10.1073/pnas.0611532104; Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Bauman AL, 2002, NAT CELL BIOL, V4, pE203, DOI 10.1038/ncb0802-e203; Beavo J A, 1974, Methods Enzymol, V38, P299; BRUNTON LL, 1979, NATURE, V280, P78, DOI 10.1038/280078a0; CARLISLE MJJ, 2004, BIOCHEM J, V381, P587; De Arcangelis V, 2008, MOL PHARMACOL, V74, P1453, DOI 10.1124/mol.108.049718; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dodge-Kafka KL, 2006, EUR J CELL BIOL, V85, P593, DOI 10.1016/j.ejcb.2006.01.007; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dodge-Kafka KL, 2006, CIRC RES, V98, P993, DOI 10.1161/01.RES.0000218273.91741.30; Dubell WH, 2002, AM J PHYSIOL-HEART C, V282, pH38, DOI 10.1152/ajpheart.00536.2001; duBell WH, 1996, J PHYSIOL-LONDON, V493, P793, DOI 10.1113/jphysiol.1996.sp021423; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Gigena MS, 2005, AM J PHYSIOL-HEART C, V289, pH285, DOI 10.1152/ajpheart.01291.2004; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Kapiloff MS, 1999, J CELL SCI, V112, P2725; Kapiloff MS, 2001, J CELL SCI, V114, P3167; KEELY SL, 1977, RES COMMUN CHEM PATH, V18, P283; KEELY SL, 1979, MOL PHARMACOL, V15, P235; Lechward K, 2001, ACTA BIOCHIM POL, V48, P921; Li JL, 2010, J MOL CELL CARDIOL, V48, P387, DOI 10.1016/j.yjmcc.2009.10.023; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Liu QH, 2004, AM J PHYSIOL-HEART C, V286, pH2204, DOI 10.1152/ajpheart.01050.2003; MacKenzie SJ, 2000, J BIOL CHEM, V275, P16609, DOI 10.1074/jbc.275.22.16609; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Michel JJC, 2005, MOL CELL, V20, P661, DOI 10.1016/j.molcel.2005.10.013; Pare GC, 2005, J CELL SCI, V118, P5637, DOI 10.1242/jcs.02675; Pare GC, 2005, EXP CELL RES, V303, P388, DOI 10.1016/j.yexcr.2004.10.009; Reiken S, 2001, CIRCULATION, V104, P2843, DOI 10.1161/hc4701.099578; Resjo S, 1999, BIOCHEM J, V341, P839, DOI 10.1042/0264-6021:3410839; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Steinberg SF, 2001, ANNU REV PHARMACOL, V41, P751, DOI 10.1146/annurev.pharmtox.41.1.751; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017; Wong W, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000026	39	69	73	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11078	11086		10.1074/jbc.M109.034868	http://dx.doi.org/10.1074/jbc.M109.034868			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20106966	hybrid, Green Published			2022-12-27	WOS:000276286200011
J	Taylor, SD; Solem, A; Kawaoka, J; Pyle, AM				Taylor, Sean David; Solem, Amanda; Kawaoka, Jane; Pyle, Anna Marie			The NPH-II Helicase Displays Efficient DNA center dot RNA Helicase Activity and a Pronounced Purine Sequence Bias	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION TERMINATION FACTOR; HEPATITIS-C VIRUS; VACCINIA VIRIONS; CRYSTAL-STRUCTURE; BOX PROTEINS; EARLY GENES; BASE-PAIR; STABILITY; SPECIFICITY; DOMAIN	The superfamily 2 vaccinia viral helicase nucleoside triphosphate phosphohydrolase-II (NPH-II) exhibits robust RNA helicase activity but typically displays little activity on DNA substrates. NPH-II is thus believed to make primary contacts with backbone residues of an RNA substrate. We report an unusual nucleobase bias, previously unreported in any superfamily 1 or 2 helicase, whereby purines are heavily preferred as components of both RNA and DNA tracking strands. The observed sequence bias allows NPH-II to efficiently unwind a DNA center dot RNA hybrid containing a purine-rich DNA track derived from the 3'-untranslated region of an early vaccinia gene. These results provide insight into potential biological functions of NPH-II and the role of sequence in targeting NPH-II to appropriate substrates. Furthermore, they demonstrate that in addition to backbone contacts, nucleotide bases play an important role in modulating the behavior of NPH-II. They also establish that processive helicase enzymes can display sequence selectivity.	[Solem, Amanda; Pyle, Anna Marie] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Taylor, Sean David] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Kawaoka, Jane] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Pyle, Anna Marie] Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Columbia University; Howard Hughes Medical Institute	Pyle, AM (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave, New Haven, CT 06520 USA.	anna.pyle@yale.edu	Solem, Amanda/M-5959-2013; Solem, Amanda/A-3553-2010	Solem, Amanda/0000-0002-2056-9419; 	National Institutes of Health [GM60620]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060620] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60620 (to A. M. P.).	Bayliss CD, 1996, J VIROL, V70, P794, DOI 10.1128/JVI.70.2.794-800.1996; Beran RKF, 2007, J BIOL CHEM, V282, P34913, DOI 10.1074/jbc.M707165200; BORK P, 1993, NUCLEIC ACIDS RES, V21, P751, DOI 10.1093/nar/21.3.751; Boudvillain M, 2000, NATURE, V406, P315, DOI 10.1038/35018589; Boudvillain M, 1998, EMBO J, V17, P7091, DOI 10.1093/emboj/17.23.7091; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Cheng W, 2007, P NATL ACAD SCI USA, V104, P13954, DOI 10.1073/pnas.0702315104; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Donmez I, 2007, J BIOL CHEM, V282, P21116, DOI 10.1074/jbc.M702136200; Fedorova O., 2005, HDB RNA BIOCH, P259; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; Gross CH, 1996, J VIROL, V70, P2615, DOI 10.1128/JVI.70.4.2615-2619.1996; Gross CH, 1998, J VIROL, V72, P4729, DOI 10.1128/JVI.72.6.4729-4736.1998; Gross CH, 1996, J VIROL, V70, P8549, DOI 10.1128/JVI.70.12.8549-8557.1996; HUNG SH, 1994, NUCLEIC ACIDS RES, V22, P4326, DOI 10.1093/nar/22.20.4326; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Jankowsky E, 2001, SCIENCE, V291, P121, DOI 10.1126/science.291.5501.121; Kawaoka J, 2005, NUCLEIC ACIDS RES, V33, P644, DOI 10.1093/nar/gki208; Kawaoka J, 2004, NAT STRUCT MOL BIOL, V11, P526, DOI 10.1038/nsmb771; Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0; KOONIN EV, 1992, J GEN VIROL, V73, P989, DOI 10.1099/0022-1317-73-4-989; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; MOSS B, 2001, FIELDS VIROLOGY, P2850; Nakano S, 2004, J AM CHEM SOC, V126, P1088, DOI 10.1021/ja037314h; Piacente S, 2008, VIROLOGY, V376, P211, DOI 10.1016/j.virol.2008.03.011; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Rocak S, 2004, NAT REV MOL CELL BIO, V5, P232, DOI 10.1038/nrm1335; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; Ryder SP, 1999, METHODS, V18, P38, DOI 10.1006/meth.1999.0755; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Schwartz A, 2009, NAT STRUCT MOL BIOL, V16, P1309, DOI 10.1038/nsmb.1711; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1989, J BIOL CHEM, V264, P21356; SHUMAN S, 1993, J BIOL CHEM, V268, P11798; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Singleton MR, 2001, CELL, V107, P79, DOI 10.1016/S0092-8674(01)00501-3; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; Tuteja N, 2004, EUR J BIOCHEM, V271, P1835, DOI 10.1111/j.1432-1033.2004.04093.x; VENKATESAN S, 1982, J VIROL, V44, P637, DOI 10.1128/JVI.44.2.637-646.1982; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	44	14	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11692	11703		10.1074/jbc.M109.088559	http://dx.doi.org/10.1074/jbc.M109.088559			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20110368	Green Published, hybrid			2022-12-27	WOS:000276286200073
J	Wang, S; Poon, K; Oswald, RE; Chuang, HH				Wang, Shu; Poon, Kinning; Oswald, Robert E.; Chuang, Huai-hu			Distinct Modulations of Human Capsaicin Receptor by Protons and Magnesium through Different Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANILLOID RECEPTOR-1; TRP CHANNELS; POTENTIAL VANILLOID-1; ION-CHANNEL; NEURONS; HYPERALGESIA; ACTIVATION; ANANDAMIDE; DETERMINANTS; SENSITIVITY	The capsaicin receptor (TRPV1) is a nonselective cation channel that integrates multiple painful stimuli, including capsaicin, protons, and heat. Protons facilitate the capsaicin- and heat-induced currents by decreasing thermal threshold or increasing agonist potency for TRPV1 activation (Tominaga, M., Caterina, M. J., Malmberg, A. B., Rosen, T. A., Gilbert, H., Skinner, K., Raumann, B. E., Basbaum, A. I., and Julius, D. ( 1998) Neuron 21, 531-543). In the presence of saturating capsaicin, rat TRPV1 (rTRPV1) reaches full activation, with no further stimulation by protons. Human TRPV1 (hTRPV1), a species ortholog with high homology to rTRPV1, is potentiated by extracellular protons and magnesium, even at saturating capsaicin. We investigated the structural basis for protons and magnesium modulation of fully capsaicin- bound human receptors. By analysis of chimeric channels between hTRPV1 and rTRPV1, we found that transmembrane domain 1-4 (TM1-4) of TRPV1 determines whether protons can further open the fully capsaicin- bound receptors. Mutational analysis identified a titratable glutamate residue (Glu-536) in the linker between TM3 and TM4 critical for further stimulation of fully liganded hTRPV1. In contrast, hTRPV1 TM5-6 is required for magnesium augmentation of capsaicin efficacy. Our results demonstrate that capsaicin efficacy of hTRPV1 correlates with the extracellular ion milieu and unravel the relevant structural basis of modulation by protons and magnesium.	[Wang, Shu; Chuang, Huai-hu] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA; [Poon, Kinning; Oswald, Robert E.] Cornell Univ, Dept Mol Med, Ithaca, NY 14853 USA	Cornell University; Cornell University	Chuang, HH (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	huai-hu.chuang@cornell.edu	Wang, Shu/F-2976-2011	Poon, Kinning/0000-0001-5671-9194	Cornell University Startup Funds; American Heart Association	Cornell University Startup Funds; American Heart Association(American Heart Association)	This work was supported by Cornell University Startup Funds and a scientist development grant from the American Heart Association (to H.-h.C.).	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Cornett PM, 2008, MOL PHARMACOL, V74, P1261, DOI 10.1124/mol.108.049684; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Hayes P, 2000, PAIN, V88, P205, DOI 10.1016/S0304-3959(00)00353-5; Hellwig N, 2004, J BIOL CHEM, V279, P34553, DOI 10.1074/jbc.M402966200; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Jahnel R, 2001, EUR J BIOCHEM, V268, P5489, DOI 10.1046/j.1432-1033.2001.02500.x; Johnson DM, 2006, MOL PHARMACOL, V70, P1005, DOI 10.1124/mol.106.023945; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Latorre R, 2007, CELL CALCIUM, V42, P427, DOI 10.1016/j.ceca.2007.04.004; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; Olah Z, 2001, J BIOL CHEM, V276, P31163, DOI 10.1074/jbc.M101607200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Pareek TK, 2007, P NATL ACAD SCI USA, V104, P660, DOI 10.1073/pnas.0609916104; Phillips E, 2004, J BIOL CHEM, V279, P17165, DOI 10.1074/jbc.M313328200; Ross RA, 2003, BRIT J PHARMACOL, V140, P790, DOI 10.1038/sj.bjp.0705467; Ryu SJ, 2007, J NEUROSCI, V27, P12797, DOI 10.1523/JNEUROSCI.2324-07.2007; Sprague J, 2001, EUR J PHARMACOL, V423, P121, DOI 10.1016/S0014-2999(01)01123-2; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; Vannier B, 1998, J BIOL CHEM, V273, P8675, DOI 10.1074/jbc.273.15.8675; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Zhang H, 2007, J NEUROSCI, V27, P12067, DOI 10.1523/JNEUROSCI.0496-07.2007; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102; Zhu WG, 2007, J NEUROSCI, V27, P13770, DOI 10.1523/JNEUROSCI.3822-07.2007	34	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11547	11556		10.1074/jbc.M109.058727	http://dx.doi.org/10.1074/jbc.M109.058727			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145248	hybrid, Green Published			2022-12-27	WOS:000276286200061
J	Chakraborty, S; Mitra, S; Falk, MM; Caplan, SH; Wheelock, MJ; Johnson, KR; Mehta, PP				Chakraborty, Souvik; Mitra, Shalini; Falk, Matthias M.; Caplan, Steve H.; Wheelock, Margaret J.; Johnson, Keith R.; Mehta, Parmender P.			E-cadherin Differentially Regulates the Assembly of Connexin43 and Connexin32 into Gap Junctions in Human Squamous Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2ND PDZ DOMAIN; PROTEIN CONNEXIN-43; ZONULA OCCLUDENS-1; PLASMA-MEMBRANE; TRAFFICKING; COMMUNICATION; ORGANIZATION; INTERACTS; CHANNELS; ADHESION	It is as yet unknown how the assembly of connexins (Cx) into gap junctions (GJ) is initiated upon cell-cell contact. We investigated whether the trafficking and assembly of Cx43 and Cx32 into GJs were contingent upon cell-cell adhesion mediated by E-cadherin. We also examined the role of the carboxyl termini of these Cxs in initiating the formation of GJs. Using cadherin and Cx-null cells, and by introducing Cx43 and Cx32, either alone or in combination with E-cadherin, our studies demonstrated that E-cadherin-mediated cell-cell adhesion was neither essential nor sufficient to initiate GJ assembly de novo in A431D human squamous carcinoma cells. However, E-cadherin facilitated the growth and assembly of preformed GJs composed of Cx43, although the growth of cells on Transwell filters was required to initiate the assembly of Cx32. Our results also documented that the carboxyl termini of both Cxs were required in this cell type to initiate the formation of GJs de novo. Our findings also showed that GJ puncta composed of Cx43 co-localized extensively with ZO-1 and actin fibers at cell peripheries and that ZO-1 knockdown attenuated Cx43 assembly. These findings suggest that the assembly of Cx43 and Cx32 into GJs is differentially modulated by E-cadherin-mediated cell-cell adhesion and that direct or indirect cross-talk between carboxyl tails of Cxs and actin cytoskeleton via ZO-1 may regulate GJ assembly and growth.	[Chakraborty, Souvik; Mitra, Shalini; Caplan, Steve H.; Wheelock, Margaret J.; Johnson, Keith R.; Mehta, Parmender P.] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol,Eppley Canc Ctr, Omaha, NE 68105 USA; [Falk, Matthias M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA	University of Nebraska System; University of Nebraska Medical Center; Lehigh University	Mehta, PP (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Dept Biochem & Mol Biol,Eppley Canc Ctr, Omaha, NE 68105 USA.	pmehta@unmc.edu			National Institutes of Health [RO-1 CA113903, RO-1DE12308, RO-1GM074876]; Department of Defense [PC081198]; Nebraska State [LB506]; Nebraska Center for Cellular Signaling; NATIONAL CANCER INSTITUTE [R01CA113903] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Nebraska State; Nebraska Center for Cellular Signaling; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO-1 CA113903 (to P. P. M.), RO-1DE12308 (to K. R. J.), and RO-1GM074876 (to S. H. C.). This work was also supported by Department of Defense Grant PC081198 and Nebraska State Grant LB506 (to P. P. M.) and the Nebraska Center for Cellular Signaling graduate fellowship (to S. M. and S. C.).	Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Bavamian Sabine, 2009, P511, DOI 10.1007/978-1-59745-489-6_26; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; Bornens M, 2008, NAT REV MOL CELL BIO, V9, P874, DOI 10.1038/nrm2524; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Bukauskas FF, 2000, P NATL ACAD SCI USA, V97, P2556, DOI 10.1073/pnas.050588497; Chen J, 2008, EMBO J, V27, P2113, DOI 10.1038/emboj.2008.138; Cotrina ML, 2008, GLIA, V56, P1791, DOI 10.1002/glia.20728; Crespin Sophie, 2009, P529, DOI 10.1007/978-1-59745-489-6_27; Duffy HS, 2007, J BIOL CHEM, V282, P9789, DOI 10.1074/jbc.M605261200; ELFGANG C, 1995, J CELL BIOL, V129, P805, DOI 10.1083/jcb.129.3.805; Falk MM, 2009, MOL BIOL CELL, V20, P3342, DOI 10.1091/mbc.E09-04-0288; Fanning AS, 2002, FASEB J, V16, P1835, DOI 10.1096/fj.02-0121fje; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giepmans BNG, 2001, J BIOL CHEM, V276, P8544, DOI 10.1074/jbc.M005847200; Giepmans BNG, 1998, CURR BIOL, V8, P931, DOI 10.1016/S0960-9822(07)00375-2; GOURDIE RG, 1991, J CELL SCI, V99, P41; Govindarajan R, 2002, J BIOL CHEM, V277, P50087, DOI 10.1074/jbc.M202652200; Hernandez-Blazquez FJ, 2001, EXP CELL RES, V270, P235, DOI 10.1006/excr.2001.5342; Herve JC, 2007, PROG BIOPHYS MOL BIO, V94, P29, DOI 10.1016/j.pbiomolbio.2007.03.010; Holm I, 1999, EUR J CELL BIOL, V78, P856, DOI 10.1016/S0171-9335(99)80087-9; Hunter AW, 2008, CELL COMMUN ADHES, V15, P55, DOI 10.1080/15419060802014370; Hunter AW, 2005, MOL BIOL CELL, V16, P5686, DOI 10.1091/mbc.E05-08-0737; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Johnson RG, 2002, EXP CELL RES, V275, P67, DOI 10.1006/excr.2002.5480; JONGEN WMF, 1991, J CELL BIOL, V114, P545, DOI 10.1083/jcb.114.3.545; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Jordan K, 2001, J CELL SCI, V114, P763; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Kojima T, 2007, J MEMBRANE BIOL, V217, P13, DOI 10.1007/s00232-007-9021-4; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; Lauf U, 2001, FEBS LETT, V498, P11, DOI 10.1016/S0014-5793(01)02462-0; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Lin JHC, 2002, J NEUROSCI, V22, P4302, DOI 10.1523/JNEUROSCI.22-11-04302.2002; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mehta P, 1999, DEV GENET, V24, P91, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<91::AID-DVG10>3.0.CO;2-#; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; MEYER RA, 1992, J CELL BIOL, V119, P179, DOI 10.1083/jcb.119.1.179; Mills IG, 1998, CURR BIOL, V8, P881, DOI 10.1016/S0960-9822(07)00351-X; Mitra S, 2006, MOL BIOL CELL, V17, P5400, DOI 10.1091/mbc.E06-04-0280; Miyaguchi K, 2000, J STRUCT BIOL, V132, P169, DOI 10.1006/jsbi.2000.4244; Musil Linda S., 2009, P225, DOI 10.1007/978-1-59745-489-6_9; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Piehl M, 2007, MOL BIOL CELL, V18, P337, DOI 10.1091/mbc.E06-06-0487; Rodriguez-Boulan E, 2005, NAT REV MOL CELL BIO, V6, P233, DOI 10.1038/nrm1593; RUDNICKI JA, 1987, TERATOCARCINOMAS EMB, P19; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Sobolik-Delmaire T, 2006, J BIOL CHEM, V281, P16962, DOI 10.1074/jbc.M600570200; Solan JL, 2009, BIOCHEM J, V419, P261, DOI 10.1042/BJ20082319; Solan Joell L., 2009, P263, DOI 10.1007/978-1-59745-489-6_11; Sosinsky GE, 2005, BBA-BIOMEMBRANES, V1711, P99, DOI 10.1016/j.bbamem.2005.04.001; Sosinsky Gina E., 2009, P241, DOI 10.1007/978-1-59745-489-6_10; STAGG RB, 1990, ENDOCR REV, V11, P302, DOI 10.1210/edrv-11-2-302; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Thomas T, 2001, CELL COMMUN ADHES, V8, P231, DOI 10.3109/15419060109080729; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; WANG YJ, 1995, J CELL SCI, V108, P3501; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135	68	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10761	10776		10.1074/jbc.M109.053348	http://dx.doi.org/10.1074/jbc.M109.053348			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20086013	Green Published, hybrid			2022-12-27	WOS:000276264600062
J	Huang, YH; Colgrave, ML; Clark, RJ; Kotze, AC; Craik, DJ				Huang, Yen-Hua; Colgrave, Michelle L.; Clark, Richard J.; Kotze, Andrew C.; Craik, David J.			Lysine-scanning Mutagenesis Reveals an Amendable Face of the Cyclotide Kalata B1 for the Optimization of Nematocidal Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS 3C PROTEASE; PLANT CYCLOTIDES; INSECTICIDAL ACTIVITY; HAEMONCHUS-CONTORTUS; MACROCYCLIC PEPTIDES; BIOLOGICAL-ACTIVITY; KNOTTED PROTEINS; FOLDING PATHWAYS; CIRCULAR PROTEIN; DRUG-RESISTANCE	Cyclotides are a family of macrocyclic peptides that combine the unique features of a head-to-tail cyclic backbone and a cystine knot motif, the combination of which imparts them with extraordinary stability. The prototypic cyclotide kalata B1 is toxic against two economically important gastrointestinal nematode parasites of sheep, Haemonchus contortus and Trichostrongylus colubriformis. A lysine scan was conducted to examine the effect of the incorporation of positive charges into the kalata B1 cyclotide framework. Each of the non-cysteine residues in this 29-amino acid peptide was successively substituted with lysine, and the nematocidal and hemolytic activities of the suite of mutants were determined. Substitution of 11 residues within kalata B1 decreased the nematocidal activity dramatically. On the other hand, six other residues that are clustered on the surface of kalata B1 were tolerant to Lys substitution, and indeed the introduction of positively charged residues into this region increased nematocidal activity. This activity was increased further in double and triple lysine mutants, with a maximal increase (relative to the native kalata B1) of 13-fold obtained with a triple lysine mutant (mutated at positions Thr-20, Asn-29, and Gly-1). Hemolytic activity correlated with the nematocidal activity of all lysine mutants. Our data clearly highlight the residues crucial for nematocidal and hemolytic activity in cyclotides, and demonstrate that the nematocidal activity of cyclotides can be increased by incorporation of basic amino acids.	[Huang, Yen-Hua; Colgrave, Michelle L.; Clark, Richard J.; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Colgrave, Michelle L.; Kotze, Andrew C.] CSIRO, CSIRO Div Livestock Ind, Brisbane, Qld 4072, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Craik, DJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	d.craik@imb.uq.edu.au	Craik, David/B-1695-2010; Clark, Richard J/G-8848-2012; Kotze, andrew C/B-5995-2012; Huang, Yen-Hua/J-9056-2014; Colgrave, Michelle/A-5710-2012	Craik, David/0000-0003-0007-6796; Clark, Richard J/0000-0002-6807-5426; Kotze, andrew C/0000-0002-8224-7634; Huang, Yen-Hua/0000-0001-6937-2660; Colgrave, Michelle/0000-0001-8463-805X	Australian Research Council; Commonwealth Scientific and Industrial Research Organization	Australian Research Council(Australian Research Council); Commonwealth Scientific and Industrial Research Organization	This work was supported in part by grants from the Australian Research Council (to D. J. C.) and a grant from Commonwealth Scientific and Industrial Research Organization (to A. C. K.).	Barbeta BL, 2008, P NATL ACAD SCI USA, V105, P1221, DOI 10.1073/pnas.0710338104; Barry DG, 2003, BIOCHEMISTRY-US, V42, P6688, DOI 10.1021/bi027323n; Besier B, 2007, TRENDS PARASITOL, V23, P21, DOI 10.1016/j.pt.2006.11.004; Broussalis AM, 2001, PHYTOCHEMISTRY, V58, P47, DOI 10.1016/S0031-9422(01)00173-X; Chen B, 2006, J NAT PROD, V69, P23, DOI 10.1021/np050317i; Claeson P, 1998, J NAT PROD, V61, P77, DOI 10.1021/np970342r; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Colgrave ML, 2008, CHEMBIOCHEM, V9, P1939, DOI 10.1002/cbic.200800174; Colgrave ML, 2008, BIOCHEMISTRY-US, V47, P5581, DOI 10.1021/bi800223y; Colgrave ML, 2009, ACTA TROP, V109, P163, DOI 10.1016/j.actatropica.2008.11.003; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Craik DJ, 2001, TOXICON, V39, P1809, DOI 10.1016/S0041-0101(01)00129-5; Craik DJ, 2004, CURR PROTEIN PEPT SC, V5, P297, DOI 10.2174/1389203043379512; Curry S, 2007, BIOCHEM SOC T, V35, P594, DOI 10.1042/BST0350594; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Daly NL, 2003, J BIOL CHEM, V278, P6314, DOI 10.1074/jbc.M210492200; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; Felizmenio-Quimio ME, 2001, J BIOL CHEM, V276, P22875, DOI 10.1074/jbc.M101666200; Goransson U, 2004, J NAT PROD, V67, P1287, DOI 10.1021/np0499719; Goransson U, 1999, J NAT PROD, V62, P283, DOI 10.1021/np9803878; Gruber CW, 2007, TOXICON, V49, P561, DOI 10.1016/j.toxicon.2006.11.018; GUSTAFSON KR, 1994, J AM CHEM SOC, V116, P9337, DOI 10.1021/ja00099a064; Hallock YF, 2000, J ORG CHEM, V65, P124, DOI 10.1021/jo990952r; Hernandez JF, 2000, BIOCHEMISTRY-US, V39, P5722, DOI 10.1021/bi9929756; Herrmann A, 2006, CELL MOL LIFE SCI, V63, P235, DOI 10.1007/s00018-005-5486-4; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; HUBERT J, 1984, CAN J COMP MED, V48, P63; Ireland DC, 2008, BIOPOLYMERS, V90, P51, DOI 10.1002/bip.20886; Ireland DC, 2006, BIOCHEM J, V400, P1, DOI 10.1042/BJ20060627; Jennings C, 2001, P NATL ACAD SCI USA, V98, P10614, DOI 10.1073/pnas.191366898; Jennings CV, 2005, BIOCHEMISTRY-US, V44, P851, DOI 10.1021/bi047837h; Kaplan RM, 2004, TRENDS PARASITOL, V20, P477, DOI 10.1016/j.pt.2004.08.001; Kotze AC, 2001, INT J PARASITOL, V31, P1563, DOI 10.1016/S0020-7519(01)00303-4; Lacey E., 1990, Resistance of parasites to antiparasitic drugs: Round Table Conference, ICOPA VII Paris 1990., P177; O'Grady J, 2004, EXP PARASITOL, V106, P164, DOI 10.1016/j.exppara.2004.03.007; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SAETHER O, 1995, BIOCHEMISTRY-US, V34, P4147, DOI 10.1021/bi00013a002; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Sweeney TR, 2007, J VIROL, V81, P115, DOI 10.1128/JVI.01587-06; Tam JP, 1998, PROTEIN SCI, V7, P1583, DOI 10.1002/pro.5560070712; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Trabi M, 2009, ORG BIOMOL CHEM, V7, P2378, DOI 10.1039/b823020j; Wang CK, 2009, J BIOL CHEM, V284, P10672, DOI 10.1074/jbc.M900021200; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; WITHERUP KM, 1994, J NAT PRODUCTS, V57, P1619, DOI 10.1021/np50114a002; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010	51	87	90	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10797	10805		10.1074/jbc.M109.089854	http://dx.doi.org/10.1074/jbc.M109.089854			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20103593	Green Published, hybrid			2022-12-27	WOS:000276264600065
J	Marcello, E; Gardoni, F; Di Luca, M; Perez-Otano, I				Marcello, Elena; Gardoni, Fabrizio; Di Luca, Monica; Perez-Otano, Isabel			An Arginine Stretch Limits ADAM10 Exit from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER RETENTION SIGNAL; ALPHA-SECRETASE ADAM10; SURFACE EXPRESSION; POTASSIUM CHANNELS; MEMBRANE-PROTEINS; TRAFFICKING; NMDA; PHOSPHORYLATION; SHEDDASES; PATHWAY	A disintegrin and metalloproteinase 10 (ADAM10) is a type I transmembrane glycoprotein responsible for the ectodomain shedding of a number of proteins implicated in the pathogenesis of diseases ranging from cancer to Alzheimer Disease. ADAM10 is synthesized in an inactive form, which is proteolytically activated during its forward transport along the secretory pathway and at the plasma membrane. Therefore, modulation of its trafficking could provide a mechanism to finely tune its shedding activity. Here we report the identification of an endoplasmic reticulum (ER) retention motif within the ADAM10 intracellular C-terminal tail. Sequential deletion/mutagenesis analyses showed that an arginine-rich ((RRR)-R-723) sequence was responsible for the retention of ADAM10 in the ER and its inefficient surface trafficking. Mutating the second arginine to alanine was sufficient to allow ER exit and surface expression in both heterologous cells and hippocampal neurons. As synapse-associated protein 97 (SAP97) binds ADAM10 at its cytoplasmic tail and facilitates forward ADAM10 trafficking in neurons, we tested whether SAP97 could modulate ER export. However, neither expression nor Ser-39 phosphorylation of SAP97 in heterologous cells or hippocampal neurons were sufficient to allow the ER exit of ADAM10, suggesting that other signaling pathways or alternative binding partners are responsible for ADAM10 ER exit. Together, these results identify a novel mechanism regulating the intracellular trafficking and membrane delivery of ADAM10.	[Marcello, Elena] Univ Milan, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy; [Perez-Otano, Isabel] Univ Navarra, CIMA, Dept Neurosci, Cellular Neurobiol Lab, Pamplona 31008, Spain	University of Milan; University of Milan; University of Navarra	Marcello, E (corresponding author), Univ Milan, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	elena.marcello@unimi.it	Marcello, Elena/A-4687-2015; DiLuca, Monica/A-7632-2012; Gardoni, Fabrizio/A-3135-2009; Perez-Otano, Isabel/S-9613-2017	Marcello, Elena/0000-0003-0452-762X; DiLuca, Monica/0000-0003-2298-615X; Gardoni, Fabrizio/0000-0003-4598-5563; Perez-Otano, Isabel/0000-0002-7222-8202	EC [LSHM-CT-2008-217902]; CARIPLO 2008; MIUR Italy-Spain Integrated Action; Kemali Foundation; UTE project CIMA; Spanish Ministry of Education and Science grants [SAF200610025, CSD2008-00005]	EC(European CommissionEuropean Commission Joint Research Centre); CARIPLO 2008; MIUR Italy-Spain Integrated Action; Kemali Foundation; UTE project CIMA; Spanish Ministry of Education and Science grants(Spanish Government)	This work was supported by EC Contract LSHM-CT-2008-217902 (cPADs), CARIPLO 2008, MIUR Italy-Spain Integrated Action (to M. D. L.), Kemali Foundation fellowship (to E. M.), UTE project CIMA and Spanish Ministry of Education and Science grants (Spain-Italy Integrated Action, SAF200610025, CSD2008-00005) (to I. P.-O.).	Anders A, 2001, FASEB J, V15, P1837, DOI 10.1096/fj.01-0007fje; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; Cao Y, 2002, J BIOL CHEM, V277, P26403, DOI 10.1074/jbc.M110814200; El Meskini R, 2001, J BIOL CHEM, V276, P3384, DOI 10.1074/jbc.M008062200; Fernandez-Larrea J, 1999, MOL CELL, V3, P423, DOI 10.1016/S1097-2765(00)80470-0; Gardoni F, 2002, EUR J NEUROSCI, V16, P777, DOI 10.1046/j.1460-9568.2002.02141.x; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Ghosh RN, 1998, J CELL BIOL, V142, P923, DOI 10.1083/jcb.142.4.923; Godde NJ, 2006, J CELL SCI, V119, P3296, DOI 10.1242/jcs.03065; Horiuchi K, 2007, MOL BIOL CELL, V18, P176, DOI 10.1091/mbc.E06-01-0014; Hougaard S, 2000, BIOCHEM BIOPH RES CO, V275, P261, DOI 10.1006/bbrc.2000.3295; Jansen EJR, 1998, J CELL SCI, V111, P2999; Kheradmand F, 2002, BIOESSAYS, V24, P8, DOI 10.1002/bies.10037; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Ma D, 2002, NEURON, V33, P715, DOI 10.1016/S0896-6273(02)00614-1; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Marcello E, 2007, J NEUROSCI, V27, P1682, DOI 10.1523/JNEUROSCI.3439-06.2007; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mauceri D, 2007, J NEUROCHEM, V100, P1032, DOI 10.1111/j.1471-4159.2006.04267.x; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Moss ML, 2004, BIOCHEMISTRY-US, V43, P7227, DOI 10.1021/bi049677f; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; SCHAFER W, 1995, EMBO J, V14, P2424, DOI 10.1002/j.1460-2075.1995.tb07240.x; Schroeder A, 2009, J ALZHEIMERS DIS, V16, P309, DOI 10.3233/JAD-2009-0952; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; TARENTINO AL, 1985, BIOCHEMISTRY-US, V24, P4665, DOI 10.1021/bi00338a028; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Tiffany AM, 2000, J CELL BIOL, V148, P147, DOI 10.1083/jcb.148.1.147; TRIMBLE RB, 1984, ANAL BIOCHEM, V141, P515, DOI 10.1016/0003-2697(84)90080-0; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Wouters S, 1998, BIOCHEM J, V336, P311, DOI 10.1042/bj3360311; Xia H, 2001, NEUROPHARMACOLOGY, V41, P714, DOI 10.1016/S0028-3908(01)00103-4; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	39	46	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10376	10384		10.1074/jbc.M109.055947	http://dx.doi.org/10.1074/jbc.M109.055947			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20100836	hybrid, Green Published			2022-12-27	WOS:000276264600023
J	Thanongsaksrikul, J; Srimanote, P; Maneewatch, S; Choowongkomon, K; Tapchaisri, P; Makino, S; Kurazono, H; Chaicumpa, W				Thanongsaksrikul, Jeeraphong; Srimanote, Potjanee; Maneewatch, Santi; Choowongkomon, Kiattawee; Tapchaisri, Pramuan; Makino, Sou-ichi; Kurazono, Hisao; Chaicumpa, Wanpen			A VHH That Neutralizes the Zinc Metalloproteinase Activity of Botulinum Neurotoxin Type A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-DOMAIN ANTIBODY; HEAVY-CHAIN ANTIBODIES; LIGHT-CHAIN; FRAGMENTS; ENZYME; TOXIN; SUBSTRATE; CAMELIDAE; PROTEINS; PROTEASE	The current treatment of botulism is to administer animal-derived antitoxin, which frequently causes severe adverse reactions in the recipients. In this study, a heavy chain antibody fragment (VH/VHH) phage display library was constructed by amplification of the immunoglobulin genes of a nonimmune camel, Camelus dromedarius, using primers specific to human VH gene segments. A recombinant light chain of type A botulinumtoxin, BoTxA/LC, with zinc endoprotease activity was used in phage bio-panning to select phage clones displaying BoTxA/LC-bound VH/VHH. Soluble VH/VHH were produced and purified from 10 VH/VHH phagemid-transformed E. coli clones. Complementary determining regions (CDRs) and immunoglobulin frameworks (FRs) of the 10 camel VH/VHH-deduced amino acid sequences were determined. FR2 sequences of two clones showed a hallmark of camel VHH, i.e. (F/Y)(ER50)-E-42-R-49(G/F)(52). The remaining eight clones had an FR2 amino acid tetrad of conventional VH, i.e. V(42)G(49)L(50)W(52). VHH of one clone (V(H)H17) neutralized the SNAP25 hydrolytic activity of BoTxA/LC, whereas mouse polyclonal anti-BoTxA/LC did not have such activity. Mimotope sequences of V(H)H17 matched with the 194-206 amino acid residues of BoTxA/LC, which are located near the S'1 subsite of the catalytic cleft of the enzyme. Molecular docking revealed that CDR3 of the V(H)H17 bound to epitope in the toxin enzymatic cleft. Therefore, the BoTxA/LC neutralization by the V(H)H17 should be due to the VHH insertion into the enzymatic cleft of the toxin, which is usually inaccessible to a conventional antibody molecule. This antibody fragment warrants further development as a therapeutic agent for botulism.	[Srimanote, Potjanee; Chaicumpa, Wanpen] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok 10700, Thailand; [Thanongsaksrikul, Jeeraphong] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Immunol, Bangkok 10700, Thailand; [Srimanote, Potjanee; Tapchaisri, Pramuan] Thammasat Univ, Fac Allied Hlth Sci, Grad Program, Pathum Thani 12120, Thailand; [Maneewatch, Santi] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok 10400, Thailand; [Choowongkomon, Kiattawee] Kasetsart Univ, Fac Sci, Dept Biochem, Bangkok 10900, Thailand; [Makino, Sou-ichi] Obihiro Univ Agr & Vet Med, Res Ctr Anim Hyg & Food Safety, Obihiro, Hokkaido 0808555, Japan; [Kurazono, Hisao] Obihiro Univ Agr & Vet Med, Dept Appl Vet Med & Publ Hlth, Obihiro, Hokkaido 0808555, Japan	Mahidol University; Mahidol University; Thammasat University; Mahidol University; Kasetsart University; Obihiro University of Agriculture & Veterinary Medicine; Obihiro University of Agriculture & Veterinary Medicine	Chaicumpa, W (corresponding author), Mahidol Univ, Siriraj Hosp, Fac Med, Dept Parasitol, Bangkok 10700, Thailand.	tmwcc@mahidol.ac.th	Srimanote, Potjanee/W-2221-2019; maneewatchararangsri, santi/K-7898-2015; choowongkomon, kiattawee/M-6528-2014; Thanongsaksrikul, Jeeraphong/AAF-5267-2020	choowongkomon, kiattawee/0000-0002-2421-7859; Thanongsaksrikul, Jeeraphong/0000-0002-7238-9591	Commission on Higher Education (CHE), Ministry of Education, Thailand	Commission on Higher Education (CHE), Ministry of Education, Thailand(Office of Higher Education Commission (OHEC))	This work was supported by the Commission on Higher Education (CHE), Ministry of Education, Thailand.	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Baral TN, 2006, NAT MED, V12, P580, DOI 10.1038/nm1395; BINZ T, 1994, J BIOL CHEM, V269, P1617; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Conrath KE, 2003, DEV COMP IMMUNOL, V27, P87, DOI 10.1016/S0145-305X(02)00071-X; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; Cortez-Retamozo V, 2004, CANCER RES, V64, P2853, DOI 10.1158/0008-5472.CAN-03-3935; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; Desmyter A, 2002, J BIOL CHEM, V277, P23645, DOI 10.1074/jbc.M202327200; Desmyter A, 2001, J BIOL CHEM, V276, P26285, DOI 10.1074/jbc.M102107200; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Ekong TAN, 1997, MICROBIOL-SGM, V143, P3337, DOI 10.1099/00221287-143-10-3337; Fernandez-Salas E, 2004, P NATL ACAD SCI USA, V101, P3208, DOI 10.1073/pnas.0400229101; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Joosten V, 2003, MICROB CELL FACT, V2, DOI 10.1186/1475-2859-2-1; Koch-Nolte F, 2007, FASEB J, V21, P3490, DOI 10.1096/fj.07-8661com; Koriazova LK, 2003, NAT STRUCT BIOL, V10, P13, DOI 10.1038/nsb879; Kulkeaw K, 2009, J PROTEOMICS, V72, P270, DOI 10.1016/j.jprot.2008.12.007; Kumaran D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000165; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauwereys M, 1998, EMBO J, V17, P3512, DOI 10.1093/emboj/17.13.3512; Lee J.O., 2008, BOTULINUM J, V1, P135, DOI [10.1504/TBJ.2008.018955, DOI 10.1504/TBJ.2008.018955]; Monegal A, 2009, PROTEIN ENG DES SEL, V22, P273, DOI 10.1093/protein/gzp002; Muruganandam A, 2001, FASEB J, V15, P240, DOI 10.1096/fj.01-0343fje; Nelson AL, 2009, NAT BIOTECHNOL, V27, P331, DOI 10.1038/nbt0409-331; Nguyen VK, 1998, J MOL BIOL, V275, P413, DOI 10.1006/jmbi.1997.1477; NOVOTNY J, 1991, MOL IMMUNOL, V28, P201, DOI 10.1016/0161-5890(91)90062-O; Palmier MO, 2007, ANAL BIOCHEM, V371, P43, DOI 10.1016/j.ab.2007.07.008; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; Schmidt JJ, 2003, APPL ENVIRON MICROB, V69, P297, DOI 10.1128/AEM.69.1.297-303.2003; SUGIYAMA H, 1980, MICROBIOL REV, V44, P419, DOI 10.1128/MMBR.44.3.419-448.1980; Swaminathan S, 2000, NAT STRUCT BIOL, V7, P693, DOI 10.1038/78005; Thathaisong U, 2008, ASIAN PAC J ALLERGY, V26, P23; Transue TR, 1998, PROTEINS, V32, P515, DOI 10.1002/(SICI)1097-0134(19980901)32:4<515::AID-PROT9>3.0.CO;2-E	42	50	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9657	9666		10.1074/jbc.M109.073163	http://dx.doi.org/10.1074/jbc.M109.073163			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093370	hybrid, Green Published			2022-12-27	WOS:000276165900039
J	Lucas, M; Gonzalez-Perez, B; Cabezas, M; Moncalian, G; Rivas, G; de la Cruz, F				Lucas, Maria; Gonzalez-Perez, Blanca; Cabezas, Matilde; Moncalian, Gabriel; Rivas, German; de la Cruz, Fernando			Relaxase DNA Binding and Cleavage Are Two Distinguishable Steps in Conjugative DNA Processing That Involve Different Sequence Elements of the nic Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CONJUGATION; PROTEIN TRWC; ORIGIN; RECOGNITION; MECHANISM; PURIFICATION; TERMINATION; INITIATION; ORIT	TrwC, the relaxase of plasmid R388, catalyzes a series of concerted DNA cleavage and strand transfer reactions on a specific site (nic) of its origin of transfer (oriT). nic contains the cleavage site and an adjacent inverted repeat (IR2). Mutation analysis in the nic region indicated that recognition of the IR2 proximal arm and the nucleotides located between IR2 and the cleavage site were essential for supercoiled DNA processing, as judged either by in vitro nic cleavage or by mobilization of a plasmid containing oriT. Formation of the IR2 cruciform and recognition of the distal IR2 arm and loop were not necessary for these reactions to take place. On the other hand, IR2 was not involved in TrwC single-stranded DNA processing in vitro. For single-stranded DNA nic cleavage, TrwC recognized a sequence embracing six nucleotides upstream of the cleavage site and two nucleotides downstream. This suggests that TrwC DNA binding and cleavage are two distinguishable steps in conjugative DNA processing and that different sequence elements are recognized by TrwC in each step. IR2-proximal arm recognition was crucial for the initial supercoiled DNA binding. Subsequent recognition of the adjacent single-stranded DNA binding site was required to position the cleavage site in the active center of the protein so that the nic cleavage reaction could take place.	[Lucas, Maria; Gonzalez-Perez, Blanca; Cabezas, Matilde; Moncalian, Gabriel; de la Cruz, Fernando] Univ Cantabria, Dept Biol Mol, Santander 39011, Spain; [Lucas, Maria; Gonzalez-Perez, Blanca; Cabezas, Matilde; Moncalian, Gabriel; de la Cruz, Fernando] CSIC, Inst Biomed & Biotecnol Cantabria, UC IDICAN, Santander 39011, Spain; [Rivas, German] CSIC, Ctr Invest Biol, Madrid 28040, Spain	Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	de la Cruz, F (corresponding author), Univ Cantabria, Dept Biol Mol, C Herrera Oria S-N, Santander 39011, Spain.	delacruz@unican.es	Rivas, German/AFL-7528-2022; Lucas, Maria/G-9788-2012; Moncalian, Gabriel/K-3493-2014; Rivas, German/AAG-7458-2022; de la Cruz, Fernando/L-2812-2014	Rivas, German/0000-0003-3450-7478; Lucas, Maria/0000-0002-7854-4249; Moncalian, Gabriel/0000-0002-3007-6490; Rivas, German/0000-0003-3450-7478; de la Cruz, Fernando/0000-0003-4758-6857	Spanish Ministry of Education [BFU2008-00995/BMC, CIT-010000-2008-4]	Spanish Ministry of Education(Spanish Government)	This work was supported by Spanish Ministry of Education Grants BFU2008-00995/BMC and CIT-010000-2008-4.	Barabas O, 2008, CELL, V132, P208, DOI 10.1016/j.cell.2007.12.029; Becker EC, 2000, J MOL BIOL, V300, P1067, DOI 10.1006/jmbi.2000.3902; Boer R, 2006, J MOL BIOL, V358, P857, DOI 10.1016/j.jmb.2006.02.018; Datta S, 2003, STRUCTURE, V11, P1369, DOI 10.1016/j.str.2003.10.001; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Fernandez-Lopez R, 2005, MICROBIOL-SGM, V151, P3517, DOI 10.1099/mic.0.28216-0; Filutowicz M, 2008, PLASMID, V60, P38, DOI 10.1016/j.plasmid.2008.03.004; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; FUKUDA H, 1995, J BIOL CHEM, V270, P21319, DOI 10.1074/jbc.270.36.21319; GAO Q, 1994, MOL MICROBIOL, V11, P449, DOI 10.1111/j.1365-2958.1994.tb00326.x; Garcillan-Barcia MP, 2007, MOL MICROBIOL, V63, P404, DOI 10.1111/j.1365-2958.2006.05523.x; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gonzalez-Perez B, 2007, EMBO J, V26, P3847, DOI 10.1038/sj.emboj.7601806; Gonzalez-Perez Blanca, 2009, Biotechnology Journal, V4, P554, DOI 10.1002/biot.200800184; GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x; Grandoso G, 2000, J MOL BIOL, V295, P1163, DOI 10.1006/jmbi.1999.3425; GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645; Guasch A, 2003, NAT STRUCT BIOL, V10, P1002, DOI 10.1038/nsb1017; Guynet C, 2008, MOL CELL, V29, P302, DOI 10.1016/j.molcel.2007.12.008; Hekman K, 2008, NUCLEIC ACIDS RES, V36, P4565, DOI 10.1093/nar/gkn422; Jubete Y, 1996, J BIOL CHEM, V271, P30798, DOI 10.1074/jbc.271.48.30798; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; LLOSA M, 1995, J MOL BIOL, V246, P54, DOI 10.1006/jmbi.1994.0065; Llosa M, 2005, RES MICROBIOL, V156, P1, DOI 10.1016/j.resmic.2004.07.008; LLOSA M, 1994, J BACTERIOL, V176, P3210, DOI 10.1128/jb.176.11.3210-3217.1994; LLOSA M, 1991, MOL GEN GENET, V226, P473, DOI 10.1007/BF00260661; Llosa M, 1996, J MOL BIOL, V264, P56, DOI 10.1006/jmbi.1996.0623; Lujan SA, 2007, P NATL ACAD SCI USA, V104, P12282, DOI 10.1073/pnas.0702760104; MARTINEZ E, 1988, MOL GEN GENET, V211, P320, DOI 10.1007/BF00330610; MATSON SW, 1991, PROG NUCLEIC ACID RE, V40, P289; MINTON AP, 1994, MODERN ANAL ULTRACEN; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Parker C, 2005, PLASMID, V53, P113, DOI 10.1016/j.plasmid.2004.12.007; Philo JS, 1997, BIOPHYS J, V72, P435, DOI 10.1016/S0006-3495(97)78684-3; Potts RG, 2008, FUTURE MICROBIOL, V3, P119, DOI 10.2217/17460913.3.2.119; REYGERS U, 1991, EMBO J, V10, P2689, DOI 10.1002/j.1460-2075.1991.tb07812.x; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; TRASK DK, 1984, EMBO J, V3, P671, DOI 10.1002/j.1460-2075.1984.tb01865.x; Williams SL, 2006, NUCLEIC ACIDS RES, V34, P426, DOI 10.1093/nar/gkj444; Zechner EL, 2000, HORIZONTAL GENE POOL	43	24	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8918	8926		10.1074/jbc.M109.057539	http://dx.doi.org/10.1074/jbc.M109.057539			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20061574	Green Published, hybrid			2022-12-27	WOS:000275553700043
J	Song, JY; Han, HS; Sabapathy, K; Lee, BM; Yu, E; Choi, J				Song, Ji-young; Han, Hye-Sook; Sabapathy, Kanaga; Lee, Byung-Moo; Yu, Eunsil; Choi, Jene			Expression of a Homeostatic Regulator, Wip1 (Wild-type p53-induced Phosphatase), Is Temporally Induced by c-Jun and p53 in Response to UV Irradiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; CELL-CYCLE; NH2-TERMINAL KINASE; PROTEIN PHOSPHATASE; INDUCED APOPTOSIS; PPM1D; ACTIVATION; PATHWAY; GENE; PHOSPHORYLATION	Wild-type p53-induced phosphatase (Wip1) is induced by p53 in response to stress, which results in the dephosphorylation of proteins (i.e. p38 MAPK, p53, and uracil DNA glycosylase) involved in DNA repair and cell cycle checkpoint pathways. p38 MAPK-p53 signaling is a unique way to induce Wip1 in response to stress. Here, we show that c-Jun directly binds to and activates the Wip1 promoter in response to UV irradiation. The binding of p53 to the promoter occurs earlier than that of c-Jun. In experiments, mutation of the p53 response element (p53RE) or c-Jun consensus sites reduced promoter activity in both non-stressed and stressed A549 cells. Overexpression of p53 significantly decreased Wip1 expression in HCT116 p53(+/+) cells but increased it in HCT116 p53(+/+) cells. Adenovirus-mediated p53 overexpression greatly decreased JNK activity. Upregulation of Wip1 via the p38 MAPK-p53 and JNK-c-Jun pathways is specific, as demonstrated by our findings that p38MAPK and JNK inhibitors affected the expression of the Wip1 protein, whereas an ERK inhibitor did not. c-Jun activation occurred much more quickly, and to a greater extent, in A549-E6 cells than in A549 cells, with delayed but fully induced Wip1 expression. These data indicate that Wip1 is activated via both the JNK-c-Jun and p38 MAPK-p53 signaling pathways and that temporal induction of Wip1 depends largely on the balance between c-Jun and p53, which compete for JNK binding. Moreover, our results suggest that JNK-c-Jun-mediated Wip1 induction could serve as a major signaling pathway in human tumors in response to frequent p53 mutation.	[Song, Ji-young; Han, Hye-Sook; Yu, Eunsil; Choi, Jene] Univ Ulsan, Coll Med, Dept Pathol, Seoul 138736, South Korea; [Song, Ji-young] Univ Ulsan, Asan Med Ctr, Asan Inst Life Sci, Seoul 138736, South Korea; [Sabapathy, Kanaga] Natl Canc Ctr, Humphrey Oei Inst Canc Res, Div Cellular & Mol Res, Singapore 169610, Singapore; [Lee, Byung-Moo] Dongguk Univ Seoul, Dept Life Sci, Seoul 100715, South Korea	University of Ulsan; University of Ulsan; Asan Medical Center; National Cancer Centre Singapore (NCCS); Dongguk University	Choi, J (corresponding author), Univ Ulsan, Coll Med, Dept Pathol, 388-1 Pungnap 2 Dong, Seoul 138736, South Korea.	jenec@amc.seoul.kr			National Research Foundation of Korea [2007-E00111, 2009-0081016]; Korean government; Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea [A062254]	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government); Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Grants 2007-E00111 and 2009-0081016 from the National Research Foundation of Korea and the Korean government. This research was also supported by Grant A062254 from the Korea Health 21 R&D Project, Ministry of Health, Welfare and Family Affairs, Republic of Korea.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Belova GI, 2005, CANCER BIOL THER, V4, P1154, DOI 10.4161/cbt.4.10.2204; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Buschmann T, 2000, CANCER RES, V60, P896; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Choi J, 2000, GENOMICS, V64, P298, DOI 10.1006/geno.2000.6134; Choi J, 2002, MOL CELL BIOL, V22, P1094, DOI 10.1128/MCB.22.4.1094-1105.2002; den Elzen NR, 2004, EMBO J, V23, P908, DOI 10.1038/sj.emboj.7600105; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Fuchs SY, 1997, J BIOL CHEM, V272, P32163, DOI 10.1074/jbc.272.51.32163; Fujimoto H, 2006, CELL DEATH DIFFER, V13, P1170, DOI 10.1038/sj.cdd.4401801; Gong XF, 2006, EXP MOL MED, V38, P428, DOI 10.1038/emm.2006.50; Han HS, 2009, MOL CANCER RES, V7, P713, DOI 10.1158/1541-7786.MCR-08-0247; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Junttila MR, 2008, FASEB J, V22, P954, DOI 10.1096/fj.06-7859rev; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lo PK, 2004, CANCER RES, V64, P8736, DOI 10.1158/0008-5472.CAN-04-2584; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Lu XB, 2005, GENE DEV, V19, P1162, DOI 10.1101/gad.1291305; Lu XB, 2004, MOL CELL, V15, P621, DOI 10.1016/j.molcel.2004.08.007; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Rayter S, 2008, ONCOGENE, V27, P1036, DOI 10.1038/sj.onc.1210729; Rossi M, 2008, NUCLEIC ACIDS RES, V36, P7168, DOI 10.1093/nar/gkn888; Saito-Ohara F, 2003, CANCER RES, V63, P1876; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Shklyaev SS, 2001, ANTICANCER RES, V21, P2569; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Toh WH, 2004, J BIOL CHEM, V279, P44713, DOI 10.1074/jbc.M407672200; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Xia Y, 2009, J BIOL CHEM, V284, P17428, DOI 10.1074/jbc.M109.007823; Xue Y, 2003, MOL CARCINOGEN, V36, P38, DOI 10.1002/mc.10096; Yu E, 2007, BREAST CANCER RES TR, V101, P269, DOI 10.1007/s10549-006-9304-y	41	20	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9067	9076		10.1074/jbc.M109.070003	http://dx.doi.org/10.1074/jbc.M109.070003			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093361	Green Published, hybrid			2022-12-27	WOS:000275553700057
J	Verdoliva, A; Bellofiore, P; Rivieccio, V; Catello, S; Colombo, M; Albertoni, C; Rosi, A; Leoni, B; Anastasi, AM; De Santis, R				Verdoliva, Antonio; Bellofiore, Piero; Rivieccio, Vincenzo; Catello, Sergio; Colombo, Maurizio; Albertoni, Claudio; Rosi, Antonio; Leoni, Barbara; Anastasi, Anna Maria; De Santis, Rita			Biochemical and Biological Characterization of a New Oxidized Avidin with Enhanced Tissue Binding Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAOPERATIVE AVIDINATION; RADIONUCLIDE TREATMENT; BIOTIN-BINDING; CHICKEN AVIDIN; ACIDIC MUTANT; PHASE-II; STREPTAVIDIN; BRACHYTHERAPY; CARBOHYDRATE; DELIVERY	Chicken avidin and bacterial streptavidin are widely employed in vitro for their capacity to bind biotin, but their pharmacokinetics and immunological properties are not always optimal, thereby limiting their use in medical treatments. Here we investigate the biochemical and biological properties of a new modified avidin, obtained by ligand-assisted sodium periodate oxidation of avidin. This method allows protection of biotin-binding sites of avidin from inactivation caused by the oxidation step and delay of avidin clearance from injected tissue by generation of aldehyde groups from avidin carbohydrate moieties. Oxidized avidin shows spectroscopic properties similar to that of native avidin, indicating that tryptophan residues are spared from oxidation damage. In strict agreement with these results, circular dichroism and isothermal titration calorimetry analyses confirm that the ligand-assisted oxidation preserves the avidin protein structure and its biotin binding capacity. In vitro cell binding and in vivo tissue residence experiments demonstrate that aldehyde groups provide oxidized avidin the property to bind cellular and interstitial protein amino groups through Schiff's base formation, resulting in a tissue half-life of 2 weeks, compared with 2 h of native avidin. In addition, the efficient uptake of the intravenously injected In-111-BiotinDOTA (ST2210) in the site previously treated with modified avidin underlines that tissue-bound oxidized avidin retains its biotin binding capacity in vivo. The results presented here indicate that oxidized avidin could be employed to create a stable artificial receptor in diseased tissues for the targeting of biotinylated therapeutics.	[Albertoni, Claudio; Rosi, Antonio; Leoni, Barbara; Anastasi, Anna Maria; De Santis, Rita] Sigma Tau Pharmaceut Co, Dept Res & Dev, I-00040 Rome, Italy; [Verdoliva, Antonio; Bellofiore, Piero; Rivieccio, Vincenzo; Catello, Sergio; Colombo, Maurizio] Tecnogen SpA, Dept Res & Dev, I-81013 Piana Monte Verna, Caserta, Italy	Leadiant Biosciences	De Santis, R (corresponding author), Sigma Tau SpA R&D, Via Pontina Km 30-400, I-00040 Rome, Italy.	rita.desantis@sigma-tau.it		DE SANTIS, Rita/0000-0002-5037-0611				Adkison JB, 2008, BRACHYTHERAPY, V7, P43, DOI 10.1016/j.brachy.2007.11.001; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Azab AK, 2007, J BIOMED MATER RES A, V83A, P414, DOI 10.1002/jbm.a.31256; Bench BJ, 2004, J COLLOID INTERF SCI, V270, P315, DOI 10.1016/j.jcis.2003.11.005; BRUCH RC, 1982, BIOCHEMISTRY-US, V21, P5334, DOI 10.1021/bi00264a033; Caliceti P, 2002, J CONTROL RELEASE, V83, P97, DOI 10.1016/S0168-3659(02)00199-2; Chinol M, 1998, BRIT J CANCER, V78, P189, DOI 10.1038/bjc.1998.463; Chung WG, 2008, ELECTROPHORESIS, V29, P1317, DOI 10.1002/elps.200700606; De Santis R, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/921434; DELANGE RJ, 1970, J BIOL CHEM, V245, P907; Denecke T., 2008, V177, P95; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; GREEN NM, 1963, BIOCHEM J, V89, P599, DOI 10.1042/bj0890599; GREEN NM, 1990, METHOD ENZYMOL, V184, P51; GREEN NM, 1965, BIOCHEM J, V94, pC23, DOI 10.1042/bj0940023C; HILLER Y, 1987, BIOCHEM J, V248, P167, DOI 10.1042/bj2480167; HNATOWICH DJ, 1987, J NUCL MED, V28, P1294; HUBBARD AL, 1979, J CELL BIOL, V83, P47, DOI 10.1083/jcb.83.1.47; Jansen N, 2007, INT J RADIAT ONCOL, V67, P1052, DOI 10.1016/j.ijrobp.2006.10.031; Kaufman SA, 2007, BRACHYTHERAPY, V6, P286, DOI 10.1016/j.brachy.2007.09.001; Kim YB, 2008, INT J RADIAT ONCOL, V71, P305, DOI 10.1016/j.ijrobp.2008.01.024; Knox SJ, 2000, CLIN CANCER RES, V6, P406; Laitinen OH, 2003, J BIOL CHEM, V278, P4010, DOI 10.1074/jbc.M205844200; Lehtolainen P, 2002, J BIOL CHEM, V277, P8545, DOI 10.1074/jbc.M109431200; MARSHALL D, 1995, BRIT J CANCER, V71, P18, DOI 10.1038/bjc.1995.5; Marttila AT, 1998, FEBS LETT, V441, P313, DOI 10.1016/S0014-5793(98)01570-1; Marttila AT, 2000, FEBS LETT, V467, P31, DOI 10.1016/S0014-5793(00)01119-4; Meyer DL, 2001, PROTEIN SCI, V10, P491, DOI 10.1110/ps.19901; Mirzaei H, 2008, PROTEOMICS, V8, P2764, DOI 10.1002/pmic.200890044; Murray S, 2002, BBA-GEN SUBJECTS, V1570, P81, DOI 10.1016/S0304-4165(02)00157-5; Nardone E, 1998, EUR J BIOCHEM, V256, P453, DOI 10.1046/j.1432-1327.1998.2560453.x; Nordlund HR, 2003, J BIOL CHEM, V278, P2479, DOI 10.1074/jbc.M210721200; OEHR P, 1988, J NUCL MED, V29, P728; OSHANNESSY DJ, 1987, J IMMUNOL METHODS, V99, P153, DOI 10.1016/0022-1759(87)90120-7; PAGANELLI G, 1991, NUCL MED COMMUN, V12, P211, DOI 10.1097/00006231-199103000-00006; Paganelli G, 2007, BREAST, V16, P17, DOI 10.1016/j.breast.2006.10.003; Paganelli G, 2007, CLIN CANCER RES, V13, p5646S, DOI 10.1158/1078-0432.CCR-07-1058; Paganelli G, 2010, EUR J NUCL MED MOL I, V37, P203, DOI 10.1007/s00259-009-1260-4; PIMM MV, 1988, NUCL MED COMMUN, V9, P931, DOI 10.1097/00006231-198811000-00010; Quesenberry MS, 1996, ANAL BIOCHEM, V234, P50, DOI 10.1006/abio.1996.0048; Rosebrough SF, 1996, J NUCL MED, V37, P1380; ROSEBROUGH SF, 1993, NUCL MED BIOL, V20, P663, DOI 10.1016/0969-8051(93)90037-U; Saito S, 2007, INT J CLIN ONCOL, V12, P395, DOI 10.1007/s10147-007-0710-x; Sakahara H, 1999, ADV DRUG DELIVER REV, V37, P89, DOI 10.1016/S0169-409X(98)00101-X; Salmaso S, 2007, INT J PHARMACEUT, V340, P20, DOI 10.1016/j.ijpharm.2007.03.010; SCHECHTER B, 1990, EUR J BIOCHEM, V189, P327, DOI 10.1111/j.1432-1033.1990.tb15493.x; SCHECHTER B, 1995, KIDNEY INT, V47, P1327, DOI 10.1038/ki.1995.188; Schellekens H, 2002, CLIN THER, V24, P1720, DOI 10.1016/S0149-2918(02)80075-3; Subramanian N, 1997, BIOCHEM MOL BIOL INT, V43, P375; Thornalley PJ, 1999, BIOCHEM J, V344, P109, DOI 10.1042/0264-6021:3440109; TOTH CA, 1982, BIOCHEM J, V204, P377, DOI 10.1042/bj2040377; TOWNSEND R, 1981, BIOCHEM J, V194, P209, DOI 10.1042/bj1940209; Urbano N, 2007, EUR J NUCL MED MOL I, V34, P68, DOI 10.1007/s00259-006-0124-4; Van Tomme SR, 2007, EXPERT REV MED DEVIC, V4, P147, DOI 10.1586/17434440.4.2.147; Veyrat-Follet C, 2009, J THROMB HAEMOST, V7, P559, DOI 10.1111/j.1538-7836.2009.03298.x; Weiden PL, 2001, CRIT REV ONCOL HEMAT, V40, P37, DOI 10.1016/S1040-8428(01)00133-0; WILCHEK M, 1990, METHOD ENZYMOL, V184, P5; Yao ZS, 1998, JNCI-J NATL CANCER I, V90, P25, DOI 10.1093/jnci/90.1.25; Yao ZS, 1999, J NUCL MED, V40, P479; ZABORSKY OR, 1974, BIOCHEM BIOPH RES CO, V61, P210, DOI 10.1016/0006-291X(74)90554-3; Zavaleta CL, 2007, INT J PHARM, V337, P316, DOI 10.1016/j.ijpharm.2007.01.010	61	26	27	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9090	9099		10.1074/jbc.M109.080457	http://dx.doi.org/10.1074/jbc.M109.080457			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20100839	Green Published, hybrid			2022-12-27	WOS:000275553700059
J	Baranova, IN; Bocharov, AV; Vishnyakova, TG; Kurlander, R; Chen, ZG; Fu, D; Arias, IM; Csako, G; Patterson, AP; Eggerman, TL				Baranova, Irina N.; Bocharov, Alexander V.; Vishnyakova, Tatyana G.; Kurlander, Roger; Chen, Zhigang; Fu, Dong; Arias, Irwin M.; Csako, Gyorgy; Patterson, Amy P.; Eggerman, Thomas L.			CD36 Is a Novel Serum Amyloid A (SAA) Receptor Mediating SAA Binding and SAA-induced Signaling in Human and Rodent Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE-PHASE RESPONSE; C-REACTIVE PROTEIN; INTERLEUKIN-8 GENE-EXPRESSION; ARTHRITIS SYNOVIAL TISSUE; CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; B SCAVENGER RECEPTOR; N-TERMINAL KINASE; RHEUMATOID-ARTHRITIS; A-PROTEIN	Serum amyloid A (SAA) is a major acute phase protein involved in multiple physiological and pathological processes. This study provides experimental evidence that CD36, a phagocyte class B scavenger receptor, functions as a novel SAA receptor mediating SAA proinflammatory activity. The uptake of Alexa Fluor (R) 488 SAA as well as of other well established CD36 ligands was increased 5-10-fold in HeLa cells stably transfected with CD36 when compared with mock-transfected cells. Unlike other apolipoproteins that bind to CD36, only SAA induced a 10-50-fold increase of interleukin-8 secretion in CD36-overexpressing HEK293 cells when compared with control cells. SAA-mediated effects were thermolabile, inhibitable by anti-SAA antibody, and also neutralized by association with high density lipoprotein but not by association with bovine serum albumin. SAA-induced cell activation was inhibited by a CD36 peptide based on the CD36 hexarelin-binding site but not by a peptide based on the thrombospondin-1-binding site. A pronounced reduction (up to 60-75%) of SAA- induced pro-inflammatory cytokine secretion was observed in cd36(-/-) rat macrophages and Kupffer cells when compared with wild type rat cells. The results of the MAPK phosphorylation assay as well as of the studies with NF-kappa B and MAPK inhibitors revealed that two MAPKs, JNK and to a lesser extent ERK1/2, primarily contribute to elevated cytokine production in CD36-overexpressing HEK293 cells. In macrophages, four signaling pathways involving NF-kappa B and three MAPKs all appeared to contribute to SAA-induced cytokine release. These observations indicate that CD36 is a receptor mediating SAA binding and SAA- induced pro-inflammatory cytokine secretion predominantly through JNK- and ERK1/2-mediated signaling.	[Baranova, Irina N.; Bocharov, Alexander V.; Vishnyakova, Tatyana G.; Kurlander, Roger; Chen, Zhigang; Csako, Gyorgy; Patterson, Amy P.; Eggerman, Thomas L.] NIDDK, Dept Lab Med, Ctr Clin, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Fu, Dong; Arias, Irwin M.] NIDDK, Cell Biol & Metab Branch, NICHD, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Patterson, Amy P.] NIDDK, Off Biotechnol Activ, Off Sci Policy, Off Director,NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Eggerman, Thomas L.] NIDDK, Div Diabet Endocrinol & Metab Dis, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Bocharov, AV (corresponding author), 9 Mem Dr,Room 1W115,MSC 0919, Bethesda, MD 20892 USA.	abocharov@mail.cc.nih.gov; Eggermant@niddk.nih.gov	Fu, Dong/J-1426-2012	Fu, Dong/0000-0002-6865-5033	National Institutes of Health Intramural Research Programs of the Clinical Center; NIDDK; NIAID; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008807] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Programs of the Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Programs of the Clinical Center, NIDDK, and NIAID.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Babitt J, 1997, J BIOL CHEM, V272, P13242, DOI 10.1074/jbc.272.20.13242; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BENSON MD, 1979, ARTHRITIS RHEUM, V22, P36, DOI 10.1002/art.1780220106; Bocharov AV, 2004, J BIOL CHEM, V279, P36072, DOI 10.1074/jbc.M314264200; Brandenburg LO, 2007, J NEUROCHEM, V101, P718, DOI 10.1111/j.1471-4159.2006.04351.x; Cabana VG, 2004, J LIPID RES, V45, P317, DOI 10.1194/jlr.M300414-JLR200; Calvo D, 1998, J LIPID RES, V39, P777; CHAMBERS RE, 1983, ANN RHEUM DIS, V42, P665, DOI 10.1136/ard.42.6.665; Charles-Schoeman C, 2008, CLIN IMMUNOL, V127, P234, DOI 10.1016/j.clim.2008.01.016; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Cunnane G, 2000, J RHEUMATOL, V27, P58; Dawson DW, 1997, J CELL BIOL, V138, P707, DOI 10.1083/jcb.138.3.707; Demers A, 2004, BIOCHEM J, V382, P417, DOI 10.1042/BJ20040036; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Ebeling P, 1999, DIABETOLOGIA, V42, P1433, DOI 10.1007/s001250051315; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; FAIRWELL T, 1987, P NATL ACAD SCI USA, V84, P4796, DOI 10.1073/pnas.84.14.4796; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; Fyfe AI, 1997, CIRCULATION, V96, P2914, DOI 10.1161/01.CIR.96.9.2914; Garber DW, 2001, J LIPID RES, V42, P545; Gon Y, 2004, AM J RESP CELL MOL, V31, P330, DOI 10.1165/rcmb.2003-0438OC; GREENWALT DE, 1992, BLOOD, V80, P1105; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Gupta H, 2005, CIRC RES, V97, P236, DOI 10.1161/01.RES.0000176530.66400.48; Haffner SM, 2000, AM J CARDIOL, V85, P1395, DOI 10.1016/S0002-9149(00)00784-0; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hoffmann E, 2002, J LEUKOCYTE BIOL, V72, P847; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; HUSEBEKK A, 1987, SCAND J IMMUNOL, V25, P375, DOI 10.1111/j.1365-3083.1987.tb02203.x; Jimenez B, 2001, ONCOGENE, V20, P3443, DOI 10.1038/sj.onc.1204464; Jousilahti P, 2001, ATHEROSCLEROSIS, V156, P451, DOI 10.1016/S0021-9150(00)00681-X; Kinkley SM, 2006, AMYLOID, V13, P123, DOI 10.1080/13506120600877201; KISILEVSKY R, 1992, LAB INVEST, V66, P778; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; Kruger AL, 2005, CIRCULATION, V111, P3126, DOI 10.1161/CIRCULATIONAHA.104.517102; Kumon Y, 1999, J RHEUMATOL, V26, P785; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; KUSHNER I, 1994, BAILLIERE CLIN RHEUM, V8, P513, DOI 10.1016/S0950-3579(05)80113-X; KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Leinonen E, 2003, ATHEROSCLEROSIS, V166, P387, DOI 10.1016/S0021-9150(02)00371-4; Leinonen ES, 2004, J INTERN MED, V256, P119, DOI 10.1111/j.1365-2796.2004.01350.x; Lepper PM, 2005, CELL MICROBIOL, V7, P519, DOI 10.1111/j.1462-5822.2005.00482.x; Liang JS, 1997, NEUROSCI LETT, V225, P73, DOI 10.1016/S0304-3940(97)00196-1; LIANG JS, 1995, J LIPID RES, V36, P37; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; MAURY CPJ, 1982, ANN RHEUM DIS, V41, P268, DOI 10.1136/ard.41.3.268; Medeiros LA, 2004, J BIOL CHEM, V279, P10643, DOI 10.1074/jbc.M311735200; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; MEEK RL, 1994, P NATL ACAD SCI USA, V91, P3186, DOI 10.1073/pnas.91.8.3186; MERRIFIELD RB, 1969, J AMER MED ASSOC, V210, P1247, DOI 10.1001/jama.210.7.1247; Moore KJ, 2002, J BIOL CHEM, V277, P47373, DOI 10.1074/jbc.M208788200; Muzio M, 1998, J EXP MED, V187, P2097, DOI 10.1084/jem.187.12.2097; Nanjee MN, 2000, J LIPID RES, V41, P1317; Navab M, 2002, CIRCULATION, V105, P290, DOI 10.1161/hc0302.103711; O'Brien KD, 2005, ARTERIOSCL THROM VAS, V25, P785, DOI 10.1161/01.ATV.0000158383.65277.2b; O'Hara R, 2000, ARTHRITIS RES, V2, P142, DOI 10.1186/ar78; Patel H, 1998, SCAND J IMMUNOL, V48, P410; Pearson AM, 1996, CURR OPIN IMMUNOL, V8, P20, DOI 10.1016/S0952-7915(96)80100-2; PEPYS MB, 1983, ADV IMMUNOL, V34, P141, DOI 10.1016/S0065-2776(08)60379-X; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Roebuck KA, 1999, J INTERF CYTOK RES, V19, P429, DOI 10.1089/107999099313866; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; SAVILL J, 1992, J CLIN INVEST, V90, P1513, DOI 10.1172/JCI116019; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; Schulthess G, 2000, BIOCHEMISTRY-US, V39, P12623, DOI 10.1021/bi0011633; Shah C, 2006, BLOOD, V108, P1751, DOI 10.1182/blood-2005-11-011932; SLOOP CH, 1983, ATHEROSCLEROSIS, V49, P9, DOI 10.1016/0021-9150(83)90003-5; SMEDSROD B, 1985, CELL TISSUE RES, V241, P639; STEINMETZ A, 1989, BIOCHIM BIOPHYS ACTA, V1006, P173, DOI 10.1016/0005-2760(89)90192-6; Stonik JA, 2004, BIOCHEM BIOPH RES CO, V321, P936, DOI 10.1016/j.bbrc.2004.07.052; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Su SB, 1999, J EXP MED, V189, P395, DOI 10.1084/jem.189.2.395; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Urieli-Shoval S, 1998, J HISTOCHEM CYTOCHEM, V46, P1377, DOI 10.1177/002215549804601206; van der Westhuyzen DR, 2005, J BIOL CHEM, V280, P35890, DOI 10.1074/jbc.M505685200; Vishnyakova TG, 2006, P NATL ACAD SCI USA, V103, P16888, DOI 10.1073/pnas.0602126103; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Wyllie DH, 2000, J IMMUNOL, V165, P7125, DOI 10.4049/jimmunol.165.12.7125; XU LL, 1995, J IMMUNOL, V155, P1184; Zaitseva E V, 1994, Biull Eksp Biol Med, V117, P268	93	74	80	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8492	8506		10.1074/jbc.M109.007526	http://dx.doi.org/10.1074/jbc.M109.007526			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20075072	Green Published, hybrid			2022-12-27	WOS:000275413800064
J	Huang, WC; Zhau, HE; Chung, LWK				Huang, Wen-Chin; Zhau, Haiyen E.; Chung, Leland W. K.			Androgen Receptor Survival Signaling Is Blocked by Anti-beta 2-microglobulin Monoclonal Antibody via a MAPK/Lipogenic Pathway in Human Prostate Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; FATTY-ACID SYNTHASE; GENE-EXPRESSION; GROWTH-FACTOR; KINASE-A; METABOLIC ONCOGENE; RAFT MICRODOMAINS; RESPONSE ELEMENT; BONE METASTASIS; BETA-2-MICROGLOBULIN	A new cis-acting element, sterol regulatory element-binding protein-1 (SREBP-1) binding site, within the 5'-flanking human androgen receptor (AR) promoter region and its binding transcription factor, SREBP-1, was identified to regulate AR transcription in AR-positive human prostate cancer cells. We further characterized the molecular mechanism by which a novel anti-beta 2-microglobulin monoclonal antibody (beta 2MmAb), shown to induce massive cell death in a number of human and mouse cancer cell lines, interrupted multiple cell signaling pathways in human prostate cancer cells. beta 2M mAb decreased AR expression through inactivation of MAPK and SREBP-1. By inactivation of MAPK, beta 2M mAb decreased prostate cancer cell proliferation and survival. By inhibition of SREBP-1, beta 2M mAb reduced fatty acid and lipid levels, an integral component of cell membrane, cell signaling mediators, and energy metabolism. These results provide for the first time a molecular link between the beta 2M intracellular signaling axis mediated by MAPK and SREBP-1 and involving lipid signaling, which collectively regulates AR expression and function. Antagonizing beta 2M by beta 2M mAb may be an effective therapeutic approach simultaneously targeting multiple downstream signaling pathways converging with MAPK, SREBP-1, and AR, important for controlling prostate cancer cell growth, survival, and progression.	[Huang, Wen-Chin; Zhau, Haiyen E.; Chung, Leland W. K.] Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA; [Huang, Wen-Chin; Zhau, Haiyen E.; Chung, Leland W. K.] Emory Univ, Sch Med, Mol Urol & Therapeut Program, Dept Urol, Atlanta, GA 30322 USA; [Huang, Wen-Chin; Zhau, Haiyen E.; Chung, Leland W. K.] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Cedars Sinai Medical Center; Emory University; Emory University	Huang, WC (corresponding author), Cedars Sinai Med Ctr, Dept Med, Urooncol Res Program, Samuel Oschin Comprehens Canc Inst, 8750 Beverly Blvd,Atrium 103, Los Angeles, CA 90048 USA.	wen-chin.huang@cshs.org; leland.chung@cshs.org	Huang, Wen-Chin/X-5879-2019	Huang, Wen-Chin/0000-0003-2342-9099	National Institutes of Health [P01 CA98912]; Department of Defense [W81XWH-07-1-0172, W81XWH-08-1-0321]; Georgia Cancer Coalition-Cancer Research Awards; NATIONAL CANCER INSTITUTE [R01CA122602, P01CA098912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Georgia Cancer Coalition-Cancer Research Awards; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 CA98912 (to L.W.K.C.). This work was also supported by Department of Defense Grants W81XWH-07-1-0172 (to L.W.K.C.) and W81XWH-08-1-0321 (to W.-C.H.) and Georgia Cancer Coalition-Cancer Research Awards (to W.-C. H.).	Abdul M, 2000, UROL ONCOL, V5, P168, DOI 10.1016/S1078-1439(00)00063-6; Attard G, 2009, CANCER RES, V69, P4937, DOI 10.1158/0008-5472.CAN-08-4531; Baron A, 2004, J CELL BIOCHEM, V91, P47, DOI 10.1002/jcb.10708; BATAILLE R, 1988, CANCER INVEST, V6, P271, DOI 10.3109/07357908809080649; Brooke GN, 2009, CURR GENOMICS, V10, P18, DOI 10.2174/138920209787581307; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002; Chen LJ, 2009, CATAL COMMUN, V10, P981, DOI 10.1016/j.catcom.2008.12.047; Chung LWK, 2006, CLIN GENITOURIN CANC, V5, P162, DOI 10.3816/CGC.2006.n.034; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; CULIG Z, 1994, CANCER RES, V54, P5474; Devlin HL, 2009, CANCER LETT, V274, P177, DOI 10.1016/j.canlet.2008.06.007; DEWINTER JAR, 1994, AM J PATHOL, V144, P735; Di Vizio D, 2008, TUMORI J, V94, P633; Di Vizio D, 2008, CELL CYCLE, V7, P2257, DOI 10.4161/cc.7.14.6475; Ettinger SL, 2004, CANCER RES, V64, P2212, DOI 10.1158/0008-5472.CAN-2148-2; Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/bj3490013; Freeman MR, 2004, J CELL BIOCHEM, V91, P54, DOI 10.1002/jcb.10724; Fuhrman B, 2007, ATHEROSCLEROSIS, V195, pE108, DOI 10.1016/j.atherosclerosis.2007.06.025; Golias Ch., 2009, Experimental Oncology, V31, P3; Gross M, 2007, CLIN CANCER RES, V13, P1979, DOI 10.1158/1078-0432.CCR-06-1156; Havel PJ, 2000, P NUTR SOC, V59, P359, DOI 10.1017/S0029665100000410; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Heinlein CA, 2004, ENDOCR REV, V25, P276, DOI 10.1210/er.2002-0032; Hobisch A, 1998, CANCER RES, V58, P4640; HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Huang WC, 2008, CLIN CANCER RES, V14, P5341, DOI 10.1158/1078-0432.CCR-08-0793; Huang WC, 2006, CANCER RES, V66, P9108, DOI 10.1158/0008-5472.CAN-06-1996; Kasbohm EA, 2005, J BIOL CHEM, V280, P11583, DOI 10.1074/jbc.M414423200; Klein T, 1996, EUR J IMMUNOGENET, V23, P417, DOI 10.1111/j.1744-313X.1996.tb00132.x; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Menendez JA, 2005, J CELL BIOCHEM, V94, P1, DOI 10.1002/jcb.20310; MIZOKAMI A, 1994, MOL ENDOCRINOL, V8, P77, DOI 10.1210/me.8.1.77; Molife LR, 2010, ANN ONCOL, V21, P109, DOI 10.1093/annonc/mdp270; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Nomura T, 2007, J UROLOGY, V178, P292, DOI 10.1016/j.juro.2007.03.007; Nomura T, 2006, CLIN CANCER RES, V12, P7294, DOI 10.1158/1078-0432.CCR-06-2060; Oh HY, 2007, PROSTATE, V67, P1061, DOI 10.1002/pros.20593; Orio F, 2002, MOL CELL ENDOCRINOL, V198, P105, DOI 10.1016/S0303-7207(02)00374-X; Sadar MD, 1999, J BIOL CHEM, V274, P7777, DOI 10.1074/jbc.274.12.7777; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8; Swinnen JV, 2004, J STEROID BIOCHEM, V92, P273, DOI 10.1016/j.jsbmb.2004.10.013; Takane KK, 1996, MOL CELL ENDOCRINOL, V119, P83, DOI 10.1016/0303-7207(96)03800-2; Taplin ME, 2008, EXPERT REV ANTICANC, V8, P1495, DOI 10.1586/14737140.8.9.1495; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; Tsimberidou AM, 2008, CLIN CANCER RES, V14, P721, DOI 10.1158/1078-0432.CCR-07-2063; Wu D, 2007, ONCOGENE, V26, P5070, DOI 10.1038/sj.onc.1210316; Wu JD, 2006, J CELL BIOCHEM, V99, P392, DOI 10.1002/jcb.20929; Yang J, 2006, CANCER CELL, V10, P295, DOI 10.1016/j.ccr.2006.08.025; Yang L, 2005, J BIOL CHEM, V280, P33558, DOI 10.1074/jbc.M504461200; Yang L, 2003, BIOCHEM BIOPH RES CO, V305, P462, DOI 10.1016/S0006-291X(03)00792-7; Yang X, 2006, ONCOGENE, V25, P3436, DOI 10.1038/sj.onc.1209366; Yang YA, 2002, EXP CELL RES, V279, P80, DOI 10.1006/excr.2002.5600; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; ZILLIACUS J, 1995, MOL ENDOCRINOL, V9, P389, DOI 10.1210/me.9.4.389	57	42	48	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7947	7956		10.1074/jbc.M109.092759	http://dx.doi.org/10.1074/jbc.M109.092759			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20071336	Green Published, hybrid			2022-12-27	WOS:000275413800012
J	Morgan, HP; McNae, IW; Nowicki, MW; Hannaert, V; Michels, PAM; Fothergill-Gilmore, LA; Walkinshaw, MD				Morgan, Hugh P.; McNae, Iain W.; Nowicki, Matthew W.; Hannaert, Veronique; Michels, Paul A. M.; Fothergill-Gilmore, Linda A.; Walkinshaw, Malcolm D.			Allosteric Mechanism of Pyruvate Kinase from Leishmania mexicana Uses a Rock and Lock Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; STRUCTURAL BASIS; MOLECULAR-BASIS; PROTEINS; M2; TRANSITIONS; ENZYME	Allosteric regulation provides a rate management system for enzymes involved in many cellular processes. Ligand-controlled regulation is easily recognizable, but the underlying molecular mechanisms have remained elusive. We have obtained the first complete series of allosteric structures, in all possible ligated states, for the tetrameric enzyme, pyruvate kinase, from Leishmania mexicana. The transition between inactive T-state and active R-state is accompanied by a simple symmetrical 6 degrees rigid body rocking motion of the A- and C-domain cores in each of the four subunits. However, formation of the R-state in this way is only part of the mechanism; eight essential salt bridge locks that form across the C-C interface provide tetramer rigidity with a coupled 7-fold increase in rate. The results presented here illustrate how conformational changes coupled with effector binding correlate with loss of flexibility and increase in thermal stability providing a general mechanism for allosteric control.	[Fothergill-Gilmore, Linda A.; Walkinshaw, Malcolm D.] Univ Edinburgh, Struct Biochem Grp, Inst Struct & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Hannaert, Veronique; Michels, Paul A. M.] Catholic Univ Louvain, Trop Dis Res Unit, Duve Inst, B-1200 Brussels, Belgium; [Hannaert, Veronique; Michels, Paul A. M.] Catholic Univ Louvain, Biochem Lab, B-1200 Brussels, Belgium	University of Edinburgh; Universite Catholique Louvain; Universite Catholique Louvain	Walkinshaw, MD (corresponding author), Univ Edinburgh, Struct Biochem Grp, Inst Struct & Mol Biol, Michael Swann Bldg,Kings Bldg,Mayfield Rd, Edinburgh EH9 3JR, Midlothian, Scotland.	m.walkinshaw@ed.ac.uk	Michels, Paul A/A-5637-2009; walkinshaw, malcolm/AAB-7497-2019	Michels, Paul A/0000-0003-3726-6104; McNae, Iain/0000-0002-6312-7936; walkinshaw, malcolm/0000-0001-5955-9325	Medical Research Council; European Commission; Wellcome Trust; Biotechnology and Biological Sciences Research Council; Medical Research Council [G0500367, G0600014] Funding Source: researchfish; MRC [G0600014, G0500367] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council, by the European Commission through its International Cooperation with Developing Countries programme. The Centre for Translational and Chemical Biology and Edinburgh Protein Production Facility were funded by the Wellcome Trust and the Biotechnology and Biological Sciences Research Council.	BLUNDELL TL, 1976, PROTEIN CRYSTALLOGRA, P75; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Collins RA, 1996, PROTEIN ENG, V9, P1203, DOI 10.1093/protein/9.12.1203; CONSLER TG, 1988, J BIOL CHEM, V263, P2794; Daily MD, 2007, PROTEINS, V67, P385, DOI 10.1002/prot.21300; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELANO WL, 2002, PYMOL V1 2; Dombrauckas JD, 2005, BIOCHEMISTRY-US, V44, P9417, DOI 10.1021/bi0474923; Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; ERNEST I, 1994, MOL BIOCHEM PARASIT, V64, P43, DOI 10.1016/0166-6851(94)90133-3; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Hannaert V, 2002, FEBS LETT, V514, P255, DOI 10.1016/S0014-5793(02)02374-8; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ikeda Y, 1997, J BIOL CHEM, V272, P20495, DOI 10.1074/jbc.272.33.20495; Jardetzky O, 1996, PROG BIOPHYS MOL BIO, V65, P171, DOI 10.1016/S0079-6107(96)00010-7; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; Lee JC, 2008, ACTA BIOCH BIOPH SIN, V40, P663, DOI 10.1111/j.1745-7270.2008.00445.x; Lindsley JE, 2006, P NATL ACAD SCI USA, V103, P10533, DOI 10.1073/pnas.0604452103; MATTEVI A, 1995, STRUCTURE, V3, P729, DOI 10.1016/S0969-2126(01)00207-6; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pendergrass DC, 2006, IUBMB LIFE, V58, P31, DOI 10.1080/15216540500531705; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rigden DJ, 1999, J MOL BIOL, V291, P615, DOI 10.1006/jmbi.1999.2918; Stetak A, 2007, CANCER RES, V67, P1602, DOI 10.1158/0008-5472.CAN-06-2870; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tulloch LB, 2008, J MOL BIOL, V383, P615, DOI 10.1016/j.jmb.2008.08.037; Valentin G, 2000, J BIOL CHEM, V275, P18145, DOI 10.1074/jbc.M001870200; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200	36	60	60	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12892	12898		10.1074/jbc.M109.079905	http://dx.doi.org/10.1074/jbc.M109.079905			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20123988	hybrid, Green Published			2022-12-27	WOS:000276787800047
J	An, S; Kyoung, M; Allen, JJ; Shokat, KM; Benkovic, SJ				An, Songon; Kyoung, Minjoung; Allen, Jasmina J.; Shokat, Kevan M.; Benkovic, Stephen J.			Dynamic Regulation of a Metabolic Multi-enzyme Complex by Protein Kinase CK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALYTIC-SUBUNIT; ENZYME COMPLEX; INHIBITORS; PURIFICATION; CHEMOTHERAPY; CANCER; TUMORS; KEY	The reversible association and dissociation of a metabolic multi-enzyme complex participating in de novo purine biosynthesis, the purinosome, was demonstrated in live cells to respond to the levels of purine nucleotides in the culture media. We also took advantage of in vitro proteomic scale studies of cellular substrates of human protein kinases (e.g. casein kinase II (CK2) and Akt), that implicated several de novo purine biosynthetic enzymes as kinase substrates. Here, we successfully identified that purinosome formation in vivo was significantly promoted in HeLa cells by the addition of small-molecule CK2-specific inhibitors (i.e. 4,5,6,7-tetrabromo-1H-benzimidazole, 2-dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole, tetrabromocinammic acid, 4,4',5,5',6,6'-hexahydroxydiphenic acid 2,2',6,6'-dilactone (ellagic acid) as well as by silencing the endogenous human CK2 alpha catalytic subunit with small interfering RNA. However, 4,5,6,7-tetrabromobenzotriazole, another CK2-specific inhibitor, triggered the dissociation of purinosome clusters in HeLa cells. Although the mechanism by which 4,5,6,7-tetrabromobenzotriazole affects purinosome clustering is not clear, we were capable of chemically reversing purinosome formation in cells by the sequential addition of two CK2 inhibitors. Collectively, we provide compelling cellular evidence that CK2-mediated pathways reversibly regulate purinosome assembly, and thus the purinosome may be one of the ultimate targets of kinase inhibitors.	[An, Songon; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Kyoung, Minjoung] Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Allen, Jasmina J.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Benkovic, SJ (corresponding author), 413 Wartik Lab, University Pk, PA 16802 USA.	sjb1@psu.edu	An, Songon/A-6714-2009	An, Songon/0000-0003-2189-7374	National Institutes of Health [GM24129, RO1 EB0001987]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024129, R37GM024129] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM24129 (to S. J. B.) and RO1 EB0001987 (to K. M. S.).	ALLEN JJ, 2008, THESIS U CALIFORNIA; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; Berwick DC, 2002, J BIOL CHEM, V277, P33895, DOI 10.1074/jbc.M204681200; Boccalatte FE, 2009, BLOOD, V113, P2776, DOI 10.1182/blood-2008-06-161018; Campanella ME, 2005, P NATL ACAD SCI USA, V102, P2402, DOI 10.1073/pnas.0409741102; Dominguez I, 2009, CELL MOL LIFE SCI, V66, P1850, DOI 10.1007/s00018-009-9153-z; Duncan JS, 2008, MOL CELL PROTEOMICS, V7, P1077, DOI 10.1074/mcp.M700559-MCP200; Duncan JS, 2008, BBA-PROTEINS PROTEOM, V1784, P33, DOI 10.1016/j.bbapap.2007.08.017; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Faust M, 2000, CELL TISSUE RES, V301, P329, DOI 10.1007/s004410000256; Field MS, 2009, ARCH BIOCHEM BIOPHYS, V481, P145, DOI 10.1016/j.abb.2008.11.001; Filhol O, 2009, CELL MOL LIFE SCI, V66, P1830, DOI 10.1007/s00018-009-9151-1; Lou DY, 2008, MOL CELL BIOL, V28, P131, DOI 10.1128/MCB.01119-07; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Pinna LA, 2009, CELL MOL LIFE SCI, V66, P1797, DOI 10.1007/s00018-009-9148-9; PINNA LA, 1990, BIOCHIM BIOPHYS ACTA, V1054, P267, DOI 10.1016/0167-4889(90)90098-X; Raaf J, 2009, J MOL BIOL, V386, P1212, DOI 10.1016/j.jmb.2009.01.033; RISCOE MK, 1989, BLOOD REV, V3, P162, DOI 10.1016/0268-960X(89)90013-1; ROWE PB, 1978, J BIOL CHEM, V253, P7711; Rubio MP, 2004, BIOCHEM J, V379, P395, DOI 10.1042/bj20031797; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; SRERE PA, 1987, ANNU REV BIOCHEM, V56, P89, DOI 10.1146/annurev.bi.56.070187.000513; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; VANGORP AG, 2007, THESIS PROEFSCHRIFT; Wang W, 2009, J BIOL CHEM, V284, P3521, DOI 10.1074/jbc.M806707200; Wilson LK, 1997, J BIOL CHEM, V272, P12961, DOI 10.1074/jbc.272.20.12961	31	49	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11093	11099		10.1074/jbc.M110.101139	http://dx.doi.org/10.1074/jbc.M110.101139			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20157113	Green Published, hybrid			2022-12-27	WOS:000276286200013
J	Ishii, S; Yano, T; Ebihara, A; Okamoto, A; Manzoku, M; Hayashi, H				Ishii, Seiji; Yano, Takato; Ebihara, Akio; Okamoto, Akihiro; Manzoku, Miho; Hayashi, Hideyuki			Crystal Structure of the Peptidase Domain of Streptococcus ComA, a Bifunctional ATP-binding Cassette Transporter Involved in the Quorum-sensing Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; BIOFILM FORMATION; GENE-EXPRESSION; COMMUNICATION; PROTEINS; BACTERIA; SYSTEM; CRYSTALLOGRAPHY; SPECIFICITY; RECOGNITION	ComA of Streptococcus is a member of the bacteriocin-associated ATP-binding cassette transporter family and is postulated to be responsible for both the processing of the propeptide ComC and secretion of the mature quorum-sensing signal. The 150-amino acid peptidase domain (PEP) of ComA specifically recognizes an extended region of ComC that is 15 amino acids in length. It has been proposed that an amphipathic alpha-helix formed by the N-terminal leader region of ComC, as well as the Gly-Gly motif at the cleavage site, is critical for the PEP-ComC interaction. To elucidate the substrate recognition mechanism, we determined the three-dimensional crystal structure of Streptococcus mutans PEP and then constructed models for the PEP.ComC complexes. PEP had an overall structure similar to the papain-like cysteine proteases as has long been predicted. The active site was located at the bottom of a narrow cleft, which is suitable for binding the Gly-Gly motif. Together with the results from mutational experiments, a shallow hydrophobic concave surface of PEP was proposed as a site that accommodates the N-terminal helix of ComC. This dual mode of substrate recognition would provide the small PEP domain with an extremely high substrate specificity.	[Ishii, Seiji; Yano, Takato; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan; [Ebihara, Akio; Manzoku, Miho] Harima Inst, RIKEN SPring Ctr 8, Sayo, Hyogo 6795148, Japan; [Okamoto, Akihiro] Tokai Univ, Dept Biol Sci & Technol, Shizuoka 4100395, Japan; [Ebihara, Akio] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan	Osaka Medical College; RIKEN; Tokai University; Gifu University	Hayashi, H (corresponding author), Osaka Med Coll, Dept Biochem, 2-7 Daigakumachi, Osaka 5698686, Japan.	hayashi@art.osaka-med.ac.jp	Ebihara, Akio/AAI-6155-2020	Ebihara, Akio/0000-0002-1763-9084	Japan Society for the Promotion of Science [19570141]; Osaka Medical Research Foundation for Incurable Diseases	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Medical Research Foundation for Incurable Diseases	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (Category C Grant 19570141 to S. I.) and a grant from the Osaka Medical Research Foundation for Incurable Diseases (to T. Y.)	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CCPR, 1994, ACTA CRYSTALLOGR D, V50, P760; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cvitkovitch DG, 2003, J CLIN INVEST, V112, P1626, DOI 10.1172/JCI200320430; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gilmore KS, 2003, INFECT IMMUN, V71, P4759, DOI 10.1128/IAI.71.8.4759-4766.2003; Gould TA, 2004, MOL MICROBIOL, V53, P1135, DOI 10.1111/j.1365-2958.2004.04211.x; Greenberg EP, 2003, J CLIN INVEST, V112, P1288, DOI 10.1172/JCI200320099; HAVARSTEIN LS, 1995, MOL MICROBIOL, V16, P229, DOI 10.1111/j.1365-2958.1995.tb02295.x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishii S, 2006, J BIOL CHEM, V281, P4726, DOI 10.1074/jbc.M512516200; Jahan N, 2009, J MOL BIOL, V392, P763, DOI 10.1016/j.jmb.2009.07.042; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kleerebezem M, 2001, PEPTIDES, V22, P1579, DOI 10.1016/S0196-9781(01)00493-4; Kotake Y, 2008, BIOCHEMISTRY-US, V47, P2531, DOI 10.1021/bi702253n; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li YH, 2002, J BACTERIOL, V184, P2699, DOI 10.1128/JB.184.10.2699-2708.2002; Luo P, 2004, MOL MICROBIOL, V54, P172, DOI 10.1111/j.1365-2958.2004.04254.x; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nicastro G, 2005, P NATL ACAD SCI USA, V102, P10493, DOI 10.1073/pnas.0501732102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petersen FC, 2004, J BACTERIOL, V186, P6327, DOI 10.1128/JB.186.18.6327-6331.2004; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; POLGAR L, 1974, FEBS LETT, V47, P15, DOI 10.1016/0014-5793(74)80415-1; Raina S, 2009, BIOTECHNOL APPL BIOC, V54, P65, DOI 10.1042/BA20090072; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Watson WT, 2002, MOL CELL, V9, P685, DOI 10.1016/S1097-2765(02)00480-X; Williams P, 2007, MICROBIOL-SGM, V153, P3923, DOI 10.1099/mic.0.2007/012856-0; Wu KH, 2004, J BIOL CHEM, V279, P901, DOI 10.1074/jbc.M308296200; YE Y, 2004, NUCLEIC ACIDS RES, V582, pW585; ZHANG YH, 1995, J CHEM PHYS, V103, P10252, DOI 10.1063/1.469927	47	40	42	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10777	10785		10.1074/jbc.M109.093781	http://dx.doi.org/10.1074/jbc.M109.093781			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20100826	hybrid, Green Published			2022-12-27	WOS:000276264600063
J	Fong, DH; Lemke, CT; Hwang, JY; Xiong, B; Berghuis, AM				Fong, Desiree H.; Lemke, Christopher T.; Hwang, Jiyoung; Xiong, Bing; Berghuis, Albert M.			Structure of the Antibiotic Resistance Factor Spectinomycin Phosphotransferase from Legionella pneumophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; AMINOGLYCOSIDE PHOSPHOTRANSFERASE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURES; CATALYTIC SUBUNIT; CHOLINE KINASE; BACTERIAL-RESISTANCE; NUCLEOTIDE-BINDING; KINETIC MECHANISM; PURIFICATION	Aminoglycoside phosphotransferases (APHs) constitute a diverse group of enzymes that are often the underlying cause of aminoglycoside resistance in the clinical setting. Several APHs have been extensively characterized, including the elucidation of the three-dimensional structure of two APH(3') isozymes and an APH(2 '') enzyme. Although many APHs are plasmid-encoded and are capable of inactivating numerous 2-deoxystreptmaine aminoglycosides with multiple regiospecificity, APH(9)-Ia, isolated from Legionella pneumophila, is an unusual enzyme among the APH family for its chromosomal origin and its specificity for a single non-2-deoxystreptamine aminoglycoside substrate, spectinomycin. We describe here the crystal structures of APH(9)-Ia in its apo form, its binary complex with the nucleotide, AMP, and its ternary complex bound with ADP and spectinomycin. The structures reveal that APH(9)-Ia adopts the bilobal protein kinase-fold, analogous to the APH(3') and APH(2 '') enzymes. However, APH(9)-Ia differs significantly from the other two types of APH enzymes in its substrate binding area and that it undergoes a conformation change upon ligand binding. Moreover, kinetic assay experiments indicate that APH(9)-Ia has stringent substrate specificity as it is unable to phosphorylate substrates of choline kinase or methylthioribose kinase despite high structural resemblance. The crystal structures of APH(9)-Ia demonstrate and expand our understanding of the diversity of the APH family, which in turn will facilitate the development of new antibiotics and inhibitors.	[Fong, Desiree H.; Hwang, Jiyoung; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Lemke, Christopher T.; Xiong, Bing; Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Berghuis, AM (corresponding author), Rm 466,Bellini Pavilion,3649 Promenade Sir Willia, Montreal, PQ H3G 0B1, Canada.	albert.berghuis@mcgill.ca	Berghuis, Albert M/A-6495-2008; Xiong, Bin/L-7560-2019; Xiong, Bing/B-8849-2008	Xiong, Bin/0000-0001-9776-8136; Xiong, Bing/0000-0001-9776-8136; Berghuis, Albert/0000-0002-2663-025X	Canadian Institutes of Health Research [MOP-13107]; Natural Sciences and Engineering Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research Grant MOP-13107.; We thank Dr. Nicholas P. Cianciotto (Norwestern University Medical School, Chicago, IL) for providing the plasmid containing APH(9)-Ia, Dr. Michael Riscoe (VA Medical Center, Portland, OR) for providing the methylthioribose for alternative substrate analysis, and Dr. Clyde Smith (Stanford Synchrotron Radiation Laboratory, Stanford University, Menlo Park, CA) for early access to the coordinates of APH(2 '')-IIa. Beamline X8C at the NSLS-BNL, Upton, NY, was supported in part from the Natural Sciences and Engineering Council of Canada and the Canadian Institutes of Health Research.	Bastida A, 2006, J AM CHEM SOC, V128, P100, DOI 10.1021/ja0543144; BRENNER S, 1987, NATURE, V329, P21, DOI 10.1038/329021a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burk DL, 2001, BIOCHEMISTRY-US, V40, P8756, DOI 10.1021/bi010504p; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cheng YH, 2005, J AM CHEM SOC, V127, P1553, DOI 10.1021/ja0464084; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; Daigle DM, 1997, J BIOL CHEM, V272, P24755, DOI 10.1074/jbc.272.40.24755; Davies J, 1997, TRENDS MICROBIOL, V5, P234, DOI 10.1016/S0966-842X(97)01033-0; Fong DH, 2009, ANTIMICROB AGENTS CH, V53, P3049, DOI 10.1128/AAC.00062-09; Fong DH, 2002, EMBO J, V21, P2323, DOI 10.1093/emboj/21.10.2323; Fridman M, 2003, ORG LETT, V5, P3575, DOI 10.1021/ol035213i; Gee P, 2003, BBA-PROTEINS PROTEOM, V1648, P33, DOI 10.1016/S1570-9639(03)00106-7; GIBBS CS, 1991, J BIOL CHEM, V266, P8923; Glockner G, 2008, INT J MED MICROBIOL, V298, P411, DOI 10.1016/j.ijmm.2007.07.012; Hanessian S, 2007, BIOORG MED CHEM LETT, V17, P3221, DOI 10.1016/j.bmcl.2007.03.014; Hayward S, 2004, J MOL BIOL, V339, P1001, DOI 10.1016/j.jmb.2004.04.004; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kim KR, 2008, CURR MICROBIOL, V57, P371, DOI 10.1007/s00284-008-9204-y; Ku SY, 2007, J BIOL CHEM, V282, P22195, DOI 10.1074/jbc.M611045200; Ku SY, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-70; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemke CT, 2005, ACTA CRYSTALLOGR F, V61, P606, DOI 10.1107/S1744309105016301; Li J, 2005, ORG LETT, V7, P3061, DOI 10.1021/ol051045d; Malito E, 2006, J MOL BIOL, V364, P136, DOI 10.1016/j.jmb.2006.08.084; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCKAY GA, 1994, BIOCHEMISTRY-US, V33, P6936, DOI 10.1021/bi00188a024; MCKAY GA, 1995, J BIOL CHEM, V270, P24686, DOI 10.1074/jbc.270.42.24686; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; Mingeot-Leclercq MP, 1999, ANTIMICROB AGENTS CH, V43, P727, DOI 10.1128/AAC.43.4.727; Nakamura A, 2008, BIOSCI BIOTECH BIOCH, V72, P2467, DOI 10.1271/bbb.80285; Narayana N, 1997, STRUCTURE, V5, P921, DOI 10.1016/S0969-2126(97)00246-3; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peisach D, 2003, STRUCTURE, V11, P703, DOI 10.1016/S0969-2126(03)00094-7; Russell RJM, 2003, J AM CHEM SOC, V125, P3410, DOI 10.1021/ja029736h; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Sekowska A, 2001, BMC Microbiol, V1, P15, DOI 10.1186/1471-2180-1-15; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SIREGAR JJ, 1995, BIOCHEMISTRY-US, V34, P12681, DOI 10.1021/bi00039a026; SIREGAR JJ, 1994, ANTIMICROB AGENTS CH, V38, P641, DOI 10.1128/AAC.38.4.641; Suter TM, 1997, ANTIMICROB AGENTS CH, V41, P1385, DOI 10.1128/AAC.41.6.1385; Thapa LP, 2008, J APPL MICROBIOL, V105, P300, DOI 10.1111/j.1365-2672.2008.03788.x; Thompson PR, 1998, J BIOL CHEM, V273, P14788, DOI 10.1074/jbc.273.24.14788; Thompson PR, 1999, J BIOL CHEM, V274, P30697, DOI 10.1074/jbc.274.43.30697; Toledo LM, 1999, CURR MED CHEM, V6, P775; Toth M, 2007, BIOCHEMISTRY-US, V46, P5570, DOI 10.1021/bi6024512; Toth M, 2009, J BIOL CHEM, V284, P6690, DOI 10.1074/jbc.M808148200; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007; WRIGHT GD, 1999, FRONT BIOSCI, V4, P9; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	61	31	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9545	9555		10.1074/jbc.M109.038364	http://dx.doi.org/10.1074/jbc.M109.038364			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089863	Green Published, hybrid			2022-12-27	WOS:000276165900028
J	Wei, SO; Kulp, SK; Chen, CS				Wei, Shuo; Kulp, Samuel K.; Chen, Ching-Shih			Energy Restriction as an Antitumor Target of Thiazolidinediones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-GAMMA; UNFOLDED PROTEIN RESPONSE; OVARIAN-CANCER CELLS; GLUCOSE-METABOLISM; CALORIE RESTRICTION; PROSTATE-CANCER; PHARMACOLOGICAL EXPLOITATION; EIF2-ALPHA PHOSPHORYLATION; AEROBIC GLYCOLYSIS; BETA-CATENIN	Cancer cells gain growth advantages in the microenvironment by shifting cellular metabolism to aerobic glycolysis, the so-called Warburg effect. There is a growing interest in targeting aerobic glycolysis for cancer therapy by exploiting the differential susceptibility of malignant versus normal cells to glycolytic inhibition, of which the proof-of-concept is provided by the in vivo efficacy of dietary caloric restriction and natural product-based energy restriction-mimetic agents (ERMAs) such as resveratrol and 2-deoxyglucose in suppressing carcinogenesis in animal models. Here, we identified thiazolidinediones as a novel class of ERMAs in that they elicited hallmark cellular responses characteristic of energy restriction, including transient induction of Sirt1 (silent information regulator 1) expression, activation of the intracellular fuel sensor AMP-activated protein kinase, and endoplasmic reticulum stress, the interplay among which culminated in autophagic and apoptotic death. The translational implications of this finding are multifold. First, the novel function of troglitazone and ciglitazone in targeting energy restriction provides a mechanistic basis to account for their peroxisome proliferator-activated receptor gamma-independent effects on a broad spectrum of signaling targets. Second, we demonstrated that Sirt1-mediated up-regulation of beta-transducin repeat-containing protein-facilitated proteolysis of cell cycle- and apoptosis-regulatory proteins is an energy restriction-elicited signaling event and is critical for the antitumor effects of ERMAs. Third, it provides a molecular rationale for using thiazolidinediones as scaffolds to develop potent ERMAs, of which the proof-of-principle is demonstrated by OSU-CG12. OSU-CG12, a peroxisome proliferator-activated receptor gamma-inactive ciglitazone derivative, exhibits 1- and 3-order of magnitude higher potency in eliciting starvation-like cellular responses relative to resveratrol and 2-deoxyglucose, respectively.	[Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA; Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem, 500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu			National Institutes of Health [CA112250]; Department of Defense Prostate Cancer Research Program [W81XWH-09-0198]; NATIONAL CANCER INSTITUTE [R01CA112250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Prostate Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112250. This work was also supported by Department of Defense Prostate Cancer Research Program Grant W81XWH-09-0198.	Anastasiou D, 2006, PHYSIOLOGY, V21, P404, DOI 10.1152/physiol.00031.2006; ASHCROFT SJ, 1972, BIOCHEM J, V126, P525, DOI 10.1042/bj1260525; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Bishayee A, 2009, CANCER PREV RES, V2, P409, DOI 10.1158/1940-6207.CAPR-08-0160; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Clemens MJ, 2001, PROG MOLEC, V27, P57; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; Demetri GD, 1999, P NATL ACAD SCI USA, V96, P3951, DOI 10.1073/pnas.96.7.3951; Deng CX, 2009, INT J BIOL SCI, V5, P147, DOI 10.7150/ijbs.5.147; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Faber AC, 2006, BIOCHEM PHARMACOL, V72, P1246, DOI 10.1016/j.bcp.2006.08.009; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gomez E, 2008, BIOCHEM J, V410, P485, DOI 10.1042/BJ20071367; Grommes C, 2004, LANCET ONCOL, V5, P419, DOI 10.1016/S1470-2045(04)01509-8; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hisatake J, 2000, CANCER RES, V60, P5494; Huang JW, 2006, J MED CHEM, V49, P4684, DOI 10.1021/jm060057h; Hursting SD, 2003, ANNU REV MED, V54, P131, DOI 10.1146/annurev.med.54.101601.152156; Jiang M, 2004, J CELL BIOCHEM, V91, P513, DOI 10.1002/jcb.10770; Jiang WQ, 2008, CANCER RES, V68, P5492, DOI 10.1158/0008-5472.CAN-07-6721; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Koeffler HP, 2003, CLIN CANCER RES, V9, P1; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kopelovich L, 2002, MOL CANCER THER, V1, P357; Kueck A, 2007, GYNECOL ONCOL, V107, P450, DOI 10.1016/j.ygyno.2007.07.065; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; LIN AY, 1984, P NATL ACAD SCI-BIOL, V81, P988, DOI 10.1073/pnas.81.4.988; Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Panchapakesan U, 2005, NAT CLIN PRACT NEPHR, V1, P33, DOI 10.1038/ncpneph0029; Park JB, 2001, J NAT PROD, V64, P381, DOI 10.1021/np000411t; Proud CG, 2005, SEMIN CELL DEV BIOL, V16, P3, DOI 10.1016/j.semcdb.2004.11.004; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Saito S, 2009, CANCER RES, V69, P4225, DOI 10.1158/0008-5472.CAN-08-2689; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Sharma AM, 2007, J CLIN ENDOCR METAB, V92, P386, DOI 10.1210/jc.2006-1268; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Singletary K, 2008, CANCER EPIDEM BIOMAR, V17, P1596, DOI 10.1158/1055-9965.EPI-07-2917; Thompson HJ, 2003, J MAMMARY GLAND BIOL, V8, P133, DOI 10.1023/A:1025743607445; Thompson JE, 2004, J CLIN ONCOL, V22, P4217, DOI 10.1200/jco.2004.01.103; Tsuchihara K, 2009, CANCER LETT, V278, P130, DOI 10.1016/j.canlet.2008.09.040; Wang Y, 2000, J BIOL CHEM, V275, P27013; Wei S, 2008, J BIOL CHEM, V283, P26759, DOI 10.1074/jbc.M802160200; Wei S, 2007, MOL PHARMACOL, V72, P725, DOI 10.1124/mol.107.035287; Wei S, 2009, MOL PHARMACOL, V76, P47, DOI 10.1124/mol.109.055376; Wei S, 2009, CANCER LETT, V276, P119, DOI 10.1016/j.canlet.2008.08.008; Weng JR, 2006, ENDOCR-RELAT CANCER, V13, P401, DOI 10.1677/erc.1.01182; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang CC, 2007, CANCER RES, V67, P3229, DOI 10.1158/0008-5472.CAN-06-2759; Yang J, 2008, J MED CHEM, V51, P2100, DOI 10.1021/jm701212m; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Zhu ZJ, 2005, CANCER RES, V65, P7023, DOI 10.1158/0008-5472.CAN-05-0453	63	66	70	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9780	9791		10.1074/jbc.M109.065466	http://dx.doi.org/10.1074/jbc.M109.065466			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20093366	Green Published, hybrid			2022-12-27	WOS:000276165900050
J	De Donatis, GM; Singh, SK; Viswanathan, S; Maurizi, MR				De Donatis, Gian Marco; Singh, Satyendra K.; Viswanathan, Sarada; Maurizi, Michael R.			A Single ClpS Monomer Is Sufficient to Direct the Activity of the ClpA Hexamer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-END RULE; ADAPTER PROTEIN CLPS; SUBSTRATE-BINDING DOMAIN; ATP-DEPENDENT PROTEASES; SSRA-TAGGED PROTEINS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CHAPERONE CLPA; PORE LOOPS; DEGRADATION	ClpS is an adaptor protein that interacts with ClpA and promotes degradation of proteins with N-end rule degradation motifs (N-degrons) by ClpAP while blocking degradation of substrates with other motifs. Although monomeric ClpS forms a 1: 1 complex with an isolated N-domain of ClpA, only one molecule of ClpS binds with high affinity to ClpA hexamers (ClpA(6)). One or two additional molecules per hexamer bind with lower affinity. Tightly bound ClpS dissociates slowly from ClpA(6) with a t(1/2) of similar to 3 min at 37 degrees C. Maximum activation of degradation of the N-end rule substrate, LR-GFP(Venus), occurs with a single ClpS bound per ClpA(6); one ClpS is also sufficient to inhibit degradation of proteins without N-degrons. ClpS competitively inhibits degradation of unfolded substrates that interact with ClpA N-domains and is a non-competitive inhibitor with substrates that depend on internal binding sites in ClpA. ClpS inhibition of substrate binding is dependent on the order of addition. When added first, ClpS blocks binding of both high and low affinity substrates; however, when substrates first form committed complexes with ClpA(6), ClpS cannot displace them or block their degradation by ClpP. We propose that the first molecule of ClpS binds to the N-domain and to an additional functional binding site, sterically blocking binding of non-N-end rule substrates as well as additional ClpS molecules to ClpA(6). Limiting ClpS-mediated substrate delivery to one per ClpA(6) avoids congestion at the axial channel and allows facile transfer of proteins to the unfolding and translocation apparatus.	[De Donatis, Gian Marco; Singh, Satyendra K.; Viswanathan, Sarada; Maurizi, Michael R.] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Maurizi, MR (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37 Rm 2128,37 Convent Dr MSC4256, Bethesda, MD 20892 USA.	mmaurizi@helix.nih.gov			National Institutes of Health, NCI, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC005597] Funding Source: NIH RePORTER	National Institutes of Health, NCI, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health, NCI, Center for Cancer Research, Intramural Research Program.	Beuron F, 1998, J STRUCT BIOL, V123, P248, DOI 10.1006/jsbi.1998.4039; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; DASGUPTA S, 1993, J MOL BIOL, V232, P23, DOI 10.1006/jmbi.1993.1367; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Farbman ME, 2008, BIOCHEMISTRY-US, V47, P13497, DOI 10.1021/bi801140y; Farrell CM, 2005, MOL MICROBIOL, V57, P1750, DOI 10.1111/j.1365-2958.2005.04798.x; GOTTESMAN S, 1990, J BIOL CHEM, V265, P7886; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200; Guo FS, 2002, J BIOL CHEM, V277, P46753, DOI 10.1074/jbc.M208104200; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247; Hoskins JR, 2000, P NATL ACAD SCI USA, V97, P8892, DOI 10.1073/pnas.97.16.8892; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Hou JY, 2008, NAT STRUCT MOL BIOL, V15, P288, DOI 10.1038/nsmb.1392; Ishikawa T, 2004, J STRUCT BIOL, V146, P180, DOI 10.1016/j.jsb.2003.11.018; KESSEL M, 1995, J MOL BIOL, V250, P587, DOI 10.1006/jmbi.1995.0400; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; LEVINE RL, 1982, BIOCHEMISTRY-US, V21, P2600, DOI 10.1021/bi00540a004; Lies M, 2008, J BIOL CHEM, V283, P22918, DOI 10.1074/jbc.M801692200; Lupas AN, 2003, J STRUCT BIOL, V141, P77, DOI 10.1016/S1047-8477(02)00582-8; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Ninnis RL, 2009, EMBO J, V28, P1732, DOI 10.1038/emboj.2009.134; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Pak M, 1997, P NATL ACAD SCI USA, V94, P4901, DOI 10.1073/pnas.94.10.4901; Piszczek G, 2005, J BIOL CHEM, V280, P12221, DOI 10.1074/jbc.M411733200; Roman-Hernandez G, 2009, P NATL ACAD SCI USA, V106, P8888, DOI 10.1073/pnas.0903614106; Sauer RT, 2004, CELL, V119, P9, DOI 10.1016/j.cell.2004.09.020; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schmidt R, 2009, MOL MICROBIOL, V72, P506, DOI 10.1111/j.1365-2958.2009.06666.x; Schuenemann VJ, 2009, EMBO REP, V10, P508, DOI 10.1038/embor.2009.62; SHRADER TE, 1993, J BACTERIOL, V175, P4364, DOI 10.1128/JB.175.14.4364-4374.1993; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Wah DA, 2003, MOL CELL, V12, P355, DOI 10.1016/S1097-2765(03)00272-7; Wang KH, 2008, J BIOL CHEM, V283, P24600, DOI 10.1074/jbc.M802213200; Wang KH, 2007, GENE DEV, V21, P403, DOI 10.1101/gad.1511907; Xia D, 2004, J STRUCT BIOL, V146, P166, DOI 10.1016/j.jsb.2003.11.025; Zeth K, 2002, NAT STRUCT BIOL, V9, P906, DOI 10.1038/nsb869	47	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8771	8781		10.1074/jbc.M109.053736	http://dx.doi.org/10.1074/jbc.M109.053736			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20068042	Green Published, hybrid			2022-12-27	WOS:000275553700029
J	Vingtdeux, V; Giliberto, L; Zhao, HT; Chandakkar, P; Wu, QL; Simon, JE; Janle, EM; Lobo, J; Ferruzzi, MG; Davies, P; Marambaud, P				Vingtdeux, Valerie; Giliberto, Luca; Zhao, Haitian; Chandakkar, Pallavi; Wu, Qingli; Simon, James E.; Janle, Elsa M.; Lobo, Jessica; Ferruzzi, Mario G.; Davies, Peter; Marambaud, Philippe			AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-beta Peptide Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; DIETARY RESTRICTION; SIRT1 ACTIVATION; MOUSE MODEL; FOOD-INTAKE; IN-VIVO; AUTOPHAGY; HOMEOSTASIS; EXPRESSION; DEMENTIA	Alzheimer disease is an age-related neurodegenerative disorder characterized by amyloid-beta (A beta) peptide deposition into cerebral amyloid plaques. The natural polyphenol resveratrol promotes anti-aging pathways via the activation of several metabolic sensors, including the AMP-activated protein kinase (AMPK). Resveratrol also lowers A beta levels in cell lines; however, the underlying mechanism responsible for this effect is largely unknown. Moreover, the bioavailability of resveratrol in the brain remains uncertain. Here we show that AMPK signaling controls A beta metabolism and mediates the anti-amyloidogenic effect of resveratrol in non-neuronal and neuronal cells, including in mouse primary neurons. Resveratrol increased cytosolic calcium levels and promoted AMPK activation by the calcium/calmodulin-dependent protein kinase kinase-beta. Direct pharmacological and genetic activation of AMPK lowered extracellular A beta accumulation, whereas AMPK inhibition reduced the effect of resveratrol on A beta levels. Furthermore, resveratrol inhibited the AMPK target mTOR (mammalian target of rapamycin) to trigger autophagy and lysosomal degradation of A beta. Finally, orally administered resveratrol in mice was detected in the brain where it activated AMPK and reduced cerebral A beta levels and deposition in the cortex. These data suggest that resveratrol and pharmacological activation ofAMPKhave therapeutic potential against Alzheimer disease.	[Vingtdeux, Valerie; Giliberto, Luca; Zhao, Haitian; Chandakkar, Pallavi; Davies, Peter; Marambaud, Philippe] Feinstein Inst Med Res, N Shore LIJ, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY 11030 USA; [Wu, Qingli; Simon, James E.] Rutgers State Univ, Dept Plant Biol & Pathol, New Use Agr & Nat Plant Prod Program, New Brunswick, NJ 08901 USA; [Janle, Elsa M.; Ferruzzi, Mario G.] Purdue Univ, Dept Foods & Nutr, W Lafayette, IN 47907 USA; [Lobo, Jessica; Ferruzzi, Mario G.] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Davies, Peter; Marambaud, Philippe] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA	Northwell Health; Rutgers State University New Brunswick; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Yeshiva University; Albert Einstein College of Medicine	Marambaud, P (corresponding author), Feinstein Inst Med Res, N Shore LIJ, Litwin Zucker Res Ctr Study Alzheimers Dis, 350 Community Dr, Manhasset, NY 11030 USA.	philippe.marambaud@einstein.yu.edu	Vingtdeux, Valerie/C-2463-2012	Vingtdeux, Valerie/0000-0003-4550-503X; Marambaud, Philippe/0000-0002-8983-1497; Ferruzzi, Mario/0000-0003-1384-2672	National Institutes of Health [PO1 AT004511]; Alzheimer's Association; Institute for the Study of Aging; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG022102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); Institute for the Study of Aging; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 AT004511 (NCCAM Project 2; to P. M.). This work was also supported in part by the Alzheimer's Association (to P. M.) and the Institute for the Study of Aging (Alzheimer's Drug Discovery Foundation (to P. M.)).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertelli AAE, 1998, DRUG EXP CLIN RES, V24, P207; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Campos-Toimil M, 2007, EUR J PHARMACOL, V577, P91, DOI 10.1016/j.ejphar.2007.08.003; Canto C, 2009, CURR OPIN LIPIDOL, V20, P98, DOI 10.1097/MOL.0b013e328328d0a4; Carling D, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.124; Chen YM, 2009, P NATL ACAD SCI USA, V106, P3907, DOI 10.1073/pnas.0807991106; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Craft S, 2009, ARCH NEUROL-CHICAGO, V66, P300, DOI 10.1001/archneurol.2009.27; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Ferruzzi MG, 2009, J ALZHEIMERS DIS, V18, P113, DOI 10.3233/JAD-2009-1135; Giliberto L, 2009, J BIOL CHEM, V284, P9027, DOI 10.1074/jbc.M805685200; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Greer EL, 2009, AGING CELL, V8, P113, DOI 10.1111/j.1474-9726.2009.00459.x; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Ho L, 2009, J ALZHEIMERS DIS, V16, P59, DOI 10.3233/JAD-2009-0916; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Hwang JT, 2007, ANN NY ACAD SCI, V1095, P441, DOI 10.1196/annals.1397.047; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Jang JH, 2003, FREE RADICAL BIO MED, V34, P1100, DOI 10.1016/S0891-5849(03)00062-5; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Karuppagounder SS, 2009, NEUROCHEM INT, V54, P111, DOI 10.1016/j.neuint.2008.10.008; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Luchsinger JA, 2004, LANCET NEUROL, V3, P579, DOI 10.1016/S1474-4422(04)00878-6; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Marambaud P, 2005, GENES BRAIN BEHAV, V4, P134, DOI 10.1111/j.1601-183X.2005.00086.x; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Ono K, 2003, J NEUROCHEM, V87, P172, DOI 10.1046/j.1471-4159.2003.01976.x; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ramassamy C, 2006, EUR J PHARMACOL, V545, P51, DOI 10.1016/j.ejphar.2006.06.025; Riviere C, 2007, BIOORGAN MED CHEM, V15, P1160, DOI 10.1016/j.bmc.2006.09.069; Roura E, 2005, J AGR FOOD CHEM, V53, P6190, DOI 10.1021/jf050377u; Saeedi R, 2008, AM J PHYSIOL-HEART C, V294, pH2497, DOI 10.1152/ajpheart.00873.2007; Sareen D, 2007, MOL PHARMACOL, V72, P1466, DOI 10.1124/mol.107.039040; Savaskan E, 2003, GERONTOLOGY, V49, P380, DOI 10.1159/000073766; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437; Thomson DM, 2008, J APPL PHYSIOL, V104, P429, DOI 10.1152/japplphysiol.00900.2007; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Turnley AM, 1999, J NEUROCHEM, V72, P1707, DOI 10.1046/j.1471-4159.1999.721707.x; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; UM JH, 2009, DIABETES IN PRESS; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com; Wilquet V, 2004, CURR OPIN NEUROBIOL, V14, P582, DOI 10.1016/j.conb.2004.08.001; Yilmaz Y, 2004, J AGR FOOD CHEM, V52, P255, DOI 10.1021/jf030117h; Zang MW, 2006, DIABETES, V55, P2180, DOI 10.2337/db05-1188; Zhao Haitian, 2008, BMC Res Notes, V1, P38, DOI 10.1186/1756-0500-1-38; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397	74	474	487	5	90	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9100	9113		10.1074/jbc.M109.060061	http://dx.doi.org/10.1074/jbc.M109.060061			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080969	Green Published, hybrid			2022-12-27	WOS:000275553700060
J	Zhang, PZ; Wang, CJ; Gao, K; Wang, DJ; Mao, J; An, J; Xu, C; Wu, D; Yu, HX; Liu, JO; Yu, L				Zhang, Pingzhao; Wang, Chenji; Gao, Kun; Wang, Dejie; Mao, Jun; An, Jian; Xu, Chen; Wu, Di; Yu, Hongxiu; Liu, Jun O.; Yu, Long			The Ubiquitin Ligase Itch Regulates Apoptosis by Targeting Thioredoxin-interacting Protein for Ubiquitin-dependent Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-PROLIFERATION; BINDING PROTEIN-2; TXNIP; CANCER; VDUP1; CARCINOMA; FAMILY; GROWTH; SKIN	Thioredoxin interacting protein (TXNIP) was originally characterized as an endogenous inhibitor of thioredoxin, a key regulator in cellular redox homeostasis. TXNIP is also known to play important roles in tumor growth and metastasis, glucose and lipid metabolism. TXNIP expression is induced by various stress stimuli. However, it has been unclear how TXNIP is down-regulated. Here, we report that TXNIP undergoes proteasomal degradation in cells. We identify Itch as the E3 ubiquitin ligase for TXNIP. We demonstrate that Itch mediates polyubiquitination of TXNIP both in vitro and in vivo. Overexpression of Itch leads to TXNIP proteasomal degradation. Knockdown of Itch by small interfering RNA causes an accumulation of the steady-state level of TXNIP. We also show that the PPXY motifs of TXNIP and the WW domains of Itch mediate their interaction. Furthermore, the Itch-TXNIP interaction regulates intracellular reactive oxygen species levels and apoptosis. These findings establish a new mechanism for the negative regulation of TXNIP by Itch and shed new light on the regulation of cellular redox homeostasis.	[Zhang, Pingzhao; Wang, Chenji; Wang, Dejie; Mao, Jun; An, Jian; Xu, Chen; Wu, Di; Yu, Long] Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Pingzhao; Yu, Hongxiu; Yu, Long] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Gao, Kun] Sichuan Univ, W China Hosp, Key Lab Transplant Engn & Immunol, Minist Hlth, Chengdu 610041, Peoples R China; [Liu, Jun O.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Liu, Jun O.] Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Fudan University; Fudan University; Sichuan University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Yu, L (corresponding author), Fudan Univ, Inst Genet, Sch Life Sci, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.	longyu@fudan.edu.cn	Wang, Dejie/AAJ-9461-2020	Wu, Di/0000-0003-4941-563X	National 973 Program of China [2004CB518605]; National 863 Project of China [2006AA020501]; National Key Sci-Tech Special Project of China [2008ZX10002-020]; Shanghai Municipal Science and Technology Commission [03dz14086]; Changjiang Visiting Scholars Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020501] Funding Source: NIH RePORTER	National 973 Program of China(National Basic Research Program of China); National 863 Project of China(National High Technology Research and Development Program of China); National Key Sci-Tech Special Project of China; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); Changjiang Visiting Scholars Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National 973 Program of China Grant 2004CB518605, National 863 Project of China Grant 2006AA020501, National Key Sci-Tech Special Project of China Grant 2008ZX10002-020, Project of the Shanghai Municipal Science and Technology Commission Grant 03dz14086, and the Changjiang Visiting Scholars Program.	Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Champliaud MF, 2003, J INVEST DERMATOL, V121, P781, DOI 10.1046/j.1523-1747.2003.12539.x; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Chung JW, 2006, J DERMATOL, V33, P662, DOI 10.1111/j.1346-8138.2006.00156.x; Chutkow WA, 2008, J BIOL CHEM, V283, P2397, DOI 10.1074/jbc.M708169200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Goldberg SF, 2003, CANCER RES, V63, P432; Hansen TM, 2007, BIOCHEM BIOPH RES CO, V361, P33, DOI 10.1016/j.bbrc.2007.06.104; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Hui TY, 2004, J BIOL CHEM, V279, P24387, DOI 10.1074/jbc.M401280200; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Ishihara T, 2008, CANCER SCI, V99, P1940, DOI 10.1111/j.1349-7006.2008.00900.x; Kaimul AM, 2007, FREE RADICAL BIO MED, V43, P861, DOI 10.1016/j.freeradbiomed.2007.05.032; Kim KY, 2004, BIOCHEM BIOPH RES CO, V315, P369, DOI 10.1016/j.bbrc.2004.01.047; Kim SY, 2007, CELL MOL IMMUNOL, V4, P345; Kisselev AF, 2001, CHEM BIOL, V8, P739, DOI 10.1016/S1074-5521(01)00056-4; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Meierhofer D, 2008, J PROTEOME RES, V7, P4566, DOI 10.1021/pr800468j; Melino G, 2008, CELL DEATH DIFFER, V15, P1103, DOI 10.1038/cdd.2008.60; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Nakamura H, 2006, SEMIN CANCER BIOL, V16, P444, DOI 10.1016/j.semcancer.2006.09.001; Nishinaka Y, 2004, J BIOL CHEM, V279, P37559, DOI 10.1074/jbc.M405473200; Oka S, 2006, FASEB J, V20, pA45, DOI 10.1096/fj.05-4439fje; Pan Y, 2003, MOL CELL BIOL, V23, P5113, DOI 10.1128/MCB.23.15.5113-5121.2003; Parikh H, 2007, PLOS MED, V4, P868, DOI 10.1371/journal.pmed.0040158; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Rossi M, 2006, P NATL ACAD SCI USA, V103, P12753, DOI 10.1073/pnas.0603449103; Schulze PC, 2002, CIRC RES, V91, P689, DOI 10.1161/01.RES.0000037982.55074.F6; Sheth SS, 2006, ONCOGENE, V25, P3528, DOI 10.1038/sj.onc.1209394; Stoltzman CA, 2008, P NATL ACAD SCI USA, V105, P6912, DOI 10.1073/pnas.0712199105; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wang Z, 2006, ONCOGENE, V25, P1903, DOI 10.1038/sj.onc.1209218; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yoshioka J, 2006, ANTIOXID REDOX SIGN, V8, P2143, DOI 10.1089/ars.2006.8.2143	38	79	82	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8869	8879		10.1074/jbc.M109.063321	http://dx.doi.org/10.1074/jbc.M109.063321			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20068034	Green Published, hybrid			2022-12-27	WOS:000275553700038
J	Carver, KC; Piazza, TM; Schuler, LA				Carver, Kristopher C.; Piazza, Timothy M.; Schuler, Linda A.			Prolactin Enhances Insulin-like Growth Factor I Receptor Phosphorylation by Decreasing Its Association with the Tyrosine Phosphatase SHP-2 in MCF-7 Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; PDGF-BETA-RECEPTOR; SRC FAMILY KINASES; MAMMARY NEOPLASIA; IGF-I; MEDIATED ENDOCYTOSIS; INDUCED ACTIVATION; EPITHELIAL-CELLS; FACTOR-ALPHA; PROTEIN	Normal mammary development requires coordinated interactions of numerous factors, including prolactin (PRL) and insulin-like growth factor I (IGF-I), both of which have also been implicated in breast cancer pathogenesis and progression. We previously reported that PRL and IGF-I synergize in breast cancer cells to activate ERK1/2 and AKT, leading to increased proliferation, survival, and invasion. Intriguingly, PRL co-treatment with IGF-I augments IGF-I receptor (IGFIR) phosphorylation 2-fold higher than IGF-I alone. Here, we showed the importance of the tyrosine phosphatase SHP-2 in this cross-talk using pharmacological inhibition and small interfering RNA. SHP-2 recruitment to IGF-IR was significantly attenuated by PRL co-treatment. Src family kinase activity was required for IGF-IR association with SHP-2, ligand-induced IGF-IR internalization, and PRL-enhanced IGF-IR phosphorylation. Inhibition of internalization, via knockdown of the GTPase, dynamin-2, prevented not only IGF-IR dephosphorylation, but also PRL-enhanced IGF-IR phosphorylation. Consistently, PRL diminished IGF-I-induced IGF-IR internalization, which may result from reduced SHP-2 association with IGF-IR, because we demonstrated an essential role for SHP-2 in IGF-IR internalization. Together, these findings describe a novel mechanism of cross- talk between PRL and IGF-I in breast cancer cells, with implications for our understanding of tumor progression and potential therapeutic strategies.	[Schuler, Linda A.] Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA; [Carver, Kristopher C.; Schuler, Linda A.] Univ Wisconsin, Cellular & Mol Biol Program, Madison, WI 53706 USA; [Carver, Kristopher C.; Schuler, Linda A.] Univ Wisconsin, Biotechnol Training Program, Madison, WI 53706 USA; [Piazza, Timothy M.; Schuler, Linda A.] Univ Wisconsin, Comparat Biomed Sci Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Schuler, LA (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, 2015 Linden Dr, Madison, WI 53706 USA.	schulerl@svm.vetmed.wisc.edu			National Institutes of Health [CA78312, DK62783, T32 GM08349]; NATIONAL CANCER INSTITUTE [R01CA078312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA78312 and DK62783 (to L. A. S.) and T32 GM08349 (to K. C. C.).	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Ali S, 2000, J BIOL CHEM, V275, P39073, DOI 10.1074/jbc.M007478200; Arendt LM, 2008, J MAMMARY GLAND BIOL, V13, P29, DOI 10.1007/s10911-008-9073-9; Arendt LM, 2008, AM J PATHOL, V172, P194, DOI 10.2353/ajpath.2008.070597; Arendt LM, 2009, AM J PATHOL, V174, P1065, DOI 10.2353/ajpath.2009.080719; Arendt LM, 2006, AM J PATHOL, V168, P1365, DOI 10.2353/ajpath.2006.050861; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Calvocoressi L, 2008, CANCER-AM CANCER SOC, V112, P473, DOI 10.1002/cncr.23210; Carver KC, 2008, MOL CANCER RES, V6, P634, DOI 10.1158/1541-7786.MCR-07-2069; Casa AJ, 2008, FRONT BIOSCI-LANDMRK, V13, P3273, DOI 10.2741/2925; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; CLEVENGER CV, 1994, MOL ENDOCRINOL, V8, P674, DOI 10.1210/me.8.6.674; Coyne CB, 2007, EMBO J, V26, P4016, DOI 10.1038/sj.emboj.7601831; Di Guglielmo GM, 1998, MOL CELL BIOCHEM, V182, P59, DOI 10.1023/A:1006883311233; Edderkaoui M, 2007, J BIOL CHEM, V282, P26646, DOI 10.1074/jbc.M702836200; Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668; Fukada T, 1996, IMMUNITY, V5, P449, DOI 10.1016/S1074-7613(00)80501-4; GRONBORG M, 1993, J BIOL CHEM, V268, P23435; Gutzman JH, 2005, MOL ENDOCRINOL, V19, P1765, DOI 10.1210/me.2004-0339; Hadsell DL, 2000, J MAMMARY GLAND BIOL, V5, P19, DOI 10.1023/A:1009559014703; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; HERNANDEZSANCHEZ C, 1995, J BIOL CHEM, V270, P29176, DOI 10.1074/jbc.270.49.29176; Huang Y, 2006, ONCOGENE, V25, P7565, DOI 10.1038/sj.onc.1209740; Johnston SRD, 2007, J STEROID BIOCHEM, V106, P180, DOI 10.1016/j.jsbmb.2007.05.019; Jones R, 2008, J MAMMARY GLAND BIOL, V13, P407, DOI 10.1007/s10911-008-9097-1; Kapur S, 2005, J BIOL CHEM, V280, P20163, DOI 10.1074/jbc.M501460200; KAZLAUSKAS A, 1993, P NATL ACAD SCI USA, V90, P6939, DOI 10.1073/pnas.90.15.6939; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Kim HY, 2006, J BIOL CHEM, V281, P11872, DOI 10.1074/jbc.M511706200; Kim HJ, 2007, MOL CELL BIOL, V27, P3165, DOI 10.1128/MCB.01315-06; Kiyan J, 2009, EXP CELL RES, V315, P1029, DOI 10.1016/j.yexcr.2008.12.011; KLINGHOFFER RA, 1995, J BIOL CHEM, V270, P22208, DOI 10.1074/jbc.270.38.22208; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Kuemmerle JF, 2006, AM J PHYSIOL-GASTR L, V290, pG1194, DOI 10.1152/ajpgi.00345.2005; Kwon M, 2006, ENDOCRINOLOGY, V147, P1458, DOI 10.1210/en.2005-1115; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lann D, 2008, J MAMMARY GLAND BIOL, V13, P371, DOI 10.1007/s10911-008-9100-x; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; LECHLEIDER RJ, 1993, J BIOL CHEM, V268, P21478; Ling Y, 2005, MOL BIOL CELL, V16, P3353, DOI 10.1091/mbc.E04-10-0918; Maile LA, 2003, CIRC RES, V93, P925, DOI 10.1161/01.RES.0000101754.33652.B7; Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200; Maile LA, 2002, ENDOCRINOLOGY, V143, P4259, DOI 10.1210/en.2002-220395; Marshman E, 2002, BREAST CANCER RES, V4, P231, DOI 10.1186/bcr535; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Mohi MG, 2007, CURR OPIN GENET DEV, V17, P23, DOI 10.1016/j.gde.2006.12.011; Monami G, 2008, J CELL PHYSIOL, V216, P426, DOI 10.1002/jcp.21405; Nakata S, 2007, J BIOL CHEM, V282, P37815, DOI 10.1074/jbc.M707461200; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Perry JK, 2008, J MAMMARY GLAND BIOL, V13, P131, DOI 10.1007/s10911-008-9070-z; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Piazza TM, 2009, MOL ENDOCRINOL, V23, P202, DOI 10.1210/me.2008-0341; PRAGER D, 1994, J BIOL CHEM, V269, P11934; Qu CK, 2002, BBA-MOL CELL RES, V1592, P297, DOI 10.1016/S0167-4889(02)00322-1; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Romanelli RJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704309200; Ronnstrand L, 1999, ONCOGENE, V18, P3696, DOI 10.1038/sj.onc.1202705; Rowzee A, 2008, J MAMMARY GLAND BIOL, V13, P361, DOI 10.1007/s10911-008-9102-8; Sachdev D, 2006, CANCER RES, V66, P2391, DOI 10.1158/0008-5472.CAN-05-3126; Sachdev D, 2007, MOL CANCER THER, V6, P1, DOI 10.1158/1535-7163.MCT-06-0080; Sachdev D, 2008, J MAMMARY GLAND BIOL, V13, P431, DOI 10.1007/s10911-008-9105-5; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Schroeder MD, 2002, MOL ENDOCRINOL, V16, P45, DOI 10.1210/me.16.1.45; Shen MR, 2006, CARCINOGENESIS, V27, P962, DOI 10.1093/carcin/bgi336; Shen Q, 2007, ENDOCRINOLOGY, V148, P4536, DOI 10.1210/en.2007-0513; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; Tworoger SS, 2008, J MAMMARY GLAND BIOL, V13, P41, DOI 10.1007/s10911-008-9063-y; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Wang N, 2006, J BIOL CHEM, V281, P21878, DOI 10.1074/jbc.M605018200; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Yamasaki Y, 2007, BIOCHEM BIOPH RES CO, V361, P7, DOI 10.1016/j.bbrc.2007.06.159; Zhang J, 1997, J BIOL CHEM, V272, P27005, DOI 10.1074/jbc.272.43.27005	75	23	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8003	8012		10.1074/jbc.M109.066480	http://dx.doi.org/10.1074/jbc.M109.066480			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20080972	Green Published, hybrid			2022-12-27	WOS:000275413800018
J	Shinohara, M; Ybanez, MD; Win, S; Than, TA; Jain, S; Gaarde, WA; Han, D; Kaplowitz, N				Shinohara, Mie; Ybanez, Maria D.; Win, Sanda; Than, Tin Aung; Jain, Shilpa; Gaarde, William A.; Han, Derick; Kaplowitz, Neil			Silencing Glycogen Synthase Kinase-3 beta Inhibits Acetaminophen Hepatotoxicity and Attenuates JNK Activation and Loss of Glutamate Cysteine Ligase and Myeloid Cell Leukemia Sequence 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; INDUCED LIVER-INJURY; MITOCHONDRIAL PERMEABILITY TRANSITION; GAMMA-GLUTAMYLCYSTEINE SYNTHETASE; PRIMARY MOUSE HEPATOCYTES; TNF-INDUCED APOPTOSIS; DIRECT PHOSPHORYLATION; MURINE HEPATOCYTES; GLUTATHIONE; METABOLISM	Previously we demonstrated that c-Jun N-terminal kinase (JNK) plays a central role in acetaminophen (APAP)-induced liver injury. In the current work, we examined other possible signaling pathways that may also contribute to APAP hepatotoxicity. APAP treatment to mice caused glycogen synthase kinase-3 beta (GSK-3 beta) activation and translocation to mitochondria during the initial phase of APAP-induced liver injury (similar to 1 h). The silencing of GSK-3 beta, but not Akt-2 (protein kinase B) or glycogen synthase kinase-3 beta (GSK-3 beta), using antisense significantly protected mice from APAP-induced liver injury. The silencing of GSK-3 beta affected several key pathways important in conferring protection against APAP-induced liver injury. APAP treatment was observed to promote the loss of glutamate cysteine ligase (GCL, rate-limiting enzyme in GSH synthesis) in liver. The silencing of GSK-3 beta decreased the loss of hepatic GCL, and promoted greater GSH recovery in liver following APAP treatment. Silencing JNK1 and -2 also prevented the loss of GCL. APAP treatment also resulted in GSK-3 beta translocation to mitochondria and the degradation of myeloid cell leukemia sequence 1 (Mcl-1) in mitochondrial membranes in liver. The silencing of GSK-3 beta reduced Mcl-1 degradation caused by APAP treatment. The silencing of GSK-3 beta also resulted in an inhibition of the early phase (0-2 h), and blunted the late phase (after 4 h) of JNK activation and translocation to mitochondria in liver following APAP treatment. Taken together our results suggest that activation of GSK-3 beta is a key mediator of the initial phase of APAP-induced liver injury through modulating GCL and Mcl-1 degradation, as well as JNK activation in liver.	[Shinohara, Mie; Ybanez, Maria D.; Win, Sanda; Than, Tin Aung; Jain, Shilpa; Han, Derick; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90089 USA; [Gaarde, William A.] ISIS Pharmaceut, Carlsbad, CA 92008 USA	University of Southern California; Isis Pharmaceuticals Inc	Kaplowitz, N (corresponding author), 2011 Zonal Ave,HMR 101, Los Angeles, CA 90089 USA.	kaplowit@usc.edu			National Institutes of Health [DK067215, AA016911]; Zumberge award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522, R01DK067215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K01AA016911] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Zumberge award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants DK067215 (to N.K.) and AA016911 (to D. H.). This work was also supported by a Zumberge award (Office of the Provost at the University of Southern California; to D. H.).	Aoki H, 2002, J BIOL CHEM, V277, P10244, DOI 10.1074/jbc.M112355200; Bajt ML, 2008, J PHARMACOL EXP THER, V324, P8, DOI 10.1124/jpet.107.129445; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; Copple IM, 2008, HEPATOLOGY, V48, P1292, DOI 10.1002/hep.22472; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franklin CC, 2003, FASEB J, V17, P1535, DOI 10.1096/fj.02-0867fje; Goldring CEP, 2004, HEPATOLOGY, V39, P1267, DOI 10.1002/hep.20183; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Gunawan BK, 2006, GASTROENTEROLOGY, V131, P165, DOI 10.1053/j.gastro.2006.03.045; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; HAN D, 2009, HDB EXP PHARM, V196, P267; Han D, 2006, FREE RADICAL BIO MED, V41, P627, DOI 10.1016/j.freeradbiomed.2006.05.002; Han D, 2009, ANTIOXID REDOX SIGN, V11, P2245, DOI [10.1089/ars.2009.2611, 10.1089/ARS.2009.2611]; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Hinson JA, 2004, DRUG METAB REV, V36, P805, DOI 10.1081/DMR-200033494; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Iles KE, 2005, FREE RADICAL BIO MED, V38, P547, DOI 10.1016/j.freeradbiomed.2004.11.012; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Juhaszova M, 2004, J CLIN INVEST, V113, P1535, DOI 10.1172/JCI200419906; Kaplowitz N, 2005, NAT REV DRUG DISCOV, V4, P489, DOI 10.1038/nrd1750; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Kaplowitz N, 2008, GASTROENTEROLOGY, V135, P1047, DOI 10.1053/j.gastro.2008.08.031; Kim JW, 2003, J BIOL CHEM, V278, P13995, DOI 10.1074/jbc.M300253200; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; LASKIN DL, 1995, HEPATOLOGY, V21, P1045, DOI 10.1002/hep.1840210424; Linseman DA, 2004, J NEUROSCI, V24, P9993, DOI 10.1523/JNEUROSCI.2057-04.2004; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Matsumaru K, 2003, HEPATOLOGY, V37, P1425, DOI 10.1053/jhep.2003.50230; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; MEISTER A, 1995, METHOD ENZYMOL, V251, P3, DOI 10.1016/0076-6879(95)51106-7; Michael SL, 1999, HEPATOLOGY, V30, P186, DOI 10.1002/hep.510300104; Mishra R, 2007, J BIOL CHEM, V282, P30393, DOI 10.1074/jbc.M705895200; Miura T, 2009, J PHARMACOL SCI, V109, P162, DOI 10.1254/jphs.08R27FM; Nakagawa H, 2008, GASTROENTEROLOGY, V135, P1311, DOI 10.1053/j.gastro.2008.07.006; Masahiro N, 2007, J MOL CELL CARDIOL, V43, P564, DOI 10.1016/j.yjmcc.2007.08.010; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; PARK YJ, 1988, TOXICOLOGY, V52, P165, DOI 10.1016/0300-483X(88)90202-8; Pastorino JG, 2005, CANCER RES, V65, P10545, DOI 10.1158/0008-5472.CAN-05-1925; Saberi B, 2008, AM J PHYSIOL-CELL PH, V295, pC50, DOI 10.1152/ajpcell.90654.2007; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; SEELIG GF, 1985, METHOD ENZYMOL, V113, P379; Sumi D, 2007, TOXICOL APPL PHARM, V223, P218, DOI 10.1016/j.taap.2007.06.001; Vick B, 2009, HEPATOLOGY, V49, P627, DOI 10.1002/hep.22664; Warr MR, 2008, CURR MOL MED, V8, P138; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	49	84	88	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8244	8255		10.1074/jbc.M109.054999	http://dx.doi.org/10.1074/jbc.M109.054999			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061376	hybrid, Green Published			2022-12-27	WOS:000275413800043
J	Sun, WJ; Ge, NL; Yu, Y; Burlingame, S; Li, XN; Zhang, M; Ye, SL; Fu, SB; Yang, JH				Sun, Wenjing; Ge, Ningling; Yu, Yang; Burlingame, Susan; Li, Xiaonan; Zhang, Ming; Ye, Shenglong; Fu, Songbin; Yang, Jianhua			Phosphorylation of Thr-516 and Ser-520 in the Kinase Activation Loop of MEKK3 Is Required for Lysophosphatidic Acid-mediated Optimal I kappa B Kinase beta (IKK beta)/Nuclear Factor-kappa B (NF-kappa B) Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; IKK-BETA; ALPHA; IDENTIFICATION; ASSOCIATION; RECEPTOR; SUBUNIT; BCL10	MEKK3 serves as a critical intermediate signaling molecule in lysophosphatidic acid-mediated nuclear factor-kappa B (NF-kappa B) activation. However, the precise regulation for MEKK3 activation at the molecular level is still not fully understood. Here we report the identification of two regulatory phosphorylation sites at Thr-516 and Ser-520 within the kinase activation loop that is essential for MEKK3-mediated I kappa B kinase beta (IKK beta)/NF-kappa B activation. Substitution of these two residues with alanine abolished the ability of MEKK3 to activate IKK beta/NF-kappa B, whereas replacement with acidic residues rendered MEKK3 constitutively active. Furthermore, substitution of these two residues with alanine abolished the ability of MEKK3 to mediate lysophosphatidic acid-induced optimal IKK beta/NF-kappa B activation.	[Sun, Wenjing; Ge, Ningling; Yu, Yang; Burlingame, Susan; Li, Xiaonan; Zhang, Ming; Yang, Jianhua] Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Sun, Wenjing; Yu, Yang; Fu, Songbin] Harbin Med Univ, Med Genet Lab, Harbin 150081, Peoples R China; [Ge, Ningling; Ye, Shenglong] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai 200032, Peoples R China	Baylor College of Medicine; Texas Children's Cancer Center; Harbin Medical University; Fudan University	Yang, JH (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, Dept Pediat, Texas Childrens Canc Ctr, 1 Baylor Plaza,BCM320,6621 Fannin St,MC 3-3320, Houston, TX 77030 USA.	jianhuay@bcm.edu			National Institutes of Health NCI [1R21CA106513-01A2]; American Cancer Society [RSG-06-070-01-TBE]; Virginia and L. E. Simmons Family Foundation Collaborative Research Fund; NATIONAL CANCER INSTITUTE [R21CA106513] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Virginia and L. E. Simmons Family Foundation Collaborative Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R21CA106513-01A2 (to J. Y.) from NCI. This work was also supported by Research Scholar Grant RSG-06-070-01-TBE (to J. Y.) from the American Cancer Society and the Virginia and L. E. Simmons Family Foundation Collaborative Research Fund (to J. Y.).	Adams DG, 2002, ARCH BIOCHEM BIOPHYS, V407, P103, DOI 10.1016/S0003-9861(02)00464-2; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; BEG AA, 1993, GENE DEV, V7, P2064, DOI 10.1101/gad.7.11.2064; Cummings R, 2004, J BIOL CHEM, V279, P41085, DOI 10.1074/jbc.M404045200; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Fritz A, 2006, J BIOL CHEM, V281, P6236, DOI 10.1074/jbc.M509249200; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Klemm S, 2007, P NATL ACAD SCI USA, V104, P134, DOI 10.1073/pnas.0608388103; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; May MJ, 1998, IMMUNOL TODAY, V19, P80, DOI 10.1016/S0167-5699(97)01197-3; McAllister-Lucas LM, 2007, P NATL ACAD SCI USA, V104, P139, DOI 10.1073/pnas.0601947103; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Schmidt C, 2003, MOL CELL, V12, P1287, DOI 10.1016/S1097-2765(03)00390-3; Sun JY, 2008, P NATL ACAD SCI USA, V105, P17085, DOI 10.1073/pnas.0802701105; Sun WJ, 2009, CELL SIGNAL, V21, P1488, DOI 10.1016/j.cellsig.2009.05.007; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang DH, 2007, P NATL ACAD SCI USA, V104, P145, DOI 10.1073/pnas.0601894104; Woronicz JD, 1997, SCIENCE, V278, P866, DOI 10.1126/science.278.5339.866; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X; Yang JH, 2001, NAT IMMUNOL, V2, P620, DOI 10.1038/89769; Yang JH, 2003, J BIOL CHEM, V278, P16797, DOI 10.1074/jbc.M211060200; Ye RD, 2001, J LEUKOCYTE BIOL, V70, P839; Zandi E, 1997, CELL, V91, P243, DOI 10.1016/S0092-8674(00)80406-7; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhao Q, 1999, J BIOL CHEM, V274, P8355, DOI 10.1074/jbc.274.13.8355	31	9	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					7911	7918		10.1074/jbc.M109.051219	http://dx.doi.org/10.1074/jbc.M109.051219			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068038	Green Published, hybrid			2022-12-27	WOS:000275413800008
J	Siarheyeva, A; Liu, R; Sharom, FJ				Siarheyeva, Alena; Liu, Ronghua; Sharom, Frances J.			Characterization of an Asymmetric Occluded State of P-glycoprotein with Two Bound Nucleotides IMPLICATIONS FOR CATALYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER HLYB; ATP-BINDING; MULTIDRUG TRANSPORTER; DRUG-BINDING; ADENOSINE-TRIPHOSPHATASE; SULFOLOBUS-SOLFATARICUS; GLUTAMATE RESIDUES; TRANSITION-STATE; HYDROLYSIS; DOMAIN	P-glycoprotein (ABCB1), a member of the ABC superfamily, functions as an ATP-driven multidrug efflux pump. The catalytic cycle of ABC proteins is believed to involve formation of a sandwich dimer in which two ATP molecules are bound at the interface of the nucleotide binding domains (NBDs). However, such dimers have only been observed in isolated NBD subunits and catalytically arrested mutants, and it is still not understood how ATP hydrolysis is coordinated between the two NBDs. We report for the first time the characterization of an asymmetric state of catalytically active native P-glycoprotein with two bound molecules of adenosine 5'-(gamma-thio) triphosphate (ATP gamma S), one of low affinity (K-d 0.74 mM), and one "occluded" nucleotide of 120-fold higher affinity (K-d 6 mu M). ATP gamma S also interacts with P-glycoprotein with high affinity as assessed by inhibition of ATP hydrolysis and protection from covalent labeling of a Walker A Cys residue, whereas other non-hydrolyzable ATP analogues do not. Binding of ATP gamma S (but not ATP) causes Trp residue heterogeneity, as indicated by collisional quenching, suggesting that it may induce conformational asymmetry. Asymmetric ATP gamma S-bound P-glycoprotein does not display reduced binding affinity for drugs, implying that transport is not driven by ATP binding and likely takes place at a later stage of the catalytic cycle. We propose that this asymmetric state with two bound nucleotides represents the next intermediate on the path toward ATP hydrolysis after nucleotide binding, and an alternating sites mode of action is achieved by simultaneous switching of the two active sites between high and low affinity states.	[Siarheyeva, Alena; Liu, Ronghua; Sharom, Frances J.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Sharom, FJ (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Sci Complex Rm 2255, Guelph, ON N1G 2W1, Canada.	fsharom@uoguelph.ca	Sharom, Frances/A-1613-2010	Sharom, Frances/0000-0002-9521-5367	Canadian Cancer Society	Canadian Cancer Society(Canadian Cancer Society (CCS))	This work was supported by a research grant from the Canadian Cancer Society.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRONNIKOV GE, 1983, ANAL BIOCHEM, V131, P69, DOI 10.1016/0003-2697(83)90136-7; Callaghan R, 2006, FEBS LETT, V580, P1056, DOI 10.1016/j.febslet.2005.11.083; Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200; Dassa E, 2001, RES MICROBIOL, V152, P211, DOI 10.1016/S0923-2508(01)01194-9; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jones PM, 1999, FEMS MICROBIOL LETT, V179, P187, DOI 10.1111/j.1574-6968.1999.tb08727.x; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; Liu RH, 2000, BIOCHEMISTRY-US, V39, P14927, DOI 10.1021/bi0018786; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lu G, 2005, P NATL ACAD SCI USA, V102, P17969, DOI 10.1073/pnas.0506039102; Lugo MR, 2009, ARCH BIOCHEM BIOPHYS, V492, P17, DOI 10.1016/j.abb.2009.10.002; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; Neumann L, 2002, J MOL BIOL, V324, P965, DOI 10.1016/S0022-2836(02)01148-8; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oloo EO, 2006, J BIOL CHEM, V281, P28397, DOI 10.1074/jbc.M513614200; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Payen L, 2005, MOL PHARMACOL, V67, P1944, DOI 10.1124/mol.104.007708; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pretz MG, 2006, BIOCHEMISTRY-US, V45, P15056, DOI 10.1021/bi061230e; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; QUAY SC, 1985, J BIOL CHEM, V260, P5055; Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u; Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q; Russell PL, 2006, BIOCHEM J, V399, P315, DOI 10.1042/BJ20060015; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Sauna ZE, 2007, MOL CANCER THER, V6, P13, DOI 10.1158/1535-7163.MCT-06-0155; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Senior AE, 1998, ACTA PHYSIOL SCAND, V163, P213; Sharom FJ, 1999, BBA-BIOMEMBRANES, V1461, P327, DOI 10.1016/S0005-2736(99)00166-2; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; SHAROM FJ, 2007, DRUG TRANSPORTERS MO, P223, DOI DOI 10.1002/9780470140505.CH10; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; STEKHOVEN FMAHS, 1984, BIOCHIM BIOPHYS ACTA, V774, P277; Tmej C, 1998, ARCH PHARM, V331, P233, DOI 10.1002/(SICI)1521-4184(199807)331:7/8<233::AID-ARDP233>3.0.CO;2-2; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008; URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956; Verdon G, 2003, J MOL BIOL, V334, P255, DOI 10.1016/j.jmb.2003.08.065; YASUOKA K, 1982, J BIOCHEM-TOKYO, V91, P1629, DOI 10.1093/oxfordjournals.jbchem.a133854; Zaitseva J, 2005, BIOCHEM SOC T, V33, P990, DOI 10.1042/BST0330990; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208; Zhou SF, 2008, XENOBIOTICA, V38, P802, DOI 10.1080/00498250701867889 	63	91	91	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7575	7586		10.1074/jbc.M109.047290	http://dx.doi.org/10.1074/jbc.M109.047290			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20061384	Green Published, hybrid			2022-12-27	WOS:000275415600069
J	Phillips, G; Chikwana, VM; Maxwell, A; El-Yacoubi, B; Swairjo, MA; Iwata-Reuyl, D; de Crecy-Lagard, V				Phillips, Gabriela; Chikwana, Vimbai M.; Maxwell, Adrienne; El-Yacoubi, Basma; Swairjo, Manal A.; Iwata-Reuyl, Dirk; de Crecy-Lagard, Valerie			Discovery and Characterization of an Amidinotransferase Involved in the Modification of Archaeal tRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTTRANSCRIPTIONAL MODIFICATION; GUANINE TRANSGLYCOSYLASE; HALOBACTERIUM-VOLCANII; THERMOPHILIC ARCHAEA; AMINO-ACIDS; BIOSYNTHESIS; BINDING; RECOGNITION; TOYOCAMYCIN; NUCLEOSIDES	The presence of the 7-deazaguanosine derivative archaeosine (G(+)) at position 15 in tRNA is one of the diagnostic molecular characteristics of the Archaea. The biosynthesis of this modified nucleoside is especially complex, involving the initial production of 7-cyano-7-deazaguanine (preQ(0)), an advanced precursor that is produced in a tRNA-independent portion of the biosynthesis, followed by its insertion into the tRNA by the enzyme tRNA-guanine transglycosylase (arcTGT), which replaces the target guanine base yielding preQ(0)-tRNA. The enzymes responsible for the biosynthesis of preQ(0) were recently identified, but the enzyme(s) catalyzing the conversion of preQ(0)-tRNA to G(+)-tRNA have remained elusive. Using a comparative genomics approach, we identified a protein family implicated in the late stages of archaeosine biosynthesis. Notably, this family is a paralog of arcTGT and is generally annotated as TgtA2. Structure-based alignments comparing arcTGT and TgtA2 reveal that TgtA2 lacks key arcTGT catalytic residues and contains an additional module. We constructed a Haloferax volcanii Delta tgtA2 derivative and demonstrated that tRNA from this strain lacks G(+) and instead accumulates preQ(0). We also cloned the corresponding gene from Methanocaldococcus jannaschii (mj1022) and characterized the purified recombinant enzyme. Recombinant MjTgtA2 was shown to convert preQ(0)-tRNA to G(+)-tRNA using several nitrogen sources and to do so in an ATP-independent process. This is the only example of the conversion of a nitrile to a formamidine known in biology and represents a new class of amidinotransferase chemistry.	[Chikwana, Vimbai M.; Iwata-Reuyl, Dirk] Portland State Univ, Dept Chem, Portland, OR 97207 USA; [de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol, Gainesville, FL 32611 USA; [de Crecy-Lagard, Valerie] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Swairjo, Manal A.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Portland State University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Sanford Burnham Prebys Medical Discovery Institute	Iwata-Reuyl, D (corresponding author), Portland State Univ, Dept Chem, POB 751, Portland, OR 97207 USA.	iwatareuyld@pdx.edu; vcrecy@ufl.edu	Swairjo, Manal/AAR-9137-2021; de Crecy-Lagard, Valerie/AAN-8995-2020		National Institutes of Health [GM70641]; National Science Foundation [MCB-05169448]; NASA [NNX07AJ26G]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070641] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM70641 (to V. C. L.), National Science Foundation Grant MCB-05169448 (to V. C. L.), and NASA Grant NNX07AJ26G (to D. I. R.).	Allers T, 2005, NAT REV GENET, V6, P58, DOI 10.1038/nrg1504; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aravind L, 1999, J MOL EVOL, V48, P291, DOI 10.1007/PL00006472; Bai Y, 2000, J BIOL CHEM, V275, P28731, DOI 10.1074/jbc.M002174200; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; EDMONDS CG, 1991, J BACTERIOL, V173, P3138, DOI 10.1128/JB.173.10.3138-3148.1991; Fukai S, 2003, RNA, V9, P100, DOI 10.1261/rna.2760703; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GREGSON JM, 1993, J BIOL CHEM, V268, P10076; GUPTA R, 1984, J BIOL CHEM, V259, P9461; GUPTA R, 1986, SYST APPL MICROBIOL, V7, P102, DOI 10.1016/S0723-2020(86)80131-X; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Ishitani R, 2003, CELL, V113, P383, DOI 10.1016/S0092-8674(03)00280-0; Iwata-Reuyl D, 2003, BIOORG CHEM, V31, P24, DOI 10.1016/S0045-2068(02)00513-8; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KUCHINO Y, 1976, NUCLEIC ACIDS RES, V3, P393, DOI 10.1093/nar/3.2.393; McCloskey J A, 2000, Nucleic Acids Symp Ser, P267; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; Oliva R, 2007, RNA, V13, P1427, DOI 10.1261/rna.574407; Ortlund E, 2000, BIOCHEMISTRY-US, V39, P1199, DOI 10.1021/bi991797d; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 1999, P NATL ACAD SCI USA, V96, P2896, DOI 10.1073/pnas.96.6.2896; Phillips G, 2008, J BACTERIOL, V190, P7876, DOI 10.1128/JB.00874-08; Sabina J, 2006, J BIOL CHEM, V281, P6993, DOI 10.1074/jbc.M512841200; Schneider KL, 2006, NUCLEIC ACIDS RES, V34, pD407, DOI 10.1093/nar/gkj134; SMULSON ME, 1967, J BIOL CHEM, V242, P2872; Sprinzl M., 1989, Nucleic Acids Research, V17, P1; SUHADOLN.RJ, 1970, J BIOL CHEM, V245, P4365; Tumbula DL, 2000, NATURE, V407, P106, DOI 10.1038/35024120; Uematsu T, 1975, Methods Enzymol, V43, P759; UEMATSU T, 1974, ARCH BIOCHEM BIOPHYS, V162, P614, DOI 10.1016/0003-9861(74)90223-9; Watanabe M, 1997, J BIOL CHEM, V272, P20146, DOI 10.1074/jbc.272.32.20146	33	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					12706	12713		10.1074/jbc.M110.102236	http://dx.doi.org/10.1074/jbc.M110.102236			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20129918	Green Published, hybrid			2022-12-27	WOS:000276787800029
J	Cole, LK; Vance, DE				Cole, Laura K.; Vance, Dennis E.			A Role for Sp1 in Transcriptional Regulation of Phosphatidylethanolamine N-Methyltransferase in Liver and 3T3-L1 Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; HORMONE RECEPTOR GENE; CELL-CYCLE; RAT-LIVER; FACTOR-BINDING; S-PHASE; EXPRESSION; ESTROGEN; PHOSPHATIDYLCHOLINE; ALPHA	Phosphatidylcholine is made in all nucleated mammalian cells via the CDP-choline pathway. Another major pathway for phosphatidylcholine biosynthesis in liver is catalyzed by phosphatidylethanolamine N-methyltransferase (PEMT). We have now identified 3T3-L1 adipocytes as a cell culture model that expresses PEMT endogenously. We have found that PEMT mRNA and protein levels increased dramatically in 3T3-L1 cells upon differentiation to adipocytes. 5'-Deletion analysis of the PEMT promoter-luciferase constructs stably expressed in 3T3-L1 adipocytes identified a regulatory region between -471 and -371 bp (relative to the transcriptional start site). Competitive and supershift assays demonstrated binding sites for transcription factors Sp1, Sp3 (-408 to -413), and YY1 (-417 to -420). During differentiation of 3T3-L1 cells to adipocytes, the amount of Sp1 protein decreased by similar to 50% just prior to activation of PEMT. Transduction of 3T3-L1 adipocytes with retrovirus containing Sp1 cDNA demonstrated that Sp1 inhibited PEMT transcriptional activity. Similarly, short hairpin RNA directed against Sp1 in 3T3-L1 adipocytes enhanced PEMT transcriptional activation. Chromatin immunoprecipitation assays confirmed that Sp1 binds to the PEMT promoter, and this interaction decreases upon differentiation to adipocytes. These experiments directly link increased PEMT expression in adipocytes to decreased transcriptional expression of Sp1. In addition, our data established that Sp1 binding was required for tamoxifen-mediated inhibition of Pemt promoter activity.	Univ Alberta, Grp Mol & Cell Biol Lipids, Edmonton, AB TG6 2S2, Canada; Univ Alberta, Dept Biochem, Edmonton, AB TG6 2S2, Canada	University of Alberta; University of Alberta		dennis.vance@ualberta.ca			Canadian Institutes of Health Research [MOP 5182]; Alberta Heritage Foundation for Medical Research; Natural Science and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Canadian Institutes of Health Research Grant MOP 5182.; Recipient of a studentship award from the Alberta Heritage Foundation for Medical Research and the Natural Science and Engineering Research Council of Canada.	Aoyama C, 2007, BBA-MOL CELL BIOL L, V1771, P1148, DOI 10.1016/j.bbalip.2007.07.003; Baker TK, 2001, CHEM RES TOXICOL, V14, P1218, DOI 10.1021/tx015518a; Banchio C, 2004, J BIOL CHEM, V279, P40220, DOI 10.1074/jbc.M406468200; Banchio C, 2003, J BIOL CHEM, V278, P32457, DOI 10.1074/jbc.M304810200; BREMER J, 1960, BIOCHIM BIOPHYS ACTA, V37, P173, DOI 10.1016/0006-3002(60)90104-9; Chang YC, 2001, MOL CELL BIOL, V21, P1121, DOI 10.1128/MCB.21.4.1121-1131.2001; Cui Z, 1997, BBA-LIPID LIPID MET, V1346, P10, DOI 10.1016/S0005-2760(97)00012-X; CUI Z, 1993, J BIOL CHEM, V268, P16655; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DERYCKERE F, 1994, BIOTECHNIQUES, V16, P405; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Dong S, 2007, MOL ENDOCRINOL, V21, P1617, DOI 10.1210/me.2006-0550; Douglas DN, 2001, J BIOL CHEM, V276, P25621, DOI 10.1074/jbc.M103874200; Feng DX, 2005, P NATL ACAD SCI USA, V102, P9896, DOI 10.1073/pnas.0502041102; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Houweling M, 1997, BBA-LIPID LIPID MET, V1346, P1, DOI 10.1016/S0005-2760(97)00011-8; Ince TA, 1995, J BIOL CHEM, V270, P30249, DOI 10.1074/jbc.270.51.30249; Jordan M, 2004, METHODS, V33, P136, DOI 10.1016/j.ymeth.2003.11.011; KLAUNIG JE, 1981, IN VITRO CELL DEV B, V17, P913; Kutoh E, 1999, CANCER LETT, V136, P187, DOI 10.1016/S0304-3835(98)00321-8; Lai KD, 2003, J BIOL CHEM, V278, P36418, DOI 10.1074/jbc.M303913200; LEE JS, 1993, P NATL ACAD SCI USA, V90, P6145, DOI 10.1073/pnas.90.13.6145; Lelliott CJ, 2005, FASEB J, V19, P1108, DOI 10.1096/fj.04-3196com; Levy N, 2008, MOL ENDOCRINOL, V22, P287, DOI 10.1210/me.2007-0340; Li ZY, 2006, CELL METAB, V3, P321, DOI 10.1016/j.cmet.2006.03.007; Li ZY, 2005, J BIOL CHEM, V280, P37798, DOI 10.1074/jbc.M508575200; Lin SY, 1996, MOL CELL BIOL, V16, P1668; Loria P, 2008, CLIN SCI, V115, P1, DOI 10.1042/CS20070311; MILLER DM, 1987, AM J MED SCI, V294, P388, DOI 10.1097/00000441-198711000-00015; Ngwenya S, 2003, ENDOCRINOLOGY, V144, P1675, DOI 10.1210/en.2002-0009; Noga AA, 2003, J BIOL CHEM, V278, P21851, DOI 10.1074/jbc.M301982200; Noga AA, 2002, J BIOL CHEM, V277, P42358, DOI 10.1074/jbc.M204542200; PELECH SL, 1983, CAN J BIOCHEM CELL B, V61, P1147, DOI 10.1139/o83-147; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Qin CH, 2004, MOL CARCINOGEN, V40, P160, DOI 10.1002/mc.20030; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; Resseguie M, 2007, FASEB J, V21, P2622, DOI 10.1096/fj.07-8227com; Roer K, 2002, BIOCHEM BIOPH RES CO, V294, P63, DOI 10.1016/S0006-291X(02)00440-0; Saadeh S, 2007, NUTR CLIN PRACT, V22, P1, DOI 10.1177/011542650702200101; Safe S, 2008, J MOL ENDOCRINOL, V41, P263, DOI 10.1677/JME-08-0103; Sesca E, 1996, BIOCHEM BIOPH RES CO, V229, P158, DOI 10.1006/bbrc.1996.1773; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Shields DJ, 2003, J BIOL CHEM, V278, P2956, DOI 10.1074/jbc.M210904200; Singh MN, 2008, MED SCI MONITOR, V14, pRA144; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; SUNDLER R, 1975, J BIOL CHEM, V250, P3359; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Vance D.E., 2008, BIOCH LIPIDS LIPOPRO, P214; VANCE DE, 1988, PROG LIPID RES, V27, P61, DOI 10.1016/0163-7827(88)90005-7; Walkey CJ, 1998, J BIOL CHEM, V273, P27043, DOI 10.1074/jbc.273.42.27043; Walkey CJ, 1996, J LIPID RES, V37, P2341; YOU JS, 2006, BIOCHEM BIOPH RES CO, V342, P1168; Zhang DP, 2006, COMP BIOCHEM PHYS A, V144, P306, DOI 10.1016/j.cbpa.2006.01.025; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zhao Y, 2009, ARTERIOSCL THROM VAS, V29, P1349, DOI 10.1161/ATVBAHA.109.188672	58	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11880	11891		10.1074/jbc.M110.109843	http://dx.doi.org/10.1074/jbc.M110.109843			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20150657	Green Published, hybrid			2022-12-27	WOS:000276787100016
J	Alegre-Cebollada, J; Badilla, CL; Fernandez, JM				Alegre-Cebollada, Jorge; Badilla, Carmen L.; Fernandez, Julio M.			Isopeptide Bonds Block the Mechanical Extension of Pili in Pathogenic Streptococcus pyogenes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE FORCE SPECTROSCOPY; GRAM-POSITIVE BACTERIA; CORYNEBACTERIUM-DIPHTHERIAE; STABILIZING ISOPEPTIDE; DISULFIDE BONDS; SINGLE-PROTEIN; TITIN; MICROSCOPY; ADHESION; MODULES	In the early stages of an infection, pathogenic bacteria use long fibrous structures known as pili as adhesive anchors for attachment to the host cells. These structures also play key roles in colony and biofilm formation. In all those processes, pili must withstand large mechanical forces. The pili of the nasty Gram-positive human pathogen Streptococcus pyogenes are assembled as single, micrometer long tandem modular proteins of covalently linked repeats of pilin proteins. Here we use single molecule force spectroscopy techniques to study the mechanical properties of the major pilin Spy0128. In our studies, we engineer polyproteins containing repeats of Spy0128 flanked by the well characterized I27 protein which provides an unambiguous mechanical fingerprint. We find that Spy0128 is an inextensible protein, even when pulled at forces of up to 800 pN. We also found that this remarkable mechanical resilience, unique among the modular proteins studied to date, results from the strategically located intramolecular isopeptide bonds recently identified in the x-ray structure of Spy0128. Removal of the isopeptide bonds by mutagenesis readily allowed Spy0128 domains to unfold and extend, albeit at relatively high forces of 172 pN (N-terminal domain) or 250 pN (C-terminal domain). Our results show that in contrast to the elastic roles played by large tandem modular proteins such as titin and fibronectin, the giant pili of S. pyogenes evolved to abrogate mechanical extensibility, a property that may be crucial in the pathogenesis of this most virulent bacterium and, therefore, become the target of new therapeutic approaches against its infections.	[Alegre-Cebollada, Jorge; Badilla, Carmen L.; Fernandez, Julio M.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Alegre-Cebollada, J (corresponding author), Columbia Univ, Dept Biol Sci, 1212 Amsterdam Ave, New York, NY 10027 USA.	ja2544@columbia.edu; jfernandez@columbia.edu	Alegre-Cebollada, Jorge/I-4301-2014	Alegre-Cebollada, Jorge/0000-0003-0542-0170	National Institutes of Health [HL66030, HL61228]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066030, R01HL061228] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL66030 and HL61228 (to J.M.F.).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Biais N, 2008, PLOS BIOL, V6, P907, DOI 10.1371/journal.pbio.0060087; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2006, J CLIN INVEST, V116, P2582, DOI 10.1172/JCI30088; Budzik JM, 2009, P NATL ACAD SCI USA, V106, P19992, DOI 10.1073/pnas.0910887106; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; Fallman E, 2005, EMBO REP, V6, P52, DOI 10.1038/sj.embor.7400310; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Forman JR, 2007, CURR OPIN STRUC BIOL, V17, P58, DOI 10.1016/j.sbi.2007.01.006; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Improta S, 1998, J MOL BIOL, V284, P761, DOI 10.1006/jmbi.1998.2028; Jass J, 2004, BIOPHYS J, V87, P4271, DOI 10.1529/biophysj.104.044867; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2009, P NATL ACAD SCI USA, V106, P16967, DOI 10.1073/pnas.0906826106; Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514; Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563; LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006; Li HB, 2003, J MOL BIOL, V334, P75, DOI 10.1016/j.jmb.2003.09.036; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Maier B, 2002, P NATL ACAD SCI USA, V99, P16012, DOI 10.1073/pnas.242523299; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Marszalek PE, 1999, NATURE, V402, P100, DOI 10.1038/47083; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102; Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Scott JR, 2006, MOL MICROBIOL, V62, P320, DOI 10.1111/j.1365-2958.2006.05279.x; Sikora M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000547; Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006; Yeates TO, 2007, SCIENCE, V318, P1558, DOI 10.1126/science.1151398	49	85	86	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11235	11242		10.1074/jbc.M110.102962	http://dx.doi.org/10.1074/jbc.M110.102962			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139067	Green Published, hybrid			2022-12-27	WOS:000276286200029
J	Fujiwara, T; Maisonneuve, S; Isshiki, M; Mizutani, M; Chen, LT; Wong, HL; Kawasaki, T; Shimamoto, K				Fujiwara, Tadashi; Maisonneuve, Sylvie; Isshiki, Masayuki; Mizutani, Masaharu; Chen, Letian; Wong, Hann Ling; Kawasaki, Tsutomu; Shimamoto, Ko			Sekiguchi Lesion Gene Encodes a Cytochrome P450 Monooxygenase That Catalyzes Conversion of Tryptamine to Serotonin in Rice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEIN; SMALL GTPASE RAC; CELL-DEATH; DISEASE RESISTANCE; BIOSYNTHESIS; FUNGUS; ACCUMULATION; INDUCTION; RESPONSES; OXIDASE	Serotonin is a well known neurotransmitter in mammals and plays an important role in various mental functions in humans. In plants, the serotonin biosynthesis pathway and its function are not well understood. The rice sekiguchi lesion (sl) mutants accumulate tryptamine, a candidate substrate for serotonin biosynthesis. We isolated the SL gene by map-based cloning and found that it encodes CYP71P1 in a cytochrome P450 monooxygenase family. A recombinant SL protein exhibited tryptamine 5-hydroxylase enzyme activity and catalyzed the conversion of tryptamine to serotonin. This pathway is novel and has not been reported in mammals. Expression of SL was induced by the N-acetylchitooligosaccharide (chitin) elicitor and by infection with Magnaporthe grisea, a causal agent for rice blast disease. Exogenously applied serotonin induced defense gene expression and cell death in rice suspension cultures and increased resistance to rice blast infection in plants. We also found that serotonin-induced defense gene expression is mediated by the RacGTPase pathway and by the G alpha subunit of the heterotrimeric G protein. These results suggest that serotonin plays an important role in rice innate immunity.	[Fujiwara, Tadashi; Maisonneuve, Sylvie; Isshiki, Masayuki; Chen, Letian; Wong, Hann Ling; Kawasaki, Tsutomu; Shimamoto, Ko] Nara Inst Sci & Technol, Plant Mol Genet Lab, Ikoma 6300192, Japan; [Mizutani, Masaharu] Kobe Univ, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan	Nara Institute of Science & Technology; Kobe University	Shimamoto, K (corresponding author), Nara Inst Sci & Technol, Plant Mol Genet Lab, 8916-5 Takayama, Ikoma 6300192, Japan.	simamoto@bs.naist.jp	Chen, Letian/B-1263-2015; Wong, Hann Ling/S-8148-2017	Chen, Letian/0000-0001-6413-636X; Wong, Hann Ling/0000-0001-8903-1812; Mizutani, Masaharu/0000-0002-4321-0644	Ministry of Agriculture, Forestry, and Fisheries of Japan [IP4001]; Japan Society for Promotion of Science [13G0023]; Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN)	This work was supported by grants-in-aid from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Rice Genome Project IP4001), the Japan Society for Promotion of Science Grant 13G0023 (to K. S.), and the Program for Promotion of Basic Research Activities for Innovative Biosciences (PROBRAIN) (to T. K.).	Arase S, 2001, J PHYTOPATHOL, V149, P409, DOI 10.1046/j.1439-0434.2001.00646.x; Bak S, 2001, PLANT CELL, V13, P101, DOI 10.1105/tpc.13.1.101; Fitzpatrick PF, 2003, BIOCHEMISTRY-US, V42, P14083, DOI 10.1021/bi035656u; Geyer MA, 2008, TRENDS PHARMACOL SCI, V29, P445, DOI 10.1016/j.tips.2008.06.006; Gingrich JA, 2001, PSYCHOPHARMACOLOGY, V155, P1, DOI 10.1007/s002130000573; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; Hammond-Kosack KE, 2003, CURR OPIN BIOTECH, V14, P177, DOI 10.1016/S0958-1669(03)00035-1; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Hayashi M, 2005, P NATL ACAD SCI USA, V102, P7020, DOI 10.1073/pnas.0502556102; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; Ishihara A, 2008, PLANT J, V54, P481, DOI 10.1111/j.1365-313X.2008.03441.x; Kang K, 2009, PLANT PHYSIOL, V150, P1380, DOI 10.1104/pp.109.138552; Kawasaki T, 1999, P NATL ACAD SCI USA, V96, P10922, DOI 10.1073/pnas.96.19.10922; Keller H, 1996, PHYTOCHEMISTRY, V42, P389, DOI 10.1016/0031-9422(95)00866-7; Lieberherr D, 2005, PLANT PHYSIOL, V138, P1644, DOI 10.1104/pp.104.057414; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Midoh N, 1996, PLANT CELL PHYSIOL, V37, P9, DOI 10.1093/oxfordjournals.pcp.a028918; Miki D, 2004, PLANT CELL PHYSIOL, V45, P490, DOI 10.1093/pcp/pch048; Miyagawa H, 1995, BIOSCI BIOTECH BIOCH, V59, P2305, DOI 10.1271/bbb.59.2305; Mizutani M, 1998, PLANT PHYSIOL, V116, P357, DOI 10.1104/pp.116.1.357; Mockus SM, 1998, J MOL NEUROSCI, V10, P163, DOI 10.1007/BF02761772; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakashima A, 2008, PLANT CELL, V20, P2265, DOI 10.1105/tpc.107.054395; Ono E, 2001, P NATL ACAD SCI USA, V98, P759, DOI 10.1073/pnas.021273498; Roshchina VV, 2001, NEUROTRANSMITTERS PL, P4; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; SATOH H, 1979, J FAC AGR KYUSHU U, V24, P165; Suharsono U, 2002, P NATL ACAD SCI USA, V99, P13307, DOI 10.1073/pnas.192244099; Thao NP, 2007, PLANT CELL, V19, P4035, DOI 10.1105/tpc.107.055517; Ueno M, 2003, PLANT J, V36, P215, DOI 10.1046/j.1365-313X.2003.01875.x; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Yamaguchi T, 2000, PLANT CELL, V12, P817, DOI 10.1105/tpc.12.5.817	33	145	169	4	56	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11308	11313		10.1074/jbc.M109.091371	http://dx.doi.org/10.1074/jbc.M109.091371			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150424	hybrid, Green Published			2022-12-27	WOS:000276286200037
J	Nemeria, NS; Arjunan, P; Chandrasekhar, K; Mossad, M; Tittmann, K; Furey, W; Jordan, F				Nemeria, Natalia S.; Arjunan, Palaniappa; Chandrasekhar, Krishnamoorthy; Mossad, Madouna; Tittmann, Kai; Furey, William; Jordan, Frank			Communication between Thiamin Cofactors in the Escherichia coli Pyruvate Dehydrogenase Complex E1 Component Active Centers EVIDENCE FOR A "DIRECT PATHWAY" BETWEEN THE 4 '-AMINOPYRIMIDINE N1' ATOMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIENZYME COMPLEX; 1',4'-IMINOPYRIMIDINE TAUTOMER; DEPENDENT ENZYMES; DIPHOSPHATE; SITES; IONIZATION; ACTIVATION; SUBSTRATE; SUBUNIT; BINDING	Kinetic, spectroscopic, and structural analysis tested the hypothesis that a chain of residues connecting the 4'-aminopyrimidine N1' atoms of thiamin diphosphates (ThDPs) in the two active centers of the Escherichia coli pyruvate dehydrogenase complex E1 component provides a signal transduction pathway. Substitution of the three acidic residues (Glu(571), Glu(235), and Glu(237)) and Arg(606) resulted in impaired binding of the second ThDP, once the first active center was filled, suggesting a pathway for communication between the two ThDPs. 1) Steady-state kinetic and fluorescence quenching studies revealed that upon E571A, E235A, E237A, and R606A substitutions, ThDP binding in the second active center was affected. 2) Analysis of the kinetics of thiazolium C2 hydrogen/deuterium exchange of enzyme-bound ThDP suggests half-of-the-sites reactivity for the E1 component, with fast (activated site) and slow exchanging sites (dormant site). The E235A and E571A variants gave no evidence for the slow exchanging site, indicating that only one of two active sites is filled with ThDP. 3) Titration of the E235A and E237A variants with methyl acetylphosphonate monitored by circular dichroism suggested that only half of the active sites were filled with a covalent predecarboxylation intermediate analog. 4) Crystal structures of E235A and E571A in complex with ThDP revealed the structural basis for the spectroscopic and kinetic observations and showed that either substitution affects cofactor binding, despite the fact that Glu(235) makes no direct contact with the cofactor. The role of the conserved Glu(571) residue in both catalysis and cofactor orientation is revealed by the combined results for the first time.	[Arjunan, Palaniappa; Chandrasekhar, Krishnamoorthy; Furey, William] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Arjunan, Palaniappa; Furey, William] Vet Affairs Med Ctr, Biocrystallog Lab, Pittsburgh, PA 15240 USA; [Nemeria, Natalia S.; Mossad, Madouna; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Tittmann, Kai] Univ Gottingen, Abt Bioanalyt, Albrecht von Haller Inst, D-37077 Gottingen, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Rutgers State University Newark; Rutgers State University New Brunswick; University of Gottingen	Furey, W (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA.	fureyw@pitt.edu; frjordan@rutgers.edu			National Institutes of Health [GM-050380, GM-061791]; Veterans Affairs Merit Review Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061791, R01GM050380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Program(US Department of Veterans Affairs); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-050380 (to F. J.) and GM-061791 (to W. F.). This work was also supported by the Veterans Affairs Merit Review Program (to W. F.).	Arjunan P, 2002, BIOCHEMISTRY-US, V41, P5213, DOI 10.1021/bi0118557; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; Ciszak EM, 2003, J BIOL CHEM, V278, P21240, DOI 10.1074/jbc.M300339200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Jordan F, 2005, ACCOUNTS CHEM RES, V38, P755, DOI 10.1021/ar040244e; Jordan F, 2004, SCIENCE, V306, P818, DOI 10.1126/science.1105457; Jordan F, 2003, J AM CHEM SOC, V125, P12732, DOI 10.1021/ja0346126; JORDAN F, 2004, THIAMINE CATALYTIC M, P407; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Li J, 2007, J BIOL CHEM, V282, P11904, DOI 10.1074/jbc.M610843200; Nemeria N, 1998, BIOCHEMISTRY-US, V37, P911, DOI 10.1021/bi9722251; Nemeria N, 2001, J BIOL CHEM, V276, P45969, DOI 10.1074/jbc.M104116200; Nemeria N, 2007, BIOCHEMISTRY-US, V46, P10739, DOI 10.1021/bi700838q; Nemeria N, 2007, P NATL ACAD SCI USA, V104, P78, DOI 10.1073/pnas.0609973104; Nemeria NS, 2009, FEBS J, V276, P2432, DOI 10.1111/j.1742-4658.2009.06964.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Segel I. H., 1993, ENZYME KINETICS BEHA, P73; Seifert F, 2006, BIOCHEMISTRY-US, V45, P12775, DOI 10.1021/bi061582l; YAN Y, 2003, THESIS RUTGERS U NEW; Yi JZ, 1996, J BIOL CHEM, V271, P33192, DOI 10.1074/jbc.271.52.33192	23	21	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11197	11209		10.1074/jbc.M109.069179	http://dx.doi.org/10.1074/jbc.M109.069179			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20106967	hybrid, Green Published			2022-12-27	WOS:000276286200025
J	Imoto, A; Okada, M; Okazaki, T; Kitasato, H; Harigae, H; Takahashi, S				Imoto, Akemi; Okada, Mami; Okazaki, Toshio; Kitasato, Hidero; Harigae, Hideo; Takahashi, Shinichiro			Metallothionein-1 Isoforms and Vimentin Are Direct PU.1 Downstream Target Genes in Leukemia Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR PU.1; ACUTE MYELOID-LEUKEMIA; PROGNOSTIC-SIGNIFICANCE; TANDEM DUPLICATION; MESSENGER-RNA; EXPRESSION; REPRESSOR; COMPLEX; FLT3; PROMOTER	PU.1 is a key transcription factor for hematopoiesis and plays important roles in various hematological malignancies. To clarify the molecular function of PU.1, we initially tried to identify bona fide target genes regulated by PU.1. Dual microarrays were employed for this study to compare PU.1-knockdown K562 cells (K562PU.1KD) stably expressing PU.1 short inhibitory RNAs versus control cells and PU.1-overexpressing K562 cells (K562PU.1OE) versus control cells. In these analyses, we found that several genes, including metallothionein (MT)-1 isoforms (MT-1G and MT-1A) and vimentin (VIM), were markedly induced while Jun dimerization protein (JDP) 2 was suppressed in K562PU.1KD cells. Furthermore, the mRNA expressions of the MT-1 and VIM genes were inversely correlated and the mRNA expression of JDP2 was positively correlated with PU.1 mRNA expression in 43 primary acute myeloid leukemia specimens (MT-1G: R = -0.50, p < 0.001; MT-1A: R = -0.58, p < 0.0005; VIM: R = -0.39, p < 0.01; and JDP2: R = 0.30, p < 0.05). Next, we analyzed the regulation of the MT-1 and VIM genes. We observed increased associations of acetylated histones H3 and H4 with the promoters of these genes in K562PU.1KD cells. Sequence analyses of the regions similar to 1 kb upstream from the transcription start sites of these genes revealed numerous CpG sites, which are potential targets for DNA methylation. Chromatin immunoprecipitation assays revealed that methyl CpG-binding protein 2 (MeCP2) and PU.1 bound to the CpG-rich regions in the MT-1 and VIM promoters. Bisulfite sequencing analyses of the PU.1-bound regions of these promoters revealed that the proportions of methylated CpG sites were tightly related to the PU.1 expression levels.	[Okazaki, Toshio; Takahashi, Shinichiro] Kitasato Univ, Sch Allied Hlth Sci, Div Hematol, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Kitasato, Hidero] Kitasato Univ, Sch Allied Hlth Sci, Div Microbiol, Minami Ku, Sagamihara, Kanagawa 2520373, Japan; [Imoto, Akemi; Okada, Mami; Okazaki, Toshio; Takahashi, Shinichiro] Kitasato Univ, Sch Med Sci, Div Mol Hematol, Sagamihara, Kanagawa 2520373, Japan; [Harigae, Hideo] Tohoku Univ, Grad Sch Med, Dept Hematol & Rheumatol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Kitasato University; Kitasato University; Kitasato University; Tohoku University	Takahashi, S (corresponding author), Kitasato Univ, Sch Allied Hlth Sci, Div Hematol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	shin@kitasato-u.ac.jp	Takahashi, Shinichiro/AAX-7125-2020	Takahashi, Shinichiro/0000-0003-0011-6065	Nakayama Foundation for Human Science; Kitasato University School of Allied Health Sciences [2007-1003, 2008-1001, 2009-1001]; Kitasato University Graduate School of Medical Sciences Research Project	Nakayama Foundation for Human Science; Kitasato University School of Allied Health Sciences; Kitasato University Graduate School of Medical Sciences Research Project	This work was supported in part by grants from Nakayama Foundation for Human Science, the Foundation from the Kitasato University School of Allied Health Sciences (Grants-in-Aid for Research Project, 2007-1003, 2008-1001, and 2009-1001), and the Foundation from the Kitasato University Graduate School of Medical Sciences Research Project.	Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; Belichenko I, 2001, ARCH BIOCHEM BIOPHYS, V390, P57, DOI 10.1006/abbi.2001.2365; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Cherian MG, 2003, MUTAT RES-FUND MOL M, V533, P201, DOI 10.1016/j.mrfmmm.2003.07.013; FERRARI S, 1986, MOL CELL BIOL, V6, P3614, DOI 10.1128/MCB.6.11.3614; FERRIER AF, 1992, J CELL BIOCHEM, V50, P245, DOI 10.1002/jcb.240500305; FOSTER R, 1988, J BIOL CHEM, V263, P11528; Ghoshal K, 2002, MOL CELL BIOL, V22, P8302, DOI 10.1128/MCB.22.23.8302-8319.2002; Heinrich R, 2004, J BIOL CHEM, V279, P5708, DOI 10.1074/jbc.M307608200; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Huh HJ, 2009, INT J LAB HEMATOL, V31, P344, DOI 10.1111/j.1751-553X.2008.01056.x; Inomata M, 2006, LEUKEMIA RES, V30, P659, DOI 10.1016/j.leukres.2005.07.015; Iseki Y, 2009, LEUKEMIA RES, V33, P1658, DOI 10.1016/j.leukres.2009.04.010; Jin CY, 2002, MOL CELL BIOL, V22, P4815, DOI 10.1128/MCB.22.13.4815-4826.2002; KACZMAREK L, 1987, EXP CELL RES, V173, P70, DOI 10.1016/0014-4827(87)90332-6; Kihara-Negishi F, 2001, ONCOGENE, V20, P6039, DOI 10.1038/sj.onc.1204756; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; Mididoddi S, 1996, TOXICOL LETT, V85, P17, DOI 10.1016/0378-4274(96)03632-6; Ozeki K, 2004, BLOOD, V103, P1901, DOI 10.1182/blood-2003-06-1845; PETTERSSON M, 1995, BLOOD, V86, P2747; Poulsen CB, 2006, BLOOD, V108, P3514, DOI 10.1182/blood-2006-04-015305; RITTLING SR, 1987, MOL CELL BIOL, V7, P3908, DOI 10.1128/MCB.7.11.3908; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Sauerbrey A, 1998, ANTICANCER RES, V18, P1231; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Shimoda R, 2003, TOXICOL SCI, V73, P294, DOI 10.1093/toxsci/kfg095; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Sugimoto T, 2009, BIOCHEM BIOPH RES CO, V390, P48, DOI 10.1016/j.bbrc.2009.09.059; Suzuki M, 2006, ONCOGENE, V25, P2477, DOI 10.1038/sj.onc.1209272; Suzuki M, 2003, ONCOGENE, V22, P8688, DOI 10.1038/sj.onc.1207182; Takahashi S, 2005, BRIT J HAEMATOL, V130, P428, DOI 10.1111/j.1365-2141.2005.05621.x; Takahashi S, 2005, LEUKEMIA RES, V29, P893, DOI 10.1016/j.leukres.2005.01.008; Takahashi S, 2004, BLOOD, V103, P4650, DOI 10.1182/blood-2003-08-2759; Torlakovic EE, 2006, J PATHOL, V209, P352, DOI 10.1002/path.1986; Wang GW, 2001, J PHARMACOL EXP THER, V298, P461; Wu YZ, 2007, GENES CELLS, V12, P905, DOI 10.1111/j.1365-2443.2007.01104.x; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Ye SK, 2001, IMMUNITY, V15, P813, DOI 10.1016/S1074-7613(01)00230-8; Zou HZ, 2007, CANCER EPIDEM BIOMAR, V16, P2686, DOI 10.1158/1055-9965.EPI-07-0518	40	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10300	10309		10.1074/jbc.M109.095810	http://dx.doi.org/10.1074/jbc.M109.095810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139074	Green Published, hybrid			2022-12-27	WOS:000276264600014
J	Krzystanek, M; Pedersen, TX; Bartels, ED; Kjaehr, J; Straarup, EM; Nielsen, LB				Krzystanek, Marcin; Pedersen, Tanja Xenia; Bartels, Emil Daniel; Kjaehr, Jacob; Straarup, Ellen Marie; Nielsen, Lars Bo			Expression of Apolipoprotein B in the Kidney Attenuates Renal Lipid Accumulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LIPOPROTEIN-LIPASE; PPAR-ALPHA; HEART; DYSFUNCTION; SECRETION; OBESITY; MUSCLE; GENES; FAT	The ability to produce apolipoprotein (apo) B-containing lipoproteins enables hepatocytes, enterocytes, and cardiomyocytes to export triglycerides. In this study, we examined secretion of apoB-containing lipoproteins from mouse kidney and its putative impact on triglyceride accumulation in the tubular epithelium. Mouse kidney expressed both the apoB and microsomal triglyceride transfer protein genes, which permit lipoprotein formation. To examine de novo lipoprotein secretion, kidneys from human apoB-transgenic mice were minced and placed in medium with S-35-amino acids. Upon sucrose gradient ultracentrifugation of the labeled medium, fractions were analyzed by apoB immunoprecipitation. S-35-Labeled apoB100 was recovered in similar to 1.03-1.04 g/ ml lipoproteins (i. e. similar to the density of plasma low density lipoproteins). Immunohistochemistry of kidney sections suggested that apoB mainly is produced by tubular epithelial cells. ApoB expression in the kidney cortex was reduced similar to 90% in vivo by treating wild type mice with apoBantisense locked nucleic acid oligonucleotide. Inhibition of apoB expression increased fasting-induced triglyceride accumulation in the kidney cortex by 20-25% (p = 0.008). Cholesterol stores were unaffected. Treatment with control oligonucleotides with 1 or 4 mismatching base pairs affected neither the triglyceride nor the cholesterol content of the kidney cortex. The results suggest that mammalian kidney secretes apoB100containing lipoproteins. One biological effect may be to dampen excess storage of triglycerides in proximal tubule cells.	[Krzystanek, Marcin; Pedersen, Tanja Xenia; Bartels, Emil Daniel; Kjaehr, Jacob; Nielsen, Lars Bo] Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Straarup, Ellen Marie] Santaris Pharma, DK-2970 Horsholm, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Nielsen, LB (corresponding author), Rigshosp, Dept Clin Biochem KB3011, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	larsbo@rh.dk	Bartels, Emil/AAY-3268-2020	Pedersen, Tanja Xenia/0000-0003-2515-3022	Danish National Research Council; Ingeborg; Leo Danins Foundations; Henry Hansen and Hustru's Fund; NovoNordisk Foundation	Danish National Research Council(Danmarks Grundforskningsfond); Ingeborg; Leo Danins Foundations; Henry Hansen and Hustru's Fund; NovoNordisk Foundation(Novo Nordisk Foundation)	This work was supported by grants from Danish National Research Council, Ingeborg and Leo Danins Foundations, Henry Hansen and Hustru's Fund, and the NovoNordisk Foundation (to L. B. N.).	Bang CA, 2007, AM J PHYSIOL-RENAL, V293, pF1325, DOI 10.1152/ajprenal.00039.2007; Bartels ED, 2002, DIABETES, V51, P1233, DOI 10.2337/diabetes.51.4.1233; Bartels ED, 2007, ATHEROSCLEROSIS, V195, pE42, DOI 10.1016/j.atherosclerosis.2007.05.002; Bartels ED, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005300; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Boren J, 1998, J CLIN INVEST, V101, P1197, DOI 10.1172/JCI1785; Christensen EI, 1999, J AM SOC NEPHROL, V10, P685; Christoffersen C, 2003, ENDOCRINOLOGY, V144, P3483, DOI 10.1210/en.2003-0242; DEMMER LA, 1986, P NATL ACAD SCI USA, V83, P8102, DOI 10.1073/pnas.83.21.8102; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Fujihara M, 2009, EXP EYE RES, V88, P1115, DOI 10.1016/j.exer.2009.01.017; Gregg Richard E., 1994, Current Opinion in Lipidology, V5, P81, DOI 10.1097/00041433-199404000-00003; LADU MJ, 1991, AM J PHYSIOL, V260, pR953, DOI 10.1152/ajpregu.1991.260.5.R953; Ledmyr H, 2004, CIRCULATION, V109, P2279, DOI 10.1161/01.CIR.0000130070.96758.7b; Li SY, 2004, AM J PHYSIOL-RENAL, V286, pF572, DOI 10.1152/ajprenal.00190.2003; Lindegaard MLS, 2008, METABOLISM, V57, P766, DOI 10.1016/j.metabol.2008.01.016; LINTON MF, 1993, J CLIN INVEST, V92, P3029, DOI 10.1172/JCI116927; Madsen EM, 2004, J BIOL CHEM, V279, P55271, DOI 10.1074/jbc.M411404200; Michalik L, 2006, J CLIN INVEST, V116, P598, DOI 10.1172/JCI27958; Nielsen LB, 1997, J BIOL CHEM, V272, P29752, DOI 10.1074/jbc.272.47.29752; Nielsen LB, 2002, J BIOL CHEM, V277, P27014, DOI 10.1074/jbc.M203458200; Nielsen LB, 1998, CIRCULATION, V98, P13, DOI 10.1161/01.CIR.98.1.13; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; ONG JM, 1994, J LIPID RES, V35, P1542; Portilla D, 2006, KIDNEY INT, V69, P2194, DOI 10.1038/sj.ki.5000433; Portilla D, 2002, KIDNEY INT, V62, P1208, DOI 10.1046/j.1523-1755.2002.00553.x; Schrauwen P, 2007, P NUTR SOC, V66, P33, DOI 10.1017/S0029665107005277; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimabukuro M, 1998, J BIOL CHEM, V273, P3547, DOI 10.1074/jbc.273.6.3547; TAN MH, 1977, J LIPID RES, V18, P363; Tarugi P, 1998, J LIPID RES, V39, P731; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Walzem RL, 1999, J NUTR, V129, p467S, DOI 10.1093/jn/129.2.467S; WETTERAU JR, 1986, BIOCHIM BIOPHYS ACTA, V875, P610, DOI 10.1016/0005-2760(86)90084-6; YOUNG SG, 1990, CIRCULATION, V82, P1574, DOI 10.1161/01.CIR.82.5.1574; Zager RA, 2005, KIDNEY INT, V67, P111, DOI 10.1111/j.1523-1755.2005.00061.x	36	32	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10583	10590		10.1074/jbc.M109.078006	http://dx.doi.org/10.1074/jbc.M109.078006			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20103594	Green Published, hybrid			2022-12-27	WOS:000276264600045
J	Paquete, CM; Saraiva, IH; Calcada, E; Louro, RO				Paquete, Catarina M.; Saraiva, Ivo H.; Calcada, Eduardo; Louro, Ricardo O.			Molecular Basis for Directional Electron Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAHEME CYTOCHROME-C; SHEWANELLA-FRIGIDIMARINA; KINETICS; IDENTIFICATION; SPECIFICITY; REDUCTION; IRON	Biological macromolecules involved in electron transfer reactions display chains of closely packed redox cofactors when long distances must be bridged. This is a consequence of the need to maintain a rate of transfer compatible with metabolic activity in the framework of the exponential decay of electron tunneling with distance. In this work intermolecular electron transfer was studied in kinetic experiments performed with the small tetraheme cytochrome from Shewanella oneidensis MR-1 and from Shewanella frigidimarina NCIMB400 using non-physiological redox partners. This choice allowed the effect of specific recognition and docking to be eliminated from the measured rates. The results were analyzed with a kinetic model that uses the extensive thermodynamic characterization of these proteins reported in the literature to discriminate the kinetic contribution of each heme to the overall rate of electron transfer. This analysis shows that, in this redox chain that spans 23A, the kinetic properties of the individual hemes establish a functional specificity for each redox center. This functional specificity combined with the thermodynamic properties of these soluble proteins ensures directional electron flow within the cytochrome even outside of the context of a functioning respiratory chain.	[Paquete, Catarina M.; Saraiva, Ivo H.; Calcada, Eduardo; Louro, Ricardo O.] Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal		Louro, RO (corresponding author), Inst Tecnol Quim & Biol, Av Republ EAN, P-2780157 Oeiras, Portugal.	louro@itqb.unl.pt	Saraiva, Ivo/M-6213-2013; Paquete, Catarina M./A-6615-2016; Louro, Ricardo O./AAB-4601-2020	Saraiva, Ivo/0000-0002-5833-7699; Paquete, Catarina M./0000-0002-1511-3732; Louro, Ricardo O./0000-0002-2392-6450; Calcada, Eduardo/0000-0002-3386-1670	Fundacao para a Ciencia e a Tecnologia (FCT)-Portugal [REEQ/336/BIO/2005, MIT-Pt/BS-BB/0014/2008]; FCT-Portugal [SFRH/BDP/34591/2007, SFRH/BD/36582/2007]	Fundacao para a Ciencia e a Tecnologia (FCT)-Portugal(Portuguese Foundation for Science and Technology); FCT-Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT)-Portugal (Grants REEQ/336/BIO/2005 and MIT-Pt/BS-BB/0014/2008) and by FCT-Portugal Grants SFRH/BDP/34591/2007 (to C. M. P.) and SFRH/BD/36582/2007 (to I. H. S.).	Abida O, 2006, PHOTOCH PHOTOBIO SCI, V5, P395, DOI 10.1039/b518211e; BENTO I, 2007, HDB METALLOPROTEINS, P1; Catarino T, 2001, CHEMBIOCHEM, V2, P416, DOI 10.1002/1439-7633(20010601)2:6<416::AID-CBIC416>3.3.CO;2-Q; Davidson VL, 1996, BIOCHEMISTRY-US, V35, P14035, DOI 10.1021/bi961577p; DIXON M, 1971, BIOCHIM BIOPHYS ACTA, V226, P241, DOI 10.1016/0005-2728(71)90092-2; Fonseca BM, 2009, J BIOL INORG CHEM, V14, P375, DOI 10.1007/s00775-008-0455-7; Fredrickson JK, 2008, GEOBIOLOGY, V6, P245, DOI 10.1111/j.1472-4669.2008.00146.x; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Gordon EHJ, 2000, BIOCHEM J, V349, P153, DOI 10.1042/0264-6021:3490153; Gray HB, 2003, Q REV BIOPHYS, V36, P341, DOI 10.1017/S0033583503003913; Harada E, 2002, FEBS LETT, V532, P333, DOI 10.1016/S0014-5793(02)03696-7; Hoffman BM, 2005, P NATL ACAD SCI USA, V102, P3564, DOI 10.1073/pnas.0408767102; Kerisit S, 2007, J PHYS CHEM C, V111, P11363, DOI 10.1021/jp072060y; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; LAMBETH DO, 1973, J BIOL CHEM, V248, P6095; Leys D, 2002, J BIOL CHEM, V277, P35703, DOI 10.1074/jbc.M203866200; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MCKENNA CE, 1991, BIOCHIM BIOPHYS ACTA, V1075, P109, DOI 10.1016/0304-4165(91)90082-R; NEALSON KH, 1994, ANNU REV MICROBIOL, V48, P311, DOI 10.1146/annurev.mi.48.100194.001523; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Paixao VB, 2008, BIOCHEMISTRY-US, V47, P11973, DOI 10.1021/bi801326j; Paquete CM, 2007, BBA-BIOENERGETICS, V1767, P1169, DOI 10.1016/j.bbabio.2007.06.005; Pessanha M, 2003, BIOCHEM J, V370, P489, DOI 10.1042/BJ20021408; Tsapin AI, 2001, APPL ENVIRON MICROB, V67, P3236, DOI 10.1128/AEM.67.7.3236-3244.2001; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08	27	19	19	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10370	10375		10.1074/jbc.M109.078337	http://dx.doi.org/10.1074/jbc.M109.078337			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20089857	hybrid, Green Published			2022-12-27	WOS:000276264600022
J	Sucic, S; Dallinger, S; Zdrazil, B; Weissensteiner, R; Jorgensen, TN; Holy, M; Kudlacek, O; Seidel, S; Cha, JH; Gether, U; Newman, AH; Ecker, GF; Freissmuth, M; Sitte, HH				Sucic, Sonja; Dallinger, Stefan; Zdrazil, Barbara; Weissensteiner, Rene; Jorgensen, Trine N.; Holy, Marion; Kudlacek, Oliver; Seidel, Stefan; Cha, Joo Hwan; Gether, Ulrik; Newman, Amy H.; Ecker, Gerhard F.; Freissmuth, Michael; Sitte, Harald H.			The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN DOPAMINE TRANSPORTER; HUMAN SEROTONIN TRANSPORTER; ENERGY-TRANSFER MICROSCOPY; INDUCED REVERSE TRANSPORT; NEUROTRANSMITTER TRANSPORTERS; GABA TRANSPORTER-1; NOREPINEPHRINE TRANSPORTERS; OUTWARD TRANSPORT; LIVING CELLS; BINDING-SITE	The serotonin transporter (SERT) terminates neurotransmission by removing serotonin from the synaptic cleft. In addition, it is the site of action of antidepressants (which block the transporter) and of amphetamines (which induce substrate efflux). We explored the functional importance of the N terminus in mediating the action of amphetamines by focusing initially on the highly conserved threonine residue at position 81, a candidate site for phosphorylation by protein kinase C. Molecular dynamics simulations of the wild type SERT, compared with its mutations SERTT81A and SERTT81D, suggested structural changes in the inner vestibule indicative of an opening of the inner vestibule. Predictions from this model (e. g. the preferential accumulation of SERTT81A in the inward conformation, its reduced turnover number, and a larger distance between its N and C termini) were verified. Most importantly, SERTT81A (and the homologous mutations in noradrenaline and dopamine) failed to support amphetamine-induced efflux, and this was not remedied by aspartate at this position. Amphetamine-induced currents through SERTT81A were comparable with those through the wild type transporter. Both abundant Na+ entry and accumulation of SERTT81A in the inward facing conformation ought to favor amphetamine-induced efflux. Thus, we surmised that the N terminus must play a direct role in driving the transporter into a state that supports amphetamine-induced efflux. This hypothesis was verified by truncating the first 64 amino acids and by tethering the N terminus to an additional transmembrane helix. Either modification abolished amphetamine-induced efflux. We therefore conclude that the N terminus of monoamine transporters acts as a lever that sustains reverse transport.	[Kudlacek, Oliver; Seidel, Stefan; Sitte, Harald H.] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Zdrazil, Barbara; Weissensteiner, Rene; Ecker, Gerhard F.] Univ Vienna, Dept Med Chem, A-1090 Vienna, Austria; [Jorgensen, Trine N.; Gether, Ulrik] Univ Copenhagen, Fac Hlth Sci, Dept Neurosci & Pharmacol, DK-2200 Copenhagen N, Denmark; [Cha, Joo Hwan; Newman, Amy H.] NIDA, Med Chem Sect, Intramural Res Program, Baltimore, MD 21224 USA	Medical University of Vienna; University of Vienna; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA)	Sitte, HH (corresponding author), Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, Waehringerstr 13A, A-1090 Vienna, Austria.	harald.sitte@meduniwien.ac.at	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013; Zdrazil, Barbara/F-1021-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Zdrazil, Barbara/0000-0001-9395-1515; Freissmuth, Michael/0000-0001-9398-1765; Sucic, Sonja/0000-0001-5136-8022; Ecker, Gerhard/0000-0003-4209-6883; Gether, Ulrik/0000-0002-0020-3807; Kudlacek, Oliver/0000-0002-3086-8551	National Institutes of Health [P01 DA 12408]; National Institute on Drug Abuse; FWF [P18706, SFB3506, SFB3502, SFB3510]; Austrian Science Fund (FWF) [F 3502, F 3506] Funding Source: researchfish; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012408, ZIADA000389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant P01 DA 12408 (to U. G.) and the National Institute on Drug Abuse Intramural Research Program (to A. H. N.). This work was also supported by FWF Grants P18706 and SFB3506 (to H. H. S.), SFB3502 (to G. F. E.), and SFB3510 (to M. F.).	Bartholomaeus I, 2008, J BIOL CHEM, V283, P10978, DOI 10.1074/jbc.M800622200; Beckman ML, 1998, J NEUROSCI, V18, P6103; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Cha JH, 2005, J MED CHEM, V48, P7513, DOI 10.1021/jm050431y; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Chen NH, 2001, J NEUROCHEM, V77, P1116, DOI 10.1046/j.1471-4159.2001.00312.x; Chen Nian-Hang, 2002, P53; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Einhauer A, 2001, J BIOCHEM BIOPH METH, V49, P455, DOI 10.1016/S0165-022X(01)00213-5; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681; Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Fog JU, 2006, NEURON, V51, P417, DOI 10.1016/j.neuron.2006.06.028; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Foster JD, 2006, HANDB EXP PHARM, V175, P197; Foster JD, 2002, J BIOL CHEM, V277, P25178, DOI 10.1074/jbc.M200294200; GALLI A, 1995, J EXP BIOL, V198, P2197; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; Gerstbrein K, 2006, HANDB EXP PHARM, V175, P95; Gnegy ME, 2003, EUR J PHARMACOL, V479, P83, DOI 10.1016/j.ejphar.2003.08.059; Gobbi M, 2008, J NEUROCHEM, V105, P1770, DOI 10.1111/j.1471-4159.2008.05272.x; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Gu HH, 2001, MOL BIOL CELL, V12, P3797, DOI 10.1091/mbc.12.12.3797; Guptaroy B, 2009, MOL PHARMACOL, V75, P514, DOI 10.1124/mol.108.048744; Haase J, 2001, BIOCHEM SOC T, V29, P722, DOI 10.1042/BST0290722; Hansra N, 2004, J NEUROSCI, V24, P4082, DOI 10.1523/JNEUROSCI.0664-04.2004; Hilber B, 2005, NEUROPHARMACOLOGY, V49, P811, DOI 10.1016/j.neuropharm.2005.08.008; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Just H, 2004, J BIOL CHEM, V279, P6650, DOI 10.1074/jbc.M306092200; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Korkhov VM, 2006, J BIOL CHEM, V281, P13439, DOI 10.1074/jbc.M511382200; Loland CJ, 2002, P NATL ACAD SCI USA, V99, P1683, DOI 10.1073/pnas.032386299; Loland CJ, 1999, J BIOL CHEM, V274, P36928, DOI 10.1074/jbc.274.52.36928; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; Mazei-Robison MS, 2008, J NEUROSCI, V28, P7040, DOI 10.1523/JNEUROSCI.0473-08.2008; Meinild AK, 2004, J BIOL CHEM, V279, P49671, DOI 10.1074/jbc.M407660200; Norgaard-Nielsen K, 2006, HANDB EXP PHARM, V175, P1; Norregaard L, 1998, EMBO J, V17, P4266, DOI 10.1093/emboj/17.15.4266; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Robertson SD, 2009, MOL NEUROBIOL, V39, P73, DOI 10.1007/s12035-009-8053-4; Rudnick G, 2006, HANDB EXP PHARM, V175, P59; RUDNICK G, 1993, BIOCHIM BIOPHYS ACTA, V1144, P249, DOI 10.1016/0005-2728(93)90109-S; Rudnick G, 1998, METHOD ENZYMOL, V296, P233; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Sakai N, 1997, J NEUROCHEM, V68, P2618; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Scholze P, 2002, J BIOL CHEM, V277, P21505, DOI 10.1074/jbc.M112265200; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Singh SK, 2008, CHANNELS, V2, P380, DOI 10.4161/chan.2.5.6904; Sitte HH, 2010, J NEUROCHEM, V112, P340, DOI 10.1111/j.1471-4159.2009.06474.x; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Sitte HH, 2001, MOL PHARMACOL, V59, P1129, DOI 10.1124/mol.59.5.1129; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Sucic S, 2002, MOL BRAIN RES, V108, P40, DOI 10.1016/S0169-328X(02)00512-0; Sucic S, 2007, EUR J PHARMACOL, V556, P27, DOI 10.1016/j.ejphar.2006.10.058; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; WALDMANN TA, 1991, J BIOL CHEM, V266, P2681; Wuller S, 2004, J BIOL CHEM, V279, P47254, DOI 10.1074/jbc.M408154200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	71	102	105	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10924	10938		10.1074/jbc.M109.083154	http://dx.doi.org/10.1074/jbc.M109.083154			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20118234	Green Published, hybrid			2022-12-27	WOS:000276264600077
J	McMichael, BK; Cheney, RE; Lee, BS				McMichael, Brooke K.; Cheney, Richard E.; Lee, Beth S.			Myosin X Regulates Sealing Zone Patterning in Osteoclasts through Linkage of Podosomes and Microtubules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN-2; PLECKSTRIN HOMOLOGY DOMAINS; PHOSPHATIDYLINOSITOL 3-KINASE; ADHESION STRUCTURES; BMP RECEPTORS; ACTIN; CYTOSKELETON; DYNAMICS; FILOPODIA; MEMBRANE	Osteoclasts use actin-rich attachment structures in place of focal adhesions for adherence to bone and non-bone substrates. On glass, osteoclasts generate podosomes, foot-like processes containing a core of F-actin and regulatory proteins that undergo high turnover. To facilitate bone resorption, osteoclasts generate an actin-rich sealing zone composed of densely packed podosome-like units. Patterning of both podosomes and sealing zones is dependent upon an intact microtubule system. A role for unconventional myosin X (Myo10), which can bind actin, microtubules, and integrins, was examined in osteoclasts. Immunolocalization showed Myo10 to be associated with the outer edges of immature podosome rings and sealing zones, suggesting a possible role in podosome and sealing zone positioning. Further, complexes containing both Myo10 and beta-tubulin were readily precipitated from osteoclasts lysates. RNAi-mediated suppression of Myo10 led to decreased cell and sealing zone perimeter, along with decreased motility and resorptive capacity. Further, siRNA-treated cells could not properly position podosomes following microtubule disruption. Osteoclasts over-expressing dominant negative Myo10 microtubule binding domains (MyTH4) showed a similar phenotype. Conversely, overexpression of full-length Myo10 led to increased formation of podosome belts along with larger sealing zones and enhanced bone resorptive capacity. These studies suggest that Myo10 plays a role in osteoclast attachment and podosome positioning by direct linkage of actin to the microtubule network.	[McMichael, Brooke K.; Lee, Beth S.] Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, Columbus, OH 43210 USA; [Cheney, Richard E.] Univ N Carolina, Dept Cell & Mol Physiol, Sch Med, Chapel Hill, NC 27599 USA	University System of Ohio; Ohio State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Lee, BS (corresponding author), Ohio State Univ, Dept Physiol & Cell Biol, Coll Med, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387; Cheney, Richard/0000-0001-6565-7888	National Institutes of Health [R01 AR051515, R01 DK052131, P01 HL080166, R01 DC03299]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR051515 and R01 DK052131 (to B. S. L.) and P01 HL080166 and R01 DC03299 (to R. E. C.).	Bennett RD, 2008, BIOCHEM BIOPH RES CO, V369, P654, DOI 10.1016/j.bbrc.2008.02.056; Bennett RD, 2007, J BIOL CHEM, V282, P3205, DOI 10.1074/jbc.M607174200; Berg JS, 2000, J CELL SCI, V113, P3439; Berg JS, 2002, NAT CELL BIOL, V4, P246, DOI 10.1038/ncb762; Bohil AB, 2006, P NATL ACAD SCI USA, V103, P12411, DOI 10.1073/pnas.0602443103; Chellaiah M, 1998, J BIOL CHEM, V273, P11908, DOI 10.1074/jbc.273.19.11908; Chishti AH, 1998, TRENDS BIOCHEM SCI, V23, P281, DOI 10.1016/S0968-0004(98)01237-7; Cowan CM, 2005, TISSUE ENG, V11, P645, DOI 10.1089/ten.2005.11.645; Cox D, 2002, NAT CELL BIOL, V4, P469, DOI 10.1038/ncb805; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Evans JG, 2003, J CELL BIOL, V161, P697, DOI 10.1083/jcb.200212037; Faccio R, 2003, J CELL BIOL, V162, P499, DOI 10.1083/jcb.200212082; HRUSKA KA, 1995, ENDOCRINOLOGY, V136, P2984, DOI 10.1210/en.136.7.2984; Isakoff SJ, 1998, EMBO J, V17, P5374, DOI 10.1093/emboj/17.18.5374; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Jeyaraj S, 2005, J BIOL CHEM, V280, P37957, DOI 10.1074/jbc.M502883200; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kaneko H, 2000, BONE, V27, P479, DOI 10.1016/S8756-3282(00)00358-6; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kopp P, 2006, MOL BIOL CELL, V17, P2811, DOI 10.1091/mbc.E05-11-1010; Kotadiya P, 2008, BONE, V43, P951, DOI 10.1016/j.bone.2008.06.017; Krits I, 2002, CALCIFIED TISSUE INT, V71, P530, DOI 10.1007/s00223-001-1112-0; Lakkakorpi PT, 1997, EXP CELL RES, V237, P296, DOI 10.1006/excr.1997.3797; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Linder S, 2000, J CELL SCI, V113, P4165; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Mashanov GI, 2004, J BIOL CHEM, V279, P15274, DOI 10.1074/jbc.M312140200; McMichael BK, 2008, EXP CELL RES, V314, P564, DOI 10.1016/j.yexcr.2007.10.018; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; McMichael BK, 2009, J BIOL CHEM, V284, P12266, DOI 10.1074/jbc.M808621200; Narasimhulu SB, 1998, PLANT CELL, V10, P957, DOI 10.1105/tpc.10.6.957; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Okamoto M, 2006, J BONE MINER RES, V21, P1022, DOI 10.1359/JBMR.060411; Okumura S, 2006, BONE, V39, P684, DOI 10.1016/j.bone.2006.04.010; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Pilkington MF, 1998, J BONE MINER RES, V13, P688, DOI 10.1359/jbmr.1998.13.4.688; Saltel F, 2004, MOL BIOL CELL, V15, P5231, DOI 10.1091/mbc.E04-06-0522; Sousa AD, 2006, J CELL SCI, V119, P184, DOI 10.1242/jcs.02726; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Tokuo H, 2004, BIOCHEM BIOPH RES CO, V319, P214, DOI 10.1016/j.bbrc.2004.04.167; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Woolner S, 2008, J CELL BIOL, V182, P77, DOI 10.1083/jcb.200804062; Wutzl A, 2006, J BIOMED MATER RES A, V77A, P75, DOI 10.1002/jbm.a.30615; Zhang HQ, 2004, NAT CELL BIOL, V6, P523, DOI 10.1038/ncb1136; Zhu XJ, 2007, NAT CELL BIOL, V9, P184, DOI 10.1038/ncb1535	50	45	49	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9506	9515		10.1074/jbc.M109.017269	http://dx.doi.org/10.1074/jbc.M109.017269			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20081229	Green Published, hybrid			2022-12-27	WOS:000276165900024
J	Bourhis, E; Tam, C; Franke, Y; Bazan, JF; Ernst, J; Hwang, J; Costa, M; Cochran, AG; Hannoush, RN				Bourhis, Eric; Tam, Christine; Franke, Yvonne; Bazan, J. Fernando; Ernst, James; Hwang, Jiyoung; Costa, Mike; Cochran, Andrea G.; Hannoush, Rami N.			Reconstitution of a Frizzled8.Wnt3a.LRP6 Signaling Complex Reveals Multiple Wnt and Dkk1 Binding Sites on LRP6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-6; EXPRESSION; DICKKOPF-1; LIGAND; INTERNALIZATION; KINETICS; ENCODES; PATHWAY; FAMILY; GROWTH	Wnt/beta-catenin signaling is initiated at the cell surface by association of secreted Wnt with its receptors Frizzled (Fz) and low density lipoprotein receptor-related protein 5/6 (LRP5/6). The study of these molecular interactions has been a significant technical challenge because the proteins have been inaccessible in sufficient purity and quantity. In this report we describe insect cell expression and purification of soluble mouse Fz8 cysteine-rich domain and human LRP6 extracellular domain and show that they inhibit Wnt/beta-catenin signaling in cellular assays. We determine the binding affinities of Wnts and Dickkopf 1 (Dkk1) to the relevant co-receptors and reconstitute in vitro the Fz8 CRD.Wnt3a.LRP6 signaling complex. Using purified fragments of LRP6, we further show that Wnt3a binds to a region including only the third and fourth beta-propeller domains of LRP6 (E3E4). Surprisingly, we find that Wnt9b binds to a different part of the LRP6 extracellular domain, E1E2, and we demonstrate that Wnt3a and Wnt9b can bind to LRP6 simultaneously. Dkk1 binds to both E1E2 and E3E4 fragments and competes with both Wnt3a and Wnt9b for binding to LRP6. The existence of multiple, independent Wnt binding sites on the LRP6 co-receptor suggests new possibilities for the architecture of Wnt signaling complexes and a model for broad-spectrum inhibition of Wnt/beta-catenin signaling by Dkk1.	[Bourhis, Eric; Bazan, J. Fernando; Ernst, James; Cochran, Andrea G.; Hannoush, Rami N.] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Tam, Christine; Franke, Yvonne; Hwang, Jiyoung] Genentech Inc, Dept Biol Struct, San Francisco, CA 94080 USA; [Ernst, James] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Costa, Mike] Genentech Inc, Dept Canc Targets, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Hannoush, RN (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, San Francisco, CA 94080 USA.	hannoush.rami@gene.com	Bazan, J. Fernando/B-4562-2010	Cochran, Andrea/0000-0001-6469-795X				Abdiche Y, 2008, ANAL BIOCHEM, V377, P209, DOI 10.1016/j.ab.2008.03.035; Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; Hannoush RN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003498; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Koduri V, 2007, BIOCHEMISTRY-US, V46, P6570, DOI 10.1021/bi700049g; Liu CC, 2009, J BIOL CHEM, V284, P15299, DOI 10.1074/jbc.M807285200; MacDonald BT, 2007, BONE, V41, P331, DOI 10.1016/j.bone.2007.05.009; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Morrell NT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002930; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Rulifson EJ, 2000, MOL CELL, V6, P117, DOI 10.1016/S1097-2765(00)00013-7; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; Smith PA, 1998, NUCLEIC ACIDS RES, V26, P1414, DOI 10.1093/nar/26.6.1414; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015	38	143	174	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9172	9179		10.1074/jbc.M109.092130	http://dx.doi.org/10.1074/jbc.M109.092130			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20093360	Green Published, hybrid			2022-12-27	WOS:000275553700066
J	Rajala, RVS; Tanito, M; Neel, BG; Rajala, A				Rajala, Raju V. S.; Tanito, Masaki; Neel, Benjamin G.; Rajala, Ammaji			Enhanced Retinal Insulin Receptor-activated Neuroprotective Survival Signal in Mice Lacking the Protein-tyrosine Phosphatase-1B Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; ROD PHOTORECEPTOR CELLS; ENDOPLASMIC-RETICULUM; INCREASED ABUNDANCE; NEGATIVE REGULATOR; IN-VIVO; 1B; PHOSPHORYLATION; PTP1B; EXPRESSION	Protein-tyrosine phosphatase 1B (PTP1B) has been implicated in the negative regulation of insulin signaling. We previously demonstrated that light-induced tyrosine phosphorylation of the retinal insulin receptor (IR) results in the activation of phosphoinositide 3-kinase/Akt survival pathway in rod photoreceptor cells. The molecular mechanism behind light-induced activation of IR is not known. We investigated the in vivo mechanism of IR activation and found that PTP1B activity in dark-adapted retinas was significantly higher than in light-adapted retinas. We made a novel finding in this study that the light-dependent regulation of PTP1B activity is signaled through photobleaching of rhodopsin. Conditional deletion of PTP1B in rod photoreceptors by the Cre-loxP system resulted in enhanced IR signaling. Further PTP1B activity negatively regulated the neuroprotective survival signaling in the retina. One of the challenging questions in the retina research is how mutations in human rhodopsin gene slowly disable and eventually disrupt photoreceptor functions. Our studies suggest that a defect in the photobleaching of rhodopsin and mutation in rhodopsin gene enhances the activity of PTP1B, and this activated activity could down-regulate the IR survival signaling. Our studies suggest that PTP1B antagonists could be potential therapeutic agents to treat stress-induced photoreceptor degenerations and provide further evidence that rhodopsin photoexcitation may trigger signaling events alternative to the classic phototransduction.	[Rajala, Raju V. S.; Tanito, Masaki; Rajala, Ammaji] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.; Tanito, Masaki; Rajala, Ammaji] Univ Oklahoma, Hlth Sci Ctr, Dean A McGee Eye Inst, Oklahoma City, OK 73104 USA; [Neel, Benjamin G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA; [Neel, Benjamin G.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program, Boston, MA 02115 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rajala, RVS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	raju-rajala@ouhsc.edu			National Institutes of Health [EY016507, EY00871, P30-EY12190]; NEI; NCRR [P20-RR17703]; Research to Prevent Blindness Inc.; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017703] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY012190, R01EY000871, R01EY016507] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY016507 and EY00871. This work was also supported by NEI, NIH Core Grant P30-EY12190, NCRR COBRE core modules P20-RR17703, and Research to Prevent Blindness Inc.	Ahmad F, 1997, METABOLISM, V46, P1140, DOI 10.1016/S0026-0495(97)90206-7; Ahmad F, 1997, J CLIN INVEST, V100, P449, DOI 10.1172/JCI119552; AHMAD F, 1995, J CLIN INVEST, V95, P2806, DOI 10.1172/JCI117985; AHMAD F, 1995, METABOLISM, V44, P1175, DOI 10.1016/0026-0495(95)90012-8; AHMAD F, 1995, J BIOL CHEM, V270, P20503, DOI 10.1074/jbc.270.35.20503; Barber AJ, 2001, J BIOL CHEM, V276, P32814, DOI 10.1074/jbc.M104738200; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Bleyle LA, 1999, CELL SIGNAL, V11, P719, DOI 10.1016/S0898-6568(99)00043-1; Byon JCH, 1998, MOL CELL BIOCHEM, V182, P101, DOI 10.1023/A:1006868409841; Byon JCH, 1997, P SOC EXP BIOL MED, V216, P1; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Chen ZX, 2010, CELL DEATH DIFFER, V17, P408, DOI 10.1038/cdd.2009.132; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; DATTA K, 1995, MOL CELL BIOL, V15, P2304; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Frolich L, 1998, J NEURAL TRANSM, V105, P423, DOI 10.1007/s007020050068; Goldstein Barry J., 2001, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V1, P265, DOI 10.2174/1568008013341163; Goldstein BJ, 2005, DIABETES, V54, P311, DOI 10.2337/diabetes.54.2.311; Goldstein BJ, 1998, MOL CELL BIOCHEM, V182, P91, DOI 10.1023/A:1006812218502; Goldstein BJ, 2002, J CLIN ENDOCR METAB, V87, P2474, DOI 10.1210/jc.87.6.2474; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HASHIMOTO N, 1992, J BIOL CHEM, V267, P13811; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Hetman M, 2000, J NEUROSCI, V20, P2567; KENNER KA, 1993, J BIOL CHEM, V268, P25455; Kenner KA, 1996, J BIOL CHEM, V271, P19810, DOI 10.1074/jbc.271.33.19810; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Klenk C, 2006, J BIOL CHEM, V281, P8357, DOI 10.1074/jbc.M513703200; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Krishnamoorthy RR, 1999, J BIOL CHEM, V274, P3734, DOI 10.1074/jbc.274.6.3734; KUHNE MR, 1993, J BIOL CHEM, V268, P11479; Le YZ, 2006, MOL VIS, V12, P389; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Li GY, 2008, J NEUROCHEM, V107, P1382, DOI 10.1111/j.1471-4159.2008.05707.x; Maegawa H, 1999, J BIOL CHEM, V274, P30236, DOI 10.1074/jbc.274.42.30236; Myers MG, 1998, J BIOL CHEM, V273, P26908, DOI 10.1074/jbc.273.41.26908; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Organisciak DT, 1998, INVEST OPHTH VIS SCI, V39, P1107; Osborne NN, 2008, J NEUROCHEM, V105, P2013, DOI 10.1111/j.1471-4159.2008.05320.x; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; Rajala A, 2008, J BIOL CHEM, V283, P19781, DOI 10.1074/jbc.M802374200; Rajala A, 2007, J BIOL CHEM, V282, P9865, DOI 10.1074/jbc.M608845200; Rajala RVS, 2010, J LIPID RES, V51, P4, DOI 10.1194/jlr.R000232; Rajala RVS, 2009, INVEST OPHTH VIS SCI, V50, P1033, DOI 10.1167/iovs.08-2851; Rajala RVS, 2005, BIOCHEMISTRY-US, V44, P15461, DOI 10.1021/bi0513148; Rajala RVS, 2002, J BIOL CHEM, V277, P43319, DOI 10.1074/jbc.M206355200; RAPP LM, 1992, INVEST OPHTH VIS SCI, V33, P3367; Ravichandran LV, 2001, MOL ENDOCRINOL, V15, P1768, DOI 10.1210/me.15.10.1768; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Salmeen A, 2003, NATURE, V423, P769, DOI 10.1038/nature01680; Seely BL, 1996, DIABETES, V45, P1379, DOI 10.2337/diabetes.45.10.1379; Simoncic PD, 2006, CAN J PHYSIOL PHARM, V84, P667, DOI 10.1139/Y06-012; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Takahashi M, 1996, NEUROSCI LETT, V204, P201, DOI 10.1016/0304-3940(96)12357-0; Tanito M, 2007, FREE RADICAL BIO MED, V42, P1838, DOI 10.1016/j.freeradbiomed.2007.03.018; Tanito M, 2007, INVEST OPHTH VIS SCI, V48, P1864, DOI 10.1167/iovs.06-1065; Terman A, 2010, ANTIOXID REDOX SIGN, V12, P503, DOI 10.1089/ars.2009.2598; Tonks NK, 2003, FEBS LETT, V546, P140, DOI 10.1016/S0014-5793(03)00603-3; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08	71	31	32	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8894	8904		10.1074/jbc.M109.070854	http://dx.doi.org/10.1074/jbc.M109.070854			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20061388	Green Published, hybrid			2022-12-27	WOS:000275553700041
J	Yang, RQ; Zhan, M; Nalabothula, NR; Yang, QY; Indig, FE; Carrier, F				Yang, Ruiqing; Zhan, Ming; Nalabothula, Narasimha Rao; Yang, Qingyuan; Indig, Fred E.; Carrier, France			Functional Significance for a Heterogenous Ribonucleoprotein A18 Signature RNA Motif in the 3 '-Untranslated Region of Ataxia Telangiectasia Mutated and Rad3-related (ATR) Transcript	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGE-INDUCIBLE TRANSCRIPTS; TARGET MESSENGER-RNAS; POSTTRANSCRIPTIONAL REGULATION; BINDING PROTEINS; KINASE; IDENTIFICATION; GENOME; THIOREDOXIN; INHIBITION; COMPLEXES	The predominantly nuclear heterogenous ribonucleoprotein A18 (hnRNP A18) translocates to the cytosol in response to cellular stress and increases translation by specifically binding to the 3'-untranslated region (UTR) of several mRNA transcripts and the eukaryotic initiation factor 4G. Here, we identified a 51-nucleotide motif that is present 11.49 times more often in the 3'-UTR of hnRNP A18 mRNA targets than in the UniGene data base. This motif was identified by computational analysis of primary sequences and secondary structures of hnRNP A18 mRNA targets against the unaligned sequences. Band shift analyses indicate that the motif is sufficient to confer binding to hnRNP A18. A search of the entire UniGene data base indicates that the hnRNP A18 motif is also present in the 3'-UTR of the ataxia telangiectasia mutated and Rad3-related (ATR) mRNA. Validation of the predicted hnRNP A18 motif is provided by amplification of endogenous ATR transcript on polysomal fractions immunoprecipitated with hnRNP A18. Moreover, overexpression of hnRNP A18 results in increased ATR protein levels and increased phosphorylation of Chk1, a preferred ATR substrate, in response to UV radiation. In addition, our data indicate that inhibition of casein kinase II or GSK3 beta significantly reduced hnRNP A18 cytosolic translocation in response to UV radiation. To our knowledge, this constitutes the first demonstration of a post-transcriptional regulatory mechanism for ATR activity. hnRNP A18 could thus become a new target to trigger ATR activity as back-up stress response mechanisms to functionally compensate for absent or defective responders.	[Yang, Ruiqing; Nalabothula, Narasimha Rao; Yang, Qingyuan; Carrier, France] Univ Maryland, Dept Radiat Oncol, Marlene & Stewart Greenebaum Canc Ctr, Sch Med, Baltimore, MD 21201 USA; [Zhan, Ming] NIA, Res Resources Branch, Intramural Res Program, Baltimore, MD 21224 USA; [Indig, Fred E.] NIA, NIH, Baltimore, MD 21224 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Carrier, F (corresponding author), 655 W Baltimore St, Baltimore, MD 21201 USA.	fcarr001@umaryland.edu		Carrier, France/0000-0002-5517-5284	National Institutes of Health [RO1 GM57827, RO1 1CA116491-01]; University of Maryland, Baltimore; NATIONAL CANCER INSTITUTE [R01CA116491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZICAG000615, ZICAG000619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland, Baltimore; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by National Institutes of Health Grants RO1 GM57827 and RO1 1CA116491-01 (to F. C.). This work was also supported by funds from the graduate program in biochemistry of the University of Maryland, Baltimore (to R. Y.).	Abraham RT, 2004, DNA REPAIR, V3, P919, DOI 10.1016/j.dnarep.2004.04.003; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Connelly MA, 1996, GENE, V175, P271, DOI 10.1016/0378-1119(96)00135-7; Cuadrado M, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-7; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; DREYFUSS G, 1993, ANNU REV BIOCHEM, V62, P289, DOI 10.1146/annurev.bi.62.070193.001445; FORNACE AJ, 1988, P NATL ACAD SCI USA, V85, P8800, DOI 10.1073/pnas.85.23.8800; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; Hammond EM, 2004, CANCER RES, V64, P6556, DOI 10.1158/0008-5472.CAN-04-1520; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kelley MR, 2008, ANTI-CANCER AGENT ME, V8, P417, DOI 10.2174/187152008784220294; Kim HS, 2007, MOL CELL BIOL, V27, P6806, DOI 10.1128/MCB.01036-07; Kim L, 2000, CURR OPIN GENET DEV, V10, P508, DOI 10.1016/S0959-437X(00)00120-9; Krecic AM, 1999, CURR OPIN CELL BIOL, V11, P363, DOI 10.1016/S0955-0674(99)80051-9; Liu QH, 2000, GENE DEV, V14, P1448; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Mannino JL, 2001, GENE, V272, P35, DOI 10.1016/S0378-1119(01)00543-1; Mazan-Mamczarz K, 2009, NUCLEIC ACIDS RES, V37, P204, DOI 10.1093/nar/gkn929; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Pluemsampant S, 2008, INT J CANCER, V122, P333, DOI 10.1002/ijc.23094; Savitsky K, 1997, NUCLEIC ACIDS RES, V25, P1678, DOI 10.1093/nar/25.9.1678; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Sheikh MS, 1997, J BIOL CHEM, V272, P26720, DOI 10.1074/jbc.272.42.26720; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Wellmann S, 2004, J CELL SCI, V117, P1785, DOI 10.1242/jcs.01026; Williamson JR, 2000, NAT STRUCT BIOL, V7, P834, DOI 10.1038/79575; Yang CL, 2001, J BIOL CHEM, V276, P47277, DOI 10.1074/jbc.M105396200; Yang RQ, 2006, NUCLEIC ACIDS RES, V34, P1224, DOI 10.1093/nar/gkj519	33	40	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8887	8893		10.1074/jbc.M109.013128	http://dx.doi.org/10.1074/jbc.M109.013128			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20103595	hybrid, Green Published			2022-12-27	WOS:000275553700040
J	Zhang, PL; Andrianakos, R; Yang, Y; Liu, CM; Lu, WG				Zhang, Peilin; Andrianakos, Rose; Yang, Yang; Liu, Chunming; Lu, Wange			Kruppel-like Factor 4 (Klf4) Prevents Embryonic Stem (ES) Cell Differentiation by Regulating Nanog Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-RENEWAL; C-MYC; MOUSE; SOX2; PLURIPOTENCY; ACTIVATION; STAT3; OCT4; FIBROBLASTS; INHIBITION	Transcription factor Kruppel-like factor 4 (Klf4) is essential for somatic cell reprogramming. In addition, Klf4 seems to play a redundant role along with other Klf family proteins in embryonic stem (ES) cell self-renewal. However, how Klf4 regulates ES cell self-renewal and somatic cell reprogramming is still poorly understood. Here we report that Klf4 is required for both ES cell self-renewal and maintenance of pluripotency and that the expression of Klf4 prevents ES cell differentiation in response to withdrawal of leukemia inhibitory factor (LIF) or bone morphogenetic protein 4 (BMP4). In addition, Klf4 directly binds to the promoter region of Nanog and regulates its expression. Expression of Nanog prevents ES cell differentiation even when Klf4 gene expression is knocked down. On the other hand, knockdown of Nanog expression induces differentiation of ES cells that overexpress Klf4. Taken together, these results demonstrate that Klf4 functions upstream of Nanog in ES cell self-renewal and in preventing ES cell differentiation.	[Zhang, Peilin; Andrianakos, Rose; Yang, Yang; Lu, Wange] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Liu, Chunming] Univ Kentucky, Dept Mol & Cellular Biochem, Markey Canc Ctr, Lexington, KY 40506 USA	University of Southern California; University of Kentucky	Lu, WG (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA.	wangelu@usc.edu	Yang-Hartwich, Yang/B-3489-2015		California Institute of Regenerative Medicine (CIRM); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071976] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by a grant from the California Institute of Regenerative Medicine (CIRM).	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McConnell BB, 2007, BIOESSAYS, V29, P946, DOI 10.1002/bies.20622; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; Orkin SH, 2005, CELL, V122, P828, DOI 10.1016/j.cell.2005.09.002; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wei Z, 2009, STEM CELLS, V27, P2969, DOI 10.1002/stem.231; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	41	160	166	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					9180	9189		10.1074/jbc.M109.077958	http://dx.doi.org/10.1074/jbc.M109.077958			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071344	Green Published, hybrid			2022-12-27	WOS:000275553700067
J	Yoneda, K; Fukuda, J; Sakuraba, H; Ohshima, T				Yoneda, Kazunari; Fukuda, Junya; Sakuraba, Haruhiko; Ohshima, Toshihisa			First Crystal Structure of L-Lysine 6-Dehydrogenase as an NAD-dependent Amine Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-GRAPHICS PROJECT; EPSILON-DEHYDROGENASE; AGROBACTERIUM-TUMEFACIENS; PSEUDOMONAS-PUTIDA; DOMAIN MOTIONS; GENE CLONING; PURIFICATION; HYDROGEN; DATABASE; DENSITY	A gene encoding an L-lysine dehydrogenase was identified in the hyperthermophilic archaeon Pyrococcus horikoshii. The gene was overexpressed in Escherichia coli, and its product was purified and characterized. The expressed enzyme is the most thermostable L-lysine dehydrogenase yet described, with a half-life of 180 min at 100 C. The product of the enzyme's catalytic activity is Delta(1)-piperideine-6-carboxylate, which makes this enzyme an L-lysine 6-dehydrogenase (EC 1.4.1.18) that catalyzes the reductive deamination of the epsilon-amino group and a type of NAD-dependent amine dehydrogenase. The three-dimensional structure of the enzyme was determined using the mercury-based multiple-wavelength anomalous dispersion method at a resolution of 2.44 angstrom in the presence of NAD and sulfate ion. The asymmetric unit consisted of two subunits, and a crystallographic 2-fold axis generated the functional dimer. Each monomer consisted of a Rossmann fold domain and a C-terminal catalytic domain, and the fold of the catalytic domain showed similarity to that of saccharopine reductase. Notably, the structures of subunits A and B differed significantly. In subunit A, the active site contained a sulfate ion that was not seen in subunit B. Consequently, subunit A adopted a closed conformation, whereas subunit B adopted an open one. In each subunit, one NAD molecule was bound to the active site in an anti-conformation, indicating that the enzyme makes use of pro-R-specific hydride transfer between the two hydrides at C-4 of NADH ( type A specificity). This is the first description of the three-dimensional structure of L-lysine 6-dehydrogenase as an NAD-dependent amine dehydrogenase.	[Fukuda, Junya; Ohshima, Toshihisa] Kyushu Univ, Fac Agr, Inst Genet Resources, Fukuoka 8128581, Japan; Tokai Univ, Sch Agr, Dept Biosci, Kumamoto 8691404, Japan; [Sakuraba, Haruhiko] Kagawa Univ, Dept Appl Biol Sci, Fac Agr, Miki, Kagawa 7610795, Japan	Kyushu University; Tokai University; Kagawa University	Ohshima, T (corresponding author), Kyushu Univ, Fac Agr, Inst Genet Resources, Fukuoka 8128581, Japan.	ohshima@agr.kyushu-u.ac.jp		Yoneda, Kazunari/0000-0001-9152-8772	Ministry of Education, Science, Sports, Culture, and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Science, Sports, Culture, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the "National Project on Protein Structural and Functional Analysis" promoted by the Ministry of Education, Science, Sports, Culture, and Technology of Japan and by a grant-in-aid for scientific research (C) from the Japan Society for the Promotion of Science.	BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; BENNER SA, 1982, EXPERIENTIA, V38, P633, DOI 10.1007/BF02327092; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGI W, 1966, NATURE, V211, P854, DOI 10.1038/211854a0; DURHAM DR, 1978, J BACTERIOL, V134, P837, DOI 10.1128/JB.134.3.837-843.1978; HASHIMOTO H, 1990, AGR BIOL CHEM TOKYO, V54, P291, DOI 10.1080/00021369.1990.10869934; HASHIMOTO H, 1989, J BIOCHEM, V106, P76, DOI 10.1093/oxfordjournals.jbchem.a122823; HASHIMOTO H, 1989, AGR BIOL CHEM TOKYO, V53, P1175, DOI 10.1080/00021369.1989.10869411; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Heydari M, 2004, APPL ENVIRON MICROB, V70, P937, DOI 10.1128/AEM.70.2.937-942.2004; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HUMMEL W, 1989, EUR J BIOCHEM, V184, P1, DOI 10.1111/j.1432-1033.1989.tb14983.x; Johansson E, 2000, STRUCTURE, V8, P1037, DOI 10.1016/S0969-2126(00)00512-8; KUSAKABE H, 1980, J BIOL CHEM, V255, P976; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Limburg J, 2005, ARCH BIOCHEM BIOPHYS, V436, P8, DOI 10.1016/j.abb.2004.11.024; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MISONO H, 1990, J BIOCHEM-TOKYO, V107, P169, DOI 10.1093/oxfordjournals.jbchem.a123003; MISONO H, 1982, J BACTERIOL, V150, P398, DOI 10.1128/JB.150.1.398-401.1982; MISONO H, 1989, J BIOCHEM, V105, P1002, DOI 10.1093/oxfordjournals.jbchem.a122757; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NOZAKI M, 1987, METHOD ENZYMOL, V142, P650; OHSHIMA T, 1978, J BIOL CHEM, V253, P5719; OHSHIMA T, 1989, TRENDS BIOTECHNOL, V7, P210, DOI 10.1016/0167-7799(89)90106-6; Ohshima T., 2000, STEREOSELECTIVE BIOC, P877; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Qi GY, 2005, BIOINFORMATICS, V21, P2832, DOI 10.1093/bioinformatics/bti420; Ruldeekulthamrong P, 2008, BMB REP, V41, P790, DOI 10.5483/BMBRep.2008.41.11.790; Satoh A, 2002, J BIOL CHEM, V277, P2830, DOI 10.1074/jbc.M109090200; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	38	7	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8444	8453		10.1074/jbc.M109.084384	http://dx.doi.org/10.1074/jbc.M109.084384			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20056607	Green Published, hybrid			2022-12-27	WOS:000275413800059
J	Gesteira, TF; Coulson-Thomas, VJ; Taunay-Rodrigues, A; Oliveira, V; Thacker, BE; Juliano, MA; Pasqualini, R; Arap, W; Tersariol, ILS; Nader, HB; Esko, JD; Pinhal, MAS				Gesteira, Tarsis F.; Coulson-Thomas, Vivien J.; Taunay-Rodrigues, Alessandro; Oliveira, Vitor; Thacker, Bryan E.; Juliano, Maria A.; Pasqualini, Renata; Arap, Wadih; Tersariol, Ivarne L. S.; Nader, Helena B.; Esko, Jeffrey D.; Pinhal, Maria A. S.			Inhibitory Peptides of the Sulfotransferase Domain of the Heparan Sulfate Enzyme, N-Deacetylase-N-sulfotransferase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-DEACETYLASE/N-SULFOTRANSFERASE; PHAGE DISPLAY; GLYCOSAMINOGLYCAN BIOSYNTHESIS; MOLECULAR DIVERSITY; BINDING-SITE; LIBRARY; LIGAND; DISCOVERY; PROTEOGLYCANS; VASCULATURE	N-Deacetylase-N-sulfotransferase 1 (Ndst1) catalyzes the initial modification of heparan sulfate and heparin during their biosynthesis by removal of acetyl groups from subsets of N-acetylglucosamine units and subsequent sulfation of the resulting free amino groups. In this study, we used a phage display library to select peptides that interact with Ndst1, with the aim of finding inhibitors of the enzyme. The phage library consisted of cyclic random 10-mer peptides expressed in the phage capsid protein pIII. Selection was based on the ability of engineered phage to bind to recombinant murine Ndst1 (mNdst1) and displacement with heparin. Peptides that were enriched through multiple cycles of binding and disassociation displayed two specific sequences, CRGWRGEKIGNC and CNMQALSMPVTC. Both peptides inhibited mNdst1 activity in vitro, however, by distinct mechanisms. The peptide CRGWRGEKIGNC presents a chemokine-like repeat motif (BXX, where B represents a basic amino acid and X is a noncharged amino acid) and binds to heparan sulfate, thus blocking the binding of substrate to the enzyme. The peptide NMQALSMPVT inhibits mNdst1 activity by direct interaction with the enzyme near the active site. The discovery of inhibitory peptides in this way suggests a method for developing peptide inhibitors of heparan sulfate biosynthesis.	[Tersariol, Ivarne L. S.; Nader, Helena B.; Pinhal, Maria A. S.] Univ Fed Sao Paulo, Dept Bioquim, BR-04044020 Sao Paulo, Brazil; [Oliveira, Vitor; Juliano, Maria A.] Univ Fed Sao Paulo, Dept Biofis, BR-04044020 Sao Paulo, Brazil; [Pasqualini, Renata; Arap, Wadih] Univ Texas MD Anderson Canc Ctr, David H Koch Ctr, Houston, TX 77030 USA; [Tersariol, Ivarne L. S.] Univ Mogi das Cruzes, Ctr Interdisciplinar Invest Bioquim, BR-05508000 Sao Paulo, Brazil; [Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Thacker, Bryan E.] Univ Calif San Diego, Biomed Sci Grad Program, San Diego, CA USA	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP); University of Texas System; UTMD Anderson Cancer Center; Universidade de Mogi das Cruzes; University of California System; University of California San Diego; University of California System; University of California San Diego	Pinhal, MAS (corresponding author), Univ Fed Sao Paulo, Dept Bioquim, Rua Tres Maio, BR-04044020 Sao Paulo, Brazil.	cidapinhal@gmail.com	Oliveira, Vitor/AAT-5981-2020; Pinhal, Maria Aparecida Silva/J-1797-2012; Oliveira, Vitor/L-3709-2013; Nader, Helena Bonciani/D-9253-2012; Complexos, INCT Fluidos/H-9172-2013; Dos Santos Tersariol, Ivarne Luis/G-4042-2012	Pinhal, Maria Aparecida Silva/0000-0003-4001-1663; Oliveira, Vitor/0000-0002-4662-1377; Dos Santos Tersariol, Ivarne Luis/0000-0002-8399-4535; NADER, HELENA/0000-0002-7569-2166; Thacker, Bryan/0000-0003-0517-0810				Aikawa J, 1999, J BIOL CHEM, V274, P2690, DOI 10.1074/jbc.274.5.2690; Aikawa J, 2001, J BIOL CHEM, V276, P5876, DOI 10.1074/jbc.M009606200; Armstrong JI, 2000, ANGEW CHEM INT EDIT, V39, P1303, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1303::AID-ANIE1303>3.0.CO;2-0; Armstrong JI, 2001, ORG LETT, V3, P2657, DOI 10.1021/ol0162217; BAME KJ, 1991, J BIOL CHEM, V266, P10287; BAME KJ, 1991, J BIOL CHEM, V266, P12461; Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Berninsone P, 1998, J BIOL CHEM, V273, P25556, DOI 10.1074/jbc.273.40.25556; Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817; Brown JR, 2007, CRIT REV BIOCHEM MOL, V42, P481, DOI 10.1080/10409230701751611; Bulow HE, 2006, ANNU REV CELL DEV BI, V22, P375, DOI 10.1146/annurev.cellbio.22.010605.093433; Burritt JB, 1996, ANAL BIOCHEM, V238, P1, DOI 10.1006/abio.1996.0241; Burster T, 2007, BIOCHEM PHARMACOL, V74, P1514, DOI 10.1016/j.bcp.2007.07.037; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chapman E, 2002, J AM CHEM SOC, V124, P14524, DOI 10.1021/ja021086u; Conrad H. E., 1998, HEPARIN BINDING PROT; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; CWIRLA SE, 1990, P NATL ACAD SCI USA, V87, P6378, DOI 10.1073/pnas.87.16.6378; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fritz T A, 2001, Methods Mol Biol, V171, P317; GASTEIGER J, 1981, ORG MAGN RESONANCE, V15, P353, DOI 10.1002/mrc.1270150408; Gorokhov A, 2000, BIOPHYS J, V79, P2909, DOI 10.1016/S0006-3495(00)76528-3; Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006; Grobe K, 2002, BBA-GEN SUBJECTS, V1573, P209, DOI 10.1016/S0304-4165(02)00386-0; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hubbard SJ, 1993, NACCESS COMPUTER PRO; INOUE Y, 1976, CARBOHYD RES, V46, P87, DOI 10.1016/S0008-6215(00)83533-8; Jakobkiewicz-Banecka J, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-26; Jarvinen TAH, 2007, AM J PATHOL, V171, P702, DOI 10.2353/ajpath.2007.061251; Jenniskens GJ, 2003, FASEB J, V17, P878, DOI 10.1096/fj.02-0572fje; Kakuta Y, 1999, J BIOL CHEM, V274, P10673, DOI 10.1074/jbc.274.16.10673; Koike R, 2008, J MOL BIOL, V379, P397, DOI 10.1016/j.jmb.2008.04.019; KOIVUNEN E, 1994, J CELL BIOL, V124, P373, DOI 10.1083/jcb.124.3.373; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Laurie ATR, 2005, BIOINFORMATICS, V21, P1908, DOI 10.1093/bioinformatics/bti315; NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565; NADER HB, 1990, J BIOL CHEM, V265, P16807; PASQUALINI R, 1995, J CELL BIOL, V130, P1189, DOI 10.1083/jcb.130.5.1189; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Peletskaya EN, 1996, MOL DIVERS, V2, P13, DOI 10.1007/BF01718695; Roberts ALK, 2006, PEDIATR RES, V60, P309, DOI 10.1203/01.pdr.0000233037.00707.da; Ruoslahti E, 2000, ANNU REV IMMUNOL, V18, P813, DOI 10.1146/annurev.immunol.18.1.813; Sampaio L. O., 2006, INSIGHTS CARBOHYDRAT; Schuksz M, 2008, P NATL ACAD SCI USA, V105, P13075, DOI 10.1073/pnas.0805862105; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Sueyoshi T, 1998, FEBS LETT, V433, P211, DOI 10.1016/S0014-5793(98)00913-2; Verdugo DE, 2001, J MED CHEM, V44, P2683, DOI 10.1021/jm010171u; Weber G., 1992, PROTEIN INTERACTIONS; Wei Z, 1999, J BIOL CHEM, V274, P1966, DOI 10.1074/jbc.274.4.1966; Wrighton NC, 1996, SCIENCE, V273, P458, DOI 10.1126/science.273.5274.458; Zhang LJ, 2006, METHOD ENZYMOL, V416, P205, DOI 10.1016/S0076-6879(06)16013-9	56	26	26	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5338	5346		10.1074/jbc.M110.100719	http://dx.doi.org/10.1074/jbc.M110.100719			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	20129923	Green Published, hybrid			2022-12-27	WOS:000287230600042
J	Bayot, A; Gareil, M; Rogowska-Wrzesinska, A; Roepstorff, P; Friguet, B; Bulteau, AL				Bayot, Aurelien; Gareil, Monique; Rogowska-Wrzesinska, Adelina; Roepstorff, Peter; Friguet, Bertrand; Bulteau, Anne-Laure			Identification of Novel Oxidized Protein Substrates and Physiological Partners of the Mitochondrial ATP-dependent Lon-like Protease Pim1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-AAA PROTEASE; YEAST SACCHAROMYCES-CEREVISIAE; DNA NUCLEOIDS; MOLECULAR CHAPERONES; OXIDATIVE STRESS; QUALITY-CONTROL; MISFOLDED PROTEINS; MASS-SPECTROMETRY; ESCHERICHIA-COLI; INNER MEMBRANE	ATP-dependent proteases are currently emerging as key regulators of mitochondrial functions. Among these proteolytic systems, Pim1, a Lon-like serine protease in Saccharomyces cerevisiae, is involved in the control of selective protein turnover in the mitochondrial matrix. In the absence of Pim1, yeast cells have been shown to accumulate electron-dense inclusion bodies in the matrix space, to lose integrity of mitochondrial genome, and to be respiration-deficient. Because of the severity of phenotypes associated with the depletion of Pim1, this protease appears to be an essential component of the protein quality control machinery in mitochondria and to exert crucial functions during the biogenesis of this organelle. Nevertheless, its physiological substrates and partners are not fully characterized. Therefore, we used the combination of different proteomic techniques to assess the nature of oxidized protein substrates and physiological partners of Pim1 protease under non-repressing growth conditions. The results presented here supply evidence that Pim1-mediated proteolysis is required for elimination of oxidatively damaged proteins in mitochondria.	[Bayot, Aurelien; Gareil, Monique; Friguet, Bertrand; Bulteau, Anne-Laure] Univ Paris 06, Lab Biol Cellulaire Vieillissement, UR4, F-75252 Paris 05, France; [Rogowska-Wrzesinska, Adelina; Roepstorff, Peter] Univ So Denmark, Dept Biochem & Mol Biol, Prot Res Grp, DK-5230 Odense, Denmark	UDICE-French Research Universities; Sorbonne Universite; University of Southern Denmark	Friguet, B (corresponding author), Univ Paris 06, Lab Biol Cellulaire Vieillissement, UR4, Case Courrier 256,Batiment A,5eme Etage,7 Quai St, F-75252 Paris 05, France.	bertrand.friguet@snv.jussieu.fr; anne-laure.bulteau@upmc.fr	bulteau, anne-laure/AAN-4004-2020; Rogowska-Wrzesinska, Adelina/F-2888-2013	Rogowska-Wrzesinska, Adelina/0000-0002-9876-0061; Bayot, Aurelien/0000-0001-7236-9948; Friguet, Bertrand/0000-0001-8085-1961	Ministere de l'Education Nationale, de la Recherche, et de la Technologie (MENRT); Proteomage [LSHM-CT-518230]	Ministere de l'Education Nationale, de la Recherche, et de la Technologie (MENRT); Proteomage	This work was supported by funds from the Ministere de l'Education Nationale, de la Recherche, et de la Technologie (MENRT), and Proteomage Grant LSHM-CT-518230.	Arnold I, 2002, BBA-MOL CELL RES, V1592, P89, DOI 10.1016/S0167-4889(02)00267-7; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Bateman JM, 2002, J BIOL CHEM, V277, P47946, DOI 10.1074/jbc.M209071200; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Bota DA, 2002, FEBS LETT, V532, P103, DOI 10.1016/S0014-5793(02)03638-4; Bulteau AL, 2007, FREE RADICAL BIO MED, V42, P1561, DOI 10.1016/j.freeradbiomed.2007.02.014; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; Chen SH, 2008, NUCLEIC ACIDS RES, V36, P1273, DOI 10.1093/nar/gkm1140; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; FOX TD, 1991, METHOD ENZYMOL, V194, P149; Fu GK, 1998, BIOCHEMISTRY-US, V37, P1905, DOI 10.1021/bi970928c; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gur E, 2008, GENE DEV, V22, P2267, DOI 10.1101/gad.1670908; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; KOBS G, 2001, PROMEGA NOTES, V68, P28; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200; Lefebvre-Legendre L, 2001, J BIOL CHEM, V276, P6789, DOI 10.1074/jbc.M009557200; Leidhold C, 2007, ANN NY ACAD SCI, V1113, P72, DOI 10.1196/annals.1391.011; Leonhard K, 1996, EMBO J, V15, P4218, DOI 10.1002/j.1460-2075.1996.tb00796.x; LITSKE JG, 1986, NUCLEIC ACIDS RES, V14, P9631, DOI 10.1093/nar/14.24.9631; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Lu B, 2003, GENE, V306, P45, DOI 10.1016/S0378-1119(03)00403-7; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; MacAlpine DM, 2000, EMBO J, V19, P767, DOI 10.1093/emboj/19.4.767; Major T, 2006, MOL CELL BIOL, V26, P762, DOI 10.1128/MCB.26.3.762-776.2006; Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Ngo JK, 2007, ANN NY ACAD SCI, V1119, P78, DOI 10.1196/annals.1404.015; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Nomura K, 2004, J BIOL CHEM, V279, P34406, DOI 10.1074/jbc.M404725200; NORAIS N, 1991, J BIOL CHEM, V266, P16541; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Onder O, 2006, MOL CELL PROTEOMICS, V5, P1426, DOI 10.1074/mcp.M600099-MCP200; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rep M, 1996, CURR GENET, V30, P367, DOI 10.1007/s002940050145; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Rosen R, 2002, FEMS MICROBIOL LETT, V207, P9, DOI 10.1111/j.1574-6968.2002.tb11020.x; Rottgers K, 2002, J BIOL CHEM, V277, P45829, DOI 10.1074/jbc.M207152200; Savel'ev AS, 1998, J BIOL CHEM, V273, P20596, DOI 10.1074/jbc.273.32.20596; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Squier TC, 2001, EXP GERONTOL, V36, P1539, DOI 10.1016/S0531-5565(01)00139-5; Stahlberg H, 1999, P NATL ACAD SCI USA, V96, P6787, DOI 10.1073/pnas.96.12.6787; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Suzuki CK, 1997, TRENDS BIOCHEM SCI, V22, P118, DOI 10.1016/S0968-0004(97)01020-7; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; Tatsuta T, 2008, EMBO J, V27, P306, DOI 10.1038/sj.emboj.7601972; van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; VANDYCK L, 1994, J BIOL CHEM, V269, P238; von Janowsky B, 2005, BIOL CHEM, V386, P1307, DOI 10.1515/BC.2005.149; Voos W, 2002, BBA-MOL CELL RES, V1592, P51, DOI 10.1016/S0167-4889(02)00264-1; Wagner I, 1997, EMBO J, V16, P7317, DOI 10.1093/emboj/16.24.7317; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; WANG N, 1993, P NATL ACAD SCI USA, V90, P11247, DOI 10.1073/pnas.90.23.11247; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200	73	74	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11445	11457		10.1074/jbc.M109.065425	http://dx.doi.org/10.1074/jbc.M109.065425			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150421	Green Published, hybrid			2022-12-27	WOS:000276286200051
J	Chen, AC; Guo, LY; Ostaszewski, BL; Selkoe, DJ; LaVoie, MJ				Chen, Allen C.; Guo, Lucie Y.; Ostaszewski, Beth L.; Selkoe, Dennis J.; LaVoie, Matthew J.			Aph-1 Associates Directly with Full-length and C-terminal Fragments of gamma-Secretase Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSMEMBRANE DOMAIN-4; PRESENILIN COMPLEXES; ALZHEIMERS-DISEASE; NOTCH LIGANDS; BETA-PROTEIN; NICASTRIN; PEN-2; MEMBRANE; CLEAVAGE	gamma-Secretase is a ubiquitous, multiprotein enzyme composed of presenilin, nicastrin, Aph-1, and Pen-2. It mediates the intramembrane proteolysis of many type 1 proteins, plays an essential role in numerous signaling pathways, and helps drive the pathogenesis of Alzheimer disease by excising the hydrophobic, aggregation-prone amyloid beta-peptide from the beta-amyloid precursor protein. A central unresolved question is how its many substrates bind and enter the gamma-secretase complex. Here, we provide evidence that both the beta-amyloid precursor protein holoprotein and its C-terminal fragments, the immediate substrates of gamma-secretase, can associate with Aph-1 at overexpressed as well as endogenous protein levels. This association was observed using bi-directional co-immunoprecipitation in multiple systems and detergent conditions, and an beta-amyloid precursor protein-Aph-1 complex was specifically isolated following in situ cross-linking in living cells. In addition, another endogenous canonical gamma-substrate, Jagged, showed association of both its full-length and C-terminal fragment forms with Aph-1. We were also able to demonstrate that this interaction with substrates was conserved across the multiple isoforms of Aph-1 (beta, alpha S, and alpha L), as they were all able to bind beta-amyloid precursor protein with similar affinity. Finally, two highly conserved intramembrane histidines (His-171 and His-197) within Aph-1, which were recently shown to be important for gamma-secretase activity, are required for efficient binding of substrates. Taken together, our data suggest a dominant role for Aph-1 in interacting with gamma-secretase substrates prior to their processing by the proteolytic complex.	[LaVoie, Matthew J.] Brigham & Womens Hosp, Ctr Neurol Dis, Harvard Inst Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	LaVoie, MJ (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Harvard Inst Med, Rm 764, Boston, MA 02115 USA.	mlavoie@rics.bwh.harvard.edu		LaVoie, Matthew/0000-0002-2583-1578	National Institutes of Health [AG015379, AG023094]; Excellence in Biomedical Research; Smith Family and Ludke Family Foundations; NATIONAL INSTITUTE ON AGING [R37AG006173, K01AG023094, P01AG015379] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Excellence in Biomedical Research; Smith Family and Ludke Family Foundations; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG015379 (to D.J.S.) and AG023094 (to M.J.L.). This work was also supported by an award for Excellence in Biomedical Research from The Smith Family and Ludke Family Foundations (to M.J.L.).	Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Berezovska O, 2003, J NEUROSCI, V23, P4560; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Capell A, 2005, J BIOL CHEM, V280, P6471, DOI 10.1074/jbc.M409106200; Chavez-Gutierrez L, 2008, J BIOL CHEM, V283, P20096, DOI 10.1074/jbc.M803040200; Coolen MW, 2005, FASEB J, V19, P175, DOI 10.1096/fj.05-4337fje; Coolen MW, 2005, NEURON, V45, P497, DOI 10.1016/j.neuron.2004.12.054; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P323, DOI 10.1021/bi035748j; Futai E, 2009, J BIOL CHEM, V284, P13013, DOI 10.1074/jbc.M807653200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Hemming ML, 2007, PLOS MED, V4, P1405, DOI 10.1371/journal.pmed.0040262; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Ikeuchi T, 2003, J BIOL CHEM, V278, P7751, DOI 10.1074/jbc.C200711200; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kornilova AY, 2005, P NATL ACAD SCI USA, V102, P3230, DOI 10.1073/pnas.0407640102; LaVoie MJ, 2003, J BIOL CHEM, V278, P37213, DOI 10.1074/jbc.M303941200; LaVoie MJ, 2003, J BIOL CHEM, V278, P34427, DOI 10.1074/jbc.M302659200; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Morais VA, 2003, J BIOL CHEM, V278, P43284, DOI 10.1074/jbc.M305685200; Pardossi-Piquard R, 2009, J BIOL CHEM, V284, P16298, DOI 10.1074/jbc.M109.000067; Prokop S, 2004, J BIOL CHEM, V279, P23255, DOI 10.1074/jbc.M401789200; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; Ray WJ, 1999, J BIOL CHEM, V274, P36801, DOI 10.1074/jbc.274.51.36801; Selkoe DJ, 2007, CELL, V131, P215, DOI 10.1016/j.cell.2007.10.012; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Steiner H, 2008, J BIOL CHEM, V283, P34677, DOI 10.1074/jbc.M709067200; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	46	28	30	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11378	11391		10.1074/jbc.M109.088815	http://dx.doi.org/10.1074/jbc.M109.088815			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145246	hybrid, Green Published			2022-12-27	WOS:000276286200044
J	Lensink, MF; Govaerts, C; Ruysschaert, JM				Lensink, Marc F.; Govaerts, Cedric; Ruysschaert, Jean-Marie			Identification of Specific Lipid-binding Sites in Integral Membrane Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LACTOSE PERMEASE; ESCHERICHIA-COLI; TOPOLOGICAL ORGANIZATION; PHOSPHOLIPID-COMPOSITION; MULTIDRUG TRANSPORTER; ATOMIC CHARGES; PHOSPHATIDYLETHANOLAMINE; BILAYER; DATABASE	Protein-lipid interactions are increasingly recognized as central to the structure and function of membrane proteins. However, with the exception of simplified models, specific protein-lipid interactions are particularly difficult to highlight experimentally. Here, we used molecular dynamics simulations to identify a specific protein-lipid interaction in lactose permease, a prototypical model for transmembrane proteins. The interactions can be correlated with the functional dependence of the protein to specific lipid species. The technique is simple and widely applicable to other membrane proteins, and a variety of lipid matrices can be used.	[Lensink, Marc F.; Govaerts, Cedric; Ruysschaert, Jean-Marie] Univ Libre Bruxelles, B-1050 Brussels, Belgium	Universite Libre de Bruxelles	Lensink, MF (corresponding author), Univ Libre Bruxelles, Blvd Triomphe,CP 263, B-1050 Brussels, Belgium.	marc.lensink@ulb.ac.be	Lensink, Marc F/A-1678-2008	Lensink, Marc F/0000-0003-3957-9470	Region Wallonne of Belgium [515993]	Region Wallonne of Belgium	Supported by DGTRE Contract 515993 from the Region Wallonne of Belgium.	Aksimentiev Aleksei, 2008, V474, P181, DOI 10.1007/978-1-59745-480-3_11; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berendsen H. J. C., 1981, INTERMOLECULAR FORCE, P331, DOI [10.1007/978-94-015-7658-1_21, DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658, DOI 10.1007/978-94-015-7658]; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bogdanov M, 1998, EMBO J, V17, P5255, DOI 10.1093/emboj/17.18.5255; BOGDANOV M, 1995, J BIOL CHEM, V270, P732, DOI 10.1074/jbc.270.2.732; Carpenter EP, 2008, CURR OPIN STRUC BIOL, V18, P581, DOI 10.1016/j.sbi.2008.07.001; CHANDRASEKHAR J, 1984, J AM CHEM SOC, V106, P903, DOI 10.1021/ja00316a012; CHEN CC, 1984, J BIOL CHEM, V259, P150; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; CHIU SW, 1995, BIOPHYS J, V69, P1230, DOI 10.1016/S0006-3495(95)80005-6; Christopher NA, 1996, COMPUT CHEM, V20, P339, DOI 10.1016/0097-8485(95)00075-5; Deol SS, 2004, BIOPHYS J, V87, P3737, DOI 10.1529/biophysj.104.048397; DEVAUX PF, 1985, BIOCHIM BIOPHYS ACTA, V822, P63, DOI 10.1016/0304-4157(85)90004-8; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Dupradeau FY, 2008, NUCLEIC ACIDS RES, V36, pD360, DOI 10.1093/nar/gkm887; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elofsson A, 2007, ANNU REV BIOCHEM, V76, P125, DOI 10.1146/annurev.biochem.76.052705.163539; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guest MF, 2005, MOL PHYS, V103, P719, DOI 10.1080/00268970512331340592; Guvench Olgun, 2008, V443, P63, DOI 10.1007/978-1-59745-177-2_4; Hakizimana P, 2008, J BIOL CHEM, V283, P9369, DOI 10.1074/jbc.M708427200; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; JESSENMARSHALL AE, 1995, J BIOL CHEM, V270, P16251, DOI 10.1074/jbc.270.27.16251; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004; Lange C, 2001, EMBO J, V20, P6591, DOI 10.1093/emboj/20.23.6591; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Lee AG, 2005, MOL BIOSYST, V1, P203, DOI 10.1039/b504527d; Lensink Marc F., 2008, V443, P161, DOI 10.1007/978-1-59745-177-2_9; Lensink MF, 2005, BIOPHYS J, V88, P939, DOI 10.1529/biophysj.104.052787; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lundstrom K, 2007, J CELL MOL MED, V11, P224, DOI 10.1111/j.1582-4934.2007.00028.x; Marrink SJ, 2002, BIOCHEMISTRY-US, V41, P5375, DOI 10.1021/bi015613i; Mazurkiewicz P, 2004, J BIOL CHEM, V279, P103, DOI 10.1074/jbc.M306579200; McAuley KE, 1999, P NATL ACAD SCI USA, V96, P14706, DOI 10.1073/pnas.96.26.14706; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mulliken R.S., 1995, J CHEM PHYS, V23, P1840; Nogi T, 2000, P NATL ACAD SCI USA, V97, P13561, DOI 10.1073/pnas.240224997; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Paila YD, 2009, BBA-BIOMEMBRANES, V1788, P295, DOI 10.1016/j.bbamem.2008.11.020; Powl AM, 2008, BIOCHEMISTRY-US, V47, P12175, DOI 10.1021/bi801352a; Saier MH, 2000, MICROBIOL-SGM, V146, P1775, DOI 10.1099/00221287-146-8-1775; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; STARLING AP, 1995, BIOCHEM J, V310, P875, DOI 10.1042/bj3100875; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; Wakeham MC, 2001, BIOPHYS J, V80, P1395, DOI 10.1016/S0006-3495(01)76112-7; Wang XY, 2002, EMBO J, V21, P5673, DOI 10.1093/emboj/cdf571; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; Xie J, 2006, J BIOL CHEM, V281, P19172, DOI 10.1074/jbc.M602565200; YAMAGUCHI A, 1990, J BIOL CHEM, V265, P15525; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P530, DOI 10.1016/j.bbamem.2006.11.018; Yin Y, 2006, BIOPHYS J, V91, P3972, DOI 10.1529/biophysj.106.085993; Yuan CB, 2004, BIOPHYS J, V86, P3620, DOI 10.1529/biophysj.103.029678; Zhang W, 2005, J BIOL CHEM, V280, P26032, DOI 10.1074/jbc.M504929200; Zhang W, 2003, J BIOL CHEM, V278, P50128, DOI 10.1074/jbc.M309840200	63	29	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10519	10526		10.1074/jbc.M109.068890	http://dx.doi.org/10.1074/jbc.M109.068890			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139086	Green Published, hybrid			2022-12-27	WOS:000276264600038
J	Prieto-Echague, V; Gucwa, A; Craddock, BP; Brown, DA; Miller, WT				Prieto-Echaguee, Victoria; Gucwa, Azad; Craddock, Barbara P.; Brown, Deborah A.; Miller, W. Todd			Cancer-associated Mutations Activate the Nonreceptor Tyrosine Kinase Ack1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR STIMULATION; RECEPTOR SAM DOMAIN; C-SRC; CDC42-ASSOCIATED KINASE; EGF RECEPTOR; CRYSTAL-STRUCTURES; STRUCTURAL BASIS; DOWN-REGULATION; PROTEIN; PHOSPHORYLATION	Ack1 is a nonreceptor tyrosine kinase that participates in tumorigenesis, cell survival, and migration. Relatively little is known about the mechanisms that regulate Ack1 activity. Recently, four somatic missense mutations of Ack1 were identified in cancer tissue samples, but the effects on Ack1 activity, and function have not been described. These mutations occur in the N-terminal region, the C-lobe of the kinase domain, and the SH3 domain. Here, we show that the cancer-associated mutations increase Ack1 autophosphorylation in mammalian cells without affecting localization and increase Ack1 activity in immune complex kinase assays. The cancer-associated mutations potentiate the ability of Ack1 to promote proliferation and migration, suggesting that point mutation is a mechanism for Ack1 deregulation. We propose that the C-terminal Mig6 homology region (MHR) (residues 802-990) participates in inhibitory intramolecular interactions. The isolated kinase domain of Ack1 interacts directly with the MHR, and the cancer-associated E346K mutation prevents binding. Likewise, mutation of a key hydrophobic residue in the MHR (Phe820) prevents the MHR-kinase interaction, activates Ack1, and increases cell migration. Thus, the cancer-associated mutation E346K appears to destabilize an autoinhibited conformation of Ack1, leading to constitutively high Ack1 activity.	[Prieto-Echaguee, Victoria; Craddock, Barbara P.; Miller, W. Todd] SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Gucwa, Azad; Brown, Deborah A.] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Miller, WT (corresponding author), SUNY Stony Brook, Sch Med, Dept Physiol & Biophys, Basic Sci Tower T6, Stony Brook, NY 11794 USA.	todd.miller@stonybrook.edu		Prieto-Echague, Victoria/0000-0001-9924-9591	National Institutes of Health [CA122091]; NATIONAL CANCER INSTITUTE [R01CA122091, R01CA058530] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA122091	Alexandropoulos K, 1996, GENE DEV, V10, P1341, DOI 10.1101/gad.10.11.1341; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Briggs SD, 1997, J BIOL CHEM, V272, P17899, DOI 10.1074/jbc.272.29.17899; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Childress C, 2006, BIOCHEM J, V394, P693, DOI 10.1042/BJ20050576; Eisenmann KM, 1999, NAT CELL BIOL, V1, P507, DOI 10.1038/70302; Galisteo ML, 2006, P NATL ACAD SCI USA, V103, P9796, DOI 10.1073/pnas.0603714103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grovdal LM, 2008, EXP CELL RES, V314, P1292, DOI 10.1016/j.yexcr.2007.12.017; Harada BT, 2008, STRUCTURE, V16, P380, DOI 10.1016/j.str.2007.12.017; Hoehn GT, 1996, ONCOGENE, V12, P903; Hopper NA, 2000, MOL CELL, V6, P65, DOI 10.1016/S1097-2765(00)00008-3; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Kato-Stankiewicz J, 2001, BIOCHEM BIOPH RES CO, V284, P470, DOI 10.1006/bbrc.2001.5004; Kim CA, 2002, NAT STRUCT BIOL, V9, P453, DOI 10.1038/nsb802; Kim CA, 2001, EMBO J, V20, P4173, DOI 10.1093/emboj/20.15.4173; Lietha D, 2007, CELL, V129, P1177, DOI 10.1016/j.cell.2007.05.041; Linseman DA, 2001, J BIOL CHEM, V276, P5622, DOI 10.1074/jbc.M006812200; LIU XQ, 1993, ONCOGENE, V8, P1119; Lougheed JC, 2004, J BIOL CHEM, V279, P44039, DOI 10.1074/jbc.M406703200; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Mahajan NP, 2007, P NATL ACAD SCI USA, V104, P8438, DOI 10.1073/pnas.0700420104; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Modzelewska K, 2006, J BIOL CHEM, V281, P37527, DOI 10.1074/jbc.M604342200; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nur-E-Kamal A, 2005, MOL CANCER RES, V3, P297, DOI 10.1158/1541-7786.MCR-04-0152; Pluk H, 2002, CELL, V108, P247, DOI 10.1016/S0092-8674(02)00623-2; Satoh T, 1996, FEBS LETT, V386, P230, DOI 10.1016/0014-5793(96)00449-8; Sem KP, 2002, MOL CELL BIOL, V22, P3685, DOI 10.1128/MCB.22.11.3685-3697.2002; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Teo M, 2001, J BIOL CHEM, V276, P18392, DOI 10.1074/jbc.M008795200; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Wu XF, 2001, J CELL BIOL, V155, P291, DOI 10.1083/jcb.200104085; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Yang WN, 1999, J BIOL CHEM, V274, P8524, DOI 10.1074/jbc.274.13.8524; Yang WN, 2001, J BIOL CHEM, V276, P17468, DOI 10.1074/jbc.M010893200; Yeow-Fong L, 2005, FEBS LETT, V579, P5040, DOI 10.1016/j.febslet.2005.07.093; Yokoyama N, 2006, METHOD ENZYMOL, V406, P250, DOI 10.1016/S0076-6879(06)06018-6; Yokoyama N, 2005, J BIOL CHEM, V280, P42219, DOI 10.1074/jbc.M506996200; Yokoyama N, 2003, J BIOL CHEM, V278, P47713, DOI 10.1074/jbc.M306716200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998	52	35	40	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10605	10615		10.1074/jbc.M109.060459	http://dx.doi.org/10.1074/jbc.M109.060459			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110370	Green Published, hybrid			2022-12-27	WOS:000276264600048
J	Stahmann, N; Woods, A; Spengler, K; Heslegrave, A; Bauer, R; Krause, S; Viollet, B; Carling, D; Heller, R				Stahmann, Nadine; Woods, Angela; Spengler, Katrin; Heslegrave, Amanda; Bauer, Reinhard; Krause, Siegfried; Viollet, Benoit; Carling, David; Heller, Regine			Activation of AMP-activated Protein Kinase by Vascular Endothelial Growth Factor Mediates Endothelial Angiogenesis Independently of Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID OXIDATION; SHEAR-STRESS; DEPENDENT ACTIVATION; SIGNAL-TRANSDUCTION; FACTOR RECEPTOR-2; UPSTREAM KINASE; NO SYNTHESIS; PKC-ALPHA; RAT-LIVER; IN-VIVO	AMP-activated protein kinase (AMPK) is a sensor of cellular energy state and a regulator of cellular homeostasis. In endothelial cells, AMPK is stimulated via the upstream kinases LKB1 and Ca2+/calmodulin-dependent protein kinase kinase beta (CaMKK beta). Previously, AMPK has been reported to activate endothelial nitric-oxide synthase (eNOS). Using genetic and pharmacological approaches, we show that vascular endothelial growth factor (VEGF) stimulates AMPK in human and mice endothelial cells via CaMKK beta. VEGF-induced AMPK activation is potentiated under conditions of energy deprivation induced by 2-deoxyglucose. To investigate the role of AMPK in endothelial function, CaMKK beta, AMPK alpha 1, or AMPK alpha 2 was down-regulated by RNA interference, and studies in AMPK alpha 1(-/-) mice were performed. We demonstrate that AMPK does not mediate eNOS phosphorylation at serine residue 1177 or 633, NO-dependent cGMP generation, or Akt phosphorylation in response to VEGF. Using inhibitors of eNOS or soluble guanylyl cyclase and small interfering RNA against eNOS, we show that NO does not act upstream of AMPK. Taken together, these data indicate that VEGF-stimulated AMPK and eNOS pathways act independently of each other. However, acetyl-CoA carboxylase, a key enzyme in the regulation of fatty acid oxidation, was phosphorylated in response to VEGF in an AMPK alpha 1- and AMPK alpha 2-dependent manner. Our results show that AMPK alpha 1 plays an essential role in VEGF-induced angiogenesis in vitro (tube formation and sprouting from spheroids) and in vivo (Matrigel plug assay). In contrast, AMPK alpha 2 was not involved in VEGF-triggered sprouting. The data suggest that AMPK alpha 1 promotes VEGF-induced angiogenesis independently of eNOS, possibly by providing energy via inhibition of acetyl-CoA carboxylase.	[Stahmann, Nadine; Spengler, Katrin; Bauer, Reinhard; Krause, Siegfried; Heller, Regine] Univ Jena, Inst Mol Cell Biol, Ctr Mol Biomed, D-07745 Jena, Germany; [Woods, Angela; Heslegrave, Amanda; Carling, David] Univ London Imperial Coll Sci Technol & Med, Cellular Stress Grp, MRC Clin Sci Ctr, Hammersmith Hosp, London W12 0NN, England; [Viollet, Benoit] Univ Paris 05, Inst Cochin, CNRS, UMR 8104, F-75014 Paris, France; [Viollet, Benoit] INSERM, U1016, F-75014 Paris, France	Friedrich Schiller University of Jena; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Heller, R (corresponding author), Univ Jena, Inst Mol Cell Biol, Ctr Mol Biomed, Hans Knoll Str 2, D-07745 Jena, Germany.	regine.heller@med.uni-jena.de	Viollet, Benoit/O-6927-2017; Heller, Regine/AAC-9353-2019; Carling, David/F-1943-2014; Viollet, Benoit/N-2397-2019	Viollet, Benoit/0000-0002-0121-0224; Carling, David/0000-0002-2316-1830; Viollet, Benoit/0000-0002-0121-0224; Heslegrave, Amanda/0000-0002-7290-6405; Spengler, Katrin/0000-0001-9611-7841	Deutsche Forchungsgemeinschaft [He2304-2/1]; Interdisziplinares Zentrum fur Klinische Forschung Jena; European Commission [LSHM-CT-2004-005272]; Medical Research Council UK; Medical Research Council [MC_U120027537] Funding Source: researchfish	Deutsche Forchungsgemeinschaft(German Research Foundation (DFG)); Interdisziplinares Zentrum fur Klinische Forschung Jena; European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Deutsche Forchungsgemeinschaft (He2304-2/1) and the Interdisziplinares Zentrum fur Klinische Forschung Jena (to R. H.). Further support was obtained from the European Commission EXGENESIS Integrated Project Grant LSHM-CT-2004-005272 (to D. C. and B. V.) and the Medical Research Council UK (to D. C. and A. W.).	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Blanes MG, 2007, J BIOL CHEM, V282, P10660, DOI 10.1074/jbc.M609048200; Boo YC, 2002, AM J PHYSIOL-HEART C, V283, pH1819, DOI 10.1152/ajpheart.00214.2002; Boyle JG, 2008, J BIOL CHEM, V283, P11210, DOI 10.1074/jbc.M710048200; Brouet A, 2001, J BIOL CHEM, V276, P32663, DOI 10.1074/jbc.M101371200; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; da Silva CG, 2006, CIRC RES, V98, pE39, DOI 10.1161/01.RES.0000215436.92414.1d; Dagher Z, 1999, BIOCHEM BIOPH RES CO, V265, P112, DOI 10.1006/bbrc.1999.1635; Dagher Z, 2001, CIRC RES, V88, P1276, DOI 10.1161/hh1201.092998; DAVIES SP, 1989, EUR J BIOCHEM, V186, P123, DOI 10.1111/j.1432-1033.1989.tb15185.x; Davis BJ, 2006, DIABETES, V55, P496, DOI 10.2337/diabetes.55.02.06.db05-1064; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Fleming I, 2005, J CELL SCI, V118, P4103, DOI 10.1242/jcs.02541; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gelinas DS, 2002, BRIT J PHARMACOL, V137, P1021, DOI 10.1038/sj.bjp.0704956; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Heller R, 2001, J BIOL CHEM, V276, P40, DOI 10.1074/jbc.M004392200; Heller R, 2008, CARDIOVASC RES, V80, P96, DOI 10.1093/cvr/cvn159; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim JE, 2008, J PHARMACOL SCI, V106, P394, DOI 10.1254/jphs.FP0071857; Kobayashi H, 2004, CIRC RES, V94, pE27, DOI 10.1161/01.RES.0000119921.86460.37; Kuhlencordt PJ, 2004, AM J PHYSIOL-CELL PH, V286, pC1195, DOI 10.1152/ajpcell.00546.2002; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Mount PF, 2008, ATHEROSCLEROSIS, V200, P28, DOI 10.1016/j.atherosclerosis.2007.12.003; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; Mount PF, 2005, AM J PHYSIOL-RENAL, V289, pF1103, DOI 10.1152/ajprenal.00458.2004; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Partovian C, 2005, CIRC RES, V97, P482, DOI 10.1161/01.RES.0000179775.04114.45; Rask-Madsen C, 2008, ARTERIOSCL THROM VAS, V28, P919, DOI 10.1161/ATVBAHA.108.162842; Reihill JA, 2007, BIOCHEM BIOPH RES CO, V354, P1084, DOI 10.1016/j.bbrc.2007.01.110; Ruderman NB, 2003, BIOCHEM SOC T, V31, P202, DOI 10.1042/bst0310202; Schulz E, 2005, CIRCULATION, V111, P3473, DOI 10.1161/CIRCULATIONAHA.105.546812; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Stahmann N, 2006, MOL CELL BIOL, V26, P5933, DOI 10.1128/MCB.00383-06; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Sun L, 1998, J MED CHEM, V41, P2588, DOI 10.1021/jm980123i; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Thors B, 2004, FEBS LETT, V573, P175, DOI 10.1016/j.febslet.2004.07.078; Thors B, 2008, BBA-MOL CELL RES, V1783, P1893, DOI 10.1016/j.bbamcr.2008.07.003; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567; Viollet B, 2009, ACTA PHYSIOL, V196, P81, DOI 10.1111/j.1748-1716.2009.01970.x; Webler AC, 2008, AM J PHYSIOL-CELL PH, V295, pC1292, DOI 10.1152/ajpcell.00230.2008; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 1996, FEBS LETT, V397, P347, DOI 10.1016/S0014-5793(96)01209-4; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xu XB, 2008, ENDOCRINOLOGY, V149, P4183, DOI 10.1210/en.2008-0255; Youn JY, 2009, CIRC RES, V104, P50, DOI 10.1161/CIRCRESAHA.108.178467; YOUNG S, 1987, BIOCHEM J, V244, P775, DOI 10.1042/bj2440775; Yun H, 2005, J BIOL CHEM, V280, P9963, DOI 10.1074/jbc.M412994200; Zhang JH, 2008, J BIOL CHEM, V283, P27452, DOI 10.1074/jbc.M802578200; Zhang YJ, 2006, ARTERIOSCL THROM VAS, V26, P1281, DOI 10.1161/01.ATV.0000221230.08596.98; Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200; Zou MH, 2003, J BIOL CHEM, V278, P34003, DOI 10.1074/jbc.M300215200; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x; Zwetsloot KA, 2008, J PHYSIOL-LONDON, V586, P6021, DOI 10.1113/jphysiol.2008.159871	84	73	78	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10638	10652		10.1074/jbc.M110.108688	http://dx.doi.org/10.1074/jbc.M110.108688			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20129920	hybrid, Green Published			2022-12-27	WOS:000276264600051
J	Yu, SY; Zhao, DM; Jothi, R; Xue, HH				Yu, Shuyang; Zhao, Dong-Mei; Jothi, Raja; Xue, Hai-Hui			Critical Requirement of GABP alpha for Normal T Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GABP; ADULT HEMATOPOIETIC STEM; CHIP-SEQ DATA; BINDING-PROTEIN; LYMPHOCYTE DEVELOPMENT; GENE-EXPRESSION; NEUROMUSCULAR-JUNCTION; RECEPTOR EXPRESSION; CYCLE PROGRESSION; TARGET GENES	GA binding protein (GABP) consists of GABP alpha and GABP beta subunits. GABP alpha is a member of Ets family transcription factors and binds DNA via its conserved Ets domain, whereas GABP beta does not bind DNA but possesses transactivation activity. In T cells, GABP has been demonstrated to regulate the gene expression of interleukin-7 receptor alpha chain (IL-7R alpha) and postulated to be critical in T cell development. To directly investigate its function in early thymocyte development, we used GABP alpha conditional knock-out mice where the exons encoding the Ets DNA-binding domain are flanked with LoxP sites. Ablation of GABP alpha with the Lck-Cre transgene greatly diminished thymic cellularity, blocked thymocyte development at the double negative 3 (DN3) stage, and resulted in reduced expression of T cell receptor (TCR) beta chain in DN4 thymocytes. By chromatin immunoprecipitation, we demonstrated in DN thymocytes that GABP alpha is associated with transcription initiation sites of genes encoding key molecules in TCR rearrangements. Among these GABP-associated genes, knockdown of GABP alpha expression by RNA interference diminished expression of DNA ligase IV, Artemis, and Ku80 components in DNA-dependent protein kinase complex. Interestingly, forced expression of prearranged TCR but not IL-7R alpha can alleviate the DN3 block in GABP alpha-targeted mice. Our observations collectively indicate that in addition to regulating IL-7R alpha expression, GABP is critically required for TCR rearrangements and hence normal T cell development.	[Yu, Shuyang; Zhao, Dong-Mei; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Iowa City, IA 52246 USA; [Zhao, Dong-Mei] Univ Iowa, Dept Internal Med, Iowa City, IA 52246 USA; [Xue, Hai-Hui] Univ Iowa, Interdisciplinary Immunol Grad Program, Carver Coll Med, Iowa City, IA 52246 USA; [Jothi, Raja] NIEHS, NIH, Biostat Branch, Res Triangle Pk, NC 27709 USA	University of Iowa; University of Iowa; University of Iowa; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Xue, HH (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52246 USA.	hai-hui-xue@uiowa.edu	Jothi, Raja/G-3780-2015	Xue, Hai-Hui/0000-0002-9163-7669; Jothi, Raja/0000-0002-4833-1090	National Institutes of Health [AI077504, HL095540]; NIEHS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095540] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI077504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077504 and HL095540 (to H. -H. X.). This work was also supported by the Intramural Research Program of the NIEHS, National Institutes of Health (to R. J.).	Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Brabb T, 1997, EUR J IMMUNOL, V27, P136, DOI 10.1002/eji.1830270121; Bradley LM, 2005, TRENDS IMMUNOL, V26, P172, DOI 10.1016/j.it.2005.01.004; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Callen E, 2007, ONCOGENE, V26, P7759, DOI 10.1038/sj.onc.1210873; Crook MF, 2008, FASEB J, V22, P225, DOI 10.1096/fj.07-8573com; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Durum SK, 1998, J EXP MED, V188, P2233, DOI 10.1084/jem.188.12.2233; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Galang CK, 2004, J BIOL CHEM, V279, P11281, DOI 10.1074/jbc.M311887200; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Garrett-Sinha LA, 2001, BLOOD, V97, P2908, DOI 10.1182/blood.V97.9.2908; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haring JS, 2008, J IMMUNOL, V180, P2855, DOI 10.4049/jimmunol.180.5.2855; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hollenhorst PC, 2004, NUCLEIC ACIDS RES, V32, P5693, DOI 10.1093/nar/gkh906; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Jaworski A, 2007, MOL CELL BIOL, V27, P5040, DOI 10.1128/MCB.02228-06; Jothi R, 2008, NUCLEIC ACIDS RES, V36, P5221, DOI 10.1093/nar/gkn488; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Lacorazza HD, 2001, J IMMUNOL, V166, P3184, DOI 10.4049/jimmunol.166.5.3184; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lucas ME, 2009, J BIOL CHEM, V284, P14698, DOI 10.1074/jbc.M901104200; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Munitic I, 2004, BLOOD, V104, P4165, DOI 10.1182/blood-2004-06-2484; O'Leary DA, 2007, MOL CELL BIOL, V27, P3470, DOI 10.1128/MCB.00659-06; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Ravel-Chapuis A, 2007, EMBO J, V26, P1117, DOI 10.1038/sj.emboj.7601572; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Robey EA, 2004, CURR OPIN IMMUNOL, V16, P360, DOI 10.1016/j.coi.2004.03.009; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Rosmarin AG, 1998, J BIOL CHEM, V273, P13097, DOI 10.1074/jbc.273.21.13097; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Soulas-Sprauel P, 2007, ONCOGENE, V26, P7780, DOI 10.1038/sj.onc.1210875; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; Staal FJT, 2005, NAT REV IMMUNOL, V5, P21, DOI 10.1038/nri1529; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wallerman O, 2009, NUCLEIC ACIDS RES, V37, P7498, DOI 10.1093/nar/gkp823; Xue HH, 2007, IMMUNITY, V26, P421, DOI 10.1016/j.immuni.2007.03.010; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548	53	23	24	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10179	10188		10.1074/jbc.M109.088740	http://dx.doi.org/10.1074/jbc.M109.088740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139079	hybrid, Green Published			2022-12-27	WOS:000276264600002
J	Dhar, SK; Xu, Y; St Clair, DK				Dhar, Sanjit K.; Xu, Yong; St Clair, Daret K.			Nuclear Factor kappa B- and Specificity Protein 1-dependent p53-mediated Bi-directional Regulation of the Human Manganese Superoxide Dismutase Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; TRANSCRIPTIONAL REPRESSION; WILD-TYPE; OXIDATIVE STRESS; CELL-GROWTH; IN-VIVO; P53; EXPRESSION; INDUCTION; IDENTIFICATION	Tumor suppressor p53 is known to activate certain sets of genes while suppressing others. However, whether p53 can both activate and suppress the same gene is unclear. To address this question, concentration-dependent p53 effect on the manganese superoxide dismutase (MnSOD) gene was investigated. By transfecting p53 in PC-3 cells, we demonstrate that low concentrations of p53 increase while high concentrations suppress MnSOD expression. The physiological relevance of this effect was determined in vitro and in vivo using combined UVB-mediated activation and small interference RNA-mediated suppression of p53. Results were consistent with the bi-directional effect of p53 on MnSOD expression. MnSOD-promoter/enhancer analysis demonstrates that p53 is suppressive to the promoter activity regardless of the presence or absence of putative p53 binding sites. However, a low level of p53 increases MnSOD gene transcription in the presence of the intronic-enhancer element, and this effect is dependent on nuclear-factor kappa B (NF-kappa B) binding sites. Expression of p53 enhances nuclear levels of p65 with corresponding increase in the DNA-binding activity of NF-kappa B as detected by electrophoretic mobility shift and chromatin immunoprecipitation assays. Transfection of p65 small interference RNA reduces the positive effect of p53 on MnSOD gene transcription. These data suggest that p65 can overcome the negative effect of p53 on MnSOD expression. However, when the level of p53 was further increased, the suppressive effect of p53 outweighed the positive effect of p65 and led to the suppression of MnSOD gene transcription. These results demonstrated that p53 can both suppress and induce MnSOD expression depending on the balance of promoter and enhancer binding transcription factors.	[Dhar, Sanjit K.; Xu, Yong; St Clair, Daret K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky	St Clair, DK (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA.	dstcl00@uky.edu			National Institutes of Health [CA49797, CA73599]; NATIONAL CANCER INSTITUTE [R01CA073599, R29CA049797, R01CA049797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA49797 and CA73599 (to D.K.S.C.).	Budhram-Mahadeo V, 1999, J BIOL CHEM, V274, P15237, DOI 10.1074/jbc.274.21.15237; Decraene D, 2005, J INVEST DERMATOL, V125, P1026, DOI 10.1111/j.0022-202X.2005.23909.x; Dhar SK, 2007, CARCINOGENESIS, V28, P2605, DOI 10.1093/carcin/bgm163; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Dhar SK, 2009, J BIOL CHEM, V284, P16409, DOI 10.1074/jbc.M109.005736; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Drane P, 2001, ONCOGENE, V20, P430, DOI 10.1038/sj.onc.1204101; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Farmer G, 1996, NUCLEIC ACIDS RES, V24, P4281, DOI 10.1093/nar/24.21.4281; Goodman RH, 2000, GENE DEV, V14, P1553; Ho J, 2003, CELL DEATH DIFFER, V10, P404, DOI 10.1038/sj.cdd.4401191; Hu YM, 2005, J BIOL CHEM, V280, P39485, DOI 10.1074/jbc.M503296200; Huang WC, 2007, MOL CELL, V26, P75, DOI 10.1016/j.molcel.2007.02.019; Hussain SP, 2004, CANCER RES, V64, P2350, DOI 10.1158/0008-5472.CAN-2287-2; Jones PL, 1997, MOL CELL BIOL, V17, P6970, DOI 10.1128/MCB.17.12.6970; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kiningham KK, 2001, BIOCHEM J, V353, P147, DOI 10.1042/bj3530147; Krause K, 2000, NUCLEIC ACIDS RES, V28, P4410, DOI 10.1093/nar/28.22.4410; KUNZ C, 1995, NUCLEIC ACIDS RES, V23, P3710, DOI 10.1093/nar/23.18.3710; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; MIYASHITA T, 1995, CELL, V80, P293; MIYASHITA T, 1994, CANCER RES, V54, P3131; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nakano T, 1996, CANCER RES, V56, P2771; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Ravi R, 1998, CANCER RES, V58, P4531; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Ruiz-Lozano P, 1999, CELL GROWTH DIFFER, V10, P295; SUBLER MA, 1992, J VIROL, V66, P4757, DOI 10.1128/JVI.66.8.4757-4762.1992; SUN Y, 1993, MOL CARCINOGEN, V8, P49, DOI 10.1002/mc.2940080111; Tan MJ, 1999, J BIOL CHEM, V274, P12061, DOI 10.1074/jbc.274.17.12061; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Werner H, 1996, P NATL ACAD SCI USA, V93, P8318, DOI 10.1073/pnas.93.16.8318; Xu Y, 1999, DNA CELL BIOL, V18, P709, DOI 10.1089/104454999314999; Yamabe Y, 1998, MOL CELL BIOL, V18, P6191, DOI 10.1128/MCB.18.11.6191	40	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9835	9846		10.1074/jbc.M109.060715	http://dx.doi.org/10.1074/jbc.M109.060715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20061391	Green Published, hybrid			2022-12-27	WOS:000276165900055
J	Martin, MS; Dutt, K; Papale, LA; Dube, CM; Dutton, SB; de Haan, G; Shankar, A; Tufik, S; Meisler, MH; Baram, TZ; Goldin, AL; Escayg, A				Martin, Melinda S.; Dutt, Karoni; Papale, Ligia A.; Dube, Celine M.; Dutton, Stacey B.; de Haan, Georgius; Shankar, Anupama; Tufik, Sergio; Meisler, Miriam H.; Baram, Tallie Z.; Goldin, Alan L.; Escayg, Andrew			Altered Function of the SCN1A Voltage-gated Sodium Channel Leads to gamma-Aminobutyric Acid-ergic (GABAergic) Interneuron Abnormalities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEBRILE SEIZURES PLUS; SEVERE MYOCLONIC EPILEPSY; CAUSE GENERALIZED EPILEPSY; FAST INACTIVATION; CORTICAL-NEURONS; GENE MUTATION; MOUSE MODEL; MICE; EXCITABILITY; INFANCY	Voltage-gated sodium channels are required for the initiation and propagation of action potentials. Mutations in the neuronal voltage-gated sodium channel SCN1A are associated with a growing number of disorders including generalized epilepsy with febrile seizures plus (GEFS+),(7) severe myoclonic epilepsy of infancy, and familial hemiplegic migraine. To gain insight into the effect of SCN1A mutations on neuronal excitability, we introduced the human GEFS+ mutation SCN1A-R1648H into the orthologous mouse gene. Scn1a(RH/RH) mice homozygous for the R1648H mutation exhibit spontaneous generalized seizures and premature death between P16 and P26, whereas Scn1a(RH/+) heterozygous mice exhibit infrequent spontaneous generalized seizures, reduced threshold and accelerated propagation of febrile seizures, and decreased threshold to flurothyl-induced seizures. Inhibitory cortical interneurons from P5-P15 Scn1a(RH/+) and Scn1a(RH/RH) mice demonstrated slower recovery from inactivation, greater use-dependent inactivation, and reduced action potential firing compared with wild-type cells. Excitatory cortical pyramidal neurons were mostly unaffected. These results suggest that this SCN1A mutation predominantly impairs sodium channel activity in interneurons, leading to decreased inhibition. Decreased inhibition may be a common mechanism underlying clinically distinct SCN1A-derived disorders.	[Dutt, Karoni; Goldin, Alan L.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Dube, Celine M.; Baram, Tallie Z.; Goldin, Alan L.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Dube, Celine M.; Baram, Tallie Z.] Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; [Martin, Melinda S.; Papale, Ligia A.; Dutton, Stacey B.; Shankar, Anupama; Escayg, Andrew] Emory Univ, Dept Human Genet, Atlanta, GA 30322 USA; [Papale, Ligia A.; Tufik, Sergio] Univ Fed Sao Paulo, Dept Psychobiol, BR-04024000 Sao Paulo, Brazil; [de Haan, Georgius; Meisler, Miriam H.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Emory University; Universidade Federal de Sao Paulo (UNIFESP); University of Michigan System; University of Michigan	Goldin, AL (corresponding author), B240 Med Sci 1, Irvine, CA 92697 USA.	agoldin@uci.edu; aescayg@emory.edu	Baram, Tallie Z/J-6447-2014; Tufik, Sergio/D-7606-2012; Goldin, Alan/A-8385-2015	Goldin, Alan/0000-0001-7159-0288	National Institutes of Health [NS046484, NS051834, NS48336, NS34509, NS35437]; McKnight Foundation [34653]; Epilepsy Foundation; Associacao Fundo de Incentivo a Psico-farmacologia; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [07/50534-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051834, R01NS048336, R01NS046484, R01NS034509, R01NS035437, R01NS065187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McKnight Foundation; Epilepsy Foundation; Associacao Fundo de Incentivo a Psico-farmacologia; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS046484 and NS051834 (to A. E.), NS48336 (to A. L. G.), NS34509 (to M. H. M.), and NS35437 (to T.Z.B.). This work was also supported by McKnight Foundation Grant 34653 (to A. L. G.). The mouse model of GEFS+ described in this article has been licensed to Allergan. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict of interest policy.; Supported by a fellowship from the Epilepsy Foundation.; Supported by fellowships from the Associacao Fundo de Incentivo a Psico-farmacologia and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grant 07/50534-0.	Alekov AK, 2000, J PHYSIOL-LONDON, V529, P533, DOI 10.1111/j.1469-7793.2000.00533.x; Barela AJ, 2006, J NEUROSCI, V26, P2714, DOI 10.1523/JNEUROSCI.2977-05.2006; Catterall WA, 2008, J NEUROSCI, V28, P11768, DOI 10.1523/JNEUROSCI.3901-08.2008; Chen CL, 2004, J NEUROSCI, V24, P4030, DOI 10.1523/JNEUROSCI.4139-03.2004; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Fong AY, 2005, J COMP NEUROL, V493, P274, DOI 10.1002/cne.20758; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hilgenberg LGW, 1999, J NEUROSCI, V19, P7384, DOI 10.1523/JNEUROSCI.19-17-07384.1999; Kearney JA, 2002, HUM MOL GENET, V11, P2765, DOI 10.1093/hmg/11.22.2765; Kuhn FJP, 1999, J GEN PHYSIOL, V114, P167, DOI 10.1085/jgp.114.2.167; Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lossin C, 2003, J NEUROSCI, V23, P11289; Mahoney K, 2009, SEIZURE-EUR J EPILEP, V18, P492, DOI 10.1016/j.seizure.2009.04.009; Martin MS, 2007, HUM MOL GENET, V16, P2892, DOI 10.1093/hmg/ddm248; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Naritoku DK, 2003, EPILEPSIA, V44, P912, DOI 10.1046/j.1528-1157.2003.48302.x; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Osaka H, 2007, EPILEPSY RES, V75, P46, DOI 10.1016/j.eplepsyres.2007.03.018; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Schank JR, 2005, EPILEPSY RES, V65, P23, DOI 10.1016/j.eplepsyres.2005.03.010; Spampanato J, 2004, J NEUROSCI, V24, P10022, DOI 10.1523/JNEUROSCI.2034-04.2004; Spampanato J, 2004, J NEUROPHYSIOL, V91, P2040, DOI 10.1152/jn.00982.2003; Spampanato J, 2003, NEUROSCIENCE, V116, P37, DOI 10.1016/S0306-4522(02)00698-X; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Vanmolkot Kaate R J, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9486; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	32	156	163	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9823	9834		10.1074/jbc.M109.078568	http://dx.doi.org/10.1074/jbc.M109.078568			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20100831	hybrid, Green Published			2022-12-27	WOS:000276165900054
J	Witte, CP; Keinath, N; Dubiella, U; Demouliere, R; Seal, A; Romeis, T				Witte, Claus-Peter; Keinath, Nana; Dubiella, Ullrich; Demouliere, Raphael; Seal, Anindita; Romeis, Tina			Tobacco Calcium-dependent Protein Kinases Are Differentially Phosphorylated in Vivo as Part of a Kinase Cascade That Regulates Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-LIKE DOMAIN; PLASMA-MEMBRANE; GUARD-CELLS; ARABIDOPSIS; CDPK; PLANT; AUTOPHOSPHORYLATION; ACTIVATION; IDENTIFICATION; LOCALIZATION	In vivo phosphorylation sites of the tobacco calcium-dependent protein kinases NtCDPK2 and NtCDPK3 were determined in response to biotic or abiotic stress. Stress-inducible phosphorylation was exclusively located in the variable N termini, where both kinases were phosphorylated differentially despite 91% overall sequence identity. In NtCDPK2, serine 40 and threonine 65 were phosphorylated within 2 min after stress. Whereas Thr(65) is subjected to intra-molecular in vivo autophosphorylation, Ser(40) represents a target for a regulatory upstream protein kinase, and correct NtCDPK2 membrane localization is required for Ser(40) phosphorylation. NtCDPK3 is phosphorylated at least at two sites in the N terminus by upstream kinase(s) upon stress stimulus, first at Ser(54), a site not present in NtCDPK2, and also at a second undetermined site not identical to Ser(40). Domain swap experiments established that differential phosphorylation of both kinases is exclusively determined by the respective N termini. A cell death-inducing response was only observed upon expression of a truncated variant lacking the junction and calcium-binding domain of NtCDPK2 (VK2). This response required protein kinase activity and was reduced when subcellular membrane localization was disturbed by a mutation in the myristoylation and palmitoylation site. Our data indicate that CDPKs are integrated in stress-dependent protein kinase signaling cascades, and regulation of CDPK function in response to in vivo stimulation is dependent on its membrane localization.	[Witte, Claus-Peter; Dubiella, Ullrich; Romeis, Tina] Free Univ Berlin, Inst Biol, Dept Plant Biochem, D-14195 Berlin, Germany; [Keinath, Nana; Demouliere, Raphael] Max Planck Inst Plant Breeding Res, Dept Plant Microbe Interact, D-50935 Cologne, Germany; [Seal, Anindita] W Bengal Univ Technol, Dept Biotechnol, Kolkata 700064, W Bengal, India	Free University of Berlin; Max Planck Society; Maulana Abul Kalam Azad University of Technology	Romeis, T (corresponding author), Free Univ Berlin, Inst Biol, Dept Plant Biochem, Konigin Luise Str 12-16, D-14195 Berlin, Germany.	romeis@zedat.fu-berlin.de	Witte, Claus-Peter/L-1676-2017; Dubiella, Ullrich/AAF-6499-2019; Seal, Anindita/AAG-4466-2019	Witte, Claus-Peter/0000-0002-3617-7807; Seal, Anindita/0000-0001-7951-7595; Dubiella, Ullrich/0000-0001-9854-9795	European Molecular Biology Organization; Deutsche Forschungsgemeinschaft Research Consortia [SFB 635, SPP1212]	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft Research Consortia(German Research Foundation (DFG))	This work was supported by a European Molecular Biology Organization long term fellowship (to C.-P. W.) and by Deutsche Forschungsgemeinschaft Research Consortia SFB 635 and SPP1212 (to T. R.).	Batistic O, 2008, PLANT CELL, V20, P1346, DOI 10.1105/tpc.108.058123; Batistic O, 2009, BBA-MOL CELL RES, V1793, P985, DOI 10.1016/j.bbamcr.2008.10.006; Bohmer M, 2007, PLANT MOL BIOL, V65, P817, DOI 10.1007/s11103-007-9245-9; BOGRE L, 1988, PLANT SCI, V58, P135, DOI 10.1016/0168-9452(88)90001-5; Chandran V, 2006, J MOL BIOL, V357, P400, DOI 10.1016/j.jmb.2005.11.093; Chaudhuri S, 1999, PLANT PHYSIOL, V120, P859, DOI 10.1104/pp.120.3.859; Chehab EW, 2004, PLANT PHYSIOL, V135, P1430, DOI 10.1104/pp.103.035238; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Gleason C, 2006, NATURE, V441, P1149, DOI 10.1038/nature04812; Glinski M, 2003, RAPID COMMUN MASS SP, V17, P1579, DOI 10.1002/rcm.1093; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; HARMON AC, 2001, NEW PHYTOL, V151, P175, DOI DOI 10.1046/j.1469-8137.2001.00171.x; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; Hegeman AD, 2004, J AM SOC MASS SPECTR, V15, P647, DOI 10.1016/j.jasms.2003.12.019; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Hrabak EM, 2003, PLANT PHYSIOL, V132, P666, DOI 10.1104/pp.102.011999; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Lee JY, 1998, BIOCHEMISTRY-US, V37, P6801, DOI 10.1021/bi980062q; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Ma SY, 2007, PLANT MOL BIOL, V65, P511, DOI 10.1007/s11103-007-9187-2; Mori IC, 2006, PLOS BIOL, V4, P1749, DOI 10.1371/journal.pbio.0040327; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Romeis T, 2000, PLANT CELL, V12, P803, DOI 10.1105/tpc.12.5.803; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Rutschmann F, 2002, PLANT PHYSIOL, V129, P156, DOI 10.1104/pp.000869; Siegel RS, 2009, PLANT J, V59, P207, DOI 10.1111/j.1365-313X.2009.03872.x; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Tirichine L, 2006, NATURE, V441, P1153, DOI 10.1038/nature04862; van Bentem SD, 2008, J PROTEOME RES, V7, P2458, DOI 10.1021/pr8000173; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Weljie AM, 2004, BIOCHEMISTRY-US, V43, P15131, DOI 10.1021/bi048751r; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Yoo BC, 1996, BIOCHEMISTRY-US, V35, P12029, DOI 10.1021/bi9606612; Yoon GM, 2006, PLANT CELL, V18, P867, DOI 10.1105/tpc.105.037135; Young JJ, 2006, P NATL ACAD SCI USA, V103, P7506, DOI 10.1073/pnas.0602225103; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666	42	72	83	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9740	9748		10.1074/jbc.M109.052126	http://dx.doi.org/10.1074/jbc.M109.052126			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118232	hybrid, Green Published			2022-12-27	WOS:000276165900046
J	Xie, ZW; Gong, MC; Su, W; Xie, DP; Turk, J; Guo, ZH				Xie, Zhongwen; Gong, Ming C.; Su, Wen; Xie, Dongping; Turk, John; Guo, Zhenheng			Role of Calcium-independent Phospholipase A(2)beta in High Glucose-induced Activation of RhoA, Rho Kinase, and CPI-17 in Cultured Vascular Smooth Muscle Cells and Vascular Smooth Muscle Hypercontractility in Diabetic Animals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM-BASED DISCRIMINATION; ARACHIDONIC-ACID RELEASE; UP-REGULATION; MYOSIN PHOSPHATASE; MOLECULAR-BIOLOGY; PHOSPHORYLATION; MICE; DIACYLGLYCEROL; INHIBITION; RABBIT	Previous studies suggest that high glucose-induced RhoA/Rho kinase/CPI-17 activation is involved in diabetes-associated vascular smooth muscle hypercontractility. However, the upstream signaling that links high glucose and RhoA/Rho kinase/CPI-17 activation is unknown. Here we report that calcium-independent phospholipase A(2)beta (iPLA(2)beta) is required for high glucose-induced RhoA/Rho kinase/CPI-17 activation and thereby contributes to diabetes-associated vascular smooth muscle hypercontractility. We demonstrate that high glucose increases iPLA(2)beta mRNA, protein, and iPLA(2) activity in a time-dependent manner. Protein kinase C is involved in high glucose-induced iPLA(2)beta protein up-regulation. Inhibiting iPLA(2)beta activity with bromoenol lactone or preventing its expression by genetic deletion abolishes high glucose-induced RhoA/Rho kinase/CPI-17 activation, and restoring expression of iPLA(2)beta in iPLA(2)beta-deficient cells also restores high glucose-induced CPI-17 phosphorylation. Pharmacological and genetic inhibition of 12/15-lipoxygenases has effects on high glucose-induced CPI-17 phosphorylation similar to iPLA(2)beta inhibition. Moreover, increases in iPLA2 activity and iPLA(2)beta protein expression are also observed in both type 1 and type 2 diabetic vasculature. Pharmacological and genetic inhibition of iPLA(2)beta, but not iPLA(2)beta, diminishes diabetes-associated vascular smooth muscle hypercontractility. In summary, our results reveal a novel mechanism by which high glucose-induced, protein kinase C-mediated iPLA(2)beta up-regulation activates the RhoA/Rho kinase/CPI-17 via 12/15-lipoxygenases and thereby contributes to diabetes-associated vascular smooth muscle hypercontractility.	[Su, Wen; Guo, Zhenheng] Univ Kentucky, Sch Med, Dept Internal Med, Lexington, KY 40536 USA; [Xie, Zhongwen; Gong, Ming C.; Xie, Dongping] Univ Kentucky, Sch Med, Dept Physiol, Lexington, KY 40536 USA; [Turk, John] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	University of Kentucky; University of Kentucky; Washington University (WUSTL)	Guo, ZH (corresponding author), Univ Kentucky, Sch Med, Dept Internal Med, 515 Wethington Bldg,900 S Limestone, Lexington, KY 40536 USA.	zguo2@uky.edu			National Institutes of Health [HL088389, HL082791]; Commonwealth of Kentucky Diabetes Research Trust Fund; American Diabetes Association [1-04-CD-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082791, R01HL088389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Commonwealth of Kentucky Diabetes Research Trust Fund; American Diabetes Association(American Diabetes Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL088389 (to Z. G.) and HL082791 (to M. C. G.). This work was also supported by funds from the Commonwealth of Kentucky Diabetes Research Trust Fund (to Z. G.) and American Diabetes Association Career Development Award 1-04-CD-04 (to M. C. G.).	Akiba S, 2002, BIOCHEM PHARMACOL, V63, P1969, DOI 10.1016/S0006-2952(02)00988-7; Balsinde J, 1999, ANNU REV PHARMACOL, V39, P175, DOI 10.1146/annurev.pharmtox.39.1.175; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Bolick DT, 2006, ARTERIOSCL THROM VAS, V26, P1260, DOI 10.1161/01.ATV.0000217909.09198.d6; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chang SH, 2006, AM J PHYSIOL-RENAL, V290, pF650, DOI 10.1152/ajprenal.00235.2005; DANIELS SB, 1983, J BIOL CHEM, V258, P5046; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Fatima S, 2001, J PHARMACOL EXP THER, V298, P331; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Fuentes L, 2003, J BIOL CHEM, V278, P44683, DOI 10.1074/jbc.M307209200; Funk CD, 1996, BBA-LIPID LIPID MET, V1304, P65, DOI 10.1016/S0005-2760(96)00107-5; GONG MC, 1995, J PHYSIOL-LONDON, V486, P113, DOI 10.1113/jphysiol.1995.sp020795; GONG MC, 1992, J BIOL CHEM, V267, P21492; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Guo ZH, 2003, J BIOL CHEM, V278, P1856, DOI 10.1074/jbc.M211075200; HAZEN SL, 1991, J BIOL CHEM, V266, P7227; Huang W, 2004, J LIPID RES, V45, P1519, DOI 10.1194/jlr.M400088-JLR200; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jenkins CM, 2002, J BIOL CHEM, V277, P32807, DOI 10.1074/jbc.M202568200; Ji X, 2007, EUR J PHARMACOL, V577, P109, DOI 10.1016/j.ejphar.2007.08.011; Lagaud GJL, 2001, J VASC RES, V38, P578, DOI 10.1159/000051094; Ma ZM, 2001, PROG NUCLEIC ACID RE, V67, P1, DOI 10.1016/S0079-6603(01)67023-5; Maeda A, 2006, GENES CELLS, V11, P1071, DOI 10.1111/j.1365-2443.2006.01001.x; McHowat J, 2000, AM J PHYSIOL-ENDOC M, V279, pE25, DOI 10.1152/ajpendo.2000.279.1.E25; Meyer MC, 2005, AM J PHYSIOL-CELL PH, V288, pC475, DOI 10.1152/ajpcell.00306.2004; Moon SH, 2008, J BIOL CHEM, V283, P33975, DOI 10.1074/jbc.M805817200; Mueed I, 2005, BRIT J PHARMACOL, V146, P972, DOI 10.1038/sj.bjp.0706398; Muller A, 2002, IMMUNOBIOLOGY, V205, P35, DOI 10.1078/0171-2985-00109; Natarajan R, 2004, ARTERIOSCL THROM VAS, V24, P1542, DOI 10.1161/01.ATV.0000133606.69732.4c; Nobe K, 2002, BRIT J PHARMACOL, V136, P441, DOI 10.1038/sj.bjp.0704722; Pang H, 2006, AM J PHYSIOL-CELL PH, V290, pC892, DOI 10.1152/ajpcell.00378.2005; Pang HA, 2005, AM J PHYSIOL-CELL PH, V289, pC352, DOI 10.1152/ajpcell.00111.2005; Park KM, 2008, AM J PHYSIOL-HEART C, V294, pH1183, DOI 10.1152/ajpheart.01148.2007; Ramana KV, 2005, DIABETES, V54, P818, DOI 10.2337/diabetes.54.3.818; Seashols SJ, 2004, BBA-MOL CELL BIOL L, V1684, P29, DOI 10.1016/j.bbalip.2004.05.003; Shimokawa H, 2005, ARTERIOSCL THROM VAS, V25, P1767, DOI 10.1161/01.ATV.0000176193.83629.c8; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STEER SA, 1983, AM J PHYSIOL-CELL PH, V283, pC1621; Teng HJ, 2009, J BIOL CHEM, V284, P26368, DOI 10.1074/jbc.M109.021360; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Velasco G, 2002, FEBS LETT, V527, P101, DOI 10.1016/S0014-5793(02)03175-7; Way KJ, 2001, DIABETIC MED, V18, P945, DOI 10.1046/j.0742-3071.2001.00638.x; Xie Z, 2007, J BIOL CHEM, V282, P25278, DOI 10.1074/jbc.M611206200; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002	49	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8628	8638		10.1074/jbc.M109.057711	http://dx.doi.org/10.1074/jbc.M109.057711			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20086008	hybrid, Green Published			2022-12-27	WOS:000275553700015
J	Broutin, I; Jomain, JB; Tallet, E; van Agthoven, J; Raynal, B; Hoos, S; Kragelund, BB; Kelly, PA; Ducruix, A; England, P; Goffin, V				Broutin, Isabelle; Jomain, Jean-Baptiste; Tallet, Estelle; van Agthoven, Jan; Raynal, Bertrand; Hoos, Sylviane; Kragelund, Birthe B.; Kelly, Paul A.; Ducruix, Arnaud; England, Patrick; Goffin, Vincent			Crystal Structure of an Affinity-matured Prolactin Complexed to Its Dimerized Receptor Reveals the Topology of Hormone Binding Site 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN GROWTH-HORMONE; EXTRACELLULAR DOMAIN; PLACENTAL-LACTOGEN; MODEL; ANTAGONISTS; PROTEINS; IDENTIFICATION; SOFTWARE; PROGRAM; ANALOGS	We report the first crystal structure of a 1:2 hormone.receptor complex that involves prolactin (PRL) as the ligand, at 3.8-angstrom resolution. Stable ternary complexes were obtained by generating affinity-matured PRL variants harboring an N-terminal tail from ovine placental lactogen, a closely related PRL receptor (PRLR) ligand. This structure allows one to draw up an exhaustive inventory of the residues involved at the PRL.PRLR site 2 interface, consistent with all previously reported site-directed mutagenesis data. We propose, with this description, an interaction model involving three structural components of PRL site 2 ("three-pin plug"): the conserved glycine 129 of helix alpha 3, the hydrogen bond network involving surrounding residues (glycine cavity), and the N terminus. The model provides a molecular basis for the properties of the different PRL analogs designed to date, including PRLR antagonists. Finally, comparison of our 1:2 PRL.PRLR2 structure with those of free PRL and its 1:1 complex indicates that the structure of PRL undergoes significant changes when binding the first, but not the second receptor. This suggests that the second PRLR moiety adapts to the 1:1 complex rather than the opposite. In conclusion, this structure will be a useful guiding tool for further investigations of the molecular mechanisms involved in PRLR dimerization and activation, as well as for the optimization of PRLR antagonists, an emerging class of compounds with high therapeutic potential against breast and prostate cancer.	[Broutin, Isabelle; van Agthoven, Jan; Ducruix, Arnaud] Univ Paris 05, Lab Cristallog & RMN Biol, CNRS, UMR 8015, F-75006 Paris, France; [Jomain, Jean-Baptiste; Tallet, Estelle; Kelly, Paul A.; Goffin, Vincent] Equipe PRL GH Pathophysiol, Ctr Rech Croissance & Signalisat, INSERM, U845, F-75015 Paris, France; [Jomain, Jean-Baptiste; Tallet, Estelle; Kelly, Paul A.; Goffin, Vincent] Univ Paris 05, Fac Med Site Necker, F-75015 Paris, France; [Raynal, Bertrand; Hoos, Sylviane; England, Patrick] Inst Pasteur, Dept Biol Struct & Chim, F-75015 Paris, France; [Raynal, Bertrand; Hoos, Sylviane; England, Patrick] CNRS, URA 2185, F-75015 Paris, France; [Kragelund, Birthe B.] Univ Copenhagen, Dept Biol, Struct Biol & NMR Lab, DK-2200 Copenhagen N, Denmark	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Copenhagen	Goffin, V (corresponding author), INSERM, Ctr Rech Croissance & Signalisat, Fac Med Necker, U845, 156 Rue Vaugirard, F-75730 Paris 15, France.	vincent.goffin@inserm.fr	GOFFIN, Vincent/G-3322-2013; Kragelund, Birthe/M-3927-2014; Broutin, Isabelle/A-2003-2017	GOFFIN, Vincent/0000-0002-8021-3086; Kragelund, Birthe/0000-0002-7454-1761; Broutin, isabelle/0000-0001-9862-1232; ENGLAND, Patrick/0000-0001-6410-5918; raynal, Bertrand/0000-0001-5634-0408	INSERM; University Paris Descartes; Agence Nationale de la Recherche [ANR-PCV07_183953]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Descartes; Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported in part by INSERM, University Paris Descartes, and the Agence Nationale de la Recherche (Grant ANR-PCV07_183953).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernichtein S, 2003, MOL CELL ENDOCRINOL, V208, P11, DOI 10.1016/S0303-7207(03)00264-8; Bernichtein S, 2003, J BIOL CHEM, V278, P35988, DOI 10.1074/jbc.M305687200; Bogorad RL, 2008, P NATL ACAD SCI USA, V105, P14533, DOI 10.1073/pnas.0800685105; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHEN WY, 1991, MOL ENDOCRINOL, V5, P1845, DOI 10.1210/mend-5-12-1845; CLEVENGER CV, 1995, AM J PATHOL, V146, P695; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Dagvadorj A, 2007, ENDOCRINOLOGY, V148, P3089, DOI 10.1210/en.2006-1761; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DePalatis L, 2009, PROTEIN EXPRES PURIF, V66, P121, DOI 10.1016/j.pep.2009.02.012; DEVOS AM, 1992, SCIENCE, V255, P306, DOI 10.1126/science.1549776; Elkins PA, 2000, NAT STRUCT BIOL, V7, P808, DOI 10.1038/79047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FUH G, 1992, SCIENCE, V256, P1677, DOI 10.1126/science.256.5064.1677; Gertler A, 1996, J BIOL CHEM, V271, P24482, DOI 10.1074/jbc.271.40.24482; GINSBURG E, 1995, CANCER RES, V55, P2591; GOFFIN V, 1994, J BIOL CHEM, V269, P32598; GOFFIN V, 1992, MOL ENDOCRINOL, V6, P1381, DOI 10.1210/me.6.9.1381; Goffin V, 2005, ENDOCR REV, V26, P400, DOI 10.1210/er.2004-0016; Goffin V, 1996, ENDOCR REV, V17, P385, DOI 10.1210/er.17.4.385; Goffin V, 1996, J BIOL CHEM, V271, P16573, DOI 10.1074/jbc.271.28.16573; Goffin V, 1995, PROTEIN ENG, V8, P1215, DOI 10.1093/protein/8.12.1215; Goffin V, 2006, NAT CLIN PRACT ENDOC, V2, P571, DOI 10.1038/ncpendmet0270; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Jomain JB, 2007, J BIOL CHEM, V282, P33118, DOI 10.1074/jbc.M704364200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kinet S, 1999, J BIOL CHEM, V274, P26033, DOI 10.1074/jbc.274.37.26033; Kopchick JJ, 2002, ENDOCR REV, V23, P623, DOI 10.1210/er.2001-0022; KOSSIAKOFF AA, 1994, PROTEIN SCI, V3, P1697, DOI 10.1002/pro.5560031008; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NICOLL CS, 1986, ENDOCR REV, V7, P169, DOI 10.1210/edrv-7-2-169; PARIS N, 1990, BIOTECHNOL APPL BIOC, V12, P436; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Read RJ, 2009, ACTA CRYSTALLOGR D, V65, P140, DOI 10.1107/S0907444908041085; ROZAKISADCOCK M, 1991, J BIOL CHEM, V266, P16472; ROZAKISADCOCK M, 1992, J BIOL CHEM, V267, P7428; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; Svensson LA, 2008, J BIOL CHEM, V283, P19085, DOI 10.1074/jbc.M801202200; Teilum K, 2005, J MOL BIOL, V351, P810, DOI 10.1016/j.jmb.2005.06.042; Walsh STR, 2003, PROTEIN SCI, V12, P1960, DOI 10.1110/ps.03133903; Wells JA, 1996, P NATL ACAD SCI USA, V93, P1, DOI 10.1073/pnas.93.1.1	47	45	46	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8422	8433		10.1074/jbc.M109.089128	http://dx.doi.org/10.1074/jbc.M109.089128			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20053995	Green Published, hybrid			2022-12-27	WOS:000275413800057
J	Janowiak, BE; Fischer, A; Collier, RJ				Janowiak, Blythe E.; Fischer, Audrey; Collier, R. John			Effects of Introducing a Single Charged Residue into the Phenylalanine Clamp of Multimeric Anthrax Protective Antigen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR LIPID-BILAYERS; LETHAL FACTOR; PROTEIN TRANSLOCATION; PORE FORMATION; TOXIN PORE; RECEPTOR; CHANNEL; BINDING; MUTATIONS; CELLS	Multimeric pores formed in the endosomal membrane by the Protective Antigen moiety of anthrax toxin translocate the enzymatic moieties of the toxin to the cytosolic compartment of mammalian cells. There is evidence that the side chains of the Phe(427) residues come into close proximity with one another in the lumen of the pore and form a structure, termed the Phe clamp, that catalyzes the translocation process. In this report we describe the effects of replacing Phe427 in a single subunit of the predominantly heptameric pore with a basic or an acidic amino acid. Incorporating any charged residue at this position inhibited cytotoxicity >= 1,000-fold in our standard assay and caused strong inhibition of translocation in a planar phospholipid bilayer system. His and Glu were the most strongly inhibitory residues, ablating both cytotoxicity and translocation. Basic residues at position 427 prevented the Phe clamp from interacting with a translocation substrate to form a seal against the passage of ions and accelerated dissociation of the substrate from the pore. Acidic residues, in contrast, allowed the seal to form and the substrate to remain firmly bound, but blocked its passage, perhaps via electrostatic interactions with the positively charged N-terminal segment. Our findings are discussed in relation to the role of the Phe clamp in a Brownian ratchet model of translocation.	[Janowiak, Blythe E.; Fischer, Audrey; Collier, R. John] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Collier, RJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	jcollier@hms.harvard.edu		Janowiak, Blythe/0000-0001-8103-2474; Collier, R John/0000-0002-2427-4239	National Institutes of Health [1F32 AI077280, 5R01 AI022021]; New England Regional Center of Excellence [A1057159]; PharmAthene, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077280, R01AI022021] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PharmAthene, Inc; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants 1F32 AI077280 (to B. E. J.) and 5R01 AI022021 (to R. J. C.). This work was also supported by New England Regional Center of Excellence Grant A1057159. RJC holds equity in PharmAthene, Inc.	Alfano RW, 2008, MOL CANCER THER, V7, P1218, DOI 10.1158/1535-7163.MCT-08-0024; Basilio D, 2009, J GEN PHYSIOL, V133, P307, DOI 10.1085/jgp.200810170; BERNARD AR, 1995, CURRENT PROTOCOLS PR; Chen D, 2008, BIOORGAN MED CHEM, V16, P7225, DOI 10.1016/j.bmc.2008.06.036; EZZELL JW, 1992, J GEN MICROBIOL, V138, P543, DOI 10.1099/00221287-138-3-543; FINKELSTEIN A, 1994, TOXICOLOGY, V87, P29, DOI 10.1016/0300-483X(94)90153-8; Goldman DL, 2008, CLIN VACCINE IMMUNOL, V15, P970, DOI 10.1128/CVI.00064-08; GORDON VM, 1988, INFECT IMMUN, V56, P1066, DOI 10.1128/IAI.56.5.1066-1069.1988; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Janowiak BE, 2009, PROTEIN SCI, V18, P348, DOI 10.1002/pro.35; Katayama H, 2008, NAT STRUCT MOL BIOL, V15, P754, DOI 10.1038/nsmb.1442; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; KLIMPEL KR, 1992, P NATL ACAD SCI USA, V89, P10277, DOI 10.1073/pnas.89.21.10277; Krantz BA, 2004, J MOL BIOL, V344, P739, DOI 10.1016/j.jmb.2004.09.067; Krantz BA, 2006, J MOL BIOL, V355, P968, DOI 10.1016/j.jmb.2005.11.030; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Leppla SH, 2001, NAT MED, V7, P659, DOI 10.1038/89025; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; Miller CJ, 1999, BIOCHEMISTRY-US, V38, P10432, DOI 10.1021/bi990792d; MILNE JC, 1995, MOL MICROBIOL, V15, P661, DOI 10.1111/j.1365-2958.1995.tb02375.x; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Mourez M, 2003, P NATL ACAD SCI USA, V100, P13803, DOI 10.1073/pnas.2436299100; MUELLER P, 1963, J THEOR BIOL, V4, P268, DOI 10.1016/0022-5193(63)90006-7; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Robinson R.A., 1965, ELECTROLYTE SOLUTION, V2nd; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; Sellman BR, 2001, SCIENCE, V292, P695, DOI 10.1126/science.109563; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Singh Y, 1999, INFECT IMMUN, V67, P1853; Singh Y, 2001, J BIOL CHEM, V276, P22090, DOI 10.1074/jbc.M010222200; Sun J, 2008, P NATL ACAD SCI USA, V105, P4346, DOI 10.1073/pnas.0800701105; Thoren KL, 2009, P NATL ACAD SCI USA, V106, P21555, DOI 10.1073/pnas.0905880106; Wesche J, 1998, BIOCHEMISTRY-US, V37, P15737, DOI 10.1021/bi981436i; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864	39	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8130	8137		10.1074/jbc.M109.093195	http://dx.doi.org/10.1074/jbc.M109.093195			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20061382	Green Published, hybrid			2022-12-27	WOS:000275413800031
J	Schreiber, R; Uliyakina, I; Kongsuphol, P; Warth, R; Mirza, M; Martins, JR; Kunzelmann, K				Schreiber, Rainer; Uliyakina, Inna; Kongsuphol, Patthara; Warth, Richard; Mirza, Myriam; Martins, Joana R.; Kunzelmann, Karl			Expression and Function of Epithelial Anoctamins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CHLORIDE CHANNELS; ION-TRANSPORT; PROTEIN; CELLS; TMEM16A; BESTROPHIN; COMPLEX; CANCER	The calcium-activated chloride channel anoctamin1 (ANO1; TMEM16A) is fundamental for the function of epithelial organs. Mice lacking ANO1 expression exhibit transport defects and a pathology similar to cystic fibrosis. They also show a general defect of epithelial electrolyte transport. Here we analyzed expression of all ten members (ANO1-ANO10) in a broad range of murine tissues and detected predominant expression of ANO1, 6, 7, 8, 9, 10 in epithelial tissues, while ANO2, 3, 4, 5 are common in neuronal and muscle tissues. When expressed in Fisher Rat Thyroid (FTR) cells, all ANO proteins localized to the plasma membrane but only ANO1, 2, 6, and 7 produced Ca2+ activated Cl- conductance, as analyzed by ATP-induced iodide quenching of YFP fluorescence. In contrast ANO9 and ANO10 suppressed baseline Cl- conductance and coexpression of ANO9 with ANO1 inhibited ANO1 activity. Patch clamping of ANO-expressing FRT cells indicated that apart from ANO1 also ANO6 and 10 produced chloride currents, albeit with very different Ca2+ sensitivity and activation time. We conclude that each tissue expresses a set of anoctamins that form cell- and tissue-specific Ca2+-dependent Cl- channels.	[Schreiber, Rainer; Uliyakina, Inna; Kongsuphol, Patthara; Warth, Richard; Mirza, Myriam; Martins, Joana R.; Kunzelmann, Karl] Univ Regensburg, Inst Physiol, D-93053 Regensburg, Germany	University of Regensburg	Kunzelmann, K (corresponding author), Univ Regensburg, Inst Physiol, Univ Str 31, D-93053 Regensburg, Germany.	Karl.Kunzelmann@vkl.uni-regensburg.de	Martins, Joana/L-2965-2016; Warth, Richard/N-7119-2014	Martins, Joana/0000-0002-3784-9775; Warth, Richard/0000-0001-6084-0659; Kunzelmann, Karl/0000-0002-4583-7037; Uliyakina, Inna/0000-0002-7091-2123	Deutsche Forschungsgemeinschaft [DFG KU 756/8-1, DFG SFB699 A6, A7]; TargetScreen [EU-FP6-2005-LH-037365]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TargetScreen	This work was supported by Deutsche Forschungsgemeinschaft DFG KU 756/8-1, DFG SFB699 A6 and A7, and TargetScreen (EU-FP6-2005-LH-037365).	Aldehni F, 2009, J AM SOC NEPHROL, V20, P1556, DOI 10.1681/ASN.2008090987; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Galietta LJV, 2002, J IMMUNOL, V168, P839, DOI 10.4049/jimmunol.168.2.839; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Galindo BE, 2005, INT J MOL MED, V16, P919; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Kidd JF, 2000, ANNU REV PHYSIOL, V62, P493, DOI 10.1146/annurev.physiol.62.1.493; Kreda SM, 2005, MOL BIOL CELL, V16, P2154, DOI 10.1091/mbc.E04-11-1010; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Leblanc N, 2005, CAN J PHYSIOL PHARM, V83, P541, DOI 10.1139/Y05-040; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; Nilius B, 2003, ACTA PHYSIOL SCAND, V177, P119, DOI 10.1046/j.1365-201X.2003.01060.x; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Pifferi S, 2009, PFLUG ARCH EUR J PHY, V458, P1023, DOI 10.1007/s00424-009-0684-9; Rochelle LG, 2000, AM J PHYSIOL-LUNG C, V279, pL14, DOI 10.1152/ajplung.2000.279.1.L14; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Rock JR, 2009, J BIOL CHEM, V284, P14875, DOI 10.1074/jbc.C109.000869; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Soria RB, 2009, J BIOL CHEM, V284, P29405, DOI 10.1074/jbc.M605716200; Spitzner M, 2008, J BIOL CHEM, V283, P7421, DOI 10.1074/jbc.M703758200; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	28	172	195	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7838	7845		10.1074/jbc.M109.065367	http://dx.doi.org/10.1074/jbc.M109.065367			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056604	hybrid, Green Published			2022-12-27	WOS:000275415600091
J	Holzel, M; Orban, M; Hochstatter, J; Rohrmoser, M; Harasim, T; Malamoussi, A; Kremmer, E; Langst, G; Eick, D				Holzel, Michael; Orban, Mathias; Hochstatter, Julia; Rohrmoser, Michaela; Harasim, Thomas; Malamoussi, Anastassia; Kremmer, Elisabeth; Langst, Gernot; Eick, Dirk			Defects in 18 S or 28 S rRNA Processing Activate the p53 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOLAR DISRUPTION; CELL-CYCLE; PROTEIN; BIOGENESIS; TRANSCRIPTION; STABILIZATION; INHIBITION; HDM2; MDM2	The p53 tumor suppressor pathway is activated by defective ribosome synthesis. Ribosomal proteins are released from the nucleolus and block human double minute-2 (Hdm2) that targets p53 for degradation. However, it remained elusive how abrogation of individual rRNA processing pathways contributes to p53 stabilization. Here, we show that selective inhibition of 18 S rRNA processing provokes accumulation of p53 as efficiently as abrogated 28 S rRNA maturation. We describe hUTP18 as a novel mammalian rRNA processing factor that is specifically involved in 18 S rRNA production. hUTP18 was essential for the cleavage of the 5'-external transcribed spacer leader sequence from the primary polymerase I transcript, but was dispensable for rRNA transcription. Because maturation of the 28 S rRNA was unaffected in hUTP18-depleted cells, our results suggest that the integrity of both the 18 S and 28 S rRNA synthesis pathways can be monitored independently by the p53 pathway. Interestingly, accumulation of p53 after hUTP18 knock down required the ribosomal protein L11. Therefore, cells survey the maturation of the small and large ribosomal subunits by separate molecular routes, which may merge in an L11-dependent signaling pathway for p53 stabilization.	[Malamoussi, Anastassia; Eick, Dirk] Ctr Integrated Prot Sci, Inst Clin Mol Biol & Tumour Genet, D-85758 Munich, Germany; [Kremmer, Elisabeth] Helmholtz Ctr Munich, Inst Mol Immunol, D-85758 Munich, Germany; [Hochstatter, Julia] Univ Munich, Inst Biochem, D-280539 Munich, Germany; [Langst, Gernot] Univ Regensburg, D-93047 Regensburg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Regensburg	Holzel, M (corresponding author), Netherlands Canc Inst, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.holzel@nki.nl; eick@helmholtz-muenchen.de	Längst, Gernot/G-5287-2015; Orban, Mathias/AAS-8461-2020	Längst, Gernot/0000-0002-8232-1179; Orban, Mathias/0000-0001-7846-8808; Groth, Julia/0000-0002-7676-6964	Deutsche Forschungsgemeinschaft [SFB684, SFB-Transregio5]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB684, SFB-Transregio5.	Chen D, 2007, ONCOGENE, V26, P5029, DOI 10.1038/sj.onc.1210327; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Grimm T, 2006, NUCLEIC ACIDS RES, V34, P3030, DOI 10.1093/nar/gkl378; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Holzel M, 2005, J CELL BIOL, V170, P367, DOI 10.1083/jcb.200501141; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Jin A, 2004, MOL CELL BIOL, V24, P7669, DOI 10.1128/MCB.24.17.7669-7680.2004; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Rubbi CP, 2003, EMBO J, V22, P6068, DOI 10.1093/emboj/cdg579; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Sun XX, 2007, J BIOL CHEM, V282, P8052, DOI 10.1074/jbc.M610621200; Yuan XJ, 2005, MOL CELL, V19, P77, DOI 10.1016/j.molcel.2005.05.023; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhu Y, 2009, MOL CELL, V35, P316, DOI 10.1016/j.molcel.2009.07.014	20	51	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2010	285	9					6364	6370		10.1074/jbc.M109.054734	http://dx.doi.org/10.1074/jbc.M109.054734			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	566JW	20056613	Green Published, hybrid			2022-12-27	WOS:000275367500040
J	Rickman, C; Medine, CN; Dun, AR; Moulton, DJ; Mandula, O; Halemani, ND; Rizzoli, SO; Chamberlain, LH; Duncan, RR				Rickman, Colin; Medine, Claire N.; Dun, Alison R.; Moulton, David J.; Mandula, Ondrej; Halemani, Nagaraj D.; Rizzoli, Silvio O.; Chamberlain, Luke H.; Duncan, Rory R.			t-SNARE Protein Conformations Patterned by the Lipid Microenvironment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE; PC12 CELLS; LIVING CELLS; EXOCYTOSIS; FUSION; DOMAINS; COMPLEX; CHOLESTEROL; MICROSCOPY; SNAP-25	The spatial distribution of the target (t-) SNARE proteins (syntaxin and SNAP-25) on the plasma membrane has been extensively characterized. However, the protein conformations and interactions of the two t-SNAREs in situ remain poorly defined. By using super-resolution optical techniques and fluorescence lifetime imaging microscopy, we observed that within the t-SNARE clusters syntaxin and SNAP-25 molecules interact, forming two distinct conformations of the t-SNARE binary intermediate. These are spatially segregated on the plasma membrane with each cluster exhibiting predominantly one of the two conformations, representing the two-and three-helical forms previously observed in vitro. We sought to explain why these two t-SNARE intermediate conformations exist in spatially distinct clusters on the plasma membrane. By disrupting plasma membrane lipid order, we found that all of the t-SNARE clusters now adopted a single conformational state corresponding to the three helical t-SNARE intermediates. Together, our results define spatially distinct t-SNARE intermediate states on the plasma membrane and how the conformation adopted can be patterned by the underlying lipid environment.	[Medine, Claire N.; Dun, Alison R.; Moulton, David J.; Chamberlain, Luke H.; Duncan, Rory R.] Univ Edinburgh, Ctr Integrat Physiol, Sch Informat, Edinburgh EH8 9XD, Midlothian, Scotland; [Mandula, Ondrej] Univ Edinburgh, Inst Adapt & Neural Computat, Sch Informat, Edinburgh EH8 9XD, Midlothian, Scotland; [Halemani, Nagaraj D.] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Rizzoli, Silvio O.] European Neurosci Inst, D-37077 Gottingen, Germany; [Rickman, Colin] Heriot Watt Univ, Sch Engn & Phys Sci, Dept Chem, Edinburgh EH14 4AS, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Max Planck Society; Heriot Watt University	Duncan, RR (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Sch Informat, Hugh Robson Bldg,George Sq, Edinburgh EH8 9XD, Midlothian, Scotland.	rory.duncan@ed.ac.uk	Rizzoli, Silvio/ABG-2227-2020	Rickman, Colin/0000-0001-8938-524X; Rizzoli, Silvio/0000-0002-1667-7839; Duncan, Rory/0000-0003-0693-910X	Wellcome Trust; MRC [G0601597] Funding Source: UKRI; Medical Research Council [G0601597] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Wellcome Trust grants ( to R. R. D. and L. H. C.).	ALTENBACH K, 2010, FUNGAL BIOL IN PRESS; An SJ, 2004, SCIENCE, V306, P1042, DOI 10.1126/science.1102559; Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Becker W, 2005, ADV TIME CORRELATED; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BINZ T, 1994, J BIOL CHEM, V269, P1617; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Fitzner D, 2006, EMBO J, V25, P5037, DOI 10.1038/sj.emboj.7601376; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Gonzalo S, 1999, J BIOL CHEM, V274, P21313, DOI 10.1074/jbc.274.30.21313; HALEMANI ND, 2010, TRAFFIC; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hofmann MW, 2006, J MOL BIOL, V364, P1048, DOI 10.1016/j.jmb.2006.09.077; HOPKINS B, 1954, ANN BOT-LONDON, V18, P213, DOI 10.1093/oxfordjournals.aob.a083391; Kroch AE, 2006, J MOL BIOL, V357, P184, DOI 10.1016/j.jmb.2005.12.060; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2002, J CELL BIOL, V158, P751, DOI 10.1083/jcb.200203088; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Lang T, 2008, PROG LIPID RES, V47, P461, DOI 10.1016/j.plipres.2008.08.002; McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007; Medine CN, 2007, J CELL SCI, V120, P4407, DOI 10.1242/jcs.020230; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Murray DH, 2009, BIOCHEMISTRY-US, V48, P4617, DOI 10.1021/bi9003217; Numahara Toshihiko, 1992, Journal of Dermatological Science, V4, P202, DOI 10.1016/0923-1811(92)90020-C; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P50805, DOI 10.1074/jbc.M207988200; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; PARASASSI T, 1994, BIOPHYS J, V66, P120, DOI 10.1016/S0006-3495(94)80763-5; Rickman C, 2004, J BIOL CHEM, V279, P644, DOI 10.1074/jbc.M310879200; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Salaun C, 2005, J BIOL CHEM, V280, P19449, DOI 10.1074/jbc.M501923200; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Valkonen M, 2007, J BIOL CHEM, V282, P22775, DOI 10.1074/jbc.M700916200; Vieira OV, 2006, P NATL ACAD SCI USA, V103, P18556, DOI 10.1073/pnas.0608291103; Weninger K, 2008, STRUCTURE, V16, P308, DOI 10.1016/j.str.2007.12.010	44	49	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 30	2010	285	18					13535	13541		10.1074/jbc.M109.091058	http://dx.doi.org/10.1074/jbc.M109.091058			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	587JL	20093362	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000276987700026
J	Cai, JL; Li, W; Su, HX; Qin, DJ; Yang, JY; Zhu, F; Xu, JY; He, WZ; Guo, XP; Labuda, K; Peterbauer, A; Wolbank, S; Zhong, M; Li, ZY; Wu, WT; So, KF; Redl, H; Zeng, LW; Esteban, MA; Pei, DQ				Cai, Jinglei; Li, Wen; Su, Huanxing; Qin, Dajiang; Yang, Jiayin; Zhu, Fan; Xu, Jianyong; He, Wenzhi; Guo, Xiangpeng; Labuda, Krystyna; Peterbauer, Anja; Wolbank, Susanne; Zhong, Mei; Li, Zhiyuan; Wu, Wutian; So, Kwok-Fai; Redl, Heinz; Zeng, Lingwen; Esteban, Miguel Angel; Pei, Duanqing			Generation of Human Induced Pluripotent Stem Cells from Umbilical Cord Matrix and Amniotic Membrane Mesenchymal Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; DIRECTED DIFFERENTIATION; IPS CELLS; NEURONS; FIBROBLASTS; DERIVATION; INDUCTION	The umbilical cord and placenta are extra-embryonic tissues of particular interest for regenerative medicine. They share an early developmental origin and are a source of vast amounts of cells with multilineage differentiation potential that are poorly immunogenic and without controversy. Moreover, these cells are likely exempt from incorporated mutations when compared with juvenile or adult donor cells such as skin fibroblasts or keratinocytes. Here we report the efficient generation of induced pluripotent stem cells (iPSCs) from mesenchymal cells of the umbilical cord matrix (up to 0.4% of the cells became reprogrammed) and the placental amniotic membrane (up to 0.1%) using exogenous factors and a chemical mixture. iPSCs from these 2 tissues homogeneously showed human embryonic stem cell (hESC)-like characteristics including morphology, positive staining for alkaline phosphatase, normal karyotype, and expression of hESC-like markers including Nanog, Rex1, Oct4, TRA-1-60, TRA-1-80, SSEA-3, and SSEA-4. Selected clones also formed embryonic bodies and teratomas containing derivatives of the 3 germ layers, and could as well be readily differentiated into functional motor neurons. Among other things, our cell lines may prove useful for comparisons between iPSCs derived from multiple tissues regarding the extent of the epigenetic reprogramming, differentiation ability, stability of the resulting lineages, and the risk of associated abnormalities.	[Cai, Jinglei; Li, Wen; Qin, Dajiang; Yang, Jiayin; Zhu, Fan; Xu, Jianyong; He, Wenzhi; Guo, Xiangpeng; Li, Zhiyuan; Zeng, Lingwen; Esteban, Miguel Angel; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Cai, Jinglei; Li, Wen; Qin, Dajiang; Yang, Jiayin; Zhu, Fan; Xu, Jianyong; He, Wenzhi; Guo, Xiangpeng; Li, Zhiyuan; Zeng, Lingwen; Esteban, Miguel Angel; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China; [Su, Huanxing; Wu, Wutian; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Labuda, Krystyna; Wolbank, Susanne; Redl, Heinz] Ludwig Boltzmann Inst Clin & Expt Traumatol, Austrian Cluster Tissue Regenerat, A-1200 Vienna, Austria; [Peterbauer, Anja] Red Cross Blood Transfus Serv Upper Austria, Austrian Cluster Tissue Regenerat, A-4020 Linz, Austria; [Zhong, Mei] Nanfang Hosp, Ctr Prenatal & Hereditary Dis Diag, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Hong Kong; Ludwig Boltzmann Institute; Southern Medical University - China	Esteban, MA (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou 510530, Guangdong, Peoples R China.	esteban@gibh.org; pei_duanqing@gibh.ac.cn	Gabriel, Christian/A-1689-2014; li, zhiyuan/HGD-9581-2022; zhou, xingru/G-4442-2012; Su, Huanxing/X-3980-2019; Redl, Heinz/AAD-8157-2019; Su, Huanxing/X-3954-2019	Gabriel, Christian/0000-0003-2043-9320; Su, Huanxing/0000-0002-0513-4943; Su, Huanxing/0000-0003-3254-825X; Wolbank, Susanne/0000-0002-1244-5854; So, Kwok-Fai/0000-0003-4039-4246	Chinese Academy of Sciences [KSCX2-YW-R-48, KSCX2-YW-R-244]; National Natural Science Foundation of China [30725012, 230725012, 90813033, 30630039]; Ministry of Science and Technology 973 Program [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902, 2010CB944800]; National High Technology Research and Development Program of China [2006AA02A103, 2007G-P034, 2007Z3-C7031]; Bureau of Science and Technology of Guangzhou Municipality [2006A50104002, 2008A1-E4011]; EFBIC (European Federation of Biotechnology)	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology 973 Program(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Bureau of Science and Technology of Guangzhou Municipality; EFBIC (European Federation of Biotechnology)	This work was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences, Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams, Chinese Academy of Sciences (KSCX2-YW-R-48, KSCX2-YW-R-244), National Natural Science Foundation of China (30725012, 230725012, 90813033, 30630039), Ministry of Science and Technology 973 Program (2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902, 2010CB944800), National High Technology Research and Development Program of China (2006AA02A103, 2007G-P034, 2007Z3-C7031), Bureau of Science and Technology of Guangzhou Municipality (2006A50104002, 2008A1-E4011), and an EFBIC (European Federation of Biotechnology) RED travel grant.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Belmonte JCI, 2009, NAT REV GENET, V10, P878, DOI 10.1038/nrg2700; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Can A, 2007, STEM CELLS, V25, P2886, DOI 10.1634/stemcells.2007-0417; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Chamberlain SJ, 2008, NEUROGENETICS, V9, P227, DOI 10.1007/s10048-008-0147-z; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hollands P, 2009, STEM CELL REV REP, V5, P195, DOI 10.1007/s12015-009-9082-0; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li CL, 2009, HUM MOL GENET, V18, P4340, DOI 10.1093/hmg/ddp386; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Miki T, 2006, STEM CELL REV, V2, P133, DOI 10.1007/s12015-006-0020-0; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Red-Horse K, 2004, J CLIN INVEST, V114, P744, DOI 10.1172/JCI200422991; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	49	138	167	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11227	11234		10.1074/jbc.M109.086389	http://dx.doi.org/10.1074/jbc.M109.086389			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139068	Green Published, hybrid			2022-12-27	WOS:000276286200028
J	Du, HN; Briggs, SD				Du, Hai-Ning; Briggs, Scott D.			A Nucleosome Surface Formed by Histone H4, H2A, and H3 Residues Is Needed for Proper Histone H3 Lys(36) Methylation, Histone Acetylation, and Repression of Cryptic Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; DOMAIN-CONTAINING GENE; SACCHAROMYCES-CEREVISIAE; BINDING MODULES; CORE PARTICLE; GENOME-WIDE; CHROMATIN; SET2; ELONGATION; LYSINE-36	Set2-mediated H3 Lys(36) methylation is a histone modification that has been demonstrated to function in transcriptional elongation by recruiting the Rpd3S histone deacetylase complex to repress intragenic cryptic transcription. Recently, we identified a trans-histone pathway in which the interaction between the N terminus of Set2 and histone H4 Lys(44) is needed to mediate trans-histone H3 Lys(36) di- and trimethylation. In the current study, we demonstrate that mutation of the lysine 44 residue in histone H4 or the Set2 mutant lacking the histone H4 interaction motif leads to intragenic cryptic transcripts, indicating that the Set2 and histone H4 interaction is important to repress intragenic cryptic transcription. We also determine that histone H2A residues (Leu(116) and Leu(117)), which are in close proximity to histone H4 Lys(44), are needed for proper trans-histone H3 Lys(36) methylation. Similar to H4 Lys(44) mutants, histone H2A Leu(116) and Leu(117) mutations exhibited decreased H3 Lys(36) di- and trimethylation, increased histone H4 acetylation, increased resistance to 6-azauracil, and cryptic transcription. Interestingly, the combined histone H4 Lys(44) and H2A mutations have more severe methylation defects and increased H4 acetylation levels. Furthermore, we identify that additional histone H2A and H3 core residues are also needed for H3 Lys(36) di- and trimethylation. Overall, our results show and suggest that multiple H4, H2A, and H3 residues contribute to and form a Set2 docking/recognition site on the nucleosomal surface so that proper Set2-mediated H3 Lys(36) di- and trimethylation, histone acetylation, and transcriptional elongation can occur.	[Briggs, Scott D.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Purdue Univ Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Briggs, SD (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ, W Lafayette, IN 47907 USA.	sdbriggs@purdue.edu	du, hai-ning/AAE-5626-2022; Du, Hai-Ning/AAI-2020-2021	Du, Hai-Ning/0000-0001-8062-5411; Briggs, Scott D/0000-0003-2852-3594	National Institutes of Health [GM74183]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM74183 (to S. D. B.).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HENSOLD JO, 1988, BLOOD, V71, P1153; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; KERPPOLA TK, 1991, FASEB J, V5, P2833, DOI 10.1096/fasebj.5.13.1916107; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Psathas JN, 2009, MOL CELL BIOL, V29, P6413, DOI 10.1128/MCB.00876-09; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; SWERDLOW PS, 1990, MOL CELL BIOL, V10, P4905, DOI 10.1128/MCB.10.9.4905; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; VAQUERO A, 2003, SCI AGING KNOWLEDGE, V14, pRE4, DOI DOI 10.1126/SAGEKE.2003.14.RE4; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08	44	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11704	11713		10.1074/jbc.M109.085043	http://dx.doi.org/10.1074/jbc.M109.085043			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20139424	hybrid, Green Published			2022-12-27	WOS:000276286200074
J	Carracedo, S; Lu, N; Popova, SN; Jonsson, R; Eckes, B; Gullberg, D				Carracedo, Sergio; Lu, Ning; Popova, Svetlana N.; Jonsson, Roland; Eckes, Beate; Gullberg, Donald			The Fibroblast Integrin alpha 11 beta 1 Is Induced in a Mechanosensitive Manner Involving Activin A and Regulates Myofibroblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; SMOOTH MUSCLE ACTIN; ACTIVATES LATENT TGF-BETA-1; EXTRACELLULAR-MATRIX; PERIODONTAL-LIGAMENT; COLLAGEN LATTICES; GENE-EXPRESSION; STEM-CELLS; RECEPTORS; ALPHA-2-BETA-1	Fibrotic tissue is characterized by an overabundance of myofibroblasts. Thus, understanding the factors that induce myofibroblast differentiation is paramount to preventing fibrotic healing. Previous studies have shown that mechanical stress derived from the integrin-mediated interaction between extracellular matrix and the cytoskeleton promotes myofibroblast differentiation. Integrin alpha 11 beta 1 is a collagen receptor on fibroblasts. To determine whether alpha 11 beta 1 can act as a mechanosensor to promote the myofibroblast phenotype, mouse embryonic fibroblasts and human corneal fibroblasts were utilized. We found that alpha 11 mRNA and protein levels were up-regulated in mouse embryonic fibroblasts grown in attached three-dimensional collagen gels and conversely down-regulated in cells grown in floating gels. alpha 11 up-regulation could be prevented by manually detaching the collagen gels or by cytochalasin-D-treatment. Furthermore, SB-431542, an inhibitor of signaling via ALK4, ALK5, and ALK7, prevented the up-regulation of alpha 11 and the concomitant phosphorylation of Smad3 under attached conditions. In attached gels, TGF-beta 1 was secreted in its inactive form but surprisingly not further activated, thus not influencing alpha 11 regulation. However, inhibition of activin A attenuated the up-regulation of alpha 11. To determine the role of alpha 11 in myofibroblast differentiation, human corneal fibroblasts were transfected with small interfering RNA to alpha 11, which decreased alpha-smooth muscle actin expression and myofibroblast differentiation. Our data suggest that alpha 11 beta 1 is regulated by cell/matrix stress involving activin A and Smad3 and that alpha 11 beta 1 regulates myofibroblast differentiation.	[Carracedo, Sergio; Lu, Ning; Popova, Svetlana N.; Gullberg, Donald] Univ Bergen, Gade Inst, Dept Biomed, N-5009 Bergen, Norway; [Jonsson, Roland] Univ Bergen, Gade Inst, Broegelmann Res Lab, N-5009 Bergen, Norway; [Eckes, Beate] Univ Cologne, Dept Dermatol, D-50937 Cologne, Germany	University of Bergen; University of Bergen; University of Cologne	Gullberg, D (corresponding author), Jonas Lies Vei 91, N-5009 Bergen, Norway.	donald.gullberg@biomed.uib.no	Gullberg, Donald/H-2495-2016	Gullberg, Donald/0000-0002-7245-4437	European Union [MEST-CT-2004-514483]; Strategic Research Program at Helse Bergen; German-Norwegian Deutsche Akademische Austauschdienst; Projektbezogenen Personenaustausch grant from the Research Council of Norway; Helse Vest, Kreftforeningen [PR 2007-0103]; Research Council of Norway [172330 V40]	European Union(European Commission); Strategic Research Program at Helse Bergen; German-Norwegian Deutsche Akademische Austauschdienst; Projektbezogenen Personenaustausch grant from the Research Council of Norway; Helse Vest, Kreftforeningen; Research Council of Norway(Research Council of Norway)	This work was supported by European Union Marie Curie Early Stage Training Contract MEST-CT-2004-514483 (to S. C.), the Strategic Research Program at Helse Bergen (to R. J.), a bilateral German-Norwegian Deutsche Akademische Austauschdienst, Program des Projektbezogenen Personenaustausch grant from the Research Council of Norway (to D. G.), Helse Vest, Kreftforeningen Grant PR 2007-0103 (to D. G.), and Research Council of Norway Grant 172330 V40 (to D. G.). org)	Abair TD, 2008, EXP CELL RES, V314, P3593, DOI 10.1016/j.yexcr.2008.08.014; ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Arany PR, 2006, P NATL ACAD SCI USA, V103, P9250, DOI 10.1073/pnas.0602473103; Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5; Asano Y, 2006, AM J PATHOL, V168, P499, DOI 10.2353/ajpath.2006.041306; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Byfield SD, 2004, MOL PHARMACOL, V65, P744, DOI 10.1124/mol.65.3.744; Bystrom B, 2009, INVEST OPHTH VIS SCI, V50, P5044, DOI 10.1167/iovs.08-3261; Chipev Constantin C, 2002, BMC Dermatol, V2, P13, DOI 10.1186/1471-5945-2-13; Chiquet M, 2003, MATRIX BIOL, V22, P73, DOI 10.1016/S0945-053X(03)00004-0; Chiquet M, 2009, BBA-MOL CELL RES, V1793, P911, DOI 10.1016/j.bbamcr.2009.01.012; CHIQUETEHRISMANN R, 1994, J CELL BIOL, V127, P2093, DOI 10.1083/jcb.127.6.2093; Cooke ME, 2000, J CELL SCI, V113, P2375; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; DELVOYE P, 1991, J INVEST DERMATOL, V97, P898, DOI 10.1111/1523-1747.ep12491651; Desmouliere A, 2004, INT J DEV BIOL, V48, P509, DOI 10.1387/ijdb.041802ad; deWinter JP, 1996, MOL CELL ENDOCRINOL, V116, P105, DOI 10.1016/0303-7207(95)03705-5; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Eckes B, 2006, J INVEST DERM SYMP P, V11, P66, DOI 10.1038/sj.jidsymp.5650003; FEIJEN A, 1994, DEVELOPMENT, V120, P3621; Fluck M, 2003, BBA-MOL CELL RES, V1593, P239, DOI 10.1016/S0167-4889(02)00394-4; Fumagalli M, 2007, EXP DERMATOL, V16, P600, DOI 10.1111/j.1600-0625.2007.00571.x; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; GULLBERG D, 1990, EXP CELL RES, V186, P264, DOI 10.1016/0014-4827(90)90305-T; Gullberg D, 2009, MATRIX BIOL, V28, P383, DOI 10.1016/j.matbio.2009.09.008; HEINO J, 1989, J BIOL CHEM, V264, P380; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz Boris, 2009, Curr Rheumatol Rep, V11, P120; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200; KLEIN CE, 1991, J CELL BIOL, V115, P1427, DOI 10.1083/jcb.115.5.1427; Lamar JM, 2008, CANCER RES, V68, P7371, DOI 10.1158/0008-5472.CAN-08-1080; LEHNERT SA, 1988, DEVELOPMENT, V104, P263; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Lindahl GE, 2002, J BIOL CHEM, V277, P6153, DOI 10.1074/jbc.M108966200; Liu SX, 2009, ARTHRITIS RHEUM-US, V60, P2817, DOI 10.1002/art.24801; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu N, 2006, MATRIX BIOL, V25, P118, DOI 10.1016/j.matbio.2005.10.002; LU N, 2009, MATRIX BIOL IN PRESS; Lygoe KA, 2004, WOUND REPAIR REGEN, V12, P461, DOI 10.1111/j.1067-1927.2004.12402.x; Maier S, 2008, BBA-MOL CELL RES, V1783, P1150, DOI 10.1016/j.bbamcr.2008.01.013; Maltseva O, 2001, INVEST OPHTH VIS SCI, V42, P2490; Marastoni S, 2008, CONNECT TISSUE RES, V49, P203, DOI 10.1080/03008200802143190; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Ng CP, 2005, J CELL SCI, V118, P4731, DOI 10.1242/jcs.02605; Ohga E, 1996, BIOCHEM BIOPH RES CO, V228, P391, DOI 10.1006/bbrc.1996.1672; Orr AW, 2006, MOL BIOL CELL, V17, P4686, DOI 10.1091/mbc.E06-04-0289; Papetti M, 2003, INVEST OPHTH VIS SCI, V44, P4994, DOI 10.1167/iovs.03-0291; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Patwari P, 2008, CIRC RES, V103, P234, DOI 10.1161/CIRCRESAHA.108.175331; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Popova SN, 2007, ACTA PHYSIOL, V190, P179, DOI 10.1111/j.1748-1716.2007.01718.x; Popova SN, 2004, DEV BIOL, V270, P427, DOI 10.1016/j.ydbio.2004.03.006; Popova SN, 2007, MOL CELL BIOL, V27, P4306, DOI 10.1128/MCB.00041-07; Pozzi M, 1998, J CELL BIOL, V142, P587; Rios HF, 2008, J PERIODONTOL, V79, P1480, DOI [10.1902/jop.2008.070624, 10.1902/jop.2008.070624 ]; Rodriguez A, 2009, J CELL MOL MED, V13, P3449, DOI 10.1111/j.1582-4934.2008.00638.x; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Shimizu A, 1998, GENES CELLS, V3, P125, DOI 10.1046/j.1365-2443.1998.00174.x; Solon J, 2007, BIOPHYS J, V93, P4453, DOI 10.1529/biophysj.106.101386; Svendsen OS, 2009, ARTERIOSCL THROM VAS, V29, P1864, DOI 10.1161/ATVBAHA.109.194308; Tiger CF, 2001, DEV BIOL, V237, P116, DOI 10.1006/dbio.2001.0363; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Varas L, 2007, STEM CELLS DEV, V16, P965, DOI 10.1089/scd.2007.0049; WHITEHEAD RH, 1994, EPITHELIAL CELL BIOL, V3, P119; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Wipff PJ, 2009, J BODYW MOV THER, V13, P121, DOI 10.1016/j.jbmt.2008.04.031; Yang ZW, 2007, J CELL BIOL, V176, P787, DOI 10.1083/jcb.200611044; You LT, 2002, INVEST OPHTH VIS SCI, V43, P72; Zhang ZG, 2006, J CELL SCI, V119, P1886, DOI 10.1242/jcs.02921; Zhu CQ, 2007, P NATL ACAD SCI USA, V104, P11754, DOI 10.1073/pnas.0703040104; Zweers MC, 2007, J INVEST DERMATOL, V127, P467, DOI 10.1038/sj.jid.5700546	83	94	97	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10434	10445		10.1074/jbc.M109.078766	http://dx.doi.org/10.1074/jbc.M109.078766			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20129924	Green Published, hybrid			2022-12-27	WOS:000276264600029
J	del Valle-Perez, B; Martinez, VG; Lacasa-Salavert, C; Figueras, A; Shapiro, SS; Takafuta, T; Casanovas, O; Capella, G; Ventura, F; Vinals, F				del Valle-Perez, Beatriz; Gabriela Martinez, Vanesa; Lacasa-Salavert, Cristina; Figueras, Agnes; Shapiro, Sandor S.; Takafuta, Toshiro; Casanovas, Oriol; Capella, Gabriel; Ventura, Francesc; Vinals, Francesc			Filamin B Plays a Key Role in Vascular Endothelial Growth Factor-induced Endothelial Cell Motility through Its Interaction with Rac-1 and Vav-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MOLECULAR SCAFFOLD; ACTIN-FILAMENTS; MIGRATION; ACTIVATION; ANGIOGENESIS; MICE; PROTEIN; MALFORMATIONS; PERMEABILITY	Actin-binding proteins filamin A (FLNA) and B (FLNB) are expressed in endothelial cells and play an essential role during vascular development. In order to investigate their role in adult endothelial cell function, we initially confirmed their expression pattern in different adult mouse tissues and cultured cell lines and found that FLNB expression is concentrated mainly in endothelial cells, whereas FLNA is more ubiquitously expressed. Functionally, small interfering RNA knockdown of endogenous FLNB in human umbilical vein endothelial cells inhibited vascular endothelial growth factor (VEGF)-induced in vitro angiogenesis by decreasing endothelial cell migration capacity, whereas FLNA ablation did not alter these parameters. Moreover, FLNB-depleted cells increased their substrate adhesion with more focal adhesions. The molecular mechanism underlying this effect implicates modulation of small GTP-binding protein Rac-1 localization and activity, with altered activation of its downstream effectors p21 protein Cdc42/Rac-activated kinase (PAK)-4/5/6 and its activating guanine nucleotide exchange factor Vav-2. Moreover, our results suggest the existence of a signaling complex, including FLNB, Rac-1, and Vav-2, under basal conditions that would further interact with VEGFR2 and integrin alpha v beta 5 after VEGF stimulation. In conclusion, our results reveal a crucial role for FLNB in endothelial cell migration and in the angiogenic process in adult endothelial cells.	[del Valle-Perez, Beatriz; Gabriela Martinez, Vanesa; Lacasa-Salavert, Cristina; Figueras, Agnes; Casanovas, Oriol; Capella, Gabriel; Vinals, Francesc] Inst Catala Oncol IDIBELL, Lab Recerca Translac, E-08907 Barcelona, Spain; [del Valle-Perez, Beatriz; Lacasa-Salavert, Cristina; Ventura, Francesc; Vinals, Francesc] Univ Barcelona IDIBELL, Dept Ciencies Fisiol 2, Unitat Bioquim & Biol Mol, E-08907 Barcelona, Spain; [Shapiro, Sandor S.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Mol Physiol & Biophys, Philadelphia, PA 19107 USA; [Takafuta, Toshiro] Nishi Kobe Med Ctr, Kobe, Hyogo 6512273, Japan	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Jefferson University; Kobe City Medical Center General Hospital	Vinals, F (corresponding author), Inst Catala Oncol IDIBELL, Lab Recerca Translac, Gran Via S-N KM 2,7, E-08907 Barcelona, Spain.	fvinyals@ico.scs.es	Ventura, Francesc/K-9700-2014; Viñals, Francesc/F-5928-2016; Vinals, Francesc/P-6278-2019; Capella, Gabriel/I-1879-2015; Ventura, Francesc/ABG-2285-2020; Casanovas, Oriol/L-5210-2014	Ventura, Francesc/0000-0001-9673-9405; Viñals, Francesc/0000-0002-9918-6751; Capella, Gabriel/0000-0002-4669-7320; Ventura, Francesc/0000-0001-9673-9405; Casanovas, Oriol/0000-0002-4298-3995	National Institutes of Health [HL-072439]; Ministerio de Ciencia y Tecnologia [SAF2004-01350, SAF2007-60955, RTICC RD2006-0092, BFU2008-02010]; Generalitat de Catalunya [2005SGR727, 2009SGR283]; National Hemophilia Foundation, Delaware Valley Chapter; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); National Hemophilia Foundation, Delaware Valley Chapter; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-072439 (to S. S. S. and T. T.). This work was also supported by Ministerio de Ciencia y Tecnologia Grants SAF2004-01350, SAF2007-60955, and RTICC RD2006-0092 (to F. Vinals) and BFU2008-02010 to (F. Ventura), Generalitat de Catalunya Grants 2005SGR727 and 2009SGR283 (to F. Vinals), and a grant from the National Hemophilia Foundation, Delaware Valley Chapter (to S. S. S.).	Calderwood DA, 2000, J BIOL CHEM, V275, P22607, DOI 10.1074/jbc.R900037199; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Conway RE, 2006, MOL CELL BIOL, V26, P5310, DOI 10.1128/MCB.00084-06; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Del Pozo MA, 2002, NAT CELL BIOL, V4, P232, DOI 10.1038/ncb759; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Farrington-Rock C, 2008, HUM MOL GENET, V17, P631, DOI 10.1093/hmg/ddm188; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; GARLANDA C, 1994, P NATL ACAD SCI USA, V91, P7291, DOI 10.1073/pnas.91.15.7291; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Gong Chunhong, 2004, Angiogenesis, V7, P313, DOI 10.1007/s10456-004-7960-2; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Jeon YJ, 2008, MOL BIOL CELL, V19, P5116, DOI 10.1091/mbc.E08-06-0576; Kanters E, 2008, J BIOL CHEM, V283, P31830, DOI 10.1074/jbc.M804888200; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Krakow D, 2004, NAT GENET, V36, P405, DOI 10.1038/ng1319; LAEMMLI UK, 1970, NATURE, V227, P685; Lee JSY, 2003, HISTOL HISTOPATHOL, V18, P879, DOI 10.14670/HH-18.879; Lu J, 2007, HUM MOL GENET, V16, P1661, DOI 10.1093/hmg/ddm114; McKenzie FR, 1996, J BIOL CHEM, V271, P13476, DOI 10.1074/jbc.271.23.13476; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Revenu C, 2004, NAT REV MOL CELL BIO, V5, P635, DOI 10.1038/nrm1437; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takafuta T, 1998, J BIOL CHEM, V273, P17531, DOI 10.1074/jbc.273.28.17531; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; van der Flier A, 2002, J CELL BIOL, V156, P361, DOI 10.1083/jcb.200103037; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Vinals F, 2002, FEBS LETT, V510, P99, DOI 10.1016/S0014-5793(01)03236-7; Wang Q, 1997, J CELL PHYSIOL, V172, P171, DOI 10.1002/(SICI)1097-4652(199708)172:2<171::AID-JCP4>3.0.CO;2-L; Zhang WJ, 1998, J NEUROSCI, V18, P914; Zhou X, 2007, P NATL ACAD SCI USA, V104, P3919, DOI 10.1073/pnas.0608360104	46	58	58	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10748	10760		10.1074/jbc.M109.062984	http://dx.doi.org/10.1074/jbc.M109.062984			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110358	hybrid, Green Published			2022-12-27	WOS:000276264600061
J	Harper, SL; Li, DH; Maksimova, Y; Gallagher, PG; Speicher, DW				Harper, Sandra L.; Li, Donghai; Maksimova, Yelena; Gallagher, Patrick G.; Speicher, David W.			A Fused alpha-beta "Mini-spectrin" Mimics the Intact Erythrocyte Spectrin Head-to-head Tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-CELL SPECTRIN; DIMER SELF-ASSOCIATION; INITIATION SITE; CROSS-LINKING; MEMBRANE; ULTRACENTRIFUGATION; CYTOSKELETON; EQUILIBRIUM; PEPTIDES; SEGMENTS	Head-to-head assembly of two spectrin heterodimers to form an actin-cross-linking tetramer is a physiologically dynamic interaction that contributes to red cell membrane integrity. Recombinant beta-spectrin C-terminal and alpha-spectrin N-terminal peptides can form tetramer-like univalent complexes, but they cannot evaluate effects of the open-closed dimer interactions or lateral associations of the two-spectrin strands on tetramer formation. In this study we produced and characterized a fused "mini-spectrin dimer" containing the beta-spectrin C-terminal region linked to the alpha-spectrin N-terminal region. This fused mini-spectrin mimics structural and functional properties of intact, full-length dimers and tetramers, including lateral association of the alpha and beta subunits in the dimer and formation of a closed dimer. High performance liquid chromatography gel filtration analyses of this mini-spectrin provide the first direct non-imaging experimental evidence for open and closed spectrin dimers and show that dimer-tetramer-oligomer interconversion is slow at low temperatures and accelerated at 30 degrees C, analogous to full-length spectrin. This protein exhibits wild type dimer-tetramer dissociation constants of similar to 1 mu M at 30 degrees C, independent of initial oligomeric state. Conformational states of the mini-spectrin dimer were probed further using chemical crosslinking, which identified distinct groups of cross-links for "open" and "closed" dimers and confirmed the N-terminal region of alpha-spectrin remains highly flexible in the complex, exhibiting closely analogous structures to those observed for the isolated alpha-spectrin N-terminal using NMR (Park, S., Caffrey, M. S., Johnson, M. E., and Fung, L. W. (2003) J. Biol. Chem. 278, 21837-21844). This fusion protein should serve as a useful template for structural and functional studies of the divalent tetramer site.	[Speicher, David W.] Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, Philadelphia, PA 19104 USA; [Li, Donghai] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Jiangsu Diabet Ctr, Nanjing 210093, Jiangsu, Peoples R China; [Maksimova, Yelena; Gallagher, Patrick G.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA	The Wistar Institute; Nanjing University; Yale University	Speicher, DW (corresponding author), Wistar Inst Anat & Biol, Ctr Syst & Computat Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	speicher@wistar.org			National Institutes of Health [HL38794, HL65448]; Wistar Institute [CA10815]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065448, R01HL038794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wistar Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL38794 ( to D. W. S.) and HL65448 ( to P. G. G.). This work was also supported by institutional grant to the Wistar Institute Grant CA10815.	An XL, 2002, J BIOL CHEM, V277, P31796, DOI 10.1074/jbc.M204567200; Baines AJ, 2009, BIOCHEM SOC T, V37, P796, DOI 10.1042/BST0370796; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1993, ANNU REV CELL BIOL, V9, P27, DOI 10.1146/annurev.cellbio.9.1.27; DESILVA TM, 1992, BIOCHEMISTRY-US, V31, P10872, DOI 10.1021/bi00159a030; El-Shafey A, 2006, PROTEIN SCI, V15, P429, DOI 10.1110/ps.051685706; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; Grum VL, 1999, CELL, V98, P523, DOI 10.1016/S0092-8674(00)81980-7; HARPER S, 1998, CURRENT PROTOCOLS PR; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Khan AA, 2008, J BIOL CHEM, V283, P14600, DOI 10.1074/jbc.M707818200; Lecomte MC, 1999, EUR BIOPHYS J BIOPHY, V28, P208, DOI 10.1007/s002490050201; Li DH, 2008, J BIOL CHEM, V283, P1553, DOI 10.1074/jbc.M706981200; Li DH, 2007, BIOCHEMISTRY-US, V46, P10585, DOI 10.1021/bi7007905; Long F, 2007, PROTEIN SCI, V16, P2519, DOI 10.1110/ps.073115307; LUCKOW EA, 1989, BIOCHEMISTRY-US, V28, P2348, DOI 10.1021/bi00431a055; Mehboob S, 2001, BIOCHEMISTRY-US, V40, P12457, DOI 10.1021/bi010984k; MORRIS M, 1989, BIOCHEMISTRY-US, V28, P8561, DOI 10.1021/bi00447a044; MORROW JS, 1981, J CELL BIOL, V88, P463, DOI 10.1083/jcb.88.2.463; OHANIAN V, 1984, BIOCHEMISTRY-US, V23, P4416, DOI 10.1021/bi00314a027; Park S, 2003, J BIOL CHEM, V278, P21837, DOI 10.1074/jbc.M300617200; RALSTON GB, 1978, J SUPRAMOL STR CELL, V8, P361, DOI 10.1002/jss.400080313; Sambrook J., 2001, MOL CLONING LAB MANU, V3rd ed.; SHAHBAKHTI F, 1986, BIOCHEMISTRY-US, V25, P5969, DOI 10.1021/bi00368a020; SPEICHER DW, 1984, NATURE, V311, P177, DOI 10.1038/311177a0; SPEICHER DW, 1993, J BIOL CHEM, V268, P4227; Speicher K D, 2000, J Biomol Tech, V11, P74; TSE WT, 1990, J CLIN INVEST, V86, P909, DOI 10.1172/JCI114792; UNGEWICKELL E, 1978, EUR J BIOCHEM, V88, P379, DOI 10.1111/j.1432-1033.1978.tb12459.x; Ursitti JA, 1996, J BIOL CHEM, V271, P6636, DOI 10.1074/jbc.271.12.6636; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; YPHANTIS DA, 1964, BIOCHEMISTRY-US, V3, P297, DOI 10.1021/bi00891a003	32	13	14	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					11003	11012		10.1074/jbc.M109.083048	http://dx.doi.org/10.1074/jbc.M109.083048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139081	hybrid, Green Published			2022-12-27	WOS:000276264600084
J	Pewzner-Jung, Y; Park, H; Laviad, EL; Silva, LC; Lahiri, S; Stiban, J; Erez-Roman, R; Brugger, B; Sachsenheimer, T; Wieland, F; Prieto, M; Merrill, AH; Futerman, AH				Pewzner-Jung, Yael; Park, Hyejung; Laviad, Elad L.; Silva, Liana C.; Lahiri, Sujoy; Stiban, Johnny; Erez-Roman, Racheli; Bruegger, Britta; Sachsenheimer, Timo; Wieland, Felix; Prieto, Manuel; Merrill, Alfred H., Jr.; Futerman, Anthony H.			A Critical Role for Ceramide Synthase 2 in Liver Homeostasis I. ALTERATIONS IN LIPID METABOLIC PATHWAYS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM MASS-SPECTROMETRY; RAT-LIVER; SUBSTRATE-SPECIFICITY; ENDOPLASMIC-RETICULUM; MAMMALIAN-CELLS; SPHINGOID BASE; FAMILY-MEMBERS; SPHINGOLIPIDS; SPHINGANINE; GLUCOSYLCERAMIDE	Ceramide is an important lipid signaling molecule that plays critical roles in regulating cell behavior. Ceramide synthesis is surprisingly complex and is orchestrated by six mammalian ceramide synthases, each of which produces ceramides with restricted acyl chain lengths. We have generated a CerS2 null mouse and characterized the changes in the long chain base and sphingolipid composition of livers from these mice. Ceramide and downstream sphingolipids were devoid of very long (C22-C24) acyl chains, consistent with the substrate specificity of CerS2 toward acyl-CoAs. Unexpectedly, C16-ceramide levels were elevated, and as a result, total ceramide levels were unaltered; however, C16-ceramide synthesis in vitro was not increased. Levels of sphinganine were also significantly elevated, by up to 50-fold, reminiscent of the effect of the ceramide synthase inhibitor, fumonisin B1. With the exceptions of glucosylceramide synthase and neutral sphingomyelinase 2, none of the other enzymes tested in either the sphingolipid biosynthetic or degradative pathways were significantly changed. Total glycerophospholipid and cholesterol levels were unaltered, although there was a marked elevation in C18:1 and C18:2 fatty acids in phosphatidylethanolamine, concomitant with a reduction in C18:0 and C20:4 fatty acids. Finally, differences were observed in the biophysical properties of lipid extracts isolated from liver microsomes, with membranes from CerS2 null mice displaying higher membrane fluidity and showing morphological changes. Together, these results demonstrate novel modes of cross-talk and regulation between the various branches of lipid metabolic pathways upon inhibition of very long acyl chain ceramide synthesis.	[Pewzner-Jung, Yael; Laviad, Elad L.; Silva, Liana C.; Lahiri, Sujoy; Stiban, Johnny; Erez-Roman, Racheli; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Silva, Liana C.; Prieto, Manuel] Ctr Quim Fis Mol, Inst Super Tecn, P-1049001 Lisbon, Portugal; [Bruegger, Britta; Sachsenheimer, Timo; Wieland, Felix] Heidelberg Univ, Biochem Ctr, D-69120 Heidelberg, Germany	Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Universidade de Lisboa; Instituto Superior Tecnico; Ruprecht Karls University Heidelberg	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il	Prieto, Manuel/N-4448-2013; Silva, Liana C./A-3025-2011; Stiban, Johnny/AAB-3468-2019; Pewzner, Faivish/I-6225-2017; Stiban, Johnny/AAC-1515-2019; iMed.ULisboa, InTraCellADD/B-4826-2014	Prieto, Manuel/0000-0003-3012-6598; Silva, Liana C./0000-0003-1311-0770; Pewzner, Faivish/0000-0002-7490-8121; Stiban, Johnny/0000-0002-3748-9976; Futerman, Anthony/0000-0003-0013-0115; Merrill, Alfred/0000-0002-6673-968X	National Institutes of Health [GM076217]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	work was supported, in whole or in part, by National Institutes of Health Grant GM076217. This work was also supported by Israel Science Foundation Grant 1404/07 and by The Minerva Foundation.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bjorkqvist YJE, 2009, BBA-BIOMEMBRANES, V1788, P1310, DOI 10.1016/j.bbamem.2009.02.019; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; COURCHAINE AJ, 1959, CLIN CHEM, V5, P609; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; DEANA AD, 1990, BIOCHIM BIOPHYS ACTA, V1051, P199, DOI 10.1016/0167-4889(90)90194-I; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Fahy E, 2005, J LIPID RES, V46, P839, DOI 10.1194/jlr.E400004-JLR200; FRIEDRICH G, 1993, METHOD ENZYMOL, V225, P681; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; FUTERMAN AH, 1991, BIOCHEM J, V280, P295, DOI 10.1042/bj2800295; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Haynes CA, 2008, J LIPID RES, V49, P1113, DOI 10.1194/jlr.D800001-JLR200; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Kim DH, 2006, J TOXICOL ENV HEAL A, V69, P2071, DOI 10.1080/15287390600746215; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; MEIVARLEVY I, 1994, BIOCHEM J, V303, P377, DOI 10.1042/bj3030377; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2007, TRENDS BIOCHEM SCI, V32, P457, DOI 10.1016/j.tibs.2007.09.004; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Mukherjee S, 1999, J CELL BIOL, V144, P1271, DOI 10.1083/jcb.144.6.1271; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pinto SN, 2008, BIOPHYS J, V95, P2867, DOI 10.1529/biophysj.108.129858; Pruett ST, 2008, J LIPID RES, V49, P1621, DOI 10.1194/jlr.R800012-JLR200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Riley RT, 2006, TOXICOL SCI, V92, P335, DOI 10.1093/toxsci/kfj198; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Silva LC, 2009, BIOPHYS J, V96, P3210, DOI 10.1016/j.bpj.2008.12.3923; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; SULLARDS MC, 2001, SCI STKE, V86, pPL1; Tani M, 1999, J BIOCHEM-TOKYO, V125, P746; Tian A, 2009, BIOPHYS J, V96, P2676, DOI 10.1016/j.bpj.2008.11.067; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; WANG E, 1991, J BIOL CHEM, V266, P14486; Yang J, 2003, ENVIRON POLLUT, V121, P345, DOI 10.1016/S0269-7491(02)00239-7	48	170	179	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10902	10910		10.1074/jbc.M109.077594	http://dx.doi.org/10.1074/jbc.M109.077594			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110363	hybrid, Green Published			2022-12-27	WOS:000276264600075
J	Yang, YW; Petkova, A; Huang, K; Xu, B; Hua, QX; Ye, IJ; Chu, YC; Hu, SQ; Phillips, NB; Whittaker, J; Ismail-Beigi, F; Mackin, RB; Katsoyannis, PG; Tycko, R; Weiss, MA				Yang, Yanwu; Petkova, Aneta; Huang, Kun; Xu, Bin; Hua, Qing-xin; Ye, I-Ju; Chu, Ying-Chi; Hu, Shi-Quan; Phillips, Nelson B.; Whittaker, Jonathan; Ismail-Beigi, Faramarz; Mackin, Robert B.; Katsoyannis, Panayotis G.; Tycko, Robert; Weiss, Michael A.			An Achilles' Heel in an Amyloidogenic Protein and Its Repair INSULIN FIBRILLATION AND THERAPEUTIC DESIGN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTO-CROSS-LINKING; CHEMICAL-SHIFT INDEX; SOLID-STATE NMR; SECONDARY-STRUCTURE; AMINO-ACIDS; A-CHAIN; CRYSTAL-STRUCTURE; RECEPTOR-BINDING; ROTATING SOLIDS; LISPRO INSULIN	Insulin fibrillation provides a model for a broad class of amyloidogenic diseases. Conformational distortion of the native monomer leads to aggregation-coupled misfolding. Whereas beta-cells are protected from proteotoxicity by hexamer assembly, fibrillation limits the storage and use of insulin at elevated temperatures. Here, we have investigated conformational distortions of an engineered insulin monomer in relation to the structure of an insulin fibril. Anomalous (13)C NMR chemical shifts and rapid (15)N-detected (1)H-(2)H amide-proton exchange were observed in one of the three classical alpha-helices (residues A1-A8) of the hormone, suggesting a conformational equilibrium between locally folded and unfolded A-chain segments. Whereas hexamer assembly resolves these anomalies in accordance with its protective role, solid-state (13)C NMR studies suggest that the A-chain segment participates in a fibril-specific beta-sheet. Accordingly, we investigated whether helicogenic substitutions in the A1-A8 segment might delay fibrillation. Simultaneous substitution of three beta-branched residues (Ile(A2) -> Leu, Val(A3) -> Leu, and Thr(A8) -> His) yielded an analog with reduced thermodynamic stability but marked resistance to fibrillation. Whereas amide-proton exchange in the A1-A8 segment remained rapid, (13)C alpha chemical shifts exhibited a more helical pattern. This analog is essentially without activity, however, as Ile(A2) and Val(A3) define conserved receptor contacts. To obtain active analogs, substitutions were restricted to A8. These analogs exhibit high receptor-binding affinity; representative potency in a rodent model of diabetes mellitus was similar to wild-type insulin. Although (13)C alpha chemical shifts remain anomalous, significant protection from fibrillation is retained. Together, our studies define an "Achilles' heel" in a globular protein whose repair may enhance the stability of pharmaceutical formulations and broaden their therapeutic deployment in the developing world.	[Yang, Yanwu; Huang, Kun; Xu, Bin; Hua, Qing-xin; Ye, I-Ju; Hu, Shi-Quan; Phillips, Nelson B.; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz; Weiss, Michael A.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Petkova, Aneta; Tycko, Robert] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA; [Chu, Ying-Chi; Katsoyannis, Panayotis G.] NYU, Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA; [Mackin, Robert B.] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA	Case Western Reserve University; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Icahn School of Medicine at Mount Sinai; New York University; Creighton University	Yang, YW (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	yanwu.yang@case.edu; Michael.Weiss@case.edu	Huang, Kun/H-4427-2012	Xu, Bin/0000-0002-0490-9540	National Institutes of Health [DK52085, DK079233, DK04949, DK054662]; American Heart Association [0530067N]; American Diabetes Association; NIDDK, National Institutes of Health; Independent University of Bangladesh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Diabetes Association(American Diabetes Association); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Independent University of Bangladesh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52085 (to R. B. M.) and DK079233, DK04949, and DK054662 (to M. A. W.). This work was also supported by Grant 0530067N from the American Heart Association (to Y. Y.) and a grant from the American Diabetes Association (to N. B. P.). This paper is a contribution from the Cleveland Center for Membrane and Structural Biology. M. A. W. has equity in and consults to Thermalin Diabetes, Inc. (Cleveland, OH).; Solid-state NMR measurements were supported by the Intramural Research Program of the NIDDK, National Institutes of Health. We thank Drs. P. Carey, G. M. Clore, G. G. Dodson, R. Levy, D. F. Steiner, and B. Sykes for discussion; and we thank M. Choquette for technical assistance in generating the labeled DKP-proinsulin. M. A. W. thanks Drs. D. Jacobson (Case Western Reserve University Mandel School of Applied Social Sciences), M. R. Miah (Director, Southern Illinois University Carbondale School of Social Work), M. O. Rahman (Provost, Independent University of Bangladesh), and B. M. Chowdhury (Vice Chancellor, Independent University of Bangladesh) for sponsorship of a student-faculty trip to study poverty, micro-finance, and medical needs in the developing world.	Ahmad A, 2004, J BIOL CHEM, V279, P14999, DOI 10.1074/jbc.M313134200; Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; BADGER J, 1991, ACTA CRYSTALLOGR B, V47, P127, DOI 10.1107/S0108768190009570; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bennett AE, 1998, J CHEM PHYS, V108, P9463, DOI 10.1063/1.476420; BENTLEY G, 1978, J MOL BIOL, V126, P871, DOI 10.1016/0022-2836(78)90026-8; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Bode BW, 2002, DIABETES-METAB RES, V18, pS14, DOI 10.1002/dmrr.205; Bode BW, 2001, DIABETES CARE, V24, P69, DOI 10.2337/diacare.24.1.69; Bouchard M, 2000, PROTEIN SCI, V9, P1960, DOI 10.1110/ps.9.10.1960; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, Pharm Biotechnol, V10, P343; BRANGE J, 1987, GALENICS INSULIN, P52; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11332, DOI 10.1073/pnas.90.23.11332; Chang XQ, 1997, BIOCHEMISTRY-US, V36, P9409, DOI 10.1021/bi9631069; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demirdjian S, 1998, DIABETES CARE, V21, P867, DOI 10.2337/diacare.21.5.867; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2003, NAT REV DRUG DISCOV, V2, P154, DOI 10.1038/nrd1013; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; DOIG AJ, 1995, PROTEIN SCI, V4, P1325, DOI 10.1002/pro.5560040708; Dong J, 2003, J MOL BIOL, V330, P431, DOI 10.1016/S0022-2836(03)00536-9; Dumoulin M, 2005, J MOL BIOL, V346, P773, DOI 10.1016/j.jmb.2004.11.020; Holleman F, 1997, NEW ENGL J MED, V337, P176, DOI 10.1056/NEJM199707173370307; Hong DP, 2005, BIOCHEMISTRY-US, V44, P16701, DOI 10.1021/bi051658y; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Ishii Y, 2001, J CHEM PHYS, V114, P8473, DOI 10.1063/1.1359445; Jacoby E, 1996, PROTEIN ENG, V9, P113, DOI 10.1093/protein/9.2.113; Jimenez JL, 2002, P NATL ACAD SCI USA, V99, P9196, DOI 10.1073/pnas.142459399; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005; Mackin RB, 2003, PROTEIN EXPRES PURIF, V27, P210, DOI 10.1016/S1046-5928(02)00643-5; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; MINOR DL, 1994, NATURE, V367, P660, DOI 10.1038/367660a0; Mudaliar SR, 1999, DIABETES CARE, V22, P1501, DOI 10.2337/diacare.22.9.1501; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; Nourse A, 1996, BIOL CHEM H-S, V377, P147; O'Donoghue SI, 2000, J BIOMOL NMR, V16, P93, DOI 10.1023/A:1008323819099; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; ONEIL KT, 1990, SCIENCE, V250, P646, DOI 10.1126/science.2237415; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; POCKER Y, 1980, BIOCHEMISTRY-US, V19, P5043, DOI 10.1021/bi00563a017; Radermecker RP, 2004, DIABETES-METAB RES, V20, P178, DOI 10.1002/dmrr.447; Renner R, 1999, DIABETES CARE, V22, P784, DOI 10.2337/diacare.22.5.784; Saker F, 1998, AM J PHYSIOL-ENDOC M, V274, pE984, DOI 10.1152/ajpendo.1998.274.6.E984; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; WAUGH DAVID F., 1957, J CELL AND COMP PHYSIOL, V49, P145, DOI 10.1002/jcp.1030490415; Weiss MA, 2002, J MOL BIOL, V315, P103, DOI 10.1006/jmbi.2001.5224; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Whittaker J, 2005, J BIOL CHEM, V280, P20932, DOI 10.1074/jbc.M411320200; Whittaker J, 2001, J BIOL CHEM, V276, P43980, DOI 10.1074/jbc.M102863200; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WOLLMER A, 1987, BIOL CHEM H-S, V368, P903, DOI 10.1515/bchm3.1987.368.2.903; Wolpert HA, 2002, BRIT MED J, V324, P1253, DOI 10.1136/bmj.324.7348.1253; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200; YU NT, 1974, ARCH BIOCHEM BIOPHYS, V160, P614, DOI 10.1016/0003-9861(74)90438-X; Yunus, 1998, BANKER POOR MICROLEN; [No title captured]	88	37	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10806	10821		10.1074/jbc.M109.067850	http://dx.doi.org/10.1074/jbc.M109.067850			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20106984	hybrid, Green Published			2022-12-27	WOS:000276264600066
J	Bermudez, VP; Farina, A; Tappin, I; Hurwitz, J				Bermudez, Vladimir P.; Farina, Andrea; Tappin, Inger; Hurwitz, Jerard			Influence of the Human Cohesion Establishment Factor Ctf4/AND-1 on DNA Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; YEAST SACCHAROMYCES-CEREVISIAE; PROTEIN-A BINDS; POLYMERASE-ALPHA; HUMAN-CELLS; CTF4; PROGRESSION; REPLISOME; COMPLEX; MCM10	Ctf4/AND-1 is a highly conserved gene product required for both DNA replication and the establishment of sister chromatid cohesion. In this report, we examined the mechanism of action of human Ctf4 (hCtf4) in DNA replication both in vitro and in vivo. Our findings show that the purified hCtf4 exists as a dimer and that the hCtf4 SepB domain likely plays a primary role determining the dimeric structure. hCtf4 binds preferentially to DNA template-primer structures, interacts directly with the replicative DNA polymerases (alpha, delta, and epsilon), and markedly stimulates the polymerase activities of DNA polymerases alpha and epsilon in vitro. Depletion of hCtf4 in HeLa cells by small interfering RNA resulted in G(1)/S phase arrest. DNA fiber analysis revealed that cells depleted of hCtf4 exhibited a rate of DNA replication slower than cells treated with control small interfering RNA. These findings suggest that in human cells, hCtf4 plays an essential role in DNA replication and its ability to stimulate the replicative DNA polymerases may contribute to this effect.	[Bermudez, Vladimir P.; Farina, Andrea; Tappin, Inger; Hurwitz, Jerard] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Hurwitz, J (corresponding author), 1275 York Ave,Box 97, New York, NY 10065 USA.	j-hurwitz@ski.mskcc.org						Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P10237, DOI 10.1073/pnas.1434308100; Bermudez VP, 2002, J BIOL CHEM, V277, P36853, DOI 10.1074/jbc.M202897200; BLACKWELL LJ, 1994, MOL CELL BIOL, V14, P3993, DOI 10.1128/MCB.14.6.3993; EKI T, 1992, J BIOL CHEM, V267, P7284; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; HARRIS SD, 1995, EMBO J, V14, P5244, DOI 10.1002/j.1460-2075.1995.tb00209.x; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jackson DA, 1998, J CELL BIOL, V140, P1285, DOI 10.1083/jcb.140.6.1285; KIM C, 1995, BIOCHEMISTRY-US, V34, P2058, DOI 10.1021/bi00006a028; Kohler A, 1997, J CELL SCI, V110, P1051; KOUPRINA N, 1993, YEAST, V9, P11, DOI 10.1002/yea.320090103; KOUPRINA N, 1992, MOL CELL BIOL, V12, P5736, DOI 10.1128/MCB.12.12.5736; MILES J, 1992, MOL CELL BIOL, V12, P5724, DOI 10.1128/MCB.12.12.5724; Schlesinger MB, 2000, GENETICS, V155, P1593; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Tanaka H, 2009, GENES CELLS, V14, P807, DOI 10.1111/j.1365-2443.2009.01310.x; Tanaka H, 2009, GENES CELLS, V14, P949, DOI 10.1111/j.1365-2443.2009.01322.x; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; WAGA S, 1994, J BIOL CHEM, V269, P10923; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607	27	45	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9493	9505		10.1074/jbc.M109.093609	http://dx.doi.org/10.1074/jbc.M109.093609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20089864	Green Published, hybrid			2022-12-27	WOS:000276165900023
J	Schulze, B; Mentzel, T; Jehle, AK; Mueller, K; Beeler, S; Boller, T; Felix, G; Chinchilla, D				Schulze, Birgit; Mentzel, Tobias; Jehle, Anna K.; Mueller, Katharina; Beeler, Seraina; Boller, Thomas; Felix, Georg; Chinchilla, Delphine			Rapid Heteromerization and Phosphorylation of Ligand-activated Plant Transmembrane Receptors and Their Associated Kinase BAK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNITY; PROTEIN-PHOSPHORYLATION; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; ELICITOR; PERCEPTION; BRI1/BAK1; COMPLEX; BINDING; BRI1	In plants leucine-rich repeat receptor kinases (LRR-RKs) located at the plasma membrane play a pivotal role in the perception of extracellular signals. For two of these LRR-RKs, the brassinosteroid receptor BRI1 and the flagellin receptor FLS2, interaction with the LRR receptor-like kinase BAK1 (BRI1-associated receptor kinase 1) was shown to be required for signal transduction. Here we report that FLS2.BAK1 heteromerization occurs almost instantaneously after perception of the ligand, the flagellin-derived peptide flg22.Flg22 can induce formation of a stable FLS2.BAK1 complex in microsomal membrane preparations in vitro, and the kinase inhibitor K-252a does not prevent complex formation. A kinase dead version of BAK1 associates with FLS2 in a flg22-dependent manner but does not restore responsiveness to flg22 in cells of bak1 plants, demonstrating that kinase activity of BAK1 is essential for FLS2 signaling. Furthermore, using in vivo phospholabeling, we are able to detect de novo phosphorylation of both FLS2 and BAK1 within 15 s of stimulation with flg22. Similarly, brassinolide induces BAK1 phosphorylation within seconds. Other triggers of plant defense, such as bacterial EF-Tu and the endogenous AtPep1 likewise induce rapid formation of heterocomplexes consisting of de novo phosphorylated BAK1 and proteins representing the ligand-specific binding receptors EF-Tu receptor and Pep1 receptor 1, respectively. Thus, we propose that several LRR-RKs form tight complexes with BAK1 almost instantaneously after ligand binding and that the subsequent phosphorylation events are key initial steps in signal transduction.	[Schulze, Birgit; Mentzel, Tobias; Beeler, Seraina; Boller, Thomas; Chinchilla, Delphine] Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, CH-4056 Basel, Switzerland; [Jehle, Anna K.; Mueller, Katharina; Felix, Georg] Univ Tubingen, Inst Plant Biochem, Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	University of Basel; Eberhard Karls University of Tubingen	Chinchilla, D (corresponding author), Univ Basel, Zurich Basel Plant Sci Ctr, Inst Bot, Hebelstr 1, CH-4056 Basel, Switzerland.	delphine.chinchilla@unibas.ch	Boller, Thomas/G-3500-2012	Boller, Thomas/0000-0001-6768-7503; Witte, Anna Kristina/0000-0001-6471-0763				Ali GS, 2007, PLANT CELL PHYSIOL, V48, P1601, DOI 10.1093/pcp/pcm132; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Asami T, 2000, PLANT PHYSIOL, V123, P93, DOI 10.1104/pp.123.1.93; Bauer Z, 2001, J BIOL CHEM, V276, P45669, DOI 10.1074/jbc.M102390200; Benschop JJ, 2007, MOL CELL PROTEOMICS, V6, P1198, DOI 10.1074/mcp.M600429-MCP200; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dardick C, 2006, PLOS PATHOG, V2, P14, DOI 10.1371/journal.ppat.0020002; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; FELIX G, 1991, P NATL ACAD SCI USA, V88, P8831, DOI 10.1073/pnas.88.19.8831; FELIX G, 1994, P NATL ACAD SCI USA, V91, P952, DOI 10.1073/pnas.91.3.952; FELIX G, 1993, PLANT J, V4, P307, DOI 10.1046/j.1365-313X.1993.04020307.x; Gomez-Gomez L, 2001, PLANT CELL, V13, P1155, DOI 10.1105/tpc.13.5.1155; Hecht V, 2001, PLANT PHYSIOL, V127, P803, DOI 10.1104/pp.010324; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Huffaker A, 2006, P NATL ACAD SCI USA, V103, P10098, DOI 10.1073/pnas.0603727103; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kierszniowska S, 2009, MOL CELL PROTEOMICS, V8, P612, DOI 10.1074/mcp.M800346-MCP200; Kinoshita T, 2005, NATURE, V433, P167, DOI 10.1038/nature03227; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Nuhse TS, 2007, PLANT J, V51, P931, DOI 10.1111/j.1365-313X.2007.03192.x; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Postel S, 2010, EUR J CELL BIOL, V89, P169, DOI 10.1016/j.ejcb.2009.11.001; Robatzek S, 2006, GENE DEV, V20, P537, DOI 10.1101/gad.366506; Ryan CA, 2007, CELL MICROBIOL, V9, P1902, DOI 10.1111/j.1462-5822.2007.00991.x; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Shah K, 2002, GENE DEV, V16, P1707, DOI 10.1101/gad.220402; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Thuerig B, 2005, PHYSIOL MOL PLANT P, V67, P180, DOI 10.1016/j.pmpp.2006.01.002; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang ZY, 2001, NATURE, V410, P380, DOI 10.1038/35066597; Yamaguchi Y, 2006, P NATL ACAD SCI USA, V103, P10104, DOI 10.1073/pnas.0603729103; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yun HS, 2009, MOL CELLS, V27, P183, DOI 10.1007/s10059-009-0023-1; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	46	302	319	3	89	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9444	9451		10.1074/jbc.M109.096842	http://dx.doi.org/10.1074/jbc.M109.096842			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20103591	hybrid, Green Published			2022-12-27	WOS:000276165900017
J	Patino-Lopez, G; Aravind, L; Dong, XY; Kruhlak, MJ; Ostap, EM; Shaw, S				Patino-Lopez, Genaro; Aravind, L.; Dong, Xiaoyun; Kruhlak, Michael J.; Ostap, E. Michael; Shaw, Stephen			Myosin 1G Is an Abundant Class I Myosin in Lymphocytes Whose Localization at the Plasma Membrane Depends on Its Ancient Divergent Pleckstrin Homology (PH) Domain (Myo1PH)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRUSH-BORDER; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TISSUE DISTRIBUTION; STRUCTURAL BASIS; L-SELECTIN; BINDING; TAIL; PROTEIN; CELLS; PHOSPHOINOSITIDES	Class I myosins, which link F-actin to membrane, are largely undefined in lymphocytes. Mass spectrometric analysis of lymphocytes identified two short tail forms: (Myo1G and Myo1C) and one long tail (Myo1F). We investigated Myo1G, the most abundant in T-lymphocytes, and compared key findings with Myo1C and Myo1F. Myo1G localizes to the plasma membrane and associates in an ATP-releasable manner to the actin-containing insoluble pellet. The IQ + tail region of Myo1G (Myo1C and Myo1F) is sufficient for membrane localization, but membrane localization is augmented by the motor domain. The minimal region lacks IQ motifs but includes: 1) a PH-like domain; 2) a "Pre-PH" region; and 3) a "Post-PH" region. The Pre-PH predicted alpha helices may contribute electrostatically, because two conserved basic residues on one face are required for optimal membrane localization. Our sequence analysis characterizes the divergent PH domain family, Myo1PH, present also in long tail myosins, in eukaryotic proteins unrelated to myosins, and in a probable ancestral protein in prokaryotes. The Myo1GMyo1PH domain utilizes the classic lipid binding site for membrane association, because mutating either of two basic residues in the "signature motif" destroys membrane localization. Mutation of each basic residue of the Myo1G Myo1PH domain reveals another critical basic residue in the beta 3 strand, which is shared only by Myo1D. Myo1G differs from Myo1C in its phosphatidylinositol 4,5-bisphosphate dependence for membrane association, because membrane localization of phosphoinositide 5-phosphatase releases Myo1C from the membrane but not Myo1G. Thus Myo1PH domains likely play universal roles in myosin I membrane association, but different isoforms have diverged in their binding specificity.	[Patino-Lopez, Genaro; Dong, Xiaoyun; Kruhlak, Michael J.; Shaw, Stephen] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; [Aravind, L.] NIH, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Ostap, E. Michael] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Ostap, E. Michael] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; University of Pennsylvania; University of Pennsylvania	Shaw, S (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10,Rm 4B36,10 Ctr Dr,MSC 1360, Bethesda, MD 20892 USA.	shaws@mail.nih.gov	Patino-Lopez, Genaro/O-3484-2018; Patiño López, Genaro/GQI-4414-2022	Patino-Lopez, Genaro/0000-0002-8716-722X; Aravind, L/0000-0003-0771-253X	National Institutes of Health [GM57247]; NCI; National Library of Medicine; NATIONAL CANCER INSTITUTE [ZICBC010915, ZIABC010993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057247, R37GM057247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM57247 and the Intramural Research Program of the National Institutes of Health, NCI. This work was also supported by the National Library of Medicine.	ADAMS RJ, 1989, NATURE, V340, P565, DOI 10.1038/340565a0; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Brown MJ, 2003, BLOOD, V102, P3890, DOI 10.1182/blood-2002-12-3807; Cozier GE, 2004, CURR TOP MICROBIOL, V282, P49; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; DEBUEGER M, 1992, J IMMUNOL, V149, P1788; DOBERSTEIN SK, 1992, J CELL BIOL, V117, P1241, DOI 10.1083/jcb.117.6.1241; Dwir O, 2001, J CELL BIOL, V155, P145, DOI 10.1083/jcb.200103042; Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Hammer J A, 1991, Trends Cell Biol, V1, P50, DOI 10.1016/0962-8924(91)90089-R; Hao JJ, 2008, J PROTEOME RES, V7, P2911, DOI 10.1021/pr800016a; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hokanson DE, 2006, MOL BIOL CELL, V17, P4856, DOI 10.1091/mbc.e06-05-0449; Hwang KJ, 2007, P NATL ACAD SCI USA, V104, P784, DOI 10.1073/pnas.0610231104; INGLEY E, 1994, J CELL BIOCHEM, V56, P436, DOI 10.1002/jcb.240560403; Jacobelli J, 2004, NAT IMMUNOL, V5, P531, DOI 10.1038/ni1065; Jontes JD, 1997, J MOL BIOL, V266, P331, DOI 10.1006/jmbi.1996.0777; Kalhammer G, 2000, Essays Biochem, V35, P33; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim SV, 2008, CELL MOL LIFE SCI, V65, P2128, DOI 10.1007/s00018-008-7435-5; Lee WL, 1999, J BIOL CHEM, V274, P35159, DOI 10.1074/jbc.274.49.35159; Lemmon MA, 2004, BIOCHEM SOC T, V32, P707, DOI 10.1042/BST0320707; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2001, BIOCHEM SOC T, V29, P377, DOI 10.1042/BST0290377; LEY K, 1993, BLOOD, V82, P1632; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106; Nambiar R, 2009, P NATL ACAD SCI USA, V106, P11972, DOI 10.1073/pnas.0901641106; Nebl T, 2002, J BIOL CHEM, V277, P43399, DOI 10.1074/jbc.M205386200; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Pierce RA, 2001, J IMMUNOL, V167, P3223, DOI 10.4049/jimmunol.167.6.3223; Richards TA, 2005, NATURE, V436, P1113, DOI 10.1038/nature03949; RUPPERT C, 1995, J CELL SCI, V108, P3775; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; Tyska MJ, 2002, BIOPHYS J, V82, P1869, DOI 10.1016/S0006-3495(02)75537-9; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; WAHL SM, 1984, CELL IMMUNOL, V85, P384, DOI 10.1016/0008-8749(84)90252-1; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17	44	55	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8675	8686		10.1074/jbc.M109.086959	http://dx.doi.org/10.1074/jbc.M109.086959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20071333	Green Published, hybrid			2022-12-27	WOS:000275553700020
J	Chen, XQ; Simon, ES; Xiang, Y; Kachman, M; Andrews, PC; Wang, YZ				Chen, Xuequn; Simon, Eric S.; Xiang, Yi; Kachman, Maureen; Andrews, Philip C.; Wang, Yanzhuang			Quantitative Proteomics Analysis of Cell Cycle-regulated Golgi Disassembly and Reassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE SYSTEM; STACKING FACTOR; PROTEINS; FRAGMENTS; CISTERNAE; NETWORK; COMPLEX; BINDING; APPARATUS; GRASP65	During mitosis, the stacked structure of the Golgi undergoes a continuous fragmentation process. The generated mitotic fragments are evenly distributed into the daughter cells and reassembled into new Golgi stacks. This disassembly and reassembly process is critical for Golgi biogenesis during cell division, but the underlying molecular mechanism is poorly understood. In this study, we have recapitulated this process using an in vitro assay and analyzed the proteins associated with interphase and mitotic Golgi membranes using a proteomic approach. Incubation of purified rat liver Golgi membranes with mitotic HeLa cell cytosol led to fragmentation of the membranes; subsequent treatment of these membranes with interphase cytosol allowed the reassembly of the Golgi fragments into new Golgi stacks. These membranes were then used for quantitative proteomics analyses by combining the isobaric tags for relative and absolute quantification approach with OFFGEL isoelectric focusing separation and liquid chromatography-matrix assisted laser desorption ionization-tandem mass spectrometry. In three independent experiments, a total of 1,193 Golgi-associated proteins were identified and quantified. These included broad functional categories, such as Golgi structural proteins, Golgi resident enzymes, SNAREs, Rab GTPases, cargo, and cytoskeletal proteins. More importantly, the combination of the quantitative approach with Western blotting allowed us to unveil 84 proteins with significant changes in abundance under the mitotic condition compared with the interphase condition. Among these proteins, several COPI coatomer subunits (alpha, beta, gamma, and delta) are of particular interest. Altogether, this systematic quantitative proteomic study revealed candidate proteins of the molecular machinery that control the Golgi disassembly and reassembly processes in the cell cycle.	[Simon, Eric S.; Kachman, Maureen; Andrews, Philip C.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Xiang, Yi; Wang, Yanzhuang] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Andrews, PC (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	andrewsp@umich.edu; yzwang@umich.edu	Wang, Yanzhuang/AAE-5299-2019	Wang, Yanzhuang/0000-0002-1864-7094; Andrews, Philip/0000-0001-6843-5420	National Institutes of Health [P41 RR018627, GM087364]; Pardee Cancer Research Foundation; American Cancer Society [RGS-09-278-01-CSM]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018627] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087364] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pardee Cancer Research Foundation; American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P41 RR018627 (to P. A.) and GM087364 (to Y. W.). This work was also partially supported by the Pardee Cancer Research Foundation and the American Cancer Society (RGS-09-278-01-CSM to Y. W.).	Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Agop-Nersesian C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000270; Angers A, 2004, J BIOL CHEM, V279, P11471, DOI 10.1074/jbc.M309934200; Barr FA, 2005, J CELL BIOL, V168, P993, DOI 10.1083/jcb.200501088; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; Bell AW, 2001, J BIOL CHEM, V276, P5152, DOI 10.1074/jbc.M006143200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BROWNHILL K, 2009, SEMIN CELL IN PRESS; Giansanti MG, 2007, MOL BIOL CELL, V18, P5034, DOI 10.1091/mbc.E07-05-0415; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83; Keshamouni VG, 2006, J PROTEOME RES, V5, P1143, DOI 10.1021/pr050455t; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Linstedt AD, 2004, CELL, V118, P271, DOI 10.1016/j.cell.2004.07.015; Liu ZH, 2007, DEV CELL, V12, P839, DOI 10.1016/j.devcel.2007.05.007; LUCOCQ JM, 1989, J CELL BIOL, V109, P463, DOI 10.1083/jcb.109.2.463; Matheson J, 2005, BIOCHEM SOC T, V33, P1290, DOI 10.1042/BST0331290; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MISTELI T, 1994, J CELL BIOL, V125, P269, DOI 10.1083/jcb.125.2.269; Mogelsvang S, 2006, CURR OPIN CELL BIOL, V18, P438, DOI 10.1016/j.ceb.2006.06.001; Pfeffer S, 2005, BIOCHEM SOC T, V33, P627, DOI 10.1042/BST0330627; Pfeffer SR, 1995, COLD SPRING HARB SYM, V60, P221, DOI 10.1101/SQB.1995.060.01.025; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; Rios RM, 2004, CELL, V118, P323; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Schonteich E, 2007, EUR J CELL BIOL, V86, P417, DOI 10.1016/j.ejcb.2007.05.004; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Seemann J, 2000, NATURE, V407, P1022, DOI 10.1038/35039538; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Tang DM, 2008, J BIOL CHEM, V283, P6085, DOI 10.1074/jbc.M707715200; Taylor RS, 2000, ELECTROPHORESIS, V21, P3441, DOI 10.1002/1522-2683(20001001)21:16<3441::AID-ELPS3441>3.0.CO;2-G; Valderrama F, 2001, TRAFFIC, V2, P717, DOI 10.1034/j.1600-0854.2001.21006.x; Wang Y, 2005, CELL BIOL LAB HDB, P33; Wang Yanzhuang, 2008, P580, DOI 10.1007/978-3-211-76310-0_34; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; Wu CC, 2004, MOL BIOL CELL, V15, P2907, DOI 10.1091/mbc.E04-02-0101; Wu CC, 2000, TRAFFIC, V1, P769, DOI 10.1034/j.1600-0854.2000.011004.x; Wu CC, 2000, TRAFFIC, V1, P963, DOI 10.1034/j.1600-0854.2000.011206.x; Xiang Y, 2007, J BIOL CHEM, V282, P21829, DOI 10.1074/jbc.M611716200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	51	31	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7197	7207		10.1074/jbc.M109.047084	http://dx.doi.org/10.1074/jbc.M109.047084			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056612	Green Published, hybrid			2022-12-27	WOS:000275415600033
J	Senatore, A; Spafford, JD				Senatore, Adriano; Spafford, J. David			Transient and Big Are Key Features of an Invertebrate T-type Channel (LCa(v)3) from the Central Nervous System of Lymnaea stagnalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-II LOOP; CALCIUM-CHANNEL; STRUCTURAL DETERMINANTS; CA2+ CHANNELS; SURFACE EXPRESSION; CA(V)3.2; BLOCK; MIBEFRADIL; INACTIVATION; PHARMACOLOGY	Here we describe features of the first non-mammalian T-type calcium channel (LCa(v)3) expressed in vitro. This molluscan channel possesses combined biophysical properties that are reminiscent of all mammalian T-type channels. It exhibits T-type features such as "transient" kinetics, but the "tiny" label, usually associated with Ba2+ conductance, is hard to reconcile with the "bigness" of this channel in many respects. LCa(v)3 is 25% larger than any voltage-gated ion channel expressed to date. It codes for a massive, 322-kDa protein that conducts large macroscopic currents in vitro. LCa(v)3 is also the most abundant Ca2+ channel transcript in the snail nervous system. A window current at typical resting potentials appears to be at least as large as that reported for mammalian channels. This distant gene provides a unique perspective to analyze the structural, functional, drug binding, and evolutionary aspects of T-type channels.	[Senatore, Adriano; Spafford, J. David] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Spafford, JD (corresponding author), Univ Waterloo, Dept Biol, B1-173, Waterloo, ON N2L 3G1, Canada.	spafford@uwaterloo.ca			Natural Science and Engineering Research Council (NSERC) of Canada; NSERC Alexander Graham Bell Canada	Natural Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC Alexander Graham Bell Canada	This work was supported by the Natural Science and Engineering Research Council (NSERC) of Canada and a NSERC Alexander Graham Bell Canada Graduate Scholarships ( doctoral) ( to A. Senatore).	Arias-Olguin II, 2008, J BIOL CHEM, V283, P8136, DOI 10.1074/jbc.M708761200; Atwood HL, 2006, SCIENCE, V312, P1008, DOI 10.1126/science.1128445; Baumgart JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002976; Bittner KC, 2008, BIOPHYS J, V95, P931, DOI 10.1529/biophysj.107.128124; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Carbone E, 2006, CELL CALCIUM, V40, P147, DOI 10.1016/j.ceca.2006.04.019; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Chemin J, 2000, FEBS LETT, V478, P166, DOI 10.1016/S0014-5793(00)01832-9; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Di Biase V, 2005, J CELL BIOL, V171, P695, DOI 10.1083/jcb.200503077; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Ertel S I, 1997, Expert Opin Investig Drugs, V6, P569, DOI 10.1517/13543784.6.5.569; Ferron L, 2003, CIRC RES, V93, P1241, DOI 10.1161/01.RES.0000106134.69300.B7; Gomora JC, 2002, BIOPHYS J, V83, P229, DOI 10.1016/S0006-3495(02)75164-3; Gray LS, 2006, CELL CALCIUM, V40, P115, DOI 10.1016/j.ceca.2006.04.014; HAGIWARA S, 1975, J GEN PHYSIOL, V65, P617, DOI 10.1085/jgp.65.5.617; Iftinca MC, 2009, TRENDS PHARMACOL SCI, V30, P32, DOI 10.1016/j.tips.2008.10.004; Kang HW, 2010, J BIOL CHEM, V285, P3271, DOI 10.1074/jbc.M109.067660; Kang HW, 2006, J BIOL CHEM, V281, P4823, DOI 10.1074/jbc.M510197200; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Lalevee N, 2005, CARDIOVASC RES, V67, P216, DOI 10.1016/j.cardiores.2005.05.009; Lee JH, 1999, BIOPHYS J, V77, P3034, DOI 10.1016/S0006-3495(99)77134-1; Lee TS, 2006, PHARMACOLOGY, V78, P11, DOI 10.1159/000094900; Lin YCJ, 2001, J EXP BIOL, V204, P3717; Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017; MACKIE GO, 1985, NATURE, V313, P791, DOI 10.1038/313791a0; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x; McRory JE, 2001, J BIOL CHEM, V276, P3999, DOI 10.1074/jbc.M008215200; Milescu M, 2009, NAT STRUCT MOL BIOL, V16, P1080, DOI 10.1038/nsmb.1679; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Obejero-Paz CA, 2008, J GEN PHYSIOL, V132, P239, DOI 10.1085/jgp.200809988; Perchenet L, 2000, N-S ARCH PHARMACOL, V361, P590, DOI 10.1007/s002100000238; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Serrano JR, 1999, J GEN PHYSIOL, V114, P185, DOI 10.1085/jgp.114.2.185; Shcheglovitov A, 2008, FEBS LETT, V582, P3765, DOI 10.1016/j.febslet.2008.10.013; Shin HS, 2008, CURR OPIN PHARMACOL, V8, P33, DOI 10.1016/j.coph.2007.12.003; Spafford JD, 2006, J NEUROPHYSIOL, V95, P42, DOI 10.1152/jn.00658.2005; Spafford JD, 2003, CURR OPIN NEUROBIOL, V13, P308, DOI 10.1016/S0959-4388(03)00061-8; Spafford JD, 2003, J BIOL CHEM, V278, P21178, DOI 10.1074/jbc.M302212200; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Steger KA, 2005, J EXP BIOL, V208, P2191, DOI 10.1242/jeb.01616; SYED NI, 1990, SCIENCE, V250, P282, DOI 10.1126/science.2218532; Talavera K, 2001, J BIOL CHEM, V276, P45628, DOI 10.1074/jbc.M103047200; Talavera K, 2006, PFLUG ARCH EUR J PHY, V453, P189, DOI 10.1007/s00424-006-0129-7; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Vitko I, 2007, J NEUROSCI, V27, P322, DOI 10.1523/JNEUROSCI.1817-06.2007; Wu SW, 2000, J PHARMACOL EXP THER, V292, P939	50	29	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7447	7458		10.1074/jbc.M109.090753	http://dx.doi.org/10.1074/jbc.M109.090753			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056611	hybrid, Green Published			2022-12-27	WOS:000275415600057
J	Emelyanov, AV; Konev, AY; Vershilova, E; Fyodorov, DV				Emelyanov, Alexander V.; Konev, Alexander Y.; Vershilova, Elena; Fyodorov, Dmitry V.			Protein Complex of Drosophila ATRX/XNP and HP1a Is Required for the Formation of Pericentric Beta-heterochromatin in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THALASSEMIA-MENTAL-RETARDATION; ALPHA-THALASSEMIA; CENTRIC HETEROCHROMATIN; CHROMOSOME STRUCTURE; CHROMATIN-STRUCTURE; ATR-X; MELANOGASTER; DNA; TRANSCRIPTION; METHYLATION	ATRX belongs to the family of SWI2/SNF2-like ATP-dependent nucleosome remodeling molecular motor proteins. Mutations of the human ATRX gene result in a severe genetic disorder termed X-linked alpha-thalassemia mental retardation (ATR-X) syndrome. Here we perform biochemical and genetic analyses of the Drosophila melanogaster ortholog of ATRX. The loss of function allele of the Drosophila ATRX/XNP gene is semilethal. Drosophila ATRX is expressed throughout development in two isoforms, p185 and p125. ATRX185 and ATRX125 form distinct multisubunit complexes in fly embryo. The ATRX185 complex comprises p185 and heterochromatin protein HP1a. Consistently, ATRX185 but not ATRX125 is highly concentrated in pericentric beta-heterochromatin of the X chromosome in larval cells. HP1a strongly stimulates biochemical activities of ATRX185 in vitro. Conversely, ATRX185 is required for HP1a deposition in pericentric beta-heterochromatin of the X chromosome. The loss of function allele of the ATRX/XNP gene and mutant allele that does not express p185 are strong suppressors of position effect variegation. These results provide evidence for essential biological functions of Drosophila ATRX in vivo and establish ATRX as a major determinant of pericentric beta-heterochromatin identity.	[Emelyanov, Alexander V.; Konev, Alexander Y.; Vershilova, Elena; Fyodorov, Dmitry V.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fyodorov, DV (corresponding author), 1300 Morris Pk Ave, Bronx, NY 10461 USA.	dfyodoro@aecom.yu.edu	Konev, Alexander/J-4401-2015	Konev, Alexander/0000-0002-4497-6377	National Institutes of Health [GM074233]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074233] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074233 ( to D. V. F.).	Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; Bassett AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002099; Berube NG, 2005, J CLIN INVEST, V115, P258, DOI 10.1172/JCI200522329; Cardoso C, 1998, HUM MOL GENET, V7, P679, DOI 10.1093/hmg/7.4.679; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Cryderman DE, 1999, EMBO J, V18, P3724, DOI 10.1093/emboj/18.13.3724; de Wit E, 2009, CHROMOSOMA, V118, P25, DOI 10.1007/s00412-008-0186-0; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Ebert A, 2006, CHROMOSOME RES, V14, P377, DOI 10.1007/s10577-006-1066-1; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Eissenberg JC, 2009, INT REV CEL MOL BIO, V273, P1, DOI 10.1016/S1937-6448(08)01801-7; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Fyodorov DV, 2001, CELL, V106, P523, DOI 10.1016/S0092-8674(01)00478-0; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gibbons R, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-15; GIBBONS RJ, 1991, J MED GENET, V28, P729, DOI 10.1136/jmg.28.11.729; GIBBONS RJ, 1995, AM J MED GENET, V55, P288, DOI 10.1002/ajmg.1320550309; Gibbons RJ, 2000, AM J MED GENET, V97, P204, DOI 10.1002/1096-8628(200023)97:3<204::AID-AJMG1038>3.0.CO;2-X; Gibbons RJ, 2000, NAT GENET, V24, P368, DOI 10.1038/74191; GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2; Guerrini R, 2000, ANN NEUROL, V47, P117; Haushalter KA, 2003, NAT REV MOL CELL BIO, V4, P613, DOI 10.1038/nrm1177; Hong YK, 2009, BIOCHEM BIOPH RES CO, V384, P160, DOI 10.1016/j.bbrc.2009.04.112; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; Konev AY, 2003, GENETICS, V165, P2039; Lavrov S, 2004, METH MOL B, V247, P289; Lechner MS, 2005, BIOCHEM BIOPH RES CO, V331, P929, DOI 10.1016/j.bbrc.2005.04.016; Lee NG, 2007, FEBS LETT, V581, P2625, DOI 10.1016/j.febslet.2007.05.005; Lomberk G, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-228; Lu XW, 2009, GENE DEV, V23, P452, DOI 10.1101/gad.1749309; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McDowell TL, 1999, P NATL ACAD SCI USA, V96, P13983, DOI 10.1073/pnas.96.24.13983; MIKLOS GLG, 1990, BIOESSAYS, V12, P1, DOI 10.1002/bies.950120102; PAZIN MJ, 1994, SCIENCE, V266, P2007, DOI 10.1126/science.7801129; Phalke S, 2009, NAT GENET, V41, P696, DOI 10.1038/ng.360; Rice JC, 2001, CURR OPIN CELL BIOL, V13, P263, DOI 10.1016/S0955-0674(00)00208-8; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Riddle NC, 2008, CURR TOP MICROBIOL, V320, P185; Ronsseray S, 2001, GENETICS, V159, P1631; Schneiderman JI, 2009, P NATL ACAD SCI USA, V106, P14472, DOI 10.1073/pnas.0905816106; Wallrath L, 1998, CURR OPIN GENET DEV, V8, P147, DOI 10.1016/S0959-437X(98)80135-4; WALLRATH LL, 1995, GENE DEV, V9, P1263, DOI 10.1101/gad.9.10.1263; WOLFFE AP, 1995, CURR BIOL, V5, P452, DOI 10.1016/S0960-9822(95)00088-1; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100; Yan CM, 2002, GENETICS, V161, P217; Yasuhara JC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040016; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	49	28	29	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 14	2010	285	20					15027	15037		10.1074/jbc.M109.064790	http://dx.doi.org/10.1074/jbc.M109.064790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	592SB	20154359	Green Published, hybrid			2022-12-27	WOS:000277399000024
J	Jaakola, VP; Lane, JR; Lin, JY; Katritch, V; IJzerman, AP; Stevens, RC				Jaakola, Veli-Pekka; Lane, J. Robert; Lin, Judy Y.; Katritch, Vsevolod; IJzerman, Adriaan P.; Stevens, Raymond C.			Ligand Binding and Subtype Selectivity of the Human A(2A) Adenosine Receptor IDENTIFICATION AND CHARACTERIZATION OF ESSENTIAL AMINO ACID RESIDUES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; PROTEIN-COUPLED RECEPTORS; RECOGNITION; ANTAGONISTS; AGONISTS; DISCOVERY; DOCKING; DOMAINS	The crystal structure of the human A(2A) adenosine receptor bound to the A(2A) receptor-specific antagonist, ZM241385, was recently determined at 2.6-angstrom resolution. Surprisingly, the antagonist binds in an extended conformation, perpendicular to the plane of the membrane, and indicates a number of interactions unidentified before in ZM241385 recognition. To further understand the selectivity of ZM241385 for the human A2A adenosine receptor, we examined the effect of mutating amino acid residues within the binding cavity likely to have key interactions and that have not been previously examined. Mutation of Phe-168 to Ala abolishes both agonist and antagonist binding as well as receptor activity, whereas mutation of this residue to Trp or Tyr had only moderate effects. The Met-177 -> Ala mutation impeded antagonist but not agonist binding. Finally, the Leu-249 -> Ala mutant showed neither agonist nor antagonist binding affinity. From our results and previously published mutagenesis data, we conclude that conserved residues Phe-168( 5.29), Glu-169(5.30), Asn-253(6.55), and Leu-249(6.51) play a central role in coordinating the bicyclic core present in both agonists and antagonists. By combining the analysis of the mutagenesis data with a comparison of the sequences of different adenosine receptor subtypes from different species, we predict that the interactions that determine subtype selectivity reside in the more divergent "upper" region of the binding cavity while the "lower" part of the binding cavity is conserved across adenosine receptor subtypes.	[Jaakola, Veli-Pekka; Katritch, Vsevolod; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Stevens, Raymond C.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Jaakola, Veli-Pekka] Univ Oulu, Dept Biochem, Oulu 90014, Finland; [Jaakola, Veli-Pekka] Univ Oulu, Oulu Bioctr, Oulu 90014, Finland; [Lane, J. Robert; Lin, Judy Y.; IJzerman, Adriaan P.] Leiden Amsterdam Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands	Scripps Research Institute; Scripps Research Institute; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu; Leiden University; Leiden University - Excl LUMC	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,GAC-1200, La Jolla, CA 92037 USA.	stevens@scripps.edu	IJzerman, Ad/ABG-1353-2020; Katritch, Vsevolod/Q-8357-2016; Katritch, Vsevolod/Y-2721-2019; Stevens, Raymond/K-7272-2015	IJzerman, Ad/0000-0002-1182-2259; Katritch, Vsevolod/0000-0003-3883-4505; Stevens, Raymond/0000-0002-4522-8725; Jaakola, Veli-Pekka/0000-0003-2943-6417; Lane, J. Robert/0000-0002-7361-7875	Protein Structure Initiative [U54 GM074961]; Dutch Top Institute Pharma [D1-105]; Oulu Biocenter (Finland) [2009]; Sigrid Juselius Foundation (Finland) [2009]; Orion-Farmos Research Foundation (Finland) [2009]; Marie Curie European; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961] Funding Source: NIH RePORTER	Protein Structure Initiative; Dutch Top Institute Pharma; Oulu Biocenter (Finland); Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation); Orion-Farmos Research Foundation (Finland); Marie Curie European; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Protein Structure Initiative Grant U54 GM074961 (ATCG3D; to R. C. S.) and by the Dutch Top Institute Pharma, Project D1-105 (to J. R. L., J. Y. L., and A. P. IJ.).; Supported by the Oulu Biocenter (Finland, 2009), the Sigrid Juselius Foundation (Finland, 2009), the Orion-Farmos Research Foundation (Finland, 2009), and an FP7 Marie Curie European	Abagyan R, 2009, METHODS MOL BIOL, V575, P249, DOI 10.1007/978-1-60761-274-2_11; BALLESTEROS JA, 1995, RECEPTOR MOL BIOL, P366; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; de Zwart M, 1999, J MED CHEM, V42, P1384, DOI 10.1021/jm9804984; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P661, DOI 10.1016/S0006-2952(00)00357-9; Hanson MA, 2007, PROTEIN EXPRES PURIF, V56, P85, DOI 10.1016/j.pep.2007.06.003; Hanson MA, 2009, STRUCTURE, V17, P8, DOI 10.1016/j.str.2008.12.003; Ivanov AA, 2009, J MED CHEM, V52, P3284, DOI 10.1021/jm801533x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jiang QL, 1996, MOL PHARMACOL, V50, P512; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kim JH, 1996, MOL PHARMACOL, V49, P683; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Kim SK, 2003, J MED CHEM, V46, P4847, DOI 10.1021/jm0300431; Mantri M, 2008, J MED CHEM, V51, P4449, DOI 10.1021/jm701594y; Martinelli A, 2008, MED RES REV, V28, P247, DOI 10.1002/med.20106; Michino M, 2009, NAT REV DRUG DISCOV, V8, P455, DOI 10.1038/nrd2877; Yuzlenko O, 2009, J COMPUT CHEM, V30, P14, DOI 10.1002/jcc.21001	22	77	79	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 23	2010	285	17					13032	13044		10.1074/jbc.M109.096974	http://dx.doi.org/10.1074/jbc.M109.096974			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XO	20147292	hybrid, Green Published			2022-12-27	WOS:000276787800061
J	Nichols, AS; Luetje, CW				Nichols, Andrew S.; Luetje, Charles W.			Transmembrane Segment 3 of Drosophila melanogaster Odorant Receptor Subunit 85b Contributes to Ligand-Receptor Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE TOPOLOGY; MODEL; EXPRESSION; PREDICTION; SYSTEM	The OR class insect odorant receptors are ligand-gated ion channels comprised of at least one common subunit (OR83b in Drosophila) and at least one putative odorant-binding subunit. However, little else is known about the molecular details of insect OR architecture. For example, nothing is known about how these receptors bind odorants, greatly limiting efforts to develop insect OR-targeted compounds for the control of insects involved in disease propagation and agricultural damage. Here we identify a portion of a Drosophila OR that is involved in odorant activation of the receptor. Using the substituted cysteine accessibility method, we identified residues 146150 of OR85b, located at the predicted interface between transmembrane segment 3 (TMS3) and extracellular loop 2 (ECL2), as playing a role in odorant (2-heptanone) activation. We found that occupation of the receptor by the competitive antagonist 2-nonanone protected the receptor from methanethiosulfonate action at position 148, placing this region close to the odorant-binding site. In addition, mutations at positions 142 and 143 within TMS3 altered odorant sensitivity. Our results identify the involvement of the extracellular half of TMS3 in Drosophila OR85b in odorant activation of the receptor. This finding can serve as a starting point for future detailed analysis of the molecular basis for odorant recognition by insect ORs, a novel class of ligand-gated channel.	[Nichols, Andrew S.; Luetje, Charles W.] Univ Miami, Dept Mol & Cellular Pharmacol, Miller Sch Med, Miami, FL 33101 USA	University of Miami	Luetje, CW (corresponding author), Univ Miami, Dept Mol & Cellular Pharmacol, Miller Sch Med, R-189,POB 016189, Miami, FL 33101 USA.	cluetje@med.miami.edu			National Institutes of Health [DC008119, T32 HL07188]; United States Department of Agriculture [2008-35302-18815]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007188] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091, R01DC008119] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC008119 (to C. W. L.). This work was also supported by United States Department of Agriculture Grant 2008-35302-18815.; Supported in part by National Institutes of Health Training Grant T32 HL07188.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kall L, 2005, BIOINFORMATICS, V21, pI251, DOI 10.1093/bioinformatics/bti1014; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2009, CURR OPIN NEUROBIOL, V19, P284, DOI 10.1016/j.conb.2009.07.015; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wanner KW, 2007, P NATL ACAD SCI USA, V104, P14383, DOI 10.1073/pnas.0705459104; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906	28	60	66	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 16	2010	285	16					11854	11862		10.1074/jbc.M109.058321	http://dx.doi.org/10.1074/jbc.M109.058321			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	584XI	20147286	hybrid, Green Published			2022-12-27	WOS:000276787100013
J	Basha, E; Jones, C; Wysocki, V; Vierling, E				Basha, Eman; Jones, Christopher; Wysocki, Vicki; Vierling, Elizabeth			Mechanistic Differences between Two Conserved Classes of Small Heat Shock Proteins Found in the Plant Cytosol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAPERONE ACTIVITY; STRESS PROTEINS; ARABIDOPSIS-THALIANA; CLASS-II; IN-VIVO; COMPLEXES; SUBSTRATE; BINDING; DISSOCIATION; EXPRESSION	The small heat shock proteins (sHSPs) and alpha-crystallins are highly effective, ATP-independent chaperones that can bind denaturing client proteins to prevent their irreversible aggregation. One model of sHSP function suggests that the oligomeric sHSPs are activated to the client-binding form by dissociation at elevated temperatures to dimers or other sub-oligomeric species. Here we examine this model in a comparison of the oligomeric structure and chaperone activity of two conserved classes of cytosolic sHSPs in plants, the class I (CI) and class II (CII) proteins. Like the CI sHSPs, recombinant CII sHSPs from three divergent plant species, pea, wheat, and Arabidopsis, are dodecamers as determined by nano-electrospray mass spectrometry. While at 35 to 45 degrees C, all three CI sHSPs reversibly dissociate to dimers, the CII sHSPs retain oligomeric structure at high temperature. The CII dodecamers are, however, dynamic and rapidly exchange subunits, but unlike CI sHSPs, the exchange unit appears larger than a dimer. Differences in dodecameric structure are also reflected in the fact that the CII proteins do not hetero-oligomerize with CI sHSPs. Binding of the hydrophobic probe bis-ANS and limited proteolysis demonstrate CII proteins undergo significant, reversible structural changes at high temperature. All three recombinant CII proteins more efficiently protect firefly luciferase from insolubilization during heating than do the CI proteins. The CI and CII proteins behave strictly additively in client protection. In total, the results demonstrate that different sHSPs can achieve effective protection of client proteins by varied mechanisms.	[Basha, Eman; Jones, Christopher; Wysocki, Vicki; Vierling, Elizabeth] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA	University of Arizona	Vierling, E (corresponding author), Univ Arizona, Dept Chem & Biochem, 1007 E Lowell St, Tucson, AZ 85721 USA.	vierling@u.arizona.edu		Vierling, Elizabeth/0000-0002-0066-4881; Wysocki, Vicki/0000-0003-0495-2538	National Institutes of Health (NIH) [R01 GM42762, 5R01 GM051387]; National Science Foundation (NSF) [IBN-0213128]; NSF DBI [CHE 024447]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042762, R01GM051387] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); NSF DBI(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant R01 GM42762 and National Science Foundation (NSF) Grant IBN-0213128 (to E. V.). This work was also supported by NSF DBI Grant CHE 024447 for development of the QToF instrument and NIH Grant 5R01 GM051387 for support of experiments on protein fragmentation (to V. W.).	Basha E, 2004, EUR J BIOCHEM, V271, P1426, DOI 10.1111/j.1432-1033.2004.04033.x; Basha E, 2004, J BIOL CHEM, V279, P7566, DOI 10.1074/jbc.M310684200; Basha E, 2006, J BIOL CHEM, V281, P39943, DOI 10.1074/jbc.M607677200; CHEN Q, 1994, J BIOL CHEM, V269, P13216; Dafny-Yelin M, 2008, PLANT MOL BIOL, V67, P363, DOI 10.1007/s11103-008-9326-4; Galhena AS, 2008, ANAL CHEM, V80, P1425, DOI 10.1021/ac701782q; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Helm KW, 1997, PLANT PHYSIOL, V114, P1477, DOI 10.1104/pp.114.4.1477; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Kirschner M, 2000, PLANT J, V24, P397, DOI 10.1046/j.1365-313x.2000.00887.x; Koteiche HA, 2003, J BIOL CHEM, V278, P10361, DOI 10.1074/jbc.M211851200; Lee GJ, 2000, PLANT PHYSIOL, V122, P189, DOI 10.1104/pp.122.1.189; LEE GJ, 1995, J BIOL CHEM, V270, P10432, DOI 10.1074/jbc.270.18.10432; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee U, 2005, PLANT CELL, V17, P559, DOI 10.1105/tpc.104.027540; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Low D, 2000, PLANTA, V211, P575, DOI 10.1007/s004250000315; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Painter AJ, 2008, CHEM BIOL, V15, P246, DOI 10.1016/j.chembiol.2008.01.009; Sathish HA, 2003, J BIOL CHEM, V278, P44214, DOI 10.1074/jbc.M307578200; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; Scharf KD, 2001, CELL STRESS CHAPERON, V6, P225, DOI 10.1379/1466-1268(2001)006<0225:TEFOAT>2.0.CO;2; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Siddique M, 2008, CELL STRESS CHAPERON, V13, P183, DOI 10.1007/s12192-008-0032-6; Sobott F, 2002, J BIOL CHEM, V277, P38921, DOI 10.1074/jbc.M206060200; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Tripp J, 2009, PLANT CELL ENVIRON, V32, P123, DOI 10.1111/j.1365-3040.2008.01902.x; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Waters ER, 1999, MOL BIOL EVOL, V16, P127, DOI 10.1093/oxfordjournals.molbev.a026033; Weber C, 2008, PLANT J, V56, P517, DOI 10.1111/j.1365-313X.2008.03623.x	32	70	71	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11489	11497		10.1074/jbc.M109.074088	http://dx.doi.org/10.1074/jbc.M109.074088			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20145254	Green Published, hybrid			2022-12-27	WOS:000276286200055
J	Jun, B; Kim, S				Jun, Bokkyoo; Kim, Sunyoung			Real-time Structural Transitions Are Coupled to Chemical Steps in ATP Hydrolysis by Eg5 Kinesin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; FTIR DIFFERENCE SPECTROSCOPY; VIBRATIONAL SPECTROSCOPY; SPECTRAL SIGNATURES; PHOSPHATE-BINDING; PROTEIN-STRUCTURE; GAMMA-PHOSPHATE; CATALYTIC SITES; GTP HYDROLYSIS; MONASTROL	At the biochemical level, motor proteins are enzymatic molecules that function by converting chemical energy into mechanical motion. The key element for energy transduction and a major unresolved question common for all motor proteins is the coordination between the chemical and conformational steps in ATP hydrolysis. Here we show time-lapse monitoring of an in vitro ATP hydrolysis reaction by the motor domain of a human Kinesin-5 protein (Eg5) using difference Fourier transform infrared spectroscopy and UV photolysis of caged ATP. In this first continuous observation of a biological reaction coordinate from substrate to product, direct spectral markers for two catalytic events are measured: proton abstraction from nucleophilic water by the catalytic base and formation of the inorganic phosphate leaving group. Simultaneous examination of conformational switching in Eg5, in parallel with catalytic steps, shows structural transitions in solution consistent with published crystal structures of the prehydrolytic and ADP-bound states. In addition, we detect structural modifications in the Eg5 motor domain during bond cleavage between the beta- and gamma-phosphates of ATP. This conclusion challenges mechanochemical models for motor proteins that utilize only two stages of the catalytic cycle to drive force and motion.	[Jun, Bokkyoo; Kim, Sunyoung] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Kim, S (corresponding author), 1901 Perdido St, New Orleans, LA 70112 USA.	skim3@lsuhsc.edu			Louisiana Board of Regents	Louisiana Board of Regents	This work was supported by a grant from the Louisiana Board of Regents (to S. K.).	Ahmad Z, 2004, J BIOL CHEM, V279, P46057, DOI 10.1074/jbc.M407608200; Allin C, 2001, BIOCHEMISTRY-US, V40, P3037, DOI 10.1021/bi0017024; Asmis KR, 2003, SCIENCE, V299, P1375, DOI 10.1126/science.1081634; Baer M, 2008, CHEMPHYSCHEM, V9, P2703, DOI 10.1002/cphc.200800473; Barth A, 1996, J BIOL CHEM, V271, P30637, DOI 10.1074/jbc.271.48.30637; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; BRAIMAN MS, 1987, P NATL ACAD SCI USA, V84, P5221, DOI 10.1073/pnas.84.15.5221; Cepus V, 1998, Methods Enzymol, V291, P223; Cheng H, 2002, J AM CHEM SOC, V124, P11295, DOI 10.1021/ja026481z; Cochran JC, 2005, J BIOL CHEM, V280, P12658, DOI 10.1074/jbc.M413140200; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; Dittrich M, 2004, BIOPHYS J, V87, P2954, DOI 10.1529/biophysj.104.046128; Du XL, 2000, J BIOL CHEM, V275, P8492, DOI 10.1074/jbc.275.12.8492; FABIAN H, 2000, ENCY ANAL CHEM, P5779; Garczarek F, 2006, NATURE, V439, P109, DOI 10.1038/nature04231; Goormaghtigh E, 1994, Subcell Biochem, V23, P329; JACKSON M, 1995, CRIT REV BIOCHEM MOL, V30, P95, DOI 10.3109/10409239509085140; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; Learman SS, 2009, BIOCHEMISTRY-US, V48, P1754, DOI 10.1021/bi801291q; Li GH, 2004, J PHYS CHEM B, V108, P3342, DOI 10.1021/jp0371783; Liu M, 2002, BIOPOLYMERS, V67, P267, DOI 10.1002/bip.10113; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Mathias G, 2007, P NATL ACAD SCI USA, V104, P6980, DOI 10.1073/pnas.0609229104; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; PRESTRELSKI SJ, 1991, INT J PEPT PROT RES, V37, P508; Scheidig AJ, 1999, STRUCTURE, V7, P1311, DOI 10.1016/S0969-2126(00)80021-0; SUREWICZ WK, 1993, BIOCHEMISTRY-US, V32, P389, DOI 10.1021/bi00053a001; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; White EM, 2008, BIOCHEMISTRY-US, V47, P84, DOI 10.1021/bi701723c; Wojcik EJ, 2004, BIOCHEMISTRY-US, V43, P9939, DOI 10.1021/bi048982y; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074	32	13	13	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11073	11077		10.1074/jbc.C110.103762	http://dx.doi.org/10.1074/jbc.C110.103762			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20154092	Green Published, hybrid			2022-12-27	WOS:000276286200010
J	Manfrini, N; Guerini, I; Citterio, A; Lucchini, G; Longhese, MP				Manfrini, Nicola; Guerini, Ilaria; Citterio, Andrea; Lucchini, Giovanna; Longhese, Maria Pia			Processing of Meiotic DNA Double Strand Breaks Requires Cyclin-dependent Kinase and Multiple Nucleases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUDDING YEAST SAE2; CELL-CYCLE; HOMOLOGOUS RECOMBINATION; SACCHAROMYCES-CEREVISIAE; END RESECTION; CHROMOSOME SEGREGATION; DAMAGE RESPONSE; HUMAN CTIP; MEIOSIS; REPAIR	Meiotic recombination requires the formation of programmed Spo11-dependent DNA double strand breaks (DSBs). In Saccharomyces cerevisiae, the Sae2 protein and the Mre11-Rad50-Xrs2 complex are necessary to remove the covalently attached Spo11 protein from the DNA ends, which are then resected by so far unknown nucleases. Here, we demonstrate that phosphorylation of Sae2 Ser-267 by cyclin-dependent kinase 1 (Cdk1) is required to initiate meiotic DSB resection by allowing Spo11 removal from DSB ends. This finding suggests that Cdk1 activity is required for the processing of Spo11-induced DSBs, thus providing a mechanism for coordinating DSB resection with progression through meiotic prophase. Furthermore, the helicase Sgs1 and the nucleases Exo1 and Dna2 participate in lengthening the 5'-3' resection tracts during meiosis by controlling a step subsequent to Spo11 removal.	[Manfrini, Nicola; Guerini, Ilaria; Citterio, Andrea; Lucchini, Giovanna; Longhese, Maria Pia] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, I-20126 Milan, Italy	University of Milano-Bicocca	Longhese, MP (corresponding author), Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	mariapia.longhese@unimib.it	Manfrini, Nicola/A-1371-2019; Pia, Maria/AAK-2693-2020; Citterio, Andrea/K-4379-2016	Citterio, Andrea/0000-0003-4462-5646; Longhese, Maria Pia/0000-0003-1726-2034	Ministero dell'Universita et della Ricerca/Universita di Milano-Bicocca; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Ministero dell'Universita et della Ricerca/Universita di Milano-Bicocca; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This work was supported by grants from Associazione Italiana Ricerca sul Cancro and Cofinanziamento 2008 Ministero dell'Universita et della Ricerca/Universita di Milano-Bicocca (to M. P. L.).	ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Aylon Y, 2004, EMBO J, V23, P4868, DOI 10.1038/sj.emboj.7600469; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Baroni E, 2004, MOL CELL BIOL, V24, P4151, DOI 10.1128/MCB.24.10.4151-4165.2004; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bonetti D, 2009, MOL CELL, V35, P70, DOI 10.1016/j.molcel.2009.05.015; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; Cartagena-Lirola H, 2006, CELL CYCLE, V5, P1549, DOI 10.4161/cc.5.14.2916; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Henderson KA, 2006, CELL, V125, P1321, DOI 10.1016/j.cell.2006.04.039; Huertas P, 2008, NATURE, V455, P689, DOI 10.1038/nature07215; Huertas P, 2009, J BIOL CHEM, V284, P9558, DOI 10.1074/jbc.M808906200; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; KEENEY S, 1995, P NATL ACAD SCI USA, V92, P11274, DOI 10.1073/pnas.92.24.11274; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Longhese MP, 2009, DNA REPAIR, V8, P1127, DOI 10.1016/j.dnarep.2009.04.005; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; McKee AHZ, 1997, GENETICS, V146, P797; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Moreau S, 1999, MOL CELL BIOL, V19, P556; Murakami H, 2003, NUCLEIC ACIDS RES, V31, P4085, DOI 10.1093/nar/gkg441; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Prieler S, 2005, GENE DEV, V19, P255, DOI 10.1101/gad.321105; Prinz S, 1997, GENETICS, V146, P781; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; Viscardi V, 2007, MOL BIOL CELL, V18, P3047, DOI 10.1091/mbc.E07-03-0285; Wan L, 2008, GENE DEV, V22, P386, DOI 10.1101/gad.1626408; Yun MH, 2009, NATURE, V459, P460, DOI 10.1038/nature07955; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	38	39	42	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11628	11637		10.1074/jbc.M110.104083	http://dx.doi.org/10.1074/jbc.M110.104083			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20150422	Green Published, hybrid			2022-12-27	WOS:000276286200068
J	Raina, K; Crews, CM				Raina, Kanak; Crews, Craig M.			Chemical Inducers of Targeted Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GENE-EXPRESSION; LIVING CELLS; UBIQUITINATION; SYSTEM; MICE; PROTEOLYSIS; PROTEASOME; MOLECULES; DIMERIZATION; MECHANISMS	The functions of many cellular proteins have been elucidated by selective gene inactivation and subsequent phenotypic analysis. For example, genetic mutations, gene knockout generation, and the use of RNA interference to target mRNA for degradation can all result in decreased production of a specific protein, yielding informative cellular phenotypes. However, these techniques each have certain inherent limitations. This minireview focuses on the recent development of new approaches to study protein function at the post-translational level, namely chemical induction of targeted protein degradation.	[Raina, Kanak; Crews, Craig M.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Crews, CM (corresponding author), Yale Univ, Dept Chem, 225 Prospect St, New Haven, CT 06520 USA.	craig.crews@yale.edu	Crews, Craig M./ABH-9346-2020	Crews, Craig M./0000-0002-8456-2005				Arakaki AK, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-315; Banaszynski LA, 2008, NAT MED, V14, P1123, DOI 10.1038/nm.1754; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Chu BW, 2008, BIOORG MED CHEM LETT, V18, P5941, DOI 10.1016/j.bmcl.2008.09.043; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Janse DM, 2004, J BIOL CHEM, V279, P21415, DOI 10.1074/jbc.M402954200; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Koepp DM, 1999, CELL, V97, P431, DOI 10.1016/S0092-8674(00)80753-9; Lee HS, 2007, CHEMBIOCHEM, V8, P2058, DOI 10.1002/cbic.200700438; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a; Muratani M, 2003, NAT REV MOL CELL BIO, V4, P192, DOI 10.1038/nrm1049; Nakayashiki H, 2006, J MOL EVOL, V63, P127, DOI 10.1007/s00239-005-0257-2; PARK EC, 1992, P NATL ACAD SCI USA, V89, P1249, DOI 10.1073/pnas.89.4.1249; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pratt MR, 2007, P NATL ACAD SCI USA, V104, P11209, DOI 10.1073/pnas.0700816104; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rollins CT, 2000, P NATL ACAD SCI USA, V97, P7096, DOI 10.1073/pnas.100101997; Sakamoto KM, 2003, MOL CELL PROTEOMICS, V2, P1350, DOI 10.1074/mcp.T300009-MCP200; Sakamoto KM, 2001, P NATL ACAD SCI USA, V98, P8554, DOI 10.1073/pnas.141230798; Schneekloth AR, 2008, BIOORG MED CHEM LETT, V18, P5904, DOI 10.1016/j.bmcl.2008.07.114; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; VIJAYKUMAR S, 1987, J BIOL CHEM, V262, P6396; Zhang D, 2004, BIOORG MED CHEM LETT, V14, P645, DOI 10.1016/j.bmcl.2003.11.042	29	50	67	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 9	2010	285	15					11057	11060		10.1074/jbc.R109.078105	http://dx.doi.org/10.1074/jbc.R109.078105			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578IF	20147751	Green Published, hybrid			2022-12-27	WOS:000276286200007
J	Bektas, M; Allende, ML; Lee, BG; Chen, WP; Amar, MJ; Remaley, AT; Saba, JD; Proia, RL				Bektas, Meryem; Allende, Maria Laura; Lee, Bridgin G.; Chen, WeiPing; Amar, Marcelo J.; Remaley, Alan T.; Saba, Julie D.; Proia, Richard L.			Sphingosine 1-Phosphate Lyase Deficiency Disrupts Lipid Homeostasis in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOLIPID METABOLISM; SPHINGOSINE-1-PHOSPHATE LYASE; SALVAGE PATHWAY; BIOSYNTHESIS; INHIBITION; SPHINGOMYELIN; CHOLESTEROL; SPECIFICITY; INSIGHTS; DISEASE	The cleavage of sphingoid base phosphates by sphingosine-1-phosphate (S1P) lyase to produce phosphoethanolamine and a fatty aldehyde is the final degradative step in the sphingolipid metabolic pathway. We have studied mice with an inactive S1P lyase gene and have found that, in addition to the expected increase of sphingoid base phosphates, other sphingolipids (including sphingosine, ceramide, and sphingomyelin) were substantially elevated in the serum and/or liver of these mice. This latter increase is consistent with a reutilization of the sphingosine backbone for sphingolipid synthesis due to its inability to exit the sphingolipid metabolic pathway. Furthermore, the S1P lyase deficiency resulted in changes in the levels of serum and liver lipids not directly within the sphingolipid pathway, including phospholipids, triacyglycerol, diacylglycerol, and cholesterol. Even though lipids in serum and lipid storage were elevated in liver, adiposity was reduced in the S1P lyase-deficient mice. Microarray analysis of lipid metabolism genes in liver showed that the S1P lyase deficiency caused widespread changes in their expression pattern, with a significant increase in the expression of PPAR gamma, a master transcriptional regulator of lipid metabolism. However, the mRNA expression of the genes encoding the sphingosine kinases and S1P phosphatases, which directly control the levels of S1P, were not significantly changed in liver of the S1P lyase-deficient mice. These results demonstrate that S1P lyase is a key regulator of the levels of multiple sphingolipid substrates and reveal functional links between the sphingolipid metabolic pathway and other lipid metabolic pathways that may be mediated by shared lipid substrates and changes in gene expression programs. The disturbance of lipid homeostasis by altered sphingolipid levels may be relevant to metabolic diseases.	[Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, Bethesda, MD 20892 USA; [Chen, WeiPing] NIDDK, Microarray Core Lab, Bethesda, MD 20892 USA; [Amar, Marcelo J.; Remaley, Alan T.] NIH, Pulm & Vasc Med Branch, NHLBI, Bethesda, MD 20892 USA; [Saba, Julie D.] CHORI, Oakland, CA 94609 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Children's Hospital Oakland Research Institute	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, Bethesda, MD 20892 USA.	proia@nih.gov	Chen, Weiping/C-9550-2011; Amar, Marcelo/AAD-5599-2019; Proia, Richard L/A-7908-2012	Bektas, Meryem/0000-0001-8080-7557; Proia, Richard/0000-0003-0456-1270	NIDDK, National Institutes of Health; NHLBI, National Institutes of Health; National Institutes of Health [CA77528, C06 RR018823]; NATIONAL CANCER INSTITUTE [R01CA077528, R01CA129438] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015, ZIADK056018, ZIADK056017] Funding Source: NIH RePORTER	NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Intramural Research Program of the NIDDK and NHLBI, National Institutes of Health, and by National Institutes of Health Grants CA77528 (to J. D. S.) and C06 RR018823 (to the MUSC Lipomics Core).	Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Cowart LA, 2009, TRENDS ENDOCRIN MET, V20, P34, DOI 10.1016/j.tem.2008.09.004; Deevska GM, 2009, J BIOL CHEM, V284, P8359, DOI 10.1074/jbc.M807800200; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; FOLCH J, 1957, J BIOL CHEM, V226, P497; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Fyrst H, 2008, BBA-MOL CELL BIOL L, V1781, P448, DOI 10.1016/j.bbalip.2008.05.005; Gavrilova O, 2003, J BIOL CHEM, V278, P34268, DOI 10.1074/jbc.M300043200; Guan XL, 2009, MOL BIOL CELL, V20, P2083, DOI 10.1091/mbc.E08-11-1126; Holland WL, 2008, ENDOCR REV, V29, P381, DOI 10.1210/er.2007-0025; KENT C, 1995, ANNU REV BIOCHEM, V64, P315, DOI 10.1146/annurev.bi.64.070195.001531; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Le Stunff H, 2007, J BIOL CHEM, V282, P34372, DOI 10.1074/jbc.M703329200; Lehner R, 1996, PROG LIPID RES, V35, P169, DOI 10.1016/0163-7827(96)00005-7; Li AC, 2004, J LIPID RES, V45, P2161, DOI 10.1194/jlr.R400010-JLR200; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizugishi K, 2007, J CLIN INVEST, V117, P2993, DOI 10.1172/JCI30674; Obert LA, 2007, TOXICOL PATHOL, V35, P728, DOI 10.1080/01926230701481956; Okino N, 2003, J BIOL CHEM, V278, P29948, DOI 10.1074/jbc.M303310200; Pagano RE, 2003, PHILOS T R SOC B, V358, P885, DOI 10.1098/rstb.2003.1275; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; Saba JD, 1997, J BIOL CHEM, V272, P26087, DOI 10.1074/jbc.272.42.26087; Scheek S, 1997, P NATL ACAD SCI USA, V94, P11179, DOI 10.1073/pnas.94.21.11179; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Simha V, 2009, CURR OPIN LIPIDOL, V20, P300, DOI 10.1097/MOL.0b013e32832d4a33; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; VANVELDHOVEN PP, 1993, ADV LIPID RES, V26, P69; VOELKER DR, 1982, BIOCHEMISTRY-US, V21, P2753, DOI 10.1021/bi00540a027; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; Witting SR, 2003, J BIOL CHEM, V278, P40121, DOI 10.1074/jbc.M305193200; Woloszynek JC, 2007, J BIOL CHEM, V282, P35765, DOI 10.1074/jbc.M705124200; Worgall Tilla S., 2008, V49, P371, DOI 10.1007/978-1-4020-8830-8_14; Zhang K, 2007, EMBO J, V26, P1094, DOI 10.1038/sj.emboj.7601565	39	139	143	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10880	10889		10.1074/jbc.M109.081489	http://dx.doi.org/10.1074/jbc.M109.081489			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20097939	Green Published, hybrid			2022-12-27	WOS:000276264600073
J	Jackson, HM; Kawahara, T; Nisimoto, Y; Smith, SME; Lambeth, JD				Jackson, Heather M.; Kawahara, Tsukasa; Nisimoto, Yukio; Smith, Susan M. E.; Lambeth, J. David			Nox4 B-loop Creates an Interface between the Transmembrane and Dehydrogenase Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENERATING NADPH OXIDASE; NAD(P)H OXIDASE; SUPEROXIDE GENERATION; FLAVOCYTOCHROME; IDENTIFICATION; ACTIVATION; P47(PHOX); PROTEINS; CLONING; SUBUNIT	By targeting redox-sensitive amino acids in signaling proteins, the NADPH oxidase (Nox) family of enzymes link reactive oxygen species to physiological processes. We previously analyzed the sequences of 107 Nox enzymes and identified conserved regions that are predicted to have important functions in Nox structure or activation. One such region is the cytosolic B-loop, which in Nox1-4 contains a conserved polybasic region. Previous studies of Nox2 showed that certain basic residues in the B-loop are important for activity and translocation of p47(phox)/p67(phox), suggesting this region participates in subunit assembly. However, conservation of this region in Nox4, which does not require p47(phox)/p67(phox), suggested an additional role for the B-loop in Nox function. Here, we show by mutation of Nox4 B-loop residues that this region is important for Nox4 activity. Fluorescence polarization detected binding between Nox4 B-loop peptide and dehydrogenase domain (K-d = 58 +/- 12 nM). This interaction was weakened with Nox4 R96E B-loop corresponding to a mutation that also markedly decreases the activity of holo-Nox4. Truncations of the dehydrogenase domain localize the B-loop-binding site to the N-terminal half of the NADPH-binding subdomain. Similarly, the Nox2 B-loop bound to the Nox2 dehydrogenase domain, and both the Nox2 and Nox4 interactions were dependent on the polybasic region of the B-loop. These data indicate that the B-loop is critical for Nox4 function; we propose that the B-loop, by binding to the dehydrogenase domain, provides the interface between the transmembrane and dehydrogenase domains of Nox enzymes.	[Jackson, Heather M.; Kawahara, Tsukasa; Nisimoto, Yukio; Smith, Susan M. E.; Lambeth, J. David] Emory Univ, Sch Med, Dept Pathol & Expt Med, Atlanta, GA 30322 USA	Emory University	Lambeth, JD (corresponding author), Emory Univ, Sch Med, Dept Pathol & Expt Med, 148 Whitehead Bldg,615 Michael St, Atlanta, GA 30322 USA.	noxdoc@mac.com			National Institutes of Health [CA105116, CA084138]; American Heart Association [0815088E]; NATIONAL CANCER INSTITUTE [R56CA105116, R01CA084138, R01CA105116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA105116 and CA084138. This work was also supported by American Heart Association Grant 0815088E.	ABO A, 1991, NATURE, V353, P668, DOI 10.1038/353668a0; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Banfi B, 2003, J BIOL CHEM, V278, P3510, DOI 10.1074/jbc.C200613200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Biberstine-Kinkade KJ, 1999, J BIOL CHEM, V274, P10451, DOI 10.1074/jbc.274.15.10451; Biberstine-Kinkade KJ, 2001, J BIOL CHEM, V276, P31105, DOI 10.1074/jbc.M103327200; Burritt JB, 2001, J BIOL CHEM, V276, P2053, DOI 10.1074/jbc.M006236200; CHEN ZW, 1994, SCIENCE, V266, P430, DOI 10.1126/science.7939681; Cheng GJ, 2004, J BIOL CHEM, V279, P34250, DOI 10.1074/jbc.M400660200; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; DELEO FR, 1995, P NATL ACAD SCI USA, V92, P7110, DOI 10.1073/pnas.92.15.7110; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Ebisu K, 2001, J BIOL CHEM, V276, P24498, DOI 10.1074/jbc.M101122200; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Geiszt M, 2003, J BIOL CHEM, V278, P20006, DOI 10.1074/jbc.M301289200; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Goyal P, 2005, BIOCHEM BIOPH RES CO, V329, P32, DOI 10.1016/j.bbrc.2005.01.089; GUNNER MR, 1991, P NATL ACAD SCI USA, V88, P9151, DOI 10.1073/pnas.88.20.9151; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hwang JN, 2005, AM J PHYSIOL-CELL PH, V288, pC899, DOI 10.1152/ajpcell.00474.2004; Ilari A, 2002, J BIOL CHEM, V277, P23725, DOI 10.1074/jbc.M202228200; IMAJOHOHMI S, 1992, J BIOL CHEM, V267, P180; Jameson DM, 1999, METHODS, V19, P222, DOI 10.1006/meth.1999.0853; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; KNAUS UG, 1991, SCIENCE, V254, P1512, DOI 10.1126/science.1660188; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; LETO TL, 1990, SCIENCE, V248, P727, DOI 10.1126/science.1692159; LOMAX KJ, 1989, SCIENCE, V245, P409, DOI 10.1126/science.2547247; Mahadev K, 2004, MOL CELL BIOL, V24, P1844, DOI 10.1128/MCB.24.5.1844-1854.2004; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; MOORE GR, 1986, P NATL ACAD SCI USA, V83, P4998, DOI 10.1073/pnas.83.14.4998; Moser CC, 2008, BBA-BIOENERGETICS, V1777, P1032, DOI 10.1016/j.bbabio.2008.04.021; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; Nisimoto Y, 1999, J BIOL CHEM, V274, P22999, DOI 10.1074/jbc.274.33.22999; NUNOI H, 1988, SCIENCE, V242, P1298, DOI 10.1126/science.2848319; Park MY, 1997, BIOCHEM BIOPH RES CO, V234, P531, DOI 10.1006/bbrc.1997.6672; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SEGAL AW, 1992, BIOCHEM J, V284, P781, DOI 10.1042/bj2840781; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; SUMIMOTO H, 1992, BIOCHEM BIOPH RES CO, V186, P1368, DOI 10.1016/S0006-291X(05)81557-8; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09	54	37	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10281	10290		10.1074/jbc.M109.084939	http://dx.doi.org/10.1074/jbc.M109.084939			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20139414	Green Published, hybrid			2022-12-27	WOS:000276264600012
J	Takabe, K; Kim, RH; Allegood, JC; Mitra, P; Ramachandran, S; Nagahashi, M; Harikumar, KB; Hait, NC; Milstien, S; Spiegel, S				Takabe, Kazuaki; Kim, Roger H.; Allegood, Jeremy C.; Mitra, Poulami; Ramachandran, Subramaniam; Nagahashi, Masayuki; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Milstien, Sheldon; Spiegel, Sarah			Estradiol Induces Export of Sphingosine 1-Phosphate from Breast Cancer Cells via ABCC1 and ABCG2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; G-PROTEIN; PLASMA-MEMBRANE; SPHINGOLIPID METABOLISM; MCF-7 CELLS; STEM-CELLS; ESTROGEN; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; RECEPTOR	Sphingosine 1-phosphate (S1P), a potent sphingolipid mediator produced by sphingosine kinase isoenzymes (SphK1 and SphK2), regulates diverse cellular processes important for breast cancer progression acting in an autocrine and/or paracrine manner. Here we show that SphK1, but not SphK2, increased S1P export from MCF-7 cells. Whereas for both estradiol (E-2) and epidermal growth factor-activated SphK1 and production of S1P, only E-2 stimulated rapid release of S1P and dihydro-S1P from MCF-7 cells. E-2-induced S1P and dihydro-S1P export required estrogen receptor-alpha, not GPR30, and was suppressed either by pharmacological inhibitors or gene silencing of ABCC1(multidrug resistant protein 1) or ABCG2(breast cancer resistance protein). Inhibiting these transporters also blocked E2-induced activation of ERK1/2, indicating that E-2 activates ERK via downstream signaling of S1P. Taken together, our findings suggest that E-2-induced export of S1P mediated by ABCC1 and ABCG2 transporters and consequent activation of S1P receptors may contribute to nongenomic signaling of E-2 important for breast cancer pathophysiology.	[Allegood, Jeremy C.; Mitra, Poulami; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Richmond, VA 23298 USA; [Takabe, Kazuaki; Kim, Roger H.; Ramachandran, Subramaniam; Nagahashi, Masayuki] Virginia Commonwealth Univ, Dept Surg, Sch Med, Div Surg Oncol, Richmond, VA 23298 USA; [Takabe, Kazuaki; Kim, Roger H.; Allegood, Jeremy C.; Mitra, Poulami; Ramachandran, Subramaniam; Nagahashi, Masayuki; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Massey Canc Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Sch Med, Med Coll Virginia Campus, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Ramachandran, Subramaniam/B-8247-2013; Harikumar, Kuzhuvelil/AAC-2407-2020; Nagahashi, Masayuki/AAB-4202-2020; Kim, Roger/I-2838-2019	Harikumar, Kuzhuvelil/0000-0002-1763-4179; Kim, Roger/0000-0003-0718-7376; Takabe, Kazuaki/0000-0002-6435-4241	National Institutes of Health [R37GM043880, R01CA61774]; Virginia Commonwealth University [BIRCWH K12HD055881]; Susan G. Komen for the Cure Career Catalyst [KG090510]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD055881] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University; Susan G. Komen for the Cure Career Catalyst(Susan G. Komen Breast Cancer Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37GM043880 and R01CA61774 (to S. S.), Virginia Commonwealth University Grant BIRCWH K12HD055881, and Susan G. Komen for the Cure Career Catalyst Research Grant KG090510 (to K. T.).	Bergelin N, 2009, ENDOCRINOLOGY, V150, P2055, DOI 10.1210/en.2008-0625; Berry DA, 2006, JAMA-J AM MED ASSOC, V295, P1658, DOI 10.1001/jama.295.14.1658; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dean M, 2009, J MAMMARY GLAND BIOL, V14, P3, DOI 10.1007/s10911-009-9109-9; Doll F, 2007, ENDOCR-RELAT CANCER, V14, P325, DOI 10.1677/ERC-06-0050; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; French KJ, 2003, CANCER RES, V63, P5962; Hait NC, 2005, J BIOL CHEM, V280, P29462, DOI 10.1074/jbc.M502922200; Hait NC, 2007, J BIOL CHEM, V282, P12058, DOI 10.1074/jbc.M609559200; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Igarashi N, 2003, J BIOL CHEM, V278, P46832, DOI 10.1074/jbc.M306577200; Johnson KR, 2002, J BIOL CHEM, V277, P35257, DOI 10.1074/jbc.M203033200; Kleuser B, 2008, MOL PHARMACOL, V74, P1533, DOI 10.1124/mol.108.046854; Kobayashi N, 2006, J LIPID RES, V47, P614, DOI 10.1194/jlr.M500468-JLR200; Kobayashi N, 2009, J BIOL CHEM, V284, P21192, DOI 10.1074/jbc.M109.006163; Lee YM, 2007, PROSTAG OTH LIPID M, V84, P154, DOI 10.1016/j.prostaglandins.2007.08.001; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Mitra P, 2007, METHOD ENZYMOL, V434, P257, DOI 10.1016/S0076-6879(07)34014-7; Mitra P, 2006, P NATL ACAD SCI USA, V103, P16394, DOI 10.1073/pnas.0603734103; Nava VE, 2002, EXP CELL RES, V281, P115, DOI 10.1006/excr.2002.5658; Nieuwenhuis B, 2009, J MOL MED, V87, P645, DOI 10.1007/s00109-009-0468-x; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Pebay A, 2007, PROSTAG OTH LIPID M, V84, P83, DOI 10.1016/j.prostaglandins.2007.08.004; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Ruckhaberle E, 2008, BREAST CANCER RES TR, V112, P41, DOI 10.1007/s10549-007-9836-9; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sankala HM, 2007, CANCER RES, V67, P10466, DOI 10.1158/0008-5472.CAN-07-2090; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Sato K, 2007, J NEUROCHEM, V103, P2610, DOI 10.1111/j.1471-4159.2007.04958.x; Shida D, 2008, CANCER RES, V68, P6569, DOI 10.1158/0008-5472.CAN-08-0411; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sukocheva O, 2006, J CELL BIOL, V173, P301, DOI 10.1083/jcb.200506033; Sukocheva OA, 2003, MOL ENDOCRINOL, V17, P2002, DOI 10.1210/me.2003-0119; Sukocheva O, 2009, ENDOCRINOLOGY, V150, P4484, DOI 10.1210/en.2009-0391; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Taha TA, 2005, FASEB J, V19, P482, DOI 10.1096/fj.05-4412fje; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; THU R, 2005, NEW ENGL J MED, V353, P2747; Visentin B, 2006, CANCER CELL, V9, P225, DOI 10.1016/j.ccr.2006.02.023; Visram H, 2006, CANCER BIOL THER, V5, P1677, DOI 10.4161/cbt.5.12.3378	54	194	203	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10477	10486		10.1074/jbc.M109.064162	http://dx.doi.org/10.1074/jbc.M109.064162			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20110355	Green Published, hybrid			2022-12-27	WOS:000276264600034
J	Thien, CBF; Dagger, SA; Steer, JH; Koentgen, F; Jansen, ES; Scott, CL; Langdon, WY				Thien, Christine B. F.; Dagger, Samantha A.; Steer, James H.; Koentgen, Frank; Jansen, Elisa S.; Scott, Clare L.; Langdon, Wallace Y.			c-Cbl Promotes T Cell Receptor-induced Thymocyte Apoptosis by Activating the Phosphatidylinositol 3-Kinase/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILY-MEMBER BIM; NEGATIVE SELECTION; TYROSINE PHOSPHORYLATION; AUTOREACTIVE THYMOCYTES; OF-FUNCTION; KINASE; DOMAIN; INHIBITORS; ZAP-70; LIGASE	The ability of thymocytes to assess T cell receptor (TCR) signaling strength and initiate the appropriate downstream response is crucial for determining their fate. We have previously shown that a c-Cbl RING finger mutant knock-in mouse, in which the E3 ubiquitin ligase activity of c-Cbl is inactivated, is highly sensitive to TCR-induced death signals that cause thymic deletion. This high intensity signal involves the enhanced tyrosine phosphorylation of the mutant c-Cbl protein promoting a marked increase in the activation of Akt. Here we show that this high intensity signal in c-Cbl RING finger mutant thymocytes also promotes the enhanced induction of two mediators of TCR-directed thymocyte apoptosis, Nur77 and the pro-apoptotic Bcl-2 family member, Bim. In contrast, a knock-in mouse harboring a mutation at Tyr-737, the site in c-Cbl that activates phosphatidylinositol 3-kinase, shows reduced TCR-mediated responses including suppression of Akt activation, a reduced induction of Nur77 and Bim, and greater resistance to thymocyte death. These findings identify tyrosine-phosphorylated c-Cbl as a critical sensor of TCR signal strength that regulates the engagement of death-promoting signals.	[Thien, Christine B. F.; Dagger, Samantha A.; Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA 6009, Australia; [Steer, James H.] Univ Western Australia, Sch Med & Pharmacol, Crawley, WA 6009, Australia; [Koentgen, Frank] Ozgene Pty Ltd, Bentley, WA 6102, Australia; [Jansen, Elisa S.; Scott, Clare L.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia	University of Western Australia; University of Western Australia; Walter & Eliza Hall Institute	Langdon, WY (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Crawley, WA 6009, Australia.	wally.langdon@uwa.edu.au	Thien, Christine/GQP-0424-2022	Thien, Christine/0000-0003-3884-5546	National Health and Medical Research Council (NHMRC) [458539]; Department of Health, Western Australia; NHMRC [406675, 303112]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Department of Health, Western Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council (NHMRC) (Canberra) Grant 458539, an infrastructure grant from the Medical and Health Research Infrastructure Fund, Department of Health, Western Australia, and NHMRC Fellowships 406675 (to C. L. S.) and 303112 ( to W.Y.L.).	Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Andoniou CE, 1996, ONCOGENE, V12, P1981; ANDONIOU CE, 1996, THESIS U W AUSTR; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; CALNAN BJ, 1995, IMMUNITY, V3, P273; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deckert M, 1998, J BIOL CHEM, V273, P8867, DOI 10.1074/jbc.273.15.8867; Dequiedt F, 2003, IMMUNITY, V18, P687, DOI 10.1016/S1074-7613(03)00109-2; Dequiedt F, 2005, J EXP MED, V201, P793, DOI 10.1084/jem.20042034; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Grossmann AH, 2004, FEBS LETT, V577, P555, DOI 10.1016/j.febslet.2004.10.054; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gustin SE, 2006, J IMMUNOL, V177, P5980, DOI 10.4049/jimmunol.177.9.5980; Harris TE, 1996, BIOCHEM BIOPH RES CO, V227, P672, DOI 10.1006/bbrc.1996.1567; Huang F, 2006, IMMUNITY, V25, P571, DOI 10.1016/j.immuni.2006.08.021; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Maltzman JS, 2005, J EXP MED, V202, P893, DOI 10.1084/jem.20051128; Molero JC, 2006, DIABETES, V55, P3411, DOI 10.2337/db06-0955; Murphy MA, 1998, MOL CELL BIOL, V18, P4872, DOI 10.1128/MCB.18.8.4872; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Neilson JR, 2004, IMMUNITY, V20, P255, DOI 10.1016/S1074-7613(04)00052-4; Ohashi PS, 2003, CURR OPIN IMMUNOL, V15, P668, DOI 10.1016/j.coi.2003.09.013; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; Sanada M, 2009, NATURE, V460, P904, DOI 10.1038/nature08240; Siggs OM, 2006, CURR OPIN IMMUNOL, V18, P175, DOI 10.1016/j.coi.2006.01.001; Sohn SJ, 2007, CURR OPIN IMMUNOL, V19, P510, DOI 10.1016/j.coi.2007.06.001; Strasser A, 2008, IMMUNOL CELL BIOL, V86, P57, DOI 10.1038/sj.icb.7100141; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thien CBF, 2005, EMBO J, V24, P3807, DOI 10.1038/sj.emboj.7600841; Thien CBF, 2003, J EXP MED, V197, P503, DOI 10.1084/jem.20021498; Thien CBF, 1999, J IMMUNOL, V162, P7133; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; Zucchelli S, 2005, IMMUNITY, V22, P385, DOI 10.1016/j.immuni.2005.01.015	43	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 2	2010	285	14					10969	10981		10.1074/jbc.M109.094920	http://dx.doi.org/10.1074/jbc.M109.094920			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	578AC	20133944	Green Published, hybrid			2022-12-27	WOS:000276264600081
J	Graham, JF; Agarwal, S; Kurian, D; Kirby, L; Pinheiro, TJT; Gill, AC				Graham, James F.; Agarwal, Sonya; Kurian, Dominic; Kirby, Louise; Pinheiro, Teresa J. T.; Gill, Andrew C.			Low Density Subcellular Fractions Enhance Disease-specific Prion Protein Misfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE CONVERSION; IN-VITRO; LIPID-MEMBRANES; RECOMBINANT PRP; INFECTIOUS PRIONS; HEPARAN-SULFATE; SCRAPIE; PROPAGATION; STRAINS; AMPLIFICATION	The production of prion particles in vitro by amplification with or without exogenous seed typically results in infectivity titers less than those associated with PrPSc isolated ex vivo and highlights the potential role of co-factors that can catalyze disease-specific prion protein misfolding in vivo. We used a cell-free conversion assay previously shown to replicate many aspects of transmissible spongiform encephalopathy disease to investigate the cellular location of disease-specific co-factors using fractions derived from gradient centrifugation of a scrapie-susceptible cell line. Fractions from the low density region of the gradient doubled the efficiency of conversion of recombinant PrP. These fractions contain plasma membrane and cytoplasmic proteins, and conversion enhancement can be achieved using PrPSc derived from two different strains of mouse-passaged scrapie as seed. Equivalent fractions from a second scrapie-susceptible cell line also stimulate conversion. We also show that subcellular fractions enhancing disease-specific prion protein conversion prevent in vitro fibrillization of recombinant prion protein, suggesting the existence of separate, competing mechanisms of disease-specific and nonspecific misfolding in vivo.	[Graham, James F.; Agarwal, Sonya; Kirby, Louise; Gill, Andrew C.] Univ Edinburgh, Neuropathogenesis Div, Roslin Inst, Easter Bush Vet Ctr, Roslin EH25 9RG, Midlothian, Scotland; [Graham, James F.; Agarwal, Sonya; Kirby, Louise; Gill, Andrew C.] Univ Edinburgh, Royal Dick Sch Vet Studies, Easter Bush Vet Ctr, Roslin EH25 9RG, Midlothian, Scotland; [Pinheiro, Teresa J. T.] Univ Warwick, Sch Biol Sci, Coventry CV4 7AL, W Midlands, England; [Kurian, Dominic] Inst Anim Hlth, Newbury RG20 7NN, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Warwick; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Gill, AC (corresponding author), Univ Edinburgh, Neuropathogenesis Div, Roslin Inst, Easter Bush Vet Ctr, Alexander Robertson Bldg, Roslin EH25 9RG, Midlothian, Scotland.	andrew.gill@roslin.ed.ac.uk	Gill, Andrew C/A-5219-2009; Gill, ANdrew/GRO-1248-2022	Gill, Andrew C/0000-0001-5201-9473; Kurian, Dominic/0000-0002-5924-665X	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom; Department for Environment, Food, and Rural Affairs; BBSRC [BBS/E/A/00001663, BBS/E/D/05241338] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/A/00001663, BBS/E/D/05241338] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food, and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Supported by a doctoral training account from the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom.; Supported through an Institute Strategic Programme Grant from the Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom.; Supported by the Department for Environment, Food, and Rural Affairs.	Arimon M, 2008, J MOL BIOL, V384, P1157, DOI 10.1016/j.jmb.2008.09.063; Atarashi R, 2008, NAT METHODS, V5, P211, DOI 10.1038/nmeth0308-211; Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Ben-Zaken O, 2003, J BIOL CHEM, V278, P40041, DOI 10.1074/jbc.M301152200; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; BORCHELT DR, 1992, J BIOL CHEM, V267, P16188; Breydo Leonid, 2008, V459, P105, DOI 10.1007/978-1-59745-234-2_8; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Caughey B, 1998, J BIOL CHEM, V273, P32230, DOI 10.1074/jbc.273.48.32230; Colby DW, 2009, P NATL ACAD SCI USA, V106, P20417, DOI 10.1073/pnas.0910350106; Critchley P, 2004, BIOCHEM BIOPH RES CO, V313, P559, DOI 10.1016/j.bbrc.2003.12.004; DebBurman SK, 1997, P NATL ACAD SCI USA, V94, P13938, DOI 10.1073/pnas.94.25.13938; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Fasano C, 2006, J MOL NEUROSCI, V29, P195, DOI 10.1385/JMN:29:3:195; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; Grimminger-Marquardt V, 2010, BIOPOLYMERS, V93, P252, DOI 10.1002/bip.21301; Hachiya NS, 2005, NEUROSCI LETT, V374, P98, DOI 10.1016/j.neulet.2004.10.044; HOPE J, 1988, EUR J BIOCHEM, V172, P271, DOI 10.1111/j.1432-1033.1988.tb13883.x; Horonchik L, 2005, J BIOL CHEM, V280, P17062, DOI 10.1074/jbc.M500122200; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kazlauskaite J, 2005, BIOCHEM SOC SYMP, V72, P211, DOI 10.1042/bss0720211; Kazlauskaite J, 2003, BIOCHEMISTRY-US, V42, P3295, DOI 10.1021/bi026872q; Kirby L, 2003, J GEN VIROL, V84, P1013, DOI 10.1099/vir.0.18903-0; Kirby L, 2004, TECHNIQUES PRION RES; Kirby L, 2006, J GEN VIROL, V87, P3747, DOI 10.1099/vir.0.82086-0; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Makarava N, 2010, ACTA NEUROPATHOL, V119, P177, DOI 10.1007/s00401-009-0633-x; Makarava Natallia, 2008, V459, P131, DOI 10.1007/978-1-59745-234-2_10; Masison DC, 2009, PRION, V3, P65, DOI 10.4161/pri.3.2.9134; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ritchie MA, 2002, J AM SOC MASS SPECTR, V13, P1065, DOI 10.1016/S1044-0305(02)00421-X; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Summers DW, 2009, PRION, V3, P59, DOI 10.4161/pri.3.2.9062; Supattapone Surachai, 2008, V459, P117, DOI 10.1007/978-1-59745-234-2_9; TARABOULOS A, 1992, MOL BIOL CELL, V3, P851, DOI 10.1091/mbc.3.8.851; Weissmann C, 2009, FOLIA NEUROPATHOL, V47, P104; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377	45	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9868	9880		10.1074/jbc.M109.093484	http://dx.doi.org/10.1074/jbc.M109.093484			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106973	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000276165900058
J	Ketsawatsomkron, P; Pelham, CJ; Groh, S; Keen, HL; Faraci, FM; Sigmund, CD				Ketsawatsomkron, Pimonrat; Pelham, Christopher J.; Groh, Severine; Keen, Henry L.; Faraci, Frank M.; Sigmund, Curt D.			Does Peroxisome Proliferator-activated Receptor-gamma (PPAR gamma) Protect from Hypertension Directly through Effects in the Vasculature?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							IMPAIRED GLUCOSE-TOLERANCE; LOWERS BLOOD-PRESSURE; INSULIN-RESISTANCE; ENDOTHELIAL FUNCTION; FASTING GLUCOSE; ROSIGLITAZONE; INTERFERENCE; PIOGLITAZONE; DYSFUNCTION; PATHWAY	Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a ligand-activated transcription factor of the nuclear hormone receptor superfamily. Increasing evidence suggests that PPAR gamma is involved in the regulation of vascular function and blood pressure in addition to its well recognized role in metabolism. Thiazolidinediones, PPAR gamma agonists, lower blood pressure and have protective vascular effects through largely unknown mechanisms. In contrast, loss-of-function dominant-negative mutations in human PPAR gamma cause insulin resistance and severe early onset hypertension. Recent studies using genetically manipulated mouse models have begun to specifically address the importance of PPAR gamma in the vasculature. In this minireview, evidence for a protective role of PPAR gamma in the endothelium and vascular smooth muscle, derived largely from studies of genetically manipulated mice, will be discussed.	[Ketsawatsomkron, Pimonrat; Pelham, Christopher J.; Groh, Severine; Keen, Henry L.; Faraci, Frank M.; Sigmund, Curt D.] Univ Iowa, Dept Internal Med, Ctr Funct Genom Hypertens, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa	Sigmund, CD (corresponding author), Univ Iowa, Dept Internal Med, Ctr Funct Genom Hypertens, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	curt-sigmund@uiowa.edu	Sigmund, Curt D./W-1611-2019	Sigmund, Curt D./0000-0002-1453-0921; Faraci, Frank/0000-0002-0203-1690				Agostini M, 2006, CELL METAB, V4, P303, DOI 10.1016/j.cmet.2006.09.003; Atkins KB, 2009, AM J PHYSIOL-CELL PH, V296, pC1151, DOI 10.1152/ajpcell.00343.2008; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barroso I, 1999, NATURE, V402, P880, DOI 10.1038/47254; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Beyer AM, 2008, CIRC RES, V103, P654, DOI 10.1161/CIRCRESAHA.108.176339; Beyer AM, 2008, HYPERTENSION, V51, P867, DOI 10.1161/HYPERTENSIONAHA.107.103648; Bosch J, 2006, NEW ENGL J MED, V355, P1551; BUCHANAN TA, 1995, J CLIN INVEST, V96, P354, DOI 10.1172/JCI118041; Chan SHH, 2009, CIRC RES, V105, P886, DOI 10.1161/CIRCRESAHA.109.199018; Chang L, 2009, CIRCULATION, V119, P2161, DOI 10.1161/CIRCULATIONAHA.108.815803; Delerive P, 1999, CIRC RES, V85, P394, DOI 10.1161/01.RES.85.5.394; Diep QN, 2002, CIRCULATION, V105, P2296, DOI 10.1161/01.CIR.0000016049.86468.23; Diep QN, 2001, HYPERTENSION, V38, P249, DOI 10.1161/01.HYP.38.2.249; Duan SZ, 2008, CIRC RES, V102, P283, DOI 10.1161/CIRCRESAHA.107.164384; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Eto K, 2001, EUR J PHARMACOL, V423, P1, DOI 10.1016/S0014-2999(01)01047-0; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Giles TD, 2007, CURR HYPERTENS REP, V9, P332, DOI 10.1007/s11906-007-0060-0; Guan HP, 2005, GENE DEV, V19, P453, DOI 10.1101/gad.1263305; Halabi CM, 2008, CELL METAB, V7, P215, DOI 10.1016/j.cmet.2007.12.008; Hegele RA, 2002, DIABETES, V51, P3586, DOI 10.2337/diabetes.51.12.3586; Heppner TJ, 2005, PHARMACOLOGY, V73, P15, DOI 10.1159/000081070; Home PD, 2007, NEW ENGL J MED, V357, P28, DOI 10.1056/NEJMoa073394; Hwang JN, 2005, AM J PHYSIOL-CELL PH, V288, pC899, DOI 10.1152/ajpcell.00474.2004; Iglarz M, 2003, ARTERIOSCL THROM VAS, V23, P45, DOI 10.1161/01.ATV.0000047447.67827.CD; Kanda T, 2009, J CLIN INVEST, V119, P110, DOI 10.1172/JCI36233; Keen HL, 2010, ARTERIOSCL THROM VAS, V30, P518, DOI 10.1161/ATVBAHA.109.200733; Kleinhenz JM, 2009, AM J PHYSIOL-HEART C, V297, pH1647, DOI 10.1152/ajpheart.00148.2009; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lombardi A, 2008, ARTERIOSCL THROM VAS, V28, P718, DOI 10.1161/ATVBAHA.107.160713; Lonn EM, 2009, J AM COLL CARDIOL, V53, P2028, DOI 10.1016/j.jacc.2008.12.072; Nicol CJ, 2005, AM J HYPERTENS, V18, P549, DOI 10.1016/j.amjhyper.2004.10.032; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Polikandriotis JA, 2005, ARTERIOSCL THROM VAS, V25, P1810, DOI 10.1161/01.ATV.0000177805.65864.d4; Potenza MA, 2009, AM J PHYSIOL-ENDOC M, V297, pE685, DOI 10.1152/ajpendo.00291.2009; Ryan MJ, 2004, HYPERTENSION, V43, P661, DOI 10.1161/01.HYP.0000116303.71408.c2; Sharabi Y, 2007, AM J HYPERTENS, V20, P206, DOI 10.1016/j.amjhyper.2006.08.002; Sigmund CD, 2010, HYPERTENSION, V55, P437, DOI 10.1161/HYPERTENSIONAHA.109.144170; Tsai YS, 2004, J CLIN INVEST, V114, P240, DOI 10.1172/JCI200420964; Verrier E, 2004, CIRC RES, V94, P1515, DOI 10.1161/01.RES.0000130527.92537.06; Wakino S, 2005, HYPERTENS RES, V28, P255, DOI 10.1291/hypres.28.255; Wakino S, 2004, CIRC RES, V95, pE45, DOI 10.1161/01.RES.0000142313.68389.92; Walker AB, 1999, DIABETES, V48, P1448, DOI 10.2337/diabetes.48.7.1448; Wan YH, 2007, NAT MED, V13, P1496, DOI 10.1038/nm1672; Wan YH, 2007, GENE DEV, V21, P1895, DOI 10.1101/gad.1567207; Wang NN, 2009, TOXICOL PATHOL, V37, P21, DOI 10.1177/0192623308328545; Wang NN, 2008, CELL METAB, V8, P482, DOI 10.1016/j.cmet.2008.10.009; Wang NP, 2002, J BIOL CHEM, V277, P34176, DOI 10.1074/jbc.M203436200	50	52	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9311	9316		10.1074/jbc.R109.025031	http://dx.doi.org/10.1074/jbc.R109.025031			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20129921	hybrid, Green Published			2022-12-27	WOS:000276165900001
J	Low, DHP; Frecer, V; Le Saux, A; Srinivasan, GA; Ho, B; Chen, JZ; Ding, JL				Low, Diana Hooi Ping; Frecer, Vladimir; Le Saux, Agnes; Srinivasan, Ganesh Anand; Ho, Bow; Chen, Jianzhu; Ding, Jeak Ling			Molecular Interfaces of the Galactose-binding Protein Tectonin Domains in Host-Pathogen Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; CRYSTAL-STRUCTURE; INNATE IMMUNITY; RECOGNITION RECEPTORS; HYDROGEN-EXCHANGE; LECTIN; DOCKING; HADDOCK; CLONING; PLASMA	beta-Propeller proteins function in catalysis, protein-protein interaction, cell cycle regulation, and innate immunity. The galactose-binding protein (GBP) from the plasma of the horseshoe crab, Carcinoscorpius rotundicauda, is a beta-propeller protein that functions in antimicrobial defense. Studies have shown that upon binding to Gram-negative bacterial lipopolysaccharide (LPS), GBP interacts with C-reactive protein (CRP) to form a pathogen-recognition complex, which helps to eliminate invading microbes. However, the molecular basis of interactions between GBP and LPS and how it interplays with CRP remain largely unknown. By homology modeling, we showed that GBP contains six beta-propeller/Tectonin domains. Ligand docking indicated that Tectonin domains 6 to 1 likely contain the LPS binding sites. Protein-protein interaction studies demonstrated that Tectonin domain 4 interacts most strongly with CRP. Hydrogen-deuterium exchange mass spectrometry mapped distinct sites of GBP that interact with LPS and with CRP, consistent with in silico predictions. Furthermore, infection condition (lowered Ca2+ level) increases GBP-CRP affinity by 1000-fold. Resupplementing the system with a physiological level of Ca2+ did not reverse the protein-protein affinity to the basal state, suggesting that the infection-induced complex had undergone irreversible conformational change. We propose that GBP serves as a bridging molecule, participating in molecular interactions, GBP-LPS and GBP-CRP, to form a stable pathogen-recognition complex. The interaction interfaces in these two partners suggest that Tectonin domains can differentiate self/nonself, crucial to frontline defense against infection. In addition, GBP shares architectural and functional homologies to a human protein, hTectonin, suggesting its evolutionarily conservation for similar to 500 million years, from horseshoe crab to human.	[Low, Diana Hooi Ping; Le Saux, Agnes; Srinivasan, Ganesh Anand; Ding, Jeak Ling] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Low, Diana Hooi Ping; Chen, Jianzhu; Ding, Jeak Ling] Singapore Massachusetts Inst Technol Alliance, Singapore 117576, Singapore; [Ho, Bow] Natl Univ Singapore, Dept Microbiol, Singapore 117543, Singapore; [Frecer, Vladimir] Lab Mol Biostruct & Nanomat Modeling, I-34149 Trieste, Italy; [Frecer, Vladimir] Slovak Acad Sci, Canc Res Inst, Bratislava 83391, Slovakia; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02142 USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA 02142 USA	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; National University of Singapore; Slovak Academy of Sciences; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Ding, JL (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.	dbsdjl@nus.edu.sg	Frecer, Vladimir/AAY-3030-2021; Ding, Jeak/H-8057-2012	Low, Diana/0000-0002-6054-8524	Singapore-MIT Alliance, Computational and Systems Biology; AcRF [T208B3109]	Singapore-MIT Alliance, Computational and Systems Biology(Singapore-MIT Alliance for Research & Technology Centre (SMART)); AcRF	This work was supported by grants from the Singapore-MIT Alliance, Computational and Systems Biology and the AcRF (T208B3109, MoE).	Aslam SN, 2008, CURR BIOL, V18, P1078, DOI 10.1016/j.cub.2008.06.061; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Blackwell JM, 2000, MICROBES INFECT, V2, P317, DOI 10.1016/S1286-4579(00)00295-1; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen SC, 2001, J BIOL CHEM, V276, P9631, DOI 10.1074/jbc.M008414200; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Daiyasu H, 2008, J BIOCHEM, V144, P467, DOI 10.1093/jb/mvn095; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Frecer V, 2000, EUR J BIOCHEM, V267, P837, DOI 10.1046/j.1432-1327.2000.01069.x; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Hubbard S, 1996, NACCESS VERSION 2 1; Huh CG, 1998, J BIOL CHEM, V273, P6565, DOI 10.1074/jbc.273.11.6565; Iwanaga S, 2002, CURR OPIN IMMUNOL, V14, P87, DOI 10.1016/S0952-7915(01)00302-8; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; Kawai F, 1999, J IND MICROBIOL BIOT, V23, P400, DOI 10.1038/sj.jim.2900730; Le Saux A, 2008, J MOL BIOL, V377, P902, DOI 10.1016/j.jmb.2008.01.045; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li Y, 2007, EUR J IMMUNOL, V37, P3477, DOI 10.1002/eji.200737078; Low DHP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006260; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Mandell JG, 1998, ANAL CHEM, V70, P3987, DOI 10.1021/ac980553g; Naberezhnykh GA, 2008, BIOCHEMISTRY-MOSCOW+, V73, P432, DOI 10.1134/S0006297908040081; Ng PML, 2007, EMBO J, V26, P3431, DOI 10.1038/sj.emboj.7601762; Ng PML, 2004, J ENDOTOXIN RES, V10, P163, DOI 10.1179/096805104225004833; Ong ST, 2006, IMMUNOBIOLOGY, V211, P295, DOI 10.1016/j.imbio.2006.02.004; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Petsko G., 2004, PROTEIN STRUCTURE FU; Rakotobe D, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-32; Ramadan MAM, 2002, ACTA CRYSTALLOGR D, V58, P992, DOI 10.1107/S0907444902005693; SAITO T, 1995, J BIOL CHEM, V270, P14493, DOI 10.1074/jbc.270.24.14493; Schroder HC, 2003, J BIOL CHEM, V278, P32810, DOI 10.1074/jbc.M304116200; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200; Yadid I, 2007, J MOL BIOL, V365, P10, DOI 10.1016/j.jmb.2006.09.055; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	38	17	19	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9898	9907		10.1074/jbc.M109.059774	http://dx.doi.org/10.1074/jbc.M109.059774			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118243	hybrid, Green Published			2022-12-27	WOS:000276165900060
J	Ma, YH; Chen, L; Wright, GM; Pillai, SR; Chellappan, SP; Cress, WD				Ma, Yihong; Chen, Lu; Wright, Gabriela M.; Pillai, Smitha R.; Chellappan, Srikumar P.; Cress, W. Douglas			CDKN1C Negatively Regulates RNA Polymerase II C-terminal Domain Phosphorylation in an E2F1-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASE; TRANSCRIPTION FACTOR TFIIH; INDUCED APOPTOSIS; PHYSICAL INTERACTION; INHIBITOR P57(KIP2); POTENTIAL MEDIATOR; TUMOR-SUPPRESSOR; UP-REGULATION; E2F ACTIVITY; P-TEFB	CDKN1C is a cyclin-dependent kinase inhibitor and is a candidate tumor suppressor gene. We previously found that the CDKN1C protein represses E2F1-driven transcription in an apparent negative feedback loop. Herein, we explore the mechanism by which CDKN1C represses transcription. We find that adenoviral-mediated overexpression of CDKN1C leads to a dramatic reduction in phosphorylation of the RNA polymerase II (pol II) C-terminal domain (CTD). RNA interference studies demonstrate that this activity is not an artifact of CDKN1C over-expression, because endogenous CDKN1C mediates an inhibition of RNA pol II CTD phosphorylation in HeLa cells upon treatment with dexamethasone. Surprisingly, we find that CDKN1C-mediated repression of RNA pol II phosphorylation is E2F1-dependent, suggesting that E2F1 may direct CDKN1C to chromatin. Chromatin immunoprecipitation assays demonstrate that CDKN1C is associated with E2F1-regulated promoters in vivo and that this association can dramatically reduce the level of RNA pol II CTD phosphorylation at both Ser-2 and Ser-5 of the C-terminal domain repeat. In addition, we show that CDKN1C interacts with both CDK7 and CDK9 (putative RNA pol II CTD kinases) and that CDKN1C blocks their ability to phosphorylate a glutathione S-transferase-CTD fusion protein in vitro. E2F1 and CDKN1C are found to form stable complexes both in vivo and in vitro. Molecular studies demonstrate that the E2F1-CDKN1C interaction is mediated by two E2F domains. A central E2F1 domain interacts directly with CDKN1C, whereas a C-terminal E2F1 domain interacts with CDKN1C via interaction with Rb. The results presented in this report highlight a novel mechanism of tumor suppression by CDKN1C.	[Ma, Yihong; Chen, Lu; Wright, Gabriela M.; Pillai, Smitha R.; Chellappan, Srikumar P.; Cress, W. Douglas] H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Cress, WD (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Mol Oncol Program, 12902 Magnolia Dr, Tampa, FL 33612 USA.	douglas.cress@moffitt.org		Pillai, Smitha/0000-0001-9718-5010	National Institutes of Health [CA90489, CA119997]; Florida Department of Health [08BB-05]; Moffitt Research Institute; NATIONAL CANCER INSTITUTE [R01CA090489, P50CA119997] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Department of Health; Moffitt Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA90489 and CA119997 from NCI. This work was also supported by the Florida Department of Health (Grant 08BB-05) and by the Moffitt Research Institute.	Afshari CA, 1996, CELL GROWTH DIFFER, V7, P979; Alheim K, 2003, J MOL ENDOCRINOL, V30, P359, DOI 10.1677/jme.0.0300359; Amini S, 2002, ONCOGENE, V21, P5797, DOI 10.1038/sj.onc.1205754; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Cowling VH, 2007, MOL CELL BIOL, V27, P2059, DOI 10.1128/MCB.01828-06; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Cress WD, 1996, MOL CELL BIOL, V16, P2119; CRESS WD, 1993, MOL CELL BIOL, V13, P6314, DOI 10.1128/MCB.13.10.6314; CRESS WD, 1994, J VIROL, V68, P4212, DOI 10.1128/JVI.68.7.4213-4219.1994; De Falco G, 2000, ONCOGENE, V19, P373, DOI 10.1038/sj.onc.1203305; DeGregori J, 2006, CURR MOL MED, V6, P739; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Devgan V, 2005, GENE DEV, V19, P1485, DOI 10.1101/gad.341405; Eberhardy SR, 2001, J BIOL CHEM, V276, P48562, DOI 10.1074/jbc.M109014200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Eymin B, 2001, ONCOGENE, V20, P1033, DOI 10.1038/sj.onc.1204220; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; HARPER JW, 1993, CELL, V75, P805; Hatada I, 1996, NAT GENET, V14, P171, DOI 10.1038/ng1096-171; Johnson DG, 2006, CURR MOL MED, V6, P731; Johnson DG, 2000, MOL CARCINOGEN, V27, P151, DOI 10.1002/(SICI)1098-2744(200003)27:3<151::AID-MC1>3.0.CO;2-C; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Kaldis P, 1998, MOL BIOL CELL, V9, P2545, DOI 10.1091/mbc.9.9.2545; Kanazawa S, 2003, ONCOGENE, V22, P5707, DOI 10.1038/sj.onc.1206800; Ko LJ, 1997, MOL CELL BIOL, V17, P7220, DOI 10.1128/MCB.17.12.7220; Lee DK, 2000, J BIOL CHEM, V275, P9308, DOI 10.1074/jbc.275.13.9308; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; Ma Y, 2007, ONCOGENE, V26, P3532, DOI 10.1038/sj.onc.1210143; Ma YH, 2004, CANCER BIOL THER, V3, P1262, DOI 10.4161/cbt.3.12.1239; Ma YH, 2003, J BIOL CHEM, V278, P16770, DOI 10.1074/jbc.M212702200; Ma YH, 2003, MOL CANCER THER, V2, P73; Martelli F, 2001, P NATL ACAD SCI USA, V98, P4455, DOI 10.1073/pnas.081061398; MARTIN K, 1995, NATURE, V375, P691, DOI 10.1038/375691a0; Mason SL, 2002, ONCOGENE, V21, P4220, DOI 10.1038/sj.onc.1205524; Matsuoka S, 1996, P NATL ACAD SCI USA, V93, P3026, DOI 10.1073/pnas.93.7.3026; Misra RN, 2004, J MED CHEM, V47, P1719, DOI 10.1021/jm0305568; Morris DP, 1997, METHODS, V12, P264, DOI 10.1006/meth.1997.0478; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Rickert P, 1996, ONCOGENE, V12, P2631; ROY R, 1994, CELL, V79, P1093, DOI 10.1016/0092-8674(94)90039-6; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Samuelsson MKR, 1999, MOL ENDOCRINOL, V13, P1811, DOI 10.1210/me.13.11.1811; Schneider E, 1998, ONCOGENE, V17, P2733, DOI 10.1038/sj.onc.1202504; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; SHIEKHATTAR R, 1995, NATURE, V374, P283, DOI 10.1038/374283a0; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Simone C, 2002, ONCOGENE, V21, P4158, DOI 10.1038/sj.onc.1205511; Stewart MC, 2004, J BONE MINER RES, V19, P123, DOI 10.1359/JBMR.0301209; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vandel L, 1999, EMBO J, V18, P4280, DOI 10.1093/emboj/18.15.4280; Wang B, 2004, J BIOL CHEM, V279, P54140, DOI 10.1074/jbc.M410493200; Wang CG, 2005, J BIOL CHEM, V280, P12339, DOI 10.1074/jbc.C400536200; Wang CG, 2007, J BIOL CHEM, V282, P29902, DOI 10.1074/jbc.M704757200; Yang XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005011; Zeng HW, 2009, J NUTR, V139, P1613, DOI 10.3945/jn.109.110320; Zhang Z, 2005, ONCOGENE, V24, P7238, DOI 10.1038/sj.onc.1208814	61	14	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9813	9822		10.1074/jbc.M109.091496	http://dx.doi.org/10.1074/jbc.M109.091496			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106982	hybrid, Green Published			2022-12-27	WOS:000276165900053
J	Popp, D; Xu, WJ; Narita, A; Brzoska, AJ; Skurray, RA; Firth, N; Goshdastider, U; Maeda, Y; Robinson, RC; Schumacher, MA				Popp, David; Xu, Weijun; Narita, Akihiro; Brzoska, Anthony J.; Skurray, Ronald A.; Firth, Neville; Goshdastider, Umesh; Maeda, Yuichiro; Robinson, Robert C.; Schumacher, Maria A.			Structure and Filament Dynamics of the pSK41 Actin-like ParM Protein IMPLICATIONS FOR PLASMID DNA SEGREGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-THURINGIENSIS; CRYSTAL-STRUCTURE; F-ACTIN; INSTABILITY; HOMOLOG; PARTITION; POLYMERIZATION; CYTOSKELETON; COMPLEX; SYSTEM	Type II plasmid partition systems utilize ParM NTPases in coordination with a centromere-binding protein called ParR to mediate accurate DNA segregation, a process critical for plasmid retention. The Staphylococcus aureus pSK41 plasmid is a medically important plasmid that confers resistance to multiple antibiotics, disinfectants, and antiseptics. In the first step of partition, the pSK41 ParR binds its DNA centromere to form a superhelical partition complex that recruits ParM, which then mediates plasmid separation. pSK41 ParM is homologous to R1 ParM, a known actin homologue, suggesting that it may also form filaments to drive partition. To gain insight into the partition function of ParM, we examined its ability to form filaments and determined the crystal structure of apoParM to 1.95 angstrom. The structure shows that pSK41 ParM belongs to the actin/Hsp70 superfamily. Unexpectedly, however, pSK41 ParM shows the strongest structural homology to the archaeal actin-like protein Thermoplasma acidophilum Ta0583, rather than its functional homologue, R1 ParM. Consistent with this divergence, we find that regions shown to be involved in R1 ParM filament formation are not important in formation of pSK41 ParM polymers. These data are also consonant with our finding that pSK41 ParM forms 1-start 10/4 helices very different from the 37/17 symmetry of R1 ParM. The polymerization kinetics of pSK41 ParM also differed from that of R1 ParM. These results indicate that type II NTPases utilize different polymeric structures to drive plasmid segregation.	[Popp, David; Narita, Akihiro; Maeda, Yuichiro] Japan Sci & Technol Corp, Harima Inst Spring, ERATO Actin Filament Dynam Project, RIKEN, Sayo, Hyogo 6795148, Japan; [Popp, David; Robinson, Robert C.] Inst Mol & Cell Biol, Proteos 138673, Singapore; [Xu, Weijun; Schumacher, Maria A.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Brzoska, Anthony J.; Skurray, Ronald A.; Firth, Neville] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia; [Narita, Akihiro; Goshdastider, Umesh; Maeda, Yuichiro] Nagoya Univ, Grad Sch Sci, Struct Biol Res Ctr, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Narita, Akihiro; Goshdastider, Umesh; Maeda, Yuichiro] Nagoya Univ, Div Biol Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Japan Science & Technology Agency (JST); RIKEN; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Texas System; UTMD Anderson Cancer Center; University of Sydney; Nagoya University; Nagoya University	Popp, D (corresponding author), Japan Sci & Technol Corp, Harima Inst Spring, ERATO Actin Filament Dynam Project, RIKEN, 1-1-1 Kouto, Sayo, Hyogo 6795148, Japan.	dpopp@imcb.A-star.edu.sg; maschuma@mdanderson.org	Robinson, Robert/G-9702-2011; Ghoshdastider, Umesh/O-5327-2015	Robinson, Robert/0000-0001-6367-6903; Firth, Neville/0000-0002-5791-7691; Ghoshdastider, Umesh/0000-0003-4471-9394	National Institutes of Health [R01 AI080687]; Australian Research Council Discovery [DP0346013]; National Health and Medical Research Council of Australia Project [571028]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080687] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council Discovery(Australian Research Council); National Health and Medical Research Council of Australia Project(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI080687 (to M. A. S.), Australian Research Council Discovery Grant DP0346013 (to N. F. and R. A. S.), and National Health and Medical Research Council of Australia Project Grant 571028 (to N. F., M. A. S., and R. A. S.).	Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell CS, 2007, J CELL BIOL, V179, P1059, DOI 10.1083/jcb.200708206; Chen YD, 2005, BIOPHYS J, V88, P505, DOI 10.1529/biophysj.104.044149; COOPER JA, 1983, BIOCHEMISTRY-US, V22, P2193, DOI 10.1021/bi00278a021; DAM M, 1994, J MOL BIOL, V236, P1289, DOI 10.1016/0022-2836(94)90058-2; DeLano W, 2002, PYMOL 0 99; Dunham TD, 2009, EMBO J, V28, P1792, DOI 10.1038/emboj.2009.120; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Erickson HP, 2007, BIOESSAYS, V29, P668, DOI 10.1002/bies.20601; Firth N., 2006, GRAM POSITIVE PATHOG, P413; Funnell BE, 2005, PLASMID, V53, P119, DOI 10.1016/j.plasmid.2004.12.009; Galkin VE, 2009, STRUCTURE, V17, P1253, DOI 10.1016/j.str.2009.07.008; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Hara F, 2007, J BACTERIOL, V189, P2039, DOI 10.1128/JB.01454-06; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Holmes K C, 1965, Methods Biochem Anal, V13, P113, DOI 10.1002/9780470110317.ch4; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; Iwasa M, 2008, J BIOL CHEM, V283, P21045, DOI 10.1074/jbc.M800570200; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Moller-Jensen J, 2003, MOL CELL, V12, P1477, DOI 10.1016/S1097-2765(03)00451-9; Moller-Jensen J, 2007, EMBO J, V26, P4413, DOI 10.1038/sj.emboj.7601864; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NISHIDA E, 1983, J BIOCHEM-TOKYO, V93, P1011, DOI 10.1093/oxfordjournals.jbchem.a134224; Orlova A, 2007, NAT STRUCT MOL BIOL, V14, P921, DOI 10.1038/nsmb1300; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Polka JK, 2009, J BACTERIOL, V191, P6219, DOI 10.1128/JB.00676-09; Popp D, 2008, BIOPOLYMERS, V89, P711, DOI 10.1002/bip.20999; Popp D, 2008, EMBO J, V27, P570, DOI 10.1038/sj.emboj.7601978; Popp D, 2007, BIOCHEM BIOPH RES CO, V353, P109, DOI 10.1016/j.bbrc.2006.11.130; Roeben A, 2006, J MOL BIOL, V358, P145, DOI 10.1016/j.jmb.2006.01.096; Rommelaere H, 2003, STRUCTURE, V11, P1279, DOI 10.1016/j.str.2003.09.002; Sablin EP, 2002, P NATL ACAD SCI USA, V99, P10945, DOI 10.1073/pnas.152329899; Salje J, 2008, EMBO J, V27, P2230, DOI 10.1038/emboj.2008.152; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, NATURE, V450, P1268, DOI 10.1038/nature06392; Simpson AE, 2003, J BACTERIOL, V185, P2143, DOI 10.1128/JB.185.7.2143-2152.2003; Tang M, 2007, J BACTERIOL, V189, P8053, DOI 10.1128/JB.00908-07; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tinsley E, 2006, J BACTERIOL, V188, P2829, DOI 10.1128/JB.188.8.2829-2835.2006; van den Ent F, 2001, NATURE, V413, P39, DOI 10.1038/35092500; van den Ent F, 2002, EMBO J, V21, P6935, DOI 10.1093/emboj/cdf672; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Yasunaga T, 1996, J STRUCT BIOL, V116, P155, DOI 10.1006/jsbi.1996.0025	55	37	38	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					10130	10140		10.1074/jbc.M109.071613	http://dx.doi.org/10.1074/jbc.M109.071613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20106979	hybrid, Green Published			2022-12-27	WOS:000276165900080
J	Ohama, T; Brautigan, DL				Ohama, Takashi; Brautigan, David L.			Endotoxin Conditioning Induces VCP/p97-mediated and Inducible Nitric-oxide Synthase-dependent Tyr(284) Nitration in Protein Phosphatase 2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VALOSIN-CONTAINING PROTEIN; KINASE PHOSPHATASE-1; REGULATORY SUBUNITS; TYROSINE PHOSPHORYLATION; CATALYTIC SUBUNIT; CELL-SURVIVAL; EXPRESSION; MACROPHAGES; GROWTH; ALPHA	Endotoxins activate Toll-like receptors and reprogram cells to be refractory to secondary exposure. Here we found that activation of different Toll-like receptors elicited a time-and dose-dependent increase in the levels of the protein phosphatase 2A catalytic subunit (PP2Ac) but not its partner A subunit. We purified the lipopolysaccharide-induced form of PP2A by chromatography plus immunoprecipitation and used mass spectrometry to identify VCP/p97 as a novel partner for PP2Ac. Endogenous VCP/p97 and PP2Ac were co-immunoprecipitated from primary murine macrophages and human lymphocytes. GST-VCP/p97 bound purified PP2A in pulldown assays, showing direct protein-protein interaction. Endotoxin conditioning of macrophages induced formation of 3-nitrotyrosine in the PP2Ac associated with VCP/p97, a response severely reduced in macrophages from iNOS knock-out mice. The reaction of purified PP2A with peroxynitrite dissociated the A subunit, and 3-nitro-Tyr(284) was identified in PP2Ac by mass spectrometry. Myc-PP2Ac (Y284F) expressed in cells was resistant to peroxynitrite-induced nitration and reduction of A subunit binding. Transient expression of either VCP/p97 or PP2Ac was sufficient to elevate levels of the dual specificity phosphatase DUSP1, reduce p38 MAPK activation, and suppress tumor necrosis factor-alpha release. We propose that VCP/p97-mediated Tyr nitration of PP2A increases the levels of phosphatases PP2A and DUSP1 to contribute to the refractory response of conditioned cells.	[Brautigan, David L.] Univ Virginia, Sch Med, Ctr Cell Signaling, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Microbiol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Brautigan, DL (corresponding author), Univ Virginia, Sch Med, Ctr Cell Signaling, Box 800577,W Complex MSB 7225, Charlottesville, VA 22908 USA.	db8g@virginia.edu			National Institutes of Health [CA40042, GM56362]; University of Virginia Pratt Committee; NATIONAL CANCER INSTITUTE [P01CA040042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Virginia Pratt Committee; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA40042 and GM56362 ( to D. L. B.). This work was also supported by the University of Virginia Pratt Committee.	Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Calvisi DF, 2008, CANCER RES, V68, P4192, DOI 10.1158/0008-5472.CAN-07-6157; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Gao JJ, 2003, J ENDOTOXIN RES, V9, P237, DOI 10.1179/096805103225001431; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Halawani D, 2006, MOL CELL, V22, P713, DOI 10.1016/j.molcel.2006.06.003; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Klein JB, 2005, J BIOL CHEM, V280, P31870, DOI 10.1074/jbc.M501802200; Kobayashi T, 2002, J BIOL CHEM, V277, P47358, DOI 10.1074/jbc.M207783200; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lin YW, 2006, J BIOL CHEM, V281, P915, DOI 10.1074/jbc.M508720200; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Nimah M, 2005, SHOCK, V23, P80, DOI 10.1097/01.shk.0000145206.28812.60; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Owen KA, 2007, J CELL BIOL, V179, P1275, DOI 10.1083/jcb.200708093; Park SK, 2009, MOL IMMUNOL, V46, P492, DOI 10.1016/j.molimm.2008.10.011; Price NE, 2000, BIOCHEMISTRY-US, V39, P11312, DOI 10.1021/bi0008478; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Vandermoere F, 2006, J BIOL CHEM, V281, P14307, DOI 10.1074/jbc.M510003200; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wu F, 2009, CARDIOVASC RES, V81, P38, DOI 10.1093/cvr/cvn246; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794; Zweitzig D R, 2008, Mol Biol Cell, V19, P5029, DOI 10.1091/mbc.E08-01-0067	40	31	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8711	8718		10.1074/jbc.M109.099788	http://dx.doi.org/10.1074/jbc.M109.099788			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20100830	Green Published, hybrid			2022-12-27	WOS:000275553700024
J	Telford, JE; Kilbride, SM; Davey, GP				Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.			Decylubiquinone Increases Mitochondrial Function in Synaptosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-Q DEFICIENCY; COMPLEX-I DEFICIENCY; AGE-RELATED-CHANGES; RESPIRATORY-CHAIN; Q(10); BIOENERGETICS; MUTATIONS; DISEASES; PROTEIN; MERRF	The effects of decylubiquinone, a ubiquinone analogue, on mitochondrial function and inhibition thresholds of the electron transport chain enzyme complexes in synaptosomes were investigated. Decylubiquinone increased complex I/III and complex II/III activities by 64 and 80%, respectively, and attenuated reductions in oxygen consumption at high concentrations of the complex III inhibitor myxothiazol. During inhibition of complex I, decylubiquinone attenuated reductions in synaptosomal oxygen respiration rates, as seen in the complex I inhibition threshold. Decylubiquinone increased the inhibition thresholds of complex I/III, complex II/III, and complex III over oxygen consumption in the nerve terminal by 25-50%, when myxothiazol was used to inhibit complex III. These results imply that decylubiquinone increases mitochondrial function in the nerve terminal during complex I or III inhibition. The potential benefits of decylubiquinone in diseases where complex I, I/III, II/III, or III activities are deficient are discussed.	[Telford, Jayne E.; Kilbride, Sean M.; Davey, Gavin P.] Trinity Coll Dublin, Inst Neurosci, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	Davey, GP (corresponding author), Trinity Coll Dublin, Inst Neurosci, Sch Biochem & Immunol, Dublin 2, Ireland.	gdavey@tcd.ie	Davey, Gavin/HGB-4233-2022		Programme for Research in Third-level Institutions; Science Foundation Ireland; Marie Curie Transfer of Knowledge [MTKD-CT-2005-030005]	Programme for Research in Third-level Institutions; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Marie Curie Transfer of Knowledge(European Commission)	This work was supported by the Programme for Research in Third-level Institutions, Science Foundation Ireland, and Marie Curie Transfer of Knowledge Grant MTKD-CT-2005-030005.	Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Beal MF, 1998, BRAIN RES, V783, P109, DOI 10.1016/S0006-8993(97)01192-X; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MD, 2000, J BIOL CHEM, V275, P39831, DOI 10.1074/jbc.M006476200; Cleren C, 2008, J NEUROCHEM, V104, P1613, DOI 10.1111/j.1471-4159.2007.05097.x; Esposti MD, 1996, BIOCHEM J, V313, P327, DOI 10.1042/bj3130327; Galpern WR, 2007, MITOCHONDRION, V7, pS146, DOI 10.1016/j.mito.2007.01.004; Hano N, 2003, J BIOENERG BIOMEMBR, V35, P257, DOI 10.1023/A:1024663715931; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; James AM, 1996, BIOCHEM J, V318, P401, DOI 10.1042/bj3180401; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Kilbride SM, 2008, BBA-BIOENERGETICS, V1777, P783, DOI 10.1016/j.bbabio.2008.05.445; Kilbride SM, 2008, J NEUROCHEM, V106, P826, DOI 10.1111/j.1471-4159.2008.05441.x; King T., 1967, METHOD ENZYMOL, V10, P217; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; Lenaz G, 1997, MOL ASPECTS MED, V18, pS25; Lenaz G, 2004, BBA-BIOENERGETICS, V1658, P89, DOI 10.1016/j.bbabio.2004.03.013; Mackey DA, 1996, AM J HUM GENET, V59, P481; Moon Y, 2005, J NEUROCHEM, V93, P1199, DOI 10.1111/j.1471-4159.2005.03112.x; Navarro A, 2002, AM J PHYSIOL-REG I, V282, pR985, DOI 10.1152/ajpregu.00537.2001; Navarro A, 2004, AM J PHYSIOL-REG I, V287, pR1244, DOI 10.1152/ajpregu.00226.2004; OGASAHARA S, 1989, P NATL ACAD SCI USA, V86, P2379, DOI 10.1073/pnas.86.7.2379; Parker WD, 2008, BRAIN RES, V1189, P215, DOI 10.1016/j.brainres.2007.10.061; Powers WJ, 2007, NEUROBIOL DIS, V27, P99, DOI 10.1016/j.nbd.2007.04.008; Ragan MT, 1987, MITOCHONDRIA PRACTIC, P79; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schagger H, 2001, J BIOL CHEM, V276, P37861; SCHAPIRA AHV, 1990, J NEUROCHEM, V54, P823, DOI 10.1111/j.1471-4159.1990.tb02325.x; SHOFFNER JM, 1990, CELL, V61, P931, DOI 10.1016/0092-8674(90)90059-N; Shults CW, 2005, PHARMACOL THERAPEUT, V107, P120, DOI 10.1016/j.pharmthera.2005.02.002; Smith KM, 2006, BBA-MOL BASIS DIS, V1762, P616, DOI 10.1016/j.bbadis.2006.03.004; Telford JE, 2009, J BIOL CHEM, V284, P9109, DOI 10.1074/jbc.M809101200; VONJAGOW G, 1984, J BIOL CHEM, V259, P6318; Wharton DC., 1967, METHOD ENZYMOL, P245; Wong LJC, 2007, MUSCLE NERVE, V36, P279, DOI 10.1002/mus.20807	38	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 19	2010	285	12					8639	8645		10.1074/jbc.M109.079780	http://dx.doi.org/10.1074/jbc.M109.079780			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	568VZ	20080966	Green Published, hybrid			2022-12-27	WOS:000275553700016
J	Kim, D; Sun, M; He, LL; Zhou, QH; Chen, J; Sun, XM; Bepler, G; Sebti, SM; Cheng, JQ				Kim, Donghwa; Sun, Mei; He, Lili; Zhou, Qing-Hua; Chen, Jun; Sun, Xia-Meng; Bepler, Gerold; Sebti, Said M.; Cheng, Jin Q.			A Small Molecule Inhibits Akt through Direct Binding to Akt and Preventing Akt Membrane Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICYCLIC NUCLEOSIDE PHOSPHATE; PLECKSTRIN HOMOLOGY DOMAIN; AKT/PROTEIN KINASE-B; RAC PROTEIN-KINASE; PHASE-II TRIAL; CANCER-CELLS; IN-VIVO; SELECTIVE INHIBITORS; ANTITUMOR-ACTIVITY; SIGNALING PATHWAY	The Akt pathway is frequently hyperactivated in human cancer and functions as a cardinal nodal point for transducing extracellular and intracellular oncogenic signals and, thus, presents an exciting target for molecular therapeutics. Here we report the identification of a small molecule Akt/protein kinase B inhibitor, API-1. Although API-1 is neither an ATP competitor nor substrate mimetic, it binds to pleckstrin homology domain of Akt and blocks Akt membrane translocation. Furthermore, API-1 treatment of cancer cells results in inhibition of the kinase activities and phosphorylation levels of the three members of the Akt family. In contrast, API-1 had no effects on the activities of the upstream Akt activators, phosphatidylinositol 3-kinase, phosphatidylinositol-dependent kinase-1, and mTORC2. Notably, the kinase activity and phosphorylation ( e. g. Thr(P)(308) and Ser(P)(473)) levels of constitutively active Akt, including a naturally occurring mutant AKT1-E17K, were inhibited by API-1. API-1 is selective for Akt and does not inhibit the activation of protein kinase C, serum and glucocorticoid-inducible kinase, protein kinase A, STAT3, ERK1/2, or JNK. The inhibition of Akt by API-1 resulted in induction of cell growth arrest and apoptosis selectively in human cancer cells that harbor constitutively activated Akt. Furthermore, API-1 inhibited tumor growth in nude mice of human cancer cells in which Akt is elevated but not of those cancer cells in which it is not. These data indicate that API-1 directly inhibits Akt through binding to the Akt pleckstrin homology domain and blocking Akt membrane translocation and that API-1 has anti-tumor activity in vitro and in vivo and could be a potential anti-cancer agent for patients whose tumors express hyperactivated Akt.	[Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Bepler, Gerold] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Surg, Tampa, FL 33612 USA; [Sebti, Said M.] H Lee Moffitt Canc Ctr & Res Inst, Dept Drug Discovery, Tampa, FL 33612 USA; [Zhou, Qing-Hua; Chen, Jun] Tianjin Med Univ, Gen Hosp, Tianjin Key Lab Lung Canc Metastasis & Tumor Micr, Lung Canc Inst, Tianjin 300052, Peoples R China	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Tianjin Medical University	Cheng, JQ (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr, Tampa, FL 33612 USA.	jin.cheng@moffitt.org	He, Lili/A-6356-2012; Sun, Ellen/ABC-8094-2020	Sun, Ellen/0000-0001-7399-4075	National Institutes of Health [CA107078, CA137041, P50 CA119997]; Department of Defense [OC073222]; Bankhead-Coley Bridge [09BB-05]; National Natural Science Foundation of China [30430300]; National High Technology Joint Research Program of China [2006DFB32330]; Hi-tech Research and Development Program of China [2006AA02401]; NATIONAL CANCER INSTITUTE [P50CA119997, R01CA107078, R01CA137041] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Bankhead-Coley Bridge; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Joint Research Program of China(National High Technology Research and Development Program of China); Hi-tech Research and Development Program of China(National High Technology Research and Development Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA107078, CA137041, and P50 CA119997. This work was also supported by Department of Defense Grant: OC073222, Bankhead-Coley Bridge Grant 09BB-05 (to J. Q. C. and G. B.), National Natural Science Foundation of China Grant 30430300, National High Technology Joint Research Program of China Grant 2006DFB32330, and Hi-tech Research and Development Program of China Grant 2006AA02401 (to Q.-H. Z.).	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bailey HH, 2006, CANCER-AM CANCER SOC, V107, P2462, DOI 10.1002/cncr.22308; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Castillo SS, 2004, CANCER RES, V64, P2782, DOI 10.1158/0008-5472.CAN-03-1530; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; Cheng JQ, 1997, ONCOGENE, V14, P2793, DOI 10.1038/sj.onc.1201121; Cheng JQ, 1996, P NATL ACAD SCI USA, V93, P3636, DOI 10.1073/pnas.93.8.3636; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; CHENG JQ, 2001, CANC RES ENCY, P35; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; FEUN LG, 1993, AM J CLIN ONCOL-CANC, V16, P506, DOI 10.1097/00000421-199312000-00010; Granville CA, 2006, CLIN CANCER RES, V12, P679, DOI 10.1158/1078-0432.CCR-05-1654; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hoffman K, 1996, CANCER CHEMOTH PHARM, V37, P254; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Jetzt A, 2003, CANCER RES, V63, P6697; Jiang K, 2000, MOL CELL BIOL, V20, P139, DOI 10.1128/MCB.20.1.139-148.2000; Jin X, 2004, BRIT J CANCER, V91, P1808, DOI 10.1038/sj.bjc.6602214; JONES PF, 1991, CELL REGUL, V2, P1001, DOI 10.1091/mbc.2.12.1001; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Kondapaka SB, 2003, MOL CANCER THER, V2, P1093; KONISHI H, 1995, BIOCHEM BIOPH RES CO, V216, P526, DOI 10.1006/bbrc.1995.2654; Lee SA, 2007, J BIOL CHEM, V282, P15271, DOI 10.1074/jbc.M701362200; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lindsley CW, 2005, BIOORG MED CHEM LETT, V15, P761, DOI 10.1016/j.bmcl.2004.11.011; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Marsh RD, 2007, AM J CLIN ONCOL-CANC, V30, P26, DOI 10.1097/01.coc.0000251235.46149.43; Meuillet EJ, 2004, ONCOL RES, V14, P513, DOI 10.3727/0965040042380487; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Persad S, 2001, J BIOL CHEM, V276, P27462, DOI 10.1074/jbc.M102940200; Ravandi F, 2007, BLOOD, V110, p278A, DOI 10.1182/blood.V110.11.913.913; RITCH PS, 1981, CANCER RES, V41, P1784; Rix U, 2007, BLOOD, V110, P4055, DOI 10.1182/blood-2007-07-102061; RIZKALLA BH, 1972, J ORG CHEM, V37, P3980, DOI 10.1021/jo00798a002; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2002, ONCOGENE, V21, P1727, DOI 10.1038/sj.onc.1205225; Solit DB, 2003, CANCER RES, V63, P2139; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Van Ummersen L, 2004, CLIN CANCER RES, V10, P7450, DOI 10.1158/1078-0432.CCR-03-0406; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Xu WP, 2003, CANCER RES, V63, P7777; Yang L, 2004, CANCER RES, V64, P4394, DOI 10.1158/0008-5472.CAN-04-0343	49	45	47	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 12	2010	285	11					8383	8394		10.1074/jbc.M109.094060	http://dx.doi.org/10.1074/jbc.M109.094060			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AE	20068047	Green Published, hybrid			2022-12-27	WOS:000275413800054
J	Rebeck, GW; Hoe, HS; Moussa, CEH				Rebeck, G. William; Hoe, Hyang-Sook; Moussa, Charbel E. -H.			beta-Amyloid(1-42) Gene Transfer Model Exhibits Intraneuronal Amyloid, Gliosis, Tau Phosphorylation, and Neuronal Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC ALZHEIMERS-DISEASE; TRIPLE-TRANSGENIC MODEL; A-BETA; TANGLE FORMATION; GOLGI NETWORK; PROTEIN; PATHOLOGY; CDK5; ACCUMULATION; INFLAMMATION	Alzheimer disease is characterized by extracellular beta-amyloid (A beta) plaques and intracellular inclusions containing neurofibrillary tangles of phospho-Tau and intraneuronal A beta associated with neuronal cell death. We generated a novel gene transfer animal model using lentiviral A beta(1-42) that resulted in intracellular but not extracellular A beta accumulations in the targeted rat primary motor cortex. Expression of intracellular A beta(1-42) led to pathological changes seen in human Alzheimer disease brains, including cell death, inflammatory signs, activation of two Tau kinases, and Tau hyperphosphorylation. Promoting clearance of lentiviral A beta(1-42) reversed these effects, demonstrating that intraneuronal A beta(1-42) is a toxic peptide that lies upstream of Tau modification. These studies reveal the role of intracellular A beta(1-42) in a novel gene transfer animal model, which is a useful tool to study intraneuronal A beta(1-42)-induced pathology in the absence of extracellular plaques. Targeted delivery of A beta will allow speedy delineation of pathological mechanisms associated with specific neurodegenerative lesions.	Georgetown Univ, Dept Neurosci, Washington, DC 20007 USA; [Moussa, Charbel E. -H.] Georgetown Univ, Dept Biochem & Mol & Cell Biol, Washington, DC 20007 USA	Georgetown University; Georgetown University	Moussa, CEH (corresponding author), Georgetown Univ, Dept Neurosci, Dept Biochem & Mol & Cell Biol, Sch Med, 3970 Reservoir Rd,NW,TRB,Rm WP26B, Washington, DC 20057 USA.	cem46@georgetown.edu	Rebeck, George William/J-2192-2012	Rebeck, George William/0000-0001-6276-248X	NATIONAL INSTITUTE ON AGING [P01AG030128] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG030128] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Anderton BH, 2001, BIOCHEM SOC SYMP, V67, P73; Augustinack JC, 2002, J NEUROPATH EXP NEUR, V61, P557, DOI 10.1093/jnen/61.6.557; BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Burns MP, 2009, HUM MOL GENET, V18, P3206, DOI 10.1093/hmg/ddp258; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Cataldo AM, 1997, J NEUROSCI, V17, P6142; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Eikelenboom P, 2002, GLIA, V40, P232, DOI 10.1002/glia.10146; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Griffin WST, 1998, BRAIN PATHOL, V8, P65; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Hof Patrick R., 1994, P197; Imahori K, 1997, J BIOCHEM, V121, P179; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Jellinger KA, 1998, J NEURAL TRANSM-SUPP, P77; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lee MS, 2003, J ALZHEIMERS DIS, V5, P127, DOI 10.3233/JAD-2003-5207; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002; Ma QL, 2006, J NEUROSCI RES, V83, P374, DOI 10.1002/jnr.20734; MASLIAH E, 1991, ACTA NEUROPATHOL, V83, P12, DOI 10.1007/BF00294425; MCGEER EG, 2003, BIOL PSYCHIAT, V27, P741; Mckee AC, 2008, BRAIN RES, V1207, P225, DOI 10.1016/j.brainres.2008.01.095; Moussa CEH, 2009, J MOL NEUROSCI, V37, P25, DOI 10.1007/s12031-008-9099-x; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Octave J N, 2005, Bull Mem Acad R Med Belg, V160, P445; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; ROGERS J, 1988, NEUROBIOL AGING, V9, P339, DOI 10.1016/S0197-4580(88)80079-4; Rogers J, 1996, NEUROBIOL AGING, V17, P681, DOI 10.1016/0197-4580(96)00115-7; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SELKOE DJ, 1989, CELL, V58, P611, DOI 10.1016/0092-8674(89)90093-7; Sheng JG, 1998, J NEUROPATH EXP NEUR, V57, P714, DOI 10.1097/00005072-199807000-00008; Sheng JG, 1998, J NEUROPATH EXP NEUR, V57, P323, DOI 10.1097/00005072-199804000-00003; Takashima A, 2006, J ALZHEIMERS DIS, V9, P309; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; Trojanowski JQ, 2000, ANN NY ACAD SCI, V924, P62; Utreras E, 2009, NEUROSCIENCE, V161, P978, DOI 10.1016/j.neuroscience.2009.04.002; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	50	45	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7440	7446		10.1074/jbc.M109.083915	http://dx.doi.org/10.1074/jbc.M109.083915			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20071340	Green Published, hybrid			2022-12-27	WOS:000275415600056
J	Sugiura, Y; Araki, K; Iemura, S; Natsume, T; Hoseki, J; Nagata, K				Sugiura, Yoshimi; Araki, Kazutaka; Iemura, Shun-ichiro; Natsume, Tohru; Hoseki, Jun; Nagata, Kazuhiro			Novel Thioredoxin-related Transmembrane Protein TMX4 Has Reductase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; MISFOLDED PROTEINS; LIVING CELLS; BINDING SITE; REDOX STATE; IN-VIVO; ISOMERASE; ERP57	In the endoplasmic reticulum (ER), a number of thioredoxin (Trx) superfamily proteins are present to enable correct disulfide bond formation of secretory and membrane proteins via Trx-like domains. Here, we identified a novel transmembrane Trx-like protein 4 (TMX4), in the ER of mammalian cells. TMX4, a type I transmembrane protein, was localized to the ER and possessed a Trx-like domain that faced the ER lumen. A maleimide alkylation assay showed that a catalytic CXXC motif in the TMX4 Trx-like domain underwent changes in its redox state depending on cellular redox conditions, and, in the normal state, most of the endogenous TMX4 existed in the oxidized form. Using a purified recombinant protein containing the Trx-like domain of TMX4 (TMX4-Trx), we confirmed that this domain had reductase activity in vitro. The redox potential of this domain (-171.5 mV; 30 degrees C at pH 7.0) indicated that TMX4 could work as a reductase in the environment of the ER. TMX4 had no effect on the acceleration of ER-associated degradation. Because TMX4 interacted with calnexin and ERp57 by co-immunoprecipitation assay, the role of TMX4 may be to enable protein folding in cooperation with these proteins consisting of folding complex in the ER.	Kyoto Univ, Dept Mol & Cellular Biol, Inst Frontier Med Sci, Kyoto 6068507, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan	Kyoto University; National Institute of Advanced Industrial Science & Technology (AIST)	Nagata, K (corresponding author), 53 Kawahara Cho,Sakyo Ku, Kyoto 6068507, Japan.	nagata@frontier.kyoto-u.ac.jp	Araki, Kazutaka/L-6296-2018; Hoseki, Jun/AAE-6704-2020; Natsume, Tohru/M-7627-2018	Araki, Kazutaka/0000-0003-2901-2454; Natsume, Tohru/0000-0002-1510-2582	Uehara Memorial Foundation [19G50314, 19058008]; Takeda Foundation; New Energy and Industrial Technology Development Organization; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [19GS0314] Funding Source: KAKEN	Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Creative Scientific Research 19G50314 and Scientific Research 19058008 (to K. N.), by the Uehara Memorial Foundation and the Takeda Foundation (to J. H.), by the New Energy and Industrial Technology Development Organization (to T. N.), and by a fellowship from the Japan Society for the Promotion of Science (to K. A.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Haugstetter J, 2007, J BIOL CHEM, V282, P33859, DOI 10.1074/jbc.M706442200; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hosokawa N, 2006, GENES CELLS, V11, P465, DOI 10.1111/j.1365-2443.2006.00957.x; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409; Jessop CE, 2007, EMBO J, V26, P28, DOI 10.1038/sj.emboj.7601505; Jessop CE, 2009, J BIOL CHEM, V284, P2194, DOI 10.1074/jbc.M808054200; Jessop CE, 2004, J BIOL CHEM, V279, P55341, DOI 10.1074/jbc.M411409200; Kang SJ, 2002, J BIOL CHEM, V277, P44838, DOI 10.1074/jbc.M207831200; KISHIGAMI S, 1995, FEBS LETT, V364, P55, DOI 10.1016/0014-5793(95)00354-C; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; LAMBERT N, 1985, BIOCHEM J, V228, P635, DOI 10.1042/bj2280635; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Matsuo Y, 2004, ARCH BIOCHEM BIOPHYS, V423, P81, DOI 10.1016/j.abb.2003.11.003; Matsuo Y, 2001, J BIOL CHEM, V276, P10032, DOI 10.1074/jbc.M011037200; Matsuo Y, 2009, MOL BIOL CELL, V20, P4552, DOI 10.1091/mbc.E09-05-0439; Meng XF, 2003, BIOCHEM GENET, V41, P99, DOI 10.1023/A:1022073917044; Mezghrani A, 2001, EMBO J, V20, P6288, DOI 10.1093/emboj/20.22.6288; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Wu HH, 2000, BIOCHEM J, V351, P87, DOI 10.1042/0264-6021:3510087; Yamamoto K, 2004, J BIOCHEM, V136, P343, DOI 10.1093/jb/mvh122; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang YN, 2006, J BIOL CHEM, V281, P14622, DOI 10.1074/jbc.M512073200	39	29	30	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 5	2010	285	10					7135	7142		10.1074/jbc.M109.082545	http://dx.doi.org/10.1074/jbc.M109.082545			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	567AV	20056998	hybrid, Green Published			2022-12-27	WOS:000275415600027
J	Huang, HR; Xie, CQ; Sun, X; Ritchie, RP; Zhang, JF; Chen, YE				Huang, Huarong; Xie, Changqing; Sun, Xuan; Ritchie, Raquel P.; Zhang, Jifeng; Chen, Y. Eugene			miR-10a Contributes to Retinoid Acid-induced Smooth Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; NF-KAPPA-B; SERUM RESPONSE FACTOR; NEOINTIMAL LESION FORMATION; HISTONE DEACETYLASES; GENE-EXPRESSION; MYELOID-LEUKEMIA; DOWN-REGULATION; MICRORNA; GROWTH	MicroRNAs (miRs) have been reported to play a critical role in muscle differentiation and function. The purpose of this study is to determine the role of miRs during smooth muscle cell (SMC) differentiation from embryonic stem cells (ESCs). MicroRNA profiling showed that miR-10a expression is steadily increased during in vitro differentiation of mouse ESCs into SMCs. Loss-of-function approaches using miR-10a inhibitors uncovered that miR-10a is a critical mediator for SMC lineage determination in our retinoic acid-induced ESC/SMC differentiation system. In addition, we have documented for the first time that histone deacetylase 4 is a novel target of miR-10a and mediates miR-10a function during ESC/SMC differentiation. To determine the molecular mechanism through which retinoic acid induced miR-10a expression, a consensus NF-kappa B element was identified in the miR-10a gene promoter by bioinformatics analysis, and chromatin immunoprecipitation assay confirmed that NF-kappa B could bind to this element. Finally, inhibition of NF-kappa B nuclear translocation repressed miR-10a expression and decreased SMC differentiation from ESCs. Our data demonstrate for the first time that miR-10a is a novel regulator in SMC differentiation from ESCs. These studies suggest that miR-10a may play important roles in vascular biology and have implications for the diagnosis and treatment of vascular diseases.	[Huang, Huarong; Xie, Changqing; Sun, Xuan; Ritchie, Raquel P.; Zhang, Jifeng; Chen, Y. Eugene] Univ Michigan, Ctr Cardiovasc, Dept Internal Med, Med Ctr, Ann Arbor, MI 48109 USA; [Sun, Xuan] Cent S Univ, Inst Reprod & Stem Cell Engn, Changsha 410078, Hunan, Peoples R China	University of Michigan System; University of Michigan; Central South University	Chen, YE (corresponding author), 1150 W Med Ctr Dr,MSRB 3,7301E, Ann Arbor, MI 48109 USA.	echenum@umich.edu		Striepen, Boris/0000-0002-7426-432X	National Institutes of Health [HL092421, HL068878, HL89544]; American Heart Association [0825837G, 09SDG2260023, 0835237N, 0840025N]; American Heart Association National Scientific Development [09SDG2260023, 0835237N, 0840025N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089544, R21HL092421, R01HL068878] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); American Heart Association National Scientific Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092421, HL068878, and HL89544 (to Y.E.C.).; Supported by American Heart Association Postdoctoral Fellowship 0825837G.; Supported by American Heart Association National Scientific Development Grant 09SDG2260023.; Supported by a National Institutes of Health Research Supplement to Promote Diversity.; Supported by American Heart Association National Scientific Development Grant 0835237N.; An American Heart Association established investigator (Grant 0840025N).	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Bai G, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-15; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Cao DS, 2005, MOL CELL BIOL, V25, P364, DOI 10.1128/MCB.25.1.364-376.2005; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Davis FJ, 2003, J BIOL CHEM, V278, P20047, DOI 10.1074/jbc.M209998200; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Drab M, 1997, FASEB J, V11, P905, DOI 10.1096/fasebj.11.11.9285489; Garzon R, 2008, BLOOD, V111, P3183, DOI 10.1182/blood-2007-07-098749; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hirschi KK, 2002, J BIOL CHEM, V277, P6287, DOI 10.1074/jbc.M106649200; Huang HR, 2006, BIOCHEM BIOPH RES CO, V351, P321, DOI 10.1016/j.bbrc.2006.09.171; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Levenberg S, 2002, P NATL ACAD SCI USA, V99, P4391, DOI 10.1073/pnas.032074999; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu XJ, 2009, CIRC RES, V104, P476, DOI 10.1161/CIRCRESAHA.108.185363; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; McDonald OG, 2007, CIRC RES, V100, P1428, DOI 10.1161/01.RES.0000266448.30370.a0; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NARAYANAN R, 1993, MOL CELL BIOL, V13, P3802, DOI 10.1128/MCB.13.6.3802; Neppl RL, 2009, CELL STEM CELL, V5, P130, DOI 10.1016/j.stem.2009.07.004; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Qiu P, 2002, CIRC RES, V90, P858, DOI 10.1161/01.RES.0000016504.08608.B9; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Sinha Sanjay, 2009, V482, P345, DOI 10.1007/978-1-59745-060-7_22; Torres J, 2008, NAT CELL BIOL, V10, P194, DOI 10.1038/ncb1680; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Varnholt H, 2008, HEPATOLOGY, V47, P1223, DOI 10.1002/hep.22158; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Walsh K, 2001, Z Kardiol, V90 Suppl 3, P12; Widera D, 2006, INT J DEV NEUROSCI, V24, P91, DOI 10.1016/j.ijdevneu.2005.11.017; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Xiao QZ, 2007, AM J PHYSIOL-CELL PH, V292, pC342, DOI 10.1152/ajpcell.00341.2006; Xie CQ, 2007, ARTERIOSCL THROM VAS, V27, pE311, DOI 10.1161/ATVBAHA.107.154260; Xie CQ, 2009, STEM CELLS DEV, V18, P741, DOI 10.1089/scd.2008.0179; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhou XB, 2000, P NATL ACAD SCI USA, V97, P1056, DOI 10.1073/pnas.97.3.1056	55	118	122	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 26	2010	285	13					9383	9389		10.1074/jbc.M109.095612	http://dx.doi.org/10.1074/jbc.M109.095612			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	576RP	20118242	Green Published, hybrid			2022-12-27	WOS:000276165900010
